data_5uk6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5uk6 _Structure_validation_residue.Date_analyzed 2017-05-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.903 0.382 . . . . 99.99 111.012 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.3 mm? -76.47 -51.91 10.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 99.99 110.602 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -70.95 -24.34 62.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 99.99 110.478 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.433 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.0 t-105 -64.9 -53.07 52.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 99.99 110.685 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.1 mt -66.33 -22.55 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 99.99 110.267 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -55.32 36.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 99.99 110.756 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 52' ' ' MET . 10.0 p -66.87 -30.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.274 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.43 80.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 99.99 111.229 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.503 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -72.4 -24.4 76.36 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.853 -0.689 . . . . 99.99 112.626 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.48 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -74.53 -41.75 60.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 99.99 111.497 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -61.83 -48.19 81.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 99.99 111.187 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 14' ' ' GLY . 2.7 pp -67.03 -22.59 29.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.964 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.49 -58.62 12.36 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.872 -0.68 . . . . 99.99 112.492 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.21 73.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.072 0.463 . . . . 99.99 110.931 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.4 tp -64.48 -33.93 77.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.956 -0.566 . . . . 99.99 110.62 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.61 -28.08 66.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.948 -0.569 . . . . 99.99 110.42 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -78.2 -29.31 48.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 99.99 110.671 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -63.84 -36.06 82.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.524 . . . . 99.99 110.818 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -84.68 -42.31 15.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.906 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.8 tp -73.22 -3.4 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.89 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 p -64.38 -24.77 67.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.528 -0.306 . . . . 99.99 111.334 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -51.09 -31.95 20.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.128 0.489 . . . . 99.99 109.784 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p30 -167.88 132.45 1.5 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.454 -0.793 . . . . 99.99 110.147 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 28.3 Cg_endo -94.78 173.71 1.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.05 2.5 . . . . 1.91 112.277 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.11 56.4 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.082 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.75 -45.87 3.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 99.99 112.747 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.3 127.07 80.09 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 120.539 0.209 . . . . 99.99 110.942 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 31.7 Cg_exo -57.74 165.18 6.67 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.412 2.075 . . . . 1.79 112.374 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.426 HE22 ' HB2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -61.59 -18.21 58.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.747 -0.66 . . . . 99.99 112.579 -178.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 4.8 p90 -47.97 -42.23 27.15 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.688 0.28 . . . . 99.99 111.652 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -68.04 -46.56 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.356 . . . . 99.99 110.886 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.12 -23.03 66.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.833 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.99 -61.23 2.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.659 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 43' ' ' ILE . 93.6 t -62.67 -33.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.224 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.31 -4.78 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 99.99 111.105 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.535 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 28.4 ttt -89.38 -39.94 13.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.055 0.455 . . . . 99.99 111.018 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -73.09 -39.33 65.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 99.99 111.883 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.64 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 91.4 mt -50.69 -51.59 64.32 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.241 0.46 . . . . 99.99 112.241 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 16.6 Cg_exo -68.65 -41.45 6.04 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.494 2.129 . . . . 0.53 113.275 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mm -55.06 -63.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.207 0.447 . . . . 99.99 112.207 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.53 -58.39 7.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 99.99 111.484 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.408 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 90.4 p -52.28 -35.97 51.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.244 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.74 16.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.885 -0.674 . . . . 99.99 112.661 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.56 -35.48 68.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 99.99 110.893 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.8 79.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.397 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -66.01 -59.68 3.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.447 -0.342 . . . . 99.99 111.564 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.63 ' HB3' HG11 ' A' ' 12' ' ' VAL . 24.0 ptm -49.01 -31.08 6.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.01 0.433 . . . . 99.99 110.6 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.84 91.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 99.99 110.831 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.9 mtt -56.36 -31.39 63.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.073 -0.512 . . . . 99.99 110.505 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.86 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 99.99 110.526 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.419 HG13 ' CB ' ' A' ' 58' ' ' GLN . 41.4 pt -78.5 3.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 99.99 110.963 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.48 30.14 19.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 99.99 111.46 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.606 HE21 ' H ' ' B' ' 123' ' ' GLU . 6.4 tp-100 -92.23 142.27 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 99.99 110.767 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.34 17.22 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 99.99 112.346 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -127.23 139.67 52.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 99.99 110.819 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.85 141.0 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.727 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.87 95.1 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 99.99 111.25 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.1 115.81 27.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 99.99 110.79 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 30.52 19.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.121 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.33 -2.01 83.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.847 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -105.82 128.95 54.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 99.99 110.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.38 127.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 99.99 111.007 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 139.89 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.069 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 56.5 m-70 -81.29 64.94 6.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.213 0.53 . . . . 99.99 110.758 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.89 -50.84 67.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.753 . . . . 99.99 111.443 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -25.31 67.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.844 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 34.8 mmt180 -67.52 -52.48 38.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.713 0.635 . . . . 99.99 112.713 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.497 ' O ' ' HG3' ' A' ' 77' ' ' MET . 6.3 p90 -75.93 -36.17 59.48 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.27 0.47 . . . . 99.99 112.27 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.0 tt -52.93 -46.54 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.775 -0.37 . . . . 99.99 110.902 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.6 t70 -67.45 -22.03 65.52 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.606 -0.516 . . . . 99.99 109.606 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -87.87 5.55 39.84 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.527 -0.76 . . . . 99.99 111.522 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 34.4 mtp -104.55 -19.15 14.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 99.99 110.516 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 1.4 p -114.64 -43.8 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 99.99 111.972 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.575 HG23 HG23 ' A' ' 43' ' ' ILE . 66.8 m -66.31 -56.09 12.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.409 . . . . 99.99 111.961 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.481 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 67.9 m -50.77 -53.93 41.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.569 0.581 . . . . 99.99 112.569 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 80' ' ' THR . 13.2 Cg_endo -56.28 -38.84 94.39 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.633 1.555 . . . . 0.74 111.195 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.406 HD13 HD12 ' A' ' 85' ' ' LEU . 2.2 mm? -67.42 -30.48 70.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.942 -0.572 . . . . 99.99 109.761 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.79 -21.79 61.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.275 -0.639 . . . . 99.99 109.275 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.433 HD22 HE22 ' A' ' 109' ' ' GLN . 20.0 tp -84.58 -31.38 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.034 -0.985 . . . . 99.99 110.292 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.406 HD12 HD13 ' A' ' 82' ' ' LEU . 87.6 mt -73.52 -32.97 64.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.757 -0.656 . . . . 99.99 111.032 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.406 ' HB3' HG11 ' A' ' 39' ' ' VAL . 88.1 p -58.17 -29.02 65.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.758 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.987 -0.551 . . . . 99.99 110.718 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -60.91 -41.86 96.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.951 -0.568 . . . . 99.99 110.955 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.84 -29.75 63.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 99.99 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.5 m -59.7 -43.39 94.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.351 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.92 -36.82 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.435 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 82.0 mtp -88.48 98.87 11.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.396 . . . . 99.99 111.124 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -82.62 -5.05 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.585 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -163.79 157.29 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.843 -0.617 . . . . 99.99 110.705 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tp -128.99 142.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.98 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.53 -30.74 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.941 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.48 138.33 39.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.151 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.6 115.81 4.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.869 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.95 149.45 21.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.1 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.2 p -94.82 -20.94 19.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 99.99 110.985 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.0 tp -54.56 -40.73 69.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 99.99 111.155 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.85 -38.19 78.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.052 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.63 -28.05 73.23 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 99.99 112.127 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -72.13 -37.07 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.921 0.391 . . . . 99.99 110.951 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.16 -36.63 61.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 99.99 111.496 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 81.0 mtp -68.31 -47.61 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.449 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.576 ' HG ' ' H ' ' A' ' 108' ' ' THR . 72.8 p -60.89 -53.64 54.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 99.99 111.45 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.576 ' H ' ' HG ' ' A' ' 107' ' ' SER . 15.3 t -56.66 -31.88 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.498 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.433 HE22 HD22 ' A' ' 84' ' ' LEU . 6.5 tp-100 -66.64 -40.18 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 99.99 110.992 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HA ' HG12 ' A' ' 113' ' ' ILE . 77.2 mt -60.16 -35.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 99.99 111.096 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -67.93 -36.96 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.359 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.78 -51.1 48.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 99.99 111.484 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 110' ' ' ILE . 41.3 pt -59.96 -24.04 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 99.99 110.822 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.518 ' HG1' ' HZ3' ' C' ' 46' ' ' TRP . 17.6 m -67.44 -43.16 81.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.465 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -68.15 -21.03 64.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.872 -0.604 . . . . 99.99 110.461 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.68 -34.03 26.07 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.043 -0.599 . . . . 99.99 113.313 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 118' ' ' ILE . 4.1 pp -79.1 -26.89 42.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 99.99 111.288 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 tp -83.93 -29.51 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.711 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.08 75.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.423 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.65 -19.3 52.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 99.99 111.066 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -90.5 28.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.42 . . . . 99.99 111.25 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -61.66 126.28 26.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 99.99 110.907 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.62 -29.7 23.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.305 -0.407 . . . . 99.99 111.075 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.408 ' H ' ' CG2' ' A' ' 127' ' ' VAL . 79.0 mtm180 -137.29 167.1 22.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.716 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.94 -13.98 59.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.793 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -90.43 -42.18 11.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.835 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.408 ' CG2' ' H ' ' A' ' 124' ' ' ARG . 18.7 m -65.34 -31.01 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.261 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -65.35 -23.68 67.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.97 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.419 ' O ' HG13 ' A' ' 133' ' ' ILE . 70.0 t80 -78.59 -25.65 45.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.009 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.46 -52.66 7.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.323 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.425 ' HZ2' ' HB2' ' C' ' 53' ' ' ALA . 9.4 m95 -60.18 -33.49 72.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.708 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.506 ' HE2' ' HB3' ' A' ' 183' ' ' TRP . 71.8 t80 -59.13 -48.51 81.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 99.99 110.926 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 129' ' ' TYR . 51.1 mt -63.6 -32.46 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 99.99 111.199 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.75 -34.64 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.364 . . . . 99.99 111.043 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.79 -52.16 44.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.749 . . . . 99.99 112.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -64.87 -42.24 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.597 0.237 . . . . 99.99 111.381 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.467 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.9 t -55.41 -40.57 71.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 99.99 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.457 ' O ' HG13 ' A' ' 142' ' ' ILE . . . -61.66 -41.86 98.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.012 -0.54 . . . . 99.99 110.731 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -63.51 -28.32 69.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 99.99 111.134 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 137' ' ' CYS . 93.9 mt -63.21 -60.79 2.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 99.99 111.221 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.6 -31.83 44.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.34 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.496 HG12 ' HG1' ' A' ' 108' ' ' THR . 79.4 mt -75.06 -29.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 99.99 111.16 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.9 tp -71.68 -44.08 64.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.811 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.538 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 16.5 t90 -67.38 -27.84 67.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 99.99 110.997 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 1.23 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -83.56 -43.16 7.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.795 -0.717 . . . . 99.99 112.627 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 tt -67.61 -16.54 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.063 0.458 . . . . 99.99 110.67 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -91.8 3.62 54.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.591 . . . . 99.99 110.646 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 1.23 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.84 -0.618 . . . . 99.99 111.844 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.935 0.398 . . . . 99.99 110.95 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.41 -24.86 63.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.872 -0.604 . . . . 99.99 111.397 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.43 -24.64 53.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 99.99 111.215 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -84.37 -39.03 19.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 99.99 111.576 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 169' ' ' VAL . 2.9 pp -77.42 -26.43 51.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.512 -0.313 . . . . 99.99 111.841 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.5 ' N ' HD12 ' A' ' 168' ' ' LEU . 13.4 p -74.9 -26.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 99.99 110.936 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.6 m -65.43 -58.61 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.387 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.16 -31.39 72.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.725 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -59.71 -48.86 79.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 99.99 111.06 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 177' ' ' ILE . 41.3 p -62.05 -37.87 86.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 99.99 111.588 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.81 -38.4 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.756 0.313 . . . . 99.99 111.503 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.533 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.0 mt -74.57 -55.1 6.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 99.99 111.395 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.48 -31.35 55.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 99.99 111.634 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.542 ' O ' HG13 ' A' ' 181' ' ' ILE . 17.6 tt -87.66 -22.41 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 99.99 110.69 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.65 -51.29 59.78 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.94 -0.573 . . . . 99.99 113.391 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 84.6 m-85 -58.17 -54.86 51.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.802 0.301 . . . . 99.99 111.737 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 76.6 Cg_exo -48.72 -30.33 16.55 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.112 1.875 . . . . 0.55 112.934 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 177' ' ' ILE . 94.3 mt -70.04 -57.46 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 99.99 111.788 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.5 m -59.14 -25.72 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.187 -0.461 . . . . 99.99 111.703 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.506 ' HB3' ' HE2' ' A' ' 132' ' ' TYR . 24.4 m95 -65.09 -25.95 68.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.505 -0.316 . . . . 99.99 111.091 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -53.03 -26.13 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 99.99 110.946 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.7 pt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.892 179.63 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.74 0.305 . . . . 99.99 110.926 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.4 -56.73 12.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.572 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 75.6 p -62.67 -18.83 63.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.891 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -83.48 -30.66 27.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.911 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.9 tp -80.84 -45.55 16.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.314 -0.403 . . . . 99.99 111.272 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -74.55 -0.7 18.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.15 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 37.8 t -96.35 -47.47 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.433 0.635 . . . . 99.99 110.31 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.16 -28.57 64.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.225 -0.898 . . . . 99.99 112.138 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.73 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 37.5 tp -67.2 -55.35 15.92 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.748 -0.381 . . . . 99.99 111.408 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.73 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.9 Cg_exo -54.86 -37.73 92.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.622 1.548 . . . . 0.64 111.207 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.47 ' O ' HG22 ' A' ' 211' ' ' VAL . 74.4 t80 -63.98 -45.76 87.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.04 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -63.55 -17.79 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 99.99 110.554 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.533 ' OG ' HD13 ' A' ' 175' ' ' LEU . 16.1 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 99.99 111.045 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 207' ' ' PHE . 18.3 m . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.736 0.303 . . . . 99.99 111.494 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.41 80.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.757 -0.735 . . . . 99.99 112.685 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -75.58 -33.18 60.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 99.99 111.223 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.3 m -60.99 -60.69 3.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.429 -0.351 . . . . 99.99 110.996 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.04 -26.9 67.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 99.99 110.951 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.94 -55.45 33.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.374 -0.375 . . . . 99.99 111.392 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.19 -34.31 71.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 99.99 111.285 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.32 -52.23 62.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.264 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -83.6 -20.72 33.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.123 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.17 -59.15 10.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.887 -0.673 . . . . 99.99 112.885 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 52.6 tp . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.596 0.236 . . . . 99.99 111.049 -179.721 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.712 0.291 . . . . 99.99 111.226 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.81 -53.61 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.782 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.624 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 77.3 m-70 -65.63 -24.26 67.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.782 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -67.18 -50.29 61.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.836 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.7 -20.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 99.99 110.331 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -61.82 -56.01 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.908 -0.587 . . . . 99.99 110.594 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -66.26 -28.45 43.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.075 -0.511 . . . . 99.99 111.26 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.08 98.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.254 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.519 ' O ' HG13 ' B' ' 17' ' ' ILE . . . -76.06 -29.27 59.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.762 -0.732 . . . . 99.99 112.59 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.48 -39.63 62.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 99.99 111.229 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . 0.41 ' HG1' ' H ' ' B' ' 17' ' ' ILE . 32.0 p -62.1 -51.12 69.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.468 -0.333 . . . . 99.99 110.833 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.519 HG13 ' O ' ' B' ' 14' ' ' GLY . 2.7 pp -64.05 -23.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.943 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.87 -56.16 24.22 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.873 -0.679 . . . . 99.99 112.667 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.87 81.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 99.99 110.932 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.04 -32.31 73.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.829 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.58 -28.21 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.46 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -81.57 -30.17 33.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.689 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.408 ' O ' ' OG ' ' B' ' 26' ' ' SER . 61.2 t-105 -60.91 -37.23 81.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.839 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.7 p -83.87 -40.54 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.892 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.74 -3.87 40.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 99.99 110.61 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 58.5 p -61.0 -23.31 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.384 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -49.8 -31.42 11.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.255 0.55 . . . . 99.99 109.841 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -173.33 132.29 0.6 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.256 -0.884 . . . . 99.99 109.992 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -94.52 174.23 1.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.691 2.261 . . . . 1.82 112.311 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.48 54.58 2.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 99.99 111.255 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.62 -35.58 2.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.872 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -79.09 130.27 70.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.603 0.239 . . . . 99.99 111.199 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.18 166.5 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.896 2.397 . . . . 2.67 113.021 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -70.55 -18.32 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.466 -0.788 . . . . 99.99 112.96 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -62.24 -24.47 67.27 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.373 -0.531 . . . . 99.99 111.367 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.9 -55.95 8.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.339 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -67.31 -21.57 65.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.739 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 64.0 tp -59.49 -63.52 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.717 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.14 -35.57 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.378 . . . . 99.99 110.63 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.8 -5.48 41.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 99.99 111.091 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.423 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 53.5 ttp -88.94 -40.92 12.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.422 . . . . 99.99 110.711 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -69.95 -32.76 71.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.651 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 79' ' ' THR . 87.2 mt -55.58 -54.2 53.97 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.234 0.457 . . . . 99.99 112.234 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.8 Cg_endo -70.14 -31.46 18.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.182 1.921 . . . . 0.49 113.342 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.32 -62.37 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.615 0.245 . . . . 99.99 111.599 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.81 -58.28 9.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 99.99 111.164 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -54.71 -31.26 57.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.025 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.8 -60.51 8.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 99.99 112.881 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 42.5 mt -60.14 -28.59 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 99.99 111.252 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -49.69 65.7 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.452 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 20.4 m-85 -63.61 -46.29 86.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.156 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' MET . . . . . 0.511 ' HB2' HG11 ' B' ' 12' ' ' VAL . 59.7 ttp -48.04 -38.69 17.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.157 0.503 . . . . 99.99 110.374 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.445 ' HB2' ' HZ2' ' C' ' 131' ' ' TRP . . . -64.21 -41.93 96.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 99.99 110.92 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 51.2 mtt -52.89 -30.96 37.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.88 -0.6 . . . . 99.99 110.553 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -70.04 -47.4 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 99.99 110.602 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mt -76.8 -1.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.797 -0.638 . . . . 99.99 111.004 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.97 52.14 2.14 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.919 -0.582 . . . . 99.99 111.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -115.69 169.32 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.965 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.64 9.99 79.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.814 -0.708 . . . . 99.99 112.493 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -117.77 141.8 48.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 99.99 110.93 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.62 138.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 99.99 111.044 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.32 94.61 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.115 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.54 115.84 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.048 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.59 31.45 20.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 99.99 111.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.19 84.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.522 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -115.03 124.48 51.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 99.99 110.845 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.74 136.28 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.65 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.47 140.58 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.96 0.41 . . . . 99.99 111.109 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.468 ' H ' ' HD2' ' B' ' 120' ' ' ASP . 50.9 m-70 -84.16 55.89 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.649 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -58.52 -58.11 10.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.603 -0.726 . . . . 99.99 111.679 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.55 -22.31 66.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.974 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.443 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 14.0 tpp180 -63.52 -51.48 65.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.023 0.379 . . . . 99.99 112.023 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 12.9 p90 -77.4 -29.07 52.94 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.87 -0.332 . . . . 99.99 111.279 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 mm -51.36 -53.21 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.806 0.336 . . . . 99.99 110.682 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.49 -21.49 66.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.082 -0.508 . . . . 99.99 109.982 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -86.98 -0.14 56.11 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.958 -0.565 . . . . 99.99 111.371 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 55.3 ttm -103.63 -18.64 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.512 . . . . 99.99 110.989 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.407 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.2 m -114.09 -31.01 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.085 0.402 . . . . 99.99 112.085 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.574 HG23 HG23 ' B' ' 43' ' ' ILE . 48.0 m -80.82 -50.57 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.844 0.313 . . . . 99.99 111.844 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.541 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 28.8 m -53.95 -51.53 76.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.257 0.466 . . . . 99.99 112.257 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.3 Cg_endo -56.85 -33.18 94.14 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.733 1.622 . . . . 0.66 111.333 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.407 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.6 mm? -75.96 -29.96 58.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.963 -0.562 . . . . 99.99 110.132 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 15.5 tp -70.23 -21.48 63.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.315 0.579 . . . . 99.99 109.527 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' B' ' 105' ' ' LEU . 2.3 tp -84.86 -44.01 13.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.217 -0.901 . . . . 99.99 110.394 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.66 -35.49 72.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.43 -0.805 . . . . 99.99 111.074 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 97.9 p -57.49 -32.6 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 99.99 110.898 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.446 HD22 HD21 ' B' ' 168' ' ' LEU . 62.3 mt -64.37 -36.79 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 99.99 110.925 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -65.11 -34.95 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.986 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -73.74 -38.6 64.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.126 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 82.2 p -69.26 -23.32 63.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 99.99 111.384 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.57 -13.59 21.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 99.99 111.147 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 44.7 tpp -127.2 106.36 9.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 99.99 110.778 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -67.62 -59.46 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.954 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -128.37 137.67 52.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.914 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.27 142.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.171 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -129.77 -23.31 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.431 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -142.36 141.46 32.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.688 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.04 119.1 12.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.047 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -84.7 162.72 19.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.48 . . . . 99.99 111.002 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 78.9 p -108.61 -22.23 12.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.019 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.76 -29.14 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 99.99 110.698 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.7 pt -64.15 -28.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.864 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.45 -39.34 22.43 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.813 -0.708 . . . . 99.99 112.547 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -67.75 -22.87 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 99.99 110.705 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.63 ' HB3' HD21 ' B' ' 84' ' ' LEU . 77.2 mt -81.91 -46.22 14.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 53.5 ttp -67.09 -30.31 70.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.91 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 64.0 m -73.63 -52.89 11.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.435 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.577 ' HG1' HG12 ' B' ' 142' ' ' ILE . 15.1 t -56.8 -28.24 61.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.443 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.628 ' HG3' HD22 ' B' ' 84' ' ' LEU . 26.3 mm-40 -69.81 -44.11 70.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.753 0.311 . . . . 99.99 110.56 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 46.2 mm -54.64 -32.69 25.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.989 0.423 . . . . 99.99 110.459 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.03 -42.38 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.835 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.76 -46.66 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.266 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' B' ' 77' ' ' MET . 37.4 mm -60.91 -33.24 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.088 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.469 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 25.0 m -60.19 -45.43 93.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 99.99 111.044 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 76.5 p -68.63 -20.77 64.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.512 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.07 -35.94 26.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.0 -0.619 . . . . 99.99 113.264 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.534 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.6 pp -76.82 -29.37 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.74 0.305 . . . . 99.99 111.409 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.534 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.85 -27.13 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 99.99 111.565 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.88 -39.71 68.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.27 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . 0.468 ' HD2' ' H ' ' B' ' 69' ' ' HIS . 8.5 t70 -82.41 -25.39 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.148 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -86.26 34.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 99.99 111.157 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 71.4 p -65.99 125.26 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 99.99 110.863 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.606 ' H ' HE21 ' A' ' 58' ' ' GLN . 23.3 mm-40 -89.02 -22.63 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.036 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' B' ' 127' ' ' VAL . 99.8 mtt180 -137.6 160.21 39.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 99.99 110.772 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.9 -15.65 60.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.121 -0.491 . . . . 99.99 110.652 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -92.7 -41.55 10.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 99.99 111.024 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' B' ' 124' ' ' ARG . 18.6 m -64.0 -24.63 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 99.99 111.112 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.92 -42.27 85.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.66 -30.85 71.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.975 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 59.7 tp -74.84 -53.63 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 99.99 111.285 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -61.15 -24.77 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.305 . . . . 99.99 111.362 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -67.52 -58.79 4.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.476 -0.329 . . . . 99.99 111.402 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.3 -22.55 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.472 -0.331 . . . . 99.99 111.317 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.36 -36.42 68.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.728 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.91 -51.28 47.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.09 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.09 -43.2 98.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 99.99 110.923 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.4 -40.49 74.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.167 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . 0.526 ' O ' HG13 ' B' ' 142' ' ' ILE . . . -62.49 -35.64 79.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 99.99 110.395 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -71.54 -24.02 61.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 99.99 110.669 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.84 -57.64 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.953 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 37.2 pt -59.2 -35.29 56.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.335 -0.393 . . . . 99.99 111.282 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.577 HG12 ' HG1' ' B' ' 108' ' ' THR . 65.4 mt -72.96 -26.49 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 99.99 110.688 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.68 -39.58 73.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 99.99 110.965 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -73.74 -30.73 62.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 99.99 111.084 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.38 -33.96 24.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.776 -0.726 . . . . 99.99 112.635 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 tt -73.91 -21.36 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 99.99 110.471 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -90.78 4.15 52.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 99.99 111.006 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 99.99 111.945 -179.597 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 C--O 1.233 0.186 0 CA-C-O 121.017 0.437 . . . . 99.99 110.813 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . 0.421 ' O ' HG23 ' B' ' 169' ' ' VAL . 2.3 t80 -75.21 -23.04 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.909 -0.587 . . . . 99.99 111.314 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.26 -54.64 22.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.92 0.39 . . . . 99.99 110.894 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.99 -30.51 71.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 99.99 111.112 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . 0.446 HD21 HD22 ' B' ' 87' ' ' LEU . 54.4 tp -68.76 -54.91 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 99.99 111.313 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 165' ' ' TYR . 91.9 t -61.96 -29.86 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.536 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.8 m -53.48 -58.99 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 99.99 111.538 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.64 -29.02 65.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.347 -0.388 . . . . 99.99 110.665 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.44 -34.32 77.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 99.99 111.319 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.401 ' O ' HG22 ' B' ' 177' ' ' ILE . 41.3 p -76.23 -38.99 55.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.372 -0.376 . . . . 99.99 111.512 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.96 -34.44 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.819 0.342 . . . . 99.99 111.041 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' B' ' 209' ' ' SER . 53.4 tp -77.87 -55.68 5.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.024 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -30.71 43.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 99.99 111.006 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.53 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.3 tp -87.82 -23.38 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.002 0.429 . . . . 99.99 110.417 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.17 -55.29 29.0 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.667 -0.697 . . . . 99.99 113.311 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.635 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 92.6 m-85 -56.19 -55.75 38.62 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.896 0.348 . . . . 99.99 111.296 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -46.87 -27.77 6.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.172 1.915 . . . . 0.64 112.826 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.53 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -74.24 -58.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 99.99 111.715 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 179' ' ' TYR . 26.0 m -58.67 -24.69 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 99.99 111.67 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -63.91 -26.99 68.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.55 -0.296 . . . . 99.99 111.246 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 85.5 mt -52.1 -29.52 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.558 -0.292 . . . . 99.99 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 43.4 pt -126.72 155.61 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 99.99 111.191 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 C-N-CA 120.917 -0.659 . . . . 99.99 112.667 179.79 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.774 0.321 . . . . 99.99 111.019 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.15 -56.85 14.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.85 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 44.6 p -68.96 -20.02 64.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 99.99 111.301 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.29 -32.93 55.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.333 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.46 -43.53 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.355 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.66 -9.33 56.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 99.99 111.845 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 19.3 p -96.6 -38.03 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 99.99 110.597 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 56.1 tp -72.38 -31.69 65.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.692 -0.685 . . . . 99.99 112.073 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.709 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.8 tp -65.7 -53.91 33.05 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.951 -0.299 . . . . 99.99 111.266 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.8 Cg_exo -54.91 -42.49 68.47 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.785 1.657 . . . . 0.6 111.864 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.83 -38.11 89.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 99.99 110.684 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.24 -24.36 65.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 99.99 110.682 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.546 ' HB2' HD22 ' B' ' 175' ' ' LEU . 86.1 p . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 99.99 111.252 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.634 0.254 . . . . 99.99 111.57 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.7 -29.19 74.57 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.79 -0.719 . . . . 99.99 112.885 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -74.01 -39.08 63.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.621 0.248 . . . . 99.99 111.358 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' B' ' 218' ' ' LEU . 49.8 m -58.41 -57.65 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.462 -0.335 . . . . 99.99 111.038 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' B' ' 218' ' ' LEU . 85.6 t80 -63.29 -23.43 67.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 99.99 111.094 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -64.2 -56.87 11.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.495 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.74 -33.88 70.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 99.99 111.637 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' B' ' 215' ' ' PHE . 87.1 mt -55.29 -50.49 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 99.99 111.063 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.66 -20.53 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 99.99 110.908 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.59 -55.03 25.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.853 -0.689 . . . . 99.99 113.084 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 C--N 1.326 -0.44 0 CA-C-O 120.704 0.288 . . . . 99.99 111.432 -179.382 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.949 0.404 . . . . 99.99 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . 0.425 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.3 mm? -70.34 -45.38 66.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.929 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 64.2 m-70 -71.83 -24.35 61.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.7 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.452 ' O ' HG12 ' C' ' 12' ' ' VAL . 61.9 t-105 -66.91 -53.72 29.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.564 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -64.9 -21.8 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.99 0.424 . . . . 99.99 110.291 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -59.51 5.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.601 -0.727 . . . . 99.99 110.5 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' C' ' 52' ' ' MET . 8.4 p -61.59 -30.86 49.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.013 -0.54 . . . . 99.99 110.967 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.06 78.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.62 -23.77 77.61 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.688 -0.767 . . . . 99.99 112.834 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.6 mmt -77.52 -45.2 26.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 99.99 111.33 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.9 p -59.29 -50.03 75.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.354 -0.384 . . . . 99.99 110.997 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -30.88 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 99.99 110.666 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.72 -60.22 9.39 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.877 -0.677 . . . . 99.99 112.589 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -30.86 63.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.812 0.339 . . . . 99.99 111.007 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.67 -33.14 70.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.648 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -60.71 -31.21 70.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 99.99 110.52 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -74.45 -29.93 61.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.793 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -62.82 -39.02 93.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.761 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -84.47 -39.09 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 99.99 110.865 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 tp -74.54 -9.21 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.72 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 53.9 p -58.16 -24.92 60.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 99.99 111.309 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -48.14 -33.53 8.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.204 0.526 . . . . 99.99 109.794 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.7 p-10 -171.08 132.46 0.86 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.276 -0.874 . . . . 99.99 109.794 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 19.5 Cg_endo . . . . . 0 N--CA 1.453 -0.876 0 C-N-CA 122.732 2.288 . . . . 2.05 112.214 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 19.2 Cg_exo . . . . . 0 N--CA 1.466 -0.121 0 CA-C-O 121.261 0.442 . . . . 1.93 112.197 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.7 -18.67 64.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 99.99 112.965 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.489 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -55.13 -36.74 66.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.969 0.414 . . . . 99.99 110.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . 0.504 ' HE2' HG22 ' C' ' 90' ' ' THR . 10.3 tp10 -64.73 -48.93 72.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 99.99 110.734 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.06 -19.05 62.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.695 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.88 -63.42 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.435 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.425 ' O ' HG13 ' C' ' 43' ' ' ILE . 3.5 m -63.33 -32.09 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.836 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.67 -6.32 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.432 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 53.7 ttp -89.83 -43.46 10.62 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.978 -0.556 . . . . 99.99 111.392 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -73.07 -39.51 65.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.142 0.423 . . . . 99.99 112.142 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.564 HG23 HG23 ' C' ' 79' ' ' THR . 96.6 mt -50.64 -50.6 71.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.255 0.465 . . . . 99.99 112.255 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.6 -36.14 6.97 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.113 1.875 . . . . 0.41 113.142 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 28.9 mm -57.41 -62.74 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.821 0.343 . . . . 99.99 111.469 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.518 ' HZ3' ' HG1' ' A' ' 114' ' ' THR . 3.2 t-105 -56.56 -57.12 13.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 99.99 111.241 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 47.1 m -51.96 -36.45 49.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 99.99 111.134 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.71 -53.02 38.34 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 99.99 112.486 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' C' ' 52' ' ' MET . 4.2 mm? -59.67 -35.92 75.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.414 . . . . 99.99 111.002 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -34.15 75.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 99.99 111.444 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.3 m-85 -70.6 -57.58 4.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 99.99 111.542 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' MET . . . . . 0.586 ' HB3' HG11 ' C' ' 12' ' ' VAL . 5.0 ppp? -48.74 -30.72 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.89 0.376 . . . . 99.99 110.707 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.425 ' HB2' ' HZ2' ' A' ' 131' ' ' TRP . . . -66.63 -44.9 80.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 99.99 110.826 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 58.0 mtt -54.54 -30.8 54.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.546 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.59 -50.62 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.133 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.37 5.94 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 99.99 111.186 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.3 54.94 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 99.99 111.106 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -123.69 139.64 53.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 99.99 111.028 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.63 -7.66 29.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.804 -0.713 . . . . 99.99 112.664 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -103.04 166.14 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.712 0.291 . . . . 99.99 110.944 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.73 145.91 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.998 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -93.51 95.11 9.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.953 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.42 107.37 19.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.136 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 33.24 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.389 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.65 2.1 88.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 99.99 112.606 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -102.44 152.23 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 99.99 110.942 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 33.2 mt -105.54 114.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.833 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.12 142.42 27.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.547 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.475 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 47.6 m-70 -84.24 58.81 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.884 -0.598 . . . . 99.99 110.478 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.69 -58.53 8.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.535 -0.757 . . . . 99.99 111.938 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.85 67.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.204 0.446 . . . . 99.99 112.204 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.475 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 17.7 tpp180 -61.64 -51.63 67.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.919 0.34 . . . . 99.99 111.919 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.43 ' O ' ' HG3' ' C' ' 77' ' ' MET . 14.0 p90 -78.13 -28.42 48.45 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.844 -0.342 . . . . 99.99 111.039 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 16.4 mm -47.31 -56.74 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 120.744 0.307 . . . . 99.99 110.907 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.35 -28.78 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.129 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -81.4 8.02 10.31 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.085 -0.507 . . . . 99.99 111.172 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.471 ' HA ' HG21 ' C' ' 113' ' ' ILE . 18.9 mtp -104.52 -25.22 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 99.99 110.458 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.441 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 24.7 m -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 99.99 111.979 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.564 HG23 HG23 ' C' ' 43' ' ' ILE . 85.1 m -67.12 -58.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.065 0.394 . . . . 99.99 112.065 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 12.6 m -47.94 -52.43 40.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 99.99 112.043 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 63.3 Cg_exo -51.95 -44.4 45.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.822 1.681 . . . . 0.67 111.794 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 98.6 mt -66.02 -32.89 74.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.555 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -31.69 64.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 99.99 109.766 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.508 HD21 ' HZ2' ' C' ' 176' ' ' TRP . 19.8 mt -77.83 -44.83 26.15 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.675 -0.693 . . . . 99.99 110.112 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -50.38 -42.0 52.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.446 -0.797 . . . . 99.99 110.384 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.416 ' O ' HG23 ' C' ' 90' ' ' THR . 43.2 t -57.62 -34.23 69.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 99.99 110.945 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 40.7 mt -65.39 -36.74 84.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 99.99 111.359 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 69.2 p -69.64 -26.19 64.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 99.99 110.95 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -80.58 -34.83 35.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 99.99 111.153 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' THR . . . . . 0.504 HG22 ' HE2' ' C' ' 36' ' ' GLU . 66.6 p -67.87 -26.68 66.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 99.99 111.049 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.65 -44.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 99.99 111.101 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.02 105.62 17.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 99.99 111.092 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -80.47 -12.09 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 99.99 110.828 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -162.7 137.44 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.557 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.8 tt -108.23 144.49 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.17 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -131.72 -25.85 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -146.17 137.58 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 99.99 110.38 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.63 124.45 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.326 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -92.84 162.4 14.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 99.99 110.98 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -103.58 -21.42 13.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 99.99 110.705 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.3 -31.75 70.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 99.99 110.67 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -62.15 -33.15 57.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.932 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.08 -27.51 60.02 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.861 -0.685 . . . . 99.99 112.098 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -64.84 -39.78 94.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.892 0.377 . . . . 99.99 110.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.88 -50.09 25.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.126 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' MET . . . . . 0.405 ' O ' HG13 ' C' ' 110' ' ' ILE . 12.6 tpt -56.88 -41.58 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.785 -0.643 . . . . 99.99 111.514 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t -66.38 -59.38 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 99.99 111.156 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 42.9 p -53.6 -26.4 21.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.326 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.471 ' NE2' HD11 ' C' ' 84' ' ' LEU . 6.9 tp-100 -68.17 -47.98 66.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 99.99 110.923 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.405 HG13 ' O ' ' C' ' 106' ' ' MET . 49.3 mt -55.26 -31.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 99.99 110.635 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.24 -45.74 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.814 -0.63 . . . . 99.99 111.118 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.2 -47.77 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.125 -0.489 . . . . 99.99 111.079 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . 0.471 HG21 ' HA ' ' C' ' 77' ' ' MET . 60.6 mt -57.53 -35.7 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.848 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' THR . . . . . 0.441 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 18.3 m -57.15 -45.88 83.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.062 0.458 . . . . 99.99 110.695 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' SER . . . . . 0.431 ' HA ' HG22 ' C' ' 118' ' ' ILE . 62.9 m -69.25 -23.22 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 99.99 110.798 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.31 -32.67 42.25 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.983 -0.627 . . . . 99.99 113.048 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.489 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.4 pp -82.54 -28.51 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 99.99 111.396 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.489 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.7 tp -83.92 -26.23 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.483 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.1 70.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.4 . . . . 99.99 111.258 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -84.89 -12.96 52.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.802 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.88 26.6 3.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 99.99 111.192 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 67.5 m -65.16 122.24 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.356 . . . . 99.99 110.876 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -86.62 -17.04 34.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.916 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . 0.447 ' HB2' HG13 ' C' ' 127' ' ' VAL . 98.5 mtt180 -137.01 169.14 18.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 99.99 110.946 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.88 -17.13 38.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.814 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . 0.447 ' HE3' ' HB3' ' C' ' 124' ' ' ARG . 15.6 m-90 -90.88 -39.19 12.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.549 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' C' ' 124' ' ' ARG . 27.3 m -63.69 -26.91 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 99.99 111.117 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -66.53 -34.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.973 -0.558 . . . . 99.99 110.994 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -73.87 -27.02 60.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.839 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.08 -41.61 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 99.99 111.227 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . 0.445 ' HZ2' ' HB2' ' B' ' 53' ' ' ALA . 6.6 m95 -71.72 -31.04 66.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 99.99 111.052 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -63.69 -58.72 6.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.817 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.08 -29.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.402 . . . . 99.99 111.041 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.12 -38.62 88.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.892 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.84 -54.47 21.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.898 -0.668 . . . . 99.99 112.604 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.56 -30.67 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.618 0.247 . . . . 99.99 111.236 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.38 -47.65 83.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 99.99 110.514 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.52 -30.16 71.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 99.99 110.861 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.6 -20.51 61.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.586 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.48 -55.67 5.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 99.99 111.028 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 36.2 pt -58.79 -35.92 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.356 -0.384 . . . . 99.99 111.891 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 17.6 tt -75.94 -23.71 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 99.99 111.114 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.13 -48.33 73.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.361 -0.381 . . . . 99.99 110.764 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -68.62 -32.89 73.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.761 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.38 -39.51 61.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 99.99 112.452 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -75.21 -19.93 16.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.161 0.505 . . . . 99.99 110.36 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -88.87 3.0 52.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.586 -0.734 . . . . 99.99 110.383 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 99.99 111.96 -179.324 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.948 0.404 . . . . 99.99 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.24 -22.95 63.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 99.99 111.138 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 -38.9 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.333 -0.394 . . . . 99.99 110.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -81.72 -23.47 36.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.47 -41.02 41.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.254 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.42 -24.49 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.377 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 170' ' ' THR . . . . . 0.43 ' O ' HG23 ' C' ' 174' ' ' VAL . 38.9 m -59.64 -58.88 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 99.99 111.309 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -67.89 -31.86 71.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.766 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.0 -38.51 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 99.99 111.639 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 173' ' ' THR . . . . . 0.423 ' O ' HG22 ' C' ' 177' ' ' ILE . 38.7 p -73.21 -33.78 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.426 -0.352 . . . . 99.99 111.657 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 170' ' ' THR . 62.5 t -60.93 -37.11 76.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.555 -0.293 . . . . 99.99 111.773 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.25 -45.5 16.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 99.99 111.344 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . 0.508 ' HZ2' HD21 ' C' ' 84' ' ' LEU . 0.9 OUTLIER -57.77 -31.79 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.464 -0.335 . . . . 99.99 110.691 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.544 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.2 tt -87.96 -20.64 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.211 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.49 -56.72 23.58 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.753 -0.658 . . . . 99.99 113.407 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.666 ' HH ' ' HG3' ' C' ' 206' ' ' PRO . 87.8 m-85 -54.21 -54.42 47.97 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.755 0.278 . . . . 99.99 111.437 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.9 Cg_exo -47.09 -30.9 10.88 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.139 1.892 . . . . 0.63 112.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.544 HG13 ' O ' ' C' ' 177' ' ' ILE . 88.2 mt -70.7 -60.49 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.639 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.477 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.6 m -56.18 -24.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.407 0.521 . . . . 99.99 112.407 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -65.69 -17.4 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.429 0.529 . . . . 99.99 112.429 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . 0.452 HG13 HG23 ' C' ' 185' ' ' ILE . 22.5 pt -65.67 -13.19 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.659 0.266 . . . . 99.99 111.563 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . 0.452 HG23 HG13 ' C' ' 184' ' ' ILE . 31.0 pt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.424 -0.353 . . . . 99.99 111.28 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.1 m . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.829 0.347 . . . . 99.99 110.807 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 46.9 mm -72.49 -48.26 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 99.99 111.279 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.3 -51.96 64.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 99.99 111.077 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 87.7 m -64.72 -25.16 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.424 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -82.47 -27.68 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 99.99 111.696 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.87 -48.29 10.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.636 0.255 . . . . 99.99 111.402 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -69.17 1.44 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 99.99 111.211 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 51.2 t -96.27 -48.8 5.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 99.99 110.7 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.8 -30.57 65.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.72 -0.673 . . . . 99.99 111.95 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.683 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 44.6 tp -62.19 -54.62 48.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 120.966 -0.293 . . . . 99.99 111.49 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 46.3 Cg_exo -57.3 -41.8 69.21 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.65 1.566 . . . . 0.63 111.516 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.42 -32.01 73.32 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.502 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.75 -25.2 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 99.99 110.839 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.012 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.8 0.333 . . . . 99.99 111.479 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.04 -31.65 81.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.656 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -75.2 -29.16 60.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.781 0.324 . . . . 99.99 111.08 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -63.78 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 99.99 111.065 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -62.71 -23.26 67.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.977 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.73 -47.37 85.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.971 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -66.78 -35.41 80.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.414 -0.357 . . . . 99.99 111.003 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.31 -43.28 88.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 99.99 111.01 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -87.44 -19.92 27.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.94 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.69 31.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.993 -0.622 . . . . 99.99 113.08 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.555 0.217 . . . . 99.99 111.417 -179.354 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.857 0.361 . . . . 99.99 110.808 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.36 -42.86 99.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.971 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 25.6 m170 -62.94 -35.88 81.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.779 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -69.04 -52.47 28.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.0 mt -56.19 -34.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.007 0.432 . . . . 99.99 110.407 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 15' ' ' MET . 20.1 t80 -57.45 -42.15 81.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 99.99 109.826 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 8' ' ' HIS . 3.1 t -57.25 -48.38 82.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 99.99 111.229 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.06 -44.95 83.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 99.99 111.681 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.31 94.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 99.99 112.705 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.54 ' HE1' ' HB3' ' A' ' 44' ' ' PRO . 56.0 mmm -69.16 -32.92 72.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 99.99 110.992 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -60.83 -60.33 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.449 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.2 -26.1 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.268 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.49 -48.55 85.44 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.571 -0.823 . . . . 99.99 112.328 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.05 -23.22 63.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 99.99 111.01 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.32 -44.13 84.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.921 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.94 -20.93 60.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.997 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.83 -48.19 80.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.891 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.512 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.1 m-90 -71.55 -35.52 70.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.88 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.0 m -70.47 -20.65 62.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 99.99 111.333 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 tp -86.18 -10.63 54.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 99.99 111.117 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 52.3 p -65.4 -23.05 66.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.385 -0.37 . . . . 99.99 111.152 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -47.07 -32.69 4.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.261 0.553 . . . . 99.99 109.699 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -174.18 132.45 0.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.092 -0.958 . . . . 99.99 110.216 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -92.47 140.8 2.12 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.777 2.318 . . . . 99.99 112.07 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -81.28 72.83 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.601 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.76 -46.9 3.19 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.106 -0.568 . . . . 99.99 113.435 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.37 140.52 21.71 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.792 0.296 . . . . 99.99 111.222 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.44 165.56 12.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.552 2.168 . . . . 99.99 112.131 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -63.5 -18.6 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 99.99 112.233 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -48.09 -36.29 12.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.754 0.311 . . . . 99.99 111.317 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.11 -53.33 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.909 0.385 . . . . 99.99 110.461 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -68.27 -18.45 64.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 99.99 110.669 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.08 -52.87 63.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.406 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 t -65.85 -36.78 78.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.155 0.502 . . . . 99.99 109.795 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.38 -8.37 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.663 -0.699 . . . . 99.99 110.623 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.453 ' O ' HG12 ' A' ' 45' ' ' ILE . 22.4 ttt -88.68 -36.98 15.9 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.2 -0.454 . . . . 99.99 110.746 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -67.99 -32.8 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.222 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 HG21 HG22 ' A' ' 79' ' ' THR . 68.5 mt -56.88 -55.01 48.12 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.307 0.484 . . . . 99.99 112.307 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HB3' ' HE1' ' A' ' 15' ' ' MET . 36.7 Cg_endo -65.38 -33.94 45.8 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.295 1.996 . . . . 99.99 113.442 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 41' ' ' MET . 38.8 mm -55.26 -62.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.881 0.326 . . . . 99.99 111.881 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.428 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.8 t90 -66.06 -47.89 72.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 99.99 110.981 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' A' ' 75' ' ' ASP . 47.4 t -61.81 -9.79 7.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 99.99 111.238 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.31 -59.53 2.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 99.99 112.134 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.36 -26.95 65.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 99.99 110.704 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -51.52 69.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.79 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 27.7 m-85 -69.65 -26.36 64.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.938 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -56.42 -36.78 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.514 -0.55 . . . . 99.99 109.514 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -73.16 -44.15 60.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.538 -0.755 . . . . 99.99 110.85 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.432 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 51.6 mtt -51.5 -26.48 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 99.99 110.597 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -79.11 -47.28 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 99.99 111.211 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -84.18 14.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.545 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 57.31 55.76 5.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.027 -0.533 . . . . 99.99 111.223 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.43 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 16.8 mm-40 -125.22 173.01 9.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 99.99 110.716 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.45 66.48 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.593 -0.813 . . . . 99.99 112.155 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.75 173.98 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 99.99 110.709 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.12 132.49 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 99.99 111.355 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -101.23 88.54 3.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 99.99 110.625 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.06 131.72 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.2 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 27.71 17.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.066 -0.515 . . . . 99.99 111.408 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.24 -11.27 37.9 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.643 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -97.87 149.74 22.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.34 . . . . 99.99 110.899 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.3 mt -94.15 117.33 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.939 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.26 144.83 30.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.233 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.3 m-70 -88.68 68.89 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 99.99 110.958 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.15 -35.71 75.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 99.99 111.102 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.46 -24.19 60.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 99.99 111.971 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.7 tpp180 -69.29 -51.71 34.59 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.335 0.494 . . . . 99.99 112.335 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -81.23 -31.1 34.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.207 0.447 . . . . 99.99 112.207 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.53 -43.91 83.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.762 -0.375 . . . . 99.99 110.537 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HD2' ' HA ' ' A' ' 47' ' ' SER . 13.3 t70 -68.85 -20.3 64.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.498 -0.556 . . . . 99.99 109.498 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -87.7 1.22 54.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.672 -0.694 . . . . 99.99 111.169 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.6 ttm -104.61 -18.71 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.915 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.11 -32.06 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.904 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 43' ' ' ILE . 27.9 m -82.9 -41.38 18.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.898 0.333 . . . . 99.99 111.898 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 72.4 m -60.19 -50.27 86.86 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.945 0.35 . . . . 99.99 111.945 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 44.9 Cg_exo -56.69 -32.92 92.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.074 1.849 . . . . 99.99 112.437 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.94 -16.97 45.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.845 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.91 -47.03 49.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 99.99 109.948 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 85' ' ' LEU . 3.6 pp -74.92 -29.47 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.555 . . . . 99.99 110.988 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' HD11 ' A' ' 84' ' ' LEU . 9.7 tp -64.03 -36.47 84.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.018 -0.537 . . . . 99.99 110.798 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -61.94 -24.41 66.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.554 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.68 -34.01 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.793 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.5 p -71.28 -28.42 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 99.99 110.52 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.86 -26.82 29.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.985 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -81.37 -25.7 36.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.966 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.5 -35.24 12.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.277 -0.419 . . . . 99.99 111.263 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 71.4 mtm -118.18 111.1 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.144 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.75 -24.45 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.69 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -137.12 141.03 42.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 99.99 110.659 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.7 pt -128.39 143.95 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 99.99 111.407 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.917 -0.583 . . . . 99.99 110.606 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.42 52.45 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.467 . . . . 99.99 110.992 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -135.29 93.69 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.858 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -71.65 80.5 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 99.99 111.097 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.4 m -120.6 -60.56 1.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.324 -0.398 . . . . 99.99 111.179 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.29 -58.84 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 99.99 111.081 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.2 tt -56.55 -36.38 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 99.99 111.24 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.15 -30.63 73.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 99.99 112.809 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.3 -48.95 75.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.745 0.307 . . . . 99.99 110.991 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.97 -43.66 98.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.506 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 89.4 mtp -56.43 -39.68 73.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 99.99 111.666 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.2 m -71.7 -45.67 61.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.959 0.409 . . . . 99.99 111.204 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.2 p -64.85 -20.28 66.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.618 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 110' ' ' ILE . 3.0 pt20 -77.76 -41.49 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.586 0.231 . . . . 99.99 110.796 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.577 HG22 ' HE1' ' C' ' 46' ' ' TRP . 43.2 mt -61.2 -33.05 54.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.947 0.403 . . . . 99.99 110.807 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.17 -47.88 76.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.916 -0.584 . . . . 99.99 111.219 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.85 -44.07 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.457 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 109' ' ' GLN . 74.8 mt -54.77 -40.28 51.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.776 0.322 . . . . 99.99 110.864 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 117' ' ' LEU . 99.0 m -60.15 -39.79 87.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 99.99 110.913 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -57.72 -57.31 13.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 99.99 110.123 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.8 -14.25 65.01 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.985 -0.626 . . . . 99.99 112.199 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 114' ' ' THR . 10.0 tt -70.29 -56.41 6.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 99.99 110.724 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.425 ' HB ' ' NE1' ' A' ' 131' ' ' TRP . 67.1 mt -83.73 -22.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.004 -0.543 . . . . 99.99 111.563 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.401 ' HA ' ' HD1' ' A' ' 131' ' ' TRP . . . -49.7 -40.13 39.26 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.849 0.357 . . . . 99.99 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.438 ' HD2' ' H ' ' A' ' 69' ' ' HIS . 18.4 t70 -86.73 -21.48 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 99.99 110.479 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.3 mt -91.87 31.87 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.775 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 t -88.02 128.14 35.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.634 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.59 -69.77 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.282 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.602 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.6 ttp180 -74.4 136.94 42.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.06 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.67 -9.88 58.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 99.99 111.181 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.602 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 64.1 t-105 -80.2 -46.65 15.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.804 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.472 ' HB ' HH21 ' A' ' 124' ' ' ARG . 13.3 p -77.19 -23.99 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 99.99 111.448 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -56.88 -32.09 65.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.396 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -72.05 -25.24 61.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.342 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.491 HD23 HG23 ' C' ' 56' ' ' ILE . 30.8 tp -83.49 -48.18 10.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.538 -0.301 . . . . 99.99 111.32 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.425 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 50.4 t-105 -59.88 -28.13 67.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 99.99 110.626 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.29 -44.33 79.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 99.99 110.666 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.48 -29.22 44.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.815 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.437 ' HG ' ' HE3' ' C' ' 52' ' ' MET . 69.2 m -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 99.99 110.717 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.8 -56.89 12.43 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 99.99 112.465 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 m -56.25 -33.17 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 99.99 111.092 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.2 t -61.69 -37.08 82.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 99.99 110.465 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.18 93.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.802 -0.635 . . . . 99.99 110.625 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.4 -14.88 58.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.518 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -56.91 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.162 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.9 pt -66.27 -37.47 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 99.99 110.839 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.97 -35.96 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.801 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.52 -43.49 93.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 99.99 110.339 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.675 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 88.3 t90 -64.49 -28.61 69.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.596 . . . . 99.99 110.434 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 1.374 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -80.25 -33.34 32.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 99.99 112.456 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.54 -24.71 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 99.99 110.443 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -88.89 5.05 45.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.863 -0.608 . . . . 99.99 111.057 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 1.374 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 99.99 112.283 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.752 0.31 . . . . 99.99 110.998 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.45 -31.17 42.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.525 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.54 -44.01 97.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 99.99 111.0 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.4 -19.72 38.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 99.99 111.479 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 42.7 tp -80.65 -39.96 26.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.978 0.362 . . . . 99.99 111.978 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.37 -31.23 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.361 0.504 . . . . 99.99 112.361 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 174' ' ' VAL . 6.4 t -57.79 -44.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.712 0.291 . . . . 99.99 111.369 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -77.09 -28.12 54.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.749 0.309 . . . . 99.99 110.612 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -65.56 -46.49 79.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.51 . . . . 99.99 111.216 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -64.11 -40.31 95.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.51 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 170' ' ' THR . 84.4 t -57.52 -35.32 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.804 0.335 . . . . 99.99 111.217 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.26 -57.56 3.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.391 -0.368 . . . . 99.99 111.434 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.63 -25.93 54.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.181 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 181' ' ' ILE . 31.1 mm -87.7 -27.38 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 99.99 110.272 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.92 -53.88 34.26 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.742 -0.663 . . . . 99.99 113.172 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 80.4 m-85 -56.42 -57.24 24.39 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.884 0.342 . . . . 99.99 111.495 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 86.0 Cg_exo -44.4 -30.36 3.73 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.215 1.943 . . . . 99.99 112.96 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -68.19 -58.31 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 99.99 111.405 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 179' ' ' TYR . 21.3 m -59.94 -24.96 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 99.99 111.614 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -70.27 -22.69 62.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.531 -0.304 . . . . 99.99 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 92.4 mt -56.35 -41.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 99.99 111.424 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 27.9 pt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.42 -0.354 . . . . 99.99 111.392 -179.85 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.665 0.269 . . . . 99.99 111.269 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.77 -60.97 2.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.081 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 8.2 t -61.8 -22.29 65.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.461 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.51 -32.32 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.942 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 40.9 tp -83.99 -42.58 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 99.99 111.577 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -70.16 0.35 6.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.751 -0.204 . . . . 99.99 111.458 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.19 -45.65 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.202 0.525 . . . . 99.99 110.466 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.53 -34.04 67.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 99.99 111.92 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.67 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 55.1 tp -59.8 -54.6 54.01 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.855 -0.338 . . . . 99.99 111.2 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 46.6 Cg_exo -57.63 -35.53 98.8 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.629 1.553 . . . . 99.99 111.094 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.406 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 55.4 t80 -60.31 -31.88 70.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.018 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -82.22 -19.16 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 99.99 110.591 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 99.99 110.806 -179.928 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.736 0.303 . . . . 99.99 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.66 -34.98 71.63 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.897 -0.668 . . . . 99.99 112.763 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -71.21 -35.19 71.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.639 0.257 . . . . 99.99 111.226 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 40.5 t -55.93 -58.2 8.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.873 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -66.97 -20.44 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.821 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -67.2 -58.66 4.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 99.99 110.815 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 -28.3 64.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 99.99 110.969 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.21 -45.53 84.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.742 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -77.42 -28.25 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.754 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.42 -23.34 68.37 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 99.99 112.185 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 99.99 110.737 179.86 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.823 0.344 . . . . 99.99 110.815 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 24.4 tp -70.51 -39.44 74.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.219 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.566 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 29.6 m80 -71.52 -31.19 66.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.86 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -65.33 -57.97 7.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 35.8 pt -55.38 -31.37 27.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.584 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.606 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 28.9 t80 -59.66 -36.36 76.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.621 -0.718 . . . . 99.99 109.672 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' B' ' 52' ' ' MET . 3.2 t -66.93 -49.86 70.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 99.99 111.047 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.64 69.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 99.99 111.653 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.28 83.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.639 -0.791 . . . . 99.99 112.422 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -76.43 -34.56 58.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.625 0.25 . . . . 99.99 111.573 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -62.63 -49.38 75.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.722 0.296 . . . . 99.99 111.467 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -36.0 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 99.99 110.683 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -49.75 56.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.728 -0.749 . . . . 99.99 112.847 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.74 65.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 99.99 111.474 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.93 -36.15 75.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 99.99 110.971 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -63.28 -21.55 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.515 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -60.8 -40.83 94.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 99.99 110.864 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -73.18 -41.89 63.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.004 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 77.7 p -71.12 -19.5 62.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 99.99 111.466 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.95 -7.85 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 99.99 111.265 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 89.8 p -69.54 -22.48 63.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.482 -0.326 . . . . 99.99 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -47.51 -36.41 10.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.292 0.568 . . . . 99.99 109.774 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.4 p-10 -171.84 132.35 0.77 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 99.99 109.988 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 55.5 Cg_endo -94.86 154.35 1.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.96 2.44 . . . . 99.99 112.24 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -85.13 63.5 8.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 99.99 110.912 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.78 -39.79 2.22 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.765 -0.731 . . . . 99.99 112.508 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.56 129.0 35.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.381 0.134 . . . . 99.99 111.142 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 32.2 Cg_exo -57.69 160.88 13.53 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.29 1.993 . . . . 99.99 111.854 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.49 -18.06 57.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.788 -0.642 . . . . 99.99 112.517 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.416 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 2.9 p90 -46.78 -36.74 7.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.938 0.399 . . . . 99.99 111.046 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -66.82 -47.32 72.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.231 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -70.58 -18.78 62.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 99.99 110.489 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 58.1 tp -60.96 -53.61 55.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 99.99 110.006 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.18 -37.13 78.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 99.99 110.307 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.33 -6.84 46.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.596 -0.729 . . . . 99.99 110.94 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.425 ' O ' HG13 ' B' ' 45' ' ' ILE . 24.8 ttt -88.79 -39.78 13.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.981 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' C' ' 107' ' ' SER . 25.1 t80 -69.74 -34.13 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.516 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.451 HG21 HG22 ' B' ' 79' ' ' THR . 76.6 mt -52.15 -54.28 43.0 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.988 0.366 . . . . 99.99 111.988 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 48.0 Cg_endo -68.62 -32.09 25.04 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.158 1.905 . . . . 99.99 112.883 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.462 HG22 HG12 ' C' ' 111' ' ' VAL . 96.1 mt -56.3 -60.12 2.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.657 0.265 . . . . 99.99 111.538 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.609 ' HE1' HG21 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -63.71 -55.26 24.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.517 -0.311 . . . . 99.99 111.204 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' B' ' 75' ' ' ASP . 90.2 p -54.74 -25.97 31.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.294 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.93 7.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.711 -0.757 . . . . 99.99 112.429 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -32.09 68.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 99.99 110.837 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.93 -53.53 57.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.57 . . . . 99.99 111.244 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -71.53 -23.26 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.385 . . . . 99.99 111.143 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' MET . . . . . 0.465 ' HA ' HG22 ' B' ' 12' ' ' VAL . 15.0 tmm? -57.72 -36.89 72.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.304 0.573 . . . . 99.99 109.466 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.33 -39.68 38.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.779 . . . . 99.99 110.778 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.9 mtt -53.89 -24.29 15.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.032 -0.531 . . . . 99.99 110.188 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -82.21 -47.95 11.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.853 -0.612 . . . . 99.99 110.822 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mt -80.94 10.93 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 99.99 111.166 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.484 ' HA ' ' HZ2' ' B' ' 60' ' ' LYS . 20.0 t70 60.54 65.23 1.08 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.982 -0.554 . . . . 99.99 111.172 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -146.66 150.78 36.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 99.99 111.291 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.99 -22.43 29.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.654 . . . . 99.99 112.697 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HZ2' ' HA ' ' B' ' 57' ' ' ASP . 22.0 pttm -103.8 143.15 33.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 99.99 111.154 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.82 151.63 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.229 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.11 107.39 18.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.778 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.33 127.68 53.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.256 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.48 37.34 23.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.059 -0.519 . . . . 99.99 111.079 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.78 -0.68 42.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.843 -0.694 . . . . 99.99 112.432 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -101.3 139.53 36.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 99.99 110.638 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.03 102.47 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.199 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.15 133.9 37.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 99.99 111.073 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.511 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 74.6 m-70 -78.66 74.97 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.166 0.508 . . . . 99.99 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.429 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 62.1 t80 -64.47 -30.02 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.611 -0.722 . . . . 99.99 111.255 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.66 -28.14 40.81 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.181 0.437 . . . . 99.99 112.181 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.517 HH21 ' HB ' ' B' ' 199' ' ' THR . 34.2 mmt180 -67.95 -51.64 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.603 0.594 . . . . 99.99 112.603 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' B' ' 77' ' ' MET . 5.9 p90 -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.231 0.456 . . . . 99.99 112.231 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.4 ' HA ' ' HG3' ' B' ' 77' ' ' MET . 10.3 tp -54.74 -43.23 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 120.846 -0.341 . . . . 99.99 110.802 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.401 ' HD2' ' HA ' ' B' ' 47' ' ' SER . 26.9 t70 -68.95 -21.64 64.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.474 -0.565 . . . . 99.99 109.474 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -87.07 6.25 33.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.472 -0.786 . . . . 99.99 110.908 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 28.2 mtp -104.91 -23.3 13.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.748 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.18 -33.64 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.56 0.578 . . . . 99.99 112.56 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.451 HG22 HG21 ' B' ' 43' ' ' ILE . 34.8 m -76.83 -47.26 21.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.192 0.441 . . . . 99.99 112.192 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 34.6 m -56.5 -51.31 82.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.154 0.427 . . . . 99.99 112.154 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 54.3 Cg_exo -52.62 -41.86 65.99 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.921 1.748 . . . . 99.99 112.065 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.62 -29.58 62.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.638 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.35 -28.75 68.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.117 0.484 . . . . 99.99 110.205 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 105' ' ' LEU . 5.9 tt -84.37 -38.75 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 99.99 110.296 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.44 -33.37 73.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.914 -0.585 . . . . 99.99 110.625 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 99.5 p -59.39 -24.1 63.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 99.99 110.715 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 46.6 mt -76.03 -27.43 57.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.909 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 52.0 m -75.94 -31.18 58.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 99.99 111.163 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.06 -37.27 39.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.297 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -73.88 -23.54 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.458 -0.337 . . . . 99.99 111.422 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.08 -36.22 12.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 99.99 111.252 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -116.52 120.24 38.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.889 0.376 . . . . 99.99 111.068 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.98 -27.33 39.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 99.99 110.562 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -137.94 148.14 44.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.795 -0.639 . . . . 99.99 110.613 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.95 144.56 36.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.372 -0.376 . . . . 99.99 111.064 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -101.18 162.67 12.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.863 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.47 91.64 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.913 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -147.53 -43.05 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 99.99 111.075 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 85.9 m95 54.78 65.25 1.55 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 99.99 110.867 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 79.7 p -117.87 -58.23 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.804 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 60.3 tp -71.67 -51.55 22.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.712 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.95 -47.37 89.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.977 -0.556 . . . . 99.99 111.154 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.4 -33.8 77.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.896 -0.669 . . . . 99.99 112.675 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -65.58 -40.28 92.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 99.99 110.866 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.434 ' HB3' HD23 ' B' ' 84' ' ' LEU . 28.8 mt -71.43 -40.72 70.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 99.99 111.201 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 85.9 mtp -58.27 -53.39 58.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.221 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 44.0 t -58.35 -39.94 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 99.99 111.128 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.513 HG22 HG22 ' B' ' 142' ' ' ILE . 91.8 m -60.71 -37.93 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.286 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.475 ' NE2' HG23 ' B' ' 80' ' ' THR . 16.1 mm100 -64.72 -46.92 80.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.31 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.428 HG22 ' HE1' ' A' ' 46' ' ' TRP . 62.3 mt -53.04 -35.03 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.323 -0.399 . . . . 99.99 111.262 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.65 -51.35 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 99.99 111.342 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.75 -49.6 82.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.489 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 71.9 mt -52.83 -36.87 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.358 -0.383 . . . . 99.99 111.329 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 49.5 m -60.09 -48.3 82.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 99.99 111.237 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 35.9 m -64.94 -21.11 66.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.124 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.27 14.3 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.821 -0.705 . . . . 99.99 113.262 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.435 HD11 ' N ' ' B' ' 118' ' ' ILE . 3.1 pp -76.24 -27.91 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.87 -0.194 . . . . 99.99 111.507 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.435 ' N ' HD11 ' B' ' 117' ' ' LEU . 8.9 tp -83.53 -31.55 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.682 0.277 . . . . 99.99 111.424 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.4 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 99.99 111.013 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.66 -30.24 46.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 99.99 111.007 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.63 14.28 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.267 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 46.6 t -75.36 120.77 21.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 99.99 110.817 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.41 -72.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.025 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.508 ' HB2' HG12 ' B' ' 127' ' ' VAL . 79.3 mtp180 -62.71 140.72 58.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 99.99 110.513 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.92 -19.31 52.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 99.99 111.466 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -78.17 -35.03 49.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 99.99 111.215 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -81.67 -23.74 9.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.341 -0.391 . . . . 99.99 111.095 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -56.35 -32.92 65.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.13 -0.487 . . . . 99.99 111.037 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -75.27 -19.51 59.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.417 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 99.3 mt -78.85 -54.89 5.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 99.99 110.97 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -39.98 76.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 99.99 111.334 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -53.01 -45.4 67.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.156 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -71.93 -28.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.288 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 76.2 m -68.77 -39.45 80.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.176 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.31 -50.8 48.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.8 -0.714 . . . . 99.99 112.457 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.97 -29.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 99.99 110.752 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.49 -47.05 87.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.645 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.46 -29.79 71.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.451 . . . . 99.99 110.622 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' B' ' 143' ' ' LEU . 82.2 t80 -75.13 -25.24 58.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 99.99 110.747 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.58 -56.84 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.476 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . 0.443 HG13 ' N ' ' B' ' 142' ' ' ILE . 23.5 pt -56.17 -44.07 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 99.99 111.128 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.513 HG22 HG22 ' B' ' 108' ' ' THR . 46.5 mm -67.85 -29.31 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' B' ' 139' ' ' PHE . 0.5 OUTLIER -55.37 -50.96 68.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.348 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -62.36 -37.55 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.666 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.98 -35.58 92.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 99.99 112.514 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 142' ' ' ILE . 98.3 mt -69.17 -27.18 33.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.871 0.367 . . . . 99.99 110.831 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -88.68 4.46 47.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.185 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.044 -0.525 . . . . 99.99 111.841 -179.403 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 121.067 0.461 . . . . 99.99 110.761 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.72 -23.48 61.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 99.99 111.076 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.21 -55.0 28.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.339 -0.391 . . . . 99.99 111.183 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -78.43 -24.19 46.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.383 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.4 tp -68.78 -43.5 75.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 99.99 111.311 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.41 -22.31 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.34 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.0 m -62.55 -58.83 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.478 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.84 -34.81 79.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.98 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.1 -36.25 74.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.048 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 66.2 m -69.97 -41.35 74.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 99.99 111.095 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.91 -37.07 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.474 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.4 mt -72.5 -56.14 5.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 99.99 111.344 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -31.58 63.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 99.99 111.51 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.439 ' O ' HG13 ' B' ' 181' ' ' ILE . 16.2 tt -87.57 -20.79 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.43 . . . . 99.99 110.566 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.44 -50.57 65.48 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.824 -0.626 . . . . 99.99 112.911 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.628 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 67.1 m-85 -58.18 -57.02 29.07 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.773 0.286 . . . . 99.99 111.538 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 88.1 Cg_exo -45.95 -31.7 8.62 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.906 1.737 . . . . 99.99 112.876 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 177' ' ' ILE . 98.0 mt -66.25 -56.85 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.567 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.43 HG21 ' O ' ' B' ' 179' ' ' TYR . 18.0 m -61.63 -25.32 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 99.99 111.546 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -68.92 -18.36 64.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.467 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.52 -34.68 66.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.521 -0.309 . . . . 99.99 111.142 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.25 162.36 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.323 . . . . 99.99 111.329 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.716 . . . . 99.99 112.721 179.792 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.804 0.335 . . . . 99.99 111.077 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.96 -56.13 25.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.974 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' THR . . . . . 0.517 ' HB ' HH21 ' B' ' 72' ' ' ARG . 64.8 p -65.43 -34.52 78.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.157 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.96 -36.0 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.144 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.53 -41.78 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.342 -0.39 . . . . 99.99 111.495 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -74.63 0.45 15.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.523 -0.308 . . . . 99.99 111.345 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.9 t -96.52 -45.03 6.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.206 0.526 . . . . 99.99 110.526 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 45.1 tp -72.11 -39.37 68.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.422 -0.808 . . . . 99.99 111.918 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 45.4 tp -55.77 -54.47 51.47 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.953 -0.299 . . . . 99.99 111.33 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.5 Cg_exo -56.11 -41.45 76.64 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.822 1.681 . . . . 99.99 111.175 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -55.2 -37.07 66.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.167 -0.469 . . . . 99.99 109.844 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -79.89 -24.27 41.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 99.99 110.433 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.84 -0.618 . . . . 99.99 111.204 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.807 0.336 . . . . 99.99 111.135 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' B' ' 216' ' ' LEU . . . -59.2 -28.07 63.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 99.99 112.24 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -76.77 -30.16 56.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.751 0.31 . . . . 99.99 110.551 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -63.74 -60.58 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.685 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.02 -26.47 67.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.853 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' B' ' 212' ' ' GLY . 6.4 tt -65.33 -50.05 67.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 99.99 110.743 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -63.02 -24.98 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.945 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 56.9 tp -71.75 -33.24 68.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 99.99 111.139 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -88.18 -29.19 20.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.43 -0.35 . . . . 99.99 111.149 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.52 -20.9 61.92 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.795 -0.717 . . . . 99.99 112.433 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 77.6 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.654 0.264 . . . . 99.99 110.606 179.784 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.54 0.21 . . . . 99.99 110.951 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 tp -65.18 -47.67 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 99.99 110.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.574 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 25.0 m170 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.745 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -75.21 -41.16 58.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.417 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.09 -20.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.281 0.562 . . . . 99.99 110.176 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . 0.616 ' HH ' ' HB2' ' C' ' 206' ' ' PRO . 27.8 t80 -67.29 -50.91 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.461 -0.79 . . . . 99.99 110.724 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.257 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.03 85.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 99.99 111.231 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -30.73 73.73 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.856 -0.687 . . . . 99.99 112.747 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.7 mmt -73.04 -28.92 62.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.977 0.418 . . . . 99.99 110.839 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.8 m -66.55 -52.91 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.917 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . 0.493 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -63.28 -24.18 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.913 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.72 -47.34 89.88 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.259 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.98 65.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 99.99 111.064 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.7 mt -68.09 -30.96 70.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.361 -0.382 . . . . 99.99 110.745 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -65.04 -21.25 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 99.99 110.812 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.32 -45.13 89.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.851 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . 0.423 ' O ' ' OG ' ' C' ' 26' ' ' SER . 42.1 t90 -71.6 -32.8 68.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.228 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 75.2 m -78.09 -23.32 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.291 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 tp -87.3 -2.76 58.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.404 -0.362 . . . . 99.99 110.863 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 71.2 p -70.97 -24.13 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 99.99 111.109 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -48.85 -32.74 9.31 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.284 0.564 . . . . 99.99 109.952 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.2 p-10 -173.79 132.18 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 99.99 109.761 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 43.8 Cg_endo . . . . . 0 N--CA 1.453 -0.892 0 C-N-CA 122.772 2.315 . . . . 99.99 112.367 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . 0.435 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 36.0 Cg_exo . . . . . 0 CA--C 1.527 0.16 0 CA-C-O 120.952 0.313 . . . . 99.99 112.132 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -60.04 -18.4 46.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 99.99 112.541 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.435 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.7 p90 -50.75 -36.19 35.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.789 0.328 . . . . 99.99 111.131 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.7 -53.68 43.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.484 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.5 -20.51 66.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.719 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.76 -52.11 66.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.198 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.53 -38.95 82.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.219 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.68 -7.22 42.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 99.99 111.188 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.408 ' O ' HG13 ' C' ' 45' ' ' ILE . 26.1 ttt -88.72 -38.77 14.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.925 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -70.77 -30.68 67.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.504 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 80.2 mt -55.82 -54.9 46.86 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.595 -0.275 . . . . 99.99 111.726 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 49.7 Cg_endo -69.41 -28.11 27.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.165 1.91 . . . . 99.99 113.096 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.408 HG13 ' O ' ' C' ' 41' ' ' MET . 91.3 mt -59.66 -62.53 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.166 -0.213 . . . . 99.99 111.332 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.577 ' HE1' HG22 ' A' ' 110' ' ' ILE . 2.8 t90 -64.95 -50.19 67.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.646 0.26 . . . . 99.99 110.813 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' C' ' 75' ' ' ASP . 36.8 t -60.98 -15.06 27.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.022 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.16 -60.32 3.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 99.99 112.364 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.09 -26.42 64.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.309 . . . . 99.99 110.845 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.58 -54.27 45.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.272 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.458 ' HA ' ' SD ' ' C' ' 54' ' ' MET . 21.1 m-85 -67.69 -36.78 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 99.99 111.136 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' MET . . . . . 0.437 ' HE3' ' HG ' ' A' ' 134' ' ' CYS . 51.8 ttp -51.53 -33.09 30.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.14 0.495 . . . . 99.99 109.998 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -75.97 -44.92 37.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 99.99 110.638 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 31.7 mtp -56.49 -19.53 15.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.85 -0.614 . . . . 99.99 110.463 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.48 -44.31 17.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.34 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.491 HG23 HD23 ' A' ' 130' ' ' LEU . 38.4 pt -84.44 10.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 99.99 111.135 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 63.96 54.04 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.915 -0.584 . . . . 99.99 111.148 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -134.77 151.4 50.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.16 14.26 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.788 -0.72 . . . . 99.99 112.58 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -124.43 160.31 28.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.801 0.334 . . . . 99.99 110.769 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.49 142.06 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 99.99 111.028 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.55 104.77 17.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 99.99 110.656 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.96 124.91 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.226 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.8 27.81 17.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 99.99 111.262 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.29 53.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.874 -0.679 . . . . 99.99 112.733 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -98.15 147.41 24.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 99.99 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.37 116.71 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 99.99 111.148 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.85 133.5 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.885 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -78.59 73.33 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.232 0.539 . . . . 99.99 111.054 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.97 -33.01 74.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.582 -0.735 . . . . 99.99 110.951 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.58 -25.89 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 99.99 111.784 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -67.92 -51.22 50.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.364 0.505 . . . . 99.99 112.364 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -82.08 -30.87 31.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.245 0.461 . . . . 99.99 112.245 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 tp -56.48 -44.13 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.758 -0.377 . . . . 99.99 110.783 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.552 ' HD2' ' HA ' ' C' ' 47' ' ' SER . 34.9 t70 -69.54 -20.56 63.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.374 -0.602 . . . . 99.99 109.374 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -87.14 3.68 45.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.567 -0.742 . . . . 99.99 111.201 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 44.8 ttm -104.61 -21.33 13.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.771 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.412 ' O ' HD22 ' C' ' 82' ' ' LEU . 31.5 m -114.48 -35.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.2 0.444 . . . . 99.99 112.2 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.411 HG23 HG22 ' C' ' 43' ' ' ILE . 24.5 m -76.78 -51.7 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.105 0.409 . . . . 99.99 112.105 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.547 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 52.3 m -52.72 -50.77 79.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.039 0.385 . . . . 99.99 112.039 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.547 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 54.4 Cg_exo -52.54 -43.49 54.45 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.943 1.762 . . . . 99.99 112.009 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.412 HD22 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -71.9 -27.28 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 99.99 110.602 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.75 -29.6 67.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.183 0.516 . . . . 99.99 109.743 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -84.04 -39.73 19.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.428 -0.805 . . . . 99.99 110.196 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.94 -32.01 73.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.506 . . . . 99.99 110.404 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -61.21 -25.47 67.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 99.99 110.328 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.448 HD22 HD13 ' C' ' 168' ' ' LEU . 51.2 mt -73.12 -26.32 61.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 99.99 110.629 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 99.99 110.795 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.83 -32.46 35.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.107 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' THR . . . . . 0.402 HG21 ' HA ' ' C' ' 87' ' ' LEU . 10.0 t -81.48 -23.27 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.227 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -36.13 15.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 99.99 111.274 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -123.24 121.63 36.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.948 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -76.35 -35.14 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.835 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.99 141.47 46.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.022 -0.536 . . . . 99.99 110.796 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.44 142.56 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 99.99 110.867 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -91.99 169.42 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.095 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.75 81.19 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 99.99 111.114 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.74 -42.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.012 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 91.7 m95 51.02 76.98 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 99.99 111.081 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 74.6 p -120.26 -57.79 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.945 -0.57 . . . . 99.99 110.985 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.22 -45.07 27.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.967 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.94 -33.35 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.341 -0.39 . . . . 99.99 110.897 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.07 -42.47 51.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.56 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -63.11 -36.61 84.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 99.99 110.869 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.619 ' HB3' HD21 ' C' ' 84' ' ' LEU . 85.1 mt -67.85 -52.88 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.551 . . . . 99.99 110.86 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -53.27 -43.1 67.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.732 . . . . 99.99 110.928 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' SER . . . . . 0.408 ' HB3' ' CD1' ' B' ' 42' ' ' PHE . 49.0 m -64.27 -42.38 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.559 . . . . 99.99 110.828 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.499 HG23 HG22 ' C' ' 142' ' ' ILE . 98.3 m -60.93 -27.26 68.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.962 -0.563 . . . . 99.99 111.252 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.542 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 6.3 tp-100 -75.14 -33.99 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.609 HG21 ' HE1' ' B' ' 46' ' ' TRP . 32.0 mm -62.41 -43.85 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.684 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . 0.462 HG12 HG22 ' B' ' 45' ' ' ILE . 19.9 m -67.07 -41.06 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.881 0.326 . . . . 99.99 111.881 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.64 -48.77 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.936 0.347 . . . . 99.99 111.936 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 70.2 mt -56.53 -36.74 48.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.718 0.294 . . . . 99.99 111.028 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 54.2 m -57.64 -49.64 75.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 99.99 111.223 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -64.29 -20.47 66.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.799 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.34 -32.89 24.28 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.912 -0.661 . . . . 99.99 113.087 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.504 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.7 pp -82.92 -25.39 32.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.707 0.289 . . . . 99.99 111.399 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.504 ' N ' HD12 ' C' ' 117' ' ' LEU . 9.8 tp -83.77 -31.55 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.161 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.9 75.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.027 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.41 -28.62 46.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.97 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.1 13.62 2.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.03 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 48.1 t -71.06 127.71 33.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 99.99 110.823 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -93.26 -65.08 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 99.99 110.707 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . 0.462 ' HB2' HG11 ' C' ' 127' ' ' VAL . 99.1 mtt180 -69.07 141.57 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 99.99 110.498 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.3 -11.57 59.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.492 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -91.68 -30.24 16.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.67 0.272 . . . . 99.99 111.157 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' C' ' 124' ' ' ARG . 8.5 p -80.5 -24.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 99.99 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -57.65 -29.41 64.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 99.99 111.029 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.05 -26.57 59.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.151 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' C' ' 127' ' ' VAL . 9.4 mp -76.71 -53.57 7.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 99.99 111.182 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -32.44 71.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 99.99 111.212 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -57.8 -52.58 64.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.382 . . . . 99.99 110.987 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.85 -32.4 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 99.99 111.296 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 81.3 m -63.73 -39.27 93.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.958 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.23 -57.4 15.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.654 -0.784 . . . . 99.99 112.411 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -57.85 -32.65 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 99.99 111.211 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.9 t -56.49 -43.55 79.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.343 -0.389 . . . . 99.99 110.812 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.11 77.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 99.99 110.644 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -75.46 -22.79 56.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.983 -0.553 . . . . 99.99 111.212 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 89.8 mt -68.05 -55.88 10.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.678 0.275 . . . . 99.99 111.275 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . 0.449 HG13 ' N ' ' C' ' 142' ' ' ILE . 37.4 pt -59.46 -42.16 86.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.859 0.361 . . . . 99.99 111.171 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.499 HG22 HG23 ' C' ' 108' ' ' THR . 49.5 mm -66.08 -35.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 99.99 110.877 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -52.61 -50.27 63.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.751 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -61.48 -32.75 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 99.99 110.504 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.42 -27.69 67.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 99.99 112.479 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . 0.412 HG12 ' O ' ' C' ' 142' ' ' ILE . 43.2 mm -74.5 -27.31 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.057 0.456 . . . . 99.99 110.767 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -89.45 4.76 48.05 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.837 -0.62 . . . . 99.99 111.233 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 116.012 -0.54 . . . . 99.99 112.402 -179.282 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . 0.469 HD12 ' N ' ' C' ' 165' ' ' TYR . 4.1 pp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.778 0.323 . . . . 99.99 111.406 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . 0.469 ' N ' HD12 ' C' ' 164' ' ' LEU . 2.4 t80 -81.39 -25.95 35.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.312 -0.404 . . . . 99.99 110.9 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.27 -46.4 64.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.11 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . 0.655 ' HZ2' ' HB3' ' C' ' 167' ' ' LYS . 4.9 ttpm? -75.33 -29.48 59.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 99.99 110.878 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . 0.448 HD13 HD22 ' C' ' 87' ' ' LEU . 52.4 tp -66.53 -61.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 99.99 111.317 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 85.5 t -53.82 -35.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.459 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -53.95 -54.15 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 99.99 111.075 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . 0.424 ' O ' HG13 ' C' ' 174' ' ' VAL . 30.0 t80 -70.92 -29.9 66.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.006 -0.543 . . . . 99.99 110.806 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -67.48 -31.21 71.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 99.99 111.55 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 40.4 p -77.19 -40.61 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.93 0.344 . . . . 99.99 111.93 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . 0.424 HG13 ' O ' ' C' ' 171' ' ' TYR . 10.9 p -64.2 -25.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 99.99 111.524 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.549 HD11 ' HG ' ' C' ' 209' ' ' SER . 87.4 mt -77.66 -57.87 3.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.031 0.443 . . . . 99.99 111.257 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 -28.06 62.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 99.99 111.424 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.423 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.1 tp -87.54 -22.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.993 0.425 . . . . 99.99 110.341 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.84 -51.52 57.63 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.768 -0.651 . . . . 99.99 112.844 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.606 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -57.01 -56.42 33.7 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.883 -0.327 . . . . 99.99 111.165 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.9 Cg_exo -45.42 -30.47 5.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.177 1.918 . . . . 99.99 112.612 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.418 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.5 mt -65.82 -57.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 99.99 111.314 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 17.3 m -62.67 -25.42 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.466 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -69.92 -16.5 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 99.99 111.017 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.21 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.0 pt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.392 -0.367 . . . . 99.99 111.157 179.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 79.0 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.887 0.375 . . . . 99.99 111.11 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.84 -43.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 99.99 111.068 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.56 -56.9 14.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.211 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 77.4 p -64.93 -20.74 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.654 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.99 -37.0 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.331 . . . . 99.99 111.136 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 52.7 tp -78.92 -39.77 33.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.44 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.09 0.62 10.99 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.435 -0.348 . . . . 99.99 111.344 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 52.9 t -96.15 -44.85 7.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.049 0.452 . . . . 99.99 110.397 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.1 -31.09 62.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.728 -0.669 . . . . 99.99 111.799 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.564 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -61.02 -54.8 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.818 -0.353 . . . . 99.99 111.053 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.616 ' HB2' ' HH ' ' C' ' 11' ' ' TYR . 41.9 Cg_exo -58.06 -37.28 96.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.68 1.587 . . . . 99.99 110.687 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.23 -26.88 66.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.975 -0.557 . . . . 99.99 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.38 -28.84 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.651 -0.704 . . . . 99.99 110.511 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 209' ' ' SER . . . . . 0.549 ' HG ' HD11 ' C' ' 175' ' ' LEU . 44.5 t . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 99.99 110.924 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.751 0.31 . . . . 99.99 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.16 -33.43 61.14 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.977 -0.63 . . . . 99.99 112.785 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -72.71 -32.52 65.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.695 0.283 . . . . 99.99 111.01 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 48.1 t -58.65 -62.64 1.71 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 99.99 110.83 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -60.94 -24.54 66.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.242 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.86 -51.52 47.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 99.99 110.91 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . 0.408 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 18.7 t70 -54.59 -40.03 68.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.169 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.13 -37.4 85.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.385 . . . . 99.99 111.241 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -75.11 -27.71 59.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 99.99 111.11 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.46 -19.86 79.74 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.687 -0.768 . . . . 99.99 112.46 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 79.4 mt . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.68 0.276 . . . . 99.99 111.206 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.412 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.711 0.291 . . . . 99.99 111.002 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.4 mm? -74.69 -27.01 60.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.351 -0.386 . . . . 99.99 110.628 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 33.9 m170 -75.37 -34.63 61.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.269 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -67.37 -48.27 67.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.426 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -66.23 -20.37 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.41 . . . . 99.99 110.223 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' O ' ' HG2' ' A' ' 15' ' ' MET . 7.9 t80 -60.48 -60.54 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.85 -0.614 . . . . 99.99 110.266 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 p -57.92 -30.07 37.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.525 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.93 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 99.99 110.943 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.97 -31.53 52.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 99.99 112.365 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 71.4 mmm -69.68 -44.31 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 99.99 110.69 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.4 p -60.22 -58.48 8.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 99.99 111.219 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.8 pp -56.78 -22.42 15.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.301 -0.409 . . . . 99.99 111.279 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.27 -62.5 5.57 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 99.99 112.407 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.42 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.289 . . . . 99.99 111.262 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 17' ' ' ILE . 86.4 mt -74.89 -35.98 62.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.801 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -58.94 -42.52 89.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 99.99 110.778 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.45 -20.4 57.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.677 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 50.2 t-105 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.264 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -79.92 -34.56 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.914 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -81.87 -1.99 49.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 99.99 110.735 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.3 p -56.42 -26.9 55.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.714 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -46.98 -36.3 7.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.257 0.551 . . . . 99.99 109.825 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -164.05 131.97 2.63 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.307 -0.861 . . . . 99.99 110.132 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -94.03 -178.84 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.074 2.516 . . . . 99.99 112.502 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -89.35 35.95 0.82 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 99.99 111.262 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.78 -40.65 2.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 99.99 112.664 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.0 m -76.46 137.51 67.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 99.99 110.889 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 24.0 Cg_exo -65.12 166.08 19.9 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.578 2.185 . . . . 99.99 112.06 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.465 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -60.7 -18.56 54.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 99.99 111.66 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HH ' ' HA ' ' A' ' 90' ' ' THR . 2.4 p90 -48.12 -39.29 20.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.737 0.303 . . . . 99.99 111.173 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.44 -48.74 63.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.922 0.392 . . . . 99.99 110.514 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -59.94 -29.4 68.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 99.99 110.632 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.54 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 99.99 110.989 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.02 -27.97 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 99.99 111.081 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.32 -9.95 59.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.993 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.411 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 49.6 ttp -89.57 -38.89 13.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.222 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.4 -41.42 73.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 99.99 111.861 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.453 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 30.7 mm -50.59 -52.25 57.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 112.313 0.486 . . . . 99.99 112.313 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HB3' ' HE1' ' A' ' 15' ' ' MET . 55.2 Cg_endo -70.15 -32.51 16.82 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.296 1.997 . . . . 99.99 113.122 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.69 -62.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.548 0.213 . . . . 99.99 111.51 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.531 ' HE1' HG23 ' B' ' 110' ' ' ILE . 0.7 OUTLIER -60.66 -58.63 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.735 0.302 . . . . 99.99 111.017 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 75' ' ' ASP . 45.2 t -55.71 -26.09 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.958 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.3 -58.88 11.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.715 -0.755 . . . . 99.99 112.249 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.47 -28.44 65.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.835 0.35 . . . . 99.99 110.834 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.24 17.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 99.99 111.161 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 30.3 m-85 -62.25 -38.67 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.914 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.2 ttp -55.72 -31.07 62.17 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.0 0.429 . . . . 99.99 110.315 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -40.04 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 99.99 110.491 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.9 mtt -55.94 -33.96 65.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.815 -0.63 . . . . 99.99 110.322 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -66.15 -49.51 67.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 99.99 110.416 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.482 HG21 HG21 ' B' ' 127' ' ' VAL . 10.5 mt -74.58 -3.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 99.99 110.818 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 60.64 51.49 4.97 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.737 -0.665 . . . . 99.99 111.269 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -133.67 122.21 23.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.933 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.07 -1.05 3.73 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.443 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -111.45 153.71 25.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.32 . . . . 99.99 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.84 140.23 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 99.99 111.46 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -87.46 92.64 9.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 99.99 110.749 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.15 118.36 35.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.147 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.83 28.32 17.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 99.99 111.562 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.66 -10.46 64.7 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.705 -0.76 . . . . 99.99 112.949 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -98.07 147.43 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 99.99 110.749 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.1 mt -89.72 122.22 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 99.99 111.134 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.92 143.9 28.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 99.99 111.202 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 92.4 m-70 -88.07 64.66 7.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.74 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.99 -56.0 18.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 99.99 111.39 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.23 -22.54 63.15 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.129 0.418 . . . . 99.99 112.129 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 10.7 mpt_? -68.43 -52.37 33.46 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.921 0.341 . . . . 99.99 111.921 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.45 ' CD2' ' HB3' ' A' ' 117' ' ' LEU . 2.4 p90 -69.31 -32.95 72.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 99.99 110.819 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.9 mm -51.48 -53.27 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.519 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.452 ' HD2' ' HB2' ' A' ' 47' ' ' SER . 22.1 t70 -62.72 -29.32 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.002 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -80.94 6.85 12.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.047 -0.524 . . . . 99.99 111.305 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 53.1 tpp -105.11 -20.29 13.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 99.99 110.452 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.26 -36.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.739 0.644 . . . . 99.99 112.739 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.1 t -79.9 -35.75 37.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.351 0.5 . . . . 99.99 112.351 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 36.7 m -65.97 -50.39 52.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.851 0.315 . . . . 99.99 111.851 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 51.8 Cg_exo -56.21 -38.24 95.32 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.787 1.658 . . . . 99.99 111.369 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.07 -32.08 63.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 99.99 110.823 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.2 tp -67.2 -28.12 67.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.939 0.399 . . . . 99.99 110.381 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' A' ' 105' ' ' LEU . 5.3 tt -84.08 -36.2 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 99.99 110.406 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -61.72 -37.51 84.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.479 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 t -56.83 -30.51 63.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 99.99 110.701 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.11 -34.51 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 99.99 111.209 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -71.71 -39.65 70.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.393 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -68.73 -26.33 65.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 99.99 111.097 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.497 ' HA ' ' HH ' ' A' ' 35' ' ' TYR . 71.8 p -82.96 -23.49 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.538 -0.301 . . . . 99.99 111.365 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -33.85 16.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.046 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 86.1 mtp -130.72 99.21 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 99.99 110.782 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -62.22 -44.93 95.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 99.99 110.902 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -109.19 147.19 32.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.139 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.83 142.05 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.599 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -125.06 -67.72 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.98 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -146.94 93.07 2.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -166.74 63.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -89.68 16.91 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 99.99 111.044 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 p -98.22 -25.64 14.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 99.99 111.314 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.96 -53.71 6.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.994 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.61 -22.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.306 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.38 -49.34 8.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 99.99 112.653 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.99 -39.69 86.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 99.99 111.056 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.562 ' HB3' HD23 ' A' ' 84' ' ' LEU . 80.4 mt -61.71 -58.62 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.027 -0.533 . . . . 99.99 111.051 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.3 ttm -53.67 -32.55 52.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.894 -0.594 . . . . 99.99 111.111 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.4 ' HB3' ' CD1' ' C' ' 42' ' ' PHE . 71.5 m -66.13 -55.63 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.167 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -53.88 -29.19 40.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.069 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.448 ' NE2' HG23 ' A' ' 80' ' ' THR . 15.5 mm100 -62.87 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.87 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.609 HG23 ' HE1' ' C' ' 46' ' ' TRP . 33.8 mm -53.42 -30.64 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 99.99 110.849 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.44 -49.15 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 99.99 111.233 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.68 -46.17 96.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.319 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 53.0 mt -58.7 -34.55 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.962 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.6 m -56.42 -51.45 68.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.695 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -65.39 -20.68 66.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 99.99 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.45 -40.71 12.52 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.803 -0.713 . . . . 99.99 113.085 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.4 pp -73.85 -29.68 62.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.557 0.217 . . . . 99.99 111.422 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.514 ' N ' HD11 ' A' ' 117' ' ' LEU . 9.4 tp -83.72 -29.64 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 99.99 111.428 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.78 68.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.402 . . . . 99.99 111.149 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -80.63 -21.66 41.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 99.99 110.816 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.61 10.75 10.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.001 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.5 p -70.08 120.94 16.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 99.99 111.151 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -96.97 -65.17 0.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.787 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.52 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.1 mtp180 -69.77 134.12 48.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.61 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.68 -11.48 60.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.966 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -81.0 -55.24 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.401 . . . . 99.99 110.635 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.7 p -65.9 -23.68 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.916 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -52.28 -37.24 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 99.99 111.327 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -73.95 -26.46 60.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 99.99 111.303 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.39 -39.08 33.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.567 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -75.75 -26.5 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 99.99 111.283 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.438 ' HE1' ' HB3' ' A' ' 183' ' ' TRP . 53.4 t80 -68.35 -48.25 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.907 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -65.9 -29.81 48.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.898 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.4 t -64.43 -38.71 91.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.792 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.68 -54.27 23.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.75 -0.738 . . . . 99.99 112.636 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.95 -30.77 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.712 0.292 . . . . 99.99 111.545 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.11 -43.65 97.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.866 0.365 . . . . 99.99 110.894 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.47 86.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 99.99 110.709 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -63.03 -28.26 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 99.99 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.87 -60.74 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.397 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 pt -59.3 -41.13 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.867 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -65.51 -33.48 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 99.99 111.391 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.3 tp -68.05 -40.14 82.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.445 -0.343 . . . . 99.99 111.049 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.702 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 54.3 t-105 -69.28 -25.01 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 99.99 110.881 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.772 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -80.9 -41.66 10.41 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.971 -0.633 . . . . 99.99 112.669 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.86 -18.18 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.374 . . . . 99.99 111.14 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -88.0 4.92 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 99.99 111.466 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.772 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 112.84 0.682 . . . . 99.99 112.84 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 CA--C 1.522 -0.13 0 CA-C-O 121.045 0.45 . . . . 99.99 110.833 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.7 -22.58 60.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.768 -0.651 . . . . 99.99 111.217 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.07 -50.66 21.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.055 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -75.01 -20.66 59.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.167 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.4 tp -77.07 -50.6 12.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.598 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.92 -35.44 49.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.226 -0.443 . . . . 99.99 112.08 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -56.95 -35.78 69.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 99.99 110.939 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -77.84 -35.29 51.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.487 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -70.01 -22.31 63.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 99.99 110.16 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 57.5 m -79.42 -48.38 14.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.852 -0.613 . . . . 99.99 111.519 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.507 HG13 HD22 ' A' ' 175' ' ' LEU . 7.3 p -62.19 -33.42 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.272 0.471 . . . . 99.99 112.272 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.507 HD22 HG13 ' A' ' 174' ' ' VAL . 4.0 mm? -76.52 -52.77 9.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.8 0.333 . . . . 99.99 110.96 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -31.4 64.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.905 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.468 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 14.4 tt -87.65 -19.51 7.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.053 0.454 . . . . 99.99 110.198 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.23 -50.91 60.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.642 -0.708 . . . . 99.99 112.773 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.575 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.1 m-85 -58.37 -54.88 51.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.719 0.26 . . . . 99.99 111.308 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.5 Cg_exo -45.7 -30.88 6.86 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.283 1.989 . . . . 99.99 112.571 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 37.3 mm -68.98 -60.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 99.99 111.454 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.32 -25.53 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.715 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.438 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 38.0 m95 -62.98 -27.23 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.623 -0.262 . . . . 99.99 111.016 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.82 -43.69 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 99.99 110.779 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 39.5 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.524 . . . . 99.99 111.011 179.876 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.628 0.252 . . . . 99.99 111.588 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.86 -60.86 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 99.99 111.271 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.4 t -62.57 -35.25 78.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.367 . . . . 99.99 111.173 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -59.11 -26.87 65.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.062 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 61.5 tp -78.11 -46.8 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.998 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -74.0 -8.19 55.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 99.99 111.377 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 99.4 m -96.06 -39.2 9.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.086 0.47 . . . . 99.99 110.897 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.0 tp -72.95 -34.34 66.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 99.99 111.734 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -59.42 -54.54 55.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 121.102 -0.239 . . . . 99.99 111.174 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -57.28 -41.89 68.44 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.734 1.623 . . . . 99.99 111.456 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.05 -28.05 69.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 99.99 110.067 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -83.73 -21.46 32.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.784 -0.644 . . . . 99.99 110.386 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 99.99 110.347 179.603 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.711 0.291 . . . . 99.99 111.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.14 -37.13 91.26 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.618 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -64.17 -35.69 81.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 99.99 110.756 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.2 m -59.83 -60.62 3.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 99.99 111.143 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.55 -21.29 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.29 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.1 tt -68.88 -44.83 72.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.434 -0.348 . . . . 99.99 110.715 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -66.99 -32.51 73.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 99.99 110.993 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.48 -40.68 96.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 99.99 110.953 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -86.61 -20.94 27.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 99.99 110.888 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.27 99.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.457 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 60.1 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 99.99 110.961 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.71 0.29 . . . . 99.99 111.273 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.58 -32.0 53.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 99.99 110.472 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 26.9 m170 -73.47 -29.12 62.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 99.99 110.414 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -70.85 -40.78 72.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.938 -0.574 . . . . 99.99 110.336 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.31 -25.27 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.348 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.67 -53.86 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.653 -0.703 . . . . 99.99 110.725 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.91 -29.78 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.778 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.68 87.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.186 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.58 -34.35 54.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.825 -0.702 . . . . 99.99 112.481 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.68 76.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 99.99 111.105 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 37.3 m -60.29 -57.34 13.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.178 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' B' ' 20' ' ' LEU . 2.7 pp -60.1 -22.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.187 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.86 -63.7 4.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.573 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -32.0 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 99.99 111.196 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 17' ' ' ILE . 95.9 mt -66.63 -39.6 88.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.88 -35.16 74.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.726 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -79.23 -20.19 48.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.637 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.489 ' O ' ' OG ' ' B' ' 26' ' ' SER . 66.1 t90 -67.05 -36.67 82.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 99.99 110.657 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.6 m -81.44 -35.03 31.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.531 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.39 -2.25 44.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.877 -0.602 . . . . 99.99 110.34 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 57.7 p -61.98 -23.19 66.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.936 -0.574 . . . . 99.99 110.828 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -49.99 -31.98 14.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.159 0.504 . . . . 99.99 109.902 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -170.49 132.13 0.94 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.342 -0.845 . . . . 99.99 109.92 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -95.26 172.72 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.092 2.528 . . . . 99.99 112.55 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.536 ' HD3' HD22 ' B' ' 218' ' ' LEU . 14.9 ptm180 -88.28 45.72 1.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.077 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.27 1.77 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.812 -0.709 . . . . 99.99 112.824 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.5 123.24 89.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.488 0.185 . . . . 99.99 110.986 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 33.3 Cg_exo -59.23 162.1 14.98 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.376 2.051 . . . . 99.99 112.365 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' B' ' 34' ' ' GLN . 0.0 OUTLIER -58.86 -18.08 29.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 99.99 112.017 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.478 ' HH ' ' HA ' ' B' ' 90' ' ' THR . 2.8 p90 -50.21 -38.09 38.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.682 0.277 . . . . 99.99 111.281 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.519 ' HE2' ' HG ' ' B' ' 86' ' ' SER . 11.0 tp10 -73.14 -40.57 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 99.99 110.651 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -64.68 -31.57 72.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 99.99 110.724 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' C' ' 104' ' ' PHE . 51.2 tp -62.14 -57.16 12.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.706 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 14.4 t -65.07 -36.3 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.808 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.12 47.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 99.99 111.205 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 27.6 ttt -89.36 -41.71 11.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.082 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -71.87 -34.62 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.972 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.436 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 99.2 mt -54.57 -53.2 62.73 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.078 0.399 . . . . 99.99 112.078 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.1 Cg_endo -70.53 -31.81 16.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.31 2.007 . . . . 99.99 113.044 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.38 -62.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.564 0.221 . . . . 99.99 111.543 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.516 ' HE1' HG21 ' C' ' 110' ' ' ILE . 0.9 OUTLIER -60.47 -56.55 20.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.73 0.3 . . . . 99.99 110.98 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -57.23 -22.31 40.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.953 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.29 -61.27 5.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.632 -0.794 . . . . 99.99 112.753 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.481 HD11 ' N ' ' B' ' 50' ' ' ALA . 3.3 pp -58.6 -22.74 57.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.625 0.25 . . . . 99.99 111.339 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.481 ' N ' HD11 ' B' ' 49' ' ' LEU . . . -64.96 -57.47 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 99.99 110.983 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.463 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 30.5 m-85 -63.67 -37.26 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.653 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -49.63 -38.51 32.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.147 0.499 . . . . 99.99 110.007 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.66 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 99.99 110.751 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 42.4 mtt -53.25 -24.91 12.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 99.99 110.527 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -77.13 -48.42 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 99.99 110.78 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.56 11.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 99.99 111.434 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 61.44 67.27 0.79 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.03 -0.532 . . . . 99.99 111.355 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -144.9 152.8 40.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.917 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.29 17.27 47.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.81 -0.709 . . . . 99.99 112.467 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -128.95 148.81 50.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 99.99 110.923 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.77 150.71 29.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.859 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.36 94.9 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.682 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.71 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.152 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.23 30.28 20.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.251 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.18 -15.64 48.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.857 -0.687 . . . . 99.99 112.913 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -98.37 146.81 25.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.801 0.334 . . . . 99.99 110.781 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 54.6 mt -86.2 131.14 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.263 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.9 143.29 32.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.436 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 72.3 m-70 -84.48 65.03 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.154 0.502 . . . . 99.99 110.682 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -63.82 -51.91 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.635 -0.712 . . . . 99.99 111.581 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.411 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -64.61 -22.46 66.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.933 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.436 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 22.4 tpp180 -68.46 -51.62 41.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.257 0.465 . . . . 99.99 112.257 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' B' ' 77' ' ' MET . 6.0 p90 -76.33 -34.4 58.99 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.147 0.425 . . . . 99.99 112.147 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.411 HG22 ' O ' ' B' ' 71' ' ' ALA . 18.2 tt -55.39 -43.74 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 120.656 -0.417 . . . . 99.99 110.623 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.67 -19.96 64.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.424 -0.584 . . . . 99.99 109.424 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -88.43 4.14 47.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.517 -0.765 . . . . 99.99 111.306 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.445 ' HG2' HG22 ' B' ' 113' ' ' ILE . 31.8 mtp -101.65 -20.42 15.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.343 -0.39 . . . . 99.99 110.383 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.413 ' O ' HD23 ' B' ' 82' ' ' LEU . 32.7 m -113.92 -29.86 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 99.99 111.87 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.426 HG22 HG22 ' B' ' 43' ' ' ILE . 30.6 m -81.3 -51.38 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.933 0.345 . . . . 99.99 111.933 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.575 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 21.8 m -52.27 -50.61 78.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.114 0.413 . . . . 99.99 112.114 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.4 Cg_exo -53.75 -49.32 17.62 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.785 1.657 . . . . 99.99 111.729 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.413 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -64.27 -31.25 72.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.717 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.54 -35.26 79.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.154 0.502 . . . . 99.99 109.956 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -84.27 -35.7 23.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 99.99 111.236 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 88.1 mt -58.61 -41.24 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.054 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' SER . . . . . 0.519 ' HG ' ' HE2' ' B' ' 36' ' ' GLU . 35.1 t -59.02 -28.65 66.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.827 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 mt -67.47 -32.32 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 99.99 110.905 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -72.93 -39.38 66.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.294 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -70.26 -24.69 63.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 99.99 111.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' THR . . . . . 0.478 ' HA ' ' HH ' ' B' ' 35' ' ' TYR . 32.6 m -78.62 -30.95 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 99.99 111.178 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.27 -25.41 25.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.187 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -132.81 99.36 4.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.815 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.28 -50.97 63.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.984 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -104.77 143.38 33.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 99.99 110.732 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 tt -124.9 142.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.887 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.426 ' HG2' ' HG3' ' B' ' 97' ' ' LYS . 38.7 ttpt -128.31 -70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 99.99 111.104 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.426 ' HG3' ' HG2' ' B' ' 96' ' ' LYS . 29.9 mtpp -141.81 95.84 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.03 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -170.24 83.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 99.99 110.907 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -106.49 14.24 27.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.721 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 2.8 t -91.15 -42.0 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 99.99 111.424 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.15 -47.07 59.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.157 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -63.2 -32.33 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.391 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.35 -31.81 33.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.729 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.09 -36.65 72.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 99.99 111.002 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' B' ' 84' ' ' LEU . 88.0 mt -74.84 -44.27 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.063 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.7 ttp -65.53 -37.38 86.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 99.99 111.351 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' SER . . . . . 0.522 ' HG ' ' H ' ' B' ' 108' ' ' THR . 80.9 p -65.7 -50.36 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.343 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.522 ' H ' ' HG ' ' B' ' 107' ' ' SER . 35.9 p -56.79 -34.33 67.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.32 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -61.52 -47.32 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 99.99 111.139 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.531 HG23 ' HE1' ' A' ' 46' ' ' TRP . 54.5 mt -54.85 -35.09 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 99.99 110.605 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 t -65.52 -47.32 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 99.99 111.094 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.56 -47.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.212 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.445 HG22 ' HG2' ' B' ' 77' ' ' MET . 47.0 mt -58.15 -33.26 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.996 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.1 m -58.89 -48.65 80.65 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.979 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.5 m -67.3 -23.23 65.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.974 -0.557 . . . . 99.99 110.852 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.35 -32.48 34.63 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.92 -0.657 . . . . 99.99 113.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.495 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.4 pp -80.85 -28.89 35.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.706 0.289 . . . . 99.99 111.206 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.495 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.55 -31.25 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.385 . . . . 99.99 111.321 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.91 -47.06 74.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.299 -0.41 . . . . 99.99 110.957 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 -21.12 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.716 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' B' ' 118' ' ' ILE . 98.8 mt -81.64 14.79 2.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.831 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 79.0 p -61.24 134.5 57.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 99.99 111.024 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -117.52 -45.21 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.832 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 59.4 ttp180 -108.23 132.66 53.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.64 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.7 -19.0 63.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 99.99 111.252 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.518 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 52.4 t-105 -71.26 -53.65 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.401 -0.363 . . . . 99.99 110.868 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' B' ' 124' ' ' ARG . 7.3 p -74.86 -24.09 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.106 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -52.42 -39.67 61.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 99.99 111.2 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -71.34 -32.59 68.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.391 . . . . 99.99 111.384 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.58 -56.84 6.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.189 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -58.01 -29.97 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.416 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.26 -53.27 57.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 99.99 110.725 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.85 -31.03 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.775 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.48 -34.34 75.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 99.99 110.859 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.05 -55.02 8.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.824 -0.703 . . . . 99.99 112.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m -59.83 -32.94 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 99.99 110.955 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.3 t -65.61 -36.74 84.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.613 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.21 91.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.627 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -68.27 -23.23 64.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 99.99 110.787 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -58.82 5.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 99.99 110.802 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 31.7 pt -62.6 -40.15 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 99.99 111.503 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 87.6 mt -64.61 -33.99 66.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 99.99 110.909 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.75 -45.0 95.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 99.99 110.942 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.81 -25.53 65.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.286 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.92 -35.66 21.01 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 99.99 112.746 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.6 -22.47 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 99.99 110.454 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -87.08 4.65 41.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 99.99 111.015 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.008 -0.542 . . . . 99.99 112.147 -179.365 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.018 0.437 . . . . 99.99 110.729 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -80.6 -25.16 38.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 99.99 111.101 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -75.28 -38.48 60.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 99.99 110.97 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -79.95 -21.6 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.791 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 48.7 tp -81.34 -46.12 15.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 99.99 111.464 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.35 -33.77 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 99.99 112.282 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 9.9 t -51.73 -41.48 61.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.617 0.246 . . . . 99.99 111.282 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . 0.407 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 37.3 m-85 -77.02 -40.3 46.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 99.99 110.709 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -62.11 -23.24 66.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.865 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 28.0 m -79.31 -50.8 10.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.577 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.51 -28.94 41.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.986 0.365 . . . . 99.99 111.986 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 77.5 mt -76.27 -57.02 4.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.905 0.383 . . . . 99.99 111.213 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -32.47 56.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.89 -0.596 . . . . 99.99 111.224 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.443 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 19.1 tt -87.4 -19.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.451 . . . . 99.99 110.385 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.26 59.45 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.742 -0.663 . . . . 99.99 112.953 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 84.5 m-85 -58.22 -54.86 51.42 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.782 0.291 . . . . 99.99 111.342 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -45.26 -32.44 7.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.164 1.91 . . . . 99.99 112.685 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.432 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.4 mt -65.62 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.462 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 35.2 m -60.23 -27.01 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.404 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -62.93 -25.91 68.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 99.99 111.178 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.27 -40.93 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 99.99 110.716 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.59 -179.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 99.99 110.798 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.414 0 C-N-CA 120.748 -0.739 . . . . 99.99 112.695 179.86 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.857 0.361 . . . . 99.99 110.833 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.23 -60.65 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.879 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 8.1 t -62.17 -36.83 83.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 99.99 111.152 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.69 -27.46 64.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.758 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -75.89 -50.35 15.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 99.99 111.049 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -73.02 -5.85 41.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.565 -0.289 . . . . 99.99 110.843 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.425 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 60.8 m -96.48 -41.86 8.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.267 0.556 . . . . 99.99 110.472 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.51 -38.38 74.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.578 -0.737 . . . . 99.99 111.909 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.659 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.3 tp -58.3 -53.94 60.95 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 120.961 -0.296 . . . . 99.99 111.321 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -53.62 -42.08 68.81 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.791 1.661 . . . . 99.99 111.399 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.09 -42.99 86.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 99.99 110.343 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -69.81 -30.19 67.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.457 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.504 . . . . 99.99 110.279 179.609 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.863 0.364 . . . . 99.99 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.79 96.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 99.99 112.339 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -69.47 -32.26 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.73 0.3 . . . . 99.99 110.875 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 49.2 m -59.91 -62.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.95 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.13 -20.33 65.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.589 . . . . 99.99 110.945 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.11 -54.18 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.279 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.98 -37.48 76.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 99.99 111.646 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.536 HD22 ' HD3' ' B' ' 30' ' ' ARG . 78.8 mt -59.16 -49.1 79.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 99.99 111.144 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -77.08 -20.53 55.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 99.99 111.051 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.28 -47.93 86.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.881 -0.676 . . . . 99.99 112.88 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.548 0.214 . . . . 99.99 111.033 -179.779 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.7 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.834 0.349 . . . . 99.99 110.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.68 -49.06 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 99.99 111.312 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.405 ' HB2' ' HB3' ' C' ' 55' ' ' ALA . 49.1 m-70 -64.72 -24.19 67.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 99.99 110.908 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -70.57 -50.03 41.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.399 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.48 -21.29 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.204 0.526 . . . . 99.99 109.932 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -58.99 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.49 -0.777 . . . . 99.99 110.413 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.97 -26.84 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 99.99 111.23 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.75 83.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.398 -0.365 . . . . 99.99 111.046 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.6 -23.81 77.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.831 -0.699 . . . . 99.99 112.499 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' MET . . . . . 0.408 ' HB3' ' HB2' ' C' ' 44' ' ' PRO . 18.9 mmt -77.89 -42.92 31.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.52 0.2 . . . . 99.99 111.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' THR . . . . . 0.496 ' HG1' ' H ' ' C' ' 17' ' ' ILE . 37.6 p -59.1 -50.94 72.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 99.99 110.893 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . 0.496 ' H ' ' HG1' ' C' ' 16' ' ' THR . 0.0 OUTLIER -62.56 -29.51 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.684 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.17 -61.59 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.861 -0.685 . . . . 99.99 112.702 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' C' ' 41' ' ' MET . . . -56.66 -31.95 64.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 99.99 111.127 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.5 mt -69.13 -29.05 67.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.247 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.26 -41.39 84.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.94 0.4 . . . . 99.99 110.596 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.94 -24.5 52.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 99.99 110.606 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -55.28 -43.17 74.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.295 -0.411 . . . . 99.99 110.631 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 44.2 t -82.73 -37.45 24.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.973 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 38.2 tp -77.42 -3.31 39.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.739 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 65.4 p -60.77 -23.62 65.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 99.99 110.928 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.6 -26.71 14.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.092 0.473 . . . . 99.99 109.771 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 14.6 t-20 -172.95 131.87 0.62 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 99.99 110.174 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 35.4 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 C-N-CA 123.147 2.564 . . . . 99.99 112.538 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . 0.492 ' HB2' ' CD1' ' C' ' 35' ' ' TYR . 38.8 Cg_exo . . . . . 0 N--CA 1.471 0.174 0 CA-C-O 121.394 0.498 . . . . 99.99 112.613 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -18.48 60.98 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.806 1.039 . . . . 99.99 113.806 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' C' ' 33' ' ' PRO . 6.5 p90 -54.79 -31.88 59.44 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.479 -0.489 . . . . 99.99 111.123 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.52 -54.56 11.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.918 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -65.18 -20.81 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 99.99 111.278 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.72 -61.48 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 99.99 110.036 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.44 -29.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 99.99 110.13 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.83 -8.85 57.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.82 -0.627 . . . . 99.99 110.807 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.425 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.1 ttt -89.02 -37.14 15.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 99.99 110.528 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 107' ' ' SER . 46.0 t80 -72.28 -29.81 64.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.7 -0.682 . . . . 99.99 111.841 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.481 HG23 HG23 ' C' ' 79' ' ' THR . 37.8 mm -60.22 -52.04 75.99 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 112.402 0.519 . . . . 99.99 112.402 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 64.1 Cg_endo -72.81 -34.55 6.66 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.348 2.032 . . . . 99.99 114.25 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.444 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.1 tp -63.17 -50.44 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.338 0.495 . . . . 99.99 112.338 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.609 ' HE1' HG23 ' A' ' 110' ' ' ILE . 1.0 OUTLIER -67.59 -58.77 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 99.99 111.345 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' C' ' 75' ' ' ASP . 89.6 p -56.64 -31.35 64.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 99.99 110.515 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.82 -57.03 19.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.986 -0.626 . . . . 99.99 112.773 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.28 -29.62 68.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.91 0.386 . . . . 99.99 110.881 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.73 95.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.974 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -69.51 -47.22 64.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.87 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 50.7 ttp -50.95 -28.23 9.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 99.99 110.457 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.446 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -74.24 -43.35 57.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.843 -0.617 . . . . 99.99 110.879 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.2 -26.42 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 99.99 110.612 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' C' ' 8' ' ' HIS . . . -77.74 -45.22 25.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 99.99 111.275 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' C' ' 53' ' ' ALA . 31.1 pt -79.45 4.86 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 99.99 111.3 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.2 68.03 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.861 -0.609 . . . . 99.99 111.377 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -149.54 136.59 19.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.822 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.28 4.84 23.53 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.712 -0.756 . . . . 99.99 112.356 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -114.22 152.68 30.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 99.99 110.872 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.18 145.47 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.61 91.2 8.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 99.99 110.796 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.02 105.94 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 99.99 111.208 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.95 36.33 24.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.367 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.43 -13.49 51.08 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 99.99 112.773 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -99.35 134.53 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 99.99 110.921 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 65.6 mt -76.59 137.25 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 99.99 111.006 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.72 143.12 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.073 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.462 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 59.0 m-70 -83.2 61.17 5.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.553 . . . . 99.99 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -60.64 -58.01 10.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 99.99 111.671 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.35 -22.44 66.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.324 0.49 . . . . 99.99 112.324 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.6 tpp180 -65.52 -51.6 58.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.101 0.408 . . . . 99.99 112.101 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -74.13 -29.42 61.81 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.875 -0.33 . . . . 99.99 111.123 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 mm -52.7 -50.53 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 120.853 0.358 . . . . 99.99 110.496 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.47 ' HD2' ' HB3' ' C' ' 47' ' ' SER . 34.7 t70 -66.66 -21.98 66.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.112 -0.495 . . . . 99.99 109.737 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.56 5.45 39.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.936 -0.574 . . . . 99.99 110.709 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 57.0 tpp -102.71 -21.81 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 99.99 110.389 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.443 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 2.5 p -113.73 -47.42 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.983 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.481 HG23 HG23 ' C' ' 43' ' ' ILE . 96.5 m -61.11 -53.64 54.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.163 0.431 . . . . 99.99 112.163 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.614 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 29.9 m -51.66 -54.48 39.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.449 0.537 . . . . 99.99 112.449 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 77.1 Cg_exo -49.3 -37.79 40.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.896 1.73 . . . . 99.99 112.143 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.404 HD21 ' O ' ' C' ' 78' ' ' VAL . 4.1 mm? -74.39 -38.39 63.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 99.99 110.63 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.82 -33.64 68.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.173 0.511 . . . . 99.99 109.99 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -80.31 -44.93 18.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.598 -0.728 . . . . 99.99 110.783 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.3 -32.81 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.681 -0.69 . . . . 99.99 111.443 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -62.14 -34.53 76.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 99.99 110.691 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.32 -44.46 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 99.99 110.9 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 43.4 t -65.83 -23.21 66.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.036 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -83.84 -26.72 29.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.666 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -77.1 -39.9 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 99.99 111.254 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.11 -44.29 54.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 99.99 111.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -111.79 101.76 10.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.825 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.44 -39.62 70.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 99.99 110.938 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -116.44 136.51 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.794 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.03 144.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.035 -0.53 . . . . 99.99 110.802 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -126.21 -65.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.078 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -149.09 110.0 4.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.379 . . . . 99.99 110.846 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -144.26 -84.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.902 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 90.9 m95 53.82 24.79 4.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.3 -0.409 . . . . 99.99 111.256 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 38.8 p -120.4 -51.93 2.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.907 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 68.1 tp -72.27 -53.1 13.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.768 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 13.5 tt -56.55 -32.77 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.033 -0.531 . . . . 99.99 111.314 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.8 -35.17 22.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 99.99 112.617 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' B' ' 38' ' ' LEU . 90.1 t80 -70.3 -29.76 66.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 99.99 111.091 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.508 ' HB3' HD23 ' C' ' 84' ' ' LEU . 95.7 mt -79.42 -50.45 10.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 99.99 111.134 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -61.53 -30.92 70.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.972 -0.558 . . . . 99.99 111.094 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 95.6 p -68.95 -52.82 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.066 0.46 . . . . 99.99 110.747 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 67.7 p -60.7 -23.96 65.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 99.99 110.677 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.7 -50.37 67.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.033 -0.531 . . . . 99.99 110.319 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.516 HG21 ' HE1' ' B' ' 46' ' ' TRP . 43.9 mm -55.85 -33.09 33.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 99.99 110.476 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.89 -45.93 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 99.99 110.797 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.64 -47.53 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.945 -0.571 . . . . 99.99 111.217 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 29.8 mt -60.15 -31.91 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.057 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 22.7 m -59.49 -48.17 82.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.022 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 44.1 m -70.15 -20.29 63.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 99.99 110.965 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.11 -33.09 30.17 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.837 -0.697 . . . . 99.99 113.26 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.517 HD11 ' N ' ' C' ' 118' ' ' ILE . 3.3 pp -79.89 -29.82 40.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.717 0.258 . . . . 99.99 111.592 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.517 ' N ' HD11 ' C' ' 117' ' ' LEU . 8.5 tp -83.81 -26.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 99.99 111.181 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.35 -40.99 68.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.169 -0.468 . . . . 99.99 111.049 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 -17.56 48.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.903 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.57 34.77 0.88 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 99.99 111.03 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 94.4 p -91.53 131.29 37.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.942 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -101.44 -53.64 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.901 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . 0.52 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 50.9 ttp180 -89.6 137.0 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.497 . . . . 99.99 111.022 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.99 -24.6 65.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 99.99 111.188 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . 0.52 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 66.7 t-105 -71.06 -57.24 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 99.99 110.75 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.502 HG12 ' HB3' ' C' ' 124' ' ' ARG . 11.5 p -63.9 -23.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.513 . . . . 99.99 110.725 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -57.78 -36.57 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 99.99 110.948 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -75.3 -18.16 60.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 99.99 110.682 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.03 -42.32 19.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.235 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -72.94 -31.09 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 99.99 111.371 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' C' ' 183' ' ' TRP . 66.6 t80 -60.66 -55.38 34.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 99.99 110.937 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.6 tt -60.94 -31.14 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.021 -0.536 . . . . 99.99 111.078 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.55 -31.49 72.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 99.99 110.724 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -53.02 15.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.868 -0.682 . . . . 99.99 112.775 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 22.2 m -60.54 -38.65 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 99.99 111.219 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . 0.411 ' HA ' HD11 ' C' ' 140' ' ' LEU . 67.3 m -56.33 -42.5 77.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.894 0.378 . . . . 99.99 110.823 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.14 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.905 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.849 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' C' ' 137' ' ' CYS . 96.3 mt -66.81 -53.24 34.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 99.99 111.09 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 33.1 pt -66.4 -31.88 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.451 -0.341 . . . . 99.99 111.418 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.89 -29.69 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.882 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.98 -37.08 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.745 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -76.07 -29.48 58.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 99.99 110.746 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.06 -27.52 49.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 99.99 112.471 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 tt -84.28 -21.51 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.057 0.456 . . . . 99.99 110.298 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -87.72 3.21 48.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 99.99 110.53 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.823 -179.326 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 CA--C 1.521 -0.159 0 CA-C-O 120.946 0.403 . . . . 99.99 110.784 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -26.16 63.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 99.99 110.991 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.05 -59.52 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.64 -26.06 63.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.14 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.86 -54.67 38.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 99.99 110.905 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.48 -28.22 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.287 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 43.5 m -52.66 -58.52 6.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.483 -0.326 . . . . 99.99 111.198 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -63.56 -38.95 93.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.53 -0.304 . . . . 99.99 110.479 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.04 -25.18 65.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.004 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 46.6 m -79.43 -49.16 12.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 99.99 111.722 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.3 -41.28 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 111.736 0.272 . . . . 99.99 111.736 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' C' ' 209' ' ' SER . 4.4 mm? -71.09 -55.72 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.855 0.317 . . . . 99.99 111.855 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -54.16 -34.63 60.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.456 -0.338 . . . . 99.99 111.528 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.45 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.43 -19.3 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 99.99 110.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.77 -44.85 95.59 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.74 -0.663 . . . . 99.99 112.806 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.611 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 82.1 m-85 -62.48 -55.98 34.42 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.704 0.252 . . . . 99.99 111.069 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 83.2 Cg_exo -48.32 -27.93 10.61 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.999 1.799 . . . . 99.99 112.453 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.43 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -69.12 -59.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 99.99 111.127 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.544 HG11 HD21 ' C' ' 201' ' ' LEU . 17.2 m -61.59 -24.76 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.006 -0.543 . . . . 99.99 111.203 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . 0.406 ' HB3' ' HE2' ' C' ' 132' ' ' TYR . 31.9 m95 -66.41 -22.75 66.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.727 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.53 -27.48 42.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.079 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.262 -0.427 . . . . 99.99 111.115 179.806 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.657 0.265 . . . . 99.99 111.243 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 7.3 tp -56.03 -36.1 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.301 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.68 -58.34 7.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.03 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 75.0 p -64.07 -20.45 65.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.049 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.26 -31.17 58.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.9 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . 0.544 HD21 HG11 ' C' ' 182' ' ' VAL . 6.1 tt -68.7 -52.02 35.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 99.99 110.598 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.05 -2.43 18.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 99.99 110.935 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 11.6 t -96.68 -46.72 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.39 0.614 . . . . 99.99 110.862 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.52 -39.52 74.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.158 -0.928 . . . . 99.99 112.134 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.656 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 45.2 tp -56.57 -54.31 54.94 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 121.031 -0.268 . . . . 99.99 111.504 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.2 Cg_exo -54.76 -41.35 78.89 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.902 1.734 . . . . 99.99 111.408 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.96 -42.43 94.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.378 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -70.78 -22.95 62.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.277 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 209' ' ' SER . . . . . 0.452 ' HB2' HD13 ' C' ' 175' ' ' LEU . 47.6 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 99.99 110.364 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.686 0.279 . . . . 99.99 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.7 61.18 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.86 -0.686 . . . . 99.99 112.634 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -64.9 -22.86 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.615 0.245 . . . . 99.99 111.312 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.3 m -63.3 -60.3 3.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 99.99 110.621 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.9 -24.78 63.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.619 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.69 -55.22 32.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.086 -0.507 . . . . 99.99 110.842 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.35 -32.3 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.073 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.27 -52.0 66.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.315 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -80.01 -19.47 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.207 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.55 75.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.041 -0.599 . . . . 99.99 113.372 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.798 0.299 . . . . 99.99 111.216 -179.77 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.726 0.298 . . . . 99.99 111.054 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.82 -43.55 83.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 22.1 m80 -68.32 -24.14 64.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.372 . . . . 99.99 110.675 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -72.31 -51.71 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.146 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.52 -21.09 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.277 0.56 . . . . 99.99 110.005 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.6 OUTLIER -63.96 -63.18 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.578 -0.737 . . . . 99.99 110.927 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.7 -33.75 18.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.021 -0.536 . . . . 99.99 111.587 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.87 98.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 99.99 111.107 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.13 -22.55 78.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.729 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 86.8 mmm -76.08 -44.36 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.785 0.326 . . . . 99.99 111.041 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.9 p -58.29 -49.87 75.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 99.99 111.061 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -29.4 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.699 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.48 -57.87 17.22 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.941 -0.647 . . . . 99.99 112.751 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.95 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 99.99 110.956 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -67.19 -36.78 82.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.958 -0.565 . . . . 99.99 110.827 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -61.67 -49.3 77.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 99.99 110.818 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.405 ' O ' ' OG ' ' A' ' 26' ' ' SER . 96.8 m-85 -68.74 -22.06 64.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.026 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 26' ' ' SER . 87.5 t90 -68.21 -32.62 72.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 99.99 110.654 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 m -78.74 -35.69 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.808 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 tp -83.72 -1.36 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 99.99 110.756 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.418 ' HG ' ' HA ' ' A' ' 23' ' ' TRP . 1.2 m -61.85 -26.21 67.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.453 . . . . 99.99 110.871 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -47.76 -35.91 10.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.159 0.504 . . . . 99.99 109.876 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.6 p-10 -164.61 131.72 2.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 99.99 110.034 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 39.6 Cg_endo -95.86 -176.35 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.097 2.531 . . . . 99.99 112.474 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.21 28.51 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 99.99 111.022 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.45 -28.5 6.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.8 -0.714 . . . . 99.99 112.795 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.47 HG21 HD21 ' A' ' 221' ' ' LEU . 71.4 t -83.62 123.21 76.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.511 0.196 . . . . 99.99 111.316 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 34.2 Cg_exo -58.92 161.63 15.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.442 2.095 . . . . 99.99 112.003 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.466 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -59.61 -17.94 37.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 99.99 112.079 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HH ' ' HA ' ' A' ' 90' ' ' THR . 2.6 p90 -49.71 -36.85 26.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.867 0.365 . . . . 99.99 110.997 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.81 -36.36 62.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.322 -0.399 . . . . 99.99 110.668 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.25 -37.67 86.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.382 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' B' ' 100' ' ' THR . 40.8 tp -60.77 -57.8 11.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.549 . . . . 99.99 111.241 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.06 -44.62 97.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.488 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -10.17 54.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 99.99 111.823 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.41 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 28.1 ttt -89.44 -33.34 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 99.99 111.067 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -75.38 -29.25 59.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 99.99 112.241 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.46 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 67.0 mt -64.08 -49.99 71.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.519 0.563 . . . . 99.99 112.519 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 75.1 Cg_endo -74.4 -38.07 2.15 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.646 2.231 . . . . 99.99 114.324 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 46' ' ' TRP . 45.1 pt -61.88 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.28 0.474 . . . . 99.99 112.28 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.54 ' HE1' HG21 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -70.27 -58.76 3.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 99.99 110.869 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.4 p -51.29 -44.16 61.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 99.99 111.091 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.0 -53.25 27.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 99.99 112.866 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.1 mt -57.44 -34.59 69.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 99.99 110.907 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.69 96.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.342 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 69.2 m-85 -61.75 -49.37 76.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 99.99 110.787 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.49 ' HE1' ' HB2' ' B' ' 134' ' ' CYS . 34.4 ttp -50.48 -34.93 26.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 99.99 110.504 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.88 89.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 99.99 111.301 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -55.59 -33.9 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.413 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -72.99 -40.71 65.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 99.99 111.113 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.63 -15.59 19.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.968 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.509 ' HA ' ' HZ2' ' A' ' 60' ' ' LYS . 14.6 t70 63.34 39.43 9.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.724 -0.671 . . . . 99.99 110.991 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.45 150.27 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 99.99 110.874 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.9 -16.52 46.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.84 -0.695 . . . . 99.99 112.161 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HZ2' ' HA ' ' A' ' 57' ' ' ASP . 8.5 ptpp? -99.38 144.17 28.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.33 . . . . 99.99 110.734 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.54 138.63 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 99.99 111.038 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -92.35 92.81 8.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.865 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.5 121.01 33.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 99.99 111.069 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.28 28.15 16.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 99.99 111.135 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.57 28.94 45.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 99.99 112.436 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -132.84 119.46 20.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 99.99 110.735 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.0 pt -80.08 136.32 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.635 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.88 143.91 37.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 99.99 111.464 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.458 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 12.4 m-70 -86.59 53.73 2.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.315 0.579 . . . . 99.99 110.695 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 74' ' ' ILE . 58.9 t80 -56.25 -59.18 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 99.99 111.893 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.54 66.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.858 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HG3' ' HZ3' ' A' ' 76' ' ' TRP . 12.4 tpp180 -58.82 -52.8 64.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.585 -0.279 . . . . 99.99 111.726 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.515 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 10.1 p90 -77.53 -17.94 57.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.713 -0.395 . . . . 99.99 111.088 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.0 mm -55.5 -41.59 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 109.36 -0.608 . . . . 99.99 109.36 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.58 -20.62 66.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.365 -0.834 . . . . 99.99 110.026 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.515 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -78.88 -21.85 46.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 99.99 111.13 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.496 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 2.3 mtp -90.07 -6.17 55.79 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.468 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.427 HG21 ' CE3' ' A' ' 46' ' ' TRP . 32.8 m -114.81 -31.18 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.507 0.558 . . . . 99.99 112.507 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 m -89.95 -58.45 2.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.157 0.429 . . . . 99.99 112.157 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.561 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -51.92 -51.31 72.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.903 0.705 . . . . 99.99 112.903 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 53.7 Cg_exo -53.91 -55.79 3.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.801 1.668 . . . . 99.99 112.288 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.42 -27.11 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.514 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -36.06 79.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.334 0.588 . . . . 99.99 109.831 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 105' ' ' LEU . 6.9 tt -84.4 -20.32 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.289 -0.869 . . . . 99.99 110.86 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.4 mt -80.15 -39.85 28.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.385 -0.37 . . . . 99.99 111.043 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.404 ' HA ' ' HD1' ' A' ' 89' ' ' TRP . 48.1 t -59.33 -20.61 56.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.929 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.12 -32.33 63.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 99.99 110.968 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -72.42 -38.52 68.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.197 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.404 ' HD1' ' HA ' ' A' ' 86' ' ' SER . 96.9 m95 -62.37 -49.84 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.424 . . . . 99.99 111.17 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.51 ' HA ' ' HH ' ' A' ' 35' ' ' TYR . 7.5 t -66.1 -23.5 66.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.213 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 -3.19 59.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 99.99 111.348 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.7 mtt -127.98 110.14 12.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -87.67 -26.29 23.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.771 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -144.76 139.4 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 99.99 110.74 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.62 HG13 ' HD2' ' A' ' 98' ' ' ASP . 18.2 tt -140.53 146.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 99.99 111.305 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -129.69 -70.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.749 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -144.83 87.1 1.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.951 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.62 ' HD2' HG13 ' A' ' 95' ' ' ILE . 2.8 p30 -158.42 124.15 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.952 0.406 . . . . 99.99 111.006 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -131.43 20.02 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 99.99 110.996 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.509 HG23 HD21 ' C' ' 38' ' ' LEU . 90.5 m -80.53 -47.85 13.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.357 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.66 -57.96 3.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.223 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.2 pt -59.61 -24.06 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.219 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.91 -38.92 10.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.896 -0.668 . . . . 99.99 112.546 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.4 -39.8 85.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 99.99 110.855 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HB3' HD21 ' A' ' 84' ' ' LEU . 71.3 mt -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.915 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 ttt -57.41 -35.45 70.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.869 -0.605 . . . . 99.99 110.895 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 t -63.61 -57.24 10.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.356 -0.384 . . . . 99.99 111.152 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.2 p -57.36 -19.48 23.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 99.99 111.681 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 6.2 tp-100 -77.54 -52.53 8.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.794 0.33 . . . . 99.99 111.081 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.581 HG22 ' HE1' ' C' ' 46' ' ' TRP . 63.6 mt -52.19 -36.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 99.99 111.856 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.02 -37.67 53.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 121.054 -0.258 . . . . 99.99 111.222 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.61 -28.47 40.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.906 0.384 . . . . 99.99 110.847 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.94 -49.01 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 99.99 110.658 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 54.7 m -52.41 -37.93 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.445 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 61.5 m -60.3 -56.86 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 99.99 110.183 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.84 -11.63 58.21 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.887 -0.673 . . . . 99.99 112.18 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 tt -74.65 -54.29 7.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.946 0.403 . . . . 99.99 110.523 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.73 -24.01 7.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.033 -0.53 . . . . 99.99 111.525 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.73 -40.76 66.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 99.99 110.812 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.5 -19.52 42.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.657 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.73 20.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.752 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.4 p -85.63 119.01 25.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 99.99 110.862 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 10.2 pt-20 -78.52 -23.29 46.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.808 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HG3' ' HG3' ' A' ' 123' ' ' GLU . 71.7 mtp180 -111.3 149.04 31.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 99.99 110.657 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.78 -9.42 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.893 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -90.16 -49.38 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -58.39 -28.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.34 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -60.53 -32.45 71.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.986 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.35 -33.04 74.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 99.99 111.005 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 127' ' ' VAL . 3.1 mm? -72.95 -50.3 24.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.807 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -67.34 -23.77 65.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.801 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -70.62 -52.96 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.069 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.0 pt -57.41 -29.2 32.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 99.99 110.902 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.1 t -67.26 -40.42 86.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 99.99 110.805 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -47.49 63.41 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.813 -0.708 . . . . 99.99 112.694 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.31 -29.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 99.99 111.173 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 40.7 t -57.86 -51.8 68.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.49 -28.33 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 99.99 110.953 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -68.99 -23.83 64.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.031 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.53 -53.02 7.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.599 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.7 pt -60.03 -37.93 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 99.99 111.784 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.5 tt -67.84 -44.91 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.643 0.258 . . . . 99.99 111.295 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 41.6 tp -55.74 -49.12 73.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 99.99 110.904 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.512 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 59.8 t-105 -68.01 -26.32 65.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.759 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.94 -17.13 68.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.877 -0.678 . . . . 99.99 113.013 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.5 pt -104.48 -8.23 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.339 . . . . 99.99 111.646 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -86.14 -23.22 26.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.734 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.46 -0.337 . . . . 99.99 111.759 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.917 0.389 . . . . 99.99 110.672 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.29 -21.66 60.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 99.99 111.026 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.11 -41.44 97.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 99.99 111.359 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -82.51 -24.14 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 99.99 110.676 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.85 -35.81 57.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 99.99 111.387 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 15.0 p -73.34 -21.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.178 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.7 m -60.03 -57.93 10.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 99.99 110.915 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.92 -26.01 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.004 -0.544 . . . . 99.99 110.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.437 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 63.9 t80 -72.27 -31.36 65.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 99.99 111.116 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 97.1 m -74.48 -50.88 16.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.518 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.66 -34.11 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.379 . . . . 99.99 111.705 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.5 tp -75.75 -53.99 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 99.99 111.362 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.97 -33.81 62.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.509 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 13.3 tt -87.64 -21.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 99.99 110.749 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.37 -57.34 20.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.084 -0.579 . . . . 99.99 113.226 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.543 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 74.3 m-85 -53.5 -54.17 48.6 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 111.668 0.247 . . . . 99.99 111.668 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.1 Cg_exo -46.28 -37.05 18.26 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.185 1.923 . . . . 99.99 112.276 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 177' ' ' ILE . 91.4 mt -59.25 -61.01 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.235 -0.438 . . . . 99.99 111.213 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.2 m -62.44 -24.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.18 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -66.93 -37.7 84.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 99.99 111.214 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.532 HG21 HG21 ' A' ' 185' ' ' ILE . 73.1 mt -53.15 -79.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.365 -0.38 . . . . 99.99 111.111 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.532 HG21 HG21 ' A' ' 184' ' ' ILE . 2.8 pp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.926 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 77.1 mt . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.818 0.342 . . . . 99.99 111.132 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.71 -60.96 2.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.992 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.4 p -75.82 -34.85 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.107 -0.497 . . . . 99.99 111.253 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.22 -26.63 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.975 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 65.9 tp -81.18 -48.58 11.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -69.69 -11.25 60.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 97.5 m -96.74 -45.38 6.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.11 0.481 . . . . 99.99 110.975 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.9 tp -69.94 -34.8 73.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.763 -0.653 . . . . 99.99 112.244 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.632 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 53.6 tp -61.32 -53.57 61.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.775 0.287 . . . . 99.99 111.775 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.6 Cg_exo -55.17 -47.74 24.7 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.012 1.808 . . . . 99.99 111.95 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.89 -31.94 73.29 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.843 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -66.67 -31.05 71.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 99.99 110.566 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.349 179.541 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.695 0.283 . . . . 99.99 111.364 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.48 98.85 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.567 -0.825 . . . . 99.99 112.366 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.59 -28.15 62.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 99.99 110.818 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.4 m -58.23 -61.71 2.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.999 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -68.25 -20.39 64.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.96 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -70.07 -49.7 48.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.984 -0.553 . . . . 99.99 111.145 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.48 ' HD2' ' HB ' ' A' ' 90' ' ' THR . 20.4 t70 -62.15 -40.51 96.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.051 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.424 HD22 HG22 ' A' ' 32' ' ' VAL . 96.9 mt -58.95 -41.75 88.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.112 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -79.12 -20.51 48.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.01 -19.49 79.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.937 -0.649 . . . . 99.99 113.083 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.47 HD21 HG21 ' A' ' 32' ' ' VAL . 41.6 tp . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 99.99 111.001 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.691 0.281 . . . . 99.99 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.29 -27.99 68.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.873 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 90.8 m-70 -76.96 -25.71 53.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.024 -0.535 . . . . 99.99 110.493 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -76.22 -45.23 33.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.405 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 43.6 mm -67.8 -22.54 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.129 0.49 . . . . 99.99 110.296 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.418 ' O ' ' HG2' ' B' ' 15' ' ' MET . 29.4 t80 -66.66 -60.69 2.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.734 -0.667 . . . . 99.99 110.969 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.39 -35.98 20.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.156 -0.474 . . . . 99.99 111.345 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.77 90.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.406 -0.361 . . . . 99.99 111.248 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.91 -23.24 78.25 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.774 -0.727 . . . . 99.99 112.571 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 80.4 mmm -73.93 -40.58 63.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.558 0.218 . . . . 99.99 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p -62.32 -51.46 67.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 99.99 111.087 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.438 ' HA ' HD13 ' B' ' 20' ' ' LEU . 2.8 pp -62.5 -25.31 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.399 -0.364 . . . . 99.99 111.156 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.25 -59.03 11.08 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.735 -0.745 . . . . 99.99 112.474 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.21 68.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.872 0.367 . . . . 99.99 111.351 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' B' ' 17' ' ' ILE . 79.0 mt -68.17 -36.68 80.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.177 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -61.59 -50.07 74.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 99.99 110.604 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.478 ' O ' ' OG ' ' B' ' 26' ' ' SER . 99.4 m-85 -66.44 -23.18 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.637 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -68.48 -30.26 69.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.791 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 91.6 p -85.03 -29.79 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 99.99 110.64 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.49 -1.34 57.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.55 . . . . 99.99 110.489 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 1.8 m -63.86 -26.2 68.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.889 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -49.66 -32.6 13.49 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.132 0.491 . . . . 99.99 109.924 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -164.61 131.62 2.36 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.774 . . . . 99.99 110.158 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.423 ' HB3' ' HH ' ' B' ' 37' ' ' TYR . 51.9 Cg_endo -98.0 175.89 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.275 2.65 . . . . 99.99 112.882 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.24 35.19 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 99.99 110.866 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.46 -41.94 1.92 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.744 -0.741 . . . . 99.99 112.713 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . 20.8 m -71.09 136.22 84.78 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.57 0.224 . . . . 99.99 111.102 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' B' ' 32' ' ' VAL . 8.1 Cg_exo -73.37 166.25 30.39 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.877 2.385 . . . . 99.99 112.763 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -58.24 -20.09 39.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 99.99 113.05 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.437 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 3.2 p90 -60.04 -33.54 72.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.952 0.406 . . . . 99.99 110.974 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -69.77 -45.61 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.904 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.423 ' HH ' ' HB3' ' B' ' 29' ' ' PRO . 97.9 m-85 -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 99.99 110.944 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.91 -61.68 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 99.99 110.864 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.81 -36.24 77.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.066 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.43 -12.69 61.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 99.99 111.457 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 60.3 ttp -88.73 -36.19 16.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.485 -0.325 . . . . 99.99 111.442 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -71.64 -34.01 69.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.34 0.496 . . . . 99.99 112.34 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.427 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 88.0 mt -56.46 -52.99 68.94 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.59 0.589 . . . . 99.99 112.59 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 61.6 Cg_endo -72.03 -36.6 5.7 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.408 2.072 . . . . 99.99 113.704 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 28.5 mm -56.45 -62.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.81 0.3 . . . . 99.99 111.81 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.575 ' HE1' HG23 ' C' ' 110' ' ' ILE . 0.3 OUTLIER -60.54 -57.27 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.418 -0.356 . . . . 99.99 111.486 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -51.18 -37.2 45.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.518 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.56 73.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.394 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.19 -32.42 73.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 99.99 110.886 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.02 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.581 . . . . 99.99 111.073 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 19.5 m-85 -61.09 -44.33 97.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.876 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -50.96 -34.17 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.074 0.464 . . . . 99.99 110.167 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.36 81.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.598 -0.728 . . . . 99.99 110.792 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 49.1 mtt -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.524 . . . . 99.99 110.24 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -62.94 -49.03 76.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.866 -0.606 . . . . 99.99 110.342 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.24 -6.69 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.968 -0.56 . . . . 99.99 110.715 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 61.98 39.63 13.16 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.778 -0.647 . . . . 99.99 111.341 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -100.14 173.77 6.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.462 ' HA3' ' HB1' ' B' ' 71' ' ' ALA . . . 70.57 27.23 72.85 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.858 -0.687 . . . . 99.99 112.428 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.75 174.19 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 99.99 110.697 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.69 140.74 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.361 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -101.02 84.52 2.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.565 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.17 109.8 22.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.353 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.22 24.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 99.99 111.534 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 11.72 82.04 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.692 -0.766 . . . . 99.99 112.661 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -115.23 129.15 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 99.99 110.778 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.07 115.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 99.99 111.237 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.64 142.27 27.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 99.99 111.349 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 25.3 m-70 -92.43 59.14 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.057 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.41 -49.91 73.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 99.99 110.925 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.462 ' HB1' ' HA3' ' B' ' 59' ' ' GLY . . . -57.31 -27.76 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 99.99 111.008 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.404 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 4.9 tpp180 -63.05 -49.22 75.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.878 -0.601 . . . . 99.99 110.775 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.447 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -71.19 -18.06 62.5 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.921 -0.312 . . . . 99.99 111.443 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 36.3 mm -65.41 -40.99 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.063 0.458 . . . . 99.99 109.842 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.426 ' O ' HG22 ' B' ' 79' ' ' THR . 13.5 t70 -66.37 -14.39 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.657 -0.701 . . . . 99.99 110.238 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -85.54 -26.14 26.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.856 -0.611 . . . . 99.99 111.173 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.599 ' HG2' ' HB ' ' B' ' 113' ' ' ILE . 19.2 mtp -91.82 4.23 53.32 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.33 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 -29.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.414 0.524 . . . . 99.99 112.414 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' B' ' 83' ' ' LEU . 12.4 t -102.83 -43.71 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.102 0.408 . . . . 99.99 112.102 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.54 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 26.0 m -58.9 -50.84 85.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.221 0.452 . . . . 99.99 112.221 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.588 ' HA ' ' HG2' ' B' ' 109' ' ' GLN . 20.3 Cg_endo -60.62 -43.78 30.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.86 1.707 . . . . 99.99 111.898 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.421 HD12 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -73.46 -12.7 60.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.692 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' B' ' 79' ' ' THR . 0.2 OUTLIER -75.63 -43.99 44.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.782 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.455 HD11 ' N ' ' B' ' 85' ' ' LEU . 3.3 pp -80.18 -23.51 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.78 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.455 ' N ' HD11 ' B' ' 84' ' ' LEU . 50.7 mt -68.18 -39.09 82.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.444 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 46.6 t -61.81 -30.08 70.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 99.99 110.713 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 69.5 mt -75.73 -26.13 57.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.601 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' SER . . . . . 0.438 ' HG ' HD11 ' B' ' 105' ' ' LEU . 49.5 m -70.49 -41.26 72.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.823 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -70.12 -35.96 74.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.593 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 61.3 m -64.99 -33.28 75.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 99.99 110.945 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.95 -34.01 39.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.15 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.8 mmm -95.07 100.93 12.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 99.99 111.168 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -78.0 -33.47 51.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.887 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -137.82 135.06 35.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.418 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 47.0 pt -138.1 143.23 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.855 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -130.15 -56.96 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.13 73.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 99.99 111.122 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.41 134.66 20.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.852 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.84 22.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.609 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.441 ' HA ' HD22 ' A' ' 38' ' ' LEU . 90.7 m -80.92 -49.83 10.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.988 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.46 -34.92 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 99.99 110.925 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.73 -33.73 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.927 0.394 . . . . 99.99 110.798 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.54 -15.19 69.04 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.771 -0.728 . . . . 99.99 112.545 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -83.38 -42.79 16.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.785 0.326 . . . . 99.99 110.94 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.438 HD11 ' HG ' ' B' ' 88' ' ' SER . 91.0 mt -72.01 -45.43 60.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.946 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' MET . . . . . 0.426 ' O ' HG13 ' B' ' 110' ' ' ILE . 25.1 ttt -63.08 -39.62 95.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.727 -0.67 . . . . 99.99 111.269 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -64.14 -54.18 37.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.541 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 59.1 p -58.68 -21.45 54.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.615 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 48.7 tp60 -79.8 -35.89 37.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.44 -0.345 . . . . 99.99 111.384 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.54 HG21 ' HE1' ' A' ' 46' ' ' TRP . 68.5 mt -67.34 -34.87 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.693 0.282 . . . . 99.99 111.512 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 m -73.61 -35.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.584 -0.28 . . . . 99.99 111.506 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.2 -41.42 78.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.616 -0.265 . . . . 99.99 111.68 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.599 ' HB ' ' HG2' ' B' ' 77' ' ' MET . 26.7 pt -70.07 -31.53 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.64 -0.254 . . . . 99.99 111.419 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -60.94 -56.95 15.09 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.912 0.387 . . . . 99.99 110.526 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.5 p -55.97 -29.03 59.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.95 -0.568 . . . . 99.99 110.172 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.02 -47.25 84.48 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.85 -0.691 . . . . 99.99 111.951 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' B' ' 73' ' ' TYR . 56.9 mt -48.89 -58.39 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.155 0.502 . . . . 99.99 110.636 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 50.3 mm -67.56 -31.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.605 -0.725 . . . . 99.99 111.722 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.53 -40.73 62.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.897 0.379 . . . . 99.99 111.178 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.4 -17.54 30.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.794 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 83.3 mt -84.84 13.96 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 99.99 111.059 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 56.3 m -76.84 126.47 31.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 99.99 110.781 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 -21.92 27.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.81 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.635 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 38.4 ttm180 -116.66 137.32 52.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 99.99 110.806 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.08 -11.56 60.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 99.99 111.433 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.635 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 83.1 t90 -87.66 -51.62 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 99.99 110.941 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' B' ' 124' ' ' ARG . 14.9 p -61.03 -26.05 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 99.99 110.945 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -67.54 -24.49 65.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 99.99 110.882 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.66 -35.12 76.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.766 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . 0.4 HD12 ' N ' ' B' ' 130' ' ' LEU . 7.1 mp -68.78 -50.47 50.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.333 -0.394 . . . . 99.99 110.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.76 -35.63 75.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.419 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.74 -51.65 68.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.179 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.8 mm -53.93 -34.09 25.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.251 -0.431 . . . . 99.99 111.101 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.49 ' HB2' ' HE1' ' A' ' 52' ' ' MET . 49.8 t -66.73 -41.15 88.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 99.99 111.133 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.98 85.21 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.745 -0.74 . . . . 99.99 112.654 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.3 -28.75 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.808 0.337 . . . . 99.99 111.28 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 50.4 t -58.2 -49.65 76.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.017 0.437 . . . . 99.99 110.603 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.07 -47.96 80.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 99.99 110.785 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.27 -24.19 26.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.056 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -59.2 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.993 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 pt -65.68 -33.74 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.398 -0.365 . . . . 99.99 111.771 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.05 -37.12 76.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.47 -0.332 . . . . 99.99 111.313 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.3 -48.59 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.373 . . . . 99.99 110.866 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . 0.463 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 77.1 t90 -68.26 -22.74 64.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.808 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -18.99 62.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.905 -0.664 . . . . 99.99 112.652 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -106.67 -10.24 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.971 0.415 . . . . 99.99 110.938 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -78.85 -21.45 47.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.493 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' B' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 111.896 0.332 . . . . 99.99 111.896 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 120.987 0.422 . . . . 99.99 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.57 -22.78 60.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.79 -0.641 . . . . 99.99 111.078 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.8 -25.44 48.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.071 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -84.15 -38.18 20.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.427 . . . . 99.99 111.384 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.54 -25.74 38.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.488 -0.323 . . . . 99.99 111.856 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.36 -26.54 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 99.99 111.069 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.2 m -54.47 -58.75 6.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.273 -0.422 . . . . 99.99 111.132 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.39 -30.4 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.459 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.9 -25.82 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.908 -0.587 . . . . 99.99 110.889 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 29.3 m -79.56 -53.15 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 99.99 111.35 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 43.2 t -60.68 -27.03 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 50.8 tp -77.61 -55.61 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.233 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -30.27 61.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 99.99 111.267 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.435 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.6 tp -87.92 -24.71 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 99.99 110.878 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.0 -46.38 91.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.915 -0.659 . . . . 99.99 113.146 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.459 ' N ' ' HD2' ' B' ' 180' ' ' PRO . 61.6 m-85 -62.2 -55.4 40.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.26 0.467 . . . . 99.99 112.26 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 13.1 Cg_endo -56.69 -28.26 74.63 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.77 1.647 . . . . 99.99 112.461 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.435 HG13 ' O ' ' B' ' 177' ' ' ILE . 49.1 mt -60.71 -49.91 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.053 0.454 . . . . 99.99 110.238 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 13.0 m -77.55 -23.45 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.709 -0.678 . . . . 99.99 110.186 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -68.57 -15.22 63.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.277 -0.874 . . . . 99.99 112.605 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.421 HG21 ' O ' ' B' ' 181' ' ' ILE . 17.1 tt -103.14 -25.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.885 0.328 . . . . 99.99 111.885 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . 0.41 HG13 ' O ' ' B' ' 185' ' ' ILE . 20.3 pt -91.06 116.54 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.177 0.436 . . . . 99.99 112.177 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.153 0 CA-C-N 115.839 -0.619 . . . . 99.99 113.814 178.837 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.732 0.301 . . . . 99.99 111.38 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.37 -57.5 12.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.367 -0.379 . . . . 99.99 111.121 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 46.3 p -68.94 -37.98 79.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 99.99 111.112 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.56 -25.1 68.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.254 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.9 tp -77.36 -43.62 32.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 99.99 110.954 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.51 -9.42 58.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 99.99 111.458 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 98.9 m -96.37 -42.16 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.137 0.494 . . . . 99.99 110.719 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.97 -48.8 62.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 99.99 112.143 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.636 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 53.6 tp -49.6 -52.86 46.82 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 111.738 0.273 . . . . 99.99 111.738 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -54.56 -50.71 12.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.982 1.788 . . . . 99.99 111.904 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.5 -35.79 72.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.284 -0.416 . . . . 99.99 110.807 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -69.88 -29.28 66.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 99.99 110.684 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.822 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.858 0.361 . . . . 99.99 110.852 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.88 58.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 99.99 112.487 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -69.65 -23.22 63.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.666 0.269 . . . . 99.99 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.2 t -58.94 -58.28 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.887 0.375 . . . . 99.99 110.584 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -72.64 -20.42 61.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 99.99 110.814 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.4 -58.37 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 99.99 110.71 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -60.09 -32.05 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 99.99 110.622 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.79 -42.32 98.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.525 . . . . 99.99 111.086 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -87.39 -20.43 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.134 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.87 76.86 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.911 -0.661 . . . . 99.99 113.053 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' B' ' 32' ' ' VAL . 50.8 tp . . . . . 0 C--N 1.329 -0.304 0 O-C-N 122.739 -0.271 . . . . 99.99 110.976 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.446 HD12 ' N ' ' C' ' 6' ' ' LEU . 4.9 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.723 0.297 . . . . 99.99 110.697 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.4 -36.99 81.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.903 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 14.6 m170 -72.15 -24.09 61.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.649 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -73.83 -51.41 16.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.48 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -66.77 -19.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 99.99 110.388 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -65.53 -58.24 6.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.674 -0.694 . . . . 99.99 110.824 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . 0.464 HG11 ' N ' ' C' ' 13' ' ' ALA . 7.7 p -58.85 -35.98 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 99.99 111.141 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . 0.464 ' N ' HG11 ' C' ' 12' ' ' VAL . . . -60.35 -37.21 79.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.34 -0.391 . . . . 99.99 110.993 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.9 -28.71 60.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.827 -0.702 . . . . 99.99 112.586 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -35.55 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.56 0.219 . . . . 99.99 111.21 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 47.5 m -64.67 -50.45 67.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 99.99 110.57 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.85 -22.33 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.782 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -59.66 9.47 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.016 -0.611 . . . . 99.99 112.535 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -30.87 68.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.919 0.39 . . . . 99.99 110.492 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.18 -33.12 74.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 99.99 110.49 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.76 -53.29 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 99.99 110.582 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . 0.587 ' O ' ' OG ' ' C' ' 26' ' ' SER . 72.9 m-85 -65.19 -24.5 67.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 99.99 110.55 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . 0.512 ' HA ' ' HG ' ' C' ' 26' ' ' SER . 55.6 t90 -69.48 -27.21 65.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 99.99 110.705 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.4 m -84.69 -34.21 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.657 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.26 -1.51 57.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 99.99 110.453 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' C' ' 22' ' ' PHE . 1.4 m -60.72 -23.95 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 99.99 110.652 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -48.76 -36.93 17.57 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.231 0.538 . . . . 99.99 109.828 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.471 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 8.4 p30 -163.18 131.56 2.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.346 -0.843 . . . . 99.99 110.034 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.8 Cg_endo . . . . . 0 N--CA 1.452 -0.958 0 C-N-CA 123.028 2.485 . . . . 99.99 112.374 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 38.9 Cg_exo . . . . . 0 CA--C 1.527 0.171 0 CA-C-O 121.053 0.355 . . . . 99.99 112.509 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -62.31 -18.32 61.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.619 -0.719 . . . . 99.99 112.417 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.409 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.1 p90 -51.72 -34.73 40.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 99.99 111.367 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -76.27 -36.97 58.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 99.99 111.12 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -66.01 -35.14 79.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.368 -0.378 . . . . 99.99 111.005 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.509 HD21 HG23 ' A' ' 100' ' ' THR . 1.1 tm? -63.95 -56.71 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.651 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.71 -45.47 97.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 99.99 111.528 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.89 -12.11 52.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 99.99 111.695 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 26.9 ttt -89.58 -33.71 16.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.693 0.282 . . . . 99.99 111.606 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -75.71 -27.57 58.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.914 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.448 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 84.8 mt -64.87 -50.63 62.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.89 0.7 . . . . 99.99 112.89 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 72.1 Cg_endo -77.54 -33.01 2.58 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.422 2.081 . . . . 99.99 114.059 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.423 HG22 ' N ' ' C' ' 46' ' ' TRP . 19.5 tt -62.2 -48.74 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 99.99 111.904 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.581 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -70.78 -57.97 4.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.728 0.299 . . . . 99.99 110.727 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.416 ' HG ' ' N ' ' C' ' 48' ' ' GLY . 89.5 p -51.21 -42.27 60.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.908 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . 0.416 ' N ' ' HG ' ' C' ' 47' ' ' SER . . . -53.68 -49.29 58.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.914 -0.66 . . . . 99.99 112.572 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 84.9 mt -55.23 -40.16 70.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 99.99 110.929 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.82 88.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.17 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 72.4 m-85 -55.55 -50.47 69.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.361 -0.381 . . . . 99.99 110.99 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' MET . . . . . 0.447 ' O ' HG12 ' C' ' 56' ' ' ILE . 15.6 tmm? -49.66 -37.87 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 99.99 110.388 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.67 -38.4 83.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 99.99 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 55.4 mtt -54.8 -30.95 58.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 99.99 110.294 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 8' ' ' HIS . . . -75.93 -37.81 58.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.842 -0.617 . . . . 99.99 110.717 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.447 HG12 ' O ' ' C' ' 52' ' ' MET . 6.6 mm -77.96 -6.4 9.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.957 -0.565 . . . . 99.99 110.99 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . 0.428 ' HA ' ' HZ3' ' C' ' 60' ' ' LYS . 7.6 m-20 62.56 46.21 5.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 99.99 111.331 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -111.41 171.35 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 99.99 110.963 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 73.08 24.4 75.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 99.99 112.518 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.428 ' HZ3' ' HA ' ' C' ' 57' ' ' ASP . 6.7 ptpp? -137.03 146.47 45.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 99.99 110.966 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 141.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.161 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.01 87.96 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 99.99 110.851 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.51 122.46 33.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.102 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.08 31.39 16.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.105 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 29.99 53.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.841 -0.695 . . . . 99.99 112.628 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . 0.452 HE21 ' N ' ' C' ' 67' ' ' ILE . 23.3 tp60 -131.34 119.05 21.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 99.99 111.054 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . 0.452 ' N ' HE21 ' C' ' 66' ' ' GLN . 26.5 pt -81.72 128.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.95 140.62 38.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.267 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -95.61 55.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 99.99 110.834 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -63.05 -51.32 67.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 99.99 111.053 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.489 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -57.28 -25.85 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.958 0.408 . . . . 99.99 110.771 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -64.37 -48.23 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 99.99 110.801 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.592 ' HB3' HD21 ' C' ' 117' ' ' LEU . 0.2 OUTLIER -72.49 -19.56 61.52 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.858 -0.337 . . . . 99.99 111.534 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.53 -41.94 94.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.172 0.51 . . . . 99.99 109.699 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.44 -15.37 63.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.548 -0.751 . . . . 99.99 110.071 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.08 -20.45 32.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 99.99 111.335 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 8.7 mtm -99.54 4.99 46.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 99.99 111.423 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -114.67 -27.15 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.855 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -103.8 -34.86 8.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.288 0.477 . . . . 99.99 112.288 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.599 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 38.5 m -69.65 -50.76 17.51 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 111.84 0.311 . . . . 99.99 111.84 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.641 ' HA ' ' HG2' ' C' ' 109' ' ' GLN . 32.2 Cg_exo -59.36 -37.51 89.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.928 1.752 . . . . 99.99 112.28 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.448 HD13 HD12 ' C' ' 85' ' ' LEU . 4.4 mm? -78.29 -16.92 57.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 99.99 110.619 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -41.75 67.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 99.99 110.609 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.441 HD11 ' N ' ' C' ' 85' ' ' LEU . 3.9 pp -78.78 -32.33 46.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.819 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . 0.448 HD12 HD13 ' C' ' 82' ' ' LEU . 43.2 mt -61.5 -41.26 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.833 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.5 t -60.89 -29.91 69.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.02 -0.537 . . . . 99.99 110.783 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.445 HD23 HD11 ' C' ' 168' ' ' LEU . 59.9 mt -74.71 -27.3 60.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.891 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.0 t -69.2 -48.6 61.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 99.99 110.865 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -63.86 -32.74 74.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 99.99 111.048 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -66.51 -32.14 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.143 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.53 -4.7 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.379 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.3 mtm -118.09 98.91 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 99.99 110.992 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -87.42 -16.2 35.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 99.99 110.608 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -146.8 133.86 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.56 . . . . 99.99 110.584 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -146.21 142.48 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.94 0.4 . . . . 99.99 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -131.46 -68.28 0.66 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.958 -0.565 . . . . 99.99 110.539 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -138.93 87.17 2.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 99.99 110.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -163.09 121.53 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.971 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -134.93 19.38 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.663 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 64.4 p -76.63 -50.77 12.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 99.99 111.174 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.4 mt -70.12 -40.06 75.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 99.99 110.976 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.06 -41.93 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 99.99 111.063 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.21 -11.15 85.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 99.99 112.575 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -80.52 -41.22 24.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.706 0.289 . . . . 99.99 110.928 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.429 ' HB3' HD13 ' C' ' 84' ' ' LEU . 55.1 mt -74.8 -44.07 51.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.182 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' MET . . . . . 0.426 ' HG2' HD22 ' C' ' 85' ' ' LEU . 71.5 mtm -58.73 -54.27 48.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.307 -0.406 . . . . 99.99 111.285 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -52.23 -50.73 61.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 99.99 111.821 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 61.5 p -63.27 -24.69 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 99.99 111.798 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.641 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 8.0 tp-100 -80.82 -35.86 32.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 99.99 111.406 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.575 HG23 ' HE1' ' B' ' 46' ' ' TRP . 80.4 mt -65.63 -30.97 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 99.99 111.399 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.31 -37.2 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.606 0.241 . . . . 99.99 111.592 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.78 -41.4 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 111.887 0.329 . . . . 99.99 111.887 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 38.8 pt -69.4 -34.42 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.748 -0.206 . . . . 99.99 111.464 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -60.87 -54.59 43.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.872 0.367 . . . . 99.99 110.644 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.5 p -55.88 -29.56 60.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 99.99 110.057 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.06 63.72 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.991 -0.623 . . . . 99.99 112.011 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' C' ' 73' ' ' TYR . 81.8 mt -48.03 -61.13 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 99.99 110.627 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.16 -32.57 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.569 -0.741 . . . . 99.99 112.002 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.51 61.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.314 . . . . 99.99 111.348 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 -19.03 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.884 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' C' ' 117' ' ' LEU . 95.9 mt -83.26 17.68 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 99.99 110.992 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -89.78 117.76 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.368 . . . . 99.99 110.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.94 -31.13 61.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . 0.462 ' HB2' HG11 ' C' ' 127' ' ' VAL . 86.5 mtm180 -93.86 144.23 25.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.607 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.37 -13.12 58.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 99.99 111.382 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -86.37 -50.73 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 99.99 111.141 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' C' ' 124' ' ' ARG . 12.2 p -57.68 -24.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.371 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -62.61 -37.35 85.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.364 . . . . 99.99 111.055 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -60.9 -36.1 78.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.39 -0.368 . . . . 99.99 111.141 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.7 mm? -66.21 -52.63 46.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.124 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -64.93 -28.93 69.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.427 . . . . 99.99 111.45 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -65.42 -46.67 79.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.539 -0.301 . . . . 99.99 110.782 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.1 mm -58.75 -36.6 61.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 99.99 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -63.88 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 99.99 110.671 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -48.83 39.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.842 -0.694 . . . . 99.99 112.661 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -68.3 -27.06 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 99.99 111.119 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 54.0 t -64.4 -43.47 94.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.614 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . 0.409 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -68.94 -29.37 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.783 -0.644 . . . . 99.99 111.034 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -71.08 -29.63 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.992 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -70.14 -56.0 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 99.99 111.548 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 28.9 pt -55.71 -37.87 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.751 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.409 HG12 ' O ' ' C' ' 138' ' ' ALA . 44.0 mm -78.33 -33.32 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 99.99 111.411 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 44.5 tp -61.43 -51.33 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 99.99 110.576 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . 0.493 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 98.7 m95 -70.65 -21.28 62.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 99.99 110.463 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.38 67.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.845 -0.693 . . . . 99.99 112.575 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -102.35 -14.67 8.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 99.99 111.201 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -77.3 -33.49 55.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 99.99 111.699 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' C' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 112.003 0.371 . . . . 99.99 112.003 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.925 0.393 . . . . 99.99 111.027 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 99.99 111.068 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.15 -42.93 93.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 99.99 111.162 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.76 -25.04 35.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.091 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . 0.445 HD11 HD23 ' C' ' 87' ' ' LEU . 54.5 tp -76.89 -39.03 52.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.544 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 10.4 p -71.64 -16.43 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.324 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 41.9 m -57.68 -59.41 5.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.258 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -71.46 -31.75 67.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.381 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -57.21 -32.97 67.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 99.99 110.975 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 66.9 m -79.66 -43.3 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 99.99 111.494 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -58.3 -36.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 112.18 0.437 . . . . 99.99 112.18 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.464 ' HG ' ' HG ' ' C' ' 209' ' ' SER . 4.4 mm? -81.16 -47.39 13.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.729 -0.214 . . . . 99.99 111.489 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -30.87 63.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.301 . . . . 99.99 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.414 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 10.9 tp -88.01 -22.9 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.472 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.19 -57.8 17.39 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.839 -0.619 . . . . 99.99 113.37 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.558 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 88.4 m-85 -53.47 -54.85 40.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.692 0.246 . . . . 99.99 111.503 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 97.1 Cg_exo -44.37 -35.82 8.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.316 2.011 . . . . 99.99 112.833 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.404 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.0 mt -64.52 -61.14 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 99.99 111.537 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.401 HG21 ' O ' ' C' ' 179' ' ' TYR . 20.2 m -59.76 -24.56 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.454 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -67.19 -52.45 41.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 99.99 111.41 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.02 -41.74 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.211 0.448 . . . . 99.99 112.211 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 10.7 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 99.99 111.739 -179.383 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 74.9 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.919 0.39 . . . . 99.99 111.023 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.98 -27.88 36.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.959 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -49.76 -60.97 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.821 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 72.4 p -72.27 -18.63 61.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 99.99 111.69 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -74.89 -26.55 59.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 99.99 111.359 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.16 -47.93 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.478 -0.328 . . . . 99.99 111.699 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.51 -14.86 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.473 -0.33 . . . . 99.99 111.65 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.473 ' HG ' ' N ' ' C' ' 204' ' ' LEU . 20.7 p -96.66 -39.07 9.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 99.99 111.53 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . 0.473 ' N ' ' HG ' ' C' ' 203' ' ' CYS . 48.3 tp -71.88 -34.01 68.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.277 -0.419 . . . . 99.99 112.046 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.519 ' N ' ' HD2' ' C' ' 206' ' ' PRO . 56.4 tp -62.47 -52.94 61.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 111.971 0.36 . . . . 99.99 111.971 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' C' ' 205' ' ' LEU . 17.9 Cg_endo -58.21 -41.9 62.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.899 1.733 . . . . 99.99 111.762 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.35 -34.48 78.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 99.99 110.372 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -70.49 -27.51 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.382 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 209' ' ' SER . . . . . 0.464 ' HG ' ' HG ' ' C' ' 175' ' ' LEU . 48.2 t . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.61 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.859 0.361 . . . . 99.99 111.034 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.28 -50.43 62.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.932 -0.652 . . . . 99.99 112.748 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -66.11 -23.69 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 99.99 111.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.1 t -60.93 -62.46 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 99.99 110.72 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -69.26 -20.42 63.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 99.99 110.973 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.26 -59.14 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 99.99 110.601 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.59 -28.54 67.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.863 0.363 . . . . 99.99 110.936 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.42 -52.11 66.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.976 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.71 -20.46 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.913 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.54 -29.8 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 99.99 112.309 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 99.99 110.626 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 6' ' ' LEU . 5.5 mp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.818 0.342 . . . . 99.99 110.85 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.24 -50.38 60.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.064 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 68.3 m-70 -63.36 -25.0 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 99.99 110.973 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -70.04 -59.67 2.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.077 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -60.56 -19.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 99.99 110.437 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 207' ' ' PHE . 8.6 t80 -62.16 -58.58 7.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.672 -0.695 . . . . 99.99 110.731 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.47 -29.2 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.885 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.32 -46.93 88.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.166 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.91 -23.58 77.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.799 -0.715 . . . . 99.99 112.352 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.69 -38.21 54.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.703 0.287 . . . . 99.99 111.131 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.437 ' HG1' ' H ' ' A' ' 17' ' ' ILE . 43.4 p -62.79 -48.6 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.096 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' H ' ' HG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -62.4 -32.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 99.99 110.659 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.04 -54.52 30.94 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.783 -0.722 . . . . 99.99 112.698 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -35.31 76.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.749 0.309 . . . . 99.99 111.389 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 HD11 ' HA ' ' A' ' 17' ' ' ILE . 93.5 mt -62.54 -30.66 71.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 99.99 111.028 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -59.94 -31.9 70.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.692 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.504 ' HB2' ' HE1' ' A' ' 41' ' ' MET . 44.7 m-85 -75.14 -28.02 59.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.685 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -62.25 -39.64 93.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.061 0.458 . . . . 99.99 109.829 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.2 m -85.49 -28.25 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.758 -0.656 . . . . 99.99 110.7 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 56.8 tp -73.13 -18.23 61.31 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.02 -0.536 . . . . 99.99 110.653 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 p -62.52 -25.03 67.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 99.99 111.085 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -51.22 -32.59 24.46 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.093 0.473 . . . . 99.99 109.938 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.7 p-10 -165.42 132.01 2.17 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 99.99 110.304 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 29.3 Cg_endo -95.99 179.86 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.193 2.595 . . . . 99.99 112.139 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -103.48 65.58 0.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.339 -0.391 . . . . 99.99 111.276 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.76 -46.61 3.71 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.917 -0.659 . . . . 99.99 112.931 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.23 146.98 32.66 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.625 0.213 . . . . 99.99 111.235 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 34.6 Cg_exo -58.89 163.29 11.63 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.382 2.055 . . . . 99.99 112.085 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.21 -17.33 63.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.694 -0.685 . . . . 99.99 112.319 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 6.4 p90 -41.27 -40.92 1.76 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.738 0.304 . . . . 99.99 111.774 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.05 -45.41 77.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.886 0.374 . . . . 99.99 110.587 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.76 -19.37 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.55 . . . . 99.99 110.439 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.0 -55.06 28.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 99.99 110.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.83 -37.31 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.348 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.75 -10.67 59.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 99.99 110.618 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 22' ' ' PHE . 41.0 ttm -88.14 -28.91 20.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.81 -0.632 . . . . 99.99 110.487 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -72.8 -40.09 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.369 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.664 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 36.8 mm -50.22 -53.04 48.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 111.99 0.367 . . . . 99.99 111.99 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 15.7 Cg_exo -68.68 -33.73 20.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.196 1.931 . . . . 99.99 112.595 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.01 -62.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.632 0.253 . . . . 99.99 111.367 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.572 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -61.72 -57.97 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 99.99 111.017 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.713 ' HA ' ' HD2' ' A' ' 75' ' ' ASP . 35.8 t -54.2 -23.06 13.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 99.99 111.356 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.54 -66.12 2.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 99.99 112.524 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.1 mt -56.3 -29.15 60.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.293 . . . . 99.99 111.144 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.98 -57.61 12.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 99.99 111.222 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.573 ' HH ' HH12 ' A' ' 72' ' ' ARG . 20.8 m-85 -61.61 -42.48 98.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 99.99 111.472 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.22 -36.33 8.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.207 0.527 . . . . 99.99 110.349 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.541 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . . . -72.37 -40.21 67.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 99.99 110.9 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 54.2 mtt -53.54 -35.57 60.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.041 0.448 . . . . 99.99 110.17 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -67.75 -40.96 84.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.855 -0.611 . . . . 99.99 109.935 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.22 3.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.727 -0.67 . . . . 99.99 110.524 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.48 44.64 9.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.667 -0.697 . . . . 99.99 111.257 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 22.4 mm-40 -102.93 170.1 8.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.823 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.48 92.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 99.99 112.23 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -123.18 145.86 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 99.99 110.783 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.84 141.04 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.845 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.7 92.24 7.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.837 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.76 110.74 22.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 99.99 111.246 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.63 34.97 25.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 99.99 111.431 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.06 74.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.847 -0.692 . . . . 99.99 112.754 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -130.28 117.65 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 99.99 110.502 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 pt -69.23 127.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.154 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.38 144.56 35.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.225 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 93.4 m-70 -89.12 62.84 6.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.29 0.567 . . . . 99.99 110.989 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -56.77 -38.15 72.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.295 -0.866 . . . . 99.99 111.191 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.33 -22.21 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.053 -0.521 . . . . 99.99 111.82 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 5.3 tpm_? -66.5 -51.72 53.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 99.99 112.022 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.9 p90 -72.59 -34.04 67.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.654 -0.418 . . . . 99.99 110.712 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -55.47 -46.33 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.324 -0.398 . . . . 99.99 110.949 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.713 ' HD2' ' HA ' ' A' ' 47' ' ' SER . 37.8 t70 -65.68 -13.01 58.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.425 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -99.75 -0.26 40.33 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.813 -0.63 . . . . 99.99 111.528 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 55.0 ttm -104.59 -6.97 20.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 99.99 110.703 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.463 HG22 HG23 ' A' ' 79' ' ' THR . 27.2 m -114.39 -36.13 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 99.99 112.128 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 47' ' ' SER . 62.7 p -88.11 -44.71 10.73 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.339 0.496 . . . . 99.99 112.339 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.525 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.6 m -56.93 -51.29 82.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.156 0.428 . . . . 99.99 112.156 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 80' ' ' THR . 14.6 Cg_endo -56.85 -36.51 98.88 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.679 1.586 . . . . 99.99 111.168 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 85' ' ' LEU . 4.0 mm? -71.1 -34.18 70.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 99.99 109.934 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -68.34 -21.25 64.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 109' ' ' GLN . 20.8 tp -83.02 -23.88 33.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.142 -0.936 . . . . 99.99 109.713 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 82' ' ' LEU . 96.1 mt -84.02 -40.67 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.454 -0.794 . . . . 99.99 110.886 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.9 p -63.19 -45.44 91.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.956 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.57 -26.17 68.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 99.99 111.039 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.6 t -68.39 -50.94 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -65.78 -21.93 66.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.024 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.6 m -73.46 -37.51 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.353 -0.385 . . . . 99.99 110.967 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.84 -23.98 26.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.937 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.0 mmm -94.0 84.84 4.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 99.99 110.796 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -73.98 -19.34 60.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.126 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.78 133.58 43.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.287 -0.415 . . . . 99.99 110.996 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.3 pt -140.8 160.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.935 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -139.97 -70.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.997 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -142.4 14.64 2.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.388 . . . . 99.99 111.04 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.93 129.39 40.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.877 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 56.5 t90 -151.63 -13.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 99.99 110.926 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -82.94 -34.06 26.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.283 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.78 -48.47 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 99.99 110.897 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 16.0 tt -59.11 -25.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 99.99 111.158 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.44 -46.64 32.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.831 -0.7 . . . . 99.99 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -56.47 -37.93 71.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.63 0.252 . . . . 99.99 111.157 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.01 -51.79 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.721 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 84.8 mtp -60.8 -26.08 67.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.981 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.7 m -68.3 -58.72 3.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 99.99 111.139 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.515 HG21 HG23 ' A' ' 142' ' ' ILE . 97.5 m -53.37 -36.18 61.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.142 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.507 ' HB2' HD23 ' A' ' 84' ' ' LEU . 6.2 tp-100 -55.14 -51.69 65.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.69 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.8 mm -54.22 -35.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 99.99 111.139 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.77 -44.22 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 99.99 111.045 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.65 -52.26 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.7 mt -53.59 -30.68 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 99.99 111.08 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.426 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 54.5 m -64.07 -48.24 76.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 99.99 110.82 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.481 ' HG ' ' HA2' ' A' ' 135' ' ' GLY . 49.8 m -62.98 -21.51 66.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.962 -0.563 . . . . 99.99 110.476 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.7 9.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.862 -0.685 . . . . 99.99 112.938 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 73' ' ' TYR . 4.0 pp -76.82 -26.75 54.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.682 0.241 . . . . 99.99 111.268 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.1 mt -84.08 -38.1 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 CA-C-O 120.709 0.29 . . . . 99.99 111.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.18 65.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.281 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.64 -22.07 47.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.887 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.72 5.1 49.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.102 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -64.13 131.03 46.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 99.99 111.028 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.72 -3.06 14.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.126 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' HB2' HG12 ' A' ' 127' ' ' VAL . 72.2 mtm180 -129.83 141.04 50.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.871 0.367 . . . . 99.99 110.97 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 99.99 111.133 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -79.3 -41.07 28.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.496 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 124' ' ' ARG . 11.6 p -84.16 -23.66 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.576 . . . . 99.99 110.955 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -51.61 -40.28 59.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.09 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -75.1 -30.36 60.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 99.99 111.167 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 127' ' ' VAL . 87.9 mt -67.56 -58.49 4.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 99.99 111.354 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -63.03 -37.02 85.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.321 -0.4 . . . . 99.99 111.928 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -55.03 -54.16 46.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.844 0.354 . . . . 99.99 110.662 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.46 -30.54 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.658 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.2 t -62.77 -35.01 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.827 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' A' ' 115' ' ' SER . . . -71.17 -51.91 15.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.878 -0.677 . . . . 99.99 112.646 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.16 -29.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.68 0.276 . . . . 99.99 110.991 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.9 t -69.48 -36.59 76.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.684 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.54 68.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.912 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.13 -22.6 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.941 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -64.62 -62.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 99.99 111.227 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.1 pt -59.05 -46.39 91.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 99.99 112.26 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.515 HG23 HG21 ' A' ' 108' ' ' THR . 33.4 mm -64.34 -31.69 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.726 0.269 . . . . 99.99 111.726 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 62.7 tp -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 99.99 110.911 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -65.51 -21.89 66.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.411 . . . . 99.99 110.56 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.33 -17.35 71.68 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.84 -0.695 . . . . 99.99 112.835 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.05 -14.51 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.823 0.344 . . . . 99.99 111.109 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -66.65 -55.59 14.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.367 0.506 . . . . 99.99 112.367 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.328 -0.333 0 N-CA-C 112.62 0.6 . . . . 99.99 112.62 -179.09 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.833 0.349 . . . . 99.99 111.275 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -22.53 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.262 -0.426 . . . . 99.99 110.839 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.68 -32.48 71.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.006 0.431 . . . . 99.99 110.314 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 170' ' ' THR . 41.3 ttmt -78.33 -22.42 48.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.903 -0.589 . . . . 99.99 110.3 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.49 -56.45 4.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.646 . . . . 99.99 111.034 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.0 -34.68 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.677 -0.692 . . . . 99.99 112.088 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 167' ' ' LYS . 14.0 t -55.16 -34.09 63.52 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.957 0.408 . . . . 99.99 110.531 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -78.24 -28.52 47.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 99.99 110.032 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -73.36 -28.0 61.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.643 -0.708 . . . . 99.99 110.84 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.455 ' HG1' ' H ' ' A' ' 174' ' ' VAL . 70.2 p -76.63 -47.91 20.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.369 -0.378 . . . . 99.99 111.073 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.455 ' H ' ' HG1' ' A' ' 173' ' ' THR . 12.2 p -64.56 -28.55 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.286 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.4 tp -75.68 -56.73 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 99.99 111.053 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.418 ' HZ2' HE22 ' A' ' 109' ' ' GLN . 1.0 OUTLIER -58.48 -29.63 66.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.412 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 181' ' ' ILE . 14.1 tt -87.41 -21.08 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 99.99 110.25 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.69 65.06 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.72 -0.673 . . . . 99.99 112.87 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.526 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.2 m-85 -55.59 -55.6 38.65 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.797 0.298 . . . . 99.99 110.985 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 85.0 Cg_exo -46.35 -31.63 9.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.062 1.841 . . . . 99.99 112.657 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.8 mm -64.8 -58.26 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.816 0.341 . . . . 99.99 111.667 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 179' ' ' TYR . 28.2 m -59.6 -27.16 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.58 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -61.65 -23.49 66.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 99.99 110.927 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 89.7 mt -56.68 -39.77 65.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.146 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.396 . . . . 99.99 111.004 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.5 mm . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.723 0.297 . . . . 99.99 111.229 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.61 -52.4 63.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.682 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -63.93 -25.07 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.519 . . . . 99.99 111.076 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -77.02 -27.59 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 99.99 110.998 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 53.7 tp -84.08 -51.17 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.506 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -69.75 1.27 4.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.522 -0.308 . . . . 99.99 111.46 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 35.9 t -96.48 -44.01 7.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 99.99 110.191 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.2 tp -72.38 -33.63 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.427 -0.806 . . . . 99.99 111.763 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.506 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.1 tt -60.09 -54.57 53.97 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.019 -0.272 . . . . 99.99 111.17 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.25 -41.63 74.52 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.654 1.57 . . . . 99.99 111.262 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.417 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 81.6 t80 -61.28 -34.01 74.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 99.99 110.053 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.0 -21.03 57.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 99.99 110.326 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 115.872 -0.604 . . . . 99.99 110.721 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.833 0.349 . . . . 99.99 110.871 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.28 96.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.866 -0.683 . . . . 99.99 112.405 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.78 -29.46 69.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.732 0.301 . . . . 99.99 110.83 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.6 t -60.49 -58.02 10.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.858 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . 0.408 ' HA ' HD13 ' A' ' 218' ' ' LEU . 75.5 t80 -69.1 -23.88 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.663 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.3 tt -67.1 -49.46 64.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.766 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.39 -38.23 83.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 99.99 110.856 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 215' ' ' PHE . 95.4 mt -59.3 -50.37 74.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 99.99 111.109 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -72.67 -21.41 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.871 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.62 -26.54 64.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 99.99 112.567 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 99.99 111.15 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.676 0.274 . . . . 99.99 111.021 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.61 -42.21 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.434 -0.348 . . . . 99.99 111.099 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.599 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 40.4 m-70 -67.71 -25.37 65.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.49 . . . . 99.99 110.35 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -72.97 -49.51 28.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 99.99 110.989 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 45.3 pt -69.0 -19.18 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.957 0.408 . . . . 99.99 110.789 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.599 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 23.2 t80 -66.55 -54.11 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 99.99 110.589 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.57 -31.77 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.003 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.39 -47.31 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.236 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.12 74.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.666 -0.778 . . . . 99.99 112.485 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.23 -31.51 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 99.99 110.804 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -63.5 -58.11 8.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.996 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -61.21 -23.61 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.206 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.7 -51.81 56.38 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.632 -0.794 . . . . 99.99 112.161 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.526 ' HB1' ' HE1' ' B' ' 41' ' ' MET . . . -68.32 -23.39 64.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 99.99 110.894 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.57 -43.2 90.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 99.99 110.622 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.22 -25.43 61.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.432 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 83.2 t80 -66.1 -37.25 85.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.666 . . . . 99.99 110.47 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.4 ' O ' ' OG ' ' B' ' 26' ' ' SER . 86.0 t90 -67.14 -35.41 79.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 99.99 110.656 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 40.8 t -80.41 -19.59 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 99.99 111.161 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.1 -22.38 39.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 99.99 111.267 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 4.8 p -59.5 -24.48 63.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.553 -0.294 . . . . 99.99 111.092 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -47.38 -32.43 4.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 99.99 110.022 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -172.93 132.06 0.63 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 99.99 110.278 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -95.01 174.52 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.978 2.452 . . . . 99.99 112.306 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -102.2 68.06 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 99.99 111.366 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 -46.66 3.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.028 -0.606 . . . . 99.99 112.84 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.02 144.93 29.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.515 0.198 . . . . 99.99 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 165.47 8.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.405 2.07 . . . . 99.99 112.218 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -69.2 -17.36 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.658 -0.701 . . . . 99.99 112.413 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -41.17 -37.76 0.97 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.765 0.317 . . . . 99.99 111.838 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.67 -57.07 12.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 99.99 110.476 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.07 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 99.99 110.783 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' B' ' 41' ' ' MET . 20.4 tp -60.38 -51.85 67.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.938 0.399 . . . . 99.99 110.281 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -63.02 -38.48 82.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.094 0.473 . . . . 99.99 109.872 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.82 -9.59 55.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 99.99 110.7 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.526 ' HE1' ' HB1' ' B' ' 19' ' ' ALA . 22.0 ttt -87.94 -31.76 19.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 99.99 110.426 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -72.65 -34.08 67.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.397 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.584 HG23 HG22 ' B' ' 79' ' ' THR . 64.3 mt -52.91 -52.29 66.39 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 111.97 0.359 . . . . 99.99 111.97 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.8 Cg_endo -71.18 -35.0 9.29 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.264 1.976 . . . . 99.99 113.516 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.453 HG12 ' O ' ' B' ' 41' ' ' MET . 33.1 mm -56.64 -62.69 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.867 0.321 . . . . 99.99 111.867 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.63 -57.38 12.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 99.99 111.341 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.548 ' HA ' ' HD2' ' B' ' 75' ' ' ASP . 97.0 p -55.78 -23.56 30.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 99.99 111.505 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.39 -64.42 3.36 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 99.99 112.552 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 60.0 mt -57.37 -27.52 62.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.325 . . . . 99.99 111.076 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.98 -55.76 26.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.16 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 13.8 m-85 -64.32 -41.09 96.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.235 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 51.6 ttp -49.41 -34.28 15.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.276 0.56 . . . . 99.99 110.139 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.27 -40.09 71.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.449 -0.796 . . . . 99.99 110.559 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 58.7 mtt -53.55 -30.6 42.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 99.99 110.299 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.599 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -72.2 -45.85 58.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 99.99 110.671 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.422 HG22 HG22 ' C' ' 127' ' ' VAL . 13.1 mt -74.34 0.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.508 . . . . 99.99 110.746 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.47 ' HB2' HH12 ' C' ' 124' ' ' ARG . 8.0 m-20 63.76 52.15 2.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.794 -0.639 . . . . 99.99 111.131 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -127.98 143.63 51.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.753 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.3 23.7 7.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.844 -0.693 . . . . 99.99 112.394 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -137.43 137.49 38.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 99.99 111.046 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.55 147.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.005 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.25 94.01 9.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.883 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.42 113.38 24.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.182 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.45 30.54 18.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.84 -11.1 60.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.58 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.565 ' HA ' HE21 ' B' ' 66' ' ' GLN . 0.1 OUTLIER -100.84 134.63 43.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 99.99 110.723 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.26 132.2 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 99.99 110.875 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.03 144.33 32.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 99.99 111.565 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.511 ' HB3' ' HD3' ' B' ' 72' ' ' ARG . 74.4 m-70 -95.5 66.58 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.941 -0.572 . . . . 99.99 110.689 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -68.65 -35.54 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 99.99 111.129 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.88 68.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.61 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.511 ' HD3' ' HB3' ' B' ' 69' ' ' HIS . 10.3 mpt_? -74.21 -51.69 14.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.193 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -49.46 77.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 99.99 111.353 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.3 -38.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.12 0.415 . . . . 99.99 112.12 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.548 ' HD2' ' HA ' ' B' ' 47' ' ' SER . 13.9 t70 -62.45 -24.75 67.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.349 . . . . 99.99 110.406 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -95.87 6.59 48.52 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.664 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 53.9 tpp -103.94 -13.82 16.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 99.99 109.455 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.437 ' O ' HD21 ' B' ' 82' ' ' LEU . 26.1 m -114.81 -35.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.437 -0.801 . . . . 99.99 111.271 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.584 HG22 HG23 ' B' ' 43' ' ' ILE . 46.2 m -81.48 -60.93 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 99.99 112.179 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.559 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 60.2 m -47.18 -51.27 42.76 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 112.675 0.62 . . . . 99.99 112.675 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' B' ' 80' ' ' THR . 11.0 Cg_endo -54.17 -34.39 78.6 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.048 1.832 . . . . 99.99 111.856 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.491 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -79.01 -29.52 43.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 99.99 110.769 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.2 tp -68.99 -30.01 68.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.018 0.437 . . . . 99.99 110.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.532 HD12 HE21 ' B' ' 109' ' ' GLN . 6.5 tt -78.6 -30.36 46.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.749 -0.659 . . . . 99.99 110.072 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.491 HD12 HD13 ' B' ' 82' ' ' LEU . 76.0 mt -68.51 -42.52 78.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.706 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -66.18 -41.51 90.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.48 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -30.33 68.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.847 -0.615 . . . . 99.99 110.53 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -70.72 -48.04 56.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 99.99 110.997 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -66.71 -19.19 65.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 99.99 111.149 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 34.3 m -79.92 -32.96 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.051 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.57 -24.6 23.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.431 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.496 ' HE1' HG23 ' B' ' 95' ' ' ILE . 90.6 mtp -100.01 104.38 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 99.99 111.157 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -84.55 -38.15 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.935 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.72 133.66 53.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.944 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.496 HG23 ' HE1' ' B' ' 92' ' ' MET . 38.0 pt -141.92 148.53 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.034 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -133.67 -67.29 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -140.85 26.63 2.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.903 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.99 106.49 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -135.15 -9.14 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 99.99 110.747 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -82.76 -37.0 25.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.959 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.59 -55.23 16.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.53 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . 0.504 ' HA ' HD12 ' B' ' 105' ' ' LEU . 16.9 tt -55.4 -28.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 99.99 111.14 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 62.97 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.868 -0.682 . . . . 99.99 112.537 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -63.47 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 99.99 110.532 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.529 ' HB3' HD21 ' B' ' 84' ' ' LEU . 85.8 mt -59.05 -46.62 87.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.772 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' MET . . . . . 0.499 ' O ' HG12 ' B' ' 110' ' ' ILE . 52.3 ttm -68.18 -22.25 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.759 -0.655 . . . . 99.99 110.967 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 56.9 m -76.45 -39.93 51.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.93 0.395 . . . . 99.99 110.939 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 60.8 p -64.82 -43.34 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 99.99 111.533 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.532 HE21 HD12 ' B' ' 84' ' ' LEU . 3.8 pt20 -59.71 -42.87 94.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.539 -0.301 . . . . 99.99 111.001 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.572 HG22 ' HE1' ' A' ' 46' ' ' TRP . 43.2 mm -53.55 -41.16 44.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.842 0.353 . . . . 99.99 110.52 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.5 t -62.16 -44.96 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.239 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.46 -50.78 78.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.757 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.57 -33.68 49.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.729 0.3 . . . . 99.99 110.866 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.8 m -56.22 -40.54 74.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.17 0.509 . . . . 99.99 110.172 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 39.2 m -60.51 -56.78 17.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 99.99 110.243 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.87 -16.38 59.3 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.94 -0.648 . . . . 99.99 112.278 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.08 -61.56 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.425 . . . . 99.99 110.596 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.77 -21.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.828 -0.624 . . . . 99.99 111.804 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.99 42.09 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.021 0.439 . . . . 99.99 110.949 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.08 -23.75 28.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 99.99 110.712 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.92 19.15 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 99.99 110.853 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -75.68 129.05 36.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 99.99 110.977 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.57 -42.62 5.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 99.99 110.7 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.464 ' HB2' HG12 ' B' ' 127' ' ' VAL . 78.7 mtt180 -79.48 148.22 31.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.269 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.39 -22.33 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.942 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 31.5 p90 -83.86 -25.98 29.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.685 0.279 . . . . 99.99 111.222 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' B' ' 124' ' ' ARG . 8.6 p -83.28 -23.74 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 99.99 110.519 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.67 -37.93 66.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.775 -0.648 . . . . 99.99 110.991 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.68 -19.96 47.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.4 . . . . 99.99 110.885 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 127' ' ' VAL . 98.7 mt -76.22 -60.37 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 99.99 111.139 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -62.74 -28.67 70.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 99.99 111.26 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.4 -59.25 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 99.99 110.838 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.3 pt -61.45 -25.81 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 99.99 111.446 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -66.4 -39.39 88.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.035 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.71 31.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.816 -0.707 . . . . 99.99 112.671 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' B' ' 180' ' ' PRO . 35.5 m -61.75 -32.42 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.65 0.262 . . . . 99.99 111.376 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.65 -30.55 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 99.99 111.076 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.03 78.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.412 . . . . 99.99 110.825 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.49 -28.41 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 99.99 110.972 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.17 -57.84 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.368 -0.378 . . . . 99.99 111.708 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . 0.44 HG13 ' N ' ' B' ' 142' ' ' ILE . 40.2 pt -55.96 -43.29 74.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.893 0.331 . . . . 99.99 111.893 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.44 ' N ' HG13 ' B' ' 141' ' ' ILE . 8.9 tp -72.57 -28.36 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.705 0.288 . . . . 99.99 111.252 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.03 -57.33 13.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 99.99 110.797 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -63.82 -27.19 69.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.559 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.21 -17.26 78.42 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.775 -0.726 . . . . 99.99 112.491 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.7 tt -109.2 0.31 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 99.99 111.467 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -86.09 -55.01 4.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.846 0.313 . . . . 99.99 111.846 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 34.0 m120 . . . . . 0 C--N 1.329 -0.306 0 N-CA-C 112.324 0.49 . . . . 99.99 112.324 -179.478 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.826 0.346 . . . . 99.99 110.968 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -22.3 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.885 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.78 -54.08 47.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 99.99 110.837 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -63.26 -30.8 71.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.919 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.87 -56.66 9.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.147 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.86 -23.01 30.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 99.99 111.443 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 52.2 m -56.41 -58.54 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.95 0.405 . . . . 99.99 110.582 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.36 -33.65 71.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 99.99 110.515 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -64.78 -35.42 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 99.99 111.278 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 53.1 m -72.83 -54.12 9.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.346 -0.388 . . . . 99.99 111.639 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.66 -26.49 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 99.99 111.885 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -77.05 -57.78 3.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 99.99 111.279 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.22 -27.54 55.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.862 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.486 ' O ' HG12 ' B' ' 181' ' ' ILE . 85.7 mt -87.65 -23.88 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.214 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.26 -55.44 29.48 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 99.99 113.029 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.551 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 60.3 m-85 -54.23 -55.35 37.82 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.854 0.327 . . . . 99.99 111.257 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.5 Cg_exo -45.22 -32.22 7.0 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.323 2.016 . . . . 99.99 113.016 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.486 HG12 ' O ' ' B' ' 177' ' ' ILE . 47.1 mm -67.26 -61.13 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.392 -0.367 . . . . 99.99 111.739 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 21.0 m -57.26 -24.76 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 99.99 112.005 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -62.82 -23.65 67.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.407 -0.361 . . . . 99.99 111.906 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.562 HG21 HG21 ' B' ' 185' ' ' ILE . 16.7 tt -57.54 -38.07 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.737 0.273 . . . . 99.99 111.737 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . 0.562 HG21 HG21 ' B' ' 184' ' ' ILE . 26.1 pt -102.34 156.6 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.759 0.314 . . . . 99.99 111.137 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 120.725 -0.75 . . . . 99.99 112.46 -179.851 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.665 0.269 . . . . 99.99 111.081 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -53.83 -51.99 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.647 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 61.6 p -63.03 -44.13 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.967 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.53 -28.83 48.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 99.99 110.965 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -84.13 -51.62 6.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 99.99 111.779 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -69.34 -2.07 9.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.9 0.333 . . . . 99.99 111.9 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -96.83 -42.0 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.044 0.45 . . . . 99.99 110.5 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.6 tp -71.82 -33.44 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.629 . . . . 99.99 111.844 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.675 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.1 tp -62.8 -54.36 47.96 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.57 -0.252 . . . . 99.99 111.44 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.9 Cg_exo -55.66 -41.22 79.83 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.884 1.723 . . . . 99.99 111.415 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -58.71 -36.48 74.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.037 0.446 . . . . 99.99 110.173 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.28 -31.9 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.896 -0.593 . . . . 99.99 110.507 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 99.99 110.78 179.768 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.814 0.34 . . . . 99.99 111.047 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.48 -36.64 93.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.653 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.66 -29.2 66.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 99.99 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -62.85 -61.24 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 99.99 110.878 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -64.0 -22.13 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.745 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.48 -49.36 42.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.674 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.52 -31.95 72.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.852 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.74 -38.27 90.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.724 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -85.28 -20.65 29.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.017 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.21 -36.1 73.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.902 -0.666 . . . . 99.99 112.762 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.681 0.277 . . . . 99.99 111.262 -179.779 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.413 ' N ' HD21 ' C' ' 6' ' ' LEU . 2.5 pt? . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.749 0.309 . . . . 99.99 111.221 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.12 -45.06 82.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.382 -0.372 . . . . 99.99 111.084 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.581 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 36.3 m-70 -68.26 -25.27 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.782 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -73.07 -48.34 36.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.887 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.9 -21.07 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 99.99 110.156 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . 0.608 ' HH ' ' HB2' ' C' ' 206' ' ' PRO . 11.2 t80 -63.73 -57.48 9.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 99.99 110.711 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.3 -31.75 49.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.106 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.4 81.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 99.99 111.301 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.07 -24.36 75.89 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 99.99 112.656 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -77.15 -34.73 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 99.99 111.166 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 46.7 m -65.44 -48.71 71.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.997 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.82 -29.38 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.379 -0.373 . . . . 99.99 110.952 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.4 -51.74 56.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 99.99 112.389 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.463 ' HB1' ' HE3' ' C' ' 41' ' ' MET . . . -66.9 -24.06 66.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 99.99 111.217 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 52.6 tp -67.71 -39.17 84.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.731 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.12 -27.62 67.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 99.99 110.618 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.63 -39.98 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.94 -0.573 . . . . 99.99 110.788 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . 0.412 ' O ' ' OG ' ' C' ' 26' ' ' SER . 23.8 t-105 -62.92 -48.14 80.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 99.99 110.763 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 55.1 m -68.54 -19.66 64.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 99.99 111.359 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.44 ' HG ' HE22 ' C' ' 34' ' ' GLN . 54.1 tp -83.34 -20.68 33.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.439 -0.346 . . . . 99.99 111.307 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 75.8 p -60.43 -21.59 62.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.686 -0.234 . . . . 99.99 111.096 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -52.03 -31.3 29.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 99.99 109.809 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.9 p-10 -171.9 131.91 0.75 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 99.99 110.293 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.7 Cg_endo . . . . . 0 N--CA 1.451 -1.009 0 C-N-CA 123.19 2.594 . . . . 99.99 112.15 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 CA--C 1.527 0.173 0 CA-C-O 121.212 0.422 . . . . 99.99 112.747 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . 0.44 HE22 ' HG ' ' C' ' 25' ' ' LEU . 84.7 mm-40 -66.53 -17.56 64.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.544 -0.753 . . . . 99.99 112.658 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -41.36 -38.22 1.17 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.812 0.301 . . . . 99.99 111.812 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.33 -53.09 58.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 99.99 110.684 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -66.73 -19.04 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.739 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' C' ' 41' ' ' MET . 22.2 tp -61.06 -49.61 76.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.094 0.473 . . . . 99.99 110.207 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.42 -42.43 96.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.025 -0.534 . . . . 99.99 110.093 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -6.8 35.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.797 -0.638 . . . . 99.99 110.872 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.463 ' HE3' ' HB1' ' C' ' 19' ' ' ALA . 25.8 ttt -87.87 -33.22 18.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 99.99 110.402 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -71.37 -36.99 71.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.32 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.494 HG23 HG22 ' C' ' 79' ' ' THR . 74.7 mt -49.33 -53.4 40.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.132 0.419 . . . . 99.99 112.132 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.445 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.27 -33.21 11.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.171 1.914 . . . . 99.99 112.912 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.431 HG13 ' O ' ' C' ' 41' ' ' MET . 77.2 mt -53.3 -62.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.631 0.253 . . . . 99.99 111.452 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -62.87 -56.08 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.446 -0.343 . . . . 99.99 111.216 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.539 ' HA ' ' HD2' ' C' ' 75' ' ' ASP . 98.6 p -51.73 -23.07 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.045 -0.525 . . . . 99.99 111.212 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.34 -64.62 2.69 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.45 -0.881 . . . . 99.99 112.058 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.94 -28.67 62.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 99.99 110.914 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 -58.79 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 99.99 111.16 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.467 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 18.4 m-85 -60.93 -40.62 93.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.387 . . . . 99.99 110.972 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.0 ttp -49.48 -38.34 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.439 . . . . 99.99 110.021 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.34 82.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 99.99 110.649 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 56.3 mtt -54.89 -33.08 61.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.174 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.7 -38.48 73.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.821 -0.627 . . . . 99.99 110.385 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mt -80.44 -0.42 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 99.99 110.527 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.32 41.84 12.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.794 -0.639 . . . . 99.99 111.177 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -117.05 134.92 54.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.612 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.89 37.66 1.66 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.833 -0.699 . . . . 99.99 112.222 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -154.11 132.49 11.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 99.99 111.119 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -114.1 142.1 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.836 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.13 96.05 8.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.056 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.44 124.71 43.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 99.99 110.962 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.31 27.19 16.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.139 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -13.59 57.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.802 -0.713 . . . . 99.99 112.517 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -100.78 145.15 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.883 0.373 . . . . 99.99 111.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -89.96 135.72 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.769 -0.651 . . . . 99.99 110.934 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.92 138.39 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 99.99 111.386 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.531 ' H ' ' HD2' ' C' ' 120' ' ' ASP . 79.9 m-70 -88.71 64.55 7.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 99.99 110.802 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.57 -35.3 77.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 99.99 111.01 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.56 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 99.99 111.576 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.515 HH22 ' HB2' ' C' ' 203' ' ' CYS . 27.3 mmt180 -70.79 -51.29 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.751 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -47.76 74.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.55 -0.296 . . . . 99.99 111.65 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.42 -40.49 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.696 0.628 . . . . 99.99 112.696 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.539 ' HD2' ' HA ' ' C' ' 47' ' ' SER . 12.5 t70 -62.48 -28.5 69.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.398 -0.521 . . . . 99.99 110.37 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -88.54 4.1 47.96 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.035 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.412 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 50.3 tpp -95.97 -20.09 19.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 99.99 109.994 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.419 ' O ' HD22 ' C' ' 82' ' ' LEU . 12.5 m -114.38 -38.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.582 -0.736 . . . . 99.99 111.653 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.494 HG22 HG23 ' C' ' 43' ' ' ILE . 78.4 m -73.65 -55.89 5.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.998 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 17.9 m -50.1 -51.85 58.55 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.505 0.557 . . . . 99.99 112.505 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.2 Cg_exo -53.21 -42.64 63.48 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.781 1.654 . . . . 99.99 111.791 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.419 HD22 ' O ' ' C' ' 78' ' ' VAL . 4.1 mm? -67.92 -32.55 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 99.99 110.004 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.412 ' O ' HD22 ' C' ' 87' ' ' LEU . 0.2 OUTLIER -68.87 -25.92 64.87 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.833 -0.802 . . . . 99.99 108.833 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' C' ' 109' ' ' GLN . 24.0 tp -80.63 -38.21 29.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.014 -0.994 . . . . 99.99 110.311 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . 0.42 ' HG ' ' HE1' ' C' ' 89' ' ' TRP . 19.7 tp -65.84 -52.78 47.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.208 -0.906 . . . . 99.99 111.15 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.3 p -50.93 -44.17 60.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.395 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.412 HD22 ' O ' ' C' ' 83' ' ' LEU . 3.6 mm? -62.37 -33.48 74.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.184 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 57.7 m -70.87 -22.67 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 99.99 111.196 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . 0.42 ' HE1' ' HG ' ' C' ' 85' ' ' LEU . 93.4 m95 -80.72 -52.12 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 99.99 111.233 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -62.71 -27.55 69.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.36 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.47 -22.97 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.174 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.0 mtp -110.53 102.34 10.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.882 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.98 -40.44 39.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.897 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -108.14 138.64 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.038 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.1 pt -145.31 146.76 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 99.99 110.969 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.63 -74.79 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.948 0.404 . . . . 99.99 111.067 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -139.07 25.89 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 99.99 110.771 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . 0.52 ' HD2' HD11 ' C' ' 101' ' ' LEU . 15.4 t70 -72.73 129.68 38.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 99.99 110.741 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -151.28 -28.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.832 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 1.7 t -63.99 -46.31 85.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.475 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . 0.52 HD11 ' HD2' ' C' ' 98' ' ' ASP . 79.3 mt -64.71 -37.19 86.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 99.99 110.823 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.87 -29.16 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.64 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.26 -30.26 46.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.956 -0.64 . . . . 99.99 112.602 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . 0.41 ' HA ' ' HG ' ' C' ' 107' ' ' SER . 91.2 t80 -71.84 -25.24 61.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 99.99 110.461 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 mt -77.69 -49.38 14.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 99.99 110.81 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.2 ptm -64.95 -24.26 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 99.99 111.045 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' SER . . . . . 0.41 ' HG ' ' HA ' ' C' ' 104' ' ' PHE . 94.5 p -72.33 -50.24 28.33 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.022 0.439 . . . . 99.99 110.504 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -60.03 -24.8 64.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.976 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.483 ' HB2' HD22 ' C' ' 84' ' ' LEU . 24.8 tp60 -66.98 -52.12 46.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.613 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.9 -35.41 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.004 -0.544 . . . . 99.99 110.758 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.26 -45.36 98.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.929 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.54 -47.86 89.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.394 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 19.7 mt -59.4 -32.55 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 99.99 111.009 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -60.5 -43.65 96.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.508 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -59.22 -53.96 52.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.428 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.54 -25.56 68.87 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.789 -0.719 . . . . 99.99 111.826 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.19 -55.9 28.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.29 0.567 . . . . 99.99 110.329 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 tp -81.22 -28.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 99.99 112.188 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.33 46.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 99.99 111.233 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . 0.531 ' HD2' ' H ' ' C' ' 69' ' ' HIS . 14.3 t70 -79.68 -31.15 41.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.843 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.79 7.49 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.323 -0.399 . . . . 99.99 110.912 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.0 t -63.42 122.98 17.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.223 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.03 -51.55 3.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.704 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . 0.59 ' HB2' HG13 ' C' ' 127' ' ' VAL . 90.6 mtt180 -75.65 143.78 42.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 99.99 110.662 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.07 -19.09 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.667 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -79.46 -54.47 5.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.709 0.29 . . . . 99.99 111.108 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' C' ' 124' ' ' ARG . 14.2 p -59.69 -24.04 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 99.99 111.367 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -51.52 -47.55 63.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.34 -0.391 . . . . 99.99 111.302 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.24 -24.78 62.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.334 -0.393 . . . . 99.99 111.339 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' C' ' 127' ' ' VAL . 95.6 mt -72.65 -52.21 16.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 99.99 111.166 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.27 -28.7 66.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 99.99 110.792 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -59.84 -60.41 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.823 -0.626 . . . . 99.99 110.451 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . 0.404 ' HA ' HG23 ' C' ' 136' ' ' VAL . 16.4 tt -63.95 -26.23 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.917 -0.583 . . . . 99.99 111.087 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.54 -35.29 80.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.793 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.61 -53.75 7.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.81 -0.709 . . . . 99.99 112.587 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' C' ' 133' ' ' ILE . 34.1 m -59.46 -30.75 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.321 . . . . 99.99 111.352 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.8 -35.27 72.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 99.99 110.67 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.58 93.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.8 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -73.16 -24.04 60.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.903 -0.59 . . . . 99.99 111.083 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -60.94 2.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 99.99 111.357 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . 0.401 HG13 ' N ' ' C' ' 142' ' ' ILE . 17.6 pt -58.34 -45.71 89.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.608 0.596 . . . . 99.99 112.608 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.402 ' O ' HG13 ' C' ' 146' ' ' ILE . 41.8 pt -66.44 -32.26 57.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.685 0.254 . . . . 99.99 111.685 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 56.5 tp -55.76 -56.64 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.603 0.239 . . . . 99.99 110.901 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -64.79 -24.52 67.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 99.99 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.38 -17.37 76.26 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.343 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . 0.402 HG13 ' O ' ' C' ' 142' ' ' ILE . 68.8 mt -109.24 -12.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.957 0.408 . . . . 99.99 111.031 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -72.4 -55.4 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 99.99 111.998 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 34.0 m120 . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.406 0.521 . . . . 99.99 112.406 -179.467 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.243 0.545 . . . . 99.99 110.469 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.62 -36.03 79.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 99.99 111.108 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.82 -56.22 17.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 99.99 111.539 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . 0.411 ' O ' HG23 ' C' ' 170' ' ' THR . 68.5 mttm -59.34 -22.21 60.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.461 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.95 -59.05 2.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 99.99 111.413 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.67 -29.27 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 99.99 112.192 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 170' ' ' THR . . . . . 0.411 HG23 ' O ' ' C' ' 167' ' ' LYS . 15.3 t -57.05 -36.17 70.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 99.99 110.988 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -77.32 -34.71 55.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 99.99 109.943 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.24 -22.59 63.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.688 -0.687 . . . . 99.99 110.474 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 90.6 m -79.52 -58.56 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.264 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.68 -28.52 32.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.785 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.34 -57.4 4.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.163 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.78 -25.55 60.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.875 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 86.4 mt -87.89 -21.57 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.045 0.45 . . . . 99.99 110.414 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . 0.5 ' O ' HG23 ' C' ' 181' ' ' ILE . . . -63.4 -41.6 99.33 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.791 -0.64 . . . . 99.99 112.998 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.51 ' N ' ' HD2' ' C' ' 180' ' ' PRO . 55.5 m-85 -64.47 -52.03 55.82 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 111.988 0.366 . . . . 99.99 111.988 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.544 ' HA ' ' NE1' ' C' ' 183' ' ' TRP . 33.1 Cg_endo -63.76 -16.78 56.78 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.01 1.807 . . . . 99.99 113.326 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.5 HG23 ' O ' ' C' ' 178' ' ' GLY . 3.6 tt -88.99 -27.09 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 112.483 0.549 . . . . 99.99 112.483 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.449 HG13 ' N ' ' C' ' 183' ' ' TRP . 3.8 p -80.88 -53.78 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.47 0.915 . . . . 99.99 113.47 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . 0.544 ' NE1' ' HA ' ' C' ' 180' ' ' PRO . 0.2 OUTLIER -58.32 -12.11 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.198 0.444 . . . . 99.99 112.198 -178.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.99 -18.84 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.996 0.427 . . . . 99.99 110.703 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 2.4 pt . . . . . 0 C--O 1.233 0.206 0 CA-C-N 115.858 -0.61 . . . . 99.99 111.201 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.642 0.258 . . . . 99.99 111.408 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 88.3 mt -72.97 -45.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.403 -0.362 . . . . 99.99 111.295 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.25 -46.97 76.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.894 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -69.52 -26.92 64.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 99.99 111.08 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -69.71 -33.36 72.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.981 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.22 -45.53 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.396 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -67.5 -7.44 25.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 99.99 111.266 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.515 ' HB2' HH22 ' C' ' 72' ' ' ARG . 44.3 t -96.47 -43.52 7.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 99.99 110.568 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 39.4 tp -67.82 -37.05 81.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.48 -0.782 . . . . 99.99 112.149 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.599 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.4 OUTLIER -60.86 -55.21 46.97 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.942 -0.303 . . . . 99.99 111.446 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.608 ' HB2' ' HH ' ' C' ' 11' ' ' TYR . 66.8 Cg_exo -53.75 -36.78 83.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.691 1.594 . . . . 99.99 111.368 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.86 -46.15 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 99.99 109.985 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -68.29 -16.55 64.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 99.99 110.483 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 99.99 110.914 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.808 0.337 . . . . 99.99 111.094 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.89 -40.11 98.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.333 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.93 -27.92 67.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 99.99 110.97 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 52.9 m -61.44 -57.15 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 99.99 110.967 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.86 -29.41 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.04 -40.44 90.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.535 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.01 -22.06 60.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.459 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 43.8 tp -74.5 -42.07 59.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 99.99 110.552 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -85.13 -20.27 30.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 99.99 111.025 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.57 49.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.991 -0.623 . . . . 99.99 112.714 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.733 0.301 . . . . 99.99 111.192 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.812 0.339 . . . . 99.99 110.775 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.85 -52.33 44.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.555 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 40.6 m-70 -68.42 -23.55 64.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.89 -0.596 . . . . 99.99 110.101 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -66.57 -52.17 48.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.681 . . . . 99.99 111.115 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.0 pt -68.53 -21.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 99.99 110.773 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -60.6 -55.06 37.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 99.99 110.56 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.98 -36.24 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.966 -0.561 . . . . 99.99 111.127 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.43 -37.63 73.12 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.935 0.398 . . . . 99.99 110.92 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.04 -29.41 58.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.721 -0.752 . . . . 99.99 112.178 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -74.81 -31.72 61.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.299 . . . . 99.99 111.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 p -68.11 -50.19 56.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.481 -0.327 . . . . 99.99 111.111 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.47 -26.58 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.287 -0.415 . . . . 99.99 110.725 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.49 44.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.61 -0.805 . . . . 99.99 111.9 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.79 -23.48 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.903 0.382 . . . . 99.99 110.716 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -68.78 -41.62 78.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.776 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -60.54 -23.53 64.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 99.99 110.305 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -60.84 -31.9 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.659 -0.7 . . . . 99.99 110.566 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.58 ' O ' ' OG ' ' A' ' 26' ' ' SER . 68.4 t-105 -78.51 -45.52 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 99.99 110.531 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 p -65.9 -19.72 65.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.978 -0.555 . . . . 99.99 110.748 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.96 -12.74 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 99.99 110.743 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 72.7 p -69.64 -18.53 63.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 99.99 111.01 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -49.56 -32.98 13.73 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.36 0.6 . . . . 99.99 109.575 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -176.86 131.82 0.37 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.959 -1.018 . . . . 99.99 110.096 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -95.54 177.41 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.007 2.471 . . . . 99.99 112.224 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -99.36 63.8 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.298 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -46.55 3.5 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.751 -0.737 . . . . 99.99 112.554 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HE2' ' A' ' 36' ' ' GLU . 34.1 m -95.6 146.43 31.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.526 0.203 . . . . 99.99 110.776 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.64 165.49 18.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.367 2.044 . . . . 99.99 112.399 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -72.32 -15.86 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.412 -0.813 . . . . 99.99 112.016 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -40.27 -38.98 0.86 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.334 0.494 . . . . 99.99 112.334 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 37' ' ' TYR . 11.7 pt-20 -64.84 -46.9 79.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 99.99 110.568 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.416 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 73.8 m-85 -70.49 -18.6 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 99.99 110.488 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 41' ' ' MET . 54.3 tp -63.2 -49.28 74.86 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.321 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -63.5 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.174 0.511 . . . . 99.99 109.663 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 -5.01 40.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.588 -0.733 . . . . 99.99 110.475 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.466 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 22.0 ttt -88.25 -34.07 17.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.473 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -75.67 -31.4 59.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 99.99 110.883 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.663 HG22 HG21 ' A' ' 79' ' ' THR . 85.2 mt -52.54 -51.75 70.17 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.597 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.466 ' HD2' ' C ' ' A' ' 41' ' ' MET . 73.5 Cg_endo -74.3 -32.21 6.76 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.408 2.072 . . . . 99.99 112.804 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 41' ' ' MET . 72.0 mt -53.67 -61.62 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.633 0.254 . . . . 99.99 111.539 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' NE1' HG23 ' B' ' 110' ' ' ILE . 2.1 t90 -64.8 -51.42 62.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.688 0.28 . . . . 99.99 111.064 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.8 p -57.67 -14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.196 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.77 -57.95 2.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.491 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.493 HD21 ' HG ' ' B' ' 134' ' ' CYS . 35.0 mt -58.78 -28.41 65.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 99.99 111.032 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.36 -59.36 5.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.541 . . . . 99.99 111.267 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.463 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 16.0 m-85 -59.47 -43.07 93.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.126 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.9 ttp -48.24 -35.4 11.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.187 0.518 . . . . 99.99 110.216 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.85 77.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.72 -0.673 . . . . 99.99 110.648 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 56.1 mtt -52.12 -27.83 15.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.244 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.11 -45.26 58.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.719 -0.673 . . . . 99.99 110.622 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.8 pt -84.18 11.15 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.109 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 60.05 50.59 6.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.923 -0.58 . . . . 99.99 111.675 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.02 158.25 30.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 99.99 110.937 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.23 34.55 32.55 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.307 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -129.9 136.37 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.309 . . . . 99.99 110.896 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.3 140.13 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.259 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.82 89.99 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.034 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.74 126.11 42.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.332 -0.394 . . . . 99.99 111.407 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 34.87 24.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 99.99 111.54 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.17 -0.31 59.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.823 -0.704 . . . . 99.99 112.835 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -98.35 134.27 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.673 0.273 . . . . 99.99 110.771 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 mt -89.3 103.79 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.942 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.38 135.52 38.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.861 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 53.0 m-70 -82.65 73.71 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.186 0.517 . . . . 99.99 110.723 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -58.92 -28.89 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.45 -0.795 . . . . 99.99 111.458 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.04 -23.96 35.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 99.99 111.805 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 12.9 tpp180 -67.24 -51.27 55.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 99.99 112.386 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 9.1 p90 -82.53 -32.5 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.275 0.472 . . . . 99.99 112.275 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.0 tt -55.23 -42.15 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 C-N-CA 120.713 -0.395 . . . . 99.99 110.489 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.33 -22.81 64.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.445 -0.576 . . . . 99.99 109.445 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -87.79 5.13 41.56 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.475 -0.784 . . . . 99.99 111.103 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.3 ttm -104.59 -18.18 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.494 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.05 -35.29 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.517 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.663 HG21 HG22 ' A' ' 43' ' ' ILE . 87.9 m -82.14 -49.0 10.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.648 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.57 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.8 m -53.39 -49.92 85.65 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.199 -0.455 . . . . 99.99 112.197 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.9 Cg_endo -58.88 -41.51 61.68 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.97 1.78 . . . . 99.99 112.17 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.8 -7.97 58.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 99.99 110.894 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -81.42 -40.29 23.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.796 0.332 . . . . 99.99 110.283 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 109' ' ' GLN . 3.6 pp -81.62 -31.59 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.223 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.54 -27.94 63.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.319 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -63.69 -24.68 67.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 99.99 110.399 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.09 -52.53 18.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 99.99 110.739 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.2 t -60.21 -21.41 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.838 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -76.4 -36.59 57.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 99.99 111.052 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 p -80.92 -23.44 38.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.353 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 -37.14 17.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.21 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.464 ' HE2' HG21 ' A' ' 95' ' ' ILE . 19.9 ttt -97.74 99.42 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.435 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -85.91 -48.8 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.244 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -104.57 137.32 42.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 99.99 111.067 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.464 HG21 ' HE2' ' A' ' 92' ' ' MET . 47.5 pt -123.71 151.43 28.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 99.99 110.843 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.12 -54.49 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 99.99 110.558 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -150.12 -159.59 1.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 99.99 110.438 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 64.68 105.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.024 0.44 . . . . 99.99 111.228 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -119.53 15.86 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.609 . . . . 99.99 110.553 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.3 t -87.16 -21.25 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 99.99 110.834 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.47 -51.52 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 99.99 110.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -59.19 -30.68 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.081 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.1 -27.19 64.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.542 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -73.43 -38.41 65.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 99.99 110.972 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.3 mt -71.74 -32.54 67.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.119 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.44 ' O ' HG12 ' A' ' 110' ' ' ILE . 61.1 mtt -74.23 -25.3 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 99.99 111.11 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -76.95 -49.44 15.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 99.99 111.256 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.539 ' HG1' HG13 ' A' ' 142' ' ' ILE . 8.5 t -62.41 -35.43 79.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 99.99 111.949 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.496 ' HB3' HD22 ' A' ' 84' ' ' LEU . 13.8 pt20 -67.3 -42.05 84.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.567 0.223 . . . . 99.99 111.465 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 106' ' ' MET . 33.1 mm -60.05 -33.45 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.827 0.346 . . . . 99.99 111.067 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.29 -44.6 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 99.99 111.458 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.64 -50.09 77.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 99.99 111.864 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.5 pt -57.2 -33.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.626 0.25 . . . . 99.99 111.437 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 85.4 m -63.67 -47.61 80.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 99.99 111.12 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -63.81 -21.76 66.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.61 -46.44 7.32 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.937 -0.649 . . . . 99.99 112.95 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -66.75 -29.13 69.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.52 0.2 . . . . 99.99 111.53 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.507 ' N ' HD11 ' A' ' 117' ' ' LEU . 10.1 tp -83.46 -28.4 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.551 -0.295 . . . . 99.99 111.161 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.68 71.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.803 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.08 -23.55 41.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 99.99 110.783 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.59 23.72 0.93 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 99.99 110.837 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.1 t -76.31 137.04 39.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.967 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.07 -34.54 8.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.922 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' HG12 ' A' ' 127' ' ' VAL . 98.5 mtt180 -116.48 143.09 46.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.982 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -74.68 -12.11 60.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.137 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -86.58 -39.53 16.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 99.99 111.072 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.538 ' HA ' HD22 ' A' ' 130' ' ' LEU . 14.5 p -77.78 -24.23 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.086 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -57.62 -29.28 64.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.754 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.03 -31.42 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 99.99 110.964 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.538 HD22 ' HA ' ' A' ' 127' ' ' VAL . 3.5 mm? -73.31 -42.28 62.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.067 -0.515 . . . . 99.99 111.163 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -74.17 -31.65 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 99.99 110.995 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.46 -56.96 15.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.654 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.8 tt -62.17 -29.4 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.233 -0.439 . . . . 99.99 110.933 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.5 t -61.18 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.197 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.26 -52.53 10.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.535 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.21 -29.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 99.99 111.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 36.4 t -64.44 -42.43 96.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.747 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.05 93.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.925 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -76.73 -15.8 59.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.02 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.67 -55.1 6.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.372 . . . . 99.99 110.621 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.53 -34.92 63.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.539 HG13 ' HG1' ' A' ' 108' ' ' THR . 39.8 mm -71.44 -44.12 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 99.99 110.969 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.23 -56.06 24.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 99.99 110.931 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -63.04 -21.89 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.097 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.74 -20.44 61.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 99.99 112.866 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 142' ' ' ILE . 70.3 mt -99.56 -12.68 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.458 . . . . 99.99 110.783 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -69.0 -50.64 47.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 99.99 111.577 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 99.99 112.143 -179.091 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 92.5 mt . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.791 0.329 . . . . 99.99 110.675 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.64 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 99.99 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -38.85 68.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 99.99 110.921 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.07 -22.79 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.256 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 74.9 mt -73.99 -60.04 2.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.361 -0.381 . . . . 99.99 111.135 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.0 t -55.84 -23.84 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.883 -0.598 . . . . 99.99 111.45 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.9 m -56.18 -58.94 5.83 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.841 0.353 . . . . 99.99 111.262 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.43 -30.66 69.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 99.99 110.805 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.81 -28.65 69.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 99.99 111.05 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 55.2 m -77.91 -56.64 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.283 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.62 -28.76 28.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.329 -0.396 . . . . 99.99 111.573 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.89 -57.77 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 99.99 111.405 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.3 -27.29 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.885 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 181' ' ' ILE . 90.9 mt -87.73 -25.0 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.3 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.81 -55.9 26.61 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.872 -0.603 . . . . 99.99 113.311 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.582 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.0 m-85 -53.33 -55.8 30.83 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.765 -0.374 . . . . 99.99 110.788 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.2 Cg_exo -45.45 -33.34 9.1 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.084 1.856 . . . . 99.99 112.423 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.1 mm -59.39 -53.82 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 121.024 0.44 . . . . 99.99 110.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 179' ' ' TYR . 1.5 m -58.43 -24.23 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 99.99 111.082 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -83.88 -16.45 44.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.286 -0.415 . . . . 99.99 111.773 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 93.4 mt -50.7 -37.41 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.818 0.342 . . . . 99.99 110.95 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.404 . . . . 99.99 111.333 179.821 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 86.1 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.687 0.279 . . . . 99.99 111.275 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.85 -56.12 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.888 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.2 p -64.91 -31.67 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 99.99 110.969 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -61.47 -30.89 70.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.03 -0.532 . . . . 99.99 111.084 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.71 -52.45 15.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.199 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.94 -6.42 41.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.572 -0.285 . . . . 99.99 111.373 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 29.1 t -96.24 -39.7 9.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 99.99 110.543 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.8 -40.99 65.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.622 -0.717 . . . . 99.99 112.094 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.548 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -56.39 -54.74 49.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.149 -0.221 . . . . 99.99 111.405 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.5 Cg_exo -55.76 -45.18 41.0 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.829 1.686 . . . . 99.99 111.538 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.01 -24.62 66.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.464 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -81.95 -21.86 36.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 99.99 110.693 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.112 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.803 0.335 . . . . 99.99 111.295 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.69 -45.26 90.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.674 -0.774 . . . . 99.99 112.916 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -69.72 -28.68 66.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.62 0.248 . . . . 99.99 111.196 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -55.19 -62.06 1.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.432 -0.349 . . . . 99.99 110.836 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -64.66 -29.34 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 99.99 110.46 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.05 -45.98 91.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 99.99 110.589 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.21 -35.08 79.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.517 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.351 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -83.77 -25.91 30.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 99.99 110.847 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -79.47 -24.39 60.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 99.99 112.34 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 99.99 110.747 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.414 HD13 ' N ' ' B' ' 6' ' ' LEU . 6.7 mp . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.747 0.308 . . . . 99.99 110.824 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 57.4 mt -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.004 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.56 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 29.0 m80 -80.01 -24.42 40.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.505 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -73.66 -35.34 65.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 99.99 110.812 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 tt -80.73 -26.52 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.693 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -62.09 -47.41 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.271 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.43 -36.94 74.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 99.99 111.084 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -36.11 79.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.978 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.74 59.15 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.781 -0.723 . . . . 99.99 112.311 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.405 ' HB3' ' HB2' ' B' ' 44' ' ' PRO . 23.1 mmt -72.73 -27.78 62.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 99.99 110.785 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -64.88 -56.41 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.88 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.28 -24.94 34.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.044 -0.525 . . . . 99.99 110.984 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.69 -57.72 18.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.636 -0.792 . . . . 99.99 112.199 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' B' ' 41' ' ' MET . . . -62.85 -23.41 67.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 99.99 110.788 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.95 -39.2 83.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.571 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -61.41 -22.55 65.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.912 -0.586 . . . . 99.99 110.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.469 ' HB2' ' HE3' ' B' ' 41' ' ' MET . 73.8 t80 -61.04 -40.55 94.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 99.99 110.358 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.525 ' O ' ' OG ' ' B' ' 26' ' ' SER . 68.7 m95 -70.8 -41.45 71.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.795 -0.639 . . . . 99.99 110.593 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -69.7 -20.81 63.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.869 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.88 -15.84 35.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.713 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.525 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 67.0 p -67.2 -17.07 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 99.99 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.33 -33.67 13.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.409 -0.589 . . . . 99.99 109.409 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -177.68 131.63 0.33 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 114.997 -1.002 . . . . 99.99 110.216 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -93.8 169.15 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.915 2.41 . . . . 99.99 112.251 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -96.41 60.97 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.458 . . . . 99.99 110.901 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.9 -46.67 3.66 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.791 -0.718 . . . . 99.99 112.416 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.14 131.65 42.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.473 0.177 . . . . 99.99 110.631 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.419 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 35.4 Cg_exo -59.82 156.66 36.94 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.241 1.961 . . . . 99.99 112.054 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -61.19 -17.72 54.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 99.99 112.459 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.419 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 3.6 p90 -43.89 -36.51 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.787 0.327 . . . . 99.99 111.567 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.521 ' HE2' HD23 ' B' ' 221' ' ' LEU . 46.0 tt0 -62.64 -57.12 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 99.99 110.664 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.49 ' HH ' HD23 ' B' ' 218' ' ' LEU . 82.8 m-85 -66.77 -18.74 65.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 99.99 110.637 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 45.4 tp -57.11 -55.6 32.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.152 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.74 -42.9 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 99.99 110.524 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.46 -12.44 52.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 99.99 111.138 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.641 ' HG3' ' HA ' ' B' ' 19' ' ' ALA . 0.0 OUTLIER -88.6 -31.03 18.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.358 -0.383 . . . . 99.99 111.289 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -72.08 -27.62 62.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 99.99 110.386 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.546 HG22 HG22 ' B' ' 79' ' ' THR . 65.3 mt -58.28 -53.94 60.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.085 -0.507 . . . . 99.99 112.003 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.473 ' HD2' ' C ' ' B' ' 41' ' ' MET . 45.2 Cg_endo -67.75 -35.14 22.56 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.17 1.913 . . . . 99.99 112.986 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.434 HG13 ' O ' ' B' ' 41' ' ' MET . 97.0 mt -53.78 -62.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.762 0.282 . . . . 99.99 111.762 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.517 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.7 t90 -61.3 -50.11 74.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.744 0.307 . . . . 99.99 111.08 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.489 ' HG ' ' HD2' ' B' ' 75' ' ' ASP . 59.5 m -60.27 -14.02 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 99.99 111.495 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.9 -55.71 3.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.709 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.432 HD23 ' SG ' ' C' ' 134' ' ' CYS . 24.0 mt -58.74 -32.08 68.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.857 0.361 . . . . 99.99 111.084 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.313 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 9.0 m-85 -60.7 -41.41 95.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.993 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -50.67 -32.36 18.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.135 0.493 . . . . 99.99 110.1 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.7 -39.86 69.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 99.99 110.504 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -54.97 -28.21 49.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.805 -0.634 . . . . 99.99 110.284 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -73.31 -49.51 27.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.737 -0.665 . . . . 99.99 110.817 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' B' ' 53' ' ' ALA . 36.1 pt -79.52 8.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.459 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.32 60.73 2.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.055 -0.52 . . . . 99.99 111.31 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -143.86 139.99 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.907 0.384 . . . . 99.99 110.876 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.38 5.63 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.882 -0.675 . . . . 99.99 112.101 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.62 150.22 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.664 0.268 . . . . 99.99 110.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.99 148.0 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.077 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.21 93.68 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.838 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.32 125.18 50.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.279 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.49 30.61 18.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.989 -0.55 . . . . 99.99 111.275 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.86 57.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.727 -0.749 . . . . 99.99 112.563 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -107.15 127.61 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.757 0.313 . . . . 99.99 110.821 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 45.0 mm -77.37 105.27 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 99.99 111.088 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.8 134.52 37.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.943 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.486 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 81.8 m-70 -79.83 76.18 6.52 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.132 0.492 . . . . 99.99 111.1 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -62.42 -28.0 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.485 -0.78 . . . . 99.99 111.082 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.27 -28.0 32.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.299 0.481 . . . . 99.99 112.299 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 29.2 mmt180 -66.56 -51.51 55.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.629 0.603 . . . . 99.99 112.629 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -82.89 -30.03 28.84 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.29 -0.564 . . . . 99.99 112.497 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 15.2 tt -56.33 -42.15 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.291 -0.563 . . . . 99.99 110.221 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.489 ' HD2' ' HG ' ' B' ' 47' ' ' SER . 26.2 t70 -69.39 -22.25 63.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.996 -0.742 . . . . 99.99 108.996 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -86.56 7.65 25.33 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.342 -0.844 . . . . 99.99 111.034 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 22.0 mtp -104.73 -21.59 13.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.797 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 m -114.08 -28.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 99.99 111.897 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.546 HG22 HG22 ' B' ' 43' ' ' ILE . 37.8 m -82.21 -52.45 6.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.266 -0.424 . . . . 99.99 112.093 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 16.9 m -52.4 -49.73 83.8 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.54 0.57 . . . . 99.99 112.54 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' B' ' 80' ' ' THR . 12.4 Cg_endo -56.08 -45.52 37.71 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.781 1.654 . . . . 99.99 112.262 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.64 -19.47 61.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.797 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.32 -30.96 57.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 99.99 110.197 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.458 HD11 ' NE2' ' B' ' 109' ' ' GLN . 4.8 tt -84.69 -27.92 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.642 -0.708 . . . . 99.99 110.128 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.96 -33.84 39.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 99.99 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -58.75 -28.08 65.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.223 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.456 ' HB3' HD22 ' B' ' 168' ' ' LEU . 52.9 mt -73.36 -34.23 65.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.4 . . . . 99.99 111.12 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.4 m -73.46 -27.04 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.418 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -76.73 -38.62 53.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.349 . . . . 99.99 111.12 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -62.41 -41.55 98.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.376 -0.375 . . . . 99.99 111.138 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.62 -47.49 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.314 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 49.3 tpp -80.4 98.58 7.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.784 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -87.8 -37.34 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.926 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.31 143.19 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.012 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.07 142.24 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.579 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -123.96 -74.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 99.99 111.159 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -156.03 108.46 2.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.034 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.1 -73.62 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.66 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 81.8 m95 53.67 36.35 23.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.323 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.5 t -120.58 -41.51 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.022 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 96.5 mt -74.31 -38.49 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.959 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.5 tt -56.12 -33.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 99.99 111.17 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.17 -29.89 36.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.728 -0.748 . . . . 99.99 112.287 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.91 -24.51 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 99.99 110.835 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -78.54 -50.08 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.993 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' MET . . . . . 0.472 ' O ' HG13 ' B' ' 110' ' ' ILE . 24.6 ptm -60.49 -31.83 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 99.99 111.043 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -67.29 -51.96 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 99.99 111.6 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 71.3 p -57.92 -25.98 61.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 99.99 111.741 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.458 ' NE2' HD11 ' B' ' 84' ' ' LEU . 18.6 mm-40 -78.31 -41.72 32.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 99.99 111.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.472 HG13 ' O ' ' B' ' 106' ' ' MET . 93.4 mt -56.4 -38.1 54.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 99.99 111.8 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.408 HG22 ' N ' ' B' ' 112' ' ' VAL . 29.7 m -72.57 -45.56 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.918 0.34 . . . . 99.99 111.918 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . 0.408 ' N ' HG22 ' B' ' 111' ' ' VAL . 84.2 t -60.12 -45.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.631 0.253 . . . . 99.99 111.586 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 109' ' ' GLN . 66.3 mt -64.43 -34.75 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 99.99 111.463 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 99.4 m -55.2 -61.0 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.234 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.9 p -57.31 -27.44 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 99.99 111.061 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.11 -49.14 59.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 99.99 112.909 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.454 HD11 HG13 ' B' ' 118' ' ' ILE . 3.3 pp -74.21 -21.88 59.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.686 0.254 . . . . 99.99 111.686 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.454 HG13 HD11 ' B' ' 117' ' ' LEU . 82.5 mt -83.4 -33.17 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.687 0.28 . . . . 99.99 111.215 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.15 71.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 99.99 110.968 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.26 -25.22 46.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.78 31.24 0.7 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.405 -0.361 . . . . 99.99 110.886 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -82.76 130.96 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.05 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -98.55 -42.98 7.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.673 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.447 ' HD3' ' HE1' ' B' ' 126' ' ' TRP . 91.4 mtt180 -98.18 146.36 25.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.285 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -80.37 -16.38 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.429 0.529 . . . . 99.99 112.429 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.447 ' HE1' ' HD3' ' B' ' 124' ' ' ARG . 67.1 p-90 -93.33 -22.44 18.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.688 0.255 . . . . 99.99 111.688 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.451 HG22 HD11 ' B' ' 130' ' ' LEU . 7.3 p -83.66 -23.33 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 99.99 110.945 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -57.76 -35.31 70.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.968 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -68.88 -22.15 64.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 99.99 111.283 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . 0.451 HD11 HG22 ' B' ' 127' ' ' VAL . 90.5 mt -76.75 -54.27 6.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.141 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.96 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.483 -0.326 . . . . 99.99 110.885 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -60.47 -50.06 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 99.99 110.595 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.6 mt -62.74 -30.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 99.99 110.822 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.493 ' HG ' HD21 ' A' ' 49' ' ' LEU . 36.1 t -65.65 -41.01 93.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.872 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.31 -54.1 39.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.908 -0.663 . . . . 99.99 112.365 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 5.8 p -63.46 -39.0 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 99.99 111.067 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.7 t -52.34 -43.56 64.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.7 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.65 84.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.688 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -71.56 -23.56 61.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 99.99 110.992 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -73.33 -61.08 1.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.266 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . 0.401 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.2 pt -51.88 -37.45 21.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.453 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.401 ' N ' HG13 ' B' ' 141' ' ' ILE . 85.3 mt -73.45 -41.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 99.99 110.891 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 tp -56.97 -57.92 10.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.885 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -62.62 -21.86 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.643 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -20.78 59.57 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.85 -0.69 . . . . 99.99 112.989 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.9 pt -100.4 -5.62 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.864 0.332 . . . . 99.99 111.178 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.61 -42.99 17.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.98 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 99.99 111.828 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.862 0.363 . . . . 99.99 110.884 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.04 -24.75 60.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 99.99 111.12 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.1 -44.66 96.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 99.99 110.719 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -79.72 -21.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.77 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' B' ' 87' ' ' LEU . 27.8 tp -68.17 -53.16 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.817 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.35 -28.26 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.028 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.7 m -49.09 -57.97 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.29 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.51 -28.83 67.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.526 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -63.8 -30.62 71.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.481 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 81.6 p -78.82 -59.05 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.595 -0.275 . . . . 99.99 111.485 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.6 p -52.89 -29.91 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.526 -0.306 . . . . 99.99 111.645 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.97 -58.19 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 99.99 111.107 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.95 -25.95 61.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 99.99 110.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 181' ' ' ILE . 80.4 mt -87.99 -27.59 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.061 -0.518 . . . . 99.99 110.269 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.95 -52.62 41.87 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.817 -0.629 . . . . 99.99 113.124 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.598 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 94.4 m-85 -56.49 -58.05 19.4 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.927 -0.309 . . . . 99.99 111.095 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 90.6 Cg_exo -42.68 -38.77 6.69 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.171 1.914 . . . . 99.99 112.924 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.6 mt -58.5 -55.39 22.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.34 -0.391 . . . . 99.99 111.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.559 HG23 ' O ' ' B' ' 179' ' ' TYR . 1.9 m -55.17 -23.88 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.02 -0.536 . . . . 99.99 111.497 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -80.88 -33.3 34.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.074 0.398 . . . . 99.99 112.074 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 tt -88.29 25.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.443 . . . . 99.99 111.561 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 42.6 pt -134.69 -21.4 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.466 -0.334 . . . . 99.99 111.533 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.262 0 C-N-CA 120.438 -0.887 . . . . 99.99 112.834 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.871 0.367 . . . . 99.99 111.188 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.39 -57.49 12.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.864 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 53.3 p -64.77 -31.05 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.932 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.98 -27.55 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.635 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.47 -50.25 14.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 99.99 110.886 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -73.14 -7.91 53.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 99.99 111.317 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.33 -38.39 10.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 99.99 110.862 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.5 tp -73.72 -40.98 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 99.99 112.065 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.568 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 2.3 tt -56.27 -54.29 54.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 121.126 -0.23 . . . . 99.99 111.34 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -56.51 -43.9 50.96 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.822 1.682 . . . . 99.99 111.373 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.403 ' O ' HG21 ' B' ' 211' ' ' VAL . 89.9 t80 -60.11 -32.74 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.29 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -74.3 -19.26 60.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.825 -0.625 . . . . 99.99 110.608 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 99.99 111.032 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.403 HG21 ' O ' ' B' ' 207' ' ' PHE . 16.1 m . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.89 0.376 . . . . 99.99 111.037 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.11 -46.65 93.83 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.899 -0.667 . . . . 99.99 112.453 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -73.24 -22.7 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.618 0.247 . . . . 99.99 110.719 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 60.5 m -60.59 -58.02 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.402 -0.363 . . . . 99.99 110.517 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -67.57 -30.09 69.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.26 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.23 -44.21 97.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.6 . . . . 99.99 110.367 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.19 -38.4 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.589 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.49 HD23 ' HH ' ' B' ' 37' ' ' TYR . 84.8 mt -61.47 -29.45 69.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.039 -0.528 . . . . 99.99 111.215 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -84.86 -42.18 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.218 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.2 -39.4 81.19 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.857 -0.687 . . . . 99.99 112.514 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . 0.521 HD23 ' HE2' ' B' ' 36' ' ' GLU . 72.2 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 99.99 111.015 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.452 ' H ' HD22 ' C' ' 6' ' ' LEU . 2.7 pt? . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.72 0.295 . . . . 99.99 110.971 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 18.1 tp -60.88 -52.68 64.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 99.99 110.669 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.633 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 33.1 m170 -61.55 -23.95 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.766 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -75.52 -42.08 53.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 99.99 111.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.71 -22.28 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 99.99 110.642 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -66.18 -48.32 71.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.533 . . . . 99.99 110.31 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.73 -31.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.565 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.81 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 99.99 111.1 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.59 73.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 99.99 112.486 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -78.37 -33.76 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 99.99 110.764 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 89.2 m -61.59 -51.77 67.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.815 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 1.9 tp -60.19 -39.69 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.965 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.54 -57.6 6.5 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.156 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.32 69.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.36 . . . . 99.99 111.106 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.77 -27.53 66.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.515 . . . . 99.99 111.26 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -60.34 -25.26 65.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 99.99 110.72 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -79.99 -22.97 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.75 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . 0.657 ' O ' ' OG ' ' C' ' 26' ' ' SER . 70.9 t-105 -69.81 -35.8 75.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.566 -0.531 . . . . 99.99 109.566 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 45.0 t -85.18 -33.21 22.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.544 -0.753 . . . . 99.99 110.468 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 tp -71.91 -20.72 61.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.41 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 0.7 OUTLIER -57.2 -25.53 59.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.873 -0.603 . . . . 99.99 110.514 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -44.82 -37.61 3.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.143 0.497 . . . . 99.99 110.134 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 24.3 p-10 -172.59 132.08 0.67 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.409 -0.814 . . . . 99.99 110.287 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 60.0 Cg_endo . . . . . 0 N--CA 1.451 -1.024 0 C-N-CA 123.016 2.478 . . . . 99.99 112.05 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 25.4 Cg_exo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 121.06 0.358 . . . . 99.99 112.192 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -61.79 -17.34 55.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 99.99 112.482 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.444 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -42.16 -40.98 2.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.669 0.271 . . . . 99.99 111.602 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -66.44 -43.61 85.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 99.99 110.575 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -71.81 -19.13 62.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.868 -0.605 . . . . 99.99 110.529 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.48 -48.87 73.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.394 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.28 -40.38 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 99.99 110.05 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.54 -6.81 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 99.99 110.726 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.429 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 36.6 ttm -87.84 -36.01 17.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 99.99 110.605 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.91 -35.53 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.858 -0.61 . . . . 99.99 111.07 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.566 HG23 HG22 ' C' ' 79' ' ' THR . 88.5 mt -49.88 -54.49 31.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.169 0.433 . . . . 99.99 112.169 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.429 ' HD2' ' C ' ' C' ' 41' ' ' MET . 60.4 Cg_endo -71.83 -32.83 10.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.182 1.921 . . . . 99.99 113.164 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 69.1 mt -53.41 -62.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.853 0.316 . . . . 99.99 111.853 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -66.44 -45.91 78.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.76 0.314 . . . . 99.99 111.074 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.685 ' HG ' ' HD2' ' C' ' 75' ' ' ASP . 45.8 t -61.85 -11.01 10.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.266 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.52 -53.6 3.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 99.99 112.494 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 69.0 mt -59.22 -32.9 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.689 0.28 . . . . 99.99 110.92 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -58.28 9.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 99.99 111.324 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.463 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 13.4 m-85 -59.02 -45.0 91.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.085 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 59.8 ttp -48.39 -30.58 5.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 99.99 110.355 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -46.13 59.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.763 -0.653 . . . . 99.99 111.077 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 1.2 mpp? -55.52 -20.14 12.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 99.99 110.824 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -78.54 -46.7 18.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.293 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.75 11.01 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.844 -0.616 . . . . 99.99 111.014 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 62.6 60.45 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 99.99 111.211 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.51 ' NE2' HG13 ' A' ' 127' ' ' VAL . 87.0 mm-40 -142.58 151.95 42.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.119 -0.492 . . . . 99.99 111.01 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.0 34.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.771 -0.728 . . . . 99.99 112.574 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -133.7 135.56 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 99.99 110.921 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.93 136.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 99.99 111.161 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.94 94.61 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.841 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.12 134.8 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.907 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 30.73 19.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.024 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.93 -1.26 55.52 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 99.99 112.509 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -103.56 122.29 44.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 99.99 111.153 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.45 118.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.947 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.4 133.65 51.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.199 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.52 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 78.0 m-70 -83.93 75.92 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.075 0.464 . . . . 99.99 110.876 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.99 -44.37 97.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.719 -0.673 . . . . 99.99 111.323 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' C' ' 74' ' ' ILE . . . -66.45 -23.59 66.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 99.99 111.878 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 16.7 tpp180 -68.71 -51.61 39.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.302 0.482 . . . . 99.99 112.302 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' C' ' 117' ' ' LEU . 5.7 p90 -83.54 -33.13 25.55 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.068 0.396 . . . . 99.99 112.068 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . 0.426 ' CG2' ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -55.85 -40.53 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 C-N-CA 120.715 -0.394 . . . . 99.99 110.583 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.685 ' HD2' ' HG ' ' C' ' 47' ' ' SER . 26.9 t70 -68.38 -25.39 65.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.121 -0.696 . . . . 99.99 109.121 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -86.66 9.77 17.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.453 -0.794 . . . . 99.99 110.756 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.409 ' HA ' HG23 ' C' ' 113' ' ' ILE . 53.6 tpp -104.49 -23.27 13.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 99.99 110.011 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -114.02 -30.05 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 99.99 111.576 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.566 HG22 HG23 ' C' ' 43' ' ' ILE . 41.3 m -83.73 -44.78 14.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.448 -0.342 . . . . 99.99 111.62 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 55.8 m -56.21 -49.76 91.42 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.875 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -56.47 -47.73 22.56 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.156 1.904 . . . . 99.99 112.312 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.74 -11.2 60.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.135 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.76 -47.15 22.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 99.99 109.971 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.99 -32.27 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 99.99 110.67 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.51 -37.33 77.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.676 -0.693 . . . . 99.99 111.045 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.2 t -60.63 -19.52 58.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.527 ' HB3' HD22 ' C' ' 168' ' ' LEU . 71.2 mt -75.99 -34.71 59.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.081 -0.509 . . . . 99.99 110.891 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 89.8 p -74.2 -26.09 60.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.102 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -75.07 -37.26 61.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.37 -0.377 . . . . 99.99 110.83 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 72.4 p -67.96 -33.85 75.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.333 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.64 -47.66 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.261 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.8 mtp -86.16 100.33 12.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.095 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -83.48 -42.61 16.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.764 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -115.31 140.42 49.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.107 -0.497 . . . . 99.99 111.119 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 68.1 mt -133.65 142.31 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 99.99 110.787 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -120.43 -81.11 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 99.99 111.205 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -143.81 97.61 3.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 99.99 111.023 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -172.85 79.66 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 99.99 110.771 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.52 42.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 99.99 110.78 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 34.5 m -101.84 -40.54 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.54 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.24 -36.72 77.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.219 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.2 -41.72 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 99.99 111.27 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.53 -33.52 60.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.838 -0.696 . . . . 99.99 112.656 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.51 -52.68 64.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 99.99 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.47 -43.13 99.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 99.99 111.357 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 42.3 ttm -60.47 -32.81 71.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.526 . . . . 99.99 111.544 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 47.2 t -78.87 -44.74 22.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.778 0.323 . . . . 99.99 111.451 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 77.6 p -64.87 -32.61 74.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 99.99 111.974 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' C' ' 81' ' ' PRO . 14.0 pt20 -71.32 -46.09 61.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.637 -0.256 . . . . 99.99 111.502 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.517 HG23 ' HE1' ' B' ' 46' ' ' TRP . 35.8 mm -56.02 -34.87 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.679 0.276 . . . . 99.99 111.274 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.85 -47.69 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.381 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.21 -48.9 86.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.608 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . 0.409 HG23 ' HA ' ' C' ' 77' ' ' MET . 47.7 mt -59.89 -34.66 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.478 -0.328 . . . . 99.99 111.207 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 32.0 m -58.63 -48.94 79.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 99.99 111.116 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 77.8 p -67.79 -22.15 65.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.92 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.04 -34.57 37.32 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.847 -0.692 . . . . 99.99 113.227 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.509 HD13 ' N ' ' C' ' 118' ' ' ILE . 3.2 pp -81.09 -30.62 34.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.651 0.262 . . . . 99.99 111.549 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.509 ' N ' HD13 ' C' ' 117' ' ' LEU . 8.8 tp -81.03 -28.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.511 -0.313 . . . . 99.99 111.124 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -38.65 78.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.071 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.75 -17.23 48.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 99.99 110.823 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.7 mt -91.49 26.99 2.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.063 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 44.6 t -83.22 142.76 30.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.913 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.17 -41.64 5.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.954 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . 0.431 ' HB2' HG11 ' C' ' 127' ' ' VAL . 0.0 OUTLIER -98.94 142.21 30.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 99.99 110.625 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.07 -11.33 60.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.521 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -91.04 -45.84 8.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 99.99 111.023 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -67.2 -24.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.272 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -61.76 -31.52 71.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.337 -0.392 . . . . 99.99 111.131 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.76 -20.02 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.91 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 98.8 mt -78.46 -55.75 4.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.174 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -60.79 -32.27 71.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.441 -0.345 . . . . 99.99 110.989 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -56.55 -47.2 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.594 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.7 mm -67.88 -30.43 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 99.99 110.953 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' B' ' 49' ' ' LEU . 38.3 t -64.34 -41.0 96.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.868 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.3 -54.26 27.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.845 -0.693 . . . . 99.99 112.757 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -61.42 -35.58 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.784 0.326 . . . . 99.99 111.221 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.26 -40.05 88.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.11 79.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.022 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -76.3 -28.87 57.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.883 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 94.4 mt -69.8 -46.71 65.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.41 -0.359 . . . . 99.99 111.478 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . 0.405 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.6 pt -62.02 -41.67 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 99.99 111.481 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.405 ' N ' HG13 ' C' ' 141' ' ' ILE . 49.0 pt -76.34 -27.07 17.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.484 -0.325 . . . . 99.99 111.366 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.69 -49.68 65.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.348 -0.387 . . . . 99.99 110.823 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . 0.445 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 85.2 t90 -68.98 -25.69 64.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.809 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.48 -17.24 66.78 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.79 -0.719 . . . . 99.99 112.964 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.67 -13.74 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 99.99 111.206 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -76.51 -45.74 29.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 99.99 111.22 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' C' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.536 0.411 0 CA-C-N 115.838 -0.619 . . . . 99.99 112.113 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.734 0.302 . . . . 99.99 110.997 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.74 -27.7 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.12 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.72 -39.63 85.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 99.99 110.685 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -82.84 -20.86 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 99.99 110.816 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' C' ' 87' ' ' LEU . 36.4 tp -70.77 -57.22 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 99.99 111.135 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 33.2 t -62.15 -20.92 25.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.295 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 20.9 m -50.43 -58.05 6.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.96 0.409 . . . . 99.99 111.271 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . 0.408 ' O ' HD23 ' C' ' 175' ' ' LEU . 83.4 m-85 -74.64 -26.13 59.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.121 -0.49 . . . . 99.99 110.583 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.47 -40.8 88.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 99.99 111.286 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 4.1 t -77.21 -42.79 36.08 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.747 0.277 . . . . 99.99 111.747 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.15 -40.53 77.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 99.99 111.526 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.408 HD23 ' O ' ' C' ' 171' ' ' TYR . 4.5 mm? -73.05 -52.09 15.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.321 -0.399 . . . . 99.99 111.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -29.59 61.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.84 0.353 . . . . 99.99 110.969 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.476 ' O ' HG13 ' C' ' 181' ' ' ILE . 38.9 mm -87.57 -23.88 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.511 . . . . 99.99 110.249 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.41 -50.59 61.61 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.909 -0.587 . . . . 99.99 113.062 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.609 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 69.4 m-85 -57.67 -55.51 44.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.904 0.352 . . . . 99.99 111.205 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.7 Cg_exo -45.84 -29.68 6.02 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.063 1.842 . . . . 99.99 112.416 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.476 HG13 ' O ' ' C' ' 177' ' ' ILE . 83.2 mt -66.05 -57.58 9.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.932 0.396 . . . . 99.99 111.484 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.485 HG23 ' O ' ' C' ' 179' ' ' TYR . 11.8 m -55.85 -23.87 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.633 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -73.35 -53.4 10.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.537 0.569 . . . . 99.99 112.537 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . 0.444 HG22 ' O ' ' C' ' 181' ' ' ILE . 10.4 tp -55.21 -27.67 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.058 0.392 . . . . 99.99 112.058 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 99.99 111.025 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.835 0.35 . . . . 99.99 111.13 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.18 -37.74 74.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.269 -0.423 . . . . 99.99 110.936 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.68 -52.39 60.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.3 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 46.1 p -70.47 -22.63 62.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.851 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.24 -27.22 65.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 99.99 110.865 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.99 -50.07 10.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 99.99 111.064 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.1 -10.18 56.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 47.5 t -96.56 -40.17 9.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 99.99 110.833 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.9 tp -71.72 -37.24 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 99.99 112.164 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.639 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 46.4 tp -60.63 -53.84 60.51 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.031 -0.267 . . . . 99.99 111.634 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.6 Cg_exo -57.25 -39.23 91.66 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.755 1.637 . . . . 99.99 111.426 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.35 -31.44 70.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 99.99 110.378 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -79.9 -22.78 42.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.514 . . . . 99.99 110.534 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.515 . . . . 99.99 110.902 179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.827 0.346 . . . . 99.99 111.058 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.68 57.62 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 99.99 112.689 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -69.58 -22.71 63.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 99.99 111.157 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 36.3 t -56.75 -62.31 1.82 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.424 . . . . 99.99 110.703 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . 0.464 ' HA ' HD11 ' C' ' 218' ' ' LEU . 97.2 m-85 -67.97 -27.52 66.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 99.99 110.793 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.09 -44.16 97.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.067 0.461 . . . . 99.99 110.113 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . 0.402 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 11.4 t70 -65.67 -33.45 75.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.845 -0.616 . . . . 99.99 110.601 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' C' ' 215' ' ' PHE . 84.4 mt -65.74 -32.97 74.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.028 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -87.88 -20.93 25.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.914 0.388 . . . . 99.99 110.964 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.76 -26.53 62.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.841 -0.695 . . . . 99.99 112.7 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 97.8 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 99.99 111.186 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.781 0.324 . . . . 99.99 110.594 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.02 -39.92 65.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.524 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.508 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 34.5 m80 -76.7 -26.46 54.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 99.99 110.121 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -70.75 -50.0 40.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 99.99 110.658 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 pt -59.9 -31.77 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 121.146 0.498 . . . . 99.99 109.971 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -55.87 -43.99 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.467 -0.788 . . . . 99.99 109.393 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.39 -49.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.79 -1.096 . . . . 99.99 111.071 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.45 -37.79 79.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 99.99 111.0 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.84 -38.45 95.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 99.99 112.673 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.3 mmm -70.31 -40.01 74.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 99.99 110.902 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 m -56.64 -58.56 7.53 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.025 -0.534 . . . . 99.99 111.117 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.36 -23.77 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.955 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.2 3.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 99.99 112.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.792 0.33 . . . . 99.99 111.006 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -57.1 -47.35 81.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.932 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -63.21 -35.21 79.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.785 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -69.94 -21.87 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.081 -0.508 . . . . 99.99 110.831 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.619 ' O ' ' OG ' ' A' ' 26' ' ' SER . 83.6 t90 -75.53 -36.18 60.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 99.99 110.892 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -68.34 -42.02 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.974 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.04 -1.4 57.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.619 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 94.8 p -63.05 -16.29 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 99.99 111.166 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -45.99 -40.2 10.12 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.266 -0.642 . . . . 99.99 109.266 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -176.96 131.35 0.36 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.695 -1.138 . . . . 99.99 109.381 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 30' ' ' ARG . 93.2 Cg_endo -91.98 -151.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.303 2.002 . . . . 99.99 111.929 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.401 ' H ' ' HB2' ' A' ' 29' ' ' PRO . 18.8 tpp180 -57.68 -13.69 4.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.097 0.475 . . . . 99.99 110.711 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 33.52 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.985 -0.626 . . . . 99.99 111.996 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.485 ' HB ' ' HE2' ' A' ' 35' ' ' TYR . 12.9 m -128.63 156.36 77.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.578 0.228 . . . . 99.99 111.013 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.0 166.35 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.536 2.157 . . . . 99.99 112.854 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -55.8 -17.42 6.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.9 . . . . 99.99 112.168 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.485 ' HE2' ' HB ' ' A' ' 32' ' ' VAL . 2.3 p90 -43.67 -33.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.656 0.265 . . . . 99.99 111.314 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.51 -50.14 74.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.99 0.424 . . . . 99.99 110.565 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -75.06 -19.55 59.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 99.99 111.04 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.401 HD21 ' HB ' ' B' ' 100' ' ' THR . 38.6 tp -57.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 99.99 110.828 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.3 -37.86 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.045 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.69 -8.43 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.173 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.9 tpt -89.41 -45.57 9.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 99.99 111.6 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -71.64 -42.81 67.14 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.552 0.575 . . . . 99.99 112.552 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.435 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 89.1 mt -48.37 -53.05 38.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.677 0.621 . . . . 99.99 112.677 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.7 Cg_endo -72.62 -37.28 4.15 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.04 1.826 . . . . 99.99 113.308 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.2 mm -59.33 -61.25 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.689 0.255 . . . . 99.99 111.689 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -58.76 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.879 0.371 . . . . 99.99 110.871 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.7 m -52.36 -31.59 34.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.831 -0.622 . . . . 99.99 111.159 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.66 -59.86 10.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 99.99 112.443 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 mt -61.14 -29.51 69.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 99.99 110.926 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.81 -52.0 66.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.253 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 42.3 m-85 -69.16 -23.21 63.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.075 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -62.46 -39.22 92.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 99.99 109.761 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.55 72.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.452 -0.794 . . . . 99.99 110.802 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.0 mtt -57.5 -26.93 62.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.232 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.27 -50.41 22.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 99.99 110.571 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.461 HG21 HG21 ' B' ' 127' ' ' VAL . 17.3 mt -74.41 -5.77 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.491 . . . . 99.99 110.634 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.63 65.68 0.72 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.696 -0.684 . . . . 99.99 111.106 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -130.56 148.01 52.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.909 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.533 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 98.21 17.58 29.09 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.872 -0.68 . . . . 99.99 112.352 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -117.44 149.47 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.68 0.276 . . . . 99.99 110.78 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.51 142.25 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.334 -0.394 . . . . 99.99 110.976 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -89.05 86.0 6.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.086 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.04 116.57 29.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 99.99 111.172 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.77 22.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.089 -0.505 . . . . 99.99 111.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.47 -15.01 48.37 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.672 -0.775 . . . . 99.99 112.656 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -98.34 147.56 24.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 99.99 110.945 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.3 pt -87.97 139.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.535 . . . . 99.99 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.37 138.77 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.708 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -90.8 57.43 3.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.105 0.478 . . . . 99.99 111.173 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -64.44 -57.69 8.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.176 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -54.74 -32.93 60.5 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.137 0.494 . . . . 99.99 110.644 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -57.17 -41.49 79.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.518 -0.764 . . . . 99.99 110.593 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.446 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.3 OUTLIER -83.04 -14.0 54.74 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.005 0.372 . . . . 99.99 112.005 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.9 mt -63.4 -45.11 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.009 0.433 . . . . 99.99 109.975 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.49 -11.53 52.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.811 -0.631 . . . . 99.99 110.648 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.18 -21.03 26.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 99.99 111.066 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.533 ' HG2' ' HB ' ' A' ' 113' ' ' ILE . 28.6 mtp -90.7 -7.8 51.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.014 -0.539 . . . . 99.99 111.125 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' HD21 ' A' ' 82' ' ' LEU . 34.9 m -114.85 -32.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 99.99 112.151 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.0 m -86.85 -53.09 5.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.936 0.347 . . . . 99.99 111.936 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.53 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 34.5 m -50.24 -51.63 61.26 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.343 0.497 . . . . 99.99 112.343 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 80' ' ' THR . 15.2 Cg_endo -56.74 -33.19 93.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.744 1.629 . . . . 99.99 111.851 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.406 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.2 mm? -79.61 -26.42 41.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 99.99 110.439 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.04 -38.53 79.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 99.99 109.71 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.431 HD11 ' HB3' ' A' ' 105' ' ' LEU . 4.9 tt -77.42 -39.54 46.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.465 -0.789 . . . . 99.99 110.439 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.498 HD21 ' SD ' ' A' ' 106' ' ' MET . 29.8 mt -59.45 -38.02 79.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.871 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -56.23 -35.61 67.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.525 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.73 -31.42 72.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.557 . . . . 99.99 110.915 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -62.47 -55.4 27.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.073 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -65.17 -21.74 66.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.236 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -37.18 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 99.99 110.927 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.31 28.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 99.99 111.154 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 81.4 mtp -120.54 112.08 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 99.99 110.732 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.476 HE22 ' HH ' ' A' ' 35' ' ' TYR . 22.8 mm-40 -68.09 -35.43 78.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 99.99 111.299 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.19 143.42 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 99.99 111.098 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -105.88 149.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 99.99 110.962 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 97' ' ' LYS . 59.1 tttp -133.18 -62.24 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.8 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 96' ' ' LYS . 13.2 mmmm -132.03 12.23 4.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.907 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.0 91.53 7.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 99.99 111.124 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -128.14 -5.05 5.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.781 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.3 p -94.0 -33.31 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 99.99 111.071 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.86 -42.43 97.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.917 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 103' ' ' GLY . 33.5 pt -66.98 -41.15 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.294 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.41 ' N ' HG13 ' A' ' 102' ' ' ILE . . . -65.01 -27.65 72.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.789 -0.72 . . . . 99.99 112.472 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.78 -54.0 32.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 99.99 110.97 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 84' ' ' LEU . 62.6 mt -64.31 -39.46 93.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 99.99 111.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.498 ' SD ' HD21 ' A' ' 85' ' ' LEU . 90.4 mtp -62.59 -46.4 88.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.238 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.6 m -56.22 -42.89 77.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.93 0.395 . . . . 99.99 110.884 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.511 HG23 HG22 ' A' ' 142' ' ' ILE . 79.6 m -59.37 -34.24 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 99.99 111.281 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 12.3 mm100 -72.63 -29.85 63.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.476 -0.329 . . . . 99.99 111.49 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.476 HG21 ' HE1' ' C' ' 46' ' ' TRP . 56.9 mt -66.26 -40.06 85.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 99.99 111.753 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 108' ' ' THR . 34.1 m -72.44 -32.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.678 0.275 . . . . 99.99 111.283 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.2 t -72.98 -42.31 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.679 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.533 ' HB ' ' HG2' ' A' ' 77' ' ' MET . 48.0 pt -67.24 -35.11 73.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.628 -0.26 . . . . 99.99 111.299 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 54.0 m -58.55 -55.35 36.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.856 0.36 . . . . 99.99 110.482 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.6 m -62.13 -21.01 64.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.411 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.46 -56.96 7.03 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.009 -0.615 . . . . 99.99 112.793 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 118' ' ' ILE . 2.5 pp -61.03 -22.22 64.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.61 0.243 . . . . 99.99 111.104 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.415 HG13 HD11 ' A' ' 117' ' ' LEU . 67.8 mt -83.15 -31.81 9.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 99.99 110.875 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.61 61.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.091 -0.504 . . . . 99.99 111.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.37 -22.06 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 99.99 110.934 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.5 15.35 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.951 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.429 ' HB2' ' HE ' ' A' ' 128' ' ' ARG . 50.1 m -82.27 122.97 28.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.66 -41.21 9.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 99.99 110.856 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.494 ' HB2' HG11 ' A' ' 127' ' ' VAL . 79.8 mtp180 -92.03 134.25 34.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.505 . . . . 99.99 110.706 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.76 -9.11 57.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 99.99 111.018 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -87.85 -42.29 12.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.852 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 124' ' ' ARG . 12.3 p -74.79 -26.14 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.101 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.429 ' HE ' ' HB2' ' A' ' 122' ' ' SER . 40.5 ttm180 -67.52 -31.15 71.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.24 -0.437 . . . . 99.99 111.007 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -63.68 -34.39 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.221 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.538 HD21 HG23 ' C' ' 56' ' ' ILE . 52.6 tp -81.75 -44.25 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.242 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.439 ' HE1' ' HG2' ' C' ' 58' ' ' GLN . 4.5 m95 -56.31 -33.73 65.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.327 . . . . 99.99 111.2 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.42 -55.84 18.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.259 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 19.4 tt -63.3 -25.27 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.788 0.328 . . . . 99.99 111.137 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 88.4 m -63.78 -42.27 97.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 99.99 110.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.03 -53.96 27.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 99.99 112.578 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 35.1 m -59.93 -34.14 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 99.99 111.38 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 47.8 t -60.16 -43.78 95.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.096 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.62 79.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.364 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.77 -27.77 61.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 99.99 111.05 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.1 mt -66.09 -49.6 67.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.409 -0.36 . . . . 99.99 111.636 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 142' ' ' ILE . 23.9 pt -62.34 -43.5 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 99.99 111.815 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 108' ' ' THR . 46.5 mm -71.86 -33.69 48.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.625 -0.261 . . . . 99.99 111.409 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.4 -42.31 82.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 99.99 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.747 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 84.9 t90 -74.27 -29.76 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.641 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.95 75.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.892 -0.671 . . . . 99.99 112.815 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.24 -19.38 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.847 0.356 . . . . 99.99 111.212 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -80.86 1.93 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.419 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 120.91 -0.316 . . . . 99.99 111.519 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.948 0.404 . . . . 99.99 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.489 ' HA ' ' HB2' ' A' ' 168' ' ' LEU . 0.6 OUTLIER -74.4 -22.63 59.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.941 -0.572 . . . . 99.99 111.333 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.5 -50.86 71.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 99.99 110.823 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.08 -20.67 48.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.744 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 165' ' ' TYR . 0.2 OUTLIER -66.69 -56.27 11.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 99.99 110.801 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.14 -24.36 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.234 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.0 -58.68 6.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.403 . . . . 99.99 111.127 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.65 -23.99 66.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 99.99 110.316 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -69.82 -32.83 71.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 99.99 111.277 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.6 p -76.41 -51.06 12.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.531 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.98 -29.0 40.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.467 -0.333 . . . . 99.99 111.609 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 62.5 tp -80.08 -57.37 3.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.375 -0.375 . . . . 99.99 110.914 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -29.17 58.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.8 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 181' ' ' ILE . 33.0 mm -87.75 -24.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.548 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.91 -50.87 58.97 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.844 -0.616 . . . . 99.99 113.22 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.577 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 95.6 m-85 -59.76 -55.65 43.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.779 0.289 . . . . 99.99 111.46 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.4 Cg_exo -45.56 -29.84 5.48 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.278 1.985 . . . . 99.99 112.92 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 177' ' ' ILE . 90.0 mt -69.11 -59.66 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 99.99 111.297 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.16 -25.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.644 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -62.97 -23.56 67.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.344 . . . . 99.99 110.929 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.76 -64.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.966 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 50.6 pt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.097 -179.874 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.79 0.328 . . . . 99.99 111.507 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.43 -43.73 93.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 99.99 111.032 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.401 HG21 ' HE2' ' A' ' 8' ' ' HIS . 13.7 m -75.02 -23.15 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 99.99 111.007 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -72.51 -31.85 65.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 99.99 111.169 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 67.1 tp -83.38 -32.25 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 99.99 111.315 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -75.4 -19.02 59.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 99.99 111.003 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 206' ' ' PRO . 27.4 p -96.34 -31.53 12.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.054 0.454 . . . . 99.99 110.763 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.3 tp -72.64 -32.83 66.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 99.99 111.297 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.516 ' N ' ' HD2' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -63.08 -54.26 47.55 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.536 -0.302 . . . . 99.99 111.471 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 205' ' ' LEU . 14.9 Cg_endo -56.5 -44.22 47.83 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.127 1.884 . . . . 99.99 111.825 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -66.24 -29.11 69.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.252 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.325 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 99.99 110.727 179.665 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.661 0.267 . . . . 99.99 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.64 87.63 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.686 -0.769 . . . . 99.99 112.386 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.29 -35.2 80.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.731 0.301 . . . . 99.99 110.99 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.4 m -60.96 -57.74 11.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.748 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -64.75 -20.05 66.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.898 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.8 -43.0 38.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.32 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.54 -30.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 99.99 111.358 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.22 -58.91 3.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.349 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -69.46 -21.72 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 99.99 111.091 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.55 -18.89 64.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.864 -0.684 . . . . 99.99 112.569 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 56.4 tp . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.279 . . . . 99.99 110.985 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.903 0.382 . . . . 99.99 110.81 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.12 -57.61 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.871 -0.604 . . . . 99.99 111.284 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.553 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 35.9 m170 -61.24 -25.23 66.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 99.99 110.894 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 59.0 t-105 -69.75 -39.92 76.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.578 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -24.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.127 0.489 . . . . 99.99 110.164 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' B' ' 207' ' ' PHE . 5.5 t80 -61.14 -55.76 28.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 99.99 110.619 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.72 -36.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.673 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.41 75.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 99.99 110.813 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.34 -29.3 64.37 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 99.99 111.991 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.35 -32.85 58.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 99.99 110.784 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -63.32 -54.35 38.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.454 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.03 -24.1 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 99.99 110.728 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.49 -62.05 6.78 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.764 -0.731 . . . . 99.99 112.099 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -34.71 65.39 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.926 0.393 . . . . 99.99 110.836 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.39 -44.03 84.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.6 . . . . 99.99 110.558 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -65.52 -39.37 91.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 99.99 110.839 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -73.24 -6.32 45.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.616 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.546 ' O ' ' OG ' ' B' ' 26' ' ' SER . 65.0 t90 -89.11 -35.78 16.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.624 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -70.72 -44.64 66.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.865 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.24 -2.81 53.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 99.99 110.701 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 92.8 p -58.3 -15.02 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.525 . . . . 99.99 111.186 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -48.81 -40.07 27.75 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.692 -0.484 . . . . 99.99 109.692 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.6 p-10 179.16 130.8 0.23 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.421 -0.808 . . . . 99.99 110.559 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.521 ' HG3' ' HB3' ' B' ' 33' ' ' PRO . 71.8 Cg_endo -102.95 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.646 2.897 . . . . 99.99 111.967 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' B' ' 30' ' ' ARG . 4.2 mmp_? -106.23 11.22 31.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.453 0.644 . . . . 99.99 109.685 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.68 -53.68 0.76 Allowed Glycine 0 CA--C 1.519 0.303 0 CA-C-N 114.857 -1.065 . . . . 99.99 112.16 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.65 104.87 5.38 Favored Pre-proline 0 CA--C 1.518 -0.275 0 CA-C-N 117.486 0.643 . . . . 99.99 111.69 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.521 ' HB3' ' HG3' ' B' ' 29' ' ' PRO . 83.2 Cg_endo -89.3 107.98 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.773 0.982 . . . . 99.99 113.602 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -92.74 -61.13 1.65 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.804 1.764 . . . . 99.99 107.735 174.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -39.85 18.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 110.317 -3.129 . . . . 99.99 113.148 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -38.3 -64.6 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.638 0.977 . . . . 99.99 113.638 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' B' ' 26' ' ' SER . 75.0 m-85 -82.69 -18.28 41.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.102 0.408 . . . . 99.99 112.102 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 tp -59.3 -65.12 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.867 0.365 . . . . 99.99 110.781 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 m -69.25 -37.82 76.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.472 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 -12.09 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.52 -0.309 . . . . 99.99 111.154 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 45.3 tpp -89.09 -48.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.665 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -65.86 -48.95 69.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.849 0.685 . . . . 99.99 112.849 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.423 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 79.5 mt -45.36 -53.61 17.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.29 0.848 . . . . 99.99 113.29 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -71.48 -38.61 4.38 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.228 1.952 . . . . 99.99 113.611 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -59.54 -61.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.852 0.315 . . . . 99.99 111.852 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.428 ' HE1' HG21 ' C' ' 110' ' ' ILE . 0.1 OUTLIER -58.26 -58.92 6.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 99.99 111.314 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.643 ' HG ' ' HD2' ' B' ' 75' ' ' ASP . 47.9 t -55.05 -26.24 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 99.99 111.025 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.58 -67.57 2.08 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.754 -0.736 . . . . 99.99 112.739 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.09 -24.32 58.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.646 0.26 . . . . 99.99 111.385 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.66 -59.15 5.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.458 -0.337 . . . . 99.99 111.182 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.8 m-85 -61.76 -35.8 79.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 99.99 110.95 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 57.6 ttp -51.5 -35.31 39.68 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.072 0.463 . . . . 99.99 110.08 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.61 -39.44 70.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.741 -0.663 . . . . 99.99 110.537 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -57.11 -21.12 29.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 99.99 110.567 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -82.63 -46.18 13.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.046 -0.525 . . . . 99.99 111.105 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 53' ' ' ALA . 27.0 pt -75.26 -0.05 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 99.99 111.299 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.93 65.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.939 -0.573 . . . . 99.99 110.904 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -146.79 114.27 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.846 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 70' ' ' TYR . . . 136.23 -1.33 3.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.532 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -108.58 151.54 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 99.99 111.018 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.26 145.67 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.1 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.32 87.95 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 99.99 111.143 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.28 118.08 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.85 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.86 31.49 20.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.13 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.14 0.56 86.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.646 -0.787 . . . . 99.99 112.548 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -101.02 147.19 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 99.99 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.3 mt -92.74 121.86 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.81 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' B' ' 121' ' ' LEU . . . -99.12 140.07 33.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 99.99 111.276 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.582 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.7 m-70 -82.99 58.29 4.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.879 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.435 ' O ' HG13 ' B' ' 74' ' ' ILE . 65.5 t80 -62.89 -55.75 23.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.506 -0.77 . . . . 99.99 111.351 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.0 67.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.068 0.396 . . . . 99.99 112.068 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.582 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 58.7 mmt-85 -64.69 -52.46 57.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.231 0.456 . . . . 99.99 112.231 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.49 ' CE1' ' HG ' ' B' ' 117' ' ' LEU . 2.1 p90 -64.29 -32.12 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.607 -0.437 . . . . 99.99 110.476 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.435 HG13 ' O ' ' B' ' 70' ' ' TYR . 57.7 mt -50.44 -53.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.992 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.643 ' HD2' ' HG ' ' B' ' 47' ' ' SER . 24.7 t70 -66.56 -22.76 66.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.311 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -89.77 5.1 47.54 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.034 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.437 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 51.9 ttm -104.89 -18.44 14.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 99.99 110.592 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.46 -33.81 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.087 -0.506 . . . . 99.99 112.106 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -79.33 -48.5 13.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.157 0.428 . . . . 99.99 112.157 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 5.6 m -55.6 -50.71 85.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.443 -0.344 . . . . 99.99 111.781 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 47.2 Cg_exo -55.54 -33.48 86.68 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.945 1.763 . . . . 99.99 111.969 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 83.8 mt -78.55 -26.47 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.868 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.58 -39.17 84.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.847 0.356 . . . . 99.99 110.281 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.433 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.8 pp -82.07 -25.96 34.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.976 -0.556 . . . . 99.99 110.323 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.433 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.1 mt -68.62 -34.05 75.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 99.99 109.804 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -58.78 -34.84 71.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 99.99 110.423 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.05 -29.33 65.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 99.99 110.88 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 56.4 m -63.57 -40.05 95.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 99.99 110.937 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -82.51 -16.24 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.033 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 89.8 m -68.08 -42.92 79.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 99.99 111.268 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.77 -33.21 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.376 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.5 mtm -118.04 110.23 17.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.829 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -76.44 -30.38 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.248 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -133.54 140.78 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.767 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -107.7 142.03 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 99.99 111.14 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -127.0 -50.62 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.854 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.594 ' HZ2' ' HB2' ' B' ' 97' ' ' LYS . 4.4 ttmp? -137.28 -17.21 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.911 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -65.52 113.26 4.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.223 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -149.21 -23.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.999 -0.546 . . . . 99.99 110.497 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.401 ' HB ' HD21 ' A' ' 38' ' ' LEU . 61.8 p -76.35 -34.92 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 99.99 110.778 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.87 -46.91 82.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.502 . . . . 99.99 110.592 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.24 -37.17 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.88 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.29 -18.26 79.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 99.99 112.409 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -72.85 -45.02 60.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 99.99 110.755 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.38 -30.41 63.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.945 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' MET . . . . . 0.404 ' O ' HG13 ' B' ' 110' ' ' ILE . 89.5 mtp -69.7 -48.69 58.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -57.61 -45.32 85.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.364 -0.38 . . . . 99.99 111.077 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.453 ' O ' HG23 ' B' ' 111' ' ' VAL . 57.8 p -59.14 -33.12 70.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.128 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.445 ' O ' HG13 ' B' ' 113' ' ' ILE . 56.8 tp60 -71.17 -36.78 72.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.356 -0.384 . . . . 99.99 110.987 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 106' ' ' MET . 54.6 mt -56.8 -43.32 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' ' 108' ' ' THR . 18.2 m -70.93 -30.59 42.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 99.99 111.347 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 88.9 t -72.64 -27.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.482 -0.327 . . . . 99.99 111.256 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 109' ' ' GLN . 69.8 mt -80.2 -43.15 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.631 -0.259 . . . . 99.99 111.213 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 9.7 t -58.92 -29.92 67.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.955 0.407 . . . . 99.99 110.176 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -69.15 -50.52 47.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.897 -0.592 . . . . 99.99 109.833 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.54 -10.1 66.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.9 -0.667 . . . . 99.99 111.51 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.49 ' HG ' ' CE1' ' B' ' 73' ' ' TYR . 4.4 tt -70.43 -56.78 5.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.506 . . . . 99.99 110.346 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.48 -20.62 9.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.647 -0.706 . . . . 99.99 111.546 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.83 -39.41 11.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 99.99 111.331 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . 0.592 ' HD2' ' HH2' ' B' ' 183' ' ' TRP . 7.5 m-20 -87.03 -23.93 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 99.99 110.842 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' B' ' 68' ' ' ALA . 87.8 mt -87.96 29.57 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 99.99 111.15 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -93.91 122.92 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.411 . . . . 99.99 110.735 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.53 -52.52 4.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 99.99 111.263 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.514 ' HB3' HG11 ' B' ' 127' ' ' VAL . 35.9 ttm180 -77.42 123.71 26.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.809 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.73 -14.24 50.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.132 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.496 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 66.1 t-105 -74.53 -56.12 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 99.99 110.56 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' B' ' 124' ' ' ARG . 7.7 p -65.15 -27.95 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.059 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -55.07 -26.93 41.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.725 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.54 -34.99 40.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 99.99 110.922 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . 0.408 HD21 ' N ' ' B' ' 130' ' ' LEU . 3.8 mm? -72.31 -49.33 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.135 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -62.47 -31.9 72.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . 0.441 ' HE1' ' HB3' ' B' ' 183' ' ' TRP . 66.5 t80 -63.34 -55.47 24.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.984 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 tt -68.34 -23.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.027 0.441 . . . . 99.99 110.865 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.8 -41.67 91.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 99.99 111.276 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.82 -50.49 35.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 99.99 112.799 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 26.9 m -61.31 -38.31 79.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.576 0.227 . . . . 99.99 111.489 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -58.31 -45.29 88.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 99.99 111.331 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.57 77.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 99.99 111.153 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -69.71 -22.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 99.99 111.361 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 80.5 mt -66.98 -60.61 2.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.703 -0.226 . . . . 99.99 111.278 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 31.0 pt -56.08 -36.33 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 99.99 111.408 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.78 -42.63 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.152 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.17 -47.47 81.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.069 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . 0.447 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 44.4 t-105 -66.59 -25.91 66.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 99.99 110.964 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.65 -21.29 58.28 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.9 -0.667 . . . . 99.99 113.229 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.1 pt -98.94 -6.58 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 99.99 111.717 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -87.59 -2.3 58.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.388 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' B' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.855 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.8 0.333 . . . . 99.99 110.962 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.67 -22.38 50.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.534 . . . . 99.99 110.885 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.71 -47.35 84.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.164 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.19 -21.0 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.633 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.2 -49.57 55.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.699 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.33 -23.63 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.006 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.82 -59.04 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.295 -0.411 . . . . 99.99 110.982 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.91 -29.15 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.069 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.98 -21.56 64.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.601 -0.727 . . . . 99.99 110.843 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 46.6 m -79.14 -58.3 3.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.539 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.08 -29.78 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 99.99 111.686 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 44.9 tp -76.39 -58.55 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.474 -0.33 . . . . 99.99 111.562 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -28.89 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.33 -0.395 . . . . 99.99 110.854 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.413 ' O ' HG12 ' B' ' 181' ' ' ILE . 42.9 mm -87.93 -24.07 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.482 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.92 48.5 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.937 -0.574 . . . . 99.99 113.228 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 83.1 m-85 -56.8 -55.78 39.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.912 0.356 . . . . 99.99 111.521 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.1 Cg_exo -44.89 -33.32 7.28 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.455 2.103 . . . . 99.99 112.84 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.413 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.0 mm -66.49 -59.58 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 99.99 111.644 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.09 -28.28 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.831 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . 0.592 ' HH2' ' HD2' ' B' ' 120' ' ' ASP . 38.2 m95 -60.07 -24.22 64.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.59 -0.277 . . . . 99.99 111.174 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 89.2 mt -55.63 -61.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.715 0.293 . . . . 99.99 111.179 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 41.2 pt -82.81 165.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 99.99 111.267 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.336 0 C-N-CA 120.891 -0.671 . . . . 99.99 112.608 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.831 0.348 . . . . 99.99 110.763 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 99.99 110.451 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -62.91 -28.06 69.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 99.99 110.762 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -66.17 -36.12 82.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 99.99 110.977 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.69 -47.81 51.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -71.38 -6.21 38.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.154 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HD2' ' B' ' 206' ' ' PRO . 47.3 t -96.34 -46.13 6.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.204 0.526 . . . . 99.99 110.599 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.1 tp -72.25 -26.01 61.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 99.99 111.578 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.66 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 62.2 tp -66.0 -54.48 27.12 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.931 -0.308 . . . . 99.99 111.123 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.5 Cg_exo -55.83 -42.52 66.29 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.697 1.598 . . . . 99.99 111.388 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' B' ' 11' ' ' TYR . 89.4 t80 -63.93 -39.19 93.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.456 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.2 -34.31 78.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 99.99 111.089 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.317 -0.401 . . . . 99.99 110.994 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.814 0.34 . . . . 99.99 111.209 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.63 63.25 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.823 -0.703 . . . . 99.99 112.563 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -66.4 -38.47 87.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 99.99 110.859 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' B' ' 217' ' ' ASP . 66.8 m -60.64 -56.39 21.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 99.99 110.733 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -63.94 -20.12 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.683 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.63 -58.18 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 99.99 111.104 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.504 ' HD2' ' HA ' ' B' ' 214' ' ' SER . 3.1 p30 -58.73 -23.89 60.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.375 . . . . 99.99 111.209 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.3 tp -68.76 -54.59 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.338 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -77.59 -20.36 54.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.285 -0.416 . . . . 99.99 111.311 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.36 67.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.913 -0.66 . . . . 99.99 113.102 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 52.7 tp . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.598 0.237 . . . . 99.99 111.125 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.449 ' H ' HD23 ' C' ' 6' ' ' LEU . 2.4 pt? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.789 0.328 . . . . 99.99 110.782 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.31 -41.79 98.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 99.99 110.498 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.532 ' HB2' ' HB3' ' C' ' 55' ' ' ALA . 46.2 m80 -74.1 -23.84 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 99.99 110.389 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -72.61 -44.49 61.9 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.914 -0.585 . . . . 99.99 110.732 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.45 -23.34 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.183 0.516 . . . . 99.99 109.911 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -60.79 -57.35 13.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 99.99 110.581 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.04 -31.42 45.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.31 -0.404 . . . . 99.99 110.805 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.16 -33.21 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.449 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.82 -28.67 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 99.99 112.008 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.4 mmt -75.7 -34.63 60.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.634 0.254 . . . . 99.99 111.232 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -63.1 -53.36 54.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 99.99 110.867 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . 0.545 ' HA ' HD11 ' C' ' 20' ' ' LEU . 2.7 pp -61.91 -26.65 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.809 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.25 -59.94 9.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 99.99 112.278 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.89 65.84 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.796 0.332 . . . . 99.99 111.277 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.545 HD11 ' HA ' ' C' ' 17' ' ' ILE . 96.2 mt -62.79 -42.5 99.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.879 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -59.52 -40.76 88.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 99.99 110.633 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -70.54 -20.01 62.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 99.99 110.831 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . 0.479 ' O ' ' OG ' ' C' ' 26' ' ' SER . 85.7 t90 -71.57 -34.36 69.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.655 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 43.9 t -71.39 -47.8 53.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.879 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 -0.93 30.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.778 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 95.1 p -56.09 -17.7 7.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.441 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -47.24 -42.83 21.18 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.742 -0.466 . . . . 99.99 109.742 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 7.7 p30 -173.67 130.66 0.53 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.468 -0.787 . . . . 99.99 110.402 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 73.4 Cg_endo . . . . . 0 N--CA 1.452 -0.936 0 C-N-CA 123.471 2.781 . . . . 99.99 112.651 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . 0.401 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 50.2 Cg_exo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 121.162 0.401 . . . . 99.99 112.969 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -60.03 -17.98 42.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 99.99 112.096 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.401 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 4.7 p90 -45.5 -30.84 1.53 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.706 0.289 . . . . 99.99 111.641 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.59 -58.75 5.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.142 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -69.76 -19.84 63.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.383 -0.371 . . . . 99.99 111.319 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.49 -63.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.819 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.53 -30.36 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.328 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.17 -13.04 61.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 99.99 111.559 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.418 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 27.2 ttt -89.79 -42.54 11.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.906 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.15 -42.0 66.47 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.751 0.648 . . . . 99.99 112.751 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 35.1 mm -51.45 -52.72 57.11 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.78 0.659 . . . . 99.99 112.78 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 12.6 Cg_exo -70.33 -39.08 5.78 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.416 2.077 . . . . 99.99 113.209 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.19 -61.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.887 0.329 . . . . 99.99 111.887 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.476 ' HE1' HG21 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -56.11 -58.94 5.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 99.99 111.234 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.409 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 30.3 t -53.42 -28.8 31.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.99 -0.55 . . . . 99.99 111.213 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.98 -62.54 6.11 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.657 -0.783 . . . . 99.99 112.445 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 56.1 mt -61.4 -24.12 66.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 99.99 110.838 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' C' ' 75' ' ' ASP . . . -64.4 -58.04 7.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.004 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 36.8 m-85 -63.59 -35.77 81.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.982 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 51.7 ttp -53.48 -35.28 60.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.138 0.494 . . . . 99.99 109.965 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.501 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.63 -34.14 64.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.698 -0.683 . . . . 99.99 110.69 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.4 mtt -61.82 -20.12 63.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 99.99 110.052 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' C' ' 8' ' ' HIS . . . -81.24 -48.07 12.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 99.99 110.713 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.538 HG23 HD21 ' A' ' 130' ' ' LEU . 39.6 pt -73.01 -5.44 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.343 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.66 67.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.943 -0.571 . . . . 99.99 111.117 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.439 ' HG2' ' HE1' ' A' ' 131' ' ' TRP . 53.0 tp60 -139.21 139.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 99.99 110.766 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.467 ' HA3' ' HB1' ' C' ' 71' ' ' ALA . . . 110.74 11.14 19.92 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.892 -0.67 . . . . 99.99 112.194 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.511 ' HZ2' HH21 ' C' ' 72' ' ' ARG . 64.5 mttm -115.09 148.21 39.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 99.99 110.925 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.93 140.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.047 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.43 86.85 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.152 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.68 118.9 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.08 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.76 28.75 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 99.99 111.284 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.49 -6.3 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 99.99 112.626 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.94 152.58 19.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 99.99 110.675 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.06 131.68 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.894 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.02 144.66 32.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.515 . . . . 99.99 111.208 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.418 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 65.2 m-70 -91.56 59.21 3.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 99.99 110.779 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.21 -58.18 5.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 99.99 111.256 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.467 ' HB1' ' HA3' ' C' ' 59' ' ' GLY . . . -55.61 -35.45 65.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.228 0.537 . . . . 99.99 110.429 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.511 HH21 ' HZ2' ' C' ' 60' ' ' LYS . 9.1 tpp180 -56.04 -39.29 71.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.338 -0.846 . . . . 99.99 111.008 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.491 ' O ' ' HG3' ' C' ' 77' ' ' MET . 0.2 OUTLIER -82.59 -20.75 35.87 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.04 0.385 . . . . 99.99 112.04 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 47.7 mm -58.77 -42.86 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 99.99 110.284 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.411 ' HB2' ' HB1' ' C' ' 50' ' ' ALA . 25.8 t70 -60.98 -22.73 64.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 99.99 110.599 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -81.27 -27.61 35.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 99.99 111.267 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.546 ' HG2' HG23 ' C' ' 113' ' ' ILE . 12.8 mtp -75.55 -14.04 60.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.736 -0.665 . . . . 99.99 111.801 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.89 -42.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.451 0.537 . . . . 99.99 112.451 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 71.7 m -72.49 -51.82 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.63 0.604 . . . . 99.99 112.63 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.0 m -54.02 -51.02 80.92 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.351 0.5 . . . . 99.99 112.351 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.7 Cg_exo -55.28 -35.53 91.57 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.939 1.759 . . . . 99.99 112.256 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.55 -23.8 49.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.663 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -46.36 75.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.492 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.494 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -74.36 -29.26 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.737 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . 0.494 ' N ' HD12 ' C' ' 84' ' ' LEU . 7.4 tp -64.52 -36.76 85.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 99.99 110.501 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 m -61.61 -32.04 72.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 99.99 110.379 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 60.8 mt -66.7 -32.43 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.8 -0.636 . . . . 99.99 110.561 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.8 t -62.94 -53.45 53.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 99.99 110.566 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.97 -26.66 68.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.845 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 86.0 m -66.31 -33.15 75.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.891 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.15 -50.73 25.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -124.07 127.58 48.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -78.48 -13.12 59.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 99.99 110.938 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -133.76 163.26 29.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.028 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 36.5 mm -126.44 143.98 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.959 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -133.22 -72.73 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.863 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.78 1.5 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.88 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.17 96.05 7.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.995 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -136.32 -9.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.647 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 82.2 p -88.25 -38.89 14.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.017 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.88 -42.12 97.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.534 . . . . 99.99 110.704 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.44 -41.14 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.959 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.36 -14.67 77.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 99.99 112.449 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.82 -46.41 24.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.878 0.37 . . . . 99.99 110.568 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.38 -38.72 68.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 99.99 110.555 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 22.5 ttt -66.36 -42.04 88.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.574 -0.739 . . . . 99.99 111.61 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 47.7 t -60.29 -50.14 74.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.792 0.33 . . . . 99.99 111.218 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.578 HG21 HG12 ' C' ' 142' ' ' ILE . 39.9 m -55.29 -36.59 66.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 99.99 111.079 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -63.74 -46.68 84.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.257 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.428 HG21 ' HE1' ' B' ' 46' ' ' TRP . 66.5 mt -52.66 -34.5 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.864 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.95 -53.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.564 . . . . 99.99 111.357 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 28.6 t -63.49 -27.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.37 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . 0.546 HG23 ' HG2' ' C' ' 77' ' ' MET . 22.2 mm -65.43 -50.27 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 99.99 111.423 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 92.4 m -54.54 -55.53 28.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.47 -0.332 . . . . 99.99 111.044 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 35.4 m -57.38 -21.49 36.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 99.99 110.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -61.6 3.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.756 -0.735 . . . . 99.99 112.847 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.413 HD13 HG12 ' C' ' 118' ' ' ILE . 3.5 pp -59.85 -22.21 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.702 0.287 . . . . 99.99 110.976 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.413 HG12 HD13 ' C' ' 117' ' ' LEU . 37.6 mm -81.42 -33.93 12.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.997 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.28 -37.73 48.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.193 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.88 -21.14 28.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 99.99 110.946 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.77 28.99 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.431 -0.35 . . . . 99.99 111.025 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -94.71 125.75 39.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 99.99 110.783 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.98 -21.2 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.245 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 52.5 ttp180 -114.86 135.83 53.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.382 -0.372 . . . . 99.99 110.676 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.01 -11.73 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.625 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . 0.584 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 56.6 t90 -81.86 -50.17 9.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 99.99 110.845 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' C' ' 124' ' ' ARG . 7.4 p -66.07 -26.61 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 99.99 111.015 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -62.37 -21.58 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 99.99 111.103 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -77.61 -36.8 51.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 99.99 110.816 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . 0.41 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.3 mp -76.76 -30.4 56.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.089 -0.505 . . . . 99.99 111.38 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -76.07 -42.53 47.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.715 0.293 . . . . 99.99 111.362 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -57.67 -50.96 71.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.944 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.5 -27.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 99.99 111.25 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.06 -45.03 90.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 99.99 111.105 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.09 47.62 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.846 -0.692 . . . . 99.99 112.878 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.96 -31.73 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.694 0.257 . . . . 99.99 111.694 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.19 -48.79 76.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 99.99 111.34 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.6 73.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 99.99 111.301 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.08 -22.64 62.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.035 -0.53 . . . . 99.99 111.455 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.44 -53.87 9.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.537 -0.301 . . . . 99.99 111.792 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . 0.414 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.7 pt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.833 0.309 . . . . 99.99 111.833 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.578 HG12 HG21 ' C' ' 108' ' ' THR . 8.1 tp -72.47 -31.19 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.773 0.32 . . . . 99.99 111.44 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.45 -44.96 95.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 99.99 111.004 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . 0.712 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 71.8 t-105 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 99.99 111.259 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.51 -17.57 77.44 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.751 -0.737 . . . . 99.99 113.165 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.64 -26.34 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.872 0.367 . . . . 99.99 110.995 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -73.02 -0.28 13.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.912 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . 0.712 ' ND2' ' O ' ' C' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 99.99 112.124 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.949 0.404 . . . . 99.99 110.77 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.43 -27.28 63.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.867 -0.606 . . . . 99.99 110.862 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.87 -42.49 99.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.892 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -81.62 -21.15 38.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 99.99 110.722 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 55.6 tp -70.61 -54.59 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 99.99 111.355 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.46 -24.04 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 99.99 111.224 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.9 m -55.05 -59.06 5.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 99.99 111.255 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.12 -26.76 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.423 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -70.22 -25.31 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.879 -0.6 . . . . 99.99 110.884 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 84.2 m -79.88 -51.69 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.515 . . . . 99.99 111.83 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.72 -26.4 34.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 111.925 0.342 . . . . 99.99 111.925 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 60.6 tp -83.2 -54.81 4.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.568 -0.287 . . . . 99.99 111.299 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -32.41 64.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.726 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.471 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.3 tt -87.73 -19.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.484 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.21 39.76 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.835 -0.62 . . . . 99.99 113.034 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 94.6 m-85 -55.31 -53.8 57.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.807 0.304 . . . . 99.99 111.19 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.2 Cg_exo -46.6 -31.6 10.43 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.122 1.881 . . . . 99.99 112.503 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -66.1 -60.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.364 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.52 -31.51 49.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.846 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -54.76 -29.03 52.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.568 -0.287 . . . . 99.99 111.469 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 74.5 mt -52.64 -62.44 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 99.99 111.237 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 34.6 pt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 99.99 111.257 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.749 0.309 . . . . 99.99 111.223 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt -63.48 -27.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 99.99 110.909 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.02 -48.37 71.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 99.99 110.8 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 68.0 p -65.4 -24.99 67.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -70.56 -36.39 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.883 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.9 tp -76.73 -32.52 57.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 99.99 110.96 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -77.41 -18.93 56.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.828 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.49 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.6 m -96.11 -34.27 11.76 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.173 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.64 -35.32 72.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.124 -0.489 . . . . 99.99 111.586 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.608 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.8 OUTLIER -59.98 -53.78 61.93 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 121.138 -0.225 . . . . 99.99 110.813 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 64.7 Cg_exo -52.16 -50.83 12.68 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.197 1.931 . . . . 99.99 112.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -63.13 -32.74 74.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.379 -0.373 . . . . 99.99 110.703 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.63 -30.97 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.555 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.827 179.805 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . 0.413 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.7 p . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.801 0.334 . . . . 99.99 110.962 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.413 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -64.3 -28.7 73.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.812 -0.709 . . . . 99.99 112.375 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.24 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 99.99 110.634 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 45.0 t -60.94 -60.71 3.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 99.99 110.85 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -62.8 -20.45 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 99.99 111.045 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.93 -56.1 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.757 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.5 -21.13 65.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.329 -0.396 . . . . 99.99 111.02 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 68.4 tp -67.27 -51.87 47.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.966 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -82.44 -22.49 35.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 99.99 111.01 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.79 -22.55 47.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.899 -0.667 . . . . 99.99 112.642 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.323 . . . . 99.99 110.574 179.892 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.79 0.329 . . . . 99.99 110.76 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.49 -40.81 83.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.094 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 39.5 m80 -62.12 -35.96 80.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.034 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.1 t-105 -69.52 -45.25 69.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.186 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mt -68.26 -21.82 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.034 0.445 . . . . 99.99 110.457 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -63.95 -54.98 26.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 99.99 110.682 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.64 -31.45 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.314 -0.403 . . . . 99.99 111.032 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.31 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.168 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.33 -33.38 75.55 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.974 -0.631 . . . . 99.99 112.951 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -70.47 -31.65 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.805 0.303 . . . . 99.99 111.201 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.8 m -63.02 -62.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.43 -0.35 . . . . 99.99 110.995 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -53.46 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.369 -0.378 . . . . 99.99 111.181 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.28 -43.24 98.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.808 -0.711 . . . . 99.99 112.236 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.437 ' HB3' ' HE3' ' A' ' 41' ' ' MET . . . -65.21 -35.86 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.865 0.364 . . . . 99.99 111.023 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.61 -31.75 69.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 99.99 111.078 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -55.89 -24.51 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.267 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -56.45 -56.51 20.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.477 -0.329 . . . . 99.99 111.085 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.653 ' O ' ' OG ' ' A' ' 26' ' ' SER . 86.2 t90 -64.24 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.978 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -70.13 -23.77 63.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 99.99 111.234 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.4 tp -87.76 -4.29 58.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 99.99 110.918 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.653 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 29.2 p -69.82 -20.22 63.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.96 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.434 ' HG3' HD21 ' A' ' 28' ' ' ASN . 24.9 tpt180 -50.6 -32.14 17.94 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.63 -0.507 . . . . 99.99 109.63 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 6.4 p30 -175.55 132.28 0.43 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.371 -0.831 . . . . 99.99 110.464 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 57.4 Cg_endo -96.15 158.21 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.226 2.617 . . . . 99.99 112.113 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -84.51 62.12 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.964 0.411 . . . . 99.99 110.99 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.69 -46.98 3.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.952 -0.642 . . . . 99.99 112.446 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.0 m -99.75 145.48 30.21 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.468 0.175 . . . . 99.99 110.658 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.25 160.83 12.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.317 2.012 . . . . 99.99 112.378 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -62.16 -16.41 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.801 . . . . 99.99 112.077 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -41.41 -37.89 1.13 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.022 0.379 . . . . 99.99 112.022 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 99.99 110.369 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -68.22 -20.19 64.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.021 -0.536 . . . . 99.99 110.282 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 41' ' ' MET . 32.8 tp -61.28 -47.75 84.57 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.002 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.67 -41.93 94.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.127 -0.488 . . . . 99.99 109.842 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.47 -6.11 33.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.62 -0.718 . . . . 99.99 110.908 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.446 ' HB3' ' O ' ' A' ' 38' ' ' LEU . 24.1 ttt -87.95 -36.42 17.1 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -71.3 -33.41 69.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 78.3 mt -50.68 -54.83 31.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.025 0.38 . . . . 99.99 112.025 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -70.62 -32.21 15.4 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.234 1.956 . . . . 99.99 113.082 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 41' ' ' MET . 24.8 mm -55.32 -62.4 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.717 0.294 . . . . 99.99 111.726 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -62.66 -53.88 47.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 99.99 111.306 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.478 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 91.3 p -58.48 -14.63 8.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.545 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.59 -61.21 2.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 99.99 112.589 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 mt -55.96 -27.57 53.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.704 0.287 . . . . 99.99 111.358 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.94 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.399 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.483 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.2 m-85 -60.86 -38.05 84.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 99.99 111.46 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.8 ttp -52.04 -40.41 61.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.11 0.481 . . . . 99.99 110.059 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.45 93.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 99.99 110.738 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.6 mtt -52.48 -35.73 53.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.323 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -65.81 -43.88 87.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.968 -0.56 . . . . 99.99 110.093 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.491 HG21 HG22 ' B' ' 127' ' ' VAL . 12.1 mt -70.61 -3.6 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 99.99 110.814 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.78 32.57 10.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.794 -0.639 . . . . 99.99 111.021 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -114.93 127.63 55.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.537 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.65 15.15 2.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.821 -0.704 . . . . 99.99 112.394 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -112.34 141.97 45.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 99.99 110.909 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.47 138.16 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.094 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.25 138.9 37.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.11 -0.496 . . . . 99.99 110.871 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.33 104.43 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.129 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.11 26.11 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.488 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.35 23.1 32.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.602 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -121.77 127.2 50.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 99.99 110.678 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -101.84 120.75 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.176 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.63 124.58 52.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.685 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 74.5 m-70 -70.22 82.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.345 0.593 . . . . 99.99 111.161 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.92 -50.96 70.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.314 -0.857 . . . . 99.99 111.253 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -22.39 66.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.958 -0.565 . . . . 99.99 112.166 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.559 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -68.89 -52.09 33.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.195 0.443 . . . . 99.99 112.195 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 4.0 p90 -76.67 -34.34 58.25 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.9 -0.32 . . . . 99.99 111.244 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 mm -52.59 -49.85 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.934 0.397 . . . . 99.99 110.532 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 26.7 t70 -65.0 -22.25 66.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.927 -0.578 . . . . 99.99 109.877 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -87.08 5.29 38.41 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.803 -0.635 . . . . 99.99 111.254 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 43.2 ttm -104.17 -19.75 14.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.61 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.438 ' O ' HD21 ' A' ' 82' ' ' LEU . 34.7 m -113.98 -32.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.746 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.418 HG21 HG21 ' A' ' 43' ' ' ILE . 28.4 m -79.17 -53.57 6.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.369 -0.378 . . . . 99.99 111.904 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.562 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 32.6 m -50.68 -50.39 73.35 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.078 0.399 . . . . 99.99 112.078 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HA ' ' HG2' ' A' ' 109' ' ' GLN . 11.9 Cg_endo -55.71 -41.6 75.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.713 1.609 . . . . 99.99 111.547 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 78' ' ' VAL . 3.6 mm? -65.73 -31.79 72.98 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.715 -0.476 . . . . 99.99 109.715 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.82 -26.98 67.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.046 -0.724 . . . . 99.99 109.046 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 109' ' ' GLN . 11.4 tp -81.74 -39.44 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.917 -1.038 . . . . 99.99 110.686 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.75 -38.31 90.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.874 -0.603 . . . . 99.99 111.046 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -57.27 -23.66 49.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.117 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -73.93 -29.0 61.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.143 -0.48 . . . . 99.99 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.6 t -80.84 -27.15 36.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.166 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -79.03 -31.49 44.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.371 . . . . 99.99 111.197 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -82.64 -26.36 32.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.519 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.86 -49.46 9.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.398 -0.364 . . . . 99.99 111.192 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.6 mtt -108.14 110.62 22.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.176 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.99 -39.26 89.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.399 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -114.39 175.72 5.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.778 -0.646 . . . . 99.99 110.471 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -130.26 142.58 43.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.44 -0.346 . . . . 99.99 111.022 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.15 174.91 9.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.272 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -70.61 -59.29 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.045 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.08 130.0 38.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.129 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -106.42 92.15 4.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.0 t -113.49 -41.07 3.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.413 . . . . 99.99 111.493 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.9 tp -76.92 -41.84 41.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 99.99 110.98 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 mm -65.94 -30.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.067 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.19 -40.3 42.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.923 -0.656 . . . . 99.99 112.441 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -63.18 -35.98 82.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 99.99 110.88 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 -56.75 13.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.176 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 57.1 ttm -56.95 -40.98 77.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.519 . . . . 99.99 111.234 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -58.31 -51.86 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 99.99 111.278 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p -60.67 -21.14 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.378 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 21.7 tp60 -77.25 -30.23 54.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.361 . . . . 99.99 110.76 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.31 -39.53 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 99.99 111.199 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.37 -35.73 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.932 -0.307 . . . . 99.99 111.063 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 81.8 t -66.26 -52.82 43.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.341 -0.39 . . . . 99.99 111.433 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.7 pt -60.03 -27.66 39.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.728 0.299 . . . . 99.99 111.336 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 30.7 m -63.39 -46.71 85.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.15 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 p -69.65 -24.85 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.795 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.98 -32.66 48.49 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.908 -0.663 . . . . 99.99 113.217 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -80.53 -28.16 37.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.635 0.255 . . . . 99.99 111.513 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.3 tp -83.49 -27.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 99.99 110.87 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.78 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.056 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.61 -21.12 60.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 99.99 111.029 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.7 mt -83.13 16.52 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.902 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -75.24 119.85 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.817 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.66 -53.87 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.588 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.7 ttp180 -78.26 132.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.606 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.19 -9.38 39.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 99.99 111.485 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.588 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 78.3 t90 -89.51 -52.23 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 99.99 110.915 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 124' ' ' ARG . 12.4 p -63.02 -23.7 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -55.12 -33.59 63.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.077 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.59 -27.52 45.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.242 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.78 -54.21 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.315 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -61.43 -32.95 72.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.769 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -58.69 -45.44 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 99.99 110.645 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.66 -26.73 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.6 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 63.4 m -68.65 -34.11 75.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.791 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.57 -51.0 33.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.868 -0.682 . . . . 99.99 112.622 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.24 -29.76 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.738 0.304 . . . . 99.99 111.019 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.31 -47.12 87.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.8 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.38 -33.42 74.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.903 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.419 ' HA ' HG12 ' A' ' 142' ' ' ILE . 80.7 t80 -72.03 -27.18 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.948 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.7 mt -65.15 -54.02 36.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.576 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 142' ' ' ILE . 37.8 pt -59.18 -42.2 86.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.355 . . . . 99.99 111.827 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.43 ' N ' HG13 ' A' ' 141' ' ' ILE . 29.3 pt -73.02 -22.29 19.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.307 . . . . 99.99 111.194 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.72 -40.14 91.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.853 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -72.66 -36.43 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 99.99 110.421 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.99 -38.35 95.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.891 -0.671 . . . . 99.99 112.642 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.85 -21.32 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 99.99 110.965 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -90.39 4.99 49.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.174 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.875 -0.602 . . . . 99.99 111.927 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.87 0.367 . . . . 99.99 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 -23.55 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.981 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.1 -42.13 94.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 99.99 110.839 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -83.99 -24.11 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.765 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.83 -51.55 61.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 99.99 111.211 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.69 -25.75 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.353 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.0 m -53.05 -59.15 4.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 99.99 111.469 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.44 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 11.2 t80 -68.11 -31.6 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 99.99 110.424 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.49 -23.42 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 99.99 111.136 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 -49.81 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.573 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.75 -29.17 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.561 -0.29 . . . . 99.99 111.738 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.443 HD22 ' HB2' ' A' ' 209' ' ' SER . 69.3 mt -77.72 -58.11 3.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.831 0.348 . . . . 99.99 111.017 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.63 -23.18 58.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.534 . . . . 99.99 110.777 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 181' ' ' ILE . 10.9 mm -88.07 -29.36 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 99.99 110.362 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -52.31 48.18 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.767 -0.651 . . . . 99.99 113.766 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.639 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 73.8 m-85 -58.64 -55.38 46.6 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.01 0.405 . . . . 99.99 111.952 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.639 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 73.1 Cg_exo -49.06 -28.03 13.17 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.136 1.89 . . . . 99.99 112.738 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.529 ' O ' HG12 ' A' ' 184' ' ' ILE . 95.0 mt -71.72 -59.96 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 99.99 111.125 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 20.4 m -58.17 -24.58 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.7 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -64.11 -17.46 63.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.064 0.394 . . . . 99.99 112.064 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.654 HG13 HG23 ' A' ' 185' ' ' ILE . 19.3 pt -69.74 -9.79 12.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.988 -0.285 . . . . 99.99 111.57 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.654 HG23 HG13 ' A' ' 184' ' ' ILE . 42.4 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 99.99 111.092 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.807 0.337 . . . . 99.99 111.473 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.9 -54.5 44.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.904 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.3 p -63.07 -30.27 71.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.021 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -56.75 -38.08 71.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 99.99 111.163 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 63.0 tp -75.77 -40.51 55.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.511 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.99 -6.1 51.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.701 0.26 . . . . 99.99 111.701 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 60.5 m -96.12 -39.96 9.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.915 0.388 . . . . 99.99 110.911 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.75 -35.79 65.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 99.99 111.922 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.657 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.7 tp -58.72 -53.99 60.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.965 -0.294 . . . . 99.99 111.252 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 32.1 Cg_exo -58.93 -37.2 94.82 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.683 1.589 . . . . 99.99 111.274 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -63.33 -34.16 77.1 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 116.021 -0.536 . . . . 99.99 110.13 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -72.25 -24.23 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.625 . . . . 99.99 110.472 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.443 ' HB2' HD22 ' A' ' 175' ' ' LEU . 29.8 t . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 99.99 111.007 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.737 0.303 . . . . 99.99 111.342 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.32 71.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.583 -0.818 . . . . 99.99 112.408 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -76.34 -34.18 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.62 0.248 . . . . 99.99 111.178 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 85.2 p -63.14 -52.22 63.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 99.99 110.912 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -62.12 -30.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.346 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.5 -47.86 74.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.632 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.72 -33.93 68.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 99.99 111.278 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.89 -47.27 84.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 99.99 111.372 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -74.12 -27.68 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 99.99 111.058 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.86 63.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 99.99 112.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.588 0.232 . . . . 99.99 111.294 -179.755 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.431 HD11 ' N ' ' B' ' 6' ' ' LEU . 5.9 mp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.911 0.386 . . . . 99.99 110.746 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 62.5 tp -68.12 -41.15 82.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.426 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.522 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 36.7 m80 -61.92 -31.81 72.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 99.99 110.474 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -69.79 -44.72 69.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.96 -0.564 . . . . 99.99 110.458 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.89 -20.72 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 99.99 110.119 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.98 -54.64 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 99.99 110.61 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.45 -32.63 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.08 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -53.17 61.23 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.037 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.47 -27.34 69.38 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.891 -0.671 . . . . 99.99 112.461 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' B' ' 44' ' ' PRO . 22.9 mmt -73.53 -26.9 61.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.696 0.284 . . . . 99.99 111.033 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 63.2 m -69.32 -54.32 15.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 99.99 110.983 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -60.49 -27.42 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 99.99 111.17 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.73 -51.71 53.87 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.535 -0.841 . . . . 99.99 112.245 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' HE3' ' B' ' 41' ' ' MET . . . -61.15 -28.16 68.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.936 0.398 . . . . 99.99 111.165 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.37 -31.54 71.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 99.99 110.85 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -61.05 -21.94 64.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 99.99 110.978 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.27 -35.67 81.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.992 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -80.3 -32.85 37.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 99.99 111.082 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 88.8 p -77.3 -19.95 55.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.353 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 tp -87.43 -1.76 58.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.342 . . . . 99.99 110.958 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 100.0 p -73.39 -19.52 60.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.833 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -52.09 -30.72 27.38 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.691 -0.485 . . . . 99.99 109.691 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.7 p-10 -174.19 131.83 0.52 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.44 -0.8 . . . . 99.99 110.319 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 56.9 Cg_endo -97.29 172.66 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.175 2.583 . . . . 99.99 111.892 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -94.5 58.74 2.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.407 . . . . 99.99 110.661 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -45.82 3.46 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.007 -0.616 . . . . 99.99 112.375 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 34.2 m -101.7 147.03 33.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 O-C-N 122.977 -0.131 . . . . 99.99 110.739 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -54.28 163.5 3.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.058 . . . . 99.99 112.516 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -64.99 -17.47 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.554 -0.748 . . . . 99.99 111.922 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -41.6 -34.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.009 0.374 . . . . 99.99 112.009 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.29 -53.43 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 99.99 110.334 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -66.48 -19.58 65.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.903 -0.589 . . . . 99.99 110.458 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' B' ' 41' ' ' MET . 8.5 tt -59.86 -47.71 84.62 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.659 -0.497 . . . . 99.99 109.659 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 52.2 t -62.79 -39.87 86.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.524 -0.547 . . . . 99.99 109.524 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.34 -5.89 39.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.663 -0.699 . . . . 99.99 110.663 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.52 ' O ' ' HD2' ' B' ' 44' ' ' PRO . 26.6 ttt -88.72 -31.32 18.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.029 -0.532 . . . . 99.99 110.455 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -75.47 -34.22 60.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 99.99 111.105 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.62 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 67.6 mt -54.21 -51.84 74.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.962 0.356 . . . . 99.99 111.962 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 12.2 Cg_exo -70.79 -33.72 12.26 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.637 2.225 . . . . 99.99 113.132 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.42 HG12 ' O ' ' B' ' 41' ' ' MET . 24.4 mm -57.28 -62.15 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 111.749 0.278 . . . . 99.99 111.749 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -59.05 -54.28 48.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.805 0.335 . . . . 99.99 111.081 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -55.33 -28.79 56.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 99.99 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.99 -58.04 14.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 99.99 112.74 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.22 -29.61 67.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 99.99 111.101 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -52.25 60.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.228 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 22.4 m-85 -64.65 -39.36 93.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.198 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -49.61 -40.8 40.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.214 0.53 . . . . 99.99 110.052 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.58 91.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.679 -0.691 . . . . 99.99 110.821 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtt -52.56 -32.27 40.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 99.99 110.197 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -69.37 -42.64 74.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.957 -0.565 . . . . 99.99 110.213 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 12.0 mt -75.67 1.89 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 99.99 110.567 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.511 ' HD2' ' HZ3' ' B' ' 60' ' ' LYS . 16.7 t70 66.16 46.75 2.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.642 -0.708 . . . . 99.99 110.714 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.407 ' CD ' HG21 ' C' ' 127' ' ' VAL . 14.6 mm100 -115.72 168.84 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 99.99 110.954 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 71' ' ' ALA . . . 83.65 23.69 52.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 99.99 112.466 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.511 ' HZ3' ' HD2' ' B' ' 57' ' ' ASP . 93.7 mttt -116.12 142.96 46.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 99.99 110.799 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.63 147.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 99.99 111.265 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.59 142.51 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.762 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.82 98.85 1.37 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.299 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.18 29.27 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.04 -0.527 . . . . 99.99 111.422 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.94 16.48 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.597 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -116.48 121.29 41.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 99.99 110.896 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.69 123.08 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 99.99 111.093 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' B' ' 120' ' ' ASP . . . -112.97 129.7 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 99.99 111.238 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.633 ' H ' ' HD2' ' B' ' 120' ' ' ASP . 87.9 m-70 -73.03 81.36 1.22 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 99.99 110.619 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -62.03 -35.4 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 99.99 111.586 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.464 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . . . -78.85 -22.56 45.92 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.311 0.486 . . . . 99.99 112.311 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 12.8 tpp180 -69.85 -51.32 34.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.132 0.419 . . . . 99.99 112.132 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.479 ' O ' ' HG3' ' B' ' 77' ' ' MET . 8.2 p90 -76.3 -38.11 56.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.861 0.319 . . . . 99.99 111.861 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 11.1 tp -54.04 -44.4 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 99.99 110.991 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.22 -21.8 65.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.495 -0.557 . . . . 99.99 109.495 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -85.9 4.92 35.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.514 -0.766 . . . . 99.99 111.267 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 42.5 mtp -104.83 -18.99 14.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.939 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.4 m -114.54 -31.65 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.876 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.543 HG22 HG21 ' B' ' 43' ' ' ILE . 60.9 m -79.47 -57.18 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 99.99 112.035 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.539 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 11.0 m -50.42 -50.13 73.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.192 0.442 . . . . 99.99 112.192 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.7 Cg_exo -53.91 -42.49 66.18 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.832 1.688 . . . . 99.99 111.64 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -66.97 -29.45 69.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.036 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 19.0 tp -70.19 -20.98 63.09 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.176 -0.676 . . . . 99.99 109.176 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' B' ' 109' ' ' GLN . 14.9 tp -83.86 -39.89 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.1 -0.954 . . . . 99.99 109.985 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 22.1 tp -66.94 -35.34 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.343 -0.844 . . . . 99.99 111.025 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -60.08 -21.78 61.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.804 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.2 -27.21 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 99.99 110.7 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -76.74 -33.1 58.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.964 -0.562 . . . . 99.99 110.783 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -80.05 -31.77 39.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 99.99 110.801 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 88.6 m -72.98 -38.48 66.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.067 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.29 -46.43 12.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.034 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 80.4 mtp -103.39 120.89 41.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 99.99 111.047 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -75.52 -30.94 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 99.99 110.574 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.63 179.44 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.907 -0.588 . . . . 99.99 110.664 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tp -132.25 148.31 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 99.99 111.25 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.2 161.26 14.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 99.99 110.936 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.37 44.51 1.04 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.109 -0.496 . . . . 99.99 111.089 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -149.13 113.57 5.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.679 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -82.93 78.72 9.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 99.99 111.189 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.8 m -120.93 -59.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.542 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.15 -61.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.443 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.8 pt -55.33 -38.09 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.57 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.84 -43.81 98.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.869 -0.681 . . . . 99.99 112.798 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -63.21 -36.0 82.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.282 . . . . 99.99 110.985 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.45 -53.47 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.118 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 87.7 mtp -57.95 -36.26 72.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 99.99 111.042 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 57.6 m -65.32 -54.43 29.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.12 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 47.4 p -53.98 -26.14 24.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 99.99 111.292 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.479 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 6.4 tp-100 -71.61 -40.99 69.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.709 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.99 -32.07 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 99.99 110.973 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.13 -43.01 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.264 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.62 -55.4 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.515 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.7 pt -54.32 -33.17 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 99.99 111.269 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -60.87 -40.77 94.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.337 -0.392 . . . . 99.99 110.607 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -61.54 -59.8 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 99.99 110.365 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.66 -16.33 44.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.781 -0.723 . . . . 99.99 112.431 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.96 -61.84 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 99.99 110.702 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 mt -84.04 -20.41 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 99.99 111.759 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.95 57.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.779 0.323 . . . . 99.99 110.956 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . 0.633 ' HD2' ' H ' ' B' ' 69' ' ' HIS . 24.8 t70 -82.97 -19.65 36.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.822 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.56 22.83 1.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.107 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.4 p -70.97 124.51 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 99.99 110.921 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -99.9 -41.71 7.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.515 ' HB2' HG12 ' B' ' 127' ' ' VAL . 80.3 mtp180 -94.5 140.05 30.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.033 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.13 -19.14 62.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 99.99 110.95 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -79.03 -54.02 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.894 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' B' ' 124' ' ' ARG . 10.6 p -62.06 -23.66 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -51.95 -41.38 62.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -77.06 -28.56 54.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.16 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' B' ' 127' ' ' VAL . 93.7 mt -70.48 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 99.99 111.137 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -56.21 -32.39 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 99.99 111.151 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -60.43 -42.6 96.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.911 0.386 . . . . 99.99 110.52 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.76 -28.87 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.653 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.7 t -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.895 -0.593 . . . . 99.99 110.724 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.28 23.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 99.99 112.501 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.42 -30.42 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.789 0.328 . . . . 99.99 111.137 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.55 -40.48 94.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 99.99 110.765 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.19 78.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.978 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -73.76 -22.72 59.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.694 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -56.46 10.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.689 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 26.7 pt -60.48 -40.86 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 99.99 111.441 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 67.3 mt -68.84 -28.86 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.475 -0.329 . . . . 99.99 110.715 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.5 -42.29 99.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.979 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . 0.412 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 94.4 m95 -72.31 -27.31 62.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.808 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . 1.019 ' HA2' HD22 ' B' ' 148' ' ' ASN . . . -76.16 -27.45 62.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 99.99 112.716 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.44 -13.49 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.771 0.32 . . . . 99.99 111.286 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -99.93 4.67 45.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.212 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 1.019 HD22 ' HA2' ' B' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.162 -0.472 . . . . 99.99 112.069 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.015 0.436 . . . . 99.99 110.824 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.19 -31.64 58.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.749 -0.66 . . . . 99.99 111.287 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.44 -42.06 91.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 99.99 110.968 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -83.42 -22.52 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 99.99 110.982 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.68 -44.63 77.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.926 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.57 -25.68 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.336 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 51.0 m -51.26 -59.13 4.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 99.99 111.367 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -67.2 -34.61 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 99.99 110.482 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -63.25 -22.21 66.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 99.99 111.003 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 48.0 m -79.73 -56.99 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.721 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.08 -29.39 15.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.365 0.506 . . . . 99.99 112.365 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' B' ' 209' ' ' SER . 57.9 tp -79.87 -57.92 3.42 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.891 0.377 . . . . 99.99 111.29 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.3 -29.54 61.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.02 -0.537 . . . . 99.99 111.04 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.448 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 9.4 tp -87.91 -21.79 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.064 0.459 . . . . 99.99 110.438 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.98 -54.94 33.49 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.789 -0.642 . . . . 99.99 113.129 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.58 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 96.3 m-85 -56.41 -54.14 56.4 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.816 0.308 . . . . 99.99 111.763 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.7 Cg_exo -46.75 -32.32 11.98 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.223 1.949 . . . . 99.99 112.612 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 177' ' ' ILE . 91.0 mt -67.93 -60.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.577 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 29.0 m -58.97 -24.71 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.861 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -62.69 -20.05 64.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.52 -0.309 . . . . 99.99 111.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 mm -54.44 -49.9 61.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 99.99 110.794 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 15.0 pt -95.5 178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.294 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.471 0 C-N-CA 120.887 -0.673 . . . . 99.99 112.505 179.881 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 14.1 tt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.703 0.287 . . . . 99.99 111.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.07 -49.42 77.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 99.99 110.869 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 63.4 p -68.98 -23.27 64.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.896 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.98 -36.8 83.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 99.99 111.19 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.26 -45.83 53.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.218 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -75.52 -3.43 34.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.745 0.307 . . . . 99.99 111.349 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 43.8 t -96.31 -43.47 7.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.279 0.561 . . . . 99.99 110.289 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 66.5 tp -71.93 -39.48 69.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.444 -0.798 . . . . 99.99 112.055 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.573 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -55.97 -54.77 48.64 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.237 -0.185 . . . . 99.99 111.384 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -56.16 -41.51 75.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.885 1.723 . . . . 99.99 111.559 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.61 -31.78 73.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.288 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -66.68 -27.49 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.572 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.4 ' HB2' HD11 ' B' ' 175' ' ' LEU . 17.3 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 99.99 111.053 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.731 0.301 . . . . 99.99 110.997 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.27 -30.66 74.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 99.99 112.549 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -74.74 -29.87 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 99.99 110.753 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.1 t -63.0 -59.93 4.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.74 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.79 -28.89 67.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.823 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.74 -43.36 89.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 99.99 110.567 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.08 -22.24 65.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.873 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.4 tp -69.62 -51.51 34.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -78.09 -30.94 49.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.302 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.66 80.43 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.792 -0.718 . . . . 99.99 112.933 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 55.1 tp . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 99.99 111.012 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.795 0.331 . . . . 99.99 110.927 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 94.3 mt -81.11 -45.16 16.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.257 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 60.8 m-70 -64.65 -26.08 68.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.931 0.396 . . . . 99.99 110.475 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -72.58 -47.75 45.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.059 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.05 -20.8 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.358 0.599 . . . . 99.99 109.503 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -59.9 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.224 -0.898 . . . . 99.99 110.69 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' C' ' 52' ' ' MET . 14.0 p -58.58 -32.81 46.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.035 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.62 41.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 99.99 111.015 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.07 -21.78 68.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.189 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' MET . . . . . 0.567 ' HA ' ' HE3' ' C' ' 15' ' ' MET . 8.2 mmt -73.54 -35.85 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.676 0.274 . . . . 99.99 110.952 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 59.8 p -66.46 -53.06 39.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 99.99 111.185 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.98 -26.09 34.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.36 . . . . 99.99 111.016 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.97 -39.51 93.26 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.418 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.508 ' HA ' ' HG3' ' C' ' 41' ' ' MET . . . -72.67 -28.29 62.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 99.99 110.926 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 28.4 tp -68.49 -29.93 68.65 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.516 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -59.19 -22.14 60.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 99.99 110.414 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -58.19 -53.73 55.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.018 -0.537 . . . . 99.99 110.91 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -60.81 -38.8 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 99.99 110.479 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 63.3 m -69.69 -19.56 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.67 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 23.7 mt -80.1 -0.39 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 99.99 111.554 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 48.8 p -57.56 -52.04 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.911 -0.316 . . . . 99.99 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.74 -27.41 69.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.158 0.98 . . . . 99.99 108.508 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.735 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 12.7 m120 -70.32 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 113.473 -1.694 . . . . 99.99 108.892 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.735 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 5.8 Cg_exo . . . . . 0 C--N 1.376 2.02 0 C-N-CA 123.763 2.976 . . . . 99.99 117.093 -174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo . . . . . 0 N--CA 1.472 0.244 0 N-CA-C 115.543 1.324 . . . . 99.99 115.543 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . 0.612 ' HG3' ' HG2' ' C' ' 29' ' ' PRO . 1.4 mp0 -60.93 -14.47 22.7 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 113.435 -1.712 . . . . 99.99 112.82 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' C' ' 38' ' ' LEU . 20.8 p90 -39.22 -36.31 0.32 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.708 0.29 . . . . 99.99 111.604 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -64.91 -48.35 74.48 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.251 0.548 . . . . 99.99 109.572 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' C' ' 34' ' ' GLN . 33.7 t80 -68.56 -20.48 64.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 99.99 110.291 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' C' ' 35' ' ' TYR . 56.1 tp -59.03 -48.29 82.13 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.571 -0.529 . . . . 99.99 109.571 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -41.27 91.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.82 -0.627 . . . . 99.99 109.581 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.87 -6.07 35.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.591 -0.732 . . . . 99.99 110.703 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.508 ' HG3' ' HA ' ' C' ' 19' ' ' ALA . 51.0 ttp -88.64 -34.14 17.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.519 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -72.43 -30.07 64.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 99.99 110.571 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.518 HG21 HG21 ' C' ' 79' ' ' THR . 93.3 mt -54.89 -54.81 45.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.548 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.6 Cg_endo -71.22 -28.64 18.36 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.224 1.949 . . . . 99.99 113.176 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 41' ' ' MET . 80.0 mt -58.1 -62.72 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.623 0.249 . . . . 99.99 111.58 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -55.42 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 99.99 111.084 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 85.8 p -52.01 -39.04 58.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 99.99 111.303 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.44 -55.14 28.35 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.925 -0.655 . . . . 99.99 112.923 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . 0.426 ' O ' ' HG2' ' C' ' 52' ' ' MET . 69.6 mt -57.04 -29.91 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 99.99 110.829 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -70.42 -35.73 73.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.136 -0.483 . . . . 99.99 111.05 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 49.6 m-85 -71.39 -52.45 18.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.466 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' MET . . . . . 0.47 ' HB3' HG12 ' C' ' 12' ' ' VAL . 23.8 ptm -49.53 -34.69 17.99 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.882 0.372 . . . . 99.99 110.498 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.07 88.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 99.99 110.727 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 54.2 mtt -52.27 -33.86 43.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.836 -0.62 . . . . 99.99 110.553 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.32 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 99.99 110.705 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.421 HG22 HG23 ' A' ' 127' ' ' VAL . 10.2 mm -72.64 -4.75 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 99.99 110.697 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 66.55 35.61 5.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.7 . . . . 99.99 110.815 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -118.35 138.21 52.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.641 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.39 16.83 5.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.847 -0.692 . . . . 99.99 112.495 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' C' ' 60' ' ' LYS . 3.3 mptp? -114.67 137.8 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 99.99 110.606 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.05 142.56 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 99.99 111.016 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.27 139.63 42.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.081 -0.509 . . . . 99.99 110.915 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.85 102.09 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.072 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.33 30.57 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.24 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.4 40.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 99.99 112.783 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 118.95 31.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.687 0.28 . . . . 99.99 110.609 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -97.18 120.11 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.105 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.49 141.92 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.108 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.543 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 55.3 m-70 -80.68 82.06 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.08 0.467 . . . . 99.99 110.864 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -67.65 -32.72 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.797 -0.638 . . . . 99.99 111.392 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.57 -24.99 41.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.288 0.477 . . . . 99.99 112.288 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.3 mmt180 -71.51 -52.01 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.284 0.476 . . . . 99.99 112.284 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.468 ' O ' ' HG3' ' C' ' 77' ' ' MET . 2.6 p90 -71.43 -40.37 70.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.82 -0.352 . . . . 99.99 111.717 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.4 tp -53.64 -44.01 56.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.581 0.229 . . . . 99.99 111.026 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.08 -21.45 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.447 -0.575 . . . . 99.99 109.447 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -87.38 6.93 31.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.436 -0.802 . . . . 99.99 111.209 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 30.0 mtp -105.34 -20.68 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.693 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -114.14 -29.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.883 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.518 HG21 HG21 ' C' ' 43' ' ' ILE . 88.2 m -81.29 -56.14 4.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.787 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 25.0 m -50.54 -50.32 72.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.412 0.523 . . . . 99.99 112.412 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' C' ' 80' ' ' THR . 12.3 Cg_endo -56.41 -38.49 95.16 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.58 1.52 . . . . 99.99 111.446 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.42 -30.94 69.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 99.99 109.577 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.89 -21.23 62.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.445 0.641 . . . . 99.99 109.336 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.32 -37.23 21.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.993 -1.003 . . . . 99.99 109.908 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 89.4 mt -67.72 -35.91 79.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.75 -0.659 . . . . 99.99 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 88.8 p -56.71 -31.14 64.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.343 -0.389 . . . . 99.99 110.981 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 70.4 mt -66.62 -33.23 75.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.797 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -73.72 -27.47 61.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 99.99 110.961 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.27 -33.6 25.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 99.99 110.952 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 82.3 m -76.52 -37.23 57.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.005 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.28 -48.3 12.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.265 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -104.0 115.14 29.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.949 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -71.54 -25.07 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.016 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -144.77 138.0 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.053 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.8 142.08 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.054 -0.521 . . . . 99.99 111.022 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -102.89 173.55 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.807 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.9 -178.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 99.99 110.758 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 28.6 t70 56.44 84.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.868 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -75.16 99.47 3.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.864 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 68.8 m -119.23 -44.86 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.261 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.64 -48.41 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 99.99 111.095 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 7.6 tp -65.9 -30.09 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 99.99 111.329 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.32 -44.84 41.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.769 . . . . 99.99 112.776 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.58 -36.54 78.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 99.99 111.352 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.72 -51.25 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 99.99 111.3 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.72 -35.87 77.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.029 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 40.9 m -66.87 -55.75 13.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.255 -0.429 . . . . 99.99 111.178 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 40.1 p -55.78 -25.91 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.997 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -68.4 -40.36 81.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.376 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 36.4 mm -59.67 -32.17 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.91 -0.586 . . . . 99.99 110.698 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.98 -42.14 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.955 -0.566 . . . . 99.99 111.171 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.23 -54.9 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 99.99 111.631 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.1 pt -55.02 -27.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 99.99 111.272 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 19.7 m -66.13 -46.57 77.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.436 . . . . 99.99 110.883 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -69.03 -23.78 64.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.412 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.63 -35.52 32.1 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.712 -0.756 . . . . 99.99 113.266 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.541 HD11 ' N ' ' C' ' 118' ' ' ILE . 3.6 pp -77.06 -29.75 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.568 0.223 . . . . 99.99 111.592 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.541 ' N ' HD11 ' C' ' 117' ' ' LEU . 10.2 tp -83.89 -24.33 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.399 -0.364 . . . . 99.99 111.202 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.24 93.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.105 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -78.36 -14.13 59.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.046 -0.525 . . . . 99.99 111.067 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' C' ' 118' ' ' ILE . 96.7 mt -86.29 17.59 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.125 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 78.5 p -68.38 121.16 15.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 99.99 111.11 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -103.23 -37.94 7.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.246 -0.433 . . . . 99.99 110.648 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . 0.504 ' HB2' HG12 ' C' ' 127' ' ' VAL . 97.7 mtt180 -102.97 137.87 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 99.99 110.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.71 -9.43 58.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.242 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -88.52 -44.36 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 99.99 111.088 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -74.16 -23.94 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.187 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -52.53 -47.29 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.283 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -67.58 -22.94 65.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.391 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' C' ' 127' ' ' VAL . 72.4 mt -80.5 -47.22 14.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 99.99 111.239 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.68 -34.49 77.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.384 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.85 -33.49 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.097 -0.501 . . . . 99.99 111.135 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.3 mm -73.26 -37.48 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.108 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.59 -30.73 71.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 99.99 110.878 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -54.83 11.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.723 -0.751 . . . . 99.99 112.278 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.56 -29.88 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 99.99 110.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.37 -49.42 77.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.054 -0.521 . . . . 99.99 110.741 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.08 -29.01 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.845 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -74.64 -20.08 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 99.99 110.708 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.3 15.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 99.99 111.293 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . 0.441 HG13 ' N ' ' C' ' 142' ' ' ILE . 29.0 pt -59.21 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 99.99 111.241 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.441 ' N ' HG13 ' C' ' 141' ' ' ILE . 7.4 tp -72.48 -27.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.494 -0.321 . . . . 99.99 111.003 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.27 -50.84 71.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.67 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -64.42 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.934 -0.575 . . . . 99.99 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.3 -39.1 97.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.794 -0.717 . . . . 99.99 112.405 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.39 -24.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 99.99 110.654 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -89.26 3.93 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 99.99 111.043 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.914 -0.585 . . . . 99.99 111.834 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.086 0.47 . . . . 99.99 110.703 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -39.57 49.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.635 . . . . 99.99 111.048 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -57.79 -37.12 73.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.443 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -81.35 -26.97 35.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.137 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.89 -52.17 18.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 99.99 111.264 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.16 -25.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 99.99 111.493 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -54.64 -58.96 5.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 99.99 111.316 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -68.32 -24.58 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.499 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -70.62 -35.97 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 99.99 111.673 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 41.0 p -70.47 -53.18 17.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.565 -0.288 . . . . 99.99 111.655 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 p -53.33 -35.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.958 0.355 . . . . 99.99 111.958 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.472 HD22 ' HG ' ' C' ' 209' ' ' SER . 41.7 tp -75.36 -57.81 3.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.794 0.33 . . . . 99.99 111.41 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -28.32 58.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.981 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.426 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 84.9 mt -87.95 -24.29 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.479 . . . . 99.99 110.225 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.53 -54.57 31.83 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.728 -0.669 . . . . 99.99 113.043 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.585 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 68.1 m-85 -57.47 -55.67 42.1 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.85 0.325 . . . . 99.99 111.623 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.0 Cg_exo -45.86 -28.2 4.68 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.254 1.969 . . . . 99.99 112.929 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.407 HG13 ' O ' ' C' ' 177' ' ' ILE . 92.7 mt -70.97 -61.25 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.467 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 25.3 m -57.5 -26.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.221 0.452 . . . . 99.99 112.221 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -60.94 -20.02 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.696 -0.229 . . . . 99.99 111.547 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . 0.58 HG22 HG21 ' C' ' 185' ' ' ILE . 14.9 tt -60.64 -29.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 99.99 111.011 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . 0.58 HG21 HG22 ' C' ' 184' ' ' ILE . 31.4 pt . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.101 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.739 0.304 . . . . 99.99 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 16.7 tt -57.82 -34.75 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 99.99 111.231 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.58 -56.06 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 99.99 110.703 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -69.43 -17.53 63.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.906 -0.588 . . . . 99.99 110.614 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -68.46 -30.81 69.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.947 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.7 -39.36 20.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.271 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -77.12 -8.11 56.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.281 . . . . 99.99 111.682 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.419 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 17.7 p -96.66 -39.08 9.67 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.148 0.499 . . . . 99.99 110.546 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.04 -33.89 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.623 -0.717 . . . . 99.99 111.745 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.623 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 42.1 tp -62.53 -53.32 58.36 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.067 -0.253 . . . . 99.99 111.577 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.8 Cg_exo -56.23 -39.34 91.91 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.842 1.695 . . . . 99.99 111.48 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -61.12 -34.32 74.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.959 -0.564 . . . . 99.99 110.721 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -66.56 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.009 -0.541 . . . . 99.99 110.951 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 209' ' ' SER . . . . . 0.472 ' HG ' HD22 ' C' ' 175' ' ' LEU . 28.0 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.999 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.751 0.31 . . . . 99.99 111.0 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.79 69.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.913 -0.661 . . . . 99.99 112.704 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -71.28 -34.85 71.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 99.99 110.788 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -60.65 -59.3 5.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.676 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.56 -23.4 65.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 99.99 110.67 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tt -72.28 -40.28 67.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.932 -0.576 . . . . 99.99 110.992 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.53 -30.16 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 99.99 111.192 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.11 -48.59 73.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 99.99 110.876 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -81.07 -22.53 39.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.853 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.46 61.55 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.772 -0.728 . . . . 99.99 112.945 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 30.3 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.704 0.288 . . . . 99.99 111.033 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.4 tp . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.577 0.227 . . . . 99.99 111.015 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.68 -34.73 77.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.406 -0.361 . . . . 99.99 111.13 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 37.4 m80 -72.25 -28.85 63.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.044 0.449 . . . . 99.99 110.379 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -72.44 -51.07 21.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 99.99 110.331 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.34 -21.74 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.096 0.474 . . . . 99.99 110.249 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.41 ' HH ' ' HB2' ' A' ' 206' ' ' PRO . 0.8 OUTLIER -61.09 -61.48 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 99.99 110.564 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.57 -30.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.01 -0.541 . . . . 99.99 111.371 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.0 -55.41 29.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 99.99 111.429 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.76 -28.45 68.2 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.884 -0.674 . . . . 99.99 112.763 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.16 -22.2 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 99.99 111.001 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -72.76 -52.13 16.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 99.99 110.844 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.4 -22.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.942 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.47 -47.84 54.81 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.854 -0.689 . . . . 99.99 112.652 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -33.88 76.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 99.99 111.042 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -68.43 -36.52 79.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.203 0.525 . . . . 99.99 110.532 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.9 t-80 -59.33 -20.99 59.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 99.99 110.485 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -62.49 -50.18 72.42 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.973 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -58.91 -45.17 90.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.495 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.3 m -69.9 -18.66 63.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 99.99 110.794 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 21' ' ' HIS . 12.7 tp -76.57 0.26 20.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 99.99 111.933 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 p -66.83 -51.44 55.55 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.277 -0.569 . . . . 99.99 111.19 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -54.17 -22.63 11.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.011 0.91 . . . . 99.99 108.548 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.811 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.41 -150.98 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 113.757 -1.565 . . . . 99.99 108.57 177.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.811 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 14.2 Cg_exo 6.91 96.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.713 2.942 . . . . 99.99 116.472 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -102.96 96.87 7.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.663 -1.153 . . . . 99.99 109.148 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.04 -36.92 2.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.502 -1.039 . . . . 99.99 110.502 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.1 t -111.77 126.2 28.96 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 109.315 -0.624 . . . . 99.99 109.315 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 16.9 Cg_exo -65.82 165.83 22.25 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.482 2.121 . . . . 99.99 113.858 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -76.08 -13.3 60.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.507 -1.224 . . . . 99.99 111.806 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 33' ' ' PRO . 1.7 p90 -38.69 -37.92 0.37 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.469 0.544 . . . . 99.99 112.469 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.09 -45.19 86.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 99.99 110.518 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -74.03 -18.57 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.613 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.413 HD13 ' HD1' ' B' ' 104' ' ' PHE . 55.7 tp -60.66 -56.86 16.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.161 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.32 -36.24 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 99.99 109.918 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.21 -6.13 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.724 -0.671 . . . . 99.99 110.89 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 23.8 ttt -88.74 -35.59 16.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.641 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -72.61 -33.32 66.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 99.99 111.101 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.588 HG23 HG22 ' A' ' 79' ' ' THR . 79.0 mt -53.63 -52.98 62.22 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.271 0.471 . . . . 99.99 112.271 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HD2' ' C ' ' A' ' 41' ' ' MET . 60.5 Cg_endo -72.15 -33.3 9.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.28 1.987 . . . . 99.99 113.236 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -57.89 -62.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.939 0.348 . . . . 99.99 111.939 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.502 ' HE1' HG22 ' B' ' 110' ' ' ILE . 3.0 t90 -61.63 -51.41 68.59 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.626 -0.261 . . . . 99.99 111.525 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' HD2' ' A' ' 75' ' ' ASP . 92.5 p -51.52 -54.13 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 99.99 111.195 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -44.58 -54.79 6.39 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.208 -0.52 . . . . 99.99 113.547 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.3 mt -52.12 -38.94 59.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.748 0.309 . . . . 99.99 111.337 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.56 83.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.059 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 96.8 m-85 -69.48 -44.19 71.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.913 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -49.61 -32.68 13.38 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.285 0.564 . . . . 99.99 110.126 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -72.13 -42.14 66.35 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 99.99 111.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.2 mtt -54.17 -26.45 28.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.363 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.05 -48.54 23.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.576 . . . . 99.99 110.673 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 53' ' ' ALA . 44.3 pt -79.94 6.65 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 99.99 111.023 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 59.59 55.1 4.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 99.99 111.194 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -125.33 124.59 41.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 99.99 110.735 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 120.34 29.88 1.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 99.99 112.398 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -150.34 144.74 25.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 99.99 111.145 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.48 145.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 99.99 111.165 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -88.74 94.44 9.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.893 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.08 133.48 55.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.019 -0.537 . . . . 99.99 111.052 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.79 23.72 12.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.14 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.97 -15.1 50.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.83 -0.7 . . . . 99.99 112.534 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -104.73 151.22 24.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.313 . . . . 99.99 110.854 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -98.17 138.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.118 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.39 118.21 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.495 . . . . 99.99 110.848 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 64.5 m-70 -78.96 79.25 5.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.295 0.569 . . . . 99.99 111.204 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.88 -41.28 86.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.547 -0.751 . . . . 99.99 110.932 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . . . -67.0 -24.05 65.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 99.99 111.595 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.9 tpp180 -67.15 -51.88 48.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.098 -0.501 . . . . 99.99 112.322 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 77' ' ' MET . 17.7 p90 -88.95 -27.98 20.57 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.511 0.56 . . . . 99.99 112.511 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 11.0 tp -57.78 -41.26 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.473 -0.491 . . . . 99.99 110.069 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.489 ' HD2' ' HA ' ' A' ' 47' ' ' SER . 16.1 t70 -70.93 -17.14 62.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.143 -0.688 . . . . 99.99 109.143 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -90.42 6.06 44.9 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.237 -0.892 . . . . 99.99 110.956 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.496 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 32.1 mtp -104.85 -17.68 14.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.748 -0.66 . . . . 99.99 110.488 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.59 -34.81 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 99.99 111.8 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.588 HG22 HG23 ' A' ' 43' ' ' ILE . 84.8 m -76.0 -59.56 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 99.99 112.007 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.562 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 83.2 m -49.14 -51.06 59.69 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.503 0.557 . . . . 99.99 112.503 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.598 ' HA ' ' HG2' ' A' ' 109' ' ' GLN . 58.4 Cg_exo -51.67 -52.85 8.1 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.765 1.643 . . . . 99.99 111.844 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.45 -25.66 68.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 99.99 110.881 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.5 tp -72.91 -28.42 62.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.999 0.428 . . . . 99.99 110.033 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -84.47 -22.22 30.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 99.99 110.103 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 81' ' ' PRO . 95.4 mt -85.07 -31.28 23.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.769 -0.65 . . . . 99.99 110.646 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -61.64 -50.34 72.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.029 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 pp -61.99 -25.74 67.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.965 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.1 t -67.63 -43.78 79.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 99.99 110.842 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -62.16 -40.6 96.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.014 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -60.5 -33.9 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.029 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.52 -30.73 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.044 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.8 tpp -75.28 117.3 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.817 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.67 -54.69 4.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.066 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -137.12 144.82 43.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 99.99 111.228 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.9 tt -107.55 148.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.817 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -133.43 -75.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 99.99 111.2 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -138.35 -13.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 99.99 111.343 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.31 106.82 1.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.457 -0.338 . . . . 99.99 110.734 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -128.57 -21.52 3.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.332 -0.394 . . . . 99.99 111.036 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.6 p -65.38 -26.01 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 99.99 111.034 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.75 -36.54 79.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.951 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.03 -39.0 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.172 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.78 93.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.848 -0.692 . . . . 99.99 112.361 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.93 -41.25 95.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 99.99 111.153 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.05 -48.41 80.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.293 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -61.24 -27.34 68.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.289 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -72.45 -43.25 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.999 0.428 . . . . 99.99 111.245 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 142' ' ' ILE . 71.6 p -72.3 -22.8 61.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.548 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.598 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 25.0 tp60 -81.79 -45.47 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.4 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.5 -34.97 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 99.99 111.473 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.9 m -71.16 -44.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 121.144 -0.223 . . . . 99.99 111.281 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.22 -55.59 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.795 0.331 . . . . 99.99 111.537 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.434 HG12 HE21 ' A' ' 109' ' ' GLN . 39.0 mm -56.75 -32.89 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.385 -0.37 . . . . 99.99 111.436 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -55.71 -45.13 77.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.875 0.369 . . . . 99.99 110.554 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -67.34 -27.03 66.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.56 . . . . 99.99 111.007 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.56 -41.04 30.73 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.876 -0.678 . . . . 99.99 113.502 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.429 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -73.96 -28.26 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.806 0.299 . . . . 99.99 111.806 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.429 ' N ' HD11 ' A' ' 117' ' ' LEU . 10.2 tp -82.49 -26.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 99.99 111.17 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.56 76.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.894 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.4 -27.41 32.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 99.99 111.041 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.18 34.3 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.257 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.6 m -85.61 131.19 34.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 99.99 110.853 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 12.1 pt-20 -80.4 -28.7 37.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.077 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.483 ' HB2' HG11 ' A' ' 127' ' ' VAL . 78.5 mtm180 -130.17 158.19 40.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.971 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.53 -11.9 59.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.048 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -90.06 -45.87 8.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.977 0.418 . . . . 99.99 110.405 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 124' ' ' ARG . 12.0 p -65.45 -27.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 99.99 110.757 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -65.28 -41.16 94.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.007 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.412 ' O ' HG12 ' A' ' 133' ' ' ILE . 72.2 t80 -56.88 -45.67 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.873 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.71 -45.22 92.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 99.99 111.376 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.18 70.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 99.99 111.049 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -67.55 -43.33 80.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.411 . . . . 99.99 111.146 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 129' ' ' TYR . 38.3 mm -59.05 -39.18 77.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 99.99 110.888 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.442 ' SG ' HD23 ' C' ' 49' ' ' LEU . 46.2 t -67.48 -28.45 67.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.901 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.65 -55.88 24.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.871 -0.68 . . . . 99.99 112.55 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.63 -37.25 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.563 0.22 . . . . 99.99 111.298 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.69 -44.2 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.454 -0.339 . . . . 99.99 111.023 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.88 -35.67 75.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.897 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -69.82 -23.13 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 99.99 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.26 -59.93 2.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 99.99 111.469 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -61.24 -27.02 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.504 -0.317 . . . . 99.99 111.69 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.401 HG22 ' HB ' ' A' ' 108' ' ' THR . 72.5 mt -77.99 -50.35 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.483 -0.326 . . . . 99.99 111.49 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.1 tp -49.44 -54.21 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 99.99 111.188 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -64.63 -34.34 78.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.984 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.59 68.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.86 -0.686 . . . . 99.99 112.77 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.0 mt -103.73 -19.85 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 99.99 111.173 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -59.73 -39.91 86.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.411 . . . . 99.99 111.995 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 112.483 0.549 . . . . 99.99 112.483 -178.726 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.413 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 60.8 mt . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.039 0.447 . . . . 99.99 110.544 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.45 ' HA ' HD13 ' A' ' 168' ' ' LEU . 0.5 OUTLIER -55.41 -39.86 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.662 -0.699 . . . . 99.99 111.08 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -51.69 -56.35 14.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 99.99 111.289 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -58.05 -28.28 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.484 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 165' ' ' TYR . 75.5 mt -72.95 -65.56 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.335 -0.393 . . . . 99.99 111.46 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.15 -36.5 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.505 . . . . 99.99 111.856 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.2 m -56.74 -52.55 64.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.311 . . . . 99.99 111.521 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.406 ' O ' HD22 ' A' ' 175' ' ' LEU . 75.5 t80 -58.41 -29.54 66.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.364 -0.38 . . . . 99.99 110.961 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -71.01 -32.11 68.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 99.99 111.354 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.3 p -79.59 -37.86 35.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 99.99 111.767 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.24 -43.75 94.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.764 0.283 . . . . 99.99 111.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.406 HD22 ' O ' ' A' ' 171' ' ' TYR . 4.3 mm? -75.18 -50.69 15.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.651 -0.249 . . . . 99.99 111.634 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.49 -31.65 62.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 99.99 110.593 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.483 ' O ' HG12 ' A' ' 181' ' ' ILE . 94.8 mt -87.66 -22.09 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.523 . . . . 99.99 110.298 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -55.74 27.98 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 115.885 -0.598 . . . . 99.99 113.097 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.56 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 86.5 m-85 -53.68 -54.98 40.18 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.835 0.317 . . . . 99.99 111.067 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.8 Cg_exo -45.95 -30.18 6.81 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.003 1.802 . . . . 99.99 112.671 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -66.36 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 99.99 111.164 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 179' ' ' TYR . 28.5 m -58.33 -26.63 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.572 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -66.22 -45.08 81.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.534 -0.303 . . . . 99.99 111.227 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.2 mt -62.04 -62.57 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 99.99 111.298 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 99.99 111.494 -179.618 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.868 0.366 . . . . 99.99 111.382 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.55 -54.45 32.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.374 . . . . 99.99 111.24 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -62.55 -32.49 73.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.706 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -54.77 -38.31 67.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 99.99 111.126 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 49.0 tp -76.67 -46.53 25.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.092 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -71.79 1.49 6.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 99.99 111.42 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.5 -46.3 6.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 99.99 110.507 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.78 -36.94 73.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 99.99 111.998 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -57.21 -54.76 51.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 121.138 -0.225 . . . . 99.99 111.293 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -55.48 -44.71 45.82 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.682 1.588 . . . . 99.99 111.596 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.29 -25.4 67.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.464 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.61 -30.85 59.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.751 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 99.99 110.998 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.785 0.326 . . . . 99.99 111.284 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.33 -28.38 72.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 99.99 112.423 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.22 -31.17 58.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.732 0.301 . . . . 99.99 110.889 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.6 m -63.55 -62.02 1.94 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.889 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.37 -27.86 66.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.851 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.39 -48.9 71.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.74 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.93 -27.77 69.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.912 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.52 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 99.99 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -70.76 -49.09 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.054 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.84 55.08 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.849 -0.691 . . . . 99.99 112.58 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.0 tp . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 99.99 110.89 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.766 0.317 . . . . 99.99 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -34.73 71.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 99.99 111.148 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.475 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 35.6 m170 -65.32 -33.25 75.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 99.99 110.757 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -73.95 -46.87 41.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.617 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.07 -22.29 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.117 0.484 . . . . 99.99 110.262 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.28 -59.13 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.706 -0.679 . . . . 99.99 110.538 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.21 -29.46 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.328 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -50.42 67.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.34 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.03 -32.8 85.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.564 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.4 mmt -71.54 -26.02 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 99.99 110.956 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.5 m -69.7 -59.2 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.853 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -56.32 -26.13 21.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.307 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.94 72.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.608 -0.806 . . . . 99.99 112.26 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.461 ' HB1' ' HE2' ' B' ' 41' ' ' MET . . . -60.09 -33.84 72.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 99.99 111.047 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.77 -33.5 72.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.335 -0.393 . . . . 99.99 110.545 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -61.14 -20.27 62.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.539 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.34 -53.35 58.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 99.99 110.968 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.64 ' O ' ' OG ' ' B' ' 26' ' ' SER . 80.8 m95 -62.62 -42.71 99.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.953 -0.567 . . . . 99.99 110.955 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.253 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -80.73 -5.66 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 99.99 110.881 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.64 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 15.7 p -72.09 -15.23 62.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.775 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -45.95 -40.71 10.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.432 -0.581 . . . . 99.99 109.432 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -179.08 130.51 0.27 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.141 -0.936 . . . . 99.99 110.219 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -96.28 179.36 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.991 2.461 . . . . 99.99 112.182 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -99.85 52.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 99.99 111.188 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.1 -46.63 2.02 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.839 -0.696 . . . . 99.99 112.552 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 32.7 m -91.87 144.82 29.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.523 0.201 . . . . 99.99 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 165.36 17.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.514 2.143 . . . . 99.99 112.581 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -62.64 -17.43 60.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 99.99 111.837 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -42.3 -35.07 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.726 0.298 . . . . 99.99 111.662 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -64.54 -48.31 75.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.932 0.396 . . . . 99.99 110.225 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.28 -18.56 61.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 99.99 110.703 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' B' ' 41' ' ' MET . 47.7 tp -60.7 -53.44 57.36 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.981 0.42 . . . . 99.99 110.325 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.23 -38.74 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 99.99 109.893 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.14 -5.62 36.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.629 -0.714 . . . . 99.99 110.734 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.461 ' HE2' ' HB1' ' B' ' 19' ' ' ALA . 25.3 ttt -88.65 -36.08 16.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.906 -0.588 . . . . 99.99 110.402 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -70.74 -34.2 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.921 -0.582 . . . . 99.99 111.078 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.584 HG23 HG23 ' B' ' 79' ' ' THR . 98.7 mt -53.54 -54.76 42.19 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.459 0.54 . . . . 99.99 112.459 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 59.9 Cg_endo -70.43 -37.31 7.71 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.405 2.07 . . . . 99.99 113.566 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.15 -62.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.748 0.277 . . . . 99.99 111.748 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.584 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -62.08 -52.75 62.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 99.99 111.355 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.441 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 38.4 t -54.04 -31.82 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 99.99 111.566 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.11 -49.75 64.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 99.99 112.757 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.428 HD23 ' SG ' ' C' ' 134' ' ' CYS . 75.7 mt -54.77 -44.56 73.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 99.99 111.503 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.15 -50.26 67.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 99.99 111.565 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -63.23 -40.04 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 99.99 111.303 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.3 ttp -52.39 -34.09 46.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.182 0.515 . . . . 99.99 110.196 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' B' ' 58' ' ' GLN . . . -69.78 -40.67 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.598 -0.728 . . . . 99.99 110.944 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 56.2 mtt -54.33 -28.64 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.489 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -72.83 -52.06 16.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.946 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.1 pt -78.65 9.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.913 -0.585 . . . . 99.99 111.539 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 60.03 63.8 1.38 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.063 -0.517 . . . . 99.99 111.036 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' B' ' 53' ' ' ALA . 26.3 tp60 -136.23 128.78 30.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.639 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.43 ' N ' HE21 ' B' ' 58' ' ' GLN . . . 109.87 38.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 99.99 112.194 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -150.43 140.81 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 99.99 110.81 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.75 141.15 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.068 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.43 94.8 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.922 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.17 125.04 51.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.144 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.05 35.92 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 99.99 111.301 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.28 4.7 51.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.547 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -108.46 140.88 41.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.64 0.257 . . . . 99.99 110.853 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 55.2 mt -99.27 119.42 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 99.99 110.892 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.48 113.86 27.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 99.99 111.136 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.582 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 93.1 m-70 -73.91 83.34 1.7 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.4 0.619 . . . . 99.99 110.792 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -52.25 -56.71 12.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 99.99 111.567 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -21.93 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.606 0.595 . . . . 99.99 112.606 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.582 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 20.3 tpp180 -64.66 -52.54 56.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.275 0.472 . . . . 99.99 112.275 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' B' ' 76' ' ' TRP . 36.7 p90 -87.34 -29.71 21.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.482 -0.487 . . . . 99.99 111.418 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.65 -45.96 79.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.692 -0.484 . . . . 99.99 109.692 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 16.3 t70 -67.72 -23.47 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 99.99 109.139 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 28.9 m0 -86.08 8.18 21.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.457 -0.792 . . . . 99.99 111.07 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 -22.51 13.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.758 -0.655 . . . . 99.99 110.571 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.88 -30.34 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 99.99 111.927 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.584 HG23 HG23 ' B' ' 43' ' ' ILE . 76.1 m -81.29 -52.13 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.008 0.373 . . . . 99.99 112.008 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.573 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 11.9 m -51.8 -49.79 81.48 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.205 0.446 . . . . 99.99 112.205 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' B' ' 80' ' ' THR . 10.4 Cg_endo -54.67 -50.94 11.65 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.803 1.669 . . . . 99.99 111.782 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.16 -26.13 68.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.637 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -36.87 79.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.18 0.514 . . . . 99.99 109.772 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.4 tt -80.36 -25.44 39.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.539 -0.755 . . . . 99.99 110.789 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 98.6 mt -77.78 -36.83 50.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.201 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 59.5 m -56.96 -39.68 75.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 99.99 110.949 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 98.2 mt -68.58 -35.59 77.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.072 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 61.1 m -61.09 -35.31 76.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.326 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -72.24 -36.22 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 99.99 110.986 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 29.7 m -66.55 -37.58 85.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.81 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -28.59 39.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.925 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.1 ttm -77.96 117.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.718 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -86.78 -61.48 1.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.223 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.22 160.52 30.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 99.99 111.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 70.0 mt -124.9 142.32 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 99.99 110.824 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -139.38 -51.08 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 99.99 110.83 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -161.93 -161.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 99.99 110.511 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 60.76 87.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.448 . . . . 99.99 110.795 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -101.13 0.08 37.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.873 -0.603 . . . . 99.99 110.852 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.1 p -71.67 -25.91 62.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.293 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.95 -39.71 90.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 99.99 110.786 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.61 -38.13 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 99.99 111.034 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.4 -29.25 71.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.215 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.416 ' HE2' HG12 ' B' ' 146' ' ' ILE . 66.2 t80 -65.74 -37.58 86.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.95 0.405 . . . . 99.99 110.588 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.425 ' HB3' HD21 ' B' ' 84' ' ' LEU . 55.4 mt -68.63 -41.37 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.793 -0.64 . . . . 99.99 111.11 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 57.9 mtt -64.45 -45.92 85.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.135 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 55.6 m -55.58 -42.07 74.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.478 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 75.9 p -69.27 -24.94 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 99.99 111.416 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -80.49 -44.59 18.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.559 -0.291 . . . . 99.99 111.566 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.502 HG22 ' HE1' ' A' ' 46' ' ' TRP . 48.5 mm -57.53 -38.72 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 99.99 111.391 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.64 -43.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 99.99 111.854 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 70.2 t -61.03 -55.29 25.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.645 0.26 . . . . 99.99 111.62 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 29.7 mm -61.0 -29.26 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 99.99 111.23 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.1 m -55.29 -49.34 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.972 0.415 . . . . 99.99 110.528 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 75.3 p -70.92 -20.44 62.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.482 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.28 -33.7 43.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.006 -0.616 . . . . 99.99 112.975 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.436 HD11 HG13 ' B' ' 118' ' ' ILE . 2.8 pp -82.89 -24.68 33.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 0.235 . . . . 99.99 111.162 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.436 HG13 HD11 ' B' ' 117' ' ' LEU . 85.7 mt -80.21 -36.24 16.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 120.803 0.335 . . . . 99.99 110.838 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.86 -38.24 48.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.539 . . . . 99.99 111.154 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -82.6 -26.74 32.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.006 -0.543 . . . . 99.99 111.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -86.35 22.27 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.341 . . . . 99.99 111.185 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -67.27 139.62 57.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 99.99 110.843 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -94.03 -17.69 22.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.044 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.596 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 48.7 ttp180 -137.88 156.46 47.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.499 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.53 -14.97 60.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.935 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.596 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 54.4 t90 -92.96 -37.98 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 99.99 111.19 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' B' ' 124' ' ' ARG . 18.4 m -65.34 -24.32 34.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.326 -0.397 . . . . 99.99 111.215 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.8 ttt-85 -63.47 -47.59 81.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 99.99 111.385 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.97 -32.82 68.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 99.99 111.557 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.17 -46.56 76.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 99.99 110.873 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -74.33 -25.57 59.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.732 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.2 -51.82 61.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.816 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.58 -33.27 60.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.31 -0.405 . . . . 99.99 110.804 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.78 -28.22 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.588 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.39 -53.68 16.31 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.925 -0.655 . . . . 99.99 112.487 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.79 -35.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.593 0.235 . . . . 99.99 111.312 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 90.8 m -61.22 -35.88 78.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.75 0.31 . . . . 99.99 110.725 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.52 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.637 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.54 -23.5 63.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 99.99 110.892 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.47 -55.62 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.418 . . . . 99.99 111.187 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 43.1 pt -66.59 -28.85 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.534 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.63 -51.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.075 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 54.2 tp -52.75 -49.62 65.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.336 -0.393 . . . . 99.99 110.672 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.06 -24.61 65.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.518 . . . . 99.99 110.602 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.82 -17.66 74.56 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 99.99 112.776 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.416 HG12 ' HE2' ' B' ' 104' ' ' PHE . 56.7 mt -103.39 -19.52 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.781 0.324 . . . . 99.99 111.127 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -54.86 -50.04 69.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.922 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.91 0.337 . . . . 99.99 111.91 -178.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.845 0.355 . . . . 99.99 110.946 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.33 -29.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 99.99 111.013 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.63 -59.04 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 99.99 111.223 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -58.41 -21.57 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.767 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.7 -63.58 1.38 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 99.99 111.399 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.23 -31.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 99.99 111.634 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -59.88 -52.2 66.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 99.99 111.152 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.96 -33.58 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 99.99 110.766 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -72.17 -25.91 61.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.763 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 27.2 m -79.35 -40.26 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 99.99 111.819 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.6 -35.02 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.492 -0.322 . . . . 99.99 111.484 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.69 -57.05 4.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.316 -0.402 . . . . 99.99 111.624 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -31.06 56.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.028 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.459 ' O ' HG12 ' B' ' 181' ' ' ILE . 92.4 mt -87.67 -21.43 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.521 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -55.9 27.93 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 99.99 113.074 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.585 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 90.5 m-85 -54.23 -53.94 53.32 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.73 0.265 . . . . 99.99 111.273 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.7 Cg_exo -45.08 -34.57 9.42 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.2 1.934 . . . . 99.99 112.966 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.459 HG12 ' O ' ' B' ' 177' ' ' ILE . 48.8 mm -65.79 -60.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.856 0.36 . . . . 99.99 111.503 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 18.9 m -56.84 -24.37 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.417 -0.356 . . . . 99.99 111.154 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -69.23 -53.66 18.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.857 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.422 HG22 ' N ' ' B' ' 185' ' ' ILE . 10.5 tt -62.06 -51.65 69.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 111.852 0.315 . . . . 99.99 111.852 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . 0.422 ' N ' HG22 ' B' ' 184' ' ' ILE . 2.3 pp -60.66 131.02 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 99.99 110.647 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 C-N-CA 120.638 -0.791 . . . . 99.99 112.365 -179.753 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.841 0.353 . . . . 99.99 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -51.4 -55.68 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.04 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -56.87 -38.09 72.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.658 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -57.0 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 99.99 111.342 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 57.1 tp -83.36 -41.75 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.339 . . . . 99.99 111.133 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -77.88 -0.97 29.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 99.99 111.162 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 37.0 t -96.14 -43.59 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.127 0.489 . . . . 99.99 110.263 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 42.9 tp -72.97 -36.82 67.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.665 -0.698 . . . . 99.99 111.98 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 34.2 tp -58.08 -54.51 54.9 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.029 -0.268 . . . . 99.99 111.596 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 34.3 Cg_exo -58.8 -39.44 81.74 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.757 1.638 . . . . 99.99 111.471 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.98 -28.23 69.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.226 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -75.43 -25.53 57.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.047 -0.524 . . . . 99.99 110.546 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 99.99 110.55 179.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.805 0.336 . . . . 99.99 110.987 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.05 60.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.837 -0.697 . . . . 99.99 112.121 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -58.97 -39.06 80.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 99.99 111.211 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 42.2 t -56.49 -61.07 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.203 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.28 -20.03 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.955 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -72.1 -45.23 61.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 99.99 110.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.37 -27.02 67.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 99.99 110.82 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.66 -46.19 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 99.99 111.201 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -74.38 -43.41 56.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 99.99 111.29 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.64 -18.73 72.33 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.781 -0.723 . . . . 99.99 112.86 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.546 0.212 . . . . 99.99 111.079 -179.904 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.435 HD12 ' N ' ' C' ' 6' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.46 0.052 0 CA-C-O 120.769 0.319 . . . . 99.99 110.452 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' C' ' 11' ' ' TYR . 3.7 mm? -60.83 -31.58 71.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 99.99 110.921 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 32.3 m170 -69.54 -32.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.746 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -75.44 -54.64 6.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.954 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 36.6 mm -57.04 -22.21 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.472 . . . . 99.99 110.32 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' C' ' 7' ' ' LEU . 4.3 t80 -67.64 -59.34 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.649 -0.705 . . . . 99.99 110.773 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.15 -29.22 46.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 99.99 111.351 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.91 -47.81 70.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.369 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.13 79.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 99.99 112.81 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 24.9 mmt -72.18 -25.04 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.363 . . . . 99.99 111.079 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 85.7 m -69.68 -53.33 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.055 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.73 -24.06 34.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.12 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -54.11 30.66 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.87 -0.681 . . . . 99.99 112.513 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' C' ' 41' ' ' MET . . . -59.35 -32.9 70.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 99.99 110.974 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -64.8 -33.68 76.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.649 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -63.84 -19.86 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 99.99 110.998 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.24 -58.24 9.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 99.99 111.127 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.78 -33.78 76.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.039 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -71.89 -22.34 61.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 99.99 111.169 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 tp -84.63 -6.0 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 99.99 111.106 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 98.5 p -67.62 -12.89 61.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 99.99 110.82 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -47.94 -42.83 28.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.189 -0.671 . . . . 99.99 109.189 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.6 p-10 -177.16 130.66 0.34 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.193 -0.912 . . . . 99.99 110.201 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 85.0 Cg_endo . . . . . 0 N--CA 1.451 -1.023 0 C-N-CA 123.242 2.628 . . . . 99.99 112.056 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 35.4 Cg_exo . . . . . 0 C--O 1.23 0.105 0 CA-C-O 121.136 0.39 . . . . 99.99 111.996 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -58.92 -17.2 22.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.63 -0.714 . . . . 99.99 112.429 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.474 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -45.1 -33.53 2.21 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.735 0.302 . . . . 99.99 111.367 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.74 -49.1 72.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.953 0.406 . . . . 99.99 110.128 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.48 -18.76 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 99.99 110.476 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' C' ' 41' ' ' MET . 39.1 tp -60.48 -56.78 17.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.496 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.26 -36.46 74.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.014 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.74 -4.34 36.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.934 -0.576 . . . . 99.99 110.747 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.461 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 23.9 ttt -88.52 -37.31 15.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.917 -0.583 . . . . 99.99 110.485 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.92 -34.57 69.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 99.99 111.252 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.55 HG22 HG23 ' C' ' 79' ' ' THR . 83.0 mt -51.08 -53.58 46.95 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.161 0.43 . . . . 99.99 112.161 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.76 -34.4 8.98 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.314 2.01 . . . . 99.99 113.231 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -55.19 -62.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 99.99 111.683 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -63.38 -53.03 58.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.551 -0.295 . . . . 99.99 111.245 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.462 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 39.9 t -53.7 -31.74 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.782 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.61 -49.37 60.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 99.99 112.652 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . 0.442 HD23 ' SG ' ' A' ' 134' ' ' CYS . 50.1 mt -58.25 -35.67 72.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 99.99 111.441 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.87 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.602 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 22.5 m-85 -61.34 -38.7 87.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.512 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 45.7 ttp -50.33 -38.23 40.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.26 0.552 . . . . 99.99 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' C' ' 58' ' ' GLN . . . -67.41 -42.64 82.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.503 -0.771 . . . . 99.99 110.777 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.8 mtt -51.42 -28.87 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 99.99 110.626 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -72.92 -51.56 18.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 99.99 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.45 ' HB ' HG22 ' A' ' 127' ' ' VAL . 29.1 pt -76.91 9.37 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 99.99 111.492 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 59.12 51.43 7.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.058 -0.519 . . . . 99.99 111.373 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' C' ' 53' ' ' ALA . 6.7 tp-100 -120.73 139.62 52.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.877 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.88 32.52 5.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 99.99 112.205 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -139.4 136.19 34.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 99.99 111.03 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.28 136.47 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.428 -0.351 . . . . 99.99 111.15 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.27 91.32 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 99.99 110.63 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.85 128.7 55.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.033 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.93 33.66 19.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.093 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 16.05 61.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.769 -0.729 . . . . 99.99 112.499 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.53 125.17 41.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.742 0.306 . . . . 99.99 110.737 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 25.8 pt -75.57 133.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.398 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.01 113.01 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 99.99 110.923 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.504 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 91.6 m-70 -75.64 79.07 2.62 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.286 0.565 . . . . 99.99 111.211 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -57.73 -34.94 70.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.404 -0.816 . . . . 99.99 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' C' ' 74' ' ' ILE . . . -76.35 -22.68 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.871 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.8 tpp180 -67.62 -51.47 49.76 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.435 0.532 . . . . 99.99 112.435 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.502 ' O ' ' HG2' ' C' ' 77' ' ' MET . 28.8 p90 -87.1 -30.95 20.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.435 0.532 . . . . 99.99 112.435 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . 0.454 HG23 ' HA ' ' C' ' 71' ' ' ALA . 10.9 tp -56.46 -41.16 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.564 -0.455 . . . . 99.99 110.108 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.462 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 19.6 t0 -69.8 -20.61 63.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.994 -0.743 . . . . 99.99 108.994 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -89.75 9.9 25.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.249 -0.887 . . . . 99.99 110.888 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 92.0 mmm -105.05 -21.86 13.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 99.99 110.152 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.57 -29.1 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 99.99 112.163 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.55 HG23 HG22 ' C' ' 43' ' ' ILE . 61.9 m -83.42 -49.49 9.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.212 0.449 . . . . 99.99 112.212 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.2 m -55.05 -50.73 84.79 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 111.898 0.333 . . . . 99.99 111.898 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.4 Cg_exo -54.69 -47.92 24.1 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.917 1.745 . . . . 99.99 111.665 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.27 -27.71 68.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.921 -0.581 . . . . 99.99 110.573 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.42 HD13 ' O ' ' C' ' 83' ' ' LEU . 1.2 tm? -67.55 -38.04 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.257 0.551 . . . . 99.99 109.632 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -78.56 -25.63 45.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 99.99 110.871 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.04 -33.0 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 60.1 m -62.91 -54.06 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 99.99 110.978 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 pp -61.8 -22.15 65.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.08 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -50.51 52.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 99.99 110.648 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -60.67 -28.23 68.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.406 . . . . 99.99 110.68 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -60.88 -52.43 65.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.801 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.25 60.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.056 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 12.9 tpt -86.86 112.89 22.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.488 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -86.55 -61.55 1.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 99.99 111.442 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -130.97 144.3 51.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 99.99 111.301 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 tt -109.32 146.13 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.739 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -124.54 -83.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.571 -0.286 . . . . 99.99 111.247 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -139.2 3.38 2.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 99.99 111.332 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.41 91.89 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 99.99 110.698 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -107.6 -13.59 15.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 99.99 111.29 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 7.3 t -69.35 -27.71 65.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 99.99 111.245 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.16 -35.5 75.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.957 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.1 -38.9 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.906 -0.588 . . . . 99.99 111.294 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -35.5 92.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 99.99 112.571 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -65.17 -35.82 82.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 99.99 110.847 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.25 -45.66 83.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.974 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' MET . . . . . 0.414 ' O ' HG13 ' C' ' 110' ' ' ILE . 91.0 mmm -62.44 -43.31 99.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.715 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -53.71 -51.2 64.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.479 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 75.7 p -59.64 -30.34 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 99.99 111.761 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -74.55 -50.45 18.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 99.99 111.654 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.584 HG22 ' HE1' ' B' ' 46' ' ' TRP . 58.9 mt -52.34 -34.92 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.399 -0.364 . . . . 99.99 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.22 -48.94 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 99.99 111.494 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.34 -56.55 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.392 -0.367 . . . . 99.99 111.874 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 25.4 pt -54.51 -32.37 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 99.99 111.804 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 20.3 m -60.66 -46.76 89.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 99.99 110.899 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -67.32 -20.58 65.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.939 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.72 -40.87 11.61 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.986 -0.626 . . . . 99.99 113.058 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.485 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.8 pp -73.68 -29.65 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.289 . . . . 99.99 111.424 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.485 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.1 tp -81.22 -28.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.806 0.336 . . . . 99.99 110.988 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.46 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.537 . . . . 99.99 110.994 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.57 -24.74 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 99.99 111.116 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 93.5 mt -88.02 33.83 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.715 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 83.4 p -77.95 132.73 38.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 99.99 111.007 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.99 -25.61 29.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 99.99 110.577 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -134.72 152.57 51.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.897 -0.592 . . . . 99.99 110.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.91 -11.09 60.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.315 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -92.81 -40.64 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.071 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.42 -23.9 25.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 99.99 110.822 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -66.74 -35.79 80.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.948 -0.569 . . . . 99.99 111.0 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -65.0 -32.15 73.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.203 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.63 -54.38 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.2 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -58.6 -28.68 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 99.99 111.286 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.72 -44.99 80.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 99.99 110.861 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 81.7 mt -56.92 -37.27 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 99.99 110.744 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . 0.428 ' SG ' HD23 ' B' ' 49' ' ' LEU . 53.8 t -70.36 -27.06 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 99.99 110.766 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.3 -56.7 20.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 99.99 112.385 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.9 -32.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 99.99 110.985 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 50.1 t -63.39 -35.71 81.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.301 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.75 92.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.775 -0.648 . . . . 99.99 110.838 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -69.81 -16.12 63.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.21 -58.59 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 99.99 110.592 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 17.2 pt -71.15 -27.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 99.99 111.596 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.98 -44.31 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.333 -0.394 . . . . 99.99 111.221 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.9 tp -55.54 -57.94 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.334 . . . . 99.99 111.078 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -62.77 -24.98 67.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 99.99 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.23 -16.84 79.61 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 99.99 112.64 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 69.1 mt -105.52 -18.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 99.99 111.183 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -62.3 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.932 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 112.344 0.498 . . . . 99.99 112.344 -178.796 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 20.0 mt . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.124 0.488 . . . . 99.99 110.774 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -23.58 46.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.373 -0.83 . . . . 99.99 111.192 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.4 -50.48 63.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 99.99 110.751 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -61.09 -35.78 77.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.821 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.7 -62.81 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 99.99 111.227 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.09 -32.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 99.99 111.479 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.7 m -57.11 -53.08 62.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.362 . . . . 99.99 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -56.16 -39.25 72.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.84 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -62.75 -32.13 73.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 99.99 111.084 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 34.2 m -73.8 -46.69 43.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.508 . . . . 99.99 111.413 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.61 -28.95 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.8 tp -80.52 -57.67 3.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.356 -0.384 . . . . 99.99 111.678 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.28 -28.14 62.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 99.99 110.748 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG13 ' C' ' 181' ' ' ILE . 34.2 mm -87.83 -23.33 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.166 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.51 24.56 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.814 -0.63 . . . . 99.99 113.155 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.576 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 66.2 m-85 -53.85 -54.97 40.73 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.899 0.349 . . . . 99.99 111.069 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 80.4 Cg_exo -45.36 -33.54 9.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.946 1.764 . . . . 99.99 112.664 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.448 HG13 ' O ' ' C' ' 177' ' ' ILE . 87.3 mt -63.9 -61.14 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.568 -0.287 . . . . 99.99 111.483 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 p -56.95 -35.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.623 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -57.13 -51.37 69.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.564 -0.289 . . . . 99.99 111.147 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.0 -65.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.371 -0.377 . . . . 99.99 111.656 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.077 0.465 . . . . 99.99 111.248 -179.548 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.861 0.362 . . . . 99.99 110.979 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -51.28 -33.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.462 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.52 -56.43 18.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.392 . . . . 99.99 111.007 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.6 p -60.99 -31.18 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 99.99 111.478 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.3 -39.0 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.333 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.0 -45.49 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 99.99 111.435 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.21 -3.22 12.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.746 0.308 . . . . 99.99 110.984 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 25.6 t -96.19 -40.95 8.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.197 0.522 . . . . 99.99 110.072 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 55.5 tp -74.12 -37.55 64.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.512 -0.767 . . . . 99.99 111.733 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 52.1 tp -57.19 -53.84 61.0 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.765 -0.198 . . . . 99.99 111.463 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 32.6 Cg_exo -58.59 -42.35 55.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.73 1.62 . . . . 99.99 111.476 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' C' ' 11' ' ' TYR . 51.3 t80 -64.11 -26.43 68.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.393 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.36 -26.01 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 99.99 110.479 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 89.2 p . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 99.99 110.811 179.85 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.779 0.323 . . . . 99.99 111.279 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.33 -32.46 62.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.78 . . . . 99.99 112.619 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.71 -36.76 70.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.671 0.272 . . . . 99.99 111.038 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.3 t -61.34 -56.31 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 99.99 110.947 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -61.23 -25.54 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 99.99 110.853 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.42 -51.08 32.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.827 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.19 -21.47 63.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.25 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.56 -35.56 39.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.203 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -82.28 -33.4 29.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.972 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -81.14 -18.75 68.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.852 -0.69 . . . . 99.99 112.364 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.553 0.216 . . . . 99.99 111.211 -179.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt . . . . . 0 N--CA 1.46 0.062 0 CA-C-O 120.651 0.263 . . . . 99.99 111.261 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.85 -59.67 2.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.332 . . . . 99.99 111.171 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 35.5 m80 -59.86 -23.69 63.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 99.99 110.586 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.429 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.4 t-105 -66.33 -54.51 23.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.765 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.45 -23.18 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.51 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -60.32 -61.28 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.64 . . . . 99.99 111.108 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 9' ' ' TRP . 8.1 p -57.19 -32.79 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.4 . . . . 99.99 111.188 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.85 98.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 99.99 111.024 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -73.57 -22.16 78.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.833 -0.699 . . . . 99.99 112.365 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.579 ' HE2' ' HA ' ' A' ' 15' ' ' MET . 27.0 mmt -73.29 -42.56 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 99.99 110.825 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.4 p -61.67 -49.85 74.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.11 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 14' ' ' GLY . 2.8 pp -63.77 -24.27 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 99.99 110.982 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.58 -46.6 91.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.766 -0.731 . . . . 99.99 112.551 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.1 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.747 0.308 . . . . 99.99 111.201 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.92 -28.62 69.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.972 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -54.96 -32.79 61.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 99.99 110.63 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -75.15 -36.7 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.842 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -54.58 -34.72 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.916 0.388 . . . . 99.99 110.678 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.8 m -85.31 -29.65 24.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.178 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.3 tp -87.27 -5.62 58.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 99.99 111.297 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.1 p -60.2 -19.81 55.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 99.99 111.188 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -50.01 -32.24 14.8 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.187 0.517 . . . . 99.99 109.726 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 7.9 p30 -176.15 132.17 0.4 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.103 -0.953 . . . . 99.99 109.912 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 60.8 Cg_endo -95.52 -176.84 0.39 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.877 2.385 . . . . 1.91 112.609 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -86.43 45.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 99.99 110.979 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.71 -45.74 3.38 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.881 -0.676 . . . . 99.99 112.613 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.8 118.99 71.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 99.99 111.265 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' TYR . 51.2 Cg_exo -55.06 168.61 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.961 2.441 . . . . 1.79 112.351 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -39.63 -18.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.335 -0.848 . . . . 99.99 113.17 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 m-30 -41.27 -60.47 1.25 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.887 0.375 . . . . 99.99 111.396 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.23 -41.95 97.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.034 -0.53 . . . . 99.99 111.597 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -69.27 -19.36 63.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.618 -0.264 . . . . 99.99 111.484 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.08 -55.55 10.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.953 0.406 . . . . 99.99 110.268 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG23 HD12 ' A' ' 82' ' ' LEU . 4.3 p -68.35 -31.32 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 99.99 111.031 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.6 -13.05 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.524 . . . . 99.99 111.663 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.492 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 17.0 tmm? -89.12 -35.51 16.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 99.99 111.287 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -77.81 -33.81 52.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.279 0.474 . . . . 99.99 112.279 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.608 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 88.6 mt -54.06 -50.54 83.74 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 111.753 0.279 . . . . 99.99 111.753 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 12.1 Cg_exo -71.23 -43.22 1.61 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.647 2.232 . . . . 0.53 113.059 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 mm -56.38 -61.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.778 0.288 . . . . 99.99 111.778 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -55.18 -58.36 8.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.652 0.263 . . . . 99.99 111.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.6 p -52.01 -42.16 62.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.535 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -48.8 -60.35 6.04 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.129 -0.557 . . . . 99.99 112.992 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.23 -34.87 58.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 99.99 111.204 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.49 83.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.29 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 57.4 m-85 -63.82 -49.64 72.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.324 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.41 ' HB2' HG11 ' A' ' 12' ' ' VAL . 57.7 ttp -47.02 -34.4 5.63 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 99.99 110.352 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.96 -44.21 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.762 -0.654 . . . . 99.99 110.926 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.5 mtt -52.42 -27.72 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.209 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.87 47.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.718 -0.674 . . . . 99.99 110.385 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.4 -2.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.847 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.52 43.11 2.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.938 -0.574 . . . . 99.99 111.108 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -121.56 159.14 27.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.947 -0.569 . . . . 99.99 110.509 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.06 13.91 44.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.114 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -132.57 140.2 48.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.787 0.327 . . . . 99.99 110.697 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.24 150.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.192 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.64 92.55 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 99.99 110.611 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.66 137.48 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.073 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.07 17.18 7.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.043 -0.526 . . . . 99.99 111.511 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.8 -13.07 63.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 99.99 112.699 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -98.45 155.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 99.99 111.164 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.6 mt -105.26 106.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.96 -0.564 . . . . 99.99 110.861 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.73 138.39 33.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.482 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.8 m-70 -97.73 74.55 2.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.979 -0.555 . . . . 99.99 110.615 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -56.41 -45.7 80.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.557 -0.747 . . . . 99.99 111.684 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -67.21 -27.16 67.02 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.189 0.44 . . . . 99.99 112.189 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.529 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.4 tpp180 -64.16 -51.61 63.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.596 0.591 . . . . 99.99 112.596 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.498 ' O ' ' HG3' ' A' ' 77' ' ' MET . 15.9 p90 -87.06 -26.15 23.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.455 -0.498 . . . . 99.99 112.297 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 71' ' ' ALA . 9.6 tp -55.87 -42.38 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.6 -0.44 . . . . 99.99 110.125 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -70.01 -21.34 63.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.16 -0.682 . . . . 99.99 109.16 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -84.77 2.81 40.44 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.364 -0.835 . . . . 99.99 111.243 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 38.9 mtp -103.06 -22.87 13.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 99.99 110.931 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' HD23 ' A' ' 82' ' ' LEU . 28.9 m -114.52 -36.04 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.453 0.538 . . . . 99.99 112.453 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 43' ' ' ILE . 36.0 m -72.58 -52.32 16.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.902 0.334 . . . . 99.99 111.902 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.575 HG22 ' NE2' ' A' ' 109' ' ' GLN . 10.5 m -53.82 -51.37 77.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.583 0.586 . . . . 99.99 112.583 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 109' ' ' GLN . 12.1 Cg_endo -55.72 -44.36 48.6 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.49 1.46 . . . . 0.74 111.511 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.647 HD12 HG23 ' A' ' 39' ' ' VAL . 3.9 mm? -64.2 -31.37 72.54 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.601 -0.518 . . . . 99.99 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 83' ' ' LEU . 1.6 tt -68.87 -24.53 64.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.531 0.682 . . . . 99.99 109.206 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.22 -32.11 24.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.129 -0.941 . . . . 99.99 110.474 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 82' ' ' LEU . 82.7 mt -74.67 -36.14 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.751 -0.659 . . . . 99.99 111.172 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -58.27 -25.09 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.943 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.57 -40.48 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.834 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -61.05 -37.26 82.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.044 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -73.83 -38.65 64.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.21 -29.07 70.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.031 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.29 -40.38 13.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.239 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.3 mtp -99.99 107.28 19.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 99.99 111.076 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -82.17 -27.53 32.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.488 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -133.55 138.9 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.596 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.04 142.94 23.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 99.99 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -124.87 -66.25 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.867 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -160.86 80.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.771 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.73 109.55 4.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.94 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -129.25 12.04 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.741 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.8 t -95.12 -32.22 13.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.395 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.42 ' O ' HD13 ' A' ' 101' ' ' LEU . 1.2 tm? -74.23 -45.13 50.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 99.99 110.57 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.37 -33.77 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.391 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.14 -34.77 64.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 99.99 112.807 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -66.98 -34.99 78.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 99.99 111.02 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.2 mt -76.14 -52.1 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.023 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -58.91 -33.25 70.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 99.99 111.451 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.4 p -72.16 -56.62 5.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.43 -0.35 . . . . 99.99 111.005 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.451 ' HB ' HG12 ' A' ' 142' ' ' ILE . 41.0 p -55.75 -25.21 39.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 99.99 110.778 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.575 ' NE2' HG22 ' A' ' 80' ' ' THR . 6.4 tp60 -68.64 -45.98 70.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.798 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.8 mt -54.37 -36.9 35.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.461 -0.336 . . . . 99.99 110.643 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.85 -44.66 99.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 99.99 111.139 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.5 t -66.11 -36.36 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.308 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 94.0 mt -60.03 -41.84 87.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.161 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 72.5 m -60.84 -51.7 68.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.113 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.9 p -59.68 -20.16 54.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.825 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.79 -36.05 17.13 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.056 -0.592 . . . . 99.99 112.898 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -83.09 -28.45 29.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.652 0.263 . . . . 99.99 111.625 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.7 tp -83.93 -28.11 7.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.603 -0.271 . . . . 99.99 111.574 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.65 74.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 99.99 110.809 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.5 -12.44 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 99.99 110.74 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 118' ' ' ILE . 91.6 mt -90.42 22.04 3.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.788 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.1 m -86.3 120.67 27.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.864 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -90.32 -68.33 0.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.849 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG12 ' A' ' 127' ' ' VAL . 99.6 mtt180 -64.81 139.63 58.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.617 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.11 -9.54 58.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.872 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -88.51 -38.5 14.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.927 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.0 p -79.88 -24.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.018 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -54.41 -43.52 71.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 99.99 111.059 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.99 -33.89 76.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.763 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.37 -58.48 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 99.99 111.135 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.421 ' HE1' ' HB3' ' C' ' 58' ' ' GLN . 4.6 m95 -55.32 -34.31 64.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 99.99 111.191 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.41 -48.92 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.067 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -61.86 -28.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.037 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.44 -33.62 74.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.458 . . . . 99.99 110.625 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.57 -50.26 26.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.882 -0.675 . . . . 99.99 112.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.65 -30.22 48.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.674 0.273 . . . . 99.99 111.262 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.15 -46.5 77.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.774 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.51 -29.88 70.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.969 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.22 -26.85 61.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.848 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.85 -53.89 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.202 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.7 pt -61.33 -44.95 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 99.99 111.443 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 108' ' ' THR . 89.6 mt -63.88 -36.6 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 99.99 111.078 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.69 -28.48 69.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.588 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -72.78 -34.22 66.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 99.99 110.313 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.73 -35.77 34.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.905 -0.664 . . . . 99.99 112.58 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.9 -26.21 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.947 0.403 . . . . 99.99 110.661 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -88.06 3.12 50.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 99.99 110.903 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 99.99 112.175 -179.131 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.6 tp . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.928 0.394 . . . . 99.99 110.783 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -81.25 -21.75 39.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 99.99 110.625 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.64 -50.62 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 99.99 111.272 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -74.97 -27.79 60.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 99.99 111.039 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.66 -47.27 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.361 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.93 -30.32 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 99.99 111.492 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -56.08 -58.4 8.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 99.99 111.309 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -61.42 -35.21 76.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 99.99 110.525 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -65.2 -26.57 68.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.813 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 88.6 m -73.93 -49.54 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 99.99 111.34 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.18 -31.45 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.39 -0.368 . . . . 99.99 111.599 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.411 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.7 mt -77.02 -57.47 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.429 -0.351 . . . . 99.99 111.401 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.545 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.519 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 9.9 tp -87.67 -21.27 7.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.125 0.488 . . . . 99.99 110.203 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -64.75 -45.29 93.16 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.711 -0.677 . . . . 99.99 112.304 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.821 ' HH ' ' HG3' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -53.32 -55.41 34.68 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.703 0.251 . . . . 99.99 111.053 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.519 ' HD2' ' C ' ' A' ' 177' ' ' ILE . 75.6 Cg_exo -48.96 -38.84 39.73 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.227 1.951 . . . . 0.55 112.4 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 184' ' ' ILE . 98.5 mt -54.62 -59.16 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.605 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.69 -24.21 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.308 -0.405 . . . . 99.99 111.288 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -59.58 -53.08 62.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.906 0.336 . . . . 99.99 111.906 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.0 tt -59.01 -20.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.855 0.317 . . . . 99.99 111.855 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.096 0.474 . . . . 99.99 111.473 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.67 0.271 . . . . 99.99 111.625 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.98 -57.73 9.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 99.99 110.639 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.5 p -60.17 -17.26 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.012 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -81.97 -30.47 31.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.937 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.76 -37.28 22.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.195 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -13.79 60.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.478 -0.328 . . . . 99.99 111.309 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.433 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 15.7 p -96.15 -37.07 10.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.972 0.415 . . . . 99.99 110.592 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 66.3 tp -72.7 -33.8 66.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 99.99 111.668 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 47.2 tp -60.72 -53.79 60.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 121.122 -0.231 . . . . 99.99 111.348 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.821 ' HG3' ' HH ' ' A' ' 179' ' ' TYR . 52.9 Cg_exo -56.03 -42.34 67.71 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.931 1.754 . . . . 0.64 111.44 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.491 ' HB2' ' OH ' ' A' ' 11' ' ' TYR . 90.5 t80 -61.72 -35.63 78.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.111 -0.495 . . . . 99.99 110.251 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.78 -20.94 57.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.834 -0.621 . . . . 99.99 110.846 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.411 ' OG ' HD13 ' A' ' 175' ' ' LEU . 29.8 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 99.99 111.127 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.88 0.372 . . . . 99.99 110.914 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.16 78.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 99.99 112.393 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.98 -38.18 90.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 99.99 110.674 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.9 m -58.68 -57.38 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.794 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -64.03 -22.8 67.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.644 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 216' ' ' LEU . 10.5 tt -69.81 -48.03 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.102 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.86 -31.5 72.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.452 -0.34 . . . . 99.99 111.253 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 52.2 mt -70.15 -57.5 4.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 99.99 111.115 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.31 -22.82 65.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.32 -59.44 10.65 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.861 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 99.99 110.738 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.89 0.376 . . . . 99.99 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 39.6 mt -66.34 -48.27 70.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.003 -0.544 . . . . 99.99 110.979 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 34.4 m80 -64.76 -24.17 67.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.831 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.467 ' O ' HG12 ' B' ' 12' ' ' VAL . 11.2 m95 -70.57 -56.15 7.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 99.99 111.194 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 pt -60.37 -20.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 99.99 110.906 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 15' ' ' MET . 6.0 t80 -65.15 -61.3 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 99.99 110.446 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.467 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.54 -29.49 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.294 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.23 74.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 99.99 110.978 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.58 -26.23 74.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.856 -0.688 . . . . 99.99 112.704 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 52.3 mmm -76.81 -37.79 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.35 . . . . 99.99 110.908 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 71.2 m -57.58 -55.4 35.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.92 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' B' ' 20' ' ' LEU . 1.9 tp -58.45 -36.72 60.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.782 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -45.81 -58.76 5.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.735 -0.745 . . . . 99.99 112.293 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.4 74.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.686 0.279 . . . . 99.99 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' B' ' 17' ' ' ILE . 97.5 mt -64.58 -28.68 69.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 99.99 110.814 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -64.63 -32.83 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.327 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.8 -20.49 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 99.99 110.587 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -69.36 -43.52 73.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.479 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 65.5 m -79.65 -30.38 41.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.7 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.9 tp -86.48 -1.3 57.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 99.99 110.58 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -60.86 -11.68 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.903 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.597 ' HG2' HD22 ' B' ' 28' ' ' ASN . 36.7 ttm180 -47.22 -47.25 24.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.001 -0.74 . . . . 99.99 109.001 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . 0.597 HD22 ' HG2' ' B' ' 27' ' ' ARG . 9.0 p30 -178.59 129.91 0.28 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.201 -0.909 . . . . 99.99 110.337 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.518 ' HD2' ' H ' ' B' ' 31' ' ' GLY . 72.9 Cg_endo -103.32 -82.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.542 2.828 . . . . 1.82 112.121 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.435 ' HE ' HD22 ' B' ' 221' ' ' LEU . 49.6 mtp180 -112.63 6.14 18.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.794 0.806 . . . . 99.99 109.234 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.518 ' H ' ' HD2' ' B' ' 29' ' ' PRO . . . 123.64 -53.39 0.75 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 114.267 -1.333 . . . . 99.99 110.731 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.26 104.98 5.11 Favored Pre-proline 0 C--O 1.232 0.171 0 O-C-N 122.906 -0.173 . . . . 99.99 110.692 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.484 ' HG3' ' HG3' ' B' ' 29' ' ' PRO . 69.6 Cg_endo -88.21 107.76 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 119.446 0.838 . . . . 2.67 113.117 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -93.47 -58.29 2.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 123.597 1.665 . . . . 99.99 108.894 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.587 ' HD2' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -83.4 -61.69 1.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 110.633 -2.985 . . . . 99.99 113.823 -177.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.587 ' H ' ' HD2' ' B' ' 35' ' ' TYR . 40.6 tt0 -37.91 -63.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.467 0.914 . . . . 99.99 113.467 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -62.34 -40.33 96.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.11 0.411 . . . . 99.99 112.11 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -59.23 -65.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.88 0.326 . . . . 99.99 111.88 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.594 HG13 HD12 ' B' ' 82' ' ' LEU . 60.5 t -61.93 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.413 0.523 . . . . 99.99 112.413 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -14.09 6.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.228 0.455 . . . . 99.99 112.228 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 27.6 ttt -88.91 -39.65 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 99.99 111.546 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -72.01 -42.65 66.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 99.99 112.226 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.476 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 93.5 mt -49.62 -52.05 54.02 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.493 0.553 . . . . 99.99 112.493 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 50.9 Cg_endo -68.79 -43.44 3.63 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.202 1.935 . . . . 0.49 113.302 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mm -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.78 0.324 . . . . 99.99 111.632 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -55.95 -58.3 8.48 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.541 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 94.8 p -51.99 -32.9 35.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.241 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.67 -57.64 18.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 99.99 112.48 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.86 -28.12 68.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 99.99 111.067 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.96 -59.11 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 99.99 111.16 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.514 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 35.1 m-85 -63.75 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.11 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 19.5 ttt -48.85 -42.74 37.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.063 0.458 . . . . 99.99 110.456 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.54 -42.05 87.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 99.99 110.616 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -51.55 -29.38 16.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 99.99 110.212 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.3 -47.34 57.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 99.99 109.901 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -71.92 2.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.499 -0.773 . . . . 99.99 110.804 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 66.78 49.15 1.26 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.751 -0.658 . . . . 99.99 111.008 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.01 173.93 7.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 99.99 110.79 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 78.5 21.3 69.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 99.99 112.498 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -139.36 144.5 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.722 0.296 . . . . 99.99 110.572 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -124.6 146.19 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.155 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -101.16 84.04 2.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.844 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.87 144.31 42.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.925 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 16.29 4.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.436 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 -15.44 58.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 99.99 112.885 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -98.19 173.17 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 99.99 110.658 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -116.93 118.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.552 . . . . 99.99 111.165 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.89 110.93 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.253 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 57.0 m-70 -70.05 80.31 0.49 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.737 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -65.23 -31.02 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.655 -0.702 . . . . 99.99 111.496 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.478 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -79.48 -25.99 41.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.052 0.389 . . . . 99.99 112.052 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 22.0 mmt180 -69.6 -51.16 37.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.323 0.49 . . . . 99.99 112.323 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 3.5 p90 -76.14 -36.06 58.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.638 -0.425 . . . . 99.99 111.964 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.412 HG23 ' N ' ' B' ' 75' ' ' ASP . 16.9 tt -54.21 -43.68 61.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.728 0.299 . . . . 99.99 110.933 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.503 ' HD2' ' HG1' ' B' ' 79' ' ' THR . 11.6 t70 -67.92 -25.59 65.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.235 -0.654 . . . . 99.99 109.235 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -85.44 8.56 18.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.677 -0.692 . . . . 99.99 110.484 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.477 ' HA ' HG21 ' B' ' 113' ' ' ILE . 45.9 tpp -105.14 -25.64 12.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.684 -0.689 . . . . 99.99 110.713 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.89 -36.75 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.26 -0.427 . . . . 99.99 112.129 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.503 ' HG1' ' HD2' ' B' ' 75' ' ' ASP . 92.0 m -70.54 -57.64 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.919 0.341 . . . . 99.99 111.919 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.617 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 31.2 m -48.92 -51.78 52.2 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.535 0.568 . . . . 99.99 112.535 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.617 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 53.0 Cg_exo -54.16 -45.79 38.34 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.5 1.467 . . . . 0.66 111.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.594 HD12 HG13 ' B' ' 39' ' ' VAL . 3.0 mm? -63.03 -32.05 73.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.85 -0.614 . . . . 99.99 109.853 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 -23.95 62.34 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.15 -0.685 . . . . 99.99 109.15 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' B' ' 109' ' ' GLN . 16.8 tp -84.41 -29.44 26.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.103 -0.953 . . . . 99.99 110.462 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.69 -38.98 46.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.753 -0.658 . . . . 99.99 111.133 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' SER . . . . . 0.435 ' HB2' HG11 ' B' ' 39' ' ' VAL . 39.8 t -56.55 -21.06 23.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.921 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.86 -37.61 62.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.517 . . . . 99.99 111.115 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.1 t -72.42 -21.69 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.176 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.53 -45.49 15.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.138 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -66.83 -23.26 66.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 99.99 111.248 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.71 -36.85 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 79.1 mtp -105.17 101.17 10.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 99.99 110.946 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -73.15 -27.79 61.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.863 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -132.14 153.49 50.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.44 144.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.322 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -165.16 88.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 99.99 110.719 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt 58.19 81.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 99.99 111.094 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.89 95.8 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.859 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -129.07 0.13 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.895 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 67.2 p -70.52 -43.3 69.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.095 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 tp -73.37 -36.03 66.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.769 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 28.1 mm -60.7 -37.84 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.791 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.06 -23.32 63.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.859 -0.686 . . . . 99.99 112.357 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.79 -38.77 89.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.332 . . . . 99.99 111.072 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.3 mt -81.06 -44.24 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.001 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 11.0 tpt -56.4 -39.76 73.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.594 -0.73 . . . . 99.99 111.476 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -72.03 -51.85 19.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 99.99 111.274 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 27.8 p -53.26 -32.79 50.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.919 0.39 . . . . 99.99 111.379 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 6.5 tp-100 -65.81 -48.55 71.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.056 -0.52 . . . . 99.99 111.024 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.95 -43.71 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.619 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.2 -44.06 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.334 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.89 -46.3 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.8 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' B' ' 77' ' ' MET . 44.6 mt -56.92 -37.74 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.586 -0.279 . . . . 99.99 111.096 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.5 m -57.84 -49.66 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.95 0.405 . . . . 99.99 110.771 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.6 m -62.89 -21.96 66.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.31 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.66 -43.77 17.71 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.02 -0.61 . . . . 99.99 112.497 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.457 HD12 HG12 ' B' ' 118' ' ' ILE . 3.7 pp -77.47 -24.89 50.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.636 0.255 . . . . 99.99 111.163 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.457 HG12 HD12 ' B' ' 117' ' ' LEU . 36.5 mm -82.34 -36.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.408 -0.36 . . . . 99.99 111.09 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.49 -46.81 76.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.435 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -70.82 -17.41 62.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.234 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.13 20.41 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.454 -0.339 . . . . 99.99 111.351 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -78.05 125.04 28.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 99.99 110.781 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.75 -67.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.976 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.571 ' HB2' HG12 ' B' ' 127' ' ' VAL . 92.0 mtt180 -71.44 152.29 43.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.584 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.53 -16.78 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.865 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -81.86 -37.01 27.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 99.99 110.747 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.8 p -78.43 -24.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.939 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -58.05 -34.88 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.827 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -76.24 -21.39 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 99.99 111.042 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.99 -60.99 2.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.162 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -59.98 -27.48 66.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.398 -0.365 . . . . 99.99 110.971 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.68 -45.75 91.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 99.99 110.284 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -65.26 -33.26 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.044 -0.525 . . . . 99.99 110.449 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 47.5 t -62.64 -31.12 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.723 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.66 -52.98 13.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.838 -0.696 . . . . 99.99 112.479 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.38 -31.69 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 99.99 111.335 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 68.5 m -65.08 -46.07 82.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 99.99 110.775 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.93 71.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.667 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -73.13 -22.77 60.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.523 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.72 -57.82 4.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 99.99 110.703 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 41.2 pt -60.1 -38.43 76.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.517 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.81 -34.74 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.956 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.78 -39.59 85.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.291 -0.413 . . . . 99.99 110.569 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . 0.681 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 89.4 t90 -62.72 -47.08 85.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.532 . . . . 99.99 110.799 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . 1.315 ' HA2' ' ND2' ' B' ' 148' ' ' ASN . . . -63.53 -34.08 88.98 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 99.99 112.63 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -74.11 -24.16 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.919 0.39 . . . . 99.99 110.603 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -90.6 3.16 54.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 99.99 110.897 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 1.315 ' ND2' ' HA2' ' B' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.913 -0.585 . . . . 99.99 112.251 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.866 0.365 . . . . 99.99 110.759 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . 0.413 ' O ' HG12 ' B' ' 169' ' ' VAL . 1.1 t80 -78.14 -23.68 47.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 99.99 111.32 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.74 -59.28 4.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 99.99 110.92 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.31 -26.9 65.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.327 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.16 -56.14 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.406 -0.361 . . . . 99.99 111.104 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . 0.413 HG12 ' O ' ' B' ' 165' ' ' TYR . 14.4 p -68.97 -22.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 99.99 111.488 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 41.4 m -54.28 -58.91 5.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.48 -0.327 . . . . 99.99 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.67 -42.53 95.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.501 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.77 -28.2 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.044 -0.526 . . . . 99.99 110.789 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 90.2 m -73.52 -50.71 20.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.119 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.25 -43.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.93 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' B' ' 209' ' ' SER . 3.8 mm? -70.92 -53.24 15.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.955 0.354 . . . . 99.99 111.955 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -24.14 63.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.704 0.288 . . . . 99.99 111.194 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.493 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 36.6 mm -87.57 -22.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 99.99 110.26 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -65.44 -41.93 96.13 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.726 -0.67 . . . . 99.99 112.696 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.739 ' HH ' ' HG3' ' B' ' 206' ' ' PRO . 0.4 OUTLIER -56.09 -55.41 42.01 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.744 0.272 . . . . 99.99 111.124 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.493 ' HD2' ' C ' ' B' ' 177' ' ' ILE . 78.3 Cg_exo -50.57 -38.75 55.43 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.154 1.903 . . . . 0.64 112.243 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.5 ' O ' HG22 ' B' ' 184' ' ' ILE . 37.0 mm -54.04 -58.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 99.99 111.512 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 20.9 m -69.23 -24.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.262 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -61.75 -52.59 63.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.026 0.38 . . . . 99.99 112.026 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.5 HG22 ' O ' ' B' ' 181' ' ' ILE . 21.1 tt -58.23 -17.21 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 111.998 0.37 . . . . 99.99 111.998 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 8.9 tt -121.54 104.02 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 99.99 111.532 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.802 -0.713 . . . . 99.99 112.501 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.769 0.318 . . . . 99.99 111.389 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.44 -52.95 63.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.914 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' THR . . . . . 0.426 HG22 ' HE2' ' B' ' 8' ' ' HIS . 11.4 m -66.64 -19.11 65.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.94 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . 0.434 ' HA ' ' SG ' ' B' ' 203' ' ' CYS . 62.2 t80 -83.51 -27.13 29.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.125 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.12 -28.78 27.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.736 0.303 . . . . 99.99 111.129 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.85 -12.0 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 99.99 111.188 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' B' ' 200' ' ' PHE . 17.2 p -96.22 -32.41 12.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 99.99 110.477 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.37 -39.33 59.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 99.99 111.408 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.6 tp -57.46 -53.16 68.37 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.622 -0.263 . . . . 99.99 111.523 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.739 ' HG3' ' HH ' ' B' ' 179' ' ' TYR . 32.0 Cg_exo -58.58 -45.0 32.52 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.918 1.745 . . . . 0.6 111.527 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -61.72 -29.52 70.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.016 -0.538 . . . . 99.99 110.234 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -76.83 -26.71 54.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 99.99 110.222 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.505 ' HB2' HD12 ' B' ' 175' ' ' LEU . 45.7 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.817 -0.629 . . . . 99.99 110.373 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.777 0.322 . . . . 99.99 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.18 -35.94 86.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.846 -0.693 . . . . 99.99 112.785 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.86 -29.17 64.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.301 . . . . 99.99 110.983 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.86 -60.77 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.918 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.98 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -38.45 89.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.963 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.58 -30.77 69.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 99.99 110.831 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.92 -58.69 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.018 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -66.35 -20.49 66.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 99.99 111.036 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.15 -57.65 18.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.8 -0.714 . . . . 99.99 112.962 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . 0.435 HD22 ' HE ' ' B' ' 30' ' ' ARG . 23.3 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.581 0.229 . . . . 99.99 111.27 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.602 0.239 . . . . 99.99 111.432 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . 0.466 ' H ' HD22 ' C' ' 7' ' ' LEU . 3.1 mm? -69.37 -42.1 75.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 99.99 110.684 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 42.4 m80 -72.22 -27.47 62.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 99.99 110.806 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -70.4 -43.87 69.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.521 . . . . 99.99 110.928 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.74 -21.47 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.661 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -64.41 -53.31 50.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 99.99 110.704 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.26 -34.12 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.216 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.66 96.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 99.99 111.224 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . 0.467 ' O ' HG13 ' C' ' 17' ' ' ILE . . . -69.68 -23.91 76.52 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 99.99 112.589 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.7 mmt -74.77 -36.86 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.56 0.219 . . . . 99.99 111.477 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 71.7 p -64.35 -52.27 59.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 99.99 110.828 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . 0.467 HG13 ' O ' ' C' ' 14' ' ' GLY . 2.8 pp -63.3 -22.55 31.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.873 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.98 -55.64 27.03 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.783 -0.723 . . . . 99.99 112.372 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -34.72 72.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.74 0.305 . . . . 99.99 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 26.6 tp -62.43 -35.14 78.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.771 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -57.16 -28.96 63.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 99.99 110.817 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -74.17 -37.5 63.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.01 -0.541 . . . . 99.99 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -56.3 -32.64 64.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.689 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -81.07 -32.27 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 99.99 111.313 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -86.42 -1.26 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.532 -0.303 . . . . 99.99 111.531 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 92.8 p -62.84 -20.12 64.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.487 -0.324 . . . . 99.99 111.15 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -48.71 -33.22 9.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.329 0.585 . . . . 99.99 109.687 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.2 p-10 -174.99 131.77 0.45 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.08 -0.964 . . . . 99.99 109.884 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 9.6 Cg_endo . . . . . 0 N--CA 1.455 -0.757 0 C-N-CA 123.012 2.475 . . . . 2.05 112.373 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' C' ' 35' ' ' TYR . 31.8 Cg_exo . . . . . 0 N--CA 1.464 -0.206 0 CA-C-O 121.164 0.402 . . . . 1.93 112.45 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -41.27 -16.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.99 -1.005 . . . . 99.99 113.661 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' C' ' 33' ' ' PRO . 3.2 m-30 -39.75 -62.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.924 0.392 . . . . 99.99 111.539 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.08 -40.67 77.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.449 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -72.02 -18.57 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.715 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.37 -45.69 68.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.915 0.388 . . . . 99.99 110.146 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.625 HG13 HD12 ' C' ' 82' ' ' LEU . 58.2 t -75.19 -33.25 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 99.99 110.788 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.38 -15.08 61.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 99.99 111.511 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 51.9 ttp -89.57 -37.84 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.45 -0.341 . . . . 99.99 111.623 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -72.61 -37.99 67.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 99.99 112.064 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.506 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -53.71 -52.5 66.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 112.215 0.45 . . . . 99.99 112.215 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 40.7 Cg_endo -67.55 -42.19 7.47 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.213 1.942 . . . . 0.41 113.1 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mm -55.88 -62.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.6 0.238 . . . . 99.99 111.518 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -57.32 -58.19 9.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.396 -0.365 . . . . 99.99 111.29 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 56.7 m -53.26 -26.76 19.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 99.99 111.493 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.81 -61.46 6.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.688 -0.768 . . . . 99.99 112.47 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.91 -25.29 63.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.683 0.278 . . . . 99.99 111.298 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -59.26 4.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.944 0.402 . . . . 99.99 111.027 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.497 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 25.7 m-85 -62.52 -41.54 98.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 99.99 111.092 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 55.0 ttp -47.93 -39.09 18.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.087 0.47 . . . . 99.99 110.104 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.66 88.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.618 -0.719 . . . . 99.99 110.763 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.1 mtt -52.45 -30.98 32.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 99.99 110.138 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.29 -38.43 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.874 -0.603 . . . . 99.99 110.238 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mt -77.53 0.34 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.755 -0.657 . . . . 99.99 110.657 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 68.33 42.28 1.69 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.795 -0.638 . . . . 99.99 111.155 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.421 ' HB3' ' HE1' ' A' ' 131' ' ' TRP . 27.6 mm-40 -118.25 173.51 6.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.087 -0.506 . . . . 99.99 110.819 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.46 16.76 67.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 99.99 112.371 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.567 ' HG2' ' HA ' ' C' ' 69' ' ' HIS . 36.6 mtmm -136.41 150.9 48.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 99.99 110.783 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.29 143.44 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.082 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.26 89.63 6.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.989 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.48 139.68 51.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.038 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.75 15.33 4.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.453 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.13 66.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.795 -0.717 . . . . 99.99 112.691 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -105.44 150.69 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 99.99 111.174 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 11.4 pt -97.12 125.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.545 . . . . 99.99 111.074 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.69 123.87 48.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.882 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.567 ' HA ' ' HG2' ' C' ' 60' ' ' LYS . 31.9 m-70 -81.07 76.44 8.02 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.35 0.595 . . . . 99.99 111.052 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -57.41 -36.44 71.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.376 -0.829 . . . . 99.99 111.544 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.37 -26.3 55.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.214 0.449 . . . . 99.99 112.214 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.9 tpp180 -64.19 -51.56 63.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.531 0.567 . . . . 99.99 112.531 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' C' ' 77' ' ' MET . 24.2 p90 -86.44 -26.45 24.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.515 0.561 . . . . 99.99 112.515 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . 0.414 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.0 tp -56.86 -41.58 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.375 -0.53 . . . . 99.99 110.272 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.52 -16.7 62.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.266 -0.642 . . . . 99.99 109.266 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -88.54 2.77 52.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.315 -0.857 . . . . 99.99 111.439 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 39.3 mtp -105.09 -20.51 13.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.245 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.469 ' O ' HD23 ' C' ' 82' ' ' LEU . 14.5 m -113.77 -39.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.3 0.482 . . . . 99.99 112.3 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.506 HG23 HG23 ' C' ' 43' ' ' ILE . 57.0 m -70.34 -49.17 52.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.046 0.387 . . . . 99.99 112.046 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.524 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 21.5 m -56.52 -52.08 76.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 99.99 112.614 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' C' ' 80' ' ' THR . 11.7 Cg_endo -55.78 -37.53 95.53 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.53 1.487 . . . . 0.67 111.736 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.625 HD12 HG13 ' C' ' 39' ' ' VAL . 3.9 mm? -70.33 -32.21 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 99.99 109.746 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -23.28 63.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.488 0.661 . . . . 99.99 109.23 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 tp -84.46 -36.51 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.984 -1.007 . . . . 99.99 110.414 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.83 -34.37 73.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 99.99 110.94 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -62.41 -18.52 61.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 99.99 111.081 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 24.0 mt -78.93 -31.88 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.027 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -73.63 -32.23 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 99.99 111.076 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -75.1 -42.04 57.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.438 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -69.17 -22.44 63.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 99.99 111.001 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.05 -13.87 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.213 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.3 ttm -128.71 100.94 5.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 99.99 110.742 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -68.4 -54.47 16.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 99.99 111.053 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -112.52 149.85 32.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 99.99 111.179 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.86 145.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.723 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.8 -71.46 0.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.432 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -140.47 29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.501 -0.318 . . . . 99.99 111.591 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -86.92 138.94 31.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.431 -0.35 . . . . 99.99 110.876 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -165.84 -22.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.686 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -70.46 -35.09 73.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 99.99 111.591 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.59 -42.46 42.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 99.99 110.949 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.91 -31.21 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 99.99 110.711 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.62 -29.04 45.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.84 -0.695 . . . . 99.99 112.346 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -65.76 -35.36 80.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 99.99 110.83 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 75.1 mt -79.53 -44.98 20.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.994 -0.548 . . . . 99.99 111.107 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' MET . . . . . 0.421 ' O ' HG13 ' C' ' 110' ' ' ILE . 10.7 tpt -59.62 -35.91 75.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 99.99 111.328 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.7 m -71.81 -58.3 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.283 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 57.6 p -52.41 -31.02 32.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.163 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 6.5 tp-100 -62.48 -54.13 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.556 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.421 HG13 ' O ' ' C' ' 106' ' ' MET . 65.3 mt -46.78 -39.94 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 115.93 -0.577 . . . . 99.99 111.316 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.78 -46.92 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.855 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.59 -32.33 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 99.99 111.156 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 44.8 mm -59.23 -41.3 83.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 99.99 110.671 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 93.9 m -62.26 -54.63 38.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.833 -0.621 . . . . 99.99 111.296 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -54.82 -24.26 22.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.385 -0.37 . . . . 99.99 110.899 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.87 -46.9 12.64 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.811 -0.709 . . . . 99.99 112.673 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' C' ' 114' ' ' THR . 4.3 pp -76.79 -21.24 55.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.716 0.293 . . . . 99.99 111.011 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' C' ' 117' ' ' LEU . 38.2 mm -83.37 -36.92 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 99.99 111.205 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.95 -32.55 61.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.327 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.39 -23.66 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 99.99 110.977 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.14 34.14 0.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 99.99 111.254 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 71.2 m -91.86 119.05 31.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 99.99 110.776 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.22 -58.29 2.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.137 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' ARG . . . . . 0.472 ' HB2' HG12 ' C' ' 127' ' ' VAL . 45.4 mtm180 -89.48 157.61 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.965 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -84.54 -15.88 44.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.885 -0.598 . . . . 99.99 110.88 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 37.6 t-105 -78.74 -38.75 38.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 99.99 110.66 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' C' ' 124' ' ' ARG . 7.4 p -80.83 -28.78 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 99.99 111.241 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -56.13 -34.61 66.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.281 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -73.68 -25.61 60.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 99.99 111.019 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.22 -46.1 24.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.968 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -64.65 -37.4 87.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 99.99 111.178 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -55.4 -46.67 76.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.906 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.3 -35.08 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.865 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.53 -31.27 72.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 99.99 110.842 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -54.02 13.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.736 -0.745 . . . . 99.99 112.635 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.45 -37.96 76.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 99.99 111.257 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -52.79 -52.44 56.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.626 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.9 -30.81 71.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.891 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . 0.649 ' HA ' HG12 ' C' ' 142' ' ' ILE . 88.9 t80 -69.58 -24.53 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 99.99 110.932 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.76 -52.91 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 99.99 111.491 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 24.6 pt -60.31 -43.99 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.528 -0.305 . . . . 99.99 111.763 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.649 HG12 ' HA ' ' C' ' 139' ' ' PHE . 43.4 pt -67.4 -29.84 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 99.99 110.957 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.12 -38.31 85.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.018 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . 0.541 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 91.8 m95 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 99.99 110.835 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . 1.326 ' HA2' ' ND2' ' C' ' 148' ' ' ASN . . . -61.07 -44.52 98.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.899 -0.667 . . . . 99.99 112.532 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.22 -24.08 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 99.99 110.758 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -88.8 4.74 46.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 99.99 111.134 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . 1.326 ' ND2' ' HA2' ' C' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.48 . . . . 99.99 112.116 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.7 tp . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.937 0.399 . . . . 99.99 110.704 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -81.38 -25.63 36.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 99.99 111.045 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.01 -55.24 31.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.162 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -72.07 -32.75 67.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.339 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.25 -50.79 72.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.276 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.06 -29.93 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 99.99 111.264 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -53.29 -58.74 6.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 99.99 111.315 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -63.29 -36.15 82.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 99.99 110.701 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.6 -22.59 66.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 99.99 110.761 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 25.9 m -73.48 -59.0 2.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.358 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.6 p -52.39 -30.82 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.394 -0.366 . . . . 99.99 111.642 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.404 HD13 ' OG ' ' C' ' 209' ' ' SER . 94.7 mt -72.38 -57.78 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 99.99 111.071 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -19.79 65.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.04 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.492 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 32.6 mm -87.66 -25.4 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.114 0.483 . . . . 99.99 110.36 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.54 95.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 99.99 112.505 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.692 ' HH ' ' HG3' ' C' ' 206' ' ' PRO . 0.3 OUTLIER -55.7 -55.72 37.63 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.592 0.196 . . . . 99.99 111.356 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.492 ' HD2' ' C ' ' C' ' 177' ' ' ILE . 67.2 Cg_exo -50.38 -41.06 52.74 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.074 1.849 . . . . 0.63 112.163 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.452 HG13 ' O ' ' C' ' 177' ' ' ILE . 82.1 mt -49.69 -61.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.493 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.448 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.2 m -63.92 -28.15 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.446 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -65.36 -27.83 68.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 99.99 111.053 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 89.2 mt -55.15 -32.93 28.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.209 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.3 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 99.99 111.132 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.843 0.354 . . . . 99.99 111.302 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 12.4 tt -57.89 -42.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.743 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.4 -53.75 54.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.702 0.287 . . . . 99.99 111.401 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 59.4 p -58.81 -21.55 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.613 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -73.35 -39.29 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 99.99 111.489 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.89 -51.56 46.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.695 0.283 . . . . 99.99 111.414 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -67.59 -8.15 32.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.531 -0.304 . . . . 99.99 111.313 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 10.9 t -95.86 -41.98 8.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.151 0.5 . . . . 99.99 110.666 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.7 tp -74.19 -31.99 62.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 99.99 111.904 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.673 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 54.9 tp -61.0 -54.22 56.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.891 -0.324 . . . . 99.99 111.624 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.692 ' HG3' ' HH ' ' C' ' 179' ' ' TYR . 33.7 Cg_exo -59.45 -39.64 74.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.795 1.663 . . . . 0.63 111.189 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.68 -28.72 70.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 99.99 110.464 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -84.45 -19.49 33.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.949 -0.568 . . . . 99.99 110.82 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 209' ' ' SER . . . . . 0.404 ' OG ' HD13 ' C' ' 175' ' ' LEU . 40.6 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.995 -0.548 . . . . 99.99 110.898 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.981 0.419 . . . . 99.99 110.891 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.12 -29.52 72.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.998 -0.62 . . . . 99.99 112.535 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -72.6 -36.87 68.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 99.99 110.817 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.0 t -59.16 -54.66 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.89 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.14 -20.42 65.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.314 -0.403 . . . . 99.99 110.856 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -72.08 -47.1 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 99.99 110.695 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.21 -21.01 64.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.573 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 64.2 tp -74.14 -54.31 8.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.887 -0.597 . . . . 99.99 111.266 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -79.41 -20.29 47.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.234 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.88 12.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.737 -0.744 . . . . 99.99 112.585 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . 0.422 HD22 ' N ' ' C' ' 221' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 99.99 110.435 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.756 0.312 . . . . 99.99 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.93 -35.21 22.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.712 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.14 100.51 5.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.851 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -123.29 145.94 48.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 99.99 110.905 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 t -130.8 159.47 37.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.914 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -137.62 2.12 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 99.99 111.012 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.3 mm? -76.47 -51.91 10.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 99.99 110.602 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -70.95 -24.34 62.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 99.99 110.478 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.433 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.0 t-105 -64.9 -53.07 52.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 99.99 110.685 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.1 mt -66.33 -22.55 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 99.99 110.267 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -55.32 36.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 99.99 110.756 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 52' ' ' MET . 10.0 p -66.87 -30.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.274 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.43 80.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 99.99 111.229 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.503 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -72.4 -24.4 76.36 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.853 -0.689 . . . . 99.99 112.626 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.48 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -74.53 -41.75 60.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 99.99 111.497 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -61.83 -48.19 81.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 99.99 111.187 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 14' ' ' GLY . 2.7 pp -67.03 -22.59 29.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.964 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.49 -58.62 12.36 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.872 -0.68 . . . . 99.99 112.492 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.21 73.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.072 0.463 . . . . 99.99 110.931 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.4 tp -64.48 -33.93 77.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.956 -0.566 . . . . 99.99 110.62 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.61 -28.08 66.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.948 -0.569 . . . . 99.99 110.42 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -78.2 -29.31 48.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 99.99 110.671 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -63.84 -36.06 82.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.524 . . . . 99.99 110.818 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -84.68 -42.31 15.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.906 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.8 tp -73.22 -3.4 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.89 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 p -64.38 -24.77 67.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.528 -0.306 . . . . 99.99 111.334 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -51.09 -31.95 20.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.128 0.489 . . . . 99.99 109.784 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p30 -167.88 132.45 1.5 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.454 -0.793 . . . . 99.99 110.147 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 28.3 Cg_endo -94.78 173.71 1.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.05 2.5 . . . . 1.91 112.277 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.11 56.4 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.082 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.75 -45.87 3.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 99.99 112.747 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.3 127.07 80.09 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 120.539 0.209 . . . . 99.99 110.942 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 31.7 Cg_exo -57.74 165.18 6.67 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.412 2.075 . . . . 1.79 112.374 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.426 HE22 ' HB2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -61.59 -18.21 58.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.747 -0.66 . . . . 99.99 112.579 -178.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 4.8 p90 -47.97 -42.23 27.15 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.688 0.28 . . . . 99.99 111.652 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -68.04 -46.56 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.356 . . . . 99.99 110.886 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.12 -23.03 66.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.833 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.99 -61.23 2.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.659 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 43' ' ' ILE . 93.6 t -62.67 -33.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.224 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.31 -4.78 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 99.99 111.105 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.535 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 28.4 ttt -89.38 -39.94 13.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.055 0.455 . . . . 99.99 111.018 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -73.09 -39.33 65.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 99.99 111.883 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.64 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 91.4 mt -50.69 -51.59 64.32 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.241 0.46 . . . . 99.99 112.241 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 16.6 Cg_exo -68.65 -41.45 6.04 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.494 2.129 . . . . 0.53 113.275 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mm -55.06 -63.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.207 0.447 . . . . 99.99 112.207 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.53 -58.39 7.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 99.99 111.484 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.408 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 90.4 p -52.28 -35.97 51.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.244 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.74 16.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.885 -0.674 . . . . 99.99 112.661 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.56 -35.48 68.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 99.99 110.893 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.8 79.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.397 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -66.01 -59.68 3.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.447 -0.342 . . . . 99.99 111.564 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.63 ' HB3' HG11 ' A' ' 12' ' ' VAL . 24.0 ptm -49.01 -31.08 6.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.01 0.433 . . . . 99.99 110.6 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.84 91.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 99.99 110.831 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.9 mtt -56.36 -31.39 63.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.073 -0.512 . . . . 99.99 110.505 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.86 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 99.99 110.526 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.419 HG13 ' CB ' ' A' ' 58' ' ' GLN . 41.4 pt -78.5 3.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 99.99 110.963 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.48 30.14 19.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 99.99 111.46 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.606 HE21 ' H ' ' B' ' 123' ' ' GLU . 6.4 tp-100 -92.23 142.27 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 99.99 110.767 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.34 17.22 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 99.99 112.346 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -127.23 139.67 52.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 99.99 110.819 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.85 141.0 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.727 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.87 95.1 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 99.99 111.25 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.1 115.81 27.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 99.99 110.79 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 30.52 19.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.121 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.33 -2.01 83.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.847 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -105.82 128.95 54.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 99.99 110.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.38 127.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 99.99 111.007 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 139.89 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.069 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 56.5 m-70 -81.29 64.94 6.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.213 0.53 . . . . 99.99 110.758 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.89 -50.84 67.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.753 . . . . 99.99 111.443 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -25.31 67.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.844 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 34.8 mmt180 -67.52 -52.48 38.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.713 0.635 . . . . 99.99 112.713 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.497 ' O ' ' HG3' ' A' ' 77' ' ' MET . 6.3 p90 -75.93 -36.17 59.48 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.27 0.47 . . . . 99.99 112.27 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.0 tt -52.93 -46.54 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.775 -0.37 . . . . 99.99 110.902 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.6 t70 -67.45 -22.03 65.52 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.606 -0.516 . . . . 99.99 109.606 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -87.87 5.55 39.84 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.527 -0.76 . . . . 99.99 111.522 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 34.4 mtp -104.55 -19.15 14.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 99.99 110.516 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 1.4 p -114.64 -43.8 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 99.99 111.972 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.575 HG23 HG23 ' A' ' 43' ' ' ILE . 66.8 m -66.31 -56.09 12.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.409 . . . . 99.99 111.961 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.481 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 67.9 m -50.77 -53.93 41.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.569 0.581 . . . . 99.99 112.569 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 80' ' ' THR . 13.2 Cg_endo -56.28 -38.84 94.39 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.633 1.555 . . . . 0.74 111.195 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.406 HD13 HD12 ' A' ' 85' ' ' LEU . 2.2 mm? -67.42 -30.48 70.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.942 -0.572 . . . . 99.99 109.761 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.79 -21.79 61.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.275 -0.639 . . . . 99.99 109.275 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.433 HD22 HE22 ' A' ' 109' ' ' GLN . 20.0 tp -84.58 -31.38 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.034 -0.985 . . . . 99.99 110.292 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.406 HD12 HD13 ' A' ' 82' ' ' LEU . 87.6 mt -73.52 -32.97 64.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.757 -0.656 . . . . 99.99 111.032 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.406 ' HB3' HG11 ' A' ' 39' ' ' VAL . 88.1 p -58.17 -29.02 65.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.758 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.987 -0.551 . . . . 99.99 110.718 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -60.91 -41.86 96.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.951 -0.568 . . . . 99.99 110.955 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.84 -29.75 63.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 99.99 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.5 m -59.7 -43.39 94.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.351 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.92 -36.82 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.435 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 82.0 mtp -88.48 98.87 11.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.396 . . . . 99.99 111.124 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -82.62 -5.05 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.585 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -163.79 157.29 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.843 -0.617 . . . . 99.99 110.705 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tp -128.99 142.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.98 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.53 -30.74 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.941 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.48 138.33 39.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.151 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.6 115.81 4.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.869 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.95 149.45 21.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.1 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.2 p -94.82 -20.94 19.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 99.99 110.985 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.0 tp -54.56 -40.73 69.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 99.99 111.155 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.85 -38.19 78.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.052 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.63 -28.05 73.23 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 99.99 112.127 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -72.13 -37.07 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.921 0.391 . . . . 99.99 110.951 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.16 -36.63 61.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 99.99 111.496 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 81.0 mtp -68.31 -47.61 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.449 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.576 ' HG ' ' H ' ' A' ' 108' ' ' THR . 72.8 p -60.89 -53.64 54.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 99.99 111.45 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.576 ' H ' ' HG ' ' A' ' 107' ' ' SER . 15.3 t -56.66 -31.88 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.498 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.433 HE22 HD22 ' A' ' 84' ' ' LEU . 6.5 tp-100 -66.64 -40.18 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 99.99 110.992 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HA ' HG12 ' A' ' 113' ' ' ILE . 77.2 mt -60.16 -35.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 99.99 111.096 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -67.93 -36.96 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.359 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.78 -51.1 48.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 99.99 111.484 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 110' ' ' ILE . 41.3 pt -59.96 -24.04 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 99.99 110.822 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.518 ' HG1' ' HZ3' ' C' ' 46' ' ' TRP . 17.6 m -67.44 -43.16 81.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.465 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -68.15 -21.03 64.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.872 -0.604 . . . . 99.99 110.461 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.68 -34.03 26.07 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.043 -0.599 . . . . 99.99 113.313 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 118' ' ' ILE . 4.1 pp -79.1 -26.89 42.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 99.99 111.288 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 tp -83.93 -29.51 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.711 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.08 75.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.423 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.65 -19.3 52.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 99.99 111.066 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -90.5 28.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.42 . . . . 99.99 111.25 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -61.66 126.28 26.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 99.99 110.907 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.62 -29.7 23.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.305 -0.407 . . . . 99.99 111.075 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.408 ' H ' ' CG2' ' A' ' 127' ' ' VAL . 79.0 mtm180 -137.29 167.1 22.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.716 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.94 -13.98 59.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.793 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -90.43 -42.18 11.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.835 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.408 ' CG2' ' H ' ' A' ' 124' ' ' ARG . 18.7 m -65.34 -31.01 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.261 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -65.35 -23.68 67.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.97 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.419 ' O ' HG13 ' A' ' 133' ' ' ILE . 70.0 t80 -78.59 -25.65 45.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.009 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.46 -52.66 7.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.323 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.425 ' HZ2' ' HB2' ' C' ' 53' ' ' ALA . 9.4 m95 -60.18 -33.49 72.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.708 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.506 ' HE2' ' HB3' ' A' ' 183' ' ' TRP . 71.8 t80 -59.13 -48.51 81.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 99.99 110.926 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 129' ' ' TYR . 51.1 mt -63.6 -32.46 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 99.99 111.199 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.75 -34.64 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.364 . . . . 99.99 111.043 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.79 -52.16 44.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.749 . . . . 99.99 112.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -64.87 -42.24 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.597 0.237 . . . . 99.99 111.381 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.467 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.9 t -55.41 -40.57 71.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 99.99 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.457 ' O ' HG13 ' A' ' 142' ' ' ILE . . . -61.66 -41.86 98.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.012 -0.54 . . . . 99.99 110.731 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -63.51 -28.32 69.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 99.99 111.134 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 137' ' ' CYS . 93.9 mt -63.21 -60.79 2.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 99.99 111.221 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.6 -31.83 44.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.34 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.496 HG12 ' HG1' ' A' ' 108' ' ' THR . 79.4 mt -75.06 -29.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 99.99 111.16 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.9 tp -71.68 -44.08 64.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.811 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.538 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 16.5 t90 -67.38 -27.84 67.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 99.99 110.997 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 1.23 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -83.56 -43.16 7.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.795 -0.717 . . . . 99.99 112.627 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 tt -67.61 -16.54 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.063 0.458 . . . . 99.99 110.67 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -91.8 3.62 54.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.591 . . . . 99.99 110.646 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 1.23 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 -82.94 -46.96 0.85 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.84 -0.618 . . . . 99.99 111.844 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 74.9 Cg_exo -41.51 -30.67 0.96 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.531 2.154 . . . . 2.6 112.644 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 150' ' ' LEU . 3.6 mm? -85.91 51.1 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.405 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -53.74 142.77 22.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.848 -0.615 . . . . 99.99 111.287 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.38 -19.76 57.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 99.99 110.97 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -84.74 -29.35 25.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.835 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.0 m -76.63 -7.58 55.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 99.99 111.011 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -61.83 -19.83 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.789 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 81.8 p -79.54 -23.85 42.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 99.99 111.07 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -64.79 -62.18 1.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.867 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.5 t -153.46 113.36 3.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.853 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.7 m -78.01 -23.54 48.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.045 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -64.42 -57.91 7.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 99.99 110.936 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.74 -25.56 67.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 99.99 111.067 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.7 -39.16 70.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 99.99 111.319 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -67.51 -40.93 85.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.993 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt -60.72 -48.62 80.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.95 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.41 -24.86 63.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.872 -0.604 . . . . 99.99 111.397 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.43 -24.64 53.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 99.99 111.215 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -84.37 -39.03 19.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 99.99 111.576 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 169' ' ' VAL . 2.9 pp -77.42 -26.43 51.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.512 -0.313 . . . . 99.99 111.841 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.5 ' N ' HD12 ' A' ' 168' ' ' LEU . 13.4 p -74.9 -26.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 99.99 110.936 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.6 m -65.43 -58.61 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.387 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.16 -31.39 72.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.725 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -59.71 -48.86 79.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 99.99 111.06 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 177' ' ' ILE . 41.3 p -62.05 -37.87 86.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 99.99 111.588 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.81 -38.4 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.756 0.313 . . . . 99.99 111.503 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.533 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.0 mt -74.57 -55.1 6.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 99.99 111.395 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.48 -31.35 55.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 99.99 111.634 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.542 ' O ' HG13 ' A' ' 181' ' ' ILE . 17.6 tt -87.66 -22.41 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 99.99 110.69 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.65 -51.29 59.78 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.94 -0.573 . . . . 99.99 113.391 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 84.6 m-85 -58.17 -54.86 51.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.802 0.301 . . . . 99.99 111.737 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 76.6 Cg_exo -48.72 -30.33 16.55 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.112 1.875 . . . . 0.55 112.934 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 177' ' ' ILE . 94.3 mt -70.04 -57.46 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 99.99 111.788 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.5 m -59.14 -25.72 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.187 -0.461 . . . . 99.99 111.703 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.506 ' HB3' ' HE2' ' A' ' 132' ' ' TYR . 24.4 m95 -65.09 -25.95 68.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.505 -0.316 . . . . 99.99 111.091 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -53.03 -26.13 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 99.99 110.946 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.7 pt -128.88 162.71 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.892 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.34 -167.89 29.22 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.426 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.56 156.81 49.39 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.53 2.154 . . . . 3.1 112.108 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.7 t 54.89 22.36 4.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.786 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -168.49 47.72 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.812 -0.708 . . . . 99.99 112.482 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 78.7 t80 58.25 93.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 99.99 111.006 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 155.37 104.56 0.23 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.842 -0.694 . . . . 99.99 112.412 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -94.33 86.24 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 99.99 110.93 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 pt -131.87 176.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.005 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.407 ' OD1' HG22 ' A' ' 197' ' ' ILE . 14.1 p30 -58.19 148.39 27.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 99.99 110.839 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -86.8 2.11 50.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 99.99 110.947 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.9 m -72.96 -52.77 13.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.005 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.407 HG22 ' OD1' ' A' ' 194' ' ' ASN . 10.2 tp -69.12 -30.0 44.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.926 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.4 -56.73 12.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.572 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 75.6 p -62.67 -18.83 63.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.891 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -83.48 -30.66 27.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.911 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.9 tp -80.84 -45.55 16.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.314 -0.403 . . . . 99.99 111.272 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -74.55 -0.7 18.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.15 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 37.8 t -96.35 -47.47 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.433 0.635 . . . . 99.99 110.31 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.16 -28.57 64.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.225 -0.898 . . . . 99.99 112.138 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.73 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 37.5 tp -67.2 -55.35 15.92 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.748 -0.381 . . . . 99.99 111.408 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.73 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.9 Cg_exo -54.86 -37.73 92.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.622 1.548 . . . . 0.64 111.207 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.47 ' O ' HG22 ' A' ' 211' ' ' VAL . 74.4 t80 -63.98 -45.76 87.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.04 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -63.55 -17.79 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 99.99 110.554 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.533 ' OG ' HD13 ' A' ' 175' ' ' LEU . 16.1 t -96.28 -33.27 12.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 99.99 111.045 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.49 H191 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 207' ' ' PHE . 18.3 m -63.69 -33.44 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.494 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.41 80.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.757 -0.735 . . . . 99.99 112.685 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -75.58 -33.18 60.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 99.99 111.223 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.3 m -60.99 -60.69 3.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.429 -0.351 . . . . 99.99 110.996 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.04 -26.9 67.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 99.99 110.951 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.94 -55.45 33.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.374 -0.375 . . . . 99.99 111.392 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.19 -34.31 71.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 99.99 111.285 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.32 -52.23 62.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.264 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -83.6 -20.72 33.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.123 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.17 -59.15 10.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.887 -0.673 . . . . 99.99 112.885 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 52.6 tp -76.07 -58.44 3.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.596 0.236 . . . . 99.99 111.049 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 52.9 75.17 0.25 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.962 0.41 . . . . 99.99 110.526 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.581 HD21 ' HB3' ' A' ' 225' ' ' ASN . 53.1 t30 -128.6 149.56 50.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 99.99 110.925 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 224' ' ' LEU . 7.0 mp -112.6 -1.08 14.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.922 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.581 ' HB3' HD21 ' A' ' 223' ' ' ASN . 29.5 t30 -87.19 115.94 24.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 99.99 110.94 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -102.9 154.62 19.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.725 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 48.7 m -149.14 107.49 3.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 99.99 111.112 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -74.33 170.91 14.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.992 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 99.99 110.914 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.675 0.274 . . . . 99.99 111.0 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -109.02 6.92 25.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.889 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.14 42.07 0.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.029 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -79.39 151.81 30.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 99.99 111.027 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -139.77 153.8 47.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.923 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.91 -1.12 5.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.226 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.81 -53.61 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.782 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.624 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 77.3 m-70 -65.63 -24.26 67.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.782 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -67.18 -50.29 61.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.836 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.7 -20.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 99.99 110.331 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -61.82 -56.01 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.908 -0.587 . . . . 99.99 110.594 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -66.26 -28.45 43.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.075 -0.511 . . . . 99.99 111.26 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.08 98.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.254 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.519 ' O ' HG13 ' B' ' 17' ' ' ILE . . . -76.06 -29.27 59.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.762 -0.732 . . . . 99.99 112.59 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.48 -39.63 62.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 99.99 111.229 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.41 ' HG1' ' H ' ' B' ' 17' ' ' ILE . 32.0 p -62.1 -51.12 69.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.468 -0.333 . . . . 99.99 110.833 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.519 HG13 ' O ' ' B' ' 14' ' ' GLY . 2.7 pp -64.05 -23.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.943 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.87 -56.16 24.22 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.873 -0.679 . . . . 99.99 112.667 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.87 81.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 99.99 110.932 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.04 -32.31 73.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.829 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.58 -28.21 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.46 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -81.57 -30.17 33.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.689 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.408 ' O ' ' OG ' ' B' ' 26' ' ' SER . 61.2 t-105 -60.91 -37.23 81.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.839 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.7 p -83.87 -40.54 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.892 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.74 -3.87 40.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 99.99 110.61 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 58.5 p -61.0 -23.31 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.384 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -49.8 -31.42 11.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.255 0.55 . . . . 99.99 109.841 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -173.33 132.29 0.6 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.256 -0.884 . . . . 99.99 109.992 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -94.52 174.23 1.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.691 2.261 . . . . 1.82 112.311 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.48 54.58 2.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 99.99 111.255 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.62 -35.58 2.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.872 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -79.09 130.27 70.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.603 0.239 . . . . 99.99 111.199 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.18 166.5 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.896 2.397 . . . . 2.67 113.021 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -70.55 -18.32 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.466 -0.788 . . . . 99.99 112.96 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -62.24 -24.47 67.27 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.373 -0.531 . . . . 99.99 111.367 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.9 -55.95 8.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.339 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -67.31 -21.57 65.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.739 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 64.0 tp -59.49 -63.52 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.717 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.14 -35.57 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.378 . . . . 99.99 110.63 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.8 -5.48 41.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 99.99 111.091 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.423 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 53.5 ttp -88.94 -40.92 12.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.422 . . . . 99.99 110.711 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -69.95 -32.76 71.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.651 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 79' ' ' THR . 87.2 mt -55.58 -54.2 53.97 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.234 0.457 . . . . 99.99 112.234 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.8 Cg_endo -70.14 -31.46 18.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.182 1.921 . . . . 0.49 113.342 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.32 -62.37 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.615 0.245 . . . . 99.99 111.599 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.81 -58.28 9.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 99.99 111.164 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -54.71 -31.26 57.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.025 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.8 -60.51 8.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 99.99 112.881 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 42.5 mt -60.14 -28.59 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 99.99 111.252 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -49.69 65.7 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.452 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 20.4 m-85 -63.61 -46.29 86.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.156 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' MET . . . . . 0.511 ' HB2' HG11 ' B' ' 12' ' ' VAL . 59.7 ttp -48.04 -38.69 17.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.157 0.503 . . . . 99.99 110.374 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.445 ' HB2' ' HZ2' ' C' ' 131' ' ' TRP . . . -64.21 -41.93 96.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 99.99 110.92 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 51.2 mtt -52.89 -30.96 37.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.88 -0.6 . . . . 99.99 110.553 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.624 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -70.04 -47.4 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 99.99 110.602 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mt -76.8 -1.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.797 -0.638 . . . . 99.99 111.004 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.97 52.14 2.14 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.919 -0.582 . . . . 99.99 111.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -115.69 169.32 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.965 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.64 9.99 79.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.814 -0.708 . . . . 99.99 112.493 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -117.77 141.8 48.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 99.99 110.93 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.62 138.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 99.99 111.044 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.32 94.61 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.115 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.54 115.84 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.048 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.59 31.45 20.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 99.99 111.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.19 84.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.522 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -115.03 124.48 51.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 99.99 110.845 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.74 136.28 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.65 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.47 140.58 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.96 0.41 . . . . 99.99 111.109 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.468 ' H ' ' HD2' ' B' ' 120' ' ' ASP . 50.9 m-70 -84.16 55.89 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.649 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -58.52 -58.11 10.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.603 -0.726 . . . . 99.99 111.679 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.55 -22.31 66.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.974 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.443 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 14.0 tpp180 -63.52 -51.48 65.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.023 0.379 . . . . 99.99 112.023 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 12.9 p90 -77.4 -29.07 52.94 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.87 -0.332 . . . . 99.99 111.279 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 mm -51.36 -53.21 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.806 0.336 . . . . 99.99 110.682 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.49 -21.49 66.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.082 -0.508 . . . . 99.99 109.982 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -86.98 -0.14 56.11 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.958 -0.565 . . . . 99.99 111.371 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 55.3 ttm -103.63 -18.64 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.512 . . . . 99.99 110.989 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.407 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.2 m -114.09 -31.01 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.085 0.402 . . . . 99.99 112.085 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.574 HG23 HG23 ' B' ' 43' ' ' ILE . 48.0 m -80.82 -50.57 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.844 0.313 . . . . 99.99 111.844 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.541 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 28.8 m -53.95 -51.53 76.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.257 0.466 . . . . 99.99 112.257 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.3 Cg_endo -56.85 -33.18 94.14 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.733 1.622 . . . . 0.66 111.333 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.407 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.6 mm? -75.96 -29.96 58.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.963 -0.562 . . . . 99.99 110.132 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 15.5 tp -70.23 -21.48 63.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.315 0.579 . . . . 99.99 109.527 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' B' ' 105' ' ' LEU . 2.3 tp -84.86 -44.01 13.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.217 -0.901 . . . . 99.99 110.394 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.66 -35.49 72.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.43 -0.805 . . . . 99.99 111.074 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 97.9 p -57.49 -32.6 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 99.99 110.898 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.446 HD22 HD21 ' B' ' 168' ' ' LEU . 62.3 mt -64.37 -36.79 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 99.99 110.925 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -65.11 -34.95 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.986 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -73.74 -38.6 64.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.126 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 82.2 p -69.26 -23.32 63.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 99.99 111.384 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.57 -13.59 21.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 99.99 111.147 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 44.7 tpp -127.2 106.36 9.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 99.99 110.778 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -67.62 -59.46 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.954 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -128.37 137.67 52.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.914 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.27 142.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.171 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -129.77 -23.31 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.431 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -142.36 141.46 32.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.688 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.04 119.1 12.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.047 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -84.7 162.72 19.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.48 . . . . 99.99 111.002 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 78.9 p -108.61 -22.23 12.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.019 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.76 -29.14 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 99.99 110.698 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.7 pt -64.15 -28.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.864 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.45 -39.34 22.43 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.813 -0.708 . . . . 99.99 112.547 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -67.75 -22.87 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 99.99 110.705 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.63 ' HB3' HD21 ' B' ' 84' ' ' LEU . 77.2 mt -81.91 -46.22 14.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 53.5 ttp -67.09 -30.31 70.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.91 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 64.0 m -73.63 -52.89 11.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.435 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.577 ' HG1' HG12 ' B' ' 142' ' ' ILE . 15.1 t -56.8 -28.24 61.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.443 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.628 ' HG3' HD22 ' B' ' 84' ' ' LEU . 26.3 mm-40 -69.81 -44.11 70.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.753 0.311 . . . . 99.99 110.56 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 46.2 mm -54.64 -32.69 25.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.989 0.423 . . . . 99.99 110.459 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.03 -42.38 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.835 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.76 -46.66 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.266 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' B' ' 77' ' ' MET . 37.4 mm -60.91 -33.24 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.088 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.469 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 25.0 m -60.19 -45.43 93.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 99.99 111.044 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 76.5 p -68.63 -20.77 64.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.512 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.07 -35.94 26.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.0 -0.619 . . . . 99.99 113.264 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.534 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.6 pp -76.82 -29.37 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.74 0.305 . . . . 99.99 111.409 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.534 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.85 -27.13 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 99.99 111.565 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.88 -39.71 68.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.27 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.468 ' HD2' ' H ' ' B' ' 69' ' ' HIS . 8.5 t70 -82.41 -25.39 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.148 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -86.26 34.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 99.99 111.157 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 71.4 p -65.99 125.26 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 99.99 110.863 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.606 ' H ' HE21 ' A' ' 58' ' ' GLN . 23.3 mm-40 -89.02 -22.63 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.036 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' B' ' 127' ' ' VAL . 99.8 mtt180 -137.6 160.21 39.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 99.99 110.772 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.9 -15.65 60.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.121 -0.491 . . . . 99.99 110.652 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -92.7 -41.55 10.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 99.99 111.024 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' B' ' 124' ' ' ARG . 18.6 m -64.0 -24.63 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 99.99 111.112 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.92 -42.27 85.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.66 -30.85 71.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.975 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 59.7 tp -74.84 -53.63 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 99.99 111.285 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -61.15 -24.77 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.305 . . . . 99.99 111.362 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -67.52 -58.79 4.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.476 -0.329 . . . . 99.99 111.402 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.3 -22.55 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.472 -0.331 . . . . 99.99 111.317 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.36 -36.42 68.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.728 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.91 -51.28 47.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.09 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.09 -43.2 98.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 99.99 110.923 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.4 -40.49 74.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.167 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . 0.526 ' O ' HG13 ' B' ' 142' ' ' ILE . . . -62.49 -35.64 79.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 99.99 110.395 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -71.54 -24.02 61.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 99.99 110.669 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.84 -57.64 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.953 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 37.2 pt -59.2 -35.29 56.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.335 -0.393 . . . . 99.99 111.282 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.577 HG12 ' HG1' ' B' ' 108' ' ' THR . 65.4 mt -72.96 -26.49 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 99.99 110.688 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.68 -39.58 73.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 99.99 110.965 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -73.74 -30.73 62.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 99.99 111.084 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.38 -33.96 24.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.776 -0.726 . . . . 99.99 112.635 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 tt -73.91 -21.36 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 99.99 110.471 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -90.78 4.15 52.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 99.99 111.006 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.506 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 58.5 t-20 -83.22 -46.46 0.83 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 99.99 111.945 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 62.0 Cg_exo -36.91 -39.9 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.775 2.316 . . . . 2.65 113.112 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 46.1 tp -84.42 65.3 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.133 0.492 . . . . 99.99 110.264 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.12 139.2 57.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.938 -0.573 . . . . 99.99 110.914 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.16 -18.35 61.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 99.99 111.142 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -86.48 -22.94 26.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.047 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 73.4 p -89.1 3.44 51.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 99.99 111.117 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -69.7 -16.37 63.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 99.99 110.725 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 80.0 p -76.77 -8.27 56.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 99.99 110.94 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -78.74 -70.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.849 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p -148.18 117.33 6.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 99.99 111.035 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 39.9 t -77.24 -18.68 57.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.839 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.01 -49.94 22.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 99.99 111.049 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 66.5 tp -67.74 -28.14 67.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.838 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.17 -52.51 16.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.144 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -58.3 -22.54 53.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.588 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 33.6 tp -71.04 -47.12 60.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.76 -0.655 . . . . 99.99 110.813 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.421 ' O ' HG23 ' B' ' 169' ' ' VAL . 2.3 t80 -75.21 -23.04 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.909 -0.587 . . . . 99.99 111.314 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.26 -54.64 22.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.92 0.39 . . . . 99.99 110.894 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.99 -30.51 71.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 99.99 111.112 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . 0.446 HD21 HD22 ' B' ' 87' ' ' LEU . 54.4 tp -68.76 -54.91 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 99.99 111.313 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 165' ' ' TYR . 91.9 t -61.96 -29.86 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.536 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.8 m -53.48 -58.99 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 99.99 111.538 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.64 -29.02 65.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.347 -0.388 . . . . 99.99 110.665 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.44 -34.32 77.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 99.99 111.319 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.401 ' O ' HG22 ' B' ' 177' ' ' ILE . 41.3 p -76.23 -38.99 55.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.372 -0.376 . . . . 99.99 111.512 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.96 -34.44 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.819 0.342 . . . . 99.99 111.041 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' B' ' 209' ' ' SER . 53.4 tp -77.87 -55.68 5.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.024 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -30.71 43.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 99.99 111.006 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.53 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.3 tp -87.82 -23.38 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.002 0.429 . . . . 99.99 110.417 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.17 -55.29 29.0 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.667 -0.697 . . . . 99.99 113.311 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.635 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 92.6 m-85 -56.19 -55.75 38.62 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.896 0.348 . . . . 99.99 111.296 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -46.87 -27.77 6.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.172 1.915 . . . . 0.64 112.826 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.53 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -74.24 -58.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 99.99 111.715 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 179' ' ' TYR . 26.0 m -58.67 -24.69 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 99.99 111.67 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -63.91 -26.99 68.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.55 -0.296 . . . . 99.99 111.246 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 85.5 mt -52.1 -29.52 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.558 -0.292 . . . . 99.99 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 43.4 pt -126.72 155.61 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 99.99 111.191 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 95.37 177.48 37.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.917 -0.659 . . . . 99.99 112.667 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.08 154.4 33.69 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.746 2.297 . . . . 2.51 112.046 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 48.4 t 56.77 15.79 2.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.043 0.449 . . . . 99.99 110.461 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -158.7 38.31 0.51 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.731 -0.668 . . . . 99.99 112.31 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 50.1 t80 58.25 86.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 99.99 110.989 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 167.64 95.72 0.1 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.975 -0.631 . . . . 99.99 112.206 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -82.56 93.79 7.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.867 0.365 . . . . 99.99 111.002 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 41.3 pt -139.29 177.18 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 99.99 111.182 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -57.95 150.15 21.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.939 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . 0.43 ' CD ' ' H ' ' B' ' 195' ' ' GLN . 0.0 OUTLIER -87.12 1.03 54.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.003 -0.544 . . . . 99.99 110.879 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 52.0 m -73.17 -56.4 5.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.117 -0.492 . . . . 99.99 111.051 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.08 -28.61 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.019 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.15 -56.85 14.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.85 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 44.6 p -68.96 -20.02 64.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 99.99 111.301 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.29 -32.93 55.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.333 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.46 -43.53 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.355 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.66 -9.33 56.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 99.99 111.845 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 19.3 p -96.6 -38.03 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 99.99 110.597 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 56.1 tp -72.38 -31.69 65.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.692 -0.685 . . . . 99.99 112.073 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.709 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.8 tp -65.7 -53.91 33.05 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.951 -0.299 . . . . 99.99 111.266 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.8 Cg_exo -54.91 -42.49 68.47 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.785 1.657 . . . . 0.6 111.864 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.83 -38.11 89.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 99.99 110.684 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.24 -24.36 65.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 99.99 110.682 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.546 ' HB2' HD22 ' B' ' 175' ' ' LEU . 86.1 p -96.95 -22.21 16.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 99.99 111.252 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.444 ' C19' ' H9 ' ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m -69.96 -33.31 54.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.57 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.7 -29.19 74.57 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.79 -0.719 . . . . 99.99 112.885 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -74.01 -39.08 63.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.621 0.248 . . . . 99.99 111.358 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' B' ' 218' ' ' LEU . 49.8 m -58.41 -57.65 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.462 -0.335 . . . . 99.99 111.038 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' B' ' 218' ' ' LEU . 85.6 t80 -63.29 -23.43 67.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 99.99 111.094 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -64.2 -56.87 11.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.495 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.74 -33.88 70.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 99.99 111.637 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' B' ' 215' ' ' PHE . 87.1 mt -55.29 -50.49 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 99.99 111.063 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.66 -20.53 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 99.99 110.908 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.59 -55.03 25.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.853 -0.689 . . . . 99.99 113.084 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 31.5 tp -79.15 -58.61 3.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.704 0.288 . . . . 99.99 111.432 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 52.66 81.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 99.99 110.779 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -129.0 145.34 51.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.75 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 62.0 mt -114.88 15.95 17.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.066 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -117.5 94.15 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 99.99 110.736 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.48 160.33 19.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.945 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 43.6 t -142.12 124.51 15.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.687 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -84.05 168.61 15.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.003 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 99.99 111.017 179.889 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.674 0.273 . . . . 99.99 111.014 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -107.68 -55.58 2.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.103 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 69.5 mt -88.18 91.39 8.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.989 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -123.95 147.38 47.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.987 -0.551 . . . . 99.99 110.906 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.0 m -121.85 178.08 5.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.759 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp -155.54 -15.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.872 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . 0.425 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.3 mm? -70.34 -45.38 66.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.929 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 64.2 m-70 -71.83 -24.35 61.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.7 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.452 ' O ' HG12 ' C' ' 12' ' ' VAL . 61.9 t-105 -66.91 -53.72 29.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.564 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -64.9 -21.8 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.99 0.424 . . . . 99.99 110.291 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -59.51 5.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.601 -0.727 . . . . 99.99 110.5 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' C' ' 52' ' ' MET . 8.4 p -61.59 -30.86 49.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.013 -0.54 . . . . 99.99 110.967 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.06 78.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.62 -23.77 77.61 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.688 -0.767 . . . . 99.99 112.834 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.6 mmt -77.52 -45.2 26.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 99.99 111.33 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.9 p -59.29 -50.03 75.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.354 -0.384 . . . . 99.99 110.997 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -30.88 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 99.99 110.666 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.72 -60.22 9.39 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.877 -0.677 . . . . 99.99 112.589 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -30.86 63.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.812 0.339 . . . . 99.99 111.007 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.67 -33.14 70.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.648 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -60.71 -31.21 70.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 99.99 110.52 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -74.45 -29.93 61.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.793 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -62.82 -39.02 93.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.761 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -84.47 -39.09 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 99.99 110.865 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 tp -74.54 -9.21 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.72 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 53.9 p -58.16 -24.92 60.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 99.99 111.309 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -48.14 -33.53 8.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.204 0.526 . . . . 99.99 109.794 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.7 p-10 -171.08 132.46 0.86 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.276 -0.874 . . . . 99.99 109.794 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 19.5 Cg_endo -91.75 172.33 2.68 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.732 2.288 . . . . 2.05 112.214 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -85.5 47.07 1.37 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.29 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 -46.71 1.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.811 -0.709 . . . . 99.99 113.055 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' C' ' 33' ' ' PRO . 17.6 m -76.48 140.39 68.42 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.607 0.241 . . . . 99.99 111.102 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 19.2 Cg_exo -65.19 166.47 18.88 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.532 2.155 . . . . 1.93 112.197 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.7 -18.67 64.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 99.99 112.965 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.489 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -55.13 -36.74 66.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.969 0.414 . . . . 99.99 110.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . 0.504 ' HE2' HG22 ' C' ' 90' ' ' THR . 10.3 tp10 -64.73 -48.93 72.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 99.99 110.734 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.06 -19.05 62.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.695 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.88 -63.42 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.435 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.425 ' O ' HG13 ' C' ' 43' ' ' ILE . 3.5 m -63.33 -32.09 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.836 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.67 -6.32 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.432 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 53.7 ttp -89.83 -43.46 10.62 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.978 -0.556 . . . . 99.99 111.392 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -73.07 -39.51 65.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.142 0.423 . . . . 99.99 112.142 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.564 HG23 HG23 ' C' ' 79' ' ' THR . 96.6 mt -50.64 -50.6 71.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.255 0.465 . . . . 99.99 112.255 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.6 -36.14 6.97 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.113 1.875 . . . . 0.41 113.142 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 28.9 mm -57.41 -62.74 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.821 0.343 . . . . 99.99 111.469 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.518 ' HZ3' ' HG1' ' A' ' 114' ' ' THR . 3.2 t-105 -56.56 -57.12 13.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 99.99 111.241 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 47.1 m -51.96 -36.45 49.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 99.99 111.134 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.71 -53.02 38.34 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 99.99 112.486 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' C' ' 52' ' ' MET . 4.2 mm? -59.67 -35.92 75.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.414 . . . . 99.99 111.002 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -34.15 75.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 99.99 111.444 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.3 m-85 -70.6 -57.58 4.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 99.99 111.542 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' MET . . . . . 0.586 ' HB3' HG11 ' C' ' 12' ' ' VAL . 5.0 ppp? -48.74 -30.72 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.89 0.376 . . . . 99.99 110.707 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.425 ' HB2' ' HZ2' ' A' ' 131' ' ' TRP . . . -66.63 -44.9 80.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 99.99 110.826 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 58.0 mtt -54.54 -30.8 54.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.546 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.59 -50.62 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.133 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.37 5.94 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 99.99 111.186 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.3 54.94 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 99.99 111.106 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -123.69 139.64 53.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 99.99 111.028 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.63 -7.66 29.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.804 -0.713 . . . . 99.99 112.664 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -103.04 166.14 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.712 0.291 . . . . 99.99 110.944 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.73 145.91 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.998 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -93.51 95.11 9.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.953 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.42 107.37 19.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.136 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 33.24 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.389 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.65 2.1 88.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 99.99 112.606 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -102.44 152.23 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 99.99 110.942 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 33.2 mt -105.54 114.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.833 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.12 142.42 27.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.547 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.475 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 47.6 m-70 -84.24 58.81 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.884 -0.598 . . . . 99.99 110.478 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.69 -58.53 8.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.535 -0.757 . . . . 99.99 111.938 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.85 67.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.204 0.446 . . . . 99.99 112.204 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.475 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 17.7 tpp180 -61.64 -51.63 67.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.919 0.34 . . . . 99.99 111.919 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.43 ' O ' ' HG3' ' C' ' 77' ' ' MET . 14.0 p90 -78.13 -28.42 48.45 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.844 -0.342 . . . . 99.99 111.039 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 16.4 mm -47.31 -56.74 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 120.744 0.307 . . . . 99.99 110.907 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.35 -28.78 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.129 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -81.4 8.02 10.31 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.085 -0.507 . . . . 99.99 111.172 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.471 ' HA ' HG21 ' C' ' 113' ' ' ILE . 18.9 mtp -104.52 -25.22 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 99.99 110.458 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.441 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 24.7 m -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 99.99 111.979 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.564 HG23 HG23 ' C' ' 43' ' ' ILE . 85.1 m -67.12 -58.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.065 0.394 . . . . 99.99 112.065 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 12.6 m -47.94 -52.43 40.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 99.99 112.043 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 63.3 Cg_exo -51.95 -44.4 45.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.822 1.681 . . . . 0.67 111.794 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 98.6 mt -66.02 -32.89 74.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.555 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -31.69 64.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 99.99 109.766 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.508 HD21 ' HZ2' ' C' ' 176' ' ' TRP . 19.8 mt -77.83 -44.83 26.15 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.675 -0.693 . . . . 99.99 110.112 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -50.38 -42.0 52.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.446 -0.797 . . . . 99.99 110.384 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.416 ' O ' HG23 ' C' ' 90' ' ' THR . 43.2 t -57.62 -34.23 69.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 99.99 110.945 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 40.7 mt -65.39 -36.74 84.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 99.99 111.359 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 69.2 p -69.64 -26.19 64.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 99.99 110.95 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -80.58 -34.83 35.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 99.99 111.153 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' THR . . . . . 0.504 HG22 ' HE2' ' C' ' 36' ' ' GLU . 66.6 p -67.87 -26.68 66.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 99.99 111.049 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.65 -44.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 99.99 111.101 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.02 105.62 17.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 99.99 111.092 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -80.47 -12.09 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 99.99 110.828 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -162.7 137.44 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.557 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.8 tt -108.23 144.49 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.17 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -131.72 -25.85 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -146.17 137.58 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 99.99 110.38 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.63 124.45 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.326 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -92.84 162.4 14.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 99.99 110.98 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -103.58 -21.42 13.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 99.99 110.705 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.3 -31.75 70.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 99.99 110.67 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -62.15 -33.15 57.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.932 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.08 -27.51 60.02 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.861 -0.685 . . . . 99.99 112.098 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -64.84 -39.78 94.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.892 0.377 . . . . 99.99 110.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.88 -50.09 25.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.126 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' MET . . . . . 0.405 ' O ' HG13 ' C' ' 110' ' ' ILE . 12.6 tpt -56.88 -41.58 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.785 -0.643 . . . . 99.99 111.514 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t -66.38 -59.38 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 99.99 111.156 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 42.9 p -53.6 -26.4 21.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.326 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.471 ' NE2' HD11 ' C' ' 84' ' ' LEU . 6.9 tp-100 -68.17 -47.98 66.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 99.99 110.923 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.405 HG13 ' O ' ' C' ' 106' ' ' MET . 49.3 mt -55.26 -31.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 99.99 110.635 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.24 -45.74 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.814 -0.63 . . . . 99.99 111.118 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.2 -47.77 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.125 -0.489 . . . . 99.99 111.079 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . 0.471 HG21 ' HA ' ' C' ' 77' ' ' MET . 60.6 mt -57.53 -35.7 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.848 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' THR . . . . . 0.441 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 18.3 m -57.15 -45.88 83.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.062 0.458 . . . . 99.99 110.695 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' SER . . . . . 0.431 ' HA ' HG22 ' C' ' 118' ' ' ILE . 62.9 m -69.25 -23.22 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 99.99 110.798 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.31 -32.67 42.25 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.983 -0.627 . . . . 99.99 113.048 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.489 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.4 pp -82.54 -28.51 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 99.99 111.396 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.489 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.7 tp -83.92 -26.23 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.483 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.1 70.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.4 . . . . 99.99 111.258 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -84.89 -12.96 52.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.802 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.88 26.6 3.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 99.99 111.192 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 67.5 m -65.16 122.24 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.356 . . . . 99.99 110.876 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -86.62 -17.04 34.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.916 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.447 ' HB2' HG13 ' C' ' 127' ' ' VAL . 98.5 mtt180 -137.01 169.14 18.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 99.99 110.946 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.88 -17.13 38.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.814 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . 0.447 ' HE3' ' HB3' ' C' ' 124' ' ' ARG . 15.6 m-90 -90.88 -39.19 12.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.549 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' C' ' 124' ' ' ARG . 27.3 m -63.69 -26.91 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 99.99 111.117 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -66.53 -34.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.973 -0.558 . . . . 99.99 110.994 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -73.87 -27.02 60.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.839 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.08 -41.61 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 99.99 111.227 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . 0.445 ' HZ2' ' HB2' ' B' ' 53' ' ' ALA . 6.6 m95 -71.72 -31.04 66.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 99.99 111.052 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -63.69 -58.72 6.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.817 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.08 -29.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.402 . . . . 99.99 111.041 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.12 -38.62 88.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.892 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.84 -54.47 21.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.898 -0.668 . . . . 99.99 112.604 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.56 -30.67 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.618 0.247 . . . . 99.99 111.236 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.38 -47.65 83.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 99.99 110.514 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.52 -30.16 71.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 99.99 110.861 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.6 -20.51 61.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.586 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.48 -55.67 5.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 99.99 111.028 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 36.2 pt -58.79 -35.92 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.356 -0.384 . . . . 99.99 111.891 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 17.6 tt -75.94 -23.71 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 99.99 111.114 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.13 -48.33 73.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.361 -0.381 . . . . 99.99 110.764 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -68.62 -32.89 73.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.761 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.38 -39.51 61.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 99.99 112.452 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -75.21 -19.93 16.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.161 0.505 . . . . 99.99 110.36 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -88.87 3.0 52.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.586 -0.734 . . . . 99.99 110.383 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.479 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 58.5 t-20 -83.52 -48.41 0.74 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 99.99 111.96 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 77.0 Cg_exo -40.92 -33.44 1.12 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.489 2.126 . . . . 2.73 112.905 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' C' ' 165' ' ' TYR . 85.7 mt -85.07 49.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 99.99 110.504 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -54.72 147.66 14.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.029 -0.532 . . . . 99.99 111.174 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.33 -18.15 49.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 99.99 110.909 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -82.46 -29.27 30.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.525 . . . . 99.99 110.857 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 58.1 p -83.52 4.16 29.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 99.99 111.288 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -67.41 -27.34 66.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 99.99 110.766 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 72.8 p -76.89 -6.3 51.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.074 -0.512 . . . . 99.99 111.224 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -80.14 -56.07 4.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.002 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 87.7 p -158.44 113.43 2.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.758 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 47.9 t -77.6 -28.38 51.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 99.99 111.021 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.03 -62.66 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.172 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 56.2 tp -61.0 -36.95 80.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.168 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.81 76.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 99.99 111.476 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -74.95 -30.11 61.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 99.99 111.018 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.05 -51.61 56.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.973 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . 0.532 ' HB3' HD21 ' C' ' 150' ' ' LEU . 1.0 OUTLIER -69.24 -22.95 63.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 99.99 111.138 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 -38.9 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.333 -0.394 . . . . 99.99 110.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -81.72 -23.47 36.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.47 -41.02 41.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.254 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.42 -24.49 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.377 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 170' ' ' THR . . . . . 0.43 ' O ' HG23 ' C' ' 174' ' ' VAL . 38.9 m -59.64 -58.88 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 99.99 111.309 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -67.89 -31.86 71.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.766 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.0 -38.51 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 99.99 111.639 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 173' ' ' THR . . . . . 0.423 ' O ' HG22 ' C' ' 177' ' ' ILE . 38.7 p -73.21 -33.78 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.426 -0.352 . . . . 99.99 111.657 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 170' ' ' THR . 62.5 t -60.93 -37.11 76.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.555 -0.293 . . . . 99.99 111.773 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.25 -45.5 16.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 99.99 111.344 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . 0.508 ' HZ2' HD21 ' C' ' 84' ' ' LEU . 0.9 OUTLIER -57.77 -31.79 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.464 -0.335 . . . . 99.99 110.691 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.544 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.2 tt -87.96 -20.64 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.211 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.49 -56.72 23.58 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.753 -0.658 . . . . 99.99 113.407 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.666 ' HH ' ' HG3' ' C' ' 206' ' ' PRO . 87.8 m-85 -54.21 -54.42 47.97 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.755 0.278 . . . . 99.99 111.437 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.9 Cg_exo -47.09 -30.9 10.88 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.139 1.892 . . . . 0.63 112.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.544 HG13 ' O ' ' C' ' 177' ' ' ILE . 88.2 mt -70.7 -60.49 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.639 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.477 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.6 m -56.18 -24.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.407 0.521 . . . . 99.99 112.407 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -65.69 -17.4 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.429 0.529 . . . . 99.99 112.429 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . 0.452 HG13 HG23 ' C' ' 185' ' ' ILE . 22.5 pt -65.67 -13.19 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.659 0.266 . . . . 99.99 111.563 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . 0.452 HG23 HG13 ' C' ' 184' ' ' ILE . 31.0 pt -139.52 151.92 22.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.424 -0.353 . . . . 99.99 111.28 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . 0.525 ' H ' ' HA3' ' C' ' 191' ' ' GLY . . . 96.26 179.83 35.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.842 -0.694 . . . . 99.99 112.698 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.96 149.1 63.83 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.739 2.293 . . . . 3.12 112.225 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 34.5 m 57.26 19.81 5.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.51 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -164.23 42.59 0.31 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.901 -0.666 . . . . 99.99 112.641 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 54.3 t80 57.9 90.68 0.04 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.941 0.4 . . . . 99.99 111.159 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . 0.525 ' HA3' ' H ' ' C' ' 186' ' ' GLY . . . 160.13 102.32 0.18 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.815 -0.707 . . . . 99.99 112.576 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -90.35 78.84 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.976 0.417 . . . . 99.99 110.585 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 23.5 pt -124.31 172.56 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 99.99 111.041 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . 0.503 HD21 HG12 ' C' ' 197' ' ' ILE . 29.8 p-10 -57.99 141.28 50.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.425 -0.352 . . . . 99.99 111.031 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -74.92 -8.5 56.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.136 -0.483 . . . . 99.99 111.218 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.1 m -65.04 -42.26 94.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.807 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . 0.503 HG12 HD21 ' C' ' 194' ' ' ASN . 46.9 mm -72.49 -48.26 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 99.99 111.279 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.3 -51.96 64.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 99.99 111.077 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 87.7 m -64.72 -25.16 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.424 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -82.47 -27.68 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 99.99 111.696 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.87 -48.29 10.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.636 0.255 . . . . 99.99 111.402 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -69.17 1.44 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 99.99 111.211 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 51.2 t -96.27 -48.8 5.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 99.99 110.7 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.8 -30.57 65.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.72 -0.673 . . . . 99.99 111.95 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.683 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 44.6 tp -62.19 -54.62 48.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 120.966 -0.293 . . . . 99.99 111.49 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 46.3 Cg_exo -57.3 -41.8 69.21 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.65 1.566 . . . . 0.63 111.516 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.42 -32.01 73.32 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.502 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.75 -25.2 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 99.99 110.839 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t -96.77 -21.96 17.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.012 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.416 ' C19' ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.4 -32.75 51.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.8 0.333 . . . . 99.99 111.479 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.04 -31.65 81.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.656 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -75.2 -29.16 60.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.781 0.324 . . . . 99.99 111.08 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -63.78 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 99.99 111.065 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -62.71 -23.26 67.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.977 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.73 -47.37 85.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.971 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -66.78 -35.41 80.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.414 -0.357 . . . . 99.99 111.003 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.31 -43.28 88.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 99.99 111.01 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -87.44 -19.92 27.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.94 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.69 31.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.993 -0.622 . . . . 99.99 113.08 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.2 -58.87 2.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.555 0.217 . . . . 99.99 111.417 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 51.66 76.37 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.769 0.319 . . . . 99.99 110.918 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -127.43 148.42 50.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 99.99 111.071 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.31 -8.19 17.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 99.99 111.009 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -82.85 115.04 21.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.686 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -111.09 146.23 37.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 99.99 111.063 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 38.8 t -132.44 133.28 43.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 99.99 110.747 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -103.67 167.6 9.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.951 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.7 179.841 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.825 0.345 . . . . 99.99 110.975 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.602 ' HA ' ' HE2' ' A' ' 4' ' ' GLU . 3.3 m-20 -98.05 -5.65 33.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.886 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.7 mp -85.19 83.92 7.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 99.99 111.205 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.602 ' HE2' ' HA ' ' A' ' 2' ' ' ASN . 1.9 mp0 -105.53 112.22 25.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 99.99 110.74 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.6 p -111.67 138.7 47.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.813 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp -114.92 -14.26 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 99.99 110.808 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.36 -42.86 99.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.971 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 25.6 m170 -62.94 -35.88 81.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.779 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -69.04 -52.47 28.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.0 mt -56.19 -34.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.007 0.432 . . . . 99.99 110.407 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 15' ' ' MET . 20.1 t80 -57.45 -42.15 81.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 99.99 109.826 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 8' ' ' HIS . 3.1 t -57.25 -48.38 82.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 99.99 111.229 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.06 -44.95 83.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 99.99 111.681 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.31 94.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 99.99 112.705 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.54 ' HE1' ' HB3' ' A' ' 44' ' ' PRO . 56.0 mmm -69.16 -32.92 72.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 99.99 110.992 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -60.83 -60.33 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.449 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.2 -26.1 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.268 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.49 -48.55 85.44 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.571 -0.823 . . . . 99.99 112.328 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.05 -23.22 63.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 99.99 111.01 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.32 -44.13 84.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.921 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.94 -20.93 60.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.997 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.83 -48.19 80.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.891 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.512 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.1 m-90 -71.55 -35.52 70.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.88 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.0 m -70.47 -20.65 62.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 99.99 111.333 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 tp -86.18 -10.63 54.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 99.99 111.117 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 52.3 p -65.4 -23.05 66.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.385 -0.37 . . . . 99.99 111.152 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -47.07 -32.69 4.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.261 0.553 . . . . 99.99 109.699 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -174.18 132.45 0.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.092 -0.958 . . . . 99.99 110.216 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -92.47 140.8 2.12 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.777 2.318 . . . . 99.99 112.07 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -81.28 72.83 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.601 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.76 -46.9 3.19 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.106 -0.568 . . . . 99.99 113.435 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.37 140.52 21.71 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.792 0.296 . . . . 99.99 111.222 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.44 165.56 12.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.552 2.168 . . . . 99.99 112.131 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -63.5 -18.6 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 99.99 112.233 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -48.09 -36.29 12.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.754 0.311 . . . . 99.99 111.317 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.11 -53.33 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.909 0.385 . . . . 99.99 110.461 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -68.27 -18.45 64.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 99.99 110.669 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.08 -52.87 63.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.406 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 t -65.85 -36.78 78.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.155 0.502 . . . . 99.99 109.795 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.38 -8.37 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.663 -0.699 . . . . 99.99 110.623 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.453 ' O ' HG12 ' A' ' 45' ' ' ILE . 22.4 ttt -88.68 -36.98 15.9 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.2 -0.454 . . . . 99.99 110.746 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -67.99 -32.8 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.222 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG21 HG22 ' A' ' 79' ' ' THR . 68.5 mt -56.88 -55.01 48.12 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.307 0.484 . . . . 99.99 112.307 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HB3' ' HE1' ' A' ' 15' ' ' MET . 36.7 Cg_endo -65.38 -33.94 45.8 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.295 1.996 . . . . 99.99 113.442 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 41' ' ' MET . 38.8 mm -55.26 -62.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.881 0.326 . . . . 99.99 111.881 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.428 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.8 t90 -66.06 -47.89 72.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 99.99 110.981 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' A' ' 75' ' ' ASP . 47.4 t -61.81 -9.79 7.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 99.99 111.238 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.31 -59.53 2.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 99.99 112.134 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.36 -26.95 65.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 99.99 110.704 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -51.52 69.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.79 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 27.7 m-85 -69.65 -26.36 64.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.938 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -56.42 -36.78 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.514 -0.55 . . . . 99.99 109.514 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -73.16 -44.15 60.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.538 -0.755 . . . . 99.99 110.85 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.432 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 51.6 mtt -51.5 -26.48 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 99.99 110.597 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -79.11 -47.28 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 99.99 111.211 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -84.18 14.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.545 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 57.31 55.76 5.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.027 -0.533 . . . . 99.99 111.223 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.43 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 16.8 mm-40 -125.22 173.01 9.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 99.99 110.716 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.45 66.48 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.593 -0.813 . . . . 99.99 112.155 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.75 173.98 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 99.99 110.709 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.12 132.49 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 99.99 111.355 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -101.23 88.54 3.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 99.99 110.625 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.06 131.72 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.2 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 27.71 17.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.066 -0.515 . . . . 99.99 111.408 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.24 -11.27 37.9 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.643 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -97.87 149.74 22.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.34 . . . . 99.99 110.899 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.3 mt -94.15 117.33 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.939 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.26 144.83 30.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.233 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.3 m-70 -88.68 68.89 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 99.99 110.958 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.15 -35.71 75.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 99.99 111.102 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.46 -24.19 60.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 99.99 111.971 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.7 tpp180 -69.29 -51.71 34.59 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.335 0.494 . . . . 99.99 112.335 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -81.23 -31.1 34.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.207 0.447 . . . . 99.99 112.207 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.53 -43.91 83.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.762 -0.375 . . . . 99.99 110.537 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HD2' ' HA ' ' A' ' 47' ' ' SER . 13.3 t70 -68.85 -20.3 64.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.498 -0.556 . . . . 99.99 109.498 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -87.7 1.22 54.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.672 -0.694 . . . . 99.99 111.169 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.6 ttm -104.61 -18.71 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.915 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.11 -32.06 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.904 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 43' ' ' ILE . 27.9 m -82.9 -41.38 18.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.898 0.333 . . . . 99.99 111.898 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 72.4 m -60.19 -50.27 86.86 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.945 0.35 . . . . 99.99 111.945 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 44.9 Cg_exo -56.69 -32.92 92.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.074 1.849 . . . . 99.99 112.437 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.94 -16.97 45.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.845 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.91 -47.03 49.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 99.99 109.948 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 85' ' ' LEU . 3.6 pp -74.92 -29.47 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.555 . . . . 99.99 110.988 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' HD11 ' A' ' 84' ' ' LEU . 9.7 tp -64.03 -36.47 84.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.018 -0.537 . . . . 99.99 110.798 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -61.94 -24.41 66.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.554 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.68 -34.01 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.793 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.5 p -71.28 -28.42 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 99.99 110.52 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.86 -26.82 29.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.985 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -81.37 -25.7 36.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.966 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.5 -35.24 12.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.277 -0.419 . . . . 99.99 111.263 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 71.4 mtm -118.18 111.1 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.144 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.75 -24.45 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.69 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -137.12 141.03 42.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 99.99 110.659 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.7 pt -128.39 143.95 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 99.99 111.407 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.917 -0.583 . . . . 99.99 110.606 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.42 52.45 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.467 . . . . 99.99 110.992 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -135.29 93.69 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.858 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -71.65 80.5 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 99.99 111.097 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.4 m -120.6 -60.56 1.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.324 -0.398 . . . . 99.99 111.179 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.29 -58.84 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 99.99 111.081 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.2 tt -56.55 -36.38 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 99.99 111.24 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.15 -30.63 73.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 99.99 112.809 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.3 -48.95 75.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.745 0.307 . . . . 99.99 110.991 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.97 -43.66 98.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.506 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 89.4 mtp -56.43 -39.68 73.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 99.99 111.666 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.2 m -71.7 -45.67 61.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.959 0.409 . . . . 99.99 111.204 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.2 p -64.85 -20.28 66.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.618 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 110' ' ' ILE . 3.0 pt20 -77.76 -41.49 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.586 0.231 . . . . 99.99 110.796 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.577 HG22 ' HE1' ' C' ' 46' ' ' TRP . 43.2 mt -61.2 -33.05 54.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.947 0.403 . . . . 99.99 110.807 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.17 -47.88 76.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.916 -0.584 . . . . 99.99 111.219 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.484 HG11 H133 ' A' ' 210' ' ' LYR . 73.8 t -61.85 -44.07 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.457 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 109' ' ' GLN . 74.8 mt -54.77 -40.28 51.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.776 0.322 . . . . 99.99 110.864 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 117' ' ' LEU . 99.0 m -60.15 -39.79 87.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 99.99 110.913 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -57.72 -57.31 13.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 99.99 110.123 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.8 -14.25 65.01 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.985 -0.626 . . . . 99.99 112.199 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 114' ' ' THR . 10.0 tt -70.29 -56.41 6.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 99.99 110.724 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.425 ' HB ' ' NE1' ' A' ' 131' ' ' TRP . 67.1 mt -83.73 -22.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.004 -0.543 . . . . 99.99 111.563 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.401 ' HA ' ' HD1' ' A' ' 131' ' ' TRP . . . -49.7 -40.13 39.26 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.849 0.357 . . . . 99.99 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.438 ' HD2' ' H ' ' A' ' 69' ' ' HIS . 18.4 t70 -86.73 -21.48 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 99.99 110.479 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.3 mt -91.87 31.87 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.775 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 t -88.02 128.14 35.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.634 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.59 -69.77 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.282 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.602 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.6 ttp180 -74.4 136.94 42.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.06 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.67 -9.88 58.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 99.99 111.181 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.602 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 64.1 t-105 -80.2 -46.65 15.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.804 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.472 ' HB ' HH21 ' A' ' 124' ' ' ARG . 13.3 p -77.19 -23.99 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 99.99 111.448 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -56.88 -32.09 65.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.396 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -72.05 -25.24 61.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.342 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.491 HD23 HG23 ' C' ' 56' ' ' ILE . 30.8 tp -83.49 -48.18 10.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.538 -0.301 . . . . 99.99 111.32 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.425 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 50.4 t-105 -59.88 -28.13 67.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 99.99 110.626 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.29 -44.33 79.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 99.99 110.666 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.48 -29.22 44.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.815 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.437 ' HG ' ' HE3' ' C' ' 52' ' ' MET . 69.2 m -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 99.99 110.717 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.8 -56.89 12.43 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 99.99 112.465 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 m -56.25 -33.17 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 99.99 111.092 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.2 t -61.69 -37.08 82.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 99.99 110.465 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.18 93.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.802 -0.635 . . . . 99.99 110.625 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.4 -14.88 58.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.518 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -56.91 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.162 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.9 pt -66.27 -37.47 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 99.99 110.839 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.97 -35.96 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.801 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.52 -43.49 93.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 99.99 110.339 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.675 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 88.3 t90 -64.49 -28.61 69.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.596 . . . . 99.99 110.434 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 1.374 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -80.25 -33.34 32.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 99.99 112.456 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.54 -24.71 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 99.99 110.443 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -88.89 5.05 45.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.863 -0.608 . . . . 99.99 111.057 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 1.374 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 -83.7 -48.31 0.73 Allowed Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 99.99 112.283 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 91.0 Cg_exo -41.42 -32.81 1.4 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.685 2.256 . . . . 99.99 112.882 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.72 46.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 99.99 110.81 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.596 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 43.7 ttp180 -55.98 148.26 17.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.746 -0.661 . . . . 99.99 110.593 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.81 -19.73 65.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.363 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.596 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 98.9 mttt -86.67 7.17 27.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.435 -0.348 . . . . 99.99 111.595 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 151' ' ' ARG . 72.8 p -79.02 -1.56 36.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.349 . . . . 99.99 111.305 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -66.66 -28.51 68.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.68 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 t -94.1 -23.61 17.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.202 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.79 -73.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.617 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.4 m -157.47 112.86 2.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.488 . . . . 99.99 110.845 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -78.33 -31.25 48.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.041 -0.527 . . . . 99.99 110.966 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -63.7 -58.58 6.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.528 . . . . 99.99 111.083 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.85 -36.37 78.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.083 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.42 -26.93 68.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 99.99 111.061 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.08 -37.7 61.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 99.99 110.865 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.54 -32.6 71.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.998 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.45 -31.17 42.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.525 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.54 -44.01 97.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 99.99 111.0 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.4 -19.72 38.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 99.99 111.479 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 42.7 tp -80.65 -39.96 26.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.978 0.362 . . . . 99.99 111.978 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.37 -31.23 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.361 0.504 . . . . 99.99 112.361 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 174' ' ' VAL . 6.4 t -57.79 -44.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.712 0.291 . . . . 99.99 111.369 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -77.09 -28.12 54.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.749 0.309 . . . . 99.99 110.612 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -65.56 -46.49 79.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.51 . . . . 99.99 111.216 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -64.11 -40.31 95.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.51 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 170' ' ' THR . 84.4 t -57.52 -35.32 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.804 0.335 . . . . 99.99 111.217 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.26 -57.56 3.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.391 -0.368 . . . . 99.99 111.434 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.63 -25.93 54.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.181 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 181' ' ' ILE . 31.1 mm -87.7 -27.38 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 99.99 110.272 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.92 -53.88 34.26 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.742 -0.663 . . . . 99.99 113.172 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 80.4 m-85 -56.42 -57.24 24.39 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.884 0.342 . . . . 99.99 111.495 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 86.0 Cg_exo -44.4 -30.36 3.73 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.215 1.943 . . . . 99.99 112.96 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -68.19 -58.31 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 99.99 111.405 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 179' ' ' TYR . 21.3 m -59.94 -24.96 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 99.99 111.614 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -70.27 -22.69 62.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.531 -0.304 . . . . 99.99 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 92.4 mt -56.35 -41.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 99.99 111.424 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.92 155.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.42 -0.354 . . . . 99.99 111.392 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.68 176.58 28.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.85 -0.69 . . . . 99.99 112.504 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.18 149.51 35.99 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.683 2.256 . . . . 99.99 112.126 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 53.2 m 58.72 15.76 3.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.44 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -128.12 -65.18 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.931 -0.652 . . . . 99.99 112.554 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -163.07 -26.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.695 0.283 . . . . 99.99 110.986 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.57 170.69 13.84 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.715 -0.755 . . . . 99.99 113.019 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -121.78 72.43 1.02 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.054 0.454 . . . . 99.99 110.558 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 194' ' ' ASN . 8.9 mt -100.79 169.52 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 99.99 110.242 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.515 ' H ' HG23 ' A' ' 193' ' ' ILE . 3.4 m-20 -47.57 141.31 5.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.93 0.395 . . . . 99.99 111.175 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -78.14 -13.65 59.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 99.99 111.173 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.6 p -70.3 -42.17 72.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.39 -0.368 . . . . 99.99 110.994 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 95.5 mt -69.96 -40.56 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 99.99 111.269 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.77 -60.97 2.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.081 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 8.2 t -61.8 -22.29 65.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.461 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.51 -32.32 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.942 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 40.9 tp -83.99 -42.58 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 99.99 111.577 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -70.16 0.35 6.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.751 -0.204 . . . . 99.99 111.458 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.19 -45.65 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.202 0.525 . . . . 99.99 110.466 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.53 -34.04 67.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 99.99 111.92 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.67 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 55.1 tp -59.8 -54.6 54.01 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.855 -0.338 . . . . 99.99 111.2 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 46.6 Cg_exo -57.63 -35.53 98.8 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.629 1.553 . . . . 99.99 111.094 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.406 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 55.4 t80 -60.31 -31.88 70.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.018 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -82.22 -19.16 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 99.99 110.591 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t -85.0 -40.99 16.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 99.99 110.806 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.484 H133 HG11 ' A' ' 112' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.24 -32.6 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.954 -0.567 . . . . 99.99 111.221 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.66 -34.98 71.63 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.897 -0.668 . . . . 99.99 112.763 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -71.21 -35.19 71.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.639 0.257 . . . . 99.99 111.226 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 40.5 t -55.93 -58.2 8.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.873 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -66.97 -20.44 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.821 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -67.2 -58.66 4.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 99.99 110.815 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 -28.3 64.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 99.99 110.969 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.21 -45.53 84.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.742 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -77.42 -28.25 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.754 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.42 -23.34 68.37 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 99.99 112.185 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.17 -56.61 17.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 99.99 110.737 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 61.42 -84.13 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.022 -0.535 . . . . 99.99 111.2 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -80.52 131.64 35.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 99.99 110.895 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.5 tp -84.43 102.3 12.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.976 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -143.41 132.9 23.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.872 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -114.41 151.76 32.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 99.99 111.008 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.6 m -107.92 122.72 47.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.879 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -74.05 -29.32 61.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.482 . . . . 99.99 111.129 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.367 -0.379 . . . . 99.99 110.855 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.1 mtm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.845 0.355 . . . . 99.99 110.826 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -110.41 16.32 21.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.08 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp -108.3 93.91 4.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.429 -0.35 . . . . 99.99 111.029 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.1 150.02 27.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.074 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -151.03 137.76 18.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.71 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt -120.07 -0.01 10.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.815 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 24.4 tp -70.51 -39.44 74.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.219 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.566 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 29.6 m80 -71.52 -31.19 66.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.86 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -65.33 -57.97 7.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 35.8 pt -55.38 -31.37 27.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.584 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.606 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 28.9 t80 -59.66 -36.36 76.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.621 -0.718 . . . . 99.99 109.672 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' B' ' 52' ' ' MET . 3.2 t -66.93 -49.86 70.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 99.99 111.047 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.64 69.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 99.99 111.653 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.28 83.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.639 -0.791 . . . . 99.99 112.422 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -76.43 -34.56 58.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.625 0.25 . . . . 99.99 111.573 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -62.63 -49.38 75.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.722 0.296 . . . . 99.99 111.467 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -36.0 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 99.99 110.683 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -49.75 56.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.728 -0.749 . . . . 99.99 112.847 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.74 65.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 99.99 111.474 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.93 -36.15 75.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 99.99 110.971 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -63.28 -21.55 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.515 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -60.8 -40.83 94.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 99.99 110.864 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -73.18 -41.89 63.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.004 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 77.7 p -71.12 -19.5 62.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 99.99 111.466 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.95 -7.85 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 99.99 111.265 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 89.8 p -69.54 -22.48 63.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.482 -0.326 . . . . 99.99 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -47.51 -36.41 10.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.292 0.568 . . . . 99.99 109.774 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.4 p-10 -171.84 132.35 0.77 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 99.99 109.988 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 55.5 Cg_endo -94.86 154.35 1.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.96 2.44 . . . . 99.99 112.24 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -85.13 63.5 8.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 99.99 110.912 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.78 -39.79 2.22 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.765 -0.731 . . . . 99.99 112.508 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.56 129.0 35.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.381 0.134 . . . . 99.99 111.142 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 32.2 Cg_exo -57.69 160.88 13.53 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.29 1.993 . . . . 99.99 111.854 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.49 -18.06 57.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.788 -0.642 . . . . 99.99 112.517 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.416 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 2.9 p90 -46.78 -36.74 7.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.938 0.399 . . . . 99.99 111.046 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -66.82 -47.32 72.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.231 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -70.58 -18.78 62.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 99.99 110.489 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 58.1 tp -60.96 -53.61 55.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 99.99 110.006 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.18 -37.13 78.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 99.99 110.307 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.33 -6.84 46.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.596 -0.729 . . . . 99.99 110.94 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.425 ' O ' HG13 ' B' ' 45' ' ' ILE . 24.8 ttt -88.79 -39.78 13.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.981 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' C' ' 107' ' ' SER . 25.1 t80 -69.74 -34.13 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.516 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.451 HG21 HG22 ' B' ' 79' ' ' THR . 76.6 mt -52.15 -54.28 43.0 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.988 0.366 . . . . 99.99 111.988 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 48.0 Cg_endo -68.62 -32.09 25.04 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.158 1.905 . . . . 99.99 112.883 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.462 HG22 HG12 ' C' ' 111' ' ' VAL . 96.1 mt -56.3 -60.12 2.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.657 0.265 . . . . 99.99 111.538 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.609 ' HE1' HG21 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -63.71 -55.26 24.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.517 -0.311 . . . . 99.99 111.204 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' B' ' 75' ' ' ASP . 90.2 p -54.74 -25.97 31.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.294 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.93 7.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.711 -0.757 . . . . 99.99 112.429 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -32.09 68.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 99.99 110.837 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.93 -53.53 57.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.57 . . . . 99.99 111.244 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -71.53 -23.26 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.385 . . . . 99.99 111.143 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' MET . . . . . 0.465 ' HA ' HG22 ' B' ' 12' ' ' VAL . 15.0 tmm? -57.72 -36.89 72.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.304 0.573 . . . . 99.99 109.466 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.33 -39.68 38.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.779 . . . . 99.99 110.778 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.9 mtt -53.89 -24.29 15.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.032 -0.531 . . . . 99.99 110.188 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -82.21 -47.95 11.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.853 -0.612 . . . . 99.99 110.822 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mt -80.94 10.93 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 99.99 111.166 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.484 ' HA ' ' HZ2' ' B' ' 60' ' ' LYS . 20.0 t70 60.54 65.23 1.08 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.982 -0.554 . . . . 99.99 111.172 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -146.66 150.78 36.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 99.99 111.291 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.99 -22.43 29.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.654 . . . . 99.99 112.697 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HZ2' ' HA ' ' B' ' 57' ' ' ASP . 22.0 pttm -103.8 143.15 33.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 99.99 111.154 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.82 151.63 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.229 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.11 107.39 18.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.778 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.33 127.68 53.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.256 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.48 37.34 23.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.059 -0.519 . . . . 99.99 111.079 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.78 -0.68 42.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.843 -0.694 . . . . 99.99 112.432 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -101.3 139.53 36.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 99.99 110.638 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.03 102.47 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.199 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.15 133.9 37.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 99.99 111.073 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.511 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 74.6 m-70 -78.66 74.97 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.166 0.508 . . . . 99.99 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.429 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 62.1 t80 -64.47 -30.02 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.611 -0.722 . . . . 99.99 111.255 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.66 -28.14 40.81 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.181 0.437 . . . . 99.99 112.181 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.517 HH21 ' HB ' ' B' ' 199' ' ' THR . 34.2 mmt180 -67.95 -51.64 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.603 0.594 . . . . 99.99 112.603 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' B' ' 77' ' ' MET . 5.9 p90 -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.231 0.456 . . . . 99.99 112.231 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.4 ' HA ' ' HG3' ' B' ' 77' ' ' MET . 10.3 tp -54.74 -43.23 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 120.846 -0.341 . . . . 99.99 110.802 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.401 ' HD2' ' HA ' ' B' ' 47' ' ' SER . 26.9 t70 -68.95 -21.64 64.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.474 -0.565 . . . . 99.99 109.474 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -87.07 6.25 33.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.472 -0.786 . . . . 99.99 110.908 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 28.2 mtp -104.91 -23.3 13.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.748 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.18 -33.64 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.56 0.578 . . . . 99.99 112.56 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.451 HG22 HG21 ' B' ' 43' ' ' ILE . 34.8 m -76.83 -47.26 21.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.192 0.441 . . . . 99.99 112.192 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 34.6 m -56.5 -51.31 82.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.154 0.427 . . . . 99.99 112.154 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 54.3 Cg_exo -52.62 -41.86 65.99 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.921 1.748 . . . . 99.99 112.065 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.62 -29.58 62.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.638 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.35 -28.75 68.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.117 0.484 . . . . 99.99 110.205 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 105' ' ' LEU . 5.9 tt -84.37 -38.75 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 99.99 110.296 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.44 -33.37 73.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.914 -0.585 . . . . 99.99 110.625 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 99.5 p -59.39 -24.1 63.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 99.99 110.715 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 46.6 mt -76.03 -27.43 57.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.909 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 52.0 m -75.94 -31.18 58.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 99.99 111.163 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.06 -37.27 39.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.297 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -73.88 -23.54 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.458 -0.337 . . . . 99.99 111.422 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.08 -36.22 12.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 99.99 111.252 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -116.52 120.24 38.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.889 0.376 . . . . 99.99 111.068 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.98 -27.33 39.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 99.99 110.562 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -137.94 148.14 44.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.795 -0.639 . . . . 99.99 110.613 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.95 144.56 36.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.372 -0.376 . . . . 99.99 111.064 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -101.18 162.67 12.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.863 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.47 91.64 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.913 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -147.53 -43.05 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 99.99 111.075 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 85.9 m95 54.78 65.25 1.55 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 99.99 110.867 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 79.7 p -117.87 -58.23 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.804 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 60.3 tp -71.67 -51.55 22.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.712 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.95 -47.37 89.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.977 -0.556 . . . . 99.99 111.154 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.4 -33.8 77.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.896 -0.669 . . . . 99.99 112.675 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -65.58 -40.28 92.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 99.99 110.866 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.434 ' HB3' HD23 ' B' ' 84' ' ' LEU . 28.8 mt -71.43 -40.72 70.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 99.99 111.201 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 85.9 mtp -58.27 -53.39 58.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.221 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 44.0 t -58.35 -39.94 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 99.99 111.128 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.513 HG22 HG22 ' B' ' 142' ' ' ILE . 91.8 m -60.71 -37.93 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.286 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.475 ' NE2' HG23 ' B' ' 80' ' ' THR . 16.1 mm100 -64.72 -46.92 80.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.31 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.428 HG22 ' HE1' ' A' ' 46' ' ' TRP . 62.3 mt -53.04 -35.03 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.323 -0.399 . . . . 99.99 111.262 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.65 -51.35 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 99.99 111.342 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . 0.535 HG11 H133 ' B' ' 210' ' ' LYR . 87.2 t -58.75 -49.6 82.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.489 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 71.9 mt -52.83 -36.87 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.358 -0.383 . . . . 99.99 111.329 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 49.5 m -60.09 -48.3 82.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 99.99 111.237 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 35.9 m -64.94 -21.11 66.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.124 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.27 14.3 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.821 -0.705 . . . . 99.99 113.262 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.435 HD11 ' N ' ' B' ' 118' ' ' ILE . 3.1 pp -76.24 -27.91 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.87 -0.194 . . . . 99.99 111.507 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.435 ' N ' HD11 ' B' ' 117' ' ' LEU . 8.9 tp -83.53 -31.55 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.682 0.277 . . . . 99.99 111.424 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.4 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 99.99 111.013 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.66 -30.24 46.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 99.99 111.007 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.63 14.28 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.267 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 46.6 t -75.36 120.77 21.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 99.99 110.817 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.41 -72.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.025 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.508 ' HB2' HG12 ' B' ' 127' ' ' VAL . 79.3 mtp180 -62.71 140.72 58.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 99.99 110.513 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.92 -19.31 52.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 99.99 111.466 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -78.17 -35.03 49.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 99.99 111.215 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -81.67 -23.74 9.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.341 -0.391 . . . . 99.99 111.095 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -56.35 -32.92 65.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.13 -0.487 . . . . 99.99 111.037 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -75.27 -19.51 59.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.417 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 99.3 mt -78.85 -54.89 5.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 99.99 110.97 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -39.98 76.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 99.99 111.334 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -53.01 -45.4 67.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.156 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -71.93 -28.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.288 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 76.2 m -68.77 -39.45 80.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.176 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.31 -50.8 48.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.8 -0.714 . . . . 99.99 112.457 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.97 -29.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 99.99 110.752 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.49 -47.05 87.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.645 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.46 -29.79 71.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.451 . . . . 99.99 110.622 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . 0.492 ' HB2' H132 ' B' ' 210' ' ' LYR . 82.2 t80 -75.13 -25.24 58.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 99.99 110.747 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.58 -56.84 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.476 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . 0.443 HG13 ' N ' ' B' ' 142' ' ' ILE . 23.5 pt -56.17 -44.07 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 99.99 111.128 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.513 HG22 HG22 ' B' ' 108' ' ' THR . 46.5 mm -67.85 -29.31 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' B' ' 139' ' ' PHE . 0.5 OUTLIER -55.37 -50.96 68.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.348 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -62.36 -37.55 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.666 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.98 -35.58 92.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 99.99 112.514 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 142' ' ' ILE . 98.3 mt -69.17 -27.18 33.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.871 0.367 . . . . 99.99 110.831 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -88.68 4.46 47.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.185 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.464 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 58.5 t-20 -81.7 -48.1 1.0 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.044 -0.525 . . . . 99.99 111.841 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 71.1 Cg_exo -41.01 -33.69 1.23 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.577 2.184 . . . . 99.99 112.578 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 32.2 tp -86.31 54.29 3.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.14 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.449 ' HD3' ' HE2' ' B' ' 153' ' ' LYS . 99.5 mtt180 -58.5 168.92 1.0 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.863 -0.608 . . . . 99.99 110.907 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.47 -23.01 37.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.305 -0.407 . . . . 99.99 111.18 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . 0.449 ' HE2' ' HD3' ' B' ' 151' ' ' ARG . 63.3 pttt -86.25 5.89 32.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.053 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 15.3 t -65.59 -19.14 65.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 99.99 110.92 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -62.73 -19.13 63.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.155 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 59.0 p -102.72 -18.84 14.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.058 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -83.01 -70.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.809 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 33.5 t -162.06 113.24 1.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 99.99 110.874 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 71.4 p -78.11 -29.85 49.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 99.99 111.281 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -67.37 -53.86 25.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.403 . . . . 99.99 110.983 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.83 -34.31 75.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.838 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.88 64.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.976 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -68.75 -48.85 62.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.869 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt -61.17 -42.19 98.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.761 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.72 -23.48 61.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 99.99 111.076 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.21 -55.0 28.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.339 -0.391 . . . . 99.99 111.183 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -78.43 -24.19 46.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.383 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.4 tp -68.78 -43.5 75.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 99.99 111.311 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.41 -22.31 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.34 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.0 m -62.55 -58.83 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.478 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.84 -34.81 79.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.98 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.1 -36.25 74.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.048 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 66.2 m -69.97 -41.35 74.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 99.99 111.095 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.91 -37.07 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.474 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.4 mt -72.5 -56.14 5.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 99.99 111.344 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -31.58 63.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 99.99 111.51 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.439 ' O ' HG13 ' B' ' 181' ' ' ILE . 16.2 tt -87.57 -20.79 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.43 . . . . 99.99 110.566 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.44 -50.57 65.48 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.824 -0.626 . . . . 99.99 112.911 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.628 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 67.1 m-85 -58.18 -57.02 29.07 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.773 0.286 . . . . 99.99 111.538 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 88.1 Cg_exo -45.95 -31.7 8.62 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.906 1.737 . . . . 99.99 112.876 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 177' ' ' ILE . 98.0 mt -66.25 -56.85 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.567 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.43 HG21 ' O ' ' B' ' 179' ' ' TYR . 18.0 m -61.63 -25.32 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 99.99 111.546 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -68.92 -18.36 64.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.467 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.52 -34.68 66.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.521 -0.309 . . . . 99.99 111.142 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.25 162.36 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.323 . . . . 99.99 111.329 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.75 -171.88 33.57 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.716 . . . . 99.99 112.721 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.02 154.46 72.59 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.809 2.34 . . . . 99.99 112.164 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 58.4 m 57.38 18.12 4.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.897 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -169.74 63.96 0.18 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.597 -0.811 . . . . 99.99 112.609 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 89.4 t80 58.29 95.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.814 0.34 . . . . 99.99 111.086 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.19 137.46 3.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.707 -0.758 . . . . 99.99 112.477 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -121.92 89.01 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 99.99 110.688 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 46.3 pt -124.76 -179.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.161 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -52.9 135.99 35.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.849 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -77.21 -11.49 59.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.002 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 60.7 p -67.3 -47.66 69.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.374 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.1 tp -68.91 -29.36 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.323 -0.399 . . . . 99.99 111.077 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.96 -56.13 25.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.974 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' THR . . . . . 0.517 ' HB ' HH21 ' B' ' 72' ' ' ARG . 64.8 p -65.43 -34.52 78.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.157 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.96 -36.0 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.144 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.53 -41.78 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.342 -0.39 . . . . 99.99 111.495 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -74.63 0.45 15.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.523 -0.308 . . . . 99.99 111.345 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.9 t -96.52 -45.03 6.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.206 0.526 . . . . 99.99 110.526 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 45.1 tp -72.11 -39.37 68.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.422 -0.808 . . . . 99.99 111.918 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 45.4 tp -55.77 -54.47 51.47 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.953 -0.299 . . . . 99.99 111.33 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.5 Cg_exo -56.11 -41.45 76.64 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.822 1.681 . . . . 99.99 111.175 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -55.2 -37.07 66.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.167 -0.469 . . . . 99.99 109.844 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -79.89 -24.27 41.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 99.99 110.433 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 56.7 m -85.11 -13.39 50.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.84 -0.618 . . . . 99.99 111.204 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.535 H133 HG11 ' B' ' 112' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.43 -29.88 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 99.99 111.135 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' B' ' 216' ' ' LEU . . . -59.2 -28.07 63.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 99.99 112.24 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -76.77 -30.16 56.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.751 0.31 . . . . 99.99 110.551 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -63.74 -60.58 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.685 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.02 -26.47 67.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.853 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' B' ' 212' ' ' GLY . 6.4 tt -65.33 -50.05 67.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 99.99 110.743 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -63.02 -24.98 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.945 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 56.9 tp -71.75 -33.24 68.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 99.99 111.139 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -88.18 -29.19 20.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.43 -0.35 . . . . 99.99 111.149 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.52 -20.9 61.92 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.795 -0.717 . . . . 99.99 112.433 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 77.6 mt -69.82 -52.55 24.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.654 0.264 . . . . 99.99 110.606 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 61.06 -82.15 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.969 -0.559 . . . . 99.99 111.115 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -88.33 146.79 25.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.419 -0.355 . . . . 99.99 110.85 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.34 119.31 29.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.011 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -152.14 106.84 3.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.038 -0.528 . . . . 99.99 110.724 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -97.28 138.44 34.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 99.99 111.134 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 42.4 m -95.1 135.28 36.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 99.99 110.729 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -91.99 -10.72 38.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.982 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.928 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 73.5 mtm . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.764 0.316 . . . . 99.99 110.993 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -93.61 -22.35 18.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.14 -0.482 . . . . 99.99 110.777 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . 0.408 HD11 ' N ' ' C' ' 3' ' ' LEU . 7.1 mp -74.13 124.31 26.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.626 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -97.61 -66.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.825 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t 60.32 98.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.06 -0.518 . . . . 99.99 111.234 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -113.35 -6.34 13.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 99.99 110.951 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 tp -65.18 -47.67 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 99.99 110.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.574 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 25.0 m170 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.745 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -75.21 -41.16 58.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.417 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.09 -20.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.281 0.562 . . . . 99.99 110.176 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . 0.616 ' HH ' ' HB2' ' C' ' 206' ' ' PRO . 27.8 t80 -67.29 -50.91 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.461 -0.79 . . . . 99.99 110.724 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.257 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.03 85.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 99.99 111.231 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -30.73 73.73 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.856 -0.687 . . . . 99.99 112.747 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.7 mmt -73.04 -28.92 62.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.977 0.418 . . . . 99.99 110.839 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.8 m -66.55 -52.91 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.917 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . 0.493 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -63.28 -24.18 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.913 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.72 -47.34 89.88 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.259 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.98 65.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 99.99 111.064 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.7 mt -68.09 -30.96 70.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.361 -0.382 . . . . 99.99 110.745 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -65.04 -21.25 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 99.99 110.812 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.32 -45.13 89.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.851 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.423 ' O ' ' OG ' ' C' ' 26' ' ' SER . 42.1 t90 -71.6 -32.8 68.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.228 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 75.2 m -78.09 -23.32 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.291 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 tp -87.3 -2.76 58.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.404 -0.362 . . . . 99.99 110.863 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 71.2 p -70.97 -24.13 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 99.99 111.109 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -48.85 -32.74 9.31 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.284 0.564 . . . . 99.99 109.952 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.2 p-10 -173.79 132.18 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 99.99 109.761 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 43.8 Cg_endo -95.3 164.79 1.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.772 2.315 . . . . 99.99 112.367 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -96.48 66.65 2.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.171 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.82 -47.09 3.6 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.724 -0.75 . . . . 99.99 112.642 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 71.1 t -91.96 131.27 35.71 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.456 0.17 . . . . 99.99 111.014 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.435 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 36.0 Cg_exo -57.44 162.16 10.57 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.516 2.144 . . . . 99.99 112.132 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -60.04 -18.4 46.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 99.99 112.541 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.435 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.7 p90 -50.75 -36.19 35.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.789 0.328 . . . . 99.99 111.131 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.7 -53.68 43.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.484 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.5 -20.51 66.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.719 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.76 -52.11 66.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.198 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.53 -38.95 82.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.219 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.68 -7.22 42.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 99.99 111.188 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.408 ' O ' HG13 ' C' ' 45' ' ' ILE . 26.1 ttt -88.72 -38.77 14.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.925 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -70.77 -30.68 67.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.504 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.469 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 80.2 mt -55.82 -54.9 46.86 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.595 -0.275 . . . . 99.99 111.726 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 49.7 Cg_endo -69.41 -28.11 27.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.165 1.91 . . . . 99.99 113.096 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.408 HG13 ' O ' ' C' ' 41' ' ' MET . 91.3 mt -59.66 -62.53 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.166 -0.213 . . . . 99.99 111.332 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.577 ' HE1' HG22 ' A' ' 110' ' ' ILE . 2.8 t90 -64.95 -50.19 67.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.646 0.26 . . . . 99.99 110.813 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' C' ' 75' ' ' ASP . 36.8 t -60.98 -15.06 27.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.022 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.16 -60.32 3.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 99.99 112.364 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.09 -26.42 64.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.309 . . . . 99.99 110.845 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.58 -54.27 45.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.272 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.458 ' HA ' ' SD ' ' C' ' 54' ' ' MET . 21.1 m-85 -67.69 -36.78 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 99.99 111.136 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' MET . . . . . 0.437 ' HE3' ' HG ' ' A' ' 134' ' ' CYS . 51.8 ttp -51.53 -33.09 30.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.14 0.495 . . . . 99.99 109.998 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -75.97 -44.92 37.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 99.99 110.638 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 31.7 mtp -56.49 -19.53 15.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.85 -0.614 . . . . 99.99 110.463 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.48 -44.31 17.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.34 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.491 HG23 HD23 ' A' ' 130' ' ' LEU . 38.4 pt -84.44 10.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 99.99 111.135 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 63.96 54.04 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.915 -0.584 . . . . 99.99 111.148 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -134.77 151.4 50.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.16 14.26 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.788 -0.72 . . . . 99.99 112.58 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -124.43 160.31 28.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.801 0.334 . . . . 99.99 110.769 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.49 142.06 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 99.99 111.028 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.55 104.77 17.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 99.99 110.656 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.96 124.91 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.226 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.8 27.81 17.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 99.99 111.262 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.29 53.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.874 -0.679 . . . . 99.99 112.733 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -98.15 147.41 24.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 99.99 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.37 116.71 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 99.99 111.148 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.85 133.5 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.885 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -78.59 73.33 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.232 0.539 . . . . 99.99 111.054 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.97 -33.01 74.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.582 -0.735 . . . . 99.99 110.951 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.58 -25.89 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 99.99 111.784 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -67.92 -51.22 50.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.364 0.505 . . . . 99.99 112.364 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -82.08 -30.87 31.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.245 0.461 . . . . 99.99 112.245 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 tp -56.48 -44.13 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.758 -0.377 . . . . 99.99 110.783 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.552 ' HD2' ' HA ' ' C' ' 47' ' ' SER . 34.9 t70 -69.54 -20.56 63.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.374 -0.602 . . . . 99.99 109.374 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -87.14 3.68 45.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.567 -0.742 . . . . 99.99 111.201 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 44.8 ttm -104.61 -21.33 13.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.771 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.412 ' O ' HD22 ' C' ' 82' ' ' LEU . 31.5 m -114.48 -35.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.2 0.444 . . . . 99.99 112.2 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.411 HG23 HG22 ' C' ' 43' ' ' ILE . 24.5 m -76.78 -51.7 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.105 0.409 . . . . 99.99 112.105 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.547 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 52.3 m -52.72 -50.77 79.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.039 0.385 . . . . 99.99 112.039 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.547 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 54.4 Cg_exo -52.54 -43.49 54.45 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.943 1.762 . . . . 99.99 112.009 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.412 HD22 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -71.9 -27.28 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 99.99 110.602 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.75 -29.6 67.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.183 0.516 . . . . 99.99 109.743 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -84.04 -39.73 19.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.428 -0.805 . . . . 99.99 110.196 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.94 -32.01 73.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.506 . . . . 99.99 110.404 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -61.21 -25.47 67.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 99.99 110.328 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.448 HD22 HD13 ' C' ' 168' ' ' LEU . 51.2 mt -73.12 -26.32 61.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 99.99 110.629 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 99.99 110.795 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.83 -32.46 35.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.107 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' THR . . . . . 0.402 HG21 ' HA ' ' C' ' 87' ' ' LEU . 10.0 t -81.48 -23.27 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.227 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -36.13 15.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 99.99 111.274 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -123.24 121.63 36.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.948 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -76.35 -35.14 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.835 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.99 141.47 46.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.022 -0.536 . . . . 99.99 110.796 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.44 142.56 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 99.99 110.867 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -91.99 169.42 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.095 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.75 81.19 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 99.99 111.114 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.74 -42.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.012 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 91.7 m95 51.02 76.98 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 99.99 111.081 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 74.6 p -120.26 -57.79 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.945 -0.57 . . . . 99.99 110.985 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.22 -45.07 27.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.967 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.94 -33.35 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.341 -0.39 . . . . 99.99 110.897 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.07 -42.47 51.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.56 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -63.11 -36.61 84.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 99.99 110.869 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.619 ' HB3' HD21 ' C' ' 84' ' ' LEU . 85.1 mt -67.85 -52.88 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.551 . . . . 99.99 110.86 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -53.27 -43.1 67.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.732 . . . . 99.99 110.928 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' SER . . . . . 0.408 ' HB3' ' CD1' ' B' ' 42' ' ' PHE . 49.0 m -64.27 -42.38 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.559 . . . . 99.99 110.828 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.499 HG23 HG22 ' C' ' 142' ' ' ILE . 98.3 m -60.93 -27.26 68.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.962 -0.563 . . . . 99.99 111.252 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.542 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 6.3 tp-100 -75.14 -33.99 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.609 HG21 ' HE1' ' B' ' 46' ' ' TRP . 32.0 mm -62.41 -43.85 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.684 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . 0.462 HG12 HG22 ' B' ' 45' ' ' ILE . 19.9 m -67.07 -41.06 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.881 0.326 . . . . 99.99 111.881 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . 0.448 HG13 H131 ' C' ' 210' ' ' LYR . 75.0 t -62.64 -48.77 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.936 0.347 . . . . 99.99 111.936 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 70.2 mt -56.53 -36.74 48.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.718 0.294 . . . . 99.99 111.028 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 54.2 m -57.64 -49.64 75.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 99.99 111.223 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -64.29 -20.47 66.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.799 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.34 -32.89 24.28 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.912 -0.661 . . . . 99.99 113.087 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.504 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.7 pp -82.92 -25.39 32.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.707 0.289 . . . . 99.99 111.399 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.504 ' N ' HD12 ' C' ' 117' ' ' LEU . 9.8 tp -83.77 -31.55 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.161 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.9 75.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.027 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.41 -28.62 46.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.97 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.1 13.62 2.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.03 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 48.1 t -71.06 127.71 33.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 99.99 110.823 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -93.26 -65.08 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 99.99 110.707 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.462 ' HB2' HG11 ' C' ' 127' ' ' VAL . 99.1 mtt180 -69.07 141.57 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 99.99 110.498 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.3 -11.57 59.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.492 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -91.68 -30.24 16.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.67 0.272 . . . . 99.99 111.157 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' C' ' 124' ' ' ARG . 8.5 p -80.5 -24.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 99.99 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -57.65 -29.41 64.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 99.99 111.029 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.05 -26.57 59.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.151 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' C' ' 127' ' ' VAL . 9.4 mp -76.71 -53.57 7.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 99.99 111.182 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -32.44 71.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 99.99 111.212 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -57.8 -52.58 64.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.382 . . . . 99.99 110.987 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.85 -32.4 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 99.99 111.296 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 81.3 m -63.73 -39.27 93.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.958 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.23 -57.4 15.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.654 -0.784 . . . . 99.99 112.411 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -57.85 -32.65 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 99.99 111.211 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.9 t -56.49 -43.55 79.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.343 -0.389 . . . . 99.99 110.812 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.11 77.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 99.99 110.644 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . 0.427 ' HB2' H133 ' C' ' 210' ' ' LYR . 75.8 t80 -75.46 -22.79 56.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.983 -0.553 . . . . 99.99 111.212 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 89.8 mt -68.05 -55.88 10.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.678 0.275 . . . . 99.99 111.275 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . 0.449 HG13 ' N ' ' C' ' 142' ' ' ILE . 37.4 pt -59.46 -42.16 86.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.859 0.361 . . . . 99.99 111.171 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.499 HG22 HG23 ' C' ' 108' ' ' THR . 49.5 mm -66.08 -35.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 99.99 110.877 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -52.61 -50.27 63.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.751 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -61.48 -32.75 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 99.99 110.504 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.42 -27.69 67.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 99.99 112.479 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . 0.412 HG12 ' O ' ' C' ' 142' ' ' ILE . 43.2 mm -74.5 -27.31 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.057 0.456 . . . . 99.99 110.767 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -89.45 4.76 48.05 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.837 -0.62 . . . . 99.99 111.233 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.47 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 58.5 t-20 -82.36 -48.69 0.87 Allowed Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.012 -0.54 . . . . 99.99 112.402 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 78.3 Cg_exo -40.33 -30.26 0.45 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.652 2.235 . . . . 99.99 113.009 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 95.6 mt -90.16 51.21 1.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 99.99 110.722 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -58.13 163.29 2.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.025 -0.534 . . . . 99.99 111.011 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.06 -23.19 52.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 99.99 111.045 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -83.1 3.54 30.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 99.99 110.649 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 28.9 m -71.91 -16.98 62.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 99.99 111.199 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -58.7 -26.63 64.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 99.99 111.014 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 68.6 p -93.74 -23.98 18.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 99.99 111.245 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.01 -70.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.102 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 79.0 p -161.33 115.46 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.045 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 48.6 m -77.6 -35.55 52.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 99.99 111.047 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.68 -50.77 67.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.235 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.06 -34.48 73.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 99.99 111.127 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.94 -22.24 59.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.13 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -68.26 -57.52 5.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.98 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . 0.469 HD12 ' N ' ' C' ' 165' ' ' TYR . 4.1 pp -65.74 -24.71 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.406 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . 0.469 ' N ' HD12 ' C' ' 164' ' ' LEU . 2.4 t80 -81.39 -25.95 35.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.312 -0.404 . . . . 99.99 110.9 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.27 -46.4 64.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.11 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . 0.655 ' HZ2' ' HB3' ' C' ' 167' ' ' LYS . 4.9 ttpm? -75.33 -29.48 59.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 99.99 110.878 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . 0.448 HD13 HD22 ' C' ' 87' ' ' LEU . 52.4 tp -66.53 -61.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 99.99 111.317 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 85.5 t -53.82 -35.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.459 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -53.95 -54.15 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 99.99 111.075 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . 0.424 ' O ' HG13 ' C' ' 174' ' ' VAL . 30.0 t80 -70.92 -29.9 66.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.006 -0.543 . . . . 99.99 110.806 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -67.48 -31.21 71.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 99.99 111.55 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 40.4 p -77.19 -40.61 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.93 0.344 . . . . 99.99 111.93 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . 0.424 HG13 ' O ' ' C' ' 171' ' ' TYR . 10.9 p -64.2 -25.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 99.99 111.524 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.549 HD11 ' HG ' ' C' ' 209' ' ' SER . 87.4 mt -77.66 -57.87 3.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.031 0.443 . . . . 99.99 111.257 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 -28.06 62.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 99.99 111.424 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.423 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.1 tp -87.54 -22.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.993 0.425 . . . . 99.99 110.341 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.84 -51.52 57.63 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.768 -0.651 . . . . 99.99 112.844 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.606 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -57.01 -56.42 33.7 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.883 -0.327 . . . . 99.99 111.165 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.9 Cg_exo -45.42 -30.47 5.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.177 1.918 . . . . 99.99 112.612 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.418 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.5 mt -65.82 -57.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 99.99 111.314 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 17.3 m -62.67 -25.42 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.466 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -69.92 -16.5 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 99.99 111.017 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.21 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.52 170.25 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.392 -0.367 . . . . 99.99 111.157 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 87.15 -170.08 40.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.801 -0.714 . . . . 99.99 112.755 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.7 158.28 56.85 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.629 2.22 . . . . 99.99 111.703 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 92.4 p 48.99 25.88 1.2 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.336 -0.393 . . . . 99.99 110.881 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -173.14 63.86 0.13 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.029 -0.605 . . . . 99.99 112.502 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 65.0 t80 56.19 91.44 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.848 0.356 . . . . 99.99 111.14 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 137.6 150.99 5.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 99.99 112.33 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -133.41 75.83 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 99.99 111.016 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 41.5 pt -106.57 -179.39 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.012 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -52.65 136.53 32.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.292 -0.413 . . . . 99.99 110.952 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -72.5 -22.04 61.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.782 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 79.0 p -66.55 -37.26 84.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 99.99 111.11 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.84 -43.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 99.99 111.068 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.56 -56.9 14.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.211 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 77.4 p -64.93 -20.74 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.654 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.99 -37.0 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.331 . . . . 99.99 111.136 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 52.7 tp -78.92 -39.77 33.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.44 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.09 0.62 10.99 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.435 -0.348 . . . . 99.99 111.344 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 52.9 t -96.15 -44.85 7.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.049 0.452 . . . . 99.99 110.397 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.1 -31.09 62.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.728 -0.669 . . . . 99.99 111.799 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.564 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -61.02 -54.8 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.818 -0.353 . . . . 99.99 111.053 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.616 ' HB2' ' HH ' ' C' ' 11' ' ' TYR . 41.9 Cg_exo -58.06 -37.28 96.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.68 1.587 . . . . 99.99 110.687 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.23 -26.88 66.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.975 -0.557 . . . . 99.99 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.38 -28.84 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.651 -0.704 . . . . 99.99 110.511 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' SER . . . . . 0.549 ' HG ' HD11 ' C' ' 175' ' ' LEU . 44.5 t -79.33 -40.51 30.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 99.99 110.924 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.475 ' H41' HG22 ' C' ' 80' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.69 -35.27 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 99.99 111.1 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.16 -33.43 61.14 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.977 -0.63 . . . . 99.99 112.785 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -72.71 -32.52 65.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.695 0.283 . . . . 99.99 111.01 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 48.1 t -58.65 -62.64 1.71 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 99.99 110.83 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -60.94 -24.54 66.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.242 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.86 -51.52 47.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 99.99 110.91 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . 0.408 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 18.7 t70 -54.59 -40.03 68.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.169 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.13 -37.4 85.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.385 . . . . 99.99 111.241 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -75.11 -27.71 59.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 99.99 111.11 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.46 -19.86 79.74 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.687 -0.768 . . . . 99.99 112.46 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 79.4 mt -58.48 -51.78 68.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.68 0.276 . . . . 99.99 111.206 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 58.86 -86.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.201 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -85.14 142.8 29.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.419 -0.355 . . . . 99.99 110.503 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.58 90.2 7.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.076 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -122.38 133.79 54.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.8 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -119.27 141.91 48.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.16 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 49.0 m -99.79 133.76 43.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.773 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -100.41 11.44 39.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.071 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.895 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.831 0.348 . . . . 99.99 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -78.09 83.9 4.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 99.99 110.797 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 78.9 mt -76.57 168.17 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 99.99 110.872 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.76 32.6 4.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 99.99 110.873 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 t -143.66 82.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.565 . . . . 99.99 110.649 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.412 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.3 mm? -97.37 100.37 11.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.002 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.4 mm? -74.69 -27.01 60.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.351 -0.386 . . . . 99.99 110.628 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 33.9 m170 -75.37 -34.63 61.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.269 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -67.37 -48.27 67.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.426 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -66.23 -20.37 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.41 . . . . 99.99 110.223 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' O ' ' HG2' ' A' ' 15' ' ' MET . 7.9 t80 -60.48 -60.54 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.85 -0.614 . . . . 99.99 110.266 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 p -57.92 -30.07 37.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.525 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.93 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 99.99 110.943 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.97 -31.53 52.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 99.99 112.365 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 71.4 mmm -69.68 -44.31 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 99.99 110.69 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.4 p -60.22 -58.48 8.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 99.99 111.219 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.8 pp -56.78 -22.42 15.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.301 -0.409 . . . . 99.99 111.279 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.27 -62.5 5.57 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 99.99 112.407 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.42 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.289 . . . . 99.99 111.262 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 17' ' ' ILE . 86.4 mt -74.89 -35.98 62.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.801 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -58.94 -42.52 89.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 99.99 110.778 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.45 -20.4 57.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.677 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.405 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 50.2 t-105 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.264 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -79.92 -34.56 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.914 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -81.87 -1.99 49.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 99.99 110.735 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.3 p -56.42 -26.9 55.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.714 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -46.98 -36.3 7.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.257 0.551 . . . . 99.99 109.825 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -164.05 131.97 2.63 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.307 -0.861 . . . . 99.99 110.132 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -94.03 -178.84 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.074 2.516 . . . . 99.99 112.502 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -89.35 35.95 0.82 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 99.99 111.262 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.78 -40.65 2.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 99.99 112.664 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.0 m -76.46 137.51 67.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 99.99 110.889 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 24.0 Cg_exo -65.12 166.08 19.9 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.578 2.185 . . . . 99.99 112.06 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.465 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -60.7 -18.56 54.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 99.99 111.66 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HH ' ' HA ' ' A' ' 90' ' ' THR . 2.4 p90 -48.12 -39.29 20.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.737 0.303 . . . . 99.99 111.173 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.44 -48.74 63.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.922 0.392 . . . . 99.99 110.514 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -59.94 -29.4 68.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 99.99 110.632 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.54 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 99.99 110.989 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.02 -27.97 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 99.99 111.081 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.32 -9.95 59.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.993 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.411 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 49.6 ttp -89.57 -38.89 13.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.222 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.4 -41.42 73.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 99.99 111.861 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.453 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 30.7 mm -50.59 -52.25 57.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 112.313 0.486 . . . . 99.99 112.313 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HB3' ' HE1' ' A' ' 15' ' ' MET . 55.2 Cg_endo -70.15 -32.51 16.82 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.296 1.997 . . . . 99.99 113.122 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.69 -62.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.548 0.213 . . . . 99.99 111.51 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.531 ' HE1' HG23 ' B' ' 110' ' ' ILE . 0.7 OUTLIER -60.66 -58.63 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.735 0.302 . . . . 99.99 111.017 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 75' ' ' ASP . 45.2 t -55.71 -26.09 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.958 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.3 -58.88 11.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.715 -0.755 . . . . 99.99 112.249 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.47 -28.44 65.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.835 0.35 . . . . 99.99 110.834 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.24 17.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 99.99 111.161 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 30.3 m-85 -62.25 -38.67 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.914 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.2 ttp -55.72 -31.07 62.17 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.0 0.429 . . . . 99.99 110.315 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -40.04 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 99.99 110.491 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.9 mtt -55.94 -33.96 65.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.815 -0.63 . . . . 99.99 110.322 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -66.15 -49.51 67.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 99.99 110.416 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.482 HG21 HG21 ' B' ' 127' ' ' VAL . 10.5 mt -74.58 -3.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 99.99 110.818 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 60.64 51.49 4.97 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.737 -0.665 . . . . 99.99 111.269 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -133.67 122.21 23.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.933 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.07 -1.05 3.73 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.443 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -111.45 153.71 25.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.32 . . . . 99.99 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.84 140.23 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 99.99 111.46 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -87.46 92.64 9.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 99.99 110.749 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.15 118.36 35.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.147 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.83 28.32 17.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 99.99 111.562 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.66 -10.46 64.7 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.705 -0.76 . . . . 99.99 112.949 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -98.07 147.43 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 99.99 110.749 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.1 mt -89.72 122.22 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 99.99 111.134 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.92 143.9 28.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 99.99 111.202 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 92.4 m-70 -88.07 64.66 7.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.74 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.99 -56.0 18.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 99.99 111.39 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.23 -22.54 63.15 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.129 0.418 . . . . 99.99 112.129 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 10.7 mpt_? -68.43 -52.37 33.46 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.921 0.341 . . . . 99.99 111.921 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' CD2' ' HB3' ' A' ' 117' ' ' LEU . 2.4 p90 -69.31 -32.95 72.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 99.99 110.819 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.9 mm -51.48 -53.27 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.519 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' HD2' ' HB2' ' A' ' 47' ' ' SER . 22.1 t70 -62.72 -29.32 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.002 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -80.94 6.85 12.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.047 -0.524 . . . . 99.99 111.305 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 53.1 tpp -105.11 -20.29 13.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 99.99 110.452 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.26 -36.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.739 0.644 . . . . 99.99 112.739 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.1 t -79.9 -35.75 37.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.351 0.5 . . . . 99.99 112.351 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 36.7 m -65.97 -50.39 52.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.851 0.315 . . . . 99.99 111.851 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 51.8 Cg_exo -56.21 -38.24 95.32 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.787 1.658 . . . . 99.99 111.369 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.07 -32.08 63.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 99.99 110.823 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.2 tp -67.2 -28.12 67.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.939 0.399 . . . . 99.99 110.381 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' A' ' 105' ' ' LEU . 5.3 tt -84.08 -36.2 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 99.99 110.406 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -61.72 -37.51 84.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.479 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 t -56.83 -30.51 63.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 99.99 110.701 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.11 -34.51 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 99.99 111.209 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -71.71 -39.65 70.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.393 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -68.73 -26.33 65.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 99.99 111.097 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.497 ' HA ' ' HH ' ' A' ' 35' ' ' TYR . 71.8 p -82.96 -23.49 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.538 -0.301 . . . . 99.99 111.365 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -33.85 16.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.046 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 86.1 mtp -130.72 99.21 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 99.99 110.782 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -62.22 -44.93 95.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 99.99 110.902 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -109.19 147.19 32.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.139 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.83 142.05 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.599 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -125.06 -67.72 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.98 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -146.94 93.07 2.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -166.74 63.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -89.68 16.91 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 99.99 111.044 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 p -98.22 -25.64 14.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 99.99 111.314 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.96 -53.71 6.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.994 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.61 -22.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.306 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.38 -49.34 8.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 99.99 112.653 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.99 -39.69 86.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 99.99 111.056 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.562 ' HB3' HD23 ' A' ' 84' ' ' LEU . 80.4 mt -61.71 -58.62 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.027 -0.533 . . . . 99.99 111.051 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.3 ttm -53.67 -32.55 52.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.894 -0.594 . . . . 99.99 111.111 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.4 ' HB3' ' CD1' ' C' ' 42' ' ' PHE . 71.5 m -66.13 -55.63 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.167 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -53.88 -29.19 40.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.069 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.448 ' NE2' HG23 ' A' ' 80' ' ' THR . 15.5 mm100 -62.87 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.87 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.609 HG23 ' HE1' ' C' ' 46' ' ' TRP . 33.8 mm -53.42 -30.64 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 99.99 110.849 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.44 -49.15 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 99.99 111.233 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.68 -46.17 96.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.319 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 53.0 mt -58.7 -34.55 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.962 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.6 m -56.42 -51.45 68.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.695 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -65.39 -20.68 66.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 99.99 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.45 -40.71 12.52 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.803 -0.713 . . . . 99.99 113.085 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.4 pp -73.85 -29.68 62.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.557 0.217 . . . . 99.99 111.422 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.514 ' N ' HD11 ' A' ' 117' ' ' LEU . 9.4 tp -83.72 -29.64 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 99.99 111.428 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.78 68.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.402 . . . . 99.99 111.149 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -80.63 -21.66 41.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 99.99 110.816 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.61 10.75 10.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.001 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.5 p -70.08 120.94 16.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 99.99 111.151 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -96.97 -65.17 0.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.787 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.52 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.1 mtp180 -69.77 134.12 48.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.61 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.68 -11.48 60.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.966 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -81.0 -55.24 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.401 . . . . 99.99 110.635 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.7 p -65.9 -23.68 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.916 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -52.28 -37.24 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 99.99 111.327 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -73.95 -26.46 60.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 99.99 111.303 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.39 -39.08 33.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.567 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -75.75 -26.5 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 99.99 111.283 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.438 ' HE1' ' HB3' ' A' ' 183' ' ' TRP . 53.4 t80 -68.35 -48.25 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.907 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -65.9 -29.81 48.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.898 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.4 t -64.43 -38.71 91.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.792 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.68 -54.27 23.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.75 -0.738 . . . . 99.99 112.636 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.95 -30.77 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.712 0.292 . . . . 99.99 111.545 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.11 -43.65 97.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.866 0.365 . . . . 99.99 110.894 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.47 86.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 99.99 110.709 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -63.03 -28.26 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 99.99 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.87 -60.74 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.397 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 pt -59.3 -41.13 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.867 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -65.51 -33.48 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 99.99 111.391 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.3 tp -68.05 -40.14 82.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.445 -0.343 . . . . 99.99 111.049 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.702 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 54.3 t-105 -69.28 -25.01 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 99.99 110.881 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.772 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -80.9 -41.66 10.41 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.971 -0.633 . . . . 99.99 112.669 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.86 -18.18 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.374 . . . . 99.99 111.14 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -88.0 4.92 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 99.99 111.466 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.772 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 -91.23 -44.61 0.38 Allowed Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.84 0.682 . . . . 99.99 112.84 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 26.8 Cg_exo -30.47 -60.68 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.13 2.554 . . . . 99.99 113.741 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.473 HD21 ' HB ' ' A' ' 154' ' ' THR . 99.0 mt -147.56 121.23 9.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.551 0.215 . . . . 99.99 111.209 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -173.92 -45.74 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.525 -0.307 . . . . 99.99 111.82 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.75 -59.18 2.59 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.797 0.665 . . . . 99.99 112.797 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.38 -39.07 54.74 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 112.47 0.544 . . . . 99.99 112.47 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.473 ' HB ' HD21 ' A' ' 150' ' ' LEU . 12.5 t -60.98 -14.68 24.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.001 0.371 . . . . 99.99 112.001 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -66.24 -34.74 78.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.619 -0.264 . . . . 99.99 111.6 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.2 m -102.71 -28.78 11.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.56 -0.291 . . . . 99.99 111.581 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -59.7 -71.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.818 0.342 . . . . 99.99 110.96 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.8 t -133.09 119.91 20.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.811 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 55.9 m -76.47 -22.46 54.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.873 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.71 -57.12 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.986 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.4 tp -65.07 -19.79 66.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.018 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.25 -41.4 34.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 99.99 111.184 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.7 -38.83 92.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.087 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.57 -46.32 79.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.833 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.7 -22.58 60.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.768 -0.651 . . . . 99.99 111.217 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.07 -50.66 21.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.055 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -75.01 -20.66 59.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.167 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.4 tp -77.07 -50.6 12.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.598 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.92 -35.44 49.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.226 -0.443 . . . . 99.99 112.08 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -56.95 -35.78 69.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 99.99 110.939 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -77.84 -35.29 51.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.487 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -70.01 -22.31 63.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 99.99 110.16 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 57.5 m -79.42 -48.38 14.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.852 -0.613 . . . . 99.99 111.519 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.507 HG13 HD22 ' A' ' 175' ' ' LEU . 7.3 p -62.19 -33.42 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.272 0.471 . . . . 99.99 112.272 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.507 HD22 HG13 ' A' ' 174' ' ' VAL . 4.0 mm? -76.52 -52.77 9.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.8 0.333 . . . . 99.99 110.96 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -31.4 64.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.905 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.468 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 14.4 tt -87.65 -19.51 7.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.053 0.454 . . . . 99.99 110.198 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.23 -50.91 60.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.642 -0.708 . . . . 99.99 112.773 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.575 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.1 m-85 -58.37 -54.88 51.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.719 0.26 . . . . 99.99 111.308 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.5 Cg_exo -45.7 -30.88 6.86 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.283 1.989 . . . . 99.99 112.571 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 37.3 mm -68.98 -60.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 99.99 111.454 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.32 -25.53 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.715 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.438 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 38.0 m95 -62.98 -27.23 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.623 -0.262 . . . . 99.99 111.016 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.82 -43.69 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 99.99 110.779 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 39.5 pt -97.67 145.68 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.524 . . . . 99.99 111.011 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.86 -163.42 17.31 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.809 -0.71 . . . . 99.99 112.491 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.39 160.98 47.69 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.463 2.109 . . . . 99.99 112.1 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 89.4 p 49.86 24.64 1.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.766 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -140.12 -68.84 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.02 -0.609 . . . . 99.99 112.376 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -167.5 -28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 99.99 110.535 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.6 -155.95 4.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.96 -0.638 . . . . 99.99 112.626 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -158.65 28.51 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.327 . . . . 99.99 110.904 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.5 pt -95.12 153.76 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.35 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -156.63 35.35 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.988 -0.551 . . . . 99.99 110.42 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -93.21 -172.52 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.96 -0.564 . . . . 99.99 111.065 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 52.3 m -64.31 -34.61 78.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.507 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt -58.23 -33.13 46.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.367 -0.378 . . . . 99.99 111.588 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.86 -60.86 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 99.99 111.271 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.4 t -62.57 -35.25 78.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.367 . . . . 99.99 111.173 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -59.11 -26.87 65.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.062 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 61.5 tp -78.11 -46.8 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.998 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -74.0 -8.19 55.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 99.99 111.377 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 99.4 m -96.06 -39.2 9.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.086 0.47 . . . . 99.99 110.897 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.0 tp -72.95 -34.34 66.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 99.99 111.734 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -59.42 -54.54 55.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 121.102 -0.239 . . . . 99.99 111.174 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -57.28 -41.89 68.44 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.734 1.623 . . . . 99.99 111.456 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.05 -28.05 69.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 99.99 110.067 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -83.73 -21.46 32.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.784 -0.644 . . . . 99.99 110.386 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.9 p -94.8 -16.11 23.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 99.99 110.347 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.496 H191 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.7 m -80.18 -37.03 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.503 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.14 -37.13 91.26 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.618 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -64.17 -35.69 81.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 99.99 110.756 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.2 m -59.83 -60.62 3.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 99.99 111.143 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.55 -21.29 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.29 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.1 tt -68.88 -44.83 72.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.434 -0.348 . . . . 99.99 110.715 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -66.99 -32.51 73.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 99.99 110.993 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.48 -40.68 96.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 99.99 110.953 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -86.61 -20.94 27.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 99.99 110.888 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.27 99.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 99.99 112.457 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.0 -55.7 17.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 99.99 110.961 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 55.4 84.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.824 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -66.57 112.07 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.05 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 52.8 tp -132.76 96.98 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.999 -0.546 . . . . 99.99 110.404 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.57 80.04 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.748 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.22 65.52 6.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.857 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 79.3 p -56.52 107.35 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.565 . . . . 99.99 111.035 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -111.41 124.19 51.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.843 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.964 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.873 0.368 . . . . 99.99 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -76.36 88.56 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.678 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.16 150.64 25.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 99.99 110.899 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -88.16 23.48 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.966 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.6 m -93.22 -70.87 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.803 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 mt 57.21 72.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 99.99 111.273 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.58 -32.0 53.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 99.99 110.472 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 26.9 m170 -73.47 -29.12 62.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 99.99 110.414 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -70.85 -40.78 72.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.938 -0.574 . . . . 99.99 110.336 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.31 -25.27 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.348 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.67 -53.86 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.653 -0.703 . . . . 99.99 110.725 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.91 -29.78 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.778 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.68 87.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.186 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.58 -34.35 54.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.825 -0.702 . . . . 99.99 112.481 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.68 76.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 99.99 111.105 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 37.3 m -60.29 -57.34 13.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.178 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' B' ' 20' ' ' LEU . 2.7 pp -60.1 -22.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.187 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.86 -63.7 4.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.573 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -32.0 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 99.99 111.196 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 17' ' ' ILE . 95.9 mt -66.63 -39.6 88.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.88 -35.16 74.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.726 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -79.23 -20.19 48.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.637 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.489 ' O ' ' OG ' ' B' ' 26' ' ' SER . 66.1 t90 -67.05 -36.67 82.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 99.99 110.657 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.6 m -81.44 -35.03 31.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.531 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.39 -2.25 44.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.877 -0.602 . . . . 99.99 110.34 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 57.7 p -61.98 -23.19 66.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.936 -0.574 . . . . 99.99 110.828 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -49.99 -31.98 14.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.159 0.504 . . . . 99.99 109.902 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -170.49 132.13 0.94 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.342 -0.845 . . . . 99.99 109.92 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -95.26 172.72 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.092 2.528 . . . . 99.99 112.55 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.536 ' HD3' HD22 ' B' ' 218' ' ' LEU . 14.9 ptm180 -88.28 45.72 1.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.077 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.27 1.77 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.812 -0.709 . . . . 99.99 112.824 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.5 123.24 89.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.488 0.185 . . . . 99.99 110.986 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 33.3 Cg_exo -59.23 162.1 14.98 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.376 2.051 . . . . 99.99 112.365 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' B' ' 34' ' ' GLN . 0.0 OUTLIER -58.86 -18.08 29.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 99.99 112.017 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.478 ' HH ' ' HA ' ' B' ' 90' ' ' THR . 2.8 p90 -50.21 -38.09 38.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.682 0.277 . . . . 99.99 111.281 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.519 ' HE2' ' HG ' ' B' ' 86' ' ' SER . 11.0 tp10 -73.14 -40.57 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 99.99 110.651 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -64.68 -31.57 72.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 99.99 110.724 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' C' ' 104' ' ' PHE . 51.2 tp -62.14 -57.16 12.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.706 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 14.4 t -65.07 -36.3 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.808 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.12 47.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 99.99 111.205 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 27.6 ttt -89.36 -41.71 11.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.082 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -71.87 -34.62 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.972 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.436 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 99.2 mt -54.57 -53.2 62.73 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.078 0.399 . . . . 99.99 112.078 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.1 Cg_endo -70.53 -31.81 16.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.31 2.007 . . . . 99.99 113.044 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.38 -62.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.564 0.221 . . . . 99.99 111.543 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.516 ' HE1' HG21 ' C' ' 110' ' ' ILE . 0.9 OUTLIER -60.47 -56.55 20.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.73 0.3 . . . . 99.99 110.98 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -57.23 -22.31 40.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.953 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.29 -61.27 5.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.632 -0.794 . . . . 99.99 112.753 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.481 HD11 ' N ' ' B' ' 50' ' ' ALA . 3.3 pp -58.6 -22.74 57.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.625 0.25 . . . . 99.99 111.339 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.481 ' N ' HD11 ' B' ' 49' ' ' LEU . . . -64.96 -57.47 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 99.99 110.983 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.463 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 30.5 m-85 -63.67 -37.26 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.653 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -49.63 -38.51 32.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.147 0.499 . . . . 99.99 110.007 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.66 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 99.99 110.751 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 42.4 mtt -53.25 -24.91 12.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 99.99 110.527 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -77.13 -48.42 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 99.99 110.78 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.56 11.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 99.99 111.434 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 61.44 67.27 0.79 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.03 -0.532 . . . . 99.99 111.355 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -144.9 152.8 40.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.917 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.29 17.27 47.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.81 -0.709 . . . . 99.99 112.467 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -128.95 148.81 50.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 99.99 110.923 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.77 150.71 29.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.859 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.36 94.9 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.682 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.71 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.152 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.23 30.28 20.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.251 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.18 -15.64 48.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.857 -0.687 . . . . 99.99 112.913 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -98.37 146.81 25.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.801 0.334 . . . . 99.99 110.781 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 54.6 mt -86.2 131.14 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.263 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.9 143.29 32.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.436 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 72.3 m-70 -84.48 65.03 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.154 0.502 . . . . 99.99 110.682 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -63.82 -51.91 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.635 -0.712 . . . . 99.99 111.581 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.411 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -64.61 -22.46 66.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.933 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.436 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 22.4 tpp180 -68.46 -51.62 41.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.257 0.465 . . . . 99.99 112.257 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' B' ' 77' ' ' MET . 6.0 p90 -76.33 -34.4 58.99 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.147 0.425 . . . . 99.99 112.147 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.411 HG22 ' O ' ' B' ' 71' ' ' ALA . 18.2 tt -55.39 -43.74 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 120.656 -0.417 . . . . 99.99 110.623 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.67 -19.96 64.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.424 -0.584 . . . . 99.99 109.424 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -88.43 4.14 47.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.517 -0.765 . . . . 99.99 111.306 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.445 ' HG2' HG22 ' B' ' 113' ' ' ILE . 31.8 mtp -101.65 -20.42 15.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.343 -0.39 . . . . 99.99 110.383 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.413 ' O ' HD23 ' B' ' 82' ' ' LEU . 32.7 m -113.92 -29.86 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 99.99 111.87 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.426 HG22 HG22 ' B' ' 43' ' ' ILE . 30.6 m -81.3 -51.38 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.933 0.345 . . . . 99.99 111.933 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.575 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 21.8 m -52.27 -50.61 78.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.114 0.413 . . . . 99.99 112.114 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.4 Cg_exo -53.75 -49.32 17.62 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.785 1.657 . . . . 99.99 111.729 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.413 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -64.27 -31.25 72.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.717 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.54 -35.26 79.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.154 0.502 . . . . 99.99 109.956 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -84.27 -35.7 23.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 99.99 111.236 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 88.1 mt -58.61 -41.24 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.054 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' SER . . . . . 0.519 ' HG ' ' HE2' ' B' ' 36' ' ' GLU . 35.1 t -59.02 -28.65 66.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.827 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 mt -67.47 -32.32 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 99.99 110.905 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -72.93 -39.38 66.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.294 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -70.26 -24.69 63.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 99.99 111.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' THR . . . . . 0.478 ' HA ' ' HH ' ' B' ' 35' ' ' TYR . 32.6 m -78.62 -30.95 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 99.99 111.178 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.27 -25.41 25.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.187 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -132.81 99.36 4.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.815 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.28 -50.97 63.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.984 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -104.77 143.38 33.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 99.99 110.732 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 tt -124.9 142.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.887 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.426 ' HG2' ' HG3' ' B' ' 97' ' ' LYS . 38.7 ttpt -128.31 -70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 99.99 111.104 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.426 ' HG3' ' HG2' ' B' ' 96' ' ' LYS . 29.9 mtpp -141.81 95.84 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.03 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -170.24 83.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 99.99 110.907 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -106.49 14.24 27.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.721 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 2.8 t -91.15 -42.0 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 99.99 111.424 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.15 -47.07 59.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.157 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -63.2 -32.33 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.391 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.35 -31.81 33.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 99.99 112.729 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.09 -36.65 72.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 99.99 111.002 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' B' ' 84' ' ' LEU . 88.0 mt -74.84 -44.27 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.063 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.7 ttp -65.53 -37.38 86.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 99.99 111.351 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.522 ' HG ' ' H ' ' B' ' 108' ' ' THR . 80.9 p -65.7 -50.36 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.343 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.522 ' H ' ' HG ' ' B' ' 107' ' ' SER . 35.9 p -56.79 -34.33 67.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.32 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -61.52 -47.32 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 99.99 111.139 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.531 HG23 ' HE1' ' A' ' 46' ' ' TRP . 54.5 mt -54.85 -35.09 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 99.99 110.605 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 t -65.52 -47.32 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 99.99 111.094 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.56 -47.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.212 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.445 HG22 ' HG2' ' B' ' 77' ' ' MET . 47.0 mt -58.15 -33.26 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.996 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.1 m -58.89 -48.65 80.65 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.979 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.5 m -67.3 -23.23 65.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.974 -0.557 . . . . 99.99 110.852 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.35 -32.48 34.63 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.92 -0.657 . . . . 99.99 113.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.495 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.4 pp -80.85 -28.89 35.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.706 0.289 . . . . 99.99 111.206 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.495 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.55 -31.25 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.385 . . . . 99.99 111.321 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.91 -47.06 74.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.299 -0.41 . . . . 99.99 110.957 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 -21.12 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.716 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' B' ' 118' ' ' ILE . 98.8 mt -81.64 14.79 2.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.831 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 79.0 p -61.24 134.5 57.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 99.99 111.024 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -117.52 -45.21 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.832 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 59.4 ttp180 -108.23 132.66 53.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.64 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.7 -19.0 63.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 99.99 111.252 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.518 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 52.4 t-105 -71.26 -53.65 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.401 -0.363 . . . . 99.99 110.868 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' B' ' 124' ' ' ARG . 7.3 p -74.86 -24.09 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.106 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -52.42 -39.67 61.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 99.99 111.2 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -71.34 -32.59 68.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.391 . . . . 99.99 111.384 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.58 -56.84 6.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.189 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -58.01 -29.97 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.416 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.26 -53.27 57.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 99.99 110.725 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.85 -31.03 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.775 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.48 -34.34 75.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 99.99 110.859 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.05 -55.02 8.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.824 -0.703 . . . . 99.99 112.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m -59.83 -32.94 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 99.99 110.955 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.3 t -65.61 -36.74 84.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.613 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.21 91.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.627 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -68.27 -23.23 64.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 99.99 110.787 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -58.82 5.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 99.99 110.802 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 31.7 pt -62.6 -40.15 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 99.99 111.503 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 87.6 mt -64.61 -33.99 66.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 99.99 110.909 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.75 -45.0 95.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 99.99 110.942 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.81 -25.53 65.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.286 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.92 -35.66 21.01 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 99.99 112.746 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.6 -22.47 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 99.99 110.454 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -87.08 4.65 41.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 99.99 111.015 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.461 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 51.4 t30 -90.3 -47.78 0.38 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.008 -0.542 . . . . 99.99 112.147 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 79.7 Cg_exo -42.05 -32.95 2.04 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.567 2.178 . . . . 99.99 112.869 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 64.6 tp -55.77 -57.7 10.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.416 . . . . 99.99 110.387 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 63.44 128.59 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.095 -0.502 . . . . 99.99 111.3 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.67 -18.02 57.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.84 -0.618 . . . . 99.99 111.161 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -62.83 -23.95 67.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.49 . . . . 99.99 111.278 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 73.3 p -80.36 -15.37 57.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.485 -0.325 . . . . 99.99 111.615 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -70.37 -27.3 64.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.409 -0.36 . . . . 99.99 110.891 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 4.6 t -107.5 -16.74 14.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.306 -0.406 . . . . 99.99 111.442 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -79.28 -49.36 12.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.425 -0.352 . . . . 99.99 110.999 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 66.7 m -151.12 116.2 5.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 99.99 110.967 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 44.8 t -77.88 -22.05 50.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.918 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.69 -61.86 1.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.977 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.91 -25.02 60.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.852 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.15 -57.74 3.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.036 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -53.52 -23.25 9.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.087 0.47 . . . . 99.99 110.427 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.0 tp -73.45 -40.32 64.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.626 -0.715 . . . . 99.99 110.729 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -80.6 -25.16 38.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 99.99 111.101 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -75.28 -38.48 60.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 99.99 110.97 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -79.95 -21.6 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.791 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 48.7 tp -81.34 -46.12 15.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 99.99 111.464 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.35 -33.77 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 99.99 112.282 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 9.9 t -51.73 -41.48 61.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.617 0.246 . . . . 99.99 111.282 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . 0.407 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 37.3 m-85 -77.02 -40.3 46.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 99.99 110.709 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -62.11 -23.24 66.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.865 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 28.0 m -79.31 -50.8 10.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.577 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.51 -28.94 41.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.986 0.365 . . . . 99.99 111.986 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 77.5 mt -76.27 -57.02 4.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.905 0.383 . . . . 99.99 111.213 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -32.47 56.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.89 -0.596 . . . . 99.99 111.224 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.443 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 19.1 tt -87.4 -19.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.451 . . . . 99.99 110.385 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.26 59.45 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.742 -0.663 . . . . 99.99 112.953 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 84.5 m-85 -58.22 -54.86 51.42 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.782 0.291 . . . . 99.99 111.342 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -45.26 -32.44 7.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.164 1.91 . . . . 99.99 112.685 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.432 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.4 mt -65.62 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.462 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 35.2 m -60.23 -27.01 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.404 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -62.93 -25.91 68.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 99.99 111.178 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.27 -40.93 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 99.99 110.716 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.59 -179.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 99.99 110.798 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 67.86 -159.36 51.01 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.748 -0.739 . . . . 99.99 112.695 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.2 160.0 36.52 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.755 2.304 . . . . 99.99 112.322 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 59.8 m 56.93 17.75 3.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.825 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -133.03 -60.13 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.038 -0.601 . . . . 99.99 112.371 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -172.3 -31.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 99.99 110.637 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -85.48 -174.78 50.16 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.878 -0.677 . . . . 99.99 112.778 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -141.31 74.49 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 99.99 110.326 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 33.7 pt -134.97 146.72 30.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 99.99 111.224 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -144.31 39.63 1.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.715 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . 0.458 ' HB2' HG22 ' B' ' 197' ' ' ILE . 84.8 mm-40 -85.94 178.39 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 99.99 111.098 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 8.6 t -67.69 -28.72 67.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.771 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' B' ' 195' ' ' GLN . 7.7 tp -62.2 -29.53 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.833 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.23 -60.65 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.879 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 8.1 t -62.17 -36.83 83.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 99.99 111.152 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.69 -27.46 64.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.758 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -75.89 -50.35 15.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 99.99 111.049 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -73.02 -5.85 41.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.565 -0.289 . . . . 99.99 110.843 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.425 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 60.8 m -96.48 -41.86 8.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.267 0.556 . . . . 99.99 110.472 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.51 -38.38 74.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.578 -0.737 . . . . 99.99 111.909 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.659 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.3 tp -58.3 -53.94 60.95 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 120.961 -0.296 . . . . 99.99 111.321 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -53.62 -42.08 68.81 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.791 1.661 . . . . 99.99 111.399 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.09 -42.99 86.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 99.99 110.343 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -69.81 -30.19 67.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.457 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -82.31 -17.99 43.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.504 . . . . 99.99 110.279 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.427 ' H9 ' ' C18' ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 10.4 p -85.29 -33.19 7.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.944 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.79 96.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 99.99 112.339 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -69.47 -32.26 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.73 0.3 . . . . 99.99 110.875 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 49.2 m -59.91 -62.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.95 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.13 -20.33 65.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.589 . . . . 99.99 110.945 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.11 -54.18 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.279 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.98 -37.48 76.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 99.99 111.646 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.536 HD22 ' HD3' ' B' ' 30' ' ' ARG . 78.8 mt -59.16 -49.1 79.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 99.99 111.144 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -77.08 -20.53 55.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 99.99 111.051 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.28 -47.93 86.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.881 -0.676 . . . . 99.99 112.88 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 58.7 tp -58.34 -56.1 26.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.548 0.214 . . . . 99.99 111.033 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 55.78 84.08 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.315 -0.402 . . . . 99.99 110.848 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.53 104.91 6.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 99.99 110.869 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 54.7 tp -88.58 -74.0 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.895 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -141.1 81.23 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.611 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.12 91.41 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 99.99 111.061 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 42.7 t -94.15 83.15 4.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.756 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -87.0 142.61 27.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.948 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 99.99 110.947 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.792 0.33 . . . . 99.99 111.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -59.65 152.75 21.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.992 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -139.82 -66.42 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.04 -0.527 . . . . 99.99 110.902 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -138.75 35.18 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.935 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -133.6 76.71 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.021 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.7 mt -100.6 94.27 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.559 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.68 -49.06 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 99.99 111.312 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.405 ' HB2' ' HB3' ' C' ' 55' ' ' ALA . 49.1 m-70 -64.72 -24.19 67.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 99.99 110.908 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -70.57 -50.03 41.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.399 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.48 -21.29 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.204 0.526 . . . . 99.99 109.932 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -58.99 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.49 -0.777 . . . . 99.99 110.413 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.97 -26.84 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 99.99 111.23 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.75 83.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.398 -0.365 . . . . 99.99 111.046 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.6 -23.81 77.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.831 -0.699 . . . . 99.99 112.499 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' MET . . . . . 0.408 ' HB3' ' HB2' ' C' ' 44' ' ' PRO . 18.9 mmt -77.89 -42.92 31.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.52 0.2 . . . . 99.99 111.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' THR . . . . . 0.496 ' HG1' ' H ' ' C' ' 17' ' ' ILE . 37.6 p -59.1 -50.94 72.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 99.99 110.893 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . 0.496 ' H ' ' HG1' ' C' ' 16' ' ' THR . 0.0 OUTLIER -62.56 -29.51 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.684 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.17 -61.59 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.861 -0.685 . . . . 99.99 112.702 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' C' ' 41' ' ' MET . . . -56.66 -31.95 64.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 99.99 111.127 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.5 mt -69.13 -29.05 67.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.247 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.26 -41.39 84.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.94 0.4 . . . . 99.99 110.596 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.94 -24.5 52.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 99.99 110.606 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -55.28 -43.17 74.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.295 -0.411 . . . . 99.99 110.631 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 44.2 t -82.73 -37.45 24.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.973 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 38.2 tp -77.42 -3.31 39.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.739 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 65.4 p -60.77 -23.62 65.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 99.99 110.928 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.6 -26.71 14.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.092 0.473 . . . . 99.99 109.771 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 14.6 t-20 -172.95 131.87 0.62 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 99.99 110.174 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 35.4 Cg_endo -95.67 170.54 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.147 2.564 . . . . 99.99 112.538 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -86.65 44.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 99.99 111.172 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.07 -45.67 1.39 Allowed Glycine 0 CA--C 1.517 0.188 0 C-N-CA 120.827 -0.701 . . . . 99.99 112.799 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 4.0 p -74.58 121.45 85.26 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.633 0.254 . . . . 99.99 111.15 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.492 ' HB2' ' CD1' ' C' ' 35' ' ' TYR . 38.8 Cg_exo -57.68 166.46 5.01 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.642 2.228 . . . . 99.99 112.613 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -18.48 60.98 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.806 1.039 . . . . 99.99 113.806 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' C' ' 33' ' ' PRO . 6.5 p90 -54.79 -31.88 59.44 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.479 -0.489 . . . . 99.99 111.123 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.52 -54.56 11.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.918 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -65.18 -20.81 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 99.99 111.278 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.72 -61.48 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 99.99 110.036 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.44 -29.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 99.99 110.13 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.83 -8.85 57.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.82 -0.627 . . . . 99.99 110.807 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.425 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.1 ttt -89.02 -37.14 15.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 99.99 110.528 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 107' ' ' SER . 46.0 t80 -72.28 -29.81 64.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.7 -0.682 . . . . 99.99 111.841 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.481 HG23 HG23 ' C' ' 79' ' ' THR . 37.8 mm -60.22 -52.04 75.99 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 112.402 0.519 . . . . 99.99 112.402 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 64.1 Cg_endo -72.81 -34.55 6.66 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.348 2.032 . . . . 99.99 114.25 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.444 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.1 tp -63.17 -50.44 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.338 0.495 . . . . 99.99 112.338 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.609 ' HE1' HG23 ' A' ' 110' ' ' ILE . 1.0 OUTLIER -67.59 -58.77 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 99.99 111.345 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' C' ' 75' ' ' ASP . 89.6 p -56.64 -31.35 64.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 99.99 110.515 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.82 -57.03 19.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.986 -0.626 . . . . 99.99 112.773 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.28 -29.62 68.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.91 0.386 . . . . 99.99 110.881 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.73 95.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.974 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -69.51 -47.22 64.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.87 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 50.7 ttp -50.95 -28.23 9.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 99.99 110.457 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.446 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -74.24 -43.35 57.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.843 -0.617 . . . . 99.99 110.879 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.2 -26.42 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 99.99 110.612 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' C' ' 8' ' ' HIS . . . -77.74 -45.22 25.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 99.99 111.275 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' C' ' 53' ' ' ALA . 31.1 pt -79.45 4.86 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 99.99 111.3 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.2 68.03 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.861 -0.609 . . . . 99.99 111.377 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -149.54 136.59 19.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.822 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.28 4.84 23.53 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.712 -0.756 . . . . 99.99 112.356 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -114.22 152.68 30.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 99.99 110.872 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.18 145.47 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.61 91.2 8.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 99.99 110.796 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.02 105.94 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 99.99 111.208 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.95 36.33 24.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.367 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.43 -13.49 51.08 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 99.99 112.773 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -99.35 134.53 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 99.99 110.921 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 65.6 mt -76.59 137.25 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 99.99 111.006 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.72 143.12 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.073 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.462 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 59.0 m-70 -83.2 61.17 5.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.553 . . . . 99.99 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -60.64 -58.01 10.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 99.99 111.671 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.35 -22.44 66.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.324 0.49 . . . . 99.99 112.324 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.6 tpp180 -65.52 -51.6 58.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.101 0.408 . . . . 99.99 112.101 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -74.13 -29.42 61.81 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.875 -0.33 . . . . 99.99 111.123 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 mm -52.7 -50.53 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 120.853 0.358 . . . . 99.99 110.496 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.47 ' HD2' ' HB3' ' C' ' 47' ' ' SER . 34.7 t70 -66.66 -21.98 66.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.112 -0.495 . . . . 99.99 109.737 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.56 5.45 39.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.936 -0.574 . . . . 99.99 110.709 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 57.0 tpp -102.71 -21.81 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 99.99 110.389 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.443 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 2.5 p -113.73 -47.42 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.983 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.481 HG23 HG23 ' C' ' 43' ' ' ILE . 96.5 m -61.11 -53.64 54.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.163 0.431 . . . . 99.99 112.163 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.614 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 29.9 m -51.66 -54.48 39.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.449 0.537 . . . . 99.99 112.449 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 77.1 Cg_exo -49.3 -37.79 40.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.896 1.73 . . . . 99.99 112.143 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.404 HD21 ' O ' ' C' ' 78' ' ' VAL . 4.1 mm? -74.39 -38.39 63.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 99.99 110.63 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.82 -33.64 68.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.173 0.511 . . . . 99.99 109.99 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.508 HD23 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -80.31 -44.93 18.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.598 -0.728 . . . . 99.99 110.783 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.3 -32.81 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.681 -0.69 . . . . 99.99 111.443 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -62.14 -34.53 76.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 99.99 110.691 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.32 -44.46 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 99.99 110.9 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 43.4 t -65.83 -23.21 66.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.036 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -83.84 -26.72 29.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 99.99 110.666 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -77.1 -39.9 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 99.99 111.254 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.11 -44.29 54.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 99.99 111.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -111.79 101.76 10.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.825 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.44 -39.62 70.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 99.99 110.938 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -116.44 136.51 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.794 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.03 144.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.035 -0.53 . . . . 99.99 110.802 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -126.21 -65.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.078 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -149.09 110.0 4.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.379 . . . . 99.99 110.846 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -144.26 -84.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.902 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 90.9 m95 53.82 24.79 4.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.3 -0.409 . . . . 99.99 111.256 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 38.8 p -120.4 -51.93 2.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.907 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 68.1 tp -72.27 -53.1 13.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.768 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 13.5 tt -56.55 -32.77 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.033 -0.531 . . . . 99.99 111.314 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.8 -35.17 22.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 99.99 112.617 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' B' ' 38' ' ' LEU . 90.1 t80 -70.3 -29.76 66.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 99.99 111.091 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.508 ' HB3' HD23 ' C' ' 84' ' ' LEU . 95.7 mt -79.42 -50.45 10.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 99.99 111.134 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -61.53 -30.92 70.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.972 -0.558 . . . . 99.99 111.094 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 95.6 p -68.95 -52.82 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.066 0.46 . . . . 99.99 110.747 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 67.7 p -60.7 -23.96 65.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 99.99 110.677 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.7 -50.37 67.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.033 -0.531 . . . . 99.99 110.319 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.516 HG21 ' HE1' ' B' ' 46' ' ' TRP . 43.9 mm -55.85 -33.09 33.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 99.99 110.476 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.89 -45.93 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 99.99 110.797 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.64 -47.53 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.945 -0.571 . . . . 99.99 111.217 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 29.8 mt -60.15 -31.91 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.057 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 22.7 m -59.49 -48.17 82.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.022 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 44.1 m -70.15 -20.29 63.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 99.99 110.965 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.11 -33.09 30.17 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.837 -0.697 . . . . 99.99 113.26 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.517 HD11 ' N ' ' C' ' 118' ' ' ILE . 3.3 pp -79.89 -29.82 40.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.717 0.258 . . . . 99.99 111.592 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.517 ' N ' HD11 ' C' ' 117' ' ' LEU . 8.5 tp -83.81 -26.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 99.99 111.181 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.35 -40.99 68.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.169 -0.468 . . . . 99.99 111.049 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 -17.56 48.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.903 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.57 34.77 0.88 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 99.99 111.03 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 94.4 p -91.53 131.29 37.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.942 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -101.44 -53.64 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.901 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.52 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 50.9 ttp180 -89.6 137.0 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.497 . . . . 99.99 111.022 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.99 -24.6 65.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 99.99 111.188 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . 0.52 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 66.7 t-105 -71.06 -57.24 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 99.99 110.75 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.502 HG12 ' HB3' ' C' ' 124' ' ' ARG . 11.5 p -63.9 -23.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.513 . . . . 99.99 110.725 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' C' ' 188' ' ' SER . 41.9 ttm180 -57.78 -36.57 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 99.99 110.948 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -75.3 -18.16 60.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 99.99 110.682 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.03 -42.32 19.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.235 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -72.94 -31.09 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 99.99 111.371 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' C' ' 183' ' ' TRP . 66.6 t80 -60.66 -55.38 34.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 99.99 110.937 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.6 tt -60.94 -31.14 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.021 -0.536 . . . . 99.99 111.078 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.55 -31.49 72.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 99.99 110.724 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -53.02 15.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.868 -0.682 . . . . 99.99 112.775 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 22.2 m -60.54 -38.65 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 99.99 111.219 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . 0.411 ' HA ' HD11 ' C' ' 140' ' ' LEU . 67.3 m -56.33 -42.5 77.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.894 0.378 . . . . 99.99 110.823 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.14 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.905 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.849 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' C' ' 137' ' ' CYS . 96.3 mt -66.81 -53.24 34.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 99.99 111.09 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 33.1 pt -66.4 -31.88 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.451 -0.341 . . . . 99.99 111.418 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.89 -29.69 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.882 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.98 -37.08 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.745 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -76.07 -29.48 58.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 99.99 110.746 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.06 -27.52 49.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 99.99 112.471 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 tt -84.28 -21.51 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.057 0.456 . . . . 99.99 110.298 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -87.72 3.21 48.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 99.99 110.53 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 51.5 t30 -87.62 -48.94 0.45 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.823 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 79.7 Cg_exo -41.69 -32.11 1.46 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.718 2.279 . . . . 99.99 113.117 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 59.4 tp -55.6 -55.23 34.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.455 -0.339 . . . . 99.99 110.281 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . 0.442 HH22 ' HZ3' ' C' ' 153' ' ' LYS . 79.5 mtp180 65.21 133.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.775 -0.648 . . . . 99.99 111.735 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.56 -18.02 65.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 99.99 110.732 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . 0.442 ' HZ3' HH22 ' C' ' 151' ' ' ARG . 39.9 ttmt -60.38 -37.73 81.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.815 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' THR . . . . . 0.452 HG22 ' HB3' ' C' ' 162' ' ' ALA . 29.2 m -64.06 -28.17 69.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.476 . . . . 99.99 111.118 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -64.8 -21.72 66.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.929 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 61.0 p -116.9 -11.87 10.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.251 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -84.41 -60.59 2.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.645 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -140.22 115.37 9.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.841 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 34.3 t -74.24 -20.0 60.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.127 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.35 -54.81 6.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 99.99 110.948 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 30.5 tp -66.77 -19.97 65.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 99.99 111.032 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' C' ' 154' ' ' THR . . . -78.58 -40.38 34.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.392 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -65.71 -36.12 82.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 99.99 110.931 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.32 -47.76 69.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.784 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -26.16 63.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 99.99 110.991 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.05 -59.52 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.64 -26.06 63.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.14 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.86 -54.67 38.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 99.99 110.905 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.48 -28.22 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.287 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 43.5 m -52.66 -58.52 6.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.483 -0.326 . . . . 99.99 111.198 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -63.56 -38.95 93.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.53 -0.304 . . . . 99.99 110.479 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.04 -25.18 65.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.004 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 46.6 m -79.43 -49.16 12.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 99.99 111.722 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.3 -41.28 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 111.736 0.272 . . . . 99.99 111.736 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' C' ' 209' ' ' SER . 4.4 mm? -71.09 -55.72 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.855 0.317 . . . . 99.99 111.855 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -54.16 -34.63 60.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.456 -0.338 . . . . 99.99 111.528 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.45 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.43 -19.3 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 99.99 110.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.77 -44.85 95.59 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.74 -0.663 . . . . 99.99 112.806 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.611 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 82.1 m-85 -62.48 -55.98 34.42 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.704 0.252 . . . . 99.99 111.069 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 83.2 Cg_exo -48.32 -27.93 10.61 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.999 1.799 . . . . 99.99 112.453 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.43 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -69.12 -59.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 99.99 111.127 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.544 HG11 HD21 ' C' ' 201' ' ' LEU . 17.2 m -61.59 -24.76 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.006 -0.543 . . . . 99.99 111.203 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . 0.406 ' HB3' ' HE2' ' C' ' 132' ' ' TYR . 31.9 m95 -66.41 -22.75 66.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.727 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.53 -27.48 42.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.079 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt -119.29 162.43 17.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.262 -0.427 . . . . 99.99 111.115 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.71 -157.22 26.25 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.755 -0.736 . . . . 99.99 112.498 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 156.17 48.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.542 2.162 . . . . 99.99 112.208 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 188' ' ' SER . . . . . 0.496 ' HA ' ' HD3' ' C' ' 128' ' ' ARG . 44.7 t 57.6 13.99 2.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.063 -0.517 . . . . 99.99 111.17 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -169.52 75.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.749 -0.739 . . . . 99.99 112.5 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 52.34 90.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.759 0.314 . . . . 99.99 111.148 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 151.27 168.52 15.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 99.99 112.468 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -136.74 31.37 2.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 99.99 110.937 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.0 140.63 15.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.319 -0.401 . . . . 99.99 110.802 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -155.06 35.45 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.352 -0.385 . . . . 99.99 111.274 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.43 -173.09 3.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.34 -0.391 . . . . 99.99 111.019 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 77.6 p -63.32 -36.9 85.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 99.99 111.243 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 7.3 tp -56.03 -36.1 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.301 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.68 -58.34 7.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.03 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 75.0 p -64.07 -20.45 65.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.049 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.26 -31.17 58.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.474 . . . . 99.99 110.9 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . 0.544 HD21 HG11 ' C' ' 182' ' ' VAL . 6.1 tt -68.7 -52.02 35.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 99.99 110.598 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.05 -2.43 18.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 99.99 110.935 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 11.6 t -96.68 -46.72 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.39 0.614 . . . . 99.99 110.862 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.52 -39.52 74.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.158 -0.928 . . . . 99.99 112.134 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.656 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 45.2 tp -56.57 -54.31 54.94 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 121.031 -0.268 . . . . 99.99 111.504 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.2 Cg_exo -54.76 -41.35 78.89 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.902 1.734 . . . . 99.99 111.408 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.96 -42.43 94.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.378 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -70.78 -22.95 62.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.277 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' SER . . . . . 0.452 ' HB2' HD13 ' C' ' 175' ' ' LEU . 47.6 t -87.0 -14.39 41.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 99.99 110.364 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.443 ' H10' ' H83' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 29.3 m -79.56 -30.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 99.99 111.173 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.7 61.18 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.86 -0.686 . . . . 99.99 112.634 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -64.9 -22.86 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.615 0.245 . . . . 99.99 111.312 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.3 m -63.3 -60.3 3.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 99.99 110.621 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.9 -24.78 63.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.619 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.69 -55.22 32.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.086 -0.507 . . . . 99.99 110.842 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.35 -32.3 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.073 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.27 -52.0 66.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.315 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . 0.425 ' O ' ' HG3' ' C' ' 222' ' ' ARG . 68.8 m80 -80.01 -19.47 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.207 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.55 75.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.041 -0.599 . . . . 99.99 113.372 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 60.9 tp -72.51 -58.68 3.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.798 0.299 . . . . 99.99 111.216 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . 0.441 ' HB3' HD21 ' C' ' 224' ' ' LEU . 97.7 mtt180 55.44 89.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 99.99 110.967 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -59.65 -73.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.008 -0.542 . . . . 99.99 110.882 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' C' ' 222' ' ' ARG . 3.7 mm? 55.59 82.29 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 99.99 111.132 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 56.57 89.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.029 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.68 -50.41 65.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.074 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 43.9 t 54.17 80.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.028 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -104.62 136.09 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.69 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.862 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.775 0.321 . . . . 99.99 110.87 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.69 142.2 51.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 99.99 110.71 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.603 HD22 ' H ' ' A' ' 3' ' ' LEU . 2.1 pt? -110.13 134.47 52.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 99.99 110.804 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -166.53 -19.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 99.99 110.683 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.2 p -105.06 125.59 51.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 99.99 110.822 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -124.62 12.65 8.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.054 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.82 -43.55 83.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 22.1 m80 -68.32 -24.14 64.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.372 . . . . 99.99 110.675 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -72.31 -51.71 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.146 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.52 -21.09 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.277 0.56 . . . . 99.99 110.005 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.6 OUTLIER -63.96 -63.18 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.578 -0.737 . . . . 99.99 110.927 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.7 -33.75 18.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.021 -0.536 . . . . 99.99 111.587 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.87 98.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 99.99 111.107 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.13 -22.55 78.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.729 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 86.8 mmm -76.08 -44.36 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.785 0.326 . . . . 99.99 111.041 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.9 p -58.29 -49.87 75.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 99.99 111.061 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -29.4 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.699 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.48 -57.87 17.22 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.941 -0.647 . . . . 99.99 112.751 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.95 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 99.99 110.956 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -67.19 -36.78 82.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.958 -0.565 . . . . 99.99 110.827 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -61.67 -49.3 77.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 99.99 110.818 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.405 ' O ' ' OG ' ' A' ' 26' ' ' SER . 96.8 m-85 -68.74 -22.06 64.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.026 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 26' ' ' SER . 87.5 t90 -68.21 -32.62 72.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 99.99 110.654 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 m -78.74 -35.69 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.808 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 tp -83.72 -1.36 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 99.99 110.756 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.418 ' HG ' ' HA ' ' A' ' 23' ' ' TRP . 1.2 m -61.85 -26.21 67.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.453 . . . . 99.99 110.871 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -47.76 -35.91 10.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.159 0.504 . . . . 99.99 109.876 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.6 p-10 -164.61 131.72 2.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 99.99 110.034 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 39.6 Cg_endo -95.86 -176.35 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.097 2.531 . . . . 99.99 112.474 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.21 28.51 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 99.99 111.022 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.45 -28.5 6.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.8 -0.714 . . . . 99.99 112.795 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.47 HG21 HD21 ' A' ' 221' ' ' LEU . 71.4 t -83.62 123.21 76.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.511 0.196 . . . . 99.99 111.316 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 34.2 Cg_exo -58.92 161.63 15.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.442 2.095 . . . . 99.99 112.003 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.466 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -59.61 -17.94 37.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 99.99 112.079 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HH ' ' HA ' ' A' ' 90' ' ' THR . 2.6 p90 -49.71 -36.85 26.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.867 0.365 . . . . 99.99 110.997 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.81 -36.36 62.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.322 -0.399 . . . . 99.99 110.668 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.25 -37.67 86.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.382 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' B' ' 100' ' ' THR . 40.8 tp -60.77 -57.8 11.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.549 . . . . 99.99 111.241 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.06 -44.62 97.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.488 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -10.17 54.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 99.99 111.823 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.41 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 28.1 ttt -89.44 -33.34 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 99.99 111.067 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -75.38 -29.25 59.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 99.99 112.241 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.46 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 67.0 mt -64.08 -49.99 71.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.519 0.563 . . . . 99.99 112.519 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 75.1 Cg_endo -74.4 -38.07 2.15 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.646 2.231 . . . . 99.99 114.324 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 46' ' ' TRP . 45.1 pt -61.88 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.28 0.474 . . . . 99.99 112.28 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.54 ' HE1' HG21 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -70.27 -58.76 3.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 99.99 110.869 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.4 p -51.29 -44.16 61.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 99.99 111.091 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.0 -53.25 27.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 99.99 112.866 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.1 mt -57.44 -34.59 69.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 99.99 110.907 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.69 96.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.342 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 69.2 m-85 -61.75 -49.37 76.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 99.99 110.787 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.49 ' HE1' ' HB2' ' B' ' 134' ' ' CYS . 34.4 ttp -50.48 -34.93 26.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 99.99 110.504 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.88 89.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 99.99 111.301 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -55.59 -33.9 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.413 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -72.99 -40.71 65.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 99.99 111.113 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.63 -15.59 19.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.968 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.509 ' HA ' ' HZ2' ' A' ' 60' ' ' LYS . 14.6 t70 63.34 39.43 9.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.724 -0.671 . . . . 99.99 110.991 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.45 150.27 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 99.99 110.874 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.9 -16.52 46.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.84 -0.695 . . . . 99.99 112.161 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' HZ2' ' HA ' ' A' ' 57' ' ' ASP . 8.5 ptpp? -99.38 144.17 28.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.33 . . . . 99.99 110.734 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.54 138.63 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 99.99 111.038 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -92.35 92.81 8.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.865 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.5 121.01 33.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 99.99 111.069 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.28 28.15 16.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 99.99 111.135 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.57 28.94 45.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 99.99 112.436 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -132.84 119.46 20.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 99.99 110.735 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.0 pt -80.08 136.32 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.635 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.88 143.91 37.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 99.99 111.464 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.458 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 12.4 m-70 -86.59 53.73 2.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.315 0.579 . . . . 99.99 110.695 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 74' ' ' ILE . 58.9 t80 -56.25 -59.18 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 99.99 111.893 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.54 66.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.858 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HG3' ' HZ3' ' A' ' 76' ' ' TRP . 12.4 tpp180 -58.82 -52.8 64.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.585 -0.279 . . . . 99.99 111.726 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.515 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 10.1 p90 -77.53 -17.94 57.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.713 -0.395 . . . . 99.99 111.088 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.0 mm -55.5 -41.59 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 109.36 -0.608 . . . . 99.99 109.36 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.58 -20.62 66.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.365 -0.834 . . . . 99.99 110.026 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.515 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -78.88 -21.85 46.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 99.99 111.13 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.496 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 2.3 mtp -90.07 -6.17 55.79 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.468 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.427 HG21 ' CE3' ' A' ' 46' ' ' TRP . 32.8 m -114.81 -31.18 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.507 0.558 . . . . 99.99 112.507 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 m -89.95 -58.45 2.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.157 0.429 . . . . 99.99 112.157 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.561 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -51.92 -51.31 72.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.903 0.705 . . . . 99.99 112.903 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 53.7 Cg_exo -53.91 -55.79 3.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.801 1.668 . . . . 99.99 112.288 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.42 -27.11 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.514 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -36.06 79.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.334 0.588 . . . . 99.99 109.831 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 105' ' ' LEU . 6.9 tt -84.4 -20.32 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.289 -0.869 . . . . 99.99 110.86 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.4 mt -80.15 -39.85 28.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.385 -0.37 . . . . 99.99 111.043 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.404 ' HA ' ' HD1' ' A' ' 89' ' ' TRP . 48.1 t -59.33 -20.61 56.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.929 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.12 -32.33 63.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 99.99 110.968 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -72.42 -38.52 68.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.197 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.404 ' HD1' ' HA ' ' A' ' 86' ' ' SER . 96.9 m95 -62.37 -49.84 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.424 . . . . 99.99 111.17 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.51 ' HA ' ' HH ' ' A' ' 35' ' ' TYR . 7.5 t -66.1 -23.5 66.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.213 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 -3.19 59.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 99.99 111.348 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.7 mtt -127.98 110.14 12.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -87.67 -26.29 23.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.771 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -144.76 139.4 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 99.99 110.74 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.62 HG13 ' HD2' ' A' ' 98' ' ' ASP . 18.2 tt -140.53 146.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 99.99 111.305 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -129.69 -70.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.749 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -144.83 87.1 1.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.951 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' HD2' HG13 ' A' ' 95' ' ' ILE . 2.8 p30 -158.42 124.15 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.952 0.406 . . . . 99.99 111.006 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -131.43 20.02 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 99.99 110.996 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.509 HG23 HD21 ' C' ' 38' ' ' LEU . 90.5 m -80.53 -47.85 13.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.357 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.66 -57.96 3.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.223 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.2 pt -59.61 -24.06 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.219 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.91 -38.92 10.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.896 -0.668 . . . . 99.99 112.546 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.4 -39.8 85.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 99.99 110.855 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HB3' HD21 ' A' ' 84' ' ' LEU . 71.3 mt -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.915 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 ttt -57.41 -35.45 70.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.869 -0.605 . . . . 99.99 110.895 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 t -63.61 -57.24 10.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.356 -0.384 . . . . 99.99 111.152 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.2 p -57.36 -19.48 23.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 99.99 111.681 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 6.2 tp-100 -77.54 -52.53 8.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.794 0.33 . . . . 99.99 111.081 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.581 HG22 ' HE1' ' C' ' 46' ' ' TRP . 63.6 mt -52.19 -36.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 99.99 111.856 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.02 -37.67 53.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 121.054 -0.258 . . . . 99.99 111.222 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.61 -28.47 40.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.906 0.384 . . . . 99.99 110.847 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.94 -49.01 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 99.99 110.658 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 54.7 m -52.41 -37.93 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.445 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 61.5 m -60.3 -56.86 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 99.99 110.183 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.84 -11.63 58.21 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.887 -0.673 . . . . 99.99 112.18 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 tt -74.65 -54.29 7.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.946 0.403 . . . . 99.99 110.523 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.73 -24.01 7.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.033 -0.53 . . . . 99.99 111.525 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.73 -40.76 66.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 99.99 110.812 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.5 -19.52 42.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.657 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.73 20.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.752 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.4 p -85.63 119.01 25.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 99.99 110.862 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 10.2 pt-20 -78.52 -23.29 46.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 99.99 110.808 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HG3' ' HG3' ' A' ' 123' ' ' GLU . 71.7 mtp180 -111.3 149.04 31.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 99.99 110.657 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.78 -9.42 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.893 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -90.16 -49.38 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -58.39 -28.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.34 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -60.53 -32.45 71.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.986 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.35 -33.04 74.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 99.99 111.005 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 127' ' ' VAL . 3.1 mm? -72.95 -50.3 24.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.807 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -67.34 -23.77 65.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.801 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -70.62 -52.96 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.069 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.0 pt -57.41 -29.2 32.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 99.99 110.902 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.1 t -67.26 -40.42 86.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 99.99 110.805 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -47.49 63.41 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.813 -0.708 . . . . 99.99 112.694 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.31 -29.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 99.99 111.173 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 40.7 t -57.86 -51.8 68.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.49 -28.33 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 99.99 110.953 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -68.99 -23.83 64.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.031 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.53 -53.02 7.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.599 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.7 pt -60.03 -37.93 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 99.99 111.784 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.5 tt -67.84 -44.91 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.643 0.258 . . . . 99.99 111.295 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 41.6 tp -55.74 -49.12 73.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 99.99 110.904 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.512 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 59.8 t-105 -68.01 -26.32 65.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.759 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.94 -17.13 68.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.877 -0.678 . . . . 99.99 113.013 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.5 pt -104.48 -8.23 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.339 . . . . 99.99 111.646 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -86.14 -23.22 26.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.734 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.657 ' HB2' ' HD3' ' A' ' 149' ' ' PRO . 69.1 m-80 -81.6 -51.51 0.84 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.46 -0.337 . . . . 99.99 111.759 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.657 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 25.0 Cg_exo -63.02 -3.6 4.99 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.001 1.8 . . . . 99.99 112.201 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' A' ' 166' ' ' ASP . 64.3 tp -61.65 -55.71 27.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 99.99 111.447 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -141.62 -16.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.511 -0.313 . . . . 99.99 111.387 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.88 -46.65 67.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.512 -0.313 . . . . 99.99 111.335 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -83.45 -39.54 20.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 99.99 110.977 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 65.4 p -76.57 5.31 7.62 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.27 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -61.31 -37.12 82.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.277 -0.42 . . . . 99.99 110.685 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 72.7 p -95.53 -16.68 22.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.071 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -83.17 -74.67 0.35 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.957 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.9 m -147.36 117.29 7.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.1 m -77.78 -31.16 51.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.029 -0.532 . . . . 99.99 111.044 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.67 -55.35 20.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.968 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.61 -20.11 62.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.69 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.13 -54.07 16.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.048 -0.524 . . . . 99.99 110.997 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -56.6 -28.3 60.09 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.068 0.461 . . . . 99.99 110.389 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.94 -52.74 58.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 99.99 110.672 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.29 -21.66 60.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 99.99 111.026 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.428 ' HA ' HD11 ' A' ' 150' ' ' LEU . 24.2 t70 -64.11 -41.44 97.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 99.99 111.359 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -82.51 -24.14 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 99.99 110.676 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.85 -35.81 57.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 99.99 111.387 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 15.0 p -73.34 -21.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.178 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.7 m -60.03 -57.93 10.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 99.99 110.915 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.92 -26.01 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.004 -0.544 . . . . 99.99 110.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.437 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 63.9 t80 -72.27 -31.36 65.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 99.99 111.116 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 97.1 m -74.48 -50.88 16.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.518 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.66 -34.11 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.379 . . . . 99.99 111.705 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.428 HD23 ' H42' ' A' ' 210' ' ' LYR . 47.5 tp -75.75 -53.99 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 99.99 111.362 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.97 -33.81 62.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.509 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 13.3 tt -87.64 -21.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 99.99 110.749 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.37 -57.34 20.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.084 -0.579 . . . . 99.99 113.226 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.543 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 74.3 m-85 -53.5 -54.17 48.6 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 111.668 0.247 . . . . 99.99 111.668 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.1 Cg_exo -46.28 -37.05 18.26 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.185 1.923 . . . . 99.99 112.276 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 177' ' ' ILE . 91.4 mt -59.25 -61.01 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.235 -0.438 . . . . 99.99 111.213 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.2 m -62.44 -24.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.18 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -66.93 -37.7 84.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 99.99 111.214 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.532 HG21 HG21 ' A' ' 185' ' ' ILE . 73.1 mt -53.15 -79.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.365 -0.38 . . . . 99.99 111.111 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.532 HG21 HG21 ' A' ' 184' ' ' ILE . 2.8 pp -111.6 173.99 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.926 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.511 ' HA2' ' HA3' ' A' ' 191' ' ' GLY . . . 88.41 -152.1 23.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.574 -0.822 . . . . 99.99 112.377 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.02 155.88 52.9 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.566 2.177 . . . . 99.99 112.138 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m 56.39 17.47 2.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.411 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -165.02 29.98 0.22 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.03 -0.605 . . . . 99.99 112.598 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 76.9 t80 60.5 96.36 0.03 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.812 0.339 . . . . 99.99 111.161 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.511 ' HA3' ' HA2' ' A' ' 186' ' ' GLY . . . -143.32 170.56 25.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.94 -0.648 . . . . 99.99 112.539 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -58.63 -20.6 49.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.962 0.411 . . . . 99.99 110.607 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.1 pt -117.45 140.99 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.876 -0.602 . . . . 99.99 111.146 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -154.83 25.31 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.138 -0.483 . . . . 99.99 110.891 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -77.59 -161.99 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 99.99 110.861 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.2 p -60.97 -22.0 64.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 99.99 111.089 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 77.1 mt -55.94 -26.11 20.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.176 -0.465 . . . . 99.99 111.132 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.71 -60.96 2.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.992 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.4 p -75.82 -34.85 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.107 -0.497 . . . . 99.99 111.253 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.22 -26.63 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.975 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 65.9 tp -81.18 -48.58 11.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -69.69 -11.25 60.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 97.5 m -96.74 -45.38 6.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.11 0.481 . . . . 99.99 110.975 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.9 tp -69.94 -34.8 73.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.763 -0.653 . . . . 99.99 112.244 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.632 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 53.6 tp -61.32 -53.57 61.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.775 0.287 . . . . 99.99 111.775 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.6 Cg_exo -55.17 -47.74 24.7 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.012 1.808 . . . . 99.99 111.95 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.89 -31.94 73.29 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.843 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -66.67 -31.05 71.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 99.99 110.566 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 88.7 p -96.84 -16.03 20.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.349 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.448 ' H7 ' ' HE1' ' A' ' 76' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.8 m -88.68 -36.82 9.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.281 -0.418 . . . . 99.99 111.364 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.48 98.85 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.567 -0.825 . . . . 99.99 112.366 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.59 -28.15 62.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 99.99 110.818 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.4 m -58.23 -61.71 2.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.999 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -68.25 -20.39 64.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.96 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -70.07 -49.7 48.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.984 -0.553 . . . . 99.99 111.145 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.48 ' HD2' ' HB ' ' A' ' 90' ' ' THR . 20.4 t70 -62.15 -40.51 96.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.051 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.424 HD22 HG22 ' A' ' 32' ' ' VAL . 96.9 mt -58.95 -41.75 88.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.112 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -79.12 -20.51 48.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.01 -19.49 79.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.937 -0.649 . . . . 99.99 113.083 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.47 HD21 HG21 ' A' ' 32' ' ' VAL . 41.6 tp -65.56 -58.74 5.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 99.99 111.001 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 54.63 79.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 99.99 110.934 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -62.92 124.85 22.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.929 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 33.4 tp -159.9 -7.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 99.99 110.947 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -92.8 -74.54 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 99.99 110.873 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -126.74 178.17 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 99.99 110.714 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 82.3 p -151.33 120.52 6.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 99.99 110.98 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -102.21 144.46 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.897 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.977 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.811 0.339 . . . . 99.99 111.116 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.552 ' N ' HD21 ' B' ' 2' ' ' ASN . 0.8 OUTLIER 59.22 97.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.042 -0.526 . . . . 99.99 111.198 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 55.3 mt -98.59 96.83 8.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.974 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -140.99 -42.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.077 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 48.3 t -80.23 128.98 34.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.001 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.6 mt -128.71 1.28 5.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.091 -0.504 . . . . 99.99 110.916 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.29 -27.99 68.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.873 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 90.8 m-70 -76.96 -25.71 53.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.024 -0.535 . . . . 99.99 110.493 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -76.22 -45.23 33.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.405 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 43.6 mm -67.8 -22.54 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.129 0.49 . . . . 99.99 110.296 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.418 ' O ' ' HG2' ' B' ' 15' ' ' MET . 29.4 t80 -66.66 -60.69 2.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.734 -0.667 . . . . 99.99 110.969 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.39 -35.98 20.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.156 -0.474 . . . . 99.99 111.345 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.77 90.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.406 -0.361 . . . . 99.99 111.248 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.91 -23.24 78.25 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.774 -0.727 . . . . 99.99 112.571 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 80.4 mmm -73.93 -40.58 63.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.558 0.218 . . . . 99.99 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p -62.32 -51.46 67.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 99.99 111.087 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.438 ' HA ' HD13 ' B' ' 20' ' ' LEU . 2.8 pp -62.5 -25.31 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.399 -0.364 . . . . 99.99 111.156 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.25 -59.03 11.08 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.735 -0.745 . . . . 99.99 112.474 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.21 68.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.872 0.367 . . . . 99.99 111.351 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' B' ' 17' ' ' ILE . 79.0 mt -68.17 -36.68 80.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.177 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -61.59 -50.07 74.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 99.99 110.604 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.478 ' O ' ' OG ' ' B' ' 26' ' ' SER . 99.4 m-85 -66.44 -23.18 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.637 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -68.48 -30.26 69.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.791 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 91.6 p -85.03 -29.79 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 99.99 110.64 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.49 -1.34 57.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.55 . . . . 99.99 110.489 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 1.8 m -63.86 -26.2 68.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.889 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -49.66 -32.6 13.49 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.132 0.491 . . . . 99.99 109.924 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -164.61 131.62 2.36 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.774 . . . . 99.99 110.158 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.423 ' HB3' ' HH ' ' B' ' 37' ' ' TYR . 51.9 Cg_endo -98.0 175.89 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.275 2.65 . . . . 99.99 112.882 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.24 35.19 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 99.99 110.866 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.46 -41.94 1.92 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.744 -0.741 . . . . 99.99 112.713 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . 20.8 m -71.09 136.22 84.78 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.57 0.224 . . . . 99.99 111.102 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' B' ' 32' ' ' VAL . 8.1 Cg_exo -73.37 166.25 30.39 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.877 2.385 . . . . 99.99 112.763 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -58.24 -20.09 39.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 99.99 113.05 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.437 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 3.2 p90 -60.04 -33.54 72.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.952 0.406 . . . . 99.99 110.974 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -69.77 -45.61 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.904 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.423 ' HH ' ' HB3' ' B' ' 29' ' ' PRO . 97.9 m-85 -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 99.99 110.944 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.91 -61.68 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 99.99 110.864 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.81 -36.24 77.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.066 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.43 -12.69 61.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 99.99 111.457 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 60.3 ttp -88.73 -36.19 16.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.485 -0.325 . . . . 99.99 111.442 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -71.64 -34.01 69.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.34 0.496 . . . . 99.99 112.34 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.427 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 88.0 mt -56.46 -52.99 68.94 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.59 0.589 . . . . 99.99 112.59 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 61.6 Cg_endo -72.03 -36.6 5.7 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.408 2.072 . . . . 99.99 113.704 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 28.5 mm -56.45 -62.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.81 0.3 . . . . 99.99 111.81 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.575 ' HE1' HG23 ' C' ' 110' ' ' ILE . 0.3 OUTLIER -60.54 -57.27 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.418 -0.356 . . . . 99.99 111.486 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -51.18 -37.2 45.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.518 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.56 73.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 99.99 112.394 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.19 -32.42 73.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 99.99 110.886 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.02 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.581 . . . . 99.99 111.073 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 19.5 m-85 -61.09 -44.33 97.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.876 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -50.96 -34.17 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.074 0.464 . . . . 99.99 110.167 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.36 81.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.598 -0.728 . . . . 99.99 110.792 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 49.1 mtt -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.524 . . . . 99.99 110.24 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -62.94 -49.03 76.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.866 -0.606 . . . . 99.99 110.342 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.24 -6.69 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.968 -0.56 . . . . 99.99 110.715 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 61.98 39.63 13.16 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.778 -0.647 . . . . 99.99 111.341 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -100.14 173.77 6.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.462 ' HA3' ' HB1' ' B' ' 71' ' ' ALA . . . 70.57 27.23 72.85 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.858 -0.687 . . . . 99.99 112.428 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.75 174.19 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 99.99 110.697 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.69 140.74 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.361 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -101.02 84.52 2.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.565 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.17 109.8 22.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.353 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.22 24.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 99.99 111.534 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 11.72 82.04 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.692 -0.766 . . . . 99.99 112.661 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -115.23 129.15 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 99.99 110.778 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.07 115.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 99.99 111.237 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.64 142.27 27.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 99.99 111.349 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 25.3 m-70 -92.43 59.14 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.057 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.41 -49.91 73.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 99.99 110.925 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.462 ' HB1' ' HA3' ' B' ' 59' ' ' GLY . . . -57.31 -27.76 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 99.99 111.008 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.404 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 4.9 tpp180 -63.05 -49.22 75.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.878 -0.601 . . . . 99.99 110.775 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.447 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -71.19 -18.06 62.5 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.921 -0.312 . . . . 99.99 111.443 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 36.3 mm -65.41 -40.99 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.063 0.458 . . . . 99.99 109.842 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.426 ' O ' HG22 ' B' ' 79' ' ' THR . 13.5 t70 -66.37 -14.39 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.657 -0.701 . . . . 99.99 110.238 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -85.54 -26.14 26.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.856 -0.611 . . . . 99.99 111.173 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.599 ' HG2' ' HB ' ' B' ' 113' ' ' ILE . 19.2 mtp -91.82 4.23 53.32 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.33 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 -29.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.414 0.524 . . . . 99.99 112.414 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' B' ' 83' ' ' LEU . 12.4 t -102.83 -43.71 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.102 0.408 . . . . 99.99 112.102 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.54 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 26.0 m -58.9 -50.84 85.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.221 0.452 . . . . 99.99 112.221 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.588 ' HA ' ' HG2' ' B' ' 109' ' ' GLN . 20.3 Cg_endo -60.62 -43.78 30.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.86 1.707 . . . . 99.99 111.898 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.421 HD12 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -73.46 -12.7 60.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.692 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' B' ' 79' ' ' THR . 0.2 OUTLIER -75.63 -43.99 44.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.782 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.455 HD11 ' N ' ' B' ' 85' ' ' LEU . 3.3 pp -80.18 -23.51 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.78 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.455 ' N ' HD11 ' B' ' 84' ' ' LEU . 50.7 mt -68.18 -39.09 82.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.444 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 46.6 t -61.81 -30.08 70.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 99.99 110.713 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 69.5 mt -75.73 -26.13 57.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.601 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' SER . . . . . 0.438 ' HG ' HD11 ' B' ' 105' ' ' LEU . 49.5 m -70.49 -41.26 72.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.823 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -70.12 -35.96 74.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.593 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 61.3 m -64.99 -33.28 75.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 99.99 110.945 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.95 -34.01 39.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.15 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.8 mmm -95.07 100.93 12.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 99.99 111.168 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -78.0 -33.47 51.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.887 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -137.82 135.06 35.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.418 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 47.0 pt -138.1 143.23 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.855 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -130.15 -56.96 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.13 73.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 99.99 111.122 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.41 134.66 20.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.852 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.84 22.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.609 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.441 ' HA ' HD22 ' A' ' 38' ' ' LEU . 90.7 m -80.92 -49.83 10.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.988 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.46 -34.92 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 99.99 110.925 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.73 -33.73 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.927 0.394 . . . . 99.99 110.798 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.54 -15.19 69.04 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.771 -0.728 . . . . 99.99 112.545 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -83.38 -42.79 16.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.785 0.326 . . . . 99.99 110.94 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.438 HD11 ' HG ' ' B' ' 88' ' ' SER . 91.0 mt -72.01 -45.43 60.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.946 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' MET . . . . . 0.426 ' O ' HG13 ' B' ' 110' ' ' ILE . 25.1 ttt -63.08 -39.62 95.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.727 -0.67 . . . . 99.99 111.269 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -64.14 -54.18 37.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.541 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 59.1 p -58.68 -21.45 54.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.615 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 48.7 tp60 -79.8 -35.89 37.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.44 -0.345 . . . . 99.99 111.384 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.54 HG21 ' HE1' ' A' ' 46' ' ' TRP . 68.5 mt -67.34 -34.87 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.693 0.282 . . . . 99.99 111.512 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 m -73.61 -35.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.584 -0.28 . . . . 99.99 111.506 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.2 -41.42 78.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.616 -0.265 . . . . 99.99 111.68 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.599 ' HB ' ' HG2' ' B' ' 77' ' ' MET . 26.7 pt -70.07 -31.53 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.64 -0.254 . . . . 99.99 111.419 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -60.94 -56.95 15.09 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.912 0.387 . . . . 99.99 110.526 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.5 p -55.97 -29.03 59.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.95 -0.568 . . . . 99.99 110.172 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.02 -47.25 84.48 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.85 -0.691 . . . . 99.99 111.951 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' B' ' 73' ' ' TYR . 56.9 mt -48.89 -58.39 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.155 0.502 . . . . 99.99 110.636 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 50.3 mm -67.56 -31.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.605 -0.725 . . . . 99.99 111.722 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.53 -40.73 62.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.897 0.379 . . . . 99.99 111.178 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.4 -17.54 30.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.794 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 83.3 mt -84.84 13.96 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 99.99 111.059 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 56.3 m -76.84 126.47 31.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 99.99 110.781 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 -21.92 27.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.81 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.635 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 38.4 ttm180 -116.66 137.32 52.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 99.99 110.806 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.08 -11.56 60.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 99.99 111.433 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.635 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 83.1 t90 -87.66 -51.62 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 99.99 110.941 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' B' ' 124' ' ' ARG . 14.9 p -61.03 -26.05 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 99.99 110.945 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -67.54 -24.49 65.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 99.99 110.882 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.66 -35.12 76.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.766 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.4 HD12 ' N ' ' B' ' 130' ' ' LEU . 7.1 mp -68.78 -50.47 50.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.333 -0.394 . . . . 99.99 110.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.76 -35.63 75.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.419 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.74 -51.65 68.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.179 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.8 mm -53.93 -34.09 25.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.251 -0.431 . . . . 99.99 111.101 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.49 ' HB2' ' HE1' ' A' ' 52' ' ' MET . 49.8 t -66.73 -41.15 88.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 99.99 111.133 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.98 85.21 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.745 -0.74 . . . . 99.99 112.654 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.3 -28.75 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.808 0.337 . . . . 99.99 111.28 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 50.4 t -58.2 -49.65 76.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.017 0.437 . . . . 99.99 110.603 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.07 -47.96 80.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 99.99 110.785 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.27 -24.19 26.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.056 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -59.2 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.993 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 pt -65.68 -33.74 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.398 -0.365 . . . . 99.99 111.771 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.05 -37.12 76.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.47 -0.332 . . . . 99.99 111.313 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.3 -48.59 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.373 . . . . 99.99 110.866 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . 0.463 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 77.1 t90 -68.26 -22.74 64.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.808 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -18.99 62.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.905 -0.664 . . . . 99.99 112.652 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -106.67 -10.24 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.971 0.415 . . . . 99.99 110.938 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -78.85 -21.45 47.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.493 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.629 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 69.1 m-80 -84.37 -50.72 0.6 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 111.896 0.332 . . . . 99.99 111.896 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 32.3 Cg_exo -58.78 -6.23 3.23 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.09 1.86 . . . . 99.99 112.371 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' B' ' 166' ' ' ASP . 55.1 tp -57.92 -46.29 85.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 99.99 111.434 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' B' ' 155' ' ' ARG . 14.3 ptp180 -156.32 -1.21 0.13 Allowed 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.755 0.28 . . . . 99.99 111.755 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.04 -41.92 18.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.517 -0.311 . . . . 99.99 111.523 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.19 -41.15 14.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 99.99 111.389 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 8.8 t -78.82 6.52 8.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 99.99 111.625 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' B' ' 151' ' ' ARG . 30.3 tpt180 -65.63 -19.34 65.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.848 0.356 . . . . 99.99 110.708 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 74.5 p -107.76 -12.39 15.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.204 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -95.25 -71.88 0.65 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 99.99 110.983 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 25.9 m -141.38 117.53 10.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 99.99 111.304 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -77.91 -36.79 49.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.926 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.36 -51.33 69.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.119 -0.492 . . . . 99.99 111.181 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.81 -32.15 69.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.916 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.87 82.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 99.99 111.462 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -68.55 -45.35 72.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.842 0.353 . . . . 99.99 110.914 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 41.8 mt -59.41 -43.44 93.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.875 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.57 -22.78 60.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.79 -0.641 . . . . 99.99 111.078 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.5 ' HA ' HD11 ' B' ' 150' ' ' LEU . 19.6 t70 -77.8 -25.44 48.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.071 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -84.15 -38.18 20.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.427 . . . . 99.99 111.384 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.54 -25.74 38.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.488 -0.323 . . . . 99.99 111.856 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.36 -26.54 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 99.99 111.069 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.2 m -54.47 -58.75 6.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.273 -0.422 . . . . 99.99 111.132 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.39 -30.4 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.459 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.9 -25.82 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.908 -0.587 . . . . 99.99 110.889 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 29.3 m -79.56 -53.15 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 99.99 111.35 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 43.2 t -60.68 -27.03 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.451 HD22 ' H42' ' B' ' 210' ' ' LYR . 50.8 tp -77.61 -55.61 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.233 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -30.27 61.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 99.99 111.267 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.435 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.6 tp -87.92 -24.71 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 99.99 110.878 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.0 -46.38 91.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.915 -0.659 . . . . 99.99 113.146 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.459 ' N ' ' HD2' ' B' ' 180' ' ' PRO . 61.6 m-85 -62.2 -55.4 40.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.26 0.467 . . . . 99.99 112.26 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 13.1 Cg_endo -56.69 -28.26 74.63 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.77 1.647 . . . . 99.99 112.461 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.435 HG13 ' O ' ' B' ' 177' ' ' ILE . 49.1 mt -60.71 -49.91 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.053 0.454 . . . . 99.99 110.238 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.519 ' HB ' ' HA2' ' B' ' 189' ' ' GLY . 13.0 m -77.55 -23.45 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.709 -0.678 . . . . 99.99 110.186 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -68.57 -15.22 63.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.277 -0.874 . . . . 99.99 112.605 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.421 HG21 ' O ' ' B' ' 181' ' ' ILE . 17.1 tt -103.14 -25.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.885 0.328 . . . . 99.99 111.885 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . 0.528 HG13 ' H ' ' B' ' 190' ' ' PHE . 20.3 pt -91.06 116.54 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.177 0.436 . . . . 99.99 112.177 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . 0.625 ' HA3' ' HA2' ' B' ' 191' ' ' GLY . . . 56.99 -171.19 2.75 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.839 -0.619 . . . . 99.99 113.814 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.8 106.35 2.24 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.963 2.442 . . . . 99.99 112.651 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 53.8 m 53.8 66.3 1.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 99.99 111.709 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . 0.519 ' HA2' ' HB ' ' B' ' 182' ' ' VAL . . . 82.57 123.39 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.628 -0.796 . . . . 99.99 113.24 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.528 ' H ' HG13 ' B' ' 185' ' ' ILE . 79.3 m-85 62.07 148.16 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.155 0.502 . . . . 99.99 111.843 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . 0.625 ' HA2' ' HA3' ' B' ' 186' ' ' GLY . . . -113.63 174.37 15.65 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.821 -0.627 . . . . 99.99 112.349 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 54.82 18.78 2.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.984 0.421 . . . . 99.99 110.633 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.05 160.09 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 99.99 110.864 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' B' ' 198' ' ' ASP . 7.5 p30 -165.58 20.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.681 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.04 -170.57 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.062 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.9 t -67.58 -15.28 63.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.139 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.09 -27.7 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.38 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . 0.409 ' HD2' ' HA ' ' B' ' 194' ' ' ASN . 7.3 m-20 -56.37 -57.5 12.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.367 -0.379 . . . . 99.99 111.121 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 46.3 p -68.94 -37.98 79.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 99.99 111.112 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.56 -25.1 68.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.254 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.9 tp -77.36 -43.62 32.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 99.99 110.954 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.51 -9.42 58.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 99.99 111.458 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 98.9 m -96.37 -42.16 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.137 0.494 . . . . 99.99 110.719 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.97 -48.8 62.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 99.99 112.143 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.636 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 53.6 tp -49.6 -52.86 46.82 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 111.738 0.273 . . . . 99.99 111.738 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -54.56 -50.71 12.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.982 1.788 . . . . 99.99 111.904 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.5 -35.79 72.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.284 -0.416 . . . . 99.99 110.807 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -69.88 -29.28 66.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 99.99 110.684 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 88.6 p -94.68 -12.7 26.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.822 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.451 ' H42' HD22 ' B' ' 175' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.55 -31.7 7.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.852 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.88 58.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 99.99 112.487 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -69.65 -23.22 63.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.666 0.269 . . . . 99.99 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.2 t -58.94 -58.28 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.887 0.375 . . . . 99.99 110.584 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -72.64 -20.42 61.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 99.99 110.814 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.4 -58.37 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 99.99 110.71 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -60.09 -32.05 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 99.99 110.622 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.79 -42.32 98.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.525 . . . . 99.99 111.086 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -87.39 -20.43 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.134 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.87 76.86 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.911 -0.661 . . . . 99.99 113.053 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' B' ' 32' ' ' VAL . 50.8 tp -63.5 -58.58 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.739 -0.271 . . . . 99.99 110.976 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.441 ' HE ' ' HA ' ' B' ' 222' ' ' ARG . 3.6 mmp_? 57.61 82.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.711 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -68.69 121.62 16.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.994 0.426 . . . . 99.99 110.927 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 pp -161.29 -5.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.991 -0.549 . . . . 99.99 110.997 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.05 -65.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.515 . . . . 99.99 110.53 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -145.12 168.45 20.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.831 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 38.1 t -134.98 144.23 47.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.782 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -132.06 132.33 43.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.08 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.739 179.781 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.446 ' HG2' HD21 ' C' ' 2' ' ' ASN . 27.2 ttt . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.669 0.271 . . . . 99.99 110.861 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . 0.446 HD21 ' HG2' ' C' ' 1' ' ' MET . 37.5 m-80 58.45 92.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.192 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.71 132.97 35.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.832 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -160.98 -21.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.85 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 53.0 m -113.67 111.5 21.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 99.99 111.138 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.446 HD12 ' N ' ' C' ' 6' ' ' LEU . 4.9 mp -104.24 9.82 35.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.697 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.4 -36.99 81.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.903 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 14.6 m170 -72.15 -24.09 61.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.649 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -73.83 -51.41 16.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.48 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -66.77 -19.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 99.99 110.388 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -65.53 -58.24 6.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.674 -0.694 . . . . 99.99 110.824 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . 0.464 HG11 ' N ' ' C' ' 13' ' ' ALA . 7.7 p -58.85 -35.98 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 99.99 111.141 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.464 ' N ' HG11 ' C' ' 12' ' ' VAL . . . -60.35 -37.21 79.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.34 -0.391 . . . . 99.99 110.993 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.9 -28.71 60.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.827 -0.702 . . . . 99.99 112.586 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -35.55 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.56 0.219 . . . . 99.99 111.21 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 47.5 m -64.67 -50.45 67.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 99.99 110.57 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.85 -22.33 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.782 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -59.66 9.47 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.016 -0.611 . . . . 99.99 112.535 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -30.87 68.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.919 0.39 . . . . 99.99 110.492 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.18 -33.12 74.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 99.99 110.49 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.76 -53.29 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 99.99 110.582 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . 0.587 ' O ' ' OG ' ' C' ' 26' ' ' SER . 72.9 m-85 -65.19 -24.5 67.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 99.99 110.55 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.512 ' HA ' ' HG ' ' C' ' 26' ' ' SER . 55.6 t90 -69.48 -27.21 65.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 99.99 110.705 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.4 m -84.69 -34.21 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.657 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.26 -1.51 57.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 99.99 110.453 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' C' ' 22' ' ' PHE . 1.4 m -60.72 -23.95 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 99.99 110.652 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -48.76 -36.93 17.57 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.231 0.538 . . . . 99.99 109.828 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.471 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 8.4 p30 -163.18 131.56 2.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.346 -0.843 . . . . 99.99 110.034 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.8 Cg_endo -95.74 -177.4 0.41 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.028 2.485 . . . . 99.99 112.374 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -97.8 37.12 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 99.99 111.212 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.58 -15.7 31.95 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.749 -0.738 . . . . 99.99 112.941 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.4 121.13 64.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.536 0.207 . . . . 99.99 111.243 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 38.9 Cg_exo -56.49 165.58 4.34 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.556 2.17 . . . . 99.99 112.509 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -62.31 -18.32 61.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.619 -0.719 . . . . 99.99 112.417 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.409 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.1 p90 -51.72 -34.73 40.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 99.99 111.367 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -76.27 -36.97 58.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 99.99 111.12 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -66.01 -35.14 79.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.368 -0.378 . . . . 99.99 111.005 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.509 HD21 HG23 ' A' ' 100' ' ' THR . 1.1 tm? -63.95 -56.71 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.651 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.71 -45.47 97.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 99.99 111.528 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.89 -12.11 52.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 99.99 111.695 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 26.9 ttt -89.58 -33.71 16.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.693 0.282 . . . . 99.99 111.606 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -75.71 -27.57 58.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.914 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.448 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 84.8 mt -64.87 -50.63 62.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.89 0.7 . . . . 99.99 112.89 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 72.1 Cg_endo -77.54 -33.01 2.58 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.422 2.081 . . . . 99.99 114.059 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.423 HG22 ' N ' ' C' ' 46' ' ' TRP . 19.5 tt -62.2 -48.74 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 99.99 111.904 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.581 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -70.78 -57.97 4.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.728 0.299 . . . . 99.99 110.727 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.416 ' HG ' ' N ' ' C' ' 48' ' ' GLY . 89.5 p -51.21 -42.27 60.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.908 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . 0.416 ' N ' ' HG ' ' C' ' 47' ' ' SER . . . -53.68 -49.29 58.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.914 -0.66 . . . . 99.99 112.572 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 84.9 mt -55.23 -40.16 70.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 99.99 110.929 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.82 88.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.17 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 72.4 m-85 -55.55 -50.47 69.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.361 -0.381 . . . . 99.99 110.99 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' MET . . . . . 0.447 ' O ' HG12 ' C' ' 56' ' ' ILE . 15.6 tmm? -49.66 -37.87 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 99.99 110.388 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.67 -38.4 83.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 99.99 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 55.4 mtt -54.8 -30.95 58.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 99.99 110.294 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 8' ' ' HIS . . . -75.93 -37.81 58.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.842 -0.617 . . . . 99.99 110.717 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.447 HG12 ' O ' ' C' ' 52' ' ' MET . 6.6 mm -77.96 -6.4 9.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.957 -0.565 . . . . 99.99 110.99 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . 0.428 ' HA ' ' HZ3' ' C' ' 60' ' ' LYS . 7.6 m-20 62.56 46.21 5.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 99.99 111.331 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -111.41 171.35 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 99.99 110.963 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 73.08 24.4 75.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 99.99 112.518 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.428 ' HZ3' ' HA ' ' C' ' 57' ' ' ASP . 6.7 ptpp? -137.03 146.47 45.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 99.99 110.966 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 141.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.161 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.01 87.96 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 99.99 110.851 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.51 122.46 33.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.102 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.08 31.39 16.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.105 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 29.99 53.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.841 -0.695 . . . . 99.99 112.628 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . 0.452 HE21 ' N ' ' C' ' 67' ' ' ILE . 23.3 tp60 -131.34 119.05 21.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 99.99 111.054 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . 0.452 ' N ' HE21 ' C' ' 66' ' ' GLN . 26.5 pt -81.72 128.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.95 140.62 38.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.267 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -95.61 55.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 99.99 110.834 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -63.05 -51.32 67.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 99.99 111.053 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.489 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -57.28 -25.85 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.958 0.408 . . . . 99.99 110.771 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -64.37 -48.23 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 99.99 110.801 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.592 ' HB3' HD21 ' C' ' 117' ' ' LEU . 0.2 OUTLIER -72.49 -19.56 61.52 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.858 -0.337 . . . . 99.99 111.534 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.53 -41.94 94.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.172 0.51 . . . . 99.99 109.699 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.44 -15.37 63.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.548 -0.751 . . . . 99.99 110.071 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.08 -20.45 32.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 99.99 111.335 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 8.7 mtm -99.54 4.99 46.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 99.99 111.423 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -114.67 -27.15 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.855 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -103.8 -34.86 8.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.288 0.477 . . . . 99.99 112.288 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.599 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 38.5 m -69.65 -50.76 17.51 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 111.84 0.311 . . . . 99.99 111.84 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.641 ' HA ' ' HG2' ' C' ' 109' ' ' GLN . 32.2 Cg_exo -59.36 -37.51 89.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.928 1.752 . . . . 99.99 112.28 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.448 HD13 HD12 ' C' ' 85' ' ' LEU . 4.4 mm? -78.29 -16.92 57.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 99.99 110.619 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.413 HD21 ' HE2' ' C' ' 210' ' ' LYR . 0.1 OUTLIER -71.92 -41.75 67.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 99.99 110.609 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.441 HD11 ' N ' ' C' ' 85' ' ' LEU . 3.9 pp -78.78 -32.33 46.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.819 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . 0.448 HD12 HD13 ' C' ' 82' ' ' LEU . 43.2 mt -61.5 -41.26 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.833 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.5 t -60.89 -29.91 69.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.02 -0.537 . . . . 99.99 110.783 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.445 HD23 HD11 ' C' ' 168' ' ' LEU . 59.9 mt -74.71 -27.3 60.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.891 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.0 t -69.2 -48.6 61.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 99.99 110.865 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -63.86 -32.74 74.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 99.99 111.048 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -66.51 -32.14 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.143 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.53 -4.7 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.379 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.3 mtm -118.09 98.91 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 99.99 110.992 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -87.42 -16.2 35.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 99.99 110.608 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -146.8 133.86 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.56 . . . . 99.99 110.584 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -146.21 142.48 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.94 0.4 . . . . 99.99 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -131.46 -68.28 0.66 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.958 -0.565 . . . . 99.99 110.539 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -138.93 87.17 2.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 99.99 110.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -163.09 121.53 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.971 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -134.93 19.38 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.663 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 64.4 p -76.63 -50.77 12.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 99.99 111.174 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.4 mt -70.12 -40.06 75.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 99.99 110.976 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.06 -41.93 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 99.99 111.063 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.21 -11.15 85.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 99.99 112.575 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -80.52 -41.22 24.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.706 0.289 . . . . 99.99 110.928 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.429 ' HB3' HD13 ' C' ' 84' ' ' LEU . 55.1 mt -74.8 -44.07 51.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.182 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' MET . . . . . 0.426 ' HG2' HD22 ' C' ' 85' ' ' LEU . 71.5 mtm -58.73 -54.27 48.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.307 -0.406 . . . . 99.99 111.285 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -52.23 -50.73 61.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 99.99 111.821 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 61.5 p -63.27 -24.69 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 99.99 111.798 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.641 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 8.0 tp-100 -80.82 -35.86 32.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 99.99 111.406 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.575 HG23 ' HE1' ' B' ' 46' ' ' TRP . 80.4 mt -65.63 -30.97 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 99.99 111.399 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.31 -37.2 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.606 0.241 . . . . 99.99 111.592 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.78 -41.4 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 111.887 0.329 . . . . 99.99 111.887 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 38.8 pt -69.4 -34.42 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.748 -0.206 . . . . 99.99 111.464 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -60.87 -54.59 43.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.872 0.367 . . . . 99.99 110.644 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.5 p -55.88 -29.56 60.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 99.99 110.057 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.06 63.72 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.991 -0.623 . . . . 99.99 112.011 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' C' ' 73' ' ' TYR . 81.8 mt -48.03 -61.13 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 99.99 110.627 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.16 -32.57 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.569 -0.741 . . . . 99.99 112.002 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.51 61.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.314 . . . . 99.99 111.348 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 -19.03 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.884 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' C' ' 117' ' ' LEU . 95.9 mt -83.26 17.68 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 99.99 110.992 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -89.78 117.76 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.368 . . . . 99.99 110.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.94 -31.13 61.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.462 ' HB2' HG11 ' C' ' 127' ' ' VAL . 86.5 mtm180 -93.86 144.23 25.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.607 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.37 -13.12 58.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 99.99 111.382 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -86.37 -50.73 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 99.99 111.141 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' C' ' 124' ' ' ARG . 12.2 p -57.68 -24.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.371 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -62.61 -37.35 85.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.364 . . . . 99.99 111.055 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -60.9 -36.1 78.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.39 -0.368 . . . . 99.99 111.141 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.7 mm? -66.21 -52.63 46.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.124 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -64.93 -28.93 69.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.427 . . . . 99.99 111.45 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -65.42 -46.67 79.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.539 -0.301 . . . . 99.99 110.782 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.1 mm -58.75 -36.6 61.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 99.99 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -63.88 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 99.99 110.671 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -48.83 39.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.842 -0.694 . . . . 99.99 112.661 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -68.3 -27.06 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 99.99 111.119 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 54.0 t -64.4 -43.47 94.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.614 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . 0.409 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -68.94 -29.37 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.783 -0.644 . . . . 99.99 111.034 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -71.08 -29.63 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.992 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -70.14 -56.0 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 99.99 111.548 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 28.9 pt -55.71 -37.87 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 99.99 111.751 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.409 HG12 ' O ' ' C' ' 138' ' ' ALA . 44.0 mm -78.33 -33.32 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 99.99 111.411 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 44.5 tp -61.43 -51.33 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 99.99 110.576 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . 0.493 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 98.7 m95 -70.65 -21.28 62.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 99.99 110.463 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.38 67.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.845 -0.693 . . . . 99.99 112.575 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -102.35 -14.67 8.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 99.99 111.201 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -77.3 -33.49 55.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 99.99 111.699 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.655 ' HB2' ' HD3' ' C' ' 149' ' ' PRO . 69.1 m-80 -70.52 -51.51 12.47 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.003 0.371 . . . . 99.99 112.003 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 25.2 Cg_exo -62.54 -0.93 2.17 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.114 1.876 . . . . 99.99 112.9 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' C' ' 166' ' ' ASP . 68.5 tp -61.11 -64.47 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.222 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . 0.441 ' HA ' ' OG1' ' C' ' 154' ' ' THR . 73.4 ttt180 -135.88 -12.7 1.96 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.407 -0.361 . . . . 99.99 111.15 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.59 -46.38 69.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.478 -0.328 . . . . 99.99 111.488 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -86.0 -33.35 21.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.5 -0.318 . . . . 99.99 111.249 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' C' ' 157' ' ' GLN . 60.7 p -78.55 6.35 8.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 99.99 111.194 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -60.5 -50.62 72.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.367 -0.378 . . . . 99.99 111.038 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 7.5 t -88.14 -10.08 51.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 99.99 110.927 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.446 ' HB3' ' HA ' ' C' ' 154' ' ' THR . 53.6 tt0 -86.35 -72.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 99.99 110.82 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.4 m -154.51 113.66 3.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.758 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 52.2 m -74.61 -33.33 62.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.943 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.44 -49.07 76.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 99.99 110.851 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.36 -24.89 67.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 99.99 110.901 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.05 -37.86 69.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.217 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -65.13 -37.93 89.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.344 -0.389 . . . . 99.99 110.836 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.89 -54.36 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 99.99 111.027 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 99.99 111.068 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' C' ' 150' ' ' LEU . 16.8 t70 -65.15 -42.93 93.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 99.99 111.162 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.76 -25.04 35.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.091 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . 0.445 HD11 HD23 ' C' ' 87' ' ' LEU . 54.5 tp -76.89 -39.03 52.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.544 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 10.4 p -71.64 -16.43 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.324 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 41.9 m -57.68 -59.41 5.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.258 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -71.46 -31.75 67.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.381 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -57.21 -32.97 67.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 99.99 110.975 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 66.9 m -79.66 -43.3 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 99.99 111.494 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -58.3 -36.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 112.18 0.437 . . . . 99.99 112.18 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.464 ' HG ' ' HG ' ' C' ' 209' ' ' SER . 4.4 mm? -81.16 -47.39 13.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.729 -0.214 . . . . 99.99 111.489 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -30.87 63.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.301 . . . . 99.99 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.414 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 10.9 tp -88.01 -22.9 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.472 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.19 -57.8 17.39 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.839 -0.619 . . . . 99.99 113.37 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.558 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 88.4 m-85 -53.47 -54.85 40.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.692 0.246 . . . . 99.99 111.503 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 97.1 Cg_exo -44.37 -35.82 8.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.316 2.011 . . . . 99.99 112.833 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.404 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.0 mt -64.52 -61.14 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 99.99 111.537 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.401 HG21 ' O ' ' C' ' 179' ' ' TYR . 20.2 m -59.76 -24.56 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.454 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -67.19 -52.45 41.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 99.99 111.41 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.02 -41.74 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.211 0.448 . . . . 99.99 112.211 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 10.7 tt -122.0 142.56 37.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 99.99 111.739 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 97.58 -143.01 16.46 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.882 -0.675 . . . . 99.99 112.814 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . 0.428 ' HB2' ' OD1' ' C' ' 198' ' ' ASP . 74.2 Cg_endo -73.85 163.52 36.85 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.668 2.246 . . . . 99.99 112.075 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 60.2 m 57.22 15.36 2.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 99.99 110.132 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.22 26.11 0.27 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.677 -0.692 . . . . 99.99 112.341 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 64.7 t80 59.83 93.84 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.988 0.423 . . . . 99.99 111.079 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -143.91 166.71 26.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.9 -0.667 . . . . 99.99 112.295 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -59.24 -28.47 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.951 0.405 . . . . 99.99 110.777 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 pt -104.6 140.85 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 99.99 111.22 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -156.91 -103.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 99.99 110.85 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 49.77 -161.15 0.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.634 0.254 . . . . 99.99 110.997 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 74.9 p -68.84 -15.65 63.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.919 0.39 . . . . 99.99 111.023 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.98 -27.88 36.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.959 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' C' ' 187' ' ' PRO . 3.1 t70 -49.76 -60.97 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 72.4 p -72.27 -18.63 61.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 99.99 111.69 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -74.89 -26.55 59.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 99.99 111.359 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.16 -47.93 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.478 -0.328 . . . . 99.99 111.699 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.51 -14.86 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.473 -0.33 . . . . 99.99 111.65 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.473 ' HG ' ' N ' ' C' ' 204' ' ' LEU . 20.7 p -96.66 -39.07 9.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 99.99 111.53 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . 0.473 ' N ' ' HG ' ' C' ' 203' ' ' CYS . 48.3 tp -71.88 -34.01 68.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.277 -0.419 . . . . 99.99 112.046 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.519 ' N ' ' HD2' ' C' ' 206' ' ' PRO . 56.4 tp -62.47 -52.94 61.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 111.971 0.36 . . . . 99.99 111.971 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' C' ' 205' ' ' LEU . 17.9 Cg_endo -58.21 -41.9 62.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.899 1.733 . . . . 99.99 111.762 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.35 -34.48 78.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 99.99 110.372 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -70.49 -27.51 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.382 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' SER . . . . . 0.464 ' HG ' ' HG ' ' C' ' 175' ' ' LEU . 48.2 t -93.78 -16.53 24.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.61 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.425 ' C19' ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t -86.28 -37.9 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 99.99 111.034 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.28 -50.43 62.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.932 -0.652 . . . . 99.99 112.748 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -66.11 -23.69 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 99.99 111.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.1 t -60.93 -62.46 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 99.99 110.72 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -69.26 -20.42 63.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 99.99 110.973 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.26 -59.14 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 99.99 110.601 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.59 -28.54 67.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.863 0.363 . . . . 99.99 110.936 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.42 -52.11 66.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.976 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.71 -20.46 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.913 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.54 -29.8 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 99.99 112.309 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 51.8 tp -68.4 -55.25 12.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 99.99 110.626 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 32.9 tpt180 52.69 89.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.069 -0.514 . . . . 99.99 111.27 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -57.69 138.24 55.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 99.99 110.916 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 36.1 tp -162.32 -26.9 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.754 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -129.18 124.98 35.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.504 . . . . 99.99 110.922 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 15.6 t70 65.15 146.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.963 -0.562 . . . . 99.99 111.431 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 36.3 t -157.62 124.7 5.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.915 -0.584 . . . . 99.99 110.748 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -100.35 161.82 13.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.426 . . . . 99.99 110.896 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.95 -179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.813 0.34 . . . . 99.99 110.815 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -130.44 42.48 3.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 99.99 110.656 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.2 mt -99.01 -41.14 7.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.751 -0.658 . . . . 99.99 111.131 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -60.17 168.15 2.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.073 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.8 t 62.1 102.94 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.087 -0.506 . . . . 99.99 111.077 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 6' ' ' LEU . 5.5 mp -117.32 4.68 12.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.85 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.24 -50.38 60.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.064 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 68.3 m-70 -63.36 -25.0 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 99.99 110.973 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -70.04 -59.67 2.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.077 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -60.56 -19.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 99.99 110.437 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 207' ' ' PHE . 8.6 t80 -62.16 -58.58 7.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.672 -0.695 . . . . 99.99 110.731 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.47 -29.2 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.885 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.32 -46.93 88.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.166 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.91 -23.58 77.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.799 -0.715 . . . . 99.99 112.352 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.69 -38.21 54.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.703 0.287 . . . . 99.99 111.131 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.437 ' HG1' ' H ' ' A' ' 17' ' ' ILE . 43.4 p -62.79 -48.6 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.096 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' H ' ' HG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -62.4 -32.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 99.99 110.659 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.04 -54.52 30.94 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.783 -0.722 . . . . 99.99 112.698 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -35.31 76.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.749 0.309 . . . . 99.99 111.389 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 HD11 ' HA ' ' A' ' 17' ' ' ILE . 93.5 mt -62.54 -30.66 71.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 99.99 111.028 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -59.94 -31.9 70.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.692 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.504 ' HB2' ' HE1' ' A' ' 41' ' ' MET . 44.7 m-85 -75.14 -28.02 59.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.685 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -62.25 -39.64 93.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.061 0.458 . . . . 99.99 109.829 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.2 m -85.49 -28.25 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.758 -0.656 . . . . 99.99 110.7 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 56.8 tp -73.13 -18.23 61.31 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.02 -0.536 . . . . 99.99 110.653 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 p -62.52 -25.03 67.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 99.99 111.085 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -51.22 -32.59 24.46 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.093 0.473 . . . . 99.99 109.938 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.7 p-10 -165.42 132.01 2.17 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 99.99 110.304 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 29.3 Cg_endo -95.99 179.86 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.193 2.595 . . . . 99.99 112.139 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -103.48 65.58 0.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.339 -0.391 . . . . 99.99 111.276 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.76 -46.61 3.71 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.917 -0.659 . . . . 99.99 112.931 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.23 146.98 32.66 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.625 0.213 . . . . 99.99 111.235 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 34.6 Cg_exo -58.89 163.29 11.63 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.382 2.055 . . . . 99.99 112.085 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.21 -17.33 63.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.694 -0.685 . . . . 99.99 112.319 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 6.4 p90 -41.27 -40.92 1.76 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.738 0.304 . . . . 99.99 111.774 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.05 -45.41 77.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.886 0.374 . . . . 99.99 110.587 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.76 -19.37 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.55 . . . . 99.99 110.439 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.0 -55.06 28.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 99.99 110.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.83 -37.31 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.348 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.75 -10.67 59.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 99.99 110.618 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 22' ' ' PHE . 41.0 ttm -88.14 -28.91 20.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.81 -0.632 . . . . 99.99 110.487 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -72.8 -40.09 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 99.99 111.369 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.664 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 36.8 mm -50.22 -53.04 48.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 111.99 0.367 . . . . 99.99 111.99 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 15.7 Cg_exo -68.68 -33.73 20.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.196 1.931 . . . . 99.99 112.595 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.01 -62.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.632 0.253 . . . . 99.99 111.367 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.572 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -61.72 -57.97 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 99.99 111.017 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.713 ' HA ' ' HD2' ' A' ' 75' ' ' ASP . 35.8 t -54.2 -23.06 13.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 99.99 111.356 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.54 -66.12 2.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 99.99 112.524 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.1 mt -56.3 -29.15 60.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.293 . . . . 99.99 111.144 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.98 -57.61 12.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 99.99 111.222 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.573 ' HH ' HH12 ' A' ' 72' ' ' ARG . 20.8 m-85 -61.61 -42.48 98.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 99.99 111.472 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.22 -36.33 8.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.207 0.527 . . . . 99.99 110.349 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.541 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . . . -72.37 -40.21 67.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 99.99 110.9 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 54.2 mtt -53.54 -35.57 60.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.041 0.448 . . . . 99.99 110.17 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -67.75 -40.96 84.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.855 -0.611 . . . . 99.99 109.935 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.22 3.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.727 -0.67 . . . . 99.99 110.524 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.48 44.64 9.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.667 -0.697 . . . . 99.99 111.257 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 22.4 mm-40 -102.93 170.1 8.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.823 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.48 92.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 99.99 112.23 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -123.18 145.86 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 99.99 110.783 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.84 141.04 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.845 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.7 92.24 7.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.837 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.76 110.74 22.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 99.99 111.246 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.63 34.97 25.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 99.99 111.431 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.06 74.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.847 -0.692 . . . . 99.99 112.754 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -130.28 117.65 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 99.99 110.502 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 pt -69.23 127.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.154 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.38 144.56 35.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.225 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 93.4 m-70 -89.12 62.84 6.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.29 0.567 . . . . 99.99 110.989 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -56.77 -38.15 72.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.295 -0.866 . . . . 99.99 111.191 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.33 -22.21 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.053 -0.521 . . . . 99.99 111.82 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 5.3 tpm_? -66.5 -51.72 53.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 99.99 112.022 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.9 p90 -72.59 -34.04 67.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.654 -0.418 . . . . 99.99 110.712 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -55.47 -46.33 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.324 -0.398 . . . . 99.99 110.949 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.713 ' HD2' ' HA ' ' A' ' 47' ' ' SER . 37.8 t70 -65.68 -13.01 58.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.425 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -99.75 -0.26 40.33 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.813 -0.63 . . . . 99.99 111.528 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 55.0 ttm -104.59 -6.97 20.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 99.99 110.703 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.463 HG22 HG23 ' A' ' 79' ' ' THR . 27.2 m -114.39 -36.13 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 99.99 112.128 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 47' ' ' SER . 62.7 p -88.11 -44.71 10.73 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.339 0.496 . . . . 99.99 112.339 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.525 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.6 m -56.93 -51.29 82.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.156 0.428 . . . . 99.99 112.156 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 80' ' ' THR . 14.6 Cg_endo -56.85 -36.51 98.88 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.679 1.586 . . . . 99.99 111.168 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 85' ' ' LEU . 4.0 mm? -71.1 -34.18 70.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 99.99 109.934 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.414 HD12 ' H43' ' A' ' 210' ' ' LYR . 27.9 mt -68.34 -21.25 64.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 109' ' ' GLN . 20.8 tp -83.02 -23.88 33.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.142 -0.936 . . . . 99.99 109.713 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 82' ' ' LEU . 96.1 mt -84.02 -40.67 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.454 -0.794 . . . . 99.99 110.886 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.9 p -63.19 -45.44 91.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.956 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.57 -26.17 68.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 99.99 111.039 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.6 t -68.39 -50.94 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -65.78 -21.93 66.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.024 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.6 m -73.46 -37.51 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.353 -0.385 . . . . 99.99 110.967 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.84 -23.98 26.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.937 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.0 mmm -94.0 84.84 4.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 99.99 110.796 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -73.98 -19.34 60.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.126 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.78 133.58 43.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.287 -0.415 . . . . 99.99 110.996 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.3 pt -140.8 160.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.935 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -139.97 -70.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.997 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -142.4 14.64 2.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.388 . . . . 99.99 111.04 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.93 129.39 40.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.877 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 56.5 t90 -151.63 -13.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 99.99 110.926 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -82.94 -34.06 26.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.283 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.78 -48.47 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 99.99 110.897 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 16.0 tt -59.11 -25.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 99.99 111.158 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.44 -46.64 32.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.831 -0.7 . . . . 99.99 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -56.47 -37.93 71.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.63 0.252 . . . . 99.99 111.157 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.01 -51.79 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.721 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 84.8 mtp -60.8 -26.08 67.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.981 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.7 m -68.3 -58.72 3.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 99.99 111.139 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.515 HG21 HG23 ' A' ' 142' ' ' ILE . 97.5 m -53.37 -36.18 61.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.142 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.507 ' HB2' HD23 ' A' ' 84' ' ' LEU . 6.2 tp-100 -55.14 -51.69 65.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.69 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.8 mm -54.22 -35.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 99.99 111.139 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.77 -44.22 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 99.99 111.045 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.65 -52.26 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 99.99 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.7 mt -53.59 -30.68 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 99.99 111.08 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.426 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 54.5 m -64.07 -48.24 76.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 99.99 110.82 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.481 ' HG ' ' HA2' ' A' ' 135' ' ' GLY . 49.8 m -62.98 -21.51 66.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.962 -0.563 . . . . 99.99 110.476 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.7 9.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.862 -0.685 . . . . 99.99 112.938 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 73' ' ' TYR . 4.0 pp -76.82 -26.75 54.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.682 0.241 . . . . 99.99 111.268 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.1 mt -84.08 -38.1 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 CA-C-O 120.709 0.29 . . . . 99.99 111.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.18 65.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.281 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.64 -22.07 47.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.887 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.72 5.1 49.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.102 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -64.13 131.03 46.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 99.99 111.028 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.72 -3.06 14.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.126 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' HB2' HG12 ' A' ' 127' ' ' VAL . 72.2 mtm180 -129.83 141.04 50.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.871 0.367 . . . . 99.99 110.97 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 99.99 111.133 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -79.3 -41.07 28.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.496 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 124' ' ' ARG . 11.6 p -84.16 -23.66 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.576 . . . . 99.99 110.955 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.447 HH11 ' H ' ' A' ' 190' ' ' PHE . 36.0 ttm180 -51.61 -40.28 59.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.09 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -75.1 -30.36 60.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 99.99 111.167 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 127' ' ' VAL . 87.9 mt -67.56 -58.49 4.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 99.99 111.354 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -63.03 -37.02 85.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.321 -0.4 . . . . 99.99 111.928 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -55.03 -54.16 46.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.844 0.354 . . . . 99.99 110.662 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.46 -30.54 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.658 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.2 t -62.77 -35.01 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.827 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' A' ' 115' ' ' SER . . . -71.17 -51.91 15.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.878 -0.677 . . . . 99.99 112.646 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.16 -29.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.68 0.276 . . . . 99.99 110.991 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.9 t -69.48 -36.59 76.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.684 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.54 68.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.912 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.13 -22.6 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.941 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -64.62 -62.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 99.99 111.227 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.1 pt -59.05 -46.39 91.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 99.99 112.26 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.515 HG23 HG21 ' A' ' 108' ' ' THR . 33.4 mm -64.34 -31.69 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.726 0.269 . . . . 99.99 111.726 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 62.7 tp -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 99.99 110.911 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -65.51 -21.89 66.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.411 . . . . 99.99 110.56 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.33 -17.35 71.68 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.84 -0.695 . . . . 99.99 112.835 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.05 -14.51 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.823 0.344 . . . . 99.99 111.109 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -66.65 -55.59 14.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.367 0.506 . . . . 99.99 112.367 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.845 ' OD1' ' CB ' ' A' ' 152' ' ' ALA . 51.5 t30 -102.06 -52.98 0.14 Allowed Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.62 0.6 . . . . 99.99 112.62 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 77.0 Cg_exo -41.96 -31.07 1.37 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.52 2.147 . . . . 99.99 113.324 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.455 ' HG ' ' HG3' ' A' ' 151' ' ' ARG . 68.1 tp -62.03 -52.35 64.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 99.99 110.451 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.455 ' HG3' ' HG ' ' A' ' 150' ' ' LEU . 99.4 mtt180 -144.42 61.14 1.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.976 -0.556 . . . . 99.99 110.676 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.845 ' CB ' ' OD1' ' A' ' 148' ' ' ASN . . . -79.37 -41.39 27.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.059 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.74 -23.15 62.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.051 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 31.9 m -65.54 -18.76 65.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 99.99 111.202 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.96 -31.65 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.153 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.2 m -99.07 -27.55 13.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.284 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -66.72 -77.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.037 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 80.6 p -127.78 113.46 15.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.251 -0.431 . . . . 99.99 110.857 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 73.4 p -77.94 -20.03 53.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 99.99 111.213 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -68.55 -54.49 16.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.152 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.41 -30.6 71.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 99.99 110.868 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.29 -30.09 69.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 99.99 110.963 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.47 -30.23 57.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.91 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.11 -59.58 3.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.275 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -22.53 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.262 -0.426 . . . . 99.99 110.839 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.68 -32.48 71.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.006 0.431 . . . . 99.99 110.314 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 170' ' ' THR . 41.3 ttmt -78.33 -22.42 48.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.903 -0.589 . . . . 99.99 110.3 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.49 -56.45 4.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.646 . . . . 99.99 111.034 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.0 -34.68 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.677 -0.692 . . . . 99.99 112.088 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 167' ' ' LYS . 14.0 t -55.16 -34.09 63.52 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.957 0.408 . . . . 99.99 110.531 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -78.24 -28.52 47.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 99.99 110.032 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -73.36 -28.0 61.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.643 -0.708 . . . . 99.99 110.84 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.455 ' HG1' ' H ' ' A' ' 174' ' ' VAL . 70.2 p -76.63 -47.91 20.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.369 -0.378 . . . . 99.99 111.073 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.455 ' H ' ' HG1' ' A' ' 173' ' ' THR . 12.2 p -64.56 -28.55 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.286 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.4 tp -75.68 -56.73 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 99.99 111.053 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.418 ' HZ2' HE22 ' A' ' 109' ' ' GLN . 1.0 OUTLIER -58.48 -29.63 66.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.412 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 181' ' ' ILE . 14.1 tt -87.41 -21.08 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 99.99 110.25 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.69 65.06 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.72 -0.673 . . . . 99.99 112.87 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.526 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.2 m-85 -55.59 -55.6 38.65 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.797 0.298 . . . . 99.99 110.985 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 85.0 Cg_exo -46.35 -31.63 9.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.062 1.841 . . . . 99.99 112.657 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.8 mm -64.8 -58.26 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.816 0.341 . . . . 99.99 111.667 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 179' ' ' TYR . 28.2 m -59.6 -27.16 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.58 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -61.65 -23.49 66.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 99.99 110.927 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 89.7 mt -56.68 -39.77 65.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.146 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 32.8 pt -108.33 140.14 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.396 . . . . 99.99 111.004 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 193' ' ' ILE . . . 110.64 -165.97 12.3 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.841 -0.695 . . . . 99.99 112.608 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.13 160.0 50.46 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.428 2.085 . . . . 99.99 112.086 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 65.2 m 56.92 17.23 3.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.334 -0.394 . . . . 99.99 110.375 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -155.83 25.55 0.57 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.784 -0.644 . . . . 99.99 112.324 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.447 ' H ' HH11 ' A' ' 128' ' ' ARG . 65.5 m-85 58.53 72.8 0.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.96 0.41 . . . . 99.99 110.528 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -124.28 -177.99 15.2 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.708 -0.758 . . . . 99.99 112.797 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -139.25 24.18 2.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 99.99 111.034 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.553 HG12 ' HA2' ' A' ' 186' ' ' GLY . 37.3 pt -97.16 175.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 99.99 111.234 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -74.63 -172.72 1.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.684 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -93.13 -33.27 14.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.868 0.366 . . . . 99.99 110.686 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.2 p -70.65 -31.52 68.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 99.99 110.941 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.5 mm -64.48 -47.94 87.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 99.99 111.229 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.61 -52.4 63.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.682 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -63.93 -25.07 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.519 . . . . 99.99 111.076 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -77.02 -27.59 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 99.99 110.998 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 53.7 tp -84.08 -51.17 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.506 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -69.75 1.27 4.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.522 -0.308 . . . . 99.99 111.46 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 35.9 t -96.48 -44.01 7.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 99.99 110.191 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.2 tp -72.38 -33.63 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.427 -0.806 . . . . 99.99 111.763 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.506 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.1 tt -60.09 -54.57 53.97 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.019 -0.272 . . . . 99.99 111.17 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.25 -41.63 74.52 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.654 1.57 . . . . 99.99 111.262 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.417 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 81.6 t80 -61.28 -34.01 74.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 99.99 110.053 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.0 -21.03 57.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 99.99 110.326 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.3 t -95.41 -20.65 18.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.872 -0.604 . . . . 99.99 110.721 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.421 ' H9 ' ' C18' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.97 -38.17 63.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.871 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.28 96.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.866 -0.683 . . . . 99.99 112.405 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.78 -29.46 69.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.732 0.301 . . . . 99.99 110.83 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.6 t -60.49 -58.02 10.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.858 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . 0.408 ' HA ' HD13 ' A' ' 218' ' ' LEU . 75.5 t80 -69.1 -23.88 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.663 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.3 tt -67.1 -49.46 64.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.766 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.39 -38.23 83.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 99.99 110.856 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 215' ' ' PHE . 95.4 mt -59.3 -50.37 74.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 99.99 111.109 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -72.67 -21.41 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 99.99 110.871 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.62 -26.54 64.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 99.99 112.567 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 98.0 mt -68.79 -32.69 72.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 99.99 111.15 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 59.77 -87.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.111 -0.495 . . . . 99.99 111.173 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -123.78 176.52 6.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.815 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 53.2 tp -124.14 115.44 21.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.871 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -148.7 -44.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.992 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -95.85 118.71 33.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.871 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 49.8 m -141.3 26.88 1.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.954 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -158.11 134.3 9.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.483 . . . . 99.99 110.978 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.986 -0.552 . . . . 99.99 111.048 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.845 0.355 . . . . 99.99 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.416 ' OD1' ' HG ' ' B' ' 3' ' ' LEU . 5.2 p30 -144.0 -23.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.032 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.416 ' HG ' ' OD1' ' B' ' 2' ' ' ASN . 94.7 mt -102.09 96.66 7.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 99.99 110.609 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.12 -27.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.994 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.4 m -131.34 154.5 48.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.845 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -134.16 -4.53 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.021 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.61 -42.21 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.434 -0.348 . . . . 99.99 111.099 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.599 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 40.4 m-70 -67.71 -25.37 65.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.49 . . . . 99.99 110.35 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -72.97 -49.51 28.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 99.99 110.989 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 45.3 pt -69.0 -19.18 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.957 0.408 . . . . 99.99 110.789 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.599 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 23.2 t80 -66.55 -54.11 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 99.99 110.589 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.57 -31.77 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.003 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.39 -47.31 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.236 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.12 74.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.666 -0.778 . . . . 99.99 112.485 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.23 -31.51 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 99.99 110.804 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -63.5 -58.11 8.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.996 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -61.21 -23.61 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.206 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.7 -51.81 56.38 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.632 -0.794 . . . . 99.99 112.161 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.526 ' HB1' ' HE1' ' B' ' 41' ' ' MET . . . -68.32 -23.39 64.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 99.99 110.894 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.57 -43.2 90.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 99.99 110.622 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.22 -25.43 61.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.432 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 83.2 t80 -66.1 -37.25 85.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.666 . . . . 99.99 110.47 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.4 ' O ' ' OG ' ' B' ' 26' ' ' SER . 86.0 t90 -67.14 -35.41 79.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 99.99 110.656 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 40.8 t -80.41 -19.59 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 99.99 111.161 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.1 -22.38 39.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 99.99 111.267 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 4.8 p -59.5 -24.48 63.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.553 -0.294 . . . . 99.99 111.092 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -47.38 -32.43 4.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 99.99 110.022 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -172.93 132.06 0.63 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 99.99 110.278 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -95.01 174.52 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.978 2.452 . . . . 99.99 112.306 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -102.2 68.06 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 99.99 111.366 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 -46.66 3.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.028 -0.606 . . . . 99.99 112.84 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.02 144.93 29.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.515 0.198 . . . . 99.99 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 165.47 8.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.405 2.07 . . . . 99.99 112.218 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -69.2 -17.36 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.658 -0.701 . . . . 99.99 112.413 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -41.17 -37.76 0.97 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.765 0.317 . . . . 99.99 111.838 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.67 -57.07 12.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 99.99 110.476 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.07 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 99.99 110.783 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' B' ' 41' ' ' MET . 20.4 tp -60.38 -51.85 67.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.938 0.399 . . . . 99.99 110.281 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -63.02 -38.48 82.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.094 0.473 . . . . 99.99 109.872 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.82 -9.59 55.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 99.99 110.7 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.526 ' HE1' ' HB1' ' B' ' 19' ' ' ALA . 22.0 ttt -87.94 -31.76 19.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 99.99 110.426 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -72.65 -34.08 67.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.397 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.584 HG23 HG22 ' B' ' 79' ' ' THR . 64.3 mt -52.91 -52.29 66.39 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 111.97 0.359 . . . . 99.99 111.97 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.8 Cg_endo -71.18 -35.0 9.29 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.264 1.976 . . . . 99.99 113.516 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.453 HG12 ' O ' ' B' ' 41' ' ' MET . 33.1 mm -56.64 -62.69 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.867 0.321 . . . . 99.99 111.867 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.63 -57.38 12.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 99.99 111.341 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.548 ' HA ' ' HD2' ' B' ' 75' ' ' ASP . 97.0 p -55.78 -23.56 30.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 99.99 111.505 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.39 -64.42 3.36 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 99.99 112.552 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 60.0 mt -57.37 -27.52 62.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.325 . . . . 99.99 111.076 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.98 -55.76 26.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.16 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 13.8 m-85 -64.32 -41.09 96.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.235 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 51.6 ttp -49.41 -34.28 15.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.276 0.56 . . . . 99.99 110.139 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.27 -40.09 71.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.449 -0.796 . . . . 99.99 110.559 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 58.7 mtt -53.55 -30.6 42.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 99.99 110.299 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.599 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -72.2 -45.85 58.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 99.99 110.671 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.422 HG22 HG22 ' C' ' 127' ' ' VAL . 13.1 mt -74.34 0.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.508 . . . . 99.99 110.746 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.47 ' HB2' HH12 ' C' ' 124' ' ' ARG . 8.0 m-20 63.76 52.15 2.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.794 -0.639 . . . . 99.99 111.131 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -127.98 143.63 51.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.753 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.3 23.7 7.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.844 -0.693 . . . . 99.99 112.394 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -137.43 137.49 38.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 99.99 111.046 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.55 147.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.005 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.25 94.01 9.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.883 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.42 113.38 24.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.182 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.45 30.54 18.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.84 -11.1 60.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.58 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.565 ' HA ' HE21 ' B' ' 66' ' ' GLN . 0.1 OUTLIER -100.84 134.63 43.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 99.99 110.723 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.26 132.2 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 99.99 110.875 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.03 144.33 32.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 99.99 111.565 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.511 ' HB3' ' HD3' ' B' ' 72' ' ' ARG . 74.4 m-70 -95.5 66.58 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.941 -0.572 . . . . 99.99 110.689 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -68.65 -35.54 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 99.99 111.129 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.88 68.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.61 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.511 ' HD3' ' HB3' ' B' ' 69' ' ' HIS . 10.3 mpt_? -74.21 -51.69 14.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.193 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -49.46 77.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 99.99 111.353 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.3 -38.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.12 0.415 . . . . 99.99 112.12 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.548 ' HD2' ' HA ' ' B' ' 47' ' ' SER . 13.9 t70 -62.45 -24.75 67.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.349 . . . . 99.99 110.406 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -95.87 6.59 48.52 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.664 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 53.9 tpp -103.94 -13.82 16.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 99.99 109.455 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.437 ' O ' HD21 ' B' ' 82' ' ' LEU . 26.1 m -114.81 -35.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.437 -0.801 . . . . 99.99 111.271 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.584 HG22 HG23 ' B' ' 43' ' ' ILE . 46.2 m -81.48 -60.93 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 99.99 112.179 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.559 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 60.2 m -47.18 -51.27 42.76 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 112.675 0.62 . . . . 99.99 112.675 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' B' ' 80' ' ' THR . 11.0 Cg_endo -54.17 -34.39 78.6 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.048 1.832 . . . . 99.99 111.856 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.491 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -79.01 -29.52 43.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 99.99 110.769 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.2 tp -68.99 -30.01 68.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.018 0.437 . . . . 99.99 110.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.532 HD12 HE21 ' B' ' 109' ' ' GLN . 6.5 tt -78.6 -30.36 46.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.749 -0.659 . . . . 99.99 110.072 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.491 HD12 HD13 ' B' ' 82' ' ' LEU . 76.0 mt -68.51 -42.52 78.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.706 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -66.18 -41.51 90.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 99.99 110.48 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -30.33 68.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.847 -0.615 . . . . 99.99 110.53 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -70.72 -48.04 56.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 99.99 110.997 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -66.71 -19.19 65.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 99.99 111.149 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 34.3 m -79.92 -32.96 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.051 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.57 -24.6 23.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.431 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.496 ' HE1' HG23 ' B' ' 95' ' ' ILE . 90.6 mtp -100.01 104.38 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 99.99 111.157 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -84.55 -38.15 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.935 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.72 133.66 53.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.944 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.496 HG23 ' HE1' ' B' ' 92' ' ' MET . 38.0 pt -141.92 148.53 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.034 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -133.67 -67.29 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -140.85 26.63 2.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.903 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.99 106.49 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -135.15 -9.14 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 99.99 110.747 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -82.76 -37.0 25.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.959 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.59 -55.23 16.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.53 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . 0.504 ' HA ' HD12 ' B' ' 105' ' ' LEU . 16.9 tt -55.4 -28.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 99.99 111.14 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 62.97 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.868 -0.682 . . . . 99.99 112.537 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -63.47 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 99.99 110.532 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.529 ' HB3' HD21 ' B' ' 84' ' ' LEU . 85.8 mt -59.05 -46.62 87.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.772 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' MET . . . . . 0.499 ' O ' HG12 ' B' ' 110' ' ' ILE . 52.3 ttm -68.18 -22.25 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.759 -0.655 . . . . 99.99 110.967 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 56.9 m -76.45 -39.93 51.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.93 0.395 . . . . 99.99 110.939 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 60.8 p -64.82 -43.34 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 99.99 111.533 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.532 HE21 HD12 ' B' ' 84' ' ' LEU . 3.8 pt20 -59.71 -42.87 94.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.539 -0.301 . . . . 99.99 111.001 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.572 HG22 ' HE1' ' A' ' 46' ' ' TRP . 43.2 mm -53.55 -41.16 44.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.842 0.353 . . . . 99.99 110.52 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.5 t -62.16 -44.96 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.239 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.46 -50.78 78.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.757 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.57 -33.68 49.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.729 0.3 . . . . 99.99 110.866 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.8 m -56.22 -40.54 74.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.17 0.509 . . . . 99.99 110.172 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 39.2 m -60.51 -56.78 17.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 99.99 110.243 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.87 -16.38 59.3 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.94 -0.648 . . . . 99.99 112.278 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.08 -61.56 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.425 . . . . 99.99 110.596 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.77 -21.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.828 -0.624 . . . . 99.99 111.804 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.99 42.09 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.021 0.439 . . . . 99.99 110.949 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.08 -23.75 28.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 99.99 110.712 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.92 19.15 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 99.99 110.853 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -75.68 129.05 36.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 99.99 110.977 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.57 -42.62 5.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 99.99 110.7 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.464 ' HB2' HG12 ' B' ' 127' ' ' VAL . 78.7 mtt180 -79.48 148.22 31.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 99.99 110.269 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.39 -22.33 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.942 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 31.5 p90 -83.86 -25.98 29.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.685 0.279 . . . . 99.99 111.222 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' B' ' 124' ' ' ARG . 8.6 p -83.28 -23.74 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 99.99 110.519 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.67 -37.93 66.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.775 -0.648 . . . . 99.99 110.991 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.68 -19.96 47.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.4 . . . . 99.99 110.885 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 127' ' ' VAL . 98.7 mt -76.22 -60.37 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 99.99 111.139 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -62.74 -28.67 70.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 99.99 111.26 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.4 -59.25 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 99.99 110.838 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.3 pt -61.45 -25.81 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 99.99 111.446 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -66.4 -39.39 88.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.035 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.71 31.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.816 -0.707 . . . . 99.99 112.671 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' B' ' 180' ' ' PRO . 35.5 m -61.75 -32.42 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.65 0.262 . . . . 99.99 111.376 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.65 -30.55 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 99.99 111.076 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.03 78.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.412 . . . . 99.99 110.825 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.49 -28.41 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 99.99 110.972 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.17 -57.84 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.368 -0.378 . . . . 99.99 111.708 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . 0.44 HG13 ' N ' ' B' ' 142' ' ' ILE . 40.2 pt -55.96 -43.29 74.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.893 0.331 . . . . 99.99 111.893 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.44 ' N ' HG13 ' B' ' 141' ' ' ILE . 8.9 tp -72.57 -28.36 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.705 0.288 . . . . 99.99 111.252 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.03 -57.33 13.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 99.99 110.797 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -63.82 -27.19 69.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.559 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . 0.455 ' HA2' ' HG2' ' B' ' 149' ' ' PRO . . . -78.21 -17.26 78.42 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.775 -0.726 . . . . 99.99 112.491 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.7 tt -109.2 0.31 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 99.99 111.467 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -86.09 -55.01 4.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.846 0.313 . . . . 99.99 111.846 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.594 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 34.0 m120 -101.73 -51.38 0.16 Allowed Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.324 0.49 . . . . 99.99 112.324 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 85.6 Cg_exo -46.46 -24.18 2.57 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.121 1.881 . . . . 99.99 112.709 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.21 -45.72 79.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.419 . . . . 99.99 110.169 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.461 ' O ' HG23 ' B' ' 154' ' ' THR . 14.3 ptp180 -163.67 66.68 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 99.99 110.515 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' B' ' 148' ' ' ASN . . . -83.28 -18.24 39.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 99.99 111.35 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -86.55 -25.27 25.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 99.99 111.637 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' THR . . . . . 0.461 HG23 ' O ' ' B' ' 151' ' ' ARG . 7.7 t -61.99 -19.33 62.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.633 0.254 . . . . 99.99 111.301 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -58.16 -35.38 71.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.395 . . . . 99.99 110.845 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 69.6 p -89.85 -22.82 21.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.874 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -78.33 -75.42 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 99.99 111.011 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 65.3 m -127.1 113.15 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.122 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 50.7 m -77.79 -20.79 52.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 99.99 111.014 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -70.85 -49.83 41.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.129 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 41.8 tp -67.4 -28.98 68.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.396 -0.366 . . . . 99.99 110.86 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.28 -27.52 60.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.197 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -76.17 -31.08 58.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.294 -0.412 . . . . 99.99 111.164 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt -67.8 -57.49 6.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.343 -0.39 . . . . 99.99 110.968 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -22.3 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.885 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.78 -54.08 47.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 99.99 110.837 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -63.26 -30.8 71.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.919 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.87 -56.66 9.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.147 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.86 -23.01 30.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 99.99 111.443 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 52.2 m -56.41 -58.54 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.95 0.405 . . . . 99.99 110.582 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.36 -33.65 71.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 99.99 110.515 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -64.78 -35.42 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 99.99 111.278 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 53.1 m -72.83 -54.12 9.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.346 -0.388 . . . . 99.99 111.639 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.66 -26.49 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 99.99 111.885 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -77.05 -57.78 3.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 99.99 111.279 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.22 -27.54 55.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.862 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.486 ' O ' HG12 ' B' ' 181' ' ' ILE . 85.7 mt -87.65 -23.88 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.214 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.26 -55.44 29.48 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 99.99 113.029 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.551 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 60.3 m-85 -54.23 -55.35 37.82 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.854 0.327 . . . . 99.99 111.257 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.5 Cg_exo -45.22 -32.22 7.0 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.323 2.016 . . . . 99.99 113.016 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.486 HG12 ' O ' ' B' ' 177' ' ' ILE . 47.1 mm -67.26 -61.13 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.392 -0.367 . . . . 99.99 111.739 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 21.0 m -57.26 -24.76 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 99.99 112.005 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -62.82 -23.65 67.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.407 -0.361 . . . . 99.99 111.906 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.562 HG21 HG21 ' B' ' 185' ' ' ILE . 16.7 tt -57.54 -38.07 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.737 0.273 . . . . 99.99 111.737 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . 0.562 HG21 HG21 ' B' ' 184' ' ' ILE . 26.1 pt -102.34 156.6 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.759 0.314 . . . . 99.99 111.137 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.39 -165.81 32.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.725 -0.75 . . . . 99.99 112.46 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.33 154.5 71.91 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.519 2.146 . . . . 99.99 112.161 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 69.9 m 57.72 17.97 4.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.667 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -135.1 -63.94 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.91 -0.587 . . . . 99.99 112.23 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -155.09 -43.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 99.99 110.4 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 99.69 117.39 3.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.861 -0.685 . . . . 99.99 113.035 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -167.93 -28.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 99.99 110.71 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 25.8 pt -114.02 174.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.17 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -78.56 -166.09 0.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.931 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -88.43 -46.37 9.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 99.99 111.009 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 24.4 m -58.45 -29.72 66.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.219 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 80.9 mt -72.3 -42.83 65.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.081 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -53.83 -51.99 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.647 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 61.6 p -63.03 -44.13 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.967 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.53 -28.83 48.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 99.99 110.965 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -84.13 -51.62 6.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 99.99 111.779 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -69.34 -2.07 9.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.9 0.333 . . . . 99.99 111.9 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -96.83 -42.0 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.044 0.45 . . . . 99.99 110.5 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.6 tp -71.82 -33.44 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.629 . . . . 99.99 111.844 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.675 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.1 tp -62.8 -54.36 47.96 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.57 -0.252 . . . . 99.99 111.44 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.9 Cg_exo -55.66 -41.22 79.83 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.884 1.723 . . . . 99.99 111.415 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -58.71 -36.48 74.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.037 0.446 . . . . 99.99 110.173 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.28 -31.9 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.896 -0.593 . . . . 99.99 110.507 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 31.3 t -79.38 -30.25 42.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 99.99 110.78 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.435 ' C19' ' H9 ' ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.87 -38.25 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.499 . . . . 99.99 111.047 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.48 -36.64 93.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.653 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.66 -29.2 66.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 99.99 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -62.85 -61.24 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 99.99 110.878 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -64.0 -22.13 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.745 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.48 -49.36 42.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.674 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.52 -31.95 72.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.852 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.74 -38.27 90.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.724 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -85.28 -20.65 29.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 99.99 111.017 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.21 -36.1 73.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.902 -0.666 . . . . 99.99 112.762 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 94.4 mt -59.42 -37.22 77.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.681 0.277 . . . . 99.99 111.262 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 61.24 -84.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.113 -0.494 . . . . 99.99 111.242 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -115.78 169.35 9.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.388 -0.369 . . . . 99.99 110.697 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.97 90.51 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.973 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -117.57 -62.62 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.826 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.68 153.09 44.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 99.99 110.963 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.6 t -166.46 4.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.028 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -149.68 127.27 11.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.427 . . . . 99.99 110.761 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.956 -179.759 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.842 0.353 . . . . 99.99 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -141.15 -26.7 0.71 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.169 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.22 93.21 4.14 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.386 -0.37 . . . . 99.99 110.997 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -139.2 -68.63 0.43 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.847 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 89.9 p -80.63 166.74 20.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 99.99 110.924 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.413 ' N ' HD21 ' C' ' 6' ' ' LEU . 2.5 pt? -148.94 -6.03 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 99.99 111.221 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.12 -45.06 82.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.382 -0.372 . . . . 99.99 111.084 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.581 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 36.3 m-70 -68.26 -25.27 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.782 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -73.07 -48.34 36.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.887 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.9 -21.07 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 99.99 110.156 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . 0.608 ' HH ' ' HB2' ' C' ' 206' ' ' PRO . 11.2 t80 -63.73 -57.48 9.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 99.99 110.711 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.3 -31.75 49.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.106 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.4 81.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 99.99 111.301 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.07 -24.36 75.89 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 99.99 112.656 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -77.15 -34.73 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 99.99 111.166 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 46.7 m -65.44 -48.71 71.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.997 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.82 -29.38 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.379 -0.373 . . . . 99.99 110.952 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.4 -51.74 56.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 99.99 112.389 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.463 ' HB1' ' HE3' ' C' ' 41' ' ' MET . . . -66.9 -24.06 66.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 99.99 111.217 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 52.6 tp -67.71 -39.17 84.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.731 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.12 -27.62 67.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 99.99 110.618 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.63 -39.98 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.94 -0.573 . . . . 99.99 110.788 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.412 ' O ' ' OG ' ' C' ' 26' ' ' SER . 23.8 t-105 -62.92 -48.14 80.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 99.99 110.763 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 55.1 m -68.54 -19.66 64.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 99.99 111.359 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.44 ' HG ' HE22 ' C' ' 34' ' ' GLN . 54.1 tp -83.34 -20.68 33.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.439 -0.346 . . . . 99.99 111.307 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 75.8 p -60.43 -21.59 62.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.686 -0.234 . . . . 99.99 111.096 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -52.03 -31.3 29.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 99.99 109.809 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.9 p-10 -171.9 131.91 0.75 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 99.99 110.293 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.7 Cg_endo -96.54 178.07 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.19 2.594 . . . . 99.99 112.15 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -103.43 67.48 0.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 99.99 110.908 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.07 -45.16 2.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 99.99 112.93 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -100.28 133.87 21.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.496 0.184 . . . . 99.99 111.496 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -48.83 161.72 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.722 2.281 . . . . 99.99 112.747 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . 0.44 HE22 ' HG ' ' C' ' 25' ' ' LEU . 84.7 mm-40 -66.53 -17.56 64.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.544 -0.753 . . . . 99.99 112.658 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -41.36 -38.22 1.17 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.812 0.301 . . . . 99.99 111.812 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.33 -53.09 58.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 99.99 110.684 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -66.73 -19.04 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.739 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' C' ' 41' ' ' MET . 22.2 tp -61.06 -49.61 76.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.094 0.473 . . . . 99.99 110.207 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.42 -42.43 96.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.025 -0.534 . . . . 99.99 110.093 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -6.8 35.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.797 -0.638 . . . . 99.99 110.872 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.463 ' HE3' ' HB1' ' C' ' 19' ' ' ALA . 25.8 ttt -87.87 -33.22 18.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 99.99 110.402 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -71.37 -36.99 71.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.32 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.494 HG23 HG22 ' C' ' 79' ' ' THR . 74.7 mt -49.33 -53.4 40.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.132 0.419 . . . . 99.99 112.132 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.445 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.27 -33.21 11.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.171 1.914 . . . . 99.99 112.912 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.431 HG13 ' O ' ' C' ' 41' ' ' MET . 77.2 mt -53.3 -62.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.631 0.253 . . . . 99.99 111.452 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -62.87 -56.08 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.446 -0.343 . . . . 99.99 111.216 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.539 ' HA ' ' HD2' ' C' ' 75' ' ' ASP . 98.6 p -51.73 -23.07 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.045 -0.525 . . . . 99.99 111.212 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.34 -64.62 2.69 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.45 -0.881 . . . . 99.99 112.058 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.94 -28.67 62.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 99.99 110.914 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 -58.79 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 99.99 111.16 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.467 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 18.4 m-85 -60.93 -40.62 93.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.387 . . . . 99.99 110.972 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.0 ttp -49.48 -38.34 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.439 . . . . 99.99 110.021 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.34 82.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 99.99 110.649 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 56.3 mtt -54.89 -33.08 61.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.174 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.7 -38.48 73.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.821 -0.627 . . . . 99.99 110.385 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mt -80.44 -0.42 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 99.99 110.527 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.32 41.84 12.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.794 -0.639 . . . . 99.99 111.177 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -117.05 134.92 54.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.612 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.89 37.66 1.66 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.833 -0.699 . . . . 99.99 112.222 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -154.11 132.49 11.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 99.99 111.119 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -114.1 142.1 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.836 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.13 96.05 8.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.056 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.44 124.71 43.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 99.99 110.962 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.31 27.19 16.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.139 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -13.59 57.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.802 -0.713 . . . . 99.99 112.517 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -100.78 145.15 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.883 0.373 . . . . 99.99 111.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -89.96 135.72 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.769 -0.651 . . . . 99.99 110.934 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.92 138.39 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 99.99 111.386 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.531 ' H ' ' HD2' ' C' ' 120' ' ' ASP . 79.9 m-70 -88.71 64.55 7.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 99.99 110.802 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.57 -35.3 77.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 99.99 111.01 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.56 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 99.99 111.576 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.515 HH22 ' HB2' ' C' ' 203' ' ' CYS . 27.3 mmt180 -70.79 -51.29 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.751 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -47.76 74.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.55 -0.296 . . . . 99.99 111.65 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.42 -40.49 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.696 0.628 . . . . 99.99 112.696 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.539 ' HD2' ' HA ' ' C' ' 47' ' ' SER . 12.5 t70 -62.48 -28.5 69.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.398 -0.521 . . . . 99.99 110.37 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -88.54 4.1 47.96 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.035 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.412 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 50.3 tpp -95.97 -20.09 19.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 99.99 109.994 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.419 ' O ' HD22 ' C' ' 82' ' ' LEU . 12.5 m -114.38 -38.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.582 -0.736 . . . . 99.99 111.653 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.494 HG22 HG23 ' C' ' 43' ' ' ILE . 78.4 m -73.65 -55.89 5.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.998 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 17.9 m -50.1 -51.85 58.55 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.505 0.557 . . . . 99.99 112.505 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.2 Cg_exo -53.21 -42.64 63.48 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.781 1.654 . . . . 99.99 111.791 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.419 HD22 ' O ' ' C' ' 78' ' ' VAL . 4.1 mm? -67.92 -32.55 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 99.99 110.004 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.412 ' O ' HD22 ' C' ' 87' ' ' LEU . 0.2 OUTLIER -68.87 -25.92 64.87 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.833 -0.802 . . . . 99.99 108.833 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' C' ' 109' ' ' GLN . 24.0 tp -80.63 -38.21 29.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.014 -0.994 . . . . 99.99 110.311 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . 0.42 ' HG ' ' HE1' ' C' ' 89' ' ' TRP . 19.7 tp -65.84 -52.78 47.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.208 -0.906 . . . . 99.99 111.15 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.3 p -50.93 -44.17 60.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.395 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.412 HD22 ' O ' ' C' ' 83' ' ' LEU . 3.6 mm? -62.37 -33.48 74.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.184 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 57.7 m -70.87 -22.67 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 99.99 111.196 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . 0.42 ' HE1' ' HG ' ' C' ' 85' ' ' LEU . 93.4 m95 -80.72 -52.12 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 99.99 111.233 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -62.71 -27.55 69.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.36 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.47 -22.97 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.174 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.0 mtp -110.53 102.34 10.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.882 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.98 -40.44 39.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.897 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -108.14 138.64 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.038 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.1 pt -145.31 146.76 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 99.99 110.969 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.63 -74.79 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.948 0.404 . . . . 99.99 111.067 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -139.07 25.89 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 99.99 110.771 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . 0.52 ' HD2' HD11 ' C' ' 101' ' ' LEU . 15.4 t70 -72.73 129.68 38.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 99.99 110.741 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -151.28 -28.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.832 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 1.7 t -63.99 -46.31 85.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.475 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.52 HD11 ' HD2' ' C' ' 98' ' ' ASP . 79.3 mt -64.71 -37.19 86.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 99.99 110.823 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.87 -29.16 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 99.99 110.64 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.26 -30.26 46.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.956 -0.64 . . . . 99.99 112.602 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . 0.41 ' HA ' ' HG ' ' C' ' 107' ' ' SER . 91.2 t80 -71.84 -25.24 61.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 99.99 110.461 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 mt -77.69 -49.38 14.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 99.99 110.81 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.2 ptm -64.95 -24.26 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 99.99 111.045 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' SER . . . . . 0.41 ' HG ' ' HA ' ' C' ' 104' ' ' PHE . 94.5 p -72.33 -50.24 28.33 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.022 0.439 . . . . 99.99 110.504 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -60.03 -24.8 64.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.976 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.483 ' HB2' HD22 ' C' ' 84' ' ' LEU . 24.8 tp60 -66.98 -52.12 46.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.613 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.9 -35.41 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.004 -0.544 . . . . 99.99 110.758 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.26 -45.36 98.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.929 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.54 -47.86 89.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.394 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 19.7 mt -59.4 -32.55 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 99.99 111.009 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -60.5 -43.65 96.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.508 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -59.22 -53.96 52.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.428 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.54 -25.56 68.87 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.789 -0.719 . . . . 99.99 111.826 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.19 -55.9 28.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.29 0.567 . . . . 99.99 110.329 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 tp -81.22 -28.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 99.99 112.188 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.33 46.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 99.99 111.233 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . 0.531 ' HD2' ' H ' ' C' ' 69' ' ' HIS . 14.3 t70 -79.68 -31.15 41.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.843 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.79 7.49 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.323 -0.399 . . . . 99.99 110.912 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.0 t -63.42 122.98 17.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.223 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.03 -51.55 3.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.704 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.59 ' HB2' HG13 ' C' ' 127' ' ' VAL . 90.6 mtt180 -75.65 143.78 42.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 99.99 110.662 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.07 -19.09 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.667 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -79.46 -54.47 5.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.709 0.29 . . . . 99.99 111.108 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' C' ' 124' ' ' ARG . 14.2 p -59.69 -24.04 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 99.99 111.367 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -51.52 -47.55 63.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.34 -0.391 . . . . 99.99 111.302 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.24 -24.78 62.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.334 -0.393 . . . . 99.99 111.339 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' C' ' 127' ' ' VAL . 95.6 mt -72.65 -52.21 16.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 99.99 111.166 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.27 -28.7 66.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 99.99 110.792 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -59.84 -60.41 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.823 -0.626 . . . . 99.99 110.451 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . 0.404 ' HA ' HG23 ' C' ' 136' ' ' VAL . 16.4 tt -63.95 -26.23 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.917 -0.583 . . . . 99.99 111.087 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.54 -35.29 80.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.793 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.61 -53.75 7.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.81 -0.709 . . . . 99.99 112.587 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' C' ' 133' ' ' ILE . 34.1 m -59.46 -30.75 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.321 . . . . 99.99 111.352 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.8 -35.27 72.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 99.99 110.67 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.58 93.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.8 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -73.16 -24.04 60.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.903 -0.59 . . . . 99.99 111.083 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -60.94 2.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 99.99 111.357 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . 0.401 HG13 ' N ' ' C' ' 142' ' ' ILE . 17.6 pt -58.34 -45.71 89.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.608 0.596 . . . . 99.99 112.608 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.402 ' O ' HG13 ' C' ' 146' ' ' ILE . 41.8 pt -66.44 -32.26 57.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.685 0.254 . . . . 99.99 111.685 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 56.5 tp -55.76 -56.64 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.603 0.239 . . . . 99.99 110.901 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -64.79 -24.52 67.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 99.99 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' C' ' 149' ' ' PRO . . . -79.38 -17.37 76.26 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.343 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . 0.402 HG13 ' O ' ' C' ' 142' ' ' ILE . 68.8 mt -109.24 -12.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.957 0.408 . . . . 99.99 111.031 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -72.4 -55.4 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 99.99 111.998 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.602 ' HB2' ' HD3' ' C' ' 149' ' ' PRO . 34.0 m120 -101.92 -53.12 0.15 Allowed Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.406 0.521 . . . . 99.99 112.406 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.602 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 88.5 Cg_exo -45.04 -25.28 1.63 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.409 2.073 . . . . 99.99 112.853 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.27 -52.96 34.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.058 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -149.09 62.89 1.04 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 99.99 110.857 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.73 -19.06 38.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.158 -0.473 . . . . 99.99 110.925 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -84.03 -24.16 30.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 99.99 111.166 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 75.5 p -68.15 -10.39 53.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 99.99 110.941 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -65.64 -26.0 67.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.02 -0.536 . . . . 99.99 110.761 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 8.0 t -110.96 -2.12 16.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 99.99 111.197 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -93.11 -68.95 0.77 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.991 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 69.9 m -134.83 115.71 13.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.732 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 64.7 m -73.63 -34.54 65.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 99.99 111.374 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -59.34 -54.09 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.823 0.344 . . . . 99.99 111.023 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 49.4 tp -58.28 -34.34 70.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.244 -0.434 . . . . 99.99 110.842 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.05 -31.6 68.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.016 -0.538 . . . . 99.99 111.2 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -67.26 -36.74 82.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.293 -0.412 . . . . 99.99 110.684 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.31 -46.4 77.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.243 0.545 . . . . 99.99 110.469 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.62 -36.03 79.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 99.99 111.108 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.82 -56.22 17.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 99.99 111.539 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . 0.411 ' O ' HG23 ' C' ' 170' ' ' THR . 68.5 mttm -59.34 -22.21 60.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.461 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.95 -59.05 2.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 99.99 111.413 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.67 -29.27 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 99.99 112.192 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 170' ' ' THR . . . . . 0.411 HG23 ' O ' ' C' ' 167' ' ' LYS . 15.3 t -57.05 -36.17 70.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 99.99 110.988 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -77.32 -34.71 55.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 99.99 109.943 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.24 -22.59 63.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.688 -0.687 . . . . 99.99 110.474 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 90.6 m -79.52 -58.56 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.264 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.68 -28.52 32.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.785 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.34 -57.4 4.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.163 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.78 -25.55 60.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.875 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 86.4 mt -87.89 -21.57 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.045 0.45 . . . . 99.99 110.414 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . 0.5 ' O ' HG23 ' C' ' 181' ' ' ILE . . . -63.4 -41.6 99.33 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.791 -0.64 . . . . 99.99 112.998 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.51 ' N ' ' HD2' ' C' ' 180' ' ' PRO . 55.5 m-85 -64.47 -52.03 55.82 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 111.988 0.366 . . . . 99.99 111.988 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.544 ' HA ' ' NE1' ' C' ' 183' ' ' TRP . 33.1 Cg_endo -63.76 -16.78 56.78 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.01 1.807 . . . . 99.99 113.326 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.5 HG23 ' O ' ' C' ' 178' ' ' GLY . 3.6 tt -88.99 -27.09 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 112.483 0.549 . . . . 99.99 112.483 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.449 HG13 ' N ' ' C' ' 183' ' ' TRP . 3.8 p -80.88 -53.78 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.47 0.915 . . . . 99.99 113.47 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . 0.544 ' NE1' ' HA ' ' C' ' 180' ' ' PRO . 0.2 OUTLIER -58.32 -12.11 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.198 0.444 . . . . 99.99 112.198 -178.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.99 -18.84 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.996 0.427 . . . . 99.99 110.703 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 2.4 pt -126.67 91.76 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.858 -0.61 . . . . 99.99 111.201 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 151.46 -161.69 29.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.968 -0.635 . . . . 99.99 112.157 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.86 149.19 42.85 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.556 2.171 . . . . 99.99 111.893 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 94.1 p 51.34 24.61 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.947 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -139.02 -91.5 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.872 -0.604 . . . . 99.99 112.238 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -125.0 -32.66 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.357 . . . . 99.99 110.66 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 86.52 123.64 1.58 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 99.99 112.785 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -174.66 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 99.99 110.694 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 22.8 pt -106.98 179.56 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 99.99 111.271 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -86.57 -167.3 1.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.093 -0.503 . . . . 99.99 111.087 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -83.71 -47.66 10.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.965 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.7 p -60.93 -27.43 68.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 99.99 111.408 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 88.3 mt -72.97 -45.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.403 -0.362 . . . . 99.99 111.295 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.25 -46.97 76.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.894 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -69.52 -26.92 64.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 99.99 111.08 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -69.71 -33.36 72.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.981 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.22 -45.53 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.396 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -67.5 -7.44 25.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 99.99 111.266 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.515 ' HB2' HH22 ' C' ' 72' ' ' ARG . 44.3 t -96.47 -43.52 7.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 99.99 110.568 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 39.4 tp -67.82 -37.05 81.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.48 -0.782 . . . . 99.99 112.149 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.599 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.4 OUTLIER -60.86 -55.21 46.97 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.942 -0.303 . . . . 99.99 111.446 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.608 ' HB2' ' HH ' ' C' ' 11' ' ' TYR . 66.8 Cg_exo -53.75 -36.78 83.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.691 1.594 . . . . 99.99 111.368 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.86 -46.15 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 99.99 109.985 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -68.29 -16.55 64.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 99.99 110.483 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 30.6 t -93.83 -27.7 16.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 99.99 110.914 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.484 ' H82' ' H10' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.86 -35.01 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.421 . . . . 99.99 111.094 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.89 -40.11 98.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.333 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.93 -27.92 67.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 99.99 110.97 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 52.9 m -61.44 -57.15 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 99.99 110.967 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.86 -29.41 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.04 -40.44 90.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.535 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.01 -22.06 60.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.459 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 43.8 tp -74.5 -42.07 59.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 99.99 110.552 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -85.13 -20.27 30.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 99.99 111.025 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.57 49.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.991 -0.623 . . . . 99.99 112.714 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.7 -29.61 69.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.733 0.301 . . . . 99.99 111.192 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 60.93 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.385 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -133.48 148.9 51.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.361 -0.381 . . . . 99.99 110.823 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 72.9 mt -92.64 113.98 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 99.99 111.026 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -146.2 -45.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.853 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.81 132.78 39.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.862 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 47.3 t -131.31 -49.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 99.99 110.906 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.81 178.83 6.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 99.99 110.758 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.824 179.911 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.811 0.339 . . . . 99.99 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -100.2 -13.71 18.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.958 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -86.04 86.95 7.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.05 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -119.49 145.35 46.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.29 -0.414 . . . . 99.99 110.733 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -153.69 127.79 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.39 -0.368 . . . . 99.99 111.082 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.0 mt -92.19 4.5 53.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.775 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.85 -52.33 44.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.555 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 40.6 m-70 -68.42 -23.55 64.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.89 -0.596 . . . . 99.99 110.101 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -66.57 -52.17 48.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.681 . . . . 99.99 111.115 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.0 pt -68.53 -21.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 99.99 110.773 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -60.6 -55.06 37.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 99.99 110.56 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.98 -36.24 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.966 -0.561 . . . . 99.99 111.127 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.43 -37.63 73.12 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.935 0.398 . . . . 99.99 110.92 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.04 -29.41 58.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.721 -0.752 . . . . 99.99 112.178 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -74.81 -31.72 61.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.299 . . . . 99.99 111.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 p -68.11 -50.19 56.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.481 -0.327 . . . . 99.99 111.111 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.47 -26.58 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.287 -0.415 . . . . 99.99 110.725 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.49 44.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.61 -0.805 . . . . 99.99 111.9 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.79 -23.48 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.903 0.382 . . . . 99.99 110.716 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -68.78 -41.62 78.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.776 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -60.54 -23.53 64.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 99.99 110.305 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -60.84 -31.9 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.659 -0.7 . . . . 99.99 110.566 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.58 ' O ' ' OG ' ' A' ' 26' ' ' SER . 68.4 t-105 -78.51 -45.52 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 99.99 110.531 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 p -65.9 -19.72 65.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.978 -0.555 . . . . 99.99 110.748 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.96 -12.74 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 99.99 110.743 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 72.7 p -69.64 -18.53 63.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 99.99 111.01 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -49.56 -32.98 13.73 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.36 0.6 . . . . 99.99 109.575 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -176.86 131.82 0.37 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.959 -1.018 . . . . 99.99 110.096 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -95.54 177.41 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.007 2.471 . . . . 99.99 112.224 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -99.36 63.8 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.298 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -46.55 3.5 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.751 -0.737 . . . . 99.99 112.554 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HE2' ' A' ' 36' ' ' GLU . 34.1 m -95.6 146.43 31.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.526 0.203 . . . . 99.99 110.776 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.64 165.49 18.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.367 2.044 . . . . 99.99 112.399 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -72.32 -15.86 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.412 -0.813 . . . . 99.99 112.016 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -40.27 -38.98 0.86 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.334 0.494 . . . . 99.99 112.334 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 37' ' ' TYR . 11.7 pt-20 -64.84 -46.9 79.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 99.99 110.568 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.416 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 73.8 m-85 -70.49 -18.6 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 99.99 110.488 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 41' ' ' MET . 54.3 tp -63.2 -49.28 74.86 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.321 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -63.5 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.174 0.511 . . . . 99.99 109.663 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 -5.01 40.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.588 -0.733 . . . . 99.99 110.475 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.466 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 22.0 ttt -88.25 -34.07 17.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.473 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -75.67 -31.4 59.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 99.99 110.883 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.663 HG22 HG21 ' A' ' 79' ' ' THR . 85.2 mt -52.54 -51.75 70.17 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.597 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.466 ' HD2' ' C ' ' A' ' 41' ' ' MET . 73.5 Cg_endo -74.3 -32.21 6.76 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.408 2.072 . . . . 99.99 112.804 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 41' ' ' MET . 72.0 mt -53.67 -61.62 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.633 0.254 . . . . 99.99 111.539 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' NE1' HG23 ' B' ' 110' ' ' ILE . 2.1 t90 -64.8 -51.42 62.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.688 0.28 . . . . 99.99 111.064 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.8 p -57.67 -14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.196 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.77 -57.95 2.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.491 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.493 HD21 ' HG ' ' B' ' 134' ' ' CYS . 35.0 mt -58.78 -28.41 65.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 99.99 111.032 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.36 -59.36 5.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.541 . . . . 99.99 111.267 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.463 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 16.0 m-85 -59.47 -43.07 93.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.126 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.9 ttp -48.24 -35.4 11.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.187 0.518 . . . . 99.99 110.216 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.85 77.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.72 -0.673 . . . . 99.99 110.648 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 56.1 mtt -52.12 -27.83 15.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.244 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.11 -45.26 58.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.719 -0.673 . . . . 99.99 110.622 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.8 pt -84.18 11.15 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.109 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 60.05 50.59 6.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.923 -0.58 . . . . 99.99 111.675 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.02 158.25 30.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 99.99 110.937 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.23 34.55 32.55 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.733 -0.746 . . . . 99.99 112.307 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -129.9 136.37 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.309 . . . . 99.99 110.896 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.3 140.13 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.259 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.82 89.99 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.034 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.74 126.11 42.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.332 -0.394 . . . . 99.99 111.407 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 34.87 24.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 99.99 111.54 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.17 -0.31 59.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.823 -0.704 . . . . 99.99 112.835 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -98.35 134.27 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.673 0.273 . . . . 99.99 110.771 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 mt -89.3 103.79 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.942 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.38 135.52 38.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.861 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 53.0 m-70 -82.65 73.71 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.186 0.517 . . . . 99.99 110.723 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -58.92 -28.89 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.45 -0.795 . . . . 99.99 111.458 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.04 -23.96 35.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 99.99 111.805 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 12.9 tpp180 -67.24 -51.27 55.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 99.99 112.386 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 9.1 p90 -82.53 -32.5 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.275 0.472 . . . . 99.99 112.275 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.0 tt -55.23 -42.15 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 C-N-CA 120.713 -0.395 . . . . 99.99 110.489 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.33 -22.81 64.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.445 -0.576 . . . . 99.99 109.445 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -87.79 5.13 41.56 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.475 -0.784 . . . . 99.99 111.103 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.3 ttm -104.59 -18.18 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.494 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.05 -35.29 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.517 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.663 HG21 HG22 ' A' ' 43' ' ' ILE . 87.9 m -82.14 -49.0 10.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.648 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.57 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.8 m -53.39 -49.92 85.65 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.199 -0.455 . . . . 99.99 112.197 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.9 Cg_endo -58.88 -41.51 61.68 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.97 1.78 . . . . 99.99 112.17 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.8 -7.97 58.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 99.99 110.894 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -81.42 -40.29 23.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.796 0.332 . . . . 99.99 110.283 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 109' ' ' GLN . 3.6 pp -81.62 -31.59 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.223 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.54 -27.94 63.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.319 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -63.69 -24.68 67.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 99.99 110.399 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.09 -52.53 18.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 99.99 110.739 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.2 t -60.21 -21.41 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.838 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -76.4 -36.59 57.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 99.99 111.052 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 p -80.92 -23.44 38.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.353 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 -37.14 17.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.21 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.464 ' HE2' HG21 ' A' ' 95' ' ' ILE . 19.9 ttt -97.74 99.42 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.435 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -85.91 -48.8 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.244 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -104.57 137.32 42.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 99.99 111.067 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.464 HG21 ' HE2' ' A' ' 92' ' ' MET . 47.5 pt -123.71 151.43 28.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 99.99 110.843 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.12 -54.49 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 99.99 110.558 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -150.12 -159.59 1.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 99.99 110.438 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 64.68 105.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.024 0.44 . . . . 99.99 111.228 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -119.53 15.86 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.609 . . . . 99.99 110.553 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.3 t -87.16 -21.25 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 99.99 110.834 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.47 -51.52 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 99.99 110.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -59.19 -30.68 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.081 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.1 -27.19 64.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.542 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -73.43 -38.41 65.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 99.99 110.972 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.3 mt -71.74 -32.54 67.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.119 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.44 ' O ' HG12 ' A' ' 110' ' ' ILE . 61.1 mtt -74.23 -25.3 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 99.99 111.11 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -76.95 -49.44 15.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 99.99 111.256 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.539 ' HG1' HG13 ' A' ' 142' ' ' ILE . 8.5 t -62.41 -35.43 79.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 99.99 111.949 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.496 ' HB3' HD22 ' A' ' 84' ' ' LEU . 13.8 pt20 -67.3 -42.05 84.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.567 0.223 . . . . 99.99 111.465 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 106' ' ' MET . 33.1 mm -60.05 -33.45 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.827 0.346 . . . . 99.99 111.067 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.29 -44.6 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 99.99 111.458 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.64 -50.09 77.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 99.99 111.864 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.5 pt -57.2 -33.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.626 0.25 . . . . 99.99 111.437 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 85.4 m -63.67 -47.61 80.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 99.99 111.12 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -63.81 -21.76 66.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.61 -46.44 7.32 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.937 -0.649 . . . . 99.99 112.95 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -66.75 -29.13 69.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.52 0.2 . . . . 99.99 111.53 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.507 ' N ' HD11 ' A' ' 117' ' ' LEU . 10.1 tp -83.46 -28.4 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.551 -0.295 . . . . 99.99 111.161 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.68 71.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.803 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.08 -23.55 41.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 99.99 110.783 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.59 23.72 0.93 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 99.99 110.837 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.1 t -76.31 137.04 39.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.967 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.07 -34.54 8.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.922 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' HG12 ' A' ' 127' ' ' VAL . 98.5 mtt180 -116.48 143.09 46.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 99.99 110.982 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -74.68 -12.11 60.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.137 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -86.58 -39.53 16.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 99.99 111.072 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.538 ' HA ' HD22 ' A' ' 130' ' ' LEU . 14.5 p -77.78 -24.23 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.086 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -57.62 -29.28 64.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.754 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.03 -31.42 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 99.99 110.964 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.538 HD22 ' HA ' ' A' ' 127' ' ' VAL . 3.5 mm? -73.31 -42.28 62.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.067 -0.515 . . . . 99.99 111.163 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -74.17 -31.65 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 99.99 110.995 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.46 -56.96 15.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.654 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.8 tt -62.17 -29.4 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.233 -0.439 . . . . 99.99 110.933 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.5 t -61.18 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.197 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.407 ' HA3' H142 ' A' ' 210' ' ' LYR . . . -72.26 -52.53 10.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.535 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.21 -29.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 99.99 111.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 36.4 t -64.44 -42.43 96.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.747 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.05 93.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.925 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -76.73 -15.8 59.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.02 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.67 -55.1 6.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.372 . . . . 99.99 110.621 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.53 -34.92 63.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.539 HG13 ' HG1' ' A' ' 108' ' ' THR . 39.8 mm -71.44 -44.12 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 99.99 110.969 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.23 -56.06 24.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 99.99 110.931 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -63.04 -21.89 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.097 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.74 -20.44 61.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 99.99 112.866 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 142' ' ' ILE . 70.3 mt -99.56 -12.68 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.458 . . . . 99.99 110.783 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -69.0 -50.64 47.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 99.99 111.577 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 69.1 m-80 -53.48 -53.13 60.09 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 99.99 112.143 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 36.2 Cg_endo -63.9 -10.47 22.87 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.096 1.864 . . . . 99.99 112.845 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.28 46.29 2.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.516 -0.311 . . . . 99.99 111.237 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -173.04 -65.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.963 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.73 -36.45 37.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 99.99 111.25 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -79.96 -22.71 42.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.979 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.491 ' HA ' ' HB3' ' A' ' 157' ' ' GLN . 40.1 p -86.76 -4.49 59.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.534 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -63.07 -38.5 91.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.503 -0.317 . . . . 99.99 110.889 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 t -100.11 -21.27 15.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 99.99 110.842 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 154' ' ' THR . 23.3 tp60 -68.17 -75.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.002 -0.544 . . . . 99.99 110.933 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.6 m -156.43 122.62 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 99.99 110.645 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 68.3 p -77.22 -25.79 52.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.073 -0.512 . . . . 99.99 111.0 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -69.1 -57.05 5.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.941 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 164' ' ' LEU . 6.7 mp -66.95 -23.66 65.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.023 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.53 -47.24 82.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 99.99 111.046 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.62 -33.81 76.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 99.99 110.698 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 161' ' ' LEU . 92.5 mt -57.76 -60.76 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 99.99 110.675 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.64 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 99.99 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -38.85 68.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 99.99 110.921 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.07 -22.79 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.256 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 74.9 mt -73.99 -60.04 2.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.361 -0.381 . . . . 99.99 111.135 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.0 t -55.84 -23.84 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.883 -0.598 . . . . 99.99 111.45 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.9 m -56.18 -58.94 5.83 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.841 0.353 . . . . 99.99 111.262 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.43 -30.66 69.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 99.99 110.805 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.81 -28.65 69.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 99.99 111.05 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 55.2 m -77.91 -56.64 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.283 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.62 -28.76 28.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.329 -0.396 . . . . 99.99 111.573 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.89 -57.77 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 99.99 111.405 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.3 -27.29 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.885 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 181' ' ' ILE . 90.9 mt -87.73 -25.0 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.3 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.81 -55.9 26.61 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.872 -0.603 . . . . 99.99 113.311 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.582 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.0 m-85 -53.33 -55.8 30.83 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.765 -0.374 . . . . 99.99 110.788 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.2 Cg_exo -45.45 -33.34 9.1 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.084 1.856 . . . . 99.99 112.423 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.1 mm -59.39 -53.82 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 121.024 0.44 . . . . 99.99 110.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 179' ' ' TYR . 1.5 m -58.43 -24.23 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 99.99 111.082 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -83.88 -16.45 44.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.286 -0.415 . . . . 99.99 111.773 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 93.4 mt -50.7 -37.41 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.818 0.342 . . . . 99.99 110.95 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 pp -141.72 157.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.404 . . . . 99.99 111.333 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.411 ' HA3' ' N ' ' A' ' 191' ' ' GLY . . . 87.12 158.01 31.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.927 -0.654 . . . . 99.99 113.285 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.91 90.02 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.755 2.303 . . . . 99.99 112.27 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 55.3 m 55.1 50.56 15.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.991 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.72 -106.84 0.19 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.695 -0.764 . . . . 99.99 112.802 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -150.61 10.94 0.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.197 0.523 . . . . 99.99 110.265 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.411 ' N ' ' HA3' ' A' ' 186' ' ' GLY . . . 83.36 145.51 6.24 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.867 -0.683 . . . . 99.99 112.564 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 71.6 m95 59.41 10.73 1.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.537 0.208 . . . . 99.99 111.35 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.55 142.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 99.99 111.58 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -157.17 -11.27 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.66 . . . . 99.99 110.126 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -74.97 -157.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.608 -0.724 . . . . 99.99 110.914 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.6 m -57.58 -28.53 63.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.332 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 86.1 mt -57.18 -40.51 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.441 -0.345 . . . . 99.99 111.275 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.85 -56.12 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.888 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.2 p -64.91 -31.67 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 99.99 110.969 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -61.47 -30.89 70.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.03 -0.532 . . . . 99.99 111.084 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.71 -52.45 15.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.199 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.94 -6.42 41.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.572 -0.285 . . . . 99.99 111.373 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 29.1 t -96.24 -39.7 9.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 99.99 110.543 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.8 -40.99 65.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.622 -0.717 . . . . 99.99 112.094 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.548 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -56.39 -54.74 49.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.149 -0.221 . . . . 99.99 111.405 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.5 Cg_exo -55.76 -45.18 41.0 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.829 1.686 . . . . 99.99 111.538 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.01 -24.62 66.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.464 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -81.95 -21.86 36.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 99.99 110.693 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 92.6 p -95.5 -39.95 9.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.112 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.485 ' HZ ' ' HB3' ' A' ' 206' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.42 -31.69 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.446 -0.343 . . . . 99.99 111.295 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.69 -45.26 90.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.674 -0.774 . . . . 99.99 112.916 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -69.72 -28.68 66.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.62 0.248 . . . . 99.99 111.196 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -55.19 -62.06 1.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.432 -0.349 . . . . 99.99 110.836 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -64.66 -29.34 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 99.99 110.46 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.05 -45.98 91.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 99.99 110.589 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.21 -35.08 79.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.517 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.351 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -83.77 -25.91 30.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 99.99 110.847 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -79.47 -24.39 60.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 99.99 112.34 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 27.0 tp -77.9 -6.29 53.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 99.99 110.747 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -58.37 -75.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.02 -0.536 . . . . 99.99 111.23 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -63.85 142.44 58.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 99.99 111.034 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.5 mt 61.34 110.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.904 -0.589 . . . . 99.99 111.354 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -136.02 85.26 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.473 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -131.19 131.06 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.982 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.7 t -164.84 103.46 0.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 99.99 111.007 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -131.72 82.83 2.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.205 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 99.99 110.808 179.803 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mmm . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.856 0.36 . . . . 99.99 110.743 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -110.31 9.53 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 99.99 110.928 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.56 63.62 0.65 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.947 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -96.09 151.82 19.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.859 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 92.3 p -159.83 130.9 5.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.447 . . . . 99.99 110.965 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.414 HD13 ' N ' ' B' ' 6' ' ' LEU . 6.7 mp -92.7 -3.02 55.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 99.99 110.824 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 57.4 mt -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.004 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.56 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 29.0 m80 -80.01 -24.42 40.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.505 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -73.66 -35.34 65.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 99.99 110.812 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 tt -80.73 -26.52 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.693 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -62.09 -47.41 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.271 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.43 -36.94 74.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 99.99 111.084 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -36.11 79.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.978 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.74 59.15 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.781 -0.723 . . . . 99.99 112.311 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.405 ' HB3' ' HB2' ' B' ' 44' ' ' PRO . 23.1 mmt -72.73 -27.78 62.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 99.99 110.785 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -64.88 -56.41 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.88 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.28 -24.94 34.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.044 -0.525 . . . . 99.99 110.984 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.69 -57.72 18.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.636 -0.792 . . . . 99.99 112.199 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' B' ' 41' ' ' MET . . . -62.85 -23.41 67.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 99.99 110.788 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.95 -39.2 83.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.571 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -61.41 -22.55 65.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.912 -0.586 . . . . 99.99 110.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.469 ' HB2' ' HE3' ' B' ' 41' ' ' MET . 73.8 t80 -61.04 -40.55 94.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 99.99 110.358 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.525 ' O ' ' OG ' ' B' ' 26' ' ' SER . 68.7 m95 -70.8 -41.45 71.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.795 -0.639 . . . . 99.99 110.593 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -69.7 -20.81 63.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.869 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.88 -15.84 35.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.713 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.525 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 67.0 p -67.2 -17.07 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 99.99 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.33 -33.67 13.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.409 -0.589 . . . . 99.99 109.409 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -177.68 131.63 0.33 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 114.997 -1.002 . . . . 99.99 110.216 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -93.8 169.15 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.915 2.41 . . . . 99.99 112.251 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -96.41 60.97 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.458 . . . . 99.99 110.901 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.9 -46.67 3.66 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.791 -0.718 . . . . 99.99 112.416 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.14 131.65 42.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.473 0.177 . . . . 99.99 110.631 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.419 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 35.4 Cg_exo -59.82 156.66 36.94 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.241 1.961 . . . . 99.99 112.054 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -61.19 -17.72 54.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 99.99 112.459 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.419 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 3.6 p90 -43.89 -36.51 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.787 0.327 . . . . 99.99 111.567 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.521 ' HE2' HD23 ' B' ' 221' ' ' LEU . 46.0 tt0 -62.64 -57.12 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 99.99 110.664 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.49 ' HH ' HD23 ' B' ' 218' ' ' LEU . 82.8 m-85 -66.77 -18.74 65.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 99.99 110.637 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 45.4 tp -57.11 -55.6 32.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.152 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.74 -42.9 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 99.99 110.524 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.46 -12.44 52.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 99.99 111.138 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.641 ' HG3' ' HA ' ' B' ' 19' ' ' ALA . 0.0 OUTLIER -88.6 -31.03 18.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.358 -0.383 . . . . 99.99 111.289 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -72.08 -27.62 62.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 99.99 110.386 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.546 HG22 HG22 ' B' ' 79' ' ' THR . 65.3 mt -58.28 -53.94 60.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.085 -0.507 . . . . 99.99 112.003 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.473 ' HD2' ' C ' ' B' ' 41' ' ' MET . 45.2 Cg_endo -67.75 -35.14 22.56 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.17 1.913 . . . . 99.99 112.986 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.434 HG13 ' O ' ' B' ' 41' ' ' MET . 97.0 mt -53.78 -62.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.762 0.282 . . . . 99.99 111.762 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.517 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.7 t90 -61.3 -50.11 74.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.744 0.307 . . . . 99.99 111.08 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.489 ' HG ' ' HD2' ' B' ' 75' ' ' ASP . 59.5 m -60.27 -14.02 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 99.99 111.495 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.9 -55.71 3.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.714 -0.755 . . . . 99.99 112.709 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.432 HD23 ' SG ' ' C' ' 134' ' ' CYS . 24.0 mt -58.74 -32.08 68.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.857 0.361 . . . . 99.99 111.084 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.313 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 9.0 m-85 -60.7 -41.41 95.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 99.99 110.993 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -50.67 -32.36 18.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.135 0.493 . . . . 99.99 110.1 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.7 -39.86 69.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 99.99 110.504 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -54.97 -28.21 49.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.805 -0.634 . . . . 99.99 110.284 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -73.31 -49.51 27.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.737 -0.665 . . . . 99.99 110.817 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' B' ' 53' ' ' ALA . 36.1 pt -79.52 8.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.459 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.32 60.73 2.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.055 -0.52 . . . . 99.99 111.31 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -143.86 139.99 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.907 0.384 . . . . 99.99 110.876 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.38 5.63 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.882 -0.675 . . . . 99.99 112.101 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.62 150.22 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.664 0.268 . . . . 99.99 110.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.99 148.0 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.077 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.21 93.68 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.838 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.32 125.18 50.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.279 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.49 30.61 18.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.989 -0.55 . . . . 99.99 111.275 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.86 57.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.727 -0.749 . . . . 99.99 112.563 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -107.15 127.61 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.757 0.313 . . . . 99.99 110.821 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 45.0 mm -77.37 105.27 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 99.99 111.088 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.8 134.52 37.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.943 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.486 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 81.8 m-70 -79.83 76.18 6.52 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.132 0.492 . . . . 99.99 111.1 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -62.42 -28.0 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.485 -0.78 . . . . 99.99 111.082 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.27 -28.0 32.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.299 0.481 . . . . 99.99 112.299 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 29.2 mmt180 -66.56 -51.51 55.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.629 0.603 . . . . 99.99 112.629 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -82.89 -30.03 28.84 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.29 -0.564 . . . . 99.99 112.497 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 15.2 tt -56.33 -42.15 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.291 -0.563 . . . . 99.99 110.221 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.489 ' HD2' ' HG ' ' B' ' 47' ' ' SER . 26.2 t70 -69.39 -22.25 63.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.996 -0.742 . . . . 99.99 108.996 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -86.56 7.65 25.33 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.342 -0.844 . . . . 99.99 111.034 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 22.0 mtp -104.73 -21.59 13.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.797 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 m -114.08 -28.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 99.99 111.897 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.546 HG22 HG22 ' B' ' 43' ' ' ILE . 37.8 m -82.21 -52.45 6.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.266 -0.424 . . . . 99.99 112.093 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 16.9 m -52.4 -49.73 83.8 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.54 0.57 . . . . 99.99 112.54 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' B' ' 80' ' ' THR . 12.4 Cg_endo -56.08 -45.52 37.71 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.781 1.654 . . . . 99.99 112.262 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.64 -19.47 61.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.797 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.32 -30.96 57.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 99.99 110.197 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.458 HD11 ' NE2' ' B' ' 109' ' ' GLN . 4.8 tt -84.69 -27.92 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.642 -0.708 . . . . 99.99 110.128 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.96 -33.84 39.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 99.99 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -58.75 -28.08 65.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.223 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.456 ' HB3' HD22 ' B' ' 168' ' ' LEU . 52.9 mt -73.36 -34.23 65.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.4 . . . . 99.99 111.12 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.4 m -73.46 -27.04 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.418 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -76.73 -38.62 53.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.349 . . . . 99.99 111.12 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -62.41 -41.55 98.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.376 -0.375 . . . . 99.99 111.138 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.62 -47.49 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.314 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 49.3 tpp -80.4 98.58 7.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.784 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -87.8 -37.34 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.926 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.31 143.19 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.012 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.07 142.24 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.579 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -123.96 -74.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 99.99 111.159 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -156.03 108.46 2.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.034 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.1 -73.62 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.66 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 81.8 m95 53.67 36.35 23.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.323 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.5 t -120.58 -41.51 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.022 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 96.5 mt -74.31 -38.49 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.959 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.5 tt -56.12 -33.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 99.99 111.17 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.17 -29.89 36.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.728 -0.748 . . . . 99.99 112.287 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.91 -24.51 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 99.99 110.835 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -78.54 -50.08 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.993 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' MET . . . . . 0.472 ' O ' HG13 ' B' ' 110' ' ' ILE . 24.6 ptm -60.49 -31.83 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 99.99 111.043 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -67.29 -51.96 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 99.99 111.6 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 71.3 p -57.92 -25.98 61.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 99.99 111.741 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.458 ' NE2' HD11 ' B' ' 84' ' ' LEU . 18.6 mm-40 -78.31 -41.72 32.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 99.99 111.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.472 HG13 ' O ' ' B' ' 106' ' ' MET . 93.4 mt -56.4 -38.1 54.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 99.99 111.8 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.408 HG22 ' N ' ' B' ' 112' ' ' VAL . 29.7 m -72.57 -45.56 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.918 0.34 . . . . 99.99 111.918 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . 0.418 HG12 H131 ' B' ' 210' ' ' LYR . 84.2 t -60.12 -45.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.631 0.253 . . . . 99.99 111.586 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 109' ' ' GLN . 66.3 mt -64.43 -34.75 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 99.99 111.463 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 99.4 m -55.2 -61.0 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 99.99 111.234 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.9 p -57.31 -27.44 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 99.99 111.061 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.11 -49.14 59.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 99.99 112.909 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.454 HD11 HG13 ' B' ' 118' ' ' ILE . 3.3 pp -74.21 -21.88 59.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.686 0.254 . . . . 99.99 111.686 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.454 HG13 HD11 ' B' ' 117' ' ' LEU . 82.5 mt -83.4 -33.17 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.687 0.28 . . . . 99.99 111.215 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.15 71.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 99.99 110.968 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.26 -25.22 46.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.78 31.24 0.7 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.405 -0.361 . . . . 99.99 110.886 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -82.76 130.96 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.05 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -98.55 -42.98 7.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.673 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.447 ' HD3' ' HE1' ' B' ' 126' ' ' TRP . 91.4 mtt180 -98.18 146.36 25.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.285 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -80.37 -16.38 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.429 0.529 . . . . 99.99 112.429 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.447 ' HE1' ' HD3' ' B' ' 124' ' ' ARG . 67.1 p-90 -93.33 -22.44 18.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.688 0.255 . . . . 99.99 111.688 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.451 HG22 HD11 ' B' ' 130' ' ' LEU . 7.3 p -83.66 -23.33 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 99.99 110.945 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -57.76 -35.31 70.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.968 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -68.88 -22.15 64.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 99.99 111.283 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.451 HD11 HG22 ' B' ' 127' ' ' VAL . 90.5 mt -76.75 -54.27 6.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.141 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.96 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.483 -0.326 . . . . 99.99 110.885 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -60.47 -50.06 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 99.99 110.595 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.6 mt -62.74 -30.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 99.99 110.822 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.493 ' HG ' HD21 ' A' ' 49' ' ' LEU . 36.1 t -65.65 -41.01 93.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.872 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . 0.485 ' HA3' H142 ' B' ' 210' ' ' LYR . . . -61.31 -54.1 39.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.908 -0.663 . . . . 99.99 112.365 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 5.8 p -63.46 -39.0 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 99.99 111.067 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.7 t -52.34 -43.56 64.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.286 -0.416 . . . . 99.99 110.7 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.65 84.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.688 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -71.56 -23.56 61.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 99.99 110.992 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -73.33 -61.08 1.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.266 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . 0.401 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.2 pt -51.88 -37.45 21.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.453 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.401 ' N ' HG13 ' B' ' 141' ' ' ILE . 85.3 mt -73.45 -41.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 99.99 110.891 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 tp -56.97 -57.92 10.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 99.99 110.885 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -62.62 -21.86 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.643 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -20.78 59.57 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.85 -0.69 . . . . 99.99 112.989 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.9 pt -100.4 -5.62 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.864 0.332 . . . . 99.99 111.178 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.61 -42.99 17.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.98 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.567 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 69.1 m-80 -58.23 -50.47 87.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 99.99 111.828 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 19.5 Cg_endo -58.92 -14.98 24.96 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.045 1.83 . . . . 99.99 112.186 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 71.4 mt -107.11 147.63 29.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.574 . . . . 99.99 110.208 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.541 ' H ' ' HG1' ' B' ' 154' ' ' THR . 17.6 mmm180 66.8 -76.9 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.729 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.29 -46.33 72.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.044 0.387 . . . . 99.99 112.044 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . 0.512 ' HG3' ' HA ' ' B' ' 149' ' ' PRO . 10.7 mmmm -81.35 -29.58 34.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.556 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' THR . . . . . 0.541 ' HG1' ' H ' ' B' ' 151' ' ' ARG . 79.1 p -86.74 5.06 38.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.566 -0.288 . . . . 99.99 111.445 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -56.85 -28.37 61.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.942 0.401 . . . . 99.99 110.577 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 50.8 m -108.23 -25.57 10.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.61 . . . . 99.99 110.574 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.43 -68.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 99.99 110.861 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 40.4 t -166.11 118.34 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 99.99 110.605 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 70.0 m -76.33 -25.92 55.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.985 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.7 -57.77 9.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 99.99 110.74 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 7.9 mp -65.27 -21.28 66.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.411 . . . . 99.99 110.787 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . 0.418 ' HB3' ' HD2' ' B' ' 151' ' ' ARG . . . -68.94 -32.62 72.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.504 . . . . 99.99 111.1 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.47 -41.38 55.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.719 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.73 -45.03 91.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.604 . . . . 99.99 110.884 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.04 -24.75 60.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 99.99 111.12 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.1 -44.66 96.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 99.99 110.719 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -79.72 -21.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 99.99 110.77 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' B' ' 87' ' ' LEU . 27.8 tp -68.17 -53.16 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.817 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.35 -28.26 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.028 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.7 m -49.09 -57.97 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.29 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.51 -28.83 67.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.526 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -63.8 -30.62 71.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.481 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 81.6 p -78.82 -59.05 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.595 -0.275 . . . . 99.99 111.485 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.6 p -52.89 -29.91 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.526 -0.306 . . . . 99.99 111.645 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.97 -58.19 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 99.99 111.107 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.95 -25.95 61.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 99.99 110.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 181' ' ' ILE . 80.4 mt -87.99 -27.59 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.061 -0.518 . . . . 99.99 110.269 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.95 -52.62 41.87 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.817 -0.629 . . . . 99.99 113.124 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.598 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 94.4 m-85 -56.49 -58.05 19.4 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.927 -0.309 . . . . 99.99 111.095 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 90.6 Cg_exo -42.68 -38.77 6.69 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.171 1.914 . . . . 99.99 112.924 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.6 mt -58.5 -55.39 22.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.34 -0.391 . . . . 99.99 111.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.559 HG23 ' O ' ' B' ' 179' ' ' TYR . 1.9 m -55.17 -23.88 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.02 -0.536 . . . . 99.99 111.497 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -80.88 -33.3 34.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.074 0.398 . . . . 99.99 112.074 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 tt -88.29 25.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.443 . . . . 99.99 111.561 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 42.6 pt -134.69 -21.4 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.466 -0.334 . . . . 99.99 111.533 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -162.53 167.28 36.98 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.438 -0.887 . . . . 99.99 112.834 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.42 91.96 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.632 2.221 . . . . 99.99 112.529 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 34.7 t 54.44 52.81 11.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.007 -0.542 . . . . 99.99 111.11 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -177.02 -117.27 0.5 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.204 -0.998 . . . . 99.99 113.054 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -128.77 -19.31 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 99.99 110.682 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 121.38 134.34 4.55 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 99.99 112.452 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 57.68 17.57 4.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.68 0.276 . . . . 99.99 111.024 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 37.5 pt -125.97 142.14 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.002 0.429 . . . . 99.99 111.577 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -153.86 2.61 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.75 -0.659 . . . . 99.99 110.516 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -85.57 -161.88 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.813 -0.63 . . . . 99.99 110.803 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 75.2 p -59.27 -27.56 65.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.465 -0.334 . . . . 99.99 111.147 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 7.9 tp -58.34 -31.04 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 99.99 111.188 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.39 -57.49 12.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.864 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 53.3 p -64.77 -31.05 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.932 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.98 -27.55 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.635 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.47 -50.25 14.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 99.99 110.886 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -73.14 -7.91 53.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 99.99 111.317 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.33 -38.39 10.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 99.99 110.862 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.5 tp -73.72 -40.98 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 99.99 112.065 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.568 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 2.3 tt -56.27 -54.29 54.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 121.126 -0.23 . . . . 99.99 111.34 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -56.51 -43.9 50.96 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.822 1.682 . . . . 99.99 111.373 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.403 ' O ' HG21 ' B' ' 211' ' ' VAL . 89.9 t80 -60.11 -32.74 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.29 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -74.3 -19.26 60.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.825 -0.625 . . . . 99.99 110.608 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.6 t -95.79 -48.57 5.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 99.99 111.032 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.485 H142 ' HA3' ' B' ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.403 HG21 ' O ' ' B' ' 207' ' ' PHE . 16.1 m -78.77 -27.42 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 99.99 111.037 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.11 -46.65 93.83 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.899 -0.667 . . . . 99.99 112.453 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -73.24 -22.7 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.618 0.247 . . . . 99.99 110.719 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 60.5 m -60.59 -58.02 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.402 -0.363 . . . . 99.99 110.517 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -67.57 -30.09 69.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.26 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.23 -44.21 97.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.6 . . . . 99.99 110.367 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.19 -38.4 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.589 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.49 HD23 ' HH ' ' B' ' 37' ' ' TYR . 84.8 mt -61.47 -29.45 69.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.039 -0.528 . . . . 99.99 111.215 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -84.86 -42.18 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.218 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.2 -39.4 81.19 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.857 -0.687 . . . . 99.99 112.514 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . 0.521 HD23 ' HE2' ' B' ' 36' ' ' GLU . 72.2 mt -64.69 -32.26 73.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 99.99 111.015 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -77.91 82.3 4.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.03 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -169.89 -36.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.789 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 65.1 tp -167.58 102.27 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.829 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -100.66 128.34 46.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.848 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -165.76 105.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.019 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 38.6 t -158.86 101.68 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.786 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -77.71 -65.44 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 99.99 111.063 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 99.99 110.874 -179.843 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.853 0.359 . . . . 99.99 110.992 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -107.58 -38.23 5.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.883 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 63.0 tp -90.58 129.53 36.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 99.99 111.017 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -154.15 108.3 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.869 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 51.3 m -119.03 110.84 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 99.99 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.452 ' H ' HD22 ' C' ' 6' ' ' LEU . 2.7 pt? -70.95 -8.54 53.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.971 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 18.1 tp -60.88 -52.68 64.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 99.99 110.669 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.633 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 33.1 m170 -61.55 -23.95 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.766 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -75.52 -42.08 53.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 99.99 111.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.71 -22.28 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 99.99 110.642 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -66.18 -48.32 71.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.533 . . . . 99.99 110.31 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.73 -31.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.565 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.81 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 99.99 111.1 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.59 73.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 99.99 112.486 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -78.37 -33.76 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 99.99 110.764 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 89.2 m -61.59 -51.77 67.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.815 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 1.9 tp -60.19 -39.69 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.965 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.54 -57.6 6.5 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.156 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.32 69.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.36 . . . . 99.99 111.106 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.77 -27.53 66.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.515 . . . . 99.99 111.26 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -60.34 -25.26 65.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 99.99 110.72 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -79.99 -22.97 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.75 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.657 ' O ' ' OG ' ' C' ' 26' ' ' SER . 70.9 t-105 -69.81 -35.8 75.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.566 -0.531 . . . . 99.99 109.566 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 45.0 t -85.18 -33.21 22.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.544 -0.753 . . . . 99.99 110.468 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 tp -71.91 -20.72 61.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.41 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 0.7 OUTLIER -57.2 -25.53 59.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.873 -0.603 . . . . 99.99 110.514 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -44.82 -37.61 3.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.143 0.497 . . . . 99.99 110.134 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 24.3 p-10 -172.59 132.08 0.67 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.409 -0.814 . . . . 99.99 110.287 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 60.0 Cg_endo -97.01 169.93 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.016 2.478 . . . . 99.99 112.05 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -96.17 64.5 2.33 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.833 0.349 . . . . 99.99 111.543 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.11 -46.58 3.41 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.834 -0.698 . . . . 99.99 112.803 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.418 HG22 HD23 ' C' ' 221' ' ' LEU . 94.4 t -89.19 131.88 39.42 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.453 0.168 . . . . 99.99 110.815 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 25.4 Cg_exo -61.12 157.69 38.32 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.347 2.031 . . . . 99.99 112.192 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -61.79 -17.34 55.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 99.99 112.482 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.444 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -42.16 -40.98 2.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.669 0.271 . . . . 99.99 111.602 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -66.44 -43.61 85.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 99.99 110.575 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -71.81 -19.13 62.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.868 -0.605 . . . . 99.99 110.529 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.48 -48.87 73.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.394 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.28 -40.38 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 99.99 110.05 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.54 -6.81 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 99.99 110.726 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.429 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 36.6 ttm -87.84 -36.01 17.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 99.99 110.605 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.91 -35.53 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.858 -0.61 . . . . 99.99 111.07 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.566 HG23 HG22 ' C' ' 79' ' ' THR . 88.5 mt -49.88 -54.49 31.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.169 0.433 . . . . 99.99 112.169 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.429 ' HD2' ' C ' ' C' ' 41' ' ' MET . 60.4 Cg_endo -71.83 -32.83 10.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.182 1.921 . . . . 99.99 113.164 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 69.1 mt -53.41 -62.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.853 0.316 . . . . 99.99 111.853 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -66.44 -45.91 78.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.76 0.314 . . . . 99.99 111.074 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.685 ' HG ' ' HD2' ' C' ' 75' ' ' ASP . 45.8 t -61.85 -11.01 10.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.266 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.52 -53.6 3.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 99.99 112.494 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 69.0 mt -59.22 -32.9 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.689 0.28 . . . . 99.99 110.92 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -58.28 9.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 99.99 111.324 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.463 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 13.4 m-85 -59.02 -45.0 91.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.085 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 59.8 ttp -48.39 -30.58 5.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 99.99 110.355 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -46.13 59.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.763 -0.653 . . . . 99.99 111.077 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 1.2 mpp? -55.52 -20.14 12.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 99.99 110.824 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -78.54 -46.7 18.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.293 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.75 11.01 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.844 -0.616 . . . . 99.99 111.014 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 62.6 60.45 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 99.99 111.211 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.51 ' NE2' HG13 ' A' ' 127' ' ' VAL . 87.0 mm-40 -142.58 151.95 42.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.119 -0.492 . . . . 99.99 111.01 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.0 34.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.771 -0.728 . . . . 99.99 112.574 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -133.7 135.56 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 99.99 110.921 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.93 136.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 99.99 111.161 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.94 94.61 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.841 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.12 134.8 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.907 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 30.73 19.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.024 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.93 -1.26 55.52 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 99.99 112.509 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -103.56 122.29 44.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 99.99 111.153 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.45 118.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.947 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.4 133.65 51.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.199 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.52 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 78.0 m-70 -83.93 75.92 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.075 0.464 . . . . 99.99 110.876 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.99 -44.37 97.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.719 -0.673 . . . . 99.99 111.323 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' C' ' 74' ' ' ILE . . . -66.45 -23.59 66.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 99.99 111.878 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 16.7 tpp180 -68.71 -51.61 39.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.302 0.482 . . . . 99.99 112.302 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' C' ' 117' ' ' LEU . 5.7 p90 -83.54 -33.13 25.55 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.068 0.396 . . . . 99.99 112.068 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . 0.426 ' CG2' ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -55.85 -40.53 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 C-N-CA 120.715 -0.394 . . . . 99.99 110.583 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.685 ' HD2' ' HG ' ' C' ' 47' ' ' SER . 26.9 t70 -68.38 -25.39 65.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.121 -0.696 . . . . 99.99 109.121 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -86.66 9.77 17.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.453 -0.794 . . . . 99.99 110.756 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.409 ' HA ' HG23 ' C' ' 113' ' ' ILE . 53.6 tpp -104.49 -23.27 13.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 99.99 110.011 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -114.02 -30.05 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 99.99 111.576 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.566 HG22 HG23 ' C' ' 43' ' ' ILE . 41.3 m -83.73 -44.78 14.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.448 -0.342 . . . . 99.99 111.62 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 55.8 m -56.21 -49.76 91.42 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.875 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -56.47 -47.73 22.56 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.156 1.904 . . . . 99.99 112.312 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.74 -11.2 60.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.135 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.76 -47.15 22.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 99.99 109.971 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.99 -32.27 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 99.99 110.67 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.51 -37.33 77.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.676 -0.693 . . . . 99.99 111.045 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.2 t -60.63 -19.52 58.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.527 ' HB3' HD22 ' C' ' 168' ' ' LEU . 71.2 mt -75.99 -34.71 59.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.081 -0.509 . . . . 99.99 110.891 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 89.8 p -74.2 -26.09 60.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.102 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -75.07 -37.26 61.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.37 -0.377 . . . . 99.99 110.83 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 72.4 p -67.96 -33.85 75.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.333 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.64 -47.66 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.261 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.8 mtp -86.16 100.33 12.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.095 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -83.48 -42.61 16.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.764 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -115.31 140.42 49.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.107 -0.497 . . . . 99.99 111.119 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 68.1 mt -133.65 142.31 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 99.99 110.787 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -120.43 -81.11 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 99.99 111.205 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -143.81 97.61 3.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 99.99 111.023 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -172.85 79.66 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 99.99 110.771 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.52 42.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 99.99 110.78 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 34.5 m -101.84 -40.54 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.54 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.24 -36.72 77.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.219 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.2 -41.72 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 99.99 111.27 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.53 -33.52 60.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.838 -0.696 . . . . 99.99 112.656 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.51 -52.68 64.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 99.99 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.47 -43.13 99.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 99.99 111.357 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 42.3 ttm -60.47 -32.81 71.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.526 . . . . 99.99 111.544 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 47.2 t -78.87 -44.74 22.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.778 0.323 . . . . 99.99 111.451 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 77.6 p -64.87 -32.61 74.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 99.99 111.974 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' C' ' 81' ' ' PRO . 14.0 pt20 -71.32 -46.09 61.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.637 -0.256 . . . . 99.99 111.502 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.517 HG23 ' HE1' ' B' ' 46' ' ' TRP . 35.8 mm -56.02 -34.87 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.679 0.276 . . . . 99.99 111.274 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.85 -47.69 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.381 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . 0.44 HG12 H133 ' C' ' 210' ' ' LYR . 62.7 t -61.21 -48.9 86.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.608 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . 0.409 HG23 ' HA ' ' C' ' 77' ' ' MET . 47.7 mt -59.89 -34.66 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.478 -0.328 . . . . 99.99 111.207 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 32.0 m -58.63 -48.94 79.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 99.99 111.116 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 77.8 p -67.79 -22.15 65.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.92 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.04 -34.57 37.32 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.847 -0.692 . . . . 99.99 113.227 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.509 HD13 ' N ' ' C' ' 118' ' ' ILE . 3.2 pp -81.09 -30.62 34.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.651 0.262 . . . . 99.99 111.549 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.509 ' N ' HD13 ' C' ' 117' ' ' LEU . 8.8 tp -81.03 -28.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.511 -0.313 . . . . 99.99 111.124 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -38.65 78.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.071 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.75 -17.23 48.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 99.99 110.823 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.7 mt -91.49 26.99 2.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.063 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 44.6 t -83.22 142.76 30.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.913 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.17 -41.64 5.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.954 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.431 ' HB2' HG11 ' C' ' 127' ' ' VAL . 0.0 OUTLIER -98.94 142.21 30.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 99.99 110.625 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.07 -11.33 60.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 99.99 111.521 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -91.04 -45.84 8.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 99.99 111.023 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -67.2 -24.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.272 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -61.76 -31.52 71.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.337 -0.392 . . . . 99.99 111.131 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.76 -20.02 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.91 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 98.8 mt -78.46 -55.75 4.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.174 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -60.79 -32.27 71.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.441 -0.345 . . . . 99.99 110.989 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -56.55 -47.2 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.594 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.7 mm -67.88 -30.43 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 99.99 110.953 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' B' ' 49' ' ' LEU . 38.3 t -64.34 -41.0 96.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.868 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.3 -54.26 27.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.845 -0.693 . . . . 99.99 112.757 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -61.42 -35.58 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.784 0.326 . . . . 99.99 111.221 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.26 -40.05 88.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.11 79.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.022 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -76.3 -28.87 57.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 99.99 110.883 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 94.4 mt -69.8 -46.71 65.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.41 -0.359 . . . . 99.99 111.478 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . 0.405 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.6 pt -62.02 -41.67 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 99.99 111.481 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.405 ' N ' HG13 ' C' ' 141' ' ' ILE . 49.0 pt -76.34 -27.07 17.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.484 -0.325 . . . . 99.99 111.366 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.69 -49.68 65.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.348 -0.387 . . . . 99.99 110.823 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . 0.445 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 85.2 t90 -68.98 -25.69 64.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.809 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.48 -17.24 66.78 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.79 -0.719 . . . . 99.99 112.964 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.67 -13.74 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 99.99 111.206 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -76.51 -45.74 29.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 99.99 111.22 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.501 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 69.1 m-80 -58.08 -50.82 85.99 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.838 -0.619 . . . . 99.99 112.113 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 48.7 Cg_endo -67.61 -0.31 5.07 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.183 1.922 . . . . 99.99 112.763 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 89.8 mt -127.07 42.42 3.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.886 0.374 . . . . 99.99 111.204 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -169.54 -62.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.863 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.65 -43.25 17.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.303 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -74.25 -9.85 59.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.186 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 73.0 p -103.21 4.49 36.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.41 -0.359 . . . . 99.99 111.589 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -67.35 -36.35 81.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 99.99 110.93 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 156' ' ' THR . . . . . 0.51 HG21 HE21 ' C' ' 157' ' ' GLN . 4.8 t -93.63 -29.53 15.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.107 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.51 HE21 HG21 ' C' ' 156' ' ' THR . 27.4 mm-40 -65.33 -74.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.084 -0.507 . . . . 99.99 111.091 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 78.4 p -157.97 122.7 4.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.974 -0.557 . . . . 99.99 110.747 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.3 p -77.79 -29.68 50.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 99.99 111.065 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -64.45 -56.61 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 99.99 111.055 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.16 -20.04 63.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.898 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.14 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.321 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -72.26 -39.21 68.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 99.99 111.096 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 mt -60.89 -50.57 72.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.997 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.74 -27.7 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 99.99 111.12 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.72 -39.63 85.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 99.99 110.685 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -82.84 -20.86 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 99.99 110.816 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' C' ' 87' ' ' LEU . 36.4 tp -70.77 -57.22 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 99.99 111.135 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 33.2 t -62.15 -20.92 25.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.295 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 20.9 m -50.43 -58.05 6.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.96 0.409 . . . . 99.99 111.271 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . 0.408 ' O ' HD23 ' C' ' 175' ' ' LEU . 83.4 m-85 -74.64 -26.13 59.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.121 -0.49 . . . . 99.99 110.583 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.47 -40.8 88.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 99.99 111.286 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 4.1 t -77.21 -42.79 36.08 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.747 0.277 . . . . 99.99 111.747 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.15 -40.53 77.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 99.99 111.526 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.408 HD23 ' O ' ' C' ' 171' ' ' TYR . 4.5 mm? -73.05 -52.09 15.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.321 -0.399 . . . . 99.99 111.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -29.59 61.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.84 0.353 . . . . 99.99 110.969 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.476 ' O ' HG13 ' C' ' 181' ' ' ILE . 38.9 mm -87.57 -23.88 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.511 . . . . 99.99 110.249 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.41 -50.59 61.61 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.909 -0.587 . . . . 99.99 113.062 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.609 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 69.4 m-85 -57.67 -55.51 44.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.904 0.352 . . . . 99.99 111.205 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.7 Cg_exo -45.84 -29.68 6.02 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.063 1.842 . . . . 99.99 112.416 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.476 HG13 ' O ' ' C' ' 177' ' ' ILE . 83.2 mt -66.05 -57.58 9.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.932 0.396 . . . . 99.99 111.484 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.485 HG23 ' O ' ' C' ' 179' ' ' TYR . 11.8 m -55.85 -23.87 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.633 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -73.35 -53.4 10.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.537 0.569 . . . . 99.99 112.537 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . 0.444 HG22 ' O ' ' C' ' 181' ' ' ILE . 10.4 tp -55.21 -27.67 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.058 0.392 . . . . 99.99 112.058 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 66.3 mt -59.92 -69.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 99.99 111.025 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' C' ' 187' ' ' PRO . . . 177.27 -50.72 0.1 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.674 -0.694 . . . . 99.99 112.288 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' C' ' 186' ' ' GLY . 70.6 Cg_exo -39.28 150.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.91 2.407 . . . . 99.99 112.648 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 68.3 m 59.25 17.43 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.561 . . . . 99.99 109.632 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -176.87 41.93 0.1 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.178 -0.919 . . . . 99.99 111.933 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 64.3 t80 67.28 95.23 0.06 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.002 0.43 . . . . 99.99 111.21 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' C' ' 186' ' ' GLY . . . -150.61 -167.19 14.27 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 116.03 -0.532 . . . . 99.99 112.301 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -63.15 -24.98 68.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 99.99 110.827 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.408 ' HB ' ' HG3' ' C' ' 187' ' ' PRO . 37.7 mm -108.68 150.07 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.993 -0.548 . . . . 99.99 110.947 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -165.71 -25.97 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.349 -0.387 . . . . 99.99 111.016 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -68.47 -164.01 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 99.99 111.124 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.3 p -55.29 -23.69 24.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 99.99 111.13 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.18 -37.74 74.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.269 -0.423 . . . . 99.99 110.936 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.68 -52.39 60.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.3 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 46.1 p -70.47 -22.63 62.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.851 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.24 -27.22 65.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 99.99 110.865 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.99 -50.07 10.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 99.99 111.064 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.1 -10.18 56.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 47.5 t -96.56 -40.17 9.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 99.99 110.833 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.9 tp -71.72 -37.24 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 99.99 112.164 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.639 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 46.4 tp -60.63 -53.84 60.51 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.031 -0.267 . . . . 99.99 111.634 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.6 Cg_exo -57.25 -39.23 91.66 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.755 1.637 . . . . 99.99 111.426 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.35 -31.44 70.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 99.99 110.378 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -79.9 -22.78 42.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.514 . . . . 99.99 110.534 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 45.7 t -87.15 -48.84 7.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.515 . . . . 99.99 110.902 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.469 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 89.0 t -79.08 -28.87 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 99.99 111.058 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.68 57.62 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 99.99 112.689 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -69.58 -22.71 63.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 99.99 111.157 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 36.3 t -56.75 -62.31 1.82 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.424 . . . . 99.99 110.703 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . 0.464 ' HA ' HD11 ' C' ' 218' ' ' LEU . 97.2 m-85 -67.97 -27.52 66.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 99.99 110.793 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.09 -44.16 97.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.067 0.461 . . . . 99.99 110.113 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . 0.402 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 11.4 t70 -65.67 -33.45 75.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.845 -0.616 . . . . 99.99 110.601 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' C' ' 215' ' ' PHE . 84.4 mt -65.74 -32.97 74.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 99.99 111.028 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -87.88 -20.93 25.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.914 0.388 . . . . 99.99 110.964 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.76 -26.53 62.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.841 -0.695 . . . . 99.99 112.7 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . 0.418 HD23 HG22 ' C' ' 32' ' ' VAL . 97.8 mt -74.89 -19.46 60.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 99.99 111.186 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . 0.444 ' NE ' ' HA ' ' C' ' 222' ' ' ARG . 6.2 tpm_? -89.55 81.55 6.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.982 0.42 . . . . 99.99 110.972 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -164.29 -33.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.573 . . . . 99.99 110.569 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 54.5 tp -173.07 107.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.877 -0.601 . . . . 99.99 110.684 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.53 128.78 49.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.846 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.39 94.83 1.41 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.917 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 79.1 p -135.96 117.41 14.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.478 . . . . 99.99 110.778 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . 0.554 ' HG3' ' HG3' ' C' ' 229' ' ' GLN . 24.6 tpp180 -107.72 -52.15 2.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.939 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . 0.554 ' HG3' ' HG3' ' C' ' 228' ' ' ARG . 47.2 mt-30 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.884 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.804 0.335 . . . . 99.99 110.804 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -130.06 9.52 5.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 99.99 111.133 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.9 tp -84.7 138.33 32.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.322 -0.399 . . . . 99.99 110.638 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -146.63 129.66 16.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.019 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -139.66 130.59 26.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.894 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.3 mt -95.1 3.52 54.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.594 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.02 -39.92 65.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.524 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.508 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 34.5 m80 -76.7 -26.46 54.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 99.99 110.121 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -70.75 -50.0 40.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 99.99 110.658 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 pt -59.9 -31.77 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 121.146 0.498 . . . . 99.99 109.971 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -55.87 -43.99 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.467 -0.788 . . . . 99.99 109.393 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.39 -49.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.79 -1.096 . . . . 99.99 111.071 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.45 -37.79 79.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 99.99 111.0 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.84 -38.45 95.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 99.99 112.673 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.3 mmm -70.31 -40.01 74.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 99.99 110.902 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 m -56.64 -58.56 7.53 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.025 -0.534 . . . . 99.99 111.117 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.36 -23.77 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.955 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.2 3.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 99.99 112.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.792 0.33 . . . . 99.99 111.006 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -57.1 -47.35 81.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.932 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -63.21 -35.21 79.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.785 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -69.94 -21.87 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.081 -0.508 . . . . 99.99 110.831 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.619 ' O ' ' OG ' ' A' ' 26' ' ' SER . 83.6 t90 -75.53 -36.18 60.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 99.99 110.892 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -68.34 -42.02 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.974 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.04 -1.4 57.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 99.99 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.619 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 94.8 p -63.05 -16.29 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 99.99 111.166 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -45.99 -40.2 10.12 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.266 -0.642 . . . . 99.99 109.266 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -176.96 131.35 0.36 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.695 -1.138 . . . . 99.99 109.381 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 30' ' ' ARG . 93.2 Cg_endo -91.98 -151.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.303 2.002 . . . . 99.99 111.929 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.401 ' H ' ' HB2' ' A' ' 29' ' ' PRO . 18.8 tpp180 -57.68 -13.69 4.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.097 0.475 . . . . 99.99 110.711 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 33.52 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.985 -0.626 . . . . 99.99 111.996 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.485 ' HB ' ' HE2' ' A' ' 35' ' ' TYR . 12.9 m -128.63 156.36 77.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.578 0.228 . . . . 99.99 111.013 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.0 166.35 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.536 2.157 . . . . 99.99 112.854 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -55.8 -17.42 6.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.9 . . . . 99.99 112.168 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.485 ' HE2' ' HB ' ' A' ' 32' ' ' VAL . 2.3 p90 -43.67 -33.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.656 0.265 . . . . 99.99 111.314 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.51 -50.14 74.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.99 0.424 . . . . 99.99 110.565 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -75.06 -19.55 59.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 99.99 111.04 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.401 HD21 ' HB ' ' B' ' 100' ' ' THR . 38.6 tp -57.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 99.99 110.828 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.3 -37.86 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.045 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.69 -8.43 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.173 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.9 tpt -89.41 -45.57 9.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 99.99 111.6 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -71.64 -42.81 67.14 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.552 0.575 . . . . 99.99 112.552 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.435 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 89.1 mt -48.37 -53.05 38.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.677 0.621 . . . . 99.99 112.677 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.7 Cg_endo -72.62 -37.28 4.15 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.04 1.826 . . . . 99.99 113.308 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.2 mm -59.33 -61.25 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.689 0.255 . . . . 99.99 111.689 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -58.76 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.879 0.371 . . . . 99.99 110.871 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.7 m -52.36 -31.59 34.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.831 -0.622 . . . . 99.99 111.159 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.66 -59.86 10.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 99.99 112.443 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 mt -61.14 -29.51 69.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 99.99 110.926 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.81 -52.0 66.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.253 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.508 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 42.3 m-85 -69.16 -23.21 63.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 99.99 111.075 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -62.46 -39.22 92.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 99.99 109.761 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.55 72.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.452 -0.794 . . . . 99.99 110.802 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.0 mtt -57.5 -26.93 62.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.232 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.27 -50.41 22.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 99.99 110.571 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.461 HG21 HG21 ' B' ' 127' ' ' VAL . 17.3 mt -74.41 -5.77 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.491 . . . . 99.99 110.634 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.63 65.68 0.72 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.696 -0.684 . . . . 99.99 111.106 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -130.56 148.01 52.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.909 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.533 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 98.21 17.58 29.09 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.872 -0.68 . . . . 99.99 112.352 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -117.44 149.47 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.68 0.276 . . . . 99.99 110.78 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.51 142.25 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.334 -0.394 . . . . 99.99 110.976 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -89.05 86.0 6.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.086 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.04 116.57 29.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 99.99 111.172 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.77 22.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.089 -0.505 . . . . 99.99 111.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.47 -15.01 48.37 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.672 -0.775 . . . . 99.99 112.656 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -98.34 147.56 24.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 99.99 110.945 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.3 pt -87.97 139.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.535 . . . . 99.99 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.37 138.77 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.708 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -90.8 57.43 3.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.105 0.478 . . . . 99.99 111.173 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -64.44 -57.69 8.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.176 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -54.74 -32.93 60.5 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.137 0.494 . . . . 99.99 110.644 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -57.17 -41.49 79.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.518 -0.764 . . . . 99.99 110.593 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.461 ' HH ' H183 ' A' ' 210' ' ' LYR . 0.3 OUTLIER -83.04 -14.0 54.74 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.005 0.372 . . . . 99.99 112.005 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.9 mt -63.4 -45.11 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.009 0.433 . . . . 99.99 109.975 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.49 -11.53 52.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.811 -0.631 . . . . 99.99 110.648 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.551 ' HE1' ' H7 ' ' A' ' 210' ' ' LYR . 1.2 m-90 -87.18 -21.03 26.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 99.99 111.066 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.533 ' HG2' ' HB ' ' A' ' 113' ' ' ILE . 28.6 mtp -90.7 -7.8 51.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.014 -0.539 . . . . 99.99 111.125 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' HD21 ' A' ' 82' ' ' LEU . 34.9 m -114.85 -32.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 99.99 112.151 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.0 m -86.85 -53.09 5.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.936 0.347 . . . . 99.99 111.936 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.53 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 34.5 m -50.24 -51.63 61.26 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.343 0.497 . . . . 99.99 112.343 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 80' ' ' THR . 15.2 Cg_endo -56.74 -33.19 93.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.744 1.629 . . . . 99.99 111.851 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.406 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.2 mm? -79.61 -26.42 41.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 99.99 110.439 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.04 -38.53 79.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 99.99 109.71 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.431 HD11 ' HB3' ' A' ' 105' ' ' LEU . 4.9 tt -77.42 -39.54 46.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.465 -0.789 . . . . 99.99 110.439 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.498 HD21 ' SD ' ' A' ' 106' ' ' MET . 29.8 mt -59.45 -38.02 79.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.871 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -56.23 -35.61 67.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.525 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.73 -31.42 72.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.557 . . . . 99.99 110.915 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -62.47 -55.4 27.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.073 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -65.17 -21.74 66.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.236 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -37.18 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 99.99 110.927 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.31 28.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 99.99 111.154 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 81.4 mtp -120.54 112.08 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 99.99 110.732 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.476 HE22 ' HH ' ' A' ' 35' ' ' TYR . 22.8 mm-40 -68.09 -35.43 78.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 99.99 111.299 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.19 143.42 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 99.99 111.098 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -105.88 149.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 99.99 110.962 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 97' ' ' LYS . 59.1 tttp -133.18 -62.24 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.8 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 96' ' ' LYS . 13.2 mmmm -132.03 12.23 4.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.907 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.0 91.53 7.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 99.99 111.124 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -128.14 -5.05 5.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.781 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.3 p -94.0 -33.31 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 99.99 111.071 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.86 -42.43 97.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.917 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 103' ' ' GLY . 33.5 pt -66.98 -41.15 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.294 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.41 ' N ' HG13 ' A' ' 102' ' ' ILE . . . -65.01 -27.65 72.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.789 -0.72 . . . . 99.99 112.472 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.78 -54.0 32.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 99.99 110.97 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 84' ' ' LEU . 62.6 mt -64.31 -39.46 93.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 99.99 111.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.498 ' SD ' HD21 ' A' ' 85' ' ' LEU . 90.4 mtp -62.59 -46.4 88.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.238 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.6 m -56.22 -42.89 77.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.93 0.395 . . . . 99.99 110.884 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.511 HG23 HG22 ' A' ' 142' ' ' ILE . 79.6 m -59.37 -34.24 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 99.99 111.281 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 12.3 mm100 -72.63 -29.85 63.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.476 -0.329 . . . . 99.99 111.49 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.476 HG21 ' HE1' ' C' ' 46' ' ' TRP . 56.9 mt -66.26 -40.06 85.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 99.99 111.753 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 108' ' ' THR . 34.1 m -72.44 -32.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.678 0.275 . . . . 99.99 111.283 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.2 t -72.98 -42.31 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.679 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.533 ' HB ' ' HG2' ' A' ' 77' ' ' MET . 48.0 pt -67.24 -35.11 73.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.628 -0.26 . . . . 99.99 111.299 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 54.0 m -58.55 -55.35 36.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.856 0.36 . . . . 99.99 110.482 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.6 m -62.13 -21.01 64.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.411 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.46 -56.96 7.03 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.009 -0.615 . . . . 99.99 112.793 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 118' ' ' ILE . 2.5 pp -61.03 -22.22 64.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.61 0.243 . . . . 99.99 111.104 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.415 HG13 HD11 ' A' ' 117' ' ' LEU . 67.8 mt -83.15 -31.81 9.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 99.99 110.875 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.61 61.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.091 -0.504 . . . . 99.99 111.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.37 -22.06 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 99.99 110.934 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.5 15.35 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 99.99 110.951 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.429 ' HB2' ' HE ' ' A' ' 128' ' ' ARG . 50.1 m -82.27 122.97 28.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.66 -41.21 9.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 99.99 110.856 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.494 ' HB2' HG11 ' A' ' 127' ' ' VAL . 79.8 mtp180 -92.03 134.25 34.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.505 . . . . 99.99 110.706 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.76 -9.11 57.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 99.99 111.018 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -87.85 -42.29 12.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.852 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 124' ' ' ARG . 12.3 p -74.79 -26.14 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.101 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.429 ' HE ' ' HB2' ' A' ' 122' ' ' SER . 40.5 ttm180 -67.52 -31.15 71.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.24 -0.437 . . . . 99.99 111.007 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -63.68 -34.39 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.221 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.538 HD21 HG23 ' C' ' 56' ' ' ILE . 52.6 tp -81.75 -44.25 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.242 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.439 ' HE1' ' HG2' ' C' ' 58' ' ' GLN . 4.5 m95 -56.31 -33.73 65.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.327 . . . . 99.99 111.2 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.42 -55.84 18.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.259 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 19.4 tt -63.3 -25.27 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.788 0.328 . . . . 99.99 111.137 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 88.4 m -63.78 -42.27 97.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 99.99 110.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.03 -53.96 27.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 99.99 112.578 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 35.1 m -59.93 -34.14 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 99.99 111.38 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 47.8 t -60.16 -43.78 95.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.096 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.62 79.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.364 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.77 -27.77 61.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 99.99 111.05 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.1 mt -66.09 -49.6 67.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.409 -0.36 . . . . 99.99 111.636 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 142' ' ' ILE . 23.9 pt -62.34 -43.5 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 99.99 111.815 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 108' ' ' THR . 46.5 mm -71.86 -33.69 48.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.625 -0.261 . . . . 99.99 111.409 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.4 -42.31 82.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 99.99 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.747 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 84.9 t90 -74.27 -29.76 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 99.99 110.641 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.95 75.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.892 -0.671 . . . . 99.99 112.815 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.24 -19.38 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.847 0.356 . . . . 99.99 111.212 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -80.86 1.93 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.419 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 144' ' ' TRP . 69.1 m-80 -100.4 -51.36 0.19 Allowed Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 120.91 -0.316 . . . . 99.99 111.519 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 17.3 Cg_exo -66.81 -8.35 21.13 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.223 1.948 . . . . 99.99 112.445 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.8 mt -96.31 28.1 3.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.117 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -167.42 -57.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.397 -0.365 . . . . 99.99 111.205 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.17 -45.47 80.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 99.99 111.21 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -75.51 -32.74 60.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.002 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.0 p -77.96 -7.68 57.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.794 0.33 . . . . 99.99 111.123 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -71.21 -33.44 69.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.324 -0.398 . . . . 99.99 110.934 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 t -101.41 -21.56 14.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 99.99 111.228 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.26 -71.09 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.921 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 161' ' ' LEU . 41.8 t -151.55 122.22 7.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.069 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -74.8 -38.43 62.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 99.99 111.085 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.01 -38.54 82.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.853 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 158' ' ' SER . 59.1 tp -71.01 -25.91 62.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.606 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.91 -34.6 69.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.967 -0.561 . . . . 99.99 111.009 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -67.06 -43.61 82.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.749 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 64.1 mt -60.71 -46.33 90.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 99.99 111.013 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.489 ' HA ' ' HB2' ' A' ' 168' ' ' LEU . 0.6 OUTLIER -74.4 -22.63 59.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.941 -0.572 . . . . 99.99 111.333 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.5 -50.86 71.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 99.99 110.823 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.08 -20.67 48.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 99.99 110.744 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 165' ' ' TYR . 0.2 OUTLIER -66.69 -56.27 11.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 99.99 110.801 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.14 -24.36 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 99.99 111.234 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.0 -58.68 6.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.403 . . . . 99.99 111.127 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.65 -23.99 66.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 99.99 110.316 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -69.82 -32.83 71.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 99.99 111.277 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.6 p -76.41 -51.06 12.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.531 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.98 -29.0 40.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.467 -0.333 . . . . 99.99 111.609 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 62.5 tp -80.08 -57.37 3.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.375 -0.375 . . . . 99.99 110.914 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -29.17 58.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.8 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 181' ' ' ILE . 33.0 mm -87.75 -24.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.548 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.91 -50.87 58.97 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.844 -0.616 . . . . 99.99 113.22 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.577 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 95.6 m-85 -59.76 -55.65 43.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.779 0.289 . . . . 99.99 111.46 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.4 Cg_exo -45.56 -29.84 5.48 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.278 1.985 . . . . 99.99 112.92 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 177' ' ' ILE . 90.0 mt -69.11 -59.66 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 99.99 111.297 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.16 -25.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.644 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -62.97 -23.56 67.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.344 . . . . 99.99 110.929 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.76 -64.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.966 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 50.6 pt -80.38 166.37 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.097 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.58 -166.15 37.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.851 -0.69 . . . . 99.99 112.531 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.6 161.5 27.91 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.581 2.188 . . . . 99.99 112.082 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.7 t 57.29 17.64 3.79 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.958 0.408 . . . . 99.99 110.567 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.97 -76.44 0.11 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.991 -0.623 . . . . 99.99 112.398 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -153.87 -26.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.964 0.411 . . . . 99.99 110.714 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -89.22 176.45 43.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.866 -0.683 . . . . 99.99 112.437 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -121.07 38.45 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.347 . . . . 99.99 110.858 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.4 mt -88.94 141.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.878 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -139.63 33.09 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.313 -0.403 . . . . 99.99 110.969 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -87.02 169.56 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.92 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.2 p -74.0 -17.91 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.501 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 8.7 tp -65.21 -31.37 53.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.507 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.43 -43.73 93.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 99.99 111.032 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.401 HG21 ' HE2' ' A' ' 8' ' ' HIS . 13.7 m -75.02 -23.15 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 99.99 111.007 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -72.51 -31.85 65.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 99.99 111.169 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 67.1 tp -83.38 -32.25 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 99.99 111.315 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -75.4 -19.02 59.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 99.99 111.003 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 206' ' ' PRO . 27.4 p -96.34 -31.53 12.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.054 0.454 . . . . 99.99 110.763 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.3 tp -72.64 -32.83 66.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 99.99 111.297 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.516 ' N ' ' HD2' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -63.08 -54.26 47.55 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.536 -0.302 . . . . 99.99 111.471 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 205' ' ' LEU . 14.9 Cg_endo -56.5 -44.22 47.83 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.127 1.884 . . . . 99.99 111.825 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -66.24 -29.11 69.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.252 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.325 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.4 p -94.17 -24.58 17.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 99.99 110.727 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.551 ' H7 ' ' HE1' ' A' ' 76' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.95 -41.85 90.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.228 -0.442 . . . . 99.99 111.044 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.64 87.63 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.686 -0.769 . . . . 99.99 112.386 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.29 -35.2 80.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.731 0.301 . . . . 99.99 110.99 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.4 m -60.96 -57.74 11.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.748 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -64.75 -20.05 66.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.898 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.8 -43.0 38.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.32 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.54 -30.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 99.99 111.358 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.22 -58.91 3.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.349 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -69.46 -21.72 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 99.99 111.091 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.55 -18.89 64.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.864 -0.684 . . . . 99.99 112.569 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 224' ' ' LEU . 56.4 tp -79.64 -29.59 41.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.279 . . . . 99.99 110.985 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 62.07 -82.24 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.023 -0.535 . . . . 99.99 111.033 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -152.99 119.13 5.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 99.99 110.677 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.451 ' HB3' HD13 ' A' ' 221' ' ' LEU . 48.0 tp -162.49 139.69 8.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.009 -0.541 . . . . 99.99 110.828 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -167.17 106.14 0.58 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.972 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -126.21 127.97 46.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 99.99 111.015 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 p -156.58 102.9 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.913 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -139.83 14.36 2.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 99.99 110.709 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.944 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.806 0.336 . . . . 99.99 110.956 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -122.62 -1.36 9.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.929 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.74 116.55 19.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 99.99 111.091 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.19 125.11 28.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.861 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 41.3 t -134.68 130.37 36.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.938 -0.573 . . . . 99.99 110.802 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -89.03 -6.99 56.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.81 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.12 -57.61 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.871 -0.604 . . . . 99.99 111.284 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.553 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 35.9 m170 -61.24 -25.23 66.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 99.99 110.894 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 59.0 t-105 -69.75 -39.92 76.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.578 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -24.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.127 0.489 . . . . 99.99 110.164 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' B' ' 207' ' ' PHE . 5.5 t80 -61.14 -55.76 28.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 99.99 110.619 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.72 -36.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.673 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.41 75.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 99.99 110.813 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.34 -29.3 64.37 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 99.99 111.991 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.35 -32.85 58.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 99.99 110.784 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -63.32 -54.35 38.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.454 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.03 -24.1 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 99.99 110.728 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.49 -62.05 6.78 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.764 -0.731 . . . . 99.99 112.099 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -34.71 65.39 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.926 0.393 . . . . 99.99 110.836 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.39 -44.03 84.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.6 . . . . 99.99 110.558 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -65.52 -39.37 91.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 99.99 110.839 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -73.24 -6.32 45.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.616 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.546 ' O ' ' OG ' ' B' ' 26' ' ' SER . 65.0 t90 -89.11 -35.78 16.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.624 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -70.72 -44.64 66.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.865 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.24 -2.81 53.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 99.99 110.701 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 92.8 p -58.3 -15.02 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.525 . . . . 99.99 111.186 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -48.81 -40.07 27.75 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.692 -0.484 . . . . 99.99 109.692 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.6 p-10 179.16 130.8 0.23 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.421 -0.808 . . . . 99.99 110.559 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.521 ' HG3' ' HB3' ' B' ' 33' ' ' PRO . 71.8 Cg_endo -102.95 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.646 2.897 . . . . 99.99 111.967 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' B' ' 30' ' ' ARG . 4.2 mmp_? -106.23 11.22 31.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.453 0.644 . . . . 99.99 109.685 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.68 -53.68 0.76 Allowed Glycine 0 CA--C 1.519 0.303 0 CA-C-N 114.857 -1.065 . . . . 99.99 112.16 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.65 104.87 5.38 Favored Pre-proline 0 CA--C 1.518 -0.275 0 CA-C-N 117.486 0.643 . . . . 99.99 111.69 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.521 ' HB3' ' HG3' ' B' ' 29' ' ' PRO . 83.2 Cg_endo -89.3 107.98 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.773 0.982 . . . . 99.99 113.602 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -92.74 -61.13 1.65 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.804 1.764 . . . . 99.99 107.735 174.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -39.85 18.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 110.317 -3.129 . . . . 99.99 113.148 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -38.3 -64.6 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.638 0.977 . . . . 99.99 113.638 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' B' ' 26' ' ' SER . 75.0 m-85 -82.69 -18.28 41.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.102 0.408 . . . . 99.99 112.102 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 tp -59.3 -65.12 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.867 0.365 . . . . 99.99 110.781 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 m -69.25 -37.82 76.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 99.99 111.472 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 -12.09 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.52 -0.309 . . . . 99.99 111.154 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 45.3 tpp -89.09 -48.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.665 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -65.86 -48.95 69.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.849 0.685 . . . . 99.99 112.849 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.423 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 79.5 mt -45.36 -53.61 17.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.29 0.848 . . . . 99.99 113.29 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -71.48 -38.61 4.38 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.228 1.952 . . . . 99.99 113.611 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -59.54 -61.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.852 0.315 . . . . 99.99 111.852 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.428 ' HE1' HG21 ' C' ' 110' ' ' ILE . 0.1 OUTLIER -58.26 -58.92 6.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 99.99 111.314 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.643 ' HG ' ' HD2' ' B' ' 75' ' ' ASP . 47.9 t -55.05 -26.24 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 99.99 111.025 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.58 -67.57 2.08 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.754 -0.736 . . . . 99.99 112.739 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.09 -24.32 58.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.646 0.26 . . . . 99.99 111.385 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.66 -59.15 5.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.458 -0.337 . . . . 99.99 111.182 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.8 m-85 -61.76 -35.8 79.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 99.99 110.95 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 57.6 ttp -51.5 -35.31 39.68 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.072 0.463 . . . . 99.99 110.08 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.61 -39.44 70.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.741 -0.663 . . . . 99.99 110.537 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -57.11 -21.12 29.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 99.99 110.567 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -82.63 -46.18 13.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.046 -0.525 . . . . 99.99 111.105 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 53' ' ' ALA . 27.0 pt -75.26 -0.05 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 99.99 111.299 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.93 65.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.939 -0.573 . . . . 99.99 110.904 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -146.79 114.27 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.846 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 70' ' ' TYR . . . 136.23 -1.33 3.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.532 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -108.58 151.54 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 99.99 111.018 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.26 145.67 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.1 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.32 87.95 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 99.99 111.143 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.28 118.08 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.85 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.86 31.49 20.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.13 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.14 0.56 86.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.646 -0.787 . . . . 99.99 112.548 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -101.02 147.19 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 99.99 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.3 mt -92.74 121.86 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.81 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' B' ' 121' ' ' LEU . . . -99.12 140.07 33.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 99.99 111.276 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.582 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.7 m-70 -82.99 58.29 4.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.879 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.435 ' O ' HG13 ' B' ' 74' ' ' ILE . 65.5 t80 -62.89 -55.75 23.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.506 -0.77 . . . . 99.99 111.351 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.0 67.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.068 0.396 . . . . 99.99 112.068 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.582 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 58.7 mmt-85 -64.69 -52.46 57.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.231 0.456 . . . . 99.99 112.231 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.49 ' CE1' ' HG ' ' B' ' 117' ' ' LEU . 2.1 p90 -64.29 -32.12 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.607 -0.437 . . . . 99.99 110.476 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.435 HG13 ' O ' ' B' ' 70' ' ' TYR . 57.7 mt -50.44 -53.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.992 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.643 ' HD2' ' HG ' ' B' ' 47' ' ' SER . 24.7 t70 -66.56 -22.76 66.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.196 -0.456 . . . . 99.99 110.311 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -89.77 5.1 47.54 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.034 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.437 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 51.9 ttm -104.89 -18.44 14.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 99.99 110.592 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.46 -33.81 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.087 -0.506 . . . . 99.99 112.106 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -79.33 -48.5 13.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.157 0.428 . . . . 99.99 112.157 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 5.6 m -55.6 -50.71 85.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.443 -0.344 . . . . 99.99 111.781 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 47.2 Cg_exo -55.54 -33.48 86.68 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.945 1.763 . . . . 99.99 111.969 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 83.8 mt -78.55 -26.47 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.868 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.58 -39.17 84.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.847 0.356 . . . . 99.99 110.281 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.433 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.8 pp -82.07 -25.96 34.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.976 -0.556 . . . . 99.99 110.323 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.433 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.1 mt -68.62 -34.05 75.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 99.99 109.804 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -58.78 -34.84 71.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 99.99 110.423 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.05 -29.33 65.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 99.99 110.88 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 56.4 m -63.57 -40.05 95.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 99.99 110.937 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -82.51 -16.24 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.033 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 89.8 m -68.08 -42.92 79.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 99.99 111.268 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.77 -33.21 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.376 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.5 mtm -118.04 110.23 17.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 99.99 110.829 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -76.44 -30.38 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.248 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -133.54 140.78 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.767 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -107.7 142.03 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 99.99 111.14 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -127.0 -50.62 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.152 -0.477 . . . . 99.99 110.854 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.594 ' HZ2' ' HB2' ' B' ' 97' ' ' LYS . 4.4 ttmp? -137.28 -17.21 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.911 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -65.52 113.26 4.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.223 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -149.21 -23.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.999 -0.546 . . . . 99.99 110.497 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.401 ' HB ' HD21 ' A' ' 38' ' ' LEU . 61.8 p -76.35 -34.92 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 99.99 110.778 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.87 -46.91 82.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.502 . . . . 99.99 110.592 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.24 -37.17 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.88 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.29 -18.26 79.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 99.99 112.409 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -72.85 -45.02 60.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 99.99 110.755 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.38 -30.41 63.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.945 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' MET . . . . . 0.404 ' O ' HG13 ' B' ' 110' ' ' ILE . 89.5 mtp -69.7 -48.69 58.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -57.61 -45.32 85.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.364 -0.38 . . . . 99.99 111.077 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.453 ' O ' HG23 ' B' ' 111' ' ' VAL . 57.8 p -59.14 -33.12 70.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.128 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.445 ' O ' HG13 ' B' ' 113' ' ' ILE . 56.8 tp60 -71.17 -36.78 72.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.356 -0.384 . . . . 99.99 110.987 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 106' ' ' MET . 54.6 mt -56.8 -43.32 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' ' 108' ' ' THR . 18.2 m -70.93 -30.59 42.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 99.99 111.347 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 88.9 t -72.64 -27.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.482 -0.327 . . . . 99.99 111.256 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 109' ' ' GLN . 69.8 mt -80.2 -43.15 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.631 -0.259 . . . . 99.99 111.213 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 9.7 t -58.92 -29.92 67.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.955 0.407 . . . . 99.99 110.176 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -69.15 -50.52 47.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.897 -0.592 . . . . 99.99 109.833 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.54 -10.1 66.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.9 -0.667 . . . . 99.99 111.51 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.49 ' HG ' ' CE1' ' B' ' 73' ' ' TYR . 4.4 tt -70.43 -56.78 5.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.506 . . . . 99.99 110.346 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.48 -20.62 9.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.647 -0.706 . . . . 99.99 111.546 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.83 -39.41 11.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 99.99 111.331 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.592 ' HD2' ' HH2' ' B' ' 183' ' ' TRP . 7.5 m-20 -87.03 -23.93 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 99.99 110.842 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' B' ' 68' ' ' ALA . 87.8 mt -87.96 29.57 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 99.99 111.15 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -93.91 122.92 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.411 . . . . 99.99 110.735 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.53 -52.52 4.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 99.99 111.263 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.514 ' HB3' HG11 ' B' ' 127' ' ' VAL . 35.9 ttm180 -77.42 123.71 26.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.809 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.73 -14.24 50.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.144 -0.48 . . . . 99.99 111.132 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.496 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 66.1 t-105 -74.53 -56.12 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 99.99 110.56 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' B' ' 124' ' ' ARG . 7.7 p -65.15 -27.95 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.059 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -55.07 -26.93 41.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 99.99 110.725 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.54 -34.99 40.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 99.99 110.922 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.408 HD21 ' N ' ' B' ' 130' ' ' LEU . 3.8 mm? -72.31 -49.33 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.135 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -62.47 -31.9 72.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . 0.441 ' HE1' ' HB3' ' B' ' 183' ' ' TRP . 66.5 t80 -63.34 -55.47 24.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.984 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 tt -68.34 -23.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.027 0.441 . . . . 99.99 110.865 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.8 -41.67 91.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 99.99 111.276 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.82 -50.49 35.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 99.99 112.799 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 26.9 m -61.31 -38.31 79.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.576 0.227 . . . . 99.99 111.489 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -58.31 -45.29 88.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 99.99 111.331 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.57 77.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 99.99 111.153 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -69.71 -22.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 99.99 111.361 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 80.5 mt -66.98 -60.61 2.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.703 -0.226 . . . . 99.99 111.278 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 31.0 pt -56.08 -36.33 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 99.99 111.408 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.78 -42.63 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.152 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.17 -47.47 81.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.069 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . 0.447 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 44.4 t-105 -66.59 -25.91 66.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 99.99 110.964 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.65 -21.29 58.28 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.9 -0.667 . . . . 99.99 113.229 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.1 pt -98.94 -6.58 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 99.99 111.717 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -87.59 -2.3 58.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.388 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.614 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 69.1 m-80 -100.36 -49.92 0.19 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.855 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 22.9 Cg_exo -64.95 -9.71 22.53 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.525 2.15 . . . . 99.99 113.021 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.46 13.23 32.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.695 0.283 . . . . 99.99 111.294 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -145.27 -61.0 0.35 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 99.99 111.133 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.94 -50.92 70.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.148 -0.478 . . . . 99.99 111.559 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . 0.474 ' HD2' ' HB3' ' B' ' 149' ' ' PRO . 67.6 mttm -70.95 -36.77 72.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 99.99 111.115 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 47.3 p -71.14 -17.42 62.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.336 . . . . 99.99 110.803 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -65.43 -32.21 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 99.99 110.871 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 60.1 m -98.62 -37.51 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.09 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -63.52 -74.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.142 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 57.0 m -148.54 120.65 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.787 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 43.7 t -73.0 -36.83 67.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 99.99 111.181 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -62.62 -49.88 73.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 99.99 110.885 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.77 -22.12 66.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.034 -0.53 . . . . 99.99 111.021 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.92 67.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.363 -0.38 . . . . 99.99 111.207 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.44 -40.09 95.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.035 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.47 -44.66 85.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.962 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.67 -22.38 50.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.534 . . . . 99.99 110.885 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.71 -47.35 84.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 99.99 111.164 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.19 -21.0 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.633 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.2 -49.57 55.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.699 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.33 -23.63 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.006 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.82 -59.04 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.295 -0.411 . . . . 99.99 110.982 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.91 -29.15 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.069 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.98 -21.56 64.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.601 -0.727 . . . . 99.99 110.843 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 46.6 m -79.14 -58.3 3.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.539 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.08 -29.78 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 99.99 111.686 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 44.9 tp -76.39 -58.55 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.474 -0.33 . . . . 99.99 111.562 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -28.89 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.33 -0.395 . . . . 99.99 110.854 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.413 ' O ' HG12 ' B' ' 181' ' ' ILE . 42.9 mm -87.93 -24.07 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.482 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.92 48.5 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.937 -0.574 . . . . 99.99 113.228 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 83.1 m-85 -56.8 -55.78 39.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.912 0.356 . . . . 99.99 111.521 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.1 Cg_exo -44.89 -33.32 7.28 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.455 2.103 . . . . 99.99 112.84 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.413 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.0 mm -66.49 -59.58 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 99.99 111.644 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.09 -28.28 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.831 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . 0.592 ' HH2' ' HD2' ' B' ' 120' ' ' ASP . 38.2 m95 -60.07 -24.22 64.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.59 -0.277 . . . . 99.99 111.174 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 89.2 mt -55.63 -61.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.715 0.293 . . . . 99.99 111.179 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 41.2 pt -82.81 165.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 99.99 111.267 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.85 -169.59 40.72 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.891 -0.671 . . . . 99.99 112.608 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.15 160.83 44.6 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.542 2.161 . . . . 99.99 111.901 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 51.4 m 56.88 17.29 3.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.373 -0.376 . . . . 99.99 110.521 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -133.18 -64.38 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.121 -0.561 . . . . 99.99 112.415 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -167.57 -32.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.321 . . . . 99.99 110.804 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -86.89 166.84 37.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.81 -0.71 . . . . 99.99 112.668 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -111.78 51.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.743 0.306 . . . . 99.99 110.867 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . 0.407 HG21 ' H ' ' B' ' 195' ' ' GLN . 24.0 mm -97.61 142.03 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.062 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -138.87 28.25 2.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.399 -0.364 . . . . 99.99 111.001 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . 0.407 ' H ' HG21 ' B' ' 193' ' ' ILE . 46.8 mt-30 -84.85 155.49 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.8 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 65.7 p -64.33 -15.54 60.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 99.99 111.657 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . 0.407 HG23 ' HB2' ' B' ' 195' ' ' GLN . 9.9 tp -66.58 -28.71 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 99.99 110.763 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 99.99 110.451 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -62.91 -28.06 69.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 99.99 110.762 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -66.17 -36.12 82.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 99.99 110.977 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.69 -47.81 51.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -71.38 -6.21 38.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.154 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HD2' ' B' ' 206' ' ' PRO . 47.3 t -96.34 -46.13 6.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.204 0.526 . . . . 99.99 110.599 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.1 tp -72.25 -26.01 61.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 99.99 111.578 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.66 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 62.2 tp -66.0 -54.48 27.12 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.931 -0.308 . . . . 99.99 111.123 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.5 Cg_exo -55.83 -42.52 66.29 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.697 1.598 . . . . 99.99 111.388 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' B' ' 11' ' ' TYR . 89.4 t80 -63.93 -39.19 93.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.456 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.2 -34.31 78.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 99.99 111.089 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -86.2 -31.57 21.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.317 -0.401 . . . . 99.99 110.994 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.446 H193 ' H9 ' ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.0 -53.86 41.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.209 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.63 63.25 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.823 -0.703 . . . . 99.99 112.563 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -66.4 -38.47 87.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 99.99 110.859 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' B' ' 217' ' ' ASP . 66.8 m -60.64 -56.39 21.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 99.99 110.733 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -63.94 -20.12 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 99.99 110.683 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.63 -58.18 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 99.99 111.104 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.504 ' HD2' ' HA ' ' B' ' 214' ' ' SER . 3.1 p30 -58.73 -23.89 60.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.375 . . . . 99.99 111.209 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.3 tp -68.76 -54.59 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 99.99 111.338 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -77.59 -20.36 54.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.285 -0.416 . . . . 99.99 111.311 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.36 67.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.913 -0.66 . . . . 99.99 113.102 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 52.7 tp -74.01 -23.08 59.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.598 0.237 . . . . 99.99 111.125 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 60.32 -83.46 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.183 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -160.35 103.65 1.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.418 -0.356 . . . . 99.99 110.726 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 61.0 tp -150.46 136.55 18.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 99.99 111.011 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -116.57 -76.97 0.57 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.138 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 15.2 t70 60.8 103.55 0.02 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.307 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 75.7 p -158.55 81.65 0.82 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 99.99 110.947 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -104.79 -42.23 5.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.296 -0.411 . . . . 99.99 111.027 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 99.99 110.961 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 45.2 tpp . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.834 0.349 . . . . 99.99 110.981 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -120.73 -11.75 8.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.965 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.88 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.827 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -153.54 120.46 5.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.896 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -130.92 124.99 32.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.107 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.449 ' H ' HD23 ' C' ' 6' ' ' LEU . 2.4 pt? -87.63 -7.21 57.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.782 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.31 -41.79 98.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 99.99 110.498 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.532 ' HB2' ' HB3' ' C' ' 55' ' ' ALA . 46.2 m80 -74.1 -23.84 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 99.99 110.389 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -72.61 -44.49 61.9 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.914 -0.585 . . . . 99.99 110.732 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.45 -23.34 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.183 0.516 . . . . 99.99 109.911 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -60.79 -57.35 13.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 99.99 110.581 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.04 -31.42 45.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.31 -0.404 . . . . 99.99 110.805 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.16 -33.21 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.449 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.82 -28.67 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 99.99 112.008 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.4 mmt -75.7 -34.63 60.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.634 0.254 . . . . 99.99 111.232 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -63.1 -53.36 54.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 99.99 110.867 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . 0.545 ' HA ' HD11 ' C' ' 20' ' ' LEU . 2.7 pp -61.91 -26.65 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.809 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.25 -59.94 9.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 99.99 112.278 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.89 65.84 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.796 0.332 . . . . 99.99 111.277 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.545 HD11 ' HA ' ' C' ' 17' ' ' ILE . 96.2 mt -62.79 -42.5 99.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.879 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -59.52 -40.76 88.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 99.99 110.633 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -70.54 -20.01 62.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 99.99 110.831 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.479 ' O ' ' OG ' ' C' ' 26' ' ' SER . 85.7 t90 -71.57 -34.36 69.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.655 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 43.9 t -71.39 -47.8 53.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.879 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 -0.93 30.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.778 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 95.1 p -56.09 -17.7 7.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.441 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -47.24 -42.83 21.18 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.742 -0.466 . . . . 99.99 109.742 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 7.7 p30 -173.67 130.66 0.53 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.468 -0.787 . . . . 99.99 110.402 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.468 ' HG2' HG21 ' C' ' 32' ' ' VAL . 73.4 Cg_endo -101.89 77.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.471 2.781 . . . . 99.99 112.651 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 61.14 6.47 1.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.422 -0.353 . . . . 99.99 111.332 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.84 39.26 5.56 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.771 -0.728 . . . . 99.99 112.932 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.468 HG21 ' HG2' ' C' ' 29' ' ' PRO . 5.4 m -122.71 152.53 62.28 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.755 0.278 . . . . 99.99 111.105 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.401 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 50.2 Cg_exo -54.28 165.69 2.07 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.661 2.241 . . . . 99.99 112.969 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -60.03 -17.98 42.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 99.99 112.096 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.401 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 4.7 p90 -45.5 -30.84 1.53 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.706 0.289 . . . . 99.99 111.641 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.59 -58.75 5.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 99.99 111.142 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -69.76 -19.84 63.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.383 -0.371 . . . . 99.99 111.319 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.49 -63.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.819 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.53 -30.36 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 99.99 111.328 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.17 -13.04 61.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 99.99 111.559 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.418 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 27.2 ttt -89.79 -42.54 11.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.906 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.15 -42.0 66.47 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.751 0.648 . . . . 99.99 112.751 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 35.1 mm -51.45 -52.72 57.11 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.78 0.659 . . . . 99.99 112.78 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 12.6 Cg_exo -70.33 -39.08 5.78 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.416 2.077 . . . . 99.99 113.209 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.19 -61.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.887 0.329 . . . . 99.99 111.887 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.476 ' HE1' HG21 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -56.11 -58.94 5.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 99.99 111.234 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.409 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 30.3 t -53.42 -28.8 31.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.99 -0.55 . . . . 99.99 111.213 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.98 -62.54 6.11 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.657 -0.783 . . . . 99.99 112.445 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 56.1 mt -61.4 -24.12 66.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 99.99 110.838 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' C' ' 75' ' ' ASP . . . -64.4 -58.04 7.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.004 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 36.8 m-85 -63.59 -35.77 81.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.982 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 51.7 ttp -53.48 -35.28 60.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.138 0.494 . . . . 99.99 109.965 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.501 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.63 -34.14 64.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.698 -0.683 . . . . 99.99 110.69 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.4 mtt -61.82 -20.12 63.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 99.99 110.052 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' C' ' 8' ' ' HIS . . . -81.24 -48.07 12.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 99.99 110.713 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.538 HG23 HD21 ' A' ' 130' ' ' LEU . 39.6 pt -73.01 -5.44 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.343 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.66 67.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.943 -0.571 . . . . 99.99 111.117 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.439 ' HG2' ' HE1' ' A' ' 131' ' ' TRP . 53.0 tp60 -139.21 139.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 99.99 110.766 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.467 ' HA3' ' HB1' ' C' ' 71' ' ' ALA . . . 110.74 11.14 19.92 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.892 -0.67 . . . . 99.99 112.194 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.511 ' HZ2' HH21 ' C' ' 72' ' ' ARG . 64.5 mttm -115.09 148.21 39.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 99.99 110.925 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.93 140.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.047 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.43 86.85 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 99.99 111.152 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.68 118.9 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.08 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.76 28.75 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 99.99 111.284 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.49 -6.3 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 99.99 112.626 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.94 152.58 19.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 99.99 110.675 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.06 131.68 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.894 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.02 144.66 32.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.515 . . . . 99.99 111.208 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.418 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 65.2 m-70 -91.56 59.21 3.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 99.99 110.779 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.21 -58.18 5.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 99.99 111.256 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.467 ' HB1' ' HA3' ' C' ' 59' ' ' GLY . . . -55.61 -35.45 65.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.228 0.537 . . . . 99.99 110.429 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.511 HH21 ' HZ2' ' C' ' 60' ' ' LYS . 9.1 tpp180 -56.04 -39.29 71.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.338 -0.846 . . . . 99.99 111.008 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.491 ' O ' ' HG3' ' C' ' 77' ' ' MET . 0.2 OUTLIER -82.59 -20.75 35.87 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.04 0.385 . . . . 99.99 112.04 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 47.7 mm -58.77 -42.86 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 99.99 110.284 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.411 ' HB2' ' HB1' ' C' ' 50' ' ' ALA . 25.8 t70 -60.98 -22.73 64.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 99.99 110.599 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -81.27 -27.61 35.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 99.99 111.267 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.546 ' HG2' HG23 ' C' ' 113' ' ' ILE . 12.8 mtp -75.55 -14.04 60.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.736 -0.665 . . . . 99.99 111.801 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.89 -42.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.451 0.537 . . . . 99.99 112.451 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 71.7 m -72.49 -51.82 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.63 0.604 . . . . 99.99 112.63 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.0 m -54.02 -51.02 80.92 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.351 0.5 . . . . 99.99 112.351 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.7 Cg_exo -55.28 -35.53 91.57 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.939 1.759 . . . . 99.99 112.256 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.55 -23.8 49.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 99.99 110.663 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -46.36 75.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 99.99 110.492 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.494 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -74.36 -29.26 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.737 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . 0.494 ' N ' HD12 ' C' ' 84' ' ' LEU . 7.4 tp -64.52 -36.76 85.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 99.99 110.501 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 m -61.61 -32.04 72.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 99.99 110.379 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 60.8 mt -66.7 -32.43 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.8 -0.636 . . . . 99.99 110.561 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.8 t -62.94 -53.45 53.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 99.99 110.566 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.97 -26.66 68.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.845 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 86.0 m -66.31 -33.15 75.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.891 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.15 -50.73 25.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -124.07 127.58 48.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -78.48 -13.12 59.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 99.99 110.938 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -133.76 163.26 29.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.028 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 36.5 mm -126.44 143.98 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.959 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -133.22 -72.73 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.863 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.78 1.5 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.88 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.17 96.05 7.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.995 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -136.32 -9.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.647 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 82.2 p -88.25 -38.89 14.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.017 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.88 -42.12 97.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.534 . . . . 99.99 110.704 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.44 -41.14 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.959 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.36 -14.67 77.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 99.99 112.449 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.82 -46.41 24.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.878 0.37 . . . . 99.99 110.568 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.38 -38.72 68.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 99.99 110.555 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 22.5 ttt -66.36 -42.04 88.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.574 -0.739 . . . . 99.99 111.61 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 47.7 t -60.29 -50.14 74.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.792 0.33 . . . . 99.99 111.218 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.578 HG21 HG12 ' C' ' 142' ' ' ILE . 39.9 m -55.29 -36.59 66.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 99.99 111.079 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -63.74 -46.68 84.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.257 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.428 HG21 ' HE1' ' B' ' 46' ' ' TRP . 66.5 mt -52.66 -34.5 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.864 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.95 -53.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.564 . . . . 99.99 111.357 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 28.6 t -63.49 -27.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 99.99 111.37 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . 0.546 HG23 ' HG2' ' C' ' 77' ' ' MET . 22.2 mm -65.43 -50.27 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 99.99 111.423 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 92.4 m -54.54 -55.53 28.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.47 -0.332 . . . . 99.99 111.044 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 35.4 m -57.38 -21.49 36.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 99.99 110.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -61.6 3.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.756 -0.735 . . . . 99.99 112.847 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.413 HD13 HG12 ' C' ' 118' ' ' ILE . 3.5 pp -59.85 -22.21 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.702 0.287 . . . . 99.99 110.976 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.413 HG12 HD13 ' C' ' 117' ' ' LEU . 37.6 mm -81.42 -33.93 12.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.997 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.28 -37.73 48.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.193 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.88 -21.14 28.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 99.99 110.946 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.77 28.99 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.431 -0.35 . . . . 99.99 111.025 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -94.71 125.75 39.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 99.99 110.783 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.98 -21.2 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.245 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 52.5 ttp180 -114.86 135.83 53.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.382 -0.372 . . . . 99.99 110.676 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.01 -11.73 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 99.99 111.625 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . 0.584 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 56.6 t90 -81.86 -50.17 9.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 99.99 110.845 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' C' ' 124' ' ' ARG . 7.4 p -66.07 -26.61 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 99.99 111.015 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -62.37 -21.58 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 99.99 111.103 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -77.61 -36.8 51.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 99.99 110.816 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . 0.41 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.3 mp -76.76 -30.4 56.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.089 -0.505 . . . . 99.99 111.38 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -76.07 -42.53 47.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.715 0.293 . . . . 99.99 111.362 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -57.67 -50.96 71.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.944 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.5 -27.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 99.99 111.25 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.06 -45.03 90.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 99.99 111.105 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.09 47.62 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.846 -0.692 . . . . 99.99 112.878 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.96 -31.73 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.694 0.257 . . . . 99.99 111.694 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.19 -48.79 76.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 99.99 111.34 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.6 73.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 99.99 111.301 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.08 -22.64 62.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.035 -0.53 . . . . 99.99 111.455 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.44 -53.87 9.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.537 -0.301 . . . . 99.99 111.792 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . 0.414 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.7 pt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.833 0.309 . . . . 99.99 111.833 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.578 HG12 HG21 ' C' ' 108' ' ' THR . 8.1 tp -72.47 -31.19 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.773 0.32 . . . . 99.99 111.44 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.45 -44.96 95.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 99.99 111.004 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . 0.712 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 71.8 t-105 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 99.99 111.259 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.51 -17.57 77.44 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.751 -0.737 . . . . 99.99 113.165 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.64 -26.34 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.872 0.367 . . . . 99.99 110.995 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -73.02 -0.28 13.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 99.99 111.912 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.712 ' ND2' ' O ' ' C' ' 144' ' ' TRP . 69.1 m-80 -100.79 -52.05 0.18 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 99.99 112.124 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 29.9 Cg_endo -62.8 -20.83 72.24 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.223 1.948 . . . . 99.99 112.732 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.83 45.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 99.99 111.231 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -170.68 -46.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.895 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.09 -49.62 9.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 99.99 111.155 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -71.27 -29.06 64.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 99.99 110.923 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 68.1 p -72.22 -19.14 61.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 99.99 111.243 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -66.78 -41.8 87.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 99.99 111.048 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 4.9 t -87.93 -27.73 21.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.391 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -75.81 -71.33 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.16 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.0 m -152.19 121.54 6.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 99.99 110.992 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 46.3 t -75.42 -34.82 61.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 99.99 111.096 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.32 -52.0 63.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.86 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.79 -24.48 66.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.496 . . . . 99.99 111.015 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.69 88.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.093 -0.503 . . . . 99.99 111.047 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -72.46 -42.68 64.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.925 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 87.7 mt -57.54 -47.62 81.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.77 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.43 -27.28 63.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.867 -0.606 . . . . 99.99 110.862 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.87 -42.49 99.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.892 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -81.62 -21.15 38.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 99.99 110.722 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 55.6 tp -70.61 -54.59 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 99.99 111.355 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.46 -24.04 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 99.99 111.224 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.9 m -55.05 -59.06 5.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 99.99 111.255 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.12 -26.76 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.423 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -70.22 -25.31 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.879 -0.6 . . . . 99.99 110.884 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 84.2 m -79.88 -51.69 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.515 . . . . 99.99 111.83 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.72 -26.4 34.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 111.925 0.342 . . . . 99.99 111.925 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 60.6 tp -83.2 -54.81 4.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.568 -0.287 . . . . 99.99 111.299 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -32.41 64.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.726 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.471 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.3 tt -87.73 -19.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.484 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.21 39.76 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.835 -0.62 . . . . 99.99 113.034 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 94.6 m-85 -55.31 -53.8 57.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.807 0.304 . . . . 99.99 111.19 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.2 Cg_exo -46.6 -31.6 10.43 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.122 1.881 . . . . 99.99 112.503 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -66.1 -60.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.364 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.52 -31.51 49.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.846 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -54.76 -29.03 52.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.568 -0.287 . . . . 99.99 111.469 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 74.5 mt -52.64 -62.44 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 99.99 111.237 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 34.6 pt -78.36 172.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 99.99 111.257 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.04 -165.32 52.08 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.884 -0.674 . . . . 99.99 112.625 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.28 163.97 22.02 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.767 2.311 . . . . 99.99 112.231 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 47.9 m 59.66 8.91 1.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.786 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -123.26 -67.2 0.22 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.084 -0.579 . . . . 99.99 112.237 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -167.06 -28.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.888 0.375 . . . . 99.99 110.501 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -83.08 -179.11 52.53 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 99.99 112.226 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -126.15 45.29 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.904 0.383 . . . . 99.99 110.923 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' C' ' 198' ' ' ASP . 28.6 mt -93.66 139.89 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.707 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -134.43 13.81 3.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.541 -0.3 . . . . 99.99 111.466 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . 0.448 ' NE2' HG22 ' C' ' 193' ' ' ILE . 2.0 mp0 -70.7 154.52 41.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 99.99 111.117 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p -67.74 -16.84 64.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 99.99 111.223 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt -63.48 -27.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 99.99 110.909 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . 0.545 ' HD2' ' CG2' ' C' ' 193' ' ' ILE . 5.7 m-20 -66.02 -48.37 71.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 99.99 110.8 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 68.0 p -65.4 -24.99 67.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -70.56 -36.39 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.883 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.9 tp -76.73 -32.52 57.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 99.99 110.96 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -77.41 -18.93 56.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.828 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.49 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.6 m -96.11 -34.27 11.76 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.173 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.64 -35.32 72.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.124 -0.489 . . . . 99.99 111.586 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.608 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.8 OUTLIER -59.98 -53.78 61.93 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 121.138 -0.225 . . . . 99.99 110.813 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 64.7 Cg_exo -52.16 -50.83 12.68 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.197 1.931 . . . . 99.99 112.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -63.13 -32.74 74.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.379 -0.373 . . . . 99.99 110.703 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.63 -30.97 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.12 -0.491 . . . . 99.99 110.555 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 88.8 p -93.07 -22.28 19.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.827 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.481 H181 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . 0.413 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.7 p -69.3 -44.76 80.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.962 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.413 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -64.3 -28.7 73.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.812 -0.709 . . . . 99.99 112.375 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.24 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 99.99 110.634 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 45.0 t -60.94 -60.71 3.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 99.99 110.85 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -62.8 -20.45 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 99.99 111.045 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.93 -56.1 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.757 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.5 -21.13 65.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.329 -0.396 . . . . 99.99 111.02 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 68.4 tp -67.27 -51.87 47.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.966 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -82.44 -22.49 35.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 99.99 111.01 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.79 -22.55 47.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.899 -0.667 . . . . 99.99 112.642 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 33.7 tp -58.86 -56.43 22.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.323 . . . . 99.99 110.574 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 56.44 59.19 3.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.522 . . . . 99.99 111.561 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 32.5 t30 57.97 108.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.614 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 47.2 tp -169.17 93.19 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 99.99 110.882 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -127.63 124.95 39.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.047 -0.524 . . . . 99.99 110.903 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -134.88 106.92 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 99.99 111.055 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.7 t -128.74 98.78 5.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.067 -0.515 . . . . 99.99 110.732 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -115.22 -47.56 2.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.756 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.453 . . . . 99.99 111.007 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.868 0.366 . . . . 99.99 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -145.08 34.76 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 99.99 110.711 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.7 mt -80.47 97.32 7.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.904 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -143.08 -39.96 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 99.99 111.235 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.1 m -63.98 125.72 25.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 99.99 111.117 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -114.07 -18.97 11.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.76 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.49 -40.81 83.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.094 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 39.5 m80 -62.12 -35.96 80.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.034 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.1 t-105 -69.52 -45.25 69.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.254 -0.43 . . . . 99.99 111.186 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mt -68.26 -21.82 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.034 0.445 . . . . 99.99 110.457 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -63.95 -54.98 26.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 99.99 110.682 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.64 -31.45 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.314 -0.403 . . . . 99.99 111.032 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.31 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.168 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.33 -33.38 75.55 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.974 -0.631 . . . . 99.99 112.951 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -70.47 -31.65 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.805 0.303 . . . . 99.99 111.201 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.8 m -63.02 -62.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.43 -0.35 . . . . 99.99 110.995 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -53.46 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.369 -0.378 . . . . 99.99 111.181 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.28 -43.24 98.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.808 -0.711 . . . . 99.99 112.236 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.437 ' HB3' ' HE3' ' A' ' 41' ' ' MET . . . -65.21 -35.86 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.865 0.364 . . . . 99.99 111.023 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.61 -31.75 69.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 99.99 111.078 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -55.89 -24.51 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.267 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -56.45 -56.51 20.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.477 -0.329 . . . . 99.99 111.085 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.653 ' O ' ' OG ' ' A' ' 26' ' ' SER . 86.2 t90 -64.24 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.978 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -70.13 -23.77 63.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 99.99 111.234 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.4 tp -87.76 -4.29 58.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 99.99 110.918 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.653 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 29.2 p -69.82 -20.22 63.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.96 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.434 ' HG3' HD21 ' A' ' 28' ' ' ASN . 24.9 tpt180 -50.6 -32.14 17.94 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.63 -0.507 . . . . 99.99 109.63 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 6.4 p30 -175.55 132.28 0.43 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.371 -0.831 . . . . 99.99 110.464 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 57.4 Cg_endo -96.15 158.21 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.226 2.617 . . . . 99.99 112.113 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -84.51 62.12 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.964 0.411 . . . . 99.99 110.99 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.69 -46.98 3.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.952 -0.642 . . . . 99.99 112.446 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.0 m -99.75 145.48 30.21 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.468 0.175 . . . . 99.99 110.658 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.25 160.83 12.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.317 2.012 . . . . 99.99 112.378 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -62.16 -16.41 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.801 . . . . 99.99 112.077 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -41.41 -37.89 1.13 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.022 0.379 . . . . 99.99 112.022 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 99.99 110.369 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -68.22 -20.19 64.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.021 -0.536 . . . . 99.99 110.282 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 41' ' ' MET . 32.8 tp -61.28 -47.75 84.57 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.266 -0.425 . . . . 99.99 110.002 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.67 -41.93 94.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.127 -0.488 . . . . 99.99 109.842 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.47 -6.11 33.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.62 -0.718 . . . . 99.99 110.908 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.446 ' HB3' ' O ' ' A' ' 38' ' ' LEU . 24.1 ttt -87.95 -36.42 17.1 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -71.3 -33.41 69.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 78.3 mt -50.68 -54.83 31.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.025 0.38 . . . . 99.99 112.025 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -70.62 -32.21 15.4 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.234 1.956 . . . . 99.99 113.082 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 41' ' ' MET . 24.8 mm -55.32 -62.4 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.717 0.294 . . . . 99.99 111.726 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -62.66 -53.88 47.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 99.99 111.306 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.478 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 91.3 p -58.48 -14.63 8.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.545 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.59 -61.21 2.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 99.99 112.589 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 mt -55.96 -27.57 53.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.704 0.287 . . . . 99.99 111.358 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.94 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.399 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.483 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.2 m-85 -60.86 -38.05 84.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 99.99 111.46 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.8 ttp -52.04 -40.41 61.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.11 0.481 . . . . 99.99 110.059 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.45 93.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 99.99 110.738 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.6 mtt -52.48 -35.73 53.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.323 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -65.81 -43.88 87.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.968 -0.56 . . . . 99.99 110.093 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.491 HG21 HG22 ' B' ' 127' ' ' VAL . 12.1 mt -70.61 -3.6 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 99.99 110.814 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.78 32.57 10.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.794 -0.639 . . . . 99.99 111.021 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -114.93 127.63 55.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 99.99 110.537 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.65 15.15 2.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.821 -0.704 . . . . 99.99 112.394 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -112.34 141.97 45.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 99.99 110.909 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.47 138.16 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 99.99 111.094 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.25 138.9 37.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.11 -0.496 . . . . 99.99 110.871 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.33 104.43 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.129 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.11 26.11 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.488 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.35 23.1 32.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 99.99 112.602 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -121.77 127.2 50.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 99.99 110.678 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -101.84 120.75 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 99.99 111.176 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.63 124.58 52.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.685 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 74.5 m-70 -70.22 82.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.345 0.593 . . . . 99.99 111.161 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.92 -50.96 70.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.314 -0.857 . . . . 99.99 111.253 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -22.39 66.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.958 -0.565 . . . . 99.99 112.166 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.559 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -68.89 -52.09 33.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.195 0.443 . . . . 99.99 112.195 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 4.0 p90 -76.67 -34.34 58.25 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.9 -0.32 . . . . 99.99 111.244 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 mm -52.59 -49.85 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.934 0.397 . . . . 99.99 110.532 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 26.7 t70 -65.0 -22.25 66.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.927 -0.578 . . . . 99.99 109.877 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -87.08 5.29 38.41 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.803 -0.635 . . . . 99.99 111.254 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 43.2 ttm -104.17 -19.75 14.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.61 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.438 ' O ' HD21 ' A' ' 82' ' ' LEU . 34.7 m -113.98 -32.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.746 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.418 HG21 HG21 ' A' ' 43' ' ' ILE . 28.4 m -79.17 -53.57 6.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.369 -0.378 . . . . 99.99 111.904 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.562 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 32.6 m -50.68 -50.39 73.35 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.078 0.399 . . . . 99.99 112.078 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HA ' ' HG2' ' A' ' 109' ' ' GLN . 11.9 Cg_endo -55.71 -41.6 75.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.713 1.609 . . . . 99.99 111.547 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 78' ' ' VAL . 3.6 mm? -65.73 -31.79 72.98 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.715 -0.476 . . . . 99.99 109.715 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.82 -26.98 67.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.046 -0.724 . . . . 99.99 109.046 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 109' ' ' GLN . 11.4 tp -81.74 -39.44 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.917 -1.038 . . . . 99.99 110.686 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.75 -38.31 90.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.874 -0.603 . . . . 99.99 111.046 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -57.27 -23.66 49.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.117 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -73.93 -29.0 61.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.143 -0.48 . . . . 99.99 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.6 t -80.84 -27.15 36.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.166 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -79.03 -31.49 44.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.371 . . . . 99.99 111.197 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -82.64 -26.36 32.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.519 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.86 -49.46 9.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.398 -0.364 . . . . 99.99 111.192 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.6 mtt -108.14 110.62 22.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.176 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.99 -39.26 89.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.399 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -114.39 175.72 5.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.778 -0.646 . . . . 99.99 110.471 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -130.26 142.58 43.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.44 -0.346 . . . . 99.99 111.022 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.15 174.91 9.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.272 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -70.61 -59.29 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.045 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.08 130.0 38.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.129 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -106.42 92.15 4.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.0 t -113.49 -41.07 3.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.413 . . . . 99.99 111.493 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.9 tp -76.92 -41.84 41.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 99.99 110.98 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 mm -65.94 -30.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.067 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.19 -40.3 42.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.923 -0.656 . . . . 99.99 112.441 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -63.18 -35.98 82.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 99.99 110.88 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 -56.75 13.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 99.99 111.176 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 57.1 ttm -56.95 -40.98 77.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.519 . . . . 99.99 111.234 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -58.31 -51.86 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 99.99 111.278 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p -60.67 -21.14 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 99.99 111.378 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 21.7 tp60 -77.25 -30.23 54.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.361 . . . . 99.99 110.76 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.31 -39.53 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 99.99 111.199 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.37 -35.73 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.932 -0.307 . . . . 99.99 111.063 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 81.8 t -66.26 -52.82 43.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.341 -0.39 . . . . 99.99 111.433 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.7 pt -60.03 -27.66 39.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.728 0.299 . . . . 99.99 111.336 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 30.7 m -63.39 -46.71 85.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.15 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 p -69.65 -24.85 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 99.99 110.795 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.98 -32.66 48.49 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.908 -0.663 . . . . 99.99 113.217 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -80.53 -28.16 37.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.635 0.255 . . . . 99.99 111.513 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.3 tp -83.49 -27.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 99.99 110.87 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.78 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.056 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.61 -21.12 60.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 99.99 111.029 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.7 mt -83.13 16.52 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.902 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -75.24 119.85 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.817 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.66 -53.87 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 99.99 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.588 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.7 ttp180 -78.26 132.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 99.99 110.606 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.19 -9.38 39.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 99.99 111.485 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.588 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 78.3 t90 -89.51 -52.23 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 99.99 110.915 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 124' ' ' ARG . 12.4 p -63.02 -23.7 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 189' ' ' GLY . 39.5 ttm180 -55.12 -33.59 63.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.077 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.59 -27.52 45.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.242 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.78 -54.21 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.315 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -61.43 -32.95 72.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.769 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -58.69 -45.44 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 99.99 110.645 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.66 -26.73 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 99.99 110.6 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 63.4 m -68.65 -34.11 75.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.791 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.57 -51.0 33.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.868 -0.682 . . . . 99.99 112.622 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.24 -29.76 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.738 0.304 . . . . 99.99 111.019 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.31 -47.12 87.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.8 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.38 -33.42 74.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.903 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.419 ' HA ' HG12 ' A' ' 142' ' ' ILE . 80.7 t80 -72.03 -27.18 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 99.99 110.948 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.7 mt -65.15 -54.02 36.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.576 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 142' ' ' ILE . 37.8 pt -59.18 -42.2 86.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.355 . . . . 99.99 111.827 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.43 ' N ' HG13 ' A' ' 141' ' ' ILE . 29.3 pt -73.02 -22.29 19.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.307 . . . . 99.99 111.194 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.72 -40.14 91.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.853 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -72.66 -36.43 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 99.99 110.421 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.99 -38.35 95.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.891 -0.671 . . . . 99.99 112.642 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.85 -21.32 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 99.99 110.965 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -90.39 4.99 49.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.174 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.479 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 51.5 t30 -60.72 -45.5 96.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.875 -0.602 . . . . 99.99 111.927 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 50.7 Cg_exo -55.33 -4.66 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.437 2.091 . . . . 99.99 113.32 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 148' ' ' ASN . 42.9 tp -50.64 -73.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.894 0.378 . . . . 99.99 110.957 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -96.95 -9.73 27.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 99.99 110.734 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.463 ' HB2' ' HA ' ' A' ' 149' ' ' PRO . . . -67.11 -17.16 64.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.598 . . . . 99.99 111.127 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -46.7 -27.08 1.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.648 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.3 p -78.31 -39.6 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 99.99 111.48 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -81.4 -14.45 57.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.335 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 49.3 p -84.94 7.08 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.486 -0.325 . . . . 99.99 111.255 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 62.69 -80.3 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.515 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.4 t -58.73 112.55 1.67 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.841 0.353 . . . . 99.99 111.122 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.8 t -79.03 -37.82 38.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.195 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.49 -50.52 73.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.207 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -59.51 -39.14 82.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.021 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.04 -31.87 73.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.231 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.73 -39.48 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.946 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 66.5 mt -61.18 -37.64 83.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.839 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 -23.55 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.981 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.1 -42.13 94.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 99.99 110.839 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -83.99 -24.11 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 99.99 110.765 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.83 -51.55 61.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 99.99 111.211 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.69 -25.75 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.353 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.0 m -53.05 -59.15 4.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 99.99 111.469 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.44 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 11.2 t80 -68.11 -31.6 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 99.99 110.424 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.49 -23.42 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 99.99 111.136 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 -49.81 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.573 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.75 -29.17 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.561 -0.29 . . . . 99.99 111.738 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.443 HD22 ' HB2' ' A' ' 209' ' ' SER . 69.3 mt -77.72 -58.11 3.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.831 0.348 . . . . 99.99 111.017 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.63 -23.18 58.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.534 . . . . 99.99 110.777 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 181' ' ' ILE . 10.9 mm -88.07 -29.36 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 99.99 110.362 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -52.31 48.18 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.767 -0.651 . . . . 99.99 113.766 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.639 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 73.8 m-85 -58.64 -55.38 46.6 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.01 0.405 . . . . 99.99 111.952 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.639 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 73.1 Cg_exo -49.06 -28.03 13.17 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.136 1.89 . . . . 99.99 112.738 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.529 ' O ' HG12 ' A' ' 184' ' ' ILE . 95.0 mt -71.72 -59.96 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 99.99 111.125 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 20.4 m -58.17 -24.58 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.7 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -64.11 -17.46 63.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.064 0.394 . . . . 99.99 112.064 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.654 HG13 HG23 ' A' ' 185' ' ' ILE . 19.3 pt -69.74 -9.79 12.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.988 -0.285 . . . . 99.99 111.57 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.654 HG23 HG13 ' A' ' 184' ' ' ILE . 42.4 pt -134.09 146.77 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 99.99 111.092 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 98.15 -160.83 20.74 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.919 -0.658 . . . . 99.99 112.47 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.51 150.13 84.2 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.573 2.182 . . . . 99.99 111.942 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 71.0 m 56.24 23.57 7.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 99.99 110.68 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.406 ' N ' ' HD3' ' A' ' 128' ' ' ARG . . . -169.0 43.81 0.22 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.883 -0.675 . . . . 99.99 112.692 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 58.13 89.9 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.756 0.312 . . . . 99.99 111.063 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.28 138.49 5.67 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.791 -0.719 . . . . 99.99 112.371 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -102.75 25.19 9.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.764 0.316 . . . . 99.99 111.03 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.9 pt -128.97 149.51 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.284 -0.416 . . . . 99.99 111.169 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -156.77 51.64 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.305 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 196' ' ' THR . 4.3 tp-100 -113.31 -179.53 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.856 -0.611 . . . . 99.99 110.587 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.563 ' H ' ' HG3' ' A' ' 195' ' ' GLN . 65.8 p -55.55 -26.95 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.688 0.255 . . . . 99.99 111.688 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt -55.76 -37.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.807 0.337 . . . . 99.99 111.473 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.9 -54.5 44.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.904 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.3 p -63.07 -30.27 71.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.021 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -56.75 -38.08 71.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 99.99 111.163 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 63.0 tp -75.77 -40.51 55.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.511 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.99 -6.1 51.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.701 0.26 . . . . 99.99 111.701 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 60.5 m -96.12 -39.96 9.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.915 0.388 . . . . 99.99 110.911 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.75 -35.79 65.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 99.99 111.922 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.657 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.7 tp -58.72 -53.99 60.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.965 -0.294 . . . . 99.99 111.252 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 32.1 Cg_exo -58.93 -37.2 94.82 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.683 1.589 . . . . 99.99 111.274 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -63.33 -34.16 77.1 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 116.021 -0.536 . . . . 99.99 110.13 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -72.25 -24.23 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.625 . . . . 99.99 110.472 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.443 ' HB2' HD22 ' A' ' 175' ' ' LEU . 29.8 t -95.65 -19.16 19.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 99.99 111.007 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.435 ' H9 ' ' C18' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 24.5 t -67.96 -33.8 63.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.22 -0.446 . . . . 99.99 111.342 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.32 71.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.583 -0.818 . . . . 99.99 112.408 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -76.34 -34.18 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.62 0.248 . . . . 99.99 111.178 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 85.2 p -63.14 -52.22 63.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 99.99 110.912 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -62.12 -30.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.346 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.5 -47.86 74.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.632 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.72 -33.93 68.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 99.99 111.278 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.89 -47.27 84.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 99.99 111.372 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -74.12 -27.68 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 99.99 111.058 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.86 63.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 99.99 112.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.77 -37.85 83.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.588 0.232 . . . . 99.99 111.294 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 222' ' ' ARG . 5.9 tpm_? 63.73 -80.97 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.008 -0.542 . . . . 99.99 111.277 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -147.09 -85.25 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.376 -0.375 . . . . 99.99 110.914 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.6 mt 63.82 130.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.377 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -124.0 137.71 54.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 99.99 110.8 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -139.85 146.41 39.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.411 . . . . 99.99 110.962 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.8 m -148.92 111.95 4.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.034 -0.53 . . . . 99.99 110.709 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -96.39 -53.38 3.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.978 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 99.99 110.876 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.904 0.383 . . . . 99.99 110.755 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.445 HD22 ' HB2' ' B' ' 4' ' ' GLU . 3.1 t-20 -91.59 95.34 9.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.662 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.409 HD13 ' N ' ' B' ' 3' ' ' LEU . 6.9 mp -94.52 2.29 55.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 99.99 111.324 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.445 ' HB2' HD22 ' B' ' 2' ' ' ASN . 46.1 mt-10 -67.51 -169.98 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.313 -0.403 . . . . 99.99 110.751 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.1 t 62.63 92.66 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.023 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.431 HD11 ' N ' ' B' ' 6' ' ' LEU . 5.9 mp -105.32 1.31 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.746 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 62.5 tp -68.12 -41.15 82.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 99.99 110.426 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.522 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 36.7 m80 -61.92 -31.81 72.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 99.99 110.474 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -69.79 -44.72 69.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.96 -0.564 . . . . 99.99 110.458 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.89 -20.72 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 99.99 110.119 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.98 -54.64 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 99.99 110.61 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.45 -32.63 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.08 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -53.17 61.23 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.199 -0.455 . . . . 99.99 111.037 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.47 -27.34 69.38 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.891 -0.671 . . . . 99.99 112.461 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' B' ' 44' ' ' PRO . 22.9 mmt -73.53 -26.9 61.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.696 0.284 . . . . 99.99 111.033 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 63.2 m -69.32 -54.32 15.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 99.99 110.983 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -60.49 -27.42 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 99.99 111.17 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.73 -51.71 53.87 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.535 -0.841 . . . . 99.99 112.245 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.431 ' HB2' ' HE3' ' B' ' 41' ' ' MET . . . -61.15 -28.16 68.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.936 0.398 . . . . 99.99 111.165 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.37 -31.54 71.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 99.99 110.85 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -61.05 -21.94 64.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 99.99 110.978 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.27 -35.67 81.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.992 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -80.3 -32.85 37.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 99.99 111.082 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 88.8 p -77.3 -19.95 55.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.353 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 tp -87.43 -1.76 58.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.342 . . . . 99.99 110.958 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 100.0 p -73.39 -19.52 60.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 99.99 110.833 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -52.09 -30.72 27.38 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.691 -0.485 . . . . 99.99 109.691 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.7 p-10 -174.19 131.83 0.52 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.44 -0.8 . . . . 99.99 110.319 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 56.9 Cg_endo -97.29 172.66 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.175 2.583 . . . . 99.99 111.892 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -94.5 58.74 2.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.407 . . . . 99.99 110.661 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -45.82 3.46 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.007 -0.616 . . . . 99.99 112.375 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 34.2 m -101.7 147.03 33.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 O-C-N 122.977 -0.131 . . . . 99.99 110.739 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -54.28 163.5 3.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.058 . . . . 99.99 112.516 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -64.99 -17.47 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.554 -0.748 . . . . 99.99 111.922 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -41.6 -34.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.009 0.374 . . . . 99.99 112.009 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.29 -53.43 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 99.99 110.334 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -66.48 -19.58 65.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.903 -0.589 . . . . 99.99 110.458 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' B' ' 41' ' ' MET . 8.5 tt -59.86 -47.71 84.62 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.659 -0.497 . . . . 99.99 109.659 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 52.2 t -62.79 -39.87 86.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.524 -0.547 . . . . 99.99 109.524 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.34 -5.89 39.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.663 -0.699 . . . . 99.99 110.663 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.52 ' O ' ' HD2' ' B' ' 44' ' ' PRO . 26.6 ttt -88.72 -31.32 18.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.029 -0.532 . . . . 99.99 110.455 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -75.47 -34.22 60.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 99.99 111.105 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.62 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 67.6 mt -54.21 -51.84 74.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.962 0.356 . . . . 99.99 111.962 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 12.2 Cg_exo -70.79 -33.72 12.26 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.637 2.225 . . . . 99.99 113.132 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.42 HG12 ' O ' ' B' ' 41' ' ' MET . 24.4 mm -57.28 -62.15 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 111.749 0.278 . . . . 99.99 111.749 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -59.05 -54.28 48.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.805 0.335 . . . . 99.99 111.081 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -55.33 -28.79 56.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 99.99 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.99 -58.04 14.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 99.99 112.74 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.22 -29.61 67.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 99.99 111.101 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -52.25 60.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.219 -0.446 . . . . 99.99 111.228 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 22.4 m-85 -64.65 -39.36 93.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.198 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -49.61 -40.8 40.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.214 0.53 . . . . 99.99 110.052 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.58 91.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.679 -0.691 . . . . 99.99 110.821 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtt -52.56 -32.27 40.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 99.99 110.197 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -69.37 -42.64 74.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.957 -0.565 . . . . 99.99 110.213 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 12.0 mt -75.67 1.89 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 99.99 110.567 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.511 ' HD2' ' HZ3' ' B' ' 60' ' ' LYS . 16.7 t70 66.16 46.75 2.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.642 -0.708 . . . . 99.99 110.714 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.407 ' CD ' HG21 ' C' ' 127' ' ' VAL . 14.6 mm100 -115.72 168.84 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 99.99 110.954 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' B' ' 71' ' ' ALA . . . 83.65 23.69 52.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 99.99 112.466 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.511 ' HZ3' ' HD2' ' B' ' 57' ' ' ASP . 93.7 mttt -116.12 142.96 46.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 99.99 110.799 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.63 147.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 99.99 111.265 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.59 142.51 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.762 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.82 98.85 1.37 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.299 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.18 29.27 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.04 -0.527 . . . . 99.99 111.422 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.94 16.48 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.597 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -116.48 121.29 41.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 99.99 110.896 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.69 123.08 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 99.99 111.093 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' B' ' 120' ' ' ASP . . . -112.97 129.7 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 99.99 111.238 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.633 ' H ' ' HD2' ' B' ' 120' ' ' ASP . 87.9 m-70 -73.03 81.36 1.22 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 99.99 110.619 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -62.03 -35.4 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 99.99 111.586 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.464 ' HB3' ' HA3' ' B' ' 59' ' ' GLY . . . -78.85 -22.56 45.92 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.311 0.486 . . . . 99.99 112.311 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 12.8 tpp180 -69.85 -51.32 34.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.132 0.419 . . . . 99.99 112.132 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.479 ' O ' ' HG3' ' B' ' 77' ' ' MET . 8.2 p90 -76.3 -38.11 56.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.861 0.319 . . . . 99.99 111.861 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 11.1 tp -54.04 -44.4 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 99.99 110.991 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.22 -21.8 65.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.495 -0.557 . . . . 99.99 109.495 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -85.9 4.92 35.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.514 -0.766 . . . . 99.99 111.267 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 42.5 mtp -104.83 -18.99 14.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.232 -0.44 . . . . 99.99 110.939 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.4 m -114.54 -31.65 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 99.99 111.876 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.543 HG22 HG21 ' B' ' 43' ' ' ILE . 60.9 m -79.47 -57.18 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 99.99 112.035 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.539 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 11.0 m -50.42 -50.13 73.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.192 0.442 . . . . 99.99 112.192 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.7 Cg_exo -53.91 -42.49 66.18 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.832 1.688 . . . . 99.99 111.64 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -66.97 -29.45 69.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.036 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.448 HD22 ' H43' ' B' ' 210' ' ' LYR . 19.0 tp -70.19 -20.98 63.09 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.176 -0.676 . . . . 99.99 109.176 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' B' ' 109' ' ' GLN . 14.9 tp -83.86 -39.89 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.1 -0.954 . . . . 99.99 109.985 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 22.1 tp -66.94 -35.34 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.343 -0.844 . . . . 99.99 111.025 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -60.08 -21.78 61.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 99.99 110.804 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.2 -27.21 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 99.99 110.7 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -76.74 -33.1 58.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.964 -0.562 . . . . 99.99 110.783 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -80.05 -31.77 39.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 99.99 110.801 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 88.6 m -72.98 -38.48 66.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.067 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.29 -46.43 12.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.034 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 80.4 mtp -103.39 120.89 41.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 99.99 111.047 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -75.52 -30.94 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 99.99 110.574 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.63 179.44 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.907 -0.588 . . . . 99.99 110.664 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tp -132.25 148.31 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 99.99 111.25 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.2 161.26 14.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 99.99 110.936 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.37 44.51 1.04 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.109 -0.496 . . . . 99.99 111.089 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -149.13 113.57 5.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.679 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -82.93 78.72 9.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 99.99 111.189 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.8 m -120.93 -59.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.542 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.15 -61.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 99.99 111.443 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.8 pt -55.33 -38.09 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.57 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.84 -43.81 98.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.869 -0.681 . . . . 99.99 112.798 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -63.21 -36.0 82.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.282 . . . . 99.99 110.985 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.45 -53.47 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.118 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 87.7 mtp -57.95 -36.26 72.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 99.99 111.042 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 57.6 m -65.32 -54.43 29.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.12 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 47.4 p -53.98 -26.14 24.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 99.99 111.292 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.479 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 6.4 tp-100 -71.61 -40.99 69.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.709 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.99 -32.07 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 99.99 110.973 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.13 -43.01 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.264 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.62 -55.4 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.515 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.7 pt -54.32 -33.17 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 99.99 111.269 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -60.87 -40.77 94.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.337 -0.392 . . . . 99.99 110.607 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -61.54 -59.8 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 99.99 110.365 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.466 ' HA3' H183 ' B' ' 210' ' ' LYR . . . -60.66 -16.33 44.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.781 -0.723 . . . . 99.99 112.431 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.96 -61.84 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 99.99 110.702 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 mt -84.04 -20.41 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 99.99 111.759 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.95 57.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.779 0.323 . . . . 99.99 110.956 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.633 ' HD2' ' H ' ' B' ' 69' ' ' HIS . 24.8 t70 -82.97 -19.65 36.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.822 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.56 22.83 1.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.107 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.4 p -70.97 124.51 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 99.99 110.921 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -99.9 -41.71 7.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 99.99 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.515 ' HB2' HG12 ' B' ' 127' ' ' VAL . 80.3 mtp180 -94.5 140.05 30.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.033 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.13 -19.14 62.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 99.99 110.95 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -79.03 -54.02 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.894 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' B' ' 124' ' ' ARG . 10.6 p -62.06 -23.66 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 99.99 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -51.95 -41.38 62.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -77.06 -28.56 54.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.16 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' B' ' 127' ' ' VAL . 93.7 mt -70.48 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 99.99 111.137 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -56.21 -32.39 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 99.99 111.151 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -60.43 -42.6 96.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.911 0.386 . . . . 99.99 110.52 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.76 -28.87 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 99.99 110.653 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.7 t -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.895 -0.593 . . . . 99.99 110.724 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.28 23.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 99.99 112.501 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.42 -30.42 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.789 0.328 . . . . 99.99 111.137 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.55 -40.48 94.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 99.99 110.765 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.19 78.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.978 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -73.76 -22.72 59.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.694 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -56.46 10.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 99.99 110.689 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 26.7 pt -60.48 -40.86 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 99.99 111.441 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 67.3 mt -68.84 -28.86 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.475 -0.329 . . . . 99.99 110.715 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.5 -42.29 99.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.979 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . 0.412 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 94.4 m95 -72.31 -27.31 62.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.808 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . 1.019 ' HA2' HD22 ' B' ' 148' ' ' ASN . . . -76.16 -27.45 62.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 99.99 112.716 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.44 -13.49 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.771 0.32 . . . . 99.99 111.286 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -99.93 4.67 45.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.212 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 1.019 HD22 ' HA2' ' B' ' 145' ' ' GLY . 69.1 m-80 -63.08 -43.44 81.52 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.162 -0.472 . . . . 99.99 112.069 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' B' ' 148' ' ' ASN . 82.7 Cg_exo -50.39 -11.03 0.3 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.502 2.134 . . . . 99.99 113.494 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 69.8 tp -50.35 -80.5 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.735 0.303 . . . . 99.99 111.171 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -89.65 1.54 55.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 99.99 110.635 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' B' ' 149' ' ' PRO . . . -82.13 -17.08 47.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.566 . . . . 99.99 110.963 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -49.32 -30.23 7.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.972 -0.558 . . . . 99.99 112.003 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 8.8 t -70.95 -35.13 72.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 99.99 110.917 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -83.08 -17.63 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.976 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 76.5 p -84.47 6.9 21.66 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.359 -0.382 . . . . 99.99 111.66 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 62.94 -82.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.367 -0.379 . . . . 99.99 111.517 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.516 ' HB2' HD21 ' B' ' 161' ' ' LEU . 75.4 p -55.56 113.18 1.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.905 0.383 . . . . 99.99 111.182 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 49.0 m -78.14 -46.47 20.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.996 -0.547 . . . . 99.99 111.026 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -52.95 -56.47 15.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.187 -0.461 . . . . 99.99 111.426 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' B' ' 158' ' ' SER . 3.8 mm? -55.21 -35.8 65.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 99.99 110.965 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.09 -31.56 70.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 99.99 111.163 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -71.77 -41.27 68.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 99.99 110.858 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.2 mt -58.43 -37.15 74.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.824 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.19 -31.64 58.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.749 -0.66 . . . . 99.99 111.287 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.44 -42.06 91.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 99.99 110.968 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -83.42 -22.52 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 99.99 110.982 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.68 -44.63 77.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.926 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.57 -25.68 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.336 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 51.0 m -51.26 -59.13 4.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 99.99 111.367 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -67.2 -34.61 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 99.99 110.482 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -63.25 -22.21 66.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 99.99 111.003 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 48.0 m -79.73 -56.99 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.721 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.08 -29.39 15.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.365 0.506 . . . . 99.99 112.365 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' B' ' 209' ' ' SER . 57.9 tp -79.87 -57.92 3.42 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.891 0.377 . . . . 99.99 111.29 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.3 -29.54 61.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.02 -0.537 . . . . 99.99 111.04 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.448 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 9.4 tp -87.91 -21.79 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.064 0.459 . . . . 99.99 110.438 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.98 -54.94 33.49 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.789 -0.642 . . . . 99.99 113.129 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.58 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 96.3 m-85 -56.41 -54.14 56.4 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.816 0.308 . . . . 99.99 111.763 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.7 Cg_exo -46.75 -32.32 11.98 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.223 1.949 . . . . 99.99 112.612 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 177' ' ' ILE . 91.0 mt -67.93 -60.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.577 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 29.0 m -58.97 -24.71 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.861 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -62.69 -20.05 64.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.52 -0.309 . . . . 99.99 111.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 mm -54.44 -49.9 61.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 99.99 110.794 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . 0.429 ' HA ' ' HB3' ' B' ' 190' ' ' PHE . 15.0 pt -95.5 178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.294 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 73.93 -162.31 54.29 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.887 -0.673 . . . . 99.99 112.505 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.67 154.62 64.02 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.634 2.223 . . . . 99.99 112.238 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' B' ' 120' ' ' ASP . 46.6 m 58.78 14.95 3.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.903 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -135.93 -85.56 0.2 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.994 -0.622 . . . . 99.99 112.111 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.429 ' HB3' ' HA ' ' B' ' 185' ' ' ILE . 83.6 t80 -113.25 -53.13 2.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.892 0.377 . . . . 99.99 110.509 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 100.7 123.7 5.2 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.785 -0.721 . . . . 99.99 112.847 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -171.87 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 99.99 110.669 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.81 177.75 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 99.99 111.078 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -168.49 16.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.771 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -85.43 -164.13 0.96 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.076 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 52.9 p -66.78 -20.76 66.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 99.99 111.343 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 14.1 tt -59.67 -40.46 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.396 . . . . 99.99 111.432 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.07 -49.42 77.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 99.99 110.869 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 63.4 p -68.98 -23.27 64.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 99.99 110.896 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.98 -36.8 83.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 99.99 111.19 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.26 -45.83 53.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.218 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -75.52 -3.43 34.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.745 0.307 . . . . 99.99 111.349 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 43.8 t -96.31 -43.47 7.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.279 0.561 . . . . 99.99 110.289 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 66.5 tp -71.93 -39.48 69.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.444 -0.798 . . . . 99.99 112.055 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.573 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -55.97 -54.77 48.64 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.237 -0.185 . . . . 99.99 111.384 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -56.16 -41.51 75.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.885 1.723 . . . . 99.99 111.559 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.61 -31.78 73.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.288 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -66.68 -27.49 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.572 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.4 ' HB2' HD11 ' B' ' 175' ' ' LEU . 17.3 t -97.04 -27.82 14.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 99.99 111.053 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.466 H183 ' HA3' ' B' ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 46.7 t -73.37 -33.52 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 99.99 110.997 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.27 -30.66 74.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 99.99 112.549 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -74.74 -29.87 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 99.99 110.753 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.1 t -63.0 -59.93 4.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 99.99 110.74 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.79 -28.89 67.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 99.99 110.823 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.74 -43.36 89.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 99.99 110.567 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.08 -22.24 65.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.873 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.4 tp -69.62 -51.51 34.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -78.09 -30.94 49.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.302 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.66 80.43 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.792 -0.718 . . . . 99.99 112.933 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 55.1 tp -73.28 -35.69 66.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 99.99 111.012 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 58.44 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.99 -0.55 . . . . 99.99 111.356 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -171.59 151.14 2.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.495 -0.321 . . . . 99.99 110.918 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.419 HD22 ' N ' ' B' ' 224' ' ' LEU . 2.5 pt? -170.14 142.54 2.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.341 -0.391 . . . . 99.99 110.77 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -105.42 140.1 39.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.493 . . . . 99.99 111.179 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -149.14 117.82 6.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 99.99 110.756 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 64.2 m -125.46 113.38 17.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 99.99 111.156 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -105.92 -26.31 11.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 99.99 110.583 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 99.99 110.924 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.888 0.375 . . . . 99.99 110.732 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -134.96 69.37 1.45 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 99.99 111.09 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.55 94.0 4.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 99.99 110.914 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -140.45 -34.41 0.53 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.853 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 48.8 m -66.48 99.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 99.99 110.844 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt -97.12 13.57 28.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.927 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 94.3 mt -81.11 -45.16 16.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.257 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 60.8 m-70 -64.65 -26.08 68.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.931 0.396 . . . . 99.99 110.475 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -72.58 -47.75 45.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.059 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.05 -20.8 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.358 0.599 . . . . 99.99 109.503 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -59.9 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.224 -0.898 . . . . 99.99 110.69 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' C' ' 52' ' ' MET . 14.0 p -58.58 -32.81 46.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.035 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.62 41.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 99.99 111.015 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.07 -21.78 68.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 99.99 112.189 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' MET . . . . . 0.567 ' HA ' ' HE3' ' C' ' 15' ' ' MET . 8.2 mmt -73.54 -35.85 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.676 0.274 . . . . 99.99 110.952 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 59.8 p -66.46 -53.06 39.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 99.99 111.185 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.98 -26.09 34.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.36 . . . . 99.99 111.016 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.97 -39.51 93.26 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.763 -0.732 . . . . 99.99 112.418 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.508 ' HA ' ' HG3' ' C' ' 41' ' ' MET . . . -72.67 -28.29 62.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 99.99 110.926 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 28.4 tp -68.49 -29.93 68.65 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.516 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -59.19 -22.14 60.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 99.99 110.414 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -58.19 -53.73 55.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.018 -0.537 . . . . 99.99 110.91 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -60.81 -38.8 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 99.99 110.479 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 63.3 m -69.69 -19.56 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.67 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 23.7 mt -80.1 -0.39 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 99.99 111.554 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 48.8 p -57.56 -52.04 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.911 -0.316 . . . . 99.99 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.74 -27.41 69.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.158 0.98 . . . . 99.99 108.508 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.735 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 12.7 m120 -70.32 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 113.473 -1.694 . . . . 99.99 108.892 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.735 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 5.8 Cg_exo 10.16 96.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.763 2.976 . . . . 99.99 117.093 -174.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -109.65 131.61 54.9 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.421 -1.263 . . . . 99.99 108.226 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.08 -43.09 3.19 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.005 -1.238 . . . . 99.99 110.005 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' C' ' 29' ' ' PRO . 3.3 p -125.66 112.22 25.21 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.331 -0.988 . . . . 99.99 108.331 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.82 167.54 21.05 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.038 2.492 . . . . 99.99 115.543 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . 0.612 ' HG3' ' HG2' ' C' ' 29' ' ' PRO . 1.4 mp0 -60.93 -14.47 22.7 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 113.435 -1.712 . . . . 99.99 112.82 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' C' ' 38' ' ' LEU . 20.8 p90 -39.22 -36.31 0.32 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.708 0.29 . . . . 99.99 111.604 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -64.91 -48.35 74.48 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.251 0.548 . . . . 99.99 109.572 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' C' ' 34' ' ' GLN . 33.7 t80 -68.56 -20.48 64.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 99.99 110.291 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' C' ' 35' ' ' TYR . 56.1 tp -59.03 -48.29 82.13 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.571 -0.529 . . . . 99.99 109.571 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -41.27 91.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.82 -0.627 . . . . 99.99 109.581 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.87 -6.07 35.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.591 -0.732 . . . . 99.99 110.703 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.508 ' HG3' ' HA ' ' C' ' 19' ' ' ALA . 51.0 ttp -88.64 -34.14 17.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.519 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -72.43 -30.07 64.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 99.99 110.571 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.518 HG21 HG21 ' C' ' 79' ' ' THR . 93.3 mt -54.89 -54.81 45.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.548 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.6 Cg_endo -71.22 -28.64 18.36 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.224 1.949 . . . . 99.99 113.176 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 41' ' ' MET . 80.0 mt -58.1 -62.72 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.623 0.249 . . . . 99.99 111.58 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -55.42 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 99.99 111.084 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 85.8 p -52.01 -39.04 58.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 99.99 111.303 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.44 -55.14 28.35 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.925 -0.655 . . . . 99.99 112.923 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . 0.426 ' O ' ' HG2' ' C' ' 52' ' ' MET . 69.6 mt -57.04 -29.91 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 99.99 110.829 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -70.42 -35.73 73.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.136 -0.483 . . . . 99.99 111.05 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 49.6 m-85 -71.39 -52.45 18.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.466 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' MET . . . . . 0.47 ' HB3' HG12 ' C' ' 12' ' ' VAL . 23.8 ptm -49.53 -34.69 17.99 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.882 0.372 . . . . 99.99 110.498 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.07 88.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 99.99 110.727 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 54.2 mtt -52.27 -33.86 43.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.836 -0.62 . . . . 99.99 110.553 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.32 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 99.99 110.705 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.421 HG22 HG23 ' A' ' 127' ' ' VAL . 10.2 mm -72.64 -4.75 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 99.99 110.697 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 66.55 35.61 5.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.7 . . . . 99.99 110.815 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -118.35 138.21 52.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.641 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.39 16.83 5.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.847 -0.692 . . . . 99.99 112.495 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' C' ' 60' ' ' LYS . 3.3 mptp? -114.67 137.8 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 99.99 110.606 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.05 142.56 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 99.99 111.016 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.27 139.63 42.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.081 -0.509 . . . . 99.99 110.915 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.85 102.09 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.072 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.33 30.57 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.24 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.4 40.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 99.99 112.783 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 118.95 31.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.687 0.28 . . . . 99.99 110.609 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -97.18 120.11 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 99.99 111.105 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.49 141.92 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.108 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.543 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 55.3 m-70 -80.68 82.06 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.08 0.467 . . . . 99.99 110.864 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -67.65 -32.72 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.797 -0.638 . . . . 99.99 111.392 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.57 -24.99 41.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.288 0.477 . . . . 99.99 112.288 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.3 mmt180 -71.51 -52.01 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.284 0.476 . . . . 99.99 112.284 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.468 ' O ' ' HG3' ' C' ' 77' ' ' MET . 2.6 p90 -71.43 -40.37 70.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.82 -0.352 . . . . 99.99 111.717 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.4 tp -53.64 -44.01 56.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.581 0.229 . . . . 99.99 111.026 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.08 -21.45 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.447 -0.575 . . . . 99.99 109.447 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -87.38 6.93 31.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.436 -0.802 . . . . 99.99 111.209 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 30.0 mtp -105.34 -20.68 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.693 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -114.14 -29.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.883 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.518 HG21 HG21 ' C' ' 43' ' ' ILE . 88.2 m -81.29 -56.14 4.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.787 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 25.0 m -50.54 -50.32 72.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.412 0.523 . . . . 99.99 112.412 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' C' ' 80' ' ' THR . 12.3 Cg_endo -56.41 -38.49 95.16 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.58 1.52 . . . . 99.99 111.446 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.42 -30.94 69.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 99.99 109.577 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.89 -21.23 62.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.445 0.641 . . . . 99.99 109.336 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.32 -37.23 21.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.993 -1.003 . . . . 99.99 109.908 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 89.4 mt -67.72 -35.91 79.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.75 -0.659 . . . . 99.99 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 88.8 p -56.71 -31.14 64.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.343 -0.389 . . . . 99.99 110.981 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 70.4 mt -66.62 -33.23 75.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.489 . . . . 99.99 110.797 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -73.72 -27.47 61.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 99.99 110.961 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.27 -33.6 25.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 99.99 110.952 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 82.3 m -76.52 -37.23 57.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 99.99 111.005 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.28 -48.3 12.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.265 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -104.0 115.14 29.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.949 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -71.54 -25.07 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.016 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -144.77 138.0 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.053 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.8 142.08 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.054 -0.521 . . . . 99.99 111.022 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -102.89 173.55 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.807 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.9 -178.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 99.99 110.758 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 28.6 t70 56.44 84.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 99.99 110.868 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -75.16 99.47 3.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.864 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 68.8 m -119.23 -44.86 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.261 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.64 -48.41 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 99.99 111.095 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 7.6 tp -65.9 -30.09 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 99.99 111.329 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.32 -44.84 41.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.769 . . . . 99.99 112.776 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.58 -36.54 78.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 99.99 111.352 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.72 -51.25 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 99.99 111.3 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.72 -35.87 77.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.029 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 40.9 m -66.87 -55.75 13.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.255 -0.429 . . . . 99.99 111.178 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 40.1 p -55.78 -25.91 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.997 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -68.4 -40.36 81.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.376 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 36.4 mm -59.67 -32.17 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.91 -0.586 . . . . 99.99 110.698 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.98 -42.14 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.955 -0.566 . . . . 99.99 111.171 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.23 -54.9 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 99.99 111.631 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.1 pt -55.02 -27.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 99.99 111.272 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 19.7 m -66.13 -46.57 77.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.436 . . . . 99.99 110.883 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -69.03 -23.78 64.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.412 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.63 -35.52 32.1 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.712 -0.756 . . . . 99.99 113.266 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.541 HD11 ' N ' ' C' ' 118' ' ' ILE . 3.6 pp -77.06 -29.75 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.568 0.223 . . . . 99.99 111.592 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.541 ' N ' HD11 ' C' ' 117' ' ' LEU . 10.2 tp -83.89 -24.33 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.399 -0.364 . . . . 99.99 111.202 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.24 93.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.105 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -78.36 -14.13 59.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.046 -0.525 . . . . 99.99 111.067 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' C' ' 118' ' ' ILE . 96.7 mt -86.29 17.59 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.125 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 78.5 p -68.38 121.16 15.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 99.99 111.11 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -103.23 -37.94 7.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.246 -0.433 . . . . 99.99 110.648 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.504 ' HB2' HG12 ' C' ' 127' ' ' VAL . 97.7 mtt180 -102.97 137.87 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 99.99 110.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.71 -9.43 58.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.242 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -88.52 -44.36 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 99.99 111.088 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -74.16 -23.94 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 99.99 111.187 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -52.53 -47.29 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.283 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -67.58 -22.94 65.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.391 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' C' ' 127' ' ' VAL . 72.4 mt -80.5 -47.22 14.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 99.99 111.239 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.68 -34.49 77.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.384 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.85 -33.49 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.097 -0.501 . . . . 99.99 111.135 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.3 mm -73.26 -37.48 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.108 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.59 -30.73 71.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 99.99 110.878 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -54.83 11.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.723 -0.751 . . . . 99.99 112.278 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.56 -29.88 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 99.99 110.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.37 -49.42 77.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.054 -0.521 . . . . 99.99 110.741 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.08 -29.01 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.845 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -74.64 -20.08 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 99.99 110.708 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.3 15.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 99.99 111.293 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . 0.441 HG13 ' N ' ' C' ' 142' ' ' ILE . 29.0 pt -59.21 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 99.99 111.241 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.441 ' N ' HG13 ' C' ' 141' ' ' ILE . 7.4 tp -72.48 -27.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.494 -0.321 . . . . 99.99 111.003 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.27 -50.84 71.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.67 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -64.42 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.934 -0.575 . . . . 99.99 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.3 -39.1 97.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.794 -0.717 . . . . 99.99 112.405 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.39 -24.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 99.99 110.654 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -89.26 3.93 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 99.99 111.043 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.456 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 51.5 t30 -61.61 -46.99 93.83 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.914 -0.585 . . . . 99.99 111.834 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 57.3 Cg_exo -38.54 -35.04 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.628 2.219 . . . . 99.99 112.761 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' C' ' 152' ' ' ALA . 44.5 tp -60.44 123.11 16.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 99.99 109.981 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' C' ' 150' ' ' LEU . 99.3 mtt180 71.64 -13.06 0.59 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.186 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' C' ' 150' ' ' LEU . . . -81.68 -17.56 47.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 99.99 110.538 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -47.96 -32.35 6.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.858 -0.61 . . . . 99.99 111.242 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 70.7 p -54.8 -48.33 72.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.1 -0.5 . . . . 99.99 111.04 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -82.07 -16.3 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 99.99 110.743 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 8.9 m -76.71 -7.26 55.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 99.99 111.022 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 66.31 -77.76 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.499 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -59.14 113.31 2.06 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.927 0.394 . . . . 99.99 111.104 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 44.7 t -78.41 -38.4 41.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.017 -0.538 . . . . 99.99 111.179 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.78 -57.06 14.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 99.99 110.982 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 63.9 tp -55.46 -34.08 64.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.959 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.14 93.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.439 . . . . 99.99 110.941 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -63.99 -38.2 90.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 99.99 111.022 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.77 -36.68 72.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.086 0.47 . . . . 99.99 110.703 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -39.57 49.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.635 . . . . 99.99 111.048 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -57.79 -37.12 73.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 99.99 111.443 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -81.35 -26.97 35.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.137 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.89 -52.17 18.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 99.99 111.264 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.16 -25.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 99.99 111.493 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -54.64 -58.96 5.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 99.99 111.316 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -68.32 -24.58 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.499 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -70.62 -35.97 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 99.99 111.673 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 41.0 p -70.47 -53.18 17.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.565 -0.288 . . . . 99.99 111.655 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 p -53.33 -35.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.958 0.355 . . . . 99.99 111.958 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.472 HD22 ' HG ' ' C' ' 209' ' ' SER . 41.7 tp -75.36 -57.81 3.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.794 0.33 . . . . 99.99 111.41 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -28.32 58.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.981 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.426 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 84.9 mt -87.95 -24.29 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.479 . . . . 99.99 110.225 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.53 -54.57 31.83 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.728 -0.669 . . . . 99.99 113.043 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.585 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 68.1 m-85 -57.47 -55.67 42.1 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.85 0.325 . . . . 99.99 111.623 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.0 Cg_exo -45.86 -28.2 4.68 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.254 1.969 . . . . 99.99 112.929 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.407 HG13 ' O ' ' C' ' 177' ' ' ILE . 92.7 mt -70.97 -61.25 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.467 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 25.3 m -57.5 -26.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.221 0.452 . . . . 99.99 112.221 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -60.94 -20.02 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.696 -0.229 . . . . 99.99 111.547 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . 0.58 HG22 HG21 ' C' ' 185' ' ' ILE . 14.9 tt -60.64 -29.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 99.99 111.011 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . 0.58 HG21 HG22 ' C' ' 184' ' ' ILE . 31.4 pt -113.38 158.19 13.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.101 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.2 -162.04 30.66 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.858 -0.687 . . . . 99.99 112.629 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.32 156.8 58.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.729 2.286 . . . . 99.99 112.298 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 38.6 m 59.7 13.76 3.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.981 -0.554 . . . . 99.99 110.785 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -140.56 -86.01 0.11 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.884 -0.598 . . . . 99.99 112.089 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -166.04 66.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.01 0.433 . . . . 99.99 110.101 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -144.85 146.56 17.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 99.99 112.801 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -101.14 2.98 40.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.337 . . . . 99.99 110.646 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 41.1 pt -103.52 154.21 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.336 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -157.23 46.97 0.4 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.947 -0.569 . . . . 99.99 110.411 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -99.07 -168.07 1.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.025 -0.534 . . . . 99.99 110.968 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 7.3 t -65.7 -27.13 68.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.17 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 16.7 tt -57.82 -34.75 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 99.99 111.231 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.58 -56.06 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 99.99 110.703 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -69.43 -17.53 63.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.906 -0.588 . . . . 99.99 110.614 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -68.46 -30.81 69.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.947 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.7 -39.36 20.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.271 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -77.12 -8.11 56.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.281 . . . . 99.99 111.682 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.419 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 17.7 p -96.66 -39.08 9.67 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.148 0.499 . . . . 99.99 110.546 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.04 -33.89 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.623 -0.717 . . . . 99.99 111.745 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.623 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 42.1 tp -62.53 -53.32 58.36 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.067 -0.253 . . . . 99.99 111.577 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.8 Cg_exo -56.23 -39.34 91.91 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.842 1.695 . . . . 99.99 111.48 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -61.12 -34.32 74.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.959 -0.564 . . . . 99.99 110.721 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -66.56 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.009 -0.541 . . . . 99.99 110.951 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' SER . . . . . 0.472 ' HG ' HD22 ' C' ' 175' ' ' LEU . 28.0 t -92.34 -28.55 16.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.999 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.45 ' H9 ' H192 ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.46 -37.28 56.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 99.99 111.0 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.79 69.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.913 -0.661 . . . . 99.99 112.704 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -71.28 -34.85 71.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 99.99 110.788 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -60.65 -59.3 5.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.676 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.56 -23.4 65.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 99.99 110.67 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tt -72.28 -40.28 67.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.932 -0.576 . . . . 99.99 110.992 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.53 -30.16 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 99.99 111.192 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.11 -48.59 73.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 99.99 110.876 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -81.07 -22.53 39.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 99.99 110.853 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.46 61.55 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.772 -0.728 . . . . 99.99 112.945 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . 0.433 HD23 HG11 ' C' ' 32' ' ' VAL . 30.3 tp -75.16 -29.46 60.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.704 0.288 . . . . 99.99 111.033 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 59.77 -86.05 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.009 -0.541 . . . . 99.99 111.2 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -165.34 156.21 13.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.663 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . 0.465 ' N ' HD22 ' C' ' 224' ' ' LEU . 1.7 pt? -161.11 -178.02 6.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 99.99 110.767 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -158.52 114.75 2.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.967 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.69 143.59 51.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 99.99 110.84 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 46.6 t -148.55 103.1 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 99.99 110.904 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -93.32 -30.07 15.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.944 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.947 -179.73 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.834 0.35 . . . . 99.99 110.902 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.27 162.14 8.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.873 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.9 tp 59.52 91.43 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.889 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.43 -46.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 99.99 110.757 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.1 t -96.68 165.09 12.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.962 -0.563 . . . . 99.99 110.639 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.4 tp -139.97 -20.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.015 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.68 -34.73 77.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.406 -0.361 . . . . 99.99 111.13 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 37.4 m80 -72.25 -28.85 63.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.044 0.449 . . . . 99.99 110.379 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -72.44 -51.07 21.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 99.99 110.331 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.34 -21.74 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.096 0.474 . . . . 99.99 110.249 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.41 ' HH ' ' HB2' ' A' ' 206' ' ' PRO . 0.8 OUTLIER -61.09 -61.48 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 99.99 110.564 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.57 -30.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.01 -0.541 . . . . 99.99 111.371 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.0 -55.41 29.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 99.99 111.429 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.76 -28.45 68.2 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.884 -0.674 . . . . 99.99 112.763 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.16 -22.2 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 99.99 111.001 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -72.76 -52.13 16.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 99.99 110.844 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.4 -22.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 99.99 110.942 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.47 -47.84 54.81 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.854 -0.689 . . . . 99.99 112.652 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -33.88 76.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 99.99 111.042 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -68.43 -36.52 79.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.203 0.525 . . . . 99.99 110.532 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.9 t-80 -59.33 -20.99 59.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 99.99 110.485 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -62.49 -50.18 72.42 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.062 -0.517 . . . . 99.99 110.973 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -58.91 -45.17 90.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 99.99 110.495 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.3 m -69.9 -18.66 63.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 99.99 110.794 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 21' ' ' HIS . 12.7 tp -76.57 0.26 20.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 99.99 111.933 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 p -66.83 -51.44 55.55 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.277 -0.569 . . . . 99.99 111.19 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -54.17 -22.63 11.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.011 0.91 . . . . 99.99 108.548 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.811 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.41 -150.98 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 113.757 -1.565 . . . . 99.99 108.57 177.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.811 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 14.2 Cg_exo 6.91 96.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.713 2.942 . . . . 99.99 116.472 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -102.96 96.87 7.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.663 -1.153 . . . . 99.99 109.148 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.04 -36.92 2.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.502 -1.039 . . . . 99.99 110.502 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.1 t -111.77 126.2 28.96 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 109.315 -0.624 . . . . 99.99 109.315 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 16.9 Cg_exo -65.82 165.83 22.25 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.482 2.121 . . . . 99.99 113.858 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -76.08 -13.3 60.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.507 -1.224 . . . . 99.99 111.806 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 33' ' ' PRO . 1.7 p90 -38.69 -37.92 0.37 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.469 0.544 . . . . 99.99 112.469 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.09 -45.19 86.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 99.99 110.518 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -74.03 -18.57 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.005 -0.543 . . . . 99.99 110.613 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.413 HD13 ' HD1' ' B' ' 104' ' ' PHE . 55.7 tp -60.66 -56.86 16.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.161 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.32 -36.24 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 99.99 109.918 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.21 -6.13 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.724 -0.671 . . . . 99.99 110.89 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 23.8 ttt -88.74 -35.59 16.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.641 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -72.61 -33.32 66.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 99.99 111.101 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.588 HG23 HG22 ' A' ' 79' ' ' THR . 79.0 mt -53.63 -52.98 62.22 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.271 0.471 . . . . 99.99 112.271 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HD2' ' C ' ' A' ' 41' ' ' MET . 60.5 Cg_endo -72.15 -33.3 9.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.28 1.987 . . . . 99.99 113.236 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -57.89 -62.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.939 0.348 . . . . 99.99 111.939 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.502 ' HE1' HG22 ' B' ' 110' ' ' ILE . 3.0 t90 -61.63 -51.41 68.59 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.626 -0.261 . . . . 99.99 111.525 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' HD2' ' A' ' 75' ' ' ASP . 92.5 p -51.52 -54.13 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 99.99 111.195 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -44.58 -54.79 6.39 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.208 -0.52 . . . . 99.99 113.547 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.3 mt -52.12 -38.94 59.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.748 0.309 . . . . 99.99 111.337 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.56 83.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 99.99 111.059 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 96.8 m-85 -69.48 -44.19 71.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 99.99 110.913 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -49.61 -32.68 13.38 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.285 0.564 . . . . 99.99 110.126 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -72.13 -42.14 66.35 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 99.99 111.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.2 mtt -54.17 -26.45 28.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.363 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.05 -48.54 23.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.576 . . . . 99.99 110.673 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 53' ' ' ALA . 44.3 pt -79.94 6.65 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 99.99 111.023 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 59.59 55.1 4.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 99.99 111.194 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -125.33 124.59 41.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 99.99 110.735 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 120.34 29.88 1.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 99.99 112.398 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -150.34 144.74 25.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 99.99 111.145 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.48 145.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 99.99 111.165 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -88.74 94.44 9.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 99.99 110.893 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.08 133.48 55.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.019 -0.537 . . . . 99.99 111.052 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.79 23.72 12.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.14 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.97 -15.1 50.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.83 -0.7 . . . . 99.99 112.534 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -104.73 151.22 24.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.313 . . . . 99.99 110.854 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -98.17 138.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.118 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.39 118.21 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.495 . . . . 99.99 110.848 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 64.5 m-70 -78.96 79.25 5.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.295 0.569 . . . . 99.99 111.204 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.88 -41.28 86.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.547 -0.751 . . . . 99.99 110.932 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . . . -67.0 -24.05 65.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 99.99 111.595 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.9 tpp180 -67.15 -51.88 48.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.098 -0.501 . . . . 99.99 112.322 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 77' ' ' MET . 17.7 p90 -88.95 -27.98 20.57 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.511 0.56 . . . . 99.99 112.511 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 71' ' ' ALA . 11.0 tp -57.78 -41.26 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.473 -0.491 . . . . 99.99 110.069 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.489 ' HD2' ' HA ' ' A' ' 47' ' ' SER . 16.1 t70 -70.93 -17.14 62.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.143 -0.688 . . . . 99.99 109.143 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -90.42 6.06 44.9 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.237 -0.892 . . . . 99.99 110.956 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.496 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 32.1 mtp -104.85 -17.68 14.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.748 -0.66 . . . . 99.99 110.488 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.59 -34.81 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 99.99 111.8 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.588 HG22 HG23 ' A' ' 43' ' ' ILE . 84.8 m -76.0 -59.56 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 99.99 112.007 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.562 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 83.2 m -49.14 -51.06 59.69 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.503 0.557 . . . . 99.99 112.503 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.598 ' HA ' ' HG2' ' A' ' 109' ' ' GLN . 58.4 Cg_exo -51.67 -52.85 8.1 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.765 1.643 . . . . 99.99 111.844 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.45 -25.66 68.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 99.99 110.881 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.5 tp -72.91 -28.42 62.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.999 0.428 . . . . 99.99 110.033 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -84.47 -22.22 30.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 99.99 110.103 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 81' ' ' PRO . 95.4 mt -85.07 -31.28 23.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.769 -0.65 . . . . 99.99 110.646 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -61.64 -50.34 72.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.029 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 pp -61.99 -25.74 67.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.965 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.1 t -67.63 -43.78 79.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 99.99 110.842 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -62.16 -40.6 96.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.014 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -60.5 -33.9 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.029 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.52 -30.73 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.044 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.8 tpp -75.28 117.3 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.817 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.67 -54.69 4.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.066 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -137.12 144.82 43.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 99.99 111.228 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.9 tt -107.55 148.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.817 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -133.43 -75.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 99.99 111.2 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -138.35 -13.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 99.99 111.343 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.31 106.82 1.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.457 -0.338 . . . . 99.99 110.734 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -128.57 -21.52 3.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.332 -0.394 . . . . 99.99 111.036 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.6 p -65.38 -26.01 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 99.99 111.034 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.75 -36.54 79.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.951 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.03 -39.0 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.172 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.78 93.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.848 -0.692 . . . . 99.99 112.361 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.93 -41.25 95.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 99.99 111.153 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.05 -48.41 80.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.293 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -61.24 -27.34 68.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 99.99 111.289 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -72.45 -43.25 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.999 0.428 . . . . 99.99 111.245 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 142' ' ' ILE . 71.6 p -72.3 -22.8 61.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.548 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.598 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 25.0 tp60 -81.79 -45.47 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.4 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 7.9 tp -59.5 -34.97 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 99.99 111.473 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.9 m -71.16 -44.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 121.144 -0.223 . . . . 99.99 111.281 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.22 -55.59 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.795 0.331 . . . . 99.99 111.537 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.434 HG12 HE21 ' A' ' 109' ' ' GLN . 39.0 mm -56.75 -32.89 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.385 -0.37 . . . . 99.99 111.436 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -55.71 -45.13 77.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.875 0.369 . . . . 99.99 110.554 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -67.34 -27.03 66.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.56 . . . . 99.99 111.007 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.56 -41.04 30.73 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.876 -0.678 . . . . 99.99 113.502 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.429 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -73.96 -28.26 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.806 0.299 . . . . 99.99 111.806 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.429 ' N ' HD11 ' A' ' 117' ' ' LEU . 10.2 tp -82.49 -26.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 99.99 111.17 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.56 76.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 99.99 110.894 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.4 -27.41 32.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 99.99 111.041 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.18 34.3 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.257 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.6 m -85.61 131.19 34.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 99.99 110.853 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 12.1 pt-20 -80.4 -28.7 37.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.077 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.483 ' HB2' HG11 ' A' ' 127' ' ' VAL . 78.5 mtm180 -130.17 158.19 40.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 99.99 110.971 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.53 -11.9 59.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.048 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -90.06 -45.87 8.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.977 0.418 . . . . 99.99 110.405 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 124' ' ' ARG . 12.0 p -65.45 -27.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 99.99 110.757 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -65.28 -41.16 94.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.007 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.412 ' O ' HG12 ' A' ' 133' ' ' ILE . 72.2 t80 -56.88 -45.67 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.873 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.71 -45.22 92.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 99.99 111.376 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.18 70.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 99.99 111.049 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -67.55 -43.33 80.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.411 . . . . 99.99 111.146 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 129' ' ' TYR . 38.3 mm -59.05 -39.18 77.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 99.99 110.888 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.442 ' SG ' HD23 ' C' ' 49' ' ' LEU . 46.2 t -67.48 -28.45 67.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.901 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.65 -55.88 24.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.871 -0.68 . . . . 99.99 112.55 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.63 -37.25 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.563 0.22 . . . . 99.99 111.298 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.69 -44.2 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.454 -0.339 . . . . 99.99 111.023 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.88 -35.67 75.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.897 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -69.82 -23.13 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 99.99 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.26 -59.93 2.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 99.99 111.469 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -61.24 -27.02 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.504 -0.317 . . . . 99.99 111.69 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.401 HG22 ' HB ' ' A' ' 108' ' ' THR . 72.5 mt -77.99 -50.35 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.483 -0.326 . . . . 99.99 111.49 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.1 tp -49.44 -54.21 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 99.99 111.188 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -64.63 -34.34 78.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.984 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.59 68.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.86 -0.686 . . . . 99.99 112.77 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.0 mt -103.73 -19.85 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 99.99 111.173 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -59.73 -39.91 86.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.411 . . . . 99.99 111.995 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.498 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 69.1 m-80 -73.83 -53.81 3.99 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.483 0.549 . . . . 99.99 112.483 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 18.9 Cg_endo -57.75 -13.57 14.87 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.169 1.913 . . . . 99.99 113.055 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.7 mt -84.35 48.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 99.99 110.917 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 55.47 70.09 0.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 99.99 110.976 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.77 -34.42 30.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.022 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.479 ' HG2' HE21 ' A' ' 157' ' ' GLN . 24.2 ttmm -72.86 -16.01 61.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.548 . . . . 99.99 110.892 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 m -79.0 -23.64 44.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.272 -0.422 . . . . 99.99 111.138 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -56.04 -32.41 64.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.393 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 7.8 t -91.13 -25.06 19.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.35 . . . . 99.99 111.199 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.479 HE21 ' HG2' ' A' ' 153' ' ' LYS . 79.7 mt-30 -70.67 -78.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 99.99 111.043 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.1 t -100.6 122.99 44.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.864 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 77.9 p -78.03 -35.53 49.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.086 -0.506 . . . . 99.99 111.253 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.42 -41.02 89.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.11 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.88 -20.35 62.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 99.99 110.655 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.75 -34.75 52.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 99.99 110.97 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -67.55 -39.41 84.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 99.99 110.41 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.413 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 60.8 mt -64.2 -57.61 8.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 99.99 110.544 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.45 ' HA ' HD13 ' A' ' 168' ' ' LEU . 0.5 OUTLIER -55.41 -39.86 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.662 -0.699 . . . . 99.99 111.08 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -51.69 -56.35 14.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 99.99 111.289 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -58.05 -28.28 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 99.99 111.484 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 165' ' ' TYR . 75.5 mt -72.95 -65.56 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.335 -0.393 . . . . 99.99 111.46 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.15 -36.5 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.505 . . . . 99.99 111.856 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.2 m -56.74 -52.55 64.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.311 . . . . 99.99 111.521 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.406 ' O ' HD22 ' A' ' 175' ' ' LEU . 75.5 t80 -58.41 -29.54 66.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.364 -0.38 . . . . 99.99 110.961 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -71.01 -32.11 68.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 99.99 111.354 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.3 p -79.59 -37.86 35.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 99.99 111.767 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.24 -43.75 94.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.764 0.283 . . . . 99.99 111.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.406 HD22 ' O ' ' A' ' 171' ' ' TYR . 4.3 mm? -75.18 -50.69 15.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.651 -0.249 . . . . 99.99 111.634 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.49 -31.65 62.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 99.99 110.593 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.483 ' O ' HG12 ' A' ' 181' ' ' ILE . 94.8 mt -87.66 -22.09 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.523 . . . . 99.99 110.298 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -55.74 27.98 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 115.885 -0.598 . . . . 99.99 113.097 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.56 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 86.5 m-85 -53.68 -54.98 40.18 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.835 0.317 . . . . 99.99 111.067 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.8 Cg_exo -45.95 -30.18 6.81 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.003 1.802 . . . . 99.99 112.671 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -66.36 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 99.99 111.164 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 179' ' ' TYR . 28.5 m -58.33 -26.63 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.501 . . . . 99.99 111.572 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -66.22 -45.08 81.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.534 -0.303 . . . . 99.99 111.227 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.2 mt -62.04 -62.57 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 99.99 111.298 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.6 pp -57.46 143.45 11.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 99.99 111.494 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 64.36 171.96 2.63 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.936 -0.65 . . . . 99.99 112.918 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.431 ' HD3' ' H ' ' A' ' 192' ' ' TRP . 85.0 Cg_endo -85.53 82.63 1.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.813 2.342 . . . . 99.99 112.231 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.4 m 58.09 37.57 26.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.917 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.73 -106.1 0.21 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.896 -0.668 . . . . 99.99 112.424 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -132.92 -30.31 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.863 0.363 . . . . 99.99 110.858 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.465 ' H ' HG12 ' A' ' 193' ' ' ILE . . . 153.15 114.74 0.57 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 99.99 112.627 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.431 ' H ' ' HD3' ' A' ' 187' ' ' PRO . 15.3 m-90 55.95 36.8 27.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.34 . . . . 99.99 111.12 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.465 HG12 ' H ' ' A' ' 191' ' ' GLY . 36.1 pt -136.06 149.16 27.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 99.99 111.367 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.454 ' HA ' ' HD2' ' A' ' 198' ' ' ASP . 3.0 p-10 -155.85 8.98 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 99.99 110.702 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -86.66 -157.26 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.13 -0.486 . . . . 99.99 110.786 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.6 t -66.11 -16.17 63.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.393 -0.367 . . . . 99.99 111.143 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.17 -32.94 29.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 99.99 111.382 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.454 ' HD2' ' HA ' ' A' ' 194' ' ' ASN . 3.9 m-20 -52.55 -54.45 32.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.374 . . . . 99.99 111.24 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -62.55 -32.49 73.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 99.99 111.706 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -54.77 -38.31 67.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 99.99 111.126 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 49.0 tp -76.67 -46.53 25.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.092 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -71.79 1.49 6.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 99.99 111.42 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.5 -46.3 6.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 99.99 110.507 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.78 -36.94 73.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 99.99 111.998 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -57.21 -54.76 51.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 121.138 -0.225 . . . . 99.99 111.293 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -55.48 -44.71 45.82 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.682 1.588 . . . . 99.99 111.596 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.29 -25.4 67.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.464 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.61 -30.85 59.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 99.99 110.751 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 87.8 p -94.23 -13.33 26.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 99.99 110.998 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.437 ' H9 ' ' C18' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 28.8 m -67.75 -34.45 67.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.284 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.33 -28.38 72.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 99.99 112.423 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.22 -31.17 58.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.732 0.301 . . . . 99.99 110.889 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.6 m -63.55 -62.02 1.94 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.889 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.37 -27.86 66.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.851 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.39 -48.9 71.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.74 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.93 -27.77 69.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 99.99 110.912 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.52 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 99.99 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -70.76 -49.09 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.054 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.84 55.08 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.849 -0.691 . . . . 99.99 112.58 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.04 -56.23 23.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 99.99 110.89 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 59.57 97.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.7 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -56.25 113.11 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.101 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 96.8 mt -140.64 150.95 44.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.922 -0.581 . . . . 99.99 111.056 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -114.11 104.87 12.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 99.99 111.045 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -139.51 -9.74 1.24 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.011 -0.54 . . . . 99.99 110.842 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 41.4 t -89.19 132.53 34.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.07 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -130.61 38.85 3.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.108 -0.497 . . . . 99.99 111.029 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 99.99 110.975 -179.86 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.866 0.365 . . . . 99.99 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -95.28 -56.78 2.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 99.99 110.912 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 26.9 tp -110.02 127.22 54.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.972 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -133.42 -44.8 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 65.4 p -85.96 160.15 19.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.046 -0.525 . . . . 99.99 110.917 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp -137.16 -28.57 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 99.99 111.148 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -34.73 71.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 99.99 111.148 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.475 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 35.6 m170 -65.32 -33.25 75.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 99.99 110.757 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -73.95 -46.87 41.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.16 -0.473 . . . . 99.99 110.617 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.07 -22.29 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.117 0.484 . . . . 99.99 110.262 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.28 -59.13 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.706 -0.679 . . . . 99.99 110.538 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.21 -29.46 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 99.99 111.328 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -50.42 67.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.34 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.03 -32.8 85.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.564 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.4 mmt -71.54 -26.02 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 99.99 110.956 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.5 m -69.7 -59.2 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 99.99 110.853 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -56.32 -26.13 21.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.096 -0.502 . . . . 99.99 111.307 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.94 72.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.608 -0.806 . . . . 99.99 112.26 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.461 ' HB1' ' HE2' ' B' ' 41' ' ' MET . . . -60.09 -33.84 72.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 99.99 111.047 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.77 -33.5 72.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.335 -0.393 . . . . 99.99 110.545 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -61.14 -20.27 62.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 99.99 110.539 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.34 -53.35 58.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 99.99 110.968 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.64 ' O ' ' OG ' ' B' ' 26' ' ' SER . 80.8 m95 -62.62 -42.71 99.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.953 -0.567 . . . . 99.99 110.955 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.253 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -80.73 -5.66 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 99.99 110.881 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.64 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 15.7 p -72.09 -15.23 62.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.775 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -45.95 -40.71 10.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.432 -0.581 . . . . 99.99 109.432 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -179.08 130.51 0.27 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.141 -0.936 . . . . 99.99 110.219 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -96.28 179.36 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.991 2.461 . . . . 99.99 112.182 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -99.85 52.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 99.99 111.188 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.1 -46.63 2.02 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.839 -0.696 . . . . 99.99 112.552 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 32.7 m -91.87 144.82 29.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.523 0.201 . . . . 99.99 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 165.36 17.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.514 2.143 . . . . 99.99 112.581 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -62.64 -17.43 60.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 99.99 111.837 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -42.3 -35.07 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.726 0.298 . . . . 99.99 111.662 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -64.54 -48.31 75.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.932 0.396 . . . . 99.99 110.225 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.28 -18.56 61.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 99.99 110.703 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' B' ' 41' ' ' MET . 47.7 tp -60.7 -53.44 57.36 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.981 0.42 . . . . 99.99 110.325 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.23 -38.74 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 99.99 109.893 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.14 -5.62 36.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.629 -0.714 . . . . 99.99 110.734 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.461 ' HE2' ' HB1' ' B' ' 19' ' ' ALA . 25.3 ttt -88.65 -36.08 16.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.906 -0.588 . . . . 99.99 110.402 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -70.74 -34.2 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.921 -0.582 . . . . 99.99 111.078 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.584 HG23 HG23 ' B' ' 79' ' ' THR . 98.7 mt -53.54 -54.76 42.19 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.459 0.54 . . . . 99.99 112.459 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 59.9 Cg_endo -70.43 -37.31 7.71 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.405 2.07 . . . . 99.99 113.566 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.15 -62.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.748 0.277 . . . . 99.99 111.748 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.584 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -62.08 -52.75 62.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 99.99 111.355 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.441 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 38.4 t -54.04 -31.82 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 99.99 111.566 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.11 -49.75 64.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 99.99 112.757 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.428 HD23 ' SG ' ' C' ' 134' ' ' CYS . 75.7 mt -54.77 -44.56 73.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 99.99 111.503 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.15 -50.26 67.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 99.99 111.565 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -63.23 -40.04 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 99.99 111.303 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.3 ttp -52.39 -34.09 46.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.182 0.515 . . . . 99.99 110.196 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' B' ' 58' ' ' GLN . . . -69.78 -40.67 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.598 -0.728 . . . . 99.99 110.944 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 56.2 mtt -54.33 -28.64 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.489 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -72.83 -52.06 16.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.946 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.1 pt -78.65 9.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.913 -0.585 . . . . 99.99 111.539 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 60.03 63.8 1.38 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.063 -0.517 . . . . 99.99 111.036 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' B' ' 53' ' ' ALA . 26.3 tp60 -136.23 128.78 30.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.639 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.43 ' N ' HE21 ' B' ' 58' ' ' GLN . . . 109.87 38.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 99.99 112.194 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -150.43 140.81 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 99.99 110.81 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.75 141.15 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 99.99 111.068 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.43 94.8 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.922 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.17 125.04 51.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.144 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.05 35.92 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 99.99 111.301 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.28 4.7 51.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.74 -0.743 . . . . 99.99 112.547 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -108.46 140.88 41.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.64 0.257 . . . . 99.99 110.853 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 55.2 mt -99.27 119.42 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 99.99 110.892 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.48 113.86 27.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 99.99 111.136 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.582 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 93.1 m-70 -73.91 83.34 1.7 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.4 0.619 . . . . 99.99 110.792 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -52.25 -56.71 12.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 99.99 111.567 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -21.93 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.606 0.595 . . . . 99.99 112.606 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.582 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 20.3 tpp180 -64.66 -52.54 56.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.275 0.472 . . . . 99.99 112.275 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' B' ' 76' ' ' TRP . 36.7 p90 -87.34 -29.71 21.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.482 -0.487 . . . . 99.99 111.418 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.65 -45.96 79.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.692 -0.484 . . . . 99.99 109.692 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 16.3 t70 -67.72 -23.47 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 99.99 109.139 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 28.9 m0 -86.08 8.18 21.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.457 -0.792 . . . . 99.99 111.07 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 -22.51 13.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.758 -0.655 . . . . 99.99 110.571 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.88 -30.34 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 99.99 111.927 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.584 HG23 HG23 ' B' ' 43' ' ' ILE . 76.1 m -81.29 -52.13 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.008 0.373 . . . . 99.99 112.008 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.573 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 11.9 m -51.8 -49.79 81.48 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.205 0.446 . . . . 99.99 112.205 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' B' ' 80' ' ' THR . 10.4 Cg_endo -54.67 -50.94 11.65 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.803 1.669 . . . . 99.99 111.782 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.16 -26.13 68.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.637 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.516 ' HG ' ' H41' ' B' ' 210' ' ' LYR . 0.2 OUTLIER -68.41 -36.87 79.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.18 0.514 . . . . 99.99 109.772 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.4 tt -80.36 -25.44 39.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.539 -0.755 . . . . 99.99 110.789 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 98.6 mt -77.78 -36.83 50.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 99.99 111.201 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 59.5 m -56.96 -39.68 75.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 99.99 110.949 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 98.2 mt -68.58 -35.59 77.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.072 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 61.1 m -61.09 -35.31 76.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.326 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -72.24 -36.22 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 99.99 110.986 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 29.7 m -66.55 -37.58 85.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 99.99 110.81 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -28.59 39.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.925 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.1 ttm -77.96 117.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.718 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -86.78 -61.48 1.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 99.99 111.223 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.22 160.52 30.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 99.99 111.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 70.0 mt -124.9 142.32 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 99.99 110.824 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -139.38 -51.08 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 99.99 110.83 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -161.93 -161.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 99.99 110.511 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 60.76 87.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.448 . . . . 99.99 110.795 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -101.13 0.08 37.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.873 -0.603 . . . . 99.99 110.852 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.1 p -71.67 -25.91 62.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 99.99 111.293 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.95 -39.71 90.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 99.99 110.786 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.61 -38.13 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 99.99 111.034 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.4 -29.25 71.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 99.99 112.215 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.416 ' HE2' HG12 ' B' ' 146' ' ' ILE . 66.2 t80 -65.74 -37.58 86.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.95 0.405 . . . . 99.99 110.588 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.425 ' HB3' HD21 ' B' ' 84' ' ' LEU . 55.4 mt -68.63 -41.37 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.793 -0.64 . . . . 99.99 111.11 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 57.9 mtt -64.45 -45.92 85.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.135 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 55.6 m -55.58 -42.07 74.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.478 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 75.9 p -69.27 -24.94 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 99.99 111.416 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -80.49 -44.59 18.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.559 -0.291 . . . . 99.99 111.566 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.502 HG22 ' HE1' ' A' ' 46' ' ' TRP . 48.5 mm -57.53 -38.72 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 99.99 111.391 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.64 -43.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 99.99 111.854 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 70.2 t -61.03 -55.29 25.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.645 0.26 . . . . 99.99 111.62 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 29.7 mm -61.0 -29.26 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 99.99 111.23 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.1 m -55.29 -49.34 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.972 0.415 . . . . 99.99 110.528 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 75.3 p -70.92 -20.44 62.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 99.99 110.482 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.28 -33.7 43.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.006 -0.616 . . . . 99.99 112.975 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.436 HD11 HG13 ' B' ' 118' ' ' ILE . 2.8 pp -82.89 -24.68 33.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 0.235 . . . . 99.99 111.162 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.436 HG13 HD11 ' B' ' 117' ' ' LEU . 85.7 mt -80.21 -36.24 16.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 120.803 0.335 . . . . 99.99 110.838 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.86 -38.24 48.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.539 . . . . 99.99 111.154 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -82.6 -26.74 32.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.006 -0.543 . . . . 99.99 111.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -86.35 22.27 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.341 . . . . 99.99 111.185 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -67.27 139.62 57.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 99.99 110.843 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -94.03 -17.69 22.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.044 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.596 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 48.7 ttp180 -137.88 156.46 47.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.499 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.53 -14.97 60.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.935 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.596 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 54.4 t90 -92.96 -37.98 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 99.99 111.19 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' B' ' 124' ' ' ARG . 18.4 m -65.34 -24.32 34.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.326 -0.397 . . . . 99.99 111.215 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.8 ttt-85 -63.47 -47.59 81.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 99.99 111.385 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.97 -32.82 68.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 99.99 111.557 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.17 -46.56 76.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 99.99 110.873 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -74.33 -25.57 59.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.732 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.2 -51.82 61.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.816 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.58 -33.27 60.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.31 -0.405 . . . . 99.99 110.804 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.78 -28.22 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 99.99 110.588 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.39 -53.68 16.31 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.925 -0.655 . . . . 99.99 112.487 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.79 -35.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.593 0.235 . . . . 99.99 111.312 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 90.8 m -61.22 -35.88 78.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.75 0.31 . . . . 99.99 110.725 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.52 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.637 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.54 -23.5 63.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 99.99 110.892 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.47 -55.62 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.418 . . . . 99.99 111.187 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 43.1 pt -66.59 -28.85 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.534 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.63 -51.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 99.99 111.075 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 54.2 tp -52.75 -49.62 65.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.336 -0.393 . . . . 99.99 110.672 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.06 -24.61 65.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.518 . . . . 99.99 110.602 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.82 -17.66 74.56 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 99.99 112.776 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.472 ' C ' ' HD2' ' B' ' 149' ' ' PRO . 56.7 mt -103.39 -19.52 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.781 0.324 . . . . 99.99 111.127 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -54.86 -50.04 69.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.449 . . . . 99.99 111.922 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.672 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 51.5 t30 -68.93 -53.07 15.32 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 111.91 0.337 . . . . 99.99 111.91 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 53.0 Cg_exo -52.05 -20.67 10.94 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.158 1.906 . . . . 99.99 112.811 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 68.6 mt -81.67 43.38 0.75 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.834 0.349 . . . . 99.99 110.957 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.415 ' NH2' ' HZ3' ' B' ' 153' ' ' LYS . 19.3 mmm180 55.04 74.64 0.35 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.647 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' B' ' 148' ' ' ASN . . . -82.63 -29.48 30.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 99.99 111.291 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . 0.415 ' HZ3' ' NH2' ' B' ' 151' ' ' ARG . 21.9 pttp -73.16 -20.0 61.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.886 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 64.1 p -80.48 -5.45 56.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 99.99 110.819 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -66.19 -36.33 82.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 99.99 110.693 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 68.9 p -98.88 -19.02 17.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 99.99 111.379 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -65.89 -68.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 99.99 110.937 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 48.0 t -117.93 114.79 23.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 99.99 110.944 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 46.6 t -67.75 -29.05 68.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.253 -0.431 . . . . 99.99 110.966 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -59.79 -60.53 3.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.11 0.481 . . . . 99.99 110.751 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.55 -30.79 70.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.856 -0.611 . . . . 99.99 111.073 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.87 97.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.956 0.408 . . . . 99.99 111.141 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -65.21 -36.36 83.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.048 -0.523 . . . . 99.99 111.039 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 74.0 mt -67.71 -56.9 7.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.419 . . . . 99.99 110.946 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.33 -29.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 99.99 111.013 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.63 -59.04 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 99.99 111.223 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -58.41 -21.57 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 99.99 111.767 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.7 -63.58 1.38 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 99.99 111.399 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.23 -31.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 99.99 111.634 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -59.88 -52.2 66.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 99.99 111.152 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.96 -33.58 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 99.99 110.766 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -72.17 -25.91 61.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.763 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 27.2 m -79.35 -40.26 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 99.99 111.819 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.6 -35.02 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.492 -0.322 . . . . 99.99 111.484 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.69 -57.05 4.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.316 -0.402 . . . . 99.99 111.624 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -31.06 56.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 99.99 111.028 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.459 ' O ' HG12 ' B' ' 181' ' ' ILE . 92.4 mt -87.67 -21.43 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 99.99 110.521 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -55.9 27.93 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 99.99 113.074 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.585 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 90.5 m-85 -54.23 -53.94 53.32 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.73 0.265 . . . . 99.99 111.273 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.7 Cg_exo -45.08 -34.57 9.42 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.2 1.934 . . . . 99.99 112.966 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.459 HG12 ' O ' ' B' ' 177' ' ' ILE . 48.8 mm -65.79 -60.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.856 0.36 . . . . 99.99 111.503 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 18.9 m -56.84 -24.37 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.417 -0.356 . . . . 99.99 111.154 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -69.23 -53.66 18.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.857 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.422 HG22 ' N ' ' B' ' 185' ' ' ILE . 10.5 tt -62.06 -51.65 69.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 111.852 0.315 . . . . 99.99 111.852 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . 0.422 ' N ' HG22 ' B' ' 184' ' ' ILE . 2.3 pp -60.66 131.02 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 99.99 110.647 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 68.28 165.83 3.57 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.638 -0.791 . . . . 99.99 112.365 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.11 85.52 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.446 2.097 . . . . 99.99 112.315 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 13.6 m 55.85 42.95 28.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 99.99 110.921 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -166.52 -124.7 0.73 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.663 -0.78 . . . . 99.99 112.574 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -113.38 -26.1 8.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 99.99 111.011 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 147.53 116.4 0.92 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.804 -0.712 . . . . 99.99 112.532 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 57.47 32.89 22.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.733 0.302 . . . . 99.99 111.159 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 47.1 pt -138.44 143.99 31.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.316 -0.402 . . . . 99.99 111.454 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -147.85 6.79 0.81 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.61 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -82.55 -162.54 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 99.99 110.827 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 73.9 p -60.22 -21.3 61.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 99.99 111.329 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 48.7 mm -48.15 -35.58 5.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.841 0.353 . . . . 99.99 111.111 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -51.4 -55.68 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 99.99 111.04 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -56.87 -38.09 72.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.658 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -57.0 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 99.99 111.342 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 57.1 tp -83.36 -41.75 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.339 . . . . 99.99 111.133 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -77.88 -0.97 29.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 99.99 111.162 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 37.0 t -96.14 -43.59 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.127 0.489 . . . . 99.99 110.263 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 42.9 tp -72.97 -36.82 67.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.665 -0.698 . . . . 99.99 111.98 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 34.2 tp -58.08 -54.51 54.9 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.029 -0.268 . . . . 99.99 111.596 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 34.3 Cg_exo -58.8 -39.44 81.74 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.757 1.638 . . . . 99.99 111.471 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.98 -28.23 69.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.226 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -75.43 -25.53 57.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.047 -0.524 . . . . 99.99 110.546 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 92.3 p -92.43 -19.25 22.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 99.99 110.55 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.516 ' H41' ' HG ' ' B' ' 83' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.76 -30.13 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.987 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.05 60.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.837 -0.697 . . . . 99.99 112.121 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -58.97 -39.06 80.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 99.99 111.211 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 42.2 t -56.49 -61.07 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.203 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.28 -20.03 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.955 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -72.1 -45.23 61.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 99.99 110.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.37 -27.02 67.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 99.99 110.82 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.66 -46.19 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 99.99 111.201 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -74.38 -43.41 56.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 99.99 111.29 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.64 -18.73 72.33 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.781 -0.723 . . . . 99.99 112.86 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.61 -55.4 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.546 0.212 . . . . 99.99 111.079 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 59.52 96.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.743 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.89 124.53 17.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.02 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 93.9 mt -141.68 179.55 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.939 -0.573 . . . . 99.99 110.743 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -145.76 94.98 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.504 . . . . 99.99 111.066 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.28 18.14 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.87 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 49.4 m -119.59 90.6 3.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.824 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -97.72 68.67 2.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.301 -0.409 . . . . 99.99 110.987 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 99.99 111.013 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.715 0.293 . . . . 99.99 110.817 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -127.25 -71.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 99.99 111.197 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . 0.596 ' H ' HD22 ' C' ' 3' ' ' LEU . 2.5 pt? -107.97 136.64 47.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.044 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -135.87 -42.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.949 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 41.0 t -96.46 138.42 34.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 99.99 110.888 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.435 HD12 ' N ' ' C' ' 6' ' ' LEU . 5.4 mp -111.32 -17.3 13.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 99.99 110.452 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' C' ' 11' ' ' TYR . 3.7 mm? -60.83 -31.58 71.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 99.99 110.921 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 32.3 m170 -69.54 -32.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 99.99 110.746 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -75.44 -54.64 6.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.954 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 36.6 mm -57.04 -22.21 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.472 . . . . 99.99 110.32 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' C' ' 7' ' ' LEU . 4.3 t80 -67.64 -59.34 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.649 -0.705 . . . . 99.99 110.773 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.15 -29.22 46.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 99.99 111.351 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.91 -47.81 70.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.369 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.13 79.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 99.99 112.81 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 24.9 mmt -72.18 -25.04 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.363 . . . . 99.99 111.079 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 85.7 m -69.68 -53.33 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.055 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.73 -24.06 34.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.12 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -54.11 30.66 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.87 -0.681 . . . . 99.99 112.513 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' C' ' 41' ' ' MET . . . -59.35 -32.9 70.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 99.99 110.974 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -64.8 -33.68 76.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.649 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -63.84 -19.86 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 99.99 110.998 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.24 -58.24 9.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 99.99 111.127 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.78 -33.78 76.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.039 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -71.89 -22.34 61.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 99.99 111.169 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 tp -84.63 -6.0 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 99.99 111.106 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 98.5 p -67.62 -12.89 61.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 99.99 110.82 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -47.94 -42.83 28.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.189 -0.671 . . . . 99.99 109.189 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.6 p-10 -177.16 130.66 0.34 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.193 -0.912 . . . . 99.99 110.201 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 85.0 Cg_endo -99.09 170.26 0.52 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.242 2.628 . . . . 99.99 112.056 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -89.22 56.03 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.371 . . . . 99.99 110.955 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.28 -44.11 3.31 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.9 -0.667 . . . . 99.99 112.648 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 p -85.23 132.27 45.77 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.456 0.169 . . . . 99.99 111.081 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 35.4 Cg_exo -59.17 158.79 24.58 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.324 2.016 . . . . 99.99 111.996 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -58.92 -17.2 22.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.63 -0.714 . . . . 99.99 112.429 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.474 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -45.1 -33.53 2.21 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.735 0.302 . . . . 99.99 111.367 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.74 -49.1 72.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.953 0.406 . . . . 99.99 110.128 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -70.48 -18.76 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 99.99 110.476 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' C' ' 41' ' ' MET . 39.1 tp -60.48 -56.78 17.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.496 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.26 -36.46 74.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.014 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.74 -4.34 36.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.934 -0.576 . . . . 99.99 110.747 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.461 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 23.9 ttt -88.52 -37.31 15.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.917 -0.583 . . . . 99.99 110.485 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.92 -34.57 69.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 99.99 111.252 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.55 HG22 HG23 ' C' ' 79' ' ' THR . 83.0 mt -51.08 -53.58 46.95 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.161 0.43 . . . . 99.99 112.161 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.76 -34.4 8.98 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.314 2.01 . . . . 99.99 113.231 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -55.19 -62.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 99.99 111.683 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -63.38 -53.03 58.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.551 -0.295 . . . . 99.99 111.245 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.462 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 39.9 t -53.7 -31.74 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.782 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.61 -49.37 60.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 99.99 112.652 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . 0.442 HD23 ' SG ' ' A' ' 134' ' ' CYS . 50.1 mt -58.25 -35.67 72.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 99.99 111.441 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.87 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.602 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 22.5 m-85 -61.34 -38.7 87.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 99.99 111.512 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 45.7 ttp -50.33 -38.23 40.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.26 0.552 . . . . 99.99 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' C' ' 58' ' ' GLN . . . -67.41 -42.64 82.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.503 -0.771 . . . . 99.99 110.777 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.8 mtt -51.42 -28.87 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 99.99 110.626 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -72.92 -51.56 18.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 99.99 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.45 ' HB ' HG22 ' A' ' 127' ' ' VAL . 29.1 pt -76.91 9.37 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 99.99 111.492 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 59.12 51.43 7.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.058 -0.519 . . . . 99.99 111.373 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' C' ' 53' ' ' ALA . 6.7 tp-100 -120.73 139.62 52.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 99.99 110.877 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.88 32.52 5.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 99.99 112.205 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -139.4 136.19 34.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 99.99 111.03 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.28 136.47 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.428 -0.351 . . . . 99.99 111.15 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.27 91.32 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 99.99 110.63 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.85 128.7 55.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 99.99 111.033 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.93 33.66 19.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.093 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 16.05 61.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.769 -0.729 . . . . 99.99 112.499 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.53 125.17 41.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.742 0.306 . . . . 99.99 110.737 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 25.8 pt -75.57 133.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.398 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.01 113.01 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 99.99 110.923 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.504 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 91.6 m-70 -75.64 79.07 2.62 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.286 0.565 . . . . 99.99 111.211 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -57.73 -34.94 70.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.404 -0.816 . . . . 99.99 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' C' ' 74' ' ' ILE . . . -76.35 -22.68 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.871 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.8 tpp180 -67.62 -51.47 49.76 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.435 0.532 . . . . 99.99 112.435 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.502 ' O ' ' HG2' ' C' ' 77' ' ' MET . 28.8 p90 -87.1 -30.95 20.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.435 0.532 . . . . 99.99 112.435 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . 0.454 HG23 ' HA ' ' C' ' 71' ' ' ALA . 10.9 tp -56.46 -41.16 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.564 -0.455 . . . . 99.99 110.108 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.462 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 19.6 t0 -69.8 -20.61 63.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.994 -0.743 . . . . 99.99 108.994 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -89.75 9.9 25.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.249 -0.887 . . . . 99.99 110.888 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 92.0 mmm -105.05 -21.86 13.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 99.99 110.152 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.57 -29.1 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 99.99 112.163 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.55 HG23 HG22 ' C' ' 43' ' ' ILE . 61.9 m -83.42 -49.49 9.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.212 0.449 . . . . 99.99 112.212 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.2 m -55.05 -50.73 84.79 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 111.898 0.333 . . . . 99.99 111.898 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.4 Cg_exo -54.69 -47.92 24.1 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.917 1.745 . . . . 99.99 111.665 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.27 -27.71 68.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.921 -0.581 . . . . 99.99 110.573 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.42 HD13 ' O ' ' C' ' 83' ' ' LEU . 1.2 tm? -67.55 -38.04 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.257 0.551 . . . . 99.99 109.632 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -78.56 -25.63 45.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 99.99 110.871 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.04 -33.0 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 99.99 111.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 60.1 m -62.91 -54.06 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 99.99 110.978 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 pp -61.8 -22.15 65.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 99.99 111.08 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -50.51 52.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 99.99 110.648 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -60.67 -28.23 68.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.406 . . . . 99.99 110.68 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -60.88 -52.43 65.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.801 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.25 60.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.056 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 12.9 tpt -86.86 112.89 22.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 99.99 110.488 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -86.55 -61.55 1.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 99.99 111.442 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -130.97 144.3 51.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 99.99 111.301 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 tt -109.32 146.13 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 99.99 110.739 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -124.54 -83.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.571 -0.286 . . . . 99.99 111.247 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -139.2 3.38 2.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 99.99 111.332 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.41 91.89 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 99.99 110.698 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -107.6 -13.59 15.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 99.99 111.29 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 7.3 t -69.35 -27.71 65.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 99.99 111.245 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.16 -35.5 75.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 99.99 110.957 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.1 -38.9 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.906 -0.588 . . . . 99.99 111.294 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -35.5 92.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 99.99 112.571 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -65.17 -35.82 82.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 99.99 110.847 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.25 -45.66 83.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.974 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' MET . . . . . 0.414 ' O ' HG13 ' C' ' 110' ' ' ILE . 91.0 mmm -62.44 -43.31 99.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 99.99 110.715 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -53.71 -51.2 64.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.479 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 75.7 p -59.64 -30.34 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 99.99 111.761 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -74.55 -50.45 18.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 99.99 111.654 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.584 HG22 ' HE1' ' B' ' 46' ' ' TRP . 58.9 mt -52.34 -34.92 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.399 -0.364 . . . . 99.99 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.22 -48.94 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 99.99 111.494 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.34 -56.55 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.392 -0.367 . . . . 99.99 111.874 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 25.4 pt -54.51 -32.37 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 99.99 111.804 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 20.3 m -60.66 -46.76 89.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 99.99 110.899 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -67.32 -20.58 65.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.939 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.72 -40.87 11.61 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.986 -0.626 . . . . 99.99 113.058 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.485 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.8 pp -73.68 -29.65 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.289 . . . . 99.99 111.424 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.485 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.1 tp -81.22 -28.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.806 0.336 . . . . 99.99 110.988 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.46 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.537 . . . . 99.99 110.994 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.57 -24.74 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 99.99 111.116 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 93.5 mt -88.02 33.83 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 99.99 110.715 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 83.4 p -77.95 132.73 38.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 99.99 111.007 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.99 -25.61 29.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 99.99 110.577 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -134.72 152.57 51.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.897 -0.592 . . . . 99.99 110.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.91 -11.09 60.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 99.99 111.315 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -92.81 -40.64 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.463 -0.335 . . . . 99.99 111.071 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.42 -23.9 25.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 99.99 110.822 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -66.74 -35.79 80.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.948 -0.569 . . . . 99.99 111.0 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -65.0 -32.15 73.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.203 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.63 -54.38 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 99.99 111.2 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -58.6 -28.68 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 99.99 111.286 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.72 -44.99 80.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 99.99 110.861 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 81.7 mt -56.92 -37.27 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 99.99 110.744 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . 0.428 ' SG ' HD23 ' B' ' 49' ' ' LEU . 53.8 t -70.36 -27.06 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 99.99 110.766 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.3 -56.7 20.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 99.99 112.385 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.9 -32.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 99.99 110.985 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 50.1 t -63.39 -35.71 81.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.301 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.75 92.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.775 -0.648 . . . . 99.99 110.838 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -69.81 -16.12 63.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 99.99 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.21 -58.59 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 99.99 110.592 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 17.2 pt -71.15 -27.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 99.99 111.596 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.98 -44.31 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.333 -0.394 . . . . 99.99 111.221 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.9 tp -55.54 -57.94 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.334 . . . . 99.99 111.078 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -62.77 -24.98 67.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 99.99 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.23 -16.84 79.61 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 99.99 112.64 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . 0.417 ' C ' ' HD2' ' C' ' 149' ' ' PRO . 69.1 mt -105.52 -18.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 99.99 111.183 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -62.3 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.932 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.685 ' HB2' ' HD3' ' C' ' 149' ' ' PRO . 69.1 m-80 -71.98 -52.7 7.41 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.344 0.498 . . . . 99.99 112.344 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.685 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 23.9 Cg_exo -64.99 -0.43 3.27 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.39 2.06 . . . . 99.99 113.228 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 15.1 tp -104.39 59.02 0.71 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 99.99 110.918 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? 53.72 64.43 1.84 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.765 -0.652 . . . . 99.99 111.238 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' C' ' 148' ' ' ASN . . . -83.22 -39.37 21.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.243 -0.435 . . . . 99.99 111.225 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -70.62 -29.15 65.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.844 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 12.7 m -66.41 -15.53 63.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 99.99 111.158 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -65.32 -25.39 67.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 99.99 111.143 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 77.1 p -102.9 5.91 38.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 99.99 111.077 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -101.13 -62.05 1.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 99.99 110.648 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 39.0 t -115.39 118.53 33.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.824 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 63.2 m -75.77 -21.3 57.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 99.99 110.738 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.92 -58.75 3.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 99.99 110.777 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.62 -22.06 66.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.135 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.78 -46.08 66.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 99.99 111.27 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -62.51 -44.02 97.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 99.99 111.412 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.16 -62.73 1.63 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.124 0.488 . . . . 99.99 110.774 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -23.58 46.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.373 -0.83 . . . . 99.99 111.192 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.4 -50.48 63.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 99.99 110.751 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -61.09 -35.78 77.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 99.99 110.821 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.7 -62.81 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 99.99 111.227 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.09 -32.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 99.99 111.479 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.7 m -57.11 -53.08 62.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.362 . . . . 99.99 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -56.16 -39.25 72.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.84 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -62.75 -32.13 73.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 99.99 111.084 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 34.2 m -73.8 -46.69 43.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.508 . . . . 99.99 111.413 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.61 -28.95 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.8 tp -80.52 -57.67 3.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.356 -0.384 . . . . 99.99 111.678 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.28 -28.14 62.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 99.99 110.748 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG13 ' C' ' 181' ' ' ILE . 34.2 mm -87.83 -23.33 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.166 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.51 24.56 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.814 -0.63 . . . . 99.99 113.155 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.576 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 66.2 m-85 -53.85 -54.97 40.73 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.899 0.349 . . . . 99.99 111.069 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 80.4 Cg_exo -45.36 -33.54 9.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.946 1.764 . . . . 99.99 112.664 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.448 HG13 ' O ' ' C' ' 177' ' ' ILE . 87.3 mt -63.9 -61.14 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.568 -0.287 . . . . 99.99 111.483 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 p -56.95 -35.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.623 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -57.13 -51.37 69.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.564 -0.289 . . . . 99.99 111.147 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.0 -65.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.371 -0.377 . . . . 99.99 111.656 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 2.5 pp -52.98 135.92 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.077 0.465 . . . . 99.99 111.248 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 66.02 161.67 0.97 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.944 -0.646 . . . . 99.99 112.425 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.51 81.43 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.369 2.046 . . . . 99.99 112.166 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 42.5 t 55.15 50.35 15.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.109 -0.496 . . . . 99.99 110.755 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -170.34 -96.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.808 -0.711 . . . . 99.99 112.524 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -145.2 -31.93 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 99.99 110.856 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . 0.531 ' H ' HG12 ' C' ' 193' ' ' ILE . . . 151.24 110.84 0.5 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.72 -0.752 . . . . 99.99 112.522 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 57.21 28.89 15.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.72 0.295 . . . . 99.99 111.092 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.531 HG12 ' H ' ' C' ' 191' ' ' GLY . 20.1 pt -120.38 160.25 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.021 0.438 . . . . 99.99 111.213 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -167.28 12.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.954 -0.567 . . . . 99.99 110.643 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -92.9 -162.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.069 -0.514 . . . . 99.99 110.961 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.8 m -63.0 -19.72 64.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 99.99 110.979 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -51.28 -33.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.185 -0.461 . . . . 99.99 111.462 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.52 -56.43 18.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.392 . . . . 99.99 111.007 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.6 p -60.99 -31.18 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 99.99 111.478 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.3 -39.0 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 99.99 111.333 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.0 -45.49 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 99.99 111.435 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.21 -3.22 12.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.746 0.308 . . . . 99.99 110.984 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 25.6 t -96.19 -40.95 8.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.197 0.522 . . . . 99.99 110.072 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 55.5 tp -74.12 -37.55 64.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.512 -0.767 . . . . 99.99 111.733 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 52.1 tp -57.19 -53.84 61.0 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.765 -0.198 . . . . 99.99 111.463 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 32.6 Cg_exo -58.59 -42.35 55.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.73 1.62 . . . . 99.99 111.476 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' C' ' 11' ' ' TYR . 51.3 t80 -64.11 -26.43 68.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.106 -0.497 . . . . 99.99 110.393 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.36 -26.01 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 99.99 110.479 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 89.2 p -93.99 -24.88 17.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 99.99 110.811 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.461 ' H1 ' ' H41' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 30.5 m -64.95 -28.57 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.279 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.33 -32.46 62.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.78 . . . . 99.99 112.619 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.71 -36.76 70.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.671 0.272 . . . . 99.99 111.038 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.3 t -61.34 -56.31 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 99.99 110.947 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -61.23 -25.54 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 99.99 110.853 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.42 -51.08 32.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 99.99 110.827 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.19 -21.47 63.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 99.99 111.25 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.56 -35.56 39.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.203 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -82.28 -33.4 29.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.972 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -81.14 -18.75 68.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.852 -0.69 . . . . 99.99 112.364 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.0 -58.21 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.553 0.216 . . . . 99.99 111.211 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' C' ' 222' ' ' ARG . 7.6 tpm_? 60.29 98.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.256 -0.429 . . . . 99.99 110.659 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.66 111.7 1.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 99.99 111.167 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 96.2 mt -134.8 151.73 51.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.962 -0.563 . . . . 99.99 110.84 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -111.62 101.0 9.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.013 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -165.31 71.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.496 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.8 t -137.26 -64.77 0.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 99.99 110.85 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 55.41 82.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 99.99 110.997 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 99.99 110.845 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.869 0.366 . . . . 99.99 110.841 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 56.13 74.26 0.4 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.03 -0.532 . . . . 99.99 110.896 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 34.1 tp -142.91 127.53 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.693 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -119.56 132.42 55.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 99.99 111.193 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -102.33 137.25 40.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 99.99 110.61 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt -104.36 -3.27 24.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.312 -0.404 . . . . 99.99 111.261 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.85 -59.67 2.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.332 . . . . 99.99 111.171 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 35.5 m80 -59.86 -23.69 63.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 99.99 110.586 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.429 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.4 t-105 -66.33 -54.51 23.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 99.99 110.765 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.45 -23.18 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 99.99 110.51 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -60.32 -61.28 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.64 . . . . 99.99 111.108 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 9' ' ' TRP . 8.1 p -57.19 -32.79 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.4 . . . . 99.99 111.188 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.85 98.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 99.99 111.024 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -73.57 -22.16 78.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.833 -0.699 . . . . 99.99 112.365 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.579 ' HE2' ' HA ' ' A' ' 15' ' ' MET . 27.0 mmt -73.29 -42.56 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 99.99 110.825 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.4 p -61.67 -49.85 74.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.11 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 14' ' ' GLY . 2.8 pp -63.77 -24.27 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 99.99 110.982 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.58 -46.6 91.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.766 -0.731 . . . . 99.99 112.551 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.1 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.747 0.308 . . . . 99.99 111.201 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.92 -28.62 69.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 99.99 110.972 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -54.96 -32.79 61.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 99.99 110.63 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -75.15 -36.7 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 99.99 110.842 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -54.58 -34.72 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.916 0.388 . . . . 99.99 110.678 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.8 m -85.31 -29.65 24.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 99.99 111.178 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.3 tp -87.27 -5.62 58.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 99.99 111.297 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.1 p -60.2 -19.81 55.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 99.99 111.188 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -50.01 -32.24 14.8 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.187 0.517 . . . . 99.99 109.726 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 7.9 p30 -176.15 132.17 0.4 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.103 -0.953 . . . . 99.99 109.912 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 60.8 Cg_endo -95.52 -176.84 0.39 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.877 2.385 . . . . 1.91 112.609 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -86.43 45.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 99.99 110.979 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.71 -45.74 3.38 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.881 -0.676 . . . . 99.99 112.613 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.8 118.99 71.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 99.99 111.265 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' TYR . 51.2 Cg_exo -55.06 168.61 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.961 2.441 . . . . 1.79 112.351 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -39.63 -18.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.335 -0.848 . . . . 99.99 113.17 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 m-30 -41.27 -60.47 1.25 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.887 0.375 . . . . 99.99 111.396 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.23 -41.95 97.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.034 -0.53 . . . . 99.99 111.597 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -69.27 -19.36 63.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.618 -0.264 . . . . 99.99 111.484 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.08 -55.55 10.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.953 0.406 . . . . 99.99 110.268 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG23 HD12 ' A' ' 82' ' ' LEU . 4.3 p -68.35 -31.32 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 99.99 111.031 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.6 -13.05 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.524 . . . . 99.99 111.663 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.492 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 17.0 tmm? -89.12 -35.51 16.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 99.99 111.287 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -77.81 -33.81 52.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.279 0.474 . . . . 99.99 112.279 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.608 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 88.6 mt -54.06 -50.54 83.74 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 111.753 0.279 . . . . 99.99 111.753 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 12.1 Cg_exo -71.23 -43.22 1.61 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.647 2.232 . . . . 0.53 113.059 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 mm -56.38 -61.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.778 0.288 . . . . 99.99 111.778 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -55.18 -58.36 8.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.652 0.263 . . . . 99.99 111.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.6 p -52.01 -42.16 62.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 99.99 111.535 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -48.8 -60.35 6.04 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.129 -0.557 . . . . 99.99 112.992 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.23 -34.87 58.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 99.99 111.204 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.49 83.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 99.99 111.29 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 57.4 m-85 -63.82 -49.64 72.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 99.99 111.324 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.41 ' HB2' HG11 ' A' ' 12' ' ' VAL . 57.7 ttp -47.02 -34.4 5.63 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 99.99 110.352 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.96 -44.21 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.762 -0.654 . . . . 99.99 110.926 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.5 mtt -52.42 -27.72 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 99.99 110.209 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.87 47.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.718 -0.674 . . . . 99.99 110.385 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.4 -2.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 99.99 110.847 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.52 43.11 2.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.938 -0.574 . . . . 99.99 111.108 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -121.56 159.14 27.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.947 -0.569 . . . . 99.99 110.509 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.06 13.91 44.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.114 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -132.57 140.2 48.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.787 0.327 . . . . 99.99 110.697 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.24 150.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 99.99 111.192 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.64 92.55 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 99.99 110.611 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.66 137.48 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.073 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.07 17.18 7.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.043 -0.526 . . . . 99.99 111.511 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.8 -13.07 63.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 99.99 112.699 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -98.45 155.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 99.99 111.164 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.6 mt -105.26 106.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.96 -0.564 . . . . 99.99 110.861 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.73 138.39 33.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 99.99 111.482 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.8 m-70 -97.73 74.55 2.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.979 -0.555 . . . . 99.99 110.615 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -56.41 -45.7 80.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.557 -0.747 . . . . 99.99 111.684 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -67.21 -27.16 67.02 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.189 0.44 . . . . 99.99 112.189 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.529 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.4 tpp180 -64.16 -51.61 63.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.596 0.591 . . . . 99.99 112.596 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.498 ' O ' ' HG3' ' A' ' 77' ' ' MET . 15.9 p90 -87.06 -26.15 23.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.455 -0.498 . . . . 99.99 112.297 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 71' ' ' ALA . 9.6 tp -55.87 -42.38 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.6 -0.44 . . . . 99.99 110.125 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -70.01 -21.34 63.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.16 -0.682 . . . . 99.99 109.16 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -84.77 2.81 40.44 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.364 -0.835 . . . . 99.99 111.243 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 38.9 mtp -103.06 -22.87 13.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 99.99 110.931 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' HD23 ' A' ' 82' ' ' LEU . 28.9 m -114.52 -36.04 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.453 0.538 . . . . 99.99 112.453 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 43' ' ' ILE . 36.0 m -72.58 -52.32 16.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.902 0.334 . . . . 99.99 111.902 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.575 HG22 ' NE2' ' A' ' 109' ' ' GLN . 10.5 m -53.82 -51.37 77.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.583 0.586 . . . . 99.99 112.583 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 109' ' ' GLN . 12.1 Cg_endo -55.72 -44.36 48.6 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.49 1.46 . . . . 0.74 111.511 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.647 HD12 HG23 ' A' ' 39' ' ' VAL . 3.9 mm? -64.2 -31.37 72.54 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.601 -0.518 . . . . 99.99 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 83' ' ' LEU . 1.6 tt -68.87 -24.53 64.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.531 0.682 . . . . 99.99 109.206 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.22 -32.11 24.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.129 -0.941 . . . . 99.99 110.474 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 82' ' ' LEU . 82.7 mt -74.67 -36.14 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.751 -0.659 . . . . 99.99 111.172 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -58.27 -25.09 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.943 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.57 -40.48 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 99.99 110.834 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -61.05 -37.26 82.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.044 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -73.83 -38.65 64.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.27 -0.423 . . . . 99.99 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.21 -29.07 70.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 99.99 111.031 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.29 -40.38 13.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.239 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.3 mtp -99.99 107.28 19.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 99.99 111.076 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -82.17 -27.53 32.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.488 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -133.55 138.9 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 99.99 110.596 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.04 142.94 23.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 99.99 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -124.87 -66.25 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 99.99 110.867 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -160.86 80.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.771 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.73 109.55 4.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.94 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -129.25 12.04 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 99.99 110.741 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.8 t -95.12 -32.22 13.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.395 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.42 ' O ' HD13 ' A' ' 101' ' ' LEU . 1.2 tm? -74.23 -45.13 50.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 99.99 110.57 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.37 -33.77 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.391 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.14 -34.77 64.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 99.99 112.807 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -66.98 -34.99 78.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 99.99 111.02 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.2 mt -76.14 -52.1 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 99.99 111.023 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -58.91 -33.25 70.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 99.99 111.451 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.4 p -72.16 -56.62 5.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.43 -0.35 . . . . 99.99 111.005 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.451 ' HB ' HG12 ' A' ' 142' ' ' ILE . 41.0 p -55.75 -25.21 39.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 99.99 110.778 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.575 ' NE2' HG22 ' A' ' 80' ' ' THR . 6.4 tp60 -68.64 -45.98 70.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.798 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.8 mt -54.37 -36.9 35.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.461 -0.336 . . . . 99.99 110.643 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.85 -44.66 99.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 99.99 111.139 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.459 HG11 H191 ' A' ' 210' ' ' LYR . 62.5 t -66.11 -36.36 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.308 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 94.0 mt -60.03 -41.84 87.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.183 -0.462 . . . . 99.99 111.161 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 72.5 m -60.84 -51.7 68.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.113 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.9 p -59.68 -20.16 54.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 99.99 110.825 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.79 -36.05 17.13 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.056 -0.592 . . . . 99.99 112.898 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -83.09 -28.45 29.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.652 0.263 . . . . 99.99 111.625 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.7 tp -83.93 -28.11 7.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.603 -0.271 . . . . 99.99 111.574 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.65 74.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 99.99 110.809 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.5 -12.44 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 99.99 110.74 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 118' ' ' ILE . 91.6 mt -90.42 22.04 3.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 99.99 110.788 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.1 m -86.3 120.67 27.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.864 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -90.32 -68.33 0.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 99.99 110.849 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG12 ' A' ' 127' ' ' VAL . 99.6 mtt180 -64.81 139.63 58.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.617 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.11 -9.54 58.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 99.99 110.872 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -88.51 -38.5 14.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 99.99 110.927 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.0 p -79.88 -24.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.018 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.48 ' NH1' ' H ' ' A' ' 188' ' ' SER . 29.2 ttm180 -54.41 -43.52 71.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 99.99 111.059 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.99 -33.89 76.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.17 -0.468 . . . . 99.99 110.763 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.37 -58.48 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 99.99 111.135 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.421 ' HE1' ' HB3' ' C' ' 58' ' ' GLN . 4.6 m95 -55.32 -34.31 64.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 99.99 111.191 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.41 -48.92 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 99.99 111.067 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -61.86 -28.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.037 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.44 -33.62 74.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.458 . . . . 99.99 110.625 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.57 -50.26 26.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.882 -0.675 . . . . 99.99 112.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.65 -30.22 48.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.674 0.273 . . . . 99.99 111.262 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.15 -46.5 77.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 99.99 110.774 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.51 -29.88 70.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 99.99 110.969 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.22 -26.85 61.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 99.99 110.848 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.85 -53.89 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 99.99 111.202 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.7 pt -61.33 -44.95 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 99.99 111.443 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 108' ' ' THR . 89.6 mt -63.88 -36.6 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 99.99 111.078 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.69 -28.48 69.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 99.99 110.588 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -72.78 -34.22 66.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 99.99 110.313 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.73 -35.77 34.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.905 -0.664 . . . . 99.99 112.58 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.437 ' O ' ' HD2' ' A' ' 149' ' ' PRO . 97.4 mt -69.9 -26.21 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.947 0.403 . . . . 99.99 110.661 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -88.06 3.12 50.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 99.99 110.903 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.508 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 51.5 t30 -80.81 -47.88 1.16 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 99.99 112.175 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 95.9 Cg_exo -44.04 -27.54 1.84 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.594 2.196 . . . . 2.6 113.16 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.9 tp -53.82 -59.17 4.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.632 -0.258 . . . . 99.99 110.735 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 61.61 110.32 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.08 -0.509 . . . . 99.99 111.343 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.53 -29.0 66.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 99.99 111.262 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -79.35 -2.67 42.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.175 -0.466 . . . . 99.99 111.178 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.2 m -102.53 -20.83 14.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.016 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -65.53 -17.79 64.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 99.99 111.144 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.9 t -89.74 -7.42 54.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.277 -0.42 . . . . 99.99 111.052 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -94.08 -72.58 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 99.99 110.985 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -114.94 113.03 23.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 99.99 110.866 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 m -78.11 -20.37 52.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.743 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -74.56 -60.03 2.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.952 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.421 HD12 HD23 ' A' ' 164' ' ' LEU . 40.2 tp -61.4 -27.13 68.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 99.99 110.903 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.8 -62.59 1.36 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.066 -0.515 . . . . 99.99 111.262 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.98 -28.76 54.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.277 -0.42 . . . . 99.99 110.549 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.421 HD23 HD12 ' A' ' 161' ' ' LEU . 25.6 tp -62.83 -44.0 97.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 99.99 110.783 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -81.25 -21.75 39.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 99.99 110.625 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.64 -50.62 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 99.99 111.272 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -74.97 -27.79 60.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 99.99 111.039 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.66 -47.27 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 99.99 111.361 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.93 -30.32 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 99.99 111.492 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -56.08 -58.4 8.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 99.99 111.309 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -61.42 -35.21 76.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 99.99 110.525 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -65.2 -26.57 68.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.813 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 88.6 m -73.93 -49.54 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 99.99 111.34 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.18 -31.45 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.39 -0.368 . . . . 99.99 111.599 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.411 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.7 mt -77.02 -57.47 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.429 -0.351 . . . . 99.99 111.401 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 99.99 111.545 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.519 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 9.9 tp -87.67 -21.27 7.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.125 0.488 . . . . 99.99 110.203 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -64.75 -45.29 93.16 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.711 -0.677 . . . . 99.99 112.304 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.821 ' HH ' ' HG3' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -53.32 -55.41 34.68 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.703 0.251 . . . . 99.99 111.053 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.519 ' HD2' ' C ' ' A' ' 177' ' ' ILE . 75.6 Cg_exo -48.96 -38.84 39.73 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.227 1.951 . . . . 0.55 112.4 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 184' ' ' ILE . 98.5 mt -54.62 -59.16 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.211 -0.45 . . . . 99.99 111.605 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.69 -24.21 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.308 -0.405 . . . . 99.99 111.288 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -59.58 -53.08 62.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.906 0.336 . . . . 99.99 111.906 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.0 tt -59.01 -20.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.855 0.317 . . . . 99.99 111.855 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 tt -115.76 102.63 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.096 0.474 . . . . 99.99 111.473 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 132.67 -164.83 23.96 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.757 -0.735 . . . . 99.99 112.579 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.5 160.56 49.06 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.614 2.209 . . . . 3.1 111.992 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.48 ' H ' ' NH1' ' A' ' 128' ' ' ARG . 47.1 t 59.25 12.01 2.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.61 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -131.72 -61.6 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.977 -0.63 . . . . 99.99 112.324 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -172.62 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 99.99 110.683 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.58 165.89 7.61 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.994 -0.622 . . . . 99.99 112.649 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -118.27 25.91 9.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 99.99 110.712 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 28.5 pt -107.58 162.7 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 99.99 111.53 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -167.93 67.63 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 99.99 110.488 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.443 ' HB2' HG22 ' A' ' 197' ' ' ILE . 48.9 mt-30 -112.35 -169.53 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 99.99 110.783 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.9 p -69.33 -26.98 64.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 99.99 111.174 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 195' ' ' GLN . 7.5 tp -60.25 -38.09 76.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 99.99 111.625 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.98 -57.73 9.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 99.99 110.639 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.5 p -60.17 -17.26 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 99.99 111.012 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -81.97 -30.47 31.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 99.99 110.937 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.76 -37.28 22.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 99.99 111.195 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -13.79 60.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.478 -0.328 . . . . 99.99 111.309 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.433 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 15.7 p -96.15 -37.07 10.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.972 0.415 . . . . 99.99 110.592 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 66.3 tp -72.7 -33.8 66.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 99.99 111.668 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 47.2 tp -60.72 -53.79 60.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 121.122 -0.231 . . . . 99.99 111.348 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.821 ' HG3' ' HH ' ' A' ' 179' ' ' TYR . 52.9 Cg_exo -56.03 -42.34 67.71 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.931 1.754 . . . . 0.64 111.44 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.491 ' HB2' ' OH ' ' A' ' 11' ' ' TYR . 90.5 t80 -61.72 -35.63 78.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.111 -0.495 . . . . 99.99 110.251 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.78 -20.94 57.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.834 -0.621 . . . . 99.99 110.846 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.411 ' OG ' HD13 ' A' ' 175' ' ' LEU . 29.8 t -87.46 -12.5 45.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 99.99 111.127 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYR . . . . . 0.459 H191 HG11 ' A' ' 112' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.1 p -72.99 -38.55 56.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.372 . . . . 99.99 110.914 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.16 78.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 99.99 112.393 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.98 -38.18 90.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 99.99 110.674 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.9 m -58.68 -57.38 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 99.99 110.794 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -64.03 -22.8 67.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 99.99 110.644 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 216' ' ' LEU . 10.5 tt -69.81 -48.03 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 99.99 111.102 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.86 -31.5 72.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.452 -0.34 . . . . 99.99 111.253 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 52.2 mt -70.15 -57.5 4.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 99.99 111.115 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.31 -22.82 65.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 99.99 111.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.32 -59.44 10.65 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.817 -0.706 . . . . 99.99 112.861 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.28 -55.05 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 99.99 110.738 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 54.82 82.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 99.99 110.841 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.487 HD22 ' ND2' ' A' ' 225' ' ' ASN . 3.0 p-10 -142.87 142.8 31.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.078 -0.51 . . . . 99.99 111.009 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.68 104.24 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 99.99 111.03 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.487 ' ND2' HD22 ' A' ' 223' ' ' ASN . 0.9 OUTLIER -100.54 141.27 33.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 99.99 110.803 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -130.32 -60.84 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 99.99 110.956 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.7 m -142.53 23.74 1.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.368 -0.378 . . . . 99.99 110.916 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -74.49 -66.69 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 99.99 111.055 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.903 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.771 0.319 . . . . 99.99 110.891 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -121.83 91.31 3.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.4 . . . . 99.99 110.825 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 19.4 tp -127.23 142.89 51.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 99.99 110.7 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -125.59 96.67 4.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.39 -0.368 . . . . 99.99 110.964 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 75.3 m -67.76 150.09 49.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.274 -0.421 . . . . 99.99 110.876 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt -115.37 -11.53 11.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 99.99 110.857 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 39.6 mt -66.34 -48.27 70.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.003 -0.544 . . . . 99.99 110.979 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 34.4 m80 -64.76 -24.17 67.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 99.99 110.831 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.467 ' O ' HG12 ' B' ' 12' ' ' VAL . 11.2 m95 -70.57 -56.15 7.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 99.99 111.194 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 pt -60.37 -20.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 99.99 110.906 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 15' ' ' MET . 6.0 t80 -65.15 -61.3 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 99.99 110.446 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.467 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.54 -29.49 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.294 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.23 74.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 99.99 110.978 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.58 -26.23 74.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.856 -0.688 . . . . 99.99 112.704 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 52.3 mmm -76.81 -37.79 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.35 . . . . 99.99 110.908 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 71.2 m -57.58 -55.4 35.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.115 -0.493 . . . . 99.99 110.92 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' B' ' 20' ' ' LEU . 1.9 tp -58.45 -36.72 60.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.782 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -45.81 -58.76 5.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.735 -0.745 . . . . 99.99 112.293 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.4 74.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.686 0.279 . . . . 99.99 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' B' ' 17' ' ' ILE . 97.5 mt -64.58 -28.68 69.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 99.99 110.814 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -64.63 -32.83 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 99.99 110.327 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.8 -20.49 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 99.99 110.587 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -69.36 -43.52 73.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 99.99 110.479 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 65.5 m -79.65 -30.38 41.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 99.99 110.7 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.9 tp -86.48 -1.3 57.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 99.99 110.58 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -60.86 -11.68 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 99.99 110.903 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.597 ' HG2' HD22 ' B' ' 28' ' ' ASN . 36.7 ttm180 -47.22 -47.25 24.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.001 -0.74 . . . . 99.99 109.001 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.597 HD22 ' HG2' ' B' ' 27' ' ' ARG . 9.0 p30 -178.59 129.91 0.28 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.201 -0.909 . . . . 99.99 110.337 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.518 ' HD2' ' H ' ' B' ' 31' ' ' GLY . 72.9 Cg_endo -103.32 -82.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.542 2.828 . . . . 1.82 112.121 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.6 ' HA ' HD21 ' B' ' 223' ' ' ASN . 49.6 mtp180 -112.63 6.14 18.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.794 0.806 . . . . 99.99 109.234 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.518 ' H ' ' HD2' ' B' ' 29' ' ' PRO . . . 123.64 -53.39 0.75 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 114.267 -1.333 . . . . 99.99 110.731 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.26 104.98 5.11 Favored Pre-proline 0 C--O 1.232 0.171 0 O-C-N 122.906 -0.173 . . . . 99.99 110.692 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.484 ' HG3' ' HG3' ' B' ' 29' ' ' PRO . 69.6 Cg_endo -88.21 107.76 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 119.446 0.838 . . . . 2.67 113.117 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -93.47 -58.29 2.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 123.597 1.665 . . . . 99.99 108.894 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.587 ' HD2' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -83.4 -61.69 1.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 110.633 -2.985 . . . . 99.99 113.823 -177.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.587 ' H ' ' HD2' ' B' ' 35' ' ' TYR . 40.6 tt0 -37.91 -63.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.467 0.914 . . . . 99.99 113.467 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -62.34 -40.33 96.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.11 0.411 . . . . 99.99 112.11 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -59.23 -65.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.88 0.326 . . . . 99.99 111.88 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.594 HG13 HD12 ' B' ' 82' ' ' LEU . 60.5 t -61.93 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.413 0.523 . . . . 99.99 112.413 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -14.09 6.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.228 0.455 . . . . 99.99 112.228 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 27.6 ttt -88.91 -39.65 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 99.99 111.546 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -72.01 -42.65 66.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 99.99 112.226 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.476 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 93.5 mt -49.62 -52.05 54.02 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.493 0.553 . . . . 99.99 112.493 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 50.9 Cg_endo -68.79 -43.44 3.63 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.202 1.935 . . . . 0.49 113.302 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mm -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.78 0.324 . . . . 99.99 111.632 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -55.95 -58.3 8.48 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.227 -0.442 . . . . 99.99 111.541 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 94.8 p -51.99 -32.9 35.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.241 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.67 -57.64 18.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 99.99 112.48 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.86 -28.12 68.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 99.99 111.067 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.96 -59.11 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 99.99 111.16 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.514 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 35.1 m-85 -63.75 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 99.99 111.11 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 19.5 ttt -48.85 -42.74 37.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.063 0.458 . . . . 99.99 110.456 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.54 -42.05 87.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 99.99 110.616 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -51.55 -29.38 16.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 99.99 110.212 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.3 -47.34 57.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 99.99 109.901 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -71.92 2.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.499 -0.773 . . . . 99.99 110.804 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 66.78 49.15 1.26 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.751 -0.658 . . . . 99.99 111.008 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.01 173.93 7.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 99.99 110.79 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 78.5 21.3 69.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 99.99 112.498 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -139.36 144.5 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.722 0.296 . . . . 99.99 110.572 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -124.6 146.19 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.155 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -101.16 84.04 2.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 99.99 110.844 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.87 144.31 42.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 99.99 110.925 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 16.29 4.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.436 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 -15.44 58.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 99.99 112.885 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -98.19 173.17 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 99.99 110.658 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -116.93 118.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.552 . . . . 99.99 111.165 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.89 110.93 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.253 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 57.0 m-70 -70.05 80.31 0.49 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.737 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -65.23 -31.02 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.655 -0.702 . . . . 99.99 111.496 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.478 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -79.48 -25.99 41.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.052 0.389 . . . . 99.99 112.052 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 22.0 mmt180 -69.6 -51.16 37.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.323 0.49 . . . . 99.99 112.323 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 3.5 p90 -76.14 -36.06 58.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.638 -0.425 . . . . 99.99 111.964 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.412 HG23 ' N ' ' B' ' 75' ' ' ASP . 16.9 tt -54.21 -43.68 61.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.728 0.299 . . . . 99.99 110.933 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.503 ' HD2' ' HG1' ' B' ' 79' ' ' THR . 11.6 t70 -67.92 -25.59 65.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.235 -0.654 . . . . 99.99 109.235 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -85.44 8.56 18.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.677 -0.692 . . . . 99.99 110.484 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.477 ' HA ' HG21 ' B' ' 113' ' ' ILE . 45.9 tpp -105.14 -25.64 12.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.684 -0.689 . . . . 99.99 110.713 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.89 -36.75 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.26 -0.427 . . . . 99.99 112.129 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.503 ' HG1' ' HD2' ' B' ' 75' ' ' ASP . 92.0 m -70.54 -57.64 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.919 0.341 . . . . 99.99 111.919 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.617 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 31.2 m -48.92 -51.78 52.2 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.535 0.568 . . . . 99.99 112.535 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.617 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 53.0 Cg_exo -54.16 -45.79 38.34 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.5 1.467 . . . . 0.66 111.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.594 HD12 HG13 ' B' ' 39' ' ' VAL . 3.0 mm? -63.03 -32.05 73.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.85 -0.614 . . . . 99.99 109.853 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 -23.95 62.34 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.15 -0.685 . . . . 99.99 109.15 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' B' ' 109' ' ' GLN . 16.8 tp -84.41 -29.44 26.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.103 -0.953 . . . . 99.99 110.462 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.69 -38.98 46.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.753 -0.658 . . . . 99.99 111.133 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' SER . . . . . 0.435 ' HB2' HG11 ' B' ' 39' ' ' VAL . 39.8 t -56.55 -21.06 23.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 99.99 110.921 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.86 -37.61 62.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.517 . . . . 99.99 111.115 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.1 t -72.42 -21.69 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 99.99 111.176 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.53 -45.49 15.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.133 -0.485 . . . . 99.99 111.138 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -66.83 -23.26 66.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 99.99 111.248 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.71 -36.85 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 99.99 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 79.1 mtp -105.17 101.17 10.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 99.99 110.946 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -73.15 -27.79 61.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 99.99 110.863 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -132.14 153.49 50.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.44 144.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 99.99 111.322 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -165.16 88.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 99.99 110.719 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt 58.19 81.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 99.99 111.094 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.89 95.8 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 99.99 110.859 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -129.07 0.13 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 99.99 110.895 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 67.2 p -70.52 -43.3 69.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 99.99 111.095 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 tp -73.37 -36.03 66.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 99.99 110.769 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 28.1 mm -60.7 -37.84 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 99.99 110.791 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.06 -23.32 63.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.859 -0.686 . . . . 99.99 112.357 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.79 -38.77 89.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.332 . . . . 99.99 111.072 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.3 mt -81.06 -44.24 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 99.99 111.001 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 11.0 tpt -56.4 -39.76 73.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.594 -0.73 . . . . 99.99 111.476 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -72.03 -51.85 19.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 99.99 111.274 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 27.8 p -53.26 -32.79 50.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.919 0.39 . . . . 99.99 111.379 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 6.5 tp-100 -65.81 -48.55 71.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.056 -0.52 . . . . 99.99 111.024 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.95 -43.71 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 99.99 111.619 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.2 -44.06 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.334 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.89 -46.3 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 99.99 111.8 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' B' ' 77' ' ' MET . 44.6 mt -56.92 -37.74 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.586 -0.279 . . . . 99.99 111.096 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.5 m -57.84 -49.66 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.95 0.405 . . . . 99.99 110.771 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.6 m -62.89 -21.96 66.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 99.99 110.31 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.66 -43.77 17.71 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.02 -0.61 . . . . 99.99 112.497 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.457 HD12 HG12 ' B' ' 118' ' ' ILE . 3.7 pp -77.47 -24.89 50.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.636 0.255 . . . . 99.99 111.163 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.457 HG12 HD12 ' B' ' 117' ' ' LEU . 36.5 mm -82.34 -36.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.408 -0.36 . . . . 99.99 111.09 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.49 -46.81 76.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.435 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -70.82 -17.41 62.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.395 -0.366 . . . . 99.99 111.234 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.13 20.41 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.454 -0.339 . . . . 99.99 111.351 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -78.05 125.04 28.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 99.99 110.781 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.75 -67.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 99.99 110.976 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.571 ' HB2' HG12 ' B' ' 127' ' ' VAL . 92.0 mtt180 -71.44 152.29 43.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 99.99 110.584 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.53 -16.78 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 99.99 110.865 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -81.86 -37.01 27.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 99.99 110.747 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.8 p -78.43 -24.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.939 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -58.05 -34.88 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 99.99 110.827 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -76.24 -21.39 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 99.99 111.042 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.99 -60.99 2.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 99.99 111.162 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -59.98 -27.48 66.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.398 -0.365 . . . . 99.99 110.971 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.68 -45.75 91.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 99.99 110.284 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -65.26 -33.26 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.044 -0.525 . . . . 99.99 110.449 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 47.5 t -62.64 -31.12 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 99.99 110.723 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.66 -52.98 13.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.838 -0.696 . . . . 99.99 112.479 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.38 -31.69 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 99.99 111.335 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 68.5 m -65.08 -46.07 82.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 99.99 110.775 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.93 71.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 99.99 110.667 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -73.13 -22.77 60.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 99.99 110.523 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.72 -57.82 4.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 99.99 110.703 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 41.2 pt -60.1 -38.43 76.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 99.99 111.517 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.81 -34.74 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 99.99 110.956 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.78 -39.59 85.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.291 -0.413 . . . . 99.99 110.569 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . 0.681 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 89.4 t90 -62.72 -47.08 85.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.532 . . . . 99.99 110.799 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . 1.315 ' HA2' ' ND2' ' B' ' 148' ' ' ASN . . . -63.53 -34.08 88.98 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 99.99 112.63 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -74.11 -24.16 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.919 0.39 . . . . 99.99 110.603 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -90.6 3.16 54.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 99.99 110.897 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 1.315 ' ND2' ' HA2' ' B' ' 145' ' ' GLY . 69.1 m-80 -80.89 -47.23 1.18 Allowed Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.913 -0.585 . . . . 99.99 112.251 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 81.8 Cg_exo -44.49 -24.09 0.97 Allowed 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.6 2.2 . . . . 2.65 113.175 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.79 -59.57 5.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.509 -0.314 . . . . 99.99 110.866 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 61.1 109.67 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.074 -0.512 . . . . 99.99 111.242 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.74 -19.72 62.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 99.99 111.245 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -75.95 -28.71 58.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.814 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 81.4 p -88.58 -6.05 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 99.99 110.928 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -62.4 -28.64 69.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 99.99 110.881 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 5.1 t -91.43 -23.71 19.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.507 . . . . 99.99 111.425 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -65.82 -77.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.441 -0.345 . . . . 99.99 110.938 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 66.0 p -111.65 113.42 25.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 99.99 110.916 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 45.5 t -77.74 -21.97 51.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 99.99 111.049 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.57 -45.1 22.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 99.99 111.396 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 47.3 tp -73.16 -28.14 62.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.812 0.339 . . . . 99.99 110.966 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.59 -61.65 1.76 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 99.99 111.099 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -53.91 -25.71 21.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.071 0.462 . . . . 99.99 110.449 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 49.2 tp -65.21 -47.68 76.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 99.99 110.759 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.413 ' O ' HG12 ' B' ' 169' ' ' VAL . 1.1 t80 -78.14 -23.68 47.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 99.99 111.32 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.74 -59.28 4.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 99.99 110.92 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.31 -26.9 65.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 99.99 111.327 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.16 -56.14 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.406 -0.361 . . . . 99.99 111.104 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.413 HG12 ' O ' ' B' ' 165' ' ' TYR . 14.4 p -68.97 -22.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 99.99 111.488 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 41.4 m -54.28 -58.91 5.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.48 -0.327 . . . . 99.99 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.67 -42.53 95.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 99.99 110.501 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.77 -28.2 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.044 -0.526 . . . . 99.99 110.789 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 90.2 m -73.52 -50.71 20.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 99.99 111.119 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.25 -43.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.315 -0.402 . . . . 99.99 111.93 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' B' ' 209' ' ' SER . 3.8 mm? -70.92 -53.24 15.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.955 0.354 . . . . 99.99 111.955 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -24.14 63.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.704 0.288 . . . . 99.99 111.194 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.493 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 36.6 mm -87.57 -22.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 99.99 110.26 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -65.44 -41.93 96.13 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.726 -0.67 . . . . 99.99 112.696 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.739 ' HH ' ' HG3' ' B' ' 206' ' ' PRO . 0.4 OUTLIER -56.09 -55.41 42.01 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.744 0.272 . . . . 99.99 111.124 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.493 ' HD2' ' C ' ' B' ' 177' ' ' ILE . 78.3 Cg_exo -50.57 -38.75 55.43 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.154 1.903 . . . . 0.64 112.243 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.5 ' O ' HG22 ' B' ' 184' ' ' ILE . 37.0 mm -54.04 -58.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 99.99 111.512 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 20.9 m -69.23 -24.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.262 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -61.75 -52.59 63.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.026 0.38 . . . . 99.99 112.026 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.5 HG22 ' O ' ' B' ' 181' ' ' ILE . 21.1 tt -58.23 -17.21 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 111.998 0.37 . . . . 99.99 111.998 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 8.9 tt -121.54 104.02 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 99.99 111.532 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 134.56 -157.71 23.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.802 -0.713 . . . . 99.99 112.501 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.08 154.8 37.77 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.614 2.21 . . . . 2.51 111.894 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 41.7 t 56.87 24.84 9.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 99.99 110.661 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . 179.96 65.13 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.699 -0.762 . . . . 99.99 112.839 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 64.9 t80 53.68 96.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 99.99 111.194 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.99 113.93 0.52 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.83 -0.7 . . . . 99.99 112.163 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -88.78 63.18 6.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.342 . . . . 99.99 110.921 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 pt -141.41 140.36 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.238 -0.437 . . . . 99.99 111.175 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -150.82 78.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 99.99 110.691 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -118.42 -172.95 2.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.97 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 46.0 m -67.98 -32.65 73.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 99.99 111.05 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 6.4 tp -57.84 -39.24 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.342 -0.39 . . . . 99.99 111.389 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.44 -52.95 63.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 99.99 110.914 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' THR . . . . . 0.426 HG22 ' HE2' ' B' ' 8' ' ' HIS . 11.4 m -66.64 -19.11 65.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 99.99 110.94 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . 0.434 ' HA ' ' SG ' ' B' ' 203' ' ' CYS . 62.2 t80 -83.51 -27.13 29.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 99.99 111.125 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.12 -28.78 27.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.736 0.303 . . . . 99.99 111.129 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.85 -12.0 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 99.99 111.188 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' B' ' 200' ' ' PHE . 17.2 p -96.22 -32.41 12.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 99.99 110.477 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.37 -39.33 59.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 99.99 111.408 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.6 tp -57.46 -53.16 68.37 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.622 -0.263 . . . . 99.99 111.523 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.739 ' HG3' ' HH ' ' B' ' 179' ' ' TYR . 32.0 Cg_exo -58.58 -45.0 32.52 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.918 1.745 . . . . 0.6 111.527 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -61.72 -29.52 70.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.016 -0.538 . . . . 99.99 110.234 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -76.83 -26.71 54.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 99.99 110.222 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.505 ' HB2' HD12 ' B' ' 175' ' ' LEU . 45.7 t -87.81 -12.72 44.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.817 -0.629 . . . . 99.99 110.373 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' LYR . . . . . 0.478 H181 ' HG3' ' B' ' 180' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.16 -40.78 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.258 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.18 -35.94 86.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.846 -0.693 . . . . 99.99 112.785 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.86 -29.17 64.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.301 . . . . 99.99 110.983 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.86 -60.77 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 99.99 110.918 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 99.99 110.98 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -38.45 89.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.963 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.58 -30.77 69.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 99.99 110.831 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.92 -58.69 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.018 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -66.35 -20.49 66.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 99.99 111.036 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.15 -57.65 18.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.8 -0.714 . . . . 99.99 112.962 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . 0.443 HD23 ' ND2' ' B' ' 223' ' ' ASN . 23.3 tp -85.23 -56.11 3.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.581 0.229 . . . . 99.99 111.27 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.506 ' HE ' ' HA ' ' B' ' 222' ' ' ARG . 4.8 mmp_? 57.38 88.5 0.05 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.352 -0.386 . . . . 99.99 110.923 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . 0.6 HD21 ' HA ' ' B' ' 30' ' ' ARG . 7.4 p30 -140.43 168.43 19.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 99.99 110.767 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 97.5 mt -133.24 98.49 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 99.99 111.088 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.542 HD21 ' H ' ' B' ' 228' ' ' ARG . 2.9 t-20 -102.55 122.59 44.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.076 -0.511 . . . . 99.99 110.711 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -116.54 -44.59 2.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.158 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.4 m -160.49 39.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 99.99 111.154 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.542 ' H ' HD21 ' B' ' 225' ' ' ASN . 40.4 ttm180 -92.74 -63.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 99.99 110.547 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . 0.48 HE22 ' HG2' ' B' ' 228' ' ' ARG . 28.6 mm-40 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 99.99 110.652 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.792 0.329 . . . . 99.99 110.855 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -127.5 121.1 29.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 99.99 110.908 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 27.4 tp -164.69 131.53 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 99.99 110.457 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -121.15 122.53 40.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.856 0.36 . . . . 99.99 111.382 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 46.1 t -92.41 120.25 32.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 99.99 110.79 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -84.29 -6.36 59.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 99.99 111.432 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . 0.466 ' H ' HD22 ' C' ' 7' ' ' LEU . 3.1 mm? -69.37 -42.1 75.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 99.99 110.684 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 42.4 m80 -72.22 -27.47 62.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 99.99 110.806 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -70.4 -43.87 69.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.521 . . . . 99.99 110.928 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.74 -21.47 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.661 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -64.41 -53.31 50.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 99.99 110.704 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.26 -34.12 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 99.99 111.216 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.66 96.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 99.99 111.224 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . 0.467 ' O ' HG13 ' C' ' 17' ' ' ILE . . . -69.68 -23.91 76.52 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 99.99 112.589 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.7 mmt -74.77 -36.86 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.56 0.219 . . . . 99.99 111.477 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 71.7 p -64.35 -52.27 59.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 99.99 110.828 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . 0.467 HG13 ' O ' ' C' ' 14' ' ' GLY . 2.8 pp -63.3 -22.55 31.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 99.99 110.873 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.98 -55.64 27.03 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.783 -0.723 . . . . 99.99 112.372 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -34.72 72.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.74 0.305 . . . . 99.99 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 26.6 tp -62.43 -35.14 78.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.167 -0.47 . . . . 99.99 110.771 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -57.16 -28.96 63.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 99.99 110.817 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -74.17 -37.5 63.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.01 -0.541 . . . . 99.99 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -56.3 -32.64 64.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.689 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -81.07 -32.27 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 99.99 111.313 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -86.42 -1.26 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.532 -0.303 . . . . 99.99 111.531 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 92.8 p -62.84 -20.12 64.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.487 -0.324 . . . . 99.99 111.15 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -48.71 -33.22 9.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.329 0.585 . . . . 99.99 109.687 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.2 p-10 -174.99 131.77 0.45 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.08 -0.964 . . . . 99.99 109.884 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 9.6 Cg_endo -90.83 -169.64 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.012 2.475 . . . . 2.05 112.373 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -89.88 35.24 0.84 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 99.99 110.9 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.8 -46.21 1.43 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.757 -0.735 . . . . 99.99 112.758 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' C' ' 33' ' ' PRO . 13.7 m -77.35 134.55 66.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.777 0.322 . . . . 99.99 110.836 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' C' ' 35' ' ' TYR . 31.8 Cg_exo -60.5 168.1 7.14 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.712 2.275 . . . . 1.93 112.45 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -41.27 -16.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.99 -1.005 . . . . 99.99 113.661 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' C' ' 33' ' ' PRO . 3.2 m-30 -39.75 -62.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.924 0.392 . . . . 99.99 111.539 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.08 -40.67 77.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 99.99 111.449 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -72.02 -18.57 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.715 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.37 -45.69 68.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.915 0.388 . . . . 99.99 110.146 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.625 HG13 HD12 ' C' ' 82' ' ' LEU . 58.2 t -75.19 -33.25 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 99.99 110.788 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.38 -15.08 61.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 99.99 111.511 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 51.9 ttp -89.57 -37.84 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.45 -0.341 . . . . 99.99 111.623 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -72.61 -37.99 67.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 99.99 112.064 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.506 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -53.71 -52.5 66.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 112.215 0.45 . . . . 99.99 112.215 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 40.7 Cg_endo -67.55 -42.19 7.47 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.213 1.942 . . . . 0.41 113.1 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mm -55.88 -62.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.6 0.238 . . . . 99.99 111.518 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -57.32 -58.19 9.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.396 -0.365 . . . . 99.99 111.29 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 56.7 m -53.26 -26.76 19.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 99.99 111.493 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.81 -61.46 6.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.688 -0.768 . . . . 99.99 112.47 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.91 -25.29 63.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.683 0.278 . . . . 99.99 111.298 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -59.26 4.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.944 0.402 . . . . 99.99 111.027 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.497 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 25.7 m-85 -62.52 -41.54 98.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 99.99 111.092 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 55.0 ttp -47.93 -39.09 18.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.087 0.47 . . . . 99.99 110.104 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.66 88.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.618 -0.719 . . . . 99.99 110.763 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.1 mtt -52.45 -30.98 32.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 99.99 110.138 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.29 -38.43 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.874 -0.603 . . . . 99.99 110.238 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mt -77.53 0.34 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.755 -0.657 . . . . 99.99 110.657 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 68.33 42.28 1.69 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.795 -0.638 . . . . 99.99 111.155 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.421 ' HB3' ' HE1' ' A' ' 131' ' ' TRP . 27.6 mm-40 -118.25 173.51 6.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.087 -0.506 . . . . 99.99 110.819 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.46 16.76 67.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 99.99 112.371 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.567 ' HG2' ' HA ' ' C' ' 69' ' ' HIS . 36.6 mtmm -136.41 150.9 48.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 99.99 110.783 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.29 143.44 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 99.99 111.082 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.26 89.63 6.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 99.99 110.989 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.48 139.68 51.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 99.99 111.038 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.75 15.33 4.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.07 -0.514 . . . . 99.99 111.453 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.13 66.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.795 -0.717 . . . . 99.99 112.691 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -105.44 150.69 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 99.99 111.174 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 11.4 pt -97.12 125.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.545 . . . . 99.99 111.074 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.69 123.87 48.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 99.99 110.882 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.567 ' HA ' ' HG2' ' C' ' 60' ' ' LYS . 31.9 m-70 -81.07 76.44 8.02 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.35 0.595 . . . . 99.99 111.052 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -57.41 -36.44 71.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.376 -0.829 . . . . 99.99 111.544 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.37 -26.3 55.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.214 0.449 . . . . 99.99 112.214 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.9 tpp180 -64.19 -51.56 63.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.531 0.567 . . . . 99.99 112.531 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' C' ' 77' ' ' MET . 24.2 p90 -86.44 -26.45 24.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.515 0.561 . . . . 99.99 112.515 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . 0.414 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.0 tp -56.86 -41.58 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.375 -0.53 . . . . 99.99 110.272 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.52 -16.7 62.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.266 -0.642 . . . . 99.99 109.266 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -88.54 2.77 52.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.315 -0.857 . . . . 99.99 111.439 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 39.3 mtp -105.09 -20.51 13.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.168 -0.469 . . . . 99.99 111.245 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.469 ' O ' HD23 ' C' ' 82' ' ' LEU . 14.5 m -113.77 -39.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.3 0.482 . . . . 99.99 112.3 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.506 HG23 HG23 ' C' ' 43' ' ' ILE . 57.0 m -70.34 -49.17 52.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.046 0.387 . . . . 99.99 112.046 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.524 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 21.5 m -56.52 -52.08 76.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 99.99 112.614 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' C' ' 80' ' ' THR . 11.7 Cg_endo -55.78 -37.53 95.53 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.53 1.487 . . . . 0.67 111.736 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.625 HD12 HG13 ' C' ' 39' ' ' VAL . 3.9 mm? -70.33 -32.21 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 99.99 109.746 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -23.28 63.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.488 0.661 . . . . 99.99 109.23 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 tp -84.46 -36.51 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.984 -1.007 . . . . 99.99 110.414 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.83 -34.37 73.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 99.99 110.94 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -62.41 -18.52 61.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 99.99 111.081 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 24.0 mt -78.93 -31.88 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 99.99 111.027 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -73.63 -32.23 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 99.99 111.076 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -75.1 -42.04 57.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 99.99 111.438 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -69.17 -22.44 63.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 99.99 111.001 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.05 -13.87 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 99.99 111.213 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.3 ttm -128.71 100.94 5.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 99.99 110.742 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -68.4 -54.47 16.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 99.99 111.053 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -112.52 149.85 32.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 99.99 111.179 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.86 145.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.163 -0.471 . . . . 99.99 110.723 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.8 -71.46 0.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.432 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -140.47 29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.501 -0.318 . . . . 99.99 111.591 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -86.92 138.94 31.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.431 -0.35 . . . . 99.99 110.876 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -165.84 -22.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 99.99 110.686 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -70.46 -35.09 73.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 99.99 111.591 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.59 -42.46 42.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 99.99 110.949 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.91 -31.21 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 99.99 110.711 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.62 -29.04 45.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.84 -0.695 . . . . 99.99 112.346 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -65.76 -35.36 80.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 99.99 110.83 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 75.1 mt -79.53 -44.98 20.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.994 -0.548 . . . . 99.99 111.107 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' MET . . . . . 0.421 ' O ' HG13 ' C' ' 110' ' ' ILE . 10.7 tpt -59.62 -35.91 75.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 99.99 111.328 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.7 m -71.81 -58.3 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 99.99 111.283 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 57.6 p -52.41 -31.02 32.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 99.99 111.163 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 6.5 tp-100 -62.48 -54.13 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 99.99 110.556 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.421 HG13 ' O ' ' C' ' 106' ' ' MET . 65.3 mt -46.78 -39.94 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 115.93 -0.577 . . . . 99.99 111.316 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.78 -46.92 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 99.99 110.855 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . 0.466 HG11 H193 ' C' ' 210' ' ' LYR . 57.0 t -66.59 -32.33 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 99.99 111.156 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 44.8 mm -59.23 -41.3 83.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 99.99 110.671 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 93.9 m -62.26 -54.63 38.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.833 -0.621 . . . . 99.99 111.296 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -54.82 -24.26 22.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.385 -0.37 . . . . 99.99 110.899 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.87 -46.9 12.64 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.811 -0.709 . . . . 99.99 112.673 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' C' ' 114' ' ' THR . 4.3 pp -76.79 -21.24 55.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.716 0.293 . . . . 99.99 111.011 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' C' ' 117' ' ' LEU . 38.2 mm -83.37 -36.92 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 99.99 111.205 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.95 -32.55 61.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 99.99 111.327 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . 0.453 ' HA ' ' HG ' ' C' ' 188' ' ' SER . 13.2 t70 -82.39 -23.66 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 99.99 110.977 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.14 34.14 0.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 99.99 111.254 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 71.2 m -91.86 119.05 31.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 99.99 110.776 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.22 -58.29 2.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 99.99 111.137 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.472 ' HB2' HG12 ' C' ' 127' ' ' VAL . 45.4 mtm180 -89.48 157.61 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 99.99 110.965 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -84.54 -15.88 44.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.885 -0.598 . . . . 99.99 110.88 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 37.6 t-105 -78.74 -38.75 38.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 99.99 110.66 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' C' ' 124' ' ' ARG . 7.4 p -80.83 -28.78 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 99.99 111.241 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -56.13 -34.61 66.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 99.99 111.281 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -73.68 -25.61 60.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 99.99 111.019 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.22 -46.1 24.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 99.99 110.968 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -64.65 -37.4 87.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 99.99 111.178 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -55.4 -46.67 76.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 99.99 110.906 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.3 -35.08 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 99.99 110.865 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.53 -31.27 72.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 99.99 110.842 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -54.02 13.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.736 -0.745 . . . . 99.99 112.635 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.45 -37.96 76.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 99.99 111.257 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -52.79 -52.44 56.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 99.99 110.626 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.9 -30.81 71.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 99.99 110.891 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . 0.649 ' HA ' HG12 ' C' ' 142' ' ' ILE . 88.9 t80 -69.58 -24.53 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 99.99 110.932 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.76 -52.91 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 99.99 111.491 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 24.6 pt -60.31 -43.99 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.528 -0.305 . . . . 99.99 111.763 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.649 HG12 ' HA ' ' C' ' 139' ' ' PHE . 43.4 pt -67.4 -29.84 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 99.99 110.957 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.12 -38.31 85.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 99.99 111.018 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . 0.541 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 91.8 m95 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 99.99 110.835 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . 1.326 ' HA2' ' ND2' ' C' ' 148' ' ' ASN . . . -61.07 -44.52 98.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.899 -0.667 . . . . 99.99 112.532 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . 0.427 ' O ' ' HD2' ' C' ' 149' ' ' PRO . 69.7 mt -66.22 -24.08 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 99.99 110.758 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -88.8 4.74 46.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 99.99 111.134 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 1.326 ' ND2' ' HA2' ' C' ' 145' ' ' GLY . 69.1 m-80 -83.2 -46.78 0.82 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.48 . . . . 99.99 112.116 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 80.6 Cg_exo -45.46 -23.99 1.56 Allowed 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.591 2.194 . . . . 2.73 112.845 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.02 -58.11 9.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.388 -0.369 . . . . 99.99 110.604 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 59.45 104.76 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.064 -0.516 . . . . 99.99 111.295 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.36 -21.56 63.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 99.99 111.051 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -83.29 -13.75 54.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.073 -0.512 . . . . 99.99 110.976 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 34.3 m -95.75 -18.48 20.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.293 -0.412 . . . . 99.99 111.368 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -64.75 -21.14 66.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 99.99 110.999 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 64.8 p -88.51 7.23 34.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 99.99 111.182 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -106.62 -68.63 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 99.99 110.672 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 51.4 m -115.46 113.67 24.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.758 -0.655 . . . . 99.99 110.555 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.6 p -76.63 -22.77 53.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 99.99 111.179 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -76.79 -54.41 6.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 99.99 111.036 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 77.2 mt -63.05 -30.74 71.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 99.99 110.951 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.77 -62.46 1.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 99.99 111.432 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.79 -22.82 26.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 99.99 110.616 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.7 tp -67.76 -44.35 77.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 99.99 110.704 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -81.38 -25.63 36.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 99.99 111.045 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.01 -55.24 31.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 99.99 111.162 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -72.07 -32.75 67.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 99.99 111.339 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.25 -50.79 72.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 99.99 111.276 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.06 -29.93 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 99.99 111.264 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -53.29 -58.74 6.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 99.99 111.315 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -63.29 -36.15 82.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 99.99 110.701 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.6 -22.59 66.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 99.99 110.761 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 25.9 m -73.48 -59.0 2.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 99.99 111.358 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.6 p -52.39 -30.82 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.394 -0.366 . . . . 99.99 111.642 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.404 HD13 ' OG ' ' C' ' 209' ' ' SER . 94.7 mt -72.38 -57.78 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 99.99 111.071 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -19.79 65.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 99.99 111.04 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.492 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 32.6 mm -87.66 -25.4 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.114 0.483 . . . . 99.99 110.36 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.54 95.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 99.99 112.505 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.692 ' HH ' ' HG3' ' C' ' 206' ' ' PRO . 0.3 OUTLIER -55.7 -55.72 37.63 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.592 0.196 . . . . 99.99 111.356 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.492 ' HD2' ' C ' ' C' ' 177' ' ' ILE . 67.2 Cg_exo -50.38 -41.06 52.74 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.074 1.849 . . . . 0.63 112.163 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.452 HG13 ' O ' ' C' ' 177' ' ' ILE . 82.1 mt -49.69 -61.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.137 -0.483 . . . . 99.99 111.493 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.448 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.2 m -63.92 -28.15 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 99.99 111.446 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . 0.427 ' HZ3' ' HB2' ' C' ' 188' ' ' SER . 20.5 m95 -65.36 -27.83 68.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 99.99 111.053 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 89.2 mt -55.15 -32.93 28.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 99.99 111.209 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.62 169.98 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 99.99 111.132 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.16 -161.5 31.63 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 99.99 112.457 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' C' ' 193' ' ' ILE . 95.3 Cg_endo -80.05 158.32 23.74 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.562 2.175 . . . . 3.12 112.225 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 188' ' ' SER . . . . . 0.453 ' HG ' ' HA ' ' C' ' 120' ' ' ASP . 54.8 m 56.95 20.68 5.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.091 -0.504 . . . . 99.99 110.825 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -169.3 48.33 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.879 -0.677 . . . . 99.99 112.364 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 60.0 t80 60.66 98.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.876 0.369 . . . . 99.99 110.908 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 152.44 117.71 0.73 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 99.99 112.393 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -86.26 49.31 1.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.799 0.333 . . . . 99.99 110.797 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.41 ' O ' ' HD3' ' C' ' 187' ' ' PRO . 43.3 mm -124.97 142.99 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 99.99 110.96 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . 0.461 HD22 ' N ' ' C' ' 195' ' ' GLN . 0.2 OUTLIER -143.22 -100.47 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.329 -0.396 . . . . 99.99 110.878 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . 0.461 ' N ' HD22 ' C' ' 194' ' ' ASN . 96.9 mt-30 57.63 -178.56 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.828 0.347 . . . . 99.99 111.609 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 81.8 p -74.25 -25.51 59.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 99.99 111.302 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . 0.449 HG22 ' HB2' ' C' ' 195' ' ' GLN . 12.4 tt -57.89 -42.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 99.99 111.743 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.4 -53.75 54.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.702 0.287 . . . . 99.99 111.401 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 59.4 p -58.81 -21.55 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 99.99 111.613 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -73.35 -39.29 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 99.99 111.489 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.89 -51.56 46.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.695 0.283 . . . . 99.99 111.414 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -67.59 -8.15 32.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.531 -0.304 . . . . 99.99 111.313 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 10.9 t -95.86 -41.98 8.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.151 0.5 . . . . 99.99 110.666 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.7 tp -74.19 -31.99 62.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 99.99 111.904 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.673 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 54.9 tp -61.0 -54.22 56.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.891 -0.324 . . . . 99.99 111.624 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.692 ' HG3' ' HH ' ' C' ' 179' ' ' TYR . 33.7 Cg_exo -59.45 -39.64 74.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.795 1.663 . . . . 0.63 111.189 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.68 -28.72 70.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 99.99 110.464 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -84.45 -19.49 33.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.949 -0.568 . . . . 99.99 110.82 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' SER . . . . . 0.404 ' OG ' HD13 ' C' ' 175' ' ' LEU . 40.6 t -88.29 -12.37 43.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.995 -0.548 . . . . 99.99 110.898 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' LYR . . . . . 0.488 H183 ' HG3' ' C' ' 180' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.19 -35.4 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.981 0.419 . . . . 99.99 110.891 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.12 -29.52 72.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.998 -0.62 . . . . 99.99 112.535 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -72.6 -36.87 68.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 99.99 110.817 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.0 t -59.16 -54.66 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 99.99 110.89 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.14 -20.42 65.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.314 -0.403 . . . . 99.99 110.856 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -72.08 -47.1 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 99.99 110.695 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.21 -21.01 64.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 99.99 110.573 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 64.2 tp -74.14 -54.31 8.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.887 -0.597 . . . . 99.99 111.266 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -79.41 -20.29 47.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 99.99 111.234 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.88 12.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.737 -0.744 . . . . 99.99 112.585 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . 0.422 HD22 ' N ' ' C' ' 221' ' ' LEU . 3.7 mm? -80.51 -56.67 4.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 99.99 110.435 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 54.46 77.97 0.18 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.023 -0.535 . . . . 99.99 110.974 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -131.82 168.84 17.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.114 -0.494 . . . . 99.99 110.879 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 52.2 tp -130.62 105.31 7.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.029 -0.532 . . . . 99.99 110.815 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -111.8 122.54 48.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 99.99 111.009 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -111.51 -62.86 1.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.727 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 33.1 t -131.51 -0.09 3.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 99.99 110.65 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -95.42 87.73 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.552 . . . . 99.99 110.842 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 99.99 111.013 -179.987 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.903 0.382 . . . . 2.4199999999999999 111.012 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.3 mm? -76.47 -51.91 10.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 2.0899999999999999 110.602 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -70.95 -24.34 62.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 110.478 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.0 t-105 -64.9 -53.07 52.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.79000000000000004 110.685 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.1 mt -66.33 -22.55 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 2.0800000000000001 110.267 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.404 ' HE2' ' HG ' ' A' ' 203' ' ' CYS . 0.1 OUTLIER -57.22 -55.32 36.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 1.28 110.756 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 52' ' ' MET . 10.0 p -66.87 -30.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 1.3200000000000001 111.274 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.43 80.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.63 111.229 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.4 76.36 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.853 -0.689 . . . . 0.55000000000000004 112.626 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.469 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -74.53 -41.75 60.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 1.03 111.497 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -61.83 -48.19 81.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.3 111.187 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -67.03 -22.59 29.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 1.3100000000000001 110.964 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.49 -58.62 12.36 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.872 -0.68 . . . . 0.77000000000000002 112.492 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.21 73.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.072 0.463 . . . . 0.80000000000000004 110.931 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.4 tp -64.48 -33.93 77.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.956 -0.566 . . . . 1.8100000000000001 110.62 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.61 -28.08 66.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.948 -0.569 . . . . 1.8799999999999999 110.42 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -78.2 -29.31 48.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 4.4500000000000002 110.671 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -63.84 -36.06 82.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.524 . . . . 3.6899999999999999 110.818 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -84.68 -42.31 15.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 1.5700000000000001 110.906 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.8 tp -73.22 -3.4 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.89 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 p -64.38 -24.77 67.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.528 -0.306 . . . . 1.3799999999999999 111.334 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -51.09 -31.95 20.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.128 0.489 . . . . 4.0700000000000003 109.784 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p30 -167.88 132.45 1.5 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.454 -0.793 . . . . 2.7200000000000002 110.147 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 28.3 Cg_endo -94.78 173.71 1.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.05 2.5 . . . . 1.9099999999999999 112.277 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.11 56.4 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 4.7599999999999998 111.082 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.75 -45.87 3.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 1.99 112.747 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.3 127.07 80.09 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 120.539 0.209 . . . . 2.7000000000000002 110.942 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 31.7 Cg_exo -57.74 165.18 6.67 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.412 2.075 . . . . 1.79 112.374 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -61.59 -18.21 58.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.747 -0.66 . . . . 4.1200000000000001 112.579 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.446 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 4.8 p90 -47.97 -42.23 27.15 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.688 0.28 . . . . 2.9300000000000002 111.652 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -68.04 -46.56 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.356 . . . . 2.8799999999999999 110.886 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.12 -23.03 66.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.077 -0.51 . . . . 4.6600000000000001 110.833 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.99 -61.23 2.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.176 -0.465 . . . . 1.45 110.659 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.67 -33.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 1.78 110.224 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.31 -4.78 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 0.63 111.105 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.534 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 28.4 ttt -89.38 -39.94 13.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.055 0.455 . . . . 1.48 111.018 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -73.09 -39.33 65.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 3.5 111.883 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 91.4 mt -50.69 -51.59 64.32 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.241 0.46 . . . . 1.0800000000000001 112.241 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 16.6 Cg_exo -68.65 -41.45 6.04 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.494 2.129 . . . . 0.53000000000000003 113.275 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 41' ' ' MET . 36.3 mm -55.06 -63.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.207 0.447 . . . . 1.6799999999999999 112.207 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.53 -58.39 7.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 1.8300000000000001 111.484 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 90.4 p -52.28 -35.97 51.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 1.0900000000000001 111.244 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.74 16.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.885 -0.674 . . . . 0.40999999999999998 112.661 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.56 -35.48 68.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.98999999999999999 110.893 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.8 79.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.47999999999999998 111.397 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -66.01 -59.68 3.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.447 -0.342 . . . . 1.8700000000000001 111.564 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.619 ' HB3' HG11 ' A' ' 12' ' ' VAL . 24.0 ptm -49.01 -31.08 6.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.01 0.433 . . . . 1.49 110.6 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.84 91.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.58999999999999997 110.831 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.9 mtt -56.36 -31.39 63.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.073 -0.512 . . . . 0.48999999999999999 110.505 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.86 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.59999999999999998 110.526 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.49 HD13 HD23 ' B' ' 130' ' ' LEU . 41.4 pt -78.5 3.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 1.3100000000000001 110.963 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.48 30.14 19.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 1.9099999999999999 111.46 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.622 HE22 ' H ' ' B' ' 123' ' ' GLU . 6.4 tp-100 -92.23 142.27 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 1.6200000000000001 110.767 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.34 17.22 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 1.04 112.346 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -127.23 139.67 52.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 2.6800000000000002 110.819 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.85 141.0 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 1.98 110.727 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.87 95.1 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 2.1800000000000002 111.25 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.1 115.81 27.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 1.5700000000000001 110.79 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 30.52 19.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 1.79 111.121 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.33 -2.01 83.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.742 -0.742 . . . . 1.48 112.847 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -105.82 128.95 54.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 2.3199999999999998 110.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 67' ' ' ILE . 4.8 mp -79.38 127.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 1.4399999999999999 111.007 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 139.89 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.81999999999999995 111.069 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 56.5 m-70 -81.29 64.94 6.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.213 0.53 . . . . 0.90000000000000002 110.758 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.89 -50.84 67.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.753 . . . . 1.8300000000000001 111.443 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -25.31 67.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.263 -0.426 . . . . 0.62 111.844 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 34.8 mmt180 -67.52 -52.48 38.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.713 0.635 . . . . 2.3399999999999999 112.713 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.506 ' O ' ' HG3' ' A' ' 77' ' ' MET . 6.3 p90 -75.93 -36.17 59.48 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.27 0.47 . . . . 3.4900000000000002 112.27 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.0 tt -52.93 -46.54 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.775 -0.37 . . . . 1.3700000000000001 110.902 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.482 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.6 t70 -67.45 -22.03 65.52 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.606 -0.516 . . . . 1.3100000000000001 109.606 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -87.87 5.55 39.84 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.527 -0.76 . . . . 1.48 111.522 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 34.4 mtp -104.55 -19.15 14.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 1.46 110.516 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 1.4 p -114.64 -43.8 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 1.1200000000000001 111.972 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.58 HG23 HG23 ' A' ' 43' ' ' ILE . 66.8 m -66.31 -56.09 12.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.409 . . . . 1.1000000000000001 111.961 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 67.9 m -50.77 -53.93 41.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.569 0.581 . . . . 0.59999999999999998 112.569 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 80' ' ' THR . 13.2 Cg_endo -56.28 -38.84 94.39 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.633 1.555 . . . . 0.73999999999999999 111.195 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -30.48 70.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.942 -0.572 . . . . 1.01 109.761 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.79 -21.79 61.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.275 -0.639 . . . . 1.48 109.275 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.58 -31.38 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.034 -0.985 . . . . 1.3799999999999999 110.292 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.52 -32.97 64.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.757 -0.656 . . . . 1.1899999999999999 111.032 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.1 p -58.17 -29.02 65.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.234 -0.439 . . . . 1.23 110.758 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.987 -0.551 . . . . 0.88 110.718 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -60.91 -41.86 96.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.951 -0.568 . . . . 1.3899999999999999 110.955 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.84 -29.75 63.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 2.3199999999999998 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.5 m -59.7 -43.39 94.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.46 111.351 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.92 -36.82 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 1.24 111.435 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 82.0 mtp -88.48 98.87 11.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.396 . . . . 2.0699999999999998 111.124 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -82.62 -5.05 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 3.5299999999999998 110.585 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -163.79 157.29 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.843 -0.617 . . . . 4.0800000000000001 110.705 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tp -128.99 142.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 2.1699999999999999 110.98 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.53 -30.74 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 4.5199999999999996 110.941 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.48 138.33 39.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 3.75 111.151 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.6 115.81 4.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 3.5299999999999998 110.869 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.95 149.45 21.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.475 . . . . 4.9100000000000001 111.1 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.2 p -94.82 -20.94 19.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 1.98 110.985 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.0 tp -54.56 -40.73 69.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 1.8300000000000001 111.155 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.85 -38.19 78.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.463 -0.335 . . . . 1.79 111.052 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.63 -28.05 73.23 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 0.62 112.127 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -72.13 -37.07 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.921 0.391 . . . . 1.5800000000000001 110.951 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.16 -36.63 61.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.97999999999999998 111.496 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 81.0 mtp -68.31 -47.61 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.463 -0.335 . . . . 1.48 111.449 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.8 p -60.89 -53.64 54.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 1.1299999999999999 111.45 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -56.66 -31.88 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 1.48 111.498 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -66.64 -40.18 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 2.7000000000000002 110.992 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.16 -35.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 1.54 111.096 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -67.93 -36.96 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 1.28 111.359 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.78 -51.1 48.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.42999999999999999 111.484 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.3 pt -59.96 -24.04 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 1.74 110.822 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 17.6 m -67.44 -43.16 81.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.63 110.465 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -68.15 -21.03 64.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.872 -0.604 . . . . 1.0900000000000001 110.461 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.68 -34.03 26.07 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.043 -0.599 . . . . 0.41999999999999998 113.313 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 118' ' ' ILE . 4.1 pp -79.1 -26.89 42.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 1.3799999999999999 111.288 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 tp -83.93 -29.51 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 1.6200000000000001 111.711 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.08 75.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.39000000000000001 111.423 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.65 -19.3 52.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 2.02 111.066 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -90.5 28.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.42 . . . . 0.76000000000000001 111.25 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -61.66 126.28 26.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 1.46 110.907 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.62 -29.7 23.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.305 -0.407 . . . . 3.3500000000000001 111.075 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.41 ' H ' ' CG2' ' A' ' 127' ' ' VAL . 79.0 mtm180 -137.29 167.1 22.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 2.9199999999999999 110.716 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.94 -13.98 59.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 2.77 110.793 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -90.43 -42.18 11.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 3.77 110.835 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.41 ' CG2' ' H ' ' A' ' 124' ' ' ARG . 18.7 m -65.34 -31.01 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.24 -0.436 . . . . 1.1599999999999999 111.261 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -65.35 -23.68 67.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 2.04 110.97 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -78.59 -25.65 45.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 2.6400000000000001 111.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.46 -52.66 7.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.8999999999999999 111.323 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -60.18 -33.49 72.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.3999999999999999 111.708 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HE2' ' HB3' ' A' ' 183' ' ' TRP . 71.8 t80 -59.13 -48.51 81.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 1.28 110.926 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.1 mt -63.6 -32.46 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 2.1600000000000001 111.199 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.75 -34.64 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.364 . . . . 1.6899999999999999 111.043 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.79 -52.16 44.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.749 . . . . 0.52000000000000002 112.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -64.87 -42.24 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.597 0.237 . . . . 1.02 111.381 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.483 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.9 t -55.41 -40.57 71.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 1.0800000000000001 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.86 98.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.62 110.731 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -63.51 -28.32 69.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 1.8400000000000001 111.134 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 137' ' ' CYS . 93.9 mt -63.21 -60.79 2.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 1.6899999999999999 111.221 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.6 -31.83 44.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.302 -0.408 . . . . 0.81000000000000005 111.34 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.4 mt -75.06 -29.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 2.3700000000000001 111.16 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.9 tp -71.68 -44.08 64.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.97999999999999998 110.811 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -67.38 -27.84 67.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 3.27 110.997 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 1.071 ' HA2' ' OD1' ' A' ' 148' ' ' ASN . . . -83.56 -43.16 7.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.795 -0.717 . . . . 1.25 112.627 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 tt -67.61 -16.54 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.063 0.458 . . . . 2.1200000000000001 110.67 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -91.8 3.62 54.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 110.646 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 1.071 ' OD1' ' HA2' ' A' ' 145' ' ' GLY . 32.1 m120 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.84 -0.618 . . . . 99.989999999999995 111.844 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.935 0.398 . . . . 2.3399999999999999 110.95 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.41 -24.86 63.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.872 -0.604 . . . . 2.77 111.397 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.43 -24.64 53.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 2.04 111.215 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -84.37 -39.03 19.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 2.77 111.576 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 169' ' ' VAL . 2.9 pp -77.42 -26.43 51.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.512 -0.313 . . . . 1.8899999999999999 111.841 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.499 ' N ' HD12 ' A' ' 168' ' ' LEU . 13.4 p -74.9 -26.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.936 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.6 m -65.43 -58.61 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 1.24 111.387 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.16 -31.39 72.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 2.9700000000000002 110.725 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -59.71 -48.86 79.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 1.48 111.06 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 177' ' ' ILE . 41.3 p -62.05 -37.87 86.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 1.55 111.588 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.81 -38.4 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.756 0.313 . . . . 1.52 111.503 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.528 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.0 mt -74.57 -55.1 6.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 1.8500000000000001 111.395 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.48 -31.35 55.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.62 111.634 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 173' ' ' THR . 17.6 tt -87.66 -22.41 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 1.3500000000000001 110.69 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.65 -51.29 59.78 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 113.391 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 84.6 m-85 -58.17 -54.86 51.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.802 0.301 . . . . 1.45 111.737 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 76.6 Cg_exo -48.72 -30.33 16.55 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.112 1.875 . . . . 0.55000000000000004 112.934 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 177' ' ' ILE . 94.3 mt -70.04 -57.46 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 1.4199999999999999 111.788 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.5 m -59.14 -25.72 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.187 -0.461 . . . . 0.78000000000000003 111.703 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.504 ' HB3' ' HE2' ' A' ' 132' ' ' TYR . 24.4 m95 -65.09 -25.95 68.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.505 -0.316 . . . . 0.93999999999999995 111.091 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -53.03 -26.13 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 1.4299999999999999 110.946 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.7 pt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 2.02 110.892 179.63 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.74 0.305 . . . . 2.48 110.926 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.4 -56.73 12.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 2.1800000000000002 110.572 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 75.6 p -62.67 -18.83 63.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 1.49 110.891 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -83.48 -30.66 27.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 1.77 110.911 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.9 tp -80.84 -45.55 16.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.314 -0.403 . . . . 1.4199999999999999 111.272 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -74.55 -0.7 18.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 1.78 111.15 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.404 ' HG ' ' HE2' ' A' ' 11' ' ' TYR . 37.8 t -96.35 -47.47 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.433 0.635 . . . . 1.3 110.31 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.16 -28.57 64.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.225 -0.898 . . . . 0.66000000000000003 112.138 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.718 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 37.5 tp -67.2 -55.35 15.92 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.748 -0.381 . . . . 1.6299999999999999 111.408 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.9 Cg_exo -54.86 -37.73 92.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.622 1.548 . . . . 0.64000000000000001 111.207 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 211' ' ' VAL . 74.4 t80 -63.98 -45.76 87.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.076 -0.511 . . . . 1.3600000000000001 110.04 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -63.55 -17.79 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 1.54 110.554 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.528 ' OG ' HD13 ' A' ' 175' ' ' LEU . 16.1 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 1.2 111.045 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 207' ' ' PHE . 18.3 m . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.736 0.303 . . . . 1.6399999999999999 111.494 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.41 80.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.757 -0.735 . . . . 0.79000000000000004 112.685 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -75.58 -33.18 60.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.6100000000000001 111.223 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.3 m -60.99 -60.69 3.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.429 -0.351 . . . . 1.1499999999999999 110.996 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.04 -26.9 67.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 3.3399999999999999 110.951 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.94 -55.45 33.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.374 -0.375 . . . . 1.1899999999999999 111.392 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.19 -34.31 71.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 2.23 111.285 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.32 -52.23 62.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 2.4700000000000002 111.264 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -83.6 -20.72 33.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.336 -0.393 . . . . 1.6200000000000001 111.123 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.17 -59.15 10.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.887 -0.673 . . . . 1.4099999999999999 112.885 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 52.6 tp . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.596 0.236 . . . . 2.5800000000000001 111.049 -179.721 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.712 0.291 . . . . 2.0699999999999998 111.226 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.81 -53.61 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 2.1000000000000001 110.782 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 77.3 m-70 -65.63 -24.26 67.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.152 -0.476 . . . . 1.0700000000000001 110.782 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -67.18 -50.29 61.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.48 110.836 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.7 -20.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 2.02 110.331 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -61.82 -56.01 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.908 -0.587 . . . . 0.92000000000000004 110.594 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -66.26 -28.45 43.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.075 -0.511 . . . . 0.93999999999999995 111.26 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.08 98.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.55000000000000004 111.254 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.06 -29.27 59.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.762 -0.732 . . . . 0.47999999999999998 112.59 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.48 -39.63 62.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 0.84999999999999998 111.229 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 32.0 p -62.1 -51.12 69.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.468 -0.333 . . . . 1.3400000000000001 110.833 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.05 -23.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 1.55 110.943 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.87 -56.16 24.22 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.873 -0.679 . . . . 0.69999999999999996 112.667 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.87 81.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.81000000000000005 110.932 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.04 -32.31 73.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 2.2599999999999998 110.829 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.58 -28.21 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.78 110.46 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -81.57 -30.17 33.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.992 -0.549 . . . . 4.5800000000000001 110.689 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -60.91 -37.23 81.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.839 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.7 p -83.87 -40.54 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 1.5800000000000001 110.892 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.74 -3.87 40.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 1.8400000000000001 110.61 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 58.5 p -61.0 -23.31 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 1.3700000000000001 111.384 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -49.8 -31.42 11.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.255 0.55 . . . . 4.9800000000000004 109.841 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.487 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 8.3 p30 -173.33 132.29 0.6 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.256 -0.884 . . . . 2.1400000000000001 109.992 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 36.0 Cg_endo -94.52 174.23 1.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.691 2.261 . . . . 1.8200000000000001 112.311 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.48 54.58 2.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 5.1900000000000004 111.255 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.62 -35.58 2.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 2.2000000000000002 112.872 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -79.09 130.27 70.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.603 0.239 . . . . 3.6499999999999999 111.199 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.18 166.5 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.896 2.397 . . . . 2.6699999999999999 113.021 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -70.55 -18.32 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.466 -0.788 . . . . 4.8799999999999999 112.96 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -62.24 -24.47 67.27 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.373 -0.531 . . . . 1.8700000000000001 111.367 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.9 -55.95 8.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 2.6800000000000002 110.339 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -67.31 -21.57 65.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 2.9199999999999999 110.739 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 64.0 tp -59.49 -63.52 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 1.6399999999999999 110.717 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.14 -35.57 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.378 . . . . 1.6000000000000001 110.63 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.8 -5.48 41.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.68999999999999995 111.091 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' B' ' 45' ' ' ILE . 53.5 ttp -88.94 -40.92 12.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.422 . . . . 2.5800000000000001 110.711 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -69.95 -32.76 71.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 3.3900000000000001 111.651 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.581 HG23 HG23 ' B' ' 79' ' ' THR . 87.2 mt -55.58 -54.2 53.97 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.234 0.457 . . . . 0.40999999999999998 112.234 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.449 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.8 Cg_endo -70.14 -31.46 18.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.182 1.921 . . . . 0.48999999999999999 113.342 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 41' ' ' MET . 38.0 mm -61.32 -62.37 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.615 0.245 . . . . 1.29 111.599 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.412 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.7 OUTLIER -57.81 -58.28 9.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 1.3999999999999999 111.164 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -54.71 -31.26 57.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.3799999999999999 111.025 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.8 -60.51 8.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 0.37 112.881 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 42.5 mt -60.14 -28.59 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 1.29 111.252 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -49.69 65.7 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.347 -0.388 . . . . 0.44 111.452 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 20.4 m-85 -63.61 -46.29 86.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.5 111.156 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' MET . . . . . 0.488 ' HB2' HG11 ' B' ' 12' ' ' VAL . 59.7 ttp -48.04 -38.69 17.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.157 0.503 . . . . 1.4099999999999999 110.374 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.93 96.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.55000000000000004 110.92 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 51.2 mtt -52.89 -30.96 37.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.88 -0.6 . . . . 0.5 110.553 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -70.04 -47.4 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.54000000000000004 110.602 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mt -76.8 -1.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.797 -0.638 . . . . 1.3 111.004 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.97 52.14 2.14 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.919 -0.582 . . . . 2.2400000000000002 111.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -115.69 169.32 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 1.77 110.965 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.64 9.99 79.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.814 -0.708 . . . . 1.0600000000000001 112.493 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -117.77 141.8 48.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 2.6600000000000001 110.93 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.62 138.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 1.8899999999999999 111.044 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.32 94.61 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 2.4100000000000001 111.115 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.54 115.84 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.5600000000000001 111.048 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.59 31.45 20.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 1.8200000000000001 111.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.19 84.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.714 -0.755 . . . . 1.51 112.522 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -115.03 124.48 51.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 2.4500000000000002 110.845 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.74 136.28 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 1.79 110.65 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.47 140.58 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.96 0.41 . . . . 0.81999999999999995 111.109 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 50.9 m-70 -84.16 55.89 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 1.05 110.649 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.442 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.7 t80 -58.52 -58.11 10.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.603 -0.726 . . . . 1.8700000000000001 111.679 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.55 -22.31 66.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.60999999999999999 111.974 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.452 ' HB3' ' HB3' ' B' ' 69' ' ' HIS . 14.0 tpp180 -63.52 -51.48 65.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.023 0.379 . . . . 2.3900000000000001 112.023 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 12.9 p90 -77.4 -29.07 52.94 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.87 -0.332 . . . . 3.6699999999999999 111.279 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.442 HG12 ' O ' ' B' ' 70' ' ' TYR . 21.1 mm -51.36 -53.21 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.806 0.336 . . . . 1.6599999999999999 110.682 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.49 -21.49 66.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.082 -0.508 . . . . 1.4099999999999999 109.982 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' TRP . . . . . 0.434 ' O ' HD12 ' B' ' 113' ' ' ILE . 44.4 m0 -86.98 -0.14 56.11 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.958 -0.565 . . . . 1.1599999999999999 111.371 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 55.3 ttm -103.63 -18.64 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.512 . . . . 1.53 110.989 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.403 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.2 m -114.09 -31.01 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.085 0.402 . . . . 0.89000000000000001 112.085 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.581 HG23 HG23 ' B' ' 43' ' ' ILE . 48.0 m -80.82 -50.57 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.844 0.313 . . . . 1.24 111.844 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 28.8 m -53.95 -51.53 76.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.257 0.466 . . . . 0.57999999999999996 112.257 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.3 Cg_endo -56.85 -33.18 94.14 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.733 1.622 . . . . 0.66000000000000003 111.333 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.403 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.6 mm? -75.96 -29.96 58.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.963 -0.562 . . . . 1.0600000000000001 110.132 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 15.5 tp -70.23 -21.48 63.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.315 0.579 . . . . 1.22 109.527 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.639 HD22 ' HG3' ' B' ' 109' ' ' GLN . 2.3 tp -84.86 -44.01 13.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.217 -0.901 . . . . 1.53 110.394 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.66 -35.49 72.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.43 -0.805 . . . . 1.5800000000000001 111.074 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 97.9 p -57.49 -32.6 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 1.3899999999999999 110.898 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.459 HD22 HD21 ' B' ' 168' ' ' LEU . 62.3 mt -64.37 -36.79 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 1.1499999999999999 110.925 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -65.11 -34.95 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 1.5700000000000001 110.986 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -73.74 -38.6 64.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 2.1699999999999999 111.126 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 82.2 p -69.26 -23.32 63.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 1.4199999999999999 111.384 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.57 -13.59 21.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 1.1799999999999999 111.147 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 44.7 tpp -127.2 106.36 9.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 1.8799999999999999 110.778 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -67.62 -59.46 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 3.4199999999999999 110.954 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -128.37 137.67 52.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 4.0599999999999996 110.914 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.27 142.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 2.0899999999999999 111.171 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -129.77 -23.31 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.8500000000000001 110.431 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -142.36 141.46 32.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 4.8200000000000003 110.688 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.04 119.1 12.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 3.7999999999999998 111.047 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -84.7 162.72 19.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.48 . . . . 5.1699999999999999 111.002 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 78.9 p -108.61 -22.23 12.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 2.02 111.019 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.76 -29.14 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 2.0899999999999999 110.698 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.7 pt -64.15 -28.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 1.8799999999999999 110.864 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.45 -39.34 22.43 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.813 -0.708 . . . . 0.56000000000000005 112.547 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -67.75 -22.87 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 1.78 110.705 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' B' ' 84' ' ' LEU . 77.2 mt -81.91 -46.22 14.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 1.03 111.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' MET . . . . . 0.404 ' O ' HG12 ' B' ' 110' ' ' ILE . 53.5 ttp -67.09 -30.31 70.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.005 -0.543 . . . . 1.6699999999999999 110.91 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 64.0 m -73.63 -52.89 11.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 1.51 111.435 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -56.8 -28.24 61.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 1.1799999999999999 111.443 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.639 ' HG3' HD22 ' B' ' 84' ' ' LEU . 26.3 mm-40 -69.81 -44.11 70.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.753 0.311 . . . . 2.1699999999999999 110.56 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.404 HG12 ' O ' ' B' ' 106' ' ' MET . 46.2 mm -54.64 -32.69 25.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.989 0.423 . . . . 1.3500000000000001 110.459 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.03 -42.38 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.886 -0.597 . . . . 1.3400000000000001 110.835 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.76 -46.66 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.42999999999999999 111.266 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.434 HD12 ' O ' ' B' ' 76' ' ' TRP . 37.4 mm -60.91 -33.24 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 1.6000000000000001 111.088 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.471 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 25.0 m -60.19 -45.43 93.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.85999999999999999 111.044 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 76.5 p -68.63 -20.77 64.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.94999999999999996 110.512 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.07 -35.94 26.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.0 -0.619 . . . . 0.46000000000000002 113.264 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.532 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.6 pp -76.82 -29.37 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.74 0.305 . . . . 1.75 111.409 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.532 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.85 -27.13 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 1.78 111.565 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.88 -39.71 68.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.38 111.27 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -82.41 -25.39 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 1.97 111.148 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -86.26 34.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.76000000000000001 111.157 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 71.4 p -65.99 125.26 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.47 110.863 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.622 ' H ' HE22 ' A' ' 58' ' ' GLN . 23.3 mm-40 -89.02 -22.63 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 2.5 111.036 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' B' ' 127' ' ' VAL . 99.8 mtt180 -137.6 160.21 39.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 2.73 110.772 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.9 -15.65 60.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.121 -0.491 . . . . 2.2000000000000002 110.652 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -92.7 -41.55 10.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 3.3999999999999999 111.024 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' B' ' 124' ' ' ARG . 18.6 m -64.0 -24.63 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 1.23 111.112 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.92 -42.27 85.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 3.04 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.66 -30.85 71.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 4.1399999999999997 110.975 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.49 HD23 HD13 ' A' ' 56' ' ' ILE . 59.7 tp -74.84 -53.63 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 1.6499999999999999 111.285 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -61.15 -24.77 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.305 . . . . 0.77000000000000002 111.362 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -67.52 -58.79 4.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.476 -0.329 . . . . 1.46 111.402 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.3 -22.55 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.472 -0.331 . . . . 1.6299999999999999 111.317 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.36 -36.42 68.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 1.4199999999999999 110.728 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.91 -51.28 47.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.48999999999999999 112.09 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.09 -43.2 98.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 1.3 110.923 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.4 -40.49 74.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.294 -0.412 . . . . 1.3 110.167 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.62 110.395 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -71.54 -24.02 61.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 1.74 110.669 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.84 -57.64 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 1.76 110.953 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 37.2 pt -59.2 -35.29 56.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.335 -0.393 . . . . 0.68999999999999995 111.282 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.96 -26.49 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 1.76 110.688 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.68 -39.58 73.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 1.0600000000000001 110.965 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -73.74 -30.73 62.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 4.1200000000000001 111.084 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.38 -33.96 24.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.776 -0.726 . . . . 1.26 112.635 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 tt -73.91 -21.36 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 1.98 110.471 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -90.78 4.15 52.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 1.4199999999999999 111.006 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 111.945 -179.597 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 C--O 1.233 0.186 0 CA-C-O 121.017 0.437 . . . . 2.4300000000000002 110.813 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.434 ' O ' HG23 ' B' ' 169' ' ' VAL . 2.3 t80 -75.21 -23.04 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.909 -0.587 . . . . 2.5800000000000001 111.314 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.26 -54.64 22.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.92 0.39 . . . . 2.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.99 -30.51 71.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 3.0299999999999998 111.112 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.459 HD21 HD22 ' B' ' 87' ' ' LEU . 54.4 tp -68.76 -54.91 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 1.1000000000000001 111.313 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 165' ' ' TYR . 91.9 t -61.96 -29.86 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.75 111.536 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.8 m -53.48 -58.99 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.97999999999999998 111.538 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.64 -29.02 65.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.347 -0.388 . . . . 4.2999999999999998 110.665 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.44 -34.32 77.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 1.3899999999999999 111.319 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.412 ' O ' HG22 ' B' ' 177' ' ' ILE . 41.3 p -76.23 -38.99 55.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.372 -0.376 . . . . 1.1100000000000001 111.512 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.96 -34.44 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.819 0.342 . . . . 1.51 111.041 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' B' ' 209' ' ' SER . 53.4 tp -77.87 -55.68 5.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 1.75 111.024 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -30.71 43.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.59999999999999998 111.006 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.443 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.3 tp -87.82 -23.38 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.002 0.429 . . . . 1.47 110.417 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.17 -55.29 29.0 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.55000000000000004 113.311 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.636 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 92.6 m-85 -56.19 -55.75 38.62 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.896 0.348 . . . . 1.6200000000000001 111.296 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -46.87 -27.77 6.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.172 1.915 . . . . 0.64000000000000001 112.826 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.443 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -74.24 -58.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 1.27 111.715 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.43 HG22 ' O ' ' B' ' 179' ' ' TYR . 26.0 m -58.67 -24.69 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.68999999999999995 111.67 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -63.91 -26.99 68.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.55 -0.296 . . . . 1.1799999999999999 111.246 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 85.5 mt -52.1 -29.52 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.558 -0.292 . . . . 1.77 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 43.4 pt -126.72 155.61 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 1.6899999999999999 111.191 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 C-N-CA 120.917 -0.659 . . . . 1.5800000000000001 112.667 179.79 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.774 0.321 . . . . 2.4700000000000002 111.019 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.15 -56.85 14.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.165 -0.47 . . . . 2.5299999999999998 110.85 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 44.6 p -68.96 -20.02 64.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 1.29 111.301 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.29 -32.93 55.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 2.6200000000000001 111.333 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.46 -43.53 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 1.6100000000000001 111.355 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.66 -9.33 56.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 1.4199999999999999 111.845 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 19.3 p -96.6 -38.03 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 1.4299999999999999 110.597 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 56.1 tp -72.38 -31.69 65.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.692 -0.685 . . . . 1.1200000000000001 112.073 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.8 tp -65.7 -53.91 33.05 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.951 -0.299 . . . . 1.26 111.266 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.8 Cg_exo -54.91 -42.49 68.47 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.785 1.657 . . . . 0.59999999999999998 111.864 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.83 -38.11 89.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 1.3999999999999999 110.684 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.24 -24.36 65.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 1.4099999999999999 110.682 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.545 ' HB2' HD22 ' B' ' 175' ' ' LEU . 86.1 p . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.3200000000000001 111.252 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.634 0.254 . . . . 1.6899999999999999 111.57 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.7 -29.19 74.57 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.79 -0.719 . . . . 0.79000000000000004 112.885 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -74.01 -39.08 63.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.621 0.248 . . . . 2.96 111.358 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' B' ' 218' ' ' LEU . 49.8 m -58.41 -57.65 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.462 -0.335 . . . . 1.29 111.038 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 215' ' ' PHE . . . . . 0.44 ' HA ' HD12 ' B' ' 218' ' ' LEU . 85.6 t80 -63.29 -23.43 67.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 3.1499999999999999 111.094 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -64.2 -56.87 11.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 1.51 111.495 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.74 -33.88 70.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 2.1899999999999999 111.637 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' B' ' 215' ' ' PHE . 87.1 mt -55.29 -50.49 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 1.98 111.063 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.66 -20.53 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.1699999999999999 110.908 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.59 -55.03 25.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.853 -0.689 . . . . 1.3600000000000001 113.084 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 C--N 1.326 -0.44 0 CA-C-O 120.704 0.288 . . . . 2.8999999999999999 111.432 -179.382 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.949 0.404 . . . . 2.52 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 7' ' ' LEU . . . . . 0.441 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.3 mm? -70.34 -45.38 66.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 1.9299999999999999 110.929 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 64.2 m-70 -71.83 -24.35 61.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 1.26 110.7 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.44 ' O ' HG12 ' C' ' 12' ' ' VAL . 61.9 t-105 -66.91 -53.72 29.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 1.6699999999999999 110.564 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -64.9 -21.8 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.99 0.424 . . . . 1.8700000000000001 110.291 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' TYR . . . . . 0.433 ' HE2' ' HG ' ' C' ' 203' ' ' CYS . 0.1 OUTLIER -57.29 -59.51 5.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.601 -0.727 . . . . 1.4399999999999999 110.5 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' C' ' 52' ' ' MET . 8.4 p -61.59 -30.86 49.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.013 -0.54 . . . . 0.46999999999999997 110.967 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.06 78.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.313 -0.403 . . . . 0.58999999999999997 111.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.62 -23.77 77.61 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.688 -0.767 . . . . 0.5 112.834 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.6 mmt -77.52 -45.2 26.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.68000000000000005 111.33 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.9 p -59.29 -50.03 75.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.354 -0.384 . . . . 1.3999999999999999 110.997 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -30.88 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 1.55 110.666 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.72 -60.22 9.39 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.877 -0.677 . . . . 0.70999999999999996 112.589 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -30.86 63.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.812 0.339 . . . . 0.77000000000000002 111.007 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.67 -33.14 70.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.9299999999999999 110.648 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -60.71 -31.21 70.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 1.8600000000000001 110.52 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -74.45 -29.93 61.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.994 -0.548 . . . . 4.1399999999999997 110.793 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -62.82 -39.02 93.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 3.1499999999999999 110.761 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -84.47 -39.09 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 1.95 110.865 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 tp -74.54 -9.21 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 2.2200000000000002 110.72 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 53.9 p -58.16 -24.92 60.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 1.3700000000000001 111.309 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -48.14 -33.53 8.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.204 0.526 . . . . 5.0300000000000002 109.794 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.7 p-10 -171.08 132.46 0.86 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.276 -0.874 . . . . 2.3700000000000001 109.794 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 19.5 Cg_endo . . . . . 0 N--CA 1.453 -0.876 0 C-N-CA 122.732 2.288 . . . . 2.0499999999999998 112.214 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 19.2 Cg_exo . . . . . 0 N--CA 1.466 -0.121 0 CA-C-O 121.261 0.442 . . . . 1.9299999999999999 112.197 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.7 -18.67 64.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 4.1200000000000001 112.965 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.521 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -55.13 -36.74 66.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.969 0.414 . . . . 2.8900000000000001 110.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.73 -48.93 72.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 2.46 110.734 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.06 -19.05 62.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 2.7799999999999998 110.695 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.88 -63.42 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 1.6200000000000001 110.435 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.33 -32.09 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 1.5900000000000001 110.836 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.67 -6.32 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.65000000000000002 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.442 ' O ' HG12 ' C' ' 45' ' ' ILE . 53.7 ttp -89.83 -43.46 10.62 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.978 -0.556 . . . . 1.6699999999999999 111.392 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -73.07 -39.51 65.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.142 0.423 . . . . 3.4199999999999999 112.142 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.565 HG23 HG23 ' C' ' 79' ' ' THR . 96.6 mt -50.64 -50.6 71.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.255 0.465 . . . . 0.89000000000000001 112.255 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.6 -36.14 6.97 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.113 1.875 . . . . 0.40999999999999998 113.142 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' C' ' 41' ' ' MET . 28.9 mm -57.41 -62.74 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.821 0.343 . . . . 1.76 111.469 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -56.56 -57.12 13.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 2.1600000000000001 111.241 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 47.1 m -51.96 -36.45 49.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 1.1699999999999999 111.134 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.71 -53.02 38.34 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 0.44 112.486 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.402 ' O ' ' HG3' ' C' ' 52' ' ' MET . 4.2 mm? -59.67 -35.92 75.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.414 . . . . 1.29 111.002 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -34.15 75.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.5 111.444 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.3 m-85 -70.6 -57.58 4.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 1.8300000000000001 111.542 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' MET . . . . . 0.58 ' HB3' HG11 ' C' ' 12' ' ' VAL . 5.0 ppp? -48.74 -30.72 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.89 0.376 . . . . 1.47 110.707 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.9 80.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.59999999999999998 110.826 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 58.0 mtt -54.54 -30.8 54.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.124 -0.489 . . . . 0.83999999999999997 110.546 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.59 -50.62 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 111.133 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.37 5.94 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 1.55 111.186 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.3 54.94 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 1.54 111.106 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.506 HE21 HD11 ' A' ' 118' ' ' ILE . 57.5 tp60 -123.69 139.64 53.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 1.79 111.028 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.63 -7.66 29.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.804 -0.713 . . . . 0.93999999999999995 112.664 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -103.04 166.14 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.712 0.291 . . . . 2.3599999999999999 110.944 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.73 145.91 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.97 110.998 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -93.51 95.11 9.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.144 -0.48 . . . . 2.4399999999999999 110.953 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.42 107.37 19.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 1.54 111.136 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 33.24 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 1.71 111.389 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.65 2.1 88.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 1.53 112.606 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -102.44 152.23 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 2.23 110.942 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 33.2 mt -105.54 114.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 1.3600000000000001 110.833 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.12 142.42 27.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.78000000000000003 111.547 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.488 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 47.6 m-70 -84.24 58.81 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.884 -0.598 . . . . 1.0800000000000001 110.478 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' TYR . . . . . 0.495 ' O ' HG12 ' C' ' 74' ' ' ILE . 69.8 t80 -58.69 -58.53 8.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.535 -0.757 . . . . 2.2999999999999998 111.938 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.85 67.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.204 0.446 . . . . 0.75 112.204 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.7 tpp180 -61.64 -51.63 67.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.919 0.34 . . . . 1.51 111.919 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.443 ' O ' ' HG3' ' C' ' 77' ' ' MET . 14.0 p90 -78.13 -28.42 48.45 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.844 -0.342 . . . . 4.6500000000000004 111.039 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.495 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.4 mm -47.31 -56.74 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 120.744 0.307 . . . . 1.22 110.907 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.35 -28.78 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.268 -0.424 . . . . 1.3100000000000001 110.129 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -81.4 8.02 10.31 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.085 -0.507 . . . . 1.6799999999999999 111.172 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.551 ' HA ' HD13 ' C' ' 113' ' ' ILE . 18.9 mtp -104.52 -25.22 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 1.8 110.458 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.44 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 24.7 m -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 1.1899999999999999 111.979 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.565 HG23 HG23 ' C' ' 43' ' ' ILE . 85.1 m -67.12 -58.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.065 0.394 . . . . 1.23 112.065 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 12.6 m -47.94 -52.43 40.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.58999999999999997 112.043 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 63.3 Cg_exo -51.95 -44.4 45.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.822 1.681 . . . . 0.67000000000000004 111.794 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 98.6 mt -66.02 -32.89 74.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 0.95999999999999996 110.555 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -31.69 64.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 1.1899999999999999 109.766 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.471 HD11 ' NE2' ' C' ' 109' ' ' GLN . 19.8 mt -77.83 -44.83 26.15 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.7 110.112 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -50.38 -42.0 52.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.446 -0.797 . . . . 1.6200000000000001 110.384 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.412 ' O ' HG23 ' C' ' 90' ' ' THR . 43.2 t -57.62 -34.23 69.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 1.26 110.945 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 40.7 mt -65.39 -36.74 84.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 1.1100000000000001 111.359 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 69.2 p -69.64 -26.19 64.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 1.51 110.95 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -80.58 -34.83 35.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 2.0600000000000001 111.153 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' THR . . . . . 0.412 HG23 ' O ' ' C' ' 86' ' ' SER . 66.6 p -67.87 -26.68 66.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 1.52 111.049 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.65 -44.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 1.3 111.101 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.02 105.62 17.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 1.6200000000000001 111.092 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -80.47 -12.09 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 3.2400000000000002 110.828 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -162.7 137.44 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 4.6299999999999999 110.557 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.8 tt -108.23 144.49 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 2.1800000000000002 111.17 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -131.72 -25.85 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 4.1200000000000001 110.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -146.17 137.58 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 4.96 110.38 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.63 124.45 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 3.9100000000000001 111.326 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -92.84 162.4 14.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 5.21 110.98 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -103.58 -21.42 13.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 1.8200000000000001 110.705 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.413 HD22 ' N ' ' C' ' 101' ' ' LEU . 3.8 mm? -60.3 -31.75 70.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 2.0800000000000001 110.67 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -62.15 -33.15 57.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 1.8600000000000001 110.932 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.08 -27.51 60.02 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.861 -0.685 . . . . 0.58999999999999997 112.098 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -64.84 -39.78 94.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.892 0.377 . . . . 1.53 110.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.88 -50.09 25.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.1100000000000001 111.126 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 106' ' ' MET . . . . . 0.412 ' O ' HG13 ' C' ' 110' ' ' ILE . 12.6 tpt -56.88 -41.58 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.785 -0.643 . . . . 2.21 111.514 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t -66.38 -59.38 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 1.28 111.156 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.501 ' HB ' HD12 ' C' ' 142' ' ' ILE . 42.9 p -53.6 -26.4 21.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.22 111.326 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.471 ' NE2' HD11 ' C' ' 84' ' ' LEU . 6.9 tp-100 -68.17 -47.98 66.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 2.3300000000000001 110.923 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.412 HG13 ' O ' ' C' ' 106' ' ' MET . 49.3 mt -55.26 -31.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 1.29 110.635 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.24 -45.74 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.814 -0.63 . . . . 1.0600000000000001 111.118 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.2 -47.77 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.125 -0.489 . . . . 0.51000000000000001 111.079 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.551 HD13 ' HA ' ' C' ' 77' ' ' MET . 60.6 mt -57.53 -35.7 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 1.3700000000000001 110.848 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 18.3 m -57.15 -45.88 83.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.062 0.458 . . . . 0.77000000000000002 110.695 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 115' ' ' SER . . . . . 0.447 ' HA ' HG22 ' C' ' 118' ' ' ILE . 62.9 m -69.25 -23.22 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 1.1899999999999999 110.798 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.31 -32.67 42.25 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.983 -0.627 . . . . 0.5 113.048 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.491 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.4 pp -82.54 -28.51 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 1.47 111.396 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.491 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.7 tp -83.92 -26.23 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 1.2 111.483 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.1 70.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.4 . . . . 0.40000000000000002 111.258 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -84.89 -12.96 52.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 2.1200000000000001 110.802 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.43 ' HB2' HD12 ' C' ' 118' ' ' ILE . 96.0 mt -95.88 26.6 3.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.75 111.192 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 67.5 m -65.16 122.24 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.356 . . . . 1.3799999999999999 110.876 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -86.62 -17.04 34.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 2.7400000000000002 110.916 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' ARG . . . . . 0.434 ' HB2' HG13 ' C' ' 127' ' ' VAL . 98.5 mtt180 -137.01 169.14 18.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 2.7999999999999998 110.946 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.88 -17.13 38.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 2.4100000000000001 110.814 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -90.88 -39.19 12.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 4.2000000000000002 110.549 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' C' ' 124' ' ' ARG . 27.3 m -63.69 -26.91 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 1.0800000000000001 111.117 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -66.53 -34.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.973 -0.558 . . . . 2.5699999999999998 110.994 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -73.87 -27.02 60.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 3.8100000000000001 110.839 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.08 -41.61 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 1.4199999999999999 111.227 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -71.72 -31.04 66.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.89000000000000001 111.052 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -63.69 -58.72 6.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 1.26 110.817 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.08 -29.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.402 . . . . 1.6799999999999999 111.041 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.12 -38.62 88.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 1.24 110.892 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.84 -54.47 21.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.898 -0.668 . . . . 0.54000000000000004 112.604 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.56 -30.67 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.618 0.247 . . . . 1.0600000000000001 111.236 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.38 -47.65 83.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 1.0800000000000001 110.514 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.52 -30.16 71.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.56999999999999995 110.861 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.6 -20.51 61.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 1.6799999999999999 110.586 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.48 -55.67 5.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 1.7 111.028 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 36.2 pt -58.79 -35.92 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.356 -0.384 . . . . 0.78000000000000003 111.891 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.501 HD12 ' HB ' ' C' ' 108' ' ' THR . 17.6 tt -75.94 -23.71 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 2.2400000000000002 111.114 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.13 -48.33 73.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.361 -0.381 . . . . 1.02 110.764 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -68.62 -32.89 73.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 3.0 110.761 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.38 -39.51 61.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 1.27 112.452 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -75.21 -19.93 16.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.161 0.505 . . . . 1.8899999999999999 110.36 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -88.87 3.0 52.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.586 -0.734 . . . . 1.6000000000000001 110.383 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 99.989999999999995 111.96 -179.324 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.948 0.404 . . . . 2.3500000000000001 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.24 -22.95 63.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 2.6200000000000001 111.138 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 -38.9 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.333 -0.394 . . . . 2.0899999999999999 110.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -81.72 -23.47 36.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 3.2400000000000002 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.47 -41.02 41.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 1.6899999999999999 111.254 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.42 -24.49 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 1.3999999999999999 111.377 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 170' ' ' THR . . . . . 0.434 ' O ' HG23 ' C' ' 174' ' ' VAL . 38.9 m -59.64 -58.88 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.95999999999999996 111.309 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -67.89 -31.86 71.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 3.6499999999999999 110.766 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.0 -38.51 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 1.3700000000000001 111.639 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.432 ' O ' HG22 ' C' ' 177' ' ' ILE . 38.7 p -73.21 -33.78 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.426 -0.352 . . . . 1.4299999999999999 111.657 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 174' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 170' ' ' THR . 62.5 t -60.93 -37.11 76.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.555 -0.293 . . . . 1.6200000000000001 111.773 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.25 -45.5 16.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 2.0299999999999998 111.344 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 176' ' ' TRP . . . . . 0.404 ' CZ2' HD21 ' C' ' 84' ' ' LEU . 0.9 OUTLIER -57.77 -31.79 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.464 -0.335 . . . . 0.62 110.691 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.434 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.2 tt -87.96 -20.64 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.5800000000000001 110.211 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.49 -56.72 23.58 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.753 -0.658 . . . . 0.56000000000000005 113.407 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.636 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 87.8 m-85 -54.21 -54.42 47.97 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.755 0.278 . . . . 1.3300000000000001 111.437 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.9 Cg_exo -47.09 -30.9 10.88 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.139 1.892 . . . . 0.63 112.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.499 ' O ' HG12 ' C' ' 184' ' ' ILE . 88.2 mt -70.7 -60.49 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.93000000000000005 111.639 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.491 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.6 m -56.18 -24.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.407 0.521 . . . . 1.27 112.407 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -65.69 -17.4 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.429 0.529 . . . . 1.77 112.429 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.586 HG13 HG23 ' C' ' 185' ' ' ILE . 22.5 pt -65.67 -13.19 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.659 0.266 . . . . 2.3900000000000001 111.563 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 185' ' ' ILE . . . . . 0.586 HG23 HG13 ' C' ' 184' ' ' ILE . 31.0 pt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.424 -0.353 . . . . 1.95 111.28 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.1 m . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.829 0.347 . . . . 2.3799999999999999 110.807 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 46.9 mm -72.49 -48.26 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 2.23 111.279 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.3 -51.96 64.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 2.1600000000000001 111.077 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 87.7 m -64.72 -25.16 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 1.27 111.424 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -82.47 -27.68 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 1.7 111.696 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.87 -48.29 10.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.636 0.255 . . . . 2.02 111.402 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -69.17 1.44 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 1.8200000000000001 111.211 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.433 ' HG ' ' HE2' ' C' ' 11' ' ' TYR . 51.2 t -96.27 -48.8 5.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 1.3500000000000001 110.7 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.8 -30.57 65.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.65000000000000002 111.95 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.659 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 44.6 tp -62.19 -54.62 48.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 120.966 -0.293 . . . . 1.4199999999999999 111.49 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 46.3 Cg_exo -57.3 -41.8 69.21 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.65 1.566 . . . . 0.63 111.516 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.42 -32.01 73.32 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.273 -0.421 . . . . 1.49 110.502 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.75 -25.2 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 1.7 110.839 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 1.25 111.012 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.8 0.333 . . . . 1.6100000000000001 111.479 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.04 -31.65 81.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.74 -0.743 . . . . 0.81999999999999995 112.656 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -75.2 -29.16 60.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.781 0.324 . . . . 3.0800000000000001 111.08 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -63.78 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 1.1499999999999999 111.065 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -62.71 -23.26 67.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 2.5600000000000001 110.977 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.73 -47.37 85.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.971 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -66.78 -35.41 80.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.414 -0.357 . . . . 2.3900000000000001 111.003 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.31 -43.28 88.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 2.0299999999999998 111.01 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -87.44 -19.92 27.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 3.21 110.94 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.69 31.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.993 -0.622 . . . . 1.3600000000000001 113.08 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.555 0.217 . . . . 2.8999999999999999 111.417 -179.354 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.857 0.361 . . . . 2.4199999999999999 110.808 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.36 -42.86 99.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.147 -0.479 . . . . 2.0899999999999999 110.971 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 25.6 m170 -62.94 -35.88 81.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 1.1599999999999999 110.779 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -69.04 -52.47 28.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.79000000000000004 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.0 mt -56.19 -34.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.007 0.432 . . . . 2.0800000000000001 110.407 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.493 ' O ' ' HG2' ' A' ' 15' ' ' MET . 20.1 t80 -57.45 -42.15 81.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 1.28 109.826 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 8' ' ' HIS . 3.1 t -57.25 -48.38 82.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.3200000000000001 111.229 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.06 -44.95 83.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.63 111.681 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.31 94.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.55000000000000004 112.705 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 56.0 mmm -69.16 -32.92 72.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 1.03 110.992 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -60.83 -60.33 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 1.3 111.449 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -57.2 -26.1 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.348 -0.387 . . . . 1.3100000000000001 111.268 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -59.49 -48.55 85.44 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.571 -0.823 . . . . 0.77000000000000002 112.328 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.05 -23.22 63.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 0.80000000000000004 111.01 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.32 -44.13 84.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 1.8100000000000001 110.921 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.94 -20.93 60.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.8799999999999999 110.997 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.83 -48.19 80.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 4.4500000000000002 110.891 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.506 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.1 m-90 -71.55 -35.52 70.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 3.6899999999999999 110.88 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.0 m -70.47 -20.65 62.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 1.5700000000000001 111.333 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 tp -86.18 -10.63 54.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 1.95 111.117 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 52.3 p -65.4 -23.05 66.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.385 -0.37 . . . . 1.3799999999999999 111.152 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -47.07 -32.69 4.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.261 0.553 . . . . 4.0700000000000003 109.699 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -174.18 132.45 0.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.092 -0.958 . . . . 2.7200000000000002 110.216 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -92.47 140.8 2.12 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.777 2.318 . . . . 1.9099999999999999 112.07 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -81.28 72.83 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 4.7599999999999998 111.601 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.76 -46.9 3.19 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.106 -0.568 . . . . 1.99 113.435 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.37 140.52 21.71 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.792 0.296 . . . . 2.7000000000000002 111.222 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.44 165.56 12.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.552 2.168 . . . . 1.79 112.131 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 5.2 pm0 -63.5 -18.6 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 4.1200000000000001 112.233 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -48.09 -36.29 12.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.754 0.311 . . . . 2.9300000000000002 111.317 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.11 -53.33 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.909 0.385 . . . . 2.8799999999999999 110.461 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -68.27 -18.45 64.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 4.6600000000000001 110.669 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.08 -52.87 63.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.189 -0.459 . . . . 1.45 110.406 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 t -65.85 -36.78 78.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.155 0.502 . . . . 1.78 109.795 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.38 -8.37 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.623 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.476 ' O ' HG12 ' A' ' 45' ' ' ILE . 22.4 ttt -88.68 -36.98 15.9 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.2 -0.454 . . . . 1.48 110.746 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -67.99 -32.8 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 3.5 111.222 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 79' ' ' THR . 68.5 mt -56.88 -55.01 48.12 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.307 0.484 . . . . 1.0800000000000001 112.307 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 36.7 Cg_endo -65.38 -33.94 45.8 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.295 1.996 . . . . 0.53000000000000003 113.442 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 41' ' ' MET . 38.8 mm -55.26 -62.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.881 0.326 . . . . 1.6799999999999999 111.881 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.454 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.8 t90 -66.06 -47.89 72.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 1.8300000000000001 110.981 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -61.81 -9.79 7.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 1.0900000000000001 111.238 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.31 -59.53 2.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.40999999999999998 112.134 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.36 -26.95 65.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 0.98999999999999999 110.704 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -51.52 69.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.47999999999999998 110.79 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 27.7 m-85 -69.65 -26.36 64.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 1.8700000000000001 110.938 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -56.42 -36.78 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.514 -0.55 . . . . 1.49 109.514 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -73.16 -44.15 60.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.538 -0.755 . . . . 0.58999999999999997 110.85 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.443 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 51.6 mtt -51.5 -26.48 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.48999999999999999 110.597 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.11 -47.28 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.59999999999999998 111.211 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -84.18 14.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 1.3100000000000001 111.545 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 57.31 55.76 5.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.027 -0.533 . . . . 1.9099999999999999 111.223 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 16.8 mm-40 -125.22 173.01 9.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 1.6200000000000001 110.716 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.45 66.48 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.593 -0.813 . . . . 1.04 112.155 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.75 173.98 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 2.6800000000000002 110.709 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.12 132.49 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 1.98 111.355 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -101.23 88.54 3.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 2.1800000000000002 110.625 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.06 131.72 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.5700000000000001 111.2 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 27.71 17.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.066 -0.515 . . . . 1.79 111.408 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.24 -11.27 37.9 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.713 -0.756 . . . . 1.48 112.643 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -97.87 149.74 22.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.34 . . . . 2.3199999999999998 110.899 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.3 mt -94.15 117.33 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 1.4399999999999999 110.939 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.26 144.83 30.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.81999999999999995 111.233 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.3 m-70 -88.68 68.89 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.90000000000000002 110.958 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.15 -35.71 75.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 1.8300000000000001 111.102 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -73.46 -24.19 60.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.62 111.971 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.7 tpp180 -69.29 -51.71 34.59 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.335 0.494 . . . . 2.3399999999999999 112.335 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -81.23 -31.1 34.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.207 0.447 . . . . 3.4900000000000002 112.207 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 71' ' ' ALA . 10.6 tp -57.53 -43.91 83.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.762 -0.375 . . . . 1.3700000000000001 110.537 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 74' ' ' ILE . 13.3 t70 -68.85 -20.3 64.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.498 -0.556 . . . . 1.3100000000000001 109.498 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -87.7 1.22 54.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.672 -0.694 . . . . 1.48 111.169 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.411 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 56.6 ttm -104.61 -18.71 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 1.46 110.915 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 82' ' ' LEU . 30.0 m -114.11 -32.06 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 1.1200000000000001 111.904 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 43' ' ' ILE . 27.9 m -82.9 -41.38 18.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.898 0.333 . . . . 1.1000000000000001 111.898 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 72.4 m -60.19 -50.27 86.86 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.945 0.35 . . . . 0.59999999999999998 111.945 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 44.9 Cg_exo -56.69 -32.92 92.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.074 1.849 . . . . 0.73999999999999999 112.437 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 78' ' ' VAL . 7.3 mp -82.94 -16.97 45.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.115 -0.493 . . . . 1.01 110.845 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -72.91 -47.03 49.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 1.48 109.948 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 85' ' ' LEU . 3.6 pp -74.92 -29.47 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.555 . . . . 1.3799999999999999 110.988 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 84' ' ' LEU . 9.7 tp -64.03 -36.47 84.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.018 -0.537 . . . . 1.1899999999999999 110.798 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -61.94 -24.41 66.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 1.23 110.554 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.68 -34.01 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.88 110.793 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.5 p -71.28 -28.42 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 1.3899999999999999 110.52 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.86 -26.82 29.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.3199999999999998 110.985 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -81.37 -25.7 36.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.244 -0.435 . . . . 1.46 110.966 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.5 -35.24 12.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.277 -0.419 . . . . 1.24 111.263 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 71.4 mtm -118.18 111.1 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 2.0699999999999998 111.144 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.75 -24.45 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 3.5299999999999998 110.69 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -137.12 141.03 42.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 4.0800000000000001 110.659 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.7 pt -128.39 143.95 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 2.1699999999999999 111.407 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.917 -0.583 . . . . 4.5199999999999996 110.606 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.42 52.45 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.467 . . . . 3.75 110.992 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -135.29 93.69 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 3.5299999999999998 110.858 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -71.65 80.5 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 4.9100000000000001 111.097 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.4 m -120.6 -60.56 1.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.324 -0.398 . . . . 1.98 111.179 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.29 -58.84 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 1.8300000000000001 111.081 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.2 tt -56.55 -36.38 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 1.79 111.24 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.15 -30.63 73.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.62 112.809 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.3 -48.95 75.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.745 0.307 . . . . 1.5800000000000001 110.991 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.97 -43.66 98.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.97999999999999998 111.506 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.412 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 89.4 mtp -56.43 -39.68 73.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 1.48 111.666 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.2 m -71.7 -45.67 61.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.959 0.409 . . . . 1.1299999999999999 111.204 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.419 ' HB ' HD13 ' A' ' 142' ' ' ILE . 68.2 p -64.85 -20.28 66.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 1.48 111.618 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 110' ' ' ILE . 3.0 pt20 -77.76 -41.49 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.586 0.231 . . . . 2.7000000000000002 110.796 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.67 HG22 ' HE1' ' C' ' 46' ' ' TRP . 43.2 mt -61.2 -33.05 54.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.947 0.403 . . . . 1.54 110.807 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.17 -47.88 76.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.916 -0.584 . . . . 1.28 111.219 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.85 -44.07 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.223 -0.444 . . . . 0.42999999999999999 111.457 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 109' ' ' GLN . 74.8 mt -54.77 -40.28 51.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.776 0.322 . . . . 1.74 110.864 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 117' ' ' LEU . 99.0 m -60.15 -39.79 87.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.63 110.913 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -57.72 -57.31 13.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 1.0900000000000001 110.123 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.8 -14.25 65.01 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.985 -0.626 . . . . 0.41999999999999998 112.199 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 114' ' ' THR . 10.0 tt -70.29 -56.41 6.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 1.3799999999999999 110.724 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.432 ' HB ' ' NE1' ' A' ' 131' ' ' TRP . 67.1 mt -83.73 -22.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.004 -0.543 . . . . 1.6200000000000001 111.563 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HA ' ' HD1' ' A' ' 131' ' ' TRP . . . -49.7 -40.13 39.26 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.849 0.357 . . . . 0.39000000000000001 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.73 -21.48 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.02 110.479 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.3 mt -91.87 31.87 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.76000000000000001 110.775 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 t -88.02 128.14 35.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 1.46 110.634 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.59 -69.77 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 3.3500000000000001 111.282 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.683 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.6 ttp180 -74.4 136.94 42.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 2.9199999999999999 111.06 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.67 -9.88 58.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 2.77 111.181 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.683 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 64.1 t-105 -80.2 -46.65 15.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 3.77 110.804 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HB ' HH21 ' A' ' 124' ' ' ARG . 13.3 p -77.19 -23.99 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 1.1599999999999999 111.448 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -56.88 -32.09 65.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 2.04 111.396 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -72.05 -25.24 61.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 2.6400000000000001 111.342 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.551 HD23 HG21 ' C' ' 56' ' ' ILE . 30.8 tp -83.49 -48.18 10.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.538 -0.301 . . . . 1.8999999999999999 111.32 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.432 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 50.4 t-105 -59.88 -28.13 67.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 1.3999999999999999 110.626 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.29 -44.33 79.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 1.28 110.666 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.48 -29.22 44.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 2.1600000000000001 110.815 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 69.2 m -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 1.6899999999999999 110.717 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.8 -56.89 12.43 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.52000000000000002 112.465 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 m -56.25 -33.17 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 1.02 111.092 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.2 t -61.69 -37.08 82.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 1.0800000000000001 110.465 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.18 93.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.802 -0.635 . . . . 0.62 110.625 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.4 -14.88 58.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 1.8400000000000001 110.518 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 140' ' ' LEU . 0.5 OUTLIER -65.85 -56.91 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 1.6899999999999999 110.162 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.9 pt -66.27 -37.47 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.81000000000000005 110.839 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.419 HD13 ' HB ' ' A' ' 108' ' ' THR . 96.6 mt -65.97 -35.96 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 2.3700000000000001 110.801 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.52 -43.49 93.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.97999999999999998 110.339 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.525 ' O ' ' OD1' ' A' ' 148' ' ' ASN . 88.3 t90 -64.49 -28.61 69.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.596 . . . . 3.27 110.434 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 1.222 ' HA2' ' OD1' ' A' ' 148' ' ' ASN . . . -80.25 -33.34 32.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 1.25 112.456 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.54 -24.71 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 2.1200000000000001 110.443 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -88.89 5.05 45.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.863 -0.608 . . . . 1.6599999999999999 111.057 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 1.222 ' OD1' ' HA2' ' A' ' 145' ' ' GLY . 32.0 m120 . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 99.989999999999995 112.283 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.752 0.31 . . . . 2.3399999999999999 110.998 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.422 ' O ' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -79.45 -31.17 42.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.525 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.54 -44.01 97.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 2.04 111.0 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.4 -19.72 38.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 2.77 111.479 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 42.7 tp -80.65 -39.96 26.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.978 0.362 . . . . 1.8899999999999999 111.978 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 165' ' ' TYR . 14.8 p -75.37 -31.23 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.361 0.504 . . . . 1.6399999999999999 112.361 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 174' ' ' VAL . 6.4 t -57.79 -44.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.712 0.291 . . . . 1.24 111.369 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.4 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 74.5 m-85 -77.09 -28.12 54.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.749 0.309 . . . . 2.9700000000000002 110.612 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -65.56 -46.49 79.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.51 . . . . 1.48 111.216 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -64.11 -40.31 95.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 1.55 111.51 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 170' ' ' THR . 84.4 t -57.52 -35.32 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.804 0.335 . . . . 1.52 111.217 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 73.0 mt -74.26 -57.56 3.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.391 -0.368 . . . . 1.8500000000000001 111.434 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.63 -25.93 54.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.62 111.181 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.469 ' O ' HG12 ' A' ' 181' ' ' ILE . 31.1 mm -87.7 -27.38 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 1.3500000000000001 110.272 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.92 -53.88 34.26 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.58999999999999997 113.172 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.668 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 80.4 m-85 -56.42 -57.24 24.39 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.884 0.342 . . . . 1.45 111.495 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.668 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 86.0 Cg_exo -44.4 -30.36 3.73 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.215 1.943 . . . . 0.55000000000000004 112.96 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -68.19 -58.31 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 1.4199999999999999 111.405 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 179' ' ' TYR . 21.3 m -59.94 -24.96 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.78000000000000003 111.614 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -70.27 -22.69 62.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.531 -0.304 . . . . 0.93999999999999995 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 92.4 mt -56.35 -41.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.4299999999999999 111.424 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 27.9 pt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.42 -0.354 . . . . 2.02 111.392 -179.85 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.665 0.269 . . . . 2.48 111.269 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.77 -60.97 2.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 2.1800000000000002 111.081 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 8.2 t -61.8 -22.29 65.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 1.49 111.461 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.51 -32.32 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 1.77 110.942 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 40.9 tp -83.99 -42.58 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.4199999999999999 111.577 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -70.16 0.35 6.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.751 -0.204 . . . . 1.78 111.458 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.19 -45.65 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.202 0.525 . . . . 1.3 110.466 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.53 -34.04 67.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 0.66000000000000003 111.92 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.691 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 55.1 tp -59.8 -54.6 54.01 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.855 -0.338 . . . . 1.6299999999999999 111.2 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 46.6 Cg_exo -57.63 -35.53 98.8 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.629 1.553 . . . . 0.64000000000000001 111.094 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.416 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 55.4 t80 -60.31 -31.88 70.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.119 -0.491 . . . . 1.3600000000000001 110.018 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -82.22 -19.16 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 1.54 110.591 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 1.2 110.806 -179.928 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.736 0.303 . . . . 1.6399999999999999 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.66 -34.98 71.63 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.897 -0.668 . . . . 0.79000000000000004 112.763 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -71.21 -35.19 71.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.639 0.257 . . . . 1.6100000000000001 111.226 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 40.5 t -55.93 -58.2 8.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 1.1499999999999999 110.873 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -66.97 -20.44 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.3399999999999999 110.821 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -67.2 -58.66 4.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.1899999999999999 110.815 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 -28.3 64.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 2.23 110.969 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.21 -45.53 84.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.192 -0.458 . . . . 2.4700000000000002 110.742 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -77.42 -28.25 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 1.6200000000000001 110.754 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.42 -23.34 68.37 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 1.4099999999999999 112.185 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 2.5800000000000001 110.737 179.86 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.823 0.344 . . . . 2.0699999999999998 110.815 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.452 HD12 HD11 ' B' ' 10' ' ' ILE . 24.4 tp -70.51 -39.44 74.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 2.1000000000000001 111.219 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.6 m80 -71.52 -31.19 66.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0700000000000001 110.86 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -65.33 -57.97 7.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 1.48 111.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.452 HD11 HD12 ' B' ' 7' ' ' LEU . 35.8 pt -55.38 -31.37 27.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.584 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -59.66 -36.36 76.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.621 -0.718 . . . . 0.92000000000000004 109.672 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' B' ' 52' ' ' MET . 3.2 t -66.93 -49.86 70.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.93999999999999995 111.047 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.64 69.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.55000000000000004 111.653 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.28 83.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.639 -0.791 . . . . 0.47999999999999998 112.422 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -76.43 -34.56 58.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.625 0.25 . . . . 0.84999999999999998 111.573 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -62.63 -49.38 75.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.722 0.296 . . . . 1.3400000000000001 111.467 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.439 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -61.55 -36.0 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 1.55 110.683 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -49.75 56.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.728 -0.749 . . . . 0.69999999999999996 112.847 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.74 65.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 0.81000000000000005 111.474 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.93 -36.15 75.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 2.2599999999999998 110.971 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -63.28 -21.55 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 1.78 110.515 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -60.8 -40.83 94.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 4.5800000000000001 110.864 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -73.18 -41.89 63.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 3.3500000000000001 111.004 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 77.7 p -71.12 -19.5 62.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 1.5800000000000001 111.466 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.95 -7.85 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 1.8400000000000001 111.265 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 89.8 p -69.54 -22.48 63.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.482 -0.326 . . . . 1.3700000000000001 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -47.51 -36.41 10.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.292 0.568 . . . . 4.9800000000000004 109.774 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.4 p-10 -171.84 132.35 0.77 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 2.1400000000000001 109.988 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 55.5 Cg_endo -94.86 154.35 1.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.96 2.44 . . . . 1.8200000000000001 112.24 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -85.13 63.5 8.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 5.1900000000000004 110.912 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.78 -39.79 2.22 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.765 -0.731 . . . . 2.2000000000000002 112.508 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.56 129.0 35.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.381 0.134 . . . . 3.6499999999999999 111.142 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 32.2 Cg_exo -57.69 160.88 13.53 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.29 1.993 . . . . 2.6699999999999999 111.854 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.49 -18.06 57.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.788 -0.642 . . . . 4.8799999999999999 112.517 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' B' ' 38' ' ' LEU . 2.9 p90 -46.78 -36.74 7.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.938 0.399 . . . . 1.8700000000000001 111.046 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -66.82 -47.32 72.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 2.6800000000000002 110.231 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -70.58 -18.78 62.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 2.9199999999999999 110.489 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 58.1 tp -60.96 -53.61 55.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 1.6399999999999999 110.006 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.18 -37.13 78.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 110.307 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' B' ' 43' ' ' ILE . . . -72.33 -6.84 46.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.596 -0.729 . . . . 0.68999999999999995 110.94 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.423 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 24.8 ttt -88.79 -39.78 13.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.203 -0.453 . . . . 2.5800000000000001 110.981 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' B' ' 45' ' ' ILE . 25.1 t80 -69.74 -34.13 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 3.3900000000000001 111.516 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.458 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 76.6 mt -52.15 -54.28 43.0 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.988 0.366 . . . . 0.40999999999999998 111.988 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 48.0 Cg_endo -68.62 -32.09 25.04 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.158 1.905 . . . . 0.48999999999999999 112.883 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' B' ' 42' ' ' PHE . 96.1 mt -56.3 -60.12 2.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.657 0.265 . . . . 1.29 111.538 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.648 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -63.71 -55.26 24.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.517 -0.311 . . . . 1.3999999999999999 111.204 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 90.2 p -54.74 -25.97 31.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 1.3799999999999999 111.294 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.93 7.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.711 -0.757 . . . . 0.37 112.429 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -32.09 68.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 1.29 110.837 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.93 -53.53 57.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.57 . . . . 0.44 111.244 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -71.53 -23.26 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.385 . . . . 0.5 111.143 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' MET . . . . . 0.48 ' HA ' HG21 ' B' ' 12' ' ' VAL . 15.0 tmm? -57.72 -36.89 72.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.304 0.573 . . . . 1.4099999999999999 109.466 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.33 -39.68 38.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.779 . . . . 0.55000000000000004 110.778 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.9 mtt -53.89 -24.29 15.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.032 -0.531 . . . . 0.5 110.188 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -82.21 -47.95 11.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.853 -0.612 . . . . 0.54000000000000004 110.822 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mt -80.94 10.93 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 1.3 111.166 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.419 ' HA ' ' NZ ' ' B' ' 60' ' ' LYS . 20.0 t70 60.54 65.23 1.08 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.982 -0.554 . . . . 2.2400000000000002 111.172 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -146.66 150.78 36.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 1.77 111.291 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.99 -22.43 29.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.654 . . . . 1.0600000000000001 112.697 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' B' ' 57' ' ' ASP . 22.0 pttm -103.8 143.15 33.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 2.6600000000000001 111.154 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.82 151.63 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.8899999999999999 111.229 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.11 107.39 18.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 2.4100000000000001 110.778 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.33 127.68 53.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.23 -0.441 . . . . 1.5600000000000001 111.256 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.48 37.34 23.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.059 -0.519 . . . . 1.8200000000000001 111.079 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.78 -0.68 42.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.843 -0.694 . . . . 1.51 112.432 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -101.3 139.53 36.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 2.4500000000000002 110.638 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.03 102.47 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 1.79 111.199 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.15 133.9 37.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.81999999999999995 111.073 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 74.6 m-70 -78.66 74.97 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.166 0.508 . . . . 1.05 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.444 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 62.1 t80 -64.47 -30.02 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.611 -0.722 . . . . 1.8700000000000001 111.255 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -79.66 -28.14 40.81 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.181 0.437 . . . . 0.60999999999999999 112.181 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.535 HH21 ' HB ' ' B' ' 199' ' ' THR . 34.2 mmt180 -67.95 -51.64 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.603 0.594 . . . . 2.3900000000000001 112.603 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.459 ' O ' ' HG3' ' B' ' 77' ' ' MET . 5.9 p90 -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.231 0.456 . . . . 3.6699999999999999 112.231 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.433 HG23 ' N ' ' B' ' 75' ' ' ASP . 10.3 tp -54.74 -43.23 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 120.846 -0.341 . . . . 1.6599999999999999 110.802 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.433 ' N ' HG23 ' B' ' 74' ' ' ILE . 26.9 t70 -68.95 -21.64 64.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.474 -0.565 . . . . 1.4099999999999999 109.474 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 19.4 m0 -87.07 6.25 33.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.472 -0.786 . . . . 1.1599999999999999 110.908 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 28.2 mtp -104.91 -23.3 13.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.077 -0.51 . . . . 1.53 110.748 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.18 -33.64 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.56 0.578 . . . . 0.89000000000000001 112.56 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.438 HG23 HG23 ' B' ' 43' ' ' ILE . 34.8 m -76.83 -47.26 21.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.192 0.441 . . . . 1.24 112.192 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 34.6 m -56.5 -51.31 82.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.154 0.427 . . . . 0.57999999999999996 112.154 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 54.3 Cg_exo -52.62 -41.86 65.99 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.921 1.748 . . . . 0.66000000000000003 112.065 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.62 -29.58 62.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 1.0600000000000001 110.638 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.35 -28.75 68.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.117 0.484 . . . . 1.22 110.205 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' B' ' 105' ' ' LEU . 5.9 tt -84.37 -38.75 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 1.53 110.296 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.44 -33.37 73.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.914 -0.585 . . . . 1.5800000000000001 110.625 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 99.5 p -59.39 -24.1 63.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 1.3899999999999999 110.715 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.419 ' HA ' HG22 ' B' ' 90' ' ' THR . 46.6 mt -76.03 -27.43 57.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 1.1499999999999999 110.909 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 52.0 m -75.94 -31.18 58.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 1.5700000000000001 111.163 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.06 -37.27 39.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 2.1699999999999999 111.297 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.419 HG22 ' HA ' ' B' ' 87' ' ' LEU . 8.8 t -73.88 -23.54 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.458 -0.337 . . . . 1.4199999999999999 111.422 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.08 -36.22 12.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 1.1799999999999999 111.252 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -116.52 120.24 38.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.889 0.376 . . . . 1.8799999999999999 111.068 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -79.98 -27.33 39.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 3.4199999999999999 110.562 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -137.94 148.14 44.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.795 -0.639 . . . . 4.0599999999999996 110.613 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' HD12 ' B' ' 95' ' ' ILE . 4.3 mp -131.95 144.56 36.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.372 -0.376 . . . . 2.0899999999999999 111.064 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -101.18 162.67 12.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 3.8500000000000001 110.863 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.47 91.64 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 4.8200000000000003 110.913 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -147.53 -43.05 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 3.7999999999999998 111.075 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 85.9 m95 54.78 65.25 1.55 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 5.1699999999999999 110.867 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 79.7 p -117.87 -58.23 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 2.02 110.804 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 60.3 tp -71.67 -51.55 22.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 2.0899999999999999 110.712 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.95 -47.37 89.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.977 -0.556 . . . . 1.8799999999999999 111.154 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.4 -33.8 77.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.896 -0.669 . . . . 0.56000000000000005 112.675 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -65.58 -40.28 92.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 1.78 110.866 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.523 ' HB3' HD21 ' B' ' 84' ' ' LEU . 28.8 mt -71.43 -40.72 70.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 1.03 111.201 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 85.9 mtp -58.27 -53.39 58.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 1.6699999999999999 111.221 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 44.0 t -58.35 -39.94 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 1.51 111.128 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.512 HG21 HG21 ' B' ' 142' ' ' ILE . 91.8 m -60.71 -37.93 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 1.1799999999999999 111.286 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -64.72 -46.92 80.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 2.1699999999999999 111.31 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.454 HG22 ' HE1' ' A' ' 46' ' ' TRP . 62.3 mt -53.04 -35.03 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.323 -0.399 . . . . 1.3500000000000001 111.262 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.65 -51.35 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.3400000000000001 111.342 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.75 -49.6 82.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.42999999999999999 111.489 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' B' ' 77' ' ' MET . 71.9 mt -52.83 -36.87 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.358 -0.383 . . . . 1.6000000000000001 111.329 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 49.5 m -60.09 -48.3 82.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.85999999999999999 111.237 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 35.9 m -64.94 -21.11 66.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.94999999999999996 111.124 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.27 14.3 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.821 -0.705 . . . . 0.46000000000000002 113.262 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.1 pp -76.24 -27.91 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.87 -0.194 . . . . 1.75 111.507 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.452 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.53 -31.55 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.682 0.277 . . . . 1.78 111.424 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.4 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 0.38 111.013 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.66 -30.24 46.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 1.97 111.007 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.63 14.28 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.76000000000000001 111.267 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 46.6 t -75.36 120.77 21.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 1.47 110.817 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.41 -72.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 2.5 111.025 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.579 ' HB2' HG12 ' B' ' 127' ' ' VAL . 79.3 mtp180 -62.71 140.72 58.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 2.73 110.513 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.92 -19.31 52.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 2.2000000000000002 111.466 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -78.17 -35.03 49.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 3.3999999999999999 111.215 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -81.67 -23.74 9.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.341 -0.391 . . . . 1.23 111.095 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -56.35 -32.92 65.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.13 -0.487 . . . . 3.04 111.037 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -75.27 -19.51 59.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 4.1399999999999997 111.417 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 99.3 mt -78.85 -54.89 5.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 1.6499999999999999 110.97 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -39.98 76.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.77000000000000002 111.334 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -53.01 -45.4 67.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 1.46 111.156 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -71.93 -28.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 1.6299999999999999 111.288 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 76.2 m -68.77 -39.45 80.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 1.4199999999999999 111.176 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.31 -50.8 48.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.8 -0.714 . . . . 0.48999999999999999 112.457 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.97 -29.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 1.3 110.752 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.49 -47.05 87.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.645 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.46 -29.79 71.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.451 . . . . 0.62 110.622 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' B' ' 143' ' ' LEU . 82.2 t80 -75.13 -25.24 58.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 1.74 110.747 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.58 -56.84 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.76 111.476 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.461 HG13 ' N ' ' B' ' 142' ' ' ILE . 23.5 pt -56.17 -44.07 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.68999999999999995 111.128 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.512 HG21 HG21 ' B' ' 108' ' ' THR . 46.5 mm -67.85 -29.31 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.76 110.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' B' ' 139' ' ' PHE . 0.5 OUTLIER -55.37 -50.96 68.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 1.0600000000000001 110.348 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -62.36 -37.55 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 4.1200000000000001 110.666 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.98 -35.58 92.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 1.26 112.514 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 142' ' ' ILE . 98.3 mt -69.17 -27.18 33.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.871 0.367 . . . . 1.98 110.831 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -88.68 4.46 47.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.199 -0.455 . . . . 1.4199999999999999 111.185 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.044 -0.525 . . . . 99.989999999999995 111.841 -179.403 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 121.067 0.461 . . . . 2.4300000000000002 110.761 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.72 -23.48 61.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 2.5800000000000001 111.076 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.21 -55.0 28.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.339 -0.391 . . . . 2.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -78.43 -24.19 46.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 3.0299999999999998 111.383 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.4 tp -68.78 -43.5 75.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 1.1000000000000001 111.311 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.41 -22.31 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 1.75 111.34 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.0 m -62.55 -58.83 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.97999999999999998 111.478 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.84 -34.81 79.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.304 -0.407 . . . . 4.2999999999999998 110.98 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.1 -36.25 74.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 1.3899999999999999 111.048 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.4 ' O ' HG22 ' B' ' 177' ' ' ILE . 66.2 m -69.97 -41.35 74.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 1.1100000000000001 111.095 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.91 -37.07 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.474 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.4 mt -72.5 -56.14 5.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 1.75 111.344 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -31.58 63.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.59999999999999998 111.51 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.437 ' O ' HG13 ' B' ' 181' ' ' ILE . 16.2 tt -87.57 -20.79 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.43 . . . . 1.47 110.566 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.44 -50.57 65.48 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.824 -0.626 . . . . 0.55000000000000004 112.911 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.665 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 67.1 m-85 -58.18 -57.02 29.07 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.773 0.286 . . . . 1.6200000000000001 111.538 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 88.1 Cg_exo -45.95 -31.7 8.62 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.906 1.737 . . . . 0.64000000000000001 112.876 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 177' ' ' ILE . 98.0 mt -66.25 -56.85 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 1.27 111.567 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.0 m -61.63 -25.32 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.68999999999999995 111.546 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -68.92 -18.36 64.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 1.1799999999999999 111.467 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.52 -34.68 66.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.521 -0.309 . . . . 1.77 111.142 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.25 162.36 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.323 . . . . 1.6899999999999999 111.329 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.716 . . . . 1.5800000000000001 112.721 179.792 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.804 0.335 . . . . 2.4700000000000002 111.077 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.96 -56.13 25.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 2.5299999999999998 110.974 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 199' ' ' THR . . . . . 0.535 ' HB ' HH21 ' B' ' 72' ' ' ARG . 64.8 p -65.43 -34.52 78.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 1.29 111.157 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.96 -36.0 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 2.6200000000000001 111.144 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.53 -41.78 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.342 -0.39 . . . . 1.6100000000000001 111.495 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -74.63 0.45 15.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.523 -0.308 . . . . 1.4199999999999999 111.345 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.9 t -96.52 -45.03 6.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.206 0.526 . . . . 1.4299999999999999 110.526 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 45.1 tp -72.11 -39.37 68.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.422 -0.808 . . . . 1.1200000000000001 111.918 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.671 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 45.4 tp -55.77 -54.47 51.47 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.953 -0.299 . . . . 1.26 111.33 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.5 Cg_exo -56.11 -41.45 76.64 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.822 1.681 . . . . 0.59999999999999998 111.175 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.457 ' O ' HG12 ' B' ' 211' ' ' VAL . 66.1 t80 -55.2 -37.07 66.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.167 -0.469 . . . . 1.3999999999999999 109.844 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -79.89 -24.27 41.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 1.4099999999999999 110.433 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.84 -0.618 . . . . 1.3200000000000001 111.204 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.457 HG12 ' O ' ' B' ' 207' ' ' PHE . 9.0 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.807 0.336 . . . . 1.6899999999999999 111.135 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 216' ' ' LEU . . . -59.2 -28.07 63.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.79000000000000004 112.24 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -76.77 -30.16 56.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.751 0.31 . . . . 2.96 110.551 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -63.74 -60.58 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.29 110.685 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.02 -26.47 67.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 3.1499999999999999 110.853 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' B' ' 212' ' ' GLY . 6.4 tt -65.33 -50.05 67.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 1.51 110.743 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.406 ' O ' ' HG ' ' B' ' 221' ' ' LEU . 16.5 t70 -63.02 -24.98 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 2.1899999999999999 110.945 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 56.9 tp -71.75 -33.24 68.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 1.98 111.139 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -88.18 -29.19 20.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.43 -0.35 . . . . 2.1699999999999999 111.149 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.52 -20.9 61.92 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.795 -0.717 . . . . 1.3600000000000001 112.433 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 217' ' ' ASP . 77.6 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.654 0.264 . . . . 2.8999999999999999 110.606 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.54 0.21 . . . . 2.52 110.951 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 tp -65.18 -47.67 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 1.9299999999999999 110.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.611 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 25.0 m170 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.26 110.745 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -75.21 -41.16 58.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 1.6699999999999999 110.417 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.09 -20.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.281 0.562 . . . . 1.8700000000000001 110.176 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.29 -50.91 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.461 -0.79 . . . . 1.4399999999999999 110.724 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.46999999999999997 111.257 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.03 85.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.58999999999999997 111.231 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -30.73 73.73 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.856 -0.687 . . . . 0.5 112.747 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.7 mmt -73.04 -28.92 62.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.977 0.418 . . . . 0.68000000000000005 110.839 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.8 m -66.55 -52.91 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 1.3999999999999999 110.917 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' ILE . . . . . 0.521 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -63.28 -24.18 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.55 110.913 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.72 -47.34 89.88 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.714 -0.755 . . . . 0.70999999999999996 112.259 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.98 65.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.77000000000000002 111.064 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.7 mt -68.09 -30.96 70.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.361 -0.382 . . . . 1.9299999999999999 110.745 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -65.04 -21.25 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 1.8600000000000001 110.812 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.32 -45.13 89.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 4.1399999999999997 110.851 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -71.6 -32.8 68.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 3.1499999999999999 111.228 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 75.2 m -78.09 -23.32 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 1.95 111.291 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 tp -87.3 -2.76 58.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.404 -0.362 . . . . 2.2200000000000002 110.863 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 71.2 p -70.97 -24.13 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 1.3700000000000001 111.109 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -48.85 -32.74 9.31 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.284 0.564 . . . . 5.0300000000000002 109.952 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.2 p-10 -173.79 132.18 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 2.3700000000000001 109.761 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 43.8 Cg_endo . . . . . 0 N--CA 1.453 -0.892 0 C-N-CA 122.772 2.315 . . . . 2.0499999999999998 112.367 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 36.0 Cg_exo . . . . . 0 CA--C 1.527 0.16 0 CA-C-O 120.952 0.313 . . . . 1.9299999999999999 112.132 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -60.04 -18.4 46.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 4.1200000000000001 112.541 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.431 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.7 p90 -50.75 -36.19 35.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.789 0.328 . . . . 2.8900000000000001 111.131 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.7 -53.68 43.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 2.46 110.484 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.5 -20.51 66.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 2.7799999999999998 110.719 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.76 -52.11 66.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 1.6200000000000001 110.198 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.53 -38.95 82.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 1.5900000000000001 110.219 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.68 -7.22 42.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.65000000000000002 111.188 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.408 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 26.1 ttt -88.72 -38.77 14.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 1.6699999999999999 110.925 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.477 ' HA ' HD12 ' C' ' 45' ' ' ILE . 28.8 m-85 -70.77 -30.68 67.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 3.4199999999999999 111.504 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 80.2 mt -55.82 -54.9 46.86 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.595 -0.275 . . . . 0.89000000000000001 111.726 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 49.7 Cg_endo -69.41 -28.11 27.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.165 1.91 . . . . 0.40999999999999998 113.096 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' C' ' 42' ' ' PHE . 91.3 mt -59.66 -62.53 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.166 -0.213 . . . . 1.76 111.332 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.67 ' HE1' HG22 ' A' ' 110' ' ' ILE . 2.8 t90 -64.95 -50.19 67.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.646 0.26 . . . . 2.1600000000000001 110.813 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' SER . . . . . 0.435 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 36.8 t -60.98 -15.06 27.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 1.1699999999999999 111.022 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.16 -60.32 3.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 0.44 112.364 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.09 -26.42 64.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.309 . . . . 1.29 110.845 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.58 -54.27 45.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.5 111.272 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.466 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.1 m-85 -67.69 -36.78 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 1.8300000000000001 111.136 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 51.8 ttp -51.53 -33.09 30.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.14 0.495 . . . . 1.47 109.998 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -75.97 -44.92 37.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.59999999999999998 110.638 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' MET . . . . . 0.466 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 31.7 mtp -56.49 -19.53 15.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.85 -0.614 . . . . 0.83999999999999997 110.463 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.48 -44.31 17.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.886 -0.597 . . . . 0.65000000000000002 110.34 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.551 HG21 HD23 ' A' ' 130' ' ' LEU . 38.4 pt -84.44 10.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 1.55 111.135 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 63.96 54.04 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.915 -0.584 . . . . 1.54 111.148 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -134.77 151.4 50.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 1.79 110.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.16 14.26 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.788 -0.72 . . . . 0.93999999999999995 112.58 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -124.43 160.31 28.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.801 0.334 . . . . 2.3599999999999999 110.769 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.49 142.06 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.97 111.028 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.55 104.77 17.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 2.4399999999999999 110.656 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.96 124.91 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 1.54 111.226 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.8 27.81 17.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 1.71 111.262 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.29 53.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.874 -0.679 . . . . 1.53 112.733 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -98.15 147.41 24.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 2.23 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.37 116.71 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 1.3600000000000001 111.148 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.85 133.5 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.78000000000000003 110.885 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.429 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 93.8 m-70 -78.59 73.33 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.232 0.539 . . . . 1.0800000000000001 111.054 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.97 -33.01 74.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.582 -0.735 . . . . 2.2999999999999998 110.951 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -75.58 -25.89 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.75 111.784 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.6 tpp180 -67.92 -51.22 50.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.364 0.505 . . . . 1.51 112.364 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -82.08 -30.87 31.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.245 0.461 . . . . 4.6500000000000004 112.245 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.6 tp -56.48 -44.13 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.758 -0.377 . . . . 1.22 110.783 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.452 ' N ' HG23 ' C' ' 74' ' ' ILE . 34.9 t70 -69.54 -20.56 63.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.374 -0.602 . . . . 1.3100000000000001 109.374 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -87.14 3.68 45.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.567 -0.742 . . . . 1.6799999999999999 111.201 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.598 ' HA ' HD13 ' C' ' 113' ' ' ILE . 44.8 ttm -104.61 -21.33 13.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.002 -0.545 . . . . 1.8 110.771 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.422 ' O ' HD23 ' C' ' 82' ' ' LEU . 31.5 m -114.48 -35.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.2 0.444 . . . . 1.1899999999999999 112.2 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.442 HG23 HG23 ' C' ' 43' ' ' ILE . 24.5 m -76.78 -51.7 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.105 0.409 . . . . 1.23 112.105 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 52.3 m -52.72 -50.77 79.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.039 0.385 . . . . 0.58999999999999997 112.039 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 54.4 Cg_exo -52.54 -43.49 54.45 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.943 1.762 . . . . 0.67000000000000004 112.009 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.422 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -71.9 -27.28 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.95999999999999996 110.602 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.75 -29.6 67.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.183 0.516 . . . . 1.1899999999999999 109.743 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -84.04 -39.73 19.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.428 -0.805 . . . . 1.7 110.196 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.94 -32.01 73.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.506 . . . . 1.6200000000000001 110.404 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -61.21 -25.47 67.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 1.26 110.328 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.429 ' HA ' HG22 ' C' ' 90' ' ' THR . 51.2 mt -73.12 -26.32 61.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 1.1100000000000001 110.629 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 1.51 110.795 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.83 -32.46 35.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 2.0600000000000001 111.107 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' THR . . . . . 0.429 HG22 ' HA ' ' C' ' 87' ' ' LEU . 10.0 t -81.48 -23.27 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.227 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -36.13 15.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.3 111.274 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -123.24 121.63 36.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 110.948 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -76.35 -35.14 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 3.2400000000000002 110.835 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.99 141.47 46.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.022 -0.536 . . . . 4.6299999999999999 110.796 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.44 142.56 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 2.1800000000000002 110.867 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -91.99 169.42 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 4.1200000000000001 111.095 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.75 81.19 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 4.96 111.114 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.74 -42.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 3.9100000000000001 111.012 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 91.7 m95 51.02 76.98 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 5.21 111.081 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 74.6 p -120.26 -57.79 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.945 -0.57 . . . . 1.8200000000000001 110.985 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.22 -45.07 27.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 2.0800000000000001 110.967 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.94 -33.35 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.341 -0.39 . . . . 1.8600000000000001 110.897 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.07 -42.47 51.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.791 -0.719 . . . . 0.58999999999999997 112.56 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -63.11 -36.61 84.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 1.53 110.869 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' C' ' 84' ' ' LEU . 85.1 mt -67.85 -52.88 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.551 . . . . 1.1100000000000001 110.86 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -53.27 -43.1 67.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.732 . . . . 2.21 110.928 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 107' ' ' SER . . . . . 0.422 ' HB3' ' CD1' ' B' ' 42' ' ' PHE . 49.0 m -64.27 -42.38 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.559 . . . . 1.28 110.828 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.567 HG21 HG21 ' C' ' 142' ' ' ILE . 98.3 m -60.93 -27.26 68.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.962 -0.563 . . . . 1.22 111.252 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 22.1 tp60 -75.14 -33.99 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 2.3300000000000001 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.648 HG22 ' HE1' ' B' ' 46' ' ' TRP . 32.0 mm -62.41 -43.85 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 1.29 111.684 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.461 HG11 HG22 ' B' ' 45' ' ' ILE . 19.9 m -67.07 -41.06 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.881 0.326 . . . . 1.0600000000000001 111.881 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.64 -48.77 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.936 0.347 . . . . 0.51000000000000001 111.936 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' C' ' 77' ' ' MET . 70.2 mt -56.53 -36.74 48.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.718 0.294 . . . . 1.3700000000000001 111.028 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 54.2 m -57.64 -49.64 75.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.77000000000000002 111.223 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -64.29 -20.47 66.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.425 . . . . 1.1899999999999999 110.799 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.34 -32.89 24.28 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.912 -0.661 . . . . 0.5 113.087 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.532 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.7 pp -82.92 -25.39 32.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.707 0.289 . . . . 1.47 111.399 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.532 ' N ' HD12 ' C' ' 117' ' ' LEU . 9.8 tp -83.77 -31.55 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.387 -0.37 . . . . 1.2 111.161 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.9 75.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.40000000000000002 111.027 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.41 -28.62 46.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 2.1200000000000001 110.97 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.1 13.62 2.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.213 -0.449 . . . . 0.75 111.03 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 48.1 t -71.06 127.71 33.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 1.3799999999999999 110.823 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -93.26 -65.08 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 2.7400000000000002 110.707 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' ARG . . . . . 0.507 ' HB2' HG12 ' C' ' 127' ' ' VAL . 99.1 mtt180 -69.07 141.57 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 2.7999999999999998 110.498 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.3 -11.57 59.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 2.4100000000000001 111.492 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -91.68 -30.24 16.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.67 0.272 . . . . 4.2000000000000002 111.157 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' C' ' 124' ' ' ARG . 8.5 p -80.5 -24.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 1.0800000000000001 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -57.65 -29.41 64.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.5699999999999998 111.029 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.05 -26.57 59.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 3.8100000000000001 111.151 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' C' ' 127' ' ' VAL . 9.4 mp -76.71 -53.57 7.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 1.4199999999999999 111.182 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -32.44 71.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.89000000000000001 111.212 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -57.8 -52.58 64.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.382 . . . . 1.26 110.987 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.85 -32.4 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 1.6799999999999999 111.296 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 81.3 m -63.73 -39.27 93.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 1.24 110.958 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.23 -57.4 15.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.654 -0.784 . . . . 0.54000000000000004 112.411 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 136' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -57.85 -32.65 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 1.0600000000000001 111.211 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.9 t -56.49 -43.55 79.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.343 -0.389 . . . . 1.0800000000000001 110.812 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 138' ' ' ALA . . . . . 0.414 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -65.16 -34.11 77.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 110.644 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -75.46 -22.79 56.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.983 -0.553 . . . . 1.6799999999999999 111.212 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 89.8 mt -68.05 -55.88 10.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.678 0.275 . . . . 1.7 111.275 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.471 HG13 ' N ' ' C' ' 142' ' ' ILE . 37.4 pt -59.46 -42.16 86.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.859 0.361 . . . . 0.78000000000000003 111.171 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.567 HG21 HG21 ' C' ' 108' ' ' THR . 49.5 mm -66.08 -35.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 2.2400000000000002 110.877 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -52.61 -50.27 63.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 1.02 110.751 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -61.48 -32.75 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 3.0 110.504 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.42 -27.69 67.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 1.27 112.479 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 146' ' ' ILE . . . . . 0.426 HG12 ' O ' ' C' ' 142' ' ' ILE . 43.2 mm -74.5 -27.31 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.057 0.456 . . . . 1.8899999999999999 110.767 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -89.45 4.76 48.05 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.837 -0.62 . . . . 1.6000000000000001 111.233 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 112.402 -179.282 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 164' ' ' LEU . . . . . 0.493 HD12 ' N ' ' C' ' 165' ' ' TYR . 4.1 pp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.778 0.323 . . . . 2.3500000000000001 111.406 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 165' ' ' TYR . . . . . 0.493 ' N ' HD12 ' C' ' 164' ' ' LEU . 2.4 t80 -81.39 -25.95 35.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.312 -0.404 . . . . 2.6200000000000001 110.9 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.27 -46.4 64.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 2.0899999999999999 111.11 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 167' ' ' LYS . . . . . 0.59 ' HB3' ' HZ3' ' C' ' 167' ' ' LYS . 4.9 ttpm? -75.33 -29.48 59.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 3.2400000000000002 110.878 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.402 HD11 HD22 ' C' ' 87' ' ' LEU . 52.4 tp -66.53 -61.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 1.6899999999999999 111.317 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 85.5 t -53.82 -35.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 1.3999999999999999 111.459 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -53.95 -54.15 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.95999999999999996 111.075 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 171' ' ' TYR . . . . . 0.511 ' O ' HG12 ' C' ' 174' ' ' VAL . 30.0 t80 -70.92 -29.9 66.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.006 -0.543 . . . . 3.6499999999999999 110.806 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -67.48 -31.21 71.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 1.3700000000000001 111.55 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 40.4 p -77.19 -40.61 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.93 0.344 . . . . 1.4299999999999999 111.93 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 174' ' ' VAL . . . . . 0.511 HG12 ' O ' ' C' ' 171' ' ' TYR . 10.9 p -64.2 -25.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 1.6200000000000001 111.524 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' C' ' 171' ' ' TYR . 87.4 mt -77.66 -57.87 3.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.031 0.443 . . . . 2.0299999999999998 111.257 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 -28.06 62.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.62 111.424 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.423 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.1 tp -87.54 -22.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.993 0.425 . . . . 1.5800000000000001 110.341 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.84 -51.52 57.63 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.56000000000000005 112.844 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.649 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -57.01 -56.42 33.7 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.883 -0.327 . . . . 1.3300000000000001 111.165 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.9 Cg_exo -45.42 -30.47 5.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.177 1.918 . . . . 0.63 112.612 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.419 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.5 mt -65.82 -57.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.93000000000000005 111.314 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.543 HG22 ' O ' ' C' ' 179' ' ' TYR . 17.3 m -62.67 -25.42 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 1.27 111.466 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -69.92 -16.5 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 1.77 111.017 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.21 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.379 -0.373 . . . . 2.3900000000000001 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.0 pt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.392 -0.367 . . . . 1.95 111.157 179.846 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 79.0 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.887 0.375 . . . . 2.3799999999999999 111.11 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.84 -43.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 2.23 111.068 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.56 -56.9 14.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 2.1600000000000001 111.211 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 77.4 p -64.93 -20.74 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 1.27 111.654 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.99 -37.0 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.331 . . . . 1.7 111.136 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 52.7 tp -78.92 -39.77 33.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 2.02 111.44 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.09 0.62 10.99 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.435 -0.348 . . . . 1.8200000000000001 111.344 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 52.9 t -96.15 -44.85 7.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.049 0.452 . . . . 1.3500000000000001 110.397 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.1 -31.09 62.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.728 -0.669 . . . . 0.65000000000000002 111.799 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.578 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -61.02 -54.8 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.818 -0.353 . . . . 1.4199999999999999 111.053 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 41.9 Cg_exo -58.06 -37.28 96.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.68 1.587 . . . . 0.63 110.687 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.23 -26.88 66.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.975 -0.557 . . . . 1.49 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.38 -28.84 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.651 -0.704 . . . . 1.7 110.511 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 1.25 110.924 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.751 0.31 . . . . 1.6100000000000001 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.16 -33.43 61.14 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.977 -0.63 . . . . 0.81999999999999995 112.785 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -72.71 -32.52 65.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.695 0.283 . . . . 3.0800000000000001 111.01 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 214' ' ' SER . . . . . 0.412 ' O ' HD13 ' C' ' 218' ' ' LEU . 48.1 t -58.65 -62.64 1.71 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 1.1499999999999999 110.83 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -60.94 -24.54 66.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 2.5600000000000001 111.242 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.86 -51.52 47.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.29 110.91 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 217' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 18.7 t70 -54.59 -40.03 68.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 2.3900000000000001 111.169 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 218' ' ' LEU . . . . . 0.412 HD13 ' O ' ' C' ' 214' ' ' SER . 11.1 mp -66.13 -37.4 85.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.385 . . . . 2.0299999999999998 111.241 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -75.11 -27.71 59.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 3.21 111.11 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.46 -19.86 79.74 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.687 -0.768 . . . . 1.3600000000000001 112.46 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 221' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 79.4 mt . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.68 0.276 . . . . 2.8999999999999999 111.206 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.711 0.291 . . . . 2.4199999999999999 111.002 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.4 mm? -74.69 -27.01 60.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.351 -0.386 . . . . 2.0899999999999999 110.628 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 33.9 m170 -75.37 -34.63 61.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 1.1599999999999999 110.269 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.466 ' O ' HG12 ' A' ' 12' ' ' VAL . 58.9 t-105 -67.37 -48.27 67.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.79000000000000004 110.426 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -66.23 -20.37 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.41 . . . . 2.0800000000000001 110.223 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.475 ' O ' ' HG2' ' A' ' 15' ' ' MET . 7.9 t80 -60.48 -60.54 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.85 -0.614 . . . . 1.28 110.266 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 9' ' ' TRP . 9.7 p -57.92 -30.07 37.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 110.525 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.93 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 0.63 110.943 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.97 -31.53 52.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.55000000000000004 112.365 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 71.4 mmm -69.68 -44.31 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 1.03 110.69 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.4 p -60.22 -58.48 8.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 1.3 111.219 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.8 pp -56.78 -22.42 15.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.301 -0.409 . . . . 1.3100000000000001 111.279 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.27 -62.5 5.57 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.77000000000000002 112.407 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.42 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.289 . . . . 0.80000000000000004 111.262 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 17' ' ' ILE . 86.4 mt -74.89 -35.98 62.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 1.8100000000000001 110.801 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -58.94 -42.52 89.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 1.8799999999999999 110.778 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.45 -20.4 57.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 4.4500000000000002 110.677 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 50.2 t-105 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 3.6899999999999999 110.264 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -79.92 -34.56 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.5700000000000001 110.914 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -81.87 -1.99 49.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 1.95 110.735 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.3 p -56.42 -26.9 55.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 1.3799999999999999 110.714 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -46.98 -36.3 7.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.257 0.551 . . . . 4.0700000000000003 109.825 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.0 p-10 -164.05 131.97 2.63 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.307 -0.861 . . . . 2.7200000000000002 110.132 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 27.7 Cg_endo -94.03 -178.84 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.074 2.516 . . . . 1.9099999999999999 112.502 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -89.35 35.95 0.82 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 4.7599999999999998 111.262 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.78 -40.65 2.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 1.99 112.664 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 HD22 ' A' ' 221' ' ' LEU . 18.0 m -76.46 137.51 67.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 2.7000000000000002 110.889 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 24.0 Cg_exo -65.12 166.08 19.9 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.578 2.185 . . . . 1.79 112.06 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -18.56 54.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 4.1200000000000001 111.66 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' HE2' ' HD2' ' A' ' 33' ' ' PRO . 2.4 p90 -48.12 -39.29 20.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.737 0.303 . . . . 2.9300000000000002 111.173 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.44 -48.74 63.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.922 0.392 . . . . 2.8799999999999999 110.514 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -59.94 -29.4 68.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 4.6600000000000001 110.632 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.54 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 1.45 110.989 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.02 -27.97 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 1.78 111.081 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.32 -9.95 59.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.63 110.993 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.408 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 49.6 ttp -89.57 -38.89 13.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 1.48 111.222 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.4 -41.42 73.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 3.5 111.861 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 30.7 mm -50.59 -52.25 57.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 112.313 0.486 . . . . 1.0800000000000001 112.313 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.2 Cg_endo -70.15 -32.51 16.82 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.296 1.997 . . . . 0.53000000000000003 113.122 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.69 -62.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.548 0.213 . . . . 1.6799999999999999 111.51 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.582 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.7 OUTLIER -60.66 -58.63 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.735 0.302 . . . . 1.8300000000000001 111.017 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.2 t -55.71 -26.09 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 1.0900000000000001 110.958 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.3 -58.88 11.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.715 -0.755 . . . . 0.40999999999999998 112.249 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.47 -28.44 65.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.835 0.35 . . . . 0.98999999999999999 110.834 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.24 17.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.47999999999999998 111.161 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 30.3 m-85 -62.25 -38.67 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 1.8700000000000001 110.914 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.2 ttp -55.72 -31.07 62.17 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.0 0.429 . . . . 1.49 110.315 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -40.04 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.58999999999999997 110.491 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.9 mtt -55.94 -33.96 65.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.815 -0.63 . . . . 0.48999999999999999 110.322 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -66.15 -49.51 67.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.59999999999999998 110.416 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.546 HG21 HG23 ' B' ' 127' ' ' VAL . 10.5 mt -74.58 -3.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 1.3100000000000001 110.818 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 60.64 51.49 4.97 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.737 -0.665 . . . . 1.9099999999999999 111.269 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -133.67 122.21 23.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 1.6200000000000001 110.933 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.07 -1.05 3.73 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.817 -0.706 . . . . 1.04 112.443 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -111.45 153.71 25.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.32 . . . . 2.6800000000000002 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.84 140.23 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 1.98 111.46 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -87.46 92.64 9.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 2.1800000000000002 110.749 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.15 118.36 35.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.5700000000000001 111.147 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.83 28.32 17.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.79 111.562 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.66 -10.46 64.7 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.705 -0.76 . . . . 1.48 112.949 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -98.07 147.43 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 2.3199999999999998 110.749 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.1 mt -89.72 122.22 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.4399999999999999 111.134 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.92 143.9 28.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.81999999999999995 111.202 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 92.4 m-70 -88.07 64.66 7.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 110.74 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.99 -56.0 18.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 1.8300000000000001 111.39 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.23 -22.54 63.15 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.129 0.418 . . . . 0.62 112.129 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 10.7 mpt_? -68.43 -52.37 33.46 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.921 0.341 . . . . 2.3399999999999999 111.921 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 117' ' ' LEU . 2.4 p90 -69.31 -32.95 72.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 3.4900000000000002 110.819 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.9 mm -51.48 -53.27 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.278 -0.419 . . . . 1.3700000000000001 110.519 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 79' ' ' THR . 22.1 t70 -62.72 -29.32 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 1.3100000000000001 110.002 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -80.94 6.85 12.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.047 -0.524 . . . . 1.48 111.305 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.578 ' HA ' HD13 ' A' ' 113' ' ' ILE . 53.1 tpp -105.11 -20.29 13.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 1.46 110.452 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.4 m -114.26 -36.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.739 0.644 . . . . 1.1200000000000001 112.739 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.1 t -79.9 -35.75 37.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.351 0.5 . . . . 1.1000000000000001 112.351 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 36.7 m -65.97 -50.39 52.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.851 0.315 . . . . 0.59999999999999998 111.851 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 51.8 Cg_exo -56.21 -38.24 95.32 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.787 1.658 . . . . 0.73999999999999999 111.369 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -74.07 -32.08 63.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 1.01 110.823 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.2 tp -67.2 -28.12 67.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.939 0.399 . . . . 1.48 110.381 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 105' ' ' LEU . 5.3 tt -84.08 -36.2 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 1.3799999999999999 110.406 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -61.72 -37.51 84.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.082 -0.508 . . . . 1.1899999999999999 110.479 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.479 ' O ' HG23 ' A' ' 90' ' ' THR . 44.6 t -56.83 -30.51 63.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 1.23 110.701 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.11 -34.51 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.88 111.209 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -71.71 -39.65 70.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 1.3899999999999999 111.393 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -68.73 -26.33 65.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 2.3199999999999998 111.097 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 86' ' ' SER . 71.8 p -82.96 -23.49 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.538 -0.301 . . . . 1.46 111.365 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -33.85 16.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 1.24 111.046 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 86.1 mtp -130.72 99.21 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 2.0699999999999998 110.782 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -62.22 -44.93 95.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 3.5299999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -109.19 147.19 32.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 4.0800000000000001 111.139 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.83 142.05 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 2.1699999999999999 110.599 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -125.06 -67.72 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 4.5199999999999996 110.98 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -146.94 93.07 2.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 3.75 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -166.74 63.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 3.5299999999999998 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -89.68 16.91 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 4.9100000000000001 111.044 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 p -98.22 -25.64 14.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 1.98 111.314 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 101' ' ' LEU . 3.8 mm? -80.96 -53.71 6.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 1.8300000000000001 110.994 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.61 -22.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 1.79 111.306 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.38 -49.34 8.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.62 112.653 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.99 -39.69 86.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 1.5800000000000001 111.056 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.698 ' HB3' HD21 ' A' ' 84' ' ' LEU . 80.4 mt -61.71 -58.62 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.027 -0.533 . . . . 0.97999999999999998 111.051 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.3 ttm -53.67 -32.55 52.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.894 -0.594 . . . . 1.48 111.111 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' C' ' 42' ' ' PHE . 71.5 m -66.13 -55.63 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.1299999999999999 111.167 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -53.88 -29.19 40.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 1.48 111.069 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -62.87 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 2.7000000000000002 110.87 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.642 HG22 ' HE1' ' C' ' 46' ' ' TRP . 33.8 mm -53.42 -30.64 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 1.54 110.849 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.44 -49.15 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 1.28 111.233 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.68 -46.17 96.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.42999999999999999 111.319 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 77' ' ' MET . 53.0 mt -58.7 -34.55 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.74 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 41.6 m -56.42 -51.45 68.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.63 110.695 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -65.39 -20.68 66.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.45 -40.71 12.52 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.803 -0.713 . . . . 0.41999999999999998 113.085 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.4 pp -73.85 -29.68 62.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.557 0.217 . . . . 1.3799999999999999 111.422 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.4 tp -83.72 -29.64 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 1.6200000000000001 111.428 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.78 68.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.402 . . . . 0.39000000000000001 111.149 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -80.63 -21.66 41.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 2.02 110.816 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 118' ' ' ILE . 76.9 mt -84.61 10.75 10.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.76000000000000001 111.001 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.5 p -70.08 120.94 16.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 1.46 111.151 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -96.97 -65.17 0.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.129 -0.487 . . . . 3.3500000000000001 110.787 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.6 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.1 mtp180 -69.77 134.12 48.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 2.9199999999999999 110.61 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.68 -11.48 60.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 2.77 110.966 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -81.0 -55.24 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.401 . . . . 3.77 110.635 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.6 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.7 p -65.9 -23.68 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 1.1599999999999999 110.916 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -52.28 -37.24 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 2.04 111.327 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -73.95 -26.46 60.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 2.6400000000000001 111.303 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 130' ' ' LEU . 8.4 mp -79.39 -39.08 33.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 1.8999999999999999 111.567 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -75.75 -26.5 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 1.3999999999999999 111.283 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HE1' ' HB3' ' A' ' 183' ' ' TRP . 53.4 t80 -68.35 -48.25 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 1.28 110.907 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -65.9 -29.81 48.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 2.1600000000000001 110.898 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.4 t -64.43 -38.71 91.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.254 -0.43 . . . . 1.6899999999999999 110.792 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.68 -54.27 23.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.75 -0.738 . . . . 0.52000000000000002 112.636 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.95 -30.77 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.712 0.292 . . . . 1.02 111.545 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.11 -43.65 97.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.866 0.365 . . . . 1.0800000000000001 110.894 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.47 86.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.62 110.709 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -63.03 -28.26 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 1.8400000000000001 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.87 -60.74 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 1.6899999999999999 111.397 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 pt -59.3 -41.13 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.325 -0.398 . . . . 0.81000000000000005 111.867 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -65.51 -33.48 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 2.3700000000000001 111.391 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.3 tp -68.05 -40.14 82.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.445 -0.343 . . . . 0.97999999999999998 111.049 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.547 ' O ' ' OD1' ' A' ' 148' ' ' ASN . 54.3 t-105 -69.28 -25.01 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 3.27 110.881 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.622 ' HA2' ' OD1' ' A' ' 148' ' ' ASN . . . -80.9 -41.66 10.41 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.971 -0.633 . . . . 1.25 112.669 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.86 -18.18 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.374 . . . . 2.1200000000000001 111.14 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -88.0 4.92 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 1.6599999999999999 111.466 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.622 ' OD1' ' HA2' ' A' ' 145' ' ' GLY . 32.0 m120 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 112.84 0.682 . . . . 99.989999999999995 112.84 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 CA--C 1.522 -0.13 0 CA-C-O 121.045 0.45 . . . . 2.3399999999999999 110.833 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.7 -22.58 60.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.768 -0.651 . . . . 2.77 111.217 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.07 -50.66 21.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 2.04 111.055 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -75.01 -20.66 59.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 2.77 111.167 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.4 tp -77.07 -50.6 12.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.338 -0.392 . . . . 1.8899999999999999 111.598 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.92 -35.44 49.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.226 -0.443 . . . . 1.6399999999999999 112.08 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -56.95 -35.78 69.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 1.24 110.939 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -77.84 -35.29 51.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 2.9700000000000002 110.487 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -70.01 -22.31 63.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 1.48 110.16 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 57.5 m -79.42 -48.38 14.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.852 -0.613 . . . . 1.55 111.519 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.57 HG13 HD22 ' A' ' 175' ' ' LEU . 7.3 p -62.19 -33.42 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.272 0.471 . . . . 1.52 112.272 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.57 HD22 HG13 ' A' ' 174' ' ' VAL . 4.0 mm? -76.52 -52.77 9.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.8 0.333 . . . . 1.8500000000000001 110.96 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -31.4 64.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.62 110.905 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.469 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 14.4 tt -87.65 -19.51 7.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.053 0.454 . . . . 1.3500000000000001 110.198 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.23 -50.91 60.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.58999999999999997 112.773 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.1 m-85 -58.37 -54.88 51.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.719 0.26 . . . . 1.45 111.308 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.5 Cg_exo -45.7 -30.88 6.86 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.283 1.989 . . . . 0.55000000000000004 112.571 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 177' ' ' ILE . 37.3 mm -68.98 -60.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 1.4199999999999999 111.454 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 179' ' ' TYR . 27.5 m -60.32 -25.53 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.78000000000000003 111.715 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.455 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 38.0 m95 -62.98 -27.23 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.623 -0.262 . . . . 0.93999999999999995 111.016 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.82 -43.69 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 1.4299999999999999 110.779 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 39.5 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.524 . . . . 2.02 111.011 179.876 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.628 0.252 . . . . 2.48 111.588 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.86 -60.86 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 2.1800000000000002 111.271 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.4 t -62.57 -35.25 78.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.367 . . . . 1.49 111.173 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -59.11 -26.87 65.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 1.77 111.062 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 61.5 tp -78.11 -46.8 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.4199999999999999 110.998 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -74.0 -8.19 55.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 1.78 111.377 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.406 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 99.4 m -96.06 -39.2 9.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.086 0.47 . . . . 1.3 110.897 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.0 tp -72.95 -34.34 66.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.66000000000000003 111.734 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.542 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -59.42 -54.54 55.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 121.102 -0.239 . . . . 1.6299999999999999 111.174 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -57.28 -41.89 68.44 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.734 1.623 . . . . 0.64000000000000001 111.456 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.05 -28.05 69.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 1.3600000000000001 110.067 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -83.73 -21.46 32.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.784 -0.644 . . . . 1.54 110.386 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 1.2 110.347 179.603 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.711 0.291 . . . . 1.6399999999999999 111.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.14 -37.13 91.26 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.733 -0.746 . . . . 0.79000000000000004 112.618 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -64.17 -35.69 81.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 1.6100000000000001 110.756 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.2 m -59.83 -60.62 3.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 1.1499999999999999 111.143 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.55 -21.29 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.23 -0.441 . . . . 3.3399999999999999 111.29 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.1 tt -68.88 -44.83 72.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.434 -0.348 . . . . 1.1899999999999999 110.715 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -66.99 -32.51 73.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 2.23 110.993 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.48 -40.68 96.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 2.4700000000000002 110.953 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -86.61 -20.94 27.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 1.6200000000000001 110.888 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.27 99.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 1.4099999999999999 112.457 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.466 HD22 HG12 ' A' ' 32' ' ' VAL . 60.1 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 2.5800000000000001 110.961 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.71 0.29 . . . . 2.0699999999999998 111.273 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.413 ' N ' HD22 ' B' ' 7' ' ' LEU . 3.6 mm? -77.58 -32.0 53.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 2.1000000000000001 110.472 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 26.9 m170 -73.47 -29.12 62.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0700000000000001 110.414 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -70.85 -40.78 72.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.938 -0.574 . . . . 1.48 110.336 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.31 -25.27 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 2.02 110.348 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.67 -53.86 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.653 -0.703 . . . . 0.92000000000000004 110.725 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.91 -29.78 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.93999999999999995 110.778 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.68 87.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.55000000000000004 111.186 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.58 -34.35 54.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.825 -0.702 . . . . 0.47999999999999998 112.481 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.68 76.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.84999999999999998 111.105 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 37.3 m -60.29 -57.34 13.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 1.3400000000000001 111.178 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -60.1 -22.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 1.55 111.187 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.86 -63.7 4.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.69999999999999996 112.573 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -32.0 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.81000000000000005 111.196 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' B' ' 17' ' ' ILE . 95.9 mt -66.63 -39.6 88.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 2.2599999999999998 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.88 -35.16 74.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 1.78 110.726 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -79.23 -20.19 48.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 4.5800000000000001 110.637 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -67.05 -36.67 82.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 3.3500000000000001 110.657 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.6 m -81.44 -35.03 31.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 1.5800000000000001 110.531 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.39 -2.25 44.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.877 -0.602 . . . . 1.8400000000000001 110.34 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 57.7 p -61.98 -23.19 66.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.936 -0.574 . . . . 1.3700000000000001 110.828 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -49.99 -31.98 14.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.159 0.504 . . . . 4.9800000000000004 109.902 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.3 p-10 -170.49 132.13 0.94 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.342 -0.845 . . . . 2.1400000000000001 109.92 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 42.9 Cg_endo -95.26 172.72 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.092 2.528 . . . . 1.8200000000000001 112.55 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.544 ' HD3' HD22 ' B' ' 218' ' ' LEU . 14.9 ptm180 -88.28 45.72 1.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 5.1900000000000004 111.077 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.27 1.77 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.812 -0.709 . . . . 2.2000000000000002 112.824 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.5 123.24 89.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.488 0.185 . . . . 3.6499999999999999 110.986 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.421 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 33.3 Cg_exo -59.23 162.1 14.98 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.376 2.051 . . . . 2.6699999999999999 112.365 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -58.86 -18.08 29.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 4.8799999999999999 112.017 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.421 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 2.8 p90 -50.21 -38.09 38.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.682 0.277 . . . . 1.8700000000000001 111.281 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.14 -40.57 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 2.6800000000000002 110.651 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -64.68 -31.57 72.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 2.9199999999999999 110.724 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 104' ' ' PHE . 51.2 tp -62.14 -57.16 12.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 1.6399999999999999 110.706 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 14.4 t -65.07 -36.3 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 1.6000000000000001 110.808 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.12 47.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.68999999999999995 111.205 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 27.6 ttt -89.36 -41.71 11.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 2.5800000000000001 111.082 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -71.87 -34.62 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 3.3900000000000001 111.972 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 99.2 mt -54.57 -53.2 62.73 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.078 0.399 . . . . 0.40999999999999998 112.078 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.1 Cg_endo -70.53 -31.81 16.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.31 2.007 . . . . 0.48999999999999999 113.044 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.38 -62.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.564 0.221 . . . . 1.29 111.543 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.583 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.9 OUTLIER -60.47 -56.55 20.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.73 0.3 . . . . 1.3999999999999999 110.98 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -57.23 -22.31 40.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 1.3799999999999999 110.953 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.29 -61.27 5.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.632 -0.794 . . . . 0.37 112.753 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.512 HD12 ' N ' ' B' ' 50' ' ' ALA . 3.3 pp -58.6 -22.74 57.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.625 0.25 . . . . 1.29 111.339 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.512 ' N ' HD12 ' B' ' 49' ' ' LEU . . . -64.96 -57.47 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.44 110.983 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 30.5 m-85 -63.67 -37.26 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.5 110.653 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -49.63 -38.51 32.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.007 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.66 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.55000000000000004 110.751 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 42.4 mtt -53.25 -24.91 12.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.5 110.527 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -77.13 -48.42 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.54000000000000004 110.78 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.56 11.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 1.3 111.434 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 61.44 67.27 0.79 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.03 -0.532 . . . . 2.2400000000000002 111.355 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -144.9 152.8 40.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.77 110.917 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 92.29 17.27 47.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.81 -0.709 . . . . 1.0600000000000001 112.467 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -128.95 148.81 50.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 2.6600000000000001 110.923 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.77 150.71 29.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 1.8899999999999999 110.859 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.36 94.9 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 2.4100000000000001 110.682 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.71 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 1.5600000000000001 111.152 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.23 30.28 20.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 1.8200000000000001 111.251 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.18 -15.64 48.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.857 -0.687 . . . . 1.51 112.913 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -98.37 146.81 25.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.801 0.334 . . . . 2.4500000000000002 110.781 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 54.6 mt -86.2 131.14 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 1.79 111.263 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.9 143.29 32.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.81999999999999995 111.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 72.3 m-70 -84.48 65.03 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.154 0.502 . . . . 1.05 110.682 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.41 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 76.7 t80 -63.82 -51.91 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.635 -0.712 . . . . 1.8700000000000001 111.581 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.427 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -64.61 -22.46 66.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.60999999999999999 111.933 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' B' ' 69' ' ' HIS . 22.4 tpp180 -68.46 -51.62 41.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.257 0.465 . . . . 2.3900000000000001 112.257 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' B' ' 77' ' ' MET . 6.0 p90 -76.33 -34.4 58.99 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.147 0.425 . . . . 3.6699999999999999 112.147 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.432 HG23 ' N ' ' B' ' 75' ' ' ASP . 18.2 tt -55.39 -43.74 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 120.656 -0.417 . . . . 1.6599999999999999 110.623 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.432 ' N ' HG23 ' B' ' 74' ' ' ILE . 29.6 t70 -68.67 -19.96 64.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.424 -0.584 . . . . 1.4099999999999999 109.424 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -88.43 4.14 47.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 111.306 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.6 ' HA ' HD13 ' B' ' 113' ' ' ILE . 31.8 mtp -101.65 -20.42 15.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.343 -0.39 . . . . 1.53 110.383 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.431 ' O ' HD23 ' B' ' 82' ' ' LEU . 32.7 m -113.92 -29.86 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.89000000000000001 111.87 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.441 HG23 HG23 ' B' ' 43' ' ' ILE . 30.6 m -81.3 -51.38 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.933 0.345 . . . . 1.24 111.933 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 21.8 m -52.27 -50.61 78.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.114 0.413 . . . . 0.57999999999999996 112.114 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.4 Cg_exo -53.75 -49.32 17.62 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.785 1.657 . . . . 0.66000000000000003 111.729 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.431 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -64.27 -31.25 72.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.135 -0.484 . . . . 1.0600000000000001 110.717 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.403 ' O ' HD13 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -63.54 -35.26 79.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.154 0.502 . . . . 1.22 109.956 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -84.27 -35.7 23.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 1.53 111.236 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 88.1 mt -58.61 -41.24 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 1.5800000000000001 111.054 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -59.02 -28.65 66.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 1.3899999999999999 110.827 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 mt -67.47 -32.32 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.1499999999999999 110.905 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -72.93 -39.38 66.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.5700000000000001 111.294 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -70.26 -24.69 63.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 2.1699999999999999 111.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 32.6 m -78.62 -30.95 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 1.4199999999999999 111.178 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.27 -25.41 25.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 1.1799999999999999 111.187 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -132.81 99.36 4.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 1.8799999999999999 110.815 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -65.28 -50.97 63.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 3.4199999999999999 110.984 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -104.77 143.38 33.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 4.0599999999999996 110.732 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 tt -124.9 142.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 2.0899999999999999 110.887 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.441 ' HG2' ' HG3' ' B' ' 97' ' ' LYS . 38.7 ttpt -128.31 -70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 3.8500000000000001 111.104 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.441 ' HG3' ' HG2' ' B' ' 96' ' ' LYS . 29.9 mtpp -141.81 95.84 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 4.8200000000000003 111.03 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -170.24 83.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 3.7999999999999998 110.907 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -106.49 14.24 27.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 5.1699999999999999 110.721 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 2.8 t -91.15 -42.0 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 2.02 111.424 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.15 -47.07 59.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 2.0899999999999999 111.157 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -63.2 -32.33 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.8799999999999999 111.391 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.35 -31.81 33.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 0.56000000000000005 112.729 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.09 -36.65 72.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 1.78 111.002 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.546 ' HB3' HD21 ' B' ' 84' ' ' LEU . 88.0 mt -74.84 -44.27 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.239 -0.437 . . . . 1.03 111.063 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.7 ttp -65.53 -37.38 86.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 1.6699999999999999 111.351 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -65.7 -50.36 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.343 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 35.9 p -56.79 -34.33 67.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.331 -0.395 . . . . 1.1799999999999999 111.32 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.406 ' CG ' HD13 ' B' ' 84' ' ' LEU . 11.8 mm100 -61.52 -47.32 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 2.1699999999999999 111.139 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.582 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.5 mt -54.85 -35.09 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 1.3500000000000001 110.605 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 t -65.52 -47.32 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 1.3400000000000001 111.094 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.56 -47.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.192 -0.458 . . . . 0.42999999999999999 111.212 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' B' ' 77' ' ' MET . 47.0 mt -58.15 -33.26 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 1.6000000000000001 110.996 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.1 m -58.89 -48.65 80.65 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.178 -0.464 . . . . 0.85999999999999999 110.979 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.5 m -67.3 -23.23 65.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.974 -0.557 . . . . 0.94999999999999996 110.852 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.35 -32.48 34.63 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.92 -0.657 . . . . 0.46000000000000002 113.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.504 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.4 pp -80.85 -28.89 35.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.706 0.289 . . . . 1.75 111.206 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.504 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.55 -31.25 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.385 . . . . 1.78 111.321 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.91 -47.06 74.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.299 -0.41 . . . . 0.38 110.957 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 -21.12 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.97 110.716 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' B' ' 118' ' ' ILE . 98.8 mt -81.64 14.79 2.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.077 -0.51 . . . . 0.76000000000000001 110.831 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 79.0 p -61.24 134.5 57.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 1.47 111.024 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -117.52 -45.21 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 2.5 110.832 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.604 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 59.4 ttp180 -108.23 132.66 53.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 2.73 110.64 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.7 -19.0 63.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 2.2000000000000002 111.252 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.604 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 52.4 t-105 -71.26 -53.65 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.401 -0.363 . . . . 3.3999999999999999 110.868 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.546 HG23 HG21 ' A' ' 56' ' ' ILE . 7.3 p -74.86 -24.09 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.23 111.106 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -52.42 -39.67 61.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 3.04 111.2 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -71.34 -32.59 68.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.391 . . . . 4.1399999999999997 111.384 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.58 -56.84 6.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 1.6499999999999999 111.189 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -58.01 -29.97 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.77000000000000002 111.416 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.26 -53.27 57.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 1.46 110.725 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.85 -31.03 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 1.6299999999999999 110.775 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.48 -34.34 75.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 1.4199999999999999 110.859 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.05 -55.02 8.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.824 -0.703 . . . . 0.48999999999999999 112.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m -59.83 -32.94 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 1.3 110.955 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.3 t -65.61 -36.74 84.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 1.3 110.613 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.21 91.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.62 110.627 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -68.27 -23.23 64.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 1.74 110.787 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -58.82 5.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 1.76 110.802 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.413 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.7 pt -62.6 -40.15 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.68999999999999995 111.503 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.413 ' N ' HG13 ' B' ' 141' ' ' ILE . 87.6 mt -64.61 -33.99 66.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.76 110.909 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.75 -45.0 95.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 1.0600000000000001 110.942 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.81 -25.53 65.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 4.1200000000000001 111.286 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.92 -35.66 21.01 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 1.26 112.746 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.6 -22.47 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 1.98 110.454 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -87.08 4.65 41.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 1.4199999999999999 111.015 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.008 -0.542 . . . . 99.989999999999995 112.147 -179.365 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.018 0.437 . . . . 2.4300000000000002 110.729 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -80.6 -25.16 38.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 2.5800000000000001 111.101 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -75.28 -38.48 60.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 2.0 110.97 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -79.95 -21.6 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 3.0299999999999998 110.791 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 48.7 tp -81.34 -46.12 15.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 1.1000000000000001 111.464 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.35 -33.77 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.75 112.282 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 9.9 t -51.73 -41.48 61.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.617 0.246 . . . . 0.97999999999999998 111.282 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' TYR . . . . . 0.447 ' O ' HG22 ' B' ' 174' ' ' VAL . 37.3 m-85 -77.02 -40.3 46.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 4.2999999999999998 110.709 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -62.11 -23.24 66.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.162 -0.472 . . . . 1.3899999999999999 110.865 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.408 ' O ' HG22 ' B' ' 177' ' ' ILE . 28.0 m -79.31 -50.8 10.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 1.1100000000000001 111.577 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 171' ' ' TYR . 32.7 m -59.51 -28.94 41.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.986 0.365 . . . . 1.51 111.986 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 77.5 mt -76.27 -57.02 4.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.905 0.383 . . . . 1.75 111.213 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -32.47 56.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.89 -0.596 . . . . 0.59999999999999998 111.224 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.442 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 19.1 tt -87.4 -19.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.451 . . . . 1.47 110.385 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.26 59.45 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.742 -0.663 . . . . 0.55000000000000004 112.953 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 84.5 m-85 -58.22 -54.86 51.42 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.782 0.291 . . . . 1.6200000000000001 111.342 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -45.26 -32.44 7.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.164 1.91 . . . . 0.64000000000000001 112.685 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.428 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.4 mt -65.62 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.27 111.462 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 179' ' ' TYR . 35.2 m -60.23 -27.01 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.68999999999999995 111.404 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -62.93 -25.91 68.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 1.1799999999999999 111.178 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.27 -40.93 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 1.77 110.716 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.59 -179.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.6899999999999999 110.798 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.414 0 C-N-CA 120.748 -0.739 . . . . 1.5800000000000001 112.695 179.86 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.857 0.361 . . . . 2.4700000000000002 110.833 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.23 -60.65 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 2.5299999999999998 110.879 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 8.1 t -62.17 -36.83 83.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 1.29 111.152 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.69 -27.46 64.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.285 -0.416 . . . . 2.6200000000000001 110.758 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -75.89 -50.35 15.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 1.6100000000000001 111.049 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -73.02 -5.85 41.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.565 -0.289 . . . . 1.4199999999999999 110.843 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 60.8 m -96.48 -41.86 8.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.267 0.556 . . . . 1.4299999999999999 110.472 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.51 -38.38 74.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.578 -0.737 . . . . 1.1200000000000001 111.909 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.675 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.3 tp -58.3 -53.94 60.95 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 120.961 -0.296 . . . . 1.26 111.321 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -53.62 -42.08 68.81 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.791 1.661 . . . . 0.59999999999999998 111.399 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.09 -42.99 86.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 1.3999999999999999 110.343 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -69.81 -30.19 67.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.4099999999999999 110.457 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.504 . . . . 1.3200000000000001 110.279 179.609 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.863 0.364 . . . . 1.6899999999999999 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.79 96.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.79000000000000004 112.339 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -69.47 -32.26 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.73 0.3 . . . . 2.96 110.875 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 49.2 m -59.91 -62.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 1.29 110.95 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.13 -20.33 65.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.589 . . . . 3.1499999999999999 110.945 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.11 -54.18 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 1.51 111.279 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.98 -37.48 76.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 2.1899999999999999 111.646 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' B' ' 30' ' ' ARG . 78.8 mt -59.16 -49.1 79.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 1.98 111.144 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -77.08 -20.53 55.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 2.1699999999999999 111.051 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.28 -47.93 86.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.881 -0.676 . . . . 1.3600000000000001 112.88 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.548 0.214 . . . . 2.8999999999999999 111.033 -179.779 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.7 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.834 0.349 . . . . 2.52 110.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.68 -49.06 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 1.9299999999999999 111.312 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 49.1 m-70 -64.72 -24.19 67.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 1.26 110.908 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.446 ' O ' HG12 ' C' ' 12' ' ' VAL . 54.7 t-105 -70.57 -50.03 41.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 1.6699999999999999 110.399 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.48 -21.29 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.204 0.526 . . . . 1.8700000000000001 109.932 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' TYR . . . . . 0.407 ' HE2' ' HG ' ' C' ' 203' ' ' CYS . 0.3 OUTLIER -61.15 -58.99 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.49 -0.777 . . . . 1.4399999999999999 110.413 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' C' ' 52' ' ' MET . 10.1 p -61.97 -26.84 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.46999999999999997 111.23 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.75 83.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.398 -0.365 . . . . 0.58999999999999997 111.046 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.6 -23.81 77.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.831 -0.699 . . . . 0.5 112.499 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' MET . . . . . 0.402 ' HB3' ' HB2' ' C' ' 44' ' ' PRO . 18.9 mmt -77.89 -42.92 31.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.52 0.2 . . . . 0.68000000000000005 111.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 37.6 p -59.1 -50.94 72.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 1.3999999999999999 110.893 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -29.51 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 1.55 110.684 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.17 -61.59 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.861 -0.685 . . . . 0.70999999999999996 112.702 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.41 ' HB1' ' HG3' ' C' ' 41' ' ' MET . . . -56.66 -31.95 64.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.77000000000000002 111.127 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' C' ' 23' ' ' TRP . 93.5 mt -69.13 -29.05 67.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 1.9299999999999999 111.247 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.26 -41.39 84.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.94 0.4 . . . . 1.8600000000000001 110.596 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.94 -24.5 52.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 4.1399999999999997 110.606 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' TRP . . . . . 0.414 ' HB3' ' O ' ' C' ' 20' ' ' LEU . 73.9 t-105 -55.28 -43.17 74.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.295 -0.411 . . . . 3.1499999999999999 110.631 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 44.2 t -82.73 -37.45 24.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 1.95 110.973 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 38.2 tp -77.42 -3.31 39.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.215 -0.448 . . . . 2.2200000000000002 110.739 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 65.4 p -60.77 -23.62 65.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 1.3700000000000001 110.928 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.6 -26.71 14.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.092 0.473 . . . . 5.0300000000000002 109.771 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 14.6 t-20 -172.95 131.87 0.62 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 2.3700000000000001 110.174 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 35.4 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 C-N-CA 123.147 2.564 . . . . 2.0499999999999998 112.538 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' PRO . . . . . 0.51 ' HB2' ' CD1' ' C' ' 35' ' ' TYR . 38.8 Cg_exo . . . . . 0 N--CA 1.471 0.174 0 CA-C-O 121.394 0.498 . . . . 1.9299999999999999 112.613 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' C' ' 34' ' ' GLN . 0.0 OUTLIER -62.13 -18.48 60.98 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.806 1.039 . . . . 4.1200000000000001 113.806 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' C' ' 33' ' ' PRO . 6.5 p90 -54.79 -31.88 59.44 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.479 -0.489 . . . . 2.8900000000000001 111.123 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.52 -54.56 11.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 2.46 110.918 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' C' ' 40' ' ' ALA . 85.4 m-85 -65.18 -20.81 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 2.7799999999999998 111.278 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.72 -61.48 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 1.6200000000000001 110.036 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.435 HG13 HD12 ' C' ' 82' ' ' LEU . 42.1 t -66.44 -29.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 1.5900000000000001 110.13 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' C' ' 37' ' ' TYR . . . -74.83 -8.85 57.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.82 -0.627 . . . . 0.65000000000000002 110.807 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.429 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.1 ttt -89.02 -37.14 15.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 1.6699999999999999 110.528 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.439 ' HA ' HG22 ' C' ' 45' ' ' ILE . 46.0 t80 -72.28 -29.81 64.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.7 -0.682 . . . . 3.4199999999999999 111.841 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' C' ' 82' ' ' LEU . 37.8 mm -60.22 -52.04 75.99 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 112.402 0.519 . . . . 0.89000000000000001 112.402 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 64.1 Cg_endo -72.81 -34.55 6.66 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.348 2.032 . . . . 0.40999999999999998 114.25 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.486 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.1 tp -63.17 -50.44 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.338 0.495 . . . . 1.76 112.338 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.642 ' HE1' HG22 ' A' ' 110' ' ' ILE . 1.0 OUTLIER -67.59 -58.77 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 2.1600000000000001 111.345 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.6 p -56.64 -31.35 64.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 1.1699999999999999 110.515 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.82 -57.03 19.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.986 -0.626 . . . . 0.44 112.773 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.28 -29.62 68.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.91 0.386 . . . . 1.29 110.881 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.73 95.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.5 110.974 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -69.51 -47.22 64.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.8300000000000001 110.87 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' MET . . . . . 0.455 ' HB2' HG11 ' C' ' 12' ' ' VAL . 50.7 ttp -50.95 -28.23 9.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 1.47 110.457 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -74.24 -43.35 57.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.843 -0.617 . . . . 0.59999999999999998 110.879 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.2 -26.42 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.83999999999999997 110.612 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -77.74 -45.22 25.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.65000000000000002 111.275 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' C' ' 53' ' ' ALA . 31.1 pt -79.45 4.86 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 1.55 111.3 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.2 68.03 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.861 -0.609 . . . . 1.54 111.377 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -149.54 136.59 19.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.79 110.822 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.28 4.84 23.53 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.712 -0.756 . . . . 0.93999999999999995 112.356 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -114.22 152.68 30.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 2.3599999999999999 110.872 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.18 145.47 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 1.97 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.61 91.2 8.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 2.4399999999999999 110.796 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.02 105.94 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 1.54 111.208 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.95 36.33 24.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 1.71 111.367 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.43 -13.49 51.08 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 1.53 112.773 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -99.35 134.53 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 2.23 110.921 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 65.6 mt -76.59 137.25 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 1.3600000000000001 111.006 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.72 143.12 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.78000000000000003 111.073 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.497 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 68.0 m80 -83.2 61.17 5.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.553 . . . . 1.0800000000000001 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' TYR . . . . . 0.412 ' O ' HG12 ' C' ' 74' ' ' ILE . 68.6 t80 -60.64 -58.01 10.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 2.2999999999999998 111.671 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.35 -22.44 66.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.324 0.49 . . . . 0.75 112.324 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.6 tpp180 -65.52 -51.6 58.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.101 0.408 . . . . 1.51 112.101 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -74.13 -29.42 61.81 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.875 -0.33 . . . . 4.6500000000000004 111.123 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.412 HG12 ' O ' ' C' ' 70' ' ' TYR . 22.6 mm -52.7 -50.53 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 120.853 0.358 . . . . 1.22 110.496 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.66 -21.98 66.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.112 -0.495 . . . . 1.3100000000000001 109.737 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.56 5.45 39.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.936 -0.574 . . . . 1.6799999999999999 110.709 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.525 ' HA ' HD13 ' C' ' 113' ' ' ILE . 57.0 tpp -102.71 -21.81 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 1.8 110.389 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 2.5 p -113.73 -47.42 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.119 -0.491 . . . . 1.1899999999999999 111.983 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.501 HG23 HG23 ' C' ' 43' ' ' ILE . 96.5 m -61.11 -53.64 54.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.163 0.431 . . . . 1.23 112.163 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 29.9 m -51.66 -54.48 39.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.449 0.537 . . . . 0.58999999999999997 112.449 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 77.1 Cg_exo -49.3 -37.79 40.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.896 1.73 . . . . 0.67000000000000004 112.143 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' C' ' 43' ' ' ILE . 4.1 mm? -74.39 -38.39 63.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.95999999999999996 110.63 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.451 HD13 ' O ' ' C' ' 83' ' ' LEU . 0.3 OUTLIER -57.82 -33.64 68.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.173 0.511 . . . . 1.1899999999999999 109.99 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -80.31 -44.93 18.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.598 -0.728 . . . . 1.7 110.783 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.3 -32.81 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.681 -0.69 . . . . 1.6200000000000001 111.443 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -62.14 -34.53 76.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 1.26 110.691 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.32 -44.46 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 1.1100000000000001 110.9 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 43.4 t -65.83 -23.21 66.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 1.51 111.036 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -83.84 -26.72 29.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 2.0600000000000001 110.666 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -77.1 -39.9 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 1.52 111.254 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.11 -44.29 54.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 1.3 111.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -111.79 101.76 10.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 1.6200000000000001 110.825 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.44 -39.62 70.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 3.2400000000000002 110.938 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -116.44 136.51 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 4.6299999999999999 110.794 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.03 144.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.035 -0.53 . . . . 2.1800000000000002 110.802 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -126.21 -65.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.315 -0.402 . . . . 4.1200000000000001 111.078 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -149.09 110.0 4.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.379 . . . . 4.96 110.846 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -144.26 -84.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 3.9100000000000001 110.902 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 90.9 m95 53.82 24.79 4.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.3 -0.409 . . . . 5.21 111.256 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 38.8 p -120.4 -51.93 2.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.217 -0.447 . . . . 1.8200000000000001 110.907 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 68.1 tp -72.27 -53.1 13.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 2.0800000000000001 110.768 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 13.5 tt -56.55 -32.77 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.033 -0.531 . . . . 1.8600000000000001 111.314 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.8 -35.17 22.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.58999999999999997 112.617 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' B' ' 38' ' ' LEU . 90.1 t80 -70.3 -29.76 66.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 1.53 111.091 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.526 ' HB3' HD21 ' C' ' 84' ' ' LEU . 95.7 mt -79.42 -50.45 10.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 1.1100000000000001 111.134 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -61.53 -30.92 70.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.972 -0.558 . . . . 2.21 111.094 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 95.6 p -68.95 -52.82 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.066 0.46 . . . . 1.28 110.747 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 67.7 p -60.7 -23.96 65.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 1.22 110.677 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -64.7 -50.37 67.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.033 -0.531 . . . . 2.3300000000000001 110.319 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.583 HG22 ' HE1' ' B' ' 46' ' ' TRP . 43.9 mm -55.85 -33.09 33.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 1.29 110.476 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.408 HG13 HD21 ' B' ' 49' ' ' LEU . 21.8 t -62.89 -45.93 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 1.0600000000000001 110.797 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.64 -47.53 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.945 -0.571 . . . . 0.51000000000000001 111.217 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' C' ' 77' ' ' MET . 29.8 mt -60.15 -31.91 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.3700000000000001 111.057 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 22.7 m -59.49 -48.17 82.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.77000000000000002 111.022 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 44.1 m -70.15 -20.29 63.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.1899999999999999 110.965 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.11 -33.09 30.17 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.837 -0.697 . . . . 0.5 113.26 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.526 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.3 pp -79.89 -29.82 40.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.717 0.258 . . . . 1.47 111.592 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' C' ' 121' ' ' LEU . 8.5 tp -83.81 -26.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 1.2 111.181 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.35 -40.99 68.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.169 -0.468 . . . . 0.40000000000000002 111.049 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 -17.56 48.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 2.1200000000000001 110.903 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' C' ' 118' ' ' ILE . 91.9 mt -90.57 34.77 0.88 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 0.75 111.03 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 94.4 p -91.53 131.29 37.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 1.3799999999999999 110.942 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -101.44 -53.64 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 2.7400000000000002 110.901 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 50.9 ttp180 -89.6 137.0 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.497 . . . . 2.7999999999999998 111.022 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.99 -24.6 65.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 2.4100000000000001 111.188 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 126' ' ' TRP . . . . . 0.615 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 66.7 t-105 -71.06 -57.24 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 4.2000000000000002 110.75 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' C' ' 124' ' ' ARG . 11.5 p -63.9 -23.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.513 . . . . 1.0800000000000001 110.725 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -57.78 -36.57 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 2.5699999999999998 110.948 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -75.3 -18.16 60.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 3.8100000000000001 110.682 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.03 -42.32 19.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 1.4199999999999999 111.235 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -72.94 -31.09 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 0.89000000000000001 111.371 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' TYR . . . . . 0.418 ' HE2' ' HB3' ' C' ' 183' ' ' TRP . 66.6 t80 -60.66 -55.38 34.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 1.26 110.937 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.6 tt -60.94 -31.14 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.021 -0.536 . . . . 1.6799999999999999 111.078 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.55 -31.49 72.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 1.24 110.724 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -53.02 15.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.868 -0.682 . . . . 0.54000000000000004 112.775 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 136' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 22.2 m -60.54 -38.65 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 1.0600000000000001 111.219 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 67.3 m -56.33 -42.5 77.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.894 0.378 . . . . 1.0800000000000001 110.823 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.14 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.56999999999999995 110.905 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 1.6799999999999999 110.849 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 96.3 mt -66.81 -53.24 34.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 1.7 111.09 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 33.1 pt -66.4 -31.88 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.451 -0.341 . . . . 0.78000000000000003 111.418 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.89 -29.69 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 2.2400000000000002 110.882 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.98 -37.08 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.745 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -76.07 -29.48 58.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 3.0 110.746 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.06 -27.52 49.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 1.27 112.471 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 tt -84.28 -21.51 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.057 0.456 . . . . 1.8899999999999999 110.298 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -87.72 3.21 48.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 1.6000000000000001 110.53 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.908 -0.587 . . . . 99.989999999999995 111.823 -179.326 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 CA--C 1.521 -0.159 0 CA-C-O 120.946 0.403 . . . . 2.3500000000000001 110.784 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -26.16 63.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 2.6200000000000001 110.991 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.05 -59.52 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 2.0899999999999999 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.64 -26.06 63.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 3.2400000000000002 111.14 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.86 -54.67 38.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 1.6899999999999999 110.905 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.48 -28.22 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.3999999999999999 111.287 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 43.5 m -52.66 -58.52 6.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.483 -0.326 . . . . 0.95999999999999996 111.198 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 171' ' ' TYR . . . . . 0.417 ' O ' HD23 ' C' ' 175' ' ' LEU . 76.1 m-85 -63.56 -38.95 93.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.53 -0.304 . . . . 3.6499999999999999 110.479 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.04 -25.18 65.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 1.3700000000000001 111.004 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.441 ' O ' HG22 ' C' ' 177' ' ' ILE . 46.6 m -79.43 -49.16 12.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 1.4299999999999999 111.722 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.3 -41.28 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 111.736 0.272 . . . . 1.6200000000000001 111.736 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' C' ' 209' ' ' SER . 4.4 mm? -71.09 -55.72 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.855 0.317 . . . . 2.0299999999999998 111.855 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -54.16 -34.63 60.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.456 -0.338 . . . . 0.62 111.528 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.455 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.43 -19.3 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 1.5800000000000001 110.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.77 -44.85 95.59 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.56000000000000005 112.806 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.654 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 82.1 m-85 -62.48 -55.98 34.42 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.704 0.252 . . . . 1.3300000000000001 111.069 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 83.2 Cg_exo -48.32 -27.93 10.61 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.999 1.799 . . . . 0.63 112.453 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.423 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -69.12 -59.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.93000000000000005 111.127 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.581 HG11 HD21 ' C' ' 201' ' ' LEU . 17.2 m -61.59 -24.76 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.006 -0.543 . . . . 1.27 111.203 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 183' ' ' TRP . . . . . 0.418 ' HB3' ' HE2' ' C' ' 132' ' ' TYR . 31.9 m95 -66.41 -22.75 66.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.27 -0.423 . . . . 1.77 110.727 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.53 -27.48 42.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 2.3900000000000001 111.079 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.262 -0.427 . . . . 1.95 111.115 179.806 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.657 0.265 . . . . 2.3799999999999999 111.243 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 7.3 tp -56.03 -36.1 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 2.23 111.301 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.68 -58.34 7.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 2.1600000000000001 111.03 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 75.0 p -64.07 -20.45 65.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 1.27 111.049 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.26 -31.17 58.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.474 . . . . 1.7 110.9 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 201' ' ' LEU . . . . . 0.581 HD21 HG11 ' C' ' 182' ' ' VAL . 6.1 tt -68.7 -52.02 35.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 2.02 110.598 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.05 -2.43 18.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 1.8200000000000001 110.935 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.407 ' HG ' ' HE2' ' C' ' 11' ' ' TYR . 11.6 t -96.68 -46.72 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.39 0.614 . . . . 1.3500000000000001 110.862 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.52 -39.52 74.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.158 -0.928 . . . . 0.65000000000000002 112.134 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.674 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 45.2 tp -56.57 -54.31 54.94 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 121.031 -0.268 . . . . 1.4199999999999999 111.504 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.2 Cg_exo -54.76 -41.35 78.89 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.902 1.734 . . . . 0.63 111.408 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.96 -42.43 94.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.188 -0.46 . . . . 1.49 110.378 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -70.78 -22.95 62.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.078 -0.51 . . . . 1.7 110.277 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 209' ' ' SER . . . . . 0.47 ' HB2' HD12 ' C' ' 175' ' ' LEU . 47.6 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 1.25 110.364 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.686 0.279 . . . . 1.6100000000000001 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.7 61.18 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.86 -0.686 . . . . 0.81999999999999995 112.634 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -64.9 -22.86 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.615 0.245 . . . . 3.0800000000000001 111.312 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.3 m -63.3 -60.3 3.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 1.1499999999999999 110.621 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.9 -24.78 63.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 2.5600000000000001 110.619 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.69 -55.22 32.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.086 -0.507 . . . . 1.29 110.842 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.35 -32.3 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 2.3900000000000001 111.073 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.27 -52.0 66.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 2.0299999999999998 111.315 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -80.01 -19.47 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.331 -0.395 . . . . 3.21 111.207 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.55 75.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.041 -0.599 . . . . 1.3600000000000001 113.372 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.798 0.299 . . . . 2.8999999999999999 111.216 -179.77 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.726 0.298 . . . . 2.4199999999999999 111.054 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.82 -43.55 83.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 2.0899999999999999 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 22.1 m80 -68.32 -24.14 64.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.372 . . . . 1.1599999999999999 110.675 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.471 ' O ' HG12 ' A' ' 12' ' ' VAL . 63.7 t-105 -72.31 -51.71 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.79000000000000004 110.146 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.52 -21.09 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.277 0.56 . . . . 2.0800000000000001 110.005 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.6 OUTLIER -63.96 -63.18 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.578 -0.737 . . . . 1.28 110.927 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 9' ' ' TRP . 10.5 p -52.7 -33.75 18.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 111.587 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.87 98.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.63 111.107 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.13 -22.55 78.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.817 -0.706 . . . . 0.55000000000000004 112.729 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 86.8 mmm -76.08 -44.36 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.785 0.326 . . . . 1.03 111.041 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.9 p -58.29 -49.87 75.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 1.3 111.061 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -63.5 -29.4 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 1.3100000000000001 110.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.48 -57.87 17.22 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.941 -0.647 . . . . 0.77000000000000002 112.751 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.95 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.80000000000000004 110.956 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -67.19 -36.78 82.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.958 -0.565 . . . . 1.8100000000000001 110.827 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -61.67 -49.3 77.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 1.8799999999999999 110.818 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.405 ' O ' ' OG ' ' A' ' 26' ' ' SER . 96.8 m-85 -68.74 -22.06 64.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 4.4500000000000002 111.026 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.412 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 87.5 t90 -68.21 -32.62 72.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 3.6899999999999999 110.654 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 m -78.74 -35.69 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 1.5700000000000001 110.808 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 tp -83.72 -1.36 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 1.95 110.756 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 23' ' ' TRP . 1.2 m -61.85 -26.21 67.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.453 . . . . 1.3799999999999999 110.871 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -47.76 -35.91 10.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.159 0.504 . . . . 4.0700000000000003 109.876 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.495 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.6 p-10 -164.61 131.72 2.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 2.7200000000000002 110.034 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 39.6 Cg_endo -95.86 -176.35 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.097 2.531 . . . . 1.9099999999999999 112.474 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.21 28.51 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 4.7599999999999998 111.022 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.45 -28.5 6.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.8 -0.714 . . . . 1.99 112.795 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.548 HG22 HD22 ' A' ' 221' ' ' LEU . 71.4 t -83.62 123.21 76.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.511 0.196 . . . . 2.7000000000000002 111.316 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 34.2 Cg_exo -58.92 161.63 15.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.442 2.095 . . . . 1.79 112.003 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -17.94 37.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 4.1200000000000001 112.079 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' HE2' ' HD2' ' A' ' 33' ' ' PRO . 2.6 p90 -49.71 -36.85 26.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.867 0.365 . . . . 2.9300000000000002 110.997 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.81 -36.36 62.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.322 -0.399 . . . . 2.8799999999999999 110.668 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.25 -37.67 86.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 4.6600000000000001 110.382 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' B' ' 100' ' ' THR . 40.8 tp -60.77 -57.8 11.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.549 . . . . 1.45 111.241 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.06 -44.62 97.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 1.78 111.488 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -10.17 54.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.63 111.823 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.414 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 28.1 ttt -89.44 -33.34 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 1.48 111.067 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -75.38 -29.25 59.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 3.5 112.241 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 67.0 mt -64.08 -49.99 71.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.519 0.563 . . . . 1.0800000000000001 112.519 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 75.1 Cg_endo -74.4 -38.07 2.15 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.646 2.231 . . . . 0.53000000000000003 114.324 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 46' ' ' TRP . 45.1 pt -61.88 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.28 0.474 . . . . 1.6799999999999999 112.28 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.619 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -70.27 -58.76 3.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 1.8300000000000001 110.869 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.4 p -51.29 -44.16 61.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 1.0900000000000001 111.091 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.0 -53.25 27.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.40999999999999998 112.866 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.1 mt -57.44 -34.59 69.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.98999999999999999 110.907 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.69 96.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.47999999999999998 111.342 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 69.2 m-85 -61.75 -49.37 76.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 1.8700000000000001 110.787 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.469 ' HB2' HG11 ' A' ' 12' ' ' VAL . 34.4 ttp -50.48 -34.93 26.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 1.49 110.504 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.88 89.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.58999999999999997 111.301 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -55.59 -33.9 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 0.48999999999999999 110.413 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -72.99 -40.71 65.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.59999999999999998 111.113 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.63 -15.59 19.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 1.3100000000000001 110.968 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t70 63.34 39.43 9.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.724 -0.671 . . . . 1.9099999999999999 110.991 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.45 150.27 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 1.6200000000000001 110.874 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.9 -16.52 46.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.84 -0.695 . . . . 1.04 112.161 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -99.38 144.17 28.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.33 . . . . 2.6800000000000002 110.734 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.54 138.63 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 1.98 111.038 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -92.35 92.81 8.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 2.1800000000000002 110.865 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.5 121.01 33.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 1.5700000000000001 111.069 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.28 28.15 16.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 1.79 111.135 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.57 28.94 45.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 1.48 112.436 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -132.84 119.46 20.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 2.3199999999999998 110.735 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.0 pt -80.08 136.32 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.4399999999999999 110.635 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.88 143.91 37.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.81999999999999995 111.464 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 12.4 m-70 -86.59 53.73 2.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.315 0.579 . . . . 0.90000000000000002 110.695 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 74' ' ' ILE . 58.9 t80 -56.25 -59.18 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 1.8300000000000001 111.893 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.54 66.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.62 111.858 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HG3' ' HZ3' ' A' ' 76' ' ' TRP . 12.4 tpp180 -58.82 -52.8 64.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.585 -0.279 . . . . 2.3399999999999999 111.726 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.518 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 10.1 p90 -77.53 -17.94 57.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.713 -0.395 . . . . 3.4900000000000002 111.088 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.0 mm -55.5 -41.59 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 109.36 -0.608 . . . . 1.3700000000000001 109.36 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.58 -20.62 66.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.365 -0.834 . . . . 1.3100000000000001 110.026 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.518 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -78.88 -21.85 46.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.48 111.13 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 2.3 mtp -90.07 -6.17 55.79 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.12 -0.491 . . . . 1.46 111.468 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.44 HG21 ' CE3' ' A' ' 46' ' ' TRP . 32.8 m -114.81 -31.18 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.507 0.558 . . . . 1.1200000000000001 112.507 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 m -89.95 -58.45 2.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.157 0.429 . . . . 1.1000000000000001 112.157 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -51.92 -51.31 72.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.903 0.705 . . . . 0.59999999999999998 112.903 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 53.7 Cg_exo -53.91 -55.79 3.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.801 1.668 . . . . 0.73999999999999999 112.288 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 HD12 ' A' ' 85' ' ' LEU . 4.2 mm? -61.42 -27.11 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 1.01 110.514 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -36.06 79.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.334 0.588 . . . . 1.48 109.831 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 105' ' ' LEU . 6.9 tt -84.4 -20.32 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.289 -0.869 . . . . 1.3799999999999999 110.86 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 82' ' ' LEU . 79.4 mt -80.15 -39.85 28.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 111.043 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.413 ' HA ' ' HD1' ' A' ' 89' ' ' TRP . 48.1 t -59.33 -20.61 56.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 1.23 110.929 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.12 -32.33 63.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.88 110.968 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -72.42 -38.52 68.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 1.3899999999999999 111.197 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.413 ' HD1' ' HA ' ' A' ' 86' ' ' SER . 96.9 m95 -62.37 -49.84 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.424 . . . . 2.3199999999999998 111.17 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -66.1 -23.5 66.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 1.46 111.213 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 -3.19 59.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 1.24 111.348 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.7 mtt -127.98 110.14 12.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 2.0699999999999998 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -87.67 -26.29 23.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 3.5299999999999998 110.771 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -144.76 139.4 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 4.0800000000000001 110.74 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.53 146.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.305 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -129.69 -70.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 4.5199999999999996 110.749 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -144.83 87.1 1.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 3.75 110.951 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.42 124.15 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.952 0.406 . . . . 3.5299999999999998 111.006 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -131.43 20.02 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 4.9100000000000001 110.996 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.562 HG23 HD23 ' C' ' 38' ' ' LEU . 90.5 m -80.53 -47.85 13.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 1.98 111.357 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.66 -57.96 3.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 1.8300000000000001 111.223 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.2 pt -59.61 -24.06 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 1.79 111.219 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.91 -38.92 10.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.896 -0.668 . . . . 0.62 112.546 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.4 -39.8 85.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 1.5800000000000001 110.855 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 84' ' ' LEU . 71.3 mt -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.97999999999999998 110.915 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 ttt -57.41 -35.45 70.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.869 -0.605 . . . . 1.48 110.895 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.406 ' HG ' ' HD1' ' C' ' 42' ' ' PHE . 11.8 t -63.61 -57.24 10.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.356 -0.384 . . . . 1.1299999999999999 111.152 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 142' ' ' ILE . 73.2 p -57.36 -19.48 23.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 1.48 111.681 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 23.1 tp60 -77.54 -52.53 8.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.794 0.33 . . . . 2.7000000000000002 111.081 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.653 HG22 ' HE1' ' C' ' 46' ' ' TRP . 63.6 mt -52.19 -36.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 1.54 111.856 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.02 -37.67 53.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 121.054 -0.258 . . . . 1.28 111.222 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 108' ' ' THR . 53.9 t -68.61 -28.47 40.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.906 0.384 . . . . 0.42999999999999999 110.847 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.94 -49.01 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 1.74 110.658 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 54.7 m -52.41 -37.93 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.63 110.445 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 61.5 m -60.3 -56.86 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 1.0900000000000001 110.183 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.84 -11.63 58.21 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.887 -0.673 . . . . 0.41999999999999998 112.18 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 tt -74.65 -54.29 7.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.946 0.403 . . . . 1.3799999999999999 110.523 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.73 -24.01 7.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.033 -0.53 . . . . 1.6200000000000001 111.525 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.73 -40.76 66.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.39000000000000001 110.812 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.5 -19.52 42.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 2.02 110.657 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.73 20.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.76000000000000001 110.752 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.4 p -85.63 119.01 25.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 1.46 110.862 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.534 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 10.2 pt-20 -78.52 -23.29 46.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 3.3500000000000001 110.808 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.7 mtp180 -111.3 149.04 31.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 2.9199999999999999 110.657 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.78 -9.42 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 2.77 110.893 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -90.16 -49.38 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 3.77 111.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -58.39 -28.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.456 . . . . 1.1599999999999999 111.34 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -60.53 -32.45 71.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 2.04 110.986 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.35 -33.04 74.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 2.6400000000000001 111.005 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 127' ' ' VAL . 3.1 mm? -72.95 -50.3 24.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 1.8999999999999999 110.807 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -67.34 -23.77 65.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 1.3999999999999999 110.801 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -70.62 -52.96 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.28 111.069 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 130' ' ' LEU . 47.0 pt -57.41 -29.2 32.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 2.1600000000000001 110.902 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.1 t -67.26 -40.42 86.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 1.6899999999999999 110.805 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -47.49 63.41 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.813 -0.708 . . . . 0.52000000000000002 112.694 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.31 -29.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 1.02 111.173 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 40.7 t -57.86 -51.8 68.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.226 -0.443 . . . . 1.0800000000000001 110.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 142' ' ' ILE . . . -65.49 -28.33 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.62 110.953 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -68.99 -23.83 64.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 1.8400000000000001 111.031 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.53 -53.02 7.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.386 . . . . 1.6899999999999999 111.599 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.7 pt -60.03 -37.93 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.81000000000000005 111.784 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 108' ' ' THR . 10.5 tt -67.84 -44.91 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.643 0.258 . . . . 2.3700000000000001 111.295 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.455 ' N ' HG23 ' A' ' 142' ' ' ILE . 41.6 tp -55.74 -49.12 73.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.97999999999999998 110.904 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -68.01 -26.32 65.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 3.27 110.759 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.94 -17.13 68.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.877 -0.678 . . . . 1.25 113.013 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.5 pt -104.48 -8.23 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.339 . . . . 2.1200000000000001 111.646 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -86.14 -23.22 26.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.419 -0.355 . . . . 1.6599999999999999 111.734 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.1 m120 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.46 -0.337 . . . . 99.989999999999995 111.759 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.917 0.389 . . . . 2.3399999999999999 110.672 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.29 -21.66 60.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 2.77 111.026 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.11 -41.44 97.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 2.04 111.359 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -82.51 -24.14 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 2.77 110.676 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.85 -35.81 57.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 1.8899999999999999 111.387 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 15.0 p -73.34 -21.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 1.6399999999999999 111.178 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.7 m -60.03 -57.93 10.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.24 110.915 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.92 -26.01 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.004 -0.544 . . . . 2.9700000000000002 110.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 63.9 t80 -72.27 -31.36 65.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 1.48 111.116 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 177' ' ' ILE . 97.1 m -74.48 -50.88 16.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 1.55 111.518 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.66 -34.11 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.379 . . . . 1.52 111.705 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.5 tp -75.75 -53.99 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 1.8500000000000001 111.362 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.97 -33.81 62.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.62 111.509 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 173' ' ' THR . 13.3 tt -87.64 -21.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 1.3500000000000001 110.749 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.37 -57.34 20.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.58999999999999997 113.226 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.579 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 74.3 m-85 -53.5 -54.17 48.6 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 111.668 0.247 . . . . 1.45 111.668 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.1 Cg_exo -46.28 -37.05 18.26 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.185 1.923 . . . . 0.55000000000000004 112.276 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 177' ' ' ILE . 91.4 mt -59.25 -61.01 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.235 -0.438 . . . . 1.4199999999999999 111.213 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 179' ' ' TYR . 23.2 m -62.44 -24.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.78000000000000003 111.18 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -66.93 -37.7 84.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.93999999999999995 111.214 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 185' ' ' ILE . 73.1 mt -53.15 -79.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.365 -0.38 . . . . 1.4299999999999999 111.111 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.566 HG23 HG22 ' A' ' 184' ' ' ILE . 2.8 pp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 2.02 110.926 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 77.1 mt . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.818 0.342 . . . . 2.48 111.132 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.71 -60.96 2.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 2.1800000000000002 110.992 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.4 p -75.82 -34.85 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.107 -0.497 . . . . 1.49 111.253 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.22 -26.63 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 1.77 110.975 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 65.9 tp -81.18 -48.58 11.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.194 -0.457 . . . . 1.4199999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -69.69 -11.25 60.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 1.78 111.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 97.5 m -96.74 -45.38 6.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.11 0.481 . . . . 1.3 110.975 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.9 tp -69.94 -34.8 73.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.763 -0.653 . . . . 0.66000000000000003 112.244 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.653 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 53.6 tp -61.32 -53.57 61.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.775 0.287 . . . . 1.6299999999999999 111.775 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.6 Cg_exo -55.17 -47.74 24.7 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.012 1.808 . . . . 0.64000000000000001 111.95 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.89 -31.94 73.29 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.249 -0.432 . . . . 1.3600000000000001 110.843 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -66.67 -31.05 71.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 1.54 110.566 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 1.2 110.349 179.541 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.695 0.283 . . . . 1.6399999999999999 111.364 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.48 98.85 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.567 -0.825 . . . . 0.79000000000000004 112.366 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.59 -28.15 62.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 1.6100000000000001 110.818 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.4 m -58.23 -61.71 2.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 1.1499999999999999 110.999 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -68.25 -20.39 64.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 3.3399999999999999 110.96 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -70.07 -49.7 48.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.984 -0.553 . . . . 1.1899999999999999 111.145 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.15 -40.51 96.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 2.23 111.051 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.462 HD23 HG21 ' A' ' 32' ' ' VAL . 96.9 mt -58.95 -41.75 88.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 2.4700000000000002 111.112 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -79.12 -20.51 48.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 1.6200000000000001 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.01 -19.49 79.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.937 -0.649 . . . . 1.4099999999999999 113.083 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.548 HD22 HG22 ' A' ' 32' ' ' VAL . 41.6 tp . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 2.5800000000000001 111.001 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.691 0.281 . . . . 2.0699999999999998 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.29 -27.99 68.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 2.1000000000000001 110.873 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 40.6 m80 -76.96 -25.71 53.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.024 -0.535 . . . . 1.0700000000000001 110.493 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -76.22 -45.23 33.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.48 110.405 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 43.6 mm -67.8 -22.54 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.129 0.49 . . . . 2.02 110.296 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' TYR . . . . . 0.422 ' O ' ' HG2' ' B' ' 15' ' ' MET . 29.4 t80 -66.66 -60.69 2.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.734 -0.667 . . . . 0.92000000000000004 110.969 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.39 -35.98 20.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.156 -0.474 . . . . 0.93999999999999995 111.345 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.77 90.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.406 -0.361 . . . . 0.55000000000000004 111.248 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.91 -23.24 78.25 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.774 -0.727 . . . . 0.47999999999999998 112.571 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 80.4 mmm -73.93 -40.58 63.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.558 0.218 . . . . 0.84999999999999998 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p -62.32 -51.46 67.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 1.3400000000000001 111.087 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.8 pp -62.5 -25.31 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.399 -0.364 . . . . 1.55 111.156 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.25 -59.03 11.08 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.735 -0.745 . . . . 0.69999999999999996 112.474 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.21 68.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.872 0.367 . . . . 0.81000000000000005 111.351 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' B' ' 17' ' ' ILE . 79.0 mt -68.17 -36.68 80.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 2.2599999999999998 111.177 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -61.59 -50.07 74.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 1.78 110.604 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.478 ' O ' ' OG ' ' B' ' 26' ' ' SER . 99.4 m-85 -66.44 -23.18 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 4.5800000000000001 110.637 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -68.48 -30.26 69.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 3.3500000000000001 110.791 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 91.6 p -85.03 -29.79 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 1.5800000000000001 110.64 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.49 -1.34 57.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.55 . . . . 1.8400000000000001 110.489 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 1.8 m -63.86 -26.2 68.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 1.3700000000000001 110.889 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -49.66 -32.6 13.49 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.132 0.491 . . . . 4.9800000000000004 109.924 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 6.2 p30 -164.61 131.62 2.36 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.774 . . . . 2.1400000000000001 110.158 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 51.9 Cg_endo -98.0 175.89 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.275 2.65 . . . . 1.8200000000000001 112.882 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.24 35.19 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 5.1900000000000004 110.866 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.46 -41.94 1.92 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.744 -0.741 . . . . 2.2000000000000002 112.713 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.494 ' HA ' HD22 ' B' ' 221' ' ' LEU . 20.8 m -71.09 136.22 84.78 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.57 0.224 . . . . 3.6499999999999999 111.102 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 32' ' ' VAL . 8.1 Cg_exo -73.37 166.25 30.39 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.877 2.385 . . . . 2.6699999999999999 112.763 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -58.24 -20.09 39.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 4.8799999999999999 113.05 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.451 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 3.2 p90 -60.04 -33.54 72.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.952 0.406 . . . . 1.8700000000000001 110.974 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -69.77 -45.61 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 2.6800000000000002 110.904 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 2.9199999999999999 110.944 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.91 -61.68 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 1.6399999999999999 110.864 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.81 -36.24 77.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 1.6000000000000001 111.066 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.43 -12.69 61.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.68999999999999995 111.457 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.423 ' O ' HG12 ' B' ' 45' ' ' ILE . 60.3 ttp -88.73 -36.19 16.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.485 -0.325 . . . . 2.5800000000000001 111.442 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -71.64 -34.01 69.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.34 0.496 . . . . 3.3900000000000001 112.34 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 88.0 mt -56.46 -52.99 68.94 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.59 0.589 . . . . 0.40999999999999998 112.59 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 61.6 Cg_endo -72.03 -36.6 5.7 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.408 2.072 . . . . 0.48999999999999999 113.704 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.423 HG12 ' O ' ' B' ' 41' ' ' MET . 28.5 mm -56.45 -62.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.81 0.3 . . . . 1.29 111.81 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.633 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.3 OUTLIER -60.54 -57.27 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.418 -0.356 . . . . 1.3999999999999999 111.486 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -51.18 -37.2 45.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 1.3799999999999999 111.518 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.56 73.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.37 112.394 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.19 -32.42 73.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 1.29 110.886 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.02 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.581 . . . . 0.44 111.073 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 19.5 m-85 -61.09 -44.33 97.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.5 110.876 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -50.96 -34.17 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.074 0.464 . . . . 1.4099999999999999 110.167 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.36 81.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.598 -0.728 . . . . 0.55000000000000004 110.792 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 49.1 mtt -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.524 . . . . 0.5 110.24 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -62.94 -49.03 76.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.866 -0.606 . . . . 0.54000000000000004 110.342 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.24 -6.69 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.968 -0.56 . . . . 1.3 110.715 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 61.98 39.63 13.16 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.778 -0.647 . . . . 2.2400000000000002 111.341 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.415 ' HG3' ' HE1' ' C' ' 131' ' ' TRP . 13.9 mm100 -100.14 173.77 6.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 1.77 111.013 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 70.57 27.23 72.85 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.858 -0.687 . . . . 1.0600000000000001 112.428 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.75 174.19 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 2.6600000000000001 110.697 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.69 140.74 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.8899999999999999 111.361 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -101.02 84.52 2.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.286 -0.416 . . . . 2.4100000000000001 110.565 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.17 109.8 22.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 1.5600000000000001 111.353 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.22 24.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 1.8200000000000001 111.534 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 11.72 82.04 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.692 -0.766 . . . . 1.51 112.661 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -115.23 129.15 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 2.4500000000000002 110.778 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.07 115.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 1.79 111.237 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.64 142.27 27.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.81999999999999995 111.349 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 25.3 m-70 -92.43 59.14 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.119 -0.491 . . . . 1.05 111.057 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.41 -49.91 73.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 1.8700000000000001 110.925 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.474 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -57.31 -27.76 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.60999999999999999 111.008 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 4.9 tpp180 -63.05 -49.22 75.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.878 -0.601 . . . . 2.3900000000000001 110.775 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -71.19 -18.06 62.5 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.921 -0.312 . . . . 3.6699999999999999 111.443 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 36.3 mm -65.41 -40.99 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.063 0.458 . . . . 1.6599999999999999 109.842 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.545 ' O ' HG22 ' B' ' 79' ' ' THR . 13.5 t70 -66.37 -14.39 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.657 -0.701 . . . . 1.4099999999999999 110.238 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -85.54 -26.14 26.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.856 -0.611 . . . . 1.1599999999999999 111.173 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.604 ' HG2' ' HB ' ' B' ' 113' ' ' ILE . 19.2 mtp -91.82 4.23 53.32 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 1.53 111.33 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 -29.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.414 0.524 . . . . 0.89000000000000001 112.414 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.545 HG22 ' O ' ' B' ' 75' ' ' ASP . 12.4 t -102.83 -43.71 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.102 0.408 . . . . 1.24 112.102 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 26.0 m -58.9 -50.84 85.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.221 0.452 . . . . 0.57999999999999996 112.221 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.559 ' HA ' ' HG2' ' B' ' 109' ' ' GLN . 20.3 Cg_endo -60.62 -43.78 30.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.86 1.707 . . . . 0.66000000000000003 111.898 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.481 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -73.46 -12.7 60.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 1.0600000000000001 110.692 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' B' ' 79' ' ' THR . 0.2 OUTLIER -75.63 -43.99 44.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 1.22 110.782 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.469 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.3 pp -80.18 -23.51 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 1.53 110.78 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.481 HD12 HD13 ' B' ' 82' ' ' LEU . 50.7 mt -68.18 -39.09 82.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 1.5800000000000001 110.444 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 46.6 t -61.81 -30.08 70.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.3899999999999999 110.713 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 69.5 mt -75.73 -26.13 57.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 1.1499999999999999 110.601 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -70.49 -41.26 72.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 1.5700000000000001 110.823 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -70.12 -35.96 74.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 110.593 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 61.3 m -64.99 -33.28 75.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.4199999999999999 110.945 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.95 -34.01 39.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.1799999999999999 111.15 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.8 mmm -95.07 100.93 12.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 1.8799999999999999 111.168 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -78.0 -33.47 51.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.115 -0.493 . . . . 3.4199999999999999 110.887 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -137.82 135.06 35.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.256 -0.429 . . . . 4.0599999999999996 111.418 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 47.0 pt -138.1 143.23 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 2.0899999999999999 110.855 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -130.15 -56.96 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 3.8500000000000001 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.13 73.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 4.8200000000000003 111.122 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.41 134.66 20.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 3.7999999999999998 110.852 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.84 22.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 5.1699999999999999 110.609 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.475 ' HA ' HD22 ' A' ' 38' ' ' LEU . 90.7 m -80.92 -49.83 10.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 2.02 110.988 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.46 -34.92 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 2.0899999999999999 110.925 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.73 -33.73 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.927 0.394 . . . . 1.8799999999999999 110.798 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.54 -15.19 69.04 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.771 -0.728 . . . . 0.56000000000000005 112.545 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -83.38 -42.79 16.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.785 0.326 . . . . 1.78 110.94 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.01 -45.43 60.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 1.03 110.946 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' MET . . . . . 0.433 ' O ' HG13 ' B' ' 110' ' ' ILE . 25.1 ttt -63.08 -39.62 95.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.727 -0.67 . . . . 1.6699999999999999 111.269 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -64.14 -54.18 37.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 1.51 111.541 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.52 ' HB ' HD13 ' B' ' 142' ' ' ILE . 59.1 p -58.68 -21.45 54.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 1.1799999999999999 111.615 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.559 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 48.7 tp60 -79.8 -35.89 37.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.44 -0.345 . . . . 2.1699999999999999 111.384 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.619 HG22 ' HE1' ' A' ' 46' ' ' TRP . 68.5 mt -67.34 -34.87 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.693 0.282 . . . . 1.3500000000000001 111.512 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 m -73.61 -35.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.584 -0.28 . . . . 1.3400000000000001 111.506 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 108' ' ' THR . 70.9 t -70.2 -41.42 78.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.616 -0.265 . . . . 0.42999999999999999 111.68 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 77' ' ' MET . 26.7 pt -70.07 -31.53 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.64 -0.254 . . . . 1.6000000000000001 111.419 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -60.94 -56.95 15.09 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.912 0.387 . . . . 0.85999999999999999 110.526 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.5 p -55.97 -29.03 59.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.95 -0.568 . . . . 0.94999999999999996 110.172 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.02 -47.25 84.48 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.85 -0.691 . . . . 0.46000000000000002 111.951 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.456 HD21 ' SD ' ' B' ' 77' ' ' MET . 56.9 mt -48.89 -58.39 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.155 0.502 . . . . 1.75 110.636 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.494 HD13 HD12 ' B' ' 121' ' ' LEU . 50.3 mm -67.56 -31.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.605 -0.725 . . . . 1.78 111.722 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.53 -40.73 62.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.897 0.379 . . . . 0.38 111.178 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.4 -17.54 30.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 1.97 110.794 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.494 HD12 HD13 ' B' ' 118' ' ' ILE . 83.3 mt -84.84 13.96 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.76000000000000001 111.059 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 56.3 m -76.84 126.47 31.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 1.47 110.781 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 -21.92 27.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 2.5 110.81 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.71 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 38.4 ttm180 -116.66 137.32 52.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 2.73 110.806 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.08 -11.56 60.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 2.2000000000000002 111.433 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.71 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 83.1 t90 -87.66 -51.62 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 3.3999999999999999 110.941 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' B' ' 124' ' ' ARG . 14.9 p -61.03 -26.05 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 1.23 110.945 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -67.54 -24.49 65.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 3.04 110.882 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.66 -35.12 76.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 4.1399999999999997 110.766 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.415 ' N ' HD12 ' B' ' 130' ' ' LEU . 7.1 mp -68.78 -50.47 50.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.333 -0.394 . . . . 1.6499999999999999 110.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.76 -35.63 75.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.77000000000000002 111.419 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.74 -51.65 68.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 1.46 111.179 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.8 mm -53.93 -34.09 25.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.251 -0.431 . . . . 1.6299999999999999 111.101 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.73 -41.15 88.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 1.4199999999999999 111.133 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.98 85.21 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.745 -0.74 . . . . 0.48999999999999999 112.654 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.3 -28.75 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.808 0.337 . . . . 1.3 111.28 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 50.4 t -58.2 -49.65 76.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.017 0.437 . . . . 1.3 110.603 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.07 -47.96 80.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.62 110.785 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.27 -24.19 26.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 1.74 111.056 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -59.2 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.76 110.993 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 pt -65.68 -33.74 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.398 -0.365 . . . . 0.68999999999999995 111.771 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.52 HD13 ' HB ' ' B' ' 108' ' ' THR . 77.4 mt -69.05 -37.12 76.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.47 -0.332 . . . . 1.76 111.313 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.3 -48.59 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.373 . . . . 1.0600000000000001 110.866 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -68.26 -22.74 64.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 4.1200000000000001 110.808 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -18.99 62.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.905 -0.664 . . . . 1.26 112.652 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -106.67 -10.24 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.971 0.415 . . . . 1.98 110.938 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -78.85 -21.45 47.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 1.4199999999999999 111.493 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 32.1 m120 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 111.896 0.332 . . . . 99.989999999999995 111.896 -179.502 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 120.987 0.422 . . . . 2.4300000000000002 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.57 -22.78 60.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.79 -0.641 . . . . 2.5800000000000001 111.078 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.8 -25.44 48.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 2.0 111.071 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -84.15 -38.18 20.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.427 . . . . 3.0299999999999998 111.384 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.54 -25.74 38.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.488 -0.323 . . . . 1.1000000000000001 111.856 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.36 -26.54 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 1.75 111.069 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.2 m -54.47 -58.75 6.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.273 -0.422 . . . . 0.97999999999999998 111.132 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.39 -30.4 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 4.2999999999999998 110.459 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.9 -25.82 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.908 -0.587 . . . . 1.3899999999999999 110.889 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.407 ' O ' HG22 ' B' ' 177' ' ' ILE . 29.3 m -79.56 -53.15 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 1.1100000000000001 111.35 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 43.2 t -60.68 -27.03 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 1.51 111.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 50.8 tp -77.61 -55.61 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 1.75 111.233 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -30.27 61.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.59999999999999998 111.267 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.427 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.6 tp -87.92 -24.71 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 1.47 110.878 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.0 -46.38 91.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.915 -0.659 . . . . 0.55000000000000004 113.146 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.492 ' O ' HG22 ' B' ' 182' ' ' VAL . 61.6 m-85 -62.2 -55.4 40.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.26 0.467 . . . . 1.6200000000000001 112.26 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 13.1 Cg_endo -56.69 -28.26 74.63 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.77 1.647 . . . . 0.64000000000000001 112.461 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.478 ' O ' HG22 ' B' ' 184' ' ' ILE . 49.1 mt -60.71 -49.91 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.053 0.454 . . . . 1.27 110.238 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 179' ' ' TYR . 13.0 m -77.55 -23.45 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.709 -0.678 . . . . 0.68999999999999995 110.186 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -68.57 -15.22 63.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.277 -0.874 . . . . 1.1799999999999999 112.605 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.478 HG22 ' O ' ' B' ' 181' ' ' ILE . 17.1 tt -103.14 -25.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.885 0.328 . . . . 1.77 111.885 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 185' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 185' ' ' ILE . 20.3 pt -91.06 116.54 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.177 0.436 . . . . 1.6899999999999999 112.177 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.153 0 CA-C-N 115.839 -0.619 . . . . 1.5800000000000001 113.814 178.837 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.732 0.301 . . . . 2.4700000000000002 111.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.37 -57.5 12.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.367 -0.379 . . . . 2.5299999999999998 111.121 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 46.3 p -68.94 -37.98 79.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 1.29 111.112 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.56 -25.1 68.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 2.6200000000000001 111.254 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.9 tp -77.36 -43.62 32.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 1.6100000000000001 110.954 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.51 -9.42 58.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 1.4199999999999999 111.458 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.462 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 98.9 m -96.37 -42.16 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.137 0.494 . . . . 1.4299999999999999 110.719 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.97 -48.8 62.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 1.1200000000000001 112.143 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.651 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 53.6 tp -49.6 -52.86 46.82 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 111.738 0.273 . . . . 1.26 111.738 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -54.56 -50.71 12.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.982 1.788 . . . . 0.59999999999999998 111.904 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.5 -35.79 72.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.284 -0.416 . . . . 1.3999999999999999 110.807 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -69.88 -29.28 66.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 1.4099999999999999 110.684 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 1.3200000000000001 110.822 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.858 0.361 . . . . 1.6899999999999999 110.852 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.88 58.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.79000000000000004 112.487 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -69.65 -23.22 63.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.666 0.269 . . . . 2.96 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.2 t -58.94 -58.28 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.887 0.375 . . . . 1.29 110.584 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -72.64 -20.42 61.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 3.1499999999999999 110.814 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.403 HD23 ' C ' ' B' ' 216' ' ' LEU . 7.3 tt -66.4 -58.37 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 1.51 110.71 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -60.09 -32.05 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.1899999999999999 110.622 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.79 -42.32 98.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.525 . . . . 1.98 111.086 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -87.39 -20.43 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 2.1699999999999999 111.134 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.87 76.86 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.911 -0.661 . . . . 1.3600000000000001 113.053 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' B' ' 32' ' ' VAL . 50.8 tp . . . . . 0 C--N 1.329 -0.304 0 O-C-N 122.739 -0.271 . . . . 2.8999999999999999 110.976 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.496 ' N ' HD12 ' C' ' 6' ' ' LEU . 4.9 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.723 0.297 . . . . 2.52 110.697 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.4 -36.99 81.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 1.9299999999999999 110.903 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 14.6 m170 -72.15 -24.09 61.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 1.26 110.649 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -73.83 -51.41 16.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.6699999999999999 110.48 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -66.77 -19.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 1.8700000000000001 110.388 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -65.53 -58.24 6.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.674 -0.694 . . . . 1.4399999999999999 110.824 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' C' ' 52' ' ' MET . 7.7 p -58.85 -35.98 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.46999999999999997 111.141 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.21 79.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.34 -0.391 . . . . 0.58999999999999997 110.993 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.9 -28.71 60.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.827 -0.702 . . . . 0.5 112.586 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -35.55 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.56 0.219 . . . . 0.68000000000000005 111.21 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 47.5 m -64.67 -50.45 67.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 1.3999999999999999 110.57 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.85 -22.33 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 1.55 110.782 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -59.66 9.47 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.016 -0.611 . . . . 0.70999999999999996 112.535 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -30.87 68.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.919 0.39 . . . . 0.77000000000000002 110.492 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.18 -33.12 74.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 1.9299999999999999 110.49 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.76 -53.29 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 1.8600000000000001 110.582 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' PHE . . . . . 0.573 ' O ' ' OG ' ' C' ' 26' ' ' SER . 72.9 m-85 -65.19 -24.5 67.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 4.1399999999999997 110.55 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' TRP . . . . . 0.452 ' HA ' ' OG ' ' C' ' 26' ' ' SER . 55.6 t90 -69.48 -27.21 65.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 3.1499999999999999 110.705 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.4 m -84.69 -34.21 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 1.95 110.657 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.26 -1.51 57.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 2.2200000000000002 110.453 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' C' ' 22' ' ' PHE . 1.4 m -60.72 -23.95 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 1.3700000000000001 110.652 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -48.76 -36.93 17.57 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.231 0.538 . . . . 5.0300000000000002 109.828 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.491 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 8.4 p30 -163.18 131.56 2.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.346 -0.843 . . . . 2.3700000000000001 110.034 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.8 Cg_endo . . . . . 0 N--CA 1.452 -0.958 0 C-N-CA 123.028 2.485 . . . . 2.0499999999999998 112.374 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' PRO . . . . . 0.4 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 38.9 Cg_exo . . . . . 0 CA--C 1.527 0.171 0 CA-C-O 121.053 0.355 . . . . 1.9299999999999999 112.509 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -62.31 -18.32 61.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.619 -0.719 . . . . 4.1200000000000001 112.417 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.4 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.1 p90 -51.72 -34.73 40.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 2.8900000000000001 111.367 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -76.27 -36.97 58.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 2.46 111.12 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -66.01 -35.14 79.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.368 -0.378 . . . . 2.7799999999999998 111.005 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.562 HD23 HG23 ' A' ' 100' ' ' THR . 1.1 tm? -63.95 -56.71 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 1.6200000000000001 110.651 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.71 -45.47 97.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 1.5900000000000001 111.528 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.89 -12.11 52.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.65000000000000002 111.695 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.406 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 26.9 ttt -89.58 -33.71 16.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.693 0.282 . . . . 1.6699999999999999 111.606 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.406 ' HD1' ' HG ' ' A' ' 107' ' ' SER . 35.2 t80 -75.71 -27.57 58.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 3.4199999999999999 111.914 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.467 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 84.8 mt -64.87 -50.63 62.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.89 0.7 . . . . 0.89000000000000001 112.89 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 72.1 Cg_endo -77.54 -33.01 2.58 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.422 2.081 . . . . 0.40999999999999998 114.059 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.486 HG23 ' N ' ' C' ' 46' ' ' TRP . 19.5 tt -62.2 -48.74 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 1.76 111.904 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.653 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -70.78 -57.97 4.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.728 0.299 . . . . 2.1600000000000001 110.727 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.5 p -51.21 -42.27 60.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 1.1699999999999999 110.908 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.68 -49.29 58.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.914 -0.66 . . . . 0.44 112.572 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' C' ' 45' ' ' ILE . 84.9 mt -55.23 -40.16 70.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 1.29 110.929 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.82 88.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.5 111.17 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 72.4 m-85 -55.55 -50.47 69.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.361 -0.381 . . . . 1.8300000000000001 110.99 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' MET . . . . . 0.516 ' HB2' HG11 ' C' ' 12' ' ' VAL . 15.6 tmm? -49.66 -37.87 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 1.47 110.388 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.67 -38.4 83.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.59999999999999998 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 55.4 mtt -54.8 -30.95 58.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.83999999999999997 110.294 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -75.93 -37.81 58.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.842 -0.617 . . . . 0.65000000000000002 110.717 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.455 HG12 ' O ' ' C' ' 52' ' ' MET . 6.6 mm -77.96 -6.4 9.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.957 -0.565 . . . . 1.55 110.99 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.56 46.21 5.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 1.54 111.331 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -111.41 171.35 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 1.79 110.963 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 73.08 24.4 75.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.93999999999999995 112.518 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -137.03 146.47 45.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 2.3599999999999999 110.966 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 141.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 1.97 111.161 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.01 87.96 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 2.4399999999999999 110.851 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.51 122.46 33.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 1.54 111.102 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.08 31.39 16.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 1.71 111.105 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 29.99 53.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.841 -0.695 . . . . 1.53 112.628 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -131.34 119.05 21.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 2.23 111.054 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 26.5 pt -81.72 128.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 111.03 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.95 140.62 38.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.78000000000000003 111.267 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -95.61 55.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 1.0800000000000001 110.834 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -63.05 -51.32 67.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 2.2999999999999998 111.053 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' C' ' 74' ' ' ILE . . . -57.28 -25.85 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.958 0.408 . . . . 0.75 110.771 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -64.37 -48.23 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.51 110.801 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.602 ' HB3' HD23 ' C' ' 117' ' ' LEU . 0.2 OUTLIER -72.49 -19.56 61.52 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.858 -0.337 . . . . 4.6500000000000004 111.534 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' C' ' 71' ' ' ALA . 65.0 mt -63.53 -41.94 94.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.172 0.51 . . . . 1.22 109.699 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.496 ' O ' HG22 ' C' ' 79' ' ' THR . 9.0 t70 -66.44 -15.37 63.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.548 -0.751 . . . . 1.3100000000000001 110.071 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.08 -20.45 32.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 1.6799999999999999 111.335 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.505 ' HB3' HD12 ' C' ' 113' ' ' ILE . 8.7 mtm -99.54 4.99 46.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 1.8 111.423 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -114.67 -27.15 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.419 -0.355 . . . . 1.1899999999999999 111.855 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.496 HG22 ' O ' ' C' ' 75' ' ' ASP . 15.1 t -103.8 -34.86 8.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.288 0.477 . . . . 1.23 112.288 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 38.5 m -69.65 -50.76 17.51 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 111.84 0.311 . . . . 0.58999999999999997 111.84 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 32.2 Cg_exo -59.36 -37.51 89.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.928 1.752 . . . . 0.67000000000000004 112.28 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.459 HD13 HD12 ' C' ' 85' ' ' LEU . 4.4 mm? -78.29 -16.92 57.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.95999999999999996 110.619 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -41.75 67.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 1.1899999999999999 110.609 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' C' ' 105' ' ' LEU . 3.9 pp -78.78 -32.33 46.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.7 110.819 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 85' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' C' ' 106' ' ' MET . 43.2 mt -61.5 -41.26 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 1.6200000000000001 110.833 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.5 t -60.89 -29.91 69.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.02 -0.537 . . . . 1.26 110.783 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.465 HD22 HD11 ' C' ' 168' ' ' LEU . 59.9 mt -74.71 -27.3 60.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 1.1100000000000001 110.891 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.0 t -69.2 -48.6 61.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 1.51 110.865 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -63.86 -32.74 74.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 2.0600000000000001 111.048 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -66.51 -32.14 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 1.52 111.143 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.53 -4.7 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 1.3 111.379 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.3 mtm -118.09 98.91 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 1.6200000000000001 110.992 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -87.42 -16.2 35.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 3.2400000000000002 110.608 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -146.8 133.86 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.56 . . . . 4.6299999999999999 110.584 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -146.21 142.48 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.94 0.4 . . . . 2.1800000000000002 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -131.46 -68.28 0.66 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.958 -0.565 . . . . 4.1200000000000001 110.539 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -138.93 87.17 2.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 4.96 110.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -163.09 121.53 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 3.9100000000000001 110.971 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -134.93 19.38 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 5.21 110.663 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 64.4 p -76.63 -50.77 12.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 1.8200000000000001 111.174 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.4 mt -70.12 -40.06 75.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 2.0800000000000001 110.976 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.06 -41.93 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 1.8600000000000001 111.063 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.21 -11.15 85.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.58999999999999997 112.575 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 104' ' ' PHE . . . . . 0.429 ' O ' HG23 ' C' ' 108' ' ' THR . 79.1 t80 -80.52 -41.22 24.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.706 0.289 . . . . 1.53 110.928 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.466 ' HB3' HD13 ' C' ' 84' ' ' LEU . 55.1 mt -74.8 -44.07 51.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 1.1100000000000001 111.182 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 106' ' ' MET . . . . . 0.487 ' HG2' HD21 ' C' ' 85' ' ' LEU . 71.5 mtm -58.73 -54.27 48.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.307 -0.406 . . . . 2.21 111.285 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -52.23 -50.73 61.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 1.28 111.821 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.429 HG23 ' O ' ' C' ' 104' ' ' PHE . 61.5 p -63.27 -24.69 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 1.22 111.798 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 8.0 tp-100 -80.82 -35.86 32.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 2.3300000000000001 111.406 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.633 HG22 ' HE1' ' B' ' 46' ' ' TRP . 80.4 mt -65.63 -30.97 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 1.29 111.399 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.31 -37.2 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.606 0.241 . . . . 1.0600000000000001 111.592 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 108' ' ' THR . 73.4 t -67.78 -41.4 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 111.887 0.329 . . . . 0.51000000000000001 111.887 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' C' ' 77' ' ' MET . 38.8 pt -69.4 -34.42 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.748 -0.206 . . . . 1.3700000000000001 111.464 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -60.87 -54.59 43.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.872 0.367 . . . . 0.77000000000000002 110.644 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.5 p -55.88 -29.56 60.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 1.1899999999999999 110.057 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.06 63.72 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.991 -0.623 . . . . 0.5 112.011 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.602 HD23 ' HB3' ' C' ' 73' ' ' TYR . 81.8 mt -48.03 -61.13 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 1.47 110.627 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.16 -32.57 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.569 -0.741 . . . . 1.2 112.002 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.51 61.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.314 . . . . 0.40000000000000002 111.348 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 -19.03 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 2.1200000000000001 110.884 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 117' ' ' LEU . 95.9 mt -83.26 17.68 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.75 110.992 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -89.78 117.76 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.368 . . . . 1.3799999999999999 110.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.94 -31.13 61.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.106 -0.497 . . . . 2.7400000000000002 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' C' ' 127' ' ' VAL . 86.5 mtm180 -93.86 144.23 25.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 2.7999999999999998 110.607 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.37 -13.12 58.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 2.4100000000000001 111.382 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -86.37 -50.73 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 4.2000000000000002 111.141 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.2 p -57.68 -24.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.0800000000000001 111.371 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -62.61 -37.35 85.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.364 . . . . 2.5699999999999998 111.055 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -60.9 -36.1 78.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.39 -0.368 . . . . 3.8100000000000001 111.141 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.7 mm? -66.21 -52.63 46.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.4199999999999999 111.124 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 131' ' ' TRP . . . . . 0.415 ' HE1' ' HG3' ' B' ' 58' ' ' GLN . 9.3 m95 -64.93 -28.93 69.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.427 . . . . 0.89000000000000001 111.45 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -65.42 -46.67 79.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.539 -0.301 . . . . 1.26 110.782 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.1 mm -58.75 -36.6 61.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 1.6799999999999999 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -63.88 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 1.24 110.671 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -48.83 39.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.842 -0.694 . . . . 0.54000000000000004 112.661 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -68.3 -27.06 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 1.0600000000000001 111.119 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 54.0 t -64.4 -43.47 94.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 1.0800000000000001 110.614 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 138' ' ' ALA . . . . . 0.434 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -68.94 -29.37 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.783 -0.644 . . . . 0.56999999999999995 111.034 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -71.08 -29.63 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.416 . . . . 1.6799999999999999 110.992 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -70.14 -56.0 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 1.7 111.548 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 28.9 pt -55.71 -37.87 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.78000000000000003 111.751 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.434 HG12 ' O ' ' C' ' 138' ' ' ALA . 44.0 mm -78.33 -33.32 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 2.2400000000000002 111.411 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 143' ' ' LEU . . . . . 0.405 ' O ' HG22 ' C' ' 146' ' ' ILE . 44.5 tp -61.43 -51.33 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 1.02 110.576 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -70.65 -21.28 62.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 3.0 110.463 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.38 67.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.845 -0.693 . . . . 1.27 112.575 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 146' ' ' ILE . . . . . 0.405 HG22 ' O ' ' C' ' 143' ' ' LEU . 19.0 tt -102.35 -14.67 8.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 1.8899999999999999 111.201 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -77.3 -33.49 55.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 1.6000000000000001 111.699 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 32.0 m120 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 112.003 0.371 . . . . 99.989999999999995 112.003 -179.287 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.925 0.393 . . . . 2.3500000000000001 111.027 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 2.6200000000000001 111.068 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.15 -42.93 93.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 2.0899999999999999 111.162 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.76 -25.04 35.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.138 -0.483 . . . . 3.2400000000000002 111.091 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.465 HD11 HD22 ' C' ' 87' ' ' LEU . 54.5 tp -76.89 -39.03 52.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 1.6899999999999999 111.544 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.4 p -71.64 -16.43 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 1.3999999999999999 111.324 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 41.9 m -57.68 -59.41 5.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.95999999999999996 111.258 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -71.46 -31.75 67.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 3.6499999999999999 110.381 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 172' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 91.1 t80 -57.21 -32.97 67.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 1.3700000000000001 110.975 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.465 ' O ' HG22 ' C' ' 177' ' ' ILE . 66.9 m -79.66 -43.3 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 1.4299999999999999 111.494 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -58.3 -36.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 112.18 0.437 . . . . 1.6200000000000001 112.18 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' C' ' 175' ' ' LEU . 4.4 mm? -81.16 -47.39 13.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.729 -0.214 . . . . 2.0299999999999998 111.489 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -30.87 63.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.301 . . . . 0.62 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.465 HG22 ' O ' ' C' ' 173' ' ' THR . 10.9 tp -88.01 -22.9 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 1.5800000000000001 110.472 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.19 -57.8 17.39 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.839 -0.619 . . . . 0.56000000000000005 113.37 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.601 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 88.4 m-85 -53.47 -54.85 40.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.692 0.246 . . . . 1.3300000000000001 111.503 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 97.1 Cg_exo -44.37 -35.82 8.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.316 2.011 . . . . 0.63 112.833 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.401 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.0 mt -64.52 -61.14 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 0.93000000000000005 111.537 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.454 HG22 ' O ' ' C' ' 179' ' ' TYR . 20.2 m -59.76 -24.56 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.27 111.454 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -67.19 -52.45 41.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 1.77 111.41 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.02 -41.74 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.211 0.448 . . . . 2.3900000000000001 112.211 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 10.7 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 1.95 111.739 -179.383 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 74.9 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.919 0.39 . . . . 2.3799999999999999 111.023 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.98 -27.88 36.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 2.23 110.959 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -49.76 -60.97 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 2.1600000000000001 110.821 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 72.4 p -72.27 -18.63 61.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 1.27 111.69 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -74.89 -26.55 59.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 1.7 111.359 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.16 -47.93 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.478 -0.328 . . . . 2.02 111.699 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.51 -14.86 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.473 -0.33 . . . . 1.8200000000000001 111.65 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.426 ' O ' ' HG2' ' C' ' 206' ' ' PRO . 20.7 p -96.66 -39.07 9.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 1.3500000000000001 111.53 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 48.3 tp -71.88 -34.01 68.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.277 -0.419 . . . . 0.65000000000000002 112.046 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' C' ' 206' ' ' PRO . 56.4 tp -62.47 -52.94 61.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 111.971 0.36 . . . . 1.4199999999999999 111.971 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' C' ' 205' ' ' LEU . 17.9 Cg_endo -58.21 -41.9 62.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.899 1.733 . . . . 0.63 111.762 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.35 -34.48 78.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 1.49 110.372 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -70.49 -27.51 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 1.7 110.382 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.002 -0.545 . . . . 1.25 110.61 179.639 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.859 0.361 . . . . 1.6100000000000001 111.034 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.28 -50.43 62.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.932 -0.652 . . . . 0.81999999999999995 112.748 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -66.11 -23.69 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 3.0800000000000001 111.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.1 t -60.93 -62.46 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 1.1499999999999999 110.72 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -69.26 -20.42 63.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 2.5600000000000001 110.973 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.26 -59.14 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 1.29 110.601 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.59 -28.54 67.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.863 0.363 . . . . 2.3900000000000001 110.936 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.42 -52.11 66.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 2.0299999999999998 110.976 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.71 -20.46 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 3.21 110.913 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.54 -29.8 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 1.3600000000000001 112.309 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 2.8999999999999999 110.626 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 6' ' ' LEU . 5.5 mp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.818 0.342 . . . . 2.4199999999999999 110.85 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.24 -50.38 60.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.0899999999999999 111.064 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 68.3 m-70 -63.36 -25.0 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 1.1599999999999999 110.973 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 12' ' ' VAL . 62.7 t-105 -70.04 -59.67 2.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.79000000000000004 111.077 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -60.56 -19.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 2.0800000000000001 110.437 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 207' ' ' PHE . 8.6 t80 -62.16 -58.58 7.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.672 -0.695 . . . . 1.28 110.731 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.4 p -60.47 -29.2 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 1.3200000000000001 110.885 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.32 -46.93 88.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.63 111.166 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.91 -23.58 77.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.799 -0.715 . . . . 0.55000000000000004 112.352 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.69 -38.21 54.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.703 0.287 . . . . 1.03 111.131 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -62.79 -48.6 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.387 -0.37 . . . . 1.3 111.096 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.4 -32.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 1.3100000000000001 110.659 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.04 -54.52 30.94 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.783 -0.722 . . . . 0.77000000000000002 112.698 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -35.31 76.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.749 0.309 . . . . 0.80000000000000004 111.389 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 17' ' ' ILE . 93.5 mt -62.54 -30.66 71.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 1.8100000000000001 111.028 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -59.94 -31.9 70.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 1.8799999999999999 110.692 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 m-85 -75.14 -28.02 59.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.188 -0.46 . . . . 4.4500000000000002 110.685 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -62.25 -39.64 93.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.061 0.458 . . . . 3.6899999999999999 109.829 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.2 m -85.49 -28.25 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.758 -0.656 . . . . 1.5700000000000001 110.7 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 56.8 tp -73.13 -18.23 61.31 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.653 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 p -62.52 -25.03 67.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 1.3799999999999999 111.085 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -51.22 -32.59 24.46 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.093 0.473 . . . . 4.0700000000000003 109.938 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.7 p-10 -165.42 132.01 2.17 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 2.7200000000000002 110.304 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 29.3 Cg_endo -95.99 179.86 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.193 2.595 . . . . 1.9099999999999999 112.139 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -103.48 65.58 0.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.339 -0.391 . . . . 4.7599999999999998 111.276 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.76 -46.61 3.71 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.917 -0.659 . . . . 1.99 112.931 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.23 146.98 32.66 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.625 0.213 . . . . 2.7000000000000002 111.235 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 34.6 Cg_exo -58.89 163.29 11.63 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.382 2.055 . . . . 1.79 112.085 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.21 -17.33 63.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.694 -0.685 . . . . 4.1200000000000001 112.319 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 6.4 p90 -41.27 -40.92 1.76 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.738 0.304 . . . . 2.9300000000000002 111.774 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.05 -45.41 77.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.886 0.374 . . . . 2.8799999999999999 110.587 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.76 -19.37 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.55 . . . . 4.6600000000000001 110.439 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.0 -55.06 28.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.45 110.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.83 -37.31 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.78 110.348 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.75 -10.67 59.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.63 110.618 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.499 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 41.0 ttm -88.14 -28.91 20.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.81 -0.632 . . . . 1.48 110.487 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -72.8 -40.09 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 3.5 111.369 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.666 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 36.8 mm -50.22 -53.04 48.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 111.99 0.367 . . . . 1.0800000000000001 111.99 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.666 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 15.7 Cg_exo -68.68 -33.73 20.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.196 1.931 . . . . 0.53000000000000003 112.595 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.01 -62.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.632 0.253 . . . . 1.6799999999999999 111.367 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.61 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -61.72 -57.97 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 1.8300000000000001 111.017 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB2' HG21 ' A' ' 79' ' ' THR . 35.8 t -54.2 -23.06 13.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 1.0900000000000001 111.356 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.54 -66.12 2.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.40999999999999998 112.524 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.1 mt -56.3 -29.15 60.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.293 . . . . 0.98999999999999999 111.144 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.98 -57.61 12.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.47999999999999998 111.222 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 20.8 m-85 -61.61 -42.48 98.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 1.8700000000000001 111.472 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.22 -36.33 8.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.207 0.527 . . . . 1.49 110.349 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -72.37 -40.21 67.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.58999999999999997 110.9 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 54.2 mtt -53.54 -35.57 60.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.041 0.448 . . . . 0.48999999999999999 110.17 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -67.75 -40.96 84.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.59999999999999998 109.935 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.22 3.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.727 -0.67 . . . . 1.3100000000000001 110.524 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.48 44.64 9.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.667 -0.697 . . . . 1.9099999999999999 111.257 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 14.6 mm100 -102.93 170.1 8.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 110.823 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.48 92.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 1.04 112.23 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -123.18 145.86 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 2.6800000000000002 110.783 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.84 141.04 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.98 110.845 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.7 92.24 7.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 2.1800000000000002 110.837 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.76 110.74 22.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 1.5700000000000001 111.246 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.63 34.97 25.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 1.79 111.431 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.06 74.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.847 -0.692 . . . . 1.48 112.754 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -130.28 117.65 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 2.3199999999999998 110.502 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 pt -69.23 127.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 1.4399999999999999 111.154 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.38 144.56 35.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.81999999999999995 111.225 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 93.4 m-70 -89.12 62.84 6.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.29 0.567 . . . . 0.90000000000000002 110.989 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -56.77 -38.15 72.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.295 -0.866 . . . . 1.8300000000000001 111.191 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.33 -22.21 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.053 -0.521 . . . . 0.62 111.82 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 5.3 tpm_? -66.5 -51.72 53.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 2.3399999999999999 112.022 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.9 p90 -72.59 -34.04 67.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.654 -0.418 . . . . 3.4900000000000002 110.712 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -55.47 -46.33 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.324 -0.398 . . . . 1.3700000000000001 110.949 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 47' ' ' SER . 37.8 t70 -65.68 -13.01 58.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 1.3100000000000001 110.425 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -99.75 -0.26 40.33 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.813 -0.63 . . . . 1.48 111.528 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.578 ' HA ' HD13 ' A' ' 113' ' ' ILE . 55.0 ttm -104.59 -6.97 20.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 1.46 110.703 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.527 HG23 HG23 ' A' ' 79' ' ' THR . 27.2 m -114.39 -36.13 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 1.1200000000000001 112.128 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 47' ' ' SER . 62.7 p -88.11 -44.71 10.73 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.339 0.496 . . . . 1.1000000000000001 112.339 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.6 m -56.93 -51.29 82.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.156 0.428 . . . . 0.59999999999999998 112.156 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 80' ' ' THR . 14.6 Cg_endo -56.85 -36.51 98.88 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.679 1.586 . . . . 0.73999999999999999 111.168 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.586 ' HB3' HD11 ' A' ' 43' ' ' ILE . 4.0 mm? -71.1 -34.18 70.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 1.01 109.934 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 83' ' ' LEU . 27.9 mt -68.34 -21.25 64.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.336 -0.616 . . . . 1.48 109.336 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 109' ' ' GLN . 20.8 tp -83.02 -23.88 33.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.142 -0.936 . . . . 1.3799999999999999 109.713 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 82' ' ' LEU . 96.1 mt -84.02 -40.67 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.454 -0.794 . . . . 1.1899999999999999 110.886 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.9 p -63.19 -45.44 91.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 1.23 110.956 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.57 -26.17 68.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.039 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.6 t -68.39 -50.94 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.294 -0.412 . . . . 1.3899999999999999 110.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -65.78 -21.93 66.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 2.3199999999999998 111.024 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.6 m -73.46 -37.51 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.353 -0.385 . . . . 1.46 110.967 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.84 -23.98 26.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 1.24 110.937 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.0 mmm -94.0 84.84 4.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 2.0699999999999998 110.796 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -73.98 -19.34 60.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 3.5299999999999998 111.126 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.78 133.58 43.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.287 -0.415 . . . . 4.0800000000000001 110.996 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.3 pt -140.8 160.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 2.1699999999999999 110.935 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -139.97 -70.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 4.5199999999999996 110.997 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -142.4 14.64 2.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.388 . . . . 3.75 111.04 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.93 129.39 40.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 3.5299999999999998 110.877 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 56.5 t90 -151.63 -13.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 4.9100000000000001 110.926 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -82.94 -34.06 26.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.98 111.283 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.78 -48.47 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 1.8300000000000001 110.897 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 16.0 tt -59.11 -25.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 1.79 111.158 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.44 -46.64 32.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.831 -0.7 . . . . 0.62 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -56.47 -37.93 71.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.63 0.252 . . . . 1.5800000000000001 111.157 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.01 -51.79 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.97999999999999998 110.721 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 84.8 mtp -60.8 -26.08 67.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.48 110.981 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.7 m -68.3 -58.72 3.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 1.1299999999999999 111.139 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.64 HG21 HG21 ' A' ' 142' ' ' ILE . 97.5 m -53.37 -36.18 61.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 1.48 111.142 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.518 ' HB2' HD22 ' A' ' 84' ' ' LEU . 22.9 tp60 -55.14 -51.69 65.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 2.7000000000000002 110.69 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.8 mm -54.22 -35.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 1.54 111.139 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.77 -44.22 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.045 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.65 -52.26 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.42999999999999999 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 77' ' ' MET . 39.7 mt -53.59 -30.68 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 1.74 111.08 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 54.5 m -64.07 -48.24 76.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.63 110.82 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.8 m -62.98 -21.51 66.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.962 -0.563 . . . . 1.0900000000000001 110.476 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.7 9.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.862 -0.685 . . . . 0.41999999999999998 112.938 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 73' ' ' TYR . 4.0 pp -76.82 -26.75 54.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.682 0.241 . . . . 1.3799999999999999 111.268 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.1 mt -84.08 -38.1 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 CA-C-O 120.709 0.29 . . . . 1.6200000000000001 111.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.18 65.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.39000000000000001 111.281 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.64 -22.07 47.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.172 -0.467 . . . . 2.02 110.887 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.72 5.1 49.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.76000000000000001 111.102 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -64.13 131.03 46.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 1.46 111.028 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.72 -3.06 14.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 3.3500000000000001 111.126 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.503 ' HB2' HG12 ' A' ' 127' ' ' VAL . 72.2 mtm180 -129.83 141.04 50.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.871 0.367 . . . . 2.9199999999999999 110.97 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 2.77 111.133 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -79.3 -41.07 28.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 3.77 110.496 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 124' ' ' ARG . 11.6 p -84.16 -23.66 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.576 . . . . 1.1599999999999999 110.955 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -51.61 -40.28 59.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.197 -0.456 . . . . 2.04 111.09 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -75.1 -30.36 60.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 2.6400000000000001 111.167 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 127' ' ' VAL . 87.9 mt -67.56 -58.49 4.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 1.8999999999999999 111.354 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -63.03 -37.02 85.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.321 -0.4 . . . . 1.3999999999999999 111.928 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -55.03 -54.16 46.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.844 0.354 . . . . 1.28 110.662 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.46 -30.54 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 2.1600000000000001 110.658 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.2 t -62.77 -35.01 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 1.6899999999999999 110.827 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.17 -51.91 15.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.878 -0.677 . . . . 0.52000000000000002 112.646 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.16 -29.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.68 0.276 . . . . 1.02 110.991 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.9 t -69.48 -36.59 76.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0800000000000001 110.684 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.54 68.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.62 110.912 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.13 -22.6 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 1.8400000000000001 110.941 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 140' ' ' LEU . 1.5 tm? -64.62 -62.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.6899999999999999 111.227 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.1 pt -59.05 -46.39 91.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.81000000000000005 112.26 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.64 HG21 HG21 ' A' ' 108' ' ' THR . 33.4 mm -64.34 -31.69 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.726 0.269 . . . . 2.3700000000000001 111.726 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 62.7 tp -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.97999999999999998 110.911 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -65.51 -21.89 66.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.411 . . . . 3.27 110.56 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.33 -17.35 71.68 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.84 -0.695 . . . . 1.25 112.835 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.05 -14.51 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.823 0.344 . . . . 2.1200000000000001 111.109 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -66.65 -55.59 14.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.367 0.506 . . . . 1.6599999999999999 112.367 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.328 -0.333 0 N-CA-C 112.62 0.6 . . . . 99.989999999999995 112.62 -179.09 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.833 0.349 . . . . 2.3399999999999999 111.275 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -22.53 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.262 -0.426 . . . . 2.77 110.839 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.68 -32.48 71.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.006 0.431 . . . . 2.04 110.314 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 170' ' ' THR . 41.3 ttmt -78.33 -22.42 48.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.903 -0.589 . . . . 2.77 110.3 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.49 -56.45 4.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.646 . . . . 1.8899999999999999 111.034 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.0 -34.68 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.677 -0.692 . . . . 1.6399999999999999 112.088 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 167' ' ' LYS . 14.0 t -55.16 -34.09 63.52 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.957 0.408 . . . . 1.24 110.531 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -78.24 -28.52 47.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 2.9700000000000002 110.032 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -73.36 -28.0 61.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.643 -0.708 . . . . 1.48 110.84 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.2 p -76.63 -47.91 20.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.369 -0.378 . . . . 1.55 111.073 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.56 -28.55 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 1.52 111.286 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.4 tp -75.68 -56.73 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 1.8500000000000001 111.053 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -29.63 66.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.908 -0.587 . . . . 0.62 111.412 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.508 ' O ' HG12 ' A' ' 181' ' ' ILE . 14.1 tt -87.41 -21.08 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 1.3500000000000001 110.25 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.69 65.06 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.72 -0.673 . . . . 0.58999999999999997 112.87 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.573 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.2 m-85 -55.59 -55.6 38.65 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.797 0.298 . . . . 1.45 110.985 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 85.0 Cg_exo -46.35 -31.63 9.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.062 1.841 . . . . 0.55000000000000004 112.657 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.8 mm -64.8 -58.26 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.816 0.341 . . . . 1.4199999999999999 111.667 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 179' ' ' TYR . 28.2 m -59.6 -27.16 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.78000000000000003 111.58 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -61.65 -23.49 66.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.93999999999999995 110.927 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 89.7 mt -56.68 -39.77 65.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 1.4299999999999999 111.146 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.396 . . . . 2.02 111.004 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.5 mm . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.723 0.297 . . . . 2.48 111.229 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.61 -52.4 63.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 2.1800000000000002 110.682 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -63.93 -25.07 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.519 . . . . 1.49 111.076 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -77.02 -27.59 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 1.77 110.998 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 53.7 tp -84.08 -51.17 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 1.4199999999999999 111.506 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -69.75 1.27 4.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.522 -0.308 . . . . 1.78 111.46 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 35.9 t -96.48 -44.01 7.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 1.3 110.191 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.2 tp -72.38 -33.63 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.427 -0.806 . . . . 0.66000000000000003 111.763 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.1 tt -60.09 -54.57 53.97 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.019 -0.272 . . . . 1.6299999999999999 111.17 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.25 -41.63 74.52 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.654 1.57 . . . . 0.64000000000000001 111.262 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.427 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 81.6 t80 -61.28 -34.01 74.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 1.3600000000000001 110.053 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.0 -21.03 57.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.326 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 115.872 -0.604 . . . . 1.2 110.721 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.833 0.349 . . . . 1.6399999999999999 110.871 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.28 96.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.866 -0.683 . . . . 0.79000000000000004 112.405 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.78 -29.46 69.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.732 0.301 . . . . 1.6100000000000001 110.83 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.6 t -60.49 -58.02 10.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.1499999999999999 110.858 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 218' ' ' LEU . 75.5 t80 -69.1 -23.88 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 3.3399999999999999 110.663 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 216' ' ' LEU . 8.3 tt -67.1 -49.46 64.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 1.1899999999999999 110.766 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.39 -38.23 83.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 2.23 110.856 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 215' ' ' PHE . 95.4 mt -59.3 -50.37 74.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 2.4700000000000002 111.109 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -72.67 -21.41 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 1.6200000000000001 110.871 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.62 -26.54 64.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 1.4099999999999999 112.567 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 2.5800000000000001 111.15 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.676 0.274 . . . . 2.0699999999999998 111.021 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.529 HD12 HD11 ' B' ' 10' ' ' ILE . 54.4 tp -67.61 -42.21 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.434 -0.348 . . . . 2.1000000000000001 111.099 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.625 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 40.4 m-70 -67.71 -25.37 65.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.49 . . . . 1.0700000000000001 110.35 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -72.97 -49.51 28.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 1.48 110.989 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.529 HD11 HD12 ' B' ' 7' ' ' LEU . 45.3 pt -69.0 -19.18 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.957 0.408 . . . . 2.02 110.789 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -66.55 -54.11 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 0.92000000000000004 110.589 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.57 -31.77 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.93999999999999995 111.003 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.39 -47.31 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.55000000000000004 111.236 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.12 74.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.666 -0.778 . . . . 0.47999999999999998 112.485 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.23 -31.51 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.84999999999999998 110.804 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -63.5 -58.11 8.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 1.3400000000000001 110.996 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.6 pp -61.21 -23.61 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 1.55 111.206 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.431 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -60.7 -51.81 56.38 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.632 -0.794 . . . . 0.69999999999999996 112.161 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -68.32 -23.39 64.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.81000000000000005 110.894 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.57 -43.2 90.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 2.2599999999999998 110.622 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.22 -25.43 61.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.78 110.432 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 83.2 t80 -66.1 -37.25 85.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.666 . . . . 4.5800000000000001 110.47 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.4 ' O ' ' OG ' ' B' ' 26' ' ' SER . 86.0 t90 -67.14 -35.41 79.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 3.3500000000000001 110.656 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 40.8 t -80.41 -19.59 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 1.5800000000000001 111.161 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.1 -22.38 39.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 1.8400000000000001 111.267 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 4.8 p -59.5 -24.48 63.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.553 -0.294 . . . . 1.3700000000000001 111.092 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -47.38 -32.43 4.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 4.9800000000000004 110.022 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.7 p-10 -172.93 132.06 0.63 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 2.1400000000000001 110.278 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 52.2 Cg_endo -95.01 174.52 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.978 2.452 . . . . 1.8200000000000001 112.306 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -102.2 68.06 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 5.1900000000000004 111.366 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 -46.66 3.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.028 -0.606 . . . . 2.2000000000000002 112.84 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.02 144.93 29.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.515 0.198 . . . . 3.6499999999999999 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 165.47 8.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.405 2.07 . . . . 2.6699999999999999 112.218 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -69.2 -17.36 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.658 -0.701 . . . . 4.8799999999999999 112.413 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -41.17 -37.76 0.97 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.765 0.317 . . . . 1.8700000000000001 111.838 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.67 -57.07 12.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 2.6800000000000002 110.476 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.07 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 2.9199999999999999 110.783 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' B' ' 41' ' ' MET . 20.4 tp -60.38 -51.85 67.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.938 0.399 . . . . 1.6399999999999999 110.281 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -63.02 -38.48 82.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.094 0.473 . . . . 1.6000000000000001 109.872 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.82 -9.59 55.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.68999999999999995 110.7 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' B' ' 45' ' ' ILE . 22.0 ttt -87.94 -31.76 19.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 2.5800000000000001 110.426 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -72.65 -34.08 67.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 3.3900000000000001 111.397 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.658 HG23 HG23 ' B' ' 79' ' ' THR . 64.3 mt -52.91 -52.29 66.39 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 111.97 0.359 . . . . 0.40999999999999998 111.97 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.8 Cg_endo -71.18 -35.0 9.29 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.264 1.976 . . . . 0.48999999999999999 113.516 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 41' ' ' MET . 33.1 mm -56.64 -62.69 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.63 -57.38 12.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 1.3999999999999999 111.341 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -55.78 -23.56 30.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 1.3799999999999999 111.505 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.39 -64.42 3.36 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.37 112.552 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 60.0 mt -57.37 -27.52 62.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.325 . . . . 1.29 111.076 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.98 -55.76 26.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.16 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 13.8 m-85 -64.32 -41.09 96.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.5 111.235 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 51.6 ttp -49.41 -34.28 15.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.276 0.56 . . . . 1.4099999999999999 110.139 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.27 -40.09 71.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.449 -0.796 . . . . 0.55000000000000004 110.559 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 58.7 mtt -53.55 -30.6 42.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.5 110.299 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.2 -45.85 58.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.54000000000000004 110.671 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.518 HG21 HG23 ' C' ' 127' ' ' VAL . 13.1 mt -74.34 0.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.508 . . . . 1.3 110.746 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.485 ' HB2' HH12 ' C' ' 124' ' ' ARG . 8.0 m-20 63.76 52.15 2.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.794 -0.639 . . . . 2.2400000000000002 111.131 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -127.98 143.63 51.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.77 110.753 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.3 23.7 7.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.844 -0.693 . . . . 1.0600000000000001 112.394 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -137.43 137.49 38.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 2.6600000000000001 111.046 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.55 147.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.8899999999999999 111.005 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.25 94.01 9.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 2.4100000000000001 110.883 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.42 113.38 24.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 1.5600000000000001 111.182 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.45 30.54 18.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.434 . . . . 1.8200000000000001 111.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.84 -11.1 60.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.733 -0.746 . . . . 1.51 112.58 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -100.84 134.63 43.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 2.4500000000000002 110.723 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.26 132.2 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 1.79 110.875 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.03 144.33 32.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.81999999999999995 111.565 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.507 ' HB3' ' HD3' ' B' ' 72' ' ' ARG . 74.4 m-70 -95.5 66.58 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.689 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -68.65 -35.54 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.8700000000000001 111.129 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.88 68.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.60999999999999999 111.61 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.507 ' HD3' ' HB3' ' B' ' 69' ' ' HIS . 10.3 mpt_? -74.21 -51.69 14.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.24 -0.436 . . . . 2.3900000000000001 111.193 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -49.46 77.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 3.6699999999999999 111.353 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.3 -38.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.12 0.415 . . . . 1.6599999999999999 112.12 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.45 -24.75 67.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.349 . . . . 1.4099999999999999 110.406 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -95.87 6.59 48.52 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.08 -0.509 . . . . 1.1599999999999999 110.664 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.62 ' HA ' HD13 ' B' ' 113' ' ' ILE . 53.9 tpp -103.94 -13.82 16.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 1.53 109.455 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.455 ' O ' HD23 ' B' ' 82' ' ' LEU . 26.1 m -114.81 -35.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.437 -0.801 . . . . 0.89000000000000001 111.271 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.658 HG23 HG23 ' B' ' 43' ' ' ILE . 46.2 m -81.48 -60.93 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 1.24 112.179 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.567 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 60.2 m -47.18 -51.27 42.76 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 112.675 0.62 . . . . 0.57999999999999996 112.675 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 80' ' ' THR . 11.0 Cg_endo -54.17 -34.39 78.6 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.048 1.832 . . . . 0.66000000000000003 111.856 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.522 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -79.01 -29.52 43.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 1.0600000000000001 110.769 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.2 tp -68.99 -30.01 68.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.018 0.437 . . . . 1.22 110.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -78.6 -30.36 46.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.749 -0.659 . . . . 1.53 110.072 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.522 HD12 HD13 ' B' ' 82' ' ' LEU . 76.0 mt -68.51 -42.52 78.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 1.5800000000000001 110.706 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -66.18 -41.51 90.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 1.3899999999999999 110.48 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -30.33 68.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.847 -0.615 . . . . 1.1499999999999999 110.53 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -70.72 -48.04 56.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 1.5700000000000001 110.997 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -66.71 -19.19 65.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 2.1699999999999999 111.149 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 34.3 m -79.92 -32.96 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 1.4199999999999999 111.051 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.57 -24.6 23.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.315 -0.402 . . . . 1.1799999999999999 111.431 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.6 mtp -100.01 104.38 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 1.8799999999999999 111.157 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -84.55 -38.15 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 3.4199999999999999 110.935 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.72 133.66 53.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 4.0599999999999996 110.944 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.92 148.53 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 2.0899999999999999 111.034 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -133.67 -67.29 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 3.8500000000000001 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -140.85 26.63 2.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 4.8200000000000003 110.903 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.99 106.49 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 3.7999999999999998 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -135.15 -9.14 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 5.1699999999999999 110.747 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -82.76 -37.0 25.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 2.02 110.959 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.59 -55.23 16.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 2.0899999999999999 110.53 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ILE . . . . . 0.495 ' HA ' HD12 ' B' ' 105' ' ' LEU . 16.9 tt -55.4 -28.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 1.8799999999999999 111.14 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 62.97 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.868 -0.682 . . . . 0.56000000000000005 112.537 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.415 ' O ' HG23 ' B' ' 108' ' ' THR . 35.3 t80 -63.47 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 1.78 110.532 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.598 ' HB3' HD21 ' B' ' 84' ' ' LEU . 85.8 mt -59.05 -46.62 87.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 1.03 110.772 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' MET . . . . . 0.523 ' O ' HG12 ' B' ' 110' ' ' ILE . 52.3 ttm -68.18 -22.25 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.759 -0.655 . . . . 1.6699999999999999 110.967 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 56.9 m -76.45 -39.93 51.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.93 0.395 . . . . 1.51 110.939 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 104' ' ' PHE . 60.8 p -64.82 -43.34 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 1.1799999999999999 111.533 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.482 ' NE2' ' HG3' ' B' ' 106' ' ' MET . 13.4 pt20 -59.71 -42.87 94.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.539 -0.301 . . . . 2.1699999999999999 111.001 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.61 HG22 ' HE1' ' A' ' 46' ' ' TRP . 43.2 mm -53.55 -41.16 44.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.842 0.353 . . . . 1.3500000000000001 110.52 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 46' ' ' TRP . 26.5 t -62.16 -44.96 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 1.3400000000000001 111.239 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.46 -50.78 78.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.42999999999999999 111.757 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' B' ' 77' ' ' MET . 21.9 mt -58.57 -33.68 49.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.729 0.3 . . . . 1.6000000000000001 110.866 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.8 m -56.22 -40.54 74.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.17 0.509 . . . . 0.85999999999999999 110.172 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 39.2 m -60.51 -56.78 17.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.94999999999999996 110.243 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.87 -16.38 59.3 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.94 -0.648 . . . . 0.46000000000000002 112.278 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.08 -61.56 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.425 . . . . 1.75 110.596 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.77 -21.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.828 -0.624 . . . . 1.78 111.804 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.99 42.09 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.021 0.439 . . . . 0.38 110.949 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.08 -23.75 28.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 1.97 110.712 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.92 19.15 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.76000000000000001 110.853 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -75.68 129.05 36.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 1.47 110.977 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.57 -42.62 5.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 2.5 110.7 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.535 ' HB2' HG12 ' B' ' 127' ' ' VAL . 78.7 mtt180 -79.48 148.22 31.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 2.73 110.269 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.39 -22.33 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 2.2000000000000002 111.942 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 31.5 p90 -83.86 -25.98 29.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.685 0.279 . . . . 3.3999999999999999 111.222 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.535 HG12 ' HB2' ' B' ' 124' ' ' ARG . 8.6 p -83.28 -23.74 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 1.23 110.519 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.67 -37.93 66.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.775 -0.648 . . . . 3.04 110.991 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.68 -19.96 47.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.4 . . . . 4.1399999999999997 110.885 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' B' ' 127' ' ' VAL . 98.7 mt -76.22 -60.37 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 1.6499999999999999 111.139 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -62.74 -28.67 70.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.77000000000000002 111.26 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.4 -59.25 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 1.46 110.838 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.3 pt -61.45 -25.81 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 1.6299999999999999 111.446 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -66.4 -39.39 88.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 1.4199999999999999 111.035 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.71 31.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.816 -0.707 . . . . 0.48999999999999999 112.671 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' B' ' 180' ' ' PRO . 35.5 m -61.75 -32.42 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.65 0.262 . . . . 1.3 111.376 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.65 -30.55 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.3 111.076 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.03 78.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.412 . . . . 0.62 110.825 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.49 -28.41 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 1.74 110.972 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.17 -57.84 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.368 -0.378 . . . . 1.76 111.708 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.462 HG13 ' N ' ' B' ' 142' ' ' ILE . 40.2 pt -55.96 -43.29 74.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.893 0.331 . . . . 0.68999999999999995 111.893 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.462 ' N ' HG13 ' B' ' 141' ' ' ILE . 8.9 tp -72.57 -28.36 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.705 0.288 . . . . 1.76 111.252 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.03 -57.33 13.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 1.0600000000000001 110.797 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -63.82 -27.19 69.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 4.1200000000000001 110.559 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.21 -17.26 78.42 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.775 -0.726 . . . . 1.26 112.491 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.7 tt -109.2 0.31 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 1.98 111.467 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -86.09 -55.01 4.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.846 0.313 . . . . 1.4199999999999999 111.846 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 34.0 m120 . . . . . 0 C--N 1.329 -0.306 0 N-CA-C 112.324 0.49 . . . . 99.989999999999995 112.324 -179.478 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.826 0.346 . . . . 2.4300000000000002 110.968 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -22.3 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 2.5800000000000001 110.885 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.78 -54.08 47.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 2.0 110.837 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -63.26 -30.8 71.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 3.0299999999999998 110.919 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.87 -56.66 9.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 1.1000000000000001 111.147 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.86 -23.01 30.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 1.75 111.443 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 52.2 m -56.41 -58.54 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.95 0.405 . . . . 0.97999999999999998 110.582 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.36 -33.65 71.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 4.2999999999999998 110.515 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -64.78 -35.42 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 1.3899999999999999 111.278 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 53.1 m -72.83 -54.12 9.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.346 -0.388 . . . . 1.1100000000000001 111.639 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.66 -26.49 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.885 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -77.05 -57.78 3.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 1.75 111.279 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.22 -27.54 55.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.59999999999999998 110.862 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.503 ' O ' HG12 ' B' ' 181' ' ' ILE . 85.7 mt -87.65 -23.88 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 1.47 110.214 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.26 -55.44 29.48 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.55000000000000004 113.029 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 60.3 m-85 -54.23 -55.35 37.82 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.854 0.327 . . . . 1.6200000000000001 111.257 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.5 Cg_exo -45.22 -32.22 7.0 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.323 2.016 . . . . 0.64000000000000001 113.016 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.509 ' O ' HG22 ' B' ' 184' ' ' ILE . 47.1 mm -67.26 -61.13 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.392 -0.367 . . . . 1.27 111.739 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.465 HG22 ' O ' ' B' ' 179' ' ' TYR . 21.0 m -57.26 -24.76 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.68999999999999995 112.005 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -62.82 -23.65 67.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.407 -0.361 . . . . 1.1799999999999999 111.906 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.601 HG23 HG23 ' B' ' 185' ' ' ILE . 16.7 tt -57.54 -38.07 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.737 0.273 . . . . 1.77 111.737 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 185' ' ' ILE . . . . . 0.601 HG23 HG23 ' B' ' 184' ' ' ILE . 26.1 pt -102.34 156.6 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.759 0.314 . . . . 1.6899999999999999 111.137 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 120.725 -0.75 . . . . 1.5800000000000001 112.46 -179.851 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.665 0.269 . . . . 2.4700000000000002 111.081 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -53.83 -51.99 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 2.5299999999999998 110.647 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 61.6 p -63.03 -44.13 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.29 110.967 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.53 -28.83 48.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 2.6200000000000001 110.965 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -84.13 -51.62 6.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 1.6100000000000001 111.779 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -69.34 -2.07 9.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.9 0.333 . . . . 1.4199999999999999 111.9 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -96.83 -42.0 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.044 0.45 . . . . 1.4299999999999999 110.5 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.6 tp -71.82 -33.44 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.629 . . . . 1.1200000000000001 111.844 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.691 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.1 tp -62.8 -54.36 47.96 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.57 -0.252 . . . . 1.26 111.44 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.9 Cg_exo -55.66 -41.22 79.83 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.884 1.723 . . . . 0.59999999999999998 111.415 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -58.71 -36.48 74.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.037 0.446 . . . . 1.3999999999999999 110.173 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.28 -31.9 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 110.507 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.78 179.768 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.047 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.48 -36.64 93.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.79000000000000004 112.653 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.66 -29.2 66.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 2.96 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -62.85 -61.24 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 1.29 110.878 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -64.0 -22.13 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 3.1499999999999999 110.745 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.408 ' C ' HD13 ' B' ' 216' ' ' LEU . 3.2 tm? -71.48 -49.36 42.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 1.51 110.674 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.52 -31.95 72.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 2.1899999999999999 110.852 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.74 -38.27 90.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 1.98 110.724 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -85.28 -20.65 29.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 2.1699999999999999 111.017 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.21 -36.1 73.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.902 -0.666 . . . . 1.3600000000000001 112.762 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.681 0.277 . . . . 2.8999999999999999 111.262 -179.779 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.465 HD23 ' N ' ' C' ' 6' ' ' LEU . 2.5 pt? . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.749 0.309 . . . . 2.52 111.221 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.12 -45.06 82.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.382 -0.372 . . . . 1.9299999999999999 111.084 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 22.7 m80 -68.26 -25.27 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 1.26 110.782 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -73.07 -48.34 36.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 1.6699999999999999 110.887 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.9 -21.07 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 1.8700000000000001 110.156 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.73 -57.48 9.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 1.4399999999999999 110.711 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.3 -31.75 49.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.199 -0.455 . . . . 0.46999999999999997 111.106 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.4 81.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 0.58999999999999997 111.301 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.07 -24.36 75.89 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.5 112.656 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -77.15 -34.73 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.68000000000000005 111.166 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 46.7 m -65.44 -48.71 71.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 1.3999999999999999 110.997 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' ILE . . . . . 0.406 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.7 pp -63.82 -29.38 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.379 -0.373 . . . . 1.55 110.952 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.406 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -58.4 -51.74 56.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.70999999999999996 112.389 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 -24.06 66.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.77000000000000002 111.217 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 52.6 tp -67.71 -39.17 84.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 1.9299999999999999 110.731 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.12 -27.62 67.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 1.8600000000000001 110.618 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.63 -39.98 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.94 -0.573 . . . . 4.1399999999999997 110.788 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -62.92 -48.14 80.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 3.1499999999999999 110.763 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 55.1 m -68.54 -19.66 64.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.95 111.359 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.474 ' HG ' HE22 ' C' ' 34' ' ' GLN . 54.1 tp -83.34 -20.68 33.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.439 -0.346 . . . . 2.2200000000000002 111.307 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 75.8 p -60.43 -21.59 62.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.686 -0.234 . . . . 1.3700000000000001 111.096 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -52.03 -31.3 29.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 5.0300000000000002 109.809 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.9 p-10 -171.9 131.91 0.75 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 2.3700000000000001 110.293 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.7 Cg_endo . . . . . 0 N--CA 1.451 -1.009 0 C-N-CA 123.19 2.594 . . . . 2.0499999999999998 112.15 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 CA--C 1.527 0.173 0 CA-C-O 121.212 0.422 . . . . 1.9299999999999999 112.747 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLN . . . . . 0.474 HE22 ' HG ' ' C' ' 25' ' ' LEU . 84.7 mm-40 -66.53 -17.56 64.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.544 -0.753 . . . . 4.1200000000000001 112.658 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -41.36 -38.22 1.17 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.812 0.301 . . . . 2.8900000000000001 111.812 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.33 -53.09 58.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 2.46 110.684 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -66.73 -19.04 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 2.7799999999999998 110.739 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' C' ' 41' ' ' MET . 22.2 tp -61.06 -49.61 76.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.094 0.473 . . . . 1.6200000000000001 110.207 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.42 -42.43 96.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.025 -0.534 . . . . 1.5900000000000001 110.093 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -6.8 35.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.797 -0.638 . . . . 0.65000000000000002 110.872 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 25.8 ttt -87.87 -33.22 18.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 1.6699999999999999 110.402 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' C' ' 45' ' ' ILE . 34.3 t80 -71.37 -36.99 71.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 3.4199999999999999 111.32 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.501 HG23 HG23 ' C' ' 79' ' ' THR . 74.7 mt -49.33 -53.4 40.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.132 0.419 . . . . 0.89000000000000001 112.132 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.27 -33.21 11.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.171 1.914 . . . . 0.40999999999999998 112.912 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 41' ' ' MET . 77.2 mt -53.3 -62.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.631 0.253 . . . . 1.76 111.452 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -62.87 -56.08 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.446 -0.343 . . . . 2.1600000000000001 111.216 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' SER . . . . . 0.41 ' HG ' ' HA ' ' C' ' 44' ' ' PRO . 98.6 p -51.73 -23.07 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.045 -0.525 . . . . 1.1699999999999999 111.212 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.34 -64.62 2.69 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.45 -0.881 . . . . 0.44 112.058 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.94 -28.67 62.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 1.29 110.914 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 -58.79 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.5 111.16 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 18.4 m-85 -60.93 -40.62 93.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.387 . . . . 1.8300000000000001 110.972 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.0 ttp -49.48 -38.34 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.439 . . . . 1.47 110.021 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.34 82.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.59999999999999998 110.649 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 56.3 mtt -54.89 -33.08 61.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.83999999999999997 110.174 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.7 -38.48 73.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.821 -0.627 . . . . 0.65000000000000002 110.385 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mt -80.44 -0.42 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 1.55 110.527 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.32 41.84 12.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.794 -0.639 . . . . 1.54 111.177 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -117.05 134.92 54.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 1.79 110.612 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.89 37.66 1.66 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.833 -0.699 . . . . 0.93999999999999995 112.222 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -154.11 132.49 11.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 2.3599999999999999 111.119 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -114.1 142.1 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 1.97 110.836 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.13 96.05 8.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 2.4399999999999999 111.056 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.44 124.71 43.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 1.54 110.962 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.31 27.19 16.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 1.71 111.139 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -13.59 57.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.802 -0.713 . . . . 1.53 112.517 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -100.78 145.15 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.883 0.373 . . . . 2.23 111.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -89.96 135.72 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.769 -0.651 . . . . 1.3600000000000001 110.934 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.92 138.39 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.78000000000000003 111.386 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -88.71 64.55 7.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 1.0800000000000001 110.802 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.57 -35.3 77.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 2.2999999999999998 111.01 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.56 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.75 111.576 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.522 HH22 ' HB2' ' C' ' 203' ' ' CYS . 27.3 mmt180 -70.79 -51.29 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 1.51 111.751 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -47.76 74.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.55 -0.296 . . . . 4.6500000000000004 111.65 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.42 -40.49 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.696 0.628 . . . . 1.22 112.696 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.48 -28.5 69.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.398 -0.521 . . . . 1.3100000000000001 110.37 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -88.54 4.1 47.96 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.181 -0.463 . . . . 1.6799999999999999 111.035 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.651 ' HA ' HD13 ' C' ' 113' ' ' ILE . 50.3 tpp -95.97 -20.09 19.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 1.8 109.994 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.437 ' O ' HD23 ' C' ' 82' ' ' LEU . 12.5 m -114.38 -38.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.582 -0.736 . . . . 1.1899999999999999 111.653 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.501 HG23 HG23 ' C' ' 43' ' ' ILE . 78.4 m -73.65 -55.89 5.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.23 111.998 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 17.9 m -50.1 -51.85 58.55 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.505 0.557 . . . . 0.58999999999999997 112.505 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.2 Cg_exo -53.21 -42.64 63.48 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.781 1.654 . . . . 0.67000000000000004 111.791 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.437 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.1 mm? -67.92 -32.55 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.95999999999999996 110.004 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.497 ' O ' HD23 ' C' ' 87' ' ' LEU . 0.2 OUTLIER -68.87 -25.92 64.87 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.833 -0.802 . . . . 1.1899999999999999 108.833 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' C' ' 109' ' ' GLN . 24.0 tp -80.63 -38.21 29.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.014 -0.994 . . . . 1.7 110.311 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' LEU . . . . . 0.435 ' HG ' ' HE1' ' C' ' 89' ' ' TRP . 19.7 tp -65.84 -52.78 47.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.208 -0.906 . . . . 1.6200000000000001 111.15 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.3 p -50.93 -44.17 60.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 1.26 111.395 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.497 HD23 ' O ' ' C' ' 83' ' ' LEU . 3.6 mm? -62.37 -33.48 74.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 1.1100000000000001 111.184 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 57.7 m -70.87 -22.67 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 1.51 111.196 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' TRP . . . . . 0.435 ' HE1' ' HG ' ' C' ' 85' ' ' LEU . 93.4 m95 -80.72 -52.12 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 2.0600000000000001 111.233 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 90' ' ' THR . . . . . 0.437 HG23 HD21 ' C' ' 168' ' ' LEU . 9.8 t -62.71 -27.55 69.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 1.52 111.36 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' C' ' 165' ' ' TYR . . . -80.47 -22.97 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.174 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.0 mtp -110.53 102.34 10.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 1.6200000000000001 110.882 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.98 -40.44 39.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 3.2400000000000002 110.897 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -108.14 138.64 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.6299999999999999 111.038 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.1 pt -145.31 146.76 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 2.1800000000000002 110.969 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.63 -74.79 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.948 0.404 . . . . 4.1200000000000001 111.067 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -139.07 25.89 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 4.96 110.771 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.73 129.68 38.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 3.9100000000000001 110.741 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -151.28 -28.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 5.21 110.832 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 1.7 t -63.99 -46.31 85.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.215 -0.448 . . . . 1.8200000000000001 111.475 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.71 -37.19 86.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 2.0800000000000001 110.823 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.87 -29.16 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.8600000000000001 110.64 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.26 -30.26 46.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.956 -0.64 . . . . 0.58999999999999997 112.602 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -71.84 -25.24 61.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 1.53 110.461 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 mt -77.69 -49.38 14.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.1100000000000001 110.81 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.2 ptm -64.95 -24.26 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 2.21 111.045 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 94.5 p -72.33 -50.24 28.33 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.022 0.439 . . . . 1.28 110.504 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -60.03 -24.8 64.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.077 -0.51 . . . . 1.22 110.976 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.507 ' HB2' HD22 ' C' ' 84' ' ' LEU . 24.8 tp60 -66.98 -52.12 46.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 2.3300000000000001 110.613 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.9 -35.41 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.004 -0.544 . . . . 1.29 110.758 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.26 -45.36 98.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 1.0600000000000001 110.929 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.54 -47.86 89.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.51000000000000001 111.394 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' C' ' 77' ' ' MET . 19.7 mt -59.4 -32.55 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 1.3700000000000001 111.009 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -60.5 -43.65 96.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.459 . . . . 0.77000000000000002 110.508 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -59.22 -53.96 52.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 1.1899999999999999 110.428 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.54 -25.56 68.87 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.789 -0.719 . . . . 0.5 111.826 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.402 HD23 ' C ' ' C' ' 117' ' ' LEU . 5.4 tt -60.19 -55.9 28.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.29 0.567 . . . . 1.47 110.329 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' C' ' 121' ' ' LEU . 4.8 tp -81.22 -28.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 1.2 112.188 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.33 46.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.40000000000000002 111.233 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -79.68 -31.15 41.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 2.1200000000000001 110.843 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.547 ' HB2' HD12 ' C' ' 118' ' ' ILE . 73.9 mt -80.79 7.49 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.323 -0.399 . . . . 0.75 110.912 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.0 t -63.42 122.98 17.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 1.3799999999999999 111.223 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.03 -51.55 3.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 2.7400000000000002 110.704 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 124' ' ' ARG . . . . . 0.661 ' HB2' HG12 ' C' ' 127' ' ' VAL . 90.6 mtt180 -75.65 143.78 42.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 2.7999999999999998 110.662 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.07 -19.09 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 111.667 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -79.46 -54.47 5.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.709 0.29 . . . . 4.2000000000000002 111.108 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' C' ' 124' ' ' ARG . 14.2 p -59.69 -24.04 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 1.0800000000000001 111.367 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -51.52 -47.55 63.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.34 -0.391 . . . . 2.5699999999999998 111.302 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.24 -24.78 62.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.334 -0.393 . . . . 3.8100000000000001 111.339 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.453 HD13 HD13 ' B' ' 56' ' ' ILE . 95.6 mt -72.65 -52.21 16.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.4199999999999999 111.166 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.27 -28.7 66.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.89000000000000001 110.792 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -59.84 -60.41 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.823 -0.626 . . . . 1.26 110.451 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' C' ' 136' ' ' VAL . 16.4 tt -63.95 -26.23 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.917 -0.583 . . . . 1.6799999999999999 111.087 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.54 -35.29 80.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 1.24 110.793 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.61 -53.75 7.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.81 -0.709 . . . . 0.54000000000000004 112.587 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 136' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' C' ' 133' ' ' ILE . 34.1 m -59.46 -30.75 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.321 . . . . 1.0600000000000001 111.352 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.8 -35.27 72.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0800000000000001 110.67 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.58 93.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.8 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 139' ' ' PHE . . . . . 0.401 ' HA ' HG12 ' C' ' 142' ' ' ILE . 79.3 t80 -73.16 -24.04 60.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.903 -0.59 . . . . 1.6799999999999999 111.083 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -60.94 2.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 1.7 111.357 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.416 HG13 ' N ' ' C' ' 142' ' ' ILE . 17.6 pt -58.34 -45.71 89.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.608 0.596 . . . . 0.78000000000000003 112.608 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.416 ' N ' HG13 ' C' ' 141' ' ' ILE . 41.8 pt -66.44 -32.26 57.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.685 0.254 . . . . 2.2400000000000002 111.685 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 56.5 tp -55.76 -56.64 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.603 0.239 . . . . 1.02 110.901 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -64.79 -24.52 67.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 3.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.38 -17.37 76.26 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.343 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 146' ' ' ILE . . . . . 0.4 HG13 ' O ' ' C' ' 142' ' ' ILE . 68.8 mt -109.24 -12.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.957 0.408 . . . . 1.8899999999999999 111.031 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -72.4 -55.4 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 1.6000000000000001 111.998 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 34.0 m120 . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.406 0.521 . . . . 99.989999999999995 112.406 -179.467 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.243 0.545 . . . . 2.3500000000000001 110.469 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 165' ' ' TYR . . . . . 0.523 ' CE2' ' HB1' ' C' ' 91' ' ' ALA . 0.4 OUTLIER -61.62 -36.03 79.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 2.6200000000000001 111.108 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.82 -56.22 17.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 2.0899999999999999 111.539 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 167' ' ' LYS . . . . . 0.418 ' O ' HG22 ' C' ' 170' ' ' THR . 68.5 mttm -59.34 -22.21 60.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 3.2400000000000002 111.461 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.437 HD21 HG23 ' C' ' 90' ' ' THR . 56.3 tp -81.95 -59.05 2.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 1.6899999999999999 111.413 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.67 -29.27 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.3999999999999999 112.192 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 170' ' ' THR . . . . . 0.418 HG22 ' O ' ' C' ' 167' ' ' LYS . 15.3 t -57.05 -36.17 70.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.95999999999999996 110.988 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -77.32 -34.71 55.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 3.6499999999999999 109.943 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.24 -22.59 63.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.688 -0.687 . . . . 1.3700000000000001 110.474 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 90.6 m -79.52 -58.56 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 1.4299999999999999 111.264 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.68 -28.52 32.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 1.6200000000000001 111.785 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.424 HD21 ' OG ' ' C' ' 209' ' ' SER . 46.8 tp -73.34 -57.4 4.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 2.0299999999999998 111.163 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.78 -25.55 60.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.62 110.875 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 86.4 mt -87.89 -21.57 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.045 0.45 . . . . 1.5800000000000001 110.414 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 178' ' ' GLY . . . . . 0.527 ' O ' HG22 ' C' ' 181' ' ' ILE . . . -63.4 -41.6 99.33 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.56000000000000005 112.998 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.525 ' N ' ' HD2' ' C' ' 180' ' ' PRO . 55.5 m-85 -64.47 -52.03 55.82 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 111.988 0.366 . . . . 1.3300000000000001 111.988 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.588 ' HA ' ' NE1' ' C' ' 183' ' ' TRP . 33.1 Cg_endo -63.76 -16.78 56.78 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.01 1.807 . . . . 0.63 113.326 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.527 HG22 ' O ' ' C' ' 178' ' ' GLY . 3.6 tt -88.99 -27.09 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 112.483 0.549 . . . . 0.93000000000000005 112.483 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.429 HG13 ' N ' ' C' ' 183' ' ' TRP . 3.8 p -80.88 -53.78 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.47 0.915 . . . . 1.27 113.47 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 183' ' ' TRP . . . . . 0.588 ' NE1' ' HA ' ' C' ' 180' ' ' PRO . 0.2 OUTLIER -58.32 -12.11 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.198 0.444 . . . . 1.77 112.198 -178.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.99 -18.84 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.996 0.427 . . . . 2.3900000000000001 110.703 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 2.4 pt . . . . . 0 C--O 1.233 0.206 0 CA-C-N 115.858 -0.61 . . . . 1.95 111.201 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.642 0.258 . . . . 2.3799999999999999 111.408 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 88.3 mt -72.97 -45.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.403 -0.362 . . . . 2.23 111.295 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.25 -46.97 76.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 2.1600000000000001 110.894 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -69.52 -26.92 64.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 1.27 111.08 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -69.71 -33.36 72.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 1.7 110.981 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.22 -45.53 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 2.02 111.396 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -67.5 -7.44 25.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 1.8200000000000001 111.266 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.522 ' HB2' HH22 ' C' ' 72' ' ' ARG . 44.3 t -96.47 -43.52 7.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 1.3500000000000001 110.568 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 39.4 tp -67.82 -37.05 81.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.48 -0.782 . . . . 0.65000000000000002 112.149 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.609 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.4 OUTLIER -60.86 -55.21 46.97 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.942 -0.303 . . . . 1.4199999999999999 111.446 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 66.8 Cg_exo -53.75 -36.78 83.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.691 1.594 . . . . 0.63 111.368 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.86 -46.15 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 1.49 109.985 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -68.29 -16.55 64.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 1.7 110.483 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 209' ' ' SER . . . . . 0.424 ' OG ' HD21 ' C' ' 175' ' ' LEU . 30.6 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 1.25 110.914 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.808 0.337 . . . . 1.6100000000000001 111.094 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.89 -40.11 98.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.81999999999999995 112.333 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.93 -27.92 67.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 3.0800000000000001 110.97 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 52.9 m -61.44 -57.15 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 1.1499999999999999 110.967 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.86 -29.41 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 2.5600000000000001 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.451 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.1 tm? -66.04 -40.44 90.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 1.29 110.535 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.01 -22.06 60.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.082 -0.508 . . . . 2.3900000000000001 110.459 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 43.8 tp -74.5 -42.07 59.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 2.0299999999999998 110.552 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -85.13 -20.27 30.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 3.21 111.025 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.57 49.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.991 -0.623 . . . . 1.3600000000000001 112.714 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.733 0.301 . . . . 2.8999999999999999 111.192 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.812 0.339 . . . . 2.4199999999999999 110.775 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.85 -52.33 44.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 2.0899999999999999 110.555 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 40.6 m-70 -68.42 -23.55 64.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.89 -0.596 . . . . 1.1599999999999999 110.101 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -66.57 -52.17 48.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.681 . . . . 0.79000000000000004 111.115 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.0 pt -68.53 -21.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0800000000000001 110.773 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -60.6 -55.06 37.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 1.28 110.56 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.98 -36.24 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.966 -0.561 . . . . 1.3200000000000001 111.127 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.43 -37.63 73.12 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.935 0.398 . . . . 0.63 110.92 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.04 -29.41 58.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.721 -0.752 . . . . 0.55000000000000004 112.178 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -74.81 -31.72 61.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.299 . . . . 1.03 111.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 p -68.11 -50.19 56.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.481 -0.327 . . . . 1.3 111.111 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.47 -26.58 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.287 -0.415 . . . . 1.3100000000000001 110.725 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.49 44.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.61 -0.805 . . . . 0.77000000000000002 111.9 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -64.79 -23.48 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.903 0.382 . . . . 0.80000000000000004 110.716 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -68.78 -41.62 78.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.08 -0.509 . . . . 1.8100000000000001 110.776 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -60.54 -23.53 64.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 1.8799999999999999 110.305 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 84.7 t80 -60.84 -31.9 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.659 -0.7 . . . . 4.4500000000000002 110.566 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.466 ' O ' ' OG ' ' A' ' 26' ' ' SER . 68.4 t-105 -78.51 -45.52 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 3.6899999999999999 110.531 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 p -65.9 -19.72 65.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.978 -0.555 . . . . 1.5700000000000001 110.748 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.96 -12.74 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 1.95 110.743 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 72.7 p -69.64 -18.53 63.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 1.3799999999999999 111.01 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -49.56 -32.98 13.73 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.36 0.6 . . . . 4.0700000000000003 109.575 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -176.86 131.82 0.37 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.959 -1.018 . . . . 2.7200000000000002 110.096 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HB3' ' NE2' ' A' ' 34' ' ' GLN . 72.5 Cg_endo -95.54 177.41 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.007 2.471 . . . . 1.9099999999999999 112.224 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -99.36 63.8 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 4.7599999999999998 111.298 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -46.55 3.5 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.751 -0.737 . . . . 1.99 112.554 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.6 146.43 31.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.526 0.203 . . . . 2.7000000000000002 110.776 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.64 165.49 18.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.367 2.044 . . . . 1.79 112.399 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 29' ' ' PRO . 27.4 mm-40 -72.32 -15.86 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.412 -0.813 . . . . 4.1200000000000001 112.016 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -40.27 -38.98 0.86 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.334 0.494 . . . . 2.9300000000000002 112.334 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 37' ' ' TYR . 11.7 pt-20 -64.84 -46.9 79.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 2.8799999999999999 110.568 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 73.8 m-85 -70.49 -18.6 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 4.6600000000000001 110.488 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 41' ' ' MET . 54.3 tp -63.2 -49.28 74.86 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.219 -0.446 . . . . 1.45 110.321 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -63.5 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.174 0.511 . . . . 1.78 109.663 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 -5.01 40.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.588 -0.733 . . . . 0.63 110.475 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.475 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 22.0 ttt -88.25 -34.07 17.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.094 -0.503 . . . . 1.48 110.473 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.443 ' HA ' HD12 ' A' ' 45' ' ' ILE . 44.3 t80 -75.67 -31.4 59.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 3.5 110.883 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.704 HG23 HG23 ' A' ' 79' ' ' THR . 85.2 mt -52.54 -51.75 70.17 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.336 -0.393 . . . . 1.0800000000000001 111.597 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' C ' ' A' ' 41' ' ' MET . 73.5 Cg_endo -74.3 -32.21 6.76 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.408 2.072 . . . . 0.53000000000000003 112.804 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 42' ' ' PHE . 72.0 mt -53.67 -61.62 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.633 0.254 . . . . 1.6799999999999999 111.539 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.482 ' NE1' HG22 ' B' ' 110' ' ' ILE . 2.1 t90 -64.8 -51.42 62.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.688 0.28 . . . . 1.8300000000000001 111.064 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 44' ' ' PRO . 95.8 p -57.67 -14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.325 -0.398 . . . . 1.0900000000000001 111.196 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.77 -57.95 2.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.40999999999999998 112.491 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.78 -28.41 65.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.98999999999999999 111.032 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.36 -59.36 5.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.541 . . . . 0.47999999999999998 111.267 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 16.0 m-85 -59.47 -43.07 93.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 1.8700000000000001 111.126 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.9 ttp -48.24 -35.4 11.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.187 0.518 . . . . 1.49 110.216 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -67.99 -43.85 77.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.72 -0.673 . . . . 0.58999999999999997 110.648 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 56.1 mtt -52.12 -27.83 15.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.48999999999999999 110.244 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.11 -45.26 58.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.719 -0.673 . . . . 0.59999999999999998 110.622 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 53' ' ' ALA . 20.8 pt -84.18 11.15 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 1.3100000000000001 111.109 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 60.05 50.59 6.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.923 -0.58 . . . . 1.9099999999999999 111.675 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.02 158.25 30.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 1.6200000000000001 110.937 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.23 34.55 32.55 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.733 -0.746 . . . . 1.04 112.307 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -129.9 136.37 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.309 . . . . 2.6800000000000002 110.896 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.3 140.13 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 1.98 111.259 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.82 89.99 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 2.1800000000000002 111.034 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.74 126.11 42.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.332 -0.394 . . . . 1.5700000000000001 111.407 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 34.87 24.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 1.79 111.54 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.17 -0.31 59.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.823 -0.704 . . . . 1.48 112.835 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -98.35 134.27 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.673 0.273 . . . . 2.3199999999999998 110.771 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 mt -89.3 103.79 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 1.4399999999999999 110.942 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.38 135.52 38.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.81999999999999995 110.861 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 53.0 m-70 -82.65 73.71 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.186 0.517 . . . . 0.90000000000000002 110.723 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -58.92 -28.89 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.45 -0.795 . . . . 1.8300000000000001 111.458 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -82.04 -23.96 35.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.62 111.805 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 12.9 tpp180 -67.24 -51.27 55.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 2.3399999999999999 112.386 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 9.1 p90 -82.53 -32.5 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.275 0.472 . . . . 3.4900000000000002 112.275 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 71' ' ' ALA . 17.0 tt -55.23 -42.15 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 C-N-CA 120.713 -0.395 . . . . 1.3700000000000001 110.489 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.33 -22.81 64.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.445 -0.576 . . . . 1.3100000000000001 109.445 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -87.79 5.13 41.56 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.475 -0.784 . . . . 1.48 111.103 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.485 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.3 ttm -104.59 -18.18 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 1.46 110.494 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.415 ' O ' HD23 ' A' ' 82' ' ' LEU . 35.2 m -114.05 -35.29 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 1.1200000000000001 111.517 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.704 HG23 HG23 ' A' ' 43' ' ' ILE . 87.9 m -82.14 -49.0 10.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.246 -0.434 . . . . 1.1000000000000001 111.648 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.582 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.8 m -53.39 -49.92 85.65 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.199 -0.455 . . . . 0.59999999999999998 112.197 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.9 Cg_endo -58.88 -41.51 61.68 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.97 1.78 . . . . 0.73999999999999999 112.17 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -78.8 -7.97 58.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 1.01 110.894 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -81.42 -40.29 23.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.796 0.332 . . . . 1.48 110.283 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 109' ' ' GLN . 3.6 pp -81.62 -31.59 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.3799999999999999 110.223 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.54 -27.94 63.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 1.1899999999999999 110.319 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -63.69 -24.68 67.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 1.23 110.399 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.09 -52.53 18.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.88 110.739 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.2 t -60.21 -21.41 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 1.3899999999999999 110.838 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -76.4 -36.59 57.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 2.3199999999999998 111.052 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 p -80.92 -23.44 38.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 1.46 111.353 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 -37.14 17.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 1.24 111.21 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.9 ttt -97.74 99.42 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 2.0699999999999998 110.435 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -85.91 -48.8 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 3.5299999999999998 111.244 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -104.57 137.32 42.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 4.0800000000000001 111.067 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 pt -123.71 151.43 28.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 2.1699999999999999 110.843 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.12 -54.49 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 4.5199999999999996 110.558 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -150.12 -159.59 1.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 3.75 110.438 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 64.68 105.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.024 0.44 . . . . 3.5299999999999998 111.228 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -119.53 15.86 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.609 . . . . 4.9100000000000001 110.553 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.3 t -87.16 -21.25 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 1.98 110.834 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.47 -51.52 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 1.8300000000000001 110.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -59.19 -30.68 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 1.79 111.081 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.1 -27.19 64.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.62 112.542 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -73.43 -38.41 65.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 1.5800000000000001 110.972 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.3 mt -71.74 -32.54 67.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.97999999999999998 111.119 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.466 ' O ' HG12 ' A' ' 110' ' ' ILE . 61.1 mtt -74.23 -25.3 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 1.48 111.11 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -76.95 -49.44 15.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 1.1299999999999999 111.256 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.5 t -62.41 -35.43 79.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 1.48 111.949 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.591 ' HB3' HD21 ' A' ' 84' ' ' LEU . 13.8 pt20 -67.3 -42.05 84.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.567 0.223 . . . . 2.7000000000000002 111.465 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 106' ' ' MET . 33.1 mm -60.05 -33.45 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.827 0.346 . . . . 1.54 111.067 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.29 -44.6 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.28 111.458 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.64 -50.09 77.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.42999999999999999 111.864 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.412 HD12 ' HG3' ' A' ' 77' ' ' MET . 48.5 pt -57.2 -33.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.626 0.25 . . . . 1.74 111.437 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 85.4 m -63.67 -47.61 80.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.63 111.12 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -63.81 -21.76 66.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.163 -0.471 . . . . 1.0900000000000001 110.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.61 -46.44 7.32 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.937 -0.649 . . . . 0.41999999999999998 112.95 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -66.75 -29.13 69.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.52 0.2 . . . . 1.3799999999999999 111.53 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.1 tp -83.46 -28.4 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.551 -0.295 . . . . 1.6200000000000001 111.161 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.68 71.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.39000000000000001 110.803 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.08 -23.55 41.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 2.02 110.783 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.404 ' HB2' HD12 ' A' ' 118' ' ' ILE . 84.2 mt -83.59 23.72 0.93 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.76000000000000001 110.837 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.1 t -76.31 137.04 39.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 1.46 110.967 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.07 -34.54 8.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 3.3500000000000001 110.922 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.57 ' HB2' HG12 ' A' ' 127' ' ' VAL . 98.5 mtt180 -116.48 143.09 46.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 2.9199999999999999 110.982 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -74.68 -12.11 60.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 2.77 111.137 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -86.58 -39.53 16.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 3.77 111.072 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 124' ' ' ARG . 14.5 p -77.78 -24.23 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 1.1599999999999999 111.086 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -57.62 -29.28 64.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.005 -0.543 . . . . 2.04 110.754 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.03 -31.42 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 2.6400000000000001 110.964 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 127' ' ' VAL . 3.5 mm? -73.31 -42.28 62.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.067 -0.515 . . . . 1.8999999999999999 111.163 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -74.17 -31.65 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 1.3999999999999999 110.995 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.46 -56.96 15.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.28 110.654 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.8 tt -62.17 -29.4 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.233 -0.439 . . . . 2.1600000000000001 110.933 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.5 t -61.18 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 1.6899999999999999 111.197 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.26 -52.53 10.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.675 -0.774 . . . . 0.52000000000000002 112.535 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.21 -29.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 1.02 111.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 36.4 t -64.44 -42.43 96.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0800000000000001 110.747 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.05 93.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.62 110.925 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -76.73 -15.8 59.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 1.8400000000000001 111.02 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.67 -55.1 6.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.372 . . . . 1.6899999999999999 110.621 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.53 -34.92 63.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.81000000000000005 111.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 146' ' ' ILE . 39.8 mm -71.44 -44.12 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 2.3700000000000001 110.969 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.23 -56.06 24.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.97999999999999998 110.931 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -63.04 -21.89 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 3.27 111.097 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.74 -20.44 61.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 1.25 112.866 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 142' ' ' ILE . 70.3 mt -99.56 -12.68 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.458 . . . . 2.1200000000000001 110.783 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -69.0 -50.64 47.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 1.6599999999999999 111.577 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 99.989999999999995 112.143 -179.091 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 92.5 mt . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.791 0.329 . . . . 2.3399999999999999 110.675 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.64 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 2.77 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -38.85 68.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 2.04 110.921 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.07 -22.79 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.256 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 74.9 mt -73.99 -60.04 2.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.361 -0.381 . . . . 1.8899999999999999 111.135 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.0 t -55.84 -23.84 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.883 -0.598 . . . . 1.6399999999999999 111.45 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.9 m -56.18 -58.94 5.83 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.841 0.353 . . . . 1.24 111.262 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.43 -30.66 69.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 2.9700000000000002 110.805 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.81 -28.65 69.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 1.48 111.05 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.403 HG22 HD12 ' A' ' 177' ' ' ILE . 55.2 m -77.91 -56.64 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 1.55 111.283 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.62 -28.76 28.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.573 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.89 -57.77 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 1.8500000000000001 111.405 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.3 -27.29 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.62 110.885 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.529 ' O ' HG12 ' A' ' 181' ' ' ILE . 90.9 mt -87.73 -25.0 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.235 -0.439 . . . . 1.3500000000000001 110.3 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 181' ' ' ILE . . . -55.81 -55.9 26.61 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.872 -0.603 . . . . 0.58999999999999997 113.311 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.0 m-85 -53.33 -55.8 30.83 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.765 -0.374 . . . . 1.45 110.788 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.2 Cg_exo -45.45 -33.34 9.1 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.084 1.856 . . . . 0.55000000000000004 112.423 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.1 mm -59.39 -53.82 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 121.024 0.44 . . . . 1.4199999999999999 110.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.5 m -58.43 -24.23 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.78000000000000003 111.082 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -83.88 -16.45 44.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.93999999999999995 111.773 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 93.4 mt -50.7 -37.41 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.818 0.342 . . . . 1.4299999999999999 110.95 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 185' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.404 . . . . 2.02 111.333 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 86.1 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.687 0.279 . . . . 2.48 111.275 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.85 -56.12 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 2.1800000000000002 110.888 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.2 p -64.91 -31.67 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 1.49 110.969 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -61.47 -30.89 70.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.03 -0.532 . . . . 1.77 111.084 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.71 -52.45 15.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 1.4199999999999999 111.199 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.94 -6.42 41.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.572 -0.285 . . . . 1.78 111.373 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 29.1 t -96.24 -39.7 9.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 1.3 110.543 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.8 -40.99 65.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.622 -0.717 . . . . 0.66000000000000003 112.094 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -56.39 -54.74 49.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.149 -0.221 . . . . 1.6299999999999999 111.405 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.5 Cg_exo -55.76 -45.18 41.0 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.829 1.686 . . . . 0.64000000000000001 111.538 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.01 -24.62 66.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 1.3600000000000001 110.464 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -81.95 -21.86 36.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 1.54 110.693 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 1.2 111.112 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.803 0.335 . . . . 1.6399999999999999 111.295 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.69 -45.26 90.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.674 -0.774 . . . . 0.79000000000000004 112.916 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -69.72 -28.68 66.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.62 0.248 . . . . 1.6100000000000001 111.196 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -55.19 -62.06 1.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.432 -0.349 . . . . 1.1499999999999999 110.836 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -64.66 -29.34 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 3.3399999999999999 110.46 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.05 -45.98 91.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 1.1899999999999999 110.589 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.21 -35.08 79.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 2.23 110.517 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.065 -0.516 . . . . 2.4700000000000002 110.351 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -83.77 -25.91 30.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 1.6200000000000001 110.847 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -79.47 -24.39 60.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 1.4099999999999999 112.34 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 2.5800000000000001 110.747 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.457 ' N ' HD12 ' B' ' 6' ' ' LEU . 6.7 mp . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.747 0.308 . . . . 2.0699999999999998 110.824 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.413 HD13 ' HD1' ' B' ' 200' ' ' PHE . 57.4 mt -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 2.1000000000000001 111.004 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.642 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.0 m80 -80.01 -24.42 40.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 1.0700000000000001 110.505 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -73.66 -35.34 65.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 1.48 110.812 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 tt -80.73 -26.52 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 2.02 110.693 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' B' ' 15' ' ' MET . 41.8 t80 -62.09 -47.41 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.92000000000000004 110.271 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.43 -36.94 74.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.93999999999999995 111.084 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -36.11 79.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.55000000000000004 110.978 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.74 59.15 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.781 -0.723 . . . . 0.47999999999999998 112.311 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 23.1 mmt -72.73 -27.78 62.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 0.84999999999999998 110.785 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -64.88 -56.41 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 1.3400000000000001 110.88 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.4 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -61.28 -24.94 34.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.044 -0.525 . . . . 1.55 110.984 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.4 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -58.69 -57.72 18.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.636 -0.792 . . . . 0.69999999999999996 112.199 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.661 ' HA ' ' HG3' ' B' ' 41' ' ' MET . . . -62.85 -23.41 67.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.81000000000000005 110.788 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.95 -39.2 83.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 2.2599999999999998 110.571 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -61.41 -22.55 65.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.912 -0.586 . . . . 1.78 110.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' B' ' 34' ' ' GLN . 73.8 t80 -61.04 -40.55 94.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 4.5800000000000001 110.358 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.489 ' O ' ' OG ' ' B' ' 26' ' ' SER . 68.7 m95 -70.8 -41.45 71.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.795 -0.639 . . . . 3.3500000000000001 110.593 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -69.7 -20.81 63.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 1.5800000000000001 110.869 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.88 -15.84 35.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.47 . . . . 1.8400000000000001 110.713 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 67.0 p -67.2 -17.07 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 1.3700000000000001 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.33 -33.67 13.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.409 -0.589 . . . . 4.9800000000000004 109.409 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -177.68 131.63 0.33 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 114.997 -1.002 . . . . 2.1400000000000001 110.216 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -93.8 169.15 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.915 2.41 . . . . 1.8200000000000001 112.251 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -96.41 60.97 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.458 . . . . 5.1900000000000004 110.901 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.9 -46.67 3.66 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.791 -0.718 . . . . 2.2000000000000002 112.416 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . 7.4 p -88.14 131.65 42.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.473 0.177 . . . . 3.6499999999999999 110.631 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 35.4 Cg_exo -59.82 156.66 36.94 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.241 1.961 . . . . 2.6699999999999999 112.054 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLN . . . . . 0.407 ' HB3' ' CZ ' ' B' ' 22' ' ' PHE . 28.0 mm-40 -61.19 -17.72 54.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 4.8799999999999999 112.459 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' B' ' 38' ' ' LEU . 3.6 p90 -43.89 -36.51 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.787 0.327 . . . . 1.8700000000000001 111.567 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.64 -57.12 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 2.6800000000000002 110.664 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -66.77 -18.74 65.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 2.9199999999999999 110.637 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 45.4 tp -57.11 -55.6 32.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 1.6399999999999999 110.152 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.74 -42.9 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 1.6000000000000001 110.524 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.46 -12.44 52.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.68999999999999995 111.138 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.661 ' HG3' ' HA ' ' B' ' 19' ' ' ALA . 0.0 OUTLIER -88.6 -31.03 18.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.358 -0.383 . . . . 2.5800000000000001 111.289 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.49 ' HA ' HD12 ' B' ' 45' ' ' ILE . 36.9 m-85 -72.08 -27.62 62.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 3.3900000000000001 110.386 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.595 HG23 HG23 ' B' ' 79' ' ' THR . 65.3 mt -58.28 -53.94 60.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.085 -0.507 . . . . 0.40999999999999998 112.003 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' C ' ' B' ' 41' ' ' MET . 45.2 Cg_endo -67.75 -35.14 22.56 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.17 1.913 . . . . 0.48999999999999999 112.986 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' B' ' 42' ' ' PHE . 97.0 mt -53.78 -62.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.762 0.282 . . . . 1.29 111.762 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.552 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.7 t90 -61.3 -50.11 74.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.744 0.307 . . . . 1.3999999999999999 111.08 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 59.5 m -60.27 -14.02 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 1.3799999999999999 111.495 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.9 -55.71 3.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.714 -0.755 . . . . 0.37 112.709 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.442 HD22 ' SG ' ' C' ' 134' ' ' CYS . 24.0 mt -58.74 -32.08 68.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.857 0.361 . . . . 1.29 111.084 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.44 111.313 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 9.0 m-85 -60.7 -41.41 95.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.5 110.993 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -50.67 -32.36 18.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.135 0.493 . . . . 1.4099999999999999 110.1 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.7 -39.86 69.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.55000000000000004 110.504 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -54.97 -28.21 49.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.284 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -73.31 -49.51 27.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.737 -0.665 . . . . 0.54000000000000004 110.817 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.43 HG12 ' HA ' ' B' ' 53' ' ' ALA . 36.1 pt -79.52 8.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.471 . . . . 1.3 111.459 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.32 60.73 2.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.055 -0.52 . . . . 2.2400000000000002 111.31 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -143.86 139.99 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.907 0.384 . . . . 1.77 110.876 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.38 5.63 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.882 -0.675 . . . . 1.0600000000000001 112.101 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.62 150.22 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.664 0.268 . . . . 2.6600000000000001 110.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.99 148.0 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 1.8899999999999999 111.077 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.21 93.68 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 2.4100000000000001 110.838 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.32 125.18 50.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 111.279 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.49 30.61 18.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.989 -0.55 . . . . 1.8200000000000001 111.275 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.86 57.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.727 -0.749 . . . . 1.51 112.563 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -107.15 127.61 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.757 0.313 . . . . 2.4500000000000002 110.821 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 45.0 mm -77.37 105.27 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 1.79 111.088 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.8 134.52 37.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.81999999999999995 110.943 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.497 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 81.8 m-70 -79.83 76.18 6.52 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.132 0.492 . . . . 1.05 111.1 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -62.42 -28.0 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.485 -0.78 . . . . 1.8700000000000001 111.082 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -82.27 -28.0 32.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.299 0.481 . . . . 0.60999999999999999 112.299 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 29.2 mmt180 -66.56 -51.51 55.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.629 0.603 . . . . 2.3900000000000001 112.629 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' B' ' 77' ' ' MET . 18.5 p90 -82.89 -30.03 28.84 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.29 -0.564 . . . . 3.6699999999999999 112.497 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' B' ' 71' ' ' ALA . 15.2 tt -56.33 -42.15 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.291 -0.563 . . . . 1.6599999999999999 110.221 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' B' ' 74' ' ' ILE . 26.2 t70 -69.39 -22.25 63.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.996 -0.742 . . . . 1.4099999999999999 108.996 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -86.56 7.65 25.33 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.342 -0.844 . . . . 1.1599999999999999 111.034 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.471 ' HA ' HD13 ' B' ' 113' ' ' ILE . 22.0 mtp -104.73 -21.59 13.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 1.53 110.797 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 m -114.08 -28.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.89000000000000001 111.897 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.595 HG23 HG23 ' B' ' 43' ' ' ILE . 37.8 m -82.21 -52.45 6.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.266 -0.424 . . . . 1.24 112.093 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.578 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 16.9 m -52.4 -49.73 83.8 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.54 0.57 . . . . 0.57999999999999996 112.54 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' B' ' 80' ' ' THR . 12.4 Cg_endo -56.08 -45.52 37.71 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.781 1.654 . . . . 0.66000000000000003 112.262 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.64 -19.47 61.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 1.0600000000000001 110.797 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.32 -30.96 57.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 1.22 110.197 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.534 HD13 ' NE2' ' B' ' 109' ' ' GLN . 4.8 tt -84.69 -27.92 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.642 -0.708 . . . . 1.53 110.128 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.96 -33.84 39.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 1.5800000000000001 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -58.75 -28.08 65.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 1.3899999999999999 111.223 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.499 HD22 HD11 ' B' ' 168' ' ' LEU . 52.9 mt -73.36 -34.23 65.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.4 . . . . 1.1499999999999999 111.12 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.4 m -73.46 -27.04 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.418 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -76.73 -38.62 53.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.349 . . . . 2.1699999999999999 111.12 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -62.41 -41.55 98.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.376 -0.375 . . . . 1.4199999999999999 111.138 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.62 -47.49 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 1.1799999999999999 111.314 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 49.3 tpp -80.4 98.58 7.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 1.8799999999999999 110.784 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -87.8 -37.34 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 3.4199999999999999 110.926 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.31 143.19 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 4.0599999999999996 111.012 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.07 142.24 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 2.0899999999999999 110.579 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -123.96 -74.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 3.8500000000000001 111.159 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -156.03 108.46 2.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 4.8200000000000003 111.034 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.1 -73.62 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 110.66 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 81.8 m95 53.67 36.35 23.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 5.1699999999999999 111.323 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.5 t -120.58 -41.51 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 2.02 111.022 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 96.5 mt -74.31 -38.49 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.16 -0.473 . . . . 2.0899999999999999 110.959 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.5 tt -56.12 -33.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 1.8799999999999999 111.17 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.17 -29.89 36.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.728 -0.748 . . . . 0.56000000000000005 112.287 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.91 -24.51 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 1.78 110.835 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -78.54 -50.08 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 1.03 110.993 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' MET . . . . . 0.471 ' O ' HG13 ' B' ' 110' ' ' ILE . 24.6 ptm -60.49 -31.83 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 1.6699999999999999 111.043 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 42' ' ' PHE . 77.6 p -67.29 -51.96 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 1.51 111.6 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.465 ' HB ' HD13 ' B' ' 142' ' ' ILE . 71.3 p -57.92 -25.98 61.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 1.1799999999999999 111.741 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.534 ' NE2' HD13 ' B' ' 84' ' ' LEU . 18.6 mm-40 -78.31 -41.72 32.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 2.1699999999999999 111.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.482 HG22 ' NE1' ' A' ' 46' ' ' TRP . 93.4 mt -56.4 -38.1 54.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 1.3500000000000001 111.8 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.415 HG23 ' N ' ' B' ' 112' ' ' VAL . 29.7 m -72.57 -45.56 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.918 0.34 . . . . 1.3400000000000001 111.918 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.415 ' N ' HG23 ' B' ' 111' ' ' VAL . 84.2 t -60.12 -45.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.631 0.253 . . . . 0.42999999999999999 111.586 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' B' ' 77' ' ' MET . 66.3 mt -64.43 -34.75 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 1.6000000000000001 111.463 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.4 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.4 m -55.2 -61.0 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.85999999999999999 111.234 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.9 p -57.31 -27.44 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.94999999999999996 111.061 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.11 -49.14 59.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.46000000000000002 112.909 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.563 HD12 HG13 ' B' ' 118' ' ' ILE . 3.3 pp -74.21 -21.88 59.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.686 0.254 . . . . 1.75 111.686 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.563 HG13 HD12 ' B' ' 117' ' ' LEU . 82.5 mt -83.4 -33.17 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.687 0.28 . . . . 1.78 111.215 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.15 71.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.38 110.968 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.26 -25.22 46.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 1.97 111.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.78 31.24 0.7 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.405 -0.361 . . . . 0.76000000000000001 110.886 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -82.76 130.96 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.05 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -98.55 -42.98 7.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 2.5 110.673 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.47 ' HB2' HG12 ' B' ' 127' ' ' VAL . 91.4 mtt180 -98.18 146.36 25.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 2.73 110.285 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -80.37 -16.38 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.429 0.529 . . . . 2.2000000000000002 112.429 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.465 ' HE1' ' HD3' ' B' ' 124' ' ' ARG . 67.1 p-90 -93.33 -22.44 18.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.688 0.255 . . . . 3.3999999999999999 111.688 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.529 HG23 HD12 ' B' ' 130' ' ' LEU . 7.3 p -83.66 -23.33 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 1.23 110.945 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -57.76 -35.31 70.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 3.04 110.968 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -68.88 -22.15 64.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 4.1399999999999997 111.283 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.529 HD12 HG23 ' B' ' 127' ' ' VAL . 90.5 mt -76.75 -54.27 6.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 1.6499999999999999 111.141 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.96 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.483 -0.326 . . . . 0.77000000000000002 110.885 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -60.47 -50.06 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 1.46 110.595 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.6 mt -62.74 -30.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 1.6299999999999999 110.822 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 36.1 t -65.65 -41.01 93.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 1.4199999999999999 110.872 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.31 -54.1 39.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.908 -0.663 . . . . 0.48999999999999999 112.365 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 5.8 p -63.46 -39.0 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 1.3 111.067 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.7 t -52.34 -43.56 64.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.286 -0.416 . . . . 1.3 110.7 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.65 84.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.62 110.688 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -71.56 -23.56 61.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 1.74 110.992 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -73.33 -61.08 1.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.379 -0.373 . . . . 1.76 111.266 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.422 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.2 pt -51.88 -37.45 21.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.68999999999999995 111.453 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' B' ' 108' ' ' THR . 85.3 mt -73.45 -41.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 1.76 110.891 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 tp -56.97 -57.92 10.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 1.0600000000000001 110.885 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -62.62 -21.86 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 4.1200000000000001 110.643 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -20.78 59.57 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.85 -0.69 . . . . 1.26 112.989 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.9 pt -100.4 -5.62 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.864 0.332 . . . . 1.98 111.178 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.61 -42.99 17.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 1.4199999999999999 110.98 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 32.0 m120 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 99.989999999999995 111.828 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.862 0.363 . . . . 2.4300000000000002 110.884 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.04 -24.75 60.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 2.5800000000000001 111.12 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.1 -44.66 96.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 2.0 110.719 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -79.72 -21.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 3.0299999999999998 110.77 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.499 HD11 HD22 ' B' ' 87' ' ' LEU . 27.8 tp -68.17 -53.16 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 1.1000000000000001 110.817 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.35 -28.26 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 1.75 111.028 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.7 m -49.09 -57.97 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.97999999999999998 111.29 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.51 -28.83 67.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.279 -0.419 . . . . 4.2999999999999998 110.526 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -63.8 -30.62 71.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 1.3899999999999999 111.481 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 81.6 p -78.82 -59.05 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.595 -0.275 . . . . 1.1100000000000001 111.485 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.6 p -52.89 -29.91 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.526 -0.306 . . . . 1.51 111.645 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.97 -58.19 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 1.75 111.107 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.95 -25.95 61.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.59999999999999998 110.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.467 ' O ' HG13 ' B' ' 181' ' ' ILE . 80.4 mt -87.99 -27.59 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.061 -0.518 . . . . 1.47 110.269 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.95 -52.62 41.87 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.817 -0.629 . . . . 0.55000000000000004 113.124 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.643 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 94.4 m-85 -56.49 -58.05 19.4 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.927 -0.309 . . . . 1.6200000000000001 111.095 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 90.6 Cg_exo -42.68 -38.77 6.69 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.171 1.914 . . . . 0.64000000000000001 112.924 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.467 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.6 mt -58.5 -55.39 22.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.34 -0.391 . . . . 1.27 111.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.628 HG22 ' O ' ' B' ' 179' ' ' TYR . 1.9 m -55.17 -23.88 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.02 -0.536 . . . . 0.68999999999999995 111.497 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -80.88 -33.3 34.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.074 0.398 . . . . 1.1799999999999999 112.074 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 tt -88.29 25.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.443 . . . . 1.77 111.561 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 42.6 pt -134.69 -21.4 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.466 -0.334 . . . . 1.6899999999999999 111.533 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.262 0 C-N-CA 120.438 -0.887 . . . . 1.5800000000000001 112.834 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.871 0.367 . . . . 2.4700000000000002 111.188 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.39 -57.49 12.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 2.5299999999999998 110.864 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 199' ' ' THR . . . . . 0.413 ' HB ' HH21 ' B' ' 72' ' ' ARG . 53.3 p -64.77 -31.05 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 1.29 110.932 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 200' ' ' PHE . . . . . 0.413 ' HD1' HD13 ' B' ' 7' ' ' LEU . 68.1 t80 -60.98 -27.55 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 2.6200000000000001 110.635 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.47 -50.25 14.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 1.6100000000000001 110.886 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -73.14 -7.91 53.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 1.4199999999999999 111.317 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.33 -38.39 10.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 1.4299999999999999 110.862 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.5 tp -73.72 -40.98 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 1.1200000000000001 112.065 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.577 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 2.3 tt -56.27 -54.29 54.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 121.126 -0.23 . . . . 1.26 111.34 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -56.51 -43.9 50.96 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.822 1.682 . . . . 0.59999999999999998 111.373 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.518 ' O ' HG22 ' B' ' 211' ' ' VAL . 89.9 t80 -60.11 -32.74 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 1.3999999999999999 110.29 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -74.3 -19.26 60.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.825 -0.625 . . . . 1.4099999999999999 110.608 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.3200000000000001 111.032 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 207' ' ' PHE . 16.1 m . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.89 0.376 . . . . 1.6899999999999999 111.037 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.11 -46.65 93.83 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.899 -0.667 . . . . 0.79000000000000004 112.453 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -73.24 -22.7 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.618 0.247 . . . . 2.96 110.719 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 60.5 m -60.59 -58.02 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.402 -0.363 . . . . 1.29 110.517 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -67.57 -30.09 69.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 3.1499999999999999 110.26 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.23 -44.21 97.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.6 . . . . 1.51 110.367 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.19 -38.4 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 2.1899999999999999 110.589 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.47 -29.45 69.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.039 -0.528 . . . . 1.98 111.215 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -84.86 -42.18 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 2.1699999999999999 111.218 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.2 -39.4 81.19 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.857 -0.687 . . . . 1.3600000000000001 112.514 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 2.8999999999999999 111.015 -179.829 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.408 HD23 ' N ' ' C' ' 6' ' ' LEU . 2.7 pt? . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.72 0.295 . . . . 2.52 110.971 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 18.1 tp -60.88 -52.68 64.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 1.9299999999999999 110.669 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.654 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 33.1 m170 -61.55 -23.95 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 1.26 110.766 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -75.52 -42.08 53.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 1.6699999999999999 111.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.71 -22.28 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 1.8700000000000001 110.642 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -66.18 -48.32 71.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.533 . . . . 1.4399999999999999 110.31 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.73 -31.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.46999999999999997 110.565 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.81 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.58999999999999997 111.1 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.59 73.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.5 112.486 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -78.37 -33.76 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 0.68000000000000005 110.764 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 89.2 m -61.59 -51.77 67.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 1.3999999999999999 110.815 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' ILE . . . . . 0.407 ' O ' HD12 ' C' ' 17' ' ' ILE . 1.9 tp -60.19 -39.69 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.135 -0.484 . . . . 1.55 110.965 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.54 -57.6 6.5 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.675 -0.774 . . . . 0.70999999999999996 112.156 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.32 69.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.36 . . . . 0.77000000000000002 111.106 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.77 -27.53 66.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.515 . . . . 1.9299999999999999 111.26 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -60.34 -25.26 65.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 1.8600000000000001 110.72 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' C' ' 37' ' ' TYR . 37.4 m-85 -79.99 -22.97 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 4.1399999999999997 110.75 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' TRP . . . . . 0.657 ' O ' ' OG ' ' C' ' 26' ' ' SER . 70.9 t-105 -69.81 -35.8 75.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.566 -0.531 . . . . 3.1499999999999999 109.566 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 45.0 t -85.18 -33.21 22.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.544 -0.753 . . . . 1.95 110.468 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 tp -71.91 -20.72 61.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 2.2200000000000002 110.41 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 0.7 OUTLIER -57.2 -25.53 59.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.873 -0.603 . . . . 1.3700000000000001 110.514 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -44.82 -37.61 3.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.143 0.497 . . . . 5.0300000000000002 110.134 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 24.3 p-10 -172.59 132.08 0.67 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.409 -0.814 . . . . 2.3700000000000001 110.287 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 60.0 Cg_endo . . . . . 0 N--CA 1.451 -1.024 0 C-N-CA 123.016 2.478 . . . . 2.0499999999999998 112.05 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 25.4 Cg_exo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 121.06 0.358 . . . . 1.9299999999999999 112.192 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -61.79 -17.34 55.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 4.1200000000000001 112.482 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.431 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -42.16 -40.98 2.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.669 0.271 . . . . 2.8900000000000001 111.602 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -66.44 -43.61 85.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 2.46 110.575 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' C' ' 22' ' ' PHE . 98.6 m-85 -71.81 -19.13 62.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.868 -0.605 . . . . 2.7799999999999998 110.529 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' C' ' 41' ' ' MET . 30.9 tp -64.48 -48.87 73.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 1.6200000000000001 110.394 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.28 -40.38 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 1.5900000000000001 110.05 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.54 -6.81 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.65000000000000002 110.726 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.432 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 36.6 ttm -87.84 -36.01 17.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 1.6699999999999999 110.605 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' C' ' 45' ' ' ILE . 23.2 t80 -70.91 -35.53 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.858 -0.61 . . . . 3.4199999999999999 111.07 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.604 HG23 HG23 ' C' ' 79' ' ' THR . 88.5 mt -49.88 -54.49 31.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.169 0.433 . . . . 0.89000000000000001 112.169 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.4 Cg_endo -71.83 -32.83 10.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.182 1.921 . . . . 0.40999999999999998 113.164 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' C' ' 42' ' ' PHE . 69.1 mt -53.41 -62.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.853 0.316 . . . . 1.76 111.853 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -66.44 -45.91 78.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.76 0.314 . . . . 2.1600000000000001 111.074 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' SER . . . . . 0.418 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 45.8 t -61.85 -11.01 10.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 1.1699999999999999 111.266 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.52 -53.6 3.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.44 112.494 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 69.0 mt -59.22 -32.9 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.689 0.28 . . . . 1.29 110.92 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -58.28 9.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.5 111.324 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 13.4 m-85 -59.02 -45.0 91.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 1.8300000000000001 111.085 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 59.8 ttp -48.39 -30.58 5.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 1.47 110.355 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -46.13 59.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.763 -0.653 . . . . 0.59999999999999998 111.077 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 1.2 mpp? -55.52 -20.14 12.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.83999999999999997 110.824 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -78.54 -46.7 18.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.139 -0.482 . . . . 0.65000000000000002 110.293 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.75 11.01 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.844 -0.616 . . . . 1.55 111.014 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 62.6 60.45 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 1.54 111.211 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.434 ' OE1' HG11 ' A' ' 127' ' ' VAL . 16.2 mm100 -142.58 151.95 42.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.119 -0.492 . . . . 1.79 111.01 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.0 34.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.771 -0.728 . . . . 0.93999999999999995 112.574 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -133.7 135.56 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 2.3599999999999999 110.921 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.93 136.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 1.97 111.161 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.94 94.61 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 2.4399999999999999 110.841 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.12 134.8 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 1.54 110.907 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 30.73 19.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 1.71 111.024 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.93 -1.26 55.52 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 1.53 112.509 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -103.56 122.29 44.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 2.23 111.153 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.45 118.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.3600000000000001 110.947 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.4 133.65 51.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 0.78000000000000003 111.199 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 78.0 m-70 -83.93 75.92 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.075 0.464 . . . . 1.0800000000000001 110.876 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.99 -44.37 97.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.719 -0.673 . . . . 2.2999999999999998 111.323 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -66.45 -23.59 66.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.75 111.878 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 16.7 tpp180 -68.71 -51.61 39.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.302 0.482 . . . . 1.51 112.302 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' C' ' 117' ' ' LEU . 5.7 p90 -83.54 -33.13 25.55 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.068 0.396 . . . . 4.6500000000000004 112.068 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -55.85 -40.53 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 C-N-CA 120.715 -0.394 . . . . 1.22 110.583 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 26.9 t70 -68.38 -25.39 65.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.121 -0.696 . . . . 1.3100000000000001 109.121 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -86.66 9.77 17.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.453 -0.794 . . . . 1.6799999999999999 110.756 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.445 ' HA ' HG21 ' C' ' 113' ' ' ILE . 53.6 tpp -104.49 -23.27 13.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 1.8 110.011 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.4 ' O ' HD23 ' C' ' 82' ' ' LEU . 31.3 m -114.02 -30.05 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 1.1899999999999999 111.576 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.604 HG23 HG23 ' C' ' 43' ' ' ILE . 41.3 m -83.73 -44.78 14.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.448 -0.342 . . . . 1.23 111.62 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 55.8 m -56.21 -49.76 91.42 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.387 -0.37 . . . . 0.58999999999999997 111.875 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -56.47 -47.73 22.56 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.156 1.904 . . . . 0.67000000000000004 112.312 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.4 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.4 mm? -74.74 -11.2 60.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.95999999999999996 111.135 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.427 HD13 ' O ' ' C' ' 83' ' ' LEU . 0.7 OUTLIER -76.76 -47.15 22.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 1.1899999999999999 109.971 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' C' ' 109' ' ' GLN . 2.8 pp -78.99 -32.27 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 1.7 110.67 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.51 -37.33 77.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.676 -0.693 . . . . 1.6200000000000001 111.045 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.2 t -60.63 -19.52 58.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 1.26 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' C' ' 168' ' ' LEU . 71.2 mt -75.99 -34.71 59.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.081 -0.509 . . . . 1.1100000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 89.8 p -74.2 -26.09 60.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 1.51 111.102 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -75.07 -37.26 61.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.37 -0.377 . . . . 2.0600000000000001 110.83 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 72.4 p -67.96 -33.85 75.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.333 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.64 -47.66 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 1.3 111.261 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.8 mtp -86.16 100.33 12.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 1.6200000000000001 111.095 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -83.48 -42.61 16.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 3.2400000000000002 110.764 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -115.31 140.42 49.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.107 -0.497 . . . . 4.6299999999999999 111.119 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 68.1 mt -133.65 142.31 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 2.1800000000000002 110.787 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -120.43 -81.11 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 4.1200000000000001 111.205 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -143.81 97.61 3.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 4.96 111.023 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -172.85 79.66 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 3.9100000000000001 110.771 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.52 42.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 5.21 110.78 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 34.5 m -101.84 -40.54 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 1.8200000000000001 111.54 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.24 -36.72 77.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 2.0800000000000001 111.219 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.2 -41.72 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.8600000000000001 111.27 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.53 -33.52 60.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.838 -0.696 . . . . 0.58999999999999997 112.656 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.51 -52.68 64.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 1.53 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.47 -43.13 99.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 1.1100000000000001 111.357 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 106' ' ' MET . . . . . 0.41 ' O ' HG12 ' C' ' 110' ' ' ILE . 42.3 ttm -60.47 -32.81 71.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.526 . . . . 2.21 111.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 107' ' ' SER . . . . . 0.474 ' O ' HG23 ' C' ' 111' ' ' VAL . 47.2 t -78.87 -44.74 22.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.778 0.323 . . . . 1.28 111.451 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 77.6 p -64.87 -32.61 74.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 1.22 111.974 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.486 ' HB3' HD21 ' C' ' 84' ' ' LEU . 14.0 pt20 -71.32 -46.09 61.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.637 -0.256 . . . . 2.3300000000000001 111.502 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.552 HG22 ' HE1' ' B' ' 46' ' ' TRP . 35.8 mm -56.02 -34.87 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.679 0.276 . . . . 1.29 111.274 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.474 HG23 ' O ' ' C' ' 107' ' ' SER . 60.1 t -67.85 -47.69 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 1.0600000000000001 111.381 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.21 -48.9 86.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 111.608 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.445 HG21 ' HA ' ' C' ' 77' ' ' MET . 47.7 mt -59.89 -34.66 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.478 -0.328 . . . . 1.3700000000000001 111.207 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 32.0 m -58.63 -48.94 79.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.77000000000000002 111.116 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' SER . . . . . 0.4 ' HA ' HG22 ' C' ' 118' ' ' ILE . 77.8 p -67.79 -22.15 65.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.21 -0.45 . . . . 1.1899999999999999 110.92 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.04 -34.57 37.32 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.847 -0.692 . . . . 0.5 113.227 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.519 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.2 pp -81.09 -30.62 34.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.651 0.262 . . . . 1.47 111.549 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.519 ' N ' HD12 ' C' ' 117' ' ' LEU . 8.8 tp -81.03 -28.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.511 -0.313 . . . . 1.2 111.124 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -38.65 78.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.071 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.75 -17.23 48.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 2.1200000000000001 110.823 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.7 mt -91.49 26.99 2.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.15 -0.477 . . . . 0.75 111.063 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' SER . . . . . 0.434 ' HB3' ' HE ' ' C' ' 128' ' ' ARG . 44.6 t -83.22 142.76 30.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 1.3799999999999999 110.913 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.17 -41.64 5.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 2.7400000000000002 110.954 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' ARG . . . . . 0.481 ' HB2' HG12 ' C' ' 127' ' ' VAL . 0.0 OUTLIER -98.94 142.21 30.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 2.7999999999999998 110.625 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.07 -11.33 60.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 2.4100000000000001 111.521 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -91.04 -45.84 8.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 4.2000000000000002 111.023 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -67.2 -24.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 1.0800000000000001 111.272 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 128' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' C' ' 122' ' ' SER . 43.1 ttm180 -61.76 -31.52 71.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.337 -0.392 . . . . 2.5699999999999998 111.131 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.76 -20.02 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 3.8100000000000001 110.91 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.424 HD13 HG21 ' B' ' 56' ' ' ILE . 98.8 mt -78.46 -55.75 4.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.257 -0.429 . . . . 1.4199999999999999 111.174 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -60.79 -32.27 71.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.441 -0.345 . . . . 0.89000000000000001 110.989 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -56.55 -47.2 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 1.26 110.594 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.7 mm -67.88 -30.43 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.6799999999999999 110.953 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 134' ' ' CYS . . . . . 0.442 ' SG ' HD22 ' B' ' 49' ' ' LEU . 38.3 t -64.34 -41.0 96.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 1.24 110.868 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.3 -54.26 27.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.845 -0.693 . . . . 0.54000000000000004 112.757 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 136' ' ' VAL . . . . . 0.463 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -61.42 -35.58 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.784 0.326 . . . . 1.0600000000000001 111.221 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.26 -40.05 88.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.257 -0.429 . . . . 1.0800000000000001 111.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.11 79.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 111.022 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -76.3 -28.87 57.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 1.6799999999999999 110.883 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 94.4 mt -69.8 -46.71 65.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.41 -0.359 . . . . 1.7 111.478 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.425 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.6 pt -62.02 -41.67 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.78000000000000003 111.481 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.425 ' N ' HG13 ' C' ' 141' ' ' ILE . 49.0 pt -76.34 -27.07 17.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.484 -0.325 . . . . 2.2400000000000002 111.366 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.69 -49.68 65.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.348 -0.387 . . . . 1.02 110.823 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 144' ' ' TRP . . . . . 0.445 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 85.2 t90 -68.98 -25.69 64.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.246 -0.434 . . . . 3.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.48 -17.24 66.78 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.964 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.67 -13.74 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 1.8899999999999999 111.206 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -76.51 -45.74 29.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 1.6000000000000001 111.22 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 148' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' C' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.536 0.411 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 112.113 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.734 0.302 . . . . 2.3500000000000001 110.997 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.74 -27.7 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 2.6200000000000001 111.12 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.72 -39.63 85.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 2.0899999999999999 110.685 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -82.84 -20.86 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 3.2400000000000002 110.816 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' C' ' 87' ' ' LEU . 36.4 tp -70.77 -57.22 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 1.6899999999999999 111.135 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 169' ' ' VAL . . . . . 0.4 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 33.2 t -62.15 -20.92 25.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 1.3999999999999999 111.295 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 20.9 m -50.43 -58.05 6.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.95999999999999996 111.271 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 171' ' ' TYR . . . . . 0.509 ' O ' HD23 ' C' ' 175' ' ' LEU . 83.4 m-85 -74.64 -26.13 59.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.121 -0.49 . . . . 3.6499999999999999 110.583 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 172' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 90.6 t80 -59.47 -40.8 88.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 1.3700000000000001 111.286 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 4.1 t -77.21 -42.79 36.08 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.747 0.277 . . . . 1.4299999999999999 111.747 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.15 -40.53 77.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 1.6200000000000001 111.526 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.509 HD23 ' O ' ' C' ' 171' ' ' TYR . 4.5 mm? -73.05 -52.09 15.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.321 -0.399 . . . . 2.0299999999999998 111.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -29.59 61.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.84 0.353 . . . . 0.62 110.969 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.48 ' O ' HG13 ' C' ' 181' ' ' ILE . 38.9 mm -87.57 -23.88 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.511 . . . . 1.5800000000000001 110.249 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 178' ' ' GLY . . . . . 0.512 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.41 -50.59 61.61 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.909 -0.587 . . . . 0.56000000000000005 113.062 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.666 ' O ' HG22 ' C' ' 182' ' ' VAL . 69.4 m-85 -57.67 -55.51 44.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.904 0.352 . . . . 1.3300000000000001 111.205 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.7 Cg_exo -45.84 -29.68 6.02 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.063 1.842 . . . . 0.63 112.416 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.565 ' O ' HG22 ' C' ' 184' ' ' ILE . 83.2 mt -66.05 -57.58 9.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.932 0.396 . . . . 0.93000000000000005 111.484 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.666 HG22 ' O ' ' C' ' 179' ' ' TYR . 11.8 m -55.85 -23.87 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 1.27 111.633 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -73.35 -53.4 10.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.537 0.569 . . . . 1.77 112.537 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.565 HG22 ' O ' ' C' ' 181' ' ' ILE . 10.4 tp -55.21 -27.67 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.058 0.392 . . . . 2.3900000000000001 112.058 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 1.95 111.025 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.835 0.35 . . . . 2.3799999999999999 111.13 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.18 -37.74 74.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.269 -0.423 . . . . 2.23 110.936 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.68 -52.39 60.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 2.1600000000000001 110.3 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 46.1 p -70.47 -22.63 62.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.851 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.24 -27.22 65.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 1.7 110.865 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.99 -50.07 10.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 2.02 111.064 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.1 -10.18 56.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.8200000000000001 111.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 47.5 t -96.56 -40.17 9.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.3500000000000001 110.833 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.9 tp -71.72 -37.24 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 0.65000000000000002 112.164 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 46.4 tp -60.63 -53.84 60.51 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.031 -0.267 . . . . 1.4199999999999999 111.634 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.6 Cg_exo -57.25 -39.23 91.66 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.755 1.637 . . . . 0.63 111.426 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.35 -31.44 70.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 1.49 110.378 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -79.9 -22.78 42.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.7 110.534 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.515 . . . . 1.25 110.902 179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.827 0.346 . . . . 1.6100000000000001 111.058 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.68 57.62 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.81999999999999995 112.689 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -69.58 -22.71 63.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 3.0800000000000001 111.157 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 36.3 t -56.75 -62.31 1.82 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.424 . . . . 1.1499999999999999 110.703 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 215' ' ' PHE . . . . . 0.492 ' HA ' HD12 ' C' ' 218' ' ' LEU . 97.2 m-85 -67.97 -27.52 66.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 2.5600000000000001 110.793 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.09 -44.16 97.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.067 0.461 . . . . 1.29 110.113 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 217' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 11.4 t70 -65.67 -33.45 75.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.845 -0.616 . . . . 2.3900000000000001 110.601 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 218' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' C' ' 215' ' ' PHE . 84.4 mt -65.74 -32.97 74.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 2.0299999999999998 111.028 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -87.88 -20.93 25.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.914 0.388 . . . . 3.21 110.964 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.76 -26.53 62.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.841 -0.695 . . . . 1.3600000000000001 112.7 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 221' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 97.8 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 2.8999999999999999 111.186 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.781 0.324 . . . . 2.4199999999999999 110.594 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.02 -39.92 65.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 2.0899999999999999 110.524 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.532 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 34.5 m80 -76.7 -26.46 54.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 1.1599999999999999 110.121 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -70.75 -50.0 40.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.79000000000000004 110.658 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 pt -59.9 -31.77 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 121.146 0.498 . . . . 2.0800000000000001 109.971 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -55.87 -43.99 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.467 -0.788 . . . . 1.28 109.393 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 12' ' ' VAL . 2.5 t -57.39 -49.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.79 -1.096 . . . . 1.3200000000000001 111.071 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.45 -37.79 79.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.63 111.0 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.84 -38.45 95.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.55000000000000004 112.673 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.3 mmm -70.31 -40.01 74.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 1.03 110.902 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 m -56.64 -58.56 7.53 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.025 -0.534 . . . . 1.3 111.117 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.36 -23.77 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 1.3100000000000001 110.955 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.2 3.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 0.77000000000000002 112.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.792 0.33 . . . . 0.80000000000000004 111.006 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -57.1 -47.35 81.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 1.8100000000000001 110.932 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -63.21 -35.21 79.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 1.8799999999999999 110.785 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -69.94 -21.87 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.081 -0.508 . . . . 4.4500000000000002 110.831 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.595 ' O ' ' OG ' ' A' ' 26' ' ' SER . 83.6 t90 -75.53 -36.18 60.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 3.6899999999999999 110.892 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -68.34 -42.02 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.266 -0.425 . . . . 1.5700000000000001 110.974 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.04 -1.4 57.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 1.95 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.595 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 94.8 p -63.05 -16.29 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 1.3799999999999999 111.166 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -45.99 -40.2 10.12 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.266 -0.642 . . . . 4.0700000000000003 109.266 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -176.96 131.35 0.36 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.695 -1.138 . . . . 2.7200000000000002 109.381 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG2' ' H ' ' A' ' 32' ' ' VAL . 93.2 Cg_endo -91.98 -151.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.303 2.002 . . . . 1.9099999999999999 111.929 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -57.68 -13.69 4.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.097 0.475 . . . . 4.7599999999999998 110.711 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 33.52 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.985 -0.626 . . . . 1.99 111.996 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.5 ' HB ' ' HE2' ' A' ' 35' ' ' TYR . 12.9 m -128.63 156.36 77.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.578 0.228 . . . . 2.7000000000000002 111.013 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.0 166.35 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.536 2.157 . . . . 1.79 112.854 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -55.8 -17.42 6.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.9 . . . . 4.1200000000000001 112.168 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HE2' ' HB ' ' A' ' 32' ' ' VAL . 2.3 p90 -43.67 -33.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.656 0.265 . . . . 2.9300000000000002 111.314 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.51 -50.14 74.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.99 0.424 . . . . 2.8799999999999999 110.565 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -75.06 -19.55 59.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 4.6600000000000001 111.04 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' B' ' 100' ' ' THR . 38.6 tp -57.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 1.45 110.828 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.3 -37.86 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 1.78 111.045 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.69 -8.43 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.63 111.173 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.418 ' O ' HG12 ' A' ' 45' ' ' ILE . 14.9 tpt -89.41 -45.57 9.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 1.48 111.6 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -71.64 -42.81 67.14 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.552 0.575 . . . . 3.5 112.552 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 89.1 mt -48.37 -53.05 38.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.677 0.621 . . . . 1.0800000000000001 112.677 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.7 Cg_endo -72.62 -37.28 4.15 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.04 1.826 . . . . 0.53000000000000003 113.308 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 41' ' ' MET . 27.2 mm -59.33 -61.25 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.689 0.255 . . . . 1.6799999999999999 111.689 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.472 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.0 OUTLIER -56.99 -58.76 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.879 0.371 . . . . 1.8300000000000001 110.871 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 49.7 m -52.36 -31.59 34.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.831 -0.622 . . . . 1.0900000000000001 111.159 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.66 -59.86 10.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.40999999999999998 112.443 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 mt -61.14 -29.51 69.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.98999999999999999 110.926 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.81 -52.0 66.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.47999999999999998 111.253 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 42.3 m-85 -69.16 -23.21 63.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 1.8700000000000001 111.075 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -62.46 -39.22 92.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.49 109.761 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.55 72.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.452 -0.794 . . . . 0.58999999999999997 110.802 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.0 mtt -57.5 -26.93 62.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.48999999999999999 110.232 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.27 -50.41 22.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.59999999999999998 110.571 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.532 HG21 HG23 ' B' ' 127' ' ' VAL . 17.3 mt -74.41 -5.77 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.491 . . . . 1.3100000000000001 110.634 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.63 65.68 0.72 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.696 -0.684 . . . . 1.9099999999999999 111.106 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -130.56 148.01 52.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 1.6200000000000001 110.909 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 98.21 17.58 29.09 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.872 -0.68 . . . . 1.04 112.352 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -117.44 149.47 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.68 0.276 . . . . 2.6800000000000002 110.78 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.51 142.25 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.334 -0.394 . . . . 1.98 110.976 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -89.05 86.0 6.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 2.1800000000000002 111.086 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.04 116.57 29.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 1.5700000000000001 111.172 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.77 22.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.089 -0.505 . . . . 1.79 111.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.47 -15.01 48.37 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.672 -0.775 . . . . 1.48 112.656 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -98.34 147.56 24.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 2.3199999999999998 110.945 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.3 pt -87.97 139.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.535 . . . . 1.4399999999999999 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.37 138.77 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.81999999999999995 110.708 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 94.5 m-70 -90.8 57.43 3.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.105 0.478 . . . . 0.90000000000000002 111.173 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -64.44 -57.69 8.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 1.8300000000000001 111.176 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -54.74 -32.93 60.5 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.137 0.494 . . . . 0.62 110.644 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.411 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 5.1 tpp180 -57.17 -41.49 79.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.518 -0.764 . . . . 2.3399999999999999 110.593 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.454 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.3 OUTLIER -83.04 -14.0 54.74 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.005 0.372 . . . . 3.4900000000000002 112.005 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 71' ' ' ALA . 48.9 mt -63.4 -45.11 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.009 0.433 . . . . 1.3700000000000001 109.975 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 38.8 t70 -66.49 -11.53 52.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.811 -0.631 . . . . 1.3100000000000001 110.648 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.18 -21.03 26.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 1.48 111.066 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.561 ' HG2' ' HB ' ' A' ' 113' ' ' ILE . 28.6 mtp -90.7 -7.8 51.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.014 -0.539 . . . . 1.46 111.125 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.419 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.9 m -114.85 -32.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 1.1200000000000001 112.151 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.0 m -86.85 -53.09 5.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.936 0.347 . . . . 1.1000000000000001 111.936 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 34.5 m -50.24 -51.63 61.26 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.343 0.497 . . . . 0.59999999999999998 112.343 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 80' ' ' THR . 15.2 Cg_endo -56.74 -33.19 93.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.744 1.629 . . . . 0.73999999999999999 111.851 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.2 mm? -79.61 -26.42 41.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 1.01 110.439 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -69.04 -38.53 79.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 1.48 109.71 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.461 HD21 ' CB ' ' A' ' 105' ' ' LEU . 4.9 tt -77.42 -39.54 46.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.465 -0.789 . . . . 1.3799999999999999 110.439 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.501 HD21 ' SD ' ' A' ' 106' ' ' MET . 29.8 mt -59.45 -38.02 79.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.186 -0.461 . . . . 1.1899999999999999 110.871 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -56.23 -35.61 67.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 1.23 110.525 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.73 -31.42 72.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.557 . . . . 0.88 110.915 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -62.47 -55.4 27.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 1.3899999999999999 111.073 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -65.17 -21.74 66.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 2.3199999999999998 111.236 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -37.18 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 1.46 110.927 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.31 28.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.154 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 81.4 mtp -120.54 112.08 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 2.0699999999999998 110.732 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -68.09 -35.43 78.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 3.5299999999999998 111.299 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.19 143.42 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 4.0800000000000001 111.098 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -105.88 149.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 2.1699999999999999 110.962 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 97' ' ' LYS . 59.1 tttp -133.18 -62.24 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 4.5199999999999996 110.8 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 96' ' ' LYS . 13.2 mmmm -132.03 12.23 4.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 3.75 110.907 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.0 91.53 7.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 3.5299999999999998 111.124 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -128.14 -5.05 5.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 4.9100000000000001 110.781 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.3 p -94.0 -33.31 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 1.98 111.071 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.86 -42.43 97.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.8300000000000001 110.917 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 103' ' ' GLY . 33.5 pt -66.98 -41.15 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 1.79 111.294 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 102' ' ' ILE . . . -65.01 -27.65 72.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.789 -0.72 . . . . 0.62 112.472 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.78 -54.0 32.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 1.5800000000000001 110.97 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.461 ' CB ' HD21 ' A' ' 84' ' ' LEU . 62.6 mt -64.31 -39.46 93.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.97999999999999998 111.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.501 ' SD ' HD21 ' A' ' 85' ' ' LEU . 90.4 mtp -62.59 -46.4 88.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.48 111.238 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.6 m -56.22 -42.89 77.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.93 0.395 . . . . 1.1299999999999999 110.884 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.573 HG21 HG21 ' A' ' 142' ' ' ILE . 79.6 m -59.37 -34.24 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 1.48 111.281 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 24.2 mm-40 -72.63 -29.85 63.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.476 -0.329 . . . . 2.7000000000000002 111.49 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.567 HG22 ' HE1' ' C' ' 46' ' ' TRP . 56.9 mt -66.26 -40.06 85.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 1.54 111.753 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 108' ' ' THR . 34.1 m -72.44 -32.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.678 0.275 . . . . 1.28 111.283 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 108' ' ' THR . 93.2 t -72.98 -42.31 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.387 -0.37 . . . . 0.42999999999999999 111.679 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.561 ' HB ' ' HG2' ' A' ' 77' ' ' MET . 48.0 pt -67.24 -35.11 73.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.628 -0.26 . . . . 1.74 111.299 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.404 ' N ' HG13 ' A' ' 113' ' ' ILE . 54.0 m -58.55 -55.35 36.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.856 0.36 . . . . 0.63 110.482 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.6 m -62.13 -21.01 64.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 1.0900000000000001 110.411 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.46 -56.96 7.03 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.009 -0.615 . . . . 0.41999999999999998 112.793 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.557 HD12 HG13 ' A' ' 118' ' ' ILE . 2.5 pp -61.03 -22.22 64.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.61 0.243 . . . . 1.3799999999999999 111.104 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.557 HG13 HD12 ' A' ' 117' ' ' LEU . 67.8 mt -83.15 -31.81 9.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 1.6200000000000001 110.875 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.61 61.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.091 -0.504 . . . . 0.39000000000000001 111.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.37 -22.06 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 2.02 110.934 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.5 15.35 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.76000000000000001 110.951 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.486 ' HB2' ' HE ' ' A' ' 128' ' ' ARG . 50.1 m -82.27 122.97 28.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.46 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.66 -41.21 9.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 3.3500000000000001 110.856 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.544 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.8 mtp180 -92.03 134.25 34.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.505 . . . . 2.9199999999999999 110.706 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.76 -9.11 57.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 2.77 111.018 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -87.85 -42.29 12.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 3.77 110.852 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.3 p -74.79 -26.14 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 1.1599999999999999 111.101 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.486 ' HE ' ' HB2' ' A' ' 122' ' ' SER . 40.5 ttm180 -67.52 -31.15 71.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.24 -0.437 . . . . 2.04 111.007 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -63.68 -34.39 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 2.6400000000000001 111.221 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.568 HD23 HG21 ' C' ' 56' ' ' ILE . 52.6 tp -81.75 -44.25 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 1.8999999999999999 111.242 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.48 ' HE1' ' HG2' ' C' ' 58' ' ' GLN . 4.5 m95 -56.31 -33.73 65.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.327 . . . . 1.3999999999999999 111.2 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.42 -55.84 18.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.48 . . . . 1.28 111.259 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 130' ' ' LEU . 19.4 tt -63.3 -25.27 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.788 0.328 . . . . 2.1600000000000001 111.137 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 88.4 m -63.78 -42.27 97.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 1.6899999999999999 110.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.03 -53.96 27.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.52000000000000002 112.578 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 35.1 m -59.93 -34.14 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 1.02 111.38 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.403 ' HA ' HD12 ' A' ' 140' ' ' LEU . 47.8 t -60.16 -43.78 95.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 1.0800000000000001 111.096 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.62 79.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.62 111.364 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.77 -27.77 61.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 1.8400000000000001 111.05 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.1 mt -66.09 -49.6 67.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.409 -0.36 . . . . 1.6899999999999999 111.636 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 142' ' ' ILE . 23.9 pt -62.34 -43.5 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.81000000000000005 111.815 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.573 HG21 HG21 ' A' ' 108' ' ' THR . 46.5 mm -71.86 -33.69 48.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.625 -0.261 . . . . 2.3700000000000001 111.409 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.4 -42.31 82.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.97999999999999998 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.595 ' O ' ' OD1' ' A' ' 148' ' ' ASN . 84.9 t90 -74.27 -29.76 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 3.27 110.641 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.95 75.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.892 -0.671 . . . . 1.25 112.815 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.24 -19.38 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.847 0.356 . . . . 2.1200000000000001 111.212 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -80.86 1.93 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 1.6599999999999999 111.419 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.595 ' OD1' ' O ' ' A' ' 144' ' ' TRP . 32.0 m120 . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 120.91 -0.316 . . . . 99.989999999999995 111.519 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.948 0.404 . . . . 2.3399999999999999 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' A' ' 168' ' ' LEU . 0.6 OUTLIER -74.4 -22.63 59.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.941 -0.572 . . . . 2.77 111.333 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.5 -50.86 71.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 2.04 110.823 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.08 -20.67 48.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 2.77 110.744 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 165' ' ' TYR . 0.2 OUTLIER -66.69 -56.27 11.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 1.8899999999999999 110.801 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.14 -24.36 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 1.6399999999999999 111.234 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.0 -58.68 6.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.403 . . . . 1.24 111.127 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.65 -23.99 66.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 2.9700000000000002 110.316 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -69.82 -32.83 71.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 1.48 111.277 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.6 p -76.41 -51.06 12.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.336 -0.393 . . . . 1.55 111.531 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.98 -29.0 40.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.467 -0.333 . . . . 1.52 111.609 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 62.5 tp -80.08 -57.37 3.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.375 -0.375 . . . . 1.8500000000000001 110.914 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -29.17 58.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.62 110.8 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 181' ' ' ILE . 33.0 mm -87.75 -24.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 1.3500000000000001 110.548 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.91 -50.87 58.97 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.844 -0.616 . . . . 0.58999999999999997 113.22 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.613 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 95.6 m-85 -59.76 -55.65 43.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.779 0.289 . . . . 1.45 111.46 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.4 Cg_exo -45.56 -29.84 5.48 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.278 1.985 . . . . 0.55000000000000004 112.92 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 177' ' ' ILE . 90.0 mt -69.11 -59.66 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 1.4199999999999999 111.297 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 179' ' ' TYR . 27.1 m -61.16 -25.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.78000000000000003 111.644 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -62.97 -23.56 67.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.344 . . . . 0.93999999999999995 110.929 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.76 -64.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 1.4299999999999999 110.966 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 50.6 pt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 2.02 111.097 -179.874 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.79 0.328 . . . . 2.48 111.507 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.43 -43.73 93.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 2.1800000000000002 111.032 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 13.7 m -75.02 -23.15 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 1.49 111.007 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -72.51 -31.85 65.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 1.77 111.169 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 67.1 tp -83.38 -32.25 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 1.4199999999999999 111.315 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -75.4 -19.02 59.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 1.78 111.003 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 206' ' ' PRO . 27.4 p -96.34 -31.53 12.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.054 0.454 . . . . 1.3 110.763 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.3 tp -72.64 -32.83 66.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.66000000000000003 111.297 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.527 ' N ' ' HD2' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -63.08 -54.26 47.55 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.536 -0.302 . . . . 1.6299999999999999 111.471 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 205' ' ' LEU . 14.9 Cg_endo -56.5 -44.22 47.83 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.127 1.884 . . . . 0.64000000000000001 111.825 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -66.24 -29.11 69.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 1.3600000000000001 110.252 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 1.54 110.325 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 1.2 110.727 179.665 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.661 0.267 . . . . 1.6399999999999999 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.64 87.63 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.686 -0.769 . . . . 0.79000000000000004 112.386 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.29 -35.2 80.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.731 0.301 . . . . 1.6100000000000001 110.99 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.4 m -60.96 -57.74 11.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 1.1499999999999999 110.748 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -64.75 -20.05 66.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 3.3399999999999999 110.898 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.8 -43.0 38.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 1.1899999999999999 111.32 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.54 -30.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 2.23 111.358 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.22 -58.91 3.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 2.4700000000000002 111.349 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -69.46 -21.72 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 1.6200000000000001 111.091 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.55 -18.89 64.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.864 -0.684 . . . . 1.4099999999999999 112.569 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 56.4 tp . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.279 . . . . 2.5800000000000001 110.985 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.903 0.382 . . . . 2.0699999999999998 110.81 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.12 -57.61 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.871 -0.604 . . . . 2.1000000000000001 111.284 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 35.9 m170 -61.24 -25.23 66.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 1.0700000000000001 110.894 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.404 ' O ' HG12 ' B' ' 12' ' ' VAL . 59.0 t-105 -69.75 -39.92 76.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.48 110.578 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -24.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.127 0.489 . . . . 2.02 110.164 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' B' ' 207' ' ' PHE . 5.5 t80 -61.14 -55.76 28.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.92000000000000004 110.619 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.404 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -58.72 -36.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.245 -0.434 . . . . 0.93999999999999995 110.673 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.41 75.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.55000000000000004 110.813 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.34 -29.3 64.37 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.47999999999999998 111.991 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.35 -32.85 58.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.84999999999999998 110.784 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -63.32 -54.35 38.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 1.3400000000000001 110.454 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.03 -24.1 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 1.55 110.728 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.49 -62.05 6.78 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.764 -0.731 . . . . 0.69999999999999996 112.099 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -34.71 65.39 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.926 0.393 . . . . 0.81000000000000005 110.836 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.39 -44.03 84.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.6 . . . . 2.2599999999999998 110.558 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -65.52 -39.37 91.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 1.78 110.839 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -73.24 -6.32 45.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 4.5800000000000001 110.616 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.445 ' O ' ' OG ' ' B' ' 26' ' ' SER . 65.0 t90 -89.11 -35.78 16.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 3.3500000000000001 110.624 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -70.72 -44.64 66.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 110.865 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.24 -2.81 53.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 1.8400000000000001 110.701 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 92.8 p -58.3 -15.02 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.525 . . . . 1.3700000000000001 111.186 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -48.81 -40.07 27.75 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.692 -0.484 . . . . 4.9800000000000004 109.692 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.6 p-10 179.16 130.8 0.23 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.421 -0.808 . . . . 2.1400000000000001 110.559 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' B' ' 33' ' ' PRO . 71.8 Cg_endo -102.95 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.646 2.897 . . . . 1.8200000000000001 111.967 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' B' ' 30' ' ' ARG . 4.2 mmp_? -106.23 11.22 31.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.453 0.644 . . . . 5.1900000000000004 109.685 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.68 -53.68 0.76 Allowed Glycine 0 CA--C 1.519 0.303 0 CA-C-N 114.857 -1.065 . . . . 2.2000000000000002 112.16 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.65 104.87 5.38 Favored Pre-proline 0 CA--C 1.518 -0.275 0 CA-C-N 117.486 0.643 . . . . 3.6499999999999999 111.69 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.573 ' HB3' ' HG3' ' B' ' 29' ' ' PRO . 83.2 Cg_endo -89.3 107.98 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.773 0.982 . . . . 2.6699999999999999 113.602 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -92.74 -61.13 1.65 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.804 1.764 . . . . 4.8799999999999999 107.735 174.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -39.85 18.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 110.317 -3.129 . . . . 1.8700000000000001 113.148 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -38.3 -64.6 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.638 0.977 . . . . 2.6800000000000002 113.638 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.43 ' CZ ' ' HA ' ' B' ' 26' ' ' SER . 75.0 m-85 -82.69 -18.28 41.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.102 0.408 . . . . 2.9199999999999999 112.102 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 tp -59.3 -65.12 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.867 0.365 . . . . 1.6399999999999999 110.781 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 m -69.25 -37.82 76.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 1.6000000000000001 111.472 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 -12.09 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.52 -0.309 . . . . 0.68999999999999995 111.154 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 45.3 tpp -89.09 -48.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 2.5800000000000001 111.665 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -65.86 -48.95 69.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.849 0.685 . . . . 3.3900000000000001 112.849 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 79.5 mt -45.36 -53.61 17.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.29 0.848 . . . . 0.40999999999999998 113.29 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -71.48 -38.61 4.38 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.228 1.952 . . . . 0.48999999999999999 113.611 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -59.54 -61.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.852 0.315 . . . . 1.29 111.852 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.507 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.1 OUTLIER -58.26 -58.92 6.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 1.3999999999999999 111.314 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.431 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 47.9 t -55.05 -26.24 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 1.3799999999999999 111.025 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.58 -67.57 2.08 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.754 -0.736 . . . . 0.37 112.739 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.09 -24.32 58.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.646 0.26 . . . . 1.29 111.385 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.66 -59.15 5.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.44 111.182 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.8 m-85 -61.76 -35.8 79.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.5 110.95 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 57.6 ttp -51.5 -35.31 39.68 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.072 0.463 . . . . 1.4099999999999999 110.08 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.61 -39.44 70.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.55000000000000004 110.537 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -57.11 -21.12 29.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.5 110.567 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -82.63 -46.18 13.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.046 -0.525 . . . . 0.54000000000000004 111.105 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' B' ' 53' ' ' ALA . 27.0 pt -75.26 -0.05 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 1.3 111.299 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.93 65.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.939 -0.573 . . . . 2.2400000000000002 110.904 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -146.79 114.27 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 1.77 110.846 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' B' ' 70' ' ' TYR . . . 136.23 -1.33 3.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 1.0600000000000001 112.532 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -108.58 151.54 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 2.6600000000000001 111.018 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.26 145.67 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 1.8899999999999999 111.1 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.32 87.95 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 2.4100000000000001 111.143 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.28 118.08 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 1.5600000000000001 110.85 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.86 31.49 20.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 1.8200000000000001 111.13 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.14 0.56 86.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.646 -0.787 . . . . 1.51 112.548 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -101.02 147.19 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 2.4500000000000002 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.3 mt -92.74 121.86 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 1.79 110.81 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.482 ' HB1' HD23 ' B' ' 121' ' ' LEU . . . -99.12 140.07 33.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.81999999999999995 111.276 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.601 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.7 m-70 -82.99 58.29 4.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 1.05 110.879 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.441 ' O ' HG13 ' B' ' 74' ' ' ILE . 65.5 t80 -62.89 -55.75 23.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.506 -0.77 . . . . 1.8700000000000001 111.351 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' B' ' 74' ' ' ILE . . . -63.2 -24.0 67.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.068 0.396 . . . . 0.60999999999999999 112.068 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 58.7 mmt-85 -64.69 -52.46 57.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.231 0.456 . . . . 2.3900000000000001 112.231 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.494 ' CE1' ' HG ' ' B' ' 117' ' ' LEU . 2.1 p90 -64.29 -32.12 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.607 -0.437 . . . . 3.6699999999999999 110.476 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' B' ' 71' ' ' ALA . 57.7 mt -50.44 -53.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 116.125 -0.489 . . . . 1.6599999999999999 110.992 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 24.7 t70 -66.56 -22.76 66.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.196 -0.456 . . . . 1.4099999999999999 110.311 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -89.77 5.1 47.54 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.105 -0.498 . . . . 1.1599999999999999 111.034 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.49 ' HA ' HD13 ' B' ' 113' ' ' ILE . 51.9 ttm -104.89 -18.44 14.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 1.53 110.592 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' B' ' 46' ' ' TRP . 28.1 m -114.46 -33.81 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.087 -0.506 . . . . 0.89000000000000001 112.106 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -79.33 -48.5 13.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.157 0.428 . . . . 1.24 112.157 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 5.6 m -55.6 -50.71 85.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.443 -0.344 . . . . 0.57999999999999996 111.781 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 47.2 Cg_exo -55.54 -33.48 86.68 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.945 1.763 . . . . 0.66000000000000003 111.969 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' B' ' 85' ' ' LEU . 83.8 mt -78.55 -26.47 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 1.0600000000000001 110.868 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.58 -39.17 84.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.847 0.356 . . . . 1.22 110.281 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.8 pp -82.07 -25.96 34.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.976 -0.556 . . . . 1.53 110.323 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.446 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.1 mt -68.62 -34.05 75.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 1.5800000000000001 109.804 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -58.78 -34.84 71.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 1.3899999999999999 110.423 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.05 -29.33 65.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 1.1499999999999999 110.88 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 56.4 m -63.57 -40.05 95.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 1.5700000000000001 110.937 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -82.51 -16.24 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 2.1699999999999999 111.033 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 89.8 m -68.08 -42.92 79.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 1.4199999999999999 111.268 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.77 -33.21 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 1.1799999999999999 111.376 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.5 mtm -118.04 110.23 17.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 1.8799999999999999 110.829 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -76.44 -30.38 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 3.4199999999999999 111.248 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -133.54 140.78 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 4.0599999999999996 110.767 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -107.7 142.03 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 2.0899999999999999 111.14 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -127.0 -50.62 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.152 -0.477 . . . . 3.8500000000000001 110.854 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -137.28 -17.21 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 4.8200000000000003 110.911 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -65.52 113.26 4.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 3.7999999999999998 111.223 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -149.21 -23.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.999 -0.546 . . . . 5.1699999999999999 110.497 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.407 ' HB ' HD22 ' A' ' 38' ' ' LEU . 61.8 p -76.35 -34.92 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 2.02 110.778 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.87 -46.91 82.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.502 . . . . 2.0899999999999999 110.592 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.24 -37.17 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.8799999999999999 110.88 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.29 -18.26 79.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 0.56000000000000005 112.409 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -72.85 -45.02 60.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.78 110.755 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.38 -30.41 63.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 1.03 110.945 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' MET . . . . . 0.416 ' O ' HG13 ' B' ' 110' ' ' ILE . 89.5 mtp -69.7 -48.69 58.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 1.6699999999999999 111.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -57.61 -45.32 85.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.364 -0.38 . . . . 1.51 111.077 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.615 ' HB ' HD13 ' B' ' 142' ' ' ILE . 57.8 p -59.14 -33.12 70.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 1.1799999999999999 111.128 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.448 ' O ' HG13 ' B' ' 113' ' ' ILE . 56.8 tp60 -71.17 -36.78 72.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.356 -0.384 . . . . 2.1699999999999999 110.987 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.472 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.6 mt -56.8 -43.32 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 1.3500000000000001 111.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.539 HG22 ' O ' ' B' ' 108' ' ' THR . 18.2 m -70.93 -30.59 42.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 1.3400000000000001 111.347 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 108' ' ' THR . 88.9 t -72.64 -27.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.482 -0.327 . . . . 0.42999999999999999 111.256 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' B' ' 77' ' ' MET . 69.8 mt -80.2 -43.15 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.631 -0.259 . . . . 1.6000000000000001 111.213 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.412 HG22 ' O ' ' B' ' 111' ' ' VAL . 9.7 t -58.92 -29.92 67.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.955 0.407 . . . . 0.85999999999999999 110.176 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -69.15 -50.52 47.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.897 -0.592 . . . . 0.94999999999999996 109.833 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.54 -10.1 66.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.9 -0.667 . . . . 0.46000000000000002 111.51 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.494 ' HG ' ' CE1' ' B' ' 73' ' ' TYR . 4.4 tt -70.43 -56.78 5.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.506 . . . . 1.75 110.346 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.48 -20.62 9.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.647 -0.706 . . . . 1.78 111.546 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.83 -39.41 11.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.38 111.331 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.03 -23.93 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.97 110.842 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.482 HD23 ' HB1' ' B' ' 68' ' ' ALA . 87.8 mt -87.96 29.57 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.76000000000000001 111.15 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -93.91 122.92 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.411 . . . . 1.47 110.735 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.53 -52.52 4.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 2.5 111.263 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.9 ttm180 -77.42 123.71 26.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 2.73 110.809 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.73 -14.24 50.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.144 -0.48 . . . . 2.2000000000000002 111.132 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.584 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 66.1 t-105 -74.53 -56.12 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 3.3999999999999999 110.56 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' B' ' 124' ' ' ARG . 7.7 p -65.15 -27.95 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 1.23 111.059 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -55.07 -26.93 41.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.725 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.54 -34.99 40.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 4.1399999999999997 110.922 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.419 HD22 ' N ' ' B' ' 130' ' ' LEU . 3.8 mm? -72.31 -49.33 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 1.6499999999999999 111.135 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -62.47 -31.9 72.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.77000000000000002 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.464 ' HE1' ' HB3' ' B' ' 183' ' ' TRP . 66.5 t80 -63.34 -55.47 24.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 1.46 110.984 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 tt -68.34 -23.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.027 0.441 . . . . 1.6299999999999999 110.865 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.8 -41.67 91.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 1.4199999999999999 111.276 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.82 -50.49 35.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.48999999999999999 112.799 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 26.9 m -61.31 -38.31 79.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.576 0.227 . . . . 1.3 111.489 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -58.31 -45.29 88.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 1.3 111.331 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.57 77.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.62 111.153 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -69.71 -22.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 1.74 111.361 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 80.5 mt -66.98 -60.61 2.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.703 -0.226 . . . . 1.76 111.278 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 31.0 pt -56.08 -36.33 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.68999999999999995 111.408 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.615 HD13 ' HB ' ' B' ' 108' ' ' THR . 74.5 mt -69.78 -42.63 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 1.76 111.152 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.17 -47.47 81.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0600000000000001 111.069 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -66.59 -25.91 66.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 4.1200000000000001 110.964 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.65 -21.29 58.28 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.9 -0.667 . . . . 1.26 113.229 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.1 pt -98.94 -6.58 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 1.98 111.717 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -87.59 -2.3 58.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 1.4199999999999999 111.388 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 32.1 m120 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.297 -0.41 . . . . 99.989999999999995 111.855 -179.545 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.8 0.333 . . . . 2.4300000000000002 110.962 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.67 -22.38 50.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.534 . . . . 2.5800000000000001 110.885 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.71 -47.35 84.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 2.0 111.164 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.19 -21.0 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 3.0299999999999998 110.633 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.2 -49.57 55.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.141 -0.481 . . . . 1.1000000000000001 110.699 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.33 -23.63 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.75 111.006 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.82 -59.04 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.295 -0.411 . . . . 0.97999999999999998 110.982 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.91 -29.15 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 4.2999999999999998 110.069 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.98 -21.56 64.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.601 -0.727 . . . . 1.3899999999999999 110.843 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 46.6 m -79.14 -58.3 3.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 1.1100000000000001 111.539 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.08 -29.78 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 1.51 111.686 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 44.9 tp -76.39 -58.55 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.474 -0.33 . . . . 1.75 111.562 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -28.89 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.33 -0.395 . . . . 0.59999999999999998 110.854 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.432 ' O ' HG12 ' B' ' 181' ' ' ILE . 42.9 mm -87.93 -24.07 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 1.47 110.482 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.92 48.5 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.55000000000000004 113.228 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.613 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 83.1 m-85 -56.8 -55.78 39.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.912 0.356 . . . . 1.6200000000000001 111.521 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.1 Cg_exo -44.89 -33.32 7.28 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.455 2.103 . . . . 0.64000000000000001 112.84 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.0 mm -66.49 -59.58 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 1.27 111.644 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.09 -28.28 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.68999999999999995 111.831 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' TRP . . . . . 0.464 ' HB3' ' HE1' ' B' ' 132' ' ' TYR . 38.2 m95 -60.07 -24.22 64.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.59 -0.277 . . . . 1.1799999999999999 111.174 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 89.2 mt -55.63 -61.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.715 0.293 . . . . 1.77 111.179 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 41.2 pt -82.81 165.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 1.6899999999999999 111.267 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.336 0 C-N-CA 120.891 -0.671 . . . . 1.5800000000000001 112.608 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.831 0.348 . . . . 2.4700000000000002 110.763 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 2.5299999999999998 110.451 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -62.91 -28.06 69.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.762 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -66.17 -36.12 82.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 2.6200000000000001 110.977 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.69 -47.81 51.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 1.6100000000000001 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -71.38 -6.21 38.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 1.4199999999999999 111.154 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HD2' ' B' ' 206' ' ' PRO . 47.3 t -96.34 -46.13 6.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.204 0.526 . . . . 1.4299999999999999 110.599 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.1 tp -72.25 -26.01 61.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 1.1200000000000001 111.578 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.671 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 62.2 tp -66.0 -54.48 27.12 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.931 -0.308 . . . . 1.26 111.123 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.5 Cg_exo -55.83 -42.52 66.29 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.697 1.598 . . . . 0.59999999999999998 111.388 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.429 ' HB2' ' CE1' ' B' ' 11' ' ' TYR . 89.4 t80 -63.93 -39.19 93.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 1.3999999999999999 110.456 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.2 -34.31 78.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 1.4099999999999999 111.089 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.317 -0.401 . . . . 1.3200000000000001 110.994 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.209 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.63 63.25 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.823 -0.703 . . . . 0.79000000000000004 112.563 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -66.4 -38.47 87.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 2.96 110.859 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.8 m -60.64 -56.39 21.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 1.29 110.733 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -63.94 -20.12 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 3.1499999999999999 110.683 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.435 ' C ' HD13 ' B' ' 216' ' ' LEU . 3.2 tm? -71.63 -58.18 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 1.51 111.104 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -58.73 -23.89 60.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.375 . . . . 2.1899999999999999 111.209 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.3 tp -68.76 -54.59 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 1.98 111.338 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -77.59 -20.36 54.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.285 -0.416 . . . . 2.1699999999999999 111.311 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.36 67.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.913 -0.66 . . . . 1.3600000000000001 113.102 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 52.7 tp . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.598 0.237 . . . . 2.8999999999999999 111.125 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.789 0.328 . . . . 2.52 110.782 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.31 -41.79 98.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 1.9299999999999999 110.498 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 46.2 m80 -74.1 -23.84 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 1.26 110.389 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.431 ' O ' HG12 ' C' ' 12' ' ' VAL . 64.4 t-105 -72.61 -44.49 61.9 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.914 -0.585 . . . . 1.6699999999999999 110.732 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.45 -23.34 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.183 0.516 . . . . 1.8700000000000001 109.911 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -60.79 -57.35 13.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 1.4399999999999999 110.581 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.431 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.2 p -59.04 -31.42 45.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.31 -0.404 . . . . 0.46999999999999997 110.805 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.16 -33.21 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.58999999999999997 110.449 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.82 -28.67 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.5 112.008 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.4 mmt -75.7 -34.63 60.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.634 0.254 . . . . 0.68000000000000005 111.232 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -63.1 -53.36 54.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 1.3999999999999999 110.867 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -61.91 -26.65 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 1.55 110.809 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.25 -59.94 9.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.70999999999999996 112.278 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.89 65.84 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.796 0.332 . . . . 0.77000000000000002 111.277 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.2 mt -62.79 -42.5 99.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.233 -0.44 . . . . 1.9299999999999999 110.879 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -59.52 -40.76 88.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 1.8600000000000001 110.633 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -70.54 -20.01 62.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 4.1399999999999997 110.831 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' TRP . . . . . 0.406 ' O ' ' OG ' ' C' ' 26' ' ' SER . 85.7 t90 -71.57 -34.36 69.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 3.1499999999999999 110.655 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 43.9 t -71.39 -47.8 53.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.95 110.879 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 -0.93 30.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 2.2200000000000002 110.778 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 95.1 p -56.09 -17.7 7.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 1.3700000000000001 111.441 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -47.24 -42.83 21.18 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.742 -0.466 . . . . 5.0300000000000002 109.742 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 7.7 p30 -173.67 130.66 0.53 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.468 -0.787 . . . . 2.3700000000000001 110.402 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 73.4 Cg_endo . . . . . 0 N--CA 1.452 -0.936 0 C-N-CA 123.471 2.781 . . . . 2.0499999999999998 112.651 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 121.162 0.401 . . . . 1.9299999999999999 112.969 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -60.03 -17.98 42.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 4.1200000000000001 112.096 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -45.5 -30.84 1.53 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.706 0.289 . . . . 2.8900000000000001 111.641 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.59 -58.75 5.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 2.46 111.142 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -69.76 -19.84 63.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.383 -0.371 . . . . 2.7799999999999998 111.319 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.49 -63.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 1.6200000000000001 110.819 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.53 -30.36 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 1.5900000000000001 111.328 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.17 -13.04 61.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.65000000000000002 111.559 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.429 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 27.2 ttt -89.79 -42.54 11.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.387 -0.37 . . . . 1.6699999999999999 111.906 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.15 -42.0 66.47 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.751 0.648 . . . . 3.4199999999999999 112.751 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.609 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 35.1 mm -51.45 -52.72 57.11 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.78 0.659 . . . . 0.89000000000000001 112.78 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 12.6 Cg_exo -70.33 -39.08 5.78 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.416 2.077 . . . . 0.40999999999999998 113.209 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.19 -61.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.887 0.329 . . . . 1.76 111.887 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.567 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -56.11 -58.94 5.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 2.1600000000000001 111.234 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 47' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 30.3 t -53.42 -28.8 31.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.99 -0.55 . . . . 1.1699999999999999 111.213 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.98 -62.54 6.11 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.657 -0.783 . . . . 0.44 112.445 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.447 ' HA ' ' HE2' ' C' ' 52' ' ' MET . 56.1 mt -61.4 -24.12 66.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 1.29 110.838 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' ALA . . . . . 0.4 ' HB1' ' HB2' ' C' ' 75' ' ' ASP . . . -64.4 -58.04 7.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.5 111.004 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.516 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 36.8 m-85 -63.59 -35.77 81.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 1.8300000000000001 110.982 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' C' ' 49' ' ' LEU . 51.7 ttp -53.48 -35.28 60.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.138 0.494 . . . . 1.47 109.965 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.63 -34.14 64.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.698 -0.683 . . . . 0.59999999999999998 110.69 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' MET . . . . . 0.404 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 50.4 mtt -61.82 -20.12 63.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.83999999999999997 110.052 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.24 -48.07 12.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.65000000000000002 110.713 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.568 HG21 HD23 ' A' ' 130' ' ' LEU . 39.6 pt -73.01 -5.44 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.004 -0.544 . . . . 1.55 111.343 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.66 67.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.943 -0.571 . . . . 1.54 111.117 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.48 ' HG2' ' HE1' ' A' ' 131' ' ' TRP . 53.0 tp60 -139.21 139.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.79 110.766 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 110.74 11.14 19.92 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.892 -0.67 . . . . 0.93999999999999995 112.194 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -115.09 148.21 39.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 2.3599999999999999 110.925 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.93 140.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 1.97 111.047 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.43 86.85 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 2.4399999999999999 111.152 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.68 118.9 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 1.54 111.08 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.76 28.75 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 1.71 111.284 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.49 -6.3 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 1.53 112.626 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.94 152.58 19.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 2.23 110.675 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.06 131.68 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 1.3600000000000001 110.894 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.02 144.66 32.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.515 . . . . 0.78000000000000003 111.208 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.438 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 65.2 m-70 -91.56 59.21 3.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 1.0800000000000001 110.779 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.21 -58.18 5.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 2.2999999999999998 111.256 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -55.61 -35.45 65.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.228 0.537 . . . . 0.75 110.429 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 9.1 tpp180 -56.04 -39.29 71.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.338 -0.846 . . . . 1.51 111.008 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.511 ' O ' ' HG3' ' C' ' 77' ' ' MET . 0.2 OUTLIER -82.59 -20.75 35.87 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.04 0.385 . . . . 4.6500000000000004 112.04 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 47.7 mm -58.77 -42.86 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 1.22 110.284 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 25.8 t70 -60.98 -22.73 64.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 1.3100000000000001 110.599 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -81.27 -27.61 35.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 1.6799999999999999 111.267 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.619 ' HG2' HG23 ' C' ' 113' ' ' ILE . 12.8 mtp -75.55 -14.04 60.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.736 -0.665 . . . . 1.8 111.801 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' C' ' 46' ' ' TRP . 16.3 m -114.89 -42.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.451 0.537 . . . . 1.1899999999999999 112.451 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 71.7 m -72.49 -51.82 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.63 0.604 . . . . 1.23 112.63 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.0 m -54.02 -51.02 80.92 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.351 0.5 . . . . 0.58999999999999997 112.351 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.7 Cg_exo -55.28 -35.53 91.57 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.939 1.759 . . . . 0.67000000000000004 112.256 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.441 ' HB3' HD11 ' C' ' 43' ' ' ILE . 4.0 mm? -77.55 -23.8 49.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.95999999999999996 110.663 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -46.36 75.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.1899999999999999 110.492 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.496 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -74.36 -29.26 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.7 110.737 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' LEU . . . . . 0.496 ' N ' HD12 ' C' ' 84' ' ' LEU . 7.4 tp -64.52 -36.76 85.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 1.6200000000000001 110.501 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 m -61.61 -32.04 72.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.379 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 60.8 mt -66.7 -32.43 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.8 -0.636 . . . . 1.1100000000000001 110.561 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.8 t -62.94 -53.45 53.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.51 110.566 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.97 -26.66 68.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 2.0600000000000001 110.845 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 86.0 m -66.31 -33.15 75.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.257 -0.429 . . . . 1.52 110.891 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.15 -50.73 25.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 1.3 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -124.07 127.58 48.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 1.6200000000000001 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -78.48 -13.12 59.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 3.2400000000000002 110.938 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -133.76 163.26 29.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.194 -0.457 . . . . 4.6299999999999999 111.028 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 36.5 mm -126.44 143.98 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 2.1800000000000002 110.959 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -133.22 -72.73 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 4.1200000000000001 110.863 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.78 1.5 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 4.96 110.88 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.17 96.05 7.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 3.9100000000000001 110.995 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -136.32 -9.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 5.21 110.647 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 82.2 p -88.25 -38.89 14.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 1.8200000000000001 111.017 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.88 -42.12 97.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.534 . . . . 2.0800000000000001 110.704 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.44 -41.14 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.959 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.36 -14.67 77.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.58999999999999997 112.449 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.82 -46.41 24.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.878 0.37 . . . . 1.53 110.568 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.38 -38.72 68.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 1.1100000000000001 110.555 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 22.5 ttt -66.36 -42.04 88.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.574 -0.739 . . . . 2.21 111.61 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 47.7 t -60.29 -50.14 74.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.792 0.33 . . . . 1.28 111.218 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.718 HG21 HG12 ' C' ' 142' ' ' ILE . 39.9 m -55.29 -36.59 66.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 1.22 111.079 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -63.74 -46.68 84.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 2.3300000000000001 111.257 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.507 HG22 ' HE1' ' B' ' 46' ' ' TRP . 66.5 mt -52.66 -34.5 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.303 -0.408 . . . . 1.29 110.864 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.95 -53.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.564 . . . . 1.0600000000000001 111.357 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 28.6 t -63.49 -27.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 111.37 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.619 HG23 ' HG2' ' C' ' 77' ' ' MET . 22.2 mm -65.43 -50.27 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 1.3700000000000001 111.423 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 92.4 m -54.54 -55.53 28.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.47 -0.332 . . . . 0.77000000000000002 111.044 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 35.4 m -57.38 -21.49 36.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 1.1899999999999999 110.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -61.6 3.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.756 -0.735 . . . . 0.5 112.847 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.41 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -59.85 -22.21 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.702 0.287 . . . . 1.47 110.976 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.41 ' N ' HD12 ' C' ' 117' ' ' LEU . 37.6 mm -81.42 -33.93 12.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 1.2 110.997 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.28 -37.73 48.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.40000000000000002 111.193 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.88 -21.14 28.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 2.1200000000000001 110.946 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.77 28.99 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.431 -0.35 . . . . 0.75 111.025 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -94.71 125.75 39.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 1.3799999999999999 110.783 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.98 -21.2 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 2.7400000000000002 111.245 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 124' ' ' ARG . . . . . 0.674 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 52.5 ttp180 -114.86 135.83 53.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.382 -0.372 . . . . 2.7999999999999998 110.676 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.01 -11.73 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 2.4100000000000001 111.625 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 126' ' ' TRP . . . . . 0.674 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 56.6 t90 -81.86 -50.17 9.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 4.2000000000000002 110.845 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' C' ' 124' ' ' ARG . 7.4 p -66.07 -26.61 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 1.0800000000000001 111.015 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -62.37 -21.58 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 2.5699999999999998 111.103 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -77.61 -36.8 51.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 3.8100000000000001 110.816 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.424 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.3 mp -76.76 -30.4 56.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.089 -0.505 . . . . 1.4199999999999999 111.38 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -76.07 -42.53 47.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.715 0.293 . . . . 0.89000000000000001 111.362 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -57.67 -50.96 71.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.247 -0.433 . . . . 1.26 110.944 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.5 -27.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 1.6799999999999999 111.25 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.06 -45.03 90.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 1.24 111.105 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.09 47.62 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.846 -0.692 . . . . 0.54000000000000004 112.878 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.96 -31.73 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.694 0.257 . . . . 1.0600000000000001 111.694 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.19 -48.79 76.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 1.0800000000000001 111.34 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.6 73.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.56999999999999995 111.301 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.08 -22.64 62.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.035 -0.53 . . . . 1.6799999999999999 111.455 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.44 -53.87 9.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.537 -0.301 . . . . 1.7 111.792 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.434 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.7 pt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.833 0.309 . . . . 0.78000000000000003 111.833 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.718 HG12 HG21 ' C' ' 108' ' ' THR . 8.1 tp -72.47 -31.19 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.773 0.32 . . . . 2.2400000000000002 111.44 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.45 -44.96 95.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 1.02 111.004 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 144' ' ' TRP . . . . . 0.564 ' O ' ' OD1' ' C' ' 148' ' ' ASN . 71.8 t-105 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 3.0 111.259 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.51 -17.57 77.44 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.751 -0.737 . . . . 1.27 113.165 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.64 -26.34 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.872 0.367 . . . . 1.8899999999999999 110.995 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -73.02 -0.28 13.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 1.6000000000000001 111.912 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 148' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' C' ' 144' ' ' TRP . 32.1 m120 . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 99.989999999999995 112.124 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.949 0.404 . . . . 2.3500000000000001 110.77 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.43 -27.28 63.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.867 -0.606 . . . . 2.6200000000000001 110.862 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.87 -42.49 99.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 2.0899999999999999 110.892 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -81.62 -21.15 38.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 3.2400000000000002 110.722 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 55.6 tp -70.61 -54.59 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 1.6899999999999999 111.355 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.46 -24.04 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 1.3999999999999999 111.224 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.9 m -55.05 -59.06 5.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.95999999999999996 111.255 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.12 -26.76 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 3.6499999999999999 110.423 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -70.22 -25.31 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.879 -0.6 . . . . 1.3700000000000001 110.884 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 84.2 m -79.88 -51.69 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.515 . . . . 1.4299999999999999 111.83 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.72 -26.4 34.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 111.925 0.342 . . . . 1.6200000000000001 111.925 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 60.6 tp -83.2 -54.81 4.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.568 -0.287 . . . . 2.0299999999999998 111.299 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -32.41 64.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.4 . . . . 0.62 110.726 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.472 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.3 tt -87.73 -19.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 1.5800000000000001 110.484 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.21 39.76 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.835 -0.62 . . . . 0.56000000000000005 113.034 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.626 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 94.6 m-85 -55.31 -53.8 57.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.807 0.304 . . . . 1.3300000000000001 111.19 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.2 Cg_exo -46.6 -31.6 10.43 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.122 1.881 . . . . 0.63 112.503 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -66.1 -60.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.351 -0.386 . . . . 0.93000000000000005 111.364 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.52 -31.51 49.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.208 -0.451 . . . . 1.27 111.846 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -54.76 -29.03 52.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.568 -0.287 . . . . 1.77 111.469 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 74.5 mt -52.64 -62.44 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 2.3900000000000001 111.237 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 34.6 pt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.95 111.257 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.749 0.309 . . . . 2.3799999999999999 111.223 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt -63.48 -27.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 2.23 110.909 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.02 -48.37 71.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 2.1600000000000001 110.8 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 68.0 p -65.4 -24.99 67.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.27 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -70.56 -36.39 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 1.7 110.883 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.9 tp -76.73 -32.52 57.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 2.02 110.96 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -77.41 -18.93 56.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 1.8200000000000001 110.828 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.5 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.6 m -96.11 -34.27 11.76 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.118 -0.492 . . . . 1.3500000000000001 111.173 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.64 -35.32 72.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.124 -0.489 . . . . 0.65000000000000002 111.586 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.619 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.8 OUTLIER -59.98 -53.78 61.93 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 121.138 -0.225 . . . . 1.4199999999999999 110.813 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 64.7 Cg_exo -52.16 -50.83 12.68 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.197 1.931 . . . . 0.63 112.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -63.13 -32.74 74.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.379 -0.373 . . . . 1.49 110.703 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.63 -30.97 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.12 -0.491 . . . . 1.7 110.555 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 1.25 110.827 179.805 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 211' ' ' VAL . . . . . 0.436 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.7 p . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.801 0.334 . . . . 1.6100000000000001 110.962 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.436 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -64.3 -28.7 73.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.812 -0.709 . . . . 0.81999999999999995 112.375 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.24 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 3.0800000000000001 110.634 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 45.0 t -60.94 -60.71 3.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 1.1499999999999999 110.85 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -62.8 -20.45 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 2.5600000000000001 111.045 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.93 -56.1 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 1.29 110.757 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.5 -21.13 65.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.329 -0.396 . . . . 2.3900000000000001 111.02 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 68.4 tp -67.27 -51.87 47.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 2.0299999999999998 110.966 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -82.44 -22.49 35.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 3.21 111.01 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.79 -22.55 47.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.899 -0.667 . . . . 1.3600000000000001 112.642 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.323 . . . . 2.8999999999999999 110.574 179.892 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.79 0.329 . . . . 2.4199999999999999 110.76 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.49 -40.81 83.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.0899999999999999 111.094 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.644 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 39.5 m80 -62.12 -35.96 80.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 1.1599999999999999 111.034 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' HG12 ' A' ' 12' ' ' VAL . 50.1 t-105 -69.52 -45.25 69.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.254 -0.43 . . . . 0.79000000000000004 111.186 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mt -68.26 -21.82 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.034 0.445 . . . . 2.0800000000000001 110.457 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -63.95 -54.98 26.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 1.28 110.682 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.3 p -61.64 -31.45 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.314 -0.403 . . . . 1.3200000000000001 111.032 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.31 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.63 111.168 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.33 -33.38 75.55 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.974 -0.631 . . . . 0.55000000000000004 112.951 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -70.47 -31.65 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.805 0.303 . . . . 1.03 111.201 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.8 m -63.02 -62.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.43 -0.35 . . . . 1.3 110.995 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -53.46 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.369 -0.378 . . . . 1.3100000000000001 111.181 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -60.28 -43.24 98.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.808 -0.711 . . . . 0.77000000000000002 112.236 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.86 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.865 0.364 . . . . 0.80000000000000004 111.023 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.61 -31.75 69.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 1.8100000000000001 111.078 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -55.89 -24.51 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.158 -0.474 . . . . 1.8799999999999999 111.267 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -56.45 -56.51 20.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.477 -0.329 . . . . 4.4500000000000002 111.085 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.643 ' O ' ' OG ' ' A' ' 26' ' ' SER . 86.2 t90 -64.24 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 3.6899999999999999 110.978 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -70.13 -23.77 63.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 1.5700000000000001 111.234 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.4 tp -87.76 -4.29 58.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 1.95 110.918 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 29.2 p -69.82 -20.22 63.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 1.3799999999999999 110.96 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -50.6 -32.14 17.94 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.63 -0.507 . . . . 4.0700000000000003 109.63 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.3 p-10 -175.55 132.28 0.43 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.371 -0.831 . . . . 2.7200000000000002 110.464 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 57.4 Cg_endo -96.15 158.21 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.226 2.617 . . . . 1.9099999999999999 112.113 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' CZ ' HD22 ' A' ' 218' ' ' LEU . 83.8 mtt180 -84.51 62.12 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.964 0.411 . . . . 4.7599999999999998 110.99 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.69 -46.98 3.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.952 -0.642 . . . . 1.99 112.446 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.0 m -99.75 145.48 30.21 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.468 0.175 . . . . 2.7000000000000002 110.658 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.25 160.83 12.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.317 2.012 . . . . 1.79 112.378 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -62.16 -16.41 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.801 . . . . 4.1200000000000001 112.077 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -41.41 -37.89 1.13 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.022 0.379 . . . . 2.9300000000000002 112.022 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 2.8799999999999999 110.369 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -68.22 -20.19 64.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.021 -0.536 . . . . 4.6600000000000001 110.282 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' MET . 32.8 tp -61.28 -47.75 84.57 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.266 -0.425 . . . . 1.45 110.002 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.67 -41.93 94.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.127 -0.488 . . . . 1.78 109.842 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -70.47 -6.11 33.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.62 -0.718 . . . . 0.63 110.908 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' LEU . 24.1 ttt -87.95 -36.42 17.1 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.17 -0.468 . . . . 1.48 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -71.3 -33.41 69.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.131 -0.486 . . . . 3.5 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 78.3 mt -50.68 -54.83 31.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.025 0.38 . . . . 1.0800000000000001 112.025 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -70.62 -32.21 15.4 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.234 1.956 . . . . 0.53000000000000003 113.082 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 41' ' ' MET . 24.8 mm -55.32 -62.4 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.717 0.294 . . . . 1.6799999999999999 111.726 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -62.66 -53.88 47.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 1.8300000000000001 111.306 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.48 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 91.3 p -58.48 -14.63 8.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 1.0900000000000001 111.545 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.59 -61.21 2.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.40999999999999998 112.589 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 mt -55.96 -27.57 53.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.704 0.287 . . . . 0.98999999999999999 111.358 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.94 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.47999999999999998 111.399 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.2 m-85 -60.86 -38.05 84.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 1.8700000000000001 111.46 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.8 ttp -52.04 -40.41 61.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.11 0.481 . . . . 1.49 110.059 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.45 93.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.58999999999999997 110.738 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.402 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 57.6 mtt -52.48 -35.73 53.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.48999999999999999 110.323 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -65.81 -43.88 87.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.968 -0.56 . . . . 0.59999999999999998 110.093 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.567 HG21 HG23 ' B' ' 127' ' ' VAL . 12.1 mt -70.61 -3.6 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 1.3100000000000001 110.814 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.78 32.57 10.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.794 -0.639 . . . . 1.9099999999999999 111.021 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -114.93 127.63 55.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 1.6200000000000001 110.537 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.65 15.15 2.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.821 -0.704 . . . . 1.04 112.394 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -112.34 141.97 45.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 2.6800000000000002 110.909 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.47 138.16 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 1.98 111.094 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.25 138.9 37.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.11 -0.496 . . . . 2.1800000000000002 110.871 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.33 104.43 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 1.5700000000000001 111.129 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.11 26.11 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 1.79 111.488 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.35 23.1 32.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 1.48 112.602 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -121.77 127.2 50.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 2.3199999999999998 110.678 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -101.84 120.75 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 1.4399999999999999 111.176 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.63 124.58 52.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.062 -0.517 . . . . 0.81999999999999995 110.685 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 74.5 m-70 -70.22 82.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.345 0.593 . . . . 0.90000000000000002 111.161 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.92 -50.96 70.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.314 -0.857 . . . . 1.8300000000000001 111.253 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -22.39 66.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.958 -0.565 . . . . 0.62 112.166 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -68.89 -52.09 33.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.195 0.443 . . . . 2.3399999999999999 112.195 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 4.0 p90 -76.67 -34.34 58.25 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.9 -0.32 . . . . 3.4900000000000002 111.244 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 mm -52.59 -49.85 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.934 0.397 . . . . 1.3700000000000001 110.532 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 26.7 t70 -65.0 -22.25 66.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.927 -0.578 . . . . 1.3100000000000001 109.877 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -87.08 5.29 38.41 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.803 -0.635 . . . . 1.48 111.254 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.479 ' HG3' HD12 ' A' ' 113' ' ' ILE . 43.2 ttm -104.17 -19.75 14.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 1.46 110.61 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.453 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.7 m -113.98 -32.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 1.1200000000000001 111.746 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 43' ' ' ILE . 28.4 m -79.17 -53.57 6.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.369 -0.378 . . . . 1.1000000000000001 111.904 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 32.6 m -50.68 -50.39 73.35 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.078 0.399 . . . . 0.59999999999999998 112.078 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 80' ' ' THR . 11.9 Cg_endo -55.71 -41.6 75.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.713 1.609 . . . . 0.73999999999999999 111.547 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 78' ' ' VAL . 3.6 mm? -65.73 -31.79 72.98 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.715 -0.476 . . . . 1.01 109.715 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -66.82 -26.98 67.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.046 -0.724 . . . . 1.48 109.046 178.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' A' ' 109' ' ' GLN . 11.4 tp -81.74 -39.44 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.917 -1.038 . . . . 1.3799999999999999 110.686 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.75 -38.31 90.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.874 -0.603 . . . . 1.1899999999999999 111.046 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -57.27 -23.66 49.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 1.23 111.117 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -73.93 -29.0 61.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.143 -0.48 . . . . 0.88 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.6 t -80.84 -27.15 36.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 1.3899999999999999 111.166 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -79.03 -31.49 44.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.371 . . . . 2.3199999999999998 111.197 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -82.64 -26.36 32.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 1.46 111.519 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.86 -49.46 9.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.398 -0.364 . . . . 1.24 111.192 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.6 mtt -108.14 110.62 22.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 111.176 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.99 -39.26 89.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 3.5299999999999998 110.399 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -114.39 175.72 5.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.778 -0.646 . . . . 4.0800000000000001 110.471 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -130.26 142.58 43.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.44 -0.346 . . . . 2.1699999999999999 111.022 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.15 174.91 9.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 4.5199999999999996 111.272 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -70.61 -59.29 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 3.75 111.045 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.08 130.0 38.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 3.5299999999999998 111.129 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -106.42 92.15 4.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 4.9100000000000001 110.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.0 t -113.49 -41.07 3.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.413 . . . . 1.98 111.493 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.9 tp -76.92 -41.84 41.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 1.8300000000000001 110.98 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 mm -65.94 -30.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 1.79 111.067 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.19 -40.3 42.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.923 -0.656 . . . . 0.62 112.441 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -63.18 -35.98 82.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 1.5800000000000001 110.88 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 -56.75 13.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.97999999999999998 111.176 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 57.1 ttm -56.95 -40.98 77.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.519 . . . . 1.48 111.234 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -58.31 -51.86 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 1.1299999999999999 111.278 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 112' ' ' VAL . 68.1 p -60.67 -21.14 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.48 111.378 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.538 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 21.7 tp60 -77.25 -30.23 54.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.361 . . . . 2.7000000000000002 110.76 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.31 -39.53 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 1.54 111.199 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 108' ' ' THR . 33.4 m -67.37 -35.73 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.932 -0.307 . . . . 1.28 111.063 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 108' ' ' THR . 81.8 t -66.26 -52.82 43.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.341 -0.39 . . . . 0.42999999999999999 111.433 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.479 HD12 ' HG3' ' A' ' 77' ' ' MET . 45.7 pt -60.03 -27.66 39.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.728 0.299 . . . . 1.74 111.336 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 30.7 m -63.39 -46.71 85.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.63 111.15 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 p -69.65 -24.85 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 1.0900000000000001 110.795 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.98 -32.66 48.49 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.908 -0.663 . . . . 0.41999999999999998 113.217 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -80.53 -28.16 37.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.635 0.255 . . . . 1.3799999999999999 111.513 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.531 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.3 tp -83.49 -27.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 1.6200000000000001 110.87 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.78 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.39000000000000001 111.056 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.61 -21.12 60.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 2.02 111.029 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.7 mt -83.13 16.52 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.76000000000000001 110.902 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -75.24 119.85 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 1.46 110.817 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.66 -53.87 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 3.3500000000000001 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.668 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.7 ttp180 -78.26 132.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 2.9199999999999999 110.606 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.19 -9.38 39.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 2.77 111.485 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.668 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 78.3 t90 -89.51 -52.23 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 3.77 110.915 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.589 HG12 ' HB3' ' A' ' 124' ' ' ARG . 12.4 p -63.02 -23.7 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 1.1599999999999999 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -55.12 -33.59 63.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 2.04 111.077 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.59 -27.52 45.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 2.6400000000000001 111.242 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 127' ' ' VAL . 4.0 mm? -74.78 -54.21 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 1.8999999999999999 111.315 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -61.43 -32.95 72.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 1.3999999999999999 111.769 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -58.69 -45.44 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 1.28 110.645 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.66 -26.73 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 2.1600000000000001 110.6 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 63.4 m -68.65 -34.11 75.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 1.6899999999999999 110.791 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.57 -51.0 33.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.868 -0.682 . . . . 0.52000000000000002 112.622 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.24 -29.76 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.738 0.304 . . . . 1.02 111.019 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.31 -47.12 87.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 1.0800000000000001 110.8 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.38 -33.42 74.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.62 110.903 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' A' ' 142' ' ' ILE . 80.7 t80 -72.03 -27.18 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.8400000000000001 110.948 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.7 mt -65.15 -54.02 36.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 1.6899999999999999 111.576 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 142' ' ' ILE . 37.8 pt -59.18 -42.2 86.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.355 . . . . 0.81000000000000005 111.827 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.45 ' N ' HG13 ' A' ' 141' ' ' ILE . 29.3 pt -73.02 -22.29 19.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.307 . . . . 2.3700000000000001 111.194 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.72 -40.14 91.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.303 -0.408 . . . . 0.97999999999999998 110.853 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -72.66 -36.43 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 3.27 110.421 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.99 -38.35 95.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.891 -0.671 . . . . 1.25 112.642 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.85 -21.32 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 2.1200000000000001 110.965 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -90.39 4.99 49.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 1.6599999999999999 111.174 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.875 -0.602 . . . . 99.989999999999995 111.927 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.87 0.367 . . . . 2.3399999999999999 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 -23.55 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.063 -0.517 . . . . 2.77 110.981 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.1 -42.13 94.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 2.04 110.839 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -83.99 -24.11 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 2.77 110.765 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.83 -51.55 61.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 1.8899999999999999 111.211 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.69 -25.75 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 1.6399999999999999 111.353 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.0 m -53.05 -59.15 4.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.24 111.469 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.451 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 11.2 t80 -68.11 -31.6 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 2.9700000000000002 110.424 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.49 -23.42 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 1.48 111.136 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 -49.81 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 1.55 111.573 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 171' ' ' TYR . 22.5 m -58.75 -29.17 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.561 -0.29 . . . . 1.52 111.738 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 209' ' ' SER . 69.3 mt -77.72 -58.11 3.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.831 0.348 . . . . 1.8500000000000001 111.017 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.63 -23.18 58.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.534 . . . . 0.62 110.777 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 181' ' ' ILE . 10.9 mm -88.07 -29.36 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 1.3500000000000001 110.362 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -52.31 48.18 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.767 -0.651 . . . . 0.58999999999999997 113.766 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.679 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 73.8 m-85 -58.64 -55.38 46.6 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.01 0.405 . . . . 1.45 111.952 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 73.1 Cg_exo -49.06 -28.03 13.17 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.136 1.89 . . . . 0.55000000000000004 112.738 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 184' ' ' ILE . 95.0 mt -71.72 -59.96 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 1.4199999999999999 111.125 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 179' ' ' TYR . 20.4 m -58.17 -24.58 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.379 -0.373 . . . . 0.78000000000000003 111.7 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -64.11 -17.46 63.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.064 0.394 . . . . 0.93999999999999995 112.064 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.702 HG13 HG23 ' A' ' 185' ' ' ILE . 19.3 pt -69.74 -9.79 12.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.988 -0.285 . . . . 1.4299999999999999 111.57 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.702 HG23 HG13 ' A' ' 184' ' ' ILE . 42.4 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 2.02 111.092 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.807 0.337 . . . . 2.48 111.473 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.9 -54.5 44.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 2.1800000000000002 110.904 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.3 p -63.07 -30.27 71.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 1.49 111.021 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -56.75 -38.08 71.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.77 111.163 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 63.0 tp -75.77 -40.51 55.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 1.4199999999999999 111.511 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.99 -6.1 51.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.701 0.26 . . . . 1.78 111.701 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 60.5 m -96.12 -39.96 9.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.915 0.388 . . . . 1.3 110.911 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.75 -35.79 65.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.66000000000000003 111.922 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.673 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.7 tp -58.72 -53.99 60.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.965 -0.294 . . . . 1.6299999999999999 111.252 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 32.1 Cg_exo -58.93 -37.2 94.82 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.683 1.589 . . . . 0.64000000000000001 111.274 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -63.33 -34.16 77.1 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 116.021 -0.536 . . . . 1.3600000000000001 110.13 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -72.25 -24.23 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.625 . . . . 1.54 110.472 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.462 ' HB2' HD22 ' A' ' 175' ' ' LEU . 29.8 t . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 1.2 111.007 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.737 0.303 . . . . 1.6399999999999999 111.342 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.32 71.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.583 -0.818 . . . . 0.79000000000000004 112.408 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -76.34 -34.18 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.62 0.248 . . . . 1.6100000000000001 111.178 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 85.2 p -63.14 -52.22 63.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 1.1499999999999999 110.912 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -62.12 -30.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 3.3399999999999999 110.346 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.5 -47.86 74.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 1.1899999999999999 110.632 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.72 -33.93 68.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.23 111.278 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.411 HD22 ' CZ ' ' A' ' 30' ' ' ARG . 90.3 mt -62.89 -47.27 84.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 2.4700000000000002 111.372 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -74.12 -27.68 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 1.6200000000000001 111.058 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.86 63.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 1.4099999999999999 112.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.588 0.232 . . . . 2.5800000000000001 111.294 -179.755 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.466 ' N ' HD12 ' B' ' 6' ' ' LEU . 5.9 mp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.911 0.386 . . . . 2.0699999999999998 110.746 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 62.5 tp -68.12 -41.15 82.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 2.1000000000000001 110.426 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.7 m80 -61.92 -31.81 72.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 1.0700000000000001 110.474 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -69.79 -44.72 69.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.96 -0.564 . . . . 1.48 110.458 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.89 -20.72 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 2.02 110.119 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.98 -54.64 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.92000000000000004 110.61 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.45 -32.63 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.93999999999999995 111.08 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -53.17 61.23 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.199 -0.455 . . . . 0.55000000000000004 111.037 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.47 -27.34 69.38 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.891 -0.671 . . . . 0.47999999999999998 112.461 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' B' ' 44' ' ' PRO . 22.9 mmt -73.53 -26.9 61.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.696 0.284 . . . . 0.84999999999999998 111.033 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 63.2 m -69.32 -54.32 15.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 1.3400000000000001 110.983 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -60.49 -27.42 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 1.55 111.17 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.73 -51.71 53.87 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.535 -0.841 . . . . 0.69999999999999996 112.245 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.16 68.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.936 0.398 . . . . 0.81000000000000005 111.165 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.37 -31.54 71.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 2.2599999999999998 110.85 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -61.05 -21.94 64.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 1.78 110.978 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.27 -35.67 81.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 4.5800000000000001 110.992 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -80.3 -32.85 37.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 3.3500000000000001 111.082 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 88.8 p -77.3 -19.95 55.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 1.5800000000000001 111.353 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 tp -87.43 -1.76 58.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.342 . . . . 1.8400000000000001 110.958 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 100.0 p -73.39 -19.52 60.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 1.3700000000000001 110.833 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -52.09 -30.72 27.38 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.691 -0.485 . . . . 4.9800000000000004 109.691 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.7 p-10 -174.19 131.83 0.52 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.44 -0.8 . . . . 2.1400000000000001 110.319 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.444 ' HB3' ' NE2' ' B' ' 34' ' ' GLN . 56.9 Cg_endo -97.29 172.66 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.175 2.583 . . . . 1.8200000000000001 111.892 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -94.5 58.74 2.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.407 . . . . 5.1900000000000004 110.661 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -45.82 3.46 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.007 -0.616 . . . . 2.2000000000000002 112.375 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 34.2 m -101.7 147.03 33.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 O-C-N 122.977 -0.131 . . . . 3.6499999999999999 110.739 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -54.28 163.5 3.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.058 . . . . 2.6699999999999999 112.516 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLN . . . . . 0.444 ' NE2' ' HB3' ' B' ' 29' ' ' PRO . 74.7 mm-40 -64.99 -17.47 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.554 -0.748 . . . . 4.8799999999999999 111.922 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -41.6 -34.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.009 0.374 . . . . 1.8700000000000001 112.009 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.29 -53.43 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 2.6800000000000002 110.334 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -66.48 -19.58 65.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.903 -0.589 . . . . 2.9199999999999999 110.458 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' B' ' 41' ' ' MET . 8.5 tt -59.86 -47.71 84.62 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.659 -0.497 . . . . 1.6399999999999999 109.659 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 52.2 t -62.79 -39.87 86.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.524 -0.547 . . . . 1.6000000000000001 109.524 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.34 -5.89 39.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.663 -0.699 . . . . 0.68999999999999995 110.663 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.535 ' O ' ' HD2' ' B' ' 44' ' ' PRO . 26.6 ttt -88.72 -31.32 18.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.029 -0.532 . . . . 2.5800000000000001 110.455 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -75.47 -34.22 60.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 3.3900000000000001 111.105 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.625 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 67.6 mt -54.21 -51.84 74.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.962 0.356 . . . . 0.40999999999999998 111.962 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 12.2 Cg_exo -70.79 -33.72 12.26 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.637 2.225 . . . . 0.48999999999999999 113.132 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.445 HG12 ' O ' ' B' ' 41' ' ' MET . 24.4 mm -57.28 -62.15 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 111.749 0.278 . . . . 1.29 111.749 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.439 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -59.05 -54.28 48.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.805 0.335 . . . . 1.3999999999999999 111.081 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -55.33 -28.79 56.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 1.3799999999999999 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.99 -58.04 14.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 0.37 112.74 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.22 -29.61 67.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 1.29 111.101 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -52.25 60.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.219 -0.446 . . . . 0.44 111.228 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 22.4 m-85 -64.65 -39.36 93.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.5 111.198 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' MET . . . . . 0.436 ' SD ' HD11 ' B' ' 56' ' ' ILE . 12.5 tmm? -49.61 -40.8 40.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.214 0.53 . . . . 1.4099999999999999 110.052 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.58 91.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.679 -0.691 . . . . 0.55000000000000004 110.821 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtt -52.56 -32.27 40.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.5 110.197 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -69.37 -42.64 74.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.957 -0.565 . . . . 0.54000000000000004 110.213 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.436 HD11 ' SD ' ' B' ' 52' ' ' MET . 12.0 mt -75.67 1.89 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 1.3 110.567 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t70 66.16 46.75 2.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.642 -0.708 . . . . 2.2400000000000002 110.714 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.42 ' CD ' HG21 ' C' ' 127' ' ' VAL . 14.6 mm100 -115.72 168.84 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.77 110.954 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 83.65 23.69 52.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 1.0600000000000001 112.466 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.12 142.96 46.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 2.6600000000000001 110.799 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.63 147.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 1.8899999999999999 111.265 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.59 142.51 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 2.4100000000000001 110.762 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.82 98.85 1.37 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 1.5600000000000001 111.299 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.18 29.27 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.04 -0.527 . . . . 1.8200000000000001 111.422 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.94 16.48 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 1.51 112.597 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -116.48 121.29 41.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 2.4500000000000002 110.896 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.69 123.08 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 1.79 111.093 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.97 129.7 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.81999999999999995 111.238 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.505 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 87.9 m-70 -73.03 81.36 1.22 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.05 110.619 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -62.03 -35.4 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 1.8700000000000001 111.586 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -78.85 -22.56 45.92 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.311 0.486 . . . . 0.60999999999999999 112.311 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.505 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 12.8 tpp180 -69.85 -51.32 34.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.132 0.419 . . . . 2.3900000000000001 112.132 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.501 ' O ' ' HG3' ' B' ' 77' ' ' MET . 8.2 p90 -76.3 -38.11 56.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.861 0.319 . . . . 3.6699999999999999 111.861 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.461 HG23 ' N ' ' B' ' 75' ' ' ASP . 11.1 tp -54.04 -44.4 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 1.6599999999999999 110.991 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.461 ' N ' HG23 ' B' ' 74' ' ' ILE . 24.7 t70 -67.22 -21.8 65.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.495 -0.557 . . . . 1.4099999999999999 109.495 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -85.9 4.92 35.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.514 -0.766 . . . . 1.1599999999999999 111.267 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 42.5 mtp -104.83 -18.99 14.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.232 -0.44 . . . . 1.53 110.939 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.516 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.4 m -114.54 -31.65 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.89000000000000001 111.876 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.599 HG23 HG23 ' B' ' 43' ' ' ILE . 60.9 m -79.47 -57.18 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 1.24 112.035 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.549 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 11.0 m -50.42 -50.13 73.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.192 0.442 . . . . 0.57999999999999996 112.192 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.7 Cg_exo -53.91 -42.49 66.18 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.832 1.688 . . . . 0.66000000000000003 111.64 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.516 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -66.97 -29.45 69.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 1.0600000000000001 110.036 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 19.0 tp -70.19 -20.98 63.09 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.176 -0.676 . . . . 1.22 109.176 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' B' ' 109' ' ' GLN . 14.9 tp -83.86 -39.89 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.1 -0.954 . . . . 1.53 109.985 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 22.1 tp -66.94 -35.34 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.343 -0.844 . . . . 1.5800000000000001 111.025 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -60.08 -21.78 61.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 1.3899999999999999 110.804 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.2 -27.21 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 1.1499999999999999 110.7 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -76.74 -33.1 58.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.964 -0.562 . . . . 1.5700000000000001 110.783 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -80.05 -31.77 39.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 2.1699999999999999 110.801 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 88.6 m -72.98 -38.48 66.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 1.4199999999999999 111.067 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.29 -46.43 12.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 1.1799999999999999 111.034 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 80.4 mtp -103.39 120.89 41.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.8799999999999999 111.047 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -75.52 -30.94 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 3.4199999999999999 110.574 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.63 179.44 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.907 -0.588 . . . . 4.0599999999999996 110.664 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tp -132.25 148.31 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 2.0899999999999999 111.25 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.2 161.26 14.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 3.8500000000000001 110.936 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.37 44.51 1.04 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.109 -0.496 . . . . 4.8200000000000003 111.089 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -149.13 113.57 5.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 3.7999999999999998 110.679 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -82.93 78.72 9.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.189 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.8 m -120.93 -59.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.304 -0.407 . . . . 2.02 111.542 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.15 -61.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 2.0899999999999999 111.443 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.8 pt -55.33 -38.09 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.8799999999999999 111.57 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.84 -43.81 98.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.869 -0.681 . . . . 0.56000000000000005 112.798 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -63.21 -36.0 82.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.282 . . . . 1.78 110.985 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.45 -53.47 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 1.03 111.118 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 87.7 mtp -57.95 -36.26 72.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 1.6699999999999999 111.042 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 57.6 m -65.32 -54.43 29.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.12 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.434 ' HB ' HD13 ' B' ' 142' ' ' ILE . 47.4 p -53.98 -26.14 24.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 1.1799999999999999 111.292 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.461 ' HB2' HD22 ' B' ' 84' ' ' LEU . 24.4 tp60 -71.61 -40.99 69.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 2.1699999999999999 110.709 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.99 -32.07 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 1.3500000000000001 110.973 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.13 -43.01 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 1.3400000000000001 111.264 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.62 -55.4 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.42999999999999999 111.515 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.7 pt -54.32 -33.17 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 1.6000000000000001 111.269 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -60.87 -40.77 94.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.337 -0.392 . . . . 0.85999999999999999 110.607 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -61.54 -59.8 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.94999999999999996 110.365 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.66 -16.33 44.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.781 -0.723 . . . . 0.46000000000000002 112.431 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.96 -61.84 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 1.75 110.702 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 mt -84.04 -20.41 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 1.78 111.759 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.95 57.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.779 0.323 . . . . 0.38 110.956 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.97 -19.65 36.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 1.97 110.822 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.56 22.83 1.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.76000000000000001 111.107 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.4 p -70.97 124.51 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 1.47 110.921 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -99.9 -41.71 7.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 2.5 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.572 ' HB2' HG12 ' B' ' 127' ' ' VAL . 80.3 mtp180 -94.5 140.05 30.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 2.73 111.033 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.13 -19.14 62.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 2.2000000000000002 110.95 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -79.03 -54.02 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 3.3999999999999999 110.894 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' B' ' 124' ' ' ARG . 10.6 p -62.06 -23.66 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.23 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -51.95 -41.38 62.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 3.04 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -77.06 -28.56 54.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.292 -0.413 . . . . 4.1399999999999997 111.16 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' B' ' 127' ' ' VAL . 93.7 mt -70.48 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 1.6499999999999999 111.137 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -56.21 -32.39 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 0.77000000000000002 111.151 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -60.43 -42.6 96.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.911 0.386 . . . . 1.46 110.52 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.76 -28.87 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 110.653 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.7 t -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.895 -0.593 . . . . 1.4199999999999999 110.724 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.28 23.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 0.48999999999999999 112.501 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.42 -30.42 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.789 0.328 . . . . 1.3 111.137 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.55 -40.48 94.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 1.3 110.765 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.19 78.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.62 110.978 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -73.76 -22.72 59.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.74 110.694 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -56.46 10.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.689 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.402 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.7 pt -60.48 -40.86 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.68999999999999995 111.441 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.434 HD13 ' HB ' ' B' ' 108' ' ' THR . 67.3 mt -68.84 -28.86 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.475 -0.329 . . . . 1.76 110.715 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.5 -42.29 99.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0600000000000001 110.979 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -72.31 -27.31 62.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 4.1200000000000001 110.808 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' GLY . . . . . 0.833 ' HA2' ' OD1' ' B' ' 148' ' ' ASN . . . -76.16 -27.45 62.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 1.26 112.716 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.44 -13.49 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.771 0.32 . . . . 1.98 111.286 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -99.93 4.67 45.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 1.4199999999999999 111.212 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.833 ' OD1' ' HA2' ' B' ' 145' ' ' GLY . 32.1 m120 . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 112.069 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.015 0.436 . . . . 2.4300000000000002 110.824 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.19 -31.64 58.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.749 -0.66 . . . . 2.5800000000000001 111.287 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.44 -42.06 91.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 2.0 110.968 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -83.42 -22.52 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 3.0299999999999998 110.982 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.68 -44.63 77.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 1.1000000000000001 110.926 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.57 -25.68 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 1.75 111.336 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 51.0 m -51.26 -59.13 4.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.97999999999999998 111.367 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -67.2 -34.61 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 4.2999999999999998 110.482 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -63.25 -22.21 66.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 1.3899999999999999 111.003 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.454 ' O ' HG22 ' B' ' 177' ' ' ILE . 48.0 m -79.73 -56.99 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 1.1100000000000001 111.721 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.08 -29.39 15.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.365 0.506 . . . . 1.51 112.365 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 209' ' ' SER . 57.9 tp -79.87 -57.92 3.42 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.891 0.377 . . . . 1.75 111.29 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.3 -29.54 61.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.02 -0.537 . . . . 0.59999999999999998 111.04 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.454 HG22 ' O ' ' B' ' 173' ' ' THR . 9.4 tp -87.91 -21.79 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.064 0.459 . . . . 1.47 110.438 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.98 -54.94 33.49 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.789 -0.642 . . . . 0.55000000000000004 113.129 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 96.3 m-85 -56.41 -54.14 56.4 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.816 0.308 . . . . 1.6200000000000001 111.763 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.7 Cg_exo -46.75 -32.32 11.98 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.223 1.949 . . . . 0.64000000000000001 112.612 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 177' ' ' ILE . 91.0 mt -67.93 -60.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 1.27 111.577 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 179' ' ' TYR . 29.0 m -58.97 -24.71 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.68999999999999995 111.861 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -62.69 -20.05 64.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.52 -0.309 . . . . 1.1799999999999999 111.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 mm -54.44 -49.9 61.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 1.77 110.794 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 15.0 pt -95.5 178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.017 -0.538 . . . . 1.6899999999999999 111.294 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.471 0 C-N-CA 120.887 -0.673 . . . . 1.5800000000000001 112.505 179.881 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 14.1 tt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.703 0.287 . . . . 2.4700000000000002 111.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.07 -49.42 77.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 2.5299999999999998 110.869 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 63.4 p -68.98 -23.27 64.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 1.29 110.896 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.98 -36.8 83.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 2.6200000000000001 111.19 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.26 -45.83 53.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.387 -0.37 . . . . 1.6100000000000001 111.218 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -75.52 -3.43 34.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.745 0.307 . . . . 1.4199999999999999 111.349 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 43.8 t -96.31 -43.47 7.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.279 0.561 . . . . 1.4299999999999999 110.289 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 66.5 tp -71.93 -39.48 69.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.444 -0.798 . . . . 1.1200000000000001 112.055 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.58 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -55.97 -54.77 48.64 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.237 -0.185 . . . . 1.26 111.384 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -56.16 -41.51 75.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.885 1.723 . . . . 0.59999999999999998 111.559 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.61 -31.78 73.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.247 -0.433 . . . . 1.3999999999999999 110.288 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -66.68 -27.49 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 1.4099999999999999 110.572 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.44 ' HB2' HD13 ' B' ' 175' ' ' LEU . 17.3 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 1.3200000000000001 111.053 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.731 0.301 . . . . 1.6899999999999999 110.997 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.27 -30.66 74.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.79000000000000004 112.549 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -74.74 -29.87 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 2.96 110.753 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.1 t -63.0 -59.93 4.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 1.29 110.74 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.79 -28.89 67.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 3.1499999999999999 110.823 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.74 -43.36 89.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 1.51 110.567 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.08 -22.24 65.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 2.1899999999999999 110.873 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.4 tp -69.62 -51.51 34.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 1.98 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -78.09 -30.94 49.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 2.1699999999999999 111.302 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.66 80.43 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.792 -0.718 . . . . 1.3600000000000001 112.933 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 55.1 tp . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 2.8999999999999999 111.012 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.795 0.331 . . . . 2.52 110.927 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 94.3 mt -81.11 -45.16 16.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 1.9299999999999999 111.257 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 39.3 m80 -64.65 -26.08 68.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.931 0.396 . . . . 1.26 110.475 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.453 ' O ' HG12 ' C' ' 12' ' ' VAL . 62.0 t-105 -72.58 -47.75 45.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 1.6699999999999999 110.059 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.05 -20.8 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.358 0.599 . . . . 1.8700000000000001 109.503 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -59.9 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.224 -0.898 . . . . 1.4399999999999999 110.69 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' C' ' 52' ' ' MET . 14.0 p -58.58 -32.81 46.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.19 -0.459 . . . . 0.46999999999999997 111.035 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.62 41.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.58999999999999997 111.015 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.07 -21.78 68.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.5 112.189 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 8.2 mmt -73.54 -35.85 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.676 0.274 . . . . 0.68000000000000005 110.952 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 59.8 p -66.46 -53.06 39.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 1.3999999999999999 111.185 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' ILE . . . . . 0.412 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.7 pp -59.98 -26.09 34.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.36 . . . . 1.55 111.016 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.412 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -66.97 -39.51 93.26 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.763 -0.732 . . . . 0.70999999999999996 112.418 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' C' ' 41' ' ' MET . . . -72.67 -28.29 62.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.77000000000000002 110.926 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 28.4 tp -68.49 -29.93 68.65 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 1.9299999999999999 110.516 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -59.19 -22.14 60.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 1.8600000000000001 110.414 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -58.19 -53.73 55.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.018 -0.537 . . . . 4.1399999999999997 110.91 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -60.81 -38.8 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 3.1499999999999999 110.479 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 63.3 m -69.69 -19.56 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 1.95 110.67 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 23.7 mt -80.1 -0.39 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 2.2200000000000002 111.554 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 48.8 p -57.56 -52.04 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.911 -0.316 . . . . 1.3700000000000001 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.74 -27.41 69.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.158 0.98 . . . . 5.0300000000000002 108.508 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.767 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 12.7 m120 -70.32 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 113.473 -1.694 . . . . 2.3700000000000001 108.892 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.767 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 5.8 Cg_exo . . . . . 0 C--N 1.376 2.02 0 C-N-CA 123.763 2.976 . . . . 2.0499999999999998 117.093 -174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo . . . . . 0 N--CA 1.472 0.244 0 N-CA-C 115.543 1.324 . . . . 1.9299999999999999 115.543 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLN . . . . . 0.628 ' HG3' ' HG2' ' C' ' 29' ' ' PRO . 24.1 mp0 -60.93 -14.47 22.7 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 113.435 -1.712 . . . . 4.1200000000000001 112.82 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' C' ' 38' ' ' LEU . 20.8 p90 -39.22 -36.31 0.32 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.708 0.29 . . . . 2.8900000000000001 111.604 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -64.91 -48.35 74.48 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.251 0.548 . . . . 2.46 109.572 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' C' ' 34' ' ' GLN . 33.7 t80 -68.56 -20.48 64.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 2.7799999999999998 110.291 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' C' ' 35' ' ' TYR . 56.1 tp -59.03 -48.29 82.13 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.571 -0.529 . . . . 1.6200000000000001 109.571 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -41.27 91.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.82 -0.627 . . . . 1.5900000000000001 109.581 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -70.87 -6.07 35.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.591 -0.732 . . . . 0.65000000000000002 110.703 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.534 ' HG3' ' HA ' ' C' ' 19' ' ' ALA . 51.0 ttp -88.64 -34.14 17.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.153 -0.476 . . . . 1.6699999999999999 110.519 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' C' ' 45' ' ' ILE . 61.8 t80 -72.43 -30.07 64.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 3.4199999999999999 110.571 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.612 HG23 HG23 ' C' ' 79' ' ' THR . 93.3 mt -54.89 -54.81 45.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.89000000000000001 111.548 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.485 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.6 Cg_endo -71.22 -28.64 18.36 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.224 1.949 . . . . 0.40999999999999998 113.176 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' C' ' 42' ' ' PHE . 80.0 mt -58.1 -62.72 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.623 0.249 . . . . 1.76 111.58 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -55.42 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 2.1600000000000001 111.084 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 85.8 p -52.01 -39.04 58.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 1.1699999999999999 111.303 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.44 -55.14 28.35 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.925 -0.655 . . . . 0.44 112.923 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' C' ' 52' ' ' MET . 69.6 mt -57.04 -29.91 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 1.29 110.829 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 50' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -70.42 -35.73 73.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.136 -0.483 . . . . 0.5 111.05 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 49.6 m-85 -71.39 -52.45 18.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 1.8300000000000001 111.466 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' MET . . . . . 0.561 ' HB3' HG11 ' C' ' 12' ' ' VAL . 23.8 ptm -49.53 -34.69 17.99 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.882 0.372 . . . . 1.47 110.498 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.07 88.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.59999999999999998 110.727 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 54.2 mtt -52.27 -33.86 43.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.836 -0.62 . . . . 0.83999999999999997 110.553 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.32 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.65000000000000002 110.705 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.465 HG21 HG23 ' A' ' 127' ' ' VAL . 10.2 mm -72.64 -4.75 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 1.55 110.697 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 66.55 35.61 5.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.7 . . . . 1.54 110.815 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -118.35 138.21 52.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 1.79 110.641 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.39 16.83 5.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.847 -0.692 . . . . 0.93999999999999995 112.495 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' C' ' 60' ' ' LYS . 3.3 mptp? -114.67 137.8 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 2.3599999999999999 110.606 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.05 142.56 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.97 111.016 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.27 139.63 42.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.081 -0.509 . . . . 2.4399999999999999 110.915 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.85 102.09 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 1.54 111.072 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.33 30.57 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 1.71 111.24 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.4 40.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 1.53 112.783 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 118.95 31.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.687 0.28 . . . . 2.23 110.609 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -97.18 120.11 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 1.3600000000000001 111.105 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.49 141.92 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.78000000000000003 111.108 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 55.3 m-70 -80.68 82.06 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.08 0.467 . . . . 1.0800000000000001 110.864 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -67.65 -32.72 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.797 -0.638 . . . . 2.2999999999999998 111.392 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.57 -24.99 41.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.288 0.477 . . . . 0.75 112.288 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.559 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.3 mmt180 -71.51 -52.01 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.284 0.476 . . . . 1.51 112.284 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.494 ' O ' ' HG3' ' C' ' 77' ' ' MET . 2.6 p90 -71.43 -40.37 70.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.82 -0.352 . . . . 4.6500000000000004 111.717 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.446 HG23 ' N ' ' C' ' 75' ' ' ASP . 10.4 tp -53.64 -44.01 56.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.581 0.229 . . . . 1.22 111.026 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.446 ' N ' HG23 ' C' ' 74' ' ' ILE . 23.4 t70 -70.08 -21.45 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.447 -0.575 . . . . 1.3100000000000001 109.447 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -87.38 6.93 31.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.436 -0.802 . . . . 1.6799999999999999 111.209 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 30.0 mtp -105.34 -20.68 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 1.8 110.693 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -114.14 -29.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 1.1899999999999999 111.883 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.612 HG23 HG23 ' C' ' 43' ' ' ILE . 88.2 m -81.29 -56.14 4.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.23 111.787 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 25.0 m -50.54 -50.32 72.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.412 0.523 . . . . 0.58999999999999997 112.412 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' C' ' 80' ' ' THR . 12.3 Cg_endo -56.41 -38.49 95.16 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.58 1.52 . . . . 0.67000000000000004 111.446 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.42 -30.94 69.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.95999999999999996 109.577 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.89 -21.23 62.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.445 0.641 . . . . 1.1899999999999999 109.336 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.32 -37.23 21.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.993 -1.003 . . . . 1.7 109.908 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 89.4 mt -67.72 -35.91 79.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.75 -0.659 . . . . 1.6200000000000001 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 88.8 p -56.71 -31.14 64.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.343 -0.389 . . . . 1.26 110.981 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 70.4 mt -66.62 -33.23 75.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.489 . . . . 1.1100000000000001 110.797 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -73.72 -27.47 61.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 1.51 110.961 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.27 -33.6 25.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 2.0600000000000001 110.952 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 82.3 m -76.52 -37.23 57.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 1.52 111.005 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.28 -48.3 12.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 1.3 111.265 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -104.0 115.14 29.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 1.6200000000000001 110.949 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -71.54 -25.07 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 3.2400000000000002 111.016 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -144.77 138.0 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 4.6299999999999999 111.053 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.8 142.08 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.054 -0.521 . . . . 2.1800000000000002 111.022 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -102.89 173.55 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 4.1200000000000001 110.807 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.9 -178.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 4.96 110.758 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 28.6 t70 56.44 84.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 3.9100000000000001 110.868 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -75.16 99.47 3.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 5.21 110.864 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 68.8 m -119.23 -44.86 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 111.261 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.43 HD22 ' N ' ' C' ' 101' ' ' LEU . 3.7 mm? -76.64 -48.41 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 2.0800000000000001 111.095 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 7.6 tp -65.9 -30.09 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 1.8600000000000001 111.329 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.32 -44.84 41.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.769 . . . . 0.58999999999999997 112.776 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.58 -36.54 78.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 1.53 111.352 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.72 -51.25 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 1.1100000000000001 111.3 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.72 -35.87 77.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 2.21 111.029 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 40.9 m -66.87 -55.75 13.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.255 -0.429 . . . . 1.28 111.178 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.444 HG21 HD13 ' C' ' 142' ' ' ILE . 40.1 p -55.78 -25.91 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 1.22 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -68.4 -40.36 81.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 2.3300000000000001 110.376 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.439 HG22 ' HE1' ' B' ' 46' ' ' TRP . 36.4 mm -59.67 -32.17 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.91 -0.586 . . . . 1.29 110.698 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.98 -42.14 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.955 -0.566 . . . . 1.0600000000000001 111.171 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.23 -54.9 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 0.51000000000000001 111.631 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.1 pt -55.02 -27.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.3700000000000001 111.272 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 19.7 m -66.13 -46.57 77.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.436 . . . . 0.77000000000000002 110.883 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -69.03 -23.78 64.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 1.1899999999999999 111.412 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.63 -35.52 32.1 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.712 -0.756 . . . . 0.5 113.266 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.55 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.6 pp -77.06 -29.75 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.568 0.223 . . . . 1.47 111.592 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.55 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.2 tp -83.89 -24.33 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.399 -0.364 . . . . 1.2 111.202 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.24 93.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.40000000000000002 111.105 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -78.36 -14.13 59.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.046 -0.525 . . . . 2.1200000000000001 111.067 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' C' ' 118' ' ' ILE . 96.7 mt -86.29 17.59 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.75 111.125 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 78.5 p -68.38 121.16 15.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 1.3799999999999999 111.11 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -103.23 -37.94 7.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.246 -0.433 . . . . 2.7400000000000002 110.648 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG12 ' C' ' 127' ' ' VAL . 97.7 mtt180 -102.97 137.87 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 2.7999999999999998 110.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.71 -9.43 58.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 2.4100000000000001 111.242 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -88.52 -44.36 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 4.2000000000000002 111.088 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -74.16 -23.94 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 111.187 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -52.53 -47.29 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 2.5699999999999998 111.283 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -67.58 -22.94 65.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 3.8100000000000001 111.391 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 72.4 mt -80.5 -47.22 14.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 1.4199999999999999 111.239 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.68 -34.49 77.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.89000000000000001 111.384 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.85 -33.49 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.097 -0.501 . . . . 1.26 111.135 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.3 mm -73.26 -37.48 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.6799999999999999 111.108 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.59 -30.73 71.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 1.24 110.878 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -54.83 11.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.723 -0.751 . . . . 0.54000000000000004 112.278 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.56 -29.88 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 1.0600000000000001 110.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.37 -49.42 77.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.054 -0.521 . . . . 1.0800000000000001 110.741 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.08 -29.01 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.56999999999999995 110.845 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -74.64 -20.08 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 1.6799999999999999 110.708 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.3 15.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 1.7 111.293 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.456 HG13 ' N ' ' C' ' 142' ' ' ILE . 29.0 pt -59.21 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.78000000000000003 111.241 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.456 ' N ' HG13 ' C' ' 141' ' ' ILE . 7.4 tp -72.48 -27.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.494 -0.321 . . . . 2.2400000000000002 111.003 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.27 -50.84 71.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 1.02 110.67 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -64.42 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.934 -0.575 . . . . 3.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.3 -39.1 97.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.794 -0.717 . . . . 1.27 112.405 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.39 -24.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 1.8899999999999999 110.654 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -89.26 3.93 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 1.6000000000000001 111.043 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.914 -0.585 . . . . 99.989999999999995 111.834 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.086 0.47 . . . . 2.3500000000000001 110.703 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 165' ' ' TYR . . . . . 0.43 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.5 OUTLIER -77.0 -39.57 49.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.635 . . . . 2.6200000000000001 111.048 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -57.79 -37.12 73.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 2.0899999999999999 111.443 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -81.35 -26.97 35.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 3.2400000000000002 111.137 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.89 -52.17 18.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 111.264 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 169' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 165' ' ' TYR . 53.4 t -56.16 -25.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.3999999999999999 111.493 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -54.64 -58.96 5.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.95999999999999996 111.316 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -68.32 -24.58 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.08 -0.509 . . . . 3.6499999999999999 110.499 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -70.62 -35.97 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 1.3700000000000001 111.673 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 41.0 p -70.47 -53.18 17.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.565 -0.288 . . . . 1.4299999999999999 111.655 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 p -53.33 -35.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.958 0.355 . . . . 1.6200000000000001 111.958 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' C' ' 209' ' ' SER . 41.7 tp -75.36 -57.81 3.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.794 0.33 . . . . 2.0299999999999998 111.41 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -28.32 58.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.109 -0.496 . . . . 0.62 110.981 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.426 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 84.9 mt -87.95 -24.29 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.479 . . . . 1.5800000000000001 110.225 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.53 -54.57 31.83 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.728 -0.669 . . . . 0.56000000000000005 113.043 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.627 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 68.1 m-85 -57.47 -55.67 42.1 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.85 0.325 . . . . 1.3300000000000001 111.623 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.0 Cg_exo -45.86 -28.2 4.68 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.254 1.969 . . . . 0.63 112.929 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.502 ' O ' HG22 ' C' ' 184' ' ' ILE . 92.7 mt -70.97 -61.25 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.93000000000000005 111.467 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.446 HG22 ' O ' ' C' ' 179' ' ' TYR . 25.3 m -57.5 -26.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.221 0.452 . . . . 1.27 112.221 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -60.94 -20.02 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.696 -0.229 . . . . 1.77 111.547 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.663 HG23 HG23 ' C' ' 185' ' ' ILE . 14.9 tt -60.64 -29.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 2.3900000000000001 111.011 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 185' ' ' ILE . . . . . 0.663 HG23 HG23 ' C' ' 184' ' ' ILE . 31.4 pt . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 1.95 111.101 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.739 0.304 . . . . 2.3799999999999999 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 197' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' C' ' 200' ' ' PHE . 16.7 tt -57.82 -34.75 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 2.23 111.231 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.58 -56.06 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 2.1600000000000001 110.703 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -69.43 -17.53 63.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.906 -0.588 . . . . 1.27 110.614 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 200' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' C' ' 197' ' ' ILE . 91.5 t80 -68.46 -30.81 69.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 1.7 110.947 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.7 -39.36 20.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 2.02 111.271 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -77.12 -8.11 56.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.281 . . . . 1.8200000000000001 111.682 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.461 ' HB3' HH22 ' C' ' 72' ' ' ARG . 17.7 p -96.66 -39.08 9.67 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.148 0.499 . . . . 1.3500000000000001 110.546 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.04 -33.89 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.623 -0.717 . . . . 0.65000000000000002 111.745 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.641 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 42.1 tp -62.53 -53.32 58.36 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.067 -0.253 . . . . 1.4199999999999999 111.577 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.8 Cg_exo -56.23 -39.34 91.91 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.842 1.695 . . . . 0.63 111.48 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -61.12 -34.32 74.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.959 -0.564 . . . . 1.49 110.721 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -66.56 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.009 -0.541 . . . . 1.7 110.951 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 209' ' ' SER . . . . . 0.472 ' HB2' HD13 ' C' ' 175' ' ' LEU . 28.0 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 1.25 110.999 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.751 0.31 . . . . 1.6100000000000001 111.0 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.79 69.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.913 -0.661 . . . . 0.81999999999999995 112.704 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -71.28 -34.85 71.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 3.0800000000000001 110.788 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -60.65 -59.3 5.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 1.1499999999999999 110.676 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.56 -23.4 65.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 2.5600000000000001 110.67 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tt -72.28 -40.28 67.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.932 -0.576 . . . . 1.29 110.992 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.53 -30.16 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 2.3900000000000001 111.192 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.11 -48.59 73.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 2.0299999999999998 110.876 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -81.07 -22.53 39.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 3.21 110.853 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.46 61.55 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.772 -0.728 . . . . 1.3600000000000001 112.945 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 30.3 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.704 0.288 . . . . 2.8999999999999999 111.033 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.4 tp . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.577 0.227 . . . . 2.4199999999999999 111.015 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.68 -34.73 77.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.406 -0.361 . . . . 2.0899999999999999 111.13 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 37.4 m80 -72.25 -28.85 63.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.044 0.449 . . . . 1.1599999999999999 110.379 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -72.44 -51.07 21.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.79000000000000004 110.331 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.34 -21.74 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.096 0.474 . . . . 2.0800000000000001 110.249 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -61.48 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 1.28 110.564 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 52' ' ' MET . 8.7 p -58.57 -30.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.01 -0.541 . . . . 1.3200000000000001 111.371 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.0 -55.41 29.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.63 111.429 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.76 -28.45 68.2 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.884 -0.674 . . . . 0.55000000000000004 112.763 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.16 -22.2 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 1.03 111.001 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -72.76 -52.13 16.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 1.3 110.844 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -65.4 -22.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 1.3100000000000001 110.942 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -68.47 -47.84 54.81 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.854 -0.689 . . . . 0.77000000000000002 112.652 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.452 ' HB1' ' HE3' ' A' ' 41' ' ' MET . . . -63.05 -33.88 76.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.80000000000000004 111.042 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -68.43 -36.52 79.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.203 0.525 . . . . 1.8100000000000001 110.532 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.9 t-80 -59.33 -20.99 59.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 110.485 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -62.49 -50.18 72.42 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.062 -0.517 . . . . 4.4500000000000002 110.973 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -58.91 -45.17 90.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 3.6899999999999999 110.495 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.3 m -69.9 -18.66 63.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 1.5700000000000001 110.794 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' HIS . 12.7 tp -76.57 0.26 20.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 1.95 111.933 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 p -66.83 -51.44 55.55 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.277 -0.569 . . . . 1.3799999999999999 111.19 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -54.17 -22.63 11.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.011 0.91 . . . . 4.0700000000000003 108.548 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.812 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.41 -150.98 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 113.757 -1.565 . . . . 2.7200000000000002 108.57 177.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 14.2 Cg_exo 6.91 96.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.713 2.942 . . . . 1.9099999999999999 116.472 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -102.96 96.87 7.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.663 -1.153 . . . . 4.7599999999999998 109.148 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.04 -36.92 2.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.502 -1.039 . . . . 1.99 110.502 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.1 t -111.77 126.2 28.96 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 109.315 -0.624 . . . . 2.7000000000000002 109.315 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 16.9 Cg_exo -65.82 165.83 22.25 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.482 2.121 . . . . 1.79 113.858 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -76.08 -13.3 60.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.507 -1.224 . . . . 4.1200000000000001 111.806 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CD2' ' HB2' ' A' ' 33' ' ' PRO . 1.7 p90 -38.69 -37.92 0.37 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.469 0.544 . . . . 2.9300000000000002 112.469 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.09 -45.19 86.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 2.8799999999999999 110.518 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -74.03 -18.57 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.005 -0.543 . . . . 4.6600000000000001 110.613 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.431 HD11 ' HD1' ' B' ' 104' ' ' PHE . 55.7 tp -60.66 -56.86 16.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.162 -0.472 . . . . 1.45 110.161 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.32 -36.24 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 1.78 109.918 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.21 -6.13 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.724 -0.671 . . . . 0.63 110.89 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.46 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 23.8 ttt -88.74 -35.59 16.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 1.48 110.641 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -72.61 -33.32 66.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 3.5 111.101 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.634 HG23 HG23 ' A' ' 79' ' ' THR . 79.0 mt -53.63 -52.98 62.22 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.271 0.471 . . . . 1.0800000000000001 112.271 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.5 Cg_endo -72.15 -33.3 9.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.28 1.987 . . . . 0.53000000000000003 113.236 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -57.89 -62.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.939 0.348 . . . . 1.6799999999999999 111.939 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.527 ' HE1' HG22 ' B' ' 110' ' ' ILE . 3.0 t90 -61.63 -51.41 68.59 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.626 -0.261 . . . . 1.8300000000000001 111.525 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.448 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 92.5 p -51.52 -54.13 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 1.0900000000000001 111.195 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -44.58 -54.79 6.39 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.208 -0.52 . . . . 0.40999999999999998 113.547 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.3 mt -52.12 -38.94 59.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.748 0.309 . . . . 0.98999999999999999 111.337 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.56 83.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.47999999999999998 111.059 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.507 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 96.8 m-85 -69.48 -44.19 71.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.8700000000000001 110.913 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.428 ' HB2' HG11 ' A' ' 12' ' ' VAL . 16.7 tmm? -49.61 -32.68 13.38 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.285 0.564 . . . . 1.49 110.126 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -72.13 -42.14 66.35 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.58999999999999997 111.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.2 mtt -54.17 -26.45 28.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.48999999999999999 110.363 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.05 -48.54 23.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.576 . . . . 0.59999999999999998 110.673 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 53' ' ' ALA . 44.3 pt -79.94 6.65 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 1.3100000000000001 111.023 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 59.59 55.1 4.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 1.9099999999999999 111.194 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -125.33 124.59 41.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 1.6200000000000001 110.735 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 120.34 29.88 1.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 1.04 112.398 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -150.34 144.74 25.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 2.6800000000000002 111.145 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.48 145.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 1.98 111.165 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -88.74 94.44 9.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 2.1800000000000002 110.893 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.08 133.48 55.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.019 -0.537 . . . . 1.5700000000000001 111.052 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.79 23.72 12.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.245 -0.434 . . . . 1.79 111.14 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.97 -15.1 50.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.83 -0.7 . . . . 1.48 112.534 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -104.73 151.22 24.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.313 . . . . 2.3199999999999998 110.854 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -98.17 138.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 1.4399999999999999 111.118 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.39 118.21 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.495 . . . . 0.81999999999999995 110.848 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 64.5 m-70 -78.96 79.25 5.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.295 0.569 . . . . 0.90000000000000002 111.204 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.88 -41.28 86.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.547 -0.751 . . . . 1.8300000000000001 110.932 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -67.0 -24.05 65.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 0.62 111.595 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.9 tpp180 -67.15 -51.88 48.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.098 -0.501 . . . . 2.3399999999999999 112.322 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.49 ' O ' ' HG3' ' A' ' 77' ' ' MET . 17.7 p90 -88.95 -27.98 20.57 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.511 0.56 . . . . 3.4900000000000002 112.511 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 71' ' ' ALA . 11.0 tp -57.78 -41.26 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.473 -0.491 . . . . 1.3700000000000001 110.069 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.448 ' OD2' ' HA ' ' A' ' 47' ' ' SER . 16.1 t70 -70.93 -17.14 62.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.143 -0.688 . . . . 1.3100000000000001 109.143 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -90.42 6.06 44.9 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.237 -0.892 . . . . 1.48 110.956 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.519 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 32.1 mtp -104.85 -17.68 14.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.488 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.439 ' O ' HD23 ' A' ' 82' ' ' LEU . 27.5 m -114.59 -34.81 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.1200000000000001 111.8 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.634 HG23 HG23 ' A' ' 43' ' ' ILE . 84.8 m -76.0 -59.56 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 1.1000000000000001 112.007 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 83.2 m -49.14 -51.06 59.69 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.503 0.557 . . . . 0.59999999999999998 112.503 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 58.4 Cg_exo -51.67 -52.85 8.1 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.765 1.643 . . . . 0.73999999999999999 111.844 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -63.45 -25.66 68.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 1.01 110.881 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.5 tp -72.91 -28.42 62.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.999 0.428 . . . . 1.48 110.033 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -84.47 -22.22 30.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.3799999999999999 110.103 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' PRO . 95.4 mt -85.07 -31.28 23.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.769 -0.65 . . . . 1.1899999999999999 110.646 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -61.64 -50.34 72.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.23 111.029 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 pp -61.99 -25.74 67.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.88 110.965 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.1 t -67.63 -43.78 79.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 1.3899999999999999 110.842 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -62.16 -40.6 96.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 2.3199999999999998 111.014 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -60.5 -33.9 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 1.46 111.029 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.52 -30.73 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 1.24 111.044 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.8 tpp -75.28 117.3 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 2.0699999999999998 110.817 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.67 -54.69 4.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 3.5299999999999998 111.066 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -137.12 144.82 43.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 4.0800000000000001 111.228 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.9 tt -107.55 148.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 2.1699999999999999 110.817 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -133.43 -75.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 4.5199999999999996 111.2 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -138.35 -13.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 3.75 111.343 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.31 106.82 1.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.457 -0.338 . . . . 3.5299999999999998 110.734 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -128.57 -21.52 3.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.332 -0.394 . . . . 4.9100000000000001 111.036 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.6 p -65.38 -26.01 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 1.98 111.034 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.75 -36.54 79.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 1.8300000000000001 110.951 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.03 -39.0 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 1.79 111.172 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.78 93.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.848 -0.692 . . . . 0.62 112.361 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.93 -41.25 95.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.5800000000000001 111.153 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.05 -48.41 80.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.97999999999999998 111.293 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -61.24 -27.34 68.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 1.48 111.289 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -72.45 -43.25 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.999 0.428 . . . . 1.1299999999999999 111.245 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 112' ' ' VAL . 71.6 p -72.3 -22.8 61.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.163 -0.471 . . . . 1.48 111.548 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 6.4 tp-100 -81.79 -45.47 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.322 -0.399 . . . . 2.7000000000000002 111.4 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' HE1' ' C' ' 46' ' ' TRP . 7.9 tp -59.5 -34.97 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.54 111.473 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 142' ' ' ILE . 17.9 m -71.16 -44.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 121.144 -0.223 . . . . 1.28 111.281 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 108' ' ' THR . 78.5 t -59.22 -55.59 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.795 0.331 . . . . 0.42999999999999999 111.537 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.0 mm -56.75 -32.89 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.385 -0.37 . . . . 1.74 111.436 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -55.71 -45.13 77.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.875 0.369 . . . . 0.63 110.554 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -67.34 -27.03 66.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.56 . . . . 1.0900000000000001 111.007 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.56 -41.04 30.73 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.876 -0.678 . . . . 0.41999999999999998 113.502 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -73.96 -28.26 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.806 0.299 . . . . 1.3799999999999999 111.806 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.472 HD11 ' HG3' ' C' ' 58' ' ' GLN . 10.2 tp -82.49 -26.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 1.6200000000000001 111.17 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.56 76.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.39000000000000001 110.894 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.4 -27.41 32.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 2.02 111.041 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.18 34.3 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.76000000000000001 111.257 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.6 m -85.61 131.19 34.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 1.46 110.853 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.472 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 12.1 pt-20 -80.4 -28.7 37.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 3.3500000000000001 111.077 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.524 ' HB2' HG12 ' A' ' 127' ' ' VAL . 78.5 mtm180 -130.17 158.19 40.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 2.9199999999999999 110.971 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.53 -11.9 59.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 2.77 111.048 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -90.06 -45.87 8.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.977 0.418 . . . . 3.77 110.405 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.0 p -65.45 -27.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 1.1599999999999999 110.757 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -65.28 -41.16 94.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 2.04 111.007 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.425 ' O ' HG12 ' A' ' 133' ' ' ILE . 72.2 t80 -56.88 -45.67 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 2.6400000000000001 110.873 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.71 -45.22 92.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 1.8999999999999999 111.376 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.18 70.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 1.3999999999999999 111.049 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -67.55 -43.33 80.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.411 . . . . 1.28 111.146 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 129' ' ' TYR . 38.3 mm -59.05 -39.18 77.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 2.1600000000000001 110.888 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.454 ' SG ' HD22 ' C' ' 49' ' ' LEU . 46.2 t -67.48 -28.45 67.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.222 -0.445 . . . . 1.6899999999999999 110.901 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.65 -55.88 24.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.871 -0.68 . . . . 0.52000000000000002 112.55 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 26.9 m -63.63 -37.25 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.563 0.22 . . . . 1.02 111.298 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.69 -44.2 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.454 -0.339 . . . . 1.0800000000000001 111.023 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.88 -35.67 75.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.62 110.897 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -69.82 -23.13 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 1.8400000000000001 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 86.9 mt -70.26 -59.93 2.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 1.6899999999999999 111.469 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -61.24 -27.02 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.504 -0.317 . . . . 0.81000000000000005 111.69 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 111' ' ' VAL . 72.5 mt -77.99 -50.35 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.483 -0.326 . . . . 2.3700000000000001 111.49 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.1 tp -49.44 -54.21 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.97999999999999998 111.188 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -64.63 -34.34 78.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 3.27 110.984 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.59 68.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.86 -0.686 . . . . 1.25 112.77 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.0 mt -103.73 -19.85 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 2.1200000000000001 111.173 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -59.73 -39.91 86.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.411 . . . . 1.6599999999999999 111.995 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 112.483 0.549 . . . . 99.989999999999995 112.483 -178.726 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 60.8 mt . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.039 0.447 . . . . 2.3399999999999999 110.544 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.46 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.5 OUTLIER -55.41 -39.86 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.662 -0.699 . . . . 2.77 111.08 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -51.69 -56.35 14.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 2.04 111.289 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -58.05 -28.28 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 2.77 111.484 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 165' ' ' TYR . 75.5 mt -72.95 -65.56 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.335 -0.393 . . . . 1.8899999999999999 111.46 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.15 -36.5 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.505 . . . . 1.6399999999999999 111.856 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.2 m -56.74 -52.55 64.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.311 . . . . 1.24 111.521 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.459 ' O ' HD23 ' A' ' 175' ' ' LEU . 75.5 t80 -58.41 -29.54 66.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.364 -0.38 . . . . 2.9700000000000002 110.961 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -71.01 -32.11 68.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 1.48 111.354 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.3 p -79.59 -37.86 35.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 1.55 111.767 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.24 -43.75 94.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.764 0.283 . . . . 1.52 111.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 171' ' ' TYR . 4.3 mm? -75.18 -50.69 15.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.651 -0.249 . . . . 1.8500000000000001 111.634 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.49 -31.65 62.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.62 110.593 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 181' ' ' ILE . 94.8 mt -87.66 -22.09 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.523 . . . . 1.3500000000000001 110.298 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -55.74 27.98 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.58999999999999997 113.097 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.606 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 86.5 m-85 -53.68 -54.98 40.18 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.835 0.317 . . . . 1.45 111.067 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.8 Cg_exo -45.95 -30.18 6.81 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.003 1.802 . . . . 0.55000000000000004 112.671 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -66.36 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 1.4199999999999999 111.164 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 179' ' ' TYR . 28.5 m -58.33 -26.63 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.501 . . . . 0.78000000000000003 111.572 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -66.22 -45.08 81.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.534 -0.303 . . . . 0.93999999999999995 111.227 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.2 mt -62.04 -62.57 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 1.4299999999999999 111.298 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 2.02 111.494 -179.618 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 200' ' ' PHE . 83.3 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.868 0.366 . . . . 2.48 111.382 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.55 -54.45 32.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.374 . . . . 2.1800000000000002 111.24 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -62.55 -32.49 73.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 1.49 111.706 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 197' ' ' ILE . 63.2 t80 -54.77 -38.31 67.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 1.77 111.126 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 49.0 tp -76.67 -46.53 25.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 1.4199999999999999 111.092 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -71.79 1.49 6.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 1.78 111.42 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.9 t -96.5 -46.3 6.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.3 110.507 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.78 -36.94 73.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.66000000000000003 111.998 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -57.21 -54.76 51.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 121.138 -0.225 . . . . 1.6299999999999999 111.293 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -55.48 -44.71 45.82 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.682 1.588 . . . . 0.64000000000000001 111.596 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.29 -25.4 67.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 1.3600000000000001 110.464 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.61 -30.85 59.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 1.54 110.751 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 1.2 110.998 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.785 0.326 . . . . 1.6399999999999999 111.284 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.33 -28.38 72.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.79000000000000004 112.423 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.22 -31.17 58.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.732 0.301 . . . . 1.6100000000000001 110.889 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.6 m -63.55 -62.02 1.94 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 1.1499999999999999 110.889 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.37 -27.86 66.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 3.3399999999999999 110.851 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.39 -48.9 71.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 1.1899999999999999 110.74 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.93 -27.77 69.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 2.23 110.912 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.52 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 2.4700000000000002 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -70.76 -49.09 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 1.6200000000000001 111.054 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.84 55.08 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.849 -0.691 . . . . 1.4099999999999999 112.58 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.0 tp . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 2.5800000000000001 110.89 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.766 0.317 . . . . 2.0699999999999998 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -34.73 71.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 2.1000000000000001 111.148 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.578 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 35.6 m170 -65.32 -33.25 75.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 1.0700000000000001 110.757 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -73.95 -46.87 41.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.16 -0.473 . . . . 1.48 110.617 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.07 -22.29 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.117 0.484 . . . . 2.02 110.262 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.28 -59.13 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.706 -0.679 . . . . 0.92000000000000004 110.538 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.21 -29.46 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.93999999999999995 111.328 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -50.42 67.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.55000000000000004 111.34 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.03 -32.8 85.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.47999999999999998 112.564 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.4 mmt -71.54 -26.02 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.84999999999999998 110.956 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.5 m -69.7 -59.2 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 1.3400000000000001 110.853 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.472 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.6 pp -56.32 -26.13 21.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.096 -0.502 . . . . 1.55 111.307 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.472 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -65.59 -47.94 72.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.608 -0.806 . . . . 0.69999999999999996 112.26 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' B' ' 41' ' ' MET . . . -60.09 -33.84 72.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.81000000000000005 111.047 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.77 -33.5 72.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.335 -0.393 . . . . 2.2599999999999998 110.545 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -61.14 -20.27 62.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 1.78 110.539 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.34 -53.35 58.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 4.5800000000000001 110.968 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.593 ' O ' ' OG ' ' B' ' 26' ' ' SER . 80.8 m95 -62.62 -42.71 99.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.953 -0.567 . . . . 3.3500000000000001 110.955 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 1.5800000000000001 111.253 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -80.73 -5.66 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 1.8400000000000001 110.881 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 15.7 p -72.09 -15.23 62.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 1.3700000000000001 110.775 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -45.95 -40.71 10.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.432 -0.581 . . . . 4.9800000000000004 109.432 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -179.08 130.51 0.27 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.141 -0.936 . . . . 2.1400000000000001 110.219 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -96.28 179.36 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.991 2.461 . . . . 1.8200000000000001 112.182 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -99.85 52.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 5.1900000000000004 111.188 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.1 -46.63 2.02 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.839 -0.696 . . . . 2.2000000000000002 112.552 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 32.7 m -91.87 144.82 29.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.523 0.201 . . . . 3.6499999999999999 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 165.36 17.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.514 2.143 . . . . 2.6699999999999999 112.581 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -62.64 -17.43 60.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 4.8799999999999999 111.837 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -42.3 -35.07 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.726 0.298 . . . . 1.8700000000000001 111.662 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -64.54 -48.31 75.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.932 0.396 . . . . 2.6800000000000002 110.225 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.28 -18.56 61.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 2.9199999999999999 110.703 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' B' ' 41' ' ' MET . 47.7 tp -60.7 -53.44 57.36 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.981 0.42 . . . . 1.6399999999999999 110.325 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.23 -38.74 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 1.6000000000000001 109.893 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.14 -5.62 36.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.629 -0.714 . . . . 0.68999999999999995 110.734 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.466 ' HE3' ' HB1' ' B' ' 19' ' ' ALA . 25.3 ttt -88.65 -36.08 16.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.906 -0.588 . . . . 2.5800000000000001 110.402 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -70.74 -34.2 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.921 -0.582 . . . . 3.3900000000000001 111.078 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.614 HG23 HG23 ' B' ' 79' ' ' THR . 98.7 mt -53.54 -54.76 42.19 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.459 0.54 . . . . 0.40999999999999998 112.459 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 59.9 Cg_endo -70.43 -37.31 7.71 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.405 2.07 . . . . 0.48999999999999999 113.566 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.15 -62.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.748 0.277 . . . . 1.29 111.748 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.619 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -62.08 -52.75 62.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.3999999999999999 111.355 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.442 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 38.4 t -54.04 -31.82 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.3799999999999999 111.566 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.11 -49.75 64.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.37 112.757 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.476 HD22 ' SG ' ' C' ' 134' ' ' CYS . 75.7 mt -54.77 -44.56 73.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 1.29 111.503 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.15 -50.26 67.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.44 111.565 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -63.23 -40.04 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.5 111.303 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.3 ttp -52.39 -34.09 46.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.182 0.515 . . . . 1.4099999999999999 110.196 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -69.78 -40.67 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.598 -0.728 . . . . 0.55000000000000004 110.944 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 56.2 mtt -54.33 -28.64 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.52 . . . . 0.5 110.489 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.83 -52.06 16.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 0.54000000000000004 110.946 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.1 pt -78.65 9.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.913 -0.585 . . . . 1.3 111.539 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 60.03 63.8 1.38 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.063 -0.517 . . . . 2.2400000000000002 111.036 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.447 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 6.8 tp-100 -136.23 128.78 30.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 1.77 110.639 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.87 38.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 1.0600000000000001 112.194 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -150.43 140.81 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 2.6600000000000001 110.81 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.75 141.15 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 1.8899999999999999 111.068 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.43 94.8 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 2.4100000000000001 110.922 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.17 125.04 51.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 1.5600000000000001 111.144 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.05 35.92 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 1.8200000000000001 111.301 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.28 4.7 51.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.74 -0.743 . . . . 1.51 112.547 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -108.46 140.88 41.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.64 0.257 . . . . 2.4500000000000002 110.853 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 55.2 mt -99.27 119.42 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 1.79 110.892 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.48 113.86 27.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.81999999999999995 111.136 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.628 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 93.1 m-70 -73.91 83.34 1.7 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.4 0.619 . . . . 1.05 110.792 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.476 ' HD2' ' HH ' ' B' ' 73' ' ' TYR . 75.6 t80 -52.25 -56.71 12.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 1.8700000000000001 111.567 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -21.93 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.606 0.595 . . . . 0.60999999999999999 112.606 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.628 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 20.3 tpp180 -64.66 -52.54 56.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.275 0.472 . . . . 2.3900000000000001 112.275 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.476 ' HH ' ' HD2' ' B' ' 70' ' ' TYR . 36.7 p90 -87.34 -29.71 21.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.482 -0.487 . . . . 3.6699999999999999 111.418 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.65 -45.96 79.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.692 -0.484 . . . . 1.6599999999999999 109.692 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 16.3 t70 -67.72 -23.47 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 1.4099999999999999 109.139 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 28.9 m0 -86.08 8.18 21.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.457 -0.792 . . . . 1.1599999999999999 111.07 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 -22.51 13.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.758 -0.655 . . . . 1.53 110.571 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.417 ' O ' HD23 ' B' ' 82' ' ' LEU . 35.4 m -113.88 -30.34 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.89000000000000001 111.927 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.614 HG23 HG23 ' B' ' 43' ' ' ILE . 76.1 m -81.29 -52.13 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.008 0.373 . . . . 1.24 112.008 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.584 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 11.9 m -51.8 -49.79 81.48 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.205 0.446 . . . . 0.57999999999999996 112.205 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' B' ' 80' ' ' THR . 10.4 Cg_endo -54.67 -50.94 11.65 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.803 1.669 . . . . 0.66000000000000003 111.782 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.417 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -65.16 -26.13 68.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 1.0600000000000001 110.637 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -36.87 79.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.18 0.514 . . . . 1.22 109.772 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.4 tt -80.36 -25.44 39.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.539 -0.755 . . . . 1.53 110.789 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 98.6 mt -77.78 -36.83 50.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 1.5800000000000001 111.201 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 59.5 m -56.96 -39.68 75.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 1.3899999999999999 110.949 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 98.2 mt -68.58 -35.59 77.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 1.1499999999999999 111.072 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 61.1 m -61.09 -35.31 76.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.326 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -72.24 -36.22 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 2.1699999999999999 110.986 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 29.7 m -66.55 -37.58 85.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 1.4199999999999999 110.81 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -28.59 39.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 1.1799999999999999 110.925 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.1 ttm -77.96 117.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.8799999999999999 110.718 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -86.78 -61.48 1.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 3.4199999999999999 111.223 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.22 160.52 30.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 4.0599999999999996 111.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 70.0 mt -124.9 142.32 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 2.0899999999999999 110.824 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -139.38 -51.08 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 3.8500000000000001 110.83 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -161.93 -161.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 4.8200000000000003 110.511 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 60.76 87.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.448 . . . . 3.7999999999999998 110.795 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -101.13 0.08 37.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 110.852 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.1 p -71.67 -25.91 62.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 2.02 111.293 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.95 -39.71 90.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 2.0899999999999999 110.786 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.61 -38.13 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 1.8799999999999999 111.034 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.4 -29.25 71.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.56000000000000005 112.215 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' B' ' 146' ' ' ILE . 66.2 t80 -65.74 -37.58 86.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.95 0.405 . . . . 1.78 110.588 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.43 ' HB3' HD21 ' B' ' 84' ' ' LEU . 55.4 mt -68.63 -41.37 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.793 -0.64 . . . . 1.03 111.11 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' MET . . . . . 0.415 ' O ' HG12 ' B' ' 110' ' ' ILE . 57.9 mtt -64.45 -45.92 85.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 1.6699999999999999 111.135 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 55.6 m -55.58 -42.07 74.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 1.51 111.478 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.479 ' O ' HG23 ' B' ' 112' ' ' VAL . 75.9 p -69.27 -24.94 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 1.1799999999999999 111.416 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -80.49 -44.59 18.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.559 -0.291 . . . . 2.1699999999999999 111.566 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.527 HG22 ' HE1' ' A' ' 46' ' ' TRP . 48.5 mm -57.53 -38.72 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 1.3500000000000001 111.391 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.64 -43.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 1.3400000000000001 111.854 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 108' ' ' THR . 70.2 t -61.03 -55.29 25.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.645 0.26 . . . . 0.42999999999999999 111.62 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.489 HD11 HG21 ' B' ' 80' ' ' THR . 29.7 mm -61.0 -29.26 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 1.6000000000000001 111.23 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.1 m -55.29 -49.34 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.972 0.415 . . . . 0.85999999999999999 110.528 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 75.3 p -70.92 -20.44 62.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.94999999999999996 110.482 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.28 -33.7 43.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.006 -0.616 . . . . 0.46000000000000002 112.975 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.529 HD12 HG13 ' B' ' 118' ' ' ILE . 2.8 pp -82.89 -24.68 33.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 0.235 . . . . 1.75 111.162 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.529 HG13 HD12 ' B' ' 117' ' ' LEU . 85.7 mt -80.21 -36.24 16.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 120.803 0.335 . . . . 1.78 110.838 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.86 -38.24 48.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.539 . . . . 0.38 111.154 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -82.6 -26.74 32.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.006 -0.543 . . . . 1.97 111.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -86.35 22.27 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.341 . . . . 0.76000000000000001 111.185 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -67.27 139.62 57.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.47 110.843 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -94.03 -17.69 22.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 2.5 111.044 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.646 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 48.7 ttp180 -137.88 156.46 47.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.499 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.53 -14.97 60.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 2.2000000000000002 110.935 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.646 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 54.4 t90 -92.96 -37.98 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 3.3999999999999999 111.19 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' B' ' 124' ' ' ARG . 18.4 m -65.34 -24.32 34.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.215 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.8 ttt-85 -63.47 -47.59 81.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 3.04 111.385 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.97 -32.82 68.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 4.1399999999999997 111.557 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.17 -46.56 76.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 1.6499999999999999 110.873 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -74.33 -25.57 59.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.77000000000000002 110.732 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.2 -51.82 61.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.816 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.58 -33.27 60.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.31 -0.405 . . . . 1.6299999999999999 110.804 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.78 -28.22 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.4199999999999999 110.588 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.39 -53.68 16.31 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.925 -0.655 . . . . 0.48999999999999999 112.487 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 28.9 m -61.79 -35.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.593 0.235 . . . . 1.3 111.312 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 90.8 m -61.22 -35.88 78.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.75 0.31 . . . . 1.3 110.725 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.52 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.62 110.637 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.54 -23.5 63.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 1.74 110.892 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 90.5 mt -71.47 -55.62 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.418 . . . . 1.76 111.187 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 43.1 pt -66.59 -28.85 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.68999999999999995 111.534 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.63 -51.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 1.76 111.075 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 54.2 tp -52.75 -49.62 65.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.336 -0.393 . . . . 1.0600000000000001 110.672 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.06 -24.61 65.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.518 . . . . 4.1200000000000001 110.602 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.82 -17.66 74.56 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 1.26 112.776 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.44 HG12 ' HE2' ' B' ' 104' ' ' PHE . 56.7 mt -103.39 -19.52 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.781 0.324 . . . . 1.98 111.127 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -54.86 -50.04 69.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.449 . . . . 1.4199999999999999 111.922 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.91 0.337 . . . . 99.989999999999995 111.91 -178.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.845 0.355 . . . . 2.4300000000000002 110.946 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.33 -29.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 2.5800000000000001 111.013 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.63 -59.04 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 2.0 111.223 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -58.41 -21.57 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 3.0299999999999998 111.767 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.7 -63.58 1.38 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 111.399 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.23 -31.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 1.75 111.634 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -59.88 -52.2 66.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 0.97999999999999998 111.152 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.96 -33.58 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 4.2999999999999998 110.766 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -72.17 -25.91 61.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 1.3899999999999999 110.763 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.438 HG22 HD12 ' B' ' 177' ' ' ILE . 27.2 m -79.35 -40.26 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 1.1100000000000001 111.819 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.6 -35.02 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.492 -0.322 . . . . 1.51 111.484 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.69 -57.05 4.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.316 -0.402 . . . . 1.75 111.624 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -31.06 56.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.59999999999999998 111.028 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.474 ' O ' HG12 ' B' ' 181' ' ' ILE . 92.4 mt -87.67 -21.43 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 1.47 110.521 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -55.9 27.93 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.55000000000000004 113.074 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 90.5 m-85 -54.23 -53.94 53.32 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.73 0.265 . . . . 1.6200000000000001 111.273 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.7 Cg_exo -45.08 -34.57 9.42 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.2 1.934 . . . . 0.64000000000000001 112.966 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.474 HG12 ' O ' ' B' ' 177' ' ' ILE . 48.8 mm -65.79 -60.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.856 0.36 . . . . 1.27 111.503 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.514 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.9 m -56.84 -24.37 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.417 -0.356 . . . . 0.68999999999999995 111.154 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -69.23 -53.66 18.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 1.1799999999999999 111.857 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 185' ' ' ILE . 10.5 tt -62.06 -51.65 69.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 111.852 0.315 . . . . 1.77 111.852 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 185' ' ' ILE . . . . . 0.425 ' N ' HG23 ' B' ' 184' ' ' ILE . 2.3 pp -60.66 131.02 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 1.6899999999999999 110.647 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 C-N-CA 120.638 -0.791 . . . . 1.5800000000000001 112.365 -179.753 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.841 0.353 . . . . 2.4700000000000002 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -51.4 -55.68 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 2.5299999999999998 111.04 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -56.87 -38.09 72.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.29 111.658 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -57.0 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 2.6200000000000001 111.342 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 57.1 tp -83.36 -41.75 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.339 . . . . 1.6100000000000001 111.133 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -77.88 -0.97 29.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 1.4199999999999999 111.162 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 37.0 t -96.14 -43.59 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.127 0.489 . . . . 1.4299999999999999 110.263 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 42.9 tp -72.97 -36.82 67.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.665 -0.698 . . . . 1.1200000000000001 111.98 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.688 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 34.2 tp -58.08 -54.51 54.9 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.029 -0.268 . . . . 1.26 111.596 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 34.3 Cg_exo -58.8 -39.44 81.74 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.757 1.638 . . . . 0.59999999999999998 111.471 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.98 -28.23 69.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 1.3999999999999999 110.226 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -75.43 -25.53 57.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.047 -0.524 . . . . 1.4099999999999999 110.546 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 1.3200000000000001 110.55 179.89 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.805 0.336 . . . . 1.6899999999999999 110.987 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.05 60.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.837 -0.697 . . . . 0.79000000000000004 112.121 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -58.97 -39.06 80.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 2.96 111.211 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 42.2 t -56.49 -61.07 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.29 111.203 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.28 -20.03 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 3.1499999999999999 110.955 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -72.1 -45.23 61.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 1.51 110.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.37 -27.02 67.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 2.1899999999999999 110.82 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.66 -46.19 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 1.98 111.201 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -74.38 -43.41 56.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 2.1699999999999999 111.29 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.64 -18.73 72.33 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.781 -0.723 . . . . 1.3600000000000001 112.86 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.546 0.212 . . . . 2.8999999999999999 111.079 -179.904 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.463 ' N ' HD12 ' C' ' 6' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.46 0.052 0 CA-C-O 120.769 0.319 . . . . 2.52 110.452 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 7' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' C' ' 11' ' ' TYR . 3.7 mm? -60.83 -31.58 71.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 1.9299999999999999 110.921 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 32.3 m170 -69.54 -32.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 1.26 110.746 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -75.44 -54.64 6.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.23 -0.441 . . . . 1.6699999999999999 110.954 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 36.6 mm -57.04 -22.21 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.472 . . . . 1.8700000000000001 110.32 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' C' ' 7' ' ' LEU . 4.3 t80 -67.64 -59.34 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.649 -0.705 . . . . 1.4399999999999999 110.773 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.15 -29.22 46.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.46999999999999997 111.351 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.91 -47.81 70.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.58999999999999997 111.369 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.13 79.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.5 112.81 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 24.9 mmt -72.18 -25.04 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.363 . . . . 0.68000000000000005 111.079 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 85.7 m -69.68 -53.33 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.055 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.73 -24.06 34.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 1.55 111.12 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -54.11 30.66 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.87 -0.681 . . . . 0.70999999999999996 112.513 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.9 70.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.77000000000000002 110.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -64.8 -33.68 76.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.128 -0.487 . . . . 1.9299999999999999 110.649 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -63.84 -19.86 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 1.8600000000000001 110.998 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.24 -58.24 9.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 4.1399999999999997 111.127 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.78 -33.78 76.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 3.1499999999999999 111.039 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -71.89 -22.34 61.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 1.95 111.169 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 tp -84.63 -6.0 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 2.2200000000000002 111.106 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 98.5 p -67.62 -12.89 61.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.3700000000000001 110.82 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -47.94 -42.83 28.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.189 -0.671 . . . . 5.0300000000000002 109.189 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.6 p-10 -177.16 130.66 0.34 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.193 -0.912 . . . . 2.3700000000000001 110.201 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 85.0 Cg_endo . . . . . 0 N--CA 1.451 -1.023 0 C-N-CA 123.242 2.628 . . . . 2.0499999999999998 112.056 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' PRO . . . . . 0.465 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 35.4 Cg_exo . . . . . 0 C--O 1.23 0.105 0 CA-C-O 121.136 0.39 . . . . 1.9299999999999999 111.996 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLN . . . . . 0.41 ' HA ' ' HD2' ' C' ' 37' ' ' TYR . 25.6 mm-40 -58.92 -17.2 22.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.63 -0.714 . . . . 4.1200000000000001 112.429 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.465 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -45.1 -33.53 2.21 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.735 0.302 . . . . 2.8900000000000001 111.367 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.74 -49.1 72.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.953 0.406 . . . . 2.46 110.128 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' TYR . . . . . 0.41 ' HD2' ' HA ' ' C' ' 34' ' ' GLN . 58.9 m-85 -70.48 -18.76 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 2.7799999999999998 110.476 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' C' ' 41' ' ' MET . 39.1 tp -60.48 -56.78 17.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.274 -0.421 . . . . 1.6200000000000001 110.496 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.26 -36.46 74.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 1.5900000000000001 110.014 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -74.74 -4.34 36.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.934 -0.576 . . . . 0.65000000000000002 110.747 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.479 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 23.9 ttt -88.52 -37.31 15.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.917 -0.583 . . . . 1.6699999999999999 110.485 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.92 -34.57 69.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 3.4199999999999999 111.252 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.605 HG23 HG23 ' C' ' 79' ' ' THR . 83.0 mt -51.08 -53.58 46.95 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.161 0.43 . . . . 0.89000000000000001 112.161 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.76 -34.4 8.98 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.314 2.01 . . . . 0.40999999999999998 113.231 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -55.19 -62.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 1.76 111.683 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.429 ' HE1' HG13 ' A' ' 110' ' ' ILE . 1.1 t90 -63.38 -53.03 58.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.551 -0.295 . . . . 2.1600000000000001 111.245 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' SER . . . . . 0.467 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 39.9 t -53.7 -31.74 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 1.1699999999999999 111.782 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.61 -49.37 60.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.44 112.652 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.454 HD22 ' SG ' ' A' ' 134' ' ' CYS . 50.1 mt -58.25 -35.67 72.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 1.29 111.441 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.87 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.5 111.602 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 22.5 m-85 -61.34 -38.7 87.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.8300000000000001 111.512 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 45.7 ttp -50.33 -38.23 40.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.26 0.552 . . . . 1.47 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.64 82.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.503 -0.771 . . . . 0.59999999999999998 110.777 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.8 mtt -51.42 -28.87 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.83999999999999997 110.626 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -72.92 -51.56 18.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.65000000000000002 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 127' ' ' VAL . 29.1 pt -76.91 9.37 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 1.55 111.492 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 59.12 51.43 7.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.058 -0.519 . . . . 1.54 111.373 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.472 ' HG3' HD11 ' A' ' 118' ' ' ILE . 6.7 tp-100 -120.73 139.62 52.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 1.79 110.877 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.88 32.52 5.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.93999999999999995 112.205 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -139.4 136.19 34.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 2.3599999999999999 111.03 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.28 136.47 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.428 -0.351 . . . . 1.97 111.15 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.27 91.32 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 2.4399999999999999 110.63 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.85 128.7 55.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 1.54 111.033 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.93 33.66 19.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.076 -0.511 . . . . 1.71 111.093 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 16.05 61.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.769 -0.729 . . . . 1.53 112.499 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.53 125.17 41.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.742 0.306 . . . . 2.23 110.737 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 25.8 pt -75.57 133.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 1.3600000000000001 111.398 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.01 113.01 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.78000000000000003 110.923 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.545 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 91.6 m-70 -75.64 79.07 2.62 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.286 0.565 . . . . 1.0800000000000001 111.211 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -57.73 -34.94 70.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.404 -0.816 . . . . 2.2999999999999998 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.35 -22.68 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.75 111.871 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.8 tpp180 -67.62 -51.47 49.76 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.435 0.532 . . . . 1.51 112.435 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' C' ' 77' ' ' MET . 28.8 p90 -87.1 -30.95 20.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.435 0.532 . . . . 4.6500000000000004 112.435 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.9 tp -56.46 -41.16 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.564 -0.455 . . . . 1.22 110.108 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 19.6 t0 -69.8 -20.61 63.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.994 -0.743 . . . . 1.3100000000000001 108.994 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -89.75 9.9 25.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.249 -0.887 . . . . 1.6799999999999999 110.888 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 92.0 mmm -105.05 -21.86 13.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 1.8 110.152 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.57 -29.1 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 1.1899999999999999 112.163 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.605 HG23 HG23 ' C' ' 43' ' ' ILE . 61.9 m -83.42 -49.49 9.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.212 0.449 . . . . 1.23 112.212 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.2 m -55.05 -50.73 84.79 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 111.898 0.333 . . . . 0.58999999999999997 111.898 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.4 Cg_exo -54.69 -47.92 24.1 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.917 1.745 . . . . 0.67000000000000004 111.665 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.27 -27.71 68.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.921 -0.581 . . . . 0.95999999999999996 110.573 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.501 HD13 ' O ' ' C' ' 83' ' ' LEU . 1.2 tm? -67.55 -38.04 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.257 0.551 . . . . 1.1899999999999999 109.632 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -78.56 -25.63 45.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 1.7 110.871 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.04 -33.0 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 1.6200000000000001 111.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 60.1 m -62.91 -54.06 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.26 110.978 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 pp -61.8 -22.15 65.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.1100000000000001 111.08 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -50.51 52.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 1.51 110.648 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -60.67 -28.23 68.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.406 . . . . 2.0600000000000001 110.68 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -60.88 -52.43 65.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 1.52 110.801 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.25 60.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.191 -0.459 . . . . 1.3 111.056 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 12.9 tpt -86.86 112.89 22.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 1.6200000000000001 110.488 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -86.55 -61.55 1.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 3.2400000000000002 111.442 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -130.97 144.3 51.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 4.6299999999999999 111.301 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 tt -109.32 146.13 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 2.1800000000000002 110.739 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -124.54 -83.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.571 -0.286 . . . . 4.1200000000000001 111.247 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -139.2 3.38 2.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 4.96 111.332 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.41 91.89 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 3.9100000000000001 110.698 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -107.6 -13.59 15.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 5.21 111.29 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 7.3 t -69.35 -27.71 65.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 1.8200000000000001 111.245 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.16 -35.5 75.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 2.0800000000000001 110.957 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.1 -38.9 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.906 -0.588 . . . . 1.8600000000000001 111.294 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -35.5 92.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.58999999999999997 112.571 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -65.17 -35.82 82.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 1.53 110.847 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.25 -45.66 83.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 110.974 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 106' ' ' MET . . . . . 0.421 ' O ' HG13 ' C' ' 110' ' ' ILE . 91.0 mmm -62.44 -43.31 99.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 2.21 110.715 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -53.71 -51.2 64.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 1.28 111.479 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 75.7 p -59.64 -30.34 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 1.22 111.761 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -74.55 -50.45 18.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 2.3300000000000001 111.654 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.619 HG22 ' HE1' ' B' ' 46' ' ' TRP . 58.9 mt -52.34 -34.92 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.399 -0.364 . . . . 1.29 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.22 -48.94 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.0600000000000001 111.494 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.34 -56.55 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.51000000000000001 111.874 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' C' ' 110' ' ' ILE . 25.4 pt -54.51 -32.37 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 1.3700000000000001 111.804 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 20.3 m -60.66 -46.76 89.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.77000000000000002 110.899 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -67.32 -20.58 65.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 1.1899999999999999 110.939 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.72 -40.87 11.61 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.986 -0.626 . . . . 0.5 113.058 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.505 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.8 pp -73.68 -29.65 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.289 . . . . 1.47 111.424 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.505 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.1 tp -81.22 -28.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.806 0.336 . . . . 1.2 110.988 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.46 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.537 . . . . 0.40000000000000002 110.994 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.57 -24.74 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 2.1200000000000001 111.116 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 93.5 mt -88.02 33.83 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.75 110.715 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 83.4 p -77.95 132.73 38.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 1.3799999999999999 111.007 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.99 -25.61 29.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 2.7400000000000002 110.577 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -134.72 152.57 51.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.897 -0.592 . . . . 2.7999999999999998 110.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.91 -11.09 60.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 2.4100000000000001 111.315 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -92.81 -40.64 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.463 -0.335 . . . . 4.2000000000000002 111.071 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.42 -23.9 25.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 1.0800000000000001 110.822 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -66.74 -35.79 80.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.948 -0.569 . . . . 2.5699999999999998 111.0 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -65.0 -32.15 73.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 3.8100000000000001 111.203 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.63 -54.38 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 1.4199999999999999 111.2 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -58.6 -28.68 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.89000000000000001 111.286 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.72 -44.99 80.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 1.26 110.861 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 81.7 mt -56.92 -37.27 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 1.6799999999999999 110.744 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 134' ' ' CYS . . . . . 0.476 ' SG ' HD22 ' B' ' 49' ' ' LEU . 53.8 t -70.36 -27.06 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 1.24 110.766 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.3 -56.7 20.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.54000000000000004 112.385 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.9 -32.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 1.0600000000000001 110.985 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 50.1 t -63.39 -35.71 81.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 110.301 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.75 92.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.775 -0.648 . . . . 0.56999999999999995 110.838 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -69.81 -16.12 63.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.6799999999999999 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.21 -58.59 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 1.7 110.592 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 17.2 pt -71.15 -27.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.78000000000000003 111.596 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.98 -44.31 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.333 -0.394 . . . . 2.2400000000000002 111.221 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.9 tp -55.54 -57.94 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.334 . . . . 1.02 111.078 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -62.77 -24.98 67.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 3.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.23 -16.84 79.61 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 1.27 112.64 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 69.1 mt -105.52 -18.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 1.8899999999999999 111.183 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -62.3 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 1.6000000000000001 111.932 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 112.344 0.498 . . . . 99.989999999999995 112.344 -178.796 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 20.0 mt . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.124 0.488 . . . . 2.3500000000000001 110.774 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -23.58 46.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.373 -0.83 . . . . 2.6200000000000001 111.192 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.4 -50.48 63.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 2.0899999999999999 110.751 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -61.09 -35.78 77.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 3.2400000000000002 110.821 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.7 -62.81 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 1.6899999999999999 111.227 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.09 -32.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 1.3999999999999999 111.479 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.7 m -57.11 -53.08 62.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.362 . . . . 0.95999999999999996 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -56.16 -39.25 72.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 3.6499999999999999 110.84 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -62.75 -32.13 73.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 1.3700000000000001 111.084 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 34.2 m -73.8 -46.69 43.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.508 . . . . 1.4299999999999999 111.413 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.61 -28.95 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 1.6200000000000001 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.8 tp -80.52 -57.67 3.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.356 -0.384 . . . . 2.0299999999999998 111.678 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.28 -28.14 62.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.748 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.449 ' O ' HG13 ' C' ' 181' ' ' ILE . 34.2 mm -87.83 -23.33 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 1.5800000000000001 110.166 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.51 24.56 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.814 -0.63 . . . . 0.56000000000000005 113.155 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 66.2 m-85 -53.85 -54.97 40.73 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.899 0.349 . . . . 1.3300000000000001 111.069 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 80.4 Cg_exo -45.36 -33.54 9.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.946 1.764 . . . . 0.63 112.664 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.449 HG13 ' O ' ' C' ' 177' ' ' ILE . 87.3 mt -63.9 -61.14 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.568 -0.287 . . . . 0.93000000000000005 111.483 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 p -56.95 -35.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 1.27 111.623 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -57.13 -51.37 69.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.564 -0.289 . . . . 1.77 111.147 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.0 -65.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.371 -0.377 . . . . 2.3900000000000001 111.656 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 185' ' ' ILE . . . . . 0.427 ' O ' HD12 ' C' ' 185' ' ' ILE . 2.5 pp . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.077 0.465 . . . . 1.95 111.248 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.861 0.362 . . . . 2.3799999999999999 110.979 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -51.28 -33.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.185 -0.461 . . . . 2.23 111.462 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.52 -56.43 18.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.392 . . . . 2.1600000000000001 111.007 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.6 p -60.99 -31.18 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 1.27 111.478 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.3 -39.0 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 1.7 111.333 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.0 -45.49 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 2.02 111.435 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.21 -3.22 12.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.746 0.308 . . . . 1.8200000000000001 110.984 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 25.6 t -96.19 -40.95 8.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.197 0.522 . . . . 1.3500000000000001 110.072 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 55.5 tp -74.12 -37.55 64.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.512 -0.767 . . . . 0.65000000000000002 111.733 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.666 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 52.1 tp -57.19 -53.84 61.0 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.765 -0.198 . . . . 1.4199999999999999 111.463 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 32.6 Cg_exo -58.59 -42.35 55.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.73 1.62 . . . . 0.63 111.476 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' C' ' 11' ' ' TYR . 51.3 t80 -64.11 -26.43 68.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.106 -0.497 . . . . 1.49 110.393 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.36 -26.01 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 1.7 110.479 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 89.2 p . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 1.25 110.811 179.85 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.779 0.323 . . . . 1.6100000000000001 111.279 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.33 -32.46 62.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.78 . . . . 0.81999999999999995 112.619 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.71 -36.76 70.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.671 0.272 . . . . 3.0800000000000001 111.038 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.3 t -61.34 -56.31 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 110.947 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -61.23 -25.54 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 2.5600000000000001 110.853 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.42 -51.08 32.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 1.29 110.827 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.19 -21.47 63.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 2.3900000000000001 111.25 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.56 -35.56 39.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 2.0299999999999998 111.203 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -82.28 -33.4 29.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.972 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -81.14 -18.75 68.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.852 -0.69 . . . . 1.3600000000000001 112.364 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.553 0.216 . . . . 2.8999999999999999 111.211 -179.93 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt . . . . . 0 N--CA 1.46 0.062 0 CA-C-O 120.651 0.263 . . . . 2.4199999999999999 111.261 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.85 -59.67 2.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.332 . . . . 2.0899999999999999 111.171 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 35.5 m80 -59.86 -23.69 63.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 1.1599999999999999 110.586 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.415 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.4 t-105 -66.33 -54.51 23.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.79000000000000004 110.765 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.45 -23.18 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 2.0800000000000001 110.51 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.488 ' OH ' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -60.32 -61.28 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.64 . . . . 1.28 111.108 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 9' ' ' TRP . 8.1 p -57.19 -32.79 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.4 . . . . 1.3200000000000001 111.188 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.85 98.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.63 111.024 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.57 -22.16 78.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.833 -0.699 . . . . 0.55000000000000004 112.365 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.0 mmt -73.29 -42.56 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 1.03 110.825 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.4 p -61.67 -49.85 74.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 1.3 111.11 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.77 -24.27 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 1.3100000000000001 110.982 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.58 -46.6 91.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.766 -0.731 . . . . 0.77000000000000002 112.551 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.1 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.747 0.308 . . . . 0.80000000000000004 111.201 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.92 -28.62 69.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 1.8100000000000001 110.972 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -54.96 -32.79 61.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 1.8799999999999999 110.63 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -75.15 -36.7 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 4.4500000000000002 110.842 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -54.58 -34.72 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.916 0.388 . . . . 3.6899999999999999 110.678 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.8 m -85.31 -29.65 24.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 1.5700000000000001 111.178 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.3 tp -87.27 -5.62 58.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 1.95 111.297 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.1 p -60.2 -19.81 55.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.3799999999999999 111.188 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -50.01 -32.24 14.8 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.187 0.517 . . . . 4.0700000000000003 109.726 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -176.15 132.17 0.4 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.103 -0.953 . . . . 2.7200000000000002 109.912 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -95.52 -176.84 0.39 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.877 2.385 . . . . 1.9099999999999999 112.609 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -86.43 45.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 4.7599999999999998 110.979 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.71 -45.74 3.38 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.881 -0.676 . . . . 1.99 112.613 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.8 118.99 71.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 2.7000000000000002 111.265 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' TYR . 51.2 Cg_exo -55.06 168.61 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.961 2.441 . . . . 1.79 112.351 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -39.63 -18.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.335 -0.848 . . . . 4.1200000000000001 113.17 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 m-30 -41.27 -60.47 1.25 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.887 0.375 . . . . 2.9300000000000002 111.396 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.23 -41.95 97.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.034 -0.53 . . . . 2.8799999999999999 111.597 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -69.27 -19.36 63.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.618 -0.264 . . . . 4.6600000000000001 111.484 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.08 -55.55 10.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.953 0.406 . . . . 1.45 110.268 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.655 HG23 HD12 ' A' ' 82' ' ' LEU . 4.3 p -68.35 -31.32 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.78 111.031 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.6 -13.05 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.524 . . . . 0.63 111.663 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.491 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 17.0 tmm? -89.12 -35.51 16.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 1.48 111.287 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -77.81 -33.81 52.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.279 0.474 . . . . 3.5 112.279 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.592 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 88.6 mt -54.06 -50.54 83.74 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 111.753 0.279 . . . . 1.0800000000000001 111.753 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 12.1 Cg_exo -71.23 -43.22 1.61 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.647 2.232 . . . . 0.53000000000000003 113.059 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 41' ' ' MET . 42.3 mm -56.38 -61.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.778 0.288 . . . . 1.6799999999999999 111.778 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -55.18 -58.36 8.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.652 0.263 . . . . 1.8300000000000001 111.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.6 p -52.01 -42.16 62.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 1.0900000000000001 111.535 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -48.8 -60.35 6.04 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.129 -0.557 . . . . 0.40999999999999998 112.992 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.23 -34.87 58.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.98999999999999999 111.204 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.49 83.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.47999999999999998 111.29 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 57.4 m-85 -63.82 -49.64 72.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.8700000000000001 111.324 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.7 ttp -47.02 -34.4 5.63 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 1.49 110.352 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.96 -44.21 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.762 -0.654 . . . . 0.58999999999999997 110.926 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.404 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 53.5 mtt -52.42 -27.72 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.48999999999999999 110.209 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.87 47.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.718 -0.674 . . . . 0.59999999999999998 110.385 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.4 -2.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 1.3100000000000001 110.847 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.52 43.11 2.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.938 -0.574 . . . . 1.9099999999999999 111.108 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.405 HE21 HG21 ' B' ' 127' ' ' VAL . 6.5 tp-100 -121.56 159.14 27.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.947 -0.569 . . . . 1.6200000000000001 110.509 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.06 13.91 44.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 1.04 112.114 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -132.57 140.2 48.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.787 0.327 . . . . 2.6800000000000002 110.697 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.24 150.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 1.98 111.192 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.64 92.55 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 2.1800000000000002 110.611 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.66 137.48 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.5700000000000001 111.073 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.07 17.18 7.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.511 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.8 -13.07 63.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 1.48 112.699 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -98.45 155.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 2.3199999999999998 111.164 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.6 mt -105.26 106.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.96 -0.564 . . . . 1.4399999999999999 110.861 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.73 138.39 33.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.81999999999999995 111.482 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.8 m-70 -97.73 74.55 2.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.979 -0.555 . . . . 0.90000000000000002 110.615 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -56.41 -45.7 80.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.557 -0.747 . . . . 1.8300000000000001 111.684 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -67.21 -27.16 67.02 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.189 0.44 . . . . 0.62 112.189 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.4 tpp180 -64.16 -51.61 63.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.596 0.591 . . . . 2.3399999999999999 112.596 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.507 ' O ' ' HG3' ' A' ' 77' ' ' MET . 15.9 p90 -87.06 -26.15 23.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.455 -0.498 . . . . 3.4900000000000002 112.297 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 71' ' ' ALA . 9.6 tp -55.87 -42.38 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.6 -0.44 . . . . 1.3700000000000001 110.125 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -70.01 -21.34 63.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.16 -0.682 . . . . 1.3100000000000001 109.16 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -84.77 2.81 40.44 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.364 -0.835 . . . . 1.48 111.243 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 38.9 mtp -103.06 -22.87 13.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 1.46 110.931 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.447 ' O ' HD23 ' A' ' 82' ' ' LEU . 28.9 m -114.52 -36.04 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.453 0.538 . . . . 1.1200000000000001 112.453 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 43' ' ' ILE . 36.0 m -72.58 -52.32 16.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.902 0.334 . . . . 1.1000000000000001 111.902 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.578 HG22 ' NE2' ' A' ' 109' ' ' GLN . 10.5 m -53.82 -51.37 77.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.583 0.586 . . . . 0.59999999999999998 112.583 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 80' ' ' THR . 12.1 Cg_endo -55.72 -44.36 48.6 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.49 1.46 . . . . 0.73999999999999999 111.511 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.655 HD12 HG23 ' A' ' 39' ' ' VAL . 3.9 mm? -64.2 -31.37 72.54 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.601 -0.518 . . . . 1.01 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 83' ' ' LEU . 1.6 tt -68.87 -24.53 64.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.531 0.682 . . . . 1.48 109.206 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.22 -32.11 24.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.129 -0.941 . . . . 1.3799999999999999 110.474 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.67 -36.14 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.751 -0.659 . . . . 1.1899999999999999 111.172 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -58.27 -25.09 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 1.23 110.943 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.57 -40.48 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.88 110.834 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -61.05 -37.26 82.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 1.3899999999999999 111.044 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -73.83 -38.65 64.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.27 -0.423 . . . . 2.3199999999999998 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.21 -29.07 70.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 1.46 111.031 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.29 -40.38 13.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.24 111.239 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.3 mtp -99.99 107.28 19.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 2.0699999999999998 111.076 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -82.17 -27.53 32.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 3.5299999999999998 110.488 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -133.55 138.9 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 4.0800000000000001 110.596 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.04 142.94 23.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 2.1699999999999999 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -124.87 -66.25 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 4.5199999999999996 110.867 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -160.86 80.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 3.75 110.771 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.73 109.55 4.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 3.5299999999999998 110.94 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -129.25 12.04 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 4.9100000000000001 110.741 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.8 t -95.12 -32.22 13.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 1.98 111.395 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 101' ' ' LEU . 1.2 tm? -74.23 -45.13 50.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 1.8300000000000001 110.57 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.37 -33.77 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.391 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.14 -34.77 64.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.62 112.807 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -66.98 -34.99 78.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 1.5800000000000001 111.02 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.2 mt -76.14 -52.1 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.97999999999999998 111.023 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -58.91 -33.25 70.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 1.48 111.451 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.4 p -72.16 -56.62 5.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.43 -0.35 . . . . 1.1299999999999999 111.005 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.0 p -55.75 -25.21 39.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 1.48 110.778 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.578 ' NE2' HG22 ' A' ' 80' ' ' THR . 6.4 tp60 -68.64 -45.98 70.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 2.7000000000000002 110.798 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.436 ' HA ' HD12 ' A' ' 113' ' ' ILE . 60.8 mt -54.37 -36.9 35.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.461 -0.336 . . . . 1.54 110.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.85 -44.66 99.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.28 111.139 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.5 t -66.11 -36.36 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.42999999999999999 111.308 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 110' ' ' ILE . 94.0 mt -60.03 -41.84 87.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.183 -0.462 . . . . 1.74 111.161 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 72.5 m -60.84 -51.7 68.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.63 111.113 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.408 ' HA ' HG22 ' A' ' 118' ' ' ILE . 78.9 p -59.68 -20.16 54.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 1.0900000000000001 110.825 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.79 -36.05 17.13 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.056 -0.592 . . . . 0.41999999999999998 112.898 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -83.09 -28.45 29.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.652 0.263 . . . . 1.3799999999999999 111.625 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.7 tp -83.93 -28.11 7.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.603 -0.271 . . . . 1.6200000000000001 111.574 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.65 74.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.39000000000000001 110.809 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.5 -12.44 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 2.02 110.74 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 118' ' ' ILE . 91.6 mt -90.42 22.04 3.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.76000000000000001 110.788 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.1 m -86.3 120.67 27.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 1.46 110.864 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -90.32 -68.33 0.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 3.3500000000000001 110.849 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.569 ' HB2' HG12 ' A' ' 127' ' ' VAL . 99.6 mtt180 -64.81 139.63 58.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 2.9199999999999999 110.617 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.11 -9.54 58.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 2.77 110.872 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -88.51 -38.5 14.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 3.77 110.927 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.0 p -79.88 -24.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.1599999999999999 111.018 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -54.41 -43.52 71.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 2.04 111.059 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.99 -33.89 76.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.17 -0.468 . . . . 2.6400000000000001 110.763 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 127' ' ' VAL . 49.8 mt -66.37 -58.48 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 1.8999999999999999 111.135 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.48 ' HE1' ' HB3' ' C' ' 58' ' ' GLN . 4.6 m95 -55.32 -34.31 64.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 1.3999999999999999 111.191 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.41 -48.92 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.28 111.067 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -61.86 -28.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 2.1600000000000001 111.037 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.44 -33.62 74.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.458 . . . . 1.6899999999999999 110.625 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.57 -50.26 26.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.882 -0.675 . . . . 0.52000000000000002 112.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.65 -30.22 48.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.674 0.273 . . . . 1.02 111.262 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.15 -46.5 77.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 1.0800000000000001 110.774 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.51 -29.88 70.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.62 110.969 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.22 -26.85 61.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 1.8400000000000001 110.848 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.85 -53.89 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 1.6899999999999999 111.202 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.7 pt -61.33 -44.95 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 0.81000000000000005 111.443 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.468 ' N ' HG13 ' A' ' 141' ' ' ILE . 89.6 mt -63.88 -36.6 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 2.3700000000000001 111.078 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.69 -28.48 69.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.97999999999999998 110.588 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -72.78 -34.22 66.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 3.27 110.313 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.73 -35.77 34.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.905 -0.664 . . . . 1.25 112.58 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.9 -26.21 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.947 0.403 . . . . 2.1200000000000001 110.661 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -88.06 3.12 50.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 1.6599999999999999 110.903 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 99.989999999999995 112.175 -179.131 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.6 tp . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.928 0.394 . . . . 2.3399999999999999 110.783 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 169' ' ' VAL . 2.4 t80 -81.25 -21.75 39.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 2.77 110.625 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.64 -50.62 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 2.04 111.272 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -74.97 -27.79 60.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.039 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.66 -47.27 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 1.8899999999999999 111.361 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 165' ' ' TYR . 14.3 p -70.93 -30.32 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 1.6399999999999999 111.492 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -56.08 -58.4 8.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 1.24 111.309 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -61.42 -35.21 76.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 2.9700000000000002 110.525 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -65.2 -26.57 68.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 1.48 110.813 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 88.6 m -73.93 -49.54 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 1.55 111.34 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.18 -31.45 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.39 -0.368 . . . . 1.52 111.599 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.413 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.7 mt -77.02 -57.47 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.429 -0.351 . . . . 1.8500000000000001 111.401 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.62 111.545 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.518 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 9.9 tp -87.67 -21.27 7.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.125 0.488 . . . . 1.3500000000000001 110.203 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -64.75 -45.29 93.16 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.711 -0.677 . . . . 0.58999999999999997 112.304 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG22 ' A' ' 182' ' ' VAL . 0.4 OUTLIER -53.32 -55.41 34.68 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.703 0.251 . . . . 1.45 111.053 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.518 ' HD2' ' C ' ' A' ' 177' ' ' ILE . 75.6 Cg_exo -48.96 -38.84 39.73 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.227 1.951 . . . . 0.55000000000000004 112.4 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 184' ' ' ILE . 98.5 mt -54.62 -59.16 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.211 -0.45 . . . . 1.4199999999999999 111.605 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 179' ' ' TYR . 26.5 m -67.69 -24.21 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.308 -0.405 . . . . 0.78000000000000003 111.288 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -59.58 -53.08 62.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.906 0.336 . . . . 0.93999999999999995 111.906 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.0 tt -59.01 -20.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.855 0.317 . . . . 1.4299999999999999 111.855 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.096 0.474 . . . . 2.02 111.473 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.67 0.271 . . . . 2.48 111.625 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.98 -57.73 9.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 2.1800000000000002 110.639 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.5 p -60.17 -17.26 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 1.49 111.012 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -81.97 -30.47 31.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 1.77 110.937 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.76 -37.28 22.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 1.4199999999999999 111.195 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -13.79 60.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.478 -0.328 . . . . 1.78 111.309 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 15.7 p -96.15 -37.07 10.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.972 0.415 . . . . 1.3 110.592 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 66.3 tp -72.7 -33.8 66.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.66000000000000003 111.668 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.665 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 47.2 tp -60.72 -53.79 60.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 121.122 -0.231 . . . . 1.6299999999999999 111.348 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.03 -42.34 67.71 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.931 1.754 . . . . 0.64000000000000001 111.44 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.488 ' HB2' ' OH ' ' A' ' 11' ' ' TYR . 90.5 t80 -61.72 -35.63 78.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.111 -0.495 . . . . 1.3600000000000001 110.251 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.418 ' HA ' HG12 ' A' ' 211' ' ' VAL . 72.7 t80 -75.78 -20.94 57.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.834 -0.621 . . . . 1.54 110.846 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.413 ' OG ' HD13 ' A' ' 175' ' ' LEU . 29.8 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 1.2 111.127 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 208' ' ' PHE . 9.1 p . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.88 0.372 . . . . 1.6399999999999999 110.914 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.16 78.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 0.79000000000000004 112.393 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.98 -38.18 90.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 1.6100000000000001 110.674 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.9 m -58.68 -57.38 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 1.1499999999999999 110.794 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -64.03 -22.8 67.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 3.3399999999999999 110.644 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.81 -48.03 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 111.102 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.86 -31.5 72.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.452 -0.34 . . . . 2.23 111.253 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 52.2 mt -70.15 -57.5 4.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 2.4700000000000002 111.115 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.31 -22.82 65.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 111.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.32 -59.44 10.65 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.817 -0.706 . . . . 1.4099999999999999 112.861 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 2.5800000000000001 110.738 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.89 0.376 . . . . 2.0699999999999998 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 39.6 mt -66.34 -48.27 70.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.003 -0.544 . . . . 2.1000000000000001 110.979 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 34.4 m80 -64.76 -24.17 67.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 1.0700000000000001 110.831 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.453 ' O ' HG12 ' B' ' 12' ' ' VAL . 11.2 m95 -70.57 -56.15 7.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 1.48 111.194 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 pt -60.37 -20.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 2.02 110.906 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' B' ' 15' ' ' MET . 6.0 t80 -65.15 -61.3 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.92000000000000004 110.446 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.54 -29.49 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.237 -0.438 . . . . 0.93999999999999995 111.294 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.23 74.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.55000000000000004 110.978 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.58 -26.23 74.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.856 -0.688 . . . . 0.47999999999999998 112.704 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 52.3 mmm -76.81 -37.79 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.35 . . . . 0.84999999999999998 110.908 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 71.2 m -57.58 -55.4 35.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.115 -0.493 . . . . 1.3400000000000001 110.92 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' B' ' 20' ' ' LEU . 1.9 tp -58.45 -36.72 60.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 1.55 110.782 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -45.81 -58.76 5.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.735 -0.745 . . . . 0.69999999999999996 112.293 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.4 74.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.686 0.279 . . . . 0.81000000000000005 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' B' ' 17' ' ' ILE . 97.5 mt -64.58 -28.68 69.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 2.2599999999999998 110.814 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -64.63 -32.83 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 1.78 110.327 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.8 -20.49 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 4.5800000000000001 110.587 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -69.36 -43.52 73.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 3.3500000000000001 110.479 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 65.5 m -79.65 -30.38 41.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 1.5800000000000001 110.7 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.9 tp -86.48 -1.3 57.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 1.8400000000000001 110.58 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -60.86 -11.68 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 1.3700000000000001 110.903 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -47.22 -47.25 24.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.001 -0.74 . . . . 4.9800000000000004 109.001 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.5 p-10 -178.59 129.91 0.28 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.201 -0.909 . . . . 2.1400000000000001 110.337 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' B' ' 31' ' ' GLY . 72.9 Cg_endo -103.32 -82.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.542 2.828 . . . . 1.8200000000000001 112.121 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.538 ' HE ' HD22 ' B' ' 221' ' ' LEU . 49.6 mtp180 -112.63 6.14 18.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.794 0.806 . . . . 5.1900000000000004 109.234 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.523 ' H ' ' HD2' ' B' ' 29' ' ' PRO . . . 123.64 -53.39 0.75 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 114.267 -1.333 . . . . 2.2000000000000002 110.731 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.26 104.98 5.11 Favored Pre-proline 0 C--O 1.232 0.171 0 O-C-N 122.906 -0.173 . . . . 3.6499999999999999 110.692 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.495 ' HG3' ' HG3' ' B' ' 29' ' ' PRO . 69.6 Cg_endo -88.21 107.76 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 119.446 0.838 . . . . 2.6699999999999999 113.117 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -93.47 -58.29 2.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 123.597 1.665 . . . . 4.8799999999999999 108.894 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.556 ' HD2' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -83.4 -61.69 1.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 110.633 -2.985 . . . . 1.8700000000000001 113.823 -177.326 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.556 ' H ' ' HD2' ' B' ' 35' ' ' TYR . 40.6 tt0 -37.91 -63.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.467 0.914 . . . . 2.6800000000000002 113.467 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -62.34 -40.33 96.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.11 0.411 . . . . 2.9199999999999999 112.11 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -59.23 -65.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.88 0.326 . . . . 1.6399999999999999 111.88 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.58 HG13 HD12 ' B' ' 82' ' ' LEU . 60.5 t -61.93 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.413 0.523 . . . . 1.6000000000000001 112.413 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -14.09 6.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.228 0.455 . . . . 0.68999999999999995 112.228 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.403 ' O ' HG12 ' B' ' 45' ' ' ILE . 27.6 ttt -88.91 -39.65 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 2.5800000000000001 111.546 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -72.01 -42.65 66.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 3.3900000000000001 112.226 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.485 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 93.5 mt -49.62 -52.05 54.02 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.493 0.553 . . . . 0.40999999999999998 112.493 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 50.9 Cg_endo -68.79 -43.44 3.63 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.202 1.935 . . . . 0.48999999999999999 113.302 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.403 HG12 ' O ' ' B' ' 41' ' ' MET . 36.3 mm -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.78 0.324 . . . . 1.29 111.632 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -55.95 -58.3 8.48 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.227 -0.442 . . . . 1.3999999999999999 111.541 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 94.8 p -51.99 -32.9 35.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 1.3799999999999999 111.241 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.67 -57.64 18.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.37 112.48 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.86 -28.12 68.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 1.29 111.067 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.96 -59.11 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.44 111.16 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 35.1 m-85 -63.75 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.5 111.11 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 19.5 ttt -48.85 -42.74 37.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.063 0.458 . . . . 1.4099999999999999 110.456 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.54 -42.05 87.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.55000000000000004 110.616 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -51.55 -29.38 16.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.5 110.212 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.3 -47.34 57.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.54000000000000004 109.901 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -71.92 2.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.499 -0.773 . . . . 1.3 110.804 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 66.78 49.15 1.26 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.751 -0.658 . . . . 2.2400000000000002 111.008 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.01 173.93 7.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 1.77 110.79 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 78.5 21.3 69.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 1.0600000000000001 112.498 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -139.36 144.5 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.722 0.296 . . . . 2.6600000000000001 110.572 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -124.6 146.19 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 1.8899999999999999 111.155 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -101.16 84.04 2.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 2.4100000000000001 110.844 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.87 144.31 42.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 1.5600000000000001 110.925 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 16.29 4.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 111.436 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 -15.44 58.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 1.51 112.885 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -98.19 173.17 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 2.4500000000000002 110.658 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -116.93 118.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.552 . . . . 1.79 111.165 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.89 110.93 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.81999999999999995 111.253 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 57.0 m-70 -70.05 80.31 0.49 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.737 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -65.23 -31.02 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.655 -0.702 . . . . 1.8700000000000001 111.496 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.468 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -79.48 -25.99 41.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.052 0.389 . . . . 0.60999999999999999 112.052 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 22.0 mmt180 -69.6 -51.16 37.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.323 0.49 . . . . 2.3900000000000001 112.323 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 3.5 p90 -76.14 -36.06 58.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.638 -0.425 . . . . 3.6699999999999999 111.964 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 75' ' ' ASP . 16.9 tt -54.21 -43.68 61.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.728 0.299 . . . . 1.6599999999999999 110.933 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.425 ' N ' HG23 ' B' ' 74' ' ' ILE . 11.6 t70 -67.92 -25.59 65.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.235 -0.654 . . . . 1.4099999999999999 109.235 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -85.44 8.56 18.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.677 -0.692 . . . . 1.1599999999999999 110.484 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.527 ' HA ' HD13 ' B' ' 113' ' ' ILE . 45.9 tpp -105.14 -25.64 12.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.684 -0.689 . . . . 1.53 110.713 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.89 -36.75 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.26 -0.427 . . . . 0.89000000000000001 112.129 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -70.54 -57.64 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.919 0.341 . . . . 1.24 111.919 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 31.2 m -48.92 -51.78 52.2 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.535 0.568 . . . . 0.57999999999999996 112.535 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 53.0 Cg_exo -54.16 -45.79 38.34 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.5 1.467 . . . . 0.66000000000000003 111.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.58 HD12 HG13 ' B' ' 39' ' ' VAL . 3.0 mm? -63.03 -32.05 73.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.85 -0.614 . . . . 1.0600000000000001 109.853 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 -23.95 62.34 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.15 -0.685 . . . . 1.22 109.15 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' B' ' 109' ' ' GLN . 16.8 tp -84.41 -29.44 26.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.103 -0.953 . . . . 1.53 110.462 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.69 -38.98 46.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.753 -0.658 . . . . 1.5800000000000001 111.133 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' SER . . . . . 0.417 ' HB2' HG11 ' B' ' 39' ' ' VAL . 39.8 t -56.55 -21.06 23.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 1.3899999999999999 110.921 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.86 -37.61 62.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.517 . . . . 1.1499999999999999 111.115 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.1 t -72.42 -21.69 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 1.5700000000000001 111.176 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.53 -45.49 15.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.133 -0.485 . . . . 2.1699999999999999 111.138 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -66.83 -23.26 66.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 1.4199999999999999 111.248 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.71 -36.85 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 1.1799999999999999 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 79.1 mtp -105.17 101.17 10.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 1.8799999999999999 110.946 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -73.15 -27.79 61.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.4199999999999999 110.863 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -132.14 153.49 50.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 4.0599999999999996 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.44 144.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 2.0899999999999999 111.322 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -165.16 88.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 3.8500000000000001 110.719 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt 58.19 81.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 4.8200000000000003 111.094 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.89 95.8 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 3.7999999999999998 110.859 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -129.07 0.13 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 5.1699999999999999 110.895 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 67.2 p -70.52 -43.3 69.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 2.02 111.095 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 tp -73.37 -36.03 66.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 2.0899999999999999 110.769 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 28.1 mm -60.7 -37.84 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 1.8799999999999999 110.791 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.06 -23.32 63.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.859 -0.686 . . . . 0.56000000000000005 112.357 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.79 -38.77 89.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.332 . . . . 1.78 111.072 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.3 mt -81.06 -44.24 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 1.03 111.001 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 11.0 tpt -56.4 -39.76 73.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.594 -0.73 . . . . 1.6699999999999999 111.476 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -72.03 -51.85 19.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 1.51 111.274 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 27.8 p -53.26 -32.79 50.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.919 0.39 . . . . 1.1799999999999999 111.379 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.466 ' HB2' HD22 ' B' ' 84' ' ' LEU . 26.1 tp60 -65.81 -48.55 71.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.056 -0.52 . . . . 2.1699999999999999 111.024 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.95 -43.71 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.3500000000000001 111.619 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.2 -44.06 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 1.3400000000000001 111.334 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.89 -46.3 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.42999999999999999 111.8 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.61 HD11 ' HG3' ' B' ' 81' ' ' PRO . 44.6 mt -56.92 -37.74 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.586 -0.279 . . . . 1.6000000000000001 111.096 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.5 m -57.84 -49.66 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.95 0.405 . . . . 0.85999999999999999 110.771 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.6 m -62.89 -21.96 66.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.94999999999999996 110.31 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.66 -43.77 17.71 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.02 -0.61 . . . . 0.46000000000000002 112.497 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.473 ' HB3' ' CD2' ' B' ' 73' ' ' TYR . 3.7 pp -77.47 -24.89 50.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.636 0.255 . . . . 1.75 111.163 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.5 mm -82.34 -36.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.408 -0.36 . . . . 1.78 111.09 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.49 -46.81 76.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.38 111.435 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -70.82 -17.41 62.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.395 -0.366 . . . . 1.97 111.234 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.13 20.41 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.454 -0.339 . . . . 0.76000000000000001 111.351 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -78.05 125.04 28.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.47 110.781 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.75 -67.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 2.5 110.976 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.583 ' HB2' HG12 ' B' ' 127' ' ' VAL . 92.0 mtt180 -71.44 152.29 43.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 2.73 110.584 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.53 -16.78 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 2.2000000000000002 110.865 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -81.86 -37.01 27.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 3.3999999999999999 110.747 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.8 p -78.43 -24.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.23 110.939 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -58.05 -34.88 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 3.04 110.827 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -76.24 -21.39 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 4.1399999999999997 111.042 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.99 -60.99 2.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 1.6499999999999999 111.162 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -59.98 -27.48 66.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.398 -0.365 . . . . 0.77000000000000002 110.971 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.68 -45.75 91.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 1.46 110.284 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -65.26 -33.26 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.044 -0.525 . . . . 1.6299999999999999 110.449 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 47.5 t -62.64 -31.12 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 1.4199999999999999 110.723 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.66 -52.98 13.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.838 -0.696 . . . . 0.48999999999999999 112.479 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.38 -31.69 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 1.3 111.335 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 68.5 m -65.08 -46.07 82.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 1.3 110.775 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.93 71.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.62 110.667 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -73.13 -22.77 60.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.74 110.523 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.72 -57.82 4.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 1.76 110.703 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.441 HG13 ' N ' ' B' ' 142' ' ' ILE . 41.2 pt -60.1 -38.43 76.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.68999999999999995 111.517 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.441 ' N ' HG13 ' B' ' 141' ' ' ILE . 94.1 mt -69.81 -34.74 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 1.76 110.956 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.78 -39.59 85.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.291 -0.413 . . . . 1.0600000000000001 110.569 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' TRP . . . . . 0.535 ' O ' ' OD1' ' B' ' 148' ' ' ASN . 89.4 t90 -62.72 -47.08 85.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.532 . . . . 4.1200000000000001 110.799 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' GLY . . . . . 1.157 ' HA2' ' OD1' ' B' ' 148' ' ' ASN . . . -63.53 -34.08 88.98 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.63 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -74.11 -24.16 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.919 0.39 . . . . 1.98 110.603 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -90.6 3.16 54.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 1.4199999999999999 110.897 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 1.157 ' OD1' ' HA2' ' B' ' 145' ' ' GLY . 32.1 m120 . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.913 -0.585 . . . . 99.989999999999995 112.251 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.866 0.365 . . . . 2.4300000000000002 110.759 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.425 ' O ' HG12 ' B' ' 169' ' ' VAL . 1.1 t80 -78.14 -23.68 47.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 2.5800000000000001 111.32 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.74 -59.28 4.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 2.0 110.92 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.31 -26.9 65.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 3.0299999999999998 111.327 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.16 -56.14 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.406 -0.361 . . . . 1.1000000000000001 111.104 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 165' ' ' TYR . 14.4 p -68.97 -22.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 1.75 111.488 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 41.4 m -54.28 -58.91 5.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.48 -0.327 . . . . 0.97999999999999998 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.67 -42.53 95.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 4.2999999999999998 110.501 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.77 -28.2 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.044 -0.526 . . . . 1.3899999999999999 110.789 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.416 ' O ' HG12 ' B' ' 177' ' ' ILE . 90.2 m -73.52 -50.71 20.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 1.1100000000000001 111.119 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.25 -43.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.315 -0.402 . . . . 1.51 111.93 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' B' ' 209' ' ' SER . 3.8 mm? -70.92 -53.24 15.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.955 0.354 . . . . 1.75 111.955 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -24.14 63.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.704 0.288 . . . . 0.59999999999999998 111.194 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.491 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 36.6 mm -87.57 -22.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 1.47 110.26 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -65.44 -41.93 96.13 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.726 -0.67 . . . . 0.55000000000000004 112.696 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.404 ' O ' HG22 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -56.09 -55.41 42.01 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.744 0.272 . . . . 1.6200000000000001 111.124 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.491 ' HD2' ' C ' ' B' ' 177' ' ' ILE . 78.3 Cg_exo -50.57 -38.75 55.43 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.154 1.903 . . . . 0.64000000000000001 112.243 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.497 ' O ' HG22 ' B' ' 184' ' ' ILE . 37.0 mm -54.04 -58.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 1.27 111.512 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 179' ' ' TYR . 20.9 m -69.23 -24.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.68999999999999995 111.262 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -61.75 -52.59 63.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.026 0.38 . . . . 1.1799999999999999 112.026 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 181' ' ' ILE . 21.1 tt -58.23 -17.21 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 111.998 0.37 . . . . 1.77 111.998 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 8.9 tt -121.54 104.02 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 1.6899999999999999 111.532 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.802 -0.713 . . . . 1.5800000000000001 112.501 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.769 0.318 . . . . 2.4700000000000002 111.389 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.44 -52.95 63.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.5299999999999998 110.914 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 11.4 m -66.64 -19.11 65.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 1.29 110.94 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 200' ' ' PHE . . . . . 0.439 ' HA ' ' SG ' ' B' ' 203' ' ' CYS . 62.2 t80 -83.51 -27.13 29.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 2.6200000000000001 111.125 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.12 -28.78 27.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.736 0.303 . . . . 1.6100000000000001 111.129 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.85 -12.0 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 1.4199999999999999 111.188 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' B' ' 200' ' ' PHE . 17.2 p -96.22 -32.41 12.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 1.4299999999999999 110.477 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.37 -39.33 59.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 1.1200000000000001 111.408 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.656 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.6 tp -57.46 -53.16 68.37 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.622 -0.263 . . . . 1.26 111.523 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 32.0 Cg_exo -58.58 -45.0 32.52 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.918 1.745 . . . . 0.59999999999999998 111.527 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.403 ' O ' HG23 ' B' ' 211' ' ' VAL . 69.8 t80 -61.72 -29.52 70.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.016 -0.538 . . . . 1.3999999999999999 110.234 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -76.83 -26.71 54.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 1.4099999999999999 110.222 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.503 ' HB2' HD12 ' B' ' 175' ' ' LEU . 45.7 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.817 -0.629 . . . . 1.3200000000000001 110.373 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.403 HG23 ' O ' ' B' ' 207' ' ' PHE . 57.3 t . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.777 0.322 . . . . 1.6899999999999999 111.258 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.18 -35.94 86.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.846 -0.693 . . . . 0.79000000000000004 112.785 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.86 -29.17 64.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.301 . . . . 2.96 110.983 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.86 -60.77 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.29 110.918 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 3.1499999999999999 110.98 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -38.45 89.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.51 110.963 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.58 -30.77 69.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 2.1899999999999999 110.831 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.92 -58.69 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 1.98 111.018 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -66.35 -20.49 66.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 2.1699999999999999 111.036 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.15 -57.65 18.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.8 -0.714 . . . . 1.3600000000000001 112.962 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' LEU . . . . . 0.538 HD22 ' HE ' ' B' ' 30' ' ' ARG . 23.3 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.581 0.229 . . . . 2.8999999999999999 111.27 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.602 0.239 . . . . 2.52 111.432 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 7' ' ' LEU . . . . . 0.449 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.1 mm? -69.37 -42.1 75.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 1.9299999999999999 110.684 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.608 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 42.4 m80 -72.22 -27.47 62.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 1.26 110.806 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -70.4 -43.87 69.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.521 . . . . 1.6699999999999999 110.928 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.74 -21.47 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 1.8700000000000001 110.661 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -64.41 -53.31 50.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 1.4399999999999999 110.704 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.26 -34.12 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.46999999999999997 111.216 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.66 96.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.58999999999999997 111.224 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.91 76.52 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.5 112.589 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.7 mmt -74.77 -36.86 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.56 0.219 . . . . 0.68000000000000005 111.477 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 71.7 p -64.35 -52.27 59.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 1.3999999999999999 110.828 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.3 -22.55 31.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 1.55 110.873 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.98 -55.64 27.03 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.783 -0.723 . . . . 0.70999999999999996 112.372 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -34.72 72.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.74 0.305 . . . . 0.77000000000000002 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 26.6 tp -62.43 -35.14 78.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.167 -0.47 . . . . 1.9299999999999999 110.771 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -57.16 -28.96 63.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 1.8600000000000001 110.817 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -74.17 -37.5 63.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.01 -0.541 . . . . 4.1399999999999997 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -56.3 -32.64 64.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 3.1499999999999999 110.689 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -81.07 -32.27 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 1.95 111.313 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -86.42 -1.26 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.532 -0.303 . . . . 2.2200000000000002 111.531 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 92.8 p -62.84 -20.12 64.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.487 -0.324 . . . . 1.3700000000000001 111.15 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -48.71 -33.22 9.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.329 0.585 . . . . 5.0300000000000002 109.687 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ASN . . . . . 0.502 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.2 p-10 -174.99 131.77 0.45 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.08 -0.964 . . . . 2.3700000000000001 109.884 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 9.6 Cg_endo . . . . . 0 N--CA 1.455 -0.757 0 C-N-CA 123.012 2.475 . . . . 2.0499999999999998 112.373 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' C' ' 35' ' ' TYR . 31.8 Cg_exo . . . . . 0 N--CA 1.464 -0.206 0 CA-C-O 121.164 0.402 . . . . 1.9299999999999999 112.45 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -41.27 -16.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.99 -1.005 . . . . 4.1200000000000001 113.661 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' C' ' 33' ' ' PRO . 3.2 m-30 -39.75 -62.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.924 0.392 . . . . 2.8900000000000001 111.539 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.08 -40.67 77.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 2.46 111.449 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -72.02 -18.57 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 2.7799999999999998 111.715 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.37 -45.69 68.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.915 0.388 . . . . 1.6200000000000001 110.146 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.605 HG13 HD12 ' C' ' 82' ' ' LEU . 58.2 t -75.19 -33.25 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 1.5900000000000001 110.788 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.38 -15.08 61.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.65000000000000002 111.511 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.407 ' O ' HG12 ' C' ' 45' ' ' ILE . 51.9 ttp -89.57 -37.84 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.45 -0.341 . . . . 1.6699999999999999 111.623 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -72.61 -37.99 67.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 3.4199999999999999 112.064 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.505 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -53.71 -52.5 66.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 112.215 0.45 . . . . 0.89000000000000001 112.215 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 40.7 Cg_endo -67.55 -42.19 7.47 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.213 1.942 . . . . 0.40999999999999998 113.1 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.407 HG12 ' O ' ' C' ' 41' ' ' MET . 37.4 mm -55.88 -62.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.6 0.238 . . . . 1.76 111.518 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -57.32 -58.19 9.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.396 -0.365 . . . . 2.1600000000000001 111.29 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 56.7 m -53.26 -26.76 19.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 1.1699999999999999 111.493 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.81 -61.46 6.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.688 -0.768 . . . . 0.44 112.47 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.91 -25.29 63.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.683 0.278 . . . . 1.29 111.298 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -59.26 4.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.944 0.402 . . . . 0.5 111.027 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.503 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 25.7 m-85 -62.52 -41.54 98.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 1.8300000000000001 111.092 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 55.0 ttp -47.93 -39.09 18.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.087 0.47 . . . . 1.47 110.104 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.66 88.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.763 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.1 mtt -52.45 -30.98 32.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 0.83999999999999997 110.138 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.29 -38.43 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.874 -0.603 . . . . 0.65000000000000002 110.238 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mt -77.53 0.34 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.755 -0.657 . . . . 1.55 110.657 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 68.33 42.28 1.69 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.795 -0.638 . . . . 1.54 111.155 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.48 ' HB3' ' HE1' ' A' ' 131' ' ' TRP . 27.6 mm-40 -118.25 173.51 6.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.819 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.46 16.76 67.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 0.93999999999999995 112.371 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' C' ' 69' ' ' HIS . 36.6 mtmm -136.41 150.9 48.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 2.3599999999999999 110.783 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.29 143.44 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.97 111.082 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.26 89.63 6.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 2.4399999999999999 110.989 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.48 139.68 51.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 1.54 111.038 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.75 15.33 4.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.07 -0.514 . . . . 1.71 111.453 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.13 66.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.795 -0.717 . . . . 1.53 112.691 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -105.44 150.69 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 2.23 111.174 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 11.4 pt -97.12 125.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.545 . . . . 1.3600000000000001 111.074 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.69 123.87 48.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.78000000000000003 110.882 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.573 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 31.9 m-70 -81.07 76.44 8.02 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.35 0.595 . . . . 1.0800000000000001 111.052 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' TYR . . . . . 0.433 ' HD2' ' HH ' ' C' ' 73' ' ' TYR . 83.8 t80 -57.41 -36.44 71.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.376 -0.829 . . . . 2.2999999999999998 111.544 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.37 -26.3 55.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.214 0.449 . . . . 0.75 112.214 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.9 tpp180 -64.19 -51.56 63.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.531 0.567 . . . . 1.51 112.531 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.537 ' O ' ' HG3' ' C' ' 77' ' ' MET . 24.2 p90 -86.44 -26.45 24.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.515 0.561 . . . . 4.6500000000000004 112.515 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.0 tp -56.86 -41.58 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.375 -0.53 . . . . 1.22 110.272 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.52 -16.7 62.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.266 -0.642 . . . . 1.3100000000000001 109.266 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 76' ' ' TRP . . . . . 0.437 ' O ' HD12 ' C' ' 113' ' ' ILE . 45.8 m0 -88.54 2.77 52.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.315 -0.857 . . . . 1.6799999999999999 111.439 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 39.3 mtp -105.09 -20.51 13.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.168 -0.469 . . . . 1.8 111.245 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.463 ' O ' HD23 ' C' ' 82' ' ' LEU . 14.5 m -113.77 -39.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.3 0.482 . . . . 1.1899999999999999 112.3 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.505 HG23 HG23 ' C' ' 43' ' ' ILE . 57.0 m -70.34 -49.17 52.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.046 0.387 . . . . 1.23 112.046 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 21.5 m -56.52 -52.08 76.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 0.58999999999999997 112.614 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 80' ' ' THR . 11.7 Cg_endo -55.78 -37.53 95.53 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.53 1.487 . . . . 0.67000000000000004 111.736 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.605 HD12 HG13 ' C' ' 39' ' ' VAL . 3.9 mm? -70.33 -32.21 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.95999999999999996 109.746 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -23.28 63.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.488 0.661 . . . . 1.1899999999999999 109.23 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 tp -84.46 -36.51 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.984 -1.007 . . . . 1.7 110.414 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.83 -34.37 73.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.6200000000000001 110.94 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -62.41 -18.52 61.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 1.26 111.081 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 24.0 mt -78.93 -31.88 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 1.1100000000000001 111.027 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -73.63 -32.23 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 1.51 111.076 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -75.1 -42.04 57.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 2.0600000000000001 111.438 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -69.17 -22.44 63.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 1.52 111.001 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.05 -13.87 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 1.3 111.213 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.3 ttm -128.71 100.94 5.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 1.6200000000000001 110.742 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -68.4 -54.47 16.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 3.2400000000000002 111.053 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -112.52 149.85 32.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 4.6299999999999999 111.179 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.86 145.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.163 -0.471 . . . . 2.1800000000000002 110.723 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.8 -71.46 0.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.303 -0.408 . . . . 4.1200000000000001 111.432 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -140.47 29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.501 -0.318 . . . . 4.96 111.591 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -86.92 138.94 31.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.431 -0.35 . . . . 3.9100000000000001 110.876 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -165.84 -22.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 5.21 110.686 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -70.46 -35.09 73.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 1.8200000000000001 111.591 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.59 -42.46 42.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 2.0800000000000001 110.949 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.91 -31.21 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 1.8600000000000001 110.711 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.62 -29.04 45.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.84 -0.695 . . . . 0.58999999999999997 112.346 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -65.76 -35.36 80.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 1.53 110.83 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 75.1 mt -79.53 -44.98 20.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.994 -0.548 . . . . 1.1100000000000001 111.107 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 10.7 tpt -59.62 -35.91 75.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 2.21 111.328 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.7 m -71.81 -58.3 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 1.28 111.283 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 57.6 p -52.41 -31.02 32.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 1.22 111.163 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.481 ' O ' HG12 ' C' ' 113' ' ' ILE . 22.2 tp60 -62.48 -54.13 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 2.3300000000000001 110.556 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -46.78 -39.94 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 115.93 -0.577 . . . . 1.29 111.316 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.78 -46.92 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.0600000000000001 110.855 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.59 -32.33 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.51000000000000001 111.156 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.481 HG12 ' O ' ' C' ' 109' ' ' GLN . 44.8 mm -59.23 -41.3 83.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 1.3700000000000001 110.671 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 93.9 m -62.26 -54.63 38.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.833 -0.621 . . . . 0.77000000000000002 111.296 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -54.82 -24.26 22.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 110.899 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.87 -46.9 12.64 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.811 -0.709 . . . . 0.5 112.673 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' C' ' 114' ' ' THR . 4.3 pp -76.79 -21.24 55.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.716 0.293 . . . . 1.47 111.011 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 38.2 mm -83.37 -36.92 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 1.2 111.205 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.95 -32.55 61.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.40000000000000002 111.327 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.39 -23.66 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 2.1200000000000001 110.977 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.14 34.14 0.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 0.75 111.254 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 71.2 m -91.86 119.05 31.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 1.3799999999999999 110.776 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.22 -58.29 2.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 2.7400000000000002 111.137 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' ARG . . . . . 0.483 ' HB2' HG12 ' C' ' 127' ' ' VAL . 45.4 mtm180 -89.48 157.61 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 2.7999999999999998 110.965 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -84.54 -15.88 44.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.885 -0.598 . . . . 2.4100000000000001 110.88 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 37.6 t-105 -78.74 -38.75 38.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 4.2000000000000002 110.66 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' C' ' 124' ' ' ARG . 7.4 p -80.83 -28.78 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 1.0800000000000001 111.241 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -56.13 -34.61 66.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 2.5699999999999998 111.281 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -73.68 -25.61 60.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 3.8100000000000001 111.019 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.22 -46.1 24.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 1.4199999999999999 110.968 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -64.65 -37.4 87.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.89000000000000001 111.178 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -55.4 -46.67 76.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 1.26 110.906 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.3 -35.08 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 1.6799999999999999 110.865 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.53 -31.27 72.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.842 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -54.02 13.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.736 -0.745 . . . . 0.54000000000000004 112.635 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.45 -37.96 76.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 1.0600000000000001 111.257 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -52.79 -52.44 56.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 1.0800000000000001 110.626 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.9 -30.81 71.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.56999999999999995 110.891 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.58 -24.53 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 1.6799999999999999 110.932 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.76 -52.91 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 1.7 111.491 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.439 HG13 ' N ' ' C' ' 142' ' ' ILE . 24.6 pt -60.31 -43.99 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.528 -0.305 . . . . 0.78000000000000003 111.763 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.439 ' N ' HG13 ' C' ' 141' ' ' ILE . 43.4 pt -67.4 -29.84 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 2.2400000000000002 110.957 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.12 -38.31 85.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.02 111.018 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 3.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 145' ' ' GLY . . . . . 1.161 ' HA2' ' OD1' ' C' ' 148' ' ' ASN . . . -61.07 -44.52 98.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.899 -0.667 . . . . 1.27 112.532 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.22 -24.08 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.8899999999999999 110.758 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -88.8 4.74 46.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.6000000000000001 111.134 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 148' ' ' ASN . . . . . 1.161 ' OD1' ' HA2' ' C' ' 145' ' ' GLY . 32.1 m120 . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.48 . . . . 99.989999999999995 112.116 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.7 tp . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.937 0.399 . . . . 2.3500000000000001 110.704 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -81.38 -25.63 36.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 2.6200000000000001 111.045 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.01 -55.24 31.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 2.0899999999999999 111.162 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -72.07 -32.75 67.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 3.2400000000000002 111.339 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.25 -50.79 72.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 1.6899999999999999 111.276 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.06 -29.93 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 1.3999999999999999 111.264 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -53.29 -58.74 6.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.95999999999999996 111.315 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -63.29 -36.15 82.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 3.6499999999999999 110.701 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.6 -22.59 66.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 1.3700000000000001 110.761 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 25.9 m -73.48 -59.0 2.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 1.4299999999999999 111.358 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.6 p -52.39 -30.82 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.394 -0.366 . . . . 1.6200000000000001 111.642 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.405 HD13 ' OG ' ' C' ' 209' ' ' SER . 94.7 mt -72.38 -57.78 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 2.0299999999999998 111.071 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -19.79 65.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.62 111.04 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.49 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 32.6 mm -87.66 -25.4 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.114 0.483 . . . . 1.5800000000000001 110.36 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 178' ' ' GLY . . . . . 0.48 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -65.76 -40.54 95.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.56000000000000005 112.505 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.465 ' O ' HG22 ' C' ' 182' ' ' VAL . 0.3 OUTLIER -55.7 -55.72 37.63 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.592 0.196 . . . . 1.3300000000000001 111.356 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' C' ' 177' ' ' ILE . 67.2 Cg_exo -50.38 -41.06 52.74 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.074 1.849 . . . . 0.63 112.163 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.48 HD12 ' HA2' ' C' ' 178' ' ' GLY . 82.1 mt -49.69 -61.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.137 -0.483 . . . . 0.93000000000000005 111.493 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.465 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.2 m -63.92 -28.15 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 1.27 111.446 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -65.36 -27.83 68.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 1.77 111.053 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 180' ' ' PRO . 89.2 mt -55.15 -32.93 28.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 2.3900000000000001 111.209 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.3 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 1.95 111.132 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.843 0.354 . . . . 2.3799999999999999 111.302 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 12.4 tt -57.89 -42.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 2.23 111.743 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.4 -53.75 54.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.702 0.287 . . . . 2.1600000000000001 111.401 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 59.4 p -58.81 -21.55 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 1.27 111.613 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -73.35 -39.29 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 1.7 111.489 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.89 -51.56 46.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.695 0.283 . . . . 2.02 111.414 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -67.59 -8.15 32.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.531 -0.304 . . . . 1.8200000000000001 111.313 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 10.9 t -95.86 -41.98 8.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.151 0.5 . . . . 1.3500000000000001 110.666 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.7 tp -74.19 -31.99 62.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.65000000000000002 111.904 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.645 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 54.9 tp -61.0 -54.22 56.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.891 -0.324 . . . . 1.4199999999999999 111.624 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 33.7 Cg_exo -59.45 -39.64 74.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.795 1.663 . . . . 0.63 111.189 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.68 -28.72 70.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 1.49 110.464 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -84.45 -19.49 33.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.949 -0.568 . . . . 1.7 110.82 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 209' ' ' SER . . . . . 0.405 ' OG ' HD13 ' C' ' 175' ' ' LEU . 40.6 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.995 -0.548 . . . . 1.25 110.898 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.981 0.419 . . . . 1.6100000000000001 110.891 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.12 -29.52 72.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.998 -0.62 . . . . 0.81999999999999995 112.535 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -72.6 -36.87 68.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 3.0800000000000001 110.817 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.0 t -59.16 -54.66 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 1.1499999999999999 110.89 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.14 -20.42 65.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.314 -0.403 . . . . 2.5600000000000001 110.856 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -72.08 -47.1 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 1.29 110.695 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.21 -21.01 64.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 2.3900000000000001 110.573 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 64.2 tp -74.14 -54.31 8.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.887 -0.597 . . . . 2.0299999999999998 111.266 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -79.41 -20.29 47.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 3.21 111.234 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.88 12.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.737 -0.744 . . . . 1.3600000000000001 112.585 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 221' ' ' LEU . . . . . 0.44 HD22 ' N ' ' C' ' 221' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 2.8999999999999999 110.435 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.756 0.312 . . . . 5.1100000000000003 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -84.93 -35.21 22.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 5.04 110.712 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.14 100.51 5.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 5.5800000000000001 110.851 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -123.29 145.94 48.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 5.0199999999999996 110.905 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 t -130.8 159.47 37.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 2.4500000000000002 110.914 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.5 pt? -137.62 2.12 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 2.4199999999999999 111.012 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.3 mm? -76.47 -51.91 10.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 2.0899999999999999 110.602 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -70.95 -24.34 62.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 110.478 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.0 t-105 -64.9 -53.07 52.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.79000000000000004 110.685 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.1 mt -66.33 -22.55 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 2.0800000000000001 110.267 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.404 ' HE2' ' HG ' ' A' ' 203' ' ' CYS . 0.1 OUTLIER -57.22 -55.32 36.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 1.28 110.756 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 52' ' ' MET . 10.0 p -66.87 -30.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 1.3200000000000001 111.274 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.43 80.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.63 111.229 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.4 76.36 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.853 -0.689 . . . . 0.55000000000000004 112.626 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.469 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -74.53 -41.75 60.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 1.03 111.497 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -61.83 -48.19 81.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.3 111.187 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -67.03 -22.59 29.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 1.3100000000000001 110.964 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.49 -58.62 12.36 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.872 -0.68 . . . . 0.77000000000000002 112.492 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.21 73.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.072 0.463 . . . . 0.80000000000000004 110.931 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.4 tp -64.48 -33.93 77.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.956 -0.566 . . . . 1.8100000000000001 110.62 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.61 -28.08 66.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.948 -0.569 . . . . 1.8799999999999999 110.42 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -78.2 -29.31 48.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 4.4500000000000002 110.671 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -63.84 -36.06 82.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.524 . . . . 3.6899999999999999 110.818 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -84.68 -42.31 15.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 1.5700000000000001 110.906 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.8 tp -73.22 -3.4 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.89 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 p -64.38 -24.77 67.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.528 -0.306 . . . . 1.3799999999999999 111.334 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -51.09 -31.95 20.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.128 0.489 . . . . 4.0700000000000003 109.784 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p30 -167.88 132.45 1.5 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.454 -0.793 . . . . 2.7200000000000002 110.147 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 28.3 Cg_endo -94.78 173.71 1.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.05 2.5 . . . . 1.9099999999999999 112.277 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.11 56.4 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 4.7599999999999998 111.082 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.75 -45.87 3.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 1.99 112.747 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.3 127.07 80.09 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 120.539 0.209 . . . . 2.7000000000000002 110.942 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 31.7 Cg_exo -57.74 165.18 6.67 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.412 2.075 . . . . 1.79 112.374 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -61.59 -18.21 58.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.747 -0.66 . . . . 4.1200000000000001 112.579 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.446 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 4.8 p90 -47.97 -42.23 27.15 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.688 0.28 . . . . 2.9300000000000002 111.652 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -68.04 -46.56 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.356 . . . . 2.8799999999999999 110.886 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.12 -23.03 66.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.077 -0.51 . . . . 4.6600000000000001 110.833 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.99 -61.23 2.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.176 -0.465 . . . . 1.45 110.659 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.67 -33.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 1.78 110.224 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.31 -4.78 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 0.63 111.105 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.534 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 28.4 ttt -89.38 -39.94 13.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.055 0.455 . . . . 1.48 111.018 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -73.09 -39.33 65.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 3.5 111.883 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 91.4 mt -50.69 -51.59 64.32 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.241 0.46 . . . . 1.0800000000000001 112.241 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 16.6 Cg_exo -68.65 -41.45 6.04 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.494 2.129 . . . . 0.53000000000000003 113.275 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 41' ' ' MET . 36.3 mm -55.06 -63.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.207 0.447 . . . . 1.6799999999999999 112.207 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.53 -58.39 7.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 1.8300000000000001 111.484 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 90.4 p -52.28 -35.97 51.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 1.0900000000000001 111.244 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.74 16.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.885 -0.674 . . . . 0.40999999999999998 112.661 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.56 -35.48 68.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.98999999999999999 110.893 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.8 79.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.47999999999999998 111.397 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -66.01 -59.68 3.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.447 -0.342 . . . . 1.8700000000000001 111.564 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.619 ' HB3' HG11 ' A' ' 12' ' ' VAL . 24.0 ptm -49.01 -31.08 6.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.01 0.433 . . . . 1.49 110.6 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.84 91.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.58999999999999997 110.831 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.9 mtt -56.36 -31.39 63.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.073 -0.512 . . . . 0.48999999999999999 110.505 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.86 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.59999999999999998 110.526 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.49 HD13 HD23 ' B' ' 130' ' ' LEU . 41.4 pt -78.5 3.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 1.3100000000000001 110.963 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.48 30.14 19.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 1.9099999999999999 111.46 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.622 HE22 ' H ' ' B' ' 123' ' ' GLU . 6.4 tp-100 -92.23 142.27 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 1.6200000000000001 110.767 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.34 17.22 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 1.04 112.346 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -127.23 139.67 52.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 2.6800000000000002 110.819 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.85 141.0 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 1.98 110.727 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.87 95.1 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 2.1800000000000002 111.25 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.1 115.81 27.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 1.5700000000000001 110.79 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 30.52 19.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 1.79 111.121 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.33 -2.01 83.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.742 -0.742 . . . . 1.48 112.847 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -105.82 128.95 54.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 2.3199999999999998 110.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 67' ' ' ILE . 4.8 mp -79.38 127.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 1.4399999999999999 111.007 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 139.89 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.81999999999999995 111.069 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 56.5 m-70 -81.29 64.94 6.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.213 0.53 . . . . 0.90000000000000002 110.758 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.89 -50.84 67.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.753 . . . . 1.8300000000000001 111.443 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -25.31 67.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.263 -0.426 . . . . 0.62 111.844 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 34.8 mmt180 -67.52 -52.48 38.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.713 0.635 . . . . 2.3399999999999999 112.713 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.506 ' O ' ' HG3' ' A' ' 77' ' ' MET . 6.3 p90 -75.93 -36.17 59.48 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.27 0.47 . . . . 3.4900000000000002 112.27 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.0 tt -52.93 -46.54 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.775 -0.37 . . . . 1.3700000000000001 110.902 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.6 t70 -67.45 -22.03 65.52 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.606 -0.516 . . . . 1.3100000000000001 109.606 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -87.87 5.55 39.84 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.527 -0.76 . . . . 1.48 111.522 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 34.4 mtp -104.55 -19.15 14.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 1.46 110.516 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 1.4 p -114.64 -43.8 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 1.1200000000000001 111.972 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.58 HG23 HG23 ' A' ' 43' ' ' ILE . 66.8 m -66.31 -56.09 12.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.409 . . . . 1.1000000000000001 111.961 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 67.9 m -50.77 -53.93 41.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.569 0.581 . . . . 0.59999999999999998 112.569 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 80' ' ' THR . 13.2 Cg_endo -56.28 -38.84 94.39 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.633 1.555 . . . . 0.73999999999999999 111.195 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -30.48 70.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.942 -0.572 . . . . 1.01 109.761 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.64 HD22 ' H43' ' A' ' 210' ' ' LYR . 12.1 tp -71.79 -21.79 61.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.275 -0.639 . . . . 1.48 109.275 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.58 -31.38 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.034 -0.985 . . . . 1.3799999999999999 110.292 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.52 -32.97 64.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.757 -0.656 . . . . 1.1899999999999999 111.032 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.1 p -58.17 -29.02 65.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.234 -0.439 . . . . 1.23 110.758 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.987 -0.551 . . . . 0.88 110.718 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -60.91 -41.86 96.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.951 -0.568 . . . . 1.3899999999999999 110.955 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.84 -29.75 63.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 2.3199999999999998 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.5 m -59.7 -43.39 94.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.46 111.351 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.92 -36.82 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 1.24 111.435 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 82.0 mtp -88.48 98.87 11.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.396 . . . . 2.0699999999999998 111.124 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -82.62 -5.05 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 3.5299999999999998 110.585 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -163.79 157.29 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.843 -0.617 . . . . 4.0800000000000001 110.705 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tp -128.99 142.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 2.1699999999999999 110.98 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.53 -30.74 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 4.5199999999999996 110.941 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.48 138.33 39.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 3.75 111.151 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.6 115.81 4.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 3.5299999999999998 110.869 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.95 149.45 21.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.475 . . . . 4.9100000000000001 111.1 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.2 p -94.82 -20.94 19.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 1.98 110.985 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.0 tp -54.56 -40.73 69.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 1.8300000000000001 111.155 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.85 -38.19 78.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.463 -0.335 . . . . 1.79 111.052 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.63 -28.05 73.23 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 0.62 112.127 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -72.13 -37.07 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.921 0.391 . . . . 1.5800000000000001 110.951 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.16 -36.63 61.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.97999999999999998 111.496 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 81.0 mtp -68.31 -47.61 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.463 -0.335 . . . . 1.48 111.449 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.8 p -60.89 -53.64 54.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 1.1299999999999999 111.45 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -56.66 -31.88 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 1.48 111.498 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -66.64 -40.18 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 2.7000000000000002 110.992 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.16 -35.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 1.54 111.096 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -67.93 -36.96 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 1.28 111.359 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.78 -51.1 48.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.42999999999999999 111.484 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.3 pt -59.96 -24.04 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 1.74 110.822 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 17.6 m -67.44 -43.16 81.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.63 110.465 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -68.15 -21.03 64.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.872 -0.604 . . . . 1.0900000000000001 110.461 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' H181 ' A' ' 210' ' ' LYR . . . -81.68 -34.03 26.07 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.043 -0.599 . . . . 0.41999999999999998 113.313 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 118' ' ' ILE . 4.1 pp -79.1 -26.89 42.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 1.3799999999999999 111.288 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 tp -83.93 -29.51 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 1.6200000000000001 111.711 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.08 75.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.39000000000000001 111.423 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.65 -19.3 52.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 2.02 111.066 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -90.5 28.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.42 . . . . 0.76000000000000001 111.25 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -61.66 126.28 26.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 1.46 110.907 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.62 -29.7 23.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.305 -0.407 . . . . 3.3500000000000001 111.075 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.41 ' H ' ' CG2' ' A' ' 127' ' ' VAL . 79.0 mtm180 -137.29 167.1 22.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 2.9199999999999999 110.716 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.94 -13.98 59.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 2.77 110.793 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -90.43 -42.18 11.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 3.77 110.835 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.41 ' CG2' ' H ' ' A' ' 124' ' ' ARG . 18.7 m -65.34 -31.01 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.24 -0.436 . . . . 1.1599999999999999 111.261 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -65.35 -23.68 67.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 2.04 110.97 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -78.59 -25.65 45.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 2.6400000000000001 111.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.46 -52.66 7.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.8999999999999999 111.323 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -60.18 -33.49 72.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.3999999999999999 111.708 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HE2' ' HB3' ' A' ' 183' ' ' TRP . 71.8 t80 -59.13 -48.51 81.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 1.28 110.926 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.1 mt -63.6 -32.46 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 2.1600000000000001 111.199 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.75 -34.64 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.364 . . . . 1.6899999999999999 111.043 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.79 -52.16 44.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.749 . . . . 0.52000000000000002 112.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -64.87 -42.24 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.597 0.237 . . . . 1.02 111.381 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.483 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.9 t -55.41 -40.57 71.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 1.0800000000000001 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.86 98.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.62 110.731 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -63.51 -28.32 69.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 1.8400000000000001 111.134 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 137' ' ' CYS . 93.9 mt -63.21 -60.79 2.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 1.6899999999999999 111.221 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.6 -31.83 44.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.302 -0.408 . . . . 0.81000000000000005 111.34 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.4 mt -75.06 -29.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 2.3700000000000001 111.16 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.9 tp -71.68 -44.08 64.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.97999999999999998 110.811 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -67.38 -27.84 67.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 3.27 110.997 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 1.071 ' HA2' ' OD1' ' A' ' 148' ' ' ASN . . . -83.56 -43.16 7.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.795 -0.717 . . . . 1.25 112.627 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 tt -67.61 -16.54 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.063 0.458 . . . . 2.1200000000000001 110.67 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -91.8 3.62 54.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 110.646 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 1.071 ' OD1' ' HA2' ' A' ' 145' ' ' GLY . 32.1 m120 -82.94 -46.96 0.85 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.84 -0.618 . . . . 99.989999999999995 111.844 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 74.9 Cg_exo -41.51 -30.67 0.96 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.531 2.154 . . . . 2.6000000000000001 112.644 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 150' ' ' LEU . 3.6 mm? -85.91 51.1 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 4.6100000000000003 110.405 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -53.74 142.77 22.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.848 -0.615 . . . . 8.3599999999999994 111.287 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.38 -19.76 57.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 2.75 110.97 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -84.74 -29.35 25.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.16 -0.473 . . . . 5.6799999999999997 110.835 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.0 m -76.63 -7.58 55.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 3.21 111.011 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -61.83 -19.83 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 6.8700000000000001 110.789 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 81.8 p -79.54 -23.85 42.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 4.5599999999999996 111.07 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -64.79 -62.18 1.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 3.5600000000000001 110.867 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.5 t -153.46 113.36 3.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 2.79 110.853 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.7 m -78.01 -23.54 48.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 2.5899999999999999 111.045 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -64.42 -57.91 7.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 3.4700000000000002 110.936 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.74 -25.56 67.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 2.5800000000000001 111.067 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.7 -39.16 70.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 1.78 111.319 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -67.51 -40.93 85.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 2.6299999999999999 110.993 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt -60.72 -48.62 80.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.153 -0.476 . . . . 2.3399999999999999 110.95 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.41 -24.86 63.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.872 -0.604 . . . . 2.77 111.397 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.43 -24.64 53.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 2.04 111.215 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -84.37 -39.03 19.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 2.77 111.576 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 169' ' ' VAL . 2.9 pp -77.42 -26.43 51.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.512 -0.313 . . . . 1.8899999999999999 111.841 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.499 ' N ' HD12 ' A' ' 168' ' ' LEU . 13.4 p -74.9 -26.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.936 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.6 m -65.43 -58.61 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 1.24 111.387 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.16 -31.39 72.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 2.9700000000000002 110.725 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -59.71 -48.86 79.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 1.48 111.06 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 177' ' ' ILE . 41.3 p -62.05 -37.87 86.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 1.55 111.588 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.81 -38.4 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.756 0.313 . . . . 1.52 111.503 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.528 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.0 mt -74.57 -55.1 6.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 1.8500000000000001 111.395 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.48 -31.35 55.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.62 111.634 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 173' ' ' THR . 17.6 tt -87.66 -22.41 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 1.3500000000000001 110.69 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.65 -51.29 59.78 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 113.391 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 84.6 m-85 -58.17 -54.86 51.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.802 0.301 . . . . 1.45 111.737 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 76.6 Cg_exo -48.72 -30.33 16.55 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.112 1.875 . . . . 0.55000000000000004 112.934 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 177' ' ' ILE . 94.3 mt -70.04 -57.46 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 1.4199999999999999 111.788 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.5 m -59.14 -25.72 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.187 -0.461 . . . . 0.78000000000000003 111.703 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.504 ' HB3' ' HE2' ' A' ' 132' ' ' TYR . 24.4 m95 -65.09 -25.95 68.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.505 -0.316 . . . . 0.93999999999999995 111.091 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -53.03 -26.13 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 1.4299999999999999 110.946 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.7 pt -128.88 162.71 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 2.02 110.892 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.34 -167.89 29.22 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.717 -0.754 . . . . 1.79 112.426 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.56 156.81 49.39 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.53 2.154 . . . . 3.1000000000000001 112.108 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.7 t 54.89 22.36 4.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 2.7400000000000002 110.786 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -168.49 47.72 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.812 -0.708 . . . . 3.4300000000000002 112.482 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 78.7 t80 58.25 93.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 6.5 111.006 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 155.37 104.56 0.23 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.842 -0.694 . . . . 3.29 112.412 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -94.33 86.24 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 6.1600000000000001 110.93 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 pt -131.87 176.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 2.4199999999999999 111.005 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.421 ' OD1' HG22 ' A' ' 197' ' ' ILE . 14.1 p30 -58.19 148.39 27.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 4.29 110.839 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -86.8 2.11 50.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 5.1500000000000004 110.947 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.9 m -72.96 -52.77 13.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 2.4500000000000002 111.005 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.421 HG22 ' OD1' ' A' ' 194' ' ' ASN . 10.2 tp -69.12 -30.0 44.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.26 -0.427 . . . . 2.48 110.926 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.4 -56.73 12.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 2.1800000000000002 110.572 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 75.6 p -62.67 -18.83 63.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 1.49 110.891 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -83.48 -30.66 27.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 1.77 110.911 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.9 tp -80.84 -45.55 16.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.314 -0.403 . . . . 1.4199999999999999 111.272 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -74.55 -0.7 18.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 1.78 111.15 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.404 ' HG ' ' HE2' ' A' ' 11' ' ' TYR . 37.8 t -96.35 -47.47 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.433 0.635 . . . . 1.3 110.31 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.16 -28.57 64.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.225 -0.898 . . . . 0.66000000000000003 112.138 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.718 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 37.5 tp -67.2 -55.35 15.92 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.748 -0.381 . . . . 1.6299999999999999 111.408 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.9 Cg_exo -54.86 -37.73 92.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.622 1.548 . . . . 0.64000000000000001 111.207 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 211' ' ' VAL . 74.4 t80 -63.98 -45.76 87.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.076 -0.511 . . . . 1.3600000000000001 110.04 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -63.55 -17.79 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 1.54 110.554 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.528 ' OG ' HD13 ' A' ' 175' ' ' LEU . 16.1 t -96.28 -33.27 12.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 1.2 111.045 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.734 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 207' ' ' PHE . 18.3 m -63.69 -33.44 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.463 -0.335 . . . . 1.6399999999999999 111.494 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.41 80.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.757 -0.735 . . . . 0.79000000000000004 112.685 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -75.58 -33.18 60.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.6100000000000001 111.223 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.3 m -60.99 -60.69 3.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.429 -0.351 . . . . 1.1499999999999999 110.996 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.04 -26.9 67.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 3.3399999999999999 110.951 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.94 -55.45 33.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.374 -0.375 . . . . 1.1899999999999999 111.392 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.19 -34.31 71.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 2.23 111.285 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.32 -52.23 62.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 2.4700000000000002 111.264 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -83.6 -20.72 33.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.336 -0.393 . . . . 1.6200000000000001 111.123 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.17 -59.15 10.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.887 -0.673 . . . . 1.4099999999999999 112.885 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 52.6 tp -76.07 -58.44 3.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.596 0.236 . . . . 2.5800000000000001 111.049 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 52.9 75.17 0.25 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.962 0.41 . . . . 4.9299999999999997 110.526 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.596 HD21 ' HB3' ' A' ' 225' ' ' ASN . 53.1 t30 -128.6 149.56 50.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 4.6299999999999999 110.925 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 224' ' ' LEU . 7.0 mp -112.6 -1.08 14.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 6.4699999999999998 110.922 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.596 ' HB3' HD21 ' A' ' 223' ' ' ASN . 29.5 t30 -87.19 115.94 24.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 5.0700000000000003 110.94 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -102.9 154.62 19.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 6.5300000000000002 110.725 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 48.7 m -149.14 107.49 3.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 5.2199999999999998 111.112 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -74.33 170.91 14.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.207 -0.451 . . . . 8.3599999999999994 110.992 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 7.96 110.914 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.675 0.274 . . . . 6.1699999999999999 111.0 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -109.02 6.92 25.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 4.8200000000000003 110.889 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.14 42.07 0.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 5.5999999999999996 111.029 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -79.39 151.81 30.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 4.7999999999999998 111.027 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -139.77 153.8 47.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 2.3700000000000001 110.923 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.91 -1.12 5.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 2.0699999999999998 111.226 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.81 -53.61 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 2.1000000000000001 110.782 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 77.3 m-70 -65.63 -24.26 67.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.152 -0.476 . . . . 1.0700000000000001 110.782 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -67.18 -50.29 61.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.48 110.836 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.7 -20.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 2.02 110.331 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -61.82 -56.01 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.908 -0.587 . . . . 0.92000000000000004 110.594 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -66.26 -28.45 43.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.075 -0.511 . . . . 0.93999999999999995 111.26 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.08 98.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.55000000000000004 111.254 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.06 -29.27 59.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.762 -0.732 . . . . 0.47999999999999998 112.59 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.48 -39.63 62.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 0.84999999999999998 111.229 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 32.0 p -62.1 -51.12 69.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.468 -0.333 . . . . 1.3400000000000001 110.833 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.05 -23.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 1.55 110.943 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.87 -56.16 24.22 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.873 -0.679 . . . . 0.69999999999999996 112.667 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.87 81.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.81000000000000005 110.932 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.04 -32.31 73.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 2.2599999999999998 110.829 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.58 -28.21 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.78 110.46 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -81.57 -30.17 33.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.992 -0.549 . . . . 4.5800000000000001 110.689 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -60.91 -37.23 81.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.839 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.7 p -83.87 -40.54 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 1.5800000000000001 110.892 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.74 -3.87 40.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 1.8400000000000001 110.61 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 58.5 p -61.0 -23.31 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 1.3700000000000001 111.384 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -49.8 -31.42 11.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.255 0.55 . . . . 4.9800000000000004 109.841 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.487 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 8.3 p30 -173.33 132.29 0.6 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.256 -0.884 . . . . 2.1400000000000001 109.992 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 36.0 Cg_endo -94.52 174.23 1.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.691 2.261 . . . . 1.8200000000000001 112.311 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.48 54.58 2.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 5.1900000000000004 111.255 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.62 -35.58 2.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 2.2000000000000002 112.872 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -79.09 130.27 70.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.603 0.239 . . . . 3.6499999999999999 111.199 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.18 166.5 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.896 2.397 . . . . 2.6699999999999999 113.021 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -70.55 -18.32 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.466 -0.788 . . . . 4.8799999999999999 112.96 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -62.24 -24.47 67.27 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.373 -0.531 . . . . 1.8700000000000001 111.367 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.9 -55.95 8.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 2.6800000000000002 110.339 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -67.31 -21.57 65.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 2.9199999999999999 110.739 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 64.0 tp -59.49 -63.52 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 1.6399999999999999 110.717 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.14 -35.57 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.378 . . . . 1.6000000000000001 110.63 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.8 -5.48 41.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.68999999999999995 111.091 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' B' ' 45' ' ' ILE . 53.5 ttp -88.94 -40.92 12.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.422 . . . . 2.5800000000000001 110.711 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -69.95 -32.76 71.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 3.3900000000000001 111.651 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.581 HG23 HG23 ' B' ' 79' ' ' THR . 87.2 mt -55.58 -54.2 53.97 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.234 0.457 . . . . 0.40999999999999998 112.234 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.449 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.8 Cg_endo -70.14 -31.46 18.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.182 1.921 . . . . 0.48999999999999999 113.342 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 41' ' ' MET . 38.0 mm -61.32 -62.37 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.615 0.245 . . . . 1.29 111.599 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.412 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.7 OUTLIER -57.81 -58.28 9.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 1.3999999999999999 111.164 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -54.71 -31.26 57.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.3799999999999999 111.025 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.8 -60.51 8.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 0.37 112.881 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 42.5 mt -60.14 -28.59 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 1.29 111.252 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -49.69 65.7 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.347 -0.388 . . . . 0.44 111.452 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 20.4 m-85 -63.61 -46.29 86.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.5 111.156 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' MET . . . . . 0.488 ' HB2' HG11 ' B' ' 12' ' ' VAL . 59.7 ttp -48.04 -38.69 17.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.157 0.503 . . . . 1.4099999999999999 110.374 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.93 96.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.55000000000000004 110.92 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 51.2 mtt -52.89 -30.96 37.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.88 -0.6 . . . . 0.5 110.553 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -70.04 -47.4 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.54000000000000004 110.602 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mt -76.8 -1.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.797 -0.638 . . . . 1.3 111.004 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.97 52.14 2.14 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.919 -0.582 . . . . 2.2400000000000002 111.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -115.69 169.32 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 1.77 110.965 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.64 9.99 79.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.814 -0.708 . . . . 1.0600000000000001 112.493 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -117.77 141.8 48.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 2.6600000000000001 110.93 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.62 138.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 1.8899999999999999 111.044 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.32 94.61 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 2.4100000000000001 111.115 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.54 115.84 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.5600000000000001 111.048 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.59 31.45 20.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 1.8200000000000001 111.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.19 84.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.714 -0.755 . . . . 1.51 112.522 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -115.03 124.48 51.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 2.4500000000000002 110.845 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.74 136.28 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 1.79 110.65 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.47 140.58 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.96 0.41 . . . . 0.81999999999999995 111.109 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 50.9 m-70 -84.16 55.89 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 1.05 110.649 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.442 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.7 t80 -58.52 -58.11 10.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.603 -0.726 . . . . 1.8700000000000001 111.679 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.55 -22.31 66.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.60999999999999999 111.974 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.452 ' HB3' ' HB3' ' B' ' 69' ' ' HIS . 14.0 tpp180 -63.52 -51.48 65.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.023 0.379 . . . . 2.3900000000000001 112.023 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 12.9 p90 -77.4 -29.07 52.94 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.87 -0.332 . . . . 3.6699999999999999 111.279 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.442 HG12 ' O ' ' B' ' 70' ' ' TYR . 21.1 mm -51.36 -53.21 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.806 0.336 . . . . 1.6599999999999999 110.682 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.49 -21.49 66.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.082 -0.508 . . . . 1.4099999999999999 109.982 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' TRP . . . . . 0.434 ' O ' HD12 ' B' ' 113' ' ' ILE . 44.4 m0 -86.98 -0.14 56.11 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.958 -0.565 . . . . 1.1599999999999999 111.371 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 55.3 ttm -103.63 -18.64 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.512 . . . . 1.53 110.989 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.403 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.2 m -114.09 -31.01 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.085 0.402 . . . . 0.89000000000000001 112.085 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.581 HG23 HG23 ' B' ' 43' ' ' ILE . 48.0 m -80.82 -50.57 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.844 0.313 . . . . 1.24 111.844 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 28.8 m -53.95 -51.53 76.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.257 0.466 . . . . 0.57999999999999996 112.257 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.3 Cg_endo -56.85 -33.18 94.14 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.733 1.622 . . . . 0.66000000000000003 111.333 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.403 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.6 mm? -75.96 -29.96 58.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.963 -0.562 . . . . 1.0600000000000001 110.132 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.52 HD22 ' H43' ' B' ' 210' ' ' LYR . 15.5 tp -70.23 -21.48 63.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.315 0.579 . . . . 1.22 109.527 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.639 HD22 ' HG3' ' B' ' 109' ' ' GLN . 2.3 tp -84.86 -44.01 13.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.217 -0.901 . . . . 1.53 110.394 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.66 -35.49 72.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.43 -0.805 . . . . 1.5800000000000001 111.074 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 97.9 p -57.49 -32.6 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 1.3899999999999999 110.898 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.459 HD22 HD21 ' B' ' 168' ' ' LEU . 62.3 mt -64.37 -36.79 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 1.1499999999999999 110.925 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -65.11 -34.95 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 1.5700000000000001 110.986 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -73.74 -38.6 64.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 2.1699999999999999 111.126 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 82.2 p -69.26 -23.32 63.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 1.4199999999999999 111.384 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.57 -13.59 21.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 1.1799999999999999 111.147 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 44.7 tpp -127.2 106.36 9.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 1.8799999999999999 110.778 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -67.62 -59.46 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 3.4199999999999999 110.954 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -128.37 137.67 52.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 4.0599999999999996 110.914 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.27 142.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 2.0899999999999999 111.171 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -129.77 -23.31 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.8500000000000001 110.431 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -142.36 141.46 32.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 4.8200000000000003 110.688 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.04 119.1 12.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 3.7999999999999998 111.047 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -84.7 162.72 19.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.48 . . . . 5.1699999999999999 111.002 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 78.9 p -108.61 -22.23 12.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 2.02 111.019 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.76 -29.14 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 2.0899999999999999 110.698 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.7 pt -64.15 -28.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 1.8799999999999999 110.864 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.45 -39.34 22.43 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.813 -0.708 . . . . 0.56000000000000005 112.547 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -67.75 -22.87 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 1.78 110.705 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' B' ' 84' ' ' LEU . 77.2 mt -81.91 -46.22 14.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 1.03 111.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' MET . . . . . 0.404 ' O ' HG12 ' B' ' 110' ' ' ILE . 53.5 ttp -67.09 -30.31 70.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.005 -0.543 . . . . 1.6699999999999999 110.91 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 64.0 m -73.63 -52.89 11.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 1.51 111.435 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -56.8 -28.24 61.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 1.1799999999999999 111.443 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.639 ' HG3' HD22 ' B' ' 84' ' ' LEU . 26.3 mm-40 -69.81 -44.11 70.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.753 0.311 . . . . 2.1699999999999999 110.56 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.404 HG12 ' O ' ' B' ' 106' ' ' MET . 46.2 mm -54.64 -32.69 25.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.989 0.423 . . . . 1.3500000000000001 110.459 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.03 -42.38 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.886 -0.597 . . . . 1.3400000000000001 110.835 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.76 -46.66 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.42999999999999999 111.266 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.434 HD12 ' O ' ' B' ' 76' ' ' TRP . 37.4 mm -60.91 -33.24 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 1.6000000000000001 111.088 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.471 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 25.0 m -60.19 -45.43 93.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.85999999999999999 111.044 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 76.5 p -68.63 -20.77 64.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.94999999999999996 110.512 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.505 ' HA3' H181 ' B' ' 210' ' ' LYR . . . -80.07 -35.94 26.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.0 -0.619 . . . . 0.46000000000000002 113.264 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.532 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.6 pp -76.82 -29.37 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.74 0.305 . . . . 1.75 111.409 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.532 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.85 -27.13 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 1.78 111.565 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.88 -39.71 68.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.38 111.27 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -82.41 -25.39 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 1.97 111.148 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -86.26 34.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.76000000000000001 111.157 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 71.4 p -65.99 125.26 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.47 110.863 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.622 ' H ' HE22 ' A' ' 58' ' ' GLN . 23.3 mm-40 -89.02 -22.63 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 2.5 111.036 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' B' ' 127' ' ' VAL . 99.8 mtt180 -137.6 160.21 39.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 2.73 110.772 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.9 -15.65 60.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.121 -0.491 . . . . 2.2000000000000002 110.652 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -92.7 -41.55 10.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 3.3999999999999999 111.024 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' B' ' 124' ' ' ARG . 18.6 m -64.0 -24.63 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 1.23 111.112 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.92 -42.27 85.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 3.04 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.66 -30.85 71.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 4.1399999999999997 110.975 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.49 HD23 HD13 ' A' ' 56' ' ' ILE . 59.7 tp -74.84 -53.63 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 1.6499999999999999 111.285 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -61.15 -24.77 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.305 . . . . 0.77000000000000002 111.362 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -67.52 -58.79 4.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.476 -0.329 . . . . 1.46 111.402 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.3 -22.55 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.472 -0.331 . . . . 1.6299999999999999 111.317 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.36 -36.42 68.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 1.4199999999999999 110.728 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.91 -51.28 47.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.48999999999999999 112.09 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.09 -43.2 98.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 1.3 110.923 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.4 -40.49 74.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.294 -0.412 . . . . 1.3 110.167 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.62 110.395 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -71.54 -24.02 61.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 1.74 110.669 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.84 -57.64 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 1.76 110.953 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 37.2 pt -59.2 -35.29 56.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.335 -0.393 . . . . 0.68999999999999995 111.282 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.96 -26.49 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 1.76 110.688 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.68 -39.58 73.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 1.0600000000000001 110.965 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -73.74 -30.73 62.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 4.1200000000000001 111.084 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.38 -33.96 24.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.776 -0.726 . . . . 1.26 112.635 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 tt -73.91 -21.36 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 1.98 110.471 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -90.78 4.15 52.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 1.4199999999999999 111.006 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.513 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 58.5 t-20 -83.22 -46.46 0.83 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 111.945 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 62.0 Cg_exo -36.91 -39.9 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.775 2.316 . . . . 2.6499999999999999 113.112 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 46.1 tp -84.42 65.3 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.133 0.492 . . . . 4.3899999999999997 110.264 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.12 139.2 57.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.938 -0.573 . . . . 7.9000000000000004 110.914 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.16 -18.35 61.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 2.77 111.142 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -86.48 -22.94 26.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 6.29 111.047 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 73.4 p -89.1 3.44 51.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 3.1000000000000001 111.117 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -69.7 -16.37 63.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 6.4299999999999997 110.725 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 80.0 p -76.77 -8.27 56.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 4.5700000000000003 110.94 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -78.74 -70.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 3.8300000000000001 110.849 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p -148.18 117.33 6.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 3.0699999999999998 111.035 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 39.9 t -77.24 -18.68 57.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 3.4300000000000002 110.839 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.01 -49.94 22.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 3.9199999999999999 111.049 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 66.5 tp -67.74 -28.14 67.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.105 -0.498 . . . . 2.7000000000000002 110.838 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.17 -52.51 16.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 1.8300000000000001 111.144 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -58.3 -22.54 53.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 2.6299999999999999 110.588 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 33.6 tp -71.04 -47.12 60.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.76 -0.655 . . . . 2.4300000000000002 110.813 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.434 ' O ' HG23 ' B' ' 169' ' ' VAL . 2.3 t80 -75.21 -23.04 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.909 -0.587 . . . . 2.5800000000000001 111.314 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.26 -54.64 22.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.92 0.39 . . . . 2.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.99 -30.51 71.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 3.0299999999999998 111.112 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.459 HD21 HD22 ' B' ' 87' ' ' LEU . 54.4 tp -68.76 -54.91 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 1.1000000000000001 111.313 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 165' ' ' TYR . 91.9 t -61.96 -29.86 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.75 111.536 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.8 m -53.48 -58.99 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.97999999999999998 111.538 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.64 -29.02 65.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.347 -0.388 . . . . 4.2999999999999998 110.665 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.44 -34.32 77.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 1.3899999999999999 111.319 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.412 ' O ' HG22 ' B' ' 177' ' ' ILE . 41.3 p -76.23 -38.99 55.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.372 -0.376 . . . . 1.1100000000000001 111.512 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.96 -34.44 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.819 0.342 . . . . 1.51 111.041 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' B' ' 209' ' ' SER . 53.4 tp -77.87 -55.68 5.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 1.75 111.024 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -30.71 43.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.59999999999999998 111.006 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.443 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.3 tp -87.82 -23.38 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.002 0.429 . . . . 1.47 110.417 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.17 -55.29 29.0 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.55000000000000004 113.311 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.636 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 92.6 m-85 -56.19 -55.75 38.62 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.896 0.348 . . . . 1.6200000000000001 111.296 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -46.87 -27.77 6.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.172 1.915 . . . . 0.64000000000000001 112.826 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.443 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -74.24 -58.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 1.27 111.715 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.43 HG22 ' O ' ' B' ' 179' ' ' TYR . 26.0 m -58.67 -24.69 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.68999999999999995 111.67 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -63.91 -26.99 68.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.55 -0.296 . . . . 1.1799999999999999 111.246 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 85.5 mt -52.1 -29.52 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.558 -0.292 . . . . 1.77 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 43.4 pt -126.72 155.61 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 1.6899999999999999 111.191 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 95.37 177.48 37.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.917 -0.659 . . . . 1.5800000000000001 112.667 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.08 154.4 33.69 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.746 2.297 . . . . 2.5099999999999998 112.046 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 48.4 t 56.77 15.79 2.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.043 0.449 . . . . 3.5800000000000001 110.461 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -158.7 38.31 0.51 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.731 -0.668 . . . . 4.0300000000000002 112.31 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 50.1 t80 58.25 86.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 6.8899999999999997 110.989 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 167.64 95.72 0.1 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.975 -0.631 . . . . 3.7000000000000002 112.206 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -82.56 93.79 7.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.867 0.365 . . . . 7.5 111.002 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 41.3 pt -139.29 177.18 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 2.3500000000000001 111.182 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -57.95 150.15 21.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 3.8599999999999999 110.939 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' GLN . . . . . 0.48 ' CD ' ' H ' ' B' ' 195' ' ' GLN . 5.4 pm0 -87.12 1.03 54.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.003 -0.544 . . . . 5.0499999999999998 110.879 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 52.0 m -73.17 -56.4 5.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.117 -0.492 . . . . 2.6800000000000002 111.051 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.08 -28.61 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 2.4700000000000002 111.019 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.15 -56.85 14.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.165 -0.47 . . . . 2.5299999999999998 110.85 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 44.6 p -68.96 -20.02 64.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 1.29 111.301 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.29 -32.93 55.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 2.6200000000000001 111.333 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.46 -43.53 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 1.6100000000000001 111.355 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.66 -9.33 56.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 1.4199999999999999 111.845 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 19.3 p -96.6 -38.03 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 1.4299999999999999 110.597 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 56.1 tp -72.38 -31.69 65.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.692 -0.685 . . . . 1.1200000000000001 112.073 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.8 tp -65.7 -53.91 33.05 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.951 -0.299 . . . . 1.26 111.266 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.8 Cg_exo -54.91 -42.49 68.47 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.785 1.657 . . . . 0.59999999999999998 111.864 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.83 -38.11 89.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 1.3999999999999999 110.684 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.24 -24.36 65.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 1.4099999999999999 110.682 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.545 ' HB2' HD22 ' B' ' 175' ' ' LEU . 86.1 p -96.95 -22.21 16.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.3200000000000001 111.252 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.764 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m -69.96 -33.31 54.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 1.6899999999999999 111.57 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.7 -29.19 74.57 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.79 -0.719 . . . . 0.79000000000000004 112.885 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -74.01 -39.08 63.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.621 0.248 . . . . 2.96 111.358 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' B' ' 218' ' ' LEU . 49.8 m -58.41 -57.65 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.462 -0.335 . . . . 1.29 111.038 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 215' ' ' PHE . . . . . 0.44 ' HA ' HD12 ' B' ' 218' ' ' LEU . 85.6 t80 -63.29 -23.43 67.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 3.1499999999999999 111.094 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -64.2 -56.87 11.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 1.51 111.495 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.74 -33.88 70.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 2.1899999999999999 111.637 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' B' ' 215' ' ' PHE . 87.1 mt -55.29 -50.49 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 1.98 111.063 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.66 -20.53 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.1699999999999999 110.908 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.59 -55.03 25.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.853 -0.689 . . . . 1.3600000000000001 113.084 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 31.5 tp -79.15 -58.61 3.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.704 0.288 . . . . 2.8999999999999999 111.432 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 52.66 81.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 5.6100000000000003 110.779 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -129.0 145.34 51.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 4.04 110.75 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 62.0 mt -114.88 15.95 17.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.214 -0.448 . . . . 6.2999999999999998 111.066 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -117.5 94.15 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 4.7999999999999998 110.736 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.48 160.33 19.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 6.3899999999999997 110.945 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 43.6 t -142.12 124.51 15.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 5.6100000000000003 110.687 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -84.05 168.61 15.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 8.1999999999999993 111.003 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 8.1699999999999999 111.017 179.889 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.674 0.273 . . . . 5.6200000000000001 111.014 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -107.68 -55.58 2.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 5.2800000000000002 111.103 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 69.5 mt -88.18 91.39 8.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 6.0499999999999998 110.989 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -123.95 147.38 47.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.987 -0.551 . . . . 4.79 110.906 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' C' ' 55' ' ' ALA . 49.0 m -121.85 178.08 5.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 2.71 110.759 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp -155.54 -15.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 2.52 110.872 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' LEU . . . . . 0.441 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.3 mm? -70.34 -45.38 66.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 1.9299999999999999 110.929 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 64.2 m-70 -71.83 -24.35 61.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 1.26 110.7 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.44 ' O ' HG12 ' C' ' 12' ' ' VAL . 61.9 t-105 -66.91 -53.72 29.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 1.6699999999999999 110.564 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -64.9 -21.8 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.99 0.424 . . . . 1.8700000000000001 110.291 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' TYR . . . . . 0.433 ' HE2' ' HG ' ' C' ' 203' ' ' CYS . 0.1 OUTLIER -57.29 -59.51 5.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.601 -0.727 . . . . 1.4399999999999999 110.5 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' C' ' 52' ' ' MET . 8.4 p -61.59 -30.86 49.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.013 -0.54 . . . . 0.46999999999999997 110.967 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.06 78.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.313 -0.403 . . . . 0.58999999999999997 111.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.62 -23.77 77.61 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.688 -0.767 . . . . 0.5 112.834 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.6 mmt -77.52 -45.2 26.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.68000000000000005 111.33 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.9 p -59.29 -50.03 75.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.354 -0.384 . . . . 1.3999999999999999 110.997 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -30.88 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 1.55 110.666 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.72 -60.22 9.39 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.877 -0.677 . . . . 0.70999999999999996 112.589 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -30.86 63.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.812 0.339 . . . . 0.77000000000000002 111.007 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.67 -33.14 70.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.9299999999999999 110.648 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -60.71 -31.21 70.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 1.8600000000000001 110.52 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -74.45 -29.93 61.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.994 -0.548 . . . . 4.1399999999999997 110.793 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -62.82 -39.02 93.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 3.1499999999999999 110.761 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -84.47 -39.09 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 1.95 110.865 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 tp -74.54 -9.21 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 2.2200000000000002 110.72 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 53.9 p -58.16 -24.92 60.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 1.3700000000000001 111.309 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -48.14 -33.53 8.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.204 0.526 . . . . 5.0300000000000002 109.794 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.7 p-10 -171.08 132.46 0.86 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.276 -0.874 . . . . 2.3700000000000001 109.794 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 19.5 Cg_endo -91.75 172.33 2.68 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.732 2.288 . . . . 2.0499999999999998 112.214 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -85.5 47.07 1.37 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.44 . . . . 4.5199999999999996 111.29 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 -46.71 1.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.811 -0.709 . . . . 2.1600000000000001 113.055 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' C' ' 33' ' ' PRO . 17.6 m -76.48 140.39 68.42 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.607 0.241 . . . . 2.5299999999999998 111.102 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 19.2 Cg_exo -65.19 166.47 18.88 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.532 2.155 . . . . 1.9299999999999999 112.197 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.7 -18.67 64.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 4.1200000000000001 112.965 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.521 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -55.13 -36.74 66.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.969 0.414 . . . . 2.8900000000000001 110.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.73 -48.93 72.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 2.46 110.734 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.06 -19.05 62.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 2.7799999999999998 110.695 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.88 -63.42 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 1.6200000000000001 110.435 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.33 -32.09 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 1.5900000000000001 110.836 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.67 -6.32 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.65000000000000002 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.442 ' O ' HG12 ' C' ' 45' ' ' ILE . 53.7 ttp -89.83 -43.46 10.62 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.978 -0.556 . . . . 1.6699999999999999 111.392 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -73.07 -39.51 65.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.142 0.423 . . . . 3.4199999999999999 112.142 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.565 HG23 HG23 ' C' ' 79' ' ' THR . 96.6 mt -50.64 -50.6 71.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.255 0.465 . . . . 0.89000000000000001 112.255 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.6 -36.14 6.97 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.113 1.875 . . . . 0.40999999999999998 113.142 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' C' ' 41' ' ' MET . 28.9 mm -57.41 -62.74 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.821 0.343 . . . . 1.76 111.469 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -56.56 -57.12 13.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 2.1600000000000001 111.241 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 47.1 m -51.96 -36.45 49.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 1.1699999999999999 111.134 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.71 -53.02 38.34 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 0.44 112.486 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.402 ' O ' ' HG3' ' C' ' 52' ' ' MET . 4.2 mm? -59.67 -35.92 75.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.414 . . . . 1.29 111.002 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -34.15 75.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.5 111.444 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.3 m-85 -70.6 -57.58 4.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 1.8300000000000001 111.542 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' MET . . . . . 0.58 ' HB3' HG11 ' C' ' 12' ' ' VAL . 5.0 ppp? -48.74 -30.72 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.89 0.376 . . . . 1.47 110.707 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.9 80.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.59999999999999998 110.826 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 58.0 mtt -54.54 -30.8 54.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.124 -0.489 . . . . 0.83999999999999997 110.546 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' C' ' 5' ' ' SER . . . -67.59 -50.62 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 111.133 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.37 5.94 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 1.55 111.186 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.3 54.94 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 1.54 111.106 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.506 HE21 HD11 ' A' ' 118' ' ' ILE . 57.5 tp60 -123.69 139.64 53.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 1.79 111.028 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.63 -7.66 29.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.804 -0.713 . . . . 0.93999999999999995 112.664 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -103.04 166.14 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.712 0.291 . . . . 2.3599999999999999 110.944 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.73 145.91 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.97 110.998 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -93.51 95.11 9.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.144 -0.48 . . . . 2.4399999999999999 110.953 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.42 107.37 19.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 1.54 111.136 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 33.24 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 1.71 111.389 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.65 2.1 88.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 1.53 112.606 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -102.44 152.23 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 2.23 110.942 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 33.2 mt -105.54 114.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 1.3600000000000001 110.833 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.12 142.42 27.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.78000000000000003 111.547 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.488 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 47.6 m-70 -84.24 58.81 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.884 -0.598 . . . . 1.0800000000000001 110.478 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' TYR . . . . . 0.495 ' O ' HG12 ' C' ' 74' ' ' ILE . 69.8 t80 -58.69 -58.53 8.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.535 -0.757 . . . . 2.2999999999999998 111.938 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.85 67.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.204 0.446 . . . . 0.75 112.204 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.7 tpp180 -61.64 -51.63 67.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.919 0.34 . . . . 1.51 111.919 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.443 ' O ' ' HG3' ' C' ' 77' ' ' MET . 14.0 p90 -78.13 -28.42 48.45 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.844 -0.342 . . . . 4.6500000000000004 111.039 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.495 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.4 mm -47.31 -56.74 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 120.744 0.307 . . . . 1.22 110.907 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.35 -28.78 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.268 -0.424 . . . . 1.3100000000000001 110.129 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -81.4 8.02 10.31 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.085 -0.507 . . . . 1.6799999999999999 111.172 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.551 ' HA ' HD13 ' C' ' 113' ' ' ILE . 18.9 mtp -104.52 -25.22 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 1.8 110.458 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.44 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 24.7 m -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 1.1899999999999999 111.979 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.565 HG23 HG23 ' C' ' 43' ' ' ILE . 85.1 m -67.12 -58.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.065 0.394 . . . . 1.23 112.065 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 12.6 m -47.94 -52.43 40.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.58999999999999997 112.043 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 63.3 Cg_exo -51.95 -44.4 45.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.822 1.681 . . . . 0.67000000000000004 111.794 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 98.6 mt -66.02 -32.89 74.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 0.95999999999999996 110.555 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -31.69 64.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 1.1899999999999999 109.766 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.471 HD11 ' NE2' ' C' ' 109' ' ' GLN . 19.8 mt -77.83 -44.83 26.15 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.7 110.112 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -50.38 -42.0 52.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.446 -0.797 . . . . 1.6200000000000001 110.384 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.412 ' O ' HG23 ' C' ' 90' ' ' THR . 43.2 t -57.62 -34.23 69.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 1.26 110.945 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 40.7 mt -65.39 -36.74 84.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 1.1100000000000001 111.359 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 69.2 p -69.64 -26.19 64.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 1.51 110.95 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -80.58 -34.83 35.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 2.0600000000000001 111.153 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' THR . . . . . 0.412 HG23 ' O ' ' C' ' 86' ' ' SER . 66.6 p -67.87 -26.68 66.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 1.52 111.049 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.65 -44.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 1.3 111.101 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.02 105.62 17.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 1.6200000000000001 111.092 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -80.47 -12.09 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 3.2400000000000002 110.828 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -162.7 137.44 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 4.6299999999999999 110.557 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.8 tt -108.23 144.49 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 2.1800000000000002 111.17 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -131.72 -25.85 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 4.1200000000000001 110.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -146.17 137.58 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 4.96 110.38 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.63 124.45 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 3.9100000000000001 111.326 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -92.84 162.4 14.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 5.21 110.98 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -103.58 -21.42 13.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 1.8200000000000001 110.705 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.413 HD22 ' N ' ' C' ' 101' ' ' LEU . 3.8 mm? -60.3 -31.75 70.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 2.0800000000000001 110.67 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -62.15 -33.15 57.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 1.8600000000000001 110.932 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.08 -27.51 60.02 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.861 -0.685 . . . . 0.58999999999999997 112.098 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -64.84 -39.78 94.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.892 0.377 . . . . 1.53 110.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.88 -50.09 25.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.1100000000000001 111.126 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 106' ' ' MET . . . . . 0.412 ' O ' HG13 ' C' ' 110' ' ' ILE . 12.6 tpt -56.88 -41.58 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.785 -0.643 . . . . 2.21 111.514 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t -66.38 -59.38 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 1.28 111.156 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.501 ' HB ' HD12 ' C' ' 142' ' ' ILE . 42.9 p -53.6 -26.4 21.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.22 111.326 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.471 ' NE2' HD11 ' C' ' 84' ' ' LEU . 6.9 tp-100 -68.17 -47.98 66.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 2.3300000000000001 110.923 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.412 HG13 ' O ' ' C' ' 106' ' ' MET . 49.3 mt -55.26 -31.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 1.29 110.635 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.24 -45.74 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.814 -0.63 . . . . 1.0600000000000001 111.118 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.2 -47.77 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.125 -0.489 . . . . 0.51000000000000001 111.079 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.551 HD13 ' HA ' ' C' ' 77' ' ' MET . 60.6 mt -57.53 -35.7 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 1.3700000000000001 110.848 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 18.3 m -57.15 -45.88 83.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.062 0.458 . . . . 0.77000000000000002 110.695 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' SER . . . . . 0.447 ' HA ' HG22 ' C' ' 118' ' ' ILE . 62.9 m -69.25 -23.22 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 1.1899999999999999 110.798 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.494 ' HA3' H181 ' C' ' 210' ' ' LYR . . . -78.31 -32.67 42.25 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.983 -0.627 . . . . 0.5 113.048 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.491 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.4 pp -82.54 -28.51 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 1.47 111.396 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.491 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.7 tp -83.92 -26.23 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 1.2 111.483 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.1 70.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.4 . . . . 0.40000000000000002 111.258 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -84.89 -12.96 52.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 2.1200000000000001 110.802 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.43 ' HB2' HD12 ' C' ' 118' ' ' ILE . 96.0 mt -95.88 26.6 3.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.75 111.192 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 67.5 m -65.16 122.24 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.356 . . . . 1.3799999999999999 110.876 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -86.62 -17.04 34.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 2.7400000000000002 110.916 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.434 ' HB2' HG13 ' C' ' 127' ' ' VAL . 98.5 mtt180 -137.01 169.14 18.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 2.7999999999999998 110.946 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.88 -17.13 38.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 2.4100000000000001 110.814 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -90.88 -39.19 12.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 4.2000000000000002 110.549 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' C' ' 124' ' ' ARG . 27.3 m -63.69 -26.91 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 1.0800000000000001 111.117 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -66.53 -34.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.973 -0.558 . . . . 2.5699999999999998 110.994 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -73.87 -27.02 60.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 3.8100000000000001 110.839 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.08 -41.61 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 1.4199999999999999 111.227 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -71.72 -31.04 66.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.89000000000000001 111.052 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -63.69 -58.72 6.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 1.26 110.817 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.08 -29.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.402 . . . . 1.6799999999999999 111.041 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.12 -38.62 88.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 1.24 110.892 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.84 -54.47 21.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.898 -0.668 . . . . 0.54000000000000004 112.604 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.56 -30.67 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.618 0.247 . . . . 1.0600000000000001 111.236 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.38 -47.65 83.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 1.0800000000000001 110.514 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.52 -30.16 71.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.56999999999999995 110.861 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.6 -20.51 61.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 1.6799999999999999 110.586 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.48 -55.67 5.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 1.7 111.028 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 36.2 pt -58.79 -35.92 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.356 -0.384 . . . . 0.78000000000000003 111.891 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.501 HD12 ' HB ' ' C' ' 108' ' ' THR . 17.6 tt -75.94 -23.71 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 2.2400000000000002 111.114 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.13 -48.33 73.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.361 -0.381 . . . . 1.02 110.764 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -68.62 -32.89 73.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 3.0 110.761 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.38 -39.51 61.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 1.27 112.452 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -75.21 -19.93 16.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.161 0.505 . . . . 1.8899999999999999 110.36 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -88.87 3.0 52.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.586 -0.734 . . . . 1.6000000000000001 110.383 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.47 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 58.5 t-20 -83.52 -48.41 0.74 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 99.989999999999995 111.96 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 77.0 Cg_exo -40.92 -33.44 1.12 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.489 2.126 . . . . 2.73 112.905 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 150' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' C' ' 165' ' ' TYR . 85.7 mt -85.07 49.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 4.2999999999999998 110.504 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -54.72 147.66 14.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.029 -0.532 . . . . 8.9000000000000004 111.174 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.33 -18.15 49.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 2.7999999999999998 110.909 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -82.46 -29.27 30.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.525 . . . . 5.4400000000000004 110.857 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 58.1 p -83.52 4.16 29.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 3.3900000000000001 111.288 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -67.41 -27.34 66.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 6.9199999999999999 110.766 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 72.8 p -76.89 -6.3 51.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.074 -0.512 . . . . 4.8700000000000001 111.224 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -80.14 -56.07 4.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.232 -0.44 . . . . 4.0499999999999998 111.002 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 87.7 p -158.44 113.43 2.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 3.0299999999999998 110.758 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 47.9 t -77.6 -28.38 51.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 2.96 111.021 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.03 -62.66 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 3.7400000000000002 111.172 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 56.2 tp -61.0 -36.95 80.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.2 -0.455 . . . . 2.6499999999999999 111.168 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.81 76.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 1.77 111.476 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -74.95 -30.11 61.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 2.96 111.018 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.05 -51.61 56.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 2.3500000000000001 110.973 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 165' ' ' TYR . . . . . 0.53 ' HB3' HD21 ' C' ' 150' ' ' LEU . 1.0 OUTLIER -69.24 -22.95 63.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 2.6200000000000001 111.138 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 -38.9 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.333 -0.394 . . . . 2.0899999999999999 110.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -81.72 -23.47 36.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 3.2400000000000002 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.47 -41.02 41.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 1.6899999999999999 111.254 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.42 -24.49 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 1.3999999999999999 111.377 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 170' ' ' THR . . . . . 0.434 ' O ' HG23 ' C' ' 174' ' ' VAL . 38.9 m -59.64 -58.88 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.95999999999999996 111.309 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -67.89 -31.86 71.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 3.6499999999999999 110.766 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.0 -38.51 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 1.3700000000000001 111.639 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.432 ' O ' HG22 ' C' ' 177' ' ' ILE . 38.7 p -73.21 -33.78 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.426 -0.352 . . . . 1.4299999999999999 111.657 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 174' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 170' ' ' THR . 62.5 t -60.93 -37.11 76.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.555 -0.293 . . . . 1.6200000000000001 111.773 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.25 -45.5 16.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 2.0299999999999998 111.344 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 176' ' ' TRP . . . . . 0.404 ' CZ2' HD21 ' C' ' 84' ' ' LEU . 0.9 OUTLIER -57.77 -31.79 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.464 -0.335 . . . . 0.62 110.691 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.434 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.2 tt -87.96 -20.64 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.5800000000000001 110.211 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.49 -56.72 23.58 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.753 -0.658 . . . . 0.56000000000000005 113.407 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.636 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 87.8 m-85 -54.21 -54.42 47.97 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.755 0.278 . . . . 1.3300000000000001 111.437 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.9 Cg_exo -47.09 -30.9 10.88 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.139 1.892 . . . . 0.63 112.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.499 ' O ' HG12 ' C' ' 184' ' ' ILE . 88.2 mt -70.7 -60.49 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.93000000000000005 111.639 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.491 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.6 m -56.18 -24.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.407 0.521 . . . . 1.27 112.407 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -65.69 -17.4 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.429 0.529 . . . . 1.77 112.429 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.586 HG13 HG23 ' C' ' 185' ' ' ILE . 22.5 pt -65.67 -13.19 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.659 0.266 . . . . 2.3900000000000001 111.563 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.586 HG23 HG13 ' C' ' 184' ' ' ILE . 31.0 pt -139.52 151.92 22.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.424 -0.353 . . . . 1.95 111.28 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 186' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' C' ' 191' ' ' GLY . . . 96.26 179.83 35.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.842 -0.694 . . . . 1.8799999999999999 112.698 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.96 149.1 63.83 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.739 2.293 . . . . 3.1200000000000001 112.225 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 34.5 m 57.26 19.81 5.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.065 -0.516 . . . . 2.6299999999999999 110.51 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -164.23 42.59 0.31 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.901 -0.666 . . . . 3.04 112.641 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 54.3 t80 57.9 90.68 0.04 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.941 0.4 . . . . 5.6900000000000004 111.159 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 191' ' ' GLY . . . . . 0.507 ' HA3' ' H ' ' C' ' 186' ' ' GLY . . . 160.13 102.32 0.18 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.815 -0.707 . . . . 3.0800000000000001 112.576 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -90.35 78.84 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.976 0.417 . . . . 7.5300000000000002 110.585 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 23.5 pt -124.31 172.56 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 2.8599999999999999 111.041 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 194' ' ' ASN . . . . . 0.496 HD21 HG12 ' C' ' 197' ' ' ILE . 29.8 p-10 -57.99 141.28 50.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.425 -0.352 . . . . 3.6899999999999999 111.031 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -74.92 -8.5 56.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.136 -0.483 . . . . 5.4800000000000004 111.218 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.1 m -65.04 -42.26 94.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 2.3799999999999999 110.807 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 197' ' ' ILE . . . . . 0.496 HG12 HD21 ' C' ' 194' ' ' ASN . 46.9 mm -72.49 -48.26 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 2.23 111.279 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.3 -51.96 64.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 2.1600000000000001 111.077 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 87.7 m -64.72 -25.16 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 1.27 111.424 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -82.47 -27.68 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 1.7 111.696 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.87 -48.29 10.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.636 0.255 . . . . 2.02 111.402 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -69.17 1.44 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 1.8200000000000001 111.211 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.433 ' HG ' ' HE2' ' C' ' 11' ' ' TYR . 51.2 t -96.27 -48.8 5.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 1.3500000000000001 110.7 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.8 -30.57 65.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.65000000000000002 111.95 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.659 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 44.6 tp -62.19 -54.62 48.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 120.966 -0.293 . . . . 1.4199999999999999 111.49 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 46.3 Cg_exo -57.3 -41.8 69.21 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.65 1.566 . . . . 0.63 111.516 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.42 -32.01 73.32 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.273 -0.421 . . . . 1.49 110.502 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.75 -25.2 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 1.7 110.839 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t -96.77 -21.96 17.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 1.25 111.012 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.749 H192 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.4 -32.75 51.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.8 0.333 . . . . 1.6100000000000001 111.479 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.04 -31.65 81.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.74 -0.743 . . . . 0.81999999999999995 112.656 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -75.2 -29.16 60.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.781 0.324 . . . . 3.0800000000000001 111.08 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -63.78 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 1.1499999999999999 111.065 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -62.71 -23.26 67.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 2.5600000000000001 110.977 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.73 -47.37 85.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.971 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -66.78 -35.41 80.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.414 -0.357 . . . . 2.3900000000000001 111.003 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.31 -43.28 88.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 2.0299999999999998 111.01 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -87.44 -19.92 27.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 3.21 110.94 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.69 31.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.993 -0.622 . . . . 1.3600000000000001 113.08 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.2 -58.87 2.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.555 0.217 . . . . 2.8999999999999999 111.417 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 51.66 76.37 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.769 0.319 . . . . 4.8899999999999997 110.918 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -127.43 148.42 50.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 4.2300000000000004 111.071 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.31 -8.19 17.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 6.1200000000000001 111.009 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.85 115.04 21.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 4.5499999999999998 110.686 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -111.09 146.23 37.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 6.7800000000000002 111.063 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 38.8 t -132.44 133.28 43.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 5.4000000000000004 110.747 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -103.67 167.6 9.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 8.3300000000000001 110.951 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 7.9100000000000001 110.7 179.841 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.825 0.345 . . . . 5.1100000000000003 110.975 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -98.05 -5.65 33.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 5.04 110.886 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 3' ' ' LEU . 6.7 mp -85.19 83.92 7.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 5.5800000000000001 111.205 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -105.53 112.22 25.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 5.0199999999999996 110.74 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.6 p -111.67 138.7 47.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.229 -0.441 . . . . 2.4500000000000002 110.813 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp -114.92 -14.26 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 2.4199999999999999 110.808 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.36 -42.86 99.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.147 -0.479 . . . . 2.0899999999999999 110.971 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 25.6 m170 -62.94 -35.88 81.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 1.1599999999999999 110.779 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -69.04 -52.47 28.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.79000000000000004 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.0 mt -56.19 -34.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.007 0.432 . . . . 2.0800000000000001 110.407 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.493 ' O ' ' HG2' ' A' ' 15' ' ' MET . 20.1 t80 -57.45 -42.15 81.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 1.28 109.826 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 8' ' ' HIS . 3.1 t -57.25 -48.38 82.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.3200000000000001 111.229 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.06 -44.95 83.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.63 111.681 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.31 94.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.55000000000000004 112.705 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 56.0 mmm -69.16 -32.92 72.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 1.03 110.992 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -60.83 -60.33 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 1.3 111.449 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -57.2 -26.1 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.348 -0.387 . . . . 1.3100000000000001 111.268 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -59.49 -48.55 85.44 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.571 -0.823 . . . . 0.77000000000000002 112.328 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.05 -23.22 63.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 0.80000000000000004 111.01 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.32 -44.13 84.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 1.8100000000000001 110.921 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.94 -20.93 60.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.8799999999999999 110.997 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.83 -48.19 80.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 4.4500000000000002 110.891 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.506 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.1 m-90 -71.55 -35.52 70.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 3.6899999999999999 110.88 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.0 m -70.47 -20.65 62.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 1.5700000000000001 111.333 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 tp -86.18 -10.63 54.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 1.95 111.117 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 52.3 p -65.4 -23.05 66.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.385 -0.37 . . . . 1.3799999999999999 111.152 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -47.07 -32.69 4.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.261 0.553 . . . . 4.0700000000000003 109.699 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -174.18 132.45 0.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.092 -0.958 . . . . 2.7200000000000002 110.216 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -92.47 140.8 2.12 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.777 2.318 . . . . 1.9099999999999999 112.07 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -81.28 72.83 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 4.7599999999999998 111.601 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.76 -46.9 3.19 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.106 -0.568 . . . . 1.99 113.435 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.37 140.52 21.71 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.792 0.296 . . . . 2.7000000000000002 111.222 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.44 165.56 12.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.552 2.168 . . . . 1.79 112.131 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 5.2 pm0 -63.5 -18.6 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 4.1200000000000001 112.233 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -48.09 -36.29 12.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.754 0.311 . . . . 2.9300000000000002 111.317 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.11 -53.33 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.909 0.385 . . . . 2.8799999999999999 110.461 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -68.27 -18.45 64.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 4.6600000000000001 110.669 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.08 -52.87 63.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.189 -0.459 . . . . 1.45 110.406 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 t -65.85 -36.78 78.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.155 0.502 . . . . 1.78 109.795 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.38 -8.37 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.623 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.476 ' O ' HG12 ' A' ' 45' ' ' ILE . 22.4 ttt -88.68 -36.98 15.9 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.2 -0.454 . . . . 1.48 110.746 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -67.99 -32.8 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 3.5 111.222 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 79' ' ' THR . 68.5 mt -56.88 -55.01 48.12 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.307 0.484 . . . . 1.0800000000000001 112.307 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 36.7 Cg_endo -65.38 -33.94 45.8 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.295 1.996 . . . . 0.53000000000000003 113.442 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 41' ' ' MET . 38.8 mm -55.26 -62.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.881 0.326 . . . . 1.6799999999999999 111.881 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.454 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.8 t90 -66.06 -47.89 72.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 1.8300000000000001 110.981 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -61.81 -9.79 7.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 1.0900000000000001 111.238 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.31 -59.53 2.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.40999999999999998 112.134 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.36 -26.95 65.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 0.98999999999999999 110.704 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -51.52 69.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.47999999999999998 110.79 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 27.7 m-85 -69.65 -26.36 64.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 1.8700000000000001 110.938 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -56.42 -36.78 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.514 -0.55 . . . . 1.49 109.514 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -73.16 -44.15 60.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.538 -0.755 . . . . 0.58999999999999997 110.85 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.443 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 51.6 mtt -51.5 -26.48 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.48999999999999999 110.597 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.11 -47.28 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.59999999999999998 111.211 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -84.18 14.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 1.3100000000000001 111.545 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 57.31 55.76 5.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.027 -0.533 . . . . 1.9099999999999999 111.223 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 16.8 mm-40 -125.22 173.01 9.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 1.6200000000000001 110.716 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.45 66.48 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.593 -0.813 . . . . 1.04 112.155 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.75 173.98 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 2.6800000000000002 110.709 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.12 132.49 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 1.98 111.355 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -101.23 88.54 3.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 2.1800000000000002 110.625 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.06 131.72 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.5700000000000001 111.2 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 27.71 17.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.066 -0.515 . . . . 1.79 111.408 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.24 -11.27 37.9 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.713 -0.756 . . . . 1.48 112.643 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -97.87 149.74 22.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.34 . . . . 2.3199999999999998 110.899 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.3 mt -94.15 117.33 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 1.4399999999999999 110.939 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.26 144.83 30.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.81999999999999995 111.233 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.3 m-70 -88.68 68.89 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.90000000000000002 110.958 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.15 -35.71 75.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 1.8300000000000001 111.102 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -73.46 -24.19 60.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.62 111.971 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.7 tpp180 -69.29 -51.71 34.59 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.335 0.494 . . . . 2.3399999999999999 112.335 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -81.23 -31.1 34.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.207 0.447 . . . . 3.4900000000000002 112.207 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 71' ' ' ALA . 10.6 tp -57.53 -43.91 83.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.762 -0.375 . . . . 1.3700000000000001 110.537 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 74' ' ' ILE . 13.3 t70 -68.85 -20.3 64.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.498 -0.556 . . . . 1.3100000000000001 109.498 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -87.7 1.22 54.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.672 -0.694 . . . . 1.48 111.169 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.411 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 56.6 ttm -104.61 -18.71 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 1.46 110.915 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 82' ' ' LEU . 30.0 m -114.11 -32.06 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 1.1200000000000001 111.904 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 43' ' ' ILE . 27.9 m -82.9 -41.38 18.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.898 0.333 . . . . 1.1000000000000001 111.898 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 72.4 m -60.19 -50.27 86.86 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.945 0.35 . . . . 0.59999999999999998 111.945 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 44.9 Cg_exo -56.69 -32.92 92.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.074 1.849 . . . . 0.73999999999999999 112.437 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 78' ' ' VAL . 7.3 mp -82.94 -16.97 45.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.115 -0.493 . . . . 1.01 110.845 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -72.91 -47.03 49.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 1.48 109.948 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 85' ' ' LEU . 3.6 pp -74.92 -29.47 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.555 . . . . 1.3799999999999999 110.988 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 84' ' ' LEU . 9.7 tp -64.03 -36.47 84.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.018 -0.537 . . . . 1.1899999999999999 110.798 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -61.94 -24.41 66.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 1.23 110.554 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.68 -34.01 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.88 110.793 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.5 p -71.28 -28.42 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 1.3899999999999999 110.52 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.86 -26.82 29.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.3199999999999998 110.985 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -81.37 -25.7 36.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.244 -0.435 . . . . 1.46 110.966 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.5 -35.24 12.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.277 -0.419 . . . . 1.24 111.263 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 71.4 mtm -118.18 111.1 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 2.0699999999999998 111.144 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.75 -24.45 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 3.5299999999999998 110.69 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -137.12 141.03 42.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 4.0800000000000001 110.659 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.7 pt -128.39 143.95 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 2.1699999999999999 111.407 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.917 -0.583 . . . . 4.5199999999999996 110.606 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.42 52.45 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.467 . . . . 3.75 110.992 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -135.29 93.69 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 3.5299999999999998 110.858 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -71.65 80.5 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 4.9100000000000001 111.097 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.4 m -120.6 -60.56 1.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.324 -0.398 . . . . 1.98 111.179 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.29 -58.84 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 1.8300000000000001 111.081 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.2 tt -56.55 -36.38 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 1.79 111.24 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.15 -30.63 73.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.62 112.809 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.3 -48.95 75.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.745 0.307 . . . . 1.5800000000000001 110.991 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.97 -43.66 98.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.97999999999999998 111.506 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.412 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 89.4 mtp -56.43 -39.68 73.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 1.48 111.666 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.2 m -71.7 -45.67 61.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.959 0.409 . . . . 1.1299999999999999 111.204 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.419 ' HB ' HD13 ' A' ' 142' ' ' ILE . 68.2 p -64.85 -20.28 66.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 1.48 111.618 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 110' ' ' ILE . 3.0 pt20 -77.76 -41.49 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.586 0.231 . . . . 2.7000000000000002 110.796 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.67 HG22 ' HE1' ' C' ' 46' ' ' TRP . 43.2 mt -61.2 -33.05 54.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.947 0.403 . . . . 1.54 110.807 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.17 -47.88 76.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.916 -0.584 . . . . 1.28 111.219 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.539 HG13 H133 ' A' ' 210' ' ' LYR . 73.8 t -61.85 -44.07 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.223 -0.444 . . . . 0.42999999999999999 111.457 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 109' ' ' GLN . 74.8 mt -54.77 -40.28 51.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.776 0.322 . . . . 1.74 110.864 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 117' ' ' LEU . 99.0 m -60.15 -39.79 87.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.63 110.913 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -57.72 -57.31 13.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 1.0900000000000001 110.123 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.8 -14.25 65.01 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.985 -0.626 . . . . 0.41999999999999998 112.199 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 114' ' ' THR . 10.0 tt -70.29 -56.41 6.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 1.3799999999999999 110.724 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.432 ' HB ' ' NE1' ' A' ' 131' ' ' TRP . 67.1 mt -83.73 -22.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.004 -0.543 . . . . 1.6200000000000001 111.563 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HA ' ' HD1' ' A' ' 131' ' ' TRP . . . -49.7 -40.13 39.26 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.849 0.357 . . . . 0.39000000000000001 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.73 -21.48 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.02 110.479 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.3 mt -91.87 31.87 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.76000000000000001 110.775 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 t -88.02 128.14 35.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 1.46 110.634 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.59 -69.77 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 3.3500000000000001 111.282 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.683 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.6 ttp180 -74.4 136.94 42.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 2.9199999999999999 111.06 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.67 -9.88 58.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 2.77 111.181 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.683 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 64.1 t-105 -80.2 -46.65 15.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 3.77 110.804 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HB ' HH21 ' A' ' 124' ' ' ARG . 13.3 p -77.19 -23.99 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 1.1599999999999999 111.448 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -56.88 -32.09 65.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 2.04 111.396 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -72.05 -25.24 61.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 2.6400000000000001 111.342 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.551 HD23 HG21 ' C' ' 56' ' ' ILE . 30.8 tp -83.49 -48.18 10.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.538 -0.301 . . . . 1.8999999999999999 111.32 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.432 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 50.4 t-105 -59.88 -28.13 67.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 1.3999999999999999 110.626 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.29 -44.33 79.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 1.28 110.666 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.48 -29.22 44.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 2.1600000000000001 110.815 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 69.2 m -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 1.6899999999999999 110.717 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.8 -56.89 12.43 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.52000000000000002 112.465 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 m -56.25 -33.17 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 1.02 111.092 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.2 t -61.69 -37.08 82.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 1.0800000000000001 110.465 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.18 93.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.802 -0.635 . . . . 0.62 110.625 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.4 -14.88 58.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 1.8400000000000001 110.518 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 140' ' ' LEU . 0.5 OUTLIER -65.85 -56.91 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 1.6899999999999999 110.162 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.9 pt -66.27 -37.47 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.81000000000000005 110.839 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.419 HD13 ' HB ' ' A' ' 108' ' ' THR . 96.6 mt -65.97 -35.96 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 2.3700000000000001 110.801 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.52 -43.49 93.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.97999999999999998 110.339 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.525 ' O ' ' OD1' ' A' ' 148' ' ' ASN . 88.3 t90 -64.49 -28.61 69.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.596 . . . . 3.27 110.434 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 1.222 ' HA2' ' OD1' ' A' ' 148' ' ' ASN . . . -80.25 -33.34 32.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 1.25 112.456 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.54 -24.71 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 2.1200000000000001 110.443 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -88.89 5.05 45.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.863 -0.608 . . . . 1.6599999999999999 111.057 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 1.222 ' OD1' ' HA2' ' A' ' 145' ' ' GLY . 32.0 m120 -83.7 -48.31 0.73 Allowed Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 99.989999999999995 112.283 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 91.0 Cg_exo -41.42 -32.81 1.4 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.685 2.256 . . . . 2.6000000000000001 112.882 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.72 46.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 4.6100000000000003 110.81 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.647 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 43.7 ttp180 -55.98 148.26 17.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.746 -0.661 . . . . 8.3599999999999994 110.593 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.81 -19.73 65.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 2.75 111.363 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.647 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 98.9 mttt -86.67 7.17 27.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.435 -0.348 . . . . 5.6799999999999997 111.595 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 151' ' ' ARG . 72.8 p -79.02 -1.56 36.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.349 . . . . 3.21 111.305 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -66.66 -28.51 68.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 6.8700000000000001 110.68 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 t -94.1 -23.61 17.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 4.5599999999999996 111.202 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.79 -73.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 3.5600000000000001 110.617 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.4 m -157.47 112.86 2.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.488 . . . . 2.79 110.845 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -78.33 -31.25 48.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.041 -0.527 . . . . 2.5899999999999999 110.966 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -63.7 -58.58 6.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.528 . . . . 3.4700000000000002 111.083 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 161' ' ' LEU . 3.5 mm? -60.85 -36.37 78.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 2.5800000000000001 111.083 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.42 -26.93 68.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 1.78 111.061 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.08 -37.7 61.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 2.6299999999999999 110.865 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.54 -32.6 71.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 2.3399999999999999 110.998 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.422 ' O ' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -79.45 -31.17 42.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.525 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.54 -44.01 97.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 2.04 111.0 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.4 -19.72 38.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 2.77 111.479 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 42.7 tp -80.65 -39.96 26.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.978 0.362 . . . . 1.8899999999999999 111.978 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 165' ' ' TYR . 14.8 p -75.37 -31.23 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.361 0.504 . . . . 1.6399999999999999 112.361 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 174' ' ' VAL . 6.4 t -57.79 -44.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.712 0.291 . . . . 1.24 111.369 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.4 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 74.5 m-85 -77.09 -28.12 54.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.749 0.309 . . . . 2.9700000000000002 110.612 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -65.56 -46.49 79.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.51 . . . . 1.48 111.216 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -64.11 -40.31 95.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 1.55 111.51 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 170' ' ' THR . 84.4 t -57.52 -35.32 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.804 0.335 . . . . 1.52 111.217 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 73.0 mt -74.26 -57.56 3.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.391 -0.368 . . . . 1.8500000000000001 111.434 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.63 -25.93 54.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.62 111.181 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.469 ' O ' HG12 ' A' ' 181' ' ' ILE . 31.1 mm -87.7 -27.38 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 1.3500000000000001 110.272 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.92 -53.88 34.26 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.58999999999999997 113.172 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.668 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 80.4 m-85 -56.42 -57.24 24.39 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.884 0.342 . . . . 1.45 111.495 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.668 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 86.0 Cg_exo -44.4 -30.36 3.73 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.215 1.943 . . . . 0.55000000000000004 112.96 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -68.19 -58.31 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 1.4199999999999999 111.405 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 179' ' ' TYR . 21.3 m -59.94 -24.96 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.78000000000000003 111.614 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -70.27 -22.69 62.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.531 -0.304 . . . . 0.93999999999999995 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 92.4 mt -56.35 -41.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.4299999999999999 111.424 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.92 155.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.42 -0.354 . . . . 2.02 111.392 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.68 176.58 28.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.85 -0.69 . . . . 1.79 112.504 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.18 149.51 35.99 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.683 2.256 . . . . 3.1000000000000001 112.126 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 53.2 m 58.72 15.76 3.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.44 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -128.12 -65.18 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.931 -0.652 . . . . 3.4300000000000002 112.554 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -163.07 -26.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.695 0.283 . . . . 6.5 110.986 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.57 170.69 13.84 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.715 -0.755 . . . . 3.29 113.019 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -121.78 72.43 1.02 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.054 0.454 . . . . 6.1600000000000001 110.558 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.546 HG22 ' H ' ' A' ' 194' ' ' ASN . 8.9 mt -100.79 169.52 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 2.4199999999999999 110.242 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 193' ' ' ILE . 3.4 m-20 -47.57 141.31 5.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.93 0.395 . . . . 4.29 111.175 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -78.14 -13.65 59.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 5.1500000000000004 111.173 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.6 p -70.3 -42.17 72.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.39 -0.368 . . . . 2.4500000000000002 110.994 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 95.5 mt -69.96 -40.56 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 2.48 111.269 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.77 -60.97 2.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 2.1800000000000002 111.081 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 8.2 t -61.8 -22.29 65.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 1.49 111.461 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.51 -32.32 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 1.77 110.942 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 40.9 tp -83.99 -42.58 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.4199999999999999 111.577 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -70.16 0.35 6.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.751 -0.204 . . . . 1.78 111.458 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.19 -45.65 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.202 0.525 . . . . 1.3 110.466 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.53 -34.04 67.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 0.66000000000000003 111.92 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.691 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 55.1 tp -59.8 -54.6 54.01 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.855 -0.338 . . . . 1.6299999999999999 111.2 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 46.6 Cg_exo -57.63 -35.53 98.8 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.629 1.553 . . . . 0.64000000000000001 111.094 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.416 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 55.4 t80 -60.31 -31.88 70.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.119 -0.491 . . . . 1.3600000000000001 110.018 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -82.22 -19.16 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 1.54 110.591 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t -85.0 -40.99 16.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 1.2 110.806 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.768 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.24 -32.6 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.954 -0.567 . . . . 1.6399999999999999 111.221 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.66 -34.98 71.63 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.897 -0.668 . . . . 0.79000000000000004 112.763 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -71.21 -35.19 71.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.639 0.257 . . . . 1.6100000000000001 111.226 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 40.5 t -55.93 -58.2 8.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 1.1499999999999999 110.873 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -66.97 -20.44 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.3399999999999999 110.821 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -67.2 -58.66 4.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.1899999999999999 110.815 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 -28.3 64.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 2.23 110.969 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.21 -45.53 84.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.192 -0.458 . . . . 2.4700000000000002 110.742 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -77.42 -28.25 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 1.6200000000000001 110.754 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.42 -23.34 68.37 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 1.4099999999999999 112.185 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.17 -56.61 17.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 2.5800000000000001 110.737 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 61.42 -84.13 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.022 -0.535 . . . . 4.9299999999999997 111.2 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -80.52 131.64 35.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 4.6299999999999999 110.895 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.5 tp -84.43 102.3 12.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 6.4699999999999998 110.976 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -143.41 132.9 23.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 5.0700000000000003 110.872 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -114.41 151.76 32.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 6.5300000000000002 111.008 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.6 m -107.92 122.72 47.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 5.2199999999999998 110.879 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -74.05 -29.32 61.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.482 . . . . 8.3599999999999994 111.129 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.367 -0.379 . . . . 7.96 110.855 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.1 mtm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.845 0.355 . . . . 6.1699999999999999 110.826 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -110.41 16.32 21.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.149 -0.478 . . . . 4.8200000000000003 111.08 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp -108.3 93.91 4.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.429 -0.35 . . . . 5.5999999999999996 111.029 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.1 150.02 27.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 4.7999999999999998 111.074 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -151.03 137.76 18.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 2.3700000000000001 110.71 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt -120.07 -0.01 10.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 2.0699999999999998 110.815 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.452 HD12 HD11 ' B' ' 10' ' ' ILE . 24.4 tp -70.51 -39.44 74.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 2.1000000000000001 111.219 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.6 m80 -71.52 -31.19 66.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0700000000000001 110.86 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -65.33 -57.97 7.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 1.48 111.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.452 HD11 HD12 ' B' ' 7' ' ' LEU . 35.8 pt -55.38 -31.37 27.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.584 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -59.66 -36.36 76.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.621 -0.718 . . . . 0.92000000000000004 109.672 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' B' ' 52' ' ' MET . 3.2 t -66.93 -49.86 70.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.93999999999999995 111.047 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.64 69.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.55000000000000004 111.653 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.28 83.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.639 -0.791 . . . . 0.47999999999999998 112.422 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -76.43 -34.56 58.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.625 0.25 . . . . 0.84999999999999998 111.573 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -62.63 -49.38 75.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.722 0.296 . . . . 1.3400000000000001 111.467 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.439 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -61.55 -36.0 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 1.55 110.683 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -49.75 56.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.728 -0.749 . . . . 0.69999999999999996 112.847 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.74 65.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 0.81000000000000005 111.474 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.93 -36.15 75.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 2.2599999999999998 110.971 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -63.28 -21.55 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 1.78 110.515 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -60.8 -40.83 94.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 4.5800000000000001 110.864 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -73.18 -41.89 63.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 3.3500000000000001 111.004 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 77.7 p -71.12 -19.5 62.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 1.5800000000000001 111.466 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.95 -7.85 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 1.8400000000000001 111.265 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 89.8 p -69.54 -22.48 63.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.482 -0.326 . . . . 1.3700000000000001 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -47.51 -36.41 10.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.292 0.568 . . . . 4.9800000000000004 109.774 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.4 p-10 -171.84 132.35 0.77 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 2.1400000000000001 109.988 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 55.5 Cg_endo -94.86 154.35 1.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.96 2.44 . . . . 1.8200000000000001 112.24 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -85.13 63.5 8.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 5.1900000000000004 110.912 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.78 -39.79 2.22 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.765 -0.731 . . . . 2.2000000000000002 112.508 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.56 129.0 35.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.381 0.134 . . . . 3.6499999999999999 111.142 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 32.2 Cg_exo -57.69 160.88 13.53 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.29 1.993 . . . . 2.6699999999999999 111.854 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.49 -18.06 57.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.788 -0.642 . . . . 4.8799999999999999 112.517 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' B' ' 38' ' ' LEU . 2.9 p90 -46.78 -36.74 7.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.938 0.399 . . . . 1.8700000000000001 111.046 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -66.82 -47.32 72.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 2.6800000000000002 110.231 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -70.58 -18.78 62.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 2.9199999999999999 110.489 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 58.1 tp -60.96 -53.61 55.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 1.6399999999999999 110.006 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.18 -37.13 78.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 110.307 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' B' ' 43' ' ' ILE . . . -72.33 -6.84 46.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.596 -0.729 . . . . 0.68999999999999995 110.94 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.423 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 24.8 ttt -88.79 -39.78 13.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.203 -0.453 . . . . 2.5800000000000001 110.981 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' B' ' 45' ' ' ILE . 25.1 t80 -69.74 -34.13 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 3.3900000000000001 111.516 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.458 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 76.6 mt -52.15 -54.28 43.0 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.988 0.366 . . . . 0.40999999999999998 111.988 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 48.0 Cg_endo -68.62 -32.09 25.04 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.158 1.905 . . . . 0.48999999999999999 112.883 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' B' ' 42' ' ' PHE . 96.1 mt -56.3 -60.12 2.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.657 0.265 . . . . 1.29 111.538 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.648 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -63.71 -55.26 24.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.517 -0.311 . . . . 1.3999999999999999 111.204 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 90.2 p -54.74 -25.97 31.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 1.3799999999999999 111.294 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.93 7.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.711 -0.757 . . . . 0.37 112.429 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -32.09 68.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 1.29 110.837 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.93 -53.53 57.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.57 . . . . 0.44 111.244 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -71.53 -23.26 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.385 . . . . 0.5 111.143 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' MET . . . . . 0.48 ' HA ' HG21 ' B' ' 12' ' ' VAL . 15.0 tmm? -57.72 -36.89 72.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.304 0.573 . . . . 1.4099999999999999 109.466 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.33 -39.68 38.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.779 . . . . 0.55000000000000004 110.778 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.9 mtt -53.89 -24.29 15.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.032 -0.531 . . . . 0.5 110.188 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -82.21 -47.95 11.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.853 -0.612 . . . . 0.54000000000000004 110.822 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mt -80.94 10.93 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 1.3 111.166 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.419 ' HA ' ' NZ ' ' B' ' 60' ' ' LYS . 20.0 t70 60.54 65.23 1.08 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.982 -0.554 . . . . 2.2400000000000002 111.172 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -146.66 150.78 36.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 1.77 111.291 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.99 -22.43 29.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.654 . . . . 1.0600000000000001 112.697 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' B' ' 57' ' ' ASP . 22.0 pttm -103.8 143.15 33.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 2.6600000000000001 111.154 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.82 151.63 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.8899999999999999 111.229 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.11 107.39 18.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 2.4100000000000001 110.778 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.33 127.68 53.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.23 -0.441 . . . . 1.5600000000000001 111.256 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.48 37.34 23.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.059 -0.519 . . . . 1.8200000000000001 111.079 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.78 -0.68 42.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.843 -0.694 . . . . 1.51 112.432 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -101.3 139.53 36.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 2.4500000000000002 110.638 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.03 102.47 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 1.79 111.199 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.15 133.9 37.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.81999999999999995 111.073 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 74.6 m-70 -78.66 74.97 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.166 0.508 . . . . 1.05 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.444 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 62.1 t80 -64.47 -30.02 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.611 -0.722 . . . . 1.8700000000000001 111.255 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -79.66 -28.14 40.81 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.181 0.437 . . . . 0.60999999999999999 112.181 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.535 HH21 ' HB ' ' B' ' 199' ' ' THR . 34.2 mmt180 -67.95 -51.64 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.603 0.594 . . . . 2.3900000000000001 112.603 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.459 ' O ' ' HG3' ' B' ' 77' ' ' MET . 5.9 p90 -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.231 0.456 . . . . 3.6699999999999999 112.231 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.433 HG23 ' N ' ' B' ' 75' ' ' ASP . 10.3 tp -54.74 -43.23 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 120.846 -0.341 . . . . 1.6599999999999999 110.802 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.433 ' N ' HG23 ' B' ' 74' ' ' ILE . 26.9 t70 -68.95 -21.64 64.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.474 -0.565 . . . . 1.4099999999999999 109.474 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 19.4 m0 -87.07 6.25 33.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.472 -0.786 . . . . 1.1599999999999999 110.908 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 28.2 mtp -104.91 -23.3 13.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.077 -0.51 . . . . 1.53 110.748 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.18 -33.64 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.56 0.578 . . . . 0.89000000000000001 112.56 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.438 HG23 HG23 ' B' ' 43' ' ' ILE . 34.8 m -76.83 -47.26 21.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.192 0.441 . . . . 1.24 112.192 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 34.6 m -56.5 -51.31 82.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.154 0.427 . . . . 0.57999999999999996 112.154 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 54.3 Cg_exo -52.62 -41.86 65.99 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.921 1.748 . . . . 0.66000000000000003 112.065 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.62 -29.58 62.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 1.0600000000000001 110.638 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.35 -28.75 68.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.117 0.484 . . . . 1.22 110.205 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' B' ' 105' ' ' LEU . 5.9 tt -84.37 -38.75 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 1.53 110.296 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.44 -33.37 73.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.914 -0.585 . . . . 1.5800000000000001 110.625 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 99.5 p -59.39 -24.1 63.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 1.3899999999999999 110.715 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.419 ' HA ' HG22 ' B' ' 90' ' ' THR . 46.6 mt -76.03 -27.43 57.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 1.1499999999999999 110.909 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 52.0 m -75.94 -31.18 58.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 1.5700000000000001 111.163 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.06 -37.27 39.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 2.1699999999999999 111.297 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.419 HG22 ' HA ' ' B' ' 87' ' ' LEU . 8.8 t -73.88 -23.54 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.458 -0.337 . . . . 1.4199999999999999 111.422 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.08 -36.22 12.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 1.1799999999999999 111.252 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -116.52 120.24 38.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.889 0.376 . . . . 1.8799999999999999 111.068 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -79.98 -27.33 39.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 3.4199999999999999 110.562 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -137.94 148.14 44.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.795 -0.639 . . . . 4.0599999999999996 110.613 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' HD12 ' B' ' 95' ' ' ILE . 4.3 mp -131.95 144.56 36.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.372 -0.376 . . . . 2.0899999999999999 111.064 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -101.18 162.67 12.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 3.8500000000000001 110.863 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.47 91.64 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 4.8200000000000003 110.913 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -147.53 -43.05 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 3.7999999999999998 111.075 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 85.9 m95 54.78 65.25 1.55 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 5.1699999999999999 110.867 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 79.7 p -117.87 -58.23 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 2.02 110.804 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 60.3 tp -71.67 -51.55 22.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 2.0899999999999999 110.712 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.95 -47.37 89.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.977 -0.556 . . . . 1.8799999999999999 111.154 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.4 -33.8 77.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.896 -0.669 . . . . 0.56000000000000005 112.675 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -65.58 -40.28 92.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 1.78 110.866 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.523 ' HB3' HD21 ' B' ' 84' ' ' LEU . 28.8 mt -71.43 -40.72 70.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 1.03 111.201 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 85.9 mtp -58.27 -53.39 58.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 1.6699999999999999 111.221 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 44.0 t -58.35 -39.94 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 1.51 111.128 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.512 HG21 HG21 ' B' ' 142' ' ' ILE . 91.8 m -60.71 -37.93 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 1.1799999999999999 111.286 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -64.72 -46.92 80.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 2.1699999999999999 111.31 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.454 HG22 ' HE1' ' A' ' 46' ' ' TRP . 62.3 mt -53.04 -35.03 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.323 -0.399 . . . . 1.3500000000000001 111.262 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.65 -51.35 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.3400000000000001 111.342 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.64 HG13 H133 ' B' ' 210' ' ' LYR . 87.2 t -58.75 -49.6 82.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.42999999999999999 111.489 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' B' ' 77' ' ' MET . 71.9 mt -52.83 -36.87 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.358 -0.383 . . . . 1.6000000000000001 111.329 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 49.5 m -60.09 -48.3 82.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.85999999999999999 111.237 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 35.9 m -64.94 -21.11 66.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.94999999999999996 111.124 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.27 14.3 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.821 -0.705 . . . . 0.46000000000000002 113.262 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.1 pp -76.24 -27.91 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.87 -0.194 . . . . 1.75 111.507 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.452 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.53 -31.55 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.682 0.277 . . . . 1.78 111.424 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.4 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 0.38 111.013 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.66 -30.24 46.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 1.97 111.007 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.63 14.28 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.76000000000000001 111.267 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 46.6 t -75.36 120.77 21.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 1.47 110.817 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.41 -72.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 2.5 111.025 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.579 ' HB2' HG12 ' B' ' 127' ' ' VAL . 79.3 mtp180 -62.71 140.72 58.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 2.73 110.513 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.92 -19.31 52.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 2.2000000000000002 111.466 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -78.17 -35.03 49.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 3.3999999999999999 111.215 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -81.67 -23.74 9.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.341 -0.391 . . . . 1.23 111.095 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -56.35 -32.92 65.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.13 -0.487 . . . . 3.04 111.037 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -75.27 -19.51 59.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 4.1399999999999997 111.417 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 99.3 mt -78.85 -54.89 5.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 1.6499999999999999 110.97 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -39.98 76.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.77000000000000002 111.334 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -53.01 -45.4 67.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 1.46 111.156 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -71.93 -28.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 1.6299999999999999 111.288 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 76.2 m -68.77 -39.45 80.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 1.4199999999999999 111.176 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.31 -50.8 48.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.8 -0.714 . . . . 0.48999999999999999 112.457 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.97 -29.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 1.3 110.752 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.49 -47.05 87.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.645 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.46 -29.79 71.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.451 . . . . 0.62 110.622 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' PHE . . . . . 0.494 ' HB2' H131 ' B' ' 210' ' ' LYR . 82.2 t80 -75.13 -25.24 58.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 1.74 110.747 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.58 -56.84 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.76 111.476 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.461 HG13 ' N ' ' B' ' 142' ' ' ILE . 23.5 pt -56.17 -44.07 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.68999999999999995 111.128 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.512 HG21 HG21 ' B' ' 108' ' ' THR . 46.5 mm -67.85 -29.31 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.76 110.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' B' ' 139' ' ' PHE . 0.5 OUTLIER -55.37 -50.96 68.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 1.0600000000000001 110.348 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -62.36 -37.55 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 4.1200000000000001 110.666 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.98 -35.58 92.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 1.26 112.514 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 142' ' ' ILE . 98.3 mt -69.17 -27.18 33.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.871 0.367 . . . . 1.98 110.831 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -88.68 4.46 47.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.199 -0.455 . . . . 1.4199999999999999 111.185 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 58.5 t-20 -81.7 -48.1 1.0 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.044 -0.525 . . . . 99.989999999999995 111.841 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 71.1 Cg_exo -41.01 -33.69 1.23 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.577 2.184 . . . . 2.6499999999999999 112.578 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 32.2 tp -86.31 54.29 3.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 4.3899999999999997 110.14 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.489 ' HD3' ' HE2' ' B' ' 153' ' ' LYS . 99.5 mtt180 -58.5 168.92 1.0 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.863 -0.608 . . . . 7.9000000000000004 110.907 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.47 -23.01 37.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.305 -0.407 . . . . 2.77 111.18 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' LYS . . . . . 0.489 ' HE2' ' HD3' ' B' ' 151' ' ' ARG . 63.3 pttt -86.25 5.89 32.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 6.29 111.053 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 15.3 t -65.59 -19.14 65.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 3.1000000000000001 110.92 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -62.73 -19.13 63.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 6.4299999999999997 111.155 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 59.0 p -102.72 -18.84 14.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.105 -0.498 . . . . 4.5700000000000003 111.058 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -83.01 -70.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 3.8300000000000001 110.809 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 33.5 t -162.06 113.24 1.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 3.0699999999999998 110.874 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 71.4 p -78.11 -29.85 49.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 3.4300000000000002 111.281 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -67.37 -53.86 25.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.403 . . . . 3.9199999999999999 110.983 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.83 -34.31 75.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 2.7000000000000002 110.838 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.88 64.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.8300000000000001 110.976 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.75 -48.85 62.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 2.6299999999999999 110.869 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt -61.17 -42.19 98.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 2.4300000000000002 110.761 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.72 -23.48 61.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 2.5800000000000001 111.076 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.21 -55.0 28.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.339 -0.391 . . . . 2.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -78.43 -24.19 46.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 3.0299999999999998 111.383 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.4 tp -68.78 -43.5 75.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 1.1000000000000001 111.311 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.41 -22.31 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 1.75 111.34 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.0 m -62.55 -58.83 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.97999999999999998 111.478 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.84 -34.81 79.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.304 -0.407 . . . . 4.2999999999999998 110.98 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.1 -36.25 74.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 1.3899999999999999 111.048 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.4 ' O ' HG22 ' B' ' 177' ' ' ILE . 66.2 m -69.97 -41.35 74.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 1.1100000000000001 111.095 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.91 -37.07 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.474 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.4 mt -72.5 -56.14 5.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 1.75 111.344 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -31.58 63.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.59999999999999998 111.51 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.437 ' O ' HG13 ' B' ' 181' ' ' ILE . 16.2 tt -87.57 -20.79 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.43 . . . . 1.47 110.566 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.44 -50.57 65.48 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.824 -0.626 . . . . 0.55000000000000004 112.911 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.665 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 67.1 m-85 -58.18 -57.02 29.07 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.773 0.286 . . . . 1.6200000000000001 111.538 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 88.1 Cg_exo -45.95 -31.7 8.62 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.906 1.737 . . . . 0.64000000000000001 112.876 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 177' ' ' ILE . 98.0 mt -66.25 -56.85 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 1.27 111.567 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.0 m -61.63 -25.32 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.68999999999999995 111.546 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' TRP . . . . . 0.415 ' CD1' H191 ' B' ' 210' ' ' LYR . 39.9 m95 -68.92 -18.36 64.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 1.1799999999999999 111.467 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.52 -34.68 66.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.521 -0.309 . . . . 1.77 111.142 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.25 162.36 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.323 . . . . 1.6899999999999999 111.329 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.75 -171.88 33.57 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.716 . . . . 1.5800000000000001 112.721 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.02 154.46 72.59 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.809 2.34 . . . . 2.5099999999999998 112.164 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 58.4 m 57.38 18.12 4.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 3.5800000000000001 110.897 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -169.74 63.96 0.18 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.597 -0.811 . . . . 4.0300000000000002 112.609 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 89.4 t80 58.29 95.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.814 0.34 . . . . 6.8899999999999997 111.086 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.19 137.46 3.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.707 -0.758 . . . . 3.7000000000000002 112.477 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -121.92 89.01 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 7.5 110.688 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 46.3 pt -124.76 -179.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 2.3500000000000001 111.161 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -52.9 135.99 35.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 3.8599999999999999 110.849 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -77.21 -11.49 59.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 5.0499999999999998 111.002 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 60.7 p -67.3 -47.66 69.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 2.6800000000000002 111.374 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.1 tp -68.91 -29.36 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.323 -0.399 . . . . 2.4700000000000002 111.077 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.96 -56.13 25.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 2.5299999999999998 110.974 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 199' ' ' THR . . . . . 0.535 ' HB ' HH21 ' B' ' 72' ' ' ARG . 64.8 p -65.43 -34.52 78.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 1.29 111.157 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.96 -36.0 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 2.6200000000000001 111.144 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.53 -41.78 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.342 -0.39 . . . . 1.6100000000000001 111.495 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -74.63 0.45 15.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.523 -0.308 . . . . 1.4199999999999999 111.345 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.9 t -96.52 -45.03 6.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.206 0.526 . . . . 1.4299999999999999 110.526 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 45.1 tp -72.11 -39.37 68.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.422 -0.808 . . . . 1.1200000000000001 111.918 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.671 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 45.4 tp -55.77 -54.47 51.47 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.953 -0.299 . . . . 1.26 111.33 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.5 Cg_exo -56.11 -41.45 76.64 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.822 1.681 . . . . 0.59999999999999998 111.175 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.457 ' O ' HG12 ' B' ' 211' ' ' VAL . 66.1 t80 -55.2 -37.07 66.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.167 -0.469 . . . . 1.3999999999999999 109.844 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -79.89 -24.27 41.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 1.4099999999999999 110.433 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 56.7 m -85.11 -13.39 50.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.84 -0.618 . . . . 1.3200000000000001 111.204 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.738 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.457 HG12 ' O ' ' B' ' 207' ' ' PHE . 9.0 p -65.43 -29.88 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 1.6899999999999999 111.135 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 216' ' ' LEU . . . -59.2 -28.07 63.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.79000000000000004 112.24 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -76.77 -30.16 56.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.751 0.31 . . . . 2.96 110.551 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -63.74 -60.58 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.29 110.685 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.02 -26.47 67.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 3.1499999999999999 110.853 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' B' ' 212' ' ' GLY . 6.4 tt -65.33 -50.05 67.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 1.51 110.743 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.406 ' O ' ' HG ' ' B' ' 221' ' ' LEU . 16.5 t70 -63.02 -24.98 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 2.1899999999999999 110.945 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 56.9 tp -71.75 -33.24 68.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 1.98 111.139 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -88.18 -29.19 20.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.43 -0.35 . . . . 2.1699999999999999 111.149 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.52 -20.9 61.92 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.795 -0.717 . . . . 1.3600000000000001 112.433 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 217' ' ' ASP . 77.6 mt -69.82 -52.55 24.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.654 0.264 . . . . 2.8999999999999999 110.606 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 61.06 -82.15 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.969 -0.559 . . . . 5.6100000000000003 111.115 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -88.33 146.79 25.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.419 -0.355 . . . . 4.04 110.85 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.34 119.31 29.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 6.2999999999999998 111.011 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -152.14 106.84 3.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.038 -0.528 . . . . 4.7999999999999998 110.724 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -97.28 138.44 34.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 6.3899999999999997 111.134 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 42.4 m -95.1 135.28 36.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 5.6100000000000003 110.729 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -91.99 -10.72 38.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.481 . . . . 8.1999999999999993 110.982 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 8.1699999999999999 110.928 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 73.5 mtm . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.764 0.316 . . . . 5.6200000000000001 110.993 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -93.61 -22.35 18.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.14 -0.482 . . . . 5.2800000000000002 110.777 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' LEU . . . . . 0.42 ' N ' HD12 ' C' ' 3' ' ' LEU . 7.1 mp -74.13 124.31 26.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 6.0499999999999998 110.626 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -97.61 -66.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 4.79 110.825 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t 60.32 98.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.06 -0.518 . . . . 2.71 111.234 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -113.35 -6.34 13.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 2.52 110.951 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 tp -65.18 -47.67 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 1.9299999999999999 110.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.611 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 25.0 m170 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.26 110.745 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -75.21 -41.16 58.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 1.6699999999999999 110.417 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.09 -20.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.281 0.562 . . . . 1.8700000000000001 110.176 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.29 -50.91 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.461 -0.79 . . . . 1.4399999999999999 110.724 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.46999999999999997 111.257 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.03 85.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.58999999999999997 111.231 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -30.73 73.73 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.856 -0.687 . . . . 0.5 112.747 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.7 mmt -73.04 -28.92 62.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.977 0.418 . . . . 0.68000000000000005 110.839 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.8 m -66.55 -52.91 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 1.3999999999999999 110.917 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ILE . . . . . 0.521 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -63.28 -24.18 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.55 110.913 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.72 -47.34 89.88 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.714 -0.755 . . . . 0.70999999999999996 112.259 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.98 65.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.77000000000000002 111.064 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.7 mt -68.09 -30.96 70.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.361 -0.382 . . . . 1.9299999999999999 110.745 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -65.04 -21.25 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 1.8600000000000001 110.812 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.32 -45.13 89.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 4.1399999999999997 110.851 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -71.6 -32.8 68.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 3.1499999999999999 111.228 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 75.2 m -78.09 -23.32 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 1.95 111.291 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 tp -87.3 -2.76 58.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.404 -0.362 . . . . 2.2200000000000002 110.863 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 71.2 p -70.97 -24.13 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 1.3700000000000001 111.109 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -48.85 -32.74 9.31 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.284 0.564 . . . . 5.0300000000000002 109.952 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.2 p-10 -173.79 132.18 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 2.3700000000000001 109.761 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 43.8 Cg_endo -95.3 164.79 1.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.772 2.315 . . . . 2.0499999999999998 112.367 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -96.48 66.65 2.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.239 -0.437 . . . . 4.5199999999999996 111.171 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.82 -47.09 3.6 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.724 -0.75 . . . . 2.1600000000000001 112.642 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 71.1 t -91.96 131.27 35.71 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.456 0.17 . . . . 2.5299999999999998 111.014 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 36.0 Cg_exo -57.44 162.16 10.57 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.516 2.144 . . . . 1.9299999999999999 112.132 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -60.04 -18.4 46.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 4.1200000000000001 112.541 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.431 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.7 p90 -50.75 -36.19 35.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.789 0.328 . . . . 2.8900000000000001 111.131 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.7 -53.68 43.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 2.46 110.484 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.5 -20.51 66.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 2.7799999999999998 110.719 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.76 -52.11 66.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 1.6200000000000001 110.198 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.53 -38.95 82.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 1.5900000000000001 110.219 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.68 -7.22 42.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.65000000000000002 111.188 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.408 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 26.1 ttt -88.72 -38.77 14.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 1.6699999999999999 110.925 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.477 ' HA ' HD12 ' C' ' 45' ' ' ILE . 28.8 m-85 -70.77 -30.68 67.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 3.4199999999999999 111.504 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 80.2 mt -55.82 -54.9 46.86 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.595 -0.275 . . . . 0.89000000000000001 111.726 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 49.7 Cg_endo -69.41 -28.11 27.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.165 1.91 . . . . 0.40999999999999998 113.096 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' C' ' 42' ' ' PHE . 91.3 mt -59.66 -62.53 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.166 -0.213 . . . . 1.76 111.332 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.67 ' HE1' HG22 ' A' ' 110' ' ' ILE . 2.8 t90 -64.95 -50.19 67.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.646 0.26 . . . . 2.1600000000000001 110.813 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' SER . . . . . 0.435 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 36.8 t -60.98 -15.06 27.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 1.1699999999999999 111.022 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.16 -60.32 3.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 0.44 112.364 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.09 -26.42 64.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.309 . . . . 1.29 110.845 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.58 -54.27 45.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.5 111.272 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.466 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.1 m-85 -67.69 -36.78 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 1.8300000000000001 111.136 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 51.8 ttp -51.53 -33.09 30.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.14 0.495 . . . . 1.47 109.998 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -75.97 -44.92 37.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.59999999999999998 110.638 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' MET . . . . . 0.466 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 31.7 mtp -56.49 -19.53 15.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.85 -0.614 . . . . 0.83999999999999997 110.463 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.48 -44.31 17.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.886 -0.597 . . . . 0.65000000000000002 110.34 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.551 HG21 HD23 ' A' ' 130' ' ' LEU . 38.4 pt -84.44 10.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 1.55 111.135 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 63.96 54.04 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.915 -0.584 . . . . 1.54 111.148 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -134.77 151.4 50.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 1.79 110.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.16 14.26 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.788 -0.72 . . . . 0.93999999999999995 112.58 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -124.43 160.31 28.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.801 0.334 . . . . 2.3599999999999999 110.769 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.49 142.06 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.97 111.028 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.55 104.77 17.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 2.4399999999999999 110.656 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.96 124.91 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 1.54 111.226 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.8 27.81 17.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 1.71 111.262 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.29 53.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.874 -0.679 . . . . 1.53 112.733 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -98.15 147.41 24.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 2.23 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.37 116.71 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 1.3600000000000001 111.148 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.85 133.5 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.78000000000000003 110.885 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.429 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 93.8 m-70 -78.59 73.33 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.232 0.539 . . . . 1.0800000000000001 111.054 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.97 -33.01 74.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.582 -0.735 . . . . 2.2999999999999998 110.951 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -75.58 -25.89 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.75 111.784 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.6 tpp180 -67.92 -51.22 50.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.364 0.505 . . . . 1.51 112.364 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -82.08 -30.87 31.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.245 0.461 . . . . 4.6500000000000004 112.245 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.6 tp -56.48 -44.13 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.758 -0.377 . . . . 1.22 110.783 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.452 ' N ' HG23 ' C' ' 74' ' ' ILE . 34.9 t70 -69.54 -20.56 63.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.374 -0.602 . . . . 1.3100000000000001 109.374 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -87.14 3.68 45.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.567 -0.742 . . . . 1.6799999999999999 111.201 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.598 ' HA ' HD13 ' C' ' 113' ' ' ILE . 44.8 ttm -104.61 -21.33 13.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.002 -0.545 . . . . 1.8 110.771 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.422 ' O ' HD23 ' C' ' 82' ' ' LEU . 31.5 m -114.48 -35.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.2 0.444 . . . . 1.1899999999999999 112.2 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.442 HG23 HG23 ' C' ' 43' ' ' ILE . 24.5 m -76.78 -51.7 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.105 0.409 . . . . 1.23 112.105 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 52.3 m -52.72 -50.77 79.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.039 0.385 . . . . 0.58999999999999997 112.039 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 54.4 Cg_exo -52.54 -43.49 54.45 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.943 1.762 . . . . 0.67000000000000004 112.009 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.422 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -71.9 -27.28 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.95999999999999996 110.602 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.75 -29.6 67.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.183 0.516 . . . . 1.1899999999999999 109.743 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -84.04 -39.73 19.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.428 -0.805 . . . . 1.7 110.196 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.94 -32.01 73.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.506 . . . . 1.6200000000000001 110.404 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -61.21 -25.47 67.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 1.26 110.328 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.429 ' HA ' HG22 ' C' ' 90' ' ' THR . 51.2 mt -73.12 -26.32 61.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 1.1100000000000001 110.629 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 1.51 110.795 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.83 -32.46 35.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 2.0600000000000001 111.107 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' THR . . . . . 0.429 HG22 ' HA ' ' C' ' 87' ' ' LEU . 10.0 t -81.48 -23.27 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.227 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -36.13 15.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.3 111.274 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -123.24 121.63 36.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 110.948 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -76.35 -35.14 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 3.2400000000000002 110.835 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.99 141.47 46.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.022 -0.536 . . . . 4.6299999999999999 110.796 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.44 142.56 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 2.1800000000000002 110.867 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -91.99 169.42 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 4.1200000000000001 111.095 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.75 81.19 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 4.96 111.114 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.74 -42.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 3.9100000000000001 111.012 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 91.7 m95 51.02 76.98 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 5.21 111.081 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 74.6 p -120.26 -57.79 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.945 -0.57 . . . . 1.8200000000000001 110.985 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.22 -45.07 27.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 2.0800000000000001 110.967 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.94 -33.35 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.341 -0.39 . . . . 1.8600000000000001 110.897 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.07 -42.47 51.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.791 -0.719 . . . . 0.58999999999999997 112.56 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -63.11 -36.61 84.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 1.53 110.869 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' C' ' 84' ' ' LEU . 85.1 mt -67.85 -52.88 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.551 . . . . 1.1100000000000001 110.86 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -53.27 -43.1 67.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.732 . . . . 2.21 110.928 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 107' ' ' SER . . . . . 0.422 ' HB3' ' CD1' ' B' ' 42' ' ' PHE . 49.0 m -64.27 -42.38 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.559 . . . . 1.28 110.828 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.567 HG21 HG21 ' C' ' 142' ' ' ILE . 98.3 m -60.93 -27.26 68.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.962 -0.563 . . . . 1.22 111.252 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 22.1 tp60 -75.14 -33.99 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 2.3300000000000001 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.648 HG22 ' HE1' ' B' ' 46' ' ' TRP . 32.0 mm -62.41 -43.85 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 1.29 111.684 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.461 HG11 HG22 ' B' ' 45' ' ' ILE . 19.9 m -67.07 -41.06 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.881 0.326 . . . . 1.0600000000000001 111.881 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.506 HG13 H133 ' C' ' 210' ' ' LYR . 75.0 t -62.64 -48.77 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.936 0.347 . . . . 0.51000000000000001 111.936 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' C' ' 77' ' ' MET . 70.2 mt -56.53 -36.74 48.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.718 0.294 . . . . 1.3700000000000001 111.028 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 54.2 m -57.64 -49.64 75.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.77000000000000002 111.223 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -64.29 -20.47 66.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.425 . . . . 1.1899999999999999 110.799 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.34 -32.89 24.28 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.912 -0.661 . . . . 0.5 113.087 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.532 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.7 pp -82.92 -25.39 32.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.707 0.289 . . . . 1.47 111.399 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.532 ' N ' HD12 ' C' ' 117' ' ' LEU . 9.8 tp -83.77 -31.55 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.387 -0.37 . . . . 1.2 111.161 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.9 75.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.40000000000000002 111.027 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.41 -28.62 46.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 2.1200000000000001 110.97 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.1 13.62 2.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.213 -0.449 . . . . 0.75 111.03 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 48.1 t -71.06 127.71 33.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 1.3799999999999999 110.823 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -93.26 -65.08 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 2.7400000000000002 110.707 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.507 ' HB2' HG12 ' C' ' 127' ' ' VAL . 99.1 mtt180 -69.07 141.57 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 2.7999999999999998 110.498 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.3 -11.57 59.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 2.4100000000000001 111.492 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -91.68 -30.24 16.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.67 0.272 . . . . 4.2000000000000002 111.157 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' C' ' 124' ' ' ARG . 8.5 p -80.5 -24.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 1.0800000000000001 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 128' ' ' ARG . . . . . 0.435 ' CZ ' ' H ' ' C' ' 190' ' ' PHE . 43.0 ttp180 -57.65 -29.41 64.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.5699999999999998 111.029 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.05 -26.57 59.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 3.8100000000000001 111.151 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' C' ' 127' ' ' VAL . 9.4 mp -76.71 -53.57 7.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 1.4199999999999999 111.182 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -32.44 71.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.89000000000000001 111.212 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -57.8 -52.58 64.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.382 . . . . 1.26 110.987 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.85 -32.4 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 1.6799999999999999 111.296 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 81.3 m -63.73 -39.27 93.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 1.24 110.958 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.23 -57.4 15.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.654 -0.784 . . . . 0.54000000000000004 112.411 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 136' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -57.85 -32.65 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 1.0600000000000001 111.211 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.9 t -56.49 -43.55 79.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.343 -0.389 . . . . 1.0800000000000001 110.812 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' ALA . . . . . 0.414 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -65.16 -34.11 77.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 110.644 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 139' ' ' PHE . . . . . 0.451 ' HB2' H131 ' C' ' 210' ' ' LYR . 75.8 t80 -75.46 -22.79 56.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.983 -0.553 . . . . 1.6799999999999999 111.212 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 89.8 mt -68.05 -55.88 10.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.678 0.275 . . . . 1.7 111.275 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.471 HG13 ' N ' ' C' ' 142' ' ' ILE . 37.4 pt -59.46 -42.16 86.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.859 0.361 . . . . 0.78000000000000003 111.171 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.567 HG21 HG21 ' C' ' 108' ' ' THR . 49.5 mm -66.08 -35.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 2.2400000000000002 110.877 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -52.61 -50.27 63.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 1.02 110.751 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -61.48 -32.75 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 3.0 110.504 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.42 -27.69 67.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 1.27 112.479 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 146' ' ' ILE . . . . . 0.426 HG12 ' O ' ' C' ' 142' ' ' ILE . 43.2 mm -74.5 -27.31 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.057 0.456 . . . . 1.8899999999999999 110.767 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -89.45 4.76 48.05 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.837 -0.62 . . . . 1.6000000000000001 111.233 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 58.5 t-20 -82.36 -48.69 0.87 Allowed Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 112.402 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 78.3 Cg_exo -40.33 -30.26 0.45 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.652 2.235 . . . . 2.73 113.009 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 95.6 mt -90.16 51.21 1.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 4.2999999999999998 110.722 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -58.13 163.29 2.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.025 -0.534 . . . . 8.9000000000000004 111.011 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.06 -23.19 52.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 2.7999999999999998 111.045 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -83.1 3.54 30.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 5.4400000000000004 110.649 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 28.9 m -71.91 -16.98 62.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 3.3900000000000001 111.199 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -58.7 -26.63 64.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 6.9199999999999999 111.014 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 68.6 p -93.74 -23.98 18.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 4.8700000000000001 111.245 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.01 -70.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 4.0499999999999998 111.102 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 79.0 p -161.33 115.46 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 3.0299999999999998 111.045 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 48.6 m -77.6 -35.55 52.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 2.96 111.047 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.68 -50.77 67.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 3.7400000000000002 111.235 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.06 -34.48 73.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 2.6499999999999999 111.127 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.94 -22.24 59.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 1.77 111.13 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -68.26 -57.52 5.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 2.96 110.98 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 164' ' ' LEU . . . . . 0.493 HD12 ' N ' ' C' ' 165' ' ' TYR . 4.1 pp -65.74 -24.71 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 2.3500000000000001 111.406 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 165' ' ' TYR . . . . . 0.493 ' N ' HD12 ' C' ' 164' ' ' LEU . 2.4 t80 -81.39 -25.95 35.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.312 -0.404 . . . . 2.6200000000000001 110.9 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.27 -46.4 64.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 2.0899999999999999 111.11 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 167' ' ' LYS . . . . . 0.59 ' HB3' ' HZ3' ' C' ' 167' ' ' LYS . 4.9 ttpm? -75.33 -29.48 59.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 3.2400000000000002 110.878 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.402 HD11 HD22 ' C' ' 87' ' ' LEU . 52.4 tp -66.53 -61.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 1.6899999999999999 111.317 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 85.5 t -53.82 -35.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 1.3999999999999999 111.459 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -53.95 -54.15 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.95999999999999996 111.075 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 171' ' ' TYR . . . . . 0.511 ' O ' HG12 ' C' ' 174' ' ' VAL . 30.0 t80 -70.92 -29.9 66.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.006 -0.543 . . . . 3.6499999999999999 110.806 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -67.48 -31.21 71.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 1.3700000000000001 111.55 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 40.4 p -77.19 -40.61 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.93 0.344 . . . . 1.4299999999999999 111.93 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 174' ' ' VAL . . . . . 0.511 HG12 ' O ' ' C' ' 171' ' ' TYR . 10.9 p -64.2 -25.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 1.6200000000000001 111.524 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' C' ' 171' ' ' TYR . 87.4 mt -77.66 -57.87 3.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.031 0.443 . . . . 2.0299999999999998 111.257 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 -28.06 62.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.62 111.424 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.423 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.1 tp -87.54 -22.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.993 0.425 . . . . 1.5800000000000001 110.341 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.84 -51.52 57.63 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.56000000000000005 112.844 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.649 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -57.01 -56.42 33.7 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.883 -0.327 . . . . 1.3300000000000001 111.165 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.9 Cg_exo -45.42 -30.47 5.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.177 1.918 . . . . 0.63 112.612 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.419 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.5 mt -65.82 -57.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.93000000000000005 111.314 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.543 HG22 ' O ' ' C' ' 179' ' ' TYR . 17.3 m -62.67 -25.42 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 1.27 111.466 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 183' ' ' TRP . . . . . 0.427 ' CD1' H191 ' C' ' 210' ' ' LYR . 40.7 m95 -69.92 -16.5 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 1.77 111.017 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.21 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.379 -0.373 . . . . 2.3900000000000001 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.52 170.25 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.392 -0.367 . . . . 1.95 111.157 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 87.15 -170.08 40.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.801 -0.714 . . . . 1.8799999999999999 112.755 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.7 158.28 56.85 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.629 2.22 . . . . 3.1200000000000001 111.703 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 92.4 p 48.99 25.88 1.2 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.336 -0.393 . . . . 2.6299999999999999 110.881 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -173.14 63.86 0.13 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.029 -0.605 . . . . 3.04 112.502 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 190' ' ' PHE . . . . . 0.435 ' H ' ' CZ ' ' C' ' 128' ' ' ARG . 65.0 t80 56.19 91.44 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.848 0.356 . . . . 5.6900000000000004 111.14 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 137.6 150.99 5.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 3.0800000000000001 112.33 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -133.41 75.83 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 7.5300000000000002 111.016 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 41.5 pt -106.57 -179.39 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 2.8599999999999999 111.012 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -52.65 136.53 32.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.292 -0.413 . . . . 3.6899999999999999 110.952 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -72.5 -22.04 61.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 5.4800000000000004 110.782 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 79.0 p -66.55 -37.26 84.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 2.3799999999999999 111.11 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.84 -43.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 2.23 111.068 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.56 -56.9 14.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 2.1600000000000001 111.211 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 77.4 p -64.93 -20.74 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 1.27 111.654 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.99 -37.0 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.331 . . . . 1.7 111.136 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 52.7 tp -78.92 -39.77 33.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 2.02 111.44 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.09 0.62 10.99 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.435 -0.348 . . . . 1.8200000000000001 111.344 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 52.9 t -96.15 -44.85 7.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.049 0.452 . . . . 1.3500000000000001 110.397 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.1 -31.09 62.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.728 -0.669 . . . . 0.65000000000000002 111.799 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.578 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -61.02 -54.8 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.818 -0.353 . . . . 1.4199999999999999 111.053 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 41.9 Cg_exo -58.06 -37.28 96.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.68 1.587 . . . . 0.63 110.687 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.23 -26.88 66.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.975 -0.557 . . . . 1.49 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.38 -28.84 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.651 -0.704 . . . . 1.7 110.511 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 44.5 t -79.33 -40.51 30.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 1.25 110.924 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.774 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.69 -35.27 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 1.6100000000000001 111.1 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.16 -33.43 61.14 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.977 -0.63 . . . . 0.81999999999999995 112.785 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -72.71 -32.52 65.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.695 0.283 . . . . 3.0800000000000001 111.01 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 214' ' ' SER . . . . . 0.412 ' O ' HD13 ' C' ' 218' ' ' LEU . 48.1 t -58.65 -62.64 1.71 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 1.1499999999999999 110.83 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -60.94 -24.54 66.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 2.5600000000000001 111.242 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.86 -51.52 47.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.29 110.91 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 217' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 18.7 t70 -54.59 -40.03 68.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 2.3900000000000001 111.169 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 218' ' ' LEU . . . . . 0.412 HD13 ' O ' ' C' ' 214' ' ' SER . 11.1 mp -66.13 -37.4 85.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.385 . . . . 2.0299999999999998 111.241 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -75.11 -27.71 59.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 3.21 111.11 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.46 -19.86 79.74 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.687 -0.768 . . . . 1.3600000000000001 112.46 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 79.4 mt -58.48 -51.78 68.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.68 0.276 . . . . 2.8999999999999999 111.206 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 58.86 -86.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.118 -0.492 . . . . 4.8899999999999997 111.201 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -85.14 142.8 29.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.419 -0.355 . . . . 4.2300000000000004 110.503 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.58 90.2 7.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 6.1200000000000001 111.076 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -122.38 133.79 54.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.051 -0.522 . . . . 4.5499999999999998 110.8 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -119.27 141.91 48.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 6.7800000000000002 111.16 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 49.0 m -99.79 133.76 43.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 5.4000000000000004 110.773 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -100.41 11.44 39.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 8.3300000000000001 111.071 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 7.9100000000000001 110.895 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.831 0.348 . . . . 5.1100000000000003 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -78.09 83.9 4.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 5.04 110.797 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 78.9 mt -76.57 168.17 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 5.5800000000000001 110.872 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.76 32.6 4.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 5.0199999999999996 110.873 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 t -143.66 82.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.565 . . . . 2.4500000000000002 110.649 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.3 mm? -97.37 100.37 11.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 2.4199999999999999 111.002 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.4 mm? -74.69 -27.01 60.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.351 -0.386 . . . . 2.0899999999999999 110.628 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 33.9 m170 -75.37 -34.63 61.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 1.1599999999999999 110.269 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.466 ' O ' HG12 ' A' ' 12' ' ' VAL . 58.9 t-105 -67.37 -48.27 67.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.79000000000000004 110.426 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -66.23 -20.37 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.41 . . . . 2.0800000000000001 110.223 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.475 ' O ' ' HG2' ' A' ' 15' ' ' MET . 7.9 t80 -60.48 -60.54 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.85 -0.614 . . . . 1.28 110.266 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 9' ' ' TRP . 9.7 p -57.92 -30.07 37.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 110.525 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.93 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 0.63 110.943 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.97 -31.53 52.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.55000000000000004 112.365 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 71.4 mmm -69.68 -44.31 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 1.03 110.69 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.4 p -60.22 -58.48 8.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 1.3 111.219 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.8 pp -56.78 -22.42 15.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.301 -0.409 . . . . 1.3100000000000001 111.279 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.27 -62.5 5.57 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.77000000000000002 112.407 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.42 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.289 . . . . 0.80000000000000004 111.262 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 17' ' ' ILE . 86.4 mt -74.89 -35.98 62.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 1.8100000000000001 110.801 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -58.94 -42.52 89.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 1.8799999999999999 110.778 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.45 -20.4 57.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 4.4500000000000002 110.677 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 50.2 t-105 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 3.6899999999999999 110.264 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -79.92 -34.56 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.5700000000000001 110.914 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -81.87 -1.99 49.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 1.95 110.735 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.3 p -56.42 -26.9 55.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 1.3799999999999999 110.714 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -46.98 -36.3 7.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.257 0.551 . . . . 4.0700000000000003 109.825 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.0 p-10 -164.05 131.97 2.63 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.307 -0.861 . . . . 2.7200000000000002 110.132 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 27.7 Cg_endo -94.03 -178.84 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.074 2.516 . . . . 1.9099999999999999 112.502 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -89.35 35.95 0.82 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 4.7599999999999998 111.262 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.78 -40.65 2.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 1.99 112.664 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 HD22 ' A' ' 221' ' ' LEU . 18.0 m -76.46 137.51 67.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 2.7000000000000002 110.889 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 24.0 Cg_exo -65.12 166.08 19.9 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.578 2.185 . . . . 1.79 112.06 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -18.56 54.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 4.1200000000000001 111.66 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' HE2' ' HD2' ' A' ' 33' ' ' PRO . 2.4 p90 -48.12 -39.29 20.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.737 0.303 . . . . 2.9300000000000002 111.173 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.44 -48.74 63.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.922 0.392 . . . . 2.8799999999999999 110.514 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -59.94 -29.4 68.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 4.6600000000000001 110.632 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.54 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 1.45 110.989 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.02 -27.97 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 1.78 111.081 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.32 -9.95 59.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.63 110.993 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.408 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 49.6 ttp -89.57 -38.89 13.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 1.48 111.222 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.4 -41.42 73.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 3.5 111.861 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 30.7 mm -50.59 -52.25 57.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 112.313 0.486 . . . . 1.0800000000000001 112.313 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.2 Cg_endo -70.15 -32.51 16.82 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.296 1.997 . . . . 0.53000000000000003 113.122 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.69 -62.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.548 0.213 . . . . 1.6799999999999999 111.51 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.582 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.7 OUTLIER -60.66 -58.63 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.735 0.302 . . . . 1.8300000000000001 111.017 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.2 t -55.71 -26.09 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 1.0900000000000001 110.958 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.3 -58.88 11.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.715 -0.755 . . . . 0.40999999999999998 112.249 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.47 -28.44 65.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.835 0.35 . . . . 0.98999999999999999 110.834 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.24 17.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.47999999999999998 111.161 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 30.3 m-85 -62.25 -38.67 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 1.8700000000000001 110.914 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.2 ttp -55.72 -31.07 62.17 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.0 0.429 . . . . 1.49 110.315 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -40.04 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.58999999999999997 110.491 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.9 mtt -55.94 -33.96 65.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.815 -0.63 . . . . 0.48999999999999999 110.322 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -66.15 -49.51 67.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.59999999999999998 110.416 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.546 HG21 HG23 ' B' ' 127' ' ' VAL . 10.5 mt -74.58 -3.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 1.3100000000000001 110.818 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 60.64 51.49 4.97 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.737 -0.665 . . . . 1.9099999999999999 111.269 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -133.67 122.21 23.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 1.6200000000000001 110.933 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.07 -1.05 3.73 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.817 -0.706 . . . . 1.04 112.443 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -111.45 153.71 25.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.32 . . . . 2.6800000000000002 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.84 140.23 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 1.98 111.46 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -87.46 92.64 9.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 2.1800000000000002 110.749 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.15 118.36 35.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.5700000000000001 111.147 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.83 28.32 17.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.79 111.562 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.66 -10.46 64.7 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.705 -0.76 . . . . 1.48 112.949 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -98.07 147.43 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 2.3199999999999998 110.749 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.1 mt -89.72 122.22 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.4399999999999999 111.134 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.92 143.9 28.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.81999999999999995 111.202 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 92.4 m-70 -88.07 64.66 7.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 110.74 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.99 -56.0 18.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 1.8300000000000001 111.39 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.23 -22.54 63.15 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.129 0.418 . . . . 0.62 112.129 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 10.7 mpt_? -68.43 -52.37 33.46 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.921 0.341 . . . . 2.3399999999999999 111.921 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 117' ' ' LEU . 2.4 p90 -69.31 -32.95 72.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 3.4900000000000002 110.819 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.9 mm -51.48 -53.27 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.278 -0.419 . . . . 1.3700000000000001 110.519 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 79' ' ' THR . 22.1 t70 -62.72 -29.32 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 1.3100000000000001 110.002 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -80.94 6.85 12.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.047 -0.524 . . . . 1.48 111.305 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.578 ' HA ' HD13 ' A' ' 113' ' ' ILE . 53.1 tpp -105.11 -20.29 13.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 1.46 110.452 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.4 m -114.26 -36.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.739 0.644 . . . . 1.1200000000000001 112.739 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.1 t -79.9 -35.75 37.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.351 0.5 . . . . 1.1000000000000001 112.351 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 36.7 m -65.97 -50.39 52.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.851 0.315 . . . . 0.59999999999999998 111.851 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 51.8 Cg_exo -56.21 -38.24 95.32 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.787 1.658 . . . . 0.73999999999999999 111.369 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -74.07 -32.08 63.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 1.01 110.823 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.464 ' CD2' ' H43' ' A' ' 210' ' ' LYR . 13.2 tp -67.2 -28.12 67.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.939 0.399 . . . . 1.48 110.381 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 105' ' ' LEU . 5.3 tt -84.08 -36.2 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 1.3799999999999999 110.406 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -61.72 -37.51 84.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.082 -0.508 . . . . 1.1899999999999999 110.479 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.479 ' O ' HG23 ' A' ' 90' ' ' THR . 44.6 t -56.83 -30.51 63.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 1.23 110.701 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.11 -34.51 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.88 111.209 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -71.71 -39.65 70.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 1.3899999999999999 111.393 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -68.73 -26.33 65.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 2.3199999999999998 111.097 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 86' ' ' SER . 71.8 p -82.96 -23.49 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.538 -0.301 . . . . 1.46 111.365 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -33.85 16.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 1.24 111.046 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 86.1 mtp -130.72 99.21 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 2.0699999999999998 110.782 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -62.22 -44.93 95.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 3.5299999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -109.19 147.19 32.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 4.0800000000000001 111.139 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.83 142.05 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 2.1699999999999999 110.599 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -125.06 -67.72 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 4.5199999999999996 110.98 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -146.94 93.07 2.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 3.75 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -166.74 63.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 3.5299999999999998 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -89.68 16.91 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 4.9100000000000001 111.044 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 p -98.22 -25.64 14.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 1.98 111.314 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 101' ' ' LEU . 3.8 mm? -80.96 -53.71 6.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 1.8300000000000001 110.994 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.61 -22.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 1.79 111.306 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.38 -49.34 8.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.62 112.653 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.99 -39.69 86.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 1.5800000000000001 111.056 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.698 ' HB3' HD21 ' A' ' 84' ' ' LEU . 80.4 mt -61.71 -58.62 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.027 -0.533 . . . . 0.97999999999999998 111.051 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.3 ttm -53.67 -32.55 52.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.894 -0.594 . . . . 1.48 111.111 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' C' ' 42' ' ' PHE . 71.5 m -66.13 -55.63 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.1299999999999999 111.167 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -53.88 -29.19 40.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 1.48 111.069 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -62.87 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 2.7000000000000002 110.87 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.642 HG22 ' HE1' ' C' ' 46' ' ' TRP . 33.8 mm -53.42 -30.64 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 1.54 110.849 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.44 -49.15 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 1.28 111.233 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.68 -46.17 96.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.42999999999999999 111.319 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 77' ' ' MET . 53.0 mt -58.7 -34.55 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.74 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 41.6 m -56.42 -51.45 68.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.63 110.695 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -65.39 -20.68 66.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' H181 ' A' ' 210' ' ' LYR . . . -80.45 -40.71 12.52 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.803 -0.713 . . . . 0.41999999999999998 113.085 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.4 pp -73.85 -29.68 62.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.557 0.217 . . . . 1.3799999999999999 111.422 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.4 tp -83.72 -29.64 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 1.6200000000000001 111.428 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.78 68.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.402 . . . . 0.39000000000000001 111.149 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -80.63 -21.66 41.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 2.02 110.816 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 118' ' ' ILE . 76.9 mt -84.61 10.75 10.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.76000000000000001 111.001 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.5 p -70.08 120.94 16.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 1.46 111.151 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -96.97 -65.17 0.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.129 -0.487 . . . . 3.3500000000000001 110.787 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.6 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.1 mtp180 -69.77 134.12 48.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 2.9199999999999999 110.61 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.68 -11.48 60.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 2.77 110.966 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -81.0 -55.24 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.401 . . . . 3.77 110.635 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.6 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.7 p -65.9 -23.68 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 1.1599999999999999 110.916 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -52.28 -37.24 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 2.04 111.327 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -73.95 -26.46 60.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 2.6400000000000001 111.303 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 130' ' ' LEU . 8.4 mp -79.39 -39.08 33.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 1.8999999999999999 111.567 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -75.75 -26.5 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 1.3999999999999999 111.283 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HE1' ' HB3' ' A' ' 183' ' ' TRP . 53.4 t80 -68.35 -48.25 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 1.28 110.907 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -65.9 -29.81 48.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 2.1600000000000001 110.898 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.4 t -64.43 -38.71 91.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.254 -0.43 . . . . 1.6899999999999999 110.792 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.68 -54.27 23.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.75 -0.738 . . . . 0.52000000000000002 112.636 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.95 -30.77 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.712 0.292 . . . . 1.02 111.545 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.11 -43.65 97.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.866 0.365 . . . . 1.0800000000000001 110.894 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.47 86.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.62 110.709 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -63.03 -28.26 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 1.8400000000000001 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.87 -60.74 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 1.6899999999999999 111.397 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 pt -59.3 -41.13 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.325 -0.398 . . . . 0.81000000000000005 111.867 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -65.51 -33.48 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 2.3700000000000001 111.391 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.3 tp -68.05 -40.14 82.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.445 -0.343 . . . . 0.97999999999999998 111.049 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.547 ' O ' ' OD1' ' A' ' 148' ' ' ASN . 54.3 t-105 -69.28 -25.01 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 3.27 110.881 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.622 ' HA2' ' OD1' ' A' ' 148' ' ' ASN . . . -80.9 -41.66 10.41 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.971 -0.633 . . . . 1.25 112.669 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.86 -18.18 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.374 . . . . 2.1200000000000001 111.14 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -88.0 4.92 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 1.6599999999999999 111.466 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.622 ' OD1' ' HA2' ' A' ' 145' ' ' GLY . 32.0 m120 -91.23 -44.61 0.38 Allowed Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.84 0.682 . . . . 99.989999999999995 112.84 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 26.8 Cg_exo -30.47 -60.68 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.13 2.554 . . . . 2.6000000000000001 113.741 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.469 HD22 ' HB ' ' A' ' 154' ' ' THR . 99.0 mt -147.56 121.23 9.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.551 0.215 . . . . 4.6100000000000003 111.209 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -173.92 -45.74 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.525 -0.307 . . . . 8.3599999999999994 111.82 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.75 -59.18 2.59 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.797 0.665 . . . . 2.75 112.797 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.38 -39.07 54.74 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 112.47 0.544 . . . . 5.6799999999999997 112.47 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.469 ' HB ' HD22 ' A' ' 150' ' ' LEU . 12.5 t -60.98 -14.68 24.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.001 0.371 . . . . 3.21 112.001 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -66.24 -34.74 78.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.619 -0.264 . . . . 6.8700000000000001 111.6 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.2 m -102.71 -28.78 11.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.56 -0.291 . . . . 4.5599999999999996 111.581 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -59.7 -71.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.818 0.342 . . . . 3.5600000000000001 110.96 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.8 t -133.09 119.91 20.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.811 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 55.9 m -76.47 -22.46 54.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 2.5899999999999999 110.873 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.71 -57.12 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 3.4700000000000002 110.986 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.4 tp -65.07 -19.79 66.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 2.5800000000000001 111.018 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.25 -41.4 34.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 1.78 111.184 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.7 -38.83 92.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 2.6299999999999999 111.087 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.57 -46.32 79.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 2.3399999999999999 110.833 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.7 -22.58 60.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.768 -0.651 . . . . 2.77 111.217 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.07 -50.66 21.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 2.04 111.055 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -75.01 -20.66 59.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 2.77 111.167 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.4 tp -77.07 -50.6 12.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.338 -0.392 . . . . 1.8899999999999999 111.598 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.92 -35.44 49.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.226 -0.443 . . . . 1.6399999999999999 112.08 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -56.95 -35.78 69.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 1.24 110.939 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -77.84 -35.29 51.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 2.9700000000000002 110.487 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -70.01 -22.31 63.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 1.48 110.16 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 57.5 m -79.42 -48.38 14.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.852 -0.613 . . . . 1.55 111.519 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.57 HG13 HD22 ' A' ' 175' ' ' LEU . 7.3 p -62.19 -33.42 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.272 0.471 . . . . 1.52 112.272 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.57 HD22 HG13 ' A' ' 174' ' ' VAL . 4.0 mm? -76.52 -52.77 9.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.8 0.333 . . . . 1.8500000000000001 110.96 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -31.4 64.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.62 110.905 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.469 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 14.4 tt -87.65 -19.51 7.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.053 0.454 . . . . 1.3500000000000001 110.198 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.23 -50.91 60.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.58999999999999997 112.773 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.1 m-85 -58.37 -54.88 51.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.719 0.26 . . . . 1.45 111.308 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.5 Cg_exo -45.7 -30.88 6.86 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.283 1.989 . . . . 0.55000000000000004 112.571 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 177' ' ' ILE . 37.3 mm -68.98 -60.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 1.4199999999999999 111.454 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 179' ' ' TYR . 27.5 m -60.32 -25.53 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.78000000000000003 111.715 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.455 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 38.0 m95 -62.98 -27.23 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.623 -0.262 . . . . 0.93999999999999995 111.016 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.82 -43.69 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 1.4299999999999999 110.779 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 39.5 pt -97.67 145.68 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.524 . . . . 2.02 111.011 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.86 -163.42 17.31 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.809 -0.71 . . . . 1.79 112.491 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.39 160.98 47.69 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.463 2.109 . . . . 3.1000000000000001 112.1 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 89.4 p 49.86 24.64 1.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 2.7400000000000002 110.766 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -140.12 -68.84 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.02 -0.609 . . . . 3.4300000000000002 112.376 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -167.5 -28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 6.5 110.535 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.6 -155.95 4.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.96 -0.638 . . . . 3.29 112.626 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -158.65 28.51 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.327 . . . . 6.1600000000000001 110.904 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.5 pt -95.12 153.76 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 2.4199999999999999 111.35 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -156.63 35.35 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.988 -0.551 . . . . 4.29 110.42 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -93.21 -172.52 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.96 -0.564 . . . . 5.1500000000000004 111.065 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 52.3 m -64.31 -34.61 78.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 2.4500000000000002 111.507 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt -58.23 -33.13 46.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.367 -0.378 . . . . 2.48 111.588 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.86 -60.86 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 2.1800000000000002 111.271 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.4 t -62.57 -35.25 78.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.367 . . . . 1.49 111.173 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -59.11 -26.87 65.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 1.77 111.062 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 61.5 tp -78.11 -46.8 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.4199999999999999 110.998 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -74.0 -8.19 55.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 1.78 111.377 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.406 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 99.4 m -96.06 -39.2 9.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.086 0.47 . . . . 1.3 110.897 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.0 tp -72.95 -34.34 66.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.66000000000000003 111.734 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.542 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -59.42 -54.54 55.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 121.102 -0.239 . . . . 1.6299999999999999 111.174 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -57.28 -41.89 68.44 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.734 1.623 . . . . 0.64000000000000001 111.456 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.05 -28.05 69.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 1.3600000000000001 110.067 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -83.73 -21.46 32.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.784 -0.644 . . . . 1.54 110.386 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.9 p -94.8 -16.11 23.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 1.2 110.347 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.74 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.7 m -80.18 -37.03 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 1.6399999999999999 111.503 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.14 -37.13 91.26 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.733 -0.746 . . . . 0.79000000000000004 112.618 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -64.17 -35.69 81.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 1.6100000000000001 110.756 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.2 m -59.83 -60.62 3.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 1.1499999999999999 111.143 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.55 -21.29 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.23 -0.441 . . . . 3.3399999999999999 111.29 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.1 tt -68.88 -44.83 72.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.434 -0.348 . . . . 1.1899999999999999 110.715 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -66.99 -32.51 73.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 2.23 110.993 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.48 -40.68 96.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 2.4700000000000002 110.953 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -86.61 -20.94 27.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 1.6200000000000001 110.888 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.27 99.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 1.4099999999999999 112.457 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.466 HD22 HG12 ' A' ' 32' ' ' VAL . 60.1 tp -65.0 -55.7 17.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 2.5800000000000001 110.961 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 55.4 84.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 4.9299999999999997 110.824 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -66.57 112.07 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 4.6299999999999999 111.05 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 52.8 tp -132.76 96.98 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.999 -0.546 . . . . 6.4699999999999998 110.404 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.57 80.04 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 5.0700000000000003 110.748 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.22 65.52 6.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.225 -0.443 . . . . 6.5300000000000002 110.857 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 79.3 p -56.52 107.35 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.565 . . . . 5.2199999999999998 111.035 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -111.41 124.19 51.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 8.3599999999999994 110.843 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 7.96 110.964 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.873 0.368 . . . . 6.1699999999999999 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -76.36 88.56 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 4.8200000000000003 110.678 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.16 150.64 25.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 5.5999999999999996 110.899 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -88.16 23.48 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.516 . . . . 4.7999999999999998 110.966 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.6 m -93.22 -70.87 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 2.3700000000000001 110.803 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 mt 57.21 72.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 2.0699999999999998 111.273 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.413 ' N ' HD22 ' B' ' 7' ' ' LEU . 3.6 mm? -77.58 -32.0 53.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 2.1000000000000001 110.472 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 26.9 m170 -73.47 -29.12 62.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0700000000000001 110.414 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -70.85 -40.78 72.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.938 -0.574 . . . . 1.48 110.336 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.31 -25.27 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 2.02 110.348 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.67 -53.86 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.653 -0.703 . . . . 0.92000000000000004 110.725 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.91 -29.78 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.93999999999999995 110.778 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.68 87.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.55000000000000004 111.186 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.58 -34.35 54.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.825 -0.702 . . . . 0.47999999999999998 112.481 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.68 76.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.84999999999999998 111.105 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 37.3 m -60.29 -57.34 13.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 1.3400000000000001 111.178 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -60.1 -22.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 1.55 111.187 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.86 -63.7 4.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.69999999999999996 112.573 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -32.0 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.81000000000000005 111.196 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' B' ' 17' ' ' ILE . 95.9 mt -66.63 -39.6 88.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 2.2599999999999998 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.88 -35.16 74.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 1.78 110.726 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -79.23 -20.19 48.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 4.5800000000000001 110.637 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -67.05 -36.67 82.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 3.3500000000000001 110.657 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.6 m -81.44 -35.03 31.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 1.5800000000000001 110.531 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.39 -2.25 44.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.877 -0.602 . . . . 1.8400000000000001 110.34 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 57.7 p -61.98 -23.19 66.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.936 -0.574 . . . . 1.3700000000000001 110.828 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -49.99 -31.98 14.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.159 0.504 . . . . 4.9800000000000004 109.902 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.3 p-10 -170.49 132.13 0.94 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.342 -0.845 . . . . 2.1400000000000001 109.92 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 42.9 Cg_endo -95.26 172.72 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.092 2.528 . . . . 1.8200000000000001 112.55 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.544 ' HD3' HD22 ' B' ' 218' ' ' LEU . 14.9 ptm180 -88.28 45.72 1.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 5.1900000000000004 111.077 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.27 1.77 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.812 -0.709 . . . . 2.2000000000000002 112.824 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.5 123.24 89.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.488 0.185 . . . . 3.6499999999999999 110.986 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.421 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 33.3 Cg_exo -59.23 162.1 14.98 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.376 2.051 . . . . 2.6699999999999999 112.365 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -58.86 -18.08 29.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 4.8799999999999999 112.017 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.421 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 2.8 p90 -50.21 -38.09 38.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.682 0.277 . . . . 1.8700000000000001 111.281 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.14 -40.57 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 2.6800000000000002 110.651 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -64.68 -31.57 72.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 2.9199999999999999 110.724 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 104' ' ' PHE . 51.2 tp -62.14 -57.16 12.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 1.6399999999999999 110.706 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 14.4 t -65.07 -36.3 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 1.6000000000000001 110.808 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.12 47.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.68999999999999995 111.205 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 27.6 ttt -89.36 -41.71 11.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 2.5800000000000001 111.082 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -71.87 -34.62 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 3.3900000000000001 111.972 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 99.2 mt -54.57 -53.2 62.73 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.078 0.399 . . . . 0.40999999999999998 112.078 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.1 Cg_endo -70.53 -31.81 16.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.31 2.007 . . . . 0.48999999999999999 113.044 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.38 -62.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.564 0.221 . . . . 1.29 111.543 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.583 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.9 OUTLIER -60.47 -56.55 20.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.73 0.3 . . . . 1.3999999999999999 110.98 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -57.23 -22.31 40.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 1.3799999999999999 110.953 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.29 -61.27 5.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.632 -0.794 . . . . 0.37 112.753 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.512 HD12 ' N ' ' B' ' 50' ' ' ALA . 3.3 pp -58.6 -22.74 57.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.625 0.25 . . . . 1.29 111.339 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.512 ' N ' HD12 ' B' ' 49' ' ' LEU . . . -64.96 -57.47 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.44 110.983 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 30.5 m-85 -63.67 -37.26 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.5 110.653 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -49.63 -38.51 32.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.007 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.66 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.55000000000000004 110.751 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 42.4 mtt -53.25 -24.91 12.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.5 110.527 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -77.13 -48.42 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.54000000000000004 110.78 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.56 11.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 1.3 111.434 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 61.44 67.27 0.79 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.03 -0.532 . . . . 2.2400000000000002 111.355 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -144.9 152.8 40.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.77 110.917 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 92.29 17.27 47.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.81 -0.709 . . . . 1.0600000000000001 112.467 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -128.95 148.81 50.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 2.6600000000000001 110.923 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.77 150.71 29.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 1.8899999999999999 110.859 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.36 94.9 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 2.4100000000000001 110.682 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.71 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 1.5600000000000001 111.152 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.23 30.28 20.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 1.8200000000000001 111.251 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.18 -15.64 48.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.857 -0.687 . . . . 1.51 112.913 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -98.37 146.81 25.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.801 0.334 . . . . 2.4500000000000002 110.781 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 54.6 mt -86.2 131.14 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 1.79 111.263 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.9 143.29 32.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.81999999999999995 111.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 72.3 m-70 -84.48 65.03 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.154 0.502 . . . . 1.05 110.682 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.41 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 76.7 t80 -63.82 -51.91 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.635 -0.712 . . . . 1.8700000000000001 111.581 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.427 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -64.61 -22.46 66.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.60999999999999999 111.933 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' B' ' 69' ' ' HIS . 22.4 tpp180 -68.46 -51.62 41.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.257 0.465 . . . . 2.3900000000000001 112.257 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' B' ' 77' ' ' MET . 6.0 p90 -76.33 -34.4 58.99 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.147 0.425 . . . . 3.6699999999999999 112.147 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.432 HG23 ' N ' ' B' ' 75' ' ' ASP . 18.2 tt -55.39 -43.74 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 120.656 -0.417 . . . . 1.6599999999999999 110.623 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.432 ' N ' HG23 ' B' ' 74' ' ' ILE . 29.6 t70 -68.67 -19.96 64.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.424 -0.584 . . . . 1.4099999999999999 109.424 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -88.43 4.14 47.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 111.306 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.6 ' HA ' HD13 ' B' ' 113' ' ' ILE . 31.8 mtp -101.65 -20.42 15.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.343 -0.39 . . . . 1.53 110.383 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.431 ' O ' HD23 ' B' ' 82' ' ' LEU . 32.7 m -113.92 -29.86 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.89000000000000001 111.87 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.441 HG23 HG23 ' B' ' 43' ' ' ILE . 30.6 m -81.3 -51.38 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.933 0.345 . . . . 1.24 111.933 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 21.8 m -52.27 -50.61 78.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.114 0.413 . . . . 0.57999999999999996 112.114 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.4 Cg_exo -53.75 -49.32 17.62 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.785 1.657 . . . . 0.66000000000000003 111.729 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.431 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -64.27 -31.25 72.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.135 -0.484 . . . . 1.0600000000000001 110.717 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.403 ' O ' HD13 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -63.54 -35.26 79.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.154 0.502 . . . . 1.22 109.956 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -84.27 -35.7 23.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 1.53 111.236 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 88.1 mt -58.61 -41.24 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 1.5800000000000001 111.054 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -59.02 -28.65 66.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 1.3899999999999999 110.827 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 mt -67.47 -32.32 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.1499999999999999 110.905 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -72.93 -39.38 66.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.5700000000000001 111.294 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -70.26 -24.69 63.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 2.1699999999999999 111.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 32.6 m -78.62 -30.95 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 1.4199999999999999 111.178 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.27 -25.41 25.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 1.1799999999999999 111.187 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -132.81 99.36 4.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 1.8799999999999999 110.815 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -65.28 -50.97 63.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 3.4199999999999999 110.984 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -104.77 143.38 33.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 4.0599999999999996 110.732 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 tt -124.9 142.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 2.0899999999999999 110.887 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.441 ' HG2' ' HG3' ' B' ' 97' ' ' LYS . 38.7 ttpt -128.31 -70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 3.8500000000000001 111.104 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.441 ' HG3' ' HG2' ' B' ' 96' ' ' LYS . 29.9 mtpp -141.81 95.84 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 4.8200000000000003 111.03 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -170.24 83.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 3.7999999999999998 110.907 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -106.49 14.24 27.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 5.1699999999999999 110.721 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 2.8 t -91.15 -42.0 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 2.02 111.424 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.15 -47.07 59.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 2.0899999999999999 111.157 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -63.2 -32.33 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.8799999999999999 111.391 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.35 -31.81 33.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 0.56000000000000005 112.729 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.09 -36.65 72.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 1.78 111.002 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.546 ' HB3' HD21 ' B' ' 84' ' ' LEU . 88.0 mt -74.84 -44.27 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.239 -0.437 . . . . 1.03 111.063 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.7 ttp -65.53 -37.38 86.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 1.6699999999999999 111.351 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -65.7 -50.36 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.343 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 35.9 p -56.79 -34.33 67.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.331 -0.395 . . . . 1.1799999999999999 111.32 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.406 ' CG ' HD13 ' B' ' 84' ' ' LEU . 11.8 mm100 -61.52 -47.32 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 2.1699999999999999 111.139 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.582 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.5 mt -54.85 -35.09 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 1.3500000000000001 110.605 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 t -65.52 -47.32 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 1.3400000000000001 111.094 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.56 -47.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.192 -0.458 . . . . 0.42999999999999999 111.212 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' B' ' 77' ' ' MET . 47.0 mt -58.15 -33.26 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 1.6000000000000001 110.996 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.1 m -58.89 -48.65 80.65 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.178 -0.464 . . . . 0.85999999999999999 110.979 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.5 m -67.3 -23.23 65.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.974 -0.557 . . . . 0.94999999999999996 110.852 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.524 ' HA3' H181 ' B' ' 210' ' ' LYR . . . -80.35 -32.48 34.63 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.92 -0.657 . . . . 0.46000000000000002 113.375 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.504 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.4 pp -80.85 -28.89 35.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.706 0.289 . . . . 1.75 111.206 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.504 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.55 -31.25 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.385 . . . . 1.78 111.321 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.91 -47.06 74.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.299 -0.41 . . . . 0.38 110.957 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 -21.12 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.97 110.716 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' B' ' 118' ' ' ILE . 98.8 mt -81.64 14.79 2.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.077 -0.51 . . . . 0.76000000000000001 110.831 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 79.0 p -61.24 134.5 57.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 1.47 111.024 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -117.52 -45.21 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 2.5 110.832 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.604 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 59.4 ttp180 -108.23 132.66 53.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 2.73 110.64 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.7 -19.0 63.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 2.2000000000000002 111.252 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.604 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 52.4 t-105 -71.26 -53.65 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.401 -0.363 . . . . 3.3999999999999999 110.868 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.546 HG23 HG21 ' A' ' 56' ' ' ILE . 7.3 p -74.86 -24.09 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.23 111.106 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -52.42 -39.67 61.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 3.04 111.2 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -71.34 -32.59 68.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.391 . . . . 4.1399999999999997 111.384 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.58 -56.84 6.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 1.6499999999999999 111.189 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -58.01 -29.97 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.77000000000000002 111.416 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.26 -53.27 57.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 1.46 110.725 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.85 -31.03 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 1.6299999999999999 110.775 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.48 -34.34 75.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 1.4199999999999999 110.859 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.05 -55.02 8.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.824 -0.703 . . . . 0.48999999999999999 112.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m -59.83 -32.94 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 1.3 110.955 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.3 t -65.61 -36.74 84.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 1.3 110.613 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.21 91.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.62 110.627 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -68.27 -23.23 64.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 1.74 110.787 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -58.82 5.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 1.76 110.802 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.413 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.7 pt -62.6 -40.15 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.68999999999999995 111.503 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.413 ' N ' HG13 ' B' ' 141' ' ' ILE . 87.6 mt -64.61 -33.99 66.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.76 110.909 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.75 -45.0 95.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 1.0600000000000001 110.942 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.81 -25.53 65.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 4.1200000000000001 111.286 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' B' ' 149' ' ' PRO . . . -81.92 -35.66 21.01 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 1.26 112.746 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.6 -22.47 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 1.98 110.454 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -87.08 4.65 41.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 1.4199999999999999 111.015 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.463 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 51.4 t30 -90.3 -47.78 0.38 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.008 -0.542 . . . . 99.989999999999995 112.147 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 79.7 Cg_exo -42.05 -32.95 2.04 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.567 2.178 . . . . 2.6499999999999999 112.869 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 64.6 tp -55.77 -57.7 10.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.416 . . . . 4.3899999999999997 110.387 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 63.44 128.59 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.095 -0.502 . . . . 7.9000000000000004 111.3 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.67 -18.02 57.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.84 -0.618 . . . . 2.77 111.161 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -62.83 -23.95 67.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.49 . . . . 6.29 111.278 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 73.3 p -80.36 -15.37 57.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.485 -0.325 . . . . 3.1000000000000001 111.615 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -70.37 -27.3 64.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.409 -0.36 . . . . 6.4299999999999997 110.891 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 4.6 t -107.5 -16.74 14.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.306 -0.406 . . . . 4.5700000000000003 111.442 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -79.28 -49.36 12.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.425 -0.352 . . . . 3.8300000000000001 110.999 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 66.7 m -151.12 116.2 5.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 3.0699999999999998 110.967 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 44.8 t -77.88 -22.05 50.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 3.4300000000000002 110.918 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.69 -61.86 1.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 3.9199999999999999 110.977 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.91 -25.02 60.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 2.7000000000000002 110.852 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.15 -57.74 3.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 1.8300000000000001 111.036 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -53.52 -23.25 9.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.087 0.47 . . . . 2.6299999999999999 110.427 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.0 tp -73.45 -40.32 64.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.626 -0.715 . . . . 2.4300000000000002 110.729 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -80.6 -25.16 38.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 2.5800000000000001 111.101 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -75.28 -38.48 60.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 2.0 110.97 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -79.95 -21.6 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 3.0299999999999998 110.791 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 48.7 tp -81.34 -46.12 15.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 1.1000000000000001 111.464 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.35 -33.77 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.75 112.282 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 9.9 t -51.73 -41.48 61.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.617 0.246 . . . . 0.97999999999999998 111.282 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' TYR . . . . . 0.447 ' O ' HG22 ' B' ' 174' ' ' VAL . 37.3 m-85 -77.02 -40.3 46.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 4.2999999999999998 110.709 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -62.11 -23.24 66.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.162 -0.472 . . . . 1.3899999999999999 110.865 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.408 ' O ' HG22 ' B' ' 177' ' ' ILE . 28.0 m -79.31 -50.8 10.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 1.1100000000000001 111.577 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 171' ' ' TYR . 32.7 m -59.51 -28.94 41.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.986 0.365 . . . . 1.51 111.986 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 77.5 mt -76.27 -57.02 4.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.905 0.383 . . . . 1.75 111.213 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -32.47 56.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.89 -0.596 . . . . 0.59999999999999998 111.224 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.442 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 19.1 tt -87.4 -19.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.451 . . . . 1.47 110.385 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.26 59.45 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.742 -0.663 . . . . 0.55000000000000004 112.953 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 84.5 m-85 -58.22 -54.86 51.42 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.782 0.291 . . . . 1.6200000000000001 111.342 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -45.26 -32.44 7.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.164 1.91 . . . . 0.64000000000000001 112.685 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.428 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.4 mt -65.62 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.27 111.462 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 179' ' ' TYR . 35.2 m -60.23 -27.01 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.68999999999999995 111.404 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -62.93 -25.91 68.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 1.1799999999999999 111.178 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.27 -40.93 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 1.77 110.716 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.59 -179.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.6899999999999999 110.798 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 67.86 -159.36 51.01 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.748 -0.739 . . . . 1.5800000000000001 112.695 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.2 160.0 36.52 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.755 2.304 . . . . 2.5099999999999998 112.322 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 59.8 m 56.93 17.75 3.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.094 -0.503 . . . . 3.5800000000000001 110.825 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -133.03 -60.13 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.038 -0.601 . . . . 4.0300000000000002 112.371 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -172.3 -31.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 6.8899999999999997 110.637 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -85.48 -174.78 50.16 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.878 -0.677 . . . . 3.7000000000000002 112.778 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -141.31 74.49 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 7.5 110.326 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 33.7 pt -134.97 146.72 30.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 2.3500000000000001 111.224 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -144.31 39.63 1.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 3.8599999999999999 110.715 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 195' ' ' GLN . . . . . 0.486 ' HB2' HG22 ' B' ' 197' ' ' ILE . 84.8 mm-40 -85.94 178.39 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 5.0499999999999998 111.098 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 8.6 t -67.69 -28.72 67.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.276 -0.42 . . . . 2.6800000000000002 110.771 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 197' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' B' ' 195' ' ' GLN . 7.7 tp -62.2 -29.53 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 2.4700000000000002 110.833 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.23 -60.65 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 2.5299999999999998 110.879 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 8.1 t -62.17 -36.83 83.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 1.29 111.152 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.69 -27.46 64.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.285 -0.416 . . . . 2.6200000000000001 110.758 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -75.89 -50.35 15.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 1.6100000000000001 111.049 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -73.02 -5.85 41.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.565 -0.289 . . . . 1.4199999999999999 110.843 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 60.8 m -96.48 -41.86 8.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.267 0.556 . . . . 1.4299999999999999 110.472 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.51 -38.38 74.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.578 -0.737 . . . . 1.1200000000000001 111.909 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.675 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.3 tp -58.3 -53.94 60.95 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 120.961 -0.296 . . . . 1.26 111.321 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -53.62 -42.08 68.81 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.791 1.661 . . . . 0.59999999999999998 111.399 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.09 -42.99 86.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 1.3999999999999999 110.343 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -69.81 -30.19 67.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.4099999999999999 110.457 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -82.31 -17.99 43.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.504 . . . . 1.3200000000000001 110.279 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.754 ' H9 ' H183 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 10.4 p -85.29 -33.19 7.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.273 -0.421 . . . . 1.6899999999999999 110.944 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.79 96.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.79000000000000004 112.339 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -69.47 -32.26 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.73 0.3 . . . . 2.96 110.875 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 49.2 m -59.91 -62.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 1.29 110.95 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.13 -20.33 65.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.589 . . . . 3.1499999999999999 110.945 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.11 -54.18 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 1.51 111.279 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.98 -37.48 76.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 2.1899999999999999 111.646 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' B' ' 30' ' ' ARG . 78.8 mt -59.16 -49.1 79.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 1.98 111.144 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -77.08 -20.53 55.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 2.1699999999999999 111.051 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.28 -47.93 86.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.881 -0.676 . . . . 1.3600000000000001 112.88 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 58.7 tp -58.34 -56.1 26.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.548 0.214 . . . . 2.8999999999999999 111.033 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 55.78 84.08 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.315 -0.402 . . . . 5.6100000000000003 110.848 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.53 104.91 6.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 4.04 110.869 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 54.7 tp -88.58 -74.0 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 6.2999999999999998 110.895 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -141.1 81.23 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 4.7999999999999998 110.611 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.12 91.41 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 6.3899999999999997 111.061 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 42.7 t -94.15 83.15 4.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.6100000000000003 110.756 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -87.0 142.61 27.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 8.1999999999999993 110.948 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 8.1699999999999999 110.947 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.792 0.33 . . . . 5.6200000000000001 111.102 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -59.65 152.75 21.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 5.2800000000000002 110.992 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -139.82 -66.42 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.04 -0.527 . . . . 6.0499999999999998 110.902 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -138.75 35.18 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 4.79 110.935 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -133.6 76.71 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 2.71 111.021 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.7 mt -100.6 94.27 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 2.52 110.559 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.68 -49.06 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 1.9299999999999999 111.312 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 49.1 m-70 -64.72 -24.19 67.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 1.26 110.908 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.446 ' O ' HG12 ' C' ' 12' ' ' VAL . 54.7 t-105 -70.57 -50.03 41.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 1.6699999999999999 110.399 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.48 -21.29 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.204 0.526 . . . . 1.8700000000000001 109.932 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' TYR . . . . . 0.407 ' HE2' ' HG ' ' C' ' 203' ' ' CYS . 0.3 OUTLIER -61.15 -58.99 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.49 -0.777 . . . . 1.4399999999999999 110.413 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' C' ' 52' ' ' MET . 10.1 p -61.97 -26.84 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.46999999999999997 111.23 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.75 83.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.398 -0.365 . . . . 0.58999999999999997 111.046 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.6 -23.81 77.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.831 -0.699 . . . . 0.5 112.499 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' MET . . . . . 0.402 ' HB3' ' HB2' ' C' ' 44' ' ' PRO . 18.9 mmt -77.89 -42.92 31.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.52 0.2 . . . . 0.68000000000000005 111.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 37.6 p -59.1 -50.94 72.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 1.3999999999999999 110.893 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -29.51 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 1.55 110.684 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.17 -61.59 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.861 -0.685 . . . . 0.70999999999999996 112.702 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.41 ' HB1' ' HG3' ' C' ' 41' ' ' MET . . . -56.66 -31.95 64.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.77000000000000002 111.127 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' C' ' 23' ' ' TRP . 93.5 mt -69.13 -29.05 67.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 1.9299999999999999 111.247 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.26 -41.39 84.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.94 0.4 . . . . 1.8600000000000001 110.596 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.94 -24.5 52.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 4.1399999999999997 110.606 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' TRP . . . . . 0.414 ' HB3' ' O ' ' C' ' 20' ' ' LEU . 73.9 t-105 -55.28 -43.17 74.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.295 -0.411 . . . . 3.1499999999999999 110.631 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 44.2 t -82.73 -37.45 24.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 1.95 110.973 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 38.2 tp -77.42 -3.31 39.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.215 -0.448 . . . . 2.2200000000000002 110.739 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 65.4 p -60.77 -23.62 65.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 1.3700000000000001 110.928 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.6 -26.71 14.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.092 0.473 . . . . 5.0300000000000002 109.771 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 14.6 t-20 -172.95 131.87 0.62 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 2.3700000000000001 110.174 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 35.4 Cg_endo -95.67 170.54 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.147 2.564 . . . . 2.0499999999999998 112.538 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -86.65 44.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 4.5199999999999996 111.172 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.07 -45.67 1.39 Allowed Glycine 0 CA--C 1.517 0.188 0 C-N-CA 120.827 -0.701 . . . . 2.1600000000000001 112.799 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 4.0 p -74.58 121.45 85.26 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.633 0.254 . . . . 2.5299999999999998 111.15 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.51 ' HB2' ' CD1' ' C' ' 35' ' ' TYR . 38.8 Cg_exo -57.68 166.46 5.01 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.642 2.228 . . . . 1.9299999999999999 112.613 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' C' ' 34' ' ' GLN . 0.0 OUTLIER -62.13 -18.48 60.98 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.806 1.039 . . . . 4.1200000000000001 113.806 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' C' ' 33' ' ' PRO . 6.5 p90 -54.79 -31.88 59.44 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.479 -0.489 . . . . 2.8900000000000001 111.123 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.52 -54.56 11.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 2.46 110.918 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' C' ' 40' ' ' ALA . 85.4 m-85 -65.18 -20.81 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 2.7799999999999998 111.278 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.72 -61.48 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 1.6200000000000001 110.036 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.435 HG13 HD12 ' C' ' 82' ' ' LEU . 42.1 t -66.44 -29.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 1.5900000000000001 110.13 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' C' ' 37' ' ' TYR . . . -74.83 -8.85 57.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.82 -0.627 . . . . 0.65000000000000002 110.807 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.429 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.1 ttt -89.02 -37.14 15.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 1.6699999999999999 110.528 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.439 ' HA ' HG22 ' C' ' 45' ' ' ILE . 46.0 t80 -72.28 -29.81 64.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.7 -0.682 . . . . 3.4199999999999999 111.841 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' C' ' 82' ' ' LEU . 37.8 mm -60.22 -52.04 75.99 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 112.402 0.519 . . . . 0.89000000000000001 112.402 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 64.1 Cg_endo -72.81 -34.55 6.66 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.348 2.032 . . . . 0.40999999999999998 114.25 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.486 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.1 tp -63.17 -50.44 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.338 0.495 . . . . 1.76 112.338 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.642 ' HE1' HG22 ' A' ' 110' ' ' ILE . 1.0 OUTLIER -67.59 -58.77 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 2.1600000000000001 111.345 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.6 p -56.64 -31.35 64.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 1.1699999999999999 110.515 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.82 -57.03 19.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.986 -0.626 . . . . 0.44 112.773 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.28 -29.62 68.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.91 0.386 . . . . 1.29 110.881 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.73 95.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.5 110.974 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -69.51 -47.22 64.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.8300000000000001 110.87 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' MET . . . . . 0.455 ' HB2' HG11 ' C' ' 12' ' ' VAL . 50.7 ttp -50.95 -28.23 9.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 1.47 110.457 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -74.24 -43.35 57.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.843 -0.617 . . . . 0.59999999999999998 110.879 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.2 -26.42 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.83999999999999997 110.612 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -77.74 -45.22 25.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.65000000000000002 111.275 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' C' ' 53' ' ' ALA . 31.1 pt -79.45 4.86 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 1.55 111.3 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.2 68.03 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.861 -0.609 . . . . 1.54 111.377 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -149.54 136.59 19.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.79 110.822 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.28 4.84 23.53 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.712 -0.756 . . . . 0.93999999999999995 112.356 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -114.22 152.68 30.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 2.3599999999999999 110.872 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.18 145.47 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 1.97 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.61 91.2 8.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 2.4399999999999999 110.796 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.02 105.94 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 1.54 111.208 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.95 36.33 24.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 1.71 111.367 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.43 -13.49 51.08 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 1.53 112.773 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -99.35 134.53 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 2.23 110.921 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 65.6 mt -76.59 137.25 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 1.3600000000000001 111.006 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.72 143.12 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.78000000000000003 111.073 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.497 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 68.0 m80 -83.2 61.17 5.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.553 . . . . 1.0800000000000001 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' TYR . . . . . 0.412 ' O ' HG12 ' C' ' 74' ' ' ILE . 68.6 t80 -60.64 -58.01 10.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 2.2999999999999998 111.671 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.35 -22.44 66.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.324 0.49 . . . . 0.75 112.324 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.6 tpp180 -65.52 -51.6 58.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.101 0.408 . . . . 1.51 112.101 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -74.13 -29.42 61.81 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.875 -0.33 . . . . 4.6500000000000004 111.123 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.412 HG12 ' O ' ' C' ' 70' ' ' TYR . 22.6 mm -52.7 -50.53 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 120.853 0.358 . . . . 1.22 110.496 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.66 -21.98 66.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.112 -0.495 . . . . 1.3100000000000001 109.737 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.56 5.45 39.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.936 -0.574 . . . . 1.6799999999999999 110.709 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.525 ' HA ' HD13 ' C' ' 113' ' ' ILE . 57.0 tpp -102.71 -21.81 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 1.8 110.389 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 2.5 p -113.73 -47.42 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.119 -0.491 . . . . 1.1899999999999999 111.983 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.501 HG23 HG23 ' C' ' 43' ' ' ILE . 96.5 m -61.11 -53.64 54.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.163 0.431 . . . . 1.23 112.163 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 29.9 m -51.66 -54.48 39.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.449 0.537 . . . . 0.58999999999999997 112.449 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 77.1 Cg_exo -49.3 -37.79 40.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.896 1.73 . . . . 0.67000000000000004 112.143 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' C' ' 43' ' ' ILE . 4.1 mm? -74.39 -38.39 63.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.95999999999999996 110.63 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.451 HD13 ' O ' ' C' ' 83' ' ' LEU . 0.3 OUTLIER -57.82 -33.64 68.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.173 0.511 . . . . 1.1899999999999999 109.99 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -80.31 -44.93 18.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.598 -0.728 . . . . 1.7 110.783 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.3 -32.81 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.681 -0.69 . . . . 1.6200000000000001 111.443 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -62.14 -34.53 76.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 1.26 110.691 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.32 -44.46 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 1.1100000000000001 110.9 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 43.4 t -65.83 -23.21 66.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 1.51 111.036 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -83.84 -26.72 29.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 2.0600000000000001 110.666 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -77.1 -39.9 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 1.52 111.254 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.11 -44.29 54.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 1.3 111.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -111.79 101.76 10.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 1.6200000000000001 110.825 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.44 -39.62 70.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 3.2400000000000002 110.938 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -116.44 136.51 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 4.6299999999999999 110.794 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.03 144.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.035 -0.53 . . . . 2.1800000000000002 110.802 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -126.21 -65.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.315 -0.402 . . . . 4.1200000000000001 111.078 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -149.09 110.0 4.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.379 . . . . 4.96 110.846 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -144.26 -84.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 3.9100000000000001 110.902 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 90.9 m95 53.82 24.79 4.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.3 -0.409 . . . . 5.21 111.256 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 38.8 p -120.4 -51.93 2.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.217 -0.447 . . . . 1.8200000000000001 110.907 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 68.1 tp -72.27 -53.1 13.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 2.0800000000000001 110.768 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 13.5 tt -56.55 -32.77 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.033 -0.531 . . . . 1.8600000000000001 111.314 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.8 -35.17 22.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.58999999999999997 112.617 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' B' ' 38' ' ' LEU . 90.1 t80 -70.3 -29.76 66.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 1.53 111.091 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.526 ' HB3' HD21 ' C' ' 84' ' ' LEU . 95.7 mt -79.42 -50.45 10.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 1.1100000000000001 111.134 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -61.53 -30.92 70.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.972 -0.558 . . . . 2.21 111.094 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 95.6 p -68.95 -52.82 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.066 0.46 . . . . 1.28 110.747 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 67.7 p -60.7 -23.96 65.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 1.22 110.677 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -64.7 -50.37 67.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.033 -0.531 . . . . 2.3300000000000001 110.319 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.583 HG22 ' HE1' ' B' ' 46' ' ' TRP . 43.9 mm -55.85 -33.09 33.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 1.29 110.476 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.408 HG13 HD21 ' B' ' 49' ' ' LEU . 21.8 t -62.89 -45.93 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 1.0600000000000001 110.797 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.64 -47.53 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.945 -0.571 . . . . 0.51000000000000001 111.217 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' C' ' 77' ' ' MET . 29.8 mt -60.15 -31.91 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.3700000000000001 111.057 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 22.7 m -59.49 -48.17 82.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.77000000000000002 111.022 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 44.1 m -70.15 -20.29 63.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.1899999999999999 110.965 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.501 ' HA3' H181 ' C' ' 210' ' ' LYR . . . -81.11 -33.09 30.17 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.837 -0.697 . . . . 0.5 113.26 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.526 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.3 pp -79.89 -29.82 40.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.717 0.258 . . . . 1.47 111.592 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' C' ' 121' ' ' LEU . 8.5 tp -83.81 -26.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 1.2 111.181 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.35 -40.99 68.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.169 -0.468 . . . . 0.40000000000000002 111.049 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 -17.56 48.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 2.1200000000000001 110.903 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' C' ' 118' ' ' ILE . 91.9 mt -90.57 34.77 0.88 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 0.75 111.03 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 94.4 p -91.53 131.29 37.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 1.3799999999999999 110.942 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -101.44 -53.64 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 2.7400000000000002 110.901 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 50.9 ttp180 -89.6 137.0 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.497 . . . . 2.7999999999999998 111.022 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.99 -24.6 65.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 2.4100000000000001 111.188 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 126' ' ' TRP . . . . . 0.615 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 66.7 t-105 -71.06 -57.24 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 4.2000000000000002 110.75 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' C' ' 124' ' ' ARG . 11.5 p -63.9 -23.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.513 . . . . 1.0800000000000001 110.725 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 128' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' C' ' 188' ' ' SER . 41.9 ttm180 -57.78 -36.57 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 2.5699999999999998 110.948 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -75.3 -18.16 60.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 3.8100000000000001 110.682 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.03 -42.32 19.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 1.4199999999999999 111.235 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -72.94 -31.09 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 0.89000000000000001 111.371 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' TYR . . . . . 0.418 ' HE2' ' HB3' ' C' ' 183' ' ' TRP . 66.6 t80 -60.66 -55.38 34.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 1.26 110.937 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.6 tt -60.94 -31.14 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.021 -0.536 . . . . 1.6799999999999999 111.078 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.55 -31.49 72.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 1.24 110.724 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -53.02 15.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.868 -0.682 . . . . 0.54000000000000004 112.775 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 136' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 22.2 m -60.54 -38.65 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 1.0600000000000001 111.219 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 67.3 m -56.33 -42.5 77.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.894 0.378 . . . . 1.0800000000000001 110.823 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.14 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.56999999999999995 110.905 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 1.6799999999999999 110.849 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 96.3 mt -66.81 -53.24 34.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 1.7 111.09 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 33.1 pt -66.4 -31.88 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.451 -0.341 . . . . 0.78000000000000003 111.418 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.89 -29.69 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 2.2400000000000002 110.882 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.98 -37.08 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.745 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -76.07 -29.48 58.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 3.0 110.746 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.06 -27.52 49.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 1.27 112.471 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 tt -84.28 -21.51 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.057 0.456 . . . . 1.8899999999999999 110.298 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 147' ' ' TRP . . . . . 0.414 ' HZ3' HD22 ' C' ' 150' ' ' LEU . 4.7 m95 -87.72 3.21 48.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 1.6000000000000001 110.53 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.502 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 51.5 t30 -87.62 -48.94 0.45 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.908 -0.587 . . . . 99.989999999999995 111.823 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 79.7 Cg_exo -41.69 -32.11 1.46 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.718 2.279 . . . . 2.73 113.117 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 150' ' ' LEU . . . . . 0.414 HD22 ' HZ3' ' C' ' 147' ' ' TRP . 59.4 tp -55.6 -55.23 34.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.455 -0.339 . . . . 4.2999999999999998 110.281 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 65.21 133.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.775 -0.648 . . . . 8.9000000000000004 111.735 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.56 -18.02 65.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 2.7999999999999998 110.732 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.38 -37.73 81.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.005 -0.543 . . . . 5.4400000000000004 110.815 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' THR . . . . . 0.5 HG22 ' HB2' ' C' ' 162' ' ' ALA . 29.2 m -64.06 -28.17 69.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.476 . . . . 3.3900000000000001 111.118 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -64.8 -21.72 66.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 6.9199999999999999 110.929 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 61.0 p -116.9 -11.87 10.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 4.8700000000000001 111.251 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -84.41 -60.59 2.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 4.0499999999999998 110.645 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -140.22 115.37 9.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.994 -0.548 . . . . 3.0299999999999998 110.841 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 34.3 t -74.24 -20.0 60.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 2.96 111.127 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.35 -54.81 6.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 3.7400000000000002 110.948 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 30.5 tp -66.77 -19.97 65.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 2.6499999999999999 111.032 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 162' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' C' ' 154' ' ' THR . . . -78.58 -40.38 34.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 1.77 111.392 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -65.71 -36.12 82.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 2.96 110.931 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.32 -47.76 69.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.494 . . . . 2.3500000000000001 110.784 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -26.16 63.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 2.6200000000000001 110.991 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.05 -59.52 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 2.0899999999999999 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.64 -26.06 63.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 3.2400000000000002 111.14 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.86 -54.67 38.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 1.6899999999999999 110.905 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.48 -28.22 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.3999999999999999 111.287 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 43.5 m -52.66 -58.52 6.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.483 -0.326 . . . . 0.95999999999999996 111.198 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 171' ' ' TYR . . . . . 0.417 ' O ' HD23 ' C' ' 175' ' ' LEU . 76.1 m-85 -63.56 -38.95 93.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.53 -0.304 . . . . 3.6499999999999999 110.479 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.04 -25.18 65.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 1.3700000000000001 111.004 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.441 ' O ' HG22 ' C' ' 177' ' ' ILE . 46.6 m -79.43 -49.16 12.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 1.4299999999999999 111.722 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.3 -41.28 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 111.736 0.272 . . . . 1.6200000000000001 111.736 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' C' ' 209' ' ' SER . 4.4 mm? -71.09 -55.72 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.855 0.317 . . . . 2.0299999999999998 111.855 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -54.16 -34.63 60.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.456 -0.338 . . . . 0.62 111.528 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.455 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.43 -19.3 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 1.5800000000000001 110.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.77 -44.85 95.59 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.56000000000000005 112.806 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.654 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 82.1 m-85 -62.48 -55.98 34.42 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.704 0.252 . . . . 1.3300000000000001 111.069 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 83.2 Cg_exo -48.32 -27.93 10.61 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.999 1.799 . . . . 0.63 112.453 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.423 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -69.12 -59.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.93000000000000005 111.127 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.581 HG11 HD21 ' C' ' 201' ' ' LEU . 17.2 m -61.59 -24.76 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.006 -0.543 . . . . 1.27 111.203 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 183' ' ' TRP . . . . . 0.418 ' HB3' ' HE2' ' C' ' 132' ' ' TYR . 31.9 m95 -66.41 -22.75 66.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.27 -0.423 . . . . 1.77 110.727 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.53 -27.48 42.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 2.3900000000000001 111.079 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt -119.29 162.43 17.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.262 -0.427 . . . . 1.95 111.115 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.71 -157.22 26.25 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.755 -0.736 . . . . 1.8799999999999999 112.498 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 156.17 48.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.542 2.162 . . . . 3.1200000000000001 112.208 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 188' ' ' SER . . . . . 0.511 ' HA ' ' HD3' ' C' ' 128' ' ' ARG . 44.7 t 57.6 13.99 2.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.063 -0.517 . . . . 2.6299999999999999 111.17 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -169.52 75.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.749 -0.739 . . . . 3.04 112.5 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 52.34 90.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.759 0.314 . . . . 5.6900000000000004 111.148 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 151.27 168.52 15.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 3.0800000000000001 112.468 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -136.74 31.37 2.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 7.5300000000000002 110.937 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.0 140.63 15.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.319 -0.401 . . . . 2.8599999999999999 110.802 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -155.06 35.45 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.352 -0.385 . . . . 3.6899999999999999 111.274 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.43 -173.09 3.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.34 -0.391 . . . . 5.4800000000000004 111.019 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 77.6 p -63.32 -36.9 85.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 2.3799999999999999 111.243 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 7.3 tp -56.03 -36.1 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 2.23 111.301 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.68 -58.34 7.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 2.1600000000000001 111.03 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 75.0 p -64.07 -20.45 65.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 1.27 111.049 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.26 -31.17 58.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.474 . . . . 1.7 110.9 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 201' ' ' LEU . . . . . 0.581 HD21 HG11 ' C' ' 182' ' ' VAL . 6.1 tt -68.7 -52.02 35.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 2.02 110.598 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.05 -2.43 18.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 1.8200000000000001 110.935 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.407 ' HG ' ' HE2' ' C' ' 11' ' ' TYR . 11.6 t -96.68 -46.72 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.39 0.614 . . . . 1.3500000000000001 110.862 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.52 -39.52 74.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.158 -0.928 . . . . 0.65000000000000002 112.134 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.674 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 45.2 tp -56.57 -54.31 54.94 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 121.031 -0.268 . . . . 1.4199999999999999 111.504 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.2 Cg_exo -54.76 -41.35 78.89 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.902 1.734 . . . . 0.63 111.408 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.96 -42.43 94.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.188 -0.46 . . . . 1.49 110.378 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -70.78 -22.95 62.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.078 -0.51 . . . . 1.7 110.277 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 209' ' ' SER . . . . . 0.47 ' HB2' HD12 ' C' ' 175' ' ' LEU . 47.6 t -87.0 -14.39 41.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 1.25 110.364 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.741 H192 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 29.3 m -79.56 -30.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 1.6100000000000001 111.173 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.7 61.18 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.86 -0.686 . . . . 0.81999999999999995 112.634 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -64.9 -22.86 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.615 0.245 . . . . 3.0800000000000001 111.312 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.3 m -63.3 -60.3 3.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 1.1499999999999999 110.621 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.9 -24.78 63.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 2.5600000000000001 110.619 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.69 -55.22 32.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.086 -0.507 . . . . 1.29 110.842 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.35 -32.3 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 2.3900000000000001 111.073 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.27 -52.0 66.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 2.0299999999999998 111.315 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 219' ' ' HIS . . . . . 0.451 ' O ' ' HG3' ' C' ' 222' ' ' ARG . 68.8 m80 -80.01 -19.47 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.331 -0.395 . . . . 3.21 111.207 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.55 75.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.041 -0.599 . . . . 1.3600000000000001 113.372 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 60.9 tp -72.51 -58.68 3.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.798 0.299 . . . . 2.8999999999999999 111.216 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 222' ' ' ARG . . . . . 0.483 ' HB3' HD23 ' C' ' 224' ' ' LEU . 97.7 mtt180 55.44 89.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 4.8899999999999997 110.967 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -59.65 -73.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.008 -0.542 . . . . 4.2300000000000004 110.882 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' C' ' 222' ' ' ARG . 3.7 mm? 55.59 82.29 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 6.1200000000000001 111.132 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 56.57 89.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 4.5499999999999998 111.029 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.68 -50.41 65.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 6.7800000000000002 111.074 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 43.9 t 54.17 80.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 5.4000000000000004 111.028 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -104.62 136.09 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 8.3300000000000001 110.69 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 7.9100000000000001 110.862 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.775 0.321 . . . . 5.1100000000000003 110.87 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.69 142.2 51.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 5.04 110.71 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.1 pt? -110.13 134.47 52.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 5.5800000000000001 110.804 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -166.53 -19.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 5.0199999999999996 110.683 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.2 p -105.06 125.59 51.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 2.4500000000000002 110.822 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -124.62 12.65 8.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 2.4199999999999999 111.054 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.82 -43.55 83.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 2.0899999999999999 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 22.1 m80 -68.32 -24.14 64.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.372 . . . . 1.1599999999999999 110.675 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.471 ' O ' HG12 ' A' ' 12' ' ' VAL . 63.7 t-105 -72.31 -51.71 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.79000000000000004 110.146 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.52 -21.09 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.277 0.56 . . . . 2.0800000000000001 110.005 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.6 OUTLIER -63.96 -63.18 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.578 -0.737 . . . . 1.28 110.927 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 9' ' ' TRP . 10.5 p -52.7 -33.75 18.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 111.587 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.87 98.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.63 111.107 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.13 -22.55 78.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.817 -0.706 . . . . 0.55000000000000004 112.729 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 86.8 mmm -76.08 -44.36 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.785 0.326 . . . . 1.03 111.041 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.9 p -58.29 -49.87 75.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 1.3 111.061 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -63.5 -29.4 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 1.3100000000000001 110.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.48 -57.87 17.22 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.941 -0.647 . . . . 0.77000000000000002 112.751 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.95 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.80000000000000004 110.956 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -67.19 -36.78 82.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.958 -0.565 . . . . 1.8100000000000001 110.827 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -61.67 -49.3 77.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 1.8799999999999999 110.818 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.405 ' O ' ' OG ' ' A' ' 26' ' ' SER . 96.8 m-85 -68.74 -22.06 64.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 4.4500000000000002 111.026 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.412 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 87.5 t90 -68.21 -32.62 72.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 3.6899999999999999 110.654 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 m -78.74 -35.69 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 1.5700000000000001 110.808 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 tp -83.72 -1.36 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 1.95 110.756 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 23' ' ' TRP . 1.2 m -61.85 -26.21 67.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.453 . . . . 1.3799999999999999 110.871 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -47.76 -35.91 10.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.159 0.504 . . . . 4.0700000000000003 109.876 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.495 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.6 p-10 -164.61 131.72 2.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 2.7200000000000002 110.034 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 39.6 Cg_endo -95.86 -176.35 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.097 2.531 . . . . 1.9099999999999999 112.474 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.21 28.51 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 4.7599999999999998 111.022 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.45 -28.5 6.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.8 -0.714 . . . . 1.99 112.795 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.548 HG22 HD22 ' A' ' 221' ' ' LEU . 71.4 t -83.62 123.21 76.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.511 0.196 . . . . 2.7000000000000002 111.316 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 34.2 Cg_exo -58.92 161.63 15.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.442 2.095 . . . . 1.79 112.003 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -17.94 37.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 4.1200000000000001 112.079 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' HE2' ' HD2' ' A' ' 33' ' ' PRO . 2.6 p90 -49.71 -36.85 26.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.867 0.365 . . . . 2.9300000000000002 110.997 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.81 -36.36 62.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.322 -0.399 . . . . 2.8799999999999999 110.668 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.25 -37.67 86.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 4.6600000000000001 110.382 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' B' ' 100' ' ' THR . 40.8 tp -60.77 -57.8 11.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.549 . . . . 1.45 111.241 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.06 -44.62 97.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 1.78 111.488 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -10.17 54.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.63 111.823 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.414 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 28.1 ttt -89.44 -33.34 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 1.48 111.067 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -75.38 -29.25 59.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 3.5 112.241 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 67.0 mt -64.08 -49.99 71.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.519 0.563 . . . . 1.0800000000000001 112.519 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 75.1 Cg_endo -74.4 -38.07 2.15 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.646 2.231 . . . . 0.53000000000000003 114.324 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 46' ' ' TRP . 45.1 pt -61.88 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.28 0.474 . . . . 1.6799999999999999 112.28 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.619 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -70.27 -58.76 3.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 1.8300000000000001 110.869 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.4 p -51.29 -44.16 61.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 1.0900000000000001 111.091 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.0 -53.25 27.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.40999999999999998 112.866 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.1 mt -57.44 -34.59 69.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.98999999999999999 110.907 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.69 96.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.47999999999999998 111.342 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 69.2 m-85 -61.75 -49.37 76.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 1.8700000000000001 110.787 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.469 ' HB2' HG11 ' A' ' 12' ' ' VAL . 34.4 ttp -50.48 -34.93 26.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 1.49 110.504 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.88 89.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.58999999999999997 111.301 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -55.59 -33.9 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 0.48999999999999999 110.413 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -72.99 -40.71 65.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.59999999999999998 111.113 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.63 -15.59 19.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 1.3100000000000001 110.968 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t70 63.34 39.43 9.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.724 -0.671 . . . . 1.9099999999999999 110.991 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.45 150.27 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 1.6200000000000001 110.874 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.9 -16.52 46.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.84 -0.695 . . . . 1.04 112.161 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -99.38 144.17 28.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.33 . . . . 2.6800000000000002 110.734 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.54 138.63 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 1.98 111.038 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -92.35 92.81 8.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 2.1800000000000002 110.865 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.5 121.01 33.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 1.5700000000000001 111.069 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.28 28.15 16.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 1.79 111.135 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.57 28.94 45.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 1.48 112.436 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -132.84 119.46 20.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 2.3199999999999998 110.735 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.0 pt -80.08 136.32 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.4399999999999999 110.635 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.88 143.91 37.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.81999999999999995 111.464 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 12.4 m-70 -86.59 53.73 2.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.315 0.579 . . . . 0.90000000000000002 110.695 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 74' ' ' ILE . 58.9 t80 -56.25 -59.18 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 1.8300000000000001 111.893 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.54 66.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.62 111.858 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HG3' ' HZ3' ' A' ' 76' ' ' TRP . 12.4 tpp180 -58.82 -52.8 64.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.585 -0.279 . . . . 2.3399999999999999 111.726 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.518 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 10.1 p90 -77.53 -17.94 57.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.713 -0.395 . . . . 3.4900000000000002 111.088 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.0 mm -55.5 -41.59 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 109.36 -0.608 . . . . 1.3700000000000001 109.36 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.58 -20.62 66.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.365 -0.834 . . . . 1.3100000000000001 110.026 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.518 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -78.88 -21.85 46.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.48 111.13 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 2.3 mtp -90.07 -6.17 55.79 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.12 -0.491 . . . . 1.46 111.468 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.44 HG21 ' CE3' ' A' ' 46' ' ' TRP . 32.8 m -114.81 -31.18 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.507 0.558 . . . . 1.1200000000000001 112.507 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 m -89.95 -58.45 2.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.157 0.429 . . . . 1.1000000000000001 112.157 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -51.92 -51.31 72.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.903 0.705 . . . . 0.59999999999999998 112.903 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 53.7 Cg_exo -53.91 -55.79 3.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.801 1.668 . . . . 0.73999999999999999 112.288 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 HD12 ' A' ' 85' ' ' LEU . 4.2 mm? -61.42 -27.11 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 1.01 110.514 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.432 ' HG ' ' H11' ' A' ' 210' ' ' LYR . 0.2 OUTLIER -67.73 -36.06 79.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.334 0.588 . . . . 1.48 109.831 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 105' ' ' LEU . 6.9 tt -84.4 -20.32 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.289 -0.869 . . . . 1.3799999999999999 110.86 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 82' ' ' LEU . 79.4 mt -80.15 -39.85 28.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 111.043 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.413 ' HA ' ' HD1' ' A' ' 89' ' ' TRP . 48.1 t -59.33 -20.61 56.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 1.23 110.929 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.12 -32.33 63.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.88 110.968 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -72.42 -38.52 68.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 1.3899999999999999 111.197 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.413 ' HD1' ' HA ' ' A' ' 86' ' ' SER . 96.9 m95 -62.37 -49.84 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.424 . . . . 2.3199999999999998 111.17 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -66.1 -23.5 66.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 1.46 111.213 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 -3.19 59.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 1.24 111.348 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.7 mtt -127.98 110.14 12.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 2.0699999999999998 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -87.67 -26.29 23.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 3.5299999999999998 110.771 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -144.76 139.4 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 4.0800000000000001 110.74 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.53 146.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.305 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -129.69 -70.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 4.5199999999999996 110.749 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -144.83 87.1 1.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 3.75 110.951 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.42 124.15 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.952 0.406 . . . . 3.5299999999999998 111.006 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -131.43 20.02 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 4.9100000000000001 110.996 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.562 HG23 HD23 ' C' ' 38' ' ' LEU . 90.5 m -80.53 -47.85 13.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 1.98 111.357 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.66 -57.96 3.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 1.8300000000000001 111.223 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.2 pt -59.61 -24.06 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 1.79 111.219 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.91 -38.92 10.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.896 -0.668 . . . . 0.62 112.546 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.4 -39.8 85.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 1.5800000000000001 110.855 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 84' ' ' LEU . 71.3 mt -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.97999999999999998 110.915 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 ttt -57.41 -35.45 70.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.869 -0.605 . . . . 1.48 110.895 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.406 ' HG ' ' HD1' ' C' ' 42' ' ' PHE . 11.8 t -63.61 -57.24 10.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.356 -0.384 . . . . 1.1299999999999999 111.152 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 142' ' ' ILE . 73.2 p -57.36 -19.48 23.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 1.48 111.681 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 23.1 tp60 -77.54 -52.53 8.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.794 0.33 . . . . 2.7000000000000002 111.081 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.653 HG22 ' HE1' ' C' ' 46' ' ' TRP . 63.6 mt -52.19 -36.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 1.54 111.856 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.02 -37.67 53.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 121.054 -0.258 . . . . 1.28 111.222 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 108' ' ' THR . 53.9 t -68.61 -28.47 40.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.906 0.384 . . . . 0.42999999999999999 110.847 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.94 -49.01 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 1.74 110.658 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 54.7 m -52.41 -37.93 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.63 110.445 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 61.5 m -60.3 -56.86 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 1.0900000000000001 110.183 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.84 -11.63 58.21 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.887 -0.673 . . . . 0.41999999999999998 112.18 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 tt -74.65 -54.29 7.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.946 0.403 . . . . 1.3799999999999999 110.523 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.73 -24.01 7.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.033 -0.53 . . . . 1.6200000000000001 111.525 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.73 -40.76 66.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.39000000000000001 110.812 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.5 -19.52 42.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 2.02 110.657 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.73 20.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.76000000000000001 110.752 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.4 p -85.63 119.01 25.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 1.46 110.862 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.534 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 10.2 pt-20 -78.52 -23.29 46.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 3.3500000000000001 110.808 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.7 mtp180 -111.3 149.04 31.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 2.9199999999999999 110.657 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.78 -9.42 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 2.77 110.893 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -90.16 -49.38 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 3.77 111.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -58.39 -28.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.456 . . . . 1.1599999999999999 111.34 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -60.53 -32.45 71.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 2.04 110.986 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.35 -33.04 74.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 2.6400000000000001 111.005 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 127' ' ' VAL . 3.1 mm? -72.95 -50.3 24.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 1.8999999999999999 110.807 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -67.34 -23.77 65.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 1.3999999999999999 110.801 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -70.62 -52.96 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.28 111.069 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 130' ' ' LEU . 47.0 pt -57.41 -29.2 32.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 2.1600000000000001 110.902 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.1 t -67.26 -40.42 86.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 1.6899999999999999 110.805 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -47.49 63.41 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.813 -0.708 . . . . 0.52000000000000002 112.694 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.31 -29.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 1.02 111.173 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 40.7 t -57.86 -51.8 68.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.226 -0.443 . . . . 1.0800000000000001 110.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 142' ' ' ILE . . . -65.49 -28.33 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.62 110.953 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -68.99 -23.83 64.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 1.8400000000000001 111.031 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.53 -53.02 7.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.386 . . . . 1.6899999999999999 111.599 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.7 pt -60.03 -37.93 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.81000000000000005 111.784 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 108' ' ' THR . 10.5 tt -67.84 -44.91 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.643 0.258 . . . . 2.3700000000000001 111.295 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.455 ' N ' HG23 ' A' ' 142' ' ' ILE . 41.6 tp -55.74 -49.12 73.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.97999999999999998 110.904 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -68.01 -26.32 65.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 3.27 110.759 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.94 -17.13 68.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.877 -0.678 . . . . 1.25 113.013 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.5 pt -104.48 -8.23 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.339 . . . . 2.1200000000000001 111.646 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -86.14 -23.22 26.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.419 -0.355 . . . . 1.6599999999999999 111.734 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.657 ' HB2' ' HD3' ' A' ' 149' ' ' PRO . 32.1 m120 -81.6 -51.51 0.84 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.46 -0.337 . . . . 99.989999999999995 111.759 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.657 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 25.0 Cg_exo -63.02 -3.6 4.99 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.001 1.8 . . . . 2.6000000000000001 112.201 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.44 HD11 ' HA ' ' A' ' 166' ' ' ASP . 64.3 tp -61.65 -55.71 27.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 4.6100000000000003 111.447 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -141.62 -16.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.511 -0.313 . . . . 8.3599999999999994 111.387 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 148' ' ' ASN . . . -68.88 -46.65 67.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.512 -0.313 . . . . 2.75 111.335 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -83.45 -39.54 20.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 5.6799999999999997 110.977 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 65.4 p -76.57 5.31 7.62 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.347 -0.388 . . . . 3.21 111.27 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -61.31 -37.12 82.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.277 -0.42 . . . . 6.8700000000000001 110.685 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 72.7 p -95.53 -16.68 22.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 4.5599999999999996 111.071 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -83.17 -74.67 0.35 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 3.5600000000000001 110.957 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.9 m -147.36 117.29 7.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.268 -0.424 . . . . 2.79 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.1 m -77.78 -31.16 51.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.029 -0.532 . . . . 2.5899999999999999 111.044 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.67 -55.35 20.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 3.4700000000000002 110.968 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.61 -20.11 62.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.176 -0.465 . . . . 2.5800000000000001 110.69 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.13 -54.07 16.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.048 -0.524 . . . . 1.78 110.997 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -56.6 -28.3 60.09 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.068 0.461 . . . . 2.6299999999999999 110.389 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.94 -52.74 58.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 2.3399999999999999 110.672 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.29 -21.66 60.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 2.77 111.026 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.44 ' HA ' HD11 ' A' ' 150' ' ' LEU . 24.2 t70 -64.11 -41.44 97.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 2.04 111.359 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -82.51 -24.14 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 2.77 110.676 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.85 -35.81 57.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 1.8899999999999999 111.387 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 15.0 p -73.34 -21.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 1.6399999999999999 111.178 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.7 m -60.03 -57.93 10.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.24 110.915 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.92 -26.01 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.004 -0.544 . . . . 2.9700000000000002 110.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 63.9 t80 -72.27 -31.36 65.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 1.48 111.116 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 177' ' ' ILE . 97.1 m -74.48 -50.88 16.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 1.55 111.518 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.66 -34.11 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.379 . . . . 1.52 111.705 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.587 HD21 ' H42' ' A' ' 210' ' ' LYR . 47.5 tp -75.75 -53.99 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 1.8500000000000001 111.362 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.97 -33.81 62.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.62 111.509 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 173' ' ' THR . 13.3 tt -87.64 -21.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 1.3500000000000001 110.749 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.37 -57.34 20.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.58999999999999997 113.226 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.579 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 74.3 m-85 -53.5 -54.17 48.6 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 111.668 0.247 . . . . 1.45 111.668 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.1 Cg_exo -46.28 -37.05 18.26 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.185 1.923 . . . . 0.55000000000000004 112.276 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 177' ' ' ILE . 91.4 mt -59.25 -61.01 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.235 -0.438 . . . . 1.4199999999999999 111.213 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 179' ' ' TYR . 23.2 m -62.44 -24.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.78000000000000003 111.18 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -66.93 -37.7 84.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.93999999999999995 111.214 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 185' ' ' ILE . 73.1 mt -53.15 -79.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.365 -0.38 . . . . 1.4299999999999999 111.111 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.566 HG23 HG22 ' A' ' 184' ' ' ILE . 2.8 pp -111.6 173.99 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 2.02 110.926 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.519 ' HA2' ' HA3' ' A' ' 191' ' ' GLY . . . 88.41 -152.1 23.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.574 -0.822 . . . . 1.79 112.377 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.02 155.88 52.9 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.566 2.177 . . . . 3.1000000000000001 112.138 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m 56.39 17.47 2.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.256 -0.429 . . . . 2.7400000000000002 110.411 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -165.02 29.98 0.22 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.03 -0.605 . . . . 3.4300000000000002 112.598 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 76.9 t80 60.5 96.36 0.03 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.812 0.339 . . . . 6.5 111.161 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.519 ' HA3' ' HA2' ' A' ' 186' ' ' GLY . . . -143.32 170.56 25.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.94 -0.648 . . . . 3.29 112.539 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -58.63 -20.6 49.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.962 0.411 . . . . 6.1600000000000001 110.607 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.1 pt -117.45 140.99 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.876 -0.602 . . . . 2.4199999999999999 111.146 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -154.83 25.31 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.138 -0.483 . . . . 4.29 110.891 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -77.59 -161.99 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 5.1500000000000004 110.861 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.2 p -60.97 -22.0 64.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 2.4500000000000002 111.089 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 77.1 mt -55.94 -26.11 20.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.176 -0.465 . . . . 2.48 111.132 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.71 -60.96 2.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 2.1800000000000002 110.992 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.4 p -75.82 -34.85 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.107 -0.497 . . . . 1.49 111.253 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.22 -26.63 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 1.77 110.975 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 65.9 tp -81.18 -48.58 11.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.194 -0.457 . . . . 1.4199999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -69.69 -11.25 60.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 1.78 111.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 97.5 m -96.74 -45.38 6.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.11 0.481 . . . . 1.3 110.975 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.9 tp -69.94 -34.8 73.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.763 -0.653 . . . . 0.66000000000000003 112.244 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.653 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 53.6 tp -61.32 -53.57 61.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.775 0.287 . . . . 1.6299999999999999 111.775 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.6 Cg_exo -55.17 -47.74 24.7 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.012 1.808 . . . . 0.64000000000000001 111.95 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.89 -31.94 73.29 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.249 -0.432 . . . . 1.3600000000000001 110.843 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -66.67 -31.05 71.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 1.54 110.566 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 88.7 p -96.84 -16.03 20.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 1.2 110.349 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.728 H183 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.8 m -88.68 -36.82 9.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.281 -0.418 . . . . 1.6399999999999999 111.364 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.48 98.85 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.567 -0.825 . . . . 0.79000000000000004 112.366 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.59 -28.15 62.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 1.6100000000000001 110.818 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.4 m -58.23 -61.71 2.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 1.1499999999999999 110.999 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -68.25 -20.39 64.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 3.3399999999999999 110.96 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -70.07 -49.7 48.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.984 -0.553 . . . . 1.1899999999999999 111.145 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.15 -40.51 96.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 2.23 111.051 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.462 HD23 HG21 ' A' ' 32' ' ' VAL . 96.9 mt -58.95 -41.75 88.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 2.4700000000000002 111.112 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -79.12 -20.51 48.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 1.6200000000000001 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.01 -19.49 79.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.937 -0.649 . . . . 1.4099999999999999 113.083 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.548 HD22 HG22 ' A' ' 32' ' ' VAL . 41.6 tp -65.56 -58.74 5.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 2.5800000000000001 111.001 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 54.63 79.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 4.9299999999999997 110.934 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -62.92 124.85 22.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.099 -0.501 . . . . 4.6299999999999999 110.929 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 33.4 tp -159.9 -7.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 6.4699999999999998 110.947 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -92.8 -74.54 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 5.0700000000000003 110.873 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -126.74 178.17 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 6.5300000000000002 110.714 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 82.3 p -151.33 120.52 6.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 5.2199999999999998 110.98 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -102.21 144.46 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 8.3599999999999994 110.897 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 7.96 110.977 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.811 0.339 . . . . 6.1699999999999999 111.116 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 59.22 97.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.042 -0.526 . . . . 4.8200000000000003 111.198 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 55.3 mt -98.59 96.83 8.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.13 -0.486 . . . . 5.5999999999999996 110.974 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -140.99 -42.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 4.7999999999999998 111.077 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 48.3 t -80.23 128.98 34.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.3700000000000001 111.001 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.6 mt -128.71 1.28 5.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.091 -0.504 . . . . 2.0699999999999998 110.916 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.29 -27.99 68.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 2.1000000000000001 110.873 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 40.6 m80 -76.96 -25.71 53.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.024 -0.535 . . . . 1.0700000000000001 110.493 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -76.22 -45.23 33.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.48 110.405 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 43.6 mm -67.8 -22.54 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.129 0.49 . . . . 2.02 110.296 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' TYR . . . . . 0.422 ' O ' ' HG2' ' B' ' 15' ' ' MET . 29.4 t80 -66.66 -60.69 2.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.734 -0.667 . . . . 0.92000000000000004 110.969 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.39 -35.98 20.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.156 -0.474 . . . . 0.93999999999999995 111.345 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.77 90.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.406 -0.361 . . . . 0.55000000000000004 111.248 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.91 -23.24 78.25 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.774 -0.727 . . . . 0.47999999999999998 112.571 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 80.4 mmm -73.93 -40.58 63.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.558 0.218 . . . . 0.84999999999999998 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p -62.32 -51.46 67.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 1.3400000000000001 111.087 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.8 pp -62.5 -25.31 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.399 -0.364 . . . . 1.55 111.156 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.25 -59.03 11.08 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.735 -0.745 . . . . 0.69999999999999996 112.474 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.21 68.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.872 0.367 . . . . 0.81000000000000005 111.351 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' B' ' 17' ' ' ILE . 79.0 mt -68.17 -36.68 80.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 2.2599999999999998 111.177 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -61.59 -50.07 74.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 1.78 110.604 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.478 ' O ' ' OG ' ' B' ' 26' ' ' SER . 99.4 m-85 -66.44 -23.18 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 4.5800000000000001 110.637 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -68.48 -30.26 69.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 3.3500000000000001 110.791 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 91.6 p -85.03 -29.79 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 1.5800000000000001 110.64 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.49 -1.34 57.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.55 . . . . 1.8400000000000001 110.489 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 1.8 m -63.86 -26.2 68.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 1.3700000000000001 110.889 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -49.66 -32.6 13.49 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.132 0.491 . . . . 4.9800000000000004 109.924 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 6.2 p30 -164.61 131.62 2.36 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.774 . . . . 2.1400000000000001 110.158 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 51.9 Cg_endo -98.0 175.89 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.275 2.65 . . . . 1.8200000000000001 112.882 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.24 35.19 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 5.1900000000000004 110.866 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.46 -41.94 1.92 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.744 -0.741 . . . . 2.2000000000000002 112.713 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.494 ' HA ' HD22 ' B' ' 221' ' ' LEU . 20.8 m -71.09 136.22 84.78 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.57 0.224 . . . . 3.6499999999999999 111.102 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 32' ' ' VAL . 8.1 Cg_exo -73.37 166.25 30.39 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.877 2.385 . . . . 2.6699999999999999 112.763 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -58.24 -20.09 39.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 4.8799999999999999 113.05 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.451 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 3.2 p90 -60.04 -33.54 72.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.952 0.406 . . . . 1.8700000000000001 110.974 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -69.77 -45.61 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 2.6800000000000002 110.904 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 2.9199999999999999 110.944 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.91 -61.68 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 1.6399999999999999 110.864 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.81 -36.24 77.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 1.6000000000000001 111.066 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.43 -12.69 61.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.68999999999999995 111.457 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.423 ' O ' HG12 ' B' ' 45' ' ' ILE . 60.3 ttp -88.73 -36.19 16.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.485 -0.325 . . . . 2.5800000000000001 111.442 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -71.64 -34.01 69.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.34 0.496 . . . . 3.3900000000000001 112.34 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 88.0 mt -56.46 -52.99 68.94 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.59 0.589 . . . . 0.40999999999999998 112.59 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 61.6 Cg_endo -72.03 -36.6 5.7 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.408 2.072 . . . . 0.48999999999999999 113.704 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.423 HG12 ' O ' ' B' ' 41' ' ' MET . 28.5 mm -56.45 -62.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.81 0.3 . . . . 1.29 111.81 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.633 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.3 OUTLIER -60.54 -57.27 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.418 -0.356 . . . . 1.3999999999999999 111.486 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -51.18 -37.2 45.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 1.3799999999999999 111.518 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.56 73.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.37 112.394 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.19 -32.42 73.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 1.29 110.886 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.02 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.581 . . . . 0.44 111.073 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 19.5 m-85 -61.09 -44.33 97.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.5 110.876 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -50.96 -34.17 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.074 0.464 . . . . 1.4099999999999999 110.167 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.36 81.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.598 -0.728 . . . . 0.55000000000000004 110.792 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 49.1 mtt -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.524 . . . . 0.5 110.24 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -62.94 -49.03 76.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.866 -0.606 . . . . 0.54000000000000004 110.342 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.24 -6.69 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.968 -0.56 . . . . 1.3 110.715 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 61.98 39.63 13.16 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.778 -0.647 . . . . 2.2400000000000002 111.341 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.415 ' HG3' ' HE1' ' C' ' 131' ' ' TRP . 13.9 mm100 -100.14 173.77 6.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 1.77 111.013 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 70.57 27.23 72.85 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.858 -0.687 . . . . 1.0600000000000001 112.428 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.75 174.19 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 2.6600000000000001 110.697 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.69 140.74 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.8899999999999999 111.361 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -101.02 84.52 2.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.286 -0.416 . . . . 2.4100000000000001 110.565 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.17 109.8 22.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 1.5600000000000001 111.353 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.22 24.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 1.8200000000000001 111.534 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 11.72 82.04 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.692 -0.766 . . . . 1.51 112.661 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -115.23 129.15 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 2.4500000000000002 110.778 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.07 115.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 1.79 111.237 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.64 142.27 27.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.81999999999999995 111.349 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 25.3 m-70 -92.43 59.14 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.119 -0.491 . . . . 1.05 111.057 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.41 -49.91 73.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 1.8700000000000001 110.925 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.474 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -57.31 -27.76 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.60999999999999999 111.008 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 4.9 tpp180 -63.05 -49.22 75.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.878 -0.601 . . . . 2.3900000000000001 110.775 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.593 ' HE2' H181 ' B' ' 210' ' ' LYR . 0.3 OUTLIER -71.19 -18.06 62.5 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.921 -0.312 . . . . 3.6699999999999999 111.443 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 36.3 mm -65.41 -40.99 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.063 0.458 . . . . 1.6599999999999999 109.842 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.545 ' O ' HG22 ' B' ' 79' ' ' THR . 13.5 t70 -66.37 -14.39 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.657 -0.701 . . . . 1.4099999999999999 110.238 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -85.54 -26.14 26.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.856 -0.611 . . . . 1.1599999999999999 111.173 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.604 ' HG2' ' HB ' ' B' ' 113' ' ' ILE . 19.2 mtp -91.82 4.23 53.32 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 1.53 111.33 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 -29.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.414 0.524 . . . . 0.89000000000000001 112.414 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.545 HG22 ' O ' ' B' ' 75' ' ' ASP . 12.4 t -102.83 -43.71 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.102 0.408 . . . . 1.24 112.102 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 26.0 m -58.9 -50.84 85.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.221 0.452 . . . . 0.57999999999999996 112.221 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.559 ' HA ' ' HG2' ' B' ' 109' ' ' GLN . 20.3 Cg_endo -60.62 -43.78 30.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.86 1.707 . . . . 0.66000000000000003 111.898 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.481 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -73.46 -12.7 60.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 1.0600000000000001 110.692 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' B' ' 79' ' ' THR . 0.2 OUTLIER -75.63 -43.99 44.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 1.22 110.782 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.469 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.3 pp -80.18 -23.51 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 1.53 110.78 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.481 HD12 HD13 ' B' ' 82' ' ' LEU . 50.7 mt -68.18 -39.09 82.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 1.5800000000000001 110.444 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 46.6 t -61.81 -30.08 70.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.3899999999999999 110.713 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 69.5 mt -75.73 -26.13 57.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 1.1499999999999999 110.601 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -70.49 -41.26 72.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 1.5700000000000001 110.823 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -70.12 -35.96 74.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 110.593 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 61.3 m -64.99 -33.28 75.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.4199999999999999 110.945 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.95 -34.01 39.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.1799999999999999 111.15 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.8 mmm -95.07 100.93 12.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 1.8799999999999999 111.168 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -78.0 -33.47 51.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.115 -0.493 . . . . 3.4199999999999999 110.887 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -137.82 135.06 35.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.256 -0.429 . . . . 4.0599999999999996 111.418 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 47.0 pt -138.1 143.23 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 2.0899999999999999 110.855 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -130.15 -56.96 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 3.8500000000000001 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.13 73.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 4.8200000000000003 111.122 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.41 134.66 20.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 3.7999999999999998 110.852 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.84 22.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 5.1699999999999999 110.609 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.475 ' HA ' HD22 ' A' ' 38' ' ' LEU . 90.7 m -80.92 -49.83 10.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 2.02 110.988 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.46 -34.92 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 2.0899999999999999 110.925 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.73 -33.73 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.927 0.394 . . . . 1.8799999999999999 110.798 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.54 -15.19 69.04 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.771 -0.728 . . . . 0.56000000000000005 112.545 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -83.38 -42.79 16.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.785 0.326 . . . . 1.78 110.94 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.01 -45.43 60.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 1.03 110.946 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' MET . . . . . 0.433 ' O ' HG13 ' B' ' 110' ' ' ILE . 25.1 ttt -63.08 -39.62 95.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.727 -0.67 . . . . 1.6699999999999999 111.269 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -64.14 -54.18 37.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 1.51 111.541 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.52 ' HB ' HD13 ' B' ' 142' ' ' ILE . 59.1 p -58.68 -21.45 54.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 1.1799999999999999 111.615 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.559 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 48.7 tp60 -79.8 -35.89 37.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.44 -0.345 . . . . 2.1699999999999999 111.384 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.619 HG22 ' HE1' ' A' ' 46' ' ' TRP . 68.5 mt -67.34 -34.87 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.693 0.282 . . . . 1.3500000000000001 111.512 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 m -73.61 -35.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.584 -0.28 . . . . 1.3400000000000001 111.506 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 108' ' ' THR . 70.9 t -70.2 -41.42 78.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.616 -0.265 . . . . 0.42999999999999999 111.68 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 77' ' ' MET . 26.7 pt -70.07 -31.53 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.64 -0.254 . . . . 1.6000000000000001 111.419 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -60.94 -56.95 15.09 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.912 0.387 . . . . 0.85999999999999999 110.526 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.5 p -55.97 -29.03 59.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.95 -0.568 . . . . 0.94999999999999996 110.172 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.02 -47.25 84.48 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.85 -0.691 . . . . 0.46000000000000002 111.951 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.456 HD21 ' SD ' ' B' ' 77' ' ' MET . 56.9 mt -48.89 -58.39 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.155 0.502 . . . . 1.75 110.636 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.494 HD13 HD12 ' B' ' 121' ' ' LEU . 50.3 mm -67.56 -31.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.605 -0.725 . . . . 1.78 111.722 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.53 -40.73 62.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.897 0.379 . . . . 0.38 111.178 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.4 -17.54 30.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 1.97 110.794 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.494 HD12 HD13 ' B' ' 118' ' ' ILE . 83.3 mt -84.84 13.96 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.76000000000000001 111.059 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 56.3 m -76.84 126.47 31.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 1.47 110.781 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 -21.92 27.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 2.5 110.81 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.71 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 38.4 ttm180 -116.66 137.32 52.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 2.73 110.806 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.08 -11.56 60.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 2.2000000000000002 111.433 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.71 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 83.1 t90 -87.66 -51.62 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 3.3999999999999999 110.941 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' B' ' 124' ' ' ARG . 14.9 p -61.03 -26.05 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 1.23 110.945 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -67.54 -24.49 65.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 3.04 110.882 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.66 -35.12 76.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 4.1399999999999997 110.766 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.415 ' N ' HD12 ' B' ' 130' ' ' LEU . 7.1 mp -68.78 -50.47 50.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.333 -0.394 . . . . 1.6499999999999999 110.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.76 -35.63 75.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.77000000000000002 111.419 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.74 -51.65 68.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 1.46 111.179 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.8 mm -53.93 -34.09 25.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.251 -0.431 . . . . 1.6299999999999999 111.101 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.73 -41.15 88.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 1.4199999999999999 111.133 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.98 85.21 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.745 -0.74 . . . . 0.48999999999999999 112.654 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.3 -28.75 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.808 0.337 . . . . 1.3 111.28 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 50.4 t -58.2 -49.65 76.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.017 0.437 . . . . 1.3 110.603 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.07 -47.96 80.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.62 110.785 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.27 -24.19 26.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 1.74 111.056 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -59.2 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.76 110.993 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 pt -65.68 -33.74 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.398 -0.365 . . . . 0.68999999999999995 111.771 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.52 HD13 ' HB ' ' B' ' 108' ' ' THR . 77.4 mt -69.05 -37.12 76.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.47 -0.332 . . . . 1.76 111.313 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.3 -48.59 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.373 . . . . 1.0600000000000001 110.866 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -68.26 -22.74 64.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 4.1200000000000001 110.808 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -18.99 62.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.905 -0.664 . . . . 1.26 112.652 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -106.67 -10.24 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.971 0.415 . . . . 1.98 110.938 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -78.85 -21.45 47.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 1.4199999999999999 111.493 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.63 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 32.1 m120 -84.37 -50.72 0.6 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 111.896 0.332 . . . . 99.989999999999995 111.896 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 32.3 Cg_exo -58.78 -6.23 3.23 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.09 1.86 . . . . 2.6499999999999999 112.371 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' B' ' 166' ' ' ASP . 55.1 tp -57.92 -46.29 85.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 4.3899999999999997 111.434 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' B' ' 155' ' ' ARG . 14.3 ptp180 -156.32 -1.21 0.13 Allowed 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.755 0.28 . . . . 7.9000000000000004 111.755 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.04 -41.92 18.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.517 -0.311 . . . . 2.77 111.523 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.19 -41.15 14.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 6.29 111.389 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 8.8 t -78.82 6.52 8.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 3.1000000000000001 111.625 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' B' ' 151' ' ' ARG . 30.3 tpt180 -65.63 -19.34 65.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.848 0.356 . . . . 6.4299999999999997 110.708 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 74.5 p -107.76 -12.39 15.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 4.5700000000000003 111.204 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -95.25 -71.88 0.65 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 3.8300000000000001 110.983 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 25.9 m -141.38 117.53 10.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 3.0699999999999998 111.304 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -77.91 -36.79 49.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 3.4300000000000002 110.926 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.36 -51.33 69.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.119 -0.492 . . . . 3.9199999999999999 111.181 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.81 -32.15 69.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 2.7000000000000002 110.916 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.87 82.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.8300000000000001 111.462 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -68.55 -45.35 72.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.842 0.353 . . . . 2.6299999999999999 110.914 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 41.8 mt -59.41 -43.44 93.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 2.4300000000000002 110.875 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.57 -22.78 60.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.79 -0.641 . . . . 2.5800000000000001 111.078 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' B' ' 150' ' ' LEU . 19.6 t70 -77.8 -25.44 48.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 2.0 111.071 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -84.15 -38.18 20.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.427 . . . . 3.0299999999999998 111.384 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.54 -25.74 38.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.488 -0.323 . . . . 1.1000000000000001 111.856 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.36 -26.54 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 1.75 111.069 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.2 m -54.47 -58.75 6.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.273 -0.422 . . . . 0.97999999999999998 111.132 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.39 -30.4 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 4.2999999999999998 110.459 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.9 -25.82 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.908 -0.587 . . . . 1.3899999999999999 110.889 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.407 ' O ' HG22 ' B' ' 177' ' ' ILE . 29.3 m -79.56 -53.15 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 1.1100000000000001 111.35 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 43.2 t -60.68 -27.03 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 1.51 111.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.612 HD21 ' H42' ' B' ' 210' ' ' LYR . 50.8 tp -77.61 -55.61 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 1.75 111.233 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -30.27 61.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.59999999999999998 111.267 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.427 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.6 tp -87.92 -24.71 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 1.47 110.878 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.0 -46.38 91.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.915 -0.659 . . . . 0.55000000000000004 113.146 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.492 ' O ' HG22 ' B' ' 182' ' ' VAL . 61.6 m-85 -62.2 -55.4 40.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.26 0.467 . . . . 1.6200000000000001 112.26 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 13.1 Cg_endo -56.69 -28.26 74.63 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.77 1.647 . . . . 0.64000000000000001 112.461 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.478 ' O ' HG22 ' B' ' 184' ' ' ILE . 49.1 mt -60.71 -49.91 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.053 0.454 . . . . 1.27 110.238 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.549 ' HB ' ' HA2' ' B' ' 189' ' ' GLY . 13.0 m -77.55 -23.45 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.709 -0.678 . . . . 0.68999999999999995 110.186 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -68.57 -15.22 63.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.277 -0.874 . . . . 1.1799999999999999 112.605 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.478 HG22 ' O ' ' B' ' 181' ' ' ILE . 17.1 tt -103.14 -25.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.885 0.328 . . . . 1.77 111.885 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' B' ' 190' ' ' PHE . 20.3 pt -91.06 116.54 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.177 0.436 . . . . 1.6899999999999999 112.177 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 186' ' ' GLY . . . . . 0.659 ' HA3' ' HA2' ' B' ' 191' ' ' GLY . . . 56.99 -171.19 2.75 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.839 -0.619 . . . . 1.5800000000000001 113.814 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.8 106.35 2.24 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.963 2.442 . . . . 2.5099999999999998 112.651 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 53.8 m 53.8 66.3 1.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 3.5800000000000001 111.709 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' GLY . . . . . 0.549 ' HA2' ' HB ' ' B' ' 182' ' ' VAL . . . 82.57 123.39 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.628 -0.796 . . . . 4.0300000000000002 113.24 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' B' ' 185' ' ' ILE . 79.3 m-85 62.07 148.16 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.155 0.502 . . . . 6.8899999999999997 111.843 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 191' ' ' GLY . . . . . 0.659 ' HA2' ' HA3' ' B' ' 186' ' ' GLY . . . -113.63 174.37 15.65 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.821 -0.627 . . . . 3.7000000000000002 112.349 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 54.82 18.78 2.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.984 0.421 . . . . 7.5 110.633 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.416 HD11 ' O ' ' B' ' 189' ' ' GLY . 2.7 pp -137.05 160.09 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 2.3500000000000001 110.864 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -165.58 20.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 3.8599999999999999 110.681 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -75.04 -170.57 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 5.0499999999999998 111.062 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.9 t -67.58 -15.28 63.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.348 -0.387 . . . . 2.6800000000000002 111.139 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.09 -27.7 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 2.4700000000000002 111.38 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.37 -57.5 12.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.367 -0.379 . . . . 2.5299999999999998 111.121 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 46.3 p -68.94 -37.98 79.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 1.29 111.112 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.56 -25.1 68.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 2.6200000000000001 111.254 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.9 tp -77.36 -43.62 32.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 1.6100000000000001 110.954 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.51 -9.42 58.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 1.4199999999999999 111.458 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.462 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 98.9 m -96.37 -42.16 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.137 0.494 . . . . 1.4299999999999999 110.719 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.97 -48.8 62.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 1.1200000000000001 112.143 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.651 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 53.6 tp -49.6 -52.86 46.82 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 111.738 0.273 . . . . 1.26 111.738 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -54.56 -50.71 12.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.982 1.788 . . . . 0.59999999999999998 111.904 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.5 -35.79 72.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.284 -0.416 . . . . 1.3999999999999999 110.807 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -69.88 -29.28 66.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 1.4099999999999999 110.684 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 88.6 p -94.68 -12.7 26.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 1.3200000000000001 110.822 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.755 ' H9 ' H183 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.55 -31.7 7.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 1.6899999999999999 110.852 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.88 58.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.79000000000000004 112.487 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -69.65 -23.22 63.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.666 0.269 . . . . 2.96 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.2 t -58.94 -58.28 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.887 0.375 . . . . 1.29 110.584 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -72.64 -20.42 61.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 3.1499999999999999 110.814 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.403 HD23 ' C ' ' B' ' 216' ' ' LEU . 7.3 tt -66.4 -58.37 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 1.51 110.71 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -60.09 -32.05 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.1899999999999999 110.622 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.79 -42.32 98.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.525 . . . . 1.98 111.086 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -87.39 -20.43 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 2.1699999999999999 111.134 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.87 76.86 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.911 -0.661 . . . . 1.3600000000000001 113.053 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' B' ' 32' ' ' VAL . 50.8 tp -63.5 -58.58 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.739 -0.271 . . . . 2.8999999999999999 110.976 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.462 ' HA ' ' HE ' ' B' ' 222' ' ' ARG . 3.6 mmp_? 57.61 82.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 5.6100000000000003 110.711 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -68.69 121.62 16.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.994 0.426 . . . . 4.04 110.927 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 pp -161.29 -5.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.991 -0.549 . . . . 6.2999999999999998 110.997 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.05 -65.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.515 . . . . 4.7999999999999998 110.53 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -145.12 168.45 20.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 6.3899999999999997 110.831 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 38.1 t -134.98 144.23 47.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 5.6100000000000003 110.782 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -132.06 132.33 43.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 8.1999999999999993 111.08 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 8.1699999999999999 110.739 179.781 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.669 0.271 . . . . 5.6200000000000001 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 m120 58.45 92.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.094 -0.503 . . . . 5.2800000000000002 111.192 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' LEU . . . . . 0.407 ' N ' HD12 ' C' ' 3' ' ' LEU . 8.8 mp -80.71 132.97 35.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 6.0499999999999998 110.832 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -160.98 -21.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 4.79 110.85 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 53.0 m -113.67 111.5 21.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 2.71 111.138 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.496 ' N ' HD12 ' C' ' 6' ' ' LEU . 4.9 mp -104.24 9.82 35.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.198 -0.456 . . . . 2.52 110.697 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.4 -36.99 81.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 1.9299999999999999 110.903 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 14.6 m170 -72.15 -24.09 61.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 1.26 110.649 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -73.83 -51.41 16.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.6699999999999999 110.48 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -66.77 -19.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 1.8700000000000001 110.388 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -65.53 -58.24 6.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.674 -0.694 . . . . 1.4399999999999999 110.824 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' C' ' 52' ' ' MET . 7.7 p -58.85 -35.98 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.46999999999999997 111.141 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.21 79.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.34 -0.391 . . . . 0.58999999999999997 110.993 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.9 -28.71 60.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.827 -0.702 . . . . 0.5 112.586 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -35.55 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.56 0.219 . . . . 0.68000000000000005 111.21 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 47.5 m -64.67 -50.45 67.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 1.3999999999999999 110.57 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.85 -22.33 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 1.55 110.782 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -59.66 9.47 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.016 -0.611 . . . . 0.70999999999999996 112.535 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -30.87 68.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.919 0.39 . . . . 0.77000000000000002 110.492 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.18 -33.12 74.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 1.9299999999999999 110.49 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.76 -53.29 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 1.8600000000000001 110.582 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' PHE . . . . . 0.573 ' O ' ' OG ' ' C' ' 26' ' ' SER . 72.9 m-85 -65.19 -24.5 67.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 4.1399999999999997 110.55 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' TRP . . . . . 0.452 ' HA ' ' OG ' ' C' ' 26' ' ' SER . 55.6 t90 -69.48 -27.21 65.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 3.1499999999999999 110.705 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.4 m -84.69 -34.21 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 1.95 110.657 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.26 -1.51 57.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 2.2200000000000002 110.453 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' C' ' 22' ' ' PHE . 1.4 m -60.72 -23.95 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 1.3700000000000001 110.652 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -48.76 -36.93 17.57 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.231 0.538 . . . . 5.0300000000000002 109.828 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.491 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 8.4 p30 -163.18 131.56 2.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.346 -0.843 . . . . 2.3700000000000001 110.034 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.8 Cg_endo -95.74 -177.4 0.41 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.028 2.485 . . . . 2.0499999999999998 112.374 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -97.8 37.12 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 4.5199999999999996 111.212 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.58 -15.7 31.95 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.749 -0.738 . . . . 2.1600000000000001 112.941 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.4 121.13 64.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.536 0.207 . . . . 2.5299999999999998 111.243 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.4 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 38.9 Cg_exo -56.49 165.58 4.34 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.556 2.17 . . . . 1.9299999999999999 112.509 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -62.31 -18.32 61.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.619 -0.719 . . . . 4.1200000000000001 112.417 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.4 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.1 p90 -51.72 -34.73 40.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 2.8900000000000001 111.367 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -76.27 -36.97 58.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 2.46 111.12 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -66.01 -35.14 79.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.368 -0.378 . . . . 2.7799999999999998 111.005 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.562 HD23 HG23 ' A' ' 100' ' ' THR . 1.1 tm? -63.95 -56.71 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 1.6200000000000001 110.651 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.71 -45.47 97.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 1.5900000000000001 111.528 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.89 -12.11 52.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.65000000000000002 111.695 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.406 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 26.9 ttt -89.58 -33.71 16.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.693 0.282 . . . . 1.6699999999999999 111.606 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.406 ' HD1' ' HG ' ' A' ' 107' ' ' SER . 35.2 t80 -75.71 -27.57 58.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 3.4199999999999999 111.914 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.467 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 84.8 mt -64.87 -50.63 62.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.89 0.7 . . . . 0.89000000000000001 112.89 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 72.1 Cg_endo -77.54 -33.01 2.58 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.422 2.081 . . . . 0.40999999999999998 114.059 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.486 HG23 ' N ' ' C' ' 46' ' ' TRP . 19.5 tt -62.2 -48.74 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 1.76 111.904 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.653 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -70.78 -57.97 4.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.728 0.299 . . . . 2.1600000000000001 110.727 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.5 p -51.21 -42.27 60.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 1.1699999999999999 110.908 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.68 -49.29 58.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.914 -0.66 . . . . 0.44 112.572 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' C' ' 45' ' ' ILE . 84.9 mt -55.23 -40.16 70.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 1.29 110.929 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.82 88.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.5 111.17 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 72.4 m-85 -55.55 -50.47 69.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.361 -0.381 . . . . 1.8300000000000001 110.99 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' MET . . . . . 0.516 ' HB2' HG11 ' C' ' 12' ' ' VAL . 15.6 tmm? -49.66 -37.87 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 1.47 110.388 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.67 -38.4 83.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.59999999999999998 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 55.4 mtt -54.8 -30.95 58.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.83999999999999997 110.294 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -75.93 -37.81 58.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.842 -0.617 . . . . 0.65000000000000002 110.717 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.455 HG12 ' O ' ' C' ' 52' ' ' MET . 6.6 mm -77.96 -6.4 9.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.957 -0.565 . . . . 1.55 110.99 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.56 46.21 5.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 1.54 111.331 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -111.41 171.35 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 1.79 110.963 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 73.08 24.4 75.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.93999999999999995 112.518 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -137.03 146.47 45.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 2.3599999999999999 110.966 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 141.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 1.97 111.161 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.01 87.96 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 2.4399999999999999 110.851 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.51 122.46 33.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 1.54 111.102 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.08 31.39 16.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 1.71 111.105 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 29.99 53.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.841 -0.695 . . . . 1.53 112.628 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -131.34 119.05 21.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 2.23 111.054 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 26.5 pt -81.72 128.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 111.03 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.95 140.62 38.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.78000000000000003 111.267 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -95.61 55.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 1.0800000000000001 110.834 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -63.05 -51.32 67.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 2.2999999999999998 111.053 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' C' ' 74' ' ' ILE . . . -57.28 -25.85 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.958 0.408 . . . . 0.75 110.771 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -64.37 -48.23 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.51 110.801 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.602 ' HB3' HD23 ' C' ' 117' ' ' LEU . 0.2 OUTLIER -72.49 -19.56 61.52 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.858 -0.337 . . . . 4.6500000000000004 111.534 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' C' ' 71' ' ' ALA . 65.0 mt -63.53 -41.94 94.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.172 0.51 . . . . 1.22 109.699 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.496 ' O ' HG22 ' C' ' 79' ' ' THR . 9.0 t70 -66.44 -15.37 63.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.548 -0.751 . . . . 1.3100000000000001 110.071 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.08 -20.45 32.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 1.6799999999999999 111.335 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.505 ' HB3' HD12 ' C' ' 113' ' ' ILE . 8.7 mtm -99.54 4.99 46.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 1.8 111.423 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -114.67 -27.15 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.419 -0.355 . . . . 1.1899999999999999 111.855 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.496 HG22 ' O ' ' C' ' 75' ' ' ASP . 15.1 t -103.8 -34.86 8.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.288 0.477 . . . . 1.23 112.288 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 38.5 m -69.65 -50.76 17.51 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 111.84 0.311 . . . . 0.58999999999999997 111.84 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 32.2 Cg_exo -59.36 -37.51 89.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.928 1.752 . . . . 0.67000000000000004 112.28 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.459 HD13 HD12 ' C' ' 85' ' ' LEU . 4.4 mm? -78.29 -16.92 57.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.95999999999999996 110.619 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -41.75 67.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 1.1899999999999999 110.609 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' C' ' 105' ' ' LEU . 3.9 pp -78.78 -32.33 46.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.7 110.819 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 85' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' C' ' 106' ' ' MET . 43.2 mt -61.5 -41.26 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 1.6200000000000001 110.833 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.5 t -60.89 -29.91 69.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.02 -0.537 . . . . 1.26 110.783 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.465 HD22 HD11 ' C' ' 168' ' ' LEU . 59.9 mt -74.71 -27.3 60.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 1.1100000000000001 110.891 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.0 t -69.2 -48.6 61.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 1.51 110.865 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -63.86 -32.74 74.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 2.0600000000000001 111.048 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -66.51 -32.14 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 1.52 111.143 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.53 -4.7 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 1.3 111.379 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.3 mtm -118.09 98.91 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 1.6200000000000001 110.992 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -87.42 -16.2 35.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 3.2400000000000002 110.608 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -146.8 133.86 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.56 . . . . 4.6299999999999999 110.584 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -146.21 142.48 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.94 0.4 . . . . 2.1800000000000002 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -131.46 -68.28 0.66 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.958 -0.565 . . . . 4.1200000000000001 110.539 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -138.93 87.17 2.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 4.96 110.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -163.09 121.53 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 3.9100000000000001 110.971 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -134.93 19.38 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 5.21 110.663 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 64.4 p -76.63 -50.77 12.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 1.8200000000000001 111.174 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.4 mt -70.12 -40.06 75.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 2.0800000000000001 110.976 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.06 -41.93 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 1.8600000000000001 111.063 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.21 -11.15 85.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.58999999999999997 112.575 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' PHE . . . . . 0.429 ' O ' HG23 ' C' ' 108' ' ' THR . 79.1 t80 -80.52 -41.22 24.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.706 0.289 . . . . 1.53 110.928 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.466 ' HB3' HD13 ' C' ' 84' ' ' LEU . 55.1 mt -74.8 -44.07 51.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 1.1100000000000001 111.182 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 106' ' ' MET . . . . . 0.487 ' HG2' HD21 ' C' ' 85' ' ' LEU . 71.5 mtm -58.73 -54.27 48.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.307 -0.406 . . . . 2.21 111.285 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -52.23 -50.73 61.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 1.28 111.821 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.429 HG23 ' O ' ' C' ' 104' ' ' PHE . 61.5 p -63.27 -24.69 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 1.22 111.798 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 8.0 tp-100 -80.82 -35.86 32.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 2.3300000000000001 111.406 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.633 HG22 ' HE1' ' B' ' 46' ' ' TRP . 80.4 mt -65.63 -30.97 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 1.29 111.399 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.31 -37.2 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.606 0.241 . . . . 1.0600000000000001 111.592 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 108' ' ' THR . 73.4 t -67.78 -41.4 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 111.887 0.329 . . . . 0.51000000000000001 111.887 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' C' ' 77' ' ' MET . 38.8 pt -69.4 -34.42 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.748 -0.206 . . . . 1.3700000000000001 111.464 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -60.87 -54.59 43.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.872 0.367 . . . . 0.77000000000000002 110.644 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.5 p -55.88 -29.56 60.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 1.1899999999999999 110.057 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.06 63.72 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.991 -0.623 . . . . 0.5 112.011 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.602 HD23 ' HB3' ' C' ' 73' ' ' TYR . 81.8 mt -48.03 -61.13 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 1.47 110.627 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.16 -32.57 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.569 -0.741 . . . . 1.2 112.002 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.51 61.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.314 . . . . 0.40000000000000002 111.348 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 -19.03 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 2.1200000000000001 110.884 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 117' ' ' LEU . 95.9 mt -83.26 17.68 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.75 110.992 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -89.78 117.76 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.368 . . . . 1.3799999999999999 110.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.94 -31.13 61.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.106 -0.497 . . . . 2.7400000000000002 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' C' ' 127' ' ' VAL . 86.5 mtm180 -93.86 144.23 25.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 2.7999999999999998 110.607 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.37 -13.12 58.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 2.4100000000000001 111.382 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -86.37 -50.73 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 4.2000000000000002 111.141 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.2 p -57.68 -24.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.0800000000000001 111.371 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -62.61 -37.35 85.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.364 . . . . 2.5699999999999998 111.055 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -60.9 -36.1 78.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.39 -0.368 . . . . 3.8100000000000001 111.141 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.7 mm? -66.21 -52.63 46.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.4199999999999999 111.124 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 131' ' ' TRP . . . . . 0.415 ' HE1' ' HG3' ' B' ' 58' ' ' GLN . 9.3 m95 -64.93 -28.93 69.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.427 . . . . 0.89000000000000001 111.45 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -65.42 -46.67 79.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.539 -0.301 . . . . 1.26 110.782 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.1 mm -58.75 -36.6 61.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 1.6799999999999999 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -63.88 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 1.24 110.671 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -48.83 39.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.842 -0.694 . . . . 0.54000000000000004 112.661 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -68.3 -27.06 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 1.0600000000000001 111.119 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 54.0 t -64.4 -43.47 94.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 1.0800000000000001 110.614 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' ALA . . . . . 0.434 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -68.94 -29.37 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.783 -0.644 . . . . 0.56999999999999995 111.034 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -71.08 -29.63 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.416 . . . . 1.6799999999999999 110.992 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -70.14 -56.0 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 1.7 111.548 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 28.9 pt -55.71 -37.87 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.78000000000000003 111.751 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.434 HG12 ' O ' ' C' ' 138' ' ' ALA . 44.0 mm -78.33 -33.32 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 2.2400000000000002 111.411 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 143' ' ' LEU . . . . . 0.405 ' O ' HG22 ' C' ' 146' ' ' ILE . 44.5 tp -61.43 -51.33 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 1.02 110.576 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -70.65 -21.28 62.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 3.0 110.463 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.38 67.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.845 -0.693 . . . . 1.27 112.575 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' ILE . . . . . 0.405 HG22 ' O ' ' C' ' 143' ' ' LEU . 19.0 tt -102.35 -14.67 8.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 1.8899999999999999 111.201 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -77.3 -33.49 55.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 1.6000000000000001 111.699 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.643 ' HB2' ' HD3' ' C' ' 149' ' ' PRO . 32.0 m120 -70.52 -51.51 12.47 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.003 0.371 . . . . 99.989999999999995 112.003 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 25.2 Cg_exo -62.54 -0.93 2.17 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.114 1.876 . . . . 2.73 112.9 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 150' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' C' ' 166' ' ' ASP . 68.5 tp -61.11 -64.47 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.463 -0.335 . . . . 4.2999999999999998 111.222 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 151' ' ' ARG . . . . . 0.456 ' HA ' ' OG1' ' C' ' 154' ' ' THR . 73.4 ttt180 -135.88 -12.7 1.96 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.407 -0.361 . . . . 8.9000000000000004 111.15 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' C' ' 148' ' ' ASN . . . -68.59 -46.38 69.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.478 -0.328 . . . . 2.7999999999999998 111.488 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -86.0 -33.35 21.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.5 -0.318 . . . . 5.4400000000000004 111.249 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 154' ' ' THR . . . . . 0.457 ' HA ' ' HB3' ' C' ' 157' ' ' GLN . 60.7 p -78.55 6.35 8.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 3.3900000000000001 111.194 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -60.5 -50.62 72.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.367 -0.378 . . . . 6.9199999999999999 111.038 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 7.5 t -88.14 -10.08 51.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 4.8700000000000001 110.927 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.457 ' HB3' ' HA ' ' C' ' 154' ' ' THR . 53.6 tt0 -86.35 -72.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 4.0499999999999998 110.82 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.4 m -154.51 113.66 3.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 3.0299999999999998 110.758 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 52.2 m -74.61 -33.33 62.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 2.96 110.943 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.44 -49.07 76.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 3.7400000000000002 110.851 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.36 -24.89 67.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 2.6499999999999999 110.901 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.05 -37.86 69.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 1.77 111.217 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.13 -37.93 89.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.344 -0.389 . . . . 2.96 110.836 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.89 -54.36 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 2.3500000000000001 111.027 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 2.6200000000000001 111.068 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 166' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' C' ' 150' ' ' LEU . 16.8 t70 -65.15 -42.93 93.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 2.0899999999999999 111.162 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.76 -25.04 35.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.138 -0.483 . . . . 3.2400000000000002 111.091 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.465 HD11 HD22 ' C' ' 87' ' ' LEU . 54.5 tp -76.89 -39.03 52.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 1.6899999999999999 111.544 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.4 p -71.64 -16.43 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 1.3999999999999999 111.324 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 41.9 m -57.68 -59.41 5.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.95999999999999996 111.258 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -71.46 -31.75 67.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 3.6499999999999999 110.381 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 172' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 91.1 t80 -57.21 -32.97 67.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 1.3700000000000001 110.975 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.465 ' O ' HG22 ' C' ' 177' ' ' ILE . 66.9 m -79.66 -43.3 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 1.4299999999999999 111.494 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -58.3 -36.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 112.18 0.437 . . . . 1.6200000000000001 112.18 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' C' ' 175' ' ' LEU . 4.4 mm? -81.16 -47.39 13.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.729 -0.214 . . . . 2.0299999999999998 111.489 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -30.87 63.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.301 . . . . 0.62 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.465 HG22 ' O ' ' C' ' 173' ' ' THR . 10.9 tp -88.01 -22.9 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 1.5800000000000001 110.472 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.19 -57.8 17.39 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.839 -0.619 . . . . 0.56000000000000005 113.37 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.601 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 88.4 m-85 -53.47 -54.85 40.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.692 0.246 . . . . 1.3300000000000001 111.503 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 97.1 Cg_exo -44.37 -35.82 8.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.316 2.011 . . . . 0.63 112.833 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.401 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.0 mt -64.52 -61.14 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 0.93000000000000005 111.537 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.454 HG22 ' O ' ' C' ' 179' ' ' TYR . 20.2 m -59.76 -24.56 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.27 111.454 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -67.19 -52.45 41.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 1.77 111.41 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.02 -41.74 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.211 0.448 . . . . 2.3900000000000001 112.211 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 10.7 tt -122.0 142.56 37.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 1.95 111.739 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 97.58 -143.01 16.46 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.882 -0.675 . . . . 1.8799999999999999 112.814 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 187' ' ' PRO . . . . . 0.436 ' HB2' ' OD1' ' C' ' 198' ' ' ASP . 74.2 Cg_endo -73.85 163.52 36.85 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.668 2.246 . . . . 3.1200000000000001 112.075 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 60.2 m 57.22 15.36 2.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 2.6299999999999999 110.132 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.22 26.11 0.27 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.677 -0.692 . . . . 3.04 112.341 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 64.7 t80 59.83 93.84 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.988 0.423 . . . . 5.6900000000000004 111.079 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -143.91 166.71 26.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.9 -0.667 . . . . 3.0800000000000001 112.295 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -59.24 -28.47 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.951 0.405 . . . . 7.5300000000000002 110.777 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 pt -104.6 140.85 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 2.8599999999999999 111.22 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -156.91 -103.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 3.6899999999999999 110.85 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 49.77 -161.15 0.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.634 0.254 . . . . 5.4800000000000004 110.997 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 74.9 p -68.84 -15.65 63.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.919 0.39 . . . . 2.3799999999999999 111.023 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.98 -27.88 36.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 2.23 110.959 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 198' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' C' ' 187' ' ' PRO . 3.1 t70 -49.76 -60.97 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 2.1600000000000001 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 72.4 p -72.27 -18.63 61.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 1.27 111.69 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -74.89 -26.55 59.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 1.7 111.359 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.16 -47.93 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.478 -0.328 . . . . 2.02 111.699 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.51 -14.86 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.473 -0.33 . . . . 1.8200000000000001 111.65 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.426 ' O ' ' HG2' ' C' ' 206' ' ' PRO . 20.7 p -96.66 -39.07 9.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 1.3500000000000001 111.53 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 48.3 tp -71.88 -34.01 68.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.277 -0.419 . . . . 0.65000000000000002 112.046 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' C' ' 206' ' ' PRO . 56.4 tp -62.47 -52.94 61.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 111.971 0.36 . . . . 1.4199999999999999 111.971 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' C' ' 205' ' ' LEU . 17.9 Cg_endo -58.21 -41.9 62.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.899 1.733 . . . . 0.63 111.762 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.35 -34.48 78.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 1.49 110.372 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -70.49 -27.51 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 1.7 110.382 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 48.2 t -93.78 -16.53 24.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.002 -0.545 . . . . 1.25 110.61 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.736 H192 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t -86.28 -37.9 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 1.6100000000000001 111.034 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.28 -50.43 62.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.932 -0.652 . . . . 0.81999999999999995 112.748 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -66.11 -23.69 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 3.0800000000000001 111.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.1 t -60.93 -62.46 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 1.1499999999999999 110.72 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -69.26 -20.42 63.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 2.5600000000000001 110.973 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.26 -59.14 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 1.29 110.601 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.59 -28.54 67.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.863 0.363 . . . . 2.3900000000000001 110.936 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.42 -52.11 66.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 2.0299999999999998 110.976 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.71 -20.46 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 3.21 110.913 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.54 -29.8 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 1.3600000000000001 112.309 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 51.8 tp -68.4 -55.25 12.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 2.8999999999999999 110.626 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 32.9 tpt180 52.69 89.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.069 -0.514 . . . . 4.8899999999999997 111.27 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -57.69 138.24 55.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 4.2300000000000004 110.916 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 36.1 tp -162.32 -26.9 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 6.1200000000000001 110.754 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -129.18 124.98 35.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.504 . . . . 4.5499999999999998 110.922 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 15.6 t70 65.15 146.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.963 -0.562 . . . . 6.7800000000000002 111.431 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 36.3 t -157.62 124.7 5.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.915 -0.584 . . . . 5.4000000000000004 110.748 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -100.35 161.82 13.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.426 . . . . 8.3300000000000001 110.896 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 7.9100000000000001 110.95 -179.961 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.813 0.34 . . . . 5.1100000000000003 110.815 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -130.44 42.48 3.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 5.04 110.656 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.2 mt -99.01 -41.14 7.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.751 -0.658 . . . . 5.5800000000000001 111.131 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -60.17 168.15 2.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.175 -0.466 . . . . 5.0199999999999996 111.073 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.8 t 62.1 102.94 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.087 -0.506 . . . . 2.4500000000000002 111.077 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 6' ' ' LEU . 5.5 mp -117.32 4.68 12.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.076 -0.511 . . . . 2.4199999999999999 110.85 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.24 -50.38 60.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.0899999999999999 111.064 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 68.3 m-70 -63.36 -25.0 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 1.1599999999999999 110.973 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 12' ' ' VAL . 62.7 t-105 -70.04 -59.67 2.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.79000000000000004 111.077 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -60.56 -19.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 2.0800000000000001 110.437 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 207' ' ' PHE . 8.6 t80 -62.16 -58.58 7.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.672 -0.695 . . . . 1.28 110.731 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.4 p -60.47 -29.2 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 1.3200000000000001 110.885 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.32 -46.93 88.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.63 111.166 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.91 -23.58 77.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.799 -0.715 . . . . 0.55000000000000004 112.352 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.69 -38.21 54.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.703 0.287 . . . . 1.03 111.131 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -62.79 -48.6 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.387 -0.37 . . . . 1.3 111.096 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.4 -32.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 1.3100000000000001 110.659 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.04 -54.52 30.94 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.783 -0.722 . . . . 0.77000000000000002 112.698 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -35.31 76.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.749 0.309 . . . . 0.80000000000000004 111.389 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 17' ' ' ILE . 93.5 mt -62.54 -30.66 71.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 1.8100000000000001 111.028 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -59.94 -31.9 70.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 1.8799999999999999 110.692 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 m-85 -75.14 -28.02 59.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.188 -0.46 . . . . 4.4500000000000002 110.685 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -62.25 -39.64 93.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.061 0.458 . . . . 3.6899999999999999 109.829 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.2 m -85.49 -28.25 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.758 -0.656 . . . . 1.5700000000000001 110.7 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 56.8 tp -73.13 -18.23 61.31 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.653 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 p -62.52 -25.03 67.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 1.3799999999999999 111.085 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -51.22 -32.59 24.46 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.093 0.473 . . . . 4.0700000000000003 109.938 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.7 p-10 -165.42 132.01 2.17 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 2.7200000000000002 110.304 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 29.3 Cg_endo -95.99 179.86 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.193 2.595 . . . . 1.9099999999999999 112.139 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -103.48 65.58 0.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.339 -0.391 . . . . 4.7599999999999998 111.276 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' HA3' HD13 ' A' ' 224' ' ' LEU . . . 84.76 -46.61 3.71 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.917 -0.659 . . . . 1.99 112.931 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.23 146.98 32.66 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.625 0.213 . . . . 2.7000000000000002 111.235 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 34.6 Cg_exo -58.89 163.29 11.63 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.382 2.055 . . . . 1.79 112.085 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.21 -17.33 63.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.694 -0.685 . . . . 4.1200000000000001 112.319 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 6.4 p90 -41.27 -40.92 1.76 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.738 0.304 . . . . 2.9300000000000002 111.774 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.05 -45.41 77.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.886 0.374 . . . . 2.8799999999999999 110.587 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.76 -19.37 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.55 . . . . 4.6600000000000001 110.439 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.0 -55.06 28.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.45 110.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.83 -37.31 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.78 110.348 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.75 -10.67 59.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.63 110.618 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.499 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 41.0 ttm -88.14 -28.91 20.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.81 -0.632 . . . . 1.48 110.487 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -72.8 -40.09 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 3.5 111.369 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.666 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 36.8 mm -50.22 -53.04 48.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 111.99 0.367 . . . . 1.0800000000000001 111.99 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.666 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 15.7 Cg_exo -68.68 -33.73 20.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.196 1.931 . . . . 0.53000000000000003 112.595 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.01 -62.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.632 0.253 . . . . 1.6799999999999999 111.367 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.61 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -61.72 -57.97 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 1.8300000000000001 111.017 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB2' HG21 ' A' ' 79' ' ' THR . 35.8 t -54.2 -23.06 13.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 1.0900000000000001 111.356 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.54 -66.12 2.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.40999999999999998 112.524 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.1 mt -56.3 -29.15 60.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.293 . . . . 0.98999999999999999 111.144 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.98 -57.61 12.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.47999999999999998 111.222 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 20.8 m-85 -61.61 -42.48 98.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 1.8700000000000001 111.472 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.22 -36.33 8.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.207 0.527 . . . . 1.49 110.349 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -72.37 -40.21 67.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.58999999999999997 110.9 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 54.2 mtt -53.54 -35.57 60.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.041 0.448 . . . . 0.48999999999999999 110.17 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -67.75 -40.96 84.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.59999999999999998 109.935 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.22 3.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.727 -0.67 . . . . 1.3100000000000001 110.524 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.48 44.64 9.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.667 -0.697 . . . . 1.9099999999999999 111.257 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 14.6 mm100 -102.93 170.1 8.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 110.823 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.48 92.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 1.04 112.23 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -123.18 145.86 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 2.6800000000000002 110.783 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.84 141.04 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.98 110.845 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.7 92.24 7.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 2.1800000000000002 110.837 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.76 110.74 22.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 1.5700000000000001 111.246 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.63 34.97 25.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 1.79 111.431 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.06 74.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.847 -0.692 . . . . 1.48 112.754 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -130.28 117.65 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 2.3199999999999998 110.502 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 pt -69.23 127.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 1.4399999999999999 111.154 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.38 144.56 35.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.81999999999999995 111.225 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 93.4 m-70 -89.12 62.84 6.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.29 0.567 . . . . 0.90000000000000002 110.989 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -56.77 -38.15 72.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.295 -0.866 . . . . 1.8300000000000001 111.191 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.33 -22.21 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.053 -0.521 . . . . 0.62 111.82 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 5.3 tpm_? -66.5 -51.72 53.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 2.3399999999999999 112.022 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.9 p90 -72.59 -34.04 67.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.654 -0.418 . . . . 3.4900000000000002 110.712 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -55.47 -46.33 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.324 -0.398 . . . . 1.3700000000000001 110.949 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 47' ' ' SER . 37.8 t70 -65.68 -13.01 58.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 1.3100000000000001 110.425 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -99.75 -0.26 40.33 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.813 -0.63 . . . . 1.48 111.528 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.578 ' HA ' HD13 ' A' ' 113' ' ' ILE . 55.0 ttm -104.59 -6.97 20.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 1.46 110.703 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.527 HG23 HG23 ' A' ' 79' ' ' THR . 27.2 m -114.39 -36.13 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 1.1200000000000001 112.128 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 47' ' ' SER . 62.7 p -88.11 -44.71 10.73 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.339 0.496 . . . . 1.1000000000000001 112.339 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.6 m -56.93 -51.29 82.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.156 0.428 . . . . 0.59999999999999998 112.156 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 80' ' ' THR . 14.6 Cg_endo -56.85 -36.51 98.88 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.679 1.586 . . . . 0.73999999999999999 111.168 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.586 ' HB3' HD11 ' A' ' 43' ' ' ILE . 4.0 mm? -71.1 -34.18 70.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 1.01 109.934 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.753 HD12 ' H43' ' A' ' 210' ' ' LYR . 27.9 mt -68.34 -21.25 64.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.336 -0.616 . . . . 1.48 109.336 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 109' ' ' GLN . 20.8 tp -83.02 -23.88 33.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.142 -0.936 . . . . 1.3799999999999999 109.713 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 82' ' ' LEU . 96.1 mt -84.02 -40.67 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.454 -0.794 . . . . 1.1899999999999999 110.886 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.9 p -63.19 -45.44 91.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 1.23 110.956 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.57 -26.17 68.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.039 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.6 t -68.39 -50.94 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.294 -0.412 . . . . 1.3899999999999999 110.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -65.78 -21.93 66.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 2.3199999999999998 111.024 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.6 m -73.46 -37.51 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.353 -0.385 . . . . 1.46 110.967 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.84 -23.98 26.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 1.24 110.937 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.0 mmm -94.0 84.84 4.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 2.0699999999999998 110.796 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -73.98 -19.34 60.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 3.5299999999999998 111.126 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.78 133.58 43.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.287 -0.415 . . . . 4.0800000000000001 110.996 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.3 pt -140.8 160.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 2.1699999999999999 110.935 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -139.97 -70.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 4.5199999999999996 110.997 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -142.4 14.64 2.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.388 . . . . 3.75 111.04 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.93 129.39 40.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 3.5299999999999998 110.877 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 56.5 t90 -151.63 -13.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 4.9100000000000001 110.926 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -82.94 -34.06 26.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.98 111.283 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.78 -48.47 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 1.8300000000000001 110.897 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 16.0 tt -59.11 -25.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 1.79 111.158 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.44 -46.64 32.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.831 -0.7 . . . . 0.62 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -56.47 -37.93 71.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.63 0.252 . . . . 1.5800000000000001 111.157 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.01 -51.79 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.97999999999999998 110.721 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 84.8 mtp -60.8 -26.08 67.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.48 110.981 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.7 m -68.3 -58.72 3.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 1.1299999999999999 111.139 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.64 HG21 HG21 ' A' ' 142' ' ' ILE . 97.5 m -53.37 -36.18 61.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 1.48 111.142 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.518 ' HB2' HD22 ' A' ' 84' ' ' LEU . 22.9 tp60 -55.14 -51.69 65.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 2.7000000000000002 110.69 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.8 mm -54.22 -35.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 1.54 111.139 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.77 -44.22 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.045 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.65 -52.26 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.42999999999999999 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 77' ' ' MET . 39.7 mt -53.59 -30.68 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 1.74 111.08 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 54.5 m -64.07 -48.24 76.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.63 110.82 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.8 m -62.98 -21.51 66.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.962 -0.563 . . . . 1.0900000000000001 110.476 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.7 9.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.862 -0.685 . . . . 0.41999999999999998 112.938 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 73' ' ' TYR . 4.0 pp -76.82 -26.75 54.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.682 0.241 . . . . 1.3799999999999999 111.268 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.1 mt -84.08 -38.1 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 CA-C-O 120.709 0.29 . . . . 1.6200000000000001 111.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.18 65.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.39000000000000001 111.281 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.64 -22.07 47.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.172 -0.467 . . . . 2.02 110.887 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.72 5.1 49.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.76000000000000001 111.102 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -64.13 131.03 46.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 1.46 111.028 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.72 -3.06 14.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 3.3500000000000001 111.126 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.503 ' HB2' HG12 ' A' ' 127' ' ' VAL . 72.2 mtm180 -129.83 141.04 50.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.871 0.367 . . . . 2.9199999999999999 110.97 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 2.77 111.133 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -79.3 -41.07 28.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 3.77 110.496 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 124' ' ' ARG . 11.6 p -84.16 -23.66 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.576 . . . . 1.1599999999999999 110.955 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.549 HH11 ' H ' ' A' ' 190' ' ' PHE . 36.0 ttm180 -51.61 -40.28 59.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.197 -0.456 . . . . 2.04 111.09 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -75.1 -30.36 60.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 2.6400000000000001 111.167 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 127' ' ' VAL . 87.9 mt -67.56 -58.49 4.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 1.8999999999999999 111.354 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -63.03 -37.02 85.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.321 -0.4 . . . . 1.3999999999999999 111.928 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -55.03 -54.16 46.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.844 0.354 . . . . 1.28 110.662 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.46 -30.54 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 2.1600000000000001 110.658 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.2 t -62.77 -35.01 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 1.6899999999999999 110.827 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.17 -51.91 15.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.878 -0.677 . . . . 0.52000000000000002 112.646 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.16 -29.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.68 0.276 . . . . 1.02 110.991 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.9 t -69.48 -36.59 76.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0800000000000001 110.684 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.54 68.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.62 110.912 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.13 -22.6 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 1.8400000000000001 110.941 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 140' ' ' LEU . 1.5 tm? -64.62 -62.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.6899999999999999 111.227 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.1 pt -59.05 -46.39 91.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.81000000000000005 112.26 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.64 HG21 HG21 ' A' ' 108' ' ' THR . 33.4 mm -64.34 -31.69 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.726 0.269 . . . . 2.3700000000000001 111.726 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 62.7 tp -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.97999999999999998 110.911 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -65.51 -21.89 66.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.411 . . . . 3.27 110.56 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.33 -17.35 71.68 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.84 -0.695 . . . . 1.25 112.835 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.05 -14.51 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.823 0.344 . . . . 2.1200000000000001 111.109 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -66.65 -55.59 14.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.367 0.506 . . . . 1.6599999999999999 112.367 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.845 ' OD1' ' CB ' ' A' ' 152' ' ' ALA . 51.5 t30 -102.06 -52.98 0.14 Allowed Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.62 0.6 . . . . 99.989999999999995 112.62 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 77.0 Cg_exo -41.96 -31.07 1.37 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.52 2.147 . . . . 2.6000000000000001 113.324 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.475 ' HG ' ' HG3' ' A' ' 151' ' ' ARG . 68.1 tp -62.03 -52.35 64.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 4.6100000000000003 110.451 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.475 ' HG3' ' HG ' ' A' ' 150' ' ' LEU . 99.4 mtt180 -144.42 61.14 1.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.976 -0.556 . . . . 8.3599999999999994 110.676 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.845 ' CB ' ' OD1' ' A' ' 148' ' ' ASN . . . -79.37 -41.39 27.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 2.75 111.059 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.74 -23.15 62.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.128 -0.487 . . . . 5.6799999999999997 111.051 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 31.9 m -65.54 -18.76 65.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 3.21 111.202 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.96 -31.65 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 6.8700000000000001 111.153 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.2 m -99.07 -27.55 13.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 4.5599999999999996 111.284 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -66.72 -77.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 3.5600000000000001 111.037 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 80.6 p -127.78 113.46 15.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.251 -0.431 . . . . 2.79 110.857 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 73.4 p -77.94 -20.03 53.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 2.5899999999999999 111.213 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -68.55 -54.49 16.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 3.4700000000000002 111.152 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.41 -30.6 71.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 2.5800000000000001 110.868 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.29 -30.09 69.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 1.78 110.963 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.47 -30.23 57.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 2.6299999999999999 110.91 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.448 HD22 ' HD3' ' A' ' 222' ' ' ARG . 96.2 mt -67.11 -59.58 3.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 2.3399999999999999 111.275 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -22.53 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.262 -0.426 . . . . 2.77 110.839 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.68 -32.48 71.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.006 0.431 . . . . 2.04 110.314 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 170' ' ' THR . 41.3 ttmt -78.33 -22.42 48.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.903 -0.589 . . . . 2.77 110.3 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.49 -56.45 4.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.646 . . . . 1.8899999999999999 111.034 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.0 -34.68 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.677 -0.692 . . . . 1.6399999999999999 112.088 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 167' ' ' LYS . 14.0 t -55.16 -34.09 63.52 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.957 0.408 . . . . 1.24 110.531 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -78.24 -28.52 47.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 2.9700000000000002 110.032 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -73.36 -28.0 61.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.643 -0.708 . . . . 1.48 110.84 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.2 p -76.63 -47.91 20.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.369 -0.378 . . . . 1.55 111.073 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.56 -28.55 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 1.52 111.286 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.4 tp -75.68 -56.73 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 1.8500000000000001 111.053 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -29.63 66.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.908 -0.587 . . . . 0.62 111.412 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.508 ' O ' HG12 ' A' ' 181' ' ' ILE . 14.1 tt -87.41 -21.08 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 1.3500000000000001 110.25 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.69 65.06 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.72 -0.673 . . . . 0.58999999999999997 112.87 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.573 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.2 m-85 -55.59 -55.6 38.65 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.797 0.298 . . . . 1.45 110.985 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 85.0 Cg_exo -46.35 -31.63 9.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.062 1.841 . . . . 0.55000000000000004 112.657 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.8 mm -64.8 -58.26 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.816 0.341 . . . . 1.4199999999999999 111.667 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 179' ' ' TYR . 28.2 m -59.6 -27.16 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.78000000000000003 111.58 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -61.65 -23.49 66.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.93999999999999995 110.927 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 89.7 mt -56.68 -39.77 65.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 1.4299999999999999 111.146 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 32.8 pt -108.33 140.14 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.396 . . . . 2.02 111.004 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 193' ' ' ILE . . . 110.64 -165.97 12.3 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.841 -0.695 . . . . 1.79 112.608 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.13 160.0 50.46 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.428 2.085 . . . . 3.1000000000000001 112.086 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 65.2 m 56.92 17.23 3.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.334 -0.394 . . . . 2.7400000000000002 110.375 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -155.83 25.55 0.57 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.784 -0.644 . . . . 3.4300000000000002 112.324 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.549 ' H ' HH11 ' A' ' 128' ' ' ARG . 65.5 m-85 58.53 72.8 0.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.96 0.41 . . . . 6.5 110.528 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 186' ' ' GLY . . . -124.28 -177.99 15.2 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.708 -0.758 . . . . 3.29 112.797 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -139.25 24.18 2.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 6.1600000000000001 111.034 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.574 HG12 ' HA2' ' A' ' 186' ' ' GLY . 37.3 pt -97.16 175.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 2.4199999999999999 111.234 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -74.63 -172.72 1.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 4.29 110.684 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -93.13 -33.27 14.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.868 0.366 . . . . 5.1500000000000004 110.686 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.2 p -70.65 -31.52 68.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 2.4500000000000002 110.941 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.5 mm -64.48 -47.94 87.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 2.48 111.229 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.61 -52.4 63.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 2.1800000000000002 110.682 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -63.93 -25.07 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.519 . . . . 1.49 111.076 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -77.02 -27.59 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 1.77 110.998 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 53.7 tp -84.08 -51.17 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 1.4199999999999999 111.506 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -69.75 1.27 4.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.522 -0.308 . . . . 1.78 111.46 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 35.9 t -96.48 -44.01 7.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 1.3 110.191 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.2 tp -72.38 -33.63 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.427 -0.806 . . . . 0.66000000000000003 111.763 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.1 tt -60.09 -54.57 53.97 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.019 -0.272 . . . . 1.6299999999999999 111.17 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.25 -41.63 74.52 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.654 1.57 . . . . 0.64000000000000001 111.262 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.427 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 81.6 t80 -61.28 -34.01 74.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 1.3600000000000001 110.053 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.0 -21.03 57.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.326 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.3 t -95.41 -20.65 18.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.872 -0.604 . . . . 1.2 110.721 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.753 ' H43' HD12 ' A' ' 83' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.97 -38.17 63.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.215 -0.448 . . . . 1.6399999999999999 110.871 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.28 96.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.866 -0.683 . . . . 0.79000000000000004 112.405 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.78 -29.46 69.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.732 0.301 . . . . 1.6100000000000001 110.83 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.6 t -60.49 -58.02 10.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.1499999999999999 110.858 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 218' ' ' LEU . 75.5 t80 -69.1 -23.88 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 3.3399999999999999 110.663 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 216' ' ' LEU . 8.3 tt -67.1 -49.46 64.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 1.1899999999999999 110.766 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.39 -38.23 83.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 2.23 110.856 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 215' ' ' PHE . 95.4 mt -59.3 -50.37 74.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 2.4700000000000002 111.109 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -72.67 -21.41 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 1.6200000000000001 110.871 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.62 -26.54 64.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 1.4099999999999999 112.567 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 98.0 mt -68.79 -32.69 72.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 2.5800000000000001 111.15 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.448 ' HD3' HD22 ' A' ' 164' ' ' LEU . 44.4 mtm180 59.77 -87.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.111 -0.495 . . . . 4.9299999999999997 111.173 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -123.78 176.52 6.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 4.6299999999999999 110.815 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.412 HD13 ' HA3' ' A' ' 31' ' ' GLY . 53.2 tp -124.14 115.44 21.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.48 . . . . 6.4699999999999998 110.871 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -148.7 -44.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 5.0700000000000003 110.992 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -95.85 118.71 33.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 6.5300000000000002 110.871 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 49.8 m -141.3 26.88 1.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 5.2199999999999998 110.954 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -158.11 134.3 9.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.483 . . . . 8.3599999999999994 110.978 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.986 -0.552 . . . . 7.96 111.048 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.845 0.355 . . . . 6.1699999999999999 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.424 ' OD1' ' HG ' ' B' ' 3' ' ' LEU . 5.2 p30 -144.0 -23.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 4.8200000000000003 111.032 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.424 ' HG ' ' OD1' ' B' ' 2' ' ' ASN . 94.7 mt -102.09 96.66 7.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 5.5999999999999996 110.609 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.12 -27.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 4.7999999999999998 110.994 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.4 m -131.34 154.5 48.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 2.3700000000000001 110.845 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -134.16 -4.53 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 2.0699999999999998 111.021 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.529 HD12 HD11 ' B' ' 10' ' ' ILE . 54.4 tp -67.61 -42.21 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.434 -0.348 . . . . 2.1000000000000001 111.099 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.625 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 40.4 m-70 -67.71 -25.37 65.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.49 . . . . 1.0700000000000001 110.35 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -72.97 -49.51 28.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 1.48 110.989 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.529 HD11 HD12 ' B' ' 7' ' ' LEU . 45.3 pt -69.0 -19.18 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.957 0.408 . . . . 2.02 110.789 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -66.55 -54.11 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 0.92000000000000004 110.589 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.57 -31.77 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.93999999999999995 111.003 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.39 -47.31 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.55000000000000004 111.236 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.12 74.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.666 -0.778 . . . . 0.47999999999999998 112.485 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.23 -31.51 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.84999999999999998 110.804 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -63.5 -58.11 8.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 1.3400000000000001 110.996 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.6 pp -61.21 -23.61 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 1.55 111.206 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.431 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -60.7 -51.81 56.38 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.632 -0.794 . . . . 0.69999999999999996 112.161 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -68.32 -23.39 64.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.81000000000000005 110.894 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.57 -43.2 90.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 2.2599999999999998 110.622 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.22 -25.43 61.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.78 110.432 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 83.2 t80 -66.1 -37.25 85.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.666 . . . . 4.5800000000000001 110.47 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.4 ' O ' ' OG ' ' B' ' 26' ' ' SER . 86.0 t90 -67.14 -35.41 79.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 3.3500000000000001 110.656 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 40.8 t -80.41 -19.59 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 1.5800000000000001 111.161 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.1 -22.38 39.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 1.8400000000000001 111.267 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 4.8 p -59.5 -24.48 63.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.553 -0.294 . . . . 1.3700000000000001 111.092 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -47.38 -32.43 4.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 4.9800000000000004 110.022 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.7 p-10 -172.93 132.06 0.63 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 2.1400000000000001 110.278 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 52.2 Cg_endo -95.01 174.52 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.978 2.452 . . . . 1.8200000000000001 112.306 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -102.2 68.06 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 5.1900000000000004 111.366 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 -46.66 3.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.028 -0.606 . . . . 2.2000000000000002 112.84 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.02 144.93 29.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.515 0.198 . . . . 3.6499999999999999 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 165.47 8.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.405 2.07 . . . . 2.6699999999999999 112.218 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -69.2 -17.36 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.658 -0.701 . . . . 4.8799999999999999 112.413 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -41.17 -37.76 0.97 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.765 0.317 . . . . 1.8700000000000001 111.838 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.67 -57.07 12.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 2.6800000000000002 110.476 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.07 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 2.9199999999999999 110.783 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' B' ' 41' ' ' MET . 20.4 tp -60.38 -51.85 67.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.938 0.399 . . . . 1.6399999999999999 110.281 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -63.02 -38.48 82.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.094 0.473 . . . . 1.6000000000000001 109.872 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.82 -9.59 55.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.68999999999999995 110.7 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' B' ' 45' ' ' ILE . 22.0 ttt -87.94 -31.76 19.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 2.5800000000000001 110.426 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -72.65 -34.08 67.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 3.3900000000000001 111.397 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.658 HG23 HG23 ' B' ' 79' ' ' THR . 64.3 mt -52.91 -52.29 66.39 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 111.97 0.359 . . . . 0.40999999999999998 111.97 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.8 Cg_endo -71.18 -35.0 9.29 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.264 1.976 . . . . 0.48999999999999999 113.516 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 41' ' ' MET . 33.1 mm -56.64 -62.69 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.63 -57.38 12.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 1.3999999999999999 111.341 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -55.78 -23.56 30.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 1.3799999999999999 111.505 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.39 -64.42 3.36 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.37 112.552 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 60.0 mt -57.37 -27.52 62.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.325 . . . . 1.29 111.076 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.98 -55.76 26.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.16 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 13.8 m-85 -64.32 -41.09 96.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.5 111.235 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 51.6 ttp -49.41 -34.28 15.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.276 0.56 . . . . 1.4099999999999999 110.139 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.27 -40.09 71.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.449 -0.796 . . . . 0.55000000000000004 110.559 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 58.7 mtt -53.55 -30.6 42.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.5 110.299 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.2 -45.85 58.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.54000000000000004 110.671 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.518 HG21 HG23 ' C' ' 127' ' ' VAL . 13.1 mt -74.34 0.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.508 . . . . 1.3 110.746 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.485 ' HB2' HH12 ' C' ' 124' ' ' ARG . 8.0 m-20 63.76 52.15 2.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.794 -0.639 . . . . 2.2400000000000002 111.131 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -127.98 143.63 51.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.77 110.753 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.3 23.7 7.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.844 -0.693 . . . . 1.0600000000000001 112.394 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -137.43 137.49 38.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 2.6600000000000001 111.046 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.55 147.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.8899999999999999 111.005 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.25 94.01 9.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 2.4100000000000001 110.883 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.42 113.38 24.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 1.5600000000000001 111.182 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.45 30.54 18.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.434 . . . . 1.8200000000000001 111.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.84 -11.1 60.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.733 -0.746 . . . . 1.51 112.58 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -100.84 134.63 43.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 2.4500000000000002 110.723 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.26 132.2 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 1.79 110.875 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.03 144.33 32.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.81999999999999995 111.565 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.507 ' HB3' ' HD3' ' B' ' 72' ' ' ARG . 74.4 m-70 -95.5 66.58 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.689 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -68.65 -35.54 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.8700000000000001 111.129 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.88 68.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.60999999999999999 111.61 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.507 ' HD3' ' HB3' ' B' ' 69' ' ' HIS . 10.3 mpt_? -74.21 -51.69 14.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.24 -0.436 . . . . 2.3900000000000001 111.193 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -49.46 77.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 3.6699999999999999 111.353 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.3 -38.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.12 0.415 . . . . 1.6599999999999999 112.12 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.45 -24.75 67.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.349 . . . . 1.4099999999999999 110.406 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -95.87 6.59 48.52 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.08 -0.509 . . . . 1.1599999999999999 110.664 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.62 ' HA ' HD13 ' B' ' 113' ' ' ILE . 53.9 tpp -103.94 -13.82 16.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 1.53 109.455 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.455 ' O ' HD23 ' B' ' 82' ' ' LEU . 26.1 m -114.81 -35.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.437 -0.801 . . . . 0.89000000000000001 111.271 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.658 HG23 HG23 ' B' ' 43' ' ' ILE . 46.2 m -81.48 -60.93 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 1.24 112.179 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.567 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 60.2 m -47.18 -51.27 42.76 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 112.675 0.62 . . . . 0.57999999999999996 112.675 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 80' ' ' THR . 11.0 Cg_endo -54.17 -34.39 78.6 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.048 1.832 . . . . 0.66000000000000003 111.856 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.522 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -79.01 -29.52 43.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 1.0600000000000001 110.769 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.547 HD22 ' H43' ' B' ' 210' ' ' LYR . 13.2 tp -68.99 -30.01 68.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.018 0.437 . . . . 1.22 110.048 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -78.6 -30.36 46.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.749 -0.659 . . . . 1.53 110.072 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.522 HD12 HD13 ' B' ' 82' ' ' LEU . 76.0 mt -68.51 -42.52 78.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 1.5800000000000001 110.706 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -66.18 -41.51 90.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 1.3899999999999999 110.48 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -30.33 68.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.847 -0.615 . . . . 1.1499999999999999 110.53 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -70.72 -48.04 56.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 1.5700000000000001 110.997 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -66.71 -19.19 65.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 2.1699999999999999 111.149 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 34.3 m -79.92 -32.96 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 1.4199999999999999 111.051 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.57 -24.6 23.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.315 -0.402 . . . . 1.1799999999999999 111.431 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.6 mtp -100.01 104.38 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 1.8799999999999999 111.157 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -84.55 -38.15 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 3.4199999999999999 110.935 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.72 133.66 53.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 4.0599999999999996 110.944 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.92 148.53 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 2.0899999999999999 111.034 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -133.67 -67.29 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 3.8500000000000001 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -140.85 26.63 2.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 4.8200000000000003 110.903 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.99 106.49 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 3.7999999999999998 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -135.15 -9.14 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 5.1699999999999999 110.747 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -82.76 -37.0 25.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 2.02 110.959 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.59 -55.23 16.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 2.0899999999999999 110.53 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ILE . . . . . 0.495 ' HA ' HD12 ' B' ' 105' ' ' LEU . 16.9 tt -55.4 -28.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 1.8799999999999999 111.14 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 62.97 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.868 -0.682 . . . . 0.56000000000000005 112.537 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.415 ' O ' HG23 ' B' ' 108' ' ' THR . 35.3 t80 -63.47 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 1.78 110.532 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.598 ' HB3' HD21 ' B' ' 84' ' ' LEU . 85.8 mt -59.05 -46.62 87.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 1.03 110.772 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' MET . . . . . 0.523 ' O ' HG12 ' B' ' 110' ' ' ILE . 52.3 ttm -68.18 -22.25 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.759 -0.655 . . . . 1.6699999999999999 110.967 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 56.9 m -76.45 -39.93 51.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.93 0.395 . . . . 1.51 110.939 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 104' ' ' PHE . 60.8 p -64.82 -43.34 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 1.1799999999999999 111.533 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.482 ' NE2' ' HG3' ' B' ' 106' ' ' MET . 13.4 pt20 -59.71 -42.87 94.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.539 -0.301 . . . . 2.1699999999999999 111.001 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.61 HG22 ' HE1' ' A' ' 46' ' ' TRP . 43.2 mm -53.55 -41.16 44.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.842 0.353 . . . . 1.3500000000000001 110.52 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 46' ' ' TRP . 26.5 t -62.16 -44.96 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 1.3400000000000001 111.239 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.46 -50.78 78.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.42999999999999999 111.757 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' B' ' 77' ' ' MET . 21.9 mt -58.57 -33.68 49.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.729 0.3 . . . . 1.6000000000000001 110.866 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.8 m -56.22 -40.54 74.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.17 0.509 . . . . 0.85999999999999999 110.172 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 39.2 m -60.51 -56.78 17.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.94999999999999996 110.243 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.87 -16.38 59.3 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.94 -0.648 . . . . 0.46000000000000002 112.278 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.08 -61.56 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.425 . . . . 1.75 110.596 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.77 -21.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.828 -0.624 . . . . 1.78 111.804 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.99 42.09 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.021 0.439 . . . . 0.38 110.949 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.08 -23.75 28.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 1.97 110.712 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.92 19.15 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.76000000000000001 110.853 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -75.68 129.05 36.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 1.47 110.977 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.57 -42.62 5.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 2.5 110.7 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.535 ' HB2' HG12 ' B' ' 127' ' ' VAL . 78.7 mtt180 -79.48 148.22 31.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 2.73 110.269 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.39 -22.33 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 2.2000000000000002 111.942 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 31.5 p90 -83.86 -25.98 29.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.685 0.279 . . . . 3.3999999999999999 111.222 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.535 HG12 ' HB2' ' B' ' 124' ' ' ARG . 8.6 p -83.28 -23.74 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 1.23 110.519 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.67 -37.93 66.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.775 -0.648 . . . . 3.04 110.991 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.68 -19.96 47.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.4 . . . . 4.1399999999999997 110.885 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' B' ' 127' ' ' VAL . 98.7 mt -76.22 -60.37 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 1.6499999999999999 111.139 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -62.74 -28.67 70.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.77000000000000002 111.26 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.4 -59.25 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 1.46 110.838 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.3 pt -61.45 -25.81 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 1.6299999999999999 111.446 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -66.4 -39.39 88.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 1.4199999999999999 111.035 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.71 31.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.816 -0.707 . . . . 0.48999999999999999 112.671 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' B' ' 180' ' ' PRO . 35.5 m -61.75 -32.42 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.65 0.262 . . . . 1.3 111.376 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.65 -30.55 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.3 111.076 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.03 78.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.412 . . . . 0.62 110.825 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.49 -28.41 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 1.74 110.972 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.17 -57.84 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.368 -0.378 . . . . 1.76 111.708 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.462 HG13 ' N ' ' B' ' 142' ' ' ILE . 40.2 pt -55.96 -43.29 74.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.893 0.331 . . . . 0.68999999999999995 111.893 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.462 ' N ' HG13 ' B' ' 141' ' ' ILE . 8.9 tp -72.57 -28.36 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.705 0.288 . . . . 1.76 111.252 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.03 -57.33 13.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 1.0600000000000001 110.797 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -63.82 -27.19 69.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 4.1200000000000001 110.559 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' B' ' 149' ' ' PRO . . . -78.21 -17.26 78.42 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.775 -0.726 . . . . 1.26 112.491 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.7 tt -109.2 0.31 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 1.98 111.467 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -86.09 -55.01 4.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.846 0.313 . . . . 1.4199999999999999 111.846 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.604 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 34.0 m120 -101.73 -51.38 0.16 Allowed Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.324 0.49 . . . . 99.989999999999995 112.324 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 85.6 Cg_exo -46.46 -24.18 2.57 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.121 1.881 . . . . 2.6499999999999999 112.709 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.21 -45.72 79.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.419 . . . . 4.3899999999999997 110.169 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.571 ' O ' HG22 ' B' ' 154' ' ' THR . 14.3 ptp180 -163.67 66.68 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 7.9000000000000004 110.515 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' B' ' 148' ' ' ASN . . . -83.28 -18.24 39.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 2.77 111.35 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -86.55 -25.27 25.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 6.29 111.637 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' THR . . . . . 0.571 HG22 ' O ' ' B' ' 151' ' ' ARG . 7.7 t -61.99 -19.33 62.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.633 0.254 . . . . 3.1000000000000001 111.301 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -58.16 -35.38 71.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.395 . . . . 6.4299999999999997 110.845 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 69.6 p -89.85 -22.82 21.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 4.5700000000000003 110.874 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -78.33 -75.42 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 3.8300000000000001 111.011 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 65.3 m -127.1 113.15 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 3.0699999999999998 111.122 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 50.7 m -77.79 -20.79 52.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 3.4300000000000002 111.014 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -70.85 -49.83 41.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 3.9199999999999999 111.129 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 41.8 tp -67.4 -28.98 68.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.396 -0.366 . . . . 2.7000000000000002 110.86 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.28 -27.52 60.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 1.8300000000000001 111.197 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -76.17 -31.08 58.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.294 -0.412 . . . . 2.6299999999999999 111.164 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt -67.8 -57.49 6.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.343 -0.39 . . . . 2.4300000000000002 110.968 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -22.3 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 2.5800000000000001 110.885 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.78 -54.08 47.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 2.0 110.837 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -63.26 -30.8 71.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 3.0299999999999998 110.919 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.87 -56.66 9.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 1.1000000000000001 111.147 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.86 -23.01 30.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 1.75 111.443 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 52.2 m -56.41 -58.54 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.95 0.405 . . . . 0.97999999999999998 110.582 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.36 -33.65 71.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 4.2999999999999998 110.515 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -64.78 -35.42 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 1.3899999999999999 111.278 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 53.1 m -72.83 -54.12 9.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.346 -0.388 . . . . 1.1100000000000001 111.639 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.66 -26.49 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.885 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -77.05 -57.78 3.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 1.75 111.279 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.22 -27.54 55.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.59999999999999998 110.862 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.503 ' O ' HG12 ' B' ' 181' ' ' ILE . 85.7 mt -87.65 -23.88 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 1.47 110.214 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.26 -55.44 29.48 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.55000000000000004 113.029 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 60.3 m-85 -54.23 -55.35 37.82 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.854 0.327 . . . . 1.6200000000000001 111.257 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.5 Cg_exo -45.22 -32.22 7.0 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.323 2.016 . . . . 0.64000000000000001 113.016 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.509 ' O ' HG22 ' B' ' 184' ' ' ILE . 47.1 mm -67.26 -61.13 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.392 -0.367 . . . . 1.27 111.739 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.465 HG22 ' O ' ' B' ' 179' ' ' TYR . 21.0 m -57.26 -24.76 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.68999999999999995 112.005 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -62.82 -23.65 67.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.407 -0.361 . . . . 1.1799999999999999 111.906 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.601 HG23 HG23 ' B' ' 185' ' ' ILE . 16.7 tt -57.54 -38.07 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.737 0.273 . . . . 1.77 111.737 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.601 HG23 HG23 ' B' ' 184' ' ' ILE . 26.1 pt -102.34 156.6 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.759 0.314 . . . . 1.6899999999999999 111.137 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.39 -165.81 32.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.725 -0.75 . . . . 1.5800000000000001 112.46 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.33 154.5 71.91 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.519 2.146 . . . . 2.5099999999999998 112.161 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 69.9 m 57.72 17.97 4.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 3.5800000000000001 110.667 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -135.1 -63.94 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.91 -0.587 . . . . 4.0300000000000002 112.23 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -155.09 -43.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 6.8899999999999997 110.4 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 99.69 117.39 3.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.861 -0.685 . . . . 3.7000000000000002 113.035 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -167.93 -28.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 7.5 110.71 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 25.8 pt -114.02 174.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 2.3500000000000001 111.17 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -78.56 -166.09 0.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.266 -0.425 . . . . 3.8599999999999999 110.931 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -88.43 -46.37 9.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 5.0499999999999998 111.009 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 24.4 m -58.45 -29.72 66.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.292 -0.413 . . . . 2.6800000000000002 111.219 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 80.9 mt -72.3 -42.83 65.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 2.4700000000000002 111.081 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -53.83 -51.99 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 2.5299999999999998 110.647 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 61.6 p -63.03 -44.13 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.29 110.967 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.53 -28.83 48.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 2.6200000000000001 110.965 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -84.13 -51.62 6.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 1.6100000000000001 111.779 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -69.34 -2.07 9.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.9 0.333 . . . . 1.4199999999999999 111.9 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -96.83 -42.0 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.044 0.45 . . . . 1.4299999999999999 110.5 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.6 tp -71.82 -33.44 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.629 . . . . 1.1200000000000001 111.844 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.691 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.1 tp -62.8 -54.36 47.96 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.57 -0.252 . . . . 1.26 111.44 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.9 Cg_exo -55.66 -41.22 79.83 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.884 1.723 . . . . 0.59999999999999998 111.415 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -58.71 -36.48 74.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.037 0.446 . . . . 1.3999999999999999 110.173 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.28 -31.9 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 110.507 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 31.3 t -79.38 -30.25 42.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.78 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.783 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.87 -38.25 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.499 . . . . 1.6899999999999999 111.047 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.48 -36.64 93.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.79000000000000004 112.653 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.66 -29.2 66.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 2.96 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -62.85 -61.24 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 1.29 110.878 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -64.0 -22.13 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 3.1499999999999999 110.745 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.408 ' C ' HD13 ' B' ' 216' ' ' LEU . 3.2 tm? -71.48 -49.36 42.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 1.51 110.674 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.52 -31.95 72.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 2.1899999999999999 110.852 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.74 -38.27 90.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 1.98 110.724 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -85.28 -20.65 29.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 2.1699999999999999 111.017 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.21 -36.1 73.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.902 -0.666 . . . . 1.3600000000000001 112.762 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 94.4 mt -59.42 -37.22 77.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.681 0.277 . . . . 2.8999999999999999 111.262 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 61.24 -84.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.113 -0.494 . . . . 5.6100000000000003 111.242 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -115.78 169.35 9.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.388 -0.369 . . . . 4.04 110.697 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.97 90.51 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 6.2999999999999998 110.973 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -117.57 -62.62 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 4.7999999999999998 110.826 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.68 153.09 44.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 6.3899999999999997 110.963 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.6 t -166.46 4.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.252 -0.431 . . . . 5.6100000000000003 111.028 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -149.68 127.27 11.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.427 . . . . 8.1999999999999993 110.761 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 8.1699999999999999 110.956 -179.759 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.842 0.353 . . . . 5.6200000000000001 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -141.15 -26.7 0.71 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.315 -0.402 . . . . 5.2800000000000002 111.169 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.22 93.21 4.14 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.386 -0.37 . . . . 6.0499999999999998 110.997 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -139.2 -68.63 0.43 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 4.79 110.847 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 89.9 p -80.63 166.74 20.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 2.71 110.924 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.465 HD23 ' N ' ' C' ' 6' ' ' LEU . 2.5 pt? -148.94 -6.03 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 2.52 111.221 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.12 -45.06 82.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.382 -0.372 . . . . 1.9299999999999999 111.084 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 22.7 m80 -68.26 -25.27 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 1.26 110.782 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -73.07 -48.34 36.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 1.6699999999999999 110.887 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.9 -21.07 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 1.8700000000000001 110.156 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.73 -57.48 9.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 1.4399999999999999 110.711 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.3 -31.75 49.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.199 -0.455 . . . . 0.46999999999999997 111.106 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.4 81.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 0.58999999999999997 111.301 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.07 -24.36 75.89 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.5 112.656 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -77.15 -34.73 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.68000000000000005 111.166 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 46.7 m -65.44 -48.71 71.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 1.3999999999999999 110.997 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ILE . . . . . 0.406 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.7 pp -63.82 -29.38 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.379 -0.373 . . . . 1.55 110.952 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.406 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -58.4 -51.74 56.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.70999999999999996 112.389 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 -24.06 66.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.77000000000000002 111.217 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 52.6 tp -67.71 -39.17 84.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 1.9299999999999999 110.731 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.12 -27.62 67.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 1.8600000000000001 110.618 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.63 -39.98 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.94 -0.573 . . . . 4.1399999999999997 110.788 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -62.92 -48.14 80.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 3.1499999999999999 110.763 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 55.1 m -68.54 -19.66 64.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.95 111.359 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.474 ' HG ' HE22 ' C' ' 34' ' ' GLN . 54.1 tp -83.34 -20.68 33.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.439 -0.346 . . . . 2.2200000000000002 111.307 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 75.8 p -60.43 -21.59 62.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.686 -0.234 . . . . 1.3700000000000001 111.096 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -52.03 -31.3 29.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 5.0300000000000002 109.809 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.9 p-10 -171.9 131.91 0.75 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 2.3700000000000001 110.293 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.7 Cg_endo -96.54 178.07 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.19 2.594 . . . . 2.0499999999999998 112.15 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -103.43 67.48 0.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 4.5199999999999996 110.908 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.07 -45.16 2.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 2.1600000000000001 112.93 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -100.28 133.87 21.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.496 0.184 . . . . 2.5299999999999998 111.496 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -48.83 161.72 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.722 2.281 . . . . 1.9299999999999999 112.747 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLN . . . . . 0.474 HE22 ' HG ' ' C' ' 25' ' ' LEU . 84.7 mm-40 -66.53 -17.56 64.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.544 -0.753 . . . . 4.1200000000000001 112.658 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -41.36 -38.22 1.17 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.812 0.301 . . . . 2.8900000000000001 111.812 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.33 -53.09 58.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 2.46 110.684 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -66.73 -19.04 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 2.7799999999999998 110.739 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' C' ' 41' ' ' MET . 22.2 tp -61.06 -49.61 76.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.094 0.473 . . . . 1.6200000000000001 110.207 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.42 -42.43 96.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.025 -0.534 . . . . 1.5900000000000001 110.093 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -6.8 35.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.797 -0.638 . . . . 0.65000000000000002 110.872 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 25.8 ttt -87.87 -33.22 18.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 1.6699999999999999 110.402 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' C' ' 45' ' ' ILE . 34.3 t80 -71.37 -36.99 71.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 3.4199999999999999 111.32 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.501 HG23 HG23 ' C' ' 79' ' ' THR . 74.7 mt -49.33 -53.4 40.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.132 0.419 . . . . 0.89000000000000001 112.132 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.27 -33.21 11.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.171 1.914 . . . . 0.40999999999999998 112.912 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 41' ' ' MET . 77.2 mt -53.3 -62.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.631 0.253 . . . . 1.76 111.452 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -62.87 -56.08 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.446 -0.343 . . . . 2.1600000000000001 111.216 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' SER . . . . . 0.41 ' HG ' ' HA ' ' C' ' 44' ' ' PRO . 98.6 p -51.73 -23.07 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.045 -0.525 . . . . 1.1699999999999999 111.212 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.34 -64.62 2.69 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.45 -0.881 . . . . 0.44 112.058 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.94 -28.67 62.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 1.29 110.914 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 -58.79 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.5 111.16 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 18.4 m-85 -60.93 -40.62 93.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.387 . . . . 1.8300000000000001 110.972 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.0 ttp -49.48 -38.34 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.439 . . . . 1.47 110.021 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.34 82.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.59999999999999998 110.649 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 56.3 mtt -54.89 -33.08 61.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.83999999999999997 110.174 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.7 -38.48 73.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.821 -0.627 . . . . 0.65000000000000002 110.385 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mt -80.44 -0.42 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 1.55 110.527 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.32 41.84 12.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.794 -0.639 . . . . 1.54 111.177 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -117.05 134.92 54.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 1.79 110.612 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.89 37.66 1.66 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.833 -0.699 . . . . 0.93999999999999995 112.222 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -154.11 132.49 11.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 2.3599999999999999 111.119 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -114.1 142.1 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 1.97 110.836 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.13 96.05 8.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 2.4399999999999999 111.056 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.44 124.71 43.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 1.54 110.962 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.31 27.19 16.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 1.71 111.139 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -13.59 57.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.802 -0.713 . . . . 1.53 112.517 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -100.78 145.15 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.883 0.373 . . . . 2.23 111.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -89.96 135.72 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.769 -0.651 . . . . 1.3600000000000001 110.934 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.92 138.39 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.78000000000000003 111.386 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -88.71 64.55 7.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 1.0800000000000001 110.802 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.57 -35.3 77.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 2.2999999999999998 111.01 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.56 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.75 111.576 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.522 HH22 ' HB2' ' C' ' 203' ' ' CYS . 27.3 mmt180 -70.79 -51.29 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 1.51 111.751 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -47.76 74.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.55 -0.296 . . . . 4.6500000000000004 111.65 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.42 -40.49 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.696 0.628 . . . . 1.22 112.696 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.48 -28.5 69.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.398 -0.521 . . . . 1.3100000000000001 110.37 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -88.54 4.1 47.96 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.181 -0.463 . . . . 1.6799999999999999 111.035 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.651 ' HA ' HD13 ' C' ' 113' ' ' ILE . 50.3 tpp -95.97 -20.09 19.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 1.8 109.994 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.437 ' O ' HD23 ' C' ' 82' ' ' LEU . 12.5 m -114.38 -38.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.582 -0.736 . . . . 1.1899999999999999 111.653 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.501 HG23 HG23 ' C' ' 43' ' ' ILE . 78.4 m -73.65 -55.89 5.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.23 111.998 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 17.9 m -50.1 -51.85 58.55 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.505 0.557 . . . . 0.58999999999999997 112.505 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.2 Cg_exo -53.21 -42.64 63.48 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.781 1.654 . . . . 0.67000000000000004 111.791 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.437 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.1 mm? -67.92 -32.55 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.95999999999999996 110.004 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.497 ' O ' HD23 ' C' ' 87' ' ' LEU . 0.2 OUTLIER -68.87 -25.92 64.87 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.833 -0.802 . . . . 1.1899999999999999 108.833 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' C' ' 109' ' ' GLN . 24.0 tp -80.63 -38.21 29.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.014 -0.994 . . . . 1.7 110.311 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' LEU . . . . . 0.435 ' HG ' ' HE1' ' C' ' 89' ' ' TRP . 19.7 tp -65.84 -52.78 47.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.208 -0.906 . . . . 1.6200000000000001 111.15 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.3 p -50.93 -44.17 60.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 1.26 111.395 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.497 HD23 ' O ' ' C' ' 83' ' ' LEU . 3.6 mm? -62.37 -33.48 74.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 1.1100000000000001 111.184 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 57.7 m -70.87 -22.67 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 1.51 111.196 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' TRP . . . . . 0.435 ' HE1' ' HG ' ' C' ' 85' ' ' LEU . 93.4 m95 -80.72 -52.12 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 2.0600000000000001 111.233 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 90' ' ' THR . . . . . 0.437 HG23 HD21 ' C' ' 168' ' ' LEU . 9.8 t -62.71 -27.55 69.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 1.52 111.36 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' C' ' 165' ' ' TYR . . . -80.47 -22.97 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.174 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.0 mtp -110.53 102.34 10.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 1.6200000000000001 110.882 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.98 -40.44 39.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 3.2400000000000002 110.897 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -108.14 138.64 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.6299999999999999 111.038 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.1 pt -145.31 146.76 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 2.1800000000000002 110.969 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.63 -74.79 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.948 0.404 . . . . 4.1200000000000001 111.067 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -139.07 25.89 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 4.96 110.771 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.73 129.68 38.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 3.9100000000000001 110.741 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -151.28 -28.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 5.21 110.832 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 1.7 t -63.99 -46.31 85.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.215 -0.448 . . . . 1.8200000000000001 111.475 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.71 -37.19 86.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 2.0800000000000001 110.823 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.87 -29.16 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.8600000000000001 110.64 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.26 -30.26 46.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.956 -0.64 . . . . 0.58999999999999997 112.602 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -71.84 -25.24 61.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 1.53 110.461 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 mt -77.69 -49.38 14.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.1100000000000001 110.81 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.2 ptm -64.95 -24.26 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 2.21 111.045 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 94.5 p -72.33 -50.24 28.33 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.022 0.439 . . . . 1.28 110.504 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -60.03 -24.8 64.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.077 -0.51 . . . . 1.22 110.976 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.507 ' HB2' HD22 ' C' ' 84' ' ' LEU . 24.8 tp60 -66.98 -52.12 46.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 2.3300000000000001 110.613 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.9 -35.41 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.004 -0.544 . . . . 1.29 110.758 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.26 -45.36 98.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 1.0600000000000001 110.929 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.54 -47.86 89.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.51000000000000001 111.394 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' C' ' 77' ' ' MET . 19.7 mt -59.4 -32.55 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 1.3700000000000001 111.009 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -60.5 -43.65 96.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.459 . . . . 0.77000000000000002 110.508 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -59.22 -53.96 52.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 1.1899999999999999 110.428 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.54 -25.56 68.87 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.789 -0.719 . . . . 0.5 111.826 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.402 HD23 ' C ' ' C' ' 117' ' ' LEU . 5.4 tt -60.19 -55.9 28.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.29 0.567 . . . . 1.47 110.329 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' C' ' 121' ' ' LEU . 4.8 tp -81.22 -28.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 1.2 112.188 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.33 46.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.40000000000000002 111.233 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -79.68 -31.15 41.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 2.1200000000000001 110.843 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.547 ' HB2' HD12 ' C' ' 118' ' ' ILE . 73.9 mt -80.79 7.49 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.323 -0.399 . . . . 0.75 110.912 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.0 t -63.42 122.98 17.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 1.3799999999999999 111.223 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.03 -51.55 3.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 2.7400000000000002 110.704 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.661 ' HB2' HG12 ' C' ' 127' ' ' VAL . 90.6 mtt180 -75.65 143.78 42.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 2.7999999999999998 110.662 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.07 -19.09 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 111.667 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -79.46 -54.47 5.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.709 0.29 . . . . 4.2000000000000002 111.108 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' C' ' 124' ' ' ARG . 14.2 p -59.69 -24.04 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 1.0800000000000001 111.367 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -51.52 -47.55 63.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.34 -0.391 . . . . 2.5699999999999998 111.302 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.24 -24.78 62.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.334 -0.393 . . . . 3.8100000000000001 111.339 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.453 HD13 HD13 ' B' ' 56' ' ' ILE . 95.6 mt -72.65 -52.21 16.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.4199999999999999 111.166 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.27 -28.7 66.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.89000000000000001 110.792 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -59.84 -60.41 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.823 -0.626 . . . . 1.26 110.451 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' C' ' 136' ' ' VAL . 16.4 tt -63.95 -26.23 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.917 -0.583 . . . . 1.6799999999999999 111.087 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.54 -35.29 80.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 1.24 110.793 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.61 -53.75 7.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.81 -0.709 . . . . 0.54000000000000004 112.587 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' C' ' 133' ' ' ILE . 34.1 m -59.46 -30.75 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.321 . . . . 1.0600000000000001 111.352 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.8 -35.27 72.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0800000000000001 110.67 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.58 93.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.8 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 139' ' ' PHE . . . . . 0.401 ' HA ' HG12 ' C' ' 142' ' ' ILE . 79.3 t80 -73.16 -24.04 60.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.903 -0.59 . . . . 1.6799999999999999 111.083 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -60.94 2.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 1.7 111.357 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.416 HG13 ' N ' ' C' ' 142' ' ' ILE . 17.6 pt -58.34 -45.71 89.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.608 0.596 . . . . 0.78000000000000003 112.608 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.416 ' N ' HG13 ' C' ' 141' ' ' ILE . 41.8 pt -66.44 -32.26 57.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.685 0.254 . . . . 2.2400000000000002 111.685 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 56.5 tp -55.76 -56.64 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.603 0.239 . . . . 1.02 110.901 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -64.79 -24.52 67.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 3.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 145' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' C' ' 149' ' ' PRO . . . -79.38 -17.37 76.26 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.343 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 146' ' ' ILE . . . . . 0.4 HG13 ' O ' ' C' ' 142' ' ' ILE . 68.8 mt -109.24 -12.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.957 0.408 . . . . 1.8899999999999999 111.031 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -72.4 -55.4 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 1.6000000000000001 111.998 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.616 ' HB2' ' HD3' ' C' ' 149' ' ' PRO . 34.0 m120 -101.92 -53.12 0.15 Allowed Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.406 0.521 . . . . 99.989999999999995 112.406 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.616 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 88.5 Cg_exo -45.04 -25.28 1.63 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.409 2.073 . . . . 2.73 112.853 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.27 -52.96 34.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 4.2999999999999998 110.058 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -149.09 62.89 1.04 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 8.9000000000000004 110.857 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.73 -19.06 38.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.158 -0.473 . . . . 2.7999999999999998 110.925 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -84.03 -24.16 30.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 5.4400000000000004 111.166 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 75.5 p -68.15 -10.39 53.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 3.3900000000000001 110.941 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -65.64 -26.0 67.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.02 -0.536 . . . . 6.9199999999999999 110.761 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 8.0 t -110.96 -2.12 16.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 4.8700000000000001 111.197 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -93.11 -68.95 0.77 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 4.0499999999999998 110.991 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 69.9 m -134.83 115.71 13.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 3.0299999999999998 110.732 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 64.7 m -73.63 -34.54 65.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 2.96 111.374 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -59.34 -54.09 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.823 0.344 . . . . 3.7400000000000002 111.023 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 49.4 tp -58.28 -34.34 70.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.244 -0.434 . . . . 2.6499999999999999 110.842 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.05 -31.6 68.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.016 -0.538 . . . . 1.77 111.2 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -67.26 -36.74 82.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.293 -0.412 . . . . 2.96 110.684 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.31 -46.4 77.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.243 0.545 . . . . 2.3500000000000001 110.469 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 165' ' ' TYR . . . . . 0.523 ' CE2' ' HB1' ' C' ' 91' ' ' ALA . 0.4 OUTLIER -61.62 -36.03 79.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 2.6200000000000001 111.108 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.82 -56.22 17.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 2.0899999999999999 111.539 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 167' ' ' LYS . . . . . 0.418 ' O ' HG22 ' C' ' 170' ' ' THR . 68.5 mttm -59.34 -22.21 60.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 3.2400000000000002 111.461 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.437 HD21 HG23 ' C' ' 90' ' ' THR . 56.3 tp -81.95 -59.05 2.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 1.6899999999999999 111.413 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.67 -29.27 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.3999999999999999 112.192 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 170' ' ' THR . . . . . 0.418 HG22 ' O ' ' C' ' 167' ' ' LYS . 15.3 t -57.05 -36.17 70.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.95999999999999996 110.988 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -77.32 -34.71 55.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 3.6499999999999999 109.943 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.24 -22.59 63.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.688 -0.687 . . . . 1.3700000000000001 110.474 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 90.6 m -79.52 -58.56 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 1.4299999999999999 111.264 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.68 -28.52 32.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 1.6200000000000001 111.785 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.424 HD21 ' OG ' ' C' ' 209' ' ' SER . 46.8 tp -73.34 -57.4 4.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 2.0299999999999998 111.163 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.78 -25.55 60.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.62 110.875 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 86.4 mt -87.89 -21.57 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.045 0.45 . . . . 1.5800000000000001 110.414 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 178' ' ' GLY . . . . . 0.527 ' O ' HG22 ' C' ' 181' ' ' ILE . . . -63.4 -41.6 99.33 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.56000000000000005 112.998 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.525 ' N ' ' HD2' ' C' ' 180' ' ' PRO . 55.5 m-85 -64.47 -52.03 55.82 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 111.988 0.366 . . . . 1.3300000000000001 111.988 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.588 ' HA ' ' NE1' ' C' ' 183' ' ' TRP . 33.1 Cg_endo -63.76 -16.78 56.78 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.01 1.807 . . . . 0.63 113.326 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.527 HG22 ' O ' ' C' ' 178' ' ' GLY . 3.6 tt -88.99 -27.09 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 112.483 0.549 . . . . 0.93000000000000005 112.483 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.429 HG13 ' N ' ' C' ' 183' ' ' TRP . 3.8 p -80.88 -53.78 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.47 0.915 . . . . 1.27 113.47 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 183' ' ' TRP . . . . . 0.588 ' NE1' ' HA ' ' C' ' 180' ' ' PRO . 0.2 OUTLIER -58.32 -12.11 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.198 0.444 . . . . 1.77 112.198 -178.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.99 -18.84 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.996 0.427 . . . . 2.3900000000000001 110.703 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 2.4 pt -126.67 91.76 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.858 -0.61 . . . . 1.95 111.201 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 151.46 -161.69 29.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.968 -0.635 . . . . 1.8799999999999999 112.157 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.86 149.19 42.85 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.556 2.171 . . . . 3.1200000000000001 111.893 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 94.1 p 51.34 24.61 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.092 -0.504 . . . . 2.6299999999999999 110.947 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -139.02 -91.5 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.872 -0.604 . . . . 3.04 112.238 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -125.0 -32.66 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.357 . . . . 5.6900000000000004 110.66 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 86.52 123.64 1.58 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 3.0800000000000001 112.785 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -174.66 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 7.5300000000000002 110.694 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 22.8 pt -106.98 179.56 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 2.8599999999999999 111.271 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 194' ' ' ASN . . . . . 0.634 ' H ' HD12 ' C' ' 197' ' ' ILE . 75.8 m-20 -86.57 -167.3 1.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.093 -0.503 . . . . 3.6899999999999999 111.087 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -83.71 -47.66 10.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 5.4800000000000004 110.965 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.7 p -60.93 -27.43 68.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 2.3799999999999999 111.408 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 197' ' ' ILE . . . . . 0.634 HD12 ' H ' ' C' ' 194' ' ' ASN . 88.3 mt -72.97 -45.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.403 -0.362 . . . . 2.23 111.295 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.25 -46.97 76.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 2.1600000000000001 110.894 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -69.52 -26.92 64.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 1.27 111.08 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -69.71 -33.36 72.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 1.7 110.981 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.22 -45.53 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 2.02 111.396 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -67.5 -7.44 25.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 1.8200000000000001 111.266 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.522 ' HB2' HH22 ' C' ' 72' ' ' ARG . 44.3 t -96.47 -43.52 7.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 1.3500000000000001 110.568 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 39.4 tp -67.82 -37.05 81.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.48 -0.782 . . . . 0.65000000000000002 112.149 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.609 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.4 OUTLIER -60.86 -55.21 46.97 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.942 -0.303 . . . . 1.4199999999999999 111.446 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 66.8 Cg_exo -53.75 -36.78 83.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.691 1.594 . . . . 0.63 111.368 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.86 -46.15 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 1.49 109.985 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -68.29 -16.55 64.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 1.7 110.483 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 209' ' ' SER . . . . . 0.424 ' OG ' HD21 ' C' ' 175' ' ' LEU . 30.6 t -93.83 -27.7 16.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 1.25 110.914 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.761 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.86 -35.01 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.421 . . . . 1.6100000000000001 111.094 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.89 -40.11 98.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.81999999999999995 112.333 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.93 -27.92 67.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 3.0800000000000001 110.97 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 52.9 m -61.44 -57.15 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 1.1499999999999999 110.967 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.86 -29.41 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 2.5600000000000001 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.451 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.1 tm? -66.04 -40.44 90.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 1.29 110.535 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.01 -22.06 60.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.082 -0.508 . . . . 2.3900000000000001 110.459 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 43.8 tp -74.5 -42.07 59.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 2.0299999999999998 110.552 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -85.13 -20.27 30.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 3.21 111.025 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.57 49.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.991 -0.623 . . . . 1.3600000000000001 112.714 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.7 -29.61 69.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.733 0.301 . . . . 2.8999999999999999 111.192 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 60.93 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.031 -0.531 . . . . 4.8899999999999997 111.385 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -133.48 148.9 51.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.361 -0.381 . . . . 4.2300000000000004 110.823 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 72.9 mt -92.64 113.98 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 6.1200000000000001 111.026 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -146.2 -45.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 4.5499999999999998 110.853 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.81 132.78 39.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 6.7800000000000002 110.862 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 47.3 t -131.31 -49.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 5.4000000000000004 110.906 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.81 178.83 6.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 8.3300000000000001 110.758 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 7.9100000000000001 110.824 179.911 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.811 0.339 . . . . 5.1100000000000003 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -100.2 -13.71 18.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 5.04 110.958 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -86.04 86.95 7.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.287 -0.415 . . . . 5.5800000000000001 111.05 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -119.49 145.35 46.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.29 -0.414 . . . . 5.0199999999999996 110.733 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -153.69 127.79 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.39 -0.368 . . . . 2.4500000000000002 111.082 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.0 mt -92.19 4.5 53.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 2.4199999999999999 110.775 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.85 -52.33 44.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 2.0899999999999999 110.555 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 40.6 m-70 -68.42 -23.55 64.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.89 -0.596 . . . . 1.1599999999999999 110.101 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -66.57 -52.17 48.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.681 . . . . 0.79000000000000004 111.115 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.0 pt -68.53 -21.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0800000000000001 110.773 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -60.6 -55.06 37.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 1.28 110.56 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.98 -36.24 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.966 -0.561 . . . . 1.3200000000000001 111.127 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.43 -37.63 73.12 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.935 0.398 . . . . 0.63 110.92 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.04 -29.41 58.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.721 -0.752 . . . . 0.55000000000000004 112.178 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -74.81 -31.72 61.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.299 . . . . 1.03 111.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 p -68.11 -50.19 56.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.481 -0.327 . . . . 1.3 111.111 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.47 -26.58 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.287 -0.415 . . . . 1.3100000000000001 110.725 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.49 44.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.61 -0.805 . . . . 0.77000000000000002 111.9 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -64.79 -23.48 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.903 0.382 . . . . 0.80000000000000004 110.716 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -68.78 -41.62 78.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.08 -0.509 . . . . 1.8100000000000001 110.776 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -60.54 -23.53 64.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 1.8799999999999999 110.305 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 84.7 t80 -60.84 -31.9 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.659 -0.7 . . . . 4.4500000000000002 110.566 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.466 ' O ' ' OG ' ' A' ' 26' ' ' SER . 68.4 t-105 -78.51 -45.52 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 3.6899999999999999 110.531 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 p -65.9 -19.72 65.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.978 -0.555 . . . . 1.5700000000000001 110.748 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.96 -12.74 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 1.95 110.743 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 72.7 p -69.64 -18.53 63.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 1.3799999999999999 111.01 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -49.56 -32.98 13.73 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.36 0.6 . . . . 4.0700000000000003 109.575 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -176.86 131.82 0.37 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.959 -1.018 . . . . 2.7200000000000002 110.096 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HB3' ' NE2' ' A' ' 34' ' ' GLN . 72.5 Cg_endo -95.54 177.41 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.007 2.471 . . . . 1.9099999999999999 112.224 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -99.36 63.8 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 4.7599999999999998 111.298 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -46.55 3.5 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.751 -0.737 . . . . 1.99 112.554 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.6 146.43 31.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.526 0.203 . . . . 2.7000000000000002 110.776 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.64 165.49 18.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.367 2.044 . . . . 1.79 112.399 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 29' ' ' PRO . 27.4 mm-40 -72.32 -15.86 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.412 -0.813 . . . . 4.1200000000000001 112.016 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -40.27 -38.98 0.86 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.334 0.494 . . . . 2.9300000000000002 112.334 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 37' ' ' TYR . 11.7 pt-20 -64.84 -46.9 79.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 2.8799999999999999 110.568 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 73.8 m-85 -70.49 -18.6 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 4.6600000000000001 110.488 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 41' ' ' MET . 54.3 tp -63.2 -49.28 74.86 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.219 -0.446 . . . . 1.45 110.321 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -63.5 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.174 0.511 . . . . 1.78 109.663 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 -5.01 40.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.588 -0.733 . . . . 0.63 110.475 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.475 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 22.0 ttt -88.25 -34.07 17.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.094 -0.503 . . . . 1.48 110.473 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.443 ' HA ' HD12 ' A' ' 45' ' ' ILE . 44.3 t80 -75.67 -31.4 59.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 3.5 110.883 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.704 HG23 HG23 ' A' ' 79' ' ' THR . 85.2 mt -52.54 -51.75 70.17 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.336 -0.393 . . . . 1.0800000000000001 111.597 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' C ' ' A' ' 41' ' ' MET . 73.5 Cg_endo -74.3 -32.21 6.76 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.408 2.072 . . . . 0.53000000000000003 112.804 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 42' ' ' PHE . 72.0 mt -53.67 -61.62 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.633 0.254 . . . . 1.6799999999999999 111.539 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.482 ' NE1' HG22 ' B' ' 110' ' ' ILE . 2.1 t90 -64.8 -51.42 62.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.688 0.28 . . . . 1.8300000000000001 111.064 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 44' ' ' PRO . 95.8 p -57.67 -14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.325 -0.398 . . . . 1.0900000000000001 111.196 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.77 -57.95 2.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.40999999999999998 112.491 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.78 -28.41 65.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.98999999999999999 111.032 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.36 -59.36 5.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.541 . . . . 0.47999999999999998 111.267 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 16.0 m-85 -59.47 -43.07 93.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 1.8700000000000001 111.126 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.9 ttp -48.24 -35.4 11.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.187 0.518 . . . . 1.49 110.216 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -67.99 -43.85 77.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.72 -0.673 . . . . 0.58999999999999997 110.648 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 56.1 mtt -52.12 -27.83 15.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.48999999999999999 110.244 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.11 -45.26 58.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.719 -0.673 . . . . 0.59999999999999998 110.622 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 53' ' ' ALA . 20.8 pt -84.18 11.15 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 1.3100000000000001 111.109 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 60.05 50.59 6.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.923 -0.58 . . . . 1.9099999999999999 111.675 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.02 158.25 30.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 1.6200000000000001 110.937 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.23 34.55 32.55 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.733 -0.746 . . . . 1.04 112.307 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -129.9 136.37 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.309 . . . . 2.6800000000000002 110.896 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.3 140.13 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 1.98 111.259 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.82 89.99 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 2.1800000000000002 111.034 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.74 126.11 42.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.332 -0.394 . . . . 1.5700000000000001 111.407 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 34.87 24.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 1.79 111.54 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.17 -0.31 59.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.823 -0.704 . . . . 1.48 112.835 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -98.35 134.27 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.673 0.273 . . . . 2.3199999999999998 110.771 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 mt -89.3 103.79 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 1.4399999999999999 110.942 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.38 135.52 38.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.81999999999999995 110.861 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 53.0 m-70 -82.65 73.71 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.186 0.517 . . . . 0.90000000000000002 110.723 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -58.92 -28.89 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.45 -0.795 . . . . 1.8300000000000001 111.458 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -82.04 -23.96 35.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.62 111.805 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 12.9 tpp180 -67.24 -51.27 55.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 2.3399999999999999 112.386 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 9.1 p90 -82.53 -32.5 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.275 0.472 . . . . 3.4900000000000002 112.275 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 71' ' ' ALA . 17.0 tt -55.23 -42.15 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 C-N-CA 120.713 -0.395 . . . . 1.3700000000000001 110.489 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.33 -22.81 64.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.445 -0.576 . . . . 1.3100000000000001 109.445 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -87.79 5.13 41.56 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.475 -0.784 . . . . 1.48 111.103 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.485 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.3 ttm -104.59 -18.18 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 1.46 110.494 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.415 ' O ' HD23 ' A' ' 82' ' ' LEU . 35.2 m -114.05 -35.29 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 1.1200000000000001 111.517 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.704 HG23 HG23 ' A' ' 43' ' ' ILE . 87.9 m -82.14 -49.0 10.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.246 -0.434 . . . . 1.1000000000000001 111.648 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.582 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.8 m -53.39 -49.92 85.65 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.199 -0.455 . . . . 0.59999999999999998 112.197 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.9 Cg_endo -58.88 -41.51 61.68 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.97 1.78 . . . . 0.73999999999999999 112.17 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -78.8 -7.97 58.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 1.01 110.894 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -81.42 -40.29 23.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.796 0.332 . . . . 1.48 110.283 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 109' ' ' GLN . 3.6 pp -81.62 -31.59 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.3799999999999999 110.223 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.54 -27.94 63.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 1.1899999999999999 110.319 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -63.69 -24.68 67.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 1.23 110.399 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.09 -52.53 18.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.88 110.739 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.2 t -60.21 -21.41 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 1.3899999999999999 110.838 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -76.4 -36.59 57.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 2.3199999999999998 111.052 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 p -80.92 -23.44 38.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 1.46 111.353 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 -37.14 17.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 1.24 111.21 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.9 ttt -97.74 99.42 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 2.0699999999999998 110.435 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -85.91 -48.8 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 3.5299999999999998 111.244 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -104.57 137.32 42.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 4.0800000000000001 111.067 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 pt -123.71 151.43 28.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 2.1699999999999999 110.843 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.12 -54.49 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 4.5199999999999996 110.558 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -150.12 -159.59 1.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 3.75 110.438 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 64.68 105.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.024 0.44 . . . . 3.5299999999999998 111.228 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -119.53 15.86 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.609 . . . . 4.9100000000000001 110.553 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.3 t -87.16 -21.25 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 1.98 110.834 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.47 -51.52 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 1.8300000000000001 110.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -59.19 -30.68 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 1.79 111.081 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.1 -27.19 64.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.62 112.542 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -73.43 -38.41 65.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 1.5800000000000001 110.972 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.3 mt -71.74 -32.54 67.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.97999999999999998 111.119 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.466 ' O ' HG12 ' A' ' 110' ' ' ILE . 61.1 mtt -74.23 -25.3 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 1.48 111.11 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -76.95 -49.44 15.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 1.1299999999999999 111.256 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.5 t -62.41 -35.43 79.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 1.48 111.949 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.591 ' HB3' HD21 ' A' ' 84' ' ' LEU . 13.8 pt20 -67.3 -42.05 84.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.567 0.223 . . . . 2.7000000000000002 111.465 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 106' ' ' MET . 33.1 mm -60.05 -33.45 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.827 0.346 . . . . 1.54 111.067 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.29 -44.6 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.28 111.458 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.64 -50.09 77.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.42999999999999999 111.864 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.412 HD12 ' HG3' ' A' ' 77' ' ' MET . 48.5 pt -57.2 -33.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.626 0.25 . . . . 1.74 111.437 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 85.4 m -63.67 -47.61 80.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.63 111.12 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -63.81 -21.76 66.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.163 -0.471 . . . . 1.0900000000000001 110.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.61 -46.44 7.32 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.937 -0.649 . . . . 0.41999999999999998 112.95 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -66.75 -29.13 69.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.52 0.2 . . . . 1.3799999999999999 111.53 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.1 tp -83.46 -28.4 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.551 -0.295 . . . . 1.6200000000000001 111.161 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.68 71.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.39000000000000001 110.803 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.08 -23.55 41.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 2.02 110.783 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.404 ' HB2' HD12 ' A' ' 118' ' ' ILE . 84.2 mt -83.59 23.72 0.93 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.76000000000000001 110.837 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.1 t -76.31 137.04 39.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 1.46 110.967 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.07 -34.54 8.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 3.3500000000000001 110.922 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.57 ' HB2' HG12 ' A' ' 127' ' ' VAL . 98.5 mtt180 -116.48 143.09 46.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 2.9199999999999999 110.982 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -74.68 -12.11 60.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 2.77 111.137 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -86.58 -39.53 16.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 3.77 111.072 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 124' ' ' ARG . 14.5 p -77.78 -24.23 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 1.1599999999999999 111.086 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -57.62 -29.28 64.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.005 -0.543 . . . . 2.04 110.754 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.03 -31.42 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 2.6400000000000001 110.964 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 127' ' ' VAL . 3.5 mm? -73.31 -42.28 62.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.067 -0.515 . . . . 1.8999999999999999 111.163 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -74.17 -31.65 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 1.3999999999999999 110.995 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.46 -56.96 15.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.28 110.654 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.8 tt -62.17 -29.4 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.233 -0.439 . . . . 2.1600000000000001 110.933 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.5 t -61.18 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 1.6899999999999999 111.197 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' HA3' H142 ' A' ' 210' ' ' LYR . . . -72.26 -52.53 10.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.675 -0.774 . . . . 0.52000000000000002 112.535 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.21 -29.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 1.02 111.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 36.4 t -64.44 -42.43 96.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0800000000000001 110.747 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.05 93.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.62 110.925 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -76.73 -15.8 59.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 1.8400000000000001 111.02 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.67 -55.1 6.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.372 . . . . 1.6899999999999999 110.621 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.53 -34.92 63.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.81000000000000005 111.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 146' ' ' ILE . 39.8 mm -71.44 -44.12 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 2.3700000000000001 110.969 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.23 -56.06 24.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.97999999999999998 110.931 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -63.04 -21.89 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 3.27 111.097 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.74 -20.44 61.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 1.25 112.866 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 142' ' ' ILE . 70.3 mt -99.56 -12.68 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.458 . . . . 2.1200000000000001 110.783 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -69.0 -50.64 47.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 1.6599999999999999 111.577 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 69.1 m-80 -53.48 -53.13 60.09 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 99.989999999999995 112.143 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 36.2 Cg_endo -63.9 -10.47 22.87 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.096 1.864 . . . . 2.6000000000000001 112.845 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.28 46.29 2.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.516 -0.311 . . . . 4.6100000000000003 111.237 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -173.04 -65.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 8.3599999999999994 110.963 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.73 -36.45 37.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 2.75 111.25 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -79.96 -22.71 42.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 5.6799999999999997 110.979 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 157' ' ' GLN . 40.1 p -86.76 -4.49 59.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 3.21 111.534 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -63.07 -38.5 91.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.503 -0.317 . . . . 6.8700000000000001 110.889 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 t -100.11 -21.27 15.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 4.5599999999999996 110.842 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 154' ' ' THR . 23.3 tp60 -68.17 -75.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.002 -0.544 . . . . 3.5600000000000001 110.933 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.6 m -156.43 122.62 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 2.79 110.645 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 68.3 p -77.22 -25.79 52.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.073 -0.512 . . . . 2.5899999999999999 111.0 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -69.1 -57.05 5.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 3.4700000000000002 110.941 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 164' ' ' LEU . 6.7 mp -66.95 -23.66 65.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 2.5800000000000001 111.023 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.53 -47.24 82.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 1.78 111.046 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -66.62 -33.81 76.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 2.6299999999999999 110.698 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 161' ' ' LEU . 92.5 mt -57.76 -60.76 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 2.3399999999999999 110.675 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.64 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 2.77 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -38.85 68.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 2.04 110.921 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.07 -22.79 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.256 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 74.9 mt -73.99 -60.04 2.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.361 -0.381 . . . . 1.8899999999999999 111.135 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.0 t -55.84 -23.84 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.883 -0.598 . . . . 1.6399999999999999 111.45 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.9 m -56.18 -58.94 5.83 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.841 0.353 . . . . 1.24 111.262 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.43 -30.66 69.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 2.9700000000000002 110.805 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.81 -28.65 69.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 1.48 111.05 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.403 HG22 HD12 ' A' ' 177' ' ' ILE . 55.2 m -77.91 -56.64 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 1.55 111.283 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.62 -28.76 28.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.573 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.89 -57.77 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 1.8500000000000001 111.405 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.3 -27.29 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.62 110.885 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.529 ' O ' HG12 ' A' ' 181' ' ' ILE . 90.9 mt -87.73 -25.0 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.235 -0.439 . . . . 1.3500000000000001 110.3 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 181' ' ' ILE . . . -55.81 -55.9 26.61 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.872 -0.603 . . . . 0.58999999999999997 113.311 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.0 m-85 -53.33 -55.8 30.83 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.765 -0.374 . . . . 1.45 110.788 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.2 Cg_exo -45.45 -33.34 9.1 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.084 1.856 . . . . 0.55000000000000004 112.423 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.1 mm -59.39 -53.82 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 121.024 0.44 . . . . 1.4199999999999999 110.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.5 m -58.43 -24.23 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.78000000000000003 111.082 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.558 ' CD1' H191 ' A' ' 210' ' ' LYR . 83.7 m95 -83.88 -16.45 44.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.93999999999999995 111.773 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 93.4 mt -50.7 -37.41 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.818 0.342 . . . . 1.4299999999999999 110.95 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 185' ' ' ILE . 2.2 pp -141.72 157.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.404 . . . . 2.02 111.333 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.427 ' HA3' ' N ' ' A' ' 191' ' ' GLY . . . 87.12 158.01 31.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.927 -0.654 . . . . 1.79 113.285 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.91 90.02 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.755 2.303 . . . . 3.1000000000000001 112.27 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 55.3 m 55.1 50.56 15.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 2.7400000000000002 110.991 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.72 -106.84 0.19 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.695 -0.764 . . . . 3.4300000000000002 112.802 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -150.61 10.94 0.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.197 0.523 . . . . 6.5 110.265 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.427 ' N ' ' HA3' ' A' ' 186' ' ' GLY . . . 83.36 145.51 6.24 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.867 -0.683 . . . . 3.29 112.564 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 71.6 m95 59.41 10.73 1.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.537 0.208 . . . . 6.1600000000000001 111.35 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.55 142.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 2.4199999999999999 111.58 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 195' ' ' GLN . 56.3 t30 -157.17 -11.27 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.66 . . . . 4.29 110.126 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.401 ' H ' ' H ' ' A' ' 194' ' ' ASN . 89.2 mt-30 -74.97 -157.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.608 -0.724 . . . . 5.1500000000000004 110.914 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.6 m -57.58 -28.53 63.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 2.4500000000000002 111.332 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 86.1 mt -57.18 -40.51 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.441 -0.345 . . . . 2.48 111.275 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.85 -56.12 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 2.1800000000000002 110.888 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.2 p -64.91 -31.67 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 1.49 110.969 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -61.47 -30.89 70.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.03 -0.532 . . . . 1.77 111.084 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.71 -52.45 15.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 1.4199999999999999 111.199 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.94 -6.42 41.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.572 -0.285 . . . . 1.78 111.373 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 29.1 t -96.24 -39.7 9.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 1.3 110.543 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.8 -40.99 65.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.622 -0.717 . . . . 0.66000000000000003 112.094 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -56.39 -54.74 49.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.149 -0.221 . . . . 1.6299999999999999 111.405 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.5 Cg_exo -55.76 -45.18 41.0 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.829 1.686 . . . . 0.64000000000000001 111.538 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.01 -24.62 66.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 1.3600000000000001 110.464 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -81.95 -21.86 36.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 1.54 110.693 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 92.6 p -95.5 -39.95 9.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 1.2 111.112 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.775 H183 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.42 -31.69 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.446 -0.343 . . . . 1.6399999999999999 111.295 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.69 -45.26 90.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.674 -0.774 . . . . 0.79000000000000004 112.916 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -69.72 -28.68 66.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.62 0.248 . . . . 1.6100000000000001 111.196 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -55.19 -62.06 1.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.432 -0.349 . . . . 1.1499999999999999 110.836 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -64.66 -29.34 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 3.3399999999999999 110.46 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.05 -45.98 91.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 1.1899999999999999 110.589 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.21 -35.08 79.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 2.23 110.517 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.065 -0.516 . . . . 2.4700000000000002 110.351 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -83.77 -25.91 30.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 1.6200000000000001 110.847 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -79.47 -24.39 60.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 1.4099999999999999 112.34 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 27.0 tp -77.9 -6.29 53.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 2.5800000000000001 110.747 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -58.37 -75.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.02 -0.536 . . . . 4.9299999999999997 111.23 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -63.85 142.44 58.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 4.6299999999999999 111.034 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.5 mt 61.34 110.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.904 -0.589 . . . . 6.4699999999999998 111.354 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -136.02 85.26 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 5.0700000000000003 110.473 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -131.19 131.06 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 6.5300000000000002 110.982 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.7 t -164.84 103.46 0.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 5.2199999999999998 111.007 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -131.72 82.83 2.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.186 -0.461 . . . . 8.3599999999999994 111.205 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 7.96 110.808 179.803 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mmm . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.856 0.36 . . . . 6.1699999999999999 110.743 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -110.31 9.53 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 4.8200000000000003 110.928 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.56 63.62 0.65 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 5.5999999999999996 110.947 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -96.09 151.82 19.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.043 -0.526 . . . . 4.7999999999999998 110.859 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 92.3 p -159.83 130.9 5.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.447 . . . . 2.3700000000000001 110.965 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.457 ' N ' HD12 ' B' ' 6' ' ' LEU . 6.7 mp -92.7 -3.02 55.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 2.0699999999999998 110.824 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.413 HD13 ' HD1' ' B' ' 200' ' ' PHE . 57.4 mt -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 2.1000000000000001 111.004 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.642 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.0 m80 -80.01 -24.42 40.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 1.0700000000000001 110.505 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -73.66 -35.34 65.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 1.48 110.812 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 tt -80.73 -26.52 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 2.02 110.693 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' B' ' 15' ' ' MET . 41.8 t80 -62.09 -47.41 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.92000000000000004 110.271 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.43 -36.94 74.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.93999999999999995 111.084 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -36.11 79.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.55000000000000004 110.978 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.74 59.15 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.781 -0.723 . . . . 0.47999999999999998 112.311 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 23.1 mmt -72.73 -27.78 62.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 0.84999999999999998 110.785 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -64.88 -56.41 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 1.3400000000000001 110.88 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.4 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -61.28 -24.94 34.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.044 -0.525 . . . . 1.55 110.984 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.4 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -58.69 -57.72 18.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.636 -0.792 . . . . 0.69999999999999996 112.199 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.661 ' HA ' ' HG3' ' B' ' 41' ' ' MET . . . -62.85 -23.41 67.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.81000000000000005 110.788 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.95 -39.2 83.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 2.2599999999999998 110.571 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -61.41 -22.55 65.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.912 -0.586 . . . . 1.78 110.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' B' ' 34' ' ' GLN . 73.8 t80 -61.04 -40.55 94.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 4.5800000000000001 110.358 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.489 ' O ' ' OG ' ' B' ' 26' ' ' SER . 68.7 m95 -70.8 -41.45 71.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.795 -0.639 . . . . 3.3500000000000001 110.593 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -69.7 -20.81 63.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 1.5800000000000001 110.869 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.88 -15.84 35.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.47 . . . . 1.8400000000000001 110.713 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 67.0 p -67.2 -17.07 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 1.3700000000000001 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.33 -33.67 13.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.409 -0.589 . . . . 4.9800000000000004 109.409 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -177.68 131.63 0.33 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 114.997 -1.002 . . . . 2.1400000000000001 110.216 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -93.8 169.15 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.915 2.41 . . . . 1.8200000000000001 112.251 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -96.41 60.97 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.458 . . . . 5.1900000000000004 110.901 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.9 -46.67 3.66 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.791 -0.718 . . . . 2.2000000000000002 112.416 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . 7.4 p -88.14 131.65 42.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.473 0.177 . . . . 3.6499999999999999 110.631 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 35.4 Cg_exo -59.82 156.66 36.94 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.241 1.961 . . . . 2.6699999999999999 112.054 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLN . . . . . 0.407 ' HB3' ' CZ ' ' B' ' 22' ' ' PHE . 28.0 mm-40 -61.19 -17.72 54.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 4.8799999999999999 112.459 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' B' ' 38' ' ' LEU . 3.6 p90 -43.89 -36.51 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.787 0.327 . . . . 1.8700000000000001 111.567 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.64 -57.12 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 2.6800000000000002 110.664 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -66.77 -18.74 65.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 2.9199999999999999 110.637 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 45.4 tp -57.11 -55.6 32.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 1.6399999999999999 110.152 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.74 -42.9 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 1.6000000000000001 110.524 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.46 -12.44 52.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.68999999999999995 111.138 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.661 ' HG3' ' HA ' ' B' ' 19' ' ' ALA . 0.0 OUTLIER -88.6 -31.03 18.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.358 -0.383 . . . . 2.5800000000000001 111.289 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.49 ' HA ' HD12 ' B' ' 45' ' ' ILE . 36.9 m-85 -72.08 -27.62 62.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 3.3900000000000001 110.386 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.595 HG23 HG23 ' B' ' 79' ' ' THR . 65.3 mt -58.28 -53.94 60.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.085 -0.507 . . . . 0.40999999999999998 112.003 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' C ' ' B' ' 41' ' ' MET . 45.2 Cg_endo -67.75 -35.14 22.56 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.17 1.913 . . . . 0.48999999999999999 112.986 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' B' ' 42' ' ' PHE . 97.0 mt -53.78 -62.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.762 0.282 . . . . 1.29 111.762 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.552 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.7 t90 -61.3 -50.11 74.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.744 0.307 . . . . 1.3999999999999999 111.08 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 59.5 m -60.27 -14.02 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 1.3799999999999999 111.495 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.9 -55.71 3.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.714 -0.755 . . . . 0.37 112.709 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.442 HD22 ' SG ' ' C' ' 134' ' ' CYS . 24.0 mt -58.74 -32.08 68.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.857 0.361 . . . . 1.29 111.084 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.44 111.313 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 9.0 m-85 -60.7 -41.41 95.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.5 110.993 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -50.67 -32.36 18.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.135 0.493 . . . . 1.4099999999999999 110.1 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.7 -39.86 69.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.55000000000000004 110.504 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -54.97 -28.21 49.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.284 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -73.31 -49.51 27.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.737 -0.665 . . . . 0.54000000000000004 110.817 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.43 HG12 ' HA ' ' B' ' 53' ' ' ALA . 36.1 pt -79.52 8.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.471 . . . . 1.3 111.459 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.32 60.73 2.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.055 -0.52 . . . . 2.2400000000000002 111.31 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -143.86 139.99 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.907 0.384 . . . . 1.77 110.876 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.38 5.63 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.882 -0.675 . . . . 1.0600000000000001 112.101 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.62 150.22 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.664 0.268 . . . . 2.6600000000000001 110.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.99 148.0 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 1.8899999999999999 111.077 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.21 93.68 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 2.4100000000000001 110.838 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.32 125.18 50.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 111.279 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.49 30.61 18.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.989 -0.55 . . . . 1.8200000000000001 111.275 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.86 57.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.727 -0.749 . . . . 1.51 112.563 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -107.15 127.61 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.757 0.313 . . . . 2.4500000000000002 110.821 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 45.0 mm -77.37 105.27 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 1.79 111.088 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.8 134.52 37.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.81999999999999995 110.943 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.497 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 81.8 m-70 -79.83 76.18 6.52 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.132 0.492 . . . . 1.05 111.1 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -62.42 -28.0 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.485 -0.78 . . . . 1.8700000000000001 111.082 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -82.27 -28.0 32.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.299 0.481 . . . . 0.60999999999999999 112.299 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 29.2 mmt180 -66.56 -51.51 55.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.629 0.603 . . . . 2.3900000000000001 112.629 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' B' ' 77' ' ' MET . 18.5 p90 -82.89 -30.03 28.84 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.29 -0.564 . . . . 3.6699999999999999 112.497 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' B' ' 71' ' ' ALA . 15.2 tt -56.33 -42.15 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.291 -0.563 . . . . 1.6599999999999999 110.221 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' B' ' 74' ' ' ILE . 26.2 t70 -69.39 -22.25 63.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.996 -0.742 . . . . 1.4099999999999999 108.996 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -86.56 7.65 25.33 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.342 -0.844 . . . . 1.1599999999999999 111.034 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.471 ' HA ' HD13 ' B' ' 113' ' ' ILE . 22.0 mtp -104.73 -21.59 13.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 1.53 110.797 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 m -114.08 -28.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.89000000000000001 111.897 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.595 HG23 HG23 ' B' ' 43' ' ' ILE . 37.8 m -82.21 -52.45 6.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.266 -0.424 . . . . 1.24 112.093 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.578 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 16.9 m -52.4 -49.73 83.8 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.54 0.57 . . . . 0.57999999999999996 112.54 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' B' ' 80' ' ' THR . 12.4 Cg_endo -56.08 -45.52 37.71 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.781 1.654 . . . . 0.66000000000000003 112.262 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.64 -19.47 61.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 1.0600000000000001 110.797 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.32 -30.96 57.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 1.22 110.197 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.534 HD13 ' NE2' ' B' ' 109' ' ' GLN . 4.8 tt -84.69 -27.92 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.642 -0.708 . . . . 1.53 110.128 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.96 -33.84 39.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 1.5800000000000001 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -58.75 -28.08 65.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 1.3899999999999999 111.223 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.499 HD22 HD11 ' B' ' 168' ' ' LEU . 52.9 mt -73.36 -34.23 65.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.4 . . . . 1.1499999999999999 111.12 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.4 m -73.46 -27.04 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.418 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -76.73 -38.62 53.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.349 . . . . 2.1699999999999999 111.12 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -62.41 -41.55 98.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.376 -0.375 . . . . 1.4199999999999999 111.138 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.62 -47.49 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 1.1799999999999999 111.314 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 49.3 tpp -80.4 98.58 7.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 1.8799999999999999 110.784 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -87.8 -37.34 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 3.4199999999999999 110.926 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.31 143.19 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 4.0599999999999996 111.012 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.07 142.24 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 2.0899999999999999 110.579 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -123.96 -74.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 3.8500000000000001 111.159 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -156.03 108.46 2.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 4.8200000000000003 111.034 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.1 -73.62 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 110.66 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 81.8 m95 53.67 36.35 23.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 5.1699999999999999 111.323 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.5 t -120.58 -41.51 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 2.02 111.022 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 96.5 mt -74.31 -38.49 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.16 -0.473 . . . . 2.0899999999999999 110.959 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.5 tt -56.12 -33.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 1.8799999999999999 111.17 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.17 -29.89 36.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.728 -0.748 . . . . 0.56000000000000005 112.287 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.91 -24.51 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 1.78 110.835 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -78.54 -50.08 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 1.03 110.993 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' MET . . . . . 0.471 ' O ' HG13 ' B' ' 110' ' ' ILE . 24.6 ptm -60.49 -31.83 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 1.6699999999999999 111.043 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 42' ' ' PHE . 77.6 p -67.29 -51.96 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 1.51 111.6 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.465 ' HB ' HD13 ' B' ' 142' ' ' ILE . 71.3 p -57.92 -25.98 61.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 1.1799999999999999 111.741 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.534 ' NE2' HD13 ' B' ' 84' ' ' LEU . 18.6 mm-40 -78.31 -41.72 32.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 2.1699999999999999 111.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.482 HG22 ' NE1' ' A' ' 46' ' ' TRP . 93.4 mt -56.4 -38.1 54.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 1.3500000000000001 111.8 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.415 HG23 ' N ' ' B' ' 112' ' ' VAL . 29.7 m -72.57 -45.56 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.918 0.34 . . . . 1.3400000000000001 111.918 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.508 HG13 H133 ' B' ' 210' ' ' LYR . 84.2 t -60.12 -45.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.631 0.253 . . . . 0.42999999999999999 111.586 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' B' ' 77' ' ' MET . 66.3 mt -64.43 -34.75 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 1.6000000000000001 111.463 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.4 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.4 m -55.2 -61.0 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.85999999999999999 111.234 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.9 p -57.31 -27.44 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.94999999999999996 111.061 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.11 -49.14 59.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.46000000000000002 112.909 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.563 HD12 HG13 ' B' ' 118' ' ' ILE . 3.3 pp -74.21 -21.88 59.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.686 0.254 . . . . 1.75 111.686 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.563 HG13 HD12 ' B' ' 117' ' ' LEU . 82.5 mt -83.4 -33.17 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.687 0.28 . . . . 1.78 111.215 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.15 71.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.38 110.968 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.26 -25.22 46.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 1.97 111.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.78 31.24 0.7 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.405 -0.361 . . . . 0.76000000000000001 110.886 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -82.76 130.96 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.05 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -98.55 -42.98 7.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 2.5 110.673 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.47 ' HB2' HG12 ' B' ' 127' ' ' VAL . 91.4 mtt180 -98.18 146.36 25.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 2.73 110.285 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -80.37 -16.38 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.429 0.529 . . . . 2.2000000000000002 112.429 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.465 ' HE1' ' HD3' ' B' ' 124' ' ' ARG . 67.1 p-90 -93.33 -22.44 18.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.688 0.255 . . . . 3.3999999999999999 111.688 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.529 HG23 HD12 ' B' ' 130' ' ' LEU . 7.3 p -83.66 -23.33 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 1.23 110.945 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -57.76 -35.31 70.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 3.04 110.968 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -68.88 -22.15 64.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 4.1399999999999997 111.283 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.529 HD12 HG23 ' B' ' 127' ' ' VAL . 90.5 mt -76.75 -54.27 6.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 1.6499999999999999 111.141 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.96 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.483 -0.326 . . . . 0.77000000000000002 110.885 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -60.47 -50.06 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 1.46 110.595 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.6 mt -62.74 -30.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 1.6299999999999999 110.822 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 36.1 t -65.65 -41.01 93.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 1.4199999999999999 110.872 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.482 ' HA3' H142 ' B' ' 210' ' ' LYR . . . -61.31 -54.1 39.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.908 -0.663 . . . . 0.48999999999999999 112.365 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 5.8 p -63.46 -39.0 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 1.3 111.067 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.7 t -52.34 -43.56 64.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.286 -0.416 . . . . 1.3 110.7 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.65 84.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.62 110.688 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -71.56 -23.56 61.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 1.74 110.992 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -73.33 -61.08 1.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.379 -0.373 . . . . 1.76 111.266 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.422 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.2 pt -51.88 -37.45 21.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.68999999999999995 111.453 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' B' ' 108' ' ' THR . 85.3 mt -73.45 -41.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 1.76 110.891 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 tp -56.97 -57.92 10.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 1.0600000000000001 110.885 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -62.62 -21.86 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 4.1200000000000001 110.643 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -20.78 59.57 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.85 -0.69 . . . . 1.26 112.989 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.9 pt -100.4 -5.62 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.864 0.332 . . . . 1.98 111.178 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.61 -42.99 17.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 1.4199999999999999 110.98 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.577 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 32.0 m120 -58.23 -50.47 87.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 99.989999999999995 111.828 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 19.5 Cg_endo -58.92 -14.98 24.96 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.045 1.83 . . . . 2.6499999999999999 112.186 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 71.4 mt -107.11 147.63 29.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.574 . . . . 4.3899999999999997 110.208 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.443 ' HD2' ' HB1' ' B' ' 162' ' ' ALA . 17.6 mmm180 66.8 -76.9 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.351 -0.386 . . . . 7.9000000000000004 111.729 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.29 -46.33 72.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.044 0.387 . . . . 2.77 112.044 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' B' ' 149' ' ' PRO . 10.7 mmmm -81.35 -29.58 34.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.348 -0.387 . . . . 6.29 111.556 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 79.1 p -86.74 5.06 38.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.566 -0.288 . . . . 3.1000000000000001 111.445 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -56.85 -28.37 61.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.942 0.401 . . . . 6.4299999999999997 110.577 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 50.8 m -108.23 -25.57 10.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.61 . . . . 4.5700000000000003 110.574 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.43 -68.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 3.8300000000000001 110.861 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 40.4 t -166.11 118.34 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 3.0699999999999998 110.605 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 70.0 m -76.33 -25.92 55.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 3.4300000000000002 110.985 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.7 -57.77 9.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 3.9199999999999999 110.74 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 7.9 mp -65.27 -21.28 66.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.411 . . . . 2.7000000000000002 110.787 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ALA . . . . . 0.443 ' HB1' ' HD2' ' B' ' 151' ' ' ARG . . . -68.94 -32.62 72.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.504 . . . . 1.8300000000000001 111.1 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -75.47 -41.38 55.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.46 . . . . 2.6299999999999999 110.719 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.73 -45.03 91.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.604 . . . . 2.4300000000000002 110.884 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.04 -24.75 60.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 2.5800000000000001 111.12 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.1 -44.66 96.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 2.0 110.719 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -79.72 -21.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 3.0299999999999998 110.77 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.499 HD11 HD22 ' B' ' 87' ' ' LEU . 27.8 tp -68.17 -53.16 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 1.1000000000000001 110.817 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.35 -28.26 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 1.75 111.028 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.7 m -49.09 -57.97 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.97999999999999998 111.29 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.51 -28.83 67.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.279 -0.419 . . . . 4.2999999999999998 110.526 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -63.8 -30.62 71.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 1.3899999999999999 111.481 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 81.6 p -78.82 -59.05 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.595 -0.275 . . . . 1.1100000000000001 111.485 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.6 p -52.89 -29.91 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.526 -0.306 . . . . 1.51 111.645 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.97 -58.19 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 1.75 111.107 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.95 -25.95 61.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.59999999999999998 110.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.467 ' O ' HG13 ' B' ' 181' ' ' ILE . 80.4 mt -87.99 -27.59 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.061 -0.518 . . . . 1.47 110.269 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.95 -52.62 41.87 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.817 -0.629 . . . . 0.55000000000000004 113.124 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.643 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 94.4 m-85 -56.49 -58.05 19.4 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.927 -0.309 . . . . 1.6200000000000001 111.095 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 90.6 Cg_exo -42.68 -38.77 6.69 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.171 1.914 . . . . 0.64000000000000001 112.924 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.467 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.6 mt -58.5 -55.39 22.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.34 -0.391 . . . . 1.27 111.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.628 HG22 ' O ' ' B' ' 179' ' ' TYR . 1.9 m -55.17 -23.88 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.02 -0.536 . . . . 0.68999999999999995 111.497 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 183' ' ' TRP . . . . . 0.583 ' CD1' H191 ' B' ' 210' ' ' LYR . 88.3 m95 -80.88 -33.3 34.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.074 0.398 . . . . 1.1799999999999999 112.074 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 tt -88.29 25.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.443 . . . . 1.77 111.561 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' B' ' 190' ' ' PHE . 42.6 pt -134.69 -21.4 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.466 -0.334 . . . . 1.6899999999999999 111.533 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -162.53 167.28 36.98 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.438 -0.887 . . . . 1.5800000000000001 112.834 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.42 91.96 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.632 2.221 . . . . 2.5099999999999998 112.529 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 34.7 t 54.44 52.81 11.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.007 -0.542 . . . . 3.5800000000000001 111.11 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -177.02 -117.27 0.5 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.204 -0.998 . . . . 4.0300000000000002 113.054 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.552 ' H ' HD11 ' B' ' 193' ' ' ILE . 33.4 t80 -128.77 -19.31 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 6.8899999999999997 110.682 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 121.38 134.34 4.55 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 3.7000000000000002 112.452 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 57.68 17.57 4.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.68 0.276 . . . . 7.5 111.024 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.552 HD11 ' H ' ' B' ' 190' ' ' PHE . 37.5 pt -125.97 142.14 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.002 0.429 . . . . 2.3500000000000001 111.577 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -153.86 2.61 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.75 -0.659 . . . . 3.8599999999999999 110.516 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -85.57 -161.88 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.813 -0.63 . . . . 5.0499999999999998 110.803 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 75.2 p -59.27 -27.56 65.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.465 -0.334 . . . . 2.6800000000000002 111.147 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 7.9 tp -58.34 -31.04 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 2.4700000000000002 111.188 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.39 -57.49 12.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 2.5299999999999998 110.864 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 199' ' ' THR . . . . . 0.413 ' HB ' HH21 ' B' ' 72' ' ' ARG . 53.3 p -64.77 -31.05 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 1.29 110.932 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 200' ' ' PHE . . . . . 0.413 ' HD1' HD13 ' B' ' 7' ' ' LEU . 68.1 t80 -60.98 -27.55 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 2.6200000000000001 110.635 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.47 -50.25 14.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 1.6100000000000001 110.886 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -73.14 -7.91 53.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 1.4199999999999999 111.317 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.33 -38.39 10.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 1.4299999999999999 110.862 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.5 tp -73.72 -40.98 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 1.1200000000000001 112.065 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.577 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 2.3 tt -56.27 -54.29 54.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 121.126 -0.23 . . . . 1.26 111.34 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -56.51 -43.9 50.96 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.822 1.682 . . . . 0.59999999999999998 111.373 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.518 ' O ' HG22 ' B' ' 211' ' ' VAL . 89.9 t80 -60.11 -32.74 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 1.3999999999999999 110.29 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -74.3 -19.26 60.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.825 -0.625 . . . . 1.4099999999999999 110.608 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.6 t -95.79 -48.57 5.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.3200000000000001 111.032 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.734 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 207' ' ' PHE . 16.1 m -78.77 -27.42 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 1.6899999999999999 111.037 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.11 -46.65 93.83 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.899 -0.667 . . . . 0.79000000000000004 112.453 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -73.24 -22.7 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.618 0.247 . . . . 2.96 110.719 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 60.5 m -60.59 -58.02 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.402 -0.363 . . . . 1.29 110.517 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -67.57 -30.09 69.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 3.1499999999999999 110.26 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.23 -44.21 97.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.6 . . . . 1.51 110.367 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.19 -38.4 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 2.1899999999999999 110.589 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.47 -29.45 69.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.039 -0.528 . . . . 1.98 111.215 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -84.86 -42.18 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 2.1699999999999999 111.218 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.2 -39.4 81.19 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.857 -0.687 . . . . 1.3600000000000001 112.514 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.69 -32.26 73.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 2.8999999999999999 111.015 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -77.91 82.3 4.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.27 -0.423 . . . . 5.6100000000000003 111.03 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -169.89 -36.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 4.04 110.789 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 65.1 tp -167.58 102.27 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 6.2999999999999998 110.829 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -100.66 128.34 46.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 4.7999999999999998 110.848 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -165.76 105.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 6.3899999999999997 111.019 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 38.6 t -158.86 101.68 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 5.6100000000000003 110.786 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -77.71 -65.44 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 8.1999999999999993 111.063 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 8.1699999999999999 110.874 -179.843 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.853 0.359 . . . . 5.6200000000000001 110.992 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -107.58 -38.23 5.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 5.2800000000000002 110.883 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 63.0 tp -90.58 129.53 36.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 6.0499999999999998 111.017 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -154.15 108.3 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 4.79 110.869 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 51.3 m -119.03 110.84 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 2.71 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.601 HD23 ' H ' ' C' ' 6' ' ' LEU . 2.7 pt? -70.95 -8.54 53.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 2.52 110.971 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 18.1 tp -60.88 -52.68 64.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 1.9299999999999999 110.669 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.654 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 33.1 m170 -61.55 -23.95 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 1.26 110.766 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -75.52 -42.08 53.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 1.6699999999999999 111.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.71 -22.28 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 1.8700000000000001 110.642 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -66.18 -48.32 71.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.533 . . . . 1.4399999999999999 110.31 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.73 -31.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.46999999999999997 110.565 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.81 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.58999999999999997 111.1 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.59 73.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.5 112.486 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -78.37 -33.76 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 0.68000000000000005 110.764 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 89.2 m -61.59 -51.77 67.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 1.3999999999999999 110.815 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ILE . . . . . 0.407 ' O ' HD12 ' C' ' 17' ' ' ILE . 1.9 tp -60.19 -39.69 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.135 -0.484 . . . . 1.55 110.965 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.54 -57.6 6.5 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.675 -0.774 . . . . 0.70999999999999996 112.156 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.32 69.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.36 . . . . 0.77000000000000002 111.106 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.77 -27.53 66.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.515 . . . . 1.9299999999999999 111.26 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -60.34 -25.26 65.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 1.8600000000000001 110.72 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' C' ' 37' ' ' TYR . 37.4 m-85 -79.99 -22.97 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 4.1399999999999997 110.75 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' TRP . . . . . 0.657 ' O ' ' OG ' ' C' ' 26' ' ' SER . 70.9 t-105 -69.81 -35.8 75.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.566 -0.531 . . . . 3.1499999999999999 109.566 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 45.0 t -85.18 -33.21 22.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.544 -0.753 . . . . 1.95 110.468 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 tp -71.91 -20.72 61.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 2.2200000000000002 110.41 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 0.7 OUTLIER -57.2 -25.53 59.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.873 -0.603 . . . . 1.3700000000000001 110.514 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -44.82 -37.61 3.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.143 0.497 . . . . 5.0300000000000002 110.134 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 24.3 p-10 -172.59 132.08 0.67 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.409 -0.814 . . . . 2.3700000000000001 110.287 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 60.0 Cg_endo -97.01 169.93 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.016 2.478 . . . . 2.0499999999999998 112.05 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -96.17 64.5 2.33 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.833 0.349 . . . . 4.5199999999999996 111.543 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.11 -46.58 3.41 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.834 -0.698 . . . . 2.1600000000000001 112.803 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.455 HG21 HD22 ' C' ' 221' ' ' LEU . 94.4 t -89.19 131.88 39.42 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.453 0.168 . . . . 2.5299999999999998 110.815 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 25.4 Cg_exo -61.12 157.69 38.32 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.347 2.031 . . . . 1.9299999999999999 112.192 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -61.79 -17.34 55.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 4.1200000000000001 112.482 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.431 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -42.16 -40.98 2.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.669 0.271 . . . . 2.8900000000000001 111.602 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -66.44 -43.61 85.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 2.46 110.575 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' C' ' 22' ' ' PHE . 98.6 m-85 -71.81 -19.13 62.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.868 -0.605 . . . . 2.7799999999999998 110.529 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' C' ' 41' ' ' MET . 30.9 tp -64.48 -48.87 73.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 1.6200000000000001 110.394 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.28 -40.38 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 1.5900000000000001 110.05 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.54 -6.81 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.65000000000000002 110.726 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.432 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 36.6 ttm -87.84 -36.01 17.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 1.6699999999999999 110.605 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' C' ' 45' ' ' ILE . 23.2 t80 -70.91 -35.53 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.858 -0.61 . . . . 3.4199999999999999 111.07 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.604 HG23 HG23 ' C' ' 79' ' ' THR . 88.5 mt -49.88 -54.49 31.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.169 0.433 . . . . 0.89000000000000001 112.169 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.4 Cg_endo -71.83 -32.83 10.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.182 1.921 . . . . 0.40999999999999998 113.164 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' C' ' 42' ' ' PHE . 69.1 mt -53.41 -62.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.853 0.316 . . . . 1.76 111.853 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -66.44 -45.91 78.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.76 0.314 . . . . 2.1600000000000001 111.074 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' SER . . . . . 0.418 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 45.8 t -61.85 -11.01 10.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 1.1699999999999999 111.266 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.52 -53.6 3.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.44 112.494 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 69.0 mt -59.22 -32.9 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.689 0.28 . . . . 1.29 110.92 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -58.28 9.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.5 111.324 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 13.4 m-85 -59.02 -45.0 91.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 1.8300000000000001 111.085 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 59.8 ttp -48.39 -30.58 5.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 1.47 110.355 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -46.13 59.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.763 -0.653 . . . . 0.59999999999999998 111.077 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 1.2 mpp? -55.52 -20.14 12.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.83999999999999997 110.824 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -78.54 -46.7 18.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.139 -0.482 . . . . 0.65000000000000002 110.293 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.75 11.01 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.844 -0.616 . . . . 1.55 111.014 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 62.6 60.45 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 1.54 111.211 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.434 ' OE1' HG11 ' A' ' 127' ' ' VAL . 16.2 mm100 -142.58 151.95 42.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.119 -0.492 . . . . 1.79 111.01 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.0 34.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.771 -0.728 . . . . 0.93999999999999995 112.574 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -133.7 135.56 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 2.3599999999999999 110.921 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.93 136.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 1.97 111.161 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.94 94.61 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 2.4399999999999999 110.841 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.12 134.8 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 1.54 110.907 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 30.73 19.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 1.71 111.024 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.93 -1.26 55.52 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 1.53 112.509 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -103.56 122.29 44.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 2.23 111.153 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.45 118.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.3600000000000001 110.947 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.4 133.65 51.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 0.78000000000000003 111.199 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 78.0 m-70 -83.93 75.92 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.075 0.464 . . . . 1.0800000000000001 110.876 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.99 -44.37 97.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.719 -0.673 . . . . 2.2999999999999998 111.323 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -66.45 -23.59 66.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.75 111.878 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 16.7 tpp180 -68.71 -51.61 39.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.302 0.482 . . . . 1.51 112.302 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' C' ' 117' ' ' LEU . 5.7 p90 -83.54 -33.13 25.55 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.068 0.396 . . . . 4.6500000000000004 112.068 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -55.85 -40.53 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 C-N-CA 120.715 -0.394 . . . . 1.22 110.583 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 26.9 t70 -68.38 -25.39 65.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.121 -0.696 . . . . 1.3100000000000001 109.121 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -86.66 9.77 17.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.453 -0.794 . . . . 1.6799999999999999 110.756 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.445 ' HA ' HG21 ' C' ' 113' ' ' ILE . 53.6 tpp -104.49 -23.27 13.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 1.8 110.011 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.4 ' O ' HD23 ' C' ' 82' ' ' LEU . 31.3 m -114.02 -30.05 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 1.1899999999999999 111.576 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.604 HG23 HG23 ' C' ' 43' ' ' ILE . 41.3 m -83.73 -44.78 14.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.448 -0.342 . . . . 1.23 111.62 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 55.8 m -56.21 -49.76 91.42 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.387 -0.37 . . . . 0.58999999999999997 111.875 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -56.47 -47.73 22.56 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.156 1.904 . . . . 0.67000000000000004 112.312 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.4 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.4 mm? -74.74 -11.2 60.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.95999999999999996 111.135 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.427 HD13 ' O ' ' C' ' 83' ' ' LEU . 0.7 OUTLIER -76.76 -47.15 22.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 1.1899999999999999 109.971 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' C' ' 109' ' ' GLN . 2.8 pp -78.99 -32.27 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 1.7 110.67 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.51 -37.33 77.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.676 -0.693 . . . . 1.6200000000000001 111.045 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.2 t -60.63 -19.52 58.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 1.26 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' C' ' 168' ' ' LEU . 71.2 mt -75.99 -34.71 59.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.081 -0.509 . . . . 1.1100000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 89.8 p -74.2 -26.09 60.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 1.51 111.102 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -75.07 -37.26 61.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.37 -0.377 . . . . 2.0600000000000001 110.83 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 72.4 p -67.96 -33.85 75.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.333 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.64 -47.66 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 1.3 111.261 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.8 mtp -86.16 100.33 12.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 1.6200000000000001 111.095 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -83.48 -42.61 16.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 3.2400000000000002 110.764 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -115.31 140.42 49.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.107 -0.497 . . . . 4.6299999999999999 111.119 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 68.1 mt -133.65 142.31 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 2.1800000000000002 110.787 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -120.43 -81.11 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 4.1200000000000001 111.205 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -143.81 97.61 3.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 4.96 111.023 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -172.85 79.66 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 3.9100000000000001 110.771 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.52 42.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 5.21 110.78 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 34.5 m -101.84 -40.54 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 1.8200000000000001 111.54 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.24 -36.72 77.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 2.0800000000000001 111.219 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.2 -41.72 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.8600000000000001 111.27 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.53 -33.52 60.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.838 -0.696 . . . . 0.58999999999999997 112.656 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.51 -52.68 64.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 1.53 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.47 -43.13 99.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 1.1100000000000001 111.357 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' MET . . . . . 0.41 ' O ' HG12 ' C' ' 110' ' ' ILE . 42.3 ttm -60.47 -32.81 71.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.526 . . . . 2.21 111.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' SER . . . . . 0.474 ' O ' HG23 ' C' ' 111' ' ' VAL . 47.2 t -78.87 -44.74 22.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.778 0.323 . . . . 1.28 111.451 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 77.6 p -64.87 -32.61 74.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 1.22 111.974 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.486 ' HB3' HD21 ' C' ' 84' ' ' LEU . 14.0 pt20 -71.32 -46.09 61.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.637 -0.256 . . . . 2.3300000000000001 111.502 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.552 HG22 ' HE1' ' B' ' 46' ' ' TRP . 35.8 mm -56.02 -34.87 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.679 0.276 . . . . 1.29 111.274 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.474 HG23 ' O ' ' C' ' 107' ' ' SER . 60.1 t -67.85 -47.69 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 1.0600000000000001 111.381 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.461 HG13 H133 ' C' ' 210' ' ' LYR . 62.7 t -61.21 -48.9 86.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 111.608 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.445 HG21 ' HA ' ' C' ' 77' ' ' MET . 47.7 mt -59.89 -34.66 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.478 -0.328 . . . . 1.3700000000000001 111.207 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 32.0 m -58.63 -48.94 79.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.77000000000000002 111.116 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' SER . . . . . 0.4 ' HA ' HG22 ' C' ' 118' ' ' ILE . 77.8 p -67.79 -22.15 65.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.21 -0.45 . . . . 1.1899999999999999 110.92 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.469 ' HA2' H182 ' C' ' 210' ' ' LYR . . . -78.04 -34.57 37.32 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.847 -0.692 . . . . 0.5 113.227 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.519 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.2 pp -81.09 -30.62 34.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.651 0.262 . . . . 1.47 111.549 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.519 ' N ' HD12 ' C' ' 117' ' ' LEU . 8.8 tp -81.03 -28.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.511 -0.313 . . . . 1.2 111.124 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -38.65 78.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.071 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.75 -17.23 48.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 2.1200000000000001 110.823 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.7 mt -91.49 26.99 2.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.15 -0.477 . . . . 0.75 111.063 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' SER . . . . . 0.434 ' HB3' ' HE ' ' C' ' 128' ' ' ARG . 44.6 t -83.22 142.76 30.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 1.3799999999999999 110.913 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.17 -41.64 5.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 2.7400000000000002 110.954 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.481 ' HB2' HG12 ' C' ' 127' ' ' VAL . 0.0 OUTLIER -98.94 142.21 30.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 2.7999999999999998 110.625 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.07 -11.33 60.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 2.4100000000000001 111.521 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -91.04 -45.84 8.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 4.2000000000000002 111.023 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -67.2 -24.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 1.0800000000000001 111.272 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 128' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' C' ' 122' ' ' SER . 43.1 ttm180 -61.76 -31.52 71.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.337 -0.392 . . . . 2.5699999999999998 111.131 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.76 -20.02 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 3.8100000000000001 110.91 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.424 HD13 HG21 ' B' ' 56' ' ' ILE . 98.8 mt -78.46 -55.75 4.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.257 -0.429 . . . . 1.4199999999999999 111.174 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -60.79 -32.27 71.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.441 -0.345 . . . . 0.89000000000000001 110.989 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -56.55 -47.2 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 1.26 110.594 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.7 mm -67.88 -30.43 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.6799999999999999 110.953 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 134' ' ' CYS . . . . . 0.442 ' SG ' HD22 ' B' ' 49' ' ' LEU . 38.3 t -64.34 -41.0 96.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 1.24 110.868 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.3 -54.26 27.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.845 -0.693 . . . . 0.54000000000000004 112.757 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 136' ' ' VAL . . . . . 0.463 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -61.42 -35.58 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.784 0.326 . . . . 1.0600000000000001 111.221 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.26 -40.05 88.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.257 -0.429 . . . . 1.0800000000000001 111.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.11 79.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 111.022 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -76.3 -28.87 57.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 1.6799999999999999 110.883 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 94.4 mt -69.8 -46.71 65.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.41 -0.359 . . . . 1.7 111.478 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.425 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.6 pt -62.02 -41.67 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.78000000000000003 111.481 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.425 ' N ' HG13 ' C' ' 141' ' ' ILE . 49.0 pt -76.34 -27.07 17.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.484 -0.325 . . . . 2.2400000000000002 111.366 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.69 -49.68 65.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.348 -0.387 . . . . 1.02 110.823 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 144' ' ' TRP . . . . . 0.445 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 85.2 t90 -68.98 -25.69 64.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.246 -0.434 . . . . 3.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.48 -17.24 66.78 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.964 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.67 -13.74 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 1.8899999999999999 111.206 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -76.51 -45.74 29.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 1.6000000000000001 111.22 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.514 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 69.1 m-80 -58.08 -50.82 85.99 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 112.113 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 48.7 Cg_endo -67.61 -0.31 5.07 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.183 1.922 . . . . 2.73 112.763 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 89.8 mt -127.07 42.42 3.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.886 0.374 . . . . 4.2999999999999998 111.204 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -169.54 -62.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 8.9000000000000004 110.863 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.65 -43.25 17.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 2.7999999999999998 111.303 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' C' ' 149' ' ' PRO . 75.7 mmtt -74.25 -9.85 59.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 5.4400000000000004 111.186 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 73.0 p -103.21 4.49 36.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.41 -0.359 . . . . 3.3900000000000001 111.589 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -67.35 -36.35 81.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 6.9199999999999999 110.93 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 4.8 t -93.63 -29.53 15.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 4.8700000000000001 111.107 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -65.33 -74.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.084 -0.507 . . . . 4.0499999999999998 111.091 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 78.4 p -157.97 122.7 4.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.974 -0.557 . . . . 3.0299999999999998 110.747 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.3 p -77.79 -29.68 50.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 2.96 111.065 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -64.45 -56.61 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 3.7400000000000002 111.055 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.16 -20.04 63.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 2.6499999999999999 110.898 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.14 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.77 111.321 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -72.26 -39.21 68.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 2.96 111.096 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 mt -60.89 -50.57 72.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 2.3500000000000001 110.997 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.74 -27.7 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 2.6200000000000001 111.12 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.72 -39.63 85.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 2.0899999999999999 110.685 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -82.84 -20.86 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 3.2400000000000002 110.816 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' C' ' 87' ' ' LEU . 36.4 tp -70.77 -57.22 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 1.6899999999999999 111.135 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 169' ' ' VAL . . . . . 0.4 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 33.2 t -62.15 -20.92 25.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 1.3999999999999999 111.295 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 20.9 m -50.43 -58.05 6.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.95999999999999996 111.271 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 171' ' ' TYR . . . . . 0.509 ' O ' HD23 ' C' ' 175' ' ' LEU . 83.4 m-85 -74.64 -26.13 59.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.121 -0.49 . . . . 3.6499999999999999 110.583 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 172' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 90.6 t80 -59.47 -40.8 88.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 1.3700000000000001 111.286 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 4.1 t -77.21 -42.79 36.08 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.747 0.277 . . . . 1.4299999999999999 111.747 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.15 -40.53 77.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 1.6200000000000001 111.526 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.509 HD23 ' O ' ' C' ' 171' ' ' TYR . 4.5 mm? -73.05 -52.09 15.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.321 -0.399 . . . . 2.0299999999999998 111.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -29.59 61.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.84 0.353 . . . . 0.62 110.969 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.48 ' O ' HG13 ' C' ' 181' ' ' ILE . 38.9 mm -87.57 -23.88 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.511 . . . . 1.5800000000000001 110.249 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 178' ' ' GLY . . . . . 0.512 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.41 -50.59 61.61 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.909 -0.587 . . . . 0.56000000000000005 113.062 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.666 ' O ' HG22 ' C' ' 182' ' ' VAL . 69.4 m-85 -57.67 -55.51 44.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.904 0.352 . . . . 1.3300000000000001 111.205 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.7 Cg_exo -45.84 -29.68 6.02 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.063 1.842 . . . . 0.63 112.416 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.565 ' O ' HG22 ' C' ' 184' ' ' ILE . 83.2 mt -66.05 -57.58 9.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.932 0.396 . . . . 0.93000000000000005 111.484 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.666 HG22 ' O ' ' C' ' 179' ' ' TYR . 11.8 m -55.85 -23.87 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 1.27 111.633 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 183' ' ' TRP . . . . . 0.462 ' CD1' H191 ' C' ' 210' ' ' LYR . 36.5 m95 -73.35 -53.4 10.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.537 0.569 . . . . 1.77 112.537 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.565 HG22 ' O ' ' C' ' 181' ' ' ILE . 10.4 tp -55.21 -27.67 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.058 0.392 . . . . 2.3900000000000001 112.058 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 66.3 mt -59.92 -69.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 1.95 111.025 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 186' ' ' GLY . . . . . 0.444 ' H ' ' HD2' ' C' ' 187' ' ' PRO . . . 177.27 -50.72 0.1 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.674 -0.694 . . . . 1.8799999999999999 112.288 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 187' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' C' ' 186' ' ' GLY . 70.6 Cg_exo -39.28 150.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.91 2.407 . . . . 3.1200000000000001 112.648 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 68.3 m 59.25 17.43 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.561 . . . . 2.6299999999999999 109.632 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -176.87 41.93 0.1 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.178 -0.919 . . . . 3.04 111.933 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 64.3 t80 67.28 95.23 0.06 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.002 0.43 . . . . 5.6900000000000004 111.21 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 191' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' C' ' 186' ' ' GLY . . . -150.61 -167.19 14.27 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 116.03 -0.532 . . . . 3.0800000000000001 112.301 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -63.15 -24.98 68.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 7.5300000000000002 110.827 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 193' ' ' ILE . . . . . 0.426 ' HB ' ' HG3' ' C' ' 187' ' ' PRO . 37.7 mm -108.68 150.07 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.993 -0.548 . . . . 2.8599999999999999 110.947 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -165.71 -25.97 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.349 -0.387 . . . . 3.6899999999999999 111.016 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.47 -164.01 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 5.4800000000000004 111.124 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.3 p -55.29 -23.69 24.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 2.3799999999999999 111.13 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.18 -37.74 74.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.269 -0.423 . . . . 2.23 110.936 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.68 -52.39 60.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 2.1600000000000001 110.3 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 46.1 p -70.47 -22.63 62.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.851 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.24 -27.22 65.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 1.7 110.865 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.99 -50.07 10.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 2.02 111.064 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.1 -10.18 56.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.8200000000000001 111.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 47.5 t -96.56 -40.17 9.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.3500000000000001 110.833 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.9 tp -71.72 -37.24 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 0.65000000000000002 112.164 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 46.4 tp -60.63 -53.84 60.51 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.031 -0.267 . . . . 1.4199999999999999 111.634 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.6 Cg_exo -57.25 -39.23 91.66 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.755 1.637 . . . . 0.63 111.426 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.35 -31.44 70.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 1.49 110.378 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -79.9 -22.78 42.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.7 110.534 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 45.7 t -87.15 -48.84 7.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.515 . . . . 1.25 110.902 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.775 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 89.0 t -79.08 -28.87 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 1.6100000000000001 111.058 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.68 57.62 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.81999999999999995 112.689 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -69.58 -22.71 63.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 3.0800000000000001 111.157 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 36.3 t -56.75 -62.31 1.82 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.424 . . . . 1.1499999999999999 110.703 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 215' ' ' PHE . . . . . 0.492 ' HA ' HD12 ' C' ' 218' ' ' LEU . 97.2 m-85 -67.97 -27.52 66.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 2.5600000000000001 110.793 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.09 -44.16 97.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.067 0.461 . . . . 1.29 110.113 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 217' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 11.4 t70 -65.67 -33.45 75.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.845 -0.616 . . . . 2.3900000000000001 110.601 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 218' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' C' ' 215' ' ' PHE . 84.4 mt -65.74 -32.97 74.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 2.0299999999999998 111.028 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -87.88 -20.93 25.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.914 0.388 . . . . 3.21 110.964 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.76 -26.53 62.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.841 -0.695 . . . . 1.3600000000000001 112.7 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 221' ' ' LEU . . . . . 0.455 HD22 HG21 ' C' ' 32' ' ' VAL . 97.8 mt -74.89 -19.46 60.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 2.8999999999999999 111.186 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 222' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' C' ' 222' ' ' ARG . 6.2 tpm_? -89.55 81.55 6.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.982 0.42 . . . . 4.8899999999999997 110.972 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -164.29 -33.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.573 . . . . 4.2300000000000004 110.569 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 54.5 tp -173.07 107.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.877 -0.601 . . . . 6.1200000000000001 110.684 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -102.53 128.78 49.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 4.5499999999999998 110.846 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.39 94.83 1.41 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.192 -0.458 . . . . 6.7800000000000002 110.917 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 79.1 p -135.96 117.41 14.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.478 . . . . 5.4000000000000004 110.778 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 228' ' ' ARG . . . . . 0.58 ' HG3' ' HG3' ' C' ' 229' ' ' GLN . 24.6 tpp180 -107.72 -52.15 2.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 8.3300000000000001 110.939 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 229' ' ' GLN . . . . . 0.58 ' HG3' ' HG3' ' C' ' 228' ' ' ARG . 47.2 mt-30 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 7.9100000000000001 110.884 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.804 0.335 . . . . 5.1100000000000003 110.804 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -130.06 9.52 5.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 5.04 111.133 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.9 tp -84.7 138.33 32.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.322 -0.399 . . . . 5.5800000000000001 110.638 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -146.63 129.66 16.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 5.0199999999999996 111.019 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -139.66 130.59 26.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 2.4500000000000002 110.894 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.3 mt -95.1 3.52 54.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 2.4199999999999999 110.594 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.02 -39.92 65.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 2.0899999999999999 110.524 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.532 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 34.5 m80 -76.7 -26.46 54.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 1.1599999999999999 110.121 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -70.75 -50.0 40.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.79000000000000004 110.658 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 pt -59.9 -31.77 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 121.146 0.498 . . . . 2.0800000000000001 109.971 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -55.87 -43.99 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.467 -0.788 . . . . 1.28 109.393 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 12' ' ' VAL . 2.5 t -57.39 -49.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.79 -1.096 . . . . 1.3200000000000001 111.071 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.45 -37.79 79.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.63 111.0 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.84 -38.45 95.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.55000000000000004 112.673 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.3 mmm -70.31 -40.01 74.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 1.03 110.902 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 m -56.64 -58.56 7.53 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.025 -0.534 . . . . 1.3 111.117 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.36 -23.77 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 1.3100000000000001 110.955 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.2 3.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 0.77000000000000002 112.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.792 0.33 . . . . 0.80000000000000004 111.006 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -57.1 -47.35 81.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 1.8100000000000001 110.932 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -63.21 -35.21 79.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 1.8799999999999999 110.785 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -69.94 -21.87 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.081 -0.508 . . . . 4.4500000000000002 110.831 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.595 ' O ' ' OG ' ' A' ' 26' ' ' SER . 83.6 t90 -75.53 -36.18 60.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 3.6899999999999999 110.892 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -68.34 -42.02 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.266 -0.425 . . . . 1.5700000000000001 110.974 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.04 -1.4 57.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 1.95 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.595 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 94.8 p -63.05 -16.29 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 1.3799999999999999 111.166 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -45.99 -40.2 10.12 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.266 -0.642 . . . . 4.0700000000000003 109.266 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -176.96 131.35 0.36 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.695 -1.138 . . . . 2.7200000000000002 109.381 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG2' ' H ' ' A' ' 32' ' ' VAL . 93.2 Cg_endo -91.98 -151.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.303 2.002 . . . . 1.9099999999999999 111.929 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -57.68 -13.69 4.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.097 0.475 . . . . 4.7599999999999998 110.711 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 33.52 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.985 -0.626 . . . . 1.99 111.996 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.5 ' HB ' ' HE2' ' A' ' 35' ' ' TYR . 12.9 m -128.63 156.36 77.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.578 0.228 . . . . 2.7000000000000002 111.013 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.0 166.35 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.536 2.157 . . . . 1.79 112.854 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -55.8 -17.42 6.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.9 . . . . 4.1200000000000001 112.168 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HE2' ' HB ' ' A' ' 32' ' ' VAL . 2.3 p90 -43.67 -33.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.656 0.265 . . . . 2.9300000000000002 111.314 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.51 -50.14 74.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.99 0.424 . . . . 2.8799999999999999 110.565 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -75.06 -19.55 59.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 4.6600000000000001 111.04 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' B' ' 100' ' ' THR . 38.6 tp -57.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 1.45 110.828 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.3 -37.86 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 1.78 111.045 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.69 -8.43 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.63 111.173 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.418 ' O ' HG12 ' A' ' 45' ' ' ILE . 14.9 tpt -89.41 -45.57 9.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 1.48 111.6 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -71.64 -42.81 67.14 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.552 0.575 . . . . 3.5 112.552 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 89.1 mt -48.37 -53.05 38.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.677 0.621 . . . . 1.0800000000000001 112.677 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.7 Cg_endo -72.62 -37.28 4.15 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.04 1.826 . . . . 0.53000000000000003 113.308 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 41' ' ' MET . 27.2 mm -59.33 -61.25 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.689 0.255 . . . . 1.6799999999999999 111.689 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.472 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.0 OUTLIER -56.99 -58.76 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.879 0.371 . . . . 1.8300000000000001 110.871 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 49.7 m -52.36 -31.59 34.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.831 -0.622 . . . . 1.0900000000000001 111.159 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.66 -59.86 10.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.40999999999999998 112.443 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 mt -61.14 -29.51 69.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.98999999999999999 110.926 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.81 -52.0 66.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.47999999999999998 111.253 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 42.3 m-85 -69.16 -23.21 63.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 1.8700000000000001 111.075 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -62.46 -39.22 92.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.49 109.761 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.55 72.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.452 -0.794 . . . . 0.58999999999999997 110.802 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.0 mtt -57.5 -26.93 62.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.48999999999999999 110.232 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.27 -50.41 22.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.59999999999999998 110.571 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.532 HG21 HG23 ' B' ' 127' ' ' VAL . 17.3 mt -74.41 -5.77 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.491 . . . . 1.3100000000000001 110.634 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.63 65.68 0.72 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.696 -0.684 . . . . 1.9099999999999999 111.106 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -130.56 148.01 52.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 1.6200000000000001 110.909 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 98.21 17.58 29.09 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.872 -0.68 . . . . 1.04 112.352 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -117.44 149.47 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.68 0.276 . . . . 2.6800000000000002 110.78 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.51 142.25 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.334 -0.394 . . . . 1.98 110.976 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -89.05 86.0 6.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 2.1800000000000002 111.086 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.04 116.57 29.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 1.5700000000000001 111.172 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.77 22.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.089 -0.505 . . . . 1.79 111.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.47 -15.01 48.37 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.672 -0.775 . . . . 1.48 112.656 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -98.34 147.56 24.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 2.3199999999999998 110.945 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.3 pt -87.97 139.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.535 . . . . 1.4399999999999999 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.37 138.77 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.81999999999999995 110.708 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 94.5 m-70 -90.8 57.43 3.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.105 0.478 . . . . 0.90000000000000002 111.173 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -64.44 -57.69 8.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 1.8300000000000001 111.176 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -54.74 -32.93 60.5 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.137 0.494 . . . . 0.62 110.644 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.411 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 5.1 tpp180 -57.17 -41.49 79.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.518 -0.764 . . . . 2.3399999999999999 110.593 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.486 ' OH ' H181 ' A' ' 210' ' ' LYR . 0.3 OUTLIER -83.04 -14.0 54.74 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.005 0.372 . . . . 3.4900000000000002 112.005 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 71' ' ' ALA . 48.9 mt -63.4 -45.11 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.009 0.433 . . . . 1.3700000000000001 109.975 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 38.8 t70 -66.49 -11.53 52.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.811 -0.631 . . . . 1.3100000000000001 110.648 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.592 ' HE1' ' H7 ' ' A' ' 210' ' ' LYR . 1.2 m-90 -87.18 -21.03 26.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 1.48 111.066 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.561 ' HG2' ' HB ' ' A' ' 113' ' ' ILE . 28.6 mtp -90.7 -7.8 51.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.014 -0.539 . . . . 1.46 111.125 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.419 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.9 m -114.85 -32.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 1.1200000000000001 112.151 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.0 m -86.85 -53.09 5.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.936 0.347 . . . . 1.1000000000000001 111.936 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 34.5 m -50.24 -51.63 61.26 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.343 0.497 . . . . 0.59999999999999998 112.343 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 80' ' ' THR . 15.2 Cg_endo -56.74 -33.19 93.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.744 1.629 . . . . 0.73999999999999999 111.851 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.2 mm? -79.61 -26.42 41.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 1.01 110.439 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -69.04 -38.53 79.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 1.48 109.71 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.461 HD21 ' CB ' ' A' ' 105' ' ' LEU . 4.9 tt -77.42 -39.54 46.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.465 -0.789 . . . . 1.3799999999999999 110.439 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.501 HD21 ' SD ' ' A' ' 106' ' ' MET . 29.8 mt -59.45 -38.02 79.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.186 -0.461 . . . . 1.1899999999999999 110.871 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -56.23 -35.61 67.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 1.23 110.525 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.73 -31.42 72.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.557 . . . . 0.88 110.915 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -62.47 -55.4 27.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 1.3899999999999999 111.073 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -65.17 -21.74 66.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 2.3199999999999998 111.236 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -37.18 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 1.46 110.927 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.31 28.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.154 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 81.4 mtp -120.54 112.08 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 2.0699999999999998 110.732 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -68.09 -35.43 78.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 3.5299999999999998 111.299 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.19 143.42 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 4.0800000000000001 111.098 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -105.88 149.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 2.1699999999999999 110.962 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 97' ' ' LYS . 59.1 tttp -133.18 -62.24 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 4.5199999999999996 110.8 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 96' ' ' LYS . 13.2 mmmm -132.03 12.23 4.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 3.75 110.907 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.0 91.53 7.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 3.5299999999999998 111.124 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -128.14 -5.05 5.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 4.9100000000000001 110.781 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.3 p -94.0 -33.31 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 1.98 111.071 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.86 -42.43 97.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.8300000000000001 110.917 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 103' ' ' GLY . 33.5 pt -66.98 -41.15 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 1.79 111.294 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 102' ' ' ILE . . . -65.01 -27.65 72.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.789 -0.72 . . . . 0.62 112.472 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.78 -54.0 32.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 1.5800000000000001 110.97 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.461 ' CB ' HD21 ' A' ' 84' ' ' LEU . 62.6 mt -64.31 -39.46 93.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.97999999999999998 111.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.501 ' SD ' HD21 ' A' ' 85' ' ' LEU . 90.4 mtp -62.59 -46.4 88.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.48 111.238 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.6 m -56.22 -42.89 77.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.93 0.395 . . . . 1.1299999999999999 110.884 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.573 HG21 HG21 ' A' ' 142' ' ' ILE . 79.6 m -59.37 -34.24 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 1.48 111.281 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 24.2 mm-40 -72.63 -29.85 63.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.476 -0.329 . . . . 2.7000000000000002 111.49 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.567 HG22 ' HE1' ' C' ' 46' ' ' TRP . 56.9 mt -66.26 -40.06 85.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 1.54 111.753 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 108' ' ' THR . 34.1 m -72.44 -32.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.678 0.275 . . . . 1.28 111.283 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 108' ' ' THR . 93.2 t -72.98 -42.31 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.387 -0.37 . . . . 0.42999999999999999 111.679 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.561 ' HB ' ' HG2' ' A' ' 77' ' ' MET . 48.0 pt -67.24 -35.11 73.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.628 -0.26 . . . . 1.74 111.299 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.404 ' N ' HG13 ' A' ' 113' ' ' ILE . 54.0 m -58.55 -55.35 36.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.856 0.36 . . . . 0.63 110.482 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.6 m -62.13 -21.01 64.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 1.0900000000000001 110.411 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.46 -56.96 7.03 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.009 -0.615 . . . . 0.41999999999999998 112.793 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.557 HD12 HG13 ' A' ' 118' ' ' ILE . 2.5 pp -61.03 -22.22 64.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.61 0.243 . . . . 1.3799999999999999 111.104 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.557 HG13 HD12 ' A' ' 117' ' ' LEU . 67.8 mt -83.15 -31.81 9.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 1.6200000000000001 110.875 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.61 61.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.091 -0.504 . . . . 0.39000000000000001 111.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.37 -22.06 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 2.02 110.934 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.5 15.35 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.76000000000000001 110.951 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.486 ' HB2' ' HE ' ' A' ' 128' ' ' ARG . 50.1 m -82.27 122.97 28.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.46 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.66 -41.21 9.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 3.3500000000000001 110.856 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.544 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.8 mtp180 -92.03 134.25 34.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.505 . . . . 2.9199999999999999 110.706 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.76 -9.11 57.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 2.77 111.018 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -87.85 -42.29 12.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 3.77 110.852 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.3 p -74.79 -26.14 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 1.1599999999999999 111.101 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.486 ' HE ' ' HB2' ' A' ' 122' ' ' SER . 40.5 ttm180 -67.52 -31.15 71.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.24 -0.437 . . . . 2.04 111.007 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -63.68 -34.39 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 2.6400000000000001 111.221 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.568 HD23 HG21 ' C' ' 56' ' ' ILE . 52.6 tp -81.75 -44.25 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 1.8999999999999999 111.242 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.48 ' HE1' ' HG2' ' C' ' 58' ' ' GLN . 4.5 m95 -56.31 -33.73 65.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.327 . . . . 1.3999999999999999 111.2 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.42 -55.84 18.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.48 . . . . 1.28 111.259 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 130' ' ' LEU . 19.4 tt -63.3 -25.27 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.788 0.328 . . . . 2.1600000000000001 111.137 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 88.4 m -63.78 -42.27 97.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 1.6899999999999999 110.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.03 -53.96 27.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.52000000000000002 112.578 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 35.1 m -59.93 -34.14 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 1.02 111.38 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.403 ' HA ' HD12 ' A' ' 140' ' ' LEU . 47.8 t -60.16 -43.78 95.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 1.0800000000000001 111.096 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.62 79.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.62 111.364 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.77 -27.77 61.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 1.8400000000000001 111.05 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.1 mt -66.09 -49.6 67.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.409 -0.36 . . . . 1.6899999999999999 111.636 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 142' ' ' ILE . 23.9 pt -62.34 -43.5 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.81000000000000005 111.815 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.573 HG21 HG21 ' A' ' 108' ' ' THR . 46.5 mm -71.86 -33.69 48.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.625 -0.261 . . . . 2.3700000000000001 111.409 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.4 -42.31 82.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.97999999999999998 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.595 ' O ' ' OD1' ' A' ' 148' ' ' ASN . 84.9 t90 -74.27 -29.76 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 3.27 110.641 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.95 75.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.892 -0.671 . . . . 1.25 112.815 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.24 -19.38 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.847 0.356 . . . . 2.1200000000000001 111.212 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -80.86 1.93 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 1.6599999999999999 111.419 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.661 ' HB2' ' HD3' ' A' ' 149' ' ' PRO . 32.0 m120 -100.4 -51.36 0.19 Allowed Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 120.91 -0.316 . . . . 99.989999999999995 111.519 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.661 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 17.3 Cg_exo -66.81 -8.35 21.13 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.223 1.948 . . . . 2.6000000000000001 112.445 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.8 mt -96.31 28.1 3.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 4.6100000000000003 111.117 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -167.42 -57.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.397 -0.365 . . . . 8.3599999999999994 111.205 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.17 -45.47 80.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 2.75 111.21 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -75.51 -32.74 60.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 5.6799999999999997 111.002 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.0 p -77.96 -7.68 57.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.794 0.33 . . . . 3.21 111.123 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -71.21 -33.44 69.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.324 -0.398 . . . . 6.8700000000000001 110.934 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 t -101.41 -21.56 14.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 4.5599999999999996 111.228 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.26 -71.09 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 3.5600000000000001 110.921 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 161' ' ' LEU . 41.8 t -151.55 122.22 7.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 2.79 111.069 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -74.8 -38.43 62.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 2.5899999999999999 111.085 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.01 -38.54 82.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 3.4700000000000002 110.853 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 158' ' ' SER . 59.1 tp -71.01 -25.91 62.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 2.5800000000000001 110.606 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.91 -34.6 69.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.967 -0.561 . . . . 1.78 111.009 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -67.06 -43.61 82.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 2.6299999999999999 110.749 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 64.1 mt -60.71 -46.33 90.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 2.3399999999999999 111.013 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' A' ' 168' ' ' LEU . 0.6 OUTLIER -74.4 -22.63 59.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.941 -0.572 . . . . 2.77 111.333 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.5 -50.86 71.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 2.04 110.823 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.08 -20.67 48.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 2.77 110.744 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 165' ' ' TYR . 0.2 OUTLIER -66.69 -56.27 11.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 1.8899999999999999 110.801 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.14 -24.36 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 1.6399999999999999 111.234 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.0 -58.68 6.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.403 . . . . 1.24 111.127 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.65 -23.99 66.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 2.9700000000000002 110.316 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -69.82 -32.83 71.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 1.48 111.277 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.6 p -76.41 -51.06 12.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.336 -0.393 . . . . 1.55 111.531 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.98 -29.0 40.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.467 -0.333 . . . . 1.52 111.609 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 62.5 tp -80.08 -57.37 3.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.375 -0.375 . . . . 1.8500000000000001 110.914 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -29.17 58.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.62 110.8 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 181' ' ' ILE . 33.0 mm -87.75 -24.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 1.3500000000000001 110.548 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.91 -50.87 58.97 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.844 -0.616 . . . . 0.58999999999999997 113.22 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.613 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 95.6 m-85 -59.76 -55.65 43.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.779 0.289 . . . . 1.45 111.46 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.4 Cg_exo -45.56 -29.84 5.48 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.278 1.985 . . . . 0.55000000000000004 112.92 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 177' ' ' ILE . 90.0 mt -69.11 -59.66 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 1.4199999999999999 111.297 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 179' ' ' TYR . 27.1 m -61.16 -25.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.78000000000000003 111.644 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -62.97 -23.56 67.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.344 . . . . 0.93999999999999995 110.929 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.76 -64.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 1.4299999999999999 110.966 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 50.6 pt -80.38 166.37 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 2.02 111.097 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.58 -166.15 37.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.851 -0.69 . . . . 1.79 112.531 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.6 161.5 27.91 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.581 2.188 . . . . 3.1000000000000001 112.082 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.7 t 57.29 17.64 3.79 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.958 0.408 . . . . 2.7400000000000002 110.567 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.97 -76.44 0.11 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.991 -0.623 . . . . 3.4300000000000002 112.398 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -153.87 -26.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.964 0.411 . . . . 6.5 110.714 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -89.22 176.45 43.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.866 -0.683 . . . . 3.29 112.437 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -121.07 38.45 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.347 . . . . 6.1600000000000001 110.858 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 195' ' ' GLN . 75.4 mt -88.94 141.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 2.4199999999999999 110.878 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -139.63 33.09 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.313 -0.403 . . . . 4.29 110.969 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.419 ' H ' HG22 ' A' ' 193' ' ' ILE . 15.2 mm100 -87.02 169.56 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 5.1500000000000004 110.92 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.2 p -74.0 -17.91 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 2.4500000000000002 111.501 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 8.7 tp -65.21 -31.37 53.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 2.48 111.507 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.43 -43.73 93.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 2.1800000000000002 111.032 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 13.7 m -75.02 -23.15 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 1.49 111.007 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -72.51 -31.85 65.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 1.77 111.169 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 67.1 tp -83.38 -32.25 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 1.4199999999999999 111.315 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -75.4 -19.02 59.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 1.78 111.003 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 206' ' ' PRO . 27.4 p -96.34 -31.53 12.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.054 0.454 . . . . 1.3 110.763 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.3 tp -72.64 -32.83 66.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.66000000000000003 111.297 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.527 ' N ' ' HD2' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -63.08 -54.26 47.55 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.536 -0.302 . . . . 1.6299999999999999 111.471 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 205' ' ' LEU . 14.9 Cg_endo -56.5 -44.22 47.83 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.127 1.884 . . . . 0.64000000000000001 111.825 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -66.24 -29.11 69.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 1.3600000000000001 110.252 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 1.54 110.325 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.4 p -94.17 -24.58 17.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 1.2 110.727 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.73 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.95 -41.85 90.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.228 -0.442 . . . . 1.6399999999999999 111.044 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.64 87.63 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.686 -0.769 . . . . 0.79000000000000004 112.386 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.29 -35.2 80.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.731 0.301 . . . . 1.6100000000000001 110.99 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.4 m -60.96 -57.74 11.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 1.1499999999999999 110.748 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -64.75 -20.05 66.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 3.3399999999999999 110.898 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.8 -43.0 38.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 1.1899999999999999 111.32 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.54 -30.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 2.23 111.358 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.22 -58.91 3.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 2.4700000000000002 111.349 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -69.46 -21.72 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 1.6200000000000001 111.091 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.55 -18.89 64.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.864 -0.684 . . . . 1.4099999999999999 112.569 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 224' ' ' LEU . 56.4 tp -79.64 -29.59 41.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.279 . . . . 2.5800000000000001 110.985 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 62.07 -82.24 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.023 -0.535 . . . . 4.9299999999999997 111.033 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -152.99 119.13 5.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 4.6299999999999999 110.677 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 221' ' ' LEU . 48.0 tp -162.49 139.69 8.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.009 -0.541 . . . . 6.4699999999999998 110.828 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -167.17 106.14 0.58 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.243 -0.435 . . . . 5.0700000000000003 110.972 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -126.21 127.97 46.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 6.5300000000000002 111.015 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 p -156.58 102.9 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 5.2199999999999998 110.913 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -139.83 14.36 2.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 8.3599999999999994 110.709 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 7.96 110.944 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.806 0.336 . . . . 6.1699999999999999 110.956 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -122.62 -1.36 9.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 4.8200000000000003 110.929 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.74 116.55 19.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 5.5999999999999996 111.091 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.19 125.11 28.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 4.7999999999999998 110.861 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 41.3 t -134.68 130.37 36.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.938 -0.573 . . . . 2.3700000000000001 110.802 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -89.03 -6.99 56.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.114 -0.494 . . . . 2.0699999999999998 110.81 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.12 -57.61 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.871 -0.604 . . . . 2.1000000000000001 111.284 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 35.9 m170 -61.24 -25.23 66.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 1.0700000000000001 110.894 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.404 ' O ' HG12 ' B' ' 12' ' ' VAL . 59.0 t-105 -69.75 -39.92 76.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.48 110.578 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -24.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.127 0.489 . . . . 2.02 110.164 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' B' ' 207' ' ' PHE . 5.5 t80 -61.14 -55.76 28.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.92000000000000004 110.619 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.404 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -58.72 -36.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.245 -0.434 . . . . 0.93999999999999995 110.673 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.41 75.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.55000000000000004 110.813 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.34 -29.3 64.37 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.47999999999999998 111.991 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.35 -32.85 58.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.84999999999999998 110.784 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -63.32 -54.35 38.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 1.3400000000000001 110.454 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.03 -24.1 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 1.55 110.728 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.49 -62.05 6.78 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.764 -0.731 . . . . 0.69999999999999996 112.099 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -34.71 65.39 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.926 0.393 . . . . 0.81000000000000005 110.836 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.39 -44.03 84.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.6 . . . . 2.2599999999999998 110.558 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -65.52 -39.37 91.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 1.78 110.839 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -73.24 -6.32 45.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 4.5800000000000001 110.616 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.445 ' O ' ' OG ' ' B' ' 26' ' ' SER . 65.0 t90 -89.11 -35.78 16.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 3.3500000000000001 110.624 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -70.72 -44.64 66.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 110.865 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.24 -2.81 53.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 1.8400000000000001 110.701 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 92.8 p -58.3 -15.02 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.525 . . . . 1.3700000000000001 111.186 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -48.81 -40.07 27.75 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.692 -0.484 . . . . 4.9800000000000004 109.692 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.6 p-10 179.16 130.8 0.23 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.421 -0.808 . . . . 2.1400000000000001 110.559 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' B' ' 33' ' ' PRO . 71.8 Cg_endo -102.95 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.646 2.897 . . . . 1.8200000000000001 111.967 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' B' ' 30' ' ' ARG . 4.2 mmp_? -106.23 11.22 31.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.453 0.644 . . . . 5.1900000000000004 109.685 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.68 -53.68 0.76 Allowed Glycine 0 CA--C 1.519 0.303 0 CA-C-N 114.857 -1.065 . . . . 2.2000000000000002 112.16 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.65 104.87 5.38 Favored Pre-proline 0 CA--C 1.518 -0.275 0 CA-C-N 117.486 0.643 . . . . 3.6499999999999999 111.69 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.573 ' HB3' ' HG3' ' B' ' 29' ' ' PRO . 83.2 Cg_endo -89.3 107.98 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.773 0.982 . . . . 2.6699999999999999 113.602 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -92.74 -61.13 1.65 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.804 1.764 . . . . 4.8799999999999999 107.735 174.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -39.85 18.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 110.317 -3.129 . . . . 1.8700000000000001 113.148 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -38.3 -64.6 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.638 0.977 . . . . 2.6800000000000002 113.638 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.43 ' CZ ' ' HA ' ' B' ' 26' ' ' SER . 75.0 m-85 -82.69 -18.28 41.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.102 0.408 . . . . 2.9199999999999999 112.102 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 tp -59.3 -65.12 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.867 0.365 . . . . 1.6399999999999999 110.781 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 m -69.25 -37.82 76.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 1.6000000000000001 111.472 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 -12.09 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.52 -0.309 . . . . 0.68999999999999995 111.154 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 45.3 tpp -89.09 -48.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 2.5800000000000001 111.665 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -65.86 -48.95 69.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.849 0.685 . . . . 3.3900000000000001 112.849 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 79.5 mt -45.36 -53.61 17.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.29 0.848 . . . . 0.40999999999999998 113.29 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -71.48 -38.61 4.38 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.228 1.952 . . . . 0.48999999999999999 113.611 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -59.54 -61.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.852 0.315 . . . . 1.29 111.852 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.507 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.1 OUTLIER -58.26 -58.92 6.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 1.3999999999999999 111.314 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.431 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 47.9 t -55.05 -26.24 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 1.3799999999999999 111.025 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.58 -67.57 2.08 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.754 -0.736 . . . . 0.37 112.739 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.09 -24.32 58.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.646 0.26 . . . . 1.29 111.385 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.66 -59.15 5.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.44 111.182 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.8 m-85 -61.76 -35.8 79.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.5 110.95 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 57.6 ttp -51.5 -35.31 39.68 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.072 0.463 . . . . 1.4099999999999999 110.08 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.61 -39.44 70.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.55000000000000004 110.537 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -57.11 -21.12 29.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.5 110.567 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -82.63 -46.18 13.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.046 -0.525 . . . . 0.54000000000000004 111.105 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' B' ' 53' ' ' ALA . 27.0 pt -75.26 -0.05 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 1.3 111.299 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.93 65.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.939 -0.573 . . . . 2.2400000000000002 110.904 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -146.79 114.27 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 1.77 110.846 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' B' ' 70' ' ' TYR . . . 136.23 -1.33 3.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 1.0600000000000001 112.532 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -108.58 151.54 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 2.6600000000000001 111.018 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.26 145.67 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 1.8899999999999999 111.1 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.32 87.95 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 2.4100000000000001 111.143 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.28 118.08 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 1.5600000000000001 110.85 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.86 31.49 20.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 1.8200000000000001 111.13 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.14 0.56 86.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.646 -0.787 . . . . 1.51 112.548 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -101.02 147.19 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 2.4500000000000002 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.3 mt -92.74 121.86 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 1.79 110.81 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.482 ' HB1' HD23 ' B' ' 121' ' ' LEU . . . -99.12 140.07 33.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.81999999999999995 111.276 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.601 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.7 m-70 -82.99 58.29 4.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 1.05 110.879 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.441 ' O ' HG13 ' B' ' 74' ' ' ILE . 65.5 t80 -62.89 -55.75 23.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.506 -0.77 . . . . 1.8700000000000001 111.351 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' B' ' 74' ' ' ILE . . . -63.2 -24.0 67.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.068 0.396 . . . . 0.60999999999999999 112.068 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 58.7 mmt-85 -64.69 -52.46 57.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.231 0.456 . . . . 2.3900000000000001 112.231 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.494 ' CE1' ' HG ' ' B' ' 117' ' ' LEU . 2.1 p90 -64.29 -32.12 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.607 -0.437 . . . . 3.6699999999999999 110.476 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' B' ' 71' ' ' ALA . 57.7 mt -50.44 -53.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 116.125 -0.489 . . . . 1.6599999999999999 110.992 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 24.7 t70 -66.56 -22.76 66.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.196 -0.456 . . . . 1.4099999999999999 110.311 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -89.77 5.1 47.54 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.105 -0.498 . . . . 1.1599999999999999 111.034 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.49 ' HA ' HD13 ' B' ' 113' ' ' ILE . 51.9 ttm -104.89 -18.44 14.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 1.53 110.592 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' B' ' 46' ' ' TRP . 28.1 m -114.46 -33.81 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.087 -0.506 . . . . 0.89000000000000001 112.106 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -79.33 -48.5 13.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.157 0.428 . . . . 1.24 112.157 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 5.6 m -55.6 -50.71 85.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.443 -0.344 . . . . 0.57999999999999996 111.781 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 47.2 Cg_exo -55.54 -33.48 86.68 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.945 1.763 . . . . 0.66000000000000003 111.969 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' B' ' 85' ' ' LEU . 83.8 mt -78.55 -26.47 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 1.0600000000000001 110.868 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.567 HD22 ' H43' ' B' ' 210' ' ' LYR . 11.5 tp -67.58 -39.17 84.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.847 0.356 . . . . 1.22 110.281 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.8 pp -82.07 -25.96 34.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.976 -0.556 . . . . 1.53 110.323 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.446 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.1 mt -68.62 -34.05 75.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 1.5800000000000001 109.804 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -58.78 -34.84 71.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 1.3899999999999999 110.423 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.05 -29.33 65.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 1.1499999999999999 110.88 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 56.4 m -63.57 -40.05 95.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 1.5700000000000001 110.937 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -82.51 -16.24 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 2.1699999999999999 111.033 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 89.8 m -68.08 -42.92 79.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 1.4199999999999999 111.268 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.77 -33.21 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 1.1799999999999999 111.376 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.5 mtm -118.04 110.23 17.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 1.8799999999999999 110.829 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -76.44 -30.38 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 3.4199999999999999 111.248 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -133.54 140.78 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 4.0599999999999996 110.767 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -107.7 142.03 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 2.0899999999999999 111.14 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -127.0 -50.62 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.152 -0.477 . . . . 3.8500000000000001 110.854 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -137.28 -17.21 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 4.8200000000000003 110.911 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -65.52 113.26 4.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 3.7999999999999998 111.223 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -149.21 -23.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.999 -0.546 . . . . 5.1699999999999999 110.497 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.407 ' HB ' HD22 ' A' ' 38' ' ' LEU . 61.8 p -76.35 -34.92 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 2.02 110.778 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.87 -46.91 82.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.502 . . . . 2.0899999999999999 110.592 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.24 -37.17 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.8799999999999999 110.88 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.29 -18.26 79.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 0.56000000000000005 112.409 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -72.85 -45.02 60.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.78 110.755 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.38 -30.41 63.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 1.03 110.945 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' MET . . . . . 0.416 ' O ' HG13 ' B' ' 110' ' ' ILE . 89.5 mtp -69.7 -48.69 58.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 1.6699999999999999 111.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -57.61 -45.32 85.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.364 -0.38 . . . . 1.51 111.077 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.615 ' HB ' HD13 ' B' ' 142' ' ' ILE . 57.8 p -59.14 -33.12 70.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 1.1799999999999999 111.128 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.448 ' O ' HG13 ' B' ' 113' ' ' ILE . 56.8 tp60 -71.17 -36.78 72.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.356 -0.384 . . . . 2.1699999999999999 110.987 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.472 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.6 mt -56.8 -43.32 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 1.3500000000000001 111.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.539 HG22 ' O ' ' B' ' 108' ' ' THR . 18.2 m -70.93 -30.59 42.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 1.3400000000000001 111.347 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 108' ' ' THR . 88.9 t -72.64 -27.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.482 -0.327 . . . . 0.42999999999999999 111.256 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' B' ' 77' ' ' MET . 69.8 mt -80.2 -43.15 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.631 -0.259 . . . . 1.6000000000000001 111.213 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.412 HG22 ' O ' ' B' ' 111' ' ' VAL . 9.7 t -58.92 -29.92 67.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.955 0.407 . . . . 0.85999999999999999 110.176 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -69.15 -50.52 47.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.897 -0.592 . . . . 0.94999999999999996 109.833 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.54 -10.1 66.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.9 -0.667 . . . . 0.46000000000000002 111.51 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.494 ' HG ' ' CE1' ' B' ' 73' ' ' TYR . 4.4 tt -70.43 -56.78 5.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.506 . . . . 1.75 110.346 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.48 -20.62 9.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.647 -0.706 . . . . 1.78 111.546 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.83 -39.41 11.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.38 111.331 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.03 -23.93 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.97 110.842 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.482 HD23 ' HB1' ' B' ' 68' ' ' ALA . 87.8 mt -87.96 29.57 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.76000000000000001 111.15 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -93.91 122.92 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.411 . . . . 1.47 110.735 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.53 -52.52 4.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 2.5 111.263 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.9 ttm180 -77.42 123.71 26.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 2.73 110.809 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.73 -14.24 50.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.144 -0.48 . . . . 2.2000000000000002 111.132 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.584 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 66.1 t-105 -74.53 -56.12 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 3.3999999999999999 110.56 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' B' ' 124' ' ' ARG . 7.7 p -65.15 -27.95 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 1.23 111.059 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -55.07 -26.93 41.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.725 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.54 -34.99 40.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 4.1399999999999997 110.922 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.419 HD22 ' N ' ' B' ' 130' ' ' LEU . 3.8 mm? -72.31 -49.33 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 1.6499999999999999 111.135 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -62.47 -31.9 72.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.77000000000000002 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.464 ' HE1' ' HB3' ' B' ' 183' ' ' TRP . 66.5 t80 -63.34 -55.47 24.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 1.46 110.984 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 tt -68.34 -23.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.027 0.441 . . . . 1.6299999999999999 110.865 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.8 -41.67 91.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 1.4199999999999999 111.276 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.82 -50.49 35.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.48999999999999999 112.799 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 26.9 m -61.31 -38.31 79.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.576 0.227 . . . . 1.3 111.489 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -58.31 -45.29 88.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 1.3 111.331 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.57 77.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.62 111.153 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -69.71 -22.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 1.74 111.361 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 80.5 mt -66.98 -60.61 2.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.703 -0.226 . . . . 1.76 111.278 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 31.0 pt -56.08 -36.33 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.68999999999999995 111.408 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.615 HD13 ' HB ' ' B' ' 108' ' ' THR . 74.5 mt -69.78 -42.63 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 1.76 111.152 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.17 -47.47 81.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0600000000000001 111.069 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -66.59 -25.91 66.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 4.1200000000000001 110.964 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.65 -21.29 58.28 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.9 -0.667 . . . . 1.26 113.229 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.1 pt -98.94 -6.58 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 1.98 111.717 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -87.59 -2.3 58.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 1.4199999999999999 111.388 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.615 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 32.1 m120 -100.36 -49.92 0.19 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.297 -0.41 . . . . 99.989999999999995 111.855 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 22.9 Cg_exo -64.95 -9.71 22.53 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.525 2.15 . . . . 2.6499999999999999 113.021 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.46 13.23 32.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.695 0.283 . . . . 4.3899999999999997 111.294 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -145.27 -61.0 0.35 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 7.9000000000000004 111.133 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.94 -50.92 70.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.148 -0.478 . . . . 2.77 111.559 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' B' ' 149' ' ' PRO . 67.6 mttm -70.95 -36.77 72.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 6.29 111.115 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 47.3 p -71.14 -17.42 62.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.336 . . . . 3.1000000000000001 110.803 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -65.43 -32.21 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 6.4299999999999997 110.871 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 60.1 m -98.62 -37.51 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 4.5700000000000003 111.09 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -63.52 -74.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 3.8300000000000001 111.142 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 57.0 m -148.54 120.65 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 3.0699999999999998 110.787 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 43.7 t -73.0 -36.83 67.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 3.4300000000000002 111.181 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -62.62 -49.88 73.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 3.9199999999999999 110.885 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.77 -22.12 66.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.034 -0.53 . . . . 2.7000000000000002 111.021 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.92 67.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.363 -0.38 . . . . 1.8300000000000001 111.207 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.44 -40.09 95.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 2.6299999999999999 111.035 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.47 -44.66 85.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.127 -0.488 . . . . 2.4300000000000002 110.962 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.67 -22.38 50.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.534 . . . . 2.5800000000000001 110.885 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.71 -47.35 84.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 2.0 111.164 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.19 -21.0 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 3.0299999999999998 110.633 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.2 -49.57 55.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.141 -0.481 . . . . 1.1000000000000001 110.699 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.33 -23.63 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.75 111.006 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.82 -59.04 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.295 -0.411 . . . . 0.97999999999999998 110.982 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.91 -29.15 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 4.2999999999999998 110.069 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.98 -21.56 64.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.601 -0.727 . . . . 1.3899999999999999 110.843 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 46.6 m -79.14 -58.3 3.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 1.1100000000000001 111.539 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.08 -29.78 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 1.51 111.686 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 44.9 tp -76.39 -58.55 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.474 -0.33 . . . . 1.75 111.562 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -28.89 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.33 -0.395 . . . . 0.59999999999999998 110.854 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.432 ' O ' HG12 ' B' ' 181' ' ' ILE . 42.9 mm -87.93 -24.07 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 1.47 110.482 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.92 48.5 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.55000000000000004 113.228 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.613 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 83.1 m-85 -56.8 -55.78 39.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.912 0.356 . . . . 1.6200000000000001 111.521 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.1 Cg_exo -44.89 -33.32 7.28 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.455 2.103 . . . . 0.64000000000000001 112.84 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.0 mm -66.49 -59.58 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 1.27 111.644 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.09 -28.28 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.68999999999999995 111.831 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' TRP . . . . . 0.464 ' HB3' ' HE1' ' B' ' 132' ' ' TYR . 38.2 m95 -60.07 -24.22 64.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.59 -0.277 . . . . 1.1799999999999999 111.174 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 89.2 mt -55.63 -61.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.715 0.293 . . . . 1.77 111.179 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 41.2 pt -82.81 165.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 1.6899999999999999 111.267 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.85 -169.59 40.72 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.891 -0.671 . . . . 1.5800000000000001 112.608 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.15 160.83 44.6 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.542 2.161 . . . . 2.5099999999999998 111.901 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 51.4 m 56.88 17.29 3.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.373 -0.376 . . . . 3.5800000000000001 110.521 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -133.18 -64.38 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.121 -0.561 . . . . 4.0300000000000002 112.415 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -167.57 -32.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.321 . . . . 6.8899999999999997 110.804 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -86.89 166.84 37.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.81 -0.71 . . . . 3.7000000000000002 112.668 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -111.78 51.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.743 0.306 . . . . 7.5 110.867 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.459 HG22 ' H ' ' B' ' 195' ' ' GLN . 24.0 mm -97.61 142.03 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 2.3500000000000001 111.062 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -138.87 28.25 2.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.399 -0.364 . . . . 3.8599999999999999 111.001 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' GLN . . . . . 0.459 ' H ' HG22 ' B' ' 193' ' ' ILE . 46.8 mt-30 -84.85 155.49 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 5.0499999999999998 110.8 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 65.7 p -64.33 -15.54 60.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 2.6800000000000002 111.657 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' ILE . . . . . 0.441 HG22 ' HB2' ' B' ' 195' ' ' GLN . 9.9 tp -66.58 -28.71 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 2.4700000000000002 110.763 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 2.5299999999999998 110.451 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -62.91 -28.06 69.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.762 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -66.17 -36.12 82.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 2.6200000000000001 110.977 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.69 -47.81 51.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 1.6100000000000001 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -71.38 -6.21 38.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 1.4199999999999999 111.154 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HD2' ' B' ' 206' ' ' PRO . 47.3 t -96.34 -46.13 6.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.204 0.526 . . . . 1.4299999999999999 110.599 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.1 tp -72.25 -26.01 61.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 1.1200000000000001 111.578 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.671 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 62.2 tp -66.0 -54.48 27.12 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.931 -0.308 . . . . 1.26 111.123 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.5 Cg_exo -55.83 -42.52 66.29 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.697 1.598 . . . . 0.59999999999999998 111.388 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.429 ' HB2' ' CE1' ' B' ' 11' ' ' TYR . 89.4 t80 -63.93 -39.19 93.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 1.3999999999999999 110.456 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.2 -34.31 78.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 1.4099999999999999 111.089 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -86.2 -31.57 21.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.317 -0.401 . . . . 1.3200000000000001 110.994 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.759 ' H9 ' H183 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.0 -53.86 41.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 1.6899999999999999 111.209 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.63 63.25 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.823 -0.703 . . . . 0.79000000000000004 112.563 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -66.4 -38.47 87.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 2.96 110.859 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.8 m -60.64 -56.39 21.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 1.29 110.733 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -63.94 -20.12 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 3.1499999999999999 110.683 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.435 ' C ' HD13 ' B' ' 216' ' ' LEU . 3.2 tm? -71.63 -58.18 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 1.51 111.104 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -58.73 -23.89 60.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.375 . . . . 2.1899999999999999 111.209 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.3 tp -68.76 -54.59 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 1.98 111.338 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -77.59 -20.36 54.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.285 -0.416 . . . . 2.1699999999999999 111.311 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.36 67.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.913 -0.66 . . . . 1.3600000000000001 113.102 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 52.7 tp -74.01 -23.08 59.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.598 0.237 . . . . 2.8999999999999999 111.125 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 60.32 -83.46 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.271 -0.422 . . . . 5.6100000000000003 111.183 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -160.35 103.65 1.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.418 -0.356 . . . . 4.04 110.726 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 61.0 tp -150.46 136.55 18.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 6.2999999999999998 111.011 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -116.57 -76.97 0.57 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 4.7999999999999998 111.138 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 15.2 t70 60.8 103.55 0.02 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.16 -0.473 . . . . 6.3899999999999997 111.307 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 75.7 p -158.55 81.65 0.82 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 5.6100000000000003 110.947 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -104.79 -42.23 5.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.296 -0.411 . . . . 8.1999999999999993 111.027 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 8.1699999999999999 110.961 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 45.2 tpp . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.834 0.349 . . . . 5.6200000000000001 110.981 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -120.73 -11.75 8.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 5.2800000000000002 110.965 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.88 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 6.0499999999999998 110.827 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -153.54 120.46 5.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 4.79 110.896 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -130.92 124.99 32.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 2.71 111.107 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.561 HD23 ' H ' ' C' ' 6' ' ' LEU . 2.4 pt? -87.63 -7.21 57.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 2.52 110.782 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.31 -41.79 98.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 1.9299999999999999 110.498 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 46.2 m80 -74.1 -23.84 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 1.26 110.389 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.431 ' O ' HG12 ' C' ' 12' ' ' VAL . 64.4 t-105 -72.61 -44.49 61.9 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.914 -0.585 . . . . 1.6699999999999999 110.732 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.45 -23.34 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.183 0.516 . . . . 1.8700000000000001 109.911 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -60.79 -57.35 13.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 1.4399999999999999 110.581 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.431 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.2 p -59.04 -31.42 45.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.31 -0.404 . . . . 0.46999999999999997 110.805 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.16 -33.21 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.58999999999999997 110.449 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.82 -28.67 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.5 112.008 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.4 mmt -75.7 -34.63 60.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.634 0.254 . . . . 0.68000000000000005 111.232 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -63.1 -53.36 54.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 1.3999999999999999 110.867 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -61.91 -26.65 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 1.55 110.809 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.25 -59.94 9.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.70999999999999996 112.278 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.89 65.84 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.796 0.332 . . . . 0.77000000000000002 111.277 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.2 mt -62.79 -42.5 99.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.233 -0.44 . . . . 1.9299999999999999 110.879 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -59.52 -40.76 88.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 1.8600000000000001 110.633 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -70.54 -20.01 62.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 4.1399999999999997 110.831 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' TRP . . . . . 0.406 ' O ' ' OG ' ' C' ' 26' ' ' SER . 85.7 t90 -71.57 -34.36 69.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 3.1499999999999999 110.655 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 43.9 t -71.39 -47.8 53.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.95 110.879 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 -0.93 30.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 2.2200000000000002 110.778 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 95.1 p -56.09 -17.7 7.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 1.3700000000000001 111.441 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -47.24 -42.83 21.18 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.742 -0.466 . . . . 5.0300000000000002 109.742 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 7.7 p30 -173.67 130.66 0.53 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.468 -0.787 . . . . 2.3700000000000001 110.402 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.473 ' O ' HG22 ' C' ' 32' ' ' VAL . 73.4 Cg_endo -101.89 77.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.471 2.781 . . . . 2.0499999999999998 112.651 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 61.14 6.47 1.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.422 -0.353 . . . . 4.5199999999999996 111.332 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.84 39.26 5.56 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.771 -0.728 . . . . 2.1600000000000001 112.932 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.473 HG22 ' O ' ' C' ' 29' ' ' PRO . 5.4 m -122.71 152.53 62.28 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.755 0.278 . . . . 2.5299999999999998 111.105 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.28 165.69 2.07 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.661 2.241 . . . . 1.9299999999999999 112.969 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -60.03 -17.98 42.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 4.1200000000000001 112.096 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -45.5 -30.84 1.53 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.706 0.289 . . . . 2.8900000000000001 111.641 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.59 -58.75 5.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 2.46 111.142 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -69.76 -19.84 63.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.383 -0.371 . . . . 2.7799999999999998 111.319 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.49 -63.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 1.6200000000000001 110.819 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.53 -30.36 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 1.5900000000000001 111.328 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.17 -13.04 61.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.65000000000000002 111.559 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.429 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 27.2 ttt -89.79 -42.54 11.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.387 -0.37 . . . . 1.6699999999999999 111.906 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.15 -42.0 66.47 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.751 0.648 . . . . 3.4199999999999999 112.751 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.609 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 35.1 mm -51.45 -52.72 57.11 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.78 0.659 . . . . 0.89000000000000001 112.78 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 12.6 Cg_exo -70.33 -39.08 5.78 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.416 2.077 . . . . 0.40999999999999998 113.209 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.19 -61.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.887 0.329 . . . . 1.76 111.887 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.567 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -56.11 -58.94 5.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 2.1600000000000001 111.234 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 47' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 30.3 t -53.42 -28.8 31.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.99 -0.55 . . . . 1.1699999999999999 111.213 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.98 -62.54 6.11 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.657 -0.783 . . . . 0.44 112.445 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.447 ' HA ' ' HE2' ' C' ' 52' ' ' MET . 56.1 mt -61.4 -24.12 66.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 1.29 110.838 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' ALA . . . . . 0.4 ' HB1' ' HB2' ' C' ' 75' ' ' ASP . . . -64.4 -58.04 7.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.5 111.004 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.516 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 36.8 m-85 -63.59 -35.77 81.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 1.8300000000000001 110.982 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' C' ' 49' ' ' LEU . 51.7 ttp -53.48 -35.28 60.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.138 0.494 . . . . 1.47 109.965 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.63 -34.14 64.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.698 -0.683 . . . . 0.59999999999999998 110.69 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' MET . . . . . 0.404 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 50.4 mtt -61.82 -20.12 63.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.83999999999999997 110.052 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.24 -48.07 12.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.65000000000000002 110.713 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.568 HG21 HD23 ' A' ' 130' ' ' LEU . 39.6 pt -73.01 -5.44 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.004 -0.544 . . . . 1.55 111.343 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.66 67.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.943 -0.571 . . . . 1.54 111.117 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.48 ' HG2' ' HE1' ' A' ' 131' ' ' TRP . 53.0 tp60 -139.21 139.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.79 110.766 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 110.74 11.14 19.92 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.892 -0.67 . . . . 0.93999999999999995 112.194 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -115.09 148.21 39.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 2.3599999999999999 110.925 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.93 140.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 1.97 111.047 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.43 86.85 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 2.4399999999999999 111.152 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.68 118.9 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 1.54 111.08 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.76 28.75 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 1.71 111.284 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.49 -6.3 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 1.53 112.626 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.94 152.58 19.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 2.23 110.675 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.06 131.68 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 1.3600000000000001 110.894 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.02 144.66 32.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.515 . . . . 0.78000000000000003 111.208 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.438 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 65.2 m-70 -91.56 59.21 3.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 1.0800000000000001 110.779 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.21 -58.18 5.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 2.2999999999999998 111.256 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -55.61 -35.45 65.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.228 0.537 . . . . 0.75 110.429 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 9.1 tpp180 -56.04 -39.29 71.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.338 -0.846 . . . . 1.51 111.008 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.577 ' OH ' H181 ' C' ' 210' ' ' LYR . 0.2 OUTLIER -82.59 -20.75 35.87 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.04 0.385 . . . . 4.6500000000000004 112.04 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 47.7 mm -58.77 -42.86 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 1.22 110.284 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 25.8 t70 -60.98 -22.73 64.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 1.3100000000000001 110.599 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' TRP . . . . . 0.416 ' HE1' ' H7 ' ' C' ' 210' ' ' LYR . 1.3 m-90 -81.27 -27.61 35.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 1.6799999999999999 111.267 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.619 ' HG2' HG23 ' C' ' 113' ' ' ILE . 12.8 mtp -75.55 -14.04 60.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.736 -0.665 . . . . 1.8 111.801 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' C' ' 46' ' ' TRP . 16.3 m -114.89 -42.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.451 0.537 . . . . 1.1899999999999999 112.451 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 71.7 m -72.49 -51.82 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.63 0.604 . . . . 1.23 112.63 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.0 m -54.02 -51.02 80.92 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.351 0.5 . . . . 0.58999999999999997 112.351 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.7 Cg_exo -55.28 -35.53 91.57 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.939 1.759 . . . . 0.67000000000000004 112.256 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.441 ' HB3' HD11 ' C' ' 43' ' ' ILE . 4.0 mm? -77.55 -23.8 49.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.95999999999999996 110.663 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -46.36 75.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.1899999999999999 110.492 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.496 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -74.36 -29.26 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.7 110.737 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' LEU . . . . . 0.496 ' N ' HD12 ' C' ' 84' ' ' LEU . 7.4 tp -64.52 -36.76 85.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 1.6200000000000001 110.501 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 m -61.61 -32.04 72.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.379 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 60.8 mt -66.7 -32.43 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.8 -0.636 . . . . 1.1100000000000001 110.561 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.8 t -62.94 -53.45 53.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.51 110.566 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.97 -26.66 68.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 2.0600000000000001 110.845 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 86.0 m -66.31 -33.15 75.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.257 -0.429 . . . . 1.52 110.891 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.15 -50.73 25.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 1.3 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -124.07 127.58 48.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 1.6200000000000001 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -78.48 -13.12 59.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 3.2400000000000002 110.938 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -133.76 163.26 29.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.194 -0.457 . . . . 4.6299999999999999 111.028 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 36.5 mm -126.44 143.98 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 2.1800000000000002 110.959 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -133.22 -72.73 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 4.1200000000000001 110.863 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.78 1.5 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 4.96 110.88 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.17 96.05 7.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 3.9100000000000001 110.995 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -136.32 -9.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 5.21 110.647 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 82.2 p -88.25 -38.89 14.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 1.8200000000000001 111.017 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.88 -42.12 97.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.534 . . . . 2.0800000000000001 110.704 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.44 -41.14 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.959 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.36 -14.67 77.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.58999999999999997 112.449 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.82 -46.41 24.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.878 0.37 . . . . 1.53 110.568 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.38 -38.72 68.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 1.1100000000000001 110.555 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 22.5 ttt -66.36 -42.04 88.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.574 -0.739 . . . . 2.21 111.61 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 47.7 t -60.29 -50.14 74.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.792 0.33 . . . . 1.28 111.218 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.718 HG21 HG12 ' C' ' 142' ' ' ILE . 39.9 m -55.29 -36.59 66.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 1.22 111.079 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -63.74 -46.68 84.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 2.3300000000000001 111.257 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.507 HG22 ' HE1' ' B' ' 46' ' ' TRP . 66.5 mt -52.66 -34.5 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.303 -0.408 . . . . 1.29 110.864 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.95 -53.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.564 . . . . 1.0600000000000001 111.357 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.519 HG12 H182 ' C' ' 210' ' ' LYR . 28.6 t -63.49 -27.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 111.37 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.619 HG23 ' HG2' ' C' ' 77' ' ' MET . 22.2 mm -65.43 -50.27 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 1.3700000000000001 111.423 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 92.4 m -54.54 -55.53 28.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.47 -0.332 . . . . 0.77000000000000002 111.044 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 35.4 m -57.38 -21.49 36.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 1.1899999999999999 110.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -61.6 3.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.756 -0.735 . . . . 0.5 112.847 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.41 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -59.85 -22.21 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.702 0.287 . . . . 1.47 110.976 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.41 ' N ' HD12 ' C' ' 117' ' ' LEU . 37.6 mm -81.42 -33.93 12.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 1.2 110.997 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.28 -37.73 48.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.40000000000000002 111.193 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.88 -21.14 28.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 2.1200000000000001 110.946 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.77 28.99 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.431 -0.35 . . . . 0.75 111.025 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -94.71 125.75 39.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 1.3799999999999999 110.783 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.98 -21.2 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 2.7400000000000002 111.245 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.674 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 52.5 ttp180 -114.86 135.83 53.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.382 -0.372 . . . . 2.7999999999999998 110.676 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.01 -11.73 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 2.4100000000000001 111.625 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 126' ' ' TRP . . . . . 0.674 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 56.6 t90 -81.86 -50.17 9.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 4.2000000000000002 110.845 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' C' ' 124' ' ' ARG . 7.4 p -66.07 -26.61 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 1.0800000000000001 111.015 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -62.37 -21.58 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 2.5699999999999998 111.103 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -77.61 -36.8 51.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 3.8100000000000001 110.816 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.424 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.3 mp -76.76 -30.4 56.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.089 -0.505 . . . . 1.4199999999999999 111.38 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -76.07 -42.53 47.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.715 0.293 . . . . 0.89000000000000001 111.362 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -57.67 -50.96 71.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.247 -0.433 . . . . 1.26 110.944 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.5 -27.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 1.6799999999999999 111.25 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.06 -45.03 90.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 1.24 111.105 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.09 47.62 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.846 -0.692 . . . . 0.54000000000000004 112.878 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.96 -31.73 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.694 0.257 . . . . 1.0600000000000001 111.694 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.19 -48.79 76.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 1.0800000000000001 111.34 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.6 73.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.56999999999999995 111.301 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.08 -22.64 62.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.035 -0.53 . . . . 1.6799999999999999 111.455 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.44 -53.87 9.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.537 -0.301 . . . . 1.7 111.792 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.434 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.7 pt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.833 0.309 . . . . 0.78000000000000003 111.833 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.718 HG12 HG21 ' C' ' 108' ' ' THR . 8.1 tp -72.47 -31.19 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.773 0.32 . . . . 2.2400000000000002 111.44 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.45 -44.96 95.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 1.02 111.004 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 144' ' ' TRP . . . . . 0.564 ' O ' ' OD1' ' C' ' 148' ' ' ASN . 71.8 t-105 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 3.0 111.259 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.51 -17.57 77.44 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.751 -0.737 . . . . 1.27 113.165 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.64 -26.34 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.872 0.367 . . . . 1.8899999999999999 110.995 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -73.02 -0.28 13.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 1.6000000000000001 111.912 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.682 ' H ' ' HD2' ' C' ' 149' ' ' PRO . 32.1 m120 -100.79 -52.05 0.18 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 99.989999999999995 112.124 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' C' ' 148' ' ' ASN . 29.9 Cg_endo -62.8 -20.83 72.24 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.223 1.948 . . . . 2.73 112.732 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.83 45.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 4.2999999999999998 111.231 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -170.68 -46.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 8.9000000000000004 110.895 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.09 -49.62 9.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 2.7999999999999998 111.155 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -71.27 -29.06 64.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 5.4400000000000004 110.923 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 154' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' C' ' 162' ' ' ALA . 68.1 p -72.22 -19.14 61.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 3.3900000000000001 111.243 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -66.78 -41.8 87.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 6.9199999999999999 111.048 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 4.9 t -87.93 -27.73 21.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 4.8700000000000001 111.391 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -75.81 -71.33 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.304 -0.407 . . . . 4.0499999999999998 111.16 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.0 m -152.19 121.54 6.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 3.0299999999999998 110.992 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 46.3 t -75.42 -34.82 61.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 2.96 111.096 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.32 -52.0 63.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 3.7400000000000002 110.86 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.79 -24.48 66.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.496 . . . . 2.6499999999999999 111.015 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 162' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' C' ' 154' ' ' THR . . . -64.59 -37.69 88.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.093 -0.503 . . . . 1.77 111.047 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -72.46 -42.68 64.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 2.96 110.925 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 87.7 mt -57.54 -47.62 81.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.256 -0.429 . . . . 2.3500000000000001 110.77 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.43 -27.28 63.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.867 -0.606 . . . . 2.6200000000000001 110.862 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.87 -42.49 99.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 2.0899999999999999 110.892 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -81.62 -21.15 38.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 3.2400000000000002 110.722 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 55.6 tp -70.61 -54.59 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 1.6899999999999999 111.355 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.46 -24.04 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 1.3999999999999999 111.224 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.9 m -55.05 -59.06 5.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.95999999999999996 111.255 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.12 -26.76 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 3.6499999999999999 110.423 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -70.22 -25.31 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.879 -0.6 . . . . 1.3700000000000001 110.884 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 84.2 m -79.88 -51.69 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.515 . . . . 1.4299999999999999 111.83 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.72 -26.4 34.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 111.925 0.342 . . . . 1.6200000000000001 111.925 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 60.6 tp -83.2 -54.81 4.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.568 -0.287 . . . . 2.0299999999999998 111.299 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -32.41 64.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.4 . . . . 0.62 110.726 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.472 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.3 tt -87.73 -19.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 1.5800000000000001 110.484 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.21 39.76 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.835 -0.62 . . . . 0.56000000000000005 113.034 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.626 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 94.6 m-85 -55.31 -53.8 57.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.807 0.304 . . . . 1.3300000000000001 111.19 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.2 Cg_exo -46.6 -31.6 10.43 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.122 1.881 . . . . 0.63 112.503 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -66.1 -60.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.351 -0.386 . . . . 0.93000000000000005 111.364 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.52 -31.51 49.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.208 -0.451 . . . . 1.27 111.846 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -54.76 -29.03 52.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.568 -0.287 . . . . 1.77 111.469 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 74.5 mt -52.64 -62.44 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 2.3900000000000001 111.237 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 34.6 pt -78.36 172.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.95 111.257 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.04 -165.32 52.08 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.884 -0.674 . . . . 1.8799999999999999 112.625 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.28 163.97 22.02 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.767 2.311 . . . . 3.1200000000000001 112.231 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 47.9 m 59.66 8.91 1.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.186 -0.461 . . . . 2.6299999999999999 110.786 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -123.26 -67.2 0.22 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.084 -0.579 . . . . 3.04 112.237 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -167.06 -28.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.888 0.375 . . . . 5.6900000000000004 110.501 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -83.08 -179.11 52.53 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 3.0800000000000001 112.226 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -126.15 45.29 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.904 0.383 . . . . 7.5300000000000002 110.923 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 28.6 mt -93.66 139.89 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 2.8599999999999999 110.707 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -134.43 13.81 3.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.541 -0.3 . . . . 3.6899999999999999 111.466 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -70.7 154.52 41.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 5.4800000000000004 111.117 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p -67.74 -16.84 64.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 2.3799999999999999 111.223 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt -63.48 -27.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 2.23 110.909 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.02 -48.37 71.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 2.1600000000000001 110.8 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 68.0 p -65.4 -24.99 67.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.27 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -70.56 -36.39 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 1.7 110.883 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.9 tp -76.73 -32.52 57.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 2.02 110.96 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -77.41 -18.93 56.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 1.8200000000000001 110.828 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.5 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.6 m -96.11 -34.27 11.76 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.118 -0.492 . . . . 1.3500000000000001 111.173 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.64 -35.32 72.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.124 -0.489 . . . . 0.65000000000000002 111.586 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.619 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.8 OUTLIER -59.98 -53.78 61.93 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 121.138 -0.225 . . . . 1.4199999999999999 110.813 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 64.7 Cg_exo -52.16 -50.83 12.68 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.197 1.931 . . . . 0.63 112.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -63.13 -32.74 74.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.379 -0.373 . . . . 1.49 110.703 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.63 -30.97 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.12 -0.491 . . . . 1.7 110.555 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 88.8 p -93.07 -22.28 19.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 1.25 110.827 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.781 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 211' ' ' VAL . . . . . 0.436 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.7 p -69.3 -44.76 80.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 1.6100000000000001 110.962 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.436 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -64.3 -28.7 73.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.812 -0.709 . . . . 0.81999999999999995 112.375 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.24 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 3.0800000000000001 110.634 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 45.0 t -60.94 -60.71 3.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 1.1499999999999999 110.85 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -62.8 -20.45 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 2.5600000000000001 111.045 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.93 -56.1 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 1.29 110.757 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.5 -21.13 65.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.329 -0.396 . . . . 2.3900000000000001 111.02 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 68.4 tp -67.27 -51.87 47.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 2.0299999999999998 110.966 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -82.44 -22.49 35.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 3.21 111.01 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.79 -22.55 47.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.899 -0.667 . . . . 1.3600000000000001 112.642 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 33.7 tp -58.86 -56.43 22.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.323 . . . . 2.8999999999999999 110.574 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 56.44 59.19 3.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.522 . . . . 4.8899999999999997 111.561 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 32.5 t30 57.97 108.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.197 -0.456 . . . . 4.2300000000000004 111.614 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 47.2 tp -169.17 93.19 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 6.1200000000000001 110.882 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -127.63 124.95 39.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.047 -0.524 . . . . 4.5499999999999998 110.903 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -134.88 106.92 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 6.7800000000000002 111.055 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.7 t -128.74 98.78 5.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.067 -0.515 . . . . 5.4000000000000004 110.732 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -115.22 -47.56 2.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 8.3300000000000001 110.756 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.453 . . . . 7.9100000000000001 111.007 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.868 0.366 . . . . 5.1100000000000003 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -145.08 34.76 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 5.04 110.711 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.7 mt -80.47 97.32 7.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 5.5800000000000001 110.904 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -143.08 -39.96 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 5.0199999999999996 111.235 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.1 m -63.98 125.72 25.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 2.4500000000000002 111.117 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -114.07 -18.97 11.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.002 -0.545 . . . . 2.4199999999999999 110.76 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.49 -40.81 83.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.0899999999999999 111.094 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.644 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 39.5 m80 -62.12 -35.96 80.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 1.1599999999999999 111.034 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' HG12 ' A' ' 12' ' ' VAL . 50.1 t-105 -69.52 -45.25 69.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.254 -0.43 . . . . 0.79000000000000004 111.186 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mt -68.26 -21.82 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.034 0.445 . . . . 2.0800000000000001 110.457 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -63.95 -54.98 26.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 1.28 110.682 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.3 p -61.64 -31.45 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.314 -0.403 . . . . 1.3200000000000001 111.032 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.31 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.63 111.168 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.33 -33.38 75.55 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.974 -0.631 . . . . 0.55000000000000004 112.951 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -70.47 -31.65 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.805 0.303 . . . . 1.03 111.201 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.8 m -63.02 -62.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.43 -0.35 . . . . 1.3 110.995 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -53.46 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.369 -0.378 . . . . 1.3100000000000001 111.181 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -60.28 -43.24 98.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.808 -0.711 . . . . 0.77000000000000002 112.236 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.86 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.865 0.364 . . . . 0.80000000000000004 111.023 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.61 -31.75 69.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 1.8100000000000001 111.078 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -55.89 -24.51 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.158 -0.474 . . . . 1.8799999999999999 111.267 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -56.45 -56.51 20.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.477 -0.329 . . . . 4.4500000000000002 111.085 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.643 ' O ' ' OG ' ' A' ' 26' ' ' SER . 86.2 t90 -64.24 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 3.6899999999999999 110.978 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -70.13 -23.77 63.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 1.5700000000000001 111.234 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.4 tp -87.76 -4.29 58.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 1.95 110.918 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 29.2 p -69.82 -20.22 63.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 1.3799999999999999 110.96 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -50.6 -32.14 17.94 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.63 -0.507 . . . . 4.0700000000000003 109.63 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.3 p-10 -175.55 132.28 0.43 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.371 -0.831 . . . . 2.7200000000000002 110.464 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 57.4 Cg_endo -96.15 158.21 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.226 2.617 . . . . 1.9099999999999999 112.113 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' CZ ' HD22 ' A' ' 218' ' ' LEU . 83.8 mtt180 -84.51 62.12 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.964 0.411 . . . . 4.7599999999999998 110.99 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.69 -46.98 3.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.952 -0.642 . . . . 1.99 112.446 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.0 m -99.75 145.48 30.21 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.468 0.175 . . . . 2.7000000000000002 110.658 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.25 160.83 12.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.317 2.012 . . . . 1.79 112.378 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -62.16 -16.41 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.801 . . . . 4.1200000000000001 112.077 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -41.41 -37.89 1.13 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.022 0.379 . . . . 2.9300000000000002 112.022 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 2.8799999999999999 110.369 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -68.22 -20.19 64.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.021 -0.536 . . . . 4.6600000000000001 110.282 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' MET . 32.8 tp -61.28 -47.75 84.57 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.266 -0.425 . . . . 1.45 110.002 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.67 -41.93 94.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.127 -0.488 . . . . 1.78 109.842 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -70.47 -6.11 33.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.62 -0.718 . . . . 0.63 110.908 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' LEU . 24.1 ttt -87.95 -36.42 17.1 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.17 -0.468 . . . . 1.48 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -71.3 -33.41 69.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.131 -0.486 . . . . 3.5 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 78.3 mt -50.68 -54.83 31.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.025 0.38 . . . . 1.0800000000000001 112.025 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -70.62 -32.21 15.4 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.234 1.956 . . . . 0.53000000000000003 113.082 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 41' ' ' MET . 24.8 mm -55.32 -62.4 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.717 0.294 . . . . 1.6799999999999999 111.726 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -62.66 -53.88 47.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 1.8300000000000001 111.306 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.48 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 91.3 p -58.48 -14.63 8.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 1.0900000000000001 111.545 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.59 -61.21 2.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.40999999999999998 112.589 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 mt -55.96 -27.57 53.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.704 0.287 . . . . 0.98999999999999999 111.358 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.94 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.47999999999999998 111.399 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.2 m-85 -60.86 -38.05 84.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 1.8700000000000001 111.46 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.8 ttp -52.04 -40.41 61.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.11 0.481 . . . . 1.49 110.059 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.45 93.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.58999999999999997 110.738 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.402 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 57.6 mtt -52.48 -35.73 53.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.48999999999999999 110.323 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -65.81 -43.88 87.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.968 -0.56 . . . . 0.59999999999999998 110.093 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.567 HG21 HG23 ' B' ' 127' ' ' VAL . 12.1 mt -70.61 -3.6 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 1.3100000000000001 110.814 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.78 32.57 10.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.794 -0.639 . . . . 1.9099999999999999 111.021 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -114.93 127.63 55.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 1.6200000000000001 110.537 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.65 15.15 2.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.821 -0.704 . . . . 1.04 112.394 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -112.34 141.97 45.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 2.6800000000000002 110.909 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.47 138.16 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 1.98 111.094 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.25 138.9 37.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.11 -0.496 . . . . 2.1800000000000002 110.871 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.33 104.43 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 1.5700000000000001 111.129 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.11 26.11 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 1.79 111.488 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.35 23.1 32.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 1.48 112.602 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -121.77 127.2 50.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 2.3199999999999998 110.678 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -101.84 120.75 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 1.4399999999999999 111.176 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.63 124.58 52.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.062 -0.517 . . . . 0.81999999999999995 110.685 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 74.5 m-70 -70.22 82.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.345 0.593 . . . . 0.90000000000000002 111.161 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.92 -50.96 70.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.314 -0.857 . . . . 1.8300000000000001 111.253 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -22.39 66.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.958 -0.565 . . . . 0.62 112.166 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -68.89 -52.09 33.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.195 0.443 . . . . 2.3399999999999999 112.195 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 4.0 p90 -76.67 -34.34 58.25 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.9 -0.32 . . . . 3.4900000000000002 111.244 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 mm -52.59 -49.85 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.934 0.397 . . . . 1.3700000000000001 110.532 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 26.7 t70 -65.0 -22.25 66.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.927 -0.578 . . . . 1.3100000000000001 109.877 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -87.08 5.29 38.41 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.803 -0.635 . . . . 1.48 111.254 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.479 ' HG3' HD12 ' A' ' 113' ' ' ILE . 43.2 ttm -104.17 -19.75 14.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 1.46 110.61 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.453 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.7 m -113.98 -32.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 1.1200000000000001 111.746 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 43' ' ' ILE . 28.4 m -79.17 -53.57 6.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.369 -0.378 . . . . 1.1000000000000001 111.904 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 32.6 m -50.68 -50.39 73.35 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.078 0.399 . . . . 0.59999999999999998 112.078 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 80' ' ' THR . 11.9 Cg_endo -55.71 -41.6 75.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.713 1.609 . . . . 0.73999999999999999 111.547 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 78' ' ' VAL . 3.6 mm? -65.73 -31.79 72.98 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.715 -0.476 . . . . 1.01 109.715 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -66.82 -26.98 67.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.046 -0.724 . . . . 1.48 109.046 178.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' A' ' 109' ' ' GLN . 11.4 tp -81.74 -39.44 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.917 -1.038 . . . . 1.3799999999999999 110.686 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.75 -38.31 90.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.874 -0.603 . . . . 1.1899999999999999 111.046 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -57.27 -23.66 49.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 1.23 111.117 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -73.93 -29.0 61.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.143 -0.48 . . . . 0.88 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.6 t -80.84 -27.15 36.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 1.3899999999999999 111.166 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -79.03 -31.49 44.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.371 . . . . 2.3199999999999998 111.197 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -82.64 -26.36 32.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 1.46 111.519 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.86 -49.46 9.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.398 -0.364 . . . . 1.24 111.192 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.6 mtt -108.14 110.62 22.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 111.176 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.99 -39.26 89.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 3.5299999999999998 110.399 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -114.39 175.72 5.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.778 -0.646 . . . . 4.0800000000000001 110.471 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -130.26 142.58 43.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.44 -0.346 . . . . 2.1699999999999999 111.022 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.15 174.91 9.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 4.5199999999999996 111.272 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -70.61 -59.29 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 3.75 111.045 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.08 130.0 38.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 3.5299999999999998 111.129 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -106.42 92.15 4.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 4.9100000000000001 110.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.0 t -113.49 -41.07 3.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.413 . . . . 1.98 111.493 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.9 tp -76.92 -41.84 41.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 1.8300000000000001 110.98 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 mm -65.94 -30.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 1.79 111.067 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.19 -40.3 42.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.923 -0.656 . . . . 0.62 112.441 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -63.18 -35.98 82.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 1.5800000000000001 110.88 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 -56.75 13.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.97999999999999998 111.176 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 57.1 ttm -56.95 -40.98 77.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.519 . . . . 1.48 111.234 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -58.31 -51.86 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 1.1299999999999999 111.278 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 112' ' ' VAL . 68.1 p -60.67 -21.14 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.48 111.378 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.538 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 21.7 tp60 -77.25 -30.23 54.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.361 . . . . 2.7000000000000002 110.76 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.31 -39.53 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 1.54 111.199 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 108' ' ' THR . 33.4 m -67.37 -35.73 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.932 -0.307 . . . . 1.28 111.063 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 108' ' ' THR . 81.8 t -66.26 -52.82 43.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.341 -0.39 . . . . 0.42999999999999999 111.433 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.479 HD12 ' HG3' ' A' ' 77' ' ' MET . 45.7 pt -60.03 -27.66 39.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.728 0.299 . . . . 1.74 111.336 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 30.7 m -63.39 -46.71 85.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.63 111.15 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 p -69.65 -24.85 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 1.0900000000000001 110.795 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.566 ' HA3' H181 ' A' ' 210' ' ' LYR . . . -76.98 -32.66 48.49 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.908 -0.663 . . . . 0.41999999999999998 113.217 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -80.53 -28.16 37.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.635 0.255 . . . . 1.3799999999999999 111.513 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.531 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.3 tp -83.49 -27.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 1.6200000000000001 110.87 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.78 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.39000000000000001 111.056 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.61 -21.12 60.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 2.02 111.029 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.7 mt -83.13 16.52 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.76000000000000001 110.902 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -75.24 119.85 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 1.46 110.817 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.66 -53.87 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 3.3500000000000001 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.668 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.7 ttp180 -78.26 132.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 2.9199999999999999 110.606 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.19 -9.38 39.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 2.77 111.485 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.668 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 78.3 t90 -89.51 -52.23 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 3.77 110.915 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.589 HG12 ' HB3' ' A' ' 124' ' ' ARG . 12.4 p -63.02 -23.7 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 1.1599999999999999 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 189' ' ' GLY . 39.5 ttm180 -55.12 -33.59 63.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 2.04 111.077 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.59 -27.52 45.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 2.6400000000000001 111.242 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 127' ' ' VAL . 4.0 mm? -74.78 -54.21 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 1.8999999999999999 111.315 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -61.43 -32.95 72.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 1.3999999999999999 111.769 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -58.69 -45.44 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 1.28 110.645 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.66 -26.73 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 2.1600000000000001 110.6 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 63.4 m -68.65 -34.11 75.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 1.6899999999999999 110.791 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.57 -51.0 33.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.868 -0.682 . . . . 0.52000000000000002 112.622 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.24 -29.76 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.738 0.304 . . . . 1.02 111.019 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.31 -47.12 87.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 1.0800000000000001 110.8 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.38 -33.42 74.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.62 110.903 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' A' ' 142' ' ' ILE . 80.7 t80 -72.03 -27.18 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.8400000000000001 110.948 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.7 mt -65.15 -54.02 36.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 1.6899999999999999 111.576 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 142' ' ' ILE . 37.8 pt -59.18 -42.2 86.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.355 . . . . 0.81000000000000005 111.827 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.45 ' N ' HG13 ' A' ' 141' ' ' ILE . 29.3 pt -73.02 -22.29 19.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.307 . . . . 2.3700000000000001 111.194 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.72 -40.14 91.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.303 -0.408 . . . . 0.97999999999999998 110.853 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -72.66 -36.43 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 3.27 110.421 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.99 -38.35 95.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.891 -0.671 . . . . 1.25 112.642 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.85 -21.32 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 2.1200000000000001 110.965 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -90.39 4.99 49.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 1.6599999999999999 111.174 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.479 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 51.5 t30 -60.72 -45.5 96.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.875 -0.602 . . . . 99.989999999999995 111.927 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.55 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 50.7 Cg_exo -55.33 -4.66 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.437 2.091 . . . . 2.6000000000000001 113.32 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.9 tp -50.64 -73.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.894 0.378 . . . . 4.6100000000000003 110.957 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -96.95 -9.73 27.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 8.3599999999999994 110.734 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 149' ' ' PRO . . . -67.11 -17.16 64.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.598 . . . . 2.75 111.127 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -46.7 -27.08 1.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 5.6799999999999997 111.648 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.3 p -78.31 -39.6 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 3.21 111.48 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -81.4 -14.45 57.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 6.8700000000000001 111.335 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 49.3 p -84.94 7.08 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.486 -0.325 . . . . 4.5599999999999996 111.255 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 62.69 -80.3 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.183 -0.462 . . . . 3.5600000000000001 111.515 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.4 t -58.73 112.55 1.67 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.841 0.353 . . . . 2.79 111.122 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.8 t -79.03 -37.82 38.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 2.5899999999999999 111.195 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.49 -50.52 73.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 3.4700000000000002 111.207 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -59.51 -39.14 82.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 111.021 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.04 -31.87 73.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.78 111.231 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.73 -39.48 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 2.6299999999999999 110.946 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 66.5 mt -61.18 -37.64 83.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.204 -0.453 . . . . 2.3399999999999999 110.839 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 -23.55 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.063 -0.517 . . . . 2.77 110.981 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.1 -42.13 94.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 2.04 110.839 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -83.99 -24.11 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 2.77 110.765 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.83 -51.55 61.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 1.8899999999999999 111.211 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.69 -25.75 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 1.6399999999999999 111.353 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.0 m -53.05 -59.15 4.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.24 111.469 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.451 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 11.2 t80 -68.11 -31.6 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 2.9700000000000002 110.424 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.49 -23.42 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 1.48 111.136 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 -49.81 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 1.55 111.573 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 171' ' ' TYR . 22.5 m -58.75 -29.17 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.561 -0.29 . . . . 1.52 111.738 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 209' ' ' SER . 69.3 mt -77.72 -58.11 3.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.831 0.348 . . . . 1.8500000000000001 111.017 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.63 -23.18 58.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.534 . . . . 0.62 110.777 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 181' ' ' ILE . 10.9 mm -88.07 -29.36 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 1.3500000000000001 110.362 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -52.31 48.18 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.767 -0.651 . . . . 0.58999999999999997 113.766 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.679 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 73.8 m-85 -58.64 -55.38 46.6 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.01 0.405 . . . . 1.45 111.952 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 73.1 Cg_exo -49.06 -28.03 13.17 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.136 1.89 . . . . 0.55000000000000004 112.738 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 184' ' ' ILE . 95.0 mt -71.72 -59.96 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 1.4199999999999999 111.125 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 179' ' ' TYR . 20.4 m -58.17 -24.58 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.379 -0.373 . . . . 0.78000000000000003 111.7 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -64.11 -17.46 63.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.064 0.394 . . . . 0.93999999999999995 112.064 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.702 HG13 HG23 ' A' ' 185' ' ' ILE . 19.3 pt -69.74 -9.79 12.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.988 -0.285 . . . . 1.4299999999999999 111.57 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.702 HG23 HG13 ' A' ' 184' ' ' ILE . 42.4 pt -134.09 146.77 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 2.02 111.092 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 98.15 -160.83 20.74 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.919 -0.658 . . . . 1.79 112.47 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.51 150.13 84.2 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.573 2.182 . . . . 3.1000000000000001 111.942 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 71.0 m 56.24 23.57 7.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 2.7400000000000002 110.68 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.412 ' N ' ' HD3' ' A' ' 128' ' ' ARG . . . -169.0 43.81 0.22 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.883 -0.675 . . . . 3.4300000000000002 112.692 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 58.13 89.9 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.756 0.312 . . . . 6.5 111.063 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.28 138.49 5.67 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.791 -0.719 . . . . 3.29 112.371 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -102.75 25.19 9.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.764 0.316 . . . . 6.1600000000000001 111.03 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.9 pt -128.97 149.51 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.284 -0.416 . . . . 2.4199999999999999 111.169 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -156.77 51.64 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 4.29 110.305 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.545 ' HG3' ' H ' ' A' ' 196' ' ' THR . 4.3 tp-100 -113.31 -179.53 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.856 -0.611 . . . . 5.1500000000000004 110.587 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.545 ' H ' ' HG3' ' A' ' 195' ' ' GLN . 65.8 p -55.55 -26.95 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.688 0.255 . . . . 2.4500000000000002 111.688 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt -55.76 -37.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.807 0.337 . . . . 2.48 111.473 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.9 -54.5 44.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 2.1800000000000002 110.904 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.3 p -63.07 -30.27 71.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 1.49 111.021 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -56.75 -38.08 71.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.77 111.163 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 63.0 tp -75.77 -40.51 55.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 1.4199999999999999 111.511 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.99 -6.1 51.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.701 0.26 . . . . 1.78 111.701 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 60.5 m -96.12 -39.96 9.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.915 0.388 . . . . 1.3 110.911 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.75 -35.79 65.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.66000000000000003 111.922 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.673 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.7 tp -58.72 -53.99 60.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.965 -0.294 . . . . 1.6299999999999999 111.252 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 32.1 Cg_exo -58.93 -37.2 94.82 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.683 1.589 . . . . 0.64000000000000001 111.274 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -63.33 -34.16 77.1 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 116.021 -0.536 . . . . 1.3600000000000001 110.13 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -72.25 -24.23 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.625 . . . . 1.54 110.472 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.462 ' HB2' HD22 ' A' ' 175' ' ' LEU . 29.8 t -95.65 -19.16 19.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 1.2 111.007 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.769 H183 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 24.5 t -67.96 -33.8 63.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.22 -0.446 . . . . 1.6399999999999999 111.342 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.32 71.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.583 -0.818 . . . . 0.79000000000000004 112.408 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -76.34 -34.18 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.62 0.248 . . . . 1.6100000000000001 111.178 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 85.2 p -63.14 -52.22 63.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 1.1499999999999999 110.912 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -62.12 -30.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 3.3399999999999999 110.346 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.5 -47.86 74.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 1.1899999999999999 110.632 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.72 -33.93 68.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.23 111.278 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.411 HD22 ' CZ ' ' A' ' 30' ' ' ARG . 90.3 mt -62.89 -47.27 84.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 2.4700000000000002 111.372 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -74.12 -27.68 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 1.6200000000000001 111.058 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.86 63.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 1.4099999999999999 112.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.77 -37.85 83.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.588 0.232 . . . . 2.5800000000000001 111.294 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.484 ' HA ' ' NE ' ' A' ' 222' ' ' ARG . 5.9 tpm_? 63.73 -80.97 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.008 -0.542 . . . . 4.9299999999999997 111.277 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -147.09 -85.25 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.376 -0.375 . . . . 4.6299999999999999 110.914 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.6 mt 63.82 130.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.185 -0.461 . . . . 6.4699999999999998 111.377 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -124.0 137.71 54.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 5.0700000000000003 110.8 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -139.85 146.41 39.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.411 . . . . 6.5300000000000002 110.962 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.8 m -148.92 111.95 4.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.034 -0.53 . . . . 5.2199999999999998 110.709 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -96.39 -53.38 3.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 8.3599999999999994 110.978 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 7.96 110.876 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.904 0.383 . . . . 6.1699999999999999 110.755 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -91.59 95.34 9.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 4.8200000000000003 110.662 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.449 ' N ' HD12 ' B' ' 3' ' ' LEU . 6.9 mp -94.52 2.29 55.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 5.5999999999999996 111.324 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.51 -169.98 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.313 -0.403 . . . . 4.7999999999999998 110.751 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.1 t 62.63 92.66 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.181 -0.463 . . . . 2.3700000000000001 111.023 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.466 ' N ' HD12 ' B' ' 6' ' ' LEU . 5.9 mp -105.32 1.31 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 2.0699999999999998 110.746 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 62.5 tp -68.12 -41.15 82.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 2.1000000000000001 110.426 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.7 m80 -61.92 -31.81 72.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 1.0700000000000001 110.474 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -69.79 -44.72 69.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.96 -0.564 . . . . 1.48 110.458 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.89 -20.72 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 2.02 110.119 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.98 -54.64 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.92000000000000004 110.61 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.45 -32.63 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.93999999999999995 111.08 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -53.17 61.23 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.199 -0.455 . . . . 0.55000000000000004 111.037 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.47 -27.34 69.38 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.891 -0.671 . . . . 0.47999999999999998 112.461 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' B' ' 44' ' ' PRO . 22.9 mmt -73.53 -26.9 61.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.696 0.284 . . . . 0.84999999999999998 111.033 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 63.2 m -69.32 -54.32 15.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 1.3400000000000001 110.983 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -60.49 -27.42 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 1.55 111.17 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.73 -51.71 53.87 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.535 -0.841 . . . . 0.69999999999999996 112.245 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.16 68.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.936 0.398 . . . . 0.81000000000000005 111.165 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.37 -31.54 71.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 2.2599999999999998 110.85 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -61.05 -21.94 64.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 1.78 110.978 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.27 -35.67 81.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 4.5800000000000001 110.992 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -80.3 -32.85 37.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 3.3500000000000001 111.082 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 88.8 p -77.3 -19.95 55.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 1.5800000000000001 111.353 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 tp -87.43 -1.76 58.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.342 . . . . 1.8400000000000001 110.958 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 100.0 p -73.39 -19.52 60.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 1.3700000000000001 110.833 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -52.09 -30.72 27.38 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.691 -0.485 . . . . 4.9800000000000004 109.691 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.7 p-10 -174.19 131.83 0.52 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.44 -0.8 . . . . 2.1400000000000001 110.319 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.444 ' HB3' ' NE2' ' B' ' 34' ' ' GLN . 56.9 Cg_endo -97.29 172.66 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.175 2.583 . . . . 1.8200000000000001 111.892 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -94.5 58.74 2.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.407 . . . . 5.1900000000000004 110.661 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -45.82 3.46 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.007 -0.616 . . . . 2.2000000000000002 112.375 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.436 HG13 HD21 ' B' ' 224' ' ' LEU . 34.2 m -101.7 147.03 33.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 O-C-N 122.977 -0.131 . . . . 3.6499999999999999 110.739 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -54.28 163.5 3.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.058 . . . . 2.6699999999999999 112.516 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLN . . . . . 0.444 ' NE2' ' HB3' ' B' ' 29' ' ' PRO . 74.7 mm-40 -64.99 -17.47 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.554 -0.748 . . . . 4.8799999999999999 111.922 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -41.6 -34.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.009 0.374 . . . . 1.8700000000000001 112.009 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.29 -53.43 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 2.6800000000000002 110.334 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -66.48 -19.58 65.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.903 -0.589 . . . . 2.9199999999999999 110.458 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' B' ' 41' ' ' MET . 8.5 tt -59.86 -47.71 84.62 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.659 -0.497 . . . . 1.6399999999999999 109.659 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 52.2 t -62.79 -39.87 86.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.524 -0.547 . . . . 1.6000000000000001 109.524 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.34 -5.89 39.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.663 -0.699 . . . . 0.68999999999999995 110.663 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.535 ' O ' ' HD2' ' B' ' 44' ' ' PRO . 26.6 ttt -88.72 -31.32 18.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.029 -0.532 . . . . 2.5800000000000001 110.455 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -75.47 -34.22 60.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 3.3900000000000001 111.105 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.625 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 67.6 mt -54.21 -51.84 74.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.962 0.356 . . . . 0.40999999999999998 111.962 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 12.2 Cg_exo -70.79 -33.72 12.26 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.637 2.225 . . . . 0.48999999999999999 113.132 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.445 HG12 ' O ' ' B' ' 41' ' ' MET . 24.4 mm -57.28 -62.15 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 111.749 0.278 . . . . 1.29 111.749 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.439 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -59.05 -54.28 48.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.805 0.335 . . . . 1.3999999999999999 111.081 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -55.33 -28.79 56.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 1.3799999999999999 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.99 -58.04 14.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 0.37 112.74 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.22 -29.61 67.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 1.29 111.101 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -52.25 60.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.219 -0.446 . . . . 0.44 111.228 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 22.4 m-85 -64.65 -39.36 93.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.5 111.198 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' MET . . . . . 0.436 ' SD ' HD11 ' B' ' 56' ' ' ILE . 12.5 tmm? -49.61 -40.8 40.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.214 0.53 . . . . 1.4099999999999999 110.052 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.58 91.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.679 -0.691 . . . . 0.55000000000000004 110.821 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtt -52.56 -32.27 40.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.5 110.197 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -69.37 -42.64 74.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.957 -0.565 . . . . 0.54000000000000004 110.213 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.436 HD11 ' SD ' ' B' ' 52' ' ' MET . 12.0 mt -75.67 1.89 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 1.3 110.567 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t70 66.16 46.75 2.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.642 -0.708 . . . . 2.2400000000000002 110.714 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.42 ' CD ' HG21 ' C' ' 127' ' ' VAL . 14.6 mm100 -115.72 168.84 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.77 110.954 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 83.65 23.69 52.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 1.0600000000000001 112.466 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.12 142.96 46.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 2.6600000000000001 110.799 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.63 147.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 1.8899999999999999 111.265 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.59 142.51 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 2.4100000000000001 110.762 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.82 98.85 1.37 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 1.5600000000000001 111.299 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.18 29.27 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.04 -0.527 . . . . 1.8200000000000001 111.422 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.94 16.48 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 1.51 112.597 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -116.48 121.29 41.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 2.4500000000000002 110.896 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.69 123.08 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 1.79 111.093 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.97 129.7 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.81999999999999995 111.238 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.505 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 87.9 m-70 -73.03 81.36 1.22 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.05 110.619 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -62.03 -35.4 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 1.8700000000000001 111.586 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -78.85 -22.56 45.92 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.311 0.486 . . . . 0.60999999999999999 112.311 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.505 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 12.8 tpp180 -69.85 -51.32 34.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.132 0.419 . . . . 2.3900000000000001 112.132 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.501 ' O ' ' HG3' ' B' ' 77' ' ' MET . 8.2 p90 -76.3 -38.11 56.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.861 0.319 . . . . 3.6699999999999999 111.861 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.461 HG23 ' N ' ' B' ' 75' ' ' ASP . 11.1 tp -54.04 -44.4 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 1.6599999999999999 110.991 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.461 ' N ' HG23 ' B' ' 74' ' ' ILE . 24.7 t70 -67.22 -21.8 65.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.495 -0.557 . . . . 1.4099999999999999 109.495 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -85.9 4.92 35.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.514 -0.766 . . . . 1.1599999999999999 111.267 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 42.5 mtp -104.83 -18.99 14.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.232 -0.44 . . . . 1.53 110.939 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.516 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.4 m -114.54 -31.65 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.89000000000000001 111.876 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.599 HG23 HG23 ' B' ' 43' ' ' ILE . 60.9 m -79.47 -57.18 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 1.24 112.035 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.549 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 11.0 m -50.42 -50.13 73.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.192 0.442 . . . . 0.57999999999999996 112.192 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.7 Cg_exo -53.91 -42.49 66.18 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.832 1.688 . . . . 0.66000000000000003 111.64 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.516 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -66.97 -29.45 69.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 1.0600000000000001 110.036 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.538 HD22 ' H43' ' B' ' 210' ' ' LYR . 19.0 tp -70.19 -20.98 63.09 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.176 -0.676 . . . . 1.22 109.176 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' B' ' 109' ' ' GLN . 14.9 tp -83.86 -39.89 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.1 -0.954 . . . . 1.53 109.985 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 22.1 tp -66.94 -35.34 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.343 -0.844 . . . . 1.5800000000000001 111.025 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -60.08 -21.78 61.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 1.3899999999999999 110.804 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.2 -27.21 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 1.1499999999999999 110.7 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -76.74 -33.1 58.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.964 -0.562 . . . . 1.5700000000000001 110.783 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -80.05 -31.77 39.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 2.1699999999999999 110.801 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 88.6 m -72.98 -38.48 66.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 1.4199999999999999 111.067 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.29 -46.43 12.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 1.1799999999999999 111.034 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 80.4 mtp -103.39 120.89 41.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.8799999999999999 111.047 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -75.52 -30.94 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 3.4199999999999999 110.574 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.63 179.44 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.907 -0.588 . . . . 4.0599999999999996 110.664 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tp -132.25 148.31 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 2.0899999999999999 111.25 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.2 161.26 14.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 3.8500000000000001 110.936 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.37 44.51 1.04 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.109 -0.496 . . . . 4.8200000000000003 111.089 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -149.13 113.57 5.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 3.7999999999999998 110.679 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -82.93 78.72 9.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.189 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.8 m -120.93 -59.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.304 -0.407 . . . . 2.02 111.542 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.15 -61.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 2.0899999999999999 111.443 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.8 pt -55.33 -38.09 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.8799999999999999 111.57 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.84 -43.81 98.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.869 -0.681 . . . . 0.56000000000000005 112.798 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -63.21 -36.0 82.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.282 . . . . 1.78 110.985 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.45 -53.47 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 1.03 111.118 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 87.7 mtp -57.95 -36.26 72.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 1.6699999999999999 111.042 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 57.6 m -65.32 -54.43 29.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.12 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.434 ' HB ' HD13 ' B' ' 142' ' ' ILE . 47.4 p -53.98 -26.14 24.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 1.1799999999999999 111.292 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.461 ' HB2' HD22 ' B' ' 84' ' ' LEU . 24.4 tp60 -71.61 -40.99 69.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 2.1699999999999999 110.709 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.99 -32.07 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 1.3500000000000001 110.973 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.13 -43.01 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 1.3400000000000001 111.264 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.62 -55.4 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.42999999999999999 111.515 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.7 pt -54.32 -33.17 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 1.6000000000000001 111.269 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -60.87 -40.77 94.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.337 -0.392 . . . . 0.85999999999999999 110.607 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -61.54 -59.8 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.94999999999999996 110.365 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.535 ' HA3' H181 ' B' ' 210' ' ' LYR . . . -60.66 -16.33 44.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.781 -0.723 . . . . 0.46000000000000002 112.431 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.96 -61.84 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 1.75 110.702 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 mt -84.04 -20.41 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 1.78 111.759 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.95 57.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.779 0.323 . . . . 0.38 110.956 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.424 ' HA ' ' OG ' ' B' ' 188' ' ' SER . 24.8 t70 -82.97 -19.65 36.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 1.97 110.822 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.56 22.83 1.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.76000000000000001 111.107 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.4 p -70.97 124.51 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 1.47 110.921 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -99.9 -41.71 7.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 2.5 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.572 ' HB2' HG12 ' B' ' 127' ' ' VAL . 80.3 mtp180 -94.5 140.05 30.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 2.73 111.033 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.13 -19.14 62.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 2.2000000000000002 110.95 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -79.03 -54.02 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 3.3999999999999999 110.894 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' B' ' 124' ' ' ARG . 10.6 p -62.06 -23.66 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.23 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -51.95 -41.38 62.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 3.04 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -77.06 -28.56 54.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.292 -0.413 . . . . 4.1399999999999997 111.16 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' B' ' 127' ' ' VAL . 93.7 mt -70.48 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 1.6499999999999999 111.137 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -56.21 -32.39 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 0.77000000000000002 111.151 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -60.43 -42.6 96.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.911 0.386 . . . . 1.46 110.52 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.76 -28.87 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 110.653 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.7 t -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.895 -0.593 . . . . 1.4199999999999999 110.724 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.28 23.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 0.48999999999999999 112.501 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.42 -30.42 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.789 0.328 . . . . 1.3 111.137 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.55 -40.48 94.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 1.3 110.765 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.19 78.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.62 110.978 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -73.76 -22.72 59.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.74 110.694 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -56.46 10.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.689 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.402 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.7 pt -60.48 -40.86 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.68999999999999995 111.441 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.434 HD13 ' HB ' ' B' ' 108' ' ' THR . 67.3 mt -68.84 -28.86 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.475 -0.329 . . . . 1.76 110.715 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.5 -42.29 99.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0600000000000001 110.979 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -72.31 -27.31 62.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 4.1200000000000001 110.808 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' GLY . . . . . 0.833 ' HA2' ' OD1' ' B' ' 148' ' ' ASN . . . -76.16 -27.45 62.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 1.26 112.716 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.44 -13.49 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.771 0.32 . . . . 1.98 111.286 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -99.93 4.67 45.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 1.4199999999999999 111.212 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.833 ' OD1' ' HA2' ' B' ' 145' ' ' GLY . 32.1 m120 -63.08 -43.44 81.52 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 112.069 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' B' ' 152' ' ' ALA . 82.7 Cg_exo -50.39 -11.03 0.3 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.502 2.134 . . . . 2.6499999999999999 113.494 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 69.8 tp -50.35 -80.5 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.735 0.303 . . . . 4.3899999999999997 111.171 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -89.65 1.54 55.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 7.9000000000000004 110.635 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' B' ' 149' ' ' PRO . . . -82.13 -17.08 47.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.566 . . . . 2.77 110.963 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -49.32 -30.23 7.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.972 -0.558 . . . . 6.29 112.003 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 8.8 t -70.95 -35.13 72.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 3.1000000000000001 110.917 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -83.08 -17.63 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 6.4299999999999997 110.976 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 76.5 p -84.47 6.9 21.66 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.359 -0.382 . . . . 4.5700000000000003 111.66 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 62.94 -82.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.367 -0.379 . . . . 3.8300000000000001 111.517 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.537 ' HB2' HD23 ' B' ' 161' ' ' LEU . 75.4 p -55.56 113.18 1.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.905 0.383 . . . . 3.0699999999999998 111.182 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 49.0 m -78.14 -46.47 20.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.996 -0.547 . . . . 3.4300000000000002 111.026 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -52.95 -56.47 15.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.187 -0.461 . . . . 3.9199999999999999 111.426 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 158' ' ' SER . 3.8 mm? -55.21 -35.8 65.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 2.7000000000000002 110.965 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.09 -31.56 70.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 1.8300000000000001 111.163 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -71.77 -41.27 68.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 2.6299999999999999 110.858 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.2 mt -58.43 -37.15 74.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.15 -0.477 . . . . 2.4300000000000002 110.824 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.19 -31.64 58.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.749 -0.66 . . . . 2.5800000000000001 111.287 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.44 -42.06 91.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 2.0 110.968 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -83.42 -22.52 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 3.0299999999999998 110.982 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.68 -44.63 77.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 1.1000000000000001 110.926 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.57 -25.68 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 1.75 111.336 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 51.0 m -51.26 -59.13 4.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.97999999999999998 111.367 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -67.2 -34.61 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 4.2999999999999998 110.482 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -63.25 -22.21 66.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 1.3899999999999999 111.003 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.454 ' O ' HG22 ' B' ' 177' ' ' ILE . 48.0 m -79.73 -56.99 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 1.1100000000000001 111.721 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.08 -29.39 15.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.365 0.506 . . . . 1.51 112.365 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 209' ' ' SER . 57.9 tp -79.87 -57.92 3.42 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.891 0.377 . . . . 1.75 111.29 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.3 -29.54 61.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.02 -0.537 . . . . 0.59999999999999998 111.04 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.454 HG22 ' O ' ' B' ' 173' ' ' THR . 9.4 tp -87.91 -21.79 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.064 0.459 . . . . 1.47 110.438 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.98 -54.94 33.49 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.789 -0.642 . . . . 0.55000000000000004 113.129 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 96.3 m-85 -56.41 -54.14 56.4 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.816 0.308 . . . . 1.6200000000000001 111.763 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.7 Cg_exo -46.75 -32.32 11.98 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.223 1.949 . . . . 0.64000000000000001 112.612 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 177' ' ' ILE . 91.0 mt -67.93 -60.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 1.27 111.577 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 179' ' ' TYR . 29.0 m -58.97 -24.71 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.68999999999999995 111.861 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -62.69 -20.05 64.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.52 -0.309 . . . . 1.1799999999999999 111.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 mm -54.44 -49.9 61.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 1.77 110.794 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.454 ' HA ' ' HB3' ' B' ' 190' ' ' PHE . 15.0 pt -95.5 178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.017 -0.538 . . . . 1.6899999999999999 111.294 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 73.93 -162.31 54.29 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.887 -0.673 . . . . 1.5800000000000001 112.505 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.67 154.62 64.02 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.634 2.223 . . . . 2.5099999999999998 112.238 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' B' ' 120' ' ' ASP . 46.6 m 58.78 14.95 3.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 3.5800000000000001 110.903 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -135.93 -85.56 0.2 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.994 -0.622 . . . . 4.0300000000000002 112.111 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' B' ' 185' ' ' ILE . 83.6 t80 -113.25 -53.13 2.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.892 0.377 . . . . 6.8899999999999997 110.509 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 100.7 123.7 5.2 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.785 -0.721 . . . . 3.7000000000000002 112.847 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -171.87 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 7.5 110.669 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.624 HD13 ' H ' ' B' ' 193' ' ' ILE . 0.2 OUTLIER -139.81 177.75 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 2.3500000000000001 111.078 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -168.49 16.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 3.8599999999999999 110.771 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -85.43 -164.13 0.96 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 5.0499999999999998 111.076 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 52.9 p -66.78 -20.76 66.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 2.6800000000000002 111.343 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 14.1 tt -59.67 -40.46 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.396 . . . . 2.4700000000000002 111.432 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.07 -49.42 77.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 2.5299999999999998 110.869 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 63.4 p -68.98 -23.27 64.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 1.29 110.896 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.98 -36.8 83.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 2.6200000000000001 111.19 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.26 -45.83 53.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.387 -0.37 . . . . 1.6100000000000001 111.218 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -75.52 -3.43 34.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.745 0.307 . . . . 1.4199999999999999 111.349 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 43.8 t -96.31 -43.47 7.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.279 0.561 . . . . 1.4299999999999999 110.289 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 66.5 tp -71.93 -39.48 69.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.444 -0.798 . . . . 1.1200000000000001 112.055 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.58 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -55.97 -54.77 48.64 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.237 -0.185 . . . . 1.26 111.384 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -56.16 -41.51 75.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.885 1.723 . . . . 0.59999999999999998 111.559 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.61 -31.78 73.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.247 -0.433 . . . . 1.3999999999999999 110.288 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -66.68 -27.49 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 1.4099999999999999 110.572 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.44 ' HB2' HD13 ' B' ' 175' ' ' LEU . 17.3 t -97.04 -27.82 14.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 1.3200000000000001 111.053 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.756 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 46.7 t -73.37 -33.52 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 1.6899999999999999 110.997 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.27 -30.66 74.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.79000000000000004 112.549 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -74.74 -29.87 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 2.96 110.753 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.1 t -63.0 -59.93 4.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 1.29 110.74 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.79 -28.89 67.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 3.1499999999999999 110.823 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.74 -43.36 89.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 1.51 110.567 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.08 -22.24 65.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 2.1899999999999999 110.873 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.4 tp -69.62 -51.51 34.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 1.98 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -78.09 -30.94 49.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 2.1699999999999999 111.302 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.66 80.43 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.792 -0.718 . . . . 1.3600000000000001 112.933 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 55.1 tp -73.28 -35.69 66.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 2.8999999999999999 111.012 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 58.44 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.99 -0.55 . . . . 5.6100000000000003 111.356 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -171.59 151.14 2.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.495 -0.321 . . . . 4.04 110.918 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.468 HD23 ' N ' ' B' ' 224' ' ' LEU . 2.5 pt? -170.14 142.54 2.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.341 -0.391 . . . . 6.2999999999999998 110.77 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -105.42 140.1 39.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.493 . . . . 4.7999999999999998 111.179 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -149.14 117.82 6.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 6.3899999999999997 110.756 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 64.2 m -125.46 113.38 17.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 5.6100000000000003 111.156 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -105.92 -26.31 11.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 8.1999999999999993 110.583 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 8.1699999999999999 110.924 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.888 0.375 . . . . 5.6200000000000001 110.732 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -134.96 69.37 1.45 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 5.2800000000000002 111.09 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.55 94.0 4.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 6.0499999999999998 110.914 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -140.45 -34.41 0.53 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.142 -0.481 . . . . 4.79 110.853 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 48.8 m -66.48 99.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 2.71 110.844 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt -97.12 13.57 28.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.52 110.927 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 94.3 mt -81.11 -45.16 16.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 1.9299999999999999 111.257 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 39.3 m80 -64.65 -26.08 68.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.931 0.396 . . . . 1.26 110.475 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.453 ' O ' HG12 ' C' ' 12' ' ' VAL . 62.0 t-105 -72.58 -47.75 45.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 1.6699999999999999 110.059 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.05 -20.8 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.358 0.599 . . . . 1.8700000000000001 109.503 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -59.9 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.224 -0.898 . . . . 1.4399999999999999 110.69 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' C' ' 52' ' ' MET . 14.0 p -58.58 -32.81 46.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.19 -0.459 . . . . 0.46999999999999997 111.035 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.62 41.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.58999999999999997 111.015 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.07 -21.78 68.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.5 112.189 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 8.2 mmt -73.54 -35.85 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.676 0.274 . . . . 0.68000000000000005 110.952 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 59.8 p -66.46 -53.06 39.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 1.3999999999999999 111.185 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ILE . . . . . 0.412 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.7 pp -59.98 -26.09 34.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.36 . . . . 1.55 111.016 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.412 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -66.97 -39.51 93.26 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.763 -0.732 . . . . 0.70999999999999996 112.418 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' C' ' 41' ' ' MET . . . -72.67 -28.29 62.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.77000000000000002 110.926 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 28.4 tp -68.49 -29.93 68.65 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 1.9299999999999999 110.516 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -59.19 -22.14 60.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 1.8600000000000001 110.414 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -58.19 -53.73 55.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.018 -0.537 . . . . 4.1399999999999997 110.91 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -60.81 -38.8 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 3.1499999999999999 110.479 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 63.3 m -69.69 -19.56 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 1.95 110.67 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 23.7 mt -80.1 -0.39 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 2.2200000000000002 111.554 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 48.8 p -57.56 -52.04 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.911 -0.316 . . . . 1.3700000000000001 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.74 -27.41 69.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.158 0.98 . . . . 5.0300000000000002 108.508 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.767 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 12.7 m120 -70.32 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 113.473 -1.694 . . . . 2.3700000000000001 108.892 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.767 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 5.8 Cg_exo 10.16 96.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.763 2.976 . . . . 2.0499999999999998 117.093 -174.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -109.65 131.61 54.9 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.421 -1.263 . . . . 4.5199999999999996 108.226 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.08 -43.09 3.19 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.005 -1.238 . . . . 2.1600000000000001 110.005 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.536 ' O ' ' HB3' ' C' ' 29' ' ' PRO . 3.3 p -125.66 112.22 25.21 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.331 -0.988 . . . . 2.5299999999999998 108.331 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.82 167.54 21.05 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.038 2.492 . . . . 1.9299999999999999 115.543 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLN . . . . . 0.628 ' HG3' ' HG2' ' C' ' 29' ' ' PRO . 24.1 mp0 -60.93 -14.47 22.7 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 113.435 -1.712 . . . . 4.1200000000000001 112.82 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' C' ' 38' ' ' LEU . 20.8 p90 -39.22 -36.31 0.32 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.708 0.29 . . . . 2.8900000000000001 111.604 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -64.91 -48.35 74.48 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.251 0.548 . . . . 2.46 109.572 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' C' ' 34' ' ' GLN . 33.7 t80 -68.56 -20.48 64.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 2.7799999999999998 110.291 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' C' ' 35' ' ' TYR . 56.1 tp -59.03 -48.29 82.13 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.571 -0.529 . . . . 1.6200000000000001 109.571 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -41.27 91.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.82 -0.627 . . . . 1.5900000000000001 109.581 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -70.87 -6.07 35.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.591 -0.732 . . . . 0.65000000000000002 110.703 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.534 ' HG3' ' HA ' ' C' ' 19' ' ' ALA . 51.0 ttp -88.64 -34.14 17.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.153 -0.476 . . . . 1.6699999999999999 110.519 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' C' ' 45' ' ' ILE . 61.8 t80 -72.43 -30.07 64.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 3.4199999999999999 110.571 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.612 HG23 HG23 ' C' ' 79' ' ' THR . 93.3 mt -54.89 -54.81 45.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.89000000000000001 111.548 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.485 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.6 Cg_endo -71.22 -28.64 18.36 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.224 1.949 . . . . 0.40999999999999998 113.176 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' C' ' 42' ' ' PHE . 80.0 mt -58.1 -62.72 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.623 0.249 . . . . 1.76 111.58 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -55.42 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 2.1600000000000001 111.084 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 85.8 p -52.01 -39.04 58.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 1.1699999999999999 111.303 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.44 -55.14 28.35 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.925 -0.655 . . . . 0.44 112.923 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' C' ' 52' ' ' MET . 69.6 mt -57.04 -29.91 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 1.29 110.829 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 50' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -70.42 -35.73 73.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.136 -0.483 . . . . 0.5 111.05 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 49.6 m-85 -71.39 -52.45 18.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 1.8300000000000001 111.466 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' MET . . . . . 0.561 ' HB3' HG11 ' C' ' 12' ' ' VAL . 23.8 ptm -49.53 -34.69 17.99 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.882 0.372 . . . . 1.47 110.498 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.07 88.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.59999999999999998 110.727 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 54.2 mtt -52.27 -33.86 43.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.836 -0.62 . . . . 0.83999999999999997 110.553 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.32 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.65000000000000002 110.705 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.465 HG21 HG23 ' A' ' 127' ' ' VAL . 10.2 mm -72.64 -4.75 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 1.55 110.697 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 66.55 35.61 5.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.7 . . . . 1.54 110.815 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -118.35 138.21 52.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 1.79 110.641 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.39 16.83 5.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.847 -0.692 . . . . 0.93999999999999995 112.495 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' C' ' 60' ' ' LYS . 3.3 mptp? -114.67 137.8 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 2.3599999999999999 110.606 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.05 142.56 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.97 111.016 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.27 139.63 42.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.081 -0.509 . . . . 2.4399999999999999 110.915 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.85 102.09 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 1.54 111.072 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.33 30.57 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 1.71 111.24 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.4 40.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 1.53 112.783 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 118.95 31.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.687 0.28 . . . . 2.23 110.609 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -97.18 120.11 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 1.3600000000000001 111.105 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.49 141.92 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.78000000000000003 111.108 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 55.3 m-70 -80.68 82.06 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.08 0.467 . . . . 1.0800000000000001 110.864 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -67.65 -32.72 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.797 -0.638 . . . . 2.2999999999999998 111.392 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.57 -24.99 41.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.288 0.477 . . . . 0.75 112.288 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.559 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.3 mmt180 -71.51 -52.01 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.284 0.476 . . . . 1.51 112.284 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.494 ' O ' ' HG3' ' C' ' 77' ' ' MET . 2.6 p90 -71.43 -40.37 70.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.82 -0.352 . . . . 4.6500000000000004 111.717 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.446 HG23 ' N ' ' C' ' 75' ' ' ASP . 10.4 tp -53.64 -44.01 56.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.581 0.229 . . . . 1.22 111.026 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.446 ' N ' HG23 ' C' ' 74' ' ' ILE . 23.4 t70 -70.08 -21.45 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.447 -0.575 . . . . 1.3100000000000001 109.447 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -87.38 6.93 31.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.436 -0.802 . . . . 1.6799999999999999 111.209 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 30.0 mtp -105.34 -20.68 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 1.8 110.693 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -114.14 -29.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 1.1899999999999999 111.883 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.612 HG23 HG23 ' C' ' 43' ' ' ILE . 88.2 m -81.29 -56.14 4.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.23 111.787 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 25.0 m -50.54 -50.32 72.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.412 0.523 . . . . 0.58999999999999997 112.412 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' C' ' 80' ' ' THR . 12.3 Cg_endo -56.41 -38.49 95.16 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.58 1.52 . . . . 0.67000000000000004 111.446 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.42 -30.94 69.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.95999999999999996 109.577 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.559 HD22 ' H43' ' C' ' 210' ' ' LYR . 25.1 tp -70.89 -21.23 62.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.445 0.641 . . . . 1.1899999999999999 109.336 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.32 -37.23 21.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.993 -1.003 . . . . 1.7 109.908 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 89.4 mt -67.72 -35.91 79.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.75 -0.659 . . . . 1.6200000000000001 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 88.8 p -56.71 -31.14 64.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.343 -0.389 . . . . 1.26 110.981 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 70.4 mt -66.62 -33.23 75.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.489 . . . . 1.1100000000000001 110.797 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -73.72 -27.47 61.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 1.51 110.961 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.27 -33.6 25.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 2.0600000000000001 110.952 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 82.3 m -76.52 -37.23 57.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 1.52 111.005 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.28 -48.3 12.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 1.3 111.265 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -104.0 115.14 29.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 1.6200000000000001 110.949 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -71.54 -25.07 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 3.2400000000000002 111.016 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -144.77 138.0 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 4.6299999999999999 111.053 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.8 142.08 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.054 -0.521 . . . . 2.1800000000000002 111.022 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -102.89 173.55 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 4.1200000000000001 110.807 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.9 -178.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 4.96 110.758 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 28.6 t70 56.44 84.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 3.9100000000000001 110.868 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -75.16 99.47 3.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 5.21 110.864 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 68.8 m -119.23 -44.86 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 111.261 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.43 HD22 ' N ' ' C' ' 101' ' ' LEU . 3.7 mm? -76.64 -48.41 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 2.0800000000000001 111.095 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 7.6 tp -65.9 -30.09 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 1.8600000000000001 111.329 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.32 -44.84 41.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.769 . . . . 0.58999999999999997 112.776 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.58 -36.54 78.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 1.53 111.352 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.72 -51.25 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 1.1100000000000001 111.3 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.72 -35.87 77.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 2.21 111.029 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 40.9 m -66.87 -55.75 13.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.255 -0.429 . . . . 1.28 111.178 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.444 HG21 HD13 ' C' ' 142' ' ' ILE . 40.1 p -55.78 -25.91 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 1.22 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -68.4 -40.36 81.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 2.3300000000000001 110.376 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.439 HG22 ' HE1' ' B' ' 46' ' ' TRP . 36.4 mm -59.67 -32.17 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.91 -0.586 . . . . 1.29 110.698 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.98 -42.14 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.955 -0.566 . . . . 1.0600000000000001 111.171 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.23 -54.9 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 0.51000000000000001 111.631 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.1 pt -55.02 -27.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.3700000000000001 111.272 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 19.7 m -66.13 -46.57 77.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.436 . . . . 0.77000000000000002 110.883 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -69.03 -23.78 64.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 1.1899999999999999 111.412 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.526 ' HA3' H181 ' C' ' 210' ' ' LYR . . . -78.63 -35.52 32.1 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.712 -0.756 . . . . 0.5 113.266 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.55 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.6 pp -77.06 -29.75 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.568 0.223 . . . . 1.47 111.592 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.55 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.2 tp -83.89 -24.33 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.399 -0.364 . . . . 1.2 111.202 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.24 93.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.40000000000000002 111.105 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -78.36 -14.13 59.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.046 -0.525 . . . . 2.1200000000000001 111.067 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' C' ' 118' ' ' ILE . 96.7 mt -86.29 17.59 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.75 111.125 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 78.5 p -68.38 121.16 15.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 1.3799999999999999 111.11 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -103.23 -37.94 7.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.246 -0.433 . . . . 2.7400000000000002 110.648 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG12 ' C' ' 127' ' ' VAL . 97.7 mtt180 -102.97 137.87 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 2.7999999999999998 110.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.71 -9.43 58.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 2.4100000000000001 111.242 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -88.52 -44.36 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 4.2000000000000002 111.088 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -74.16 -23.94 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 111.187 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -52.53 -47.29 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 2.5699999999999998 111.283 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -67.58 -22.94 65.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 3.8100000000000001 111.391 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 72.4 mt -80.5 -47.22 14.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 1.4199999999999999 111.239 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.68 -34.49 77.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.89000000000000001 111.384 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.85 -33.49 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.097 -0.501 . . . . 1.26 111.135 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.3 mm -73.26 -37.48 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.6799999999999999 111.108 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.59 -30.73 71.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 1.24 110.878 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -54.83 11.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.723 -0.751 . . . . 0.54000000000000004 112.278 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.56 -29.88 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 1.0600000000000001 110.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.37 -49.42 77.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.054 -0.521 . . . . 1.0800000000000001 110.741 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.08 -29.01 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.56999999999999995 110.845 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -74.64 -20.08 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 1.6799999999999999 110.708 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.3 15.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 1.7 111.293 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.456 HG13 ' N ' ' C' ' 142' ' ' ILE . 29.0 pt -59.21 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.78000000000000003 111.241 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.456 ' N ' HG13 ' C' ' 141' ' ' ILE . 7.4 tp -72.48 -27.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.494 -0.321 . . . . 2.2400000000000002 111.003 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.27 -50.84 71.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 1.02 110.67 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -64.42 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.934 -0.575 . . . . 3.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.3 -39.1 97.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.794 -0.717 . . . . 1.27 112.405 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 146' ' ' ILE . . . . . 0.405 ' O ' ' HD2' ' C' ' 149' ' ' PRO . 82.6 mt -78.39 -24.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 1.8899999999999999 110.654 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -89.26 3.93 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 1.6000000000000001 111.043 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 51.5 t30 -61.61 -46.99 93.83 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.914 -0.585 . . . . 99.989999999999995 111.834 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 57.3 Cg_exo -38.54 -35.04 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.628 2.219 . . . . 2.73 112.761 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 150' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' C' ' 151' ' ' ARG . 44.5 tp -60.44 123.11 16.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 4.2999999999999998 109.981 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 151' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' C' ' 150' ' ' LEU . 99.3 mtt180 71.64 -13.06 0.59 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.118 -0.492 . . . . 8.9000000000000004 111.186 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' C' ' 150' ' ' LEU . . . -81.68 -17.56 47.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 2.7999999999999998 110.538 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -47.96 -32.35 6.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.858 -0.61 . . . . 5.4400000000000004 111.242 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 70.7 p -54.8 -48.33 72.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.1 -0.5 . . . . 3.3900000000000001 111.04 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -82.07 -16.3 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 6.9199999999999999 110.743 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 8.9 m -76.71 -7.26 55.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 4.8700000000000001 111.022 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 66.31 -77.76 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.004 -0.544 . . . . 4.0499999999999998 111.499 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -59.14 113.31 2.06 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.927 0.394 . . . . 3.0299999999999998 111.104 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 44.7 t -78.41 -38.4 41.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.017 -0.538 . . . . 2.96 111.179 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.78 -57.06 14.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 3.7400000000000002 110.982 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 63.9 tp -55.46 -34.08 64.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 2.6499999999999999 110.959 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.14 93.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.439 . . . . 1.77 110.941 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -63.99 -38.2 90.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 2.96 111.022 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.77 -36.68 72.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.086 0.47 . . . . 2.3500000000000001 110.703 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 165' ' ' TYR . . . . . 0.43 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.5 OUTLIER -77.0 -39.57 49.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.635 . . . . 2.6200000000000001 111.048 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -57.79 -37.12 73.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 2.0899999999999999 111.443 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -81.35 -26.97 35.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 3.2400000000000002 111.137 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.89 -52.17 18.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 111.264 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 169' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 165' ' ' TYR . 53.4 t -56.16 -25.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.3999999999999999 111.493 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -54.64 -58.96 5.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.95999999999999996 111.316 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -68.32 -24.58 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.08 -0.509 . . . . 3.6499999999999999 110.499 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -70.62 -35.97 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 1.3700000000000001 111.673 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 41.0 p -70.47 -53.18 17.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.565 -0.288 . . . . 1.4299999999999999 111.655 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 p -53.33 -35.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.958 0.355 . . . . 1.6200000000000001 111.958 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' C' ' 209' ' ' SER . 41.7 tp -75.36 -57.81 3.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.794 0.33 . . . . 2.0299999999999998 111.41 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -28.32 58.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.109 -0.496 . . . . 0.62 110.981 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.426 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 84.9 mt -87.95 -24.29 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.479 . . . . 1.5800000000000001 110.225 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.53 -54.57 31.83 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.728 -0.669 . . . . 0.56000000000000005 113.043 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.627 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 68.1 m-85 -57.47 -55.67 42.1 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.85 0.325 . . . . 1.3300000000000001 111.623 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.0 Cg_exo -45.86 -28.2 4.68 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.254 1.969 . . . . 0.63 112.929 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.502 ' O ' HG22 ' C' ' 184' ' ' ILE . 92.7 mt -70.97 -61.25 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.93000000000000005 111.467 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.446 HG22 ' O ' ' C' ' 179' ' ' TYR . 25.3 m -57.5 -26.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.221 0.452 . . . . 1.27 112.221 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -60.94 -20.02 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.696 -0.229 . . . . 1.77 111.547 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.663 HG23 HG23 ' C' ' 185' ' ' ILE . 14.9 tt -60.64 -29.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 2.3900000000000001 111.011 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.663 HG23 HG23 ' C' ' 184' ' ' ILE . 31.4 pt -113.38 158.19 13.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 1.95 111.101 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.2 -162.04 30.66 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.858 -0.687 . . . . 1.8799999999999999 112.629 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.32 156.8 58.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.729 2.286 . . . . 3.1200000000000001 112.298 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 38.6 m 59.7 13.76 3.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.981 -0.554 . . . . 2.6299999999999999 110.785 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -140.56 -86.01 0.11 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.884 -0.598 . . . . 3.04 112.089 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -166.04 66.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.01 0.433 . . . . 5.6900000000000004 110.101 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -144.85 146.56 17.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 3.0800000000000001 112.801 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -101.14 2.98 40.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.337 . . . . 7.5300000000000002 110.646 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 41.1 pt -103.52 154.21 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 2.8599999999999999 111.336 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -157.23 46.97 0.4 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.947 -0.569 . . . . 3.6899999999999999 110.411 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -99.07 -168.07 1.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.025 -0.534 . . . . 5.4800000000000004 110.968 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 7.3 t -65.7 -27.13 68.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 2.3799999999999999 111.17 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 197' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' C' ' 200' ' ' PHE . 16.7 tt -57.82 -34.75 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 2.23 111.231 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.58 -56.06 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 2.1600000000000001 110.703 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -69.43 -17.53 63.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.906 -0.588 . . . . 1.27 110.614 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 200' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' C' ' 197' ' ' ILE . 91.5 t80 -68.46 -30.81 69.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 1.7 110.947 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.7 -39.36 20.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 2.02 111.271 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -77.12 -8.11 56.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.281 . . . . 1.8200000000000001 111.682 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.461 ' HB3' HH22 ' C' ' 72' ' ' ARG . 17.7 p -96.66 -39.08 9.67 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.148 0.499 . . . . 1.3500000000000001 110.546 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.04 -33.89 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.623 -0.717 . . . . 0.65000000000000002 111.745 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.641 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 42.1 tp -62.53 -53.32 58.36 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.067 -0.253 . . . . 1.4199999999999999 111.577 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.8 Cg_exo -56.23 -39.34 91.91 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.842 1.695 . . . . 0.63 111.48 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -61.12 -34.32 74.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.959 -0.564 . . . . 1.49 110.721 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -66.56 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.009 -0.541 . . . . 1.7 110.951 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 209' ' ' SER . . . . . 0.472 ' HB2' HD13 ' C' ' 175' ' ' LEU . 28.0 t -92.34 -28.55 16.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 1.25 110.999 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.743 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.46 -37.28 56.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 1.6100000000000001 111.0 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.79 69.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.913 -0.661 . . . . 0.81999999999999995 112.704 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -71.28 -34.85 71.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 3.0800000000000001 110.788 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -60.65 -59.3 5.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 1.1499999999999999 110.676 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.56 -23.4 65.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 2.5600000000000001 110.67 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tt -72.28 -40.28 67.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.932 -0.576 . . . . 1.29 110.992 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.53 -30.16 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 2.3900000000000001 111.192 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.11 -48.59 73.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 2.0299999999999998 110.876 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -81.07 -22.53 39.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 3.21 110.853 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.46 61.55 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.772 -0.728 . . . . 1.3600000000000001 112.945 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 221' ' ' LEU . . . . . 0.472 HD21 HG11 ' C' ' 32' ' ' VAL . 30.3 tp -75.16 -29.46 60.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.704 0.288 . . . . 2.8999999999999999 111.033 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 59.77 -86.05 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.009 -0.541 . . . . 4.8899999999999997 111.2 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -165.34 156.21 13.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 4.2300000000000004 110.663 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.54 ' N ' HD23 ' C' ' 224' ' ' LEU . 1.7 pt? -161.11 -178.02 6.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 6.1200000000000001 110.767 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -158.52 114.75 2.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 4.5499999999999998 110.967 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.69 143.59 51.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 6.7800000000000002 110.84 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 46.6 t -148.55 103.1 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 5.4000000000000004 110.904 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -93.32 -30.07 15.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 8.3300000000000001 110.944 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 7.9100000000000001 110.947 -179.73 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.834 0.35 . . . . 5.1100000000000003 110.902 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.27 162.14 8.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 5.04 110.873 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.9 tp 59.52 91.43 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 5.5800000000000001 110.889 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.43 -46.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 5.0199999999999996 110.757 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.1 t -96.68 165.09 12.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.962 -0.563 . . . . 2.4500000000000002 110.639 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.4 tp -139.97 -20.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 2.4199999999999999 111.015 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.68 -34.73 77.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.406 -0.361 . . . . 2.0899999999999999 111.13 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 37.4 m80 -72.25 -28.85 63.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.044 0.449 . . . . 1.1599999999999999 110.379 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -72.44 -51.07 21.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.79000000000000004 110.331 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.34 -21.74 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.096 0.474 . . . . 2.0800000000000001 110.249 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -61.48 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 1.28 110.564 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 52' ' ' MET . 8.7 p -58.57 -30.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.01 -0.541 . . . . 1.3200000000000001 111.371 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.0 -55.41 29.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.63 111.429 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.76 -28.45 68.2 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.884 -0.674 . . . . 0.55000000000000004 112.763 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.16 -22.2 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 1.03 111.001 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -72.76 -52.13 16.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 1.3 110.844 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -65.4 -22.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 1.3100000000000001 110.942 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -68.47 -47.84 54.81 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.854 -0.689 . . . . 0.77000000000000002 112.652 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.452 ' HB1' ' HE3' ' A' ' 41' ' ' MET . . . -63.05 -33.88 76.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.80000000000000004 111.042 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -68.43 -36.52 79.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.203 0.525 . . . . 1.8100000000000001 110.532 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.9 t-80 -59.33 -20.99 59.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 110.485 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -62.49 -50.18 72.42 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.062 -0.517 . . . . 4.4500000000000002 110.973 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -58.91 -45.17 90.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 3.6899999999999999 110.495 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.3 m -69.9 -18.66 63.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 1.5700000000000001 110.794 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' HIS . 12.7 tp -76.57 0.26 20.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 1.95 111.933 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 p -66.83 -51.44 55.55 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.277 -0.569 . . . . 1.3799999999999999 111.19 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -54.17 -22.63 11.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.011 0.91 . . . . 4.0700000000000003 108.548 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.812 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.41 -150.98 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 113.757 -1.565 . . . . 2.7200000000000002 108.57 177.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 14.2 Cg_exo 6.91 96.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.713 2.942 . . . . 1.9099999999999999 116.472 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -102.96 96.87 7.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.663 -1.153 . . . . 4.7599999999999998 109.148 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.04 -36.92 2.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.502 -1.039 . . . . 1.99 110.502 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.1 t -111.77 126.2 28.96 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 109.315 -0.624 . . . . 2.7000000000000002 109.315 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 16.9 Cg_exo -65.82 165.83 22.25 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.482 2.121 . . . . 1.79 113.858 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -76.08 -13.3 60.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.507 -1.224 . . . . 4.1200000000000001 111.806 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CD2' ' HB2' ' A' ' 33' ' ' PRO . 1.7 p90 -38.69 -37.92 0.37 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.469 0.544 . . . . 2.9300000000000002 112.469 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.09 -45.19 86.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 2.8799999999999999 110.518 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -74.03 -18.57 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.005 -0.543 . . . . 4.6600000000000001 110.613 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.431 HD11 ' HD1' ' B' ' 104' ' ' PHE . 55.7 tp -60.66 -56.86 16.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.162 -0.472 . . . . 1.45 110.161 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.32 -36.24 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 1.78 109.918 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.21 -6.13 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.724 -0.671 . . . . 0.63 110.89 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.46 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 23.8 ttt -88.74 -35.59 16.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 1.48 110.641 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -72.61 -33.32 66.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 3.5 111.101 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.634 HG23 HG23 ' A' ' 79' ' ' THR . 79.0 mt -53.63 -52.98 62.22 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.271 0.471 . . . . 1.0800000000000001 112.271 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.5 Cg_endo -72.15 -33.3 9.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.28 1.987 . . . . 0.53000000000000003 113.236 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -57.89 -62.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.939 0.348 . . . . 1.6799999999999999 111.939 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.527 ' HE1' HG22 ' B' ' 110' ' ' ILE . 3.0 t90 -61.63 -51.41 68.59 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.626 -0.261 . . . . 1.8300000000000001 111.525 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.448 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 92.5 p -51.52 -54.13 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 1.0900000000000001 111.195 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -44.58 -54.79 6.39 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.208 -0.52 . . . . 0.40999999999999998 113.547 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.3 mt -52.12 -38.94 59.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.748 0.309 . . . . 0.98999999999999999 111.337 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.56 83.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.47999999999999998 111.059 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.507 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 96.8 m-85 -69.48 -44.19 71.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.8700000000000001 110.913 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.428 ' HB2' HG11 ' A' ' 12' ' ' VAL . 16.7 tmm? -49.61 -32.68 13.38 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.285 0.564 . . . . 1.49 110.126 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -72.13 -42.14 66.35 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.58999999999999997 111.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.2 mtt -54.17 -26.45 28.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.48999999999999999 110.363 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.05 -48.54 23.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.576 . . . . 0.59999999999999998 110.673 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 53' ' ' ALA . 44.3 pt -79.94 6.65 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 1.3100000000000001 111.023 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 59.59 55.1 4.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 1.9099999999999999 111.194 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -125.33 124.59 41.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 1.6200000000000001 110.735 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 120.34 29.88 1.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 1.04 112.398 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -150.34 144.74 25.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 2.6800000000000002 111.145 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.48 145.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 1.98 111.165 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -88.74 94.44 9.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 2.1800000000000002 110.893 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.08 133.48 55.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.019 -0.537 . . . . 1.5700000000000001 111.052 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.79 23.72 12.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.245 -0.434 . . . . 1.79 111.14 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.97 -15.1 50.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.83 -0.7 . . . . 1.48 112.534 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -104.73 151.22 24.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.313 . . . . 2.3199999999999998 110.854 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -98.17 138.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 1.4399999999999999 111.118 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.39 118.21 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.495 . . . . 0.81999999999999995 110.848 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 64.5 m-70 -78.96 79.25 5.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.295 0.569 . . . . 0.90000000000000002 111.204 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.88 -41.28 86.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.547 -0.751 . . . . 1.8300000000000001 110.932 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -67.0 -24.05 65.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 0.62 111.595 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.9 tpp180 -67.15 -51.88 48.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.098 -0.501 . . . . 2.3399999999999999 112.322 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.49 ' O ' ' HG3' ' A' ' 77' ' ' MET . 17.7 p90 -88.95 -27.98 20.57 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.511 0.56 . . . . 3.4900000000000002 112.511 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 71' ' ' ALA . 11.0 tp -57.78 -41.26 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.473 -0.491 . . . . 1.3700000000000001 110.069 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' OD2' ' HA ' ' A' ' 47' ' ' SER . 16.1 t70 -70.93 -17.14 62.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.143 -0.688 . . . . 1.3100000000000001 109.143 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -90.42 6.06 44.9 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.237 -0.892 . . . . 1.48 110.956 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.519 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 32.1 mtp -104.85 -17.68 14.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.488 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.439 ' O ' HD23 ' A' ' 82' ' ' LEU . 27.5 m -114.59 -34.81 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.1200000000000001 111.8 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.634 HG23 HG23 ' A' ' 43' ' ' ILE . 84.8 m -76.0 -59.56 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 1.1000000000000001 112.007 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 83.2 m -49.14 -51.06 59.69 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.503 0.557 . . . . 0.59999999999999998 112.503 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 58.4 Cg_exo -51.67 -52.85 8.1 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.765 1.643 . . . . 0.73999999999999999 111.844 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -63.45 -25.66 68.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 1.01 110.881 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.422 HD22 ' H43' ' A' ' 210' ' ' LYR . 23.5 tp -72.91 -28.42 62.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.999 0.428 . . . . 1.48 110.033 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -84.47 -22.22 30.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.3799999999999999 110.103 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' PRO . 95.4 mt -85.07 -31.28 23.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.769 -0.65 . . . . 1.1899999999999999 110.646 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -61.64 -50.34 72.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.23 111.029 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 pp -61.99 -25.74 67.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.88 110.965 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.1 t -67.63 -43.78 79.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 1.3899999999999999 110.842 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -62.16 -40.6 96.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 2.3199999999999998 111.014 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -60.5 -33.9 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 1.46 111.029 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.52 -30.73 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 1.24 111.044 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.8 tpp -75.28 117.3 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 2.0699999999999998 110.817 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.67 -54.69 4.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 3.5299999999999998 111.066 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -137.12 144.82 43.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 4.0800000000000001 111.228 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.9 tt -107.55 148.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 2.1699999999999999 110.817 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -133.43 -75.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 4.5199999999999996 111.2 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -138.35 -13.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 3.75 111.343 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.31 106.82 1.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.457 -0.338 . . . . 3.5299999999999998 110.734 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -128.57 -21.52 3.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.332 -0.394 . . . . 4.9100000000000001 111.036 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.6 p -65.38 -26.01 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 1.98 111.034 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.75 -36.54 79.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 1.8300000000000001 110.951 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.03 -39.0 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 1.79 111.172 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.78 93.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.848 -0.692 . . . . 0.62 112.361 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.93 -41.25 95.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.5800000000000001 111.153 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.05 -48.41 80.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.97999999999999998 111.293 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -61.24 -27.34 68.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 1.48 111.289 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -72.45 -43.25 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.999 0.428 . . . . 1.1299999999999999 111.245 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 112' ' ' VAL . 71.6 p -72.3 -22.8 61.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.163 -0.471 . . . . 1.48 111.548 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 6.4 tp-100 -81.79 -45.47 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.322 -0.399 . . . . 2.7000000000000002 111.4 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' HE1' ' C' ' 46' ' ' TRP . 7.9 tp -59.5 -34.97 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.54 111.473 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 142' ' ' ILE . 17.9 m -71.16 -44.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 121.144 -0.223 . . . . 1.28 111.281 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 108' ' ' THR . 78.5 t -59.22 -55.59 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.795 0.331 . . . . 0.42999999999999999 111.537 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.0 mm -56.75 -32.89 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.385 -0.37 . . . . 1.74 111.436 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -55.71 -45.13 77.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.875 0.369 . . . . 0.63 110.554 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -67.34 -27.03 66.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.56 . . . . 1.0900000000000001 111.007 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.56 -41.04 30.73 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.876 -0.678 . . . . 0.41999999999999998 113.502 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -73.96 -28.26 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.806 0.299 . . . . 1.3799999999999999 111.806 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.472 HD11 ' HG3' ' C' ' 58' ' ' GLN . 10.2 tp -82.49 -26.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 1.6200000000000001 111.17 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.56 76.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.39000000000000001 110.894 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.4 -27.41 32.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 2.02 111.041 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.18 34.3 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.76000000000000001 111.257 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.6 m -85.61 131.19 34.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 1.46 110.853 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.472 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 12.1 pt-20 -80.4 -28.7 37.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 3.3500000000000001 111.077 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.524 ' HB2' HG12 ' A' ' 127' ' ' VAL . 78.5 mtm180 -130.17 158.19 40.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 2.9199999999999999 110.971 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.53 -11.9 59.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 2.77 111.048 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -90.06 -45.87 8.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.977 0.418 . . . . 3.77 110.405 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.0 p -65.45 -27.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 1.1599999999999999 110.757 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -65.28 -41.16 94.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 2.04 111.007 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.425 ' O ' HG12 ' A' ' 133' ' ' ILE . 72.2 t80 -56.88 -45.67 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 2.6400000000000001 110.873 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.71 -45.22 92.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 1.8999999999999999 111.376 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.18 70.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 1.3999999999999999 111.049 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -67.55 -43.33 80.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.411 . . . . 1.28 111.146 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 129' ' ' TYR . 38.3 mm -59.05 -39.18 77.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 2.1600000000000001 110.888 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.454 ' SG ' HD22 ' C' ' 49' ' ' LEU . 46.2 t -67.48 -28.45 67.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.222 -0.445 . . . . 1.6899999999999999 110.901 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.65 -55.88 24.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.871 -0.68 . . . . 0.52000000000000002 112.55 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 26.9 m -63.63 -37.25 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.563 0.22 . . . . 1.02 111.298 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.69 -44.2 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.454 -0.339 . . . . 1.0800000000000001 111.023 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.88 -35.67 75.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.62 110.897 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -69.82 -23.13 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 1.8400000000000001 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 86.9 mt -70.26 -59.93 2.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 1.6899999999999999 111.469 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -61.24 -27.02 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.504 -0.317 . . . . 0.81000000000000005 111.69 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 111' ' ' VAL . 72.5 mt -77.99 -50.35 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.483 -0.326 . . . . 2.3700000000000001 111.49 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.1 tp -49.44 -54.21 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.97999999999999998 111.188 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -64.63 -34.34 78.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 3.27 110.984 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.59 68.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.86 -0.686 . . . . 1.25 112.77 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.0 mt -103.73 -19.85 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 2.1200000000000001 111.173 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -59.73 -39.91 86.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.411 . . . . 1.6599999999999999 111.995 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.512 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 69.1 m-80 -73.83 -53.81 3.99 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.483 0.549 . . . . 99.989999999999995 112.483 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 18.9 Cg_endo -57.75 -13.57 14.87 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.169 1.913 . . . . 2.6000000000000001 113.055 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.7 mt -84.35 48.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 4.6100000000000003 110.917 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 55.47 70.09 0.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 8.3599999999999994 110.976 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . . . -81.77 -34.42 30.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 2.75 111.022 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -72.86 -16.01 61.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.548 . . . . 5.6799999999999997 110.892 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 m -79.0 -23.64 44.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.272 -0.422 . . . . 3.21 111.138 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -56.04 -32.41 64.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 6.8700000000000001 111.393 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 7.8 t -91.13 -25.06 19.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.35 . . . . 4.5599999999999996 111.199 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -70.67 -78.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 3.5600000000000001 111.043 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.1 t -100.6 122.99 44.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 2.79 110.864 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 77.9 p -78.03 -35.53 49.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.086 -0.506 . . . . 2.5899999999999999 111.253 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.42 -41.02 89.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 3.4700000000000002 111.11 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.88 -20.35 62.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 2.5800000000000001 110.655 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.75 -34.75 52.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 1.78 110.97 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -67.55 -39.41 84.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 2.6299999999999999 110.41 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 60.8 mt -64.2 -57.61 8.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 2.3399999999999999 110.544 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.46 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.5 OUTLIER -55.41 -39.86 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.662 -0.699 . . . . 2.77 111.08 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -51.69 -56.35 14.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 2.04 111.289 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -58.05 -28.28 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 2.77 111.484 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 165' ' ' TYR . 75.5 mt -72.95 -65.56 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.335 -0.393 . . . . 1.8899999999999999 111.46 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.15 -36.5 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.505 . . . . 1.6399999999999999 111.856 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.2 m -56.74 -52.55 64.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.311 . . . . 1.24 111.521 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.459 ' O ' HD23 ' A' ' 175' ' ' LEU . 75.5 t80 -58.41 -29.54 66.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.364 -0.38 . . . . 2.9700000000000002 110.961 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -71.01 -32.11 68.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 1.48 111.354 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.3 p -79.59 -37.86 35.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 1.55 111.767 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.24 -43.75 94.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.764 0.283 . . . . 1.52 111.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 171' ' ' TYR . 4.3 mm? -75.18 -50.69 15.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.651 -0.249 . . . . 1.8500000000000001 111.634 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.49 -31.65 62.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.62 110.593 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 181' ' ' ILE . 94.8 mt -87.66 -22.09 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.523 . . . . 1.3500000000000001 110.298 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -55.74 27.98 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.58999999999999997 113.097 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.606 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 86.5 m-85 -53.68 -54.98 40.18 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.835 0.317 . . . . 1.45 111.067 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.8 Cg_exo -45.95 -30.18 6.81 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.003 1.802 . . . . 0.55000000000000004 112.671 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -66.36 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 1.4199999999999999 111.164 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 179' ' ' TYR . 28.5 m -58.33 -26.63 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.501 . . . . 0.78000000000000003 111.572 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -66.22 -45.08 81.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.534 -0.303 . . . . 0.93999999999999995 111.227 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.2 mt -62.04 -62.57 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 1.4299999999999999 111.298 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.6 pp -57.46 143.45 11.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 2.02 111.494 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 64.36 171.96 2.63 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.936 -0.65 . . . . 1.79 112.918 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.464 ' HD3' ' H ' ' A' ' 192' ' ' TRP . 85.0 Cg_endo -85.53 82.63 1.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.813 2.342 . . . . 3.1000000000000001 112.231 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.4 m 58.09 37.57 26.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 2.7400000000000002 110.917 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.73 -106.1 0.21 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.896 -0.668 . . . . 3.4300000000000002 112.424 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.507 ' N ' HD11 ' A' ' 193' ' ' ILE . 81.4 t80 -132.92 -30.31 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.863 0.363 . . . . 6.5 110.858 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 193' ' ' ILE . . . 153.15 114.74 0.57 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 3.29 112.627 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.464 ' H ' ' HD3' ' A' ' 187' ' ' PRO . 15.3 m-90 55.95 36.8 27.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.34 . . . . 6.1600000000000001 111.12 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.534 HG12 ' H ' ' A' ' 191' ' ' GLY . 36.1 pt -136.06 149.16 27.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 2.4199999999999999 111.367 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -155.85 8.98 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 4.29 110.702 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -86.66 -157.26 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.13 -0.486 . . . . 5.1500000000000004 110.786 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.6 t -66.11 -16.17 63.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.393 -0.367 . . . . 2.4500000000000002 111.143 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 200' ' ' PHE . 83.3 mt -55.17 -32.94 29.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 2.48 111.382 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.55 -54.45 32.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.374 . . . . 2.1800000000000002 111.24 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -62.55 -32.49 73.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 1.49 111.706 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 197' ' ' ILE . 63.2 t80 -54.77 -38.31 67.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 1.77 111.126 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 49.0 tp -76.67 -46.53 25.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 1.4199999999999999 111.092 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -71.79 1.49 6.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 1.78 111.42 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.9 t -96.5 -46.3 6.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.3 110.507 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.78 -36.94 73.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.66000000000000003 111.998 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -57.21 -54.76 51.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 121.138 -0.225 . . . . 1.6299999999999999 111.293 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -55.48 -44.71 45.82 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.682 1.588 . . . . 0.64000000000000001 111.596 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.29 -25.4 67.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 1.3600000000000001 110.464 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.61 -30.85 59.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 1.54 110.751 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 87.8 p -94.23 -13.33 26.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 1.2 110.998 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.761 H183 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 28.8 m -67.75 -34.45 67.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 1.6399999999999999 111.284 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.33 -28.38 72.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.79000000000000004 112.423 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.22 -31.17 58.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.732 0.301 . . . . 1.6100000000000001 110.889 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.6 m -63.55 -62.02 1.94 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 1.1499999999999999 110.889 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.37 -27.86 66.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 3.3399999999999999 110.851 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.39 -48.9 71.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 1.1899999999999999 110.74 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.93 -27.77 69.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 2.23 110.912 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.52 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 2.4700000000000002 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -70.76 -49.09 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 1.6200000000000001 111.054 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.84 55.08 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.849 -0.691 . . . . 1.4099999999999999 112.58 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.04 -56.23 23.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 2.5800000000000001 110.89 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 59.57 97.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 4.9299999999999997 110.7 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -56.25 113.11 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 4.6299999999999999 111.101 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 96.8 mt -140.64 150.95 44.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.922 -0.581 . . . . 6.4699999999999998 111.056 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -114.11 104.87 12.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 5.0700000000000003 111.045 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -139.51 -9.74 1.24 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.011 -0.54 . . . . 6.5300000000000002 110.842 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 41.4 t -89.19 132.53 34.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 5.2199999999999998 111.07 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -130.61 38.85 3.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.108 -0.497 . . . . 8.3599999999999994 111.029 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 7.96 110.975 -179.86 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.866 0.365 . . . . 6.1699999999999999 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -95.28 -56.78 2.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 4.8200000000000003 110.912 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 26.9 tp -110.02 127.22 54.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 5.5999999999999996 110.972 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -133.42 -44.8 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 4.7999999999999998 110.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 65.4 p -85.96 160.15 19.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.046 -0.525 . . . . 2.3700000000000001 110.917 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp -137.16 -28.57 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 2.0699999999999998 111.148 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -34.73 71.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 2.1000000000000001 111.148 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.578 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 35.6 m170 -65.32 -33.25 75.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 1.0700000000000001 110.757 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -73.95 -46.87 41.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.16 -0.473 . . . . 1.48 110.617 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.07 -22.29 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.117 0.484 . . . . 2.02 110.262 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.28 -59.13 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.706 -0.679 . . . . 0.92000000000000004 110.538 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.21 -29.46 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.93999999999999995 111.328 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -50.42 67.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.55000000000000004 111.34 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.03 -32.8 85.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.47999999999999998 112.564 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.4 mmt -71.54 -26.02 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.84999999999999998 110.956 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.5 m -69.7 -59.2 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 1.3400000000000001 110.853 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.472 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.6 pp -56.32 -26.13 21.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.096 -0.502 . . . . 1.55 111.307 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.472 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -65.59 -47.94 72.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.608 -0.806 . . . . 0.69999999999999996 112.26 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' B' ' 41' ' ' MET . . . -60.09 -33.84 72.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.81000000000000005 111.047 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.77 -33.5 72.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.335 -0.393 . . . . 2.2599999999999998 110.545 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -61.14 -20.27 62.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 1.78 110.539 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.34 -53.35 58.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 4.5800000000000001 110.968 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.593 ' O ' ' OG ' ' B' ' 26' ' ' SER . 80.8 m95 -62.62 -42.71 99.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.953 -0.567 . . . . 3.3500000000000001 110.955 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 1.5800000000000001 111.253 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -80.73 -5.66 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 1.8400000000000001 110.881 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 15.7 p -72.09 -15.23 62.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 1.3700000000000001 110.775 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -45.95 -40.71 10.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.432 -0.581 . . . . 4.9800000000000004 109.432 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -179.08 130.51 0.27 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.141 -0.936 . . . . 2.1400000000000001 110.219 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -96.28 179.36 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.991 2.461 . . . . 1.8200000000000001 112.182 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -99.85 52.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 5.1900000000000004 111.188 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.1 -46.63 2.02 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.839 -0.696 . . . . 2.2000000000000002 112.552 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 32.7 m -91.87 144.82 29.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.523 0.201 . . . . 3.6499999999999999 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 165.36 17.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.514 2.143 . . . . 2.6699999999999999 112.581 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -62.64 -17.43 60.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 4.8799999999999999 111.837 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -42.3 -35.07 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.726 0.298 . . . . 1.8700000000000001 111.662 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -64.54 -48.31 75.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.932 0.396 . . . . 2.6800000000000002 110.225 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.28 -18.56 61.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 2.9199999999999999 110.703 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' B' ' 41' ' ' MET . 47.7 tp -60.7 -53.44 57.36 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.981 0.42 . . . . 1.6399999999999999 110.325 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.23 -38.74 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 1.6000000000000001 109.893 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.14 -5.62 36.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.629 -0.714 . . . . 0.68999999999999995 110.734 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.466 ' HE3' ' HB1' ' B' ' 19' ' ' ALA . 25.3 ttt -88.65 -36.08 16.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.906 -0.588 . . . . 2.5800000000000001 110.402 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -70.74 -34.2 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.921 -0.582 . . . . 3.3900000000000001 111.078 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.614 HG23 HG23 ' B' ' 79' ' ' THR . 98.7 mt -53.54 -54.76 42.19 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.459 0.54 . . . . 0.40999999999999998 112.459 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 59.9 Cg_endo -70.43 -37.31 7.71 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.405 2.07 . . . . 0.48999999999999999 113.566 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.15 -62.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.748 0.277 . . . . 1.29 111.748 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.619 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -62.08 -52.75 62.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.3999999999999999 111.355 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.442 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 38.4 t -54.04 -31.82 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.3799999999999999 111.566 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.11 -49.75 64.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.37 112.757 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.476 HD22 ' SG ' ' C' ' 134' ' ' CYS . 75.7 mt -54.77 -44.56 73.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 1.29 111.503 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.15 -50.26 67.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.44 111.565 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -63.23 -40.04 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.5 111.303 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.3 ttp -52.39 -34.09 46.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.182 0.515 . . . . 1.4099999999999999 110.196 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -69.78 -40.67 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.598 -0.728 . . . . 0.55000000000000004 110.944 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 56.2 mtt -54.33 -28.64 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.52 . . . . 0.5 110.489 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.83 -52.06 16.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 0.54000000000000004 110.946 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.1 pt -78.65 9.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.913 -0.585 . . . . 1.3 111.539 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 60.03 63.8 1.38 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.063 -0.517 . . . . 2.2400000000000002 111.036 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.447 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 6.8 tp-100 -136.23 128.78 30.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 1.77 110.639 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.87 38.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 1.0600000000000001 112.194 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -150.43 140.81 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 2.6600000000000001 110.81 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.75 141.15 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 1.8899999999999999 111.068 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.43 94.8 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 2.4100000000000001 110.922 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.17 125.04 51.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 1.5600000000000001 111.144 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.05 35.92 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 1.8200000000000001 111.301 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.28 4.7 51.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.74 -0.743 . . . . 1.51 112.547 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -108.46 140.88 41.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.64 0.257 . . . . 2.4500000000000002 110.853 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 55.2 mt -99.27 119.42 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 1.79 110.892 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.48 113.86 27.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.81999999999999995 111.136 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.628 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 93.1 m-70 -73.91 83.34 1.7 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.4 0.619 . . . . 1.05 110.792 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.476 ' HD2' ' HH ' ' B' ' 73' ' ' TYR . 75.6 t80 -52.25 -56.71 12.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 1.8700000000000001 111.567 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -21.93 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.606 0.595 . . . . 0.60999999999999999 112.606 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.628 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 20.3 tpp180 -64.66 -52.54 56.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.275 0.472 . . . . 2.3900000000000001 112.275 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.476 ' HH ' ' HD2' ' B' ' 70' ' ' TYR . 36.7 p90 -87.34 -29.71 21.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.482 -0.487 . . . . 3.6699999999999999 111.418 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.65 -45.96 79.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.692 -0.484 . . . . 1.6599999999999999 109.692 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 16.3 t70 -67.72 -23.47 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 1.4099999999999999 109.139 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 28.9 m0 -86.08 8.18 21.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.457 -0.792 . . . . 1.1599999999999999 111.07 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 -22.51 13.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.758 -0.655 . . . . 1.53 110.571 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.417 ' O ' HD23 ' B' ' 82' ' ' LEU . 35.4 m -113.88 -30.34 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.89000000000000001 111.927 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.614 HG23 HG23 ' B' ' 43' ' ' ILE . 76.1 m -81.29 -52.13 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.008 0.373 . . . . 1.24 112.008 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.584 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 11.9 m -51.8 -49.79 81.48 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.205 0.446 . . . . 0.57999999999999996 112.205 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' B' ' 80' ' ' THR . 10.4 Cg_endo -54.67 -50.94 11.65 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.803 1.669 . . . . 0.66000000000000003 111.782 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.417 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -65.16 -26.13 68.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 1.0600000000000001 110.637 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.5 ' HG ' ' H43' ' B' ' 210' ' ' LYR . 0.2 OUTLIER -68.41 -36.87 79.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.18 0.514 . . . . 1.22 109.772 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.4 tt -80.36 -25.44 39.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.539 -0.755 . . . . 1.53 110.789 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 98.6 mt -77.78 -36.83 50.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 1.5800000000000001 111.201 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 59.5 m -56.96 -39.68 75.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 1.3899999999999999 110.949 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 98.2 mt -68.58 -35.59 77.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 1.1499999999999999 111.072 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 61.1 m -61.09 -35.31 76.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.326 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -72.24 -36.22 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 2.1699999999999999 110.986 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 29.7 m -66.55 -37.58 85.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 1.4199999999999999 110.81 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -28.59 39.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 1.1799999999999999 110.925 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.1 ttm -77.96 117.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.8799999999999999 110.718 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -86.78 -61.48 1.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 3.4199999999999999 111.223 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.22 160.52 30.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 4.0599999999999996 111.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 70.0 mt -124.9 142.32 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 2.0899999999999999 110.824 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -139.38 -51.08 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 3.8500000000000001 110.83 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -161.93 -161.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 4.8200000000000003 110.511 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 60.76 87.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.448 . . . . 3.7999999999999998 110.795 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -101.13 0.08 37.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 110.852 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.1 p -71.67 -25.91 62.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 2.02 111.293 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.95 -39.71 90.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 2.0899999999999999 110.786 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.61 -38.13 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 1.8799999999999999 111.034 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.4 -29.25 71.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.56000000000000005 112.215 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' B' ' 146' ' ' ILE . 66.2 t80 -65.74 -37.58 86.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.95 0.405 . . . . 1.78 110.588 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.43 ' HB3' HD21 ' B' ' 84' ' ' LEU . 55.4 mt -68.63 -41.37 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.793 -0.64 . . . . 1.03 111.11 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' MET . . . . . 0.415 ' O ' HG12 ' B' ' 110' ' ' ILE . 57.9 mtt -64.45 -45.92 85.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 1.6699999999999999 111.135 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 55.6 m -55.58 -42.07 74.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 1.51 111.478 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.479 ' O ' HG23 ' B' ' 112' ' ' VAL . 75.9 p -69.27 -24.94 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 1.1799999999999999 111.416 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -80.49 -44.59 18.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.559 -0.291 . . . . 2.1699999999999999 111.566 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.527 HG22 ' HE1' ' A' ' 46' ' ' TRP . 48.5 mm -57.53 -38.72 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 1.3500000000000001 111.391 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.64 -43.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 1.3400000000000001 111.854 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 108' ' ' THR . 70.2 t -61.03 -55.29 25.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.645 0.26 . . . . 0.42999999999999999 111.62 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.489 HD11 HG21 ' B' ' 80' ' ' THR . 29.7 mm -61.0 -29.26 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 1.6000000000000001 111.23 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.1 m -55.29 -49.34 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.972 0.415 . . . . 0.85999999999999999 110.528 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 75.3 p -70.92 -20.44 62.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.94999999999999996 110.482 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.28 -33.7 43.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.006 -0.616 . . . . 0.46000000000000002 112.975 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.529 HD12 HG13 ' B' ' 118' ' ' ILE . 2.8 pp -82.89 -24.68 33.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 0.235 . . . . 1.75 111.162 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.529 HG13 HD12 ' B' ' 117' ' ' LEU . 85.7 mt -80.21 -36.24 16.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 120.803 0.335 . . . . 1.78 110.838 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.86 -38.24 48.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.539 . . . . 0.38 111.154 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -82.6 -26.74 32.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.006 -0.543 . . . . 1.97 111.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -86.35 22.27 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.341 . . . . 0.76000000000000001 111.185 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -67.27 139.62 57.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.47 110.843 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -94.03 -17.69 22.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 2.5 111.044 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.646 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 48.7 ttp180 -137.88 156.46 47.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.499 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.53 -14.97 60.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 2.2000000000000002 110.935 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.646 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 54.4 t90 -92.96 -37.98 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 3.3999999999999999 111.19 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' B' ' 124' ' ' ARG . 18.4 m -65.34 -24.32 34.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.215 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.8 ttt-85 -63.47 -47.59 81.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 3.04 111.385 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.97 -32.82 68.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 4.1399999999999997 111.557 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.17 -46.56 76.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 1.6499999999999999 110.873 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -74.33 -25.57 59.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.77000000000000002 110.732 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.2 -51.82 61.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.816 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.58 -33.27 60.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.31 -0.405 . . . . 1.6299999999999999 110.804 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.78 -28.22 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.4199999999999999 110.588 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.39 -53.68 16.31 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.925 -0.655 . . . . 0.48999999999999999 112.487 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 28.9 m -61.79 -35.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.593 0.235 . . . . 1.3 111.312 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 90.8 m -61.22 -35.88 78.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.75 0.31 . . . . 1.3 110.725 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.52 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.62 110.637 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.54 -23.5 63.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 1.74 110.892 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 90.5 mt -71.47 -55.62 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.418 . . . . 1.76 111.187 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 43.1 pt -66.59 -28.85 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.68999999999999995 111.534 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.63 -51.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 1.76 111.075 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 54.2 tp -52.75 -49.62 65.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.336 -0.393 . . . . 1.0600000000000001 110.672 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.06 -24.61 65.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.518 . . . . 4.1200000000000001 110.602 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.82 -17.66 74.56 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 1.26 112.776 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.476 ' C ' ' HD2' ' B' ' 149' ' ' PRO . 56.7 mt -103.39 -19.52 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.781 0.324 . . . . 1.98 111.127 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -54.86 -50.04 69.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.449 . . . . 1.4199999999999999 111.922 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.678 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 51.5 t30 -68.93 -53.07 15.32 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 111.91 0.337 . . . . 99.989999999999995 111.91 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 53.0 Cg_exo -52.05 -20.67 10.94 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.158 1.906 . . . . 2.6499999999999999 112.811 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 68.6 mt -81.67 43.38 0.75 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.834 0.349 . . . . 4.3899999999999997 110.957 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 55.04 74.64 0.35 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.036 -0.529 . . . . 7.9000000000000004 110.647 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' B' ' 148' ' ' ASN . . . -82.63 -29.48 30.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 2.77 111.291 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -73.16 -20.0 61.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 6.29 110.886 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 64.1 p -80.48 -5.45 56.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 3.1000000000000001 110.819 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -66.19 -36.33 82.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 6.4299999999999997 110.693 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 68.9 p -98.88 -19.02 17.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 4.5700000000000003 111.379 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -65.89 -68.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 3.8300000000000001 110.937 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 48.0 t -117.93 114.79 23.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 3.0699999999999998 110.944 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 46.6 t -67.75 -29.05 68.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.253 -0.431 . . . . 3.4300000000000002 110.966 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -59.79 -60.53 3.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.11 0.481 . . . . 3.9199999999999999 110.751 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.55 -30.79 70.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.856 -0.611 . . . . 2.7000000000000002 111.073 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.87 97.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.956 0.408 . . . . 1.8300000000000001 111.141 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -65.21 -36.36 83.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.048 -0.523 . . . . 2.6299999999999999 111.039 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.403 HD11 ' NH1' ' B' ' 222' ' ' ARG . 74.0 mt -67.71 -56.9 7.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.419 . . . . 2.4300000000000002 110.946 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.33 -29.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 2.5800000000000001 111.013 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.63 -59.04 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 2.0 111.223 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -58.41 -21.57 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 3.0299999999999998 111.767 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.7 -63.58 1.38 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 111.399 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.23 -31.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 1.75 111.634 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -59.88 -52.2 66.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 0.97999999999999998 111.152 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.96 -33.58 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 4.2999999999999998 110.766 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -72.17 -25.91 61.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 1.3899999999999999 110.763 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.438 HG22 HD12 ' B' ' 177' ' ' ILE . 27.2 m -79.35 -40.26 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 1.1100000000000001 111.819 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.6 -35.02 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.492 -0.322 . . . . 1.51 111.484 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.69 -57.05 4.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.316 -0.402 . . . . 1.75 111.624 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -31.06 56.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.59999999999999998 111.028 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.474 ' O ' HG12 ' B' ' 181' ' ' ILE . 92.4 mt -87.67 -21.43 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 1.47 110.521 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -55.9 27.93 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.55000000000000004 113.074 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 90.5 m-85 -54.23 -53.94 53.32 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.73 0.265 . . . . 1.6200000000000001 111.273 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.7 Cg_exo -45.08 -34.57 9.42 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.2 1.934 . . . . 0.64000000000000001 112.966 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.474 HG12 ' O ' ' B' ' 177' ' ' ILE . 48.8 mm -65.79 -60.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.856 0.36 . . . . 1.27 111.503 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.514 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.9 m -56.84 -24.37 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.417 -0.356 . . . . 0.68999999999999995 111.154 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -69.23 -53.66 18.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 1.1799999999999999 111.857 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 185' ' ' ILE . 10.5 tt -62.06 -51.65 69.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 111.852 0.315 . . . . 1.77 111.852 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.425 ' N ' HG23 ' B' ' 184' ' ' ILE . 2.3 pp -60.66 131.02 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 1.6899999999999999 110.647 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 68.28 165.83 3.57 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.638 -0.791 . . . . 1.5800000000000001 112.365 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.11 85.52 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.446 2.097 . . . . 2.5099999999999998 112.315 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 13.6 m 55.85 42.95 28.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 3.5800000000000001 110.921 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -166.52 -124.7 0.73 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.663 -0.78 . . . . 4.0300000000000002 112.574 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.516 ' H ' HD11 ' B' ' 193' ' ' ILE . 48.6 t80 -113.38 -26.1 8.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 6.8899999999999997 111.011 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 191' ' ' GLY . . . . . 0.448 ' H ' HG12 ' B' ' 193' ' ' ILE . . . 147.53 116.4 0.92 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.804 -0.712 . . . . 3.7000000000000002 112.532 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 57.47 32.89 22.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.733 0.302 . . . . 7.5 111.159 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.516 HD11 ' H ' ' B' ' 190' ' ' PHE . 47.1 pt -138.44 143.99 31.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.316 -0.402 . . . . 2.3500000000000001 111.454 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -147.85 6.79 0.81 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.05 -0.523 . . . . 3.8599999999999999 110.61 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -82.55 -162.54 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 5.0499999999999998 110.827 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 73.9 p -60.22 -21.3 61.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 2.6800000000000002 111.329 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 48.7 mm -48.15 -35.58 5.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.841 0.353 . . . . 2.4700000000000002 111.111 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -51.4 -55.68 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 2.5299999999999998 111.04 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -56.87 -38.09 72.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.29 111.658 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -57.0 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 2.6200000000000001 111.342 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 57.1 tp -83.36 -41.75 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.339 . . . . 1.6100000000000001 111.133 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -77.88 -0.97 29.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 1.4199999999999999 111.162 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 37.0 t -96.14 -43.59 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.127 0.489 . . . . 1.4299999999999999 110.263 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 42.9 tp -72.97 -36.82 67.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.665 -0.698 . . . . 1.1200000000000001 111.98 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.688 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 34.2 tp -58.08 -54.51 54.9 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.029 -0.268 . . . . 1.26 111.596 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 34.3 Cg_exo -58.8 -39.44 81.74 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.757 1.638 . . . . 0.59999999999999998 111.471 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.98 -28.23 69.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 1.3999999999999999 110.226 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -75.43 -25.53 57.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.047 -0.524 . . . . 1.4099999999999999 110.546 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 92.3 p -92.43 -19.25 22.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 1.3200000000000001 110.55 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.762 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.76 -30.13 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 1.6899999999999999 110.987 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.05 60.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.837 -0.697 . . . . 0.79000000000000004 112.121 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -58.97 -39.06 80.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 2.96 111.211 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 42.2 t -56.49 -61.07 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.29 111.203 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.28 -20.03 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 3.1499999999999999 110.955 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -72.1 -45.23 61.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 1.51 110.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.37 -27.02 67.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 2.1899999999999999 110.82 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.66 -46.19 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 1.98 111.201 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -74.38 -43.41 56.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 2.1699999999999999 111.29 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.64 -18.73 72.33 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.781 -0.723 . . . . 1.3600000000000001 112.86 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.61 -55.4 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.546 0.212 . . . . 2.8999999999999999 111.079 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' B' ' 164' ' ' LEU . 80.2 mtp180 59.52 96.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.236 -0.438 . . . . 5.6100000000000003 110.743 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.89 124.53 17.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 4.04 111.02 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 93.9 mt -141.68 179.55 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.939 -0.573 . . . . 6.2999999999999998 110.743 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -145.76 94.98 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.504 . . . . 4.7999999999999998 111.066 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.28 18.14 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 6.3899999999999997 110.87 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 49.4 m -119.59 90.6 3.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 5.6100000000000003 110.824 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -97.72 68.67 2.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.301 -0.409 . . . . 8.1999999999999993 110.987 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 8.1699999999999999 111.013 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.715 0.293 . . . . 5.6200000000000001 110.817 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -127.25 -71.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 5.2800000000000002 111.197 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' LEU . . . . . 0.744 HD23 ' H ' ' C' ' 3' ' ' LEU . 2.5 pt? -107.97 136.64 47.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 6.0499999999999998 111.044 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -135.87 -42.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 4.79 110.949 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 41.0 t -96.46 138.42 34.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 2.71 110.888 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.463 ' N ' HD12 ' C' ' 6' ' ' LEU . 5.4 mp -111.32 -17.3 13.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 2.52 110.452 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' C' ' 11' ' ' TYR . 3.7 mm? -60.83 -31.58 71.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 1.9299999999999999 110.921 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 32.3 m170 -69.54 -32.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 1.26 110.746 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -75.44 -54.64 6.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.23 -0.441 . . . . 1.6699999999999999 110.954 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 36.6 mm -57.04 -22.21 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.472 . . . . 1.8700000000000001 110.32 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' C' ' 7' ' ' LEU . 4.3 t80 -67.64 -59.34 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.649 -0.705 . . . . 1.4399999999999999 110.773 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.15 -29.22 46.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.46999999999999997 111.351 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.91 -47.81 70.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.58999999999999997 111.369 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.13 79.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.5 112.81 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 24.9 mmt -72.18 -25.04 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.363 . . . . 0.68000000000000005 111.079 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 85.7 m -69.68 -53.33 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.055 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.73 -24.06 34.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 1.55 111.12 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -54.11 30.66 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.87 -0.681 . . . . 0.70999999999999996 112.513 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.9 70.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.77000000000000002 110.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -64.8 -33.68 76.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.128 -0.487 . . . . 1.9299999999999999 110.649 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -63.84 -19.86 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 1.8600000000000001 110.998 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.24 -58.24 9.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 4.1399999999999997 111.127 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.78 -33.78 76.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 3.1499999999999999 111.039 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -71.89 -22.34 61.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 1.95 111.169 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 tp -84.63 -6.0 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 2.2200000000000002 111.106 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 98.5 p -67.62 -12.89 61.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.3700000000000001 110.82 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -47.94 -42.83 28.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.189 -0.671 . . . . 5.0300000000000002 109.189 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.6 p-10 -177.16 130.66 0.34 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.193 -0.912 . . . . 2.3700000000000001 110.201 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 85.0 Cg_endo -99.09 170.26 0.52 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.242 2.628 . . . . 2.0499999999999998 112.056 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -89.22 56.03 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.371 . . . . 4.5199999999999996 110.955 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.28 -44.11 3.31 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.9 -0.667 . . . . 2.1600000000000001 112.648 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.43 HG12 HD21 ' C' ' 221' ' ' LEU . 10.2 p -85.23 132.27 45.77 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.456 0.169 . . . . 2.5299999999999998 111.081 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.465 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 35.4 Cg_exo -59.17 158.79 24.58 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.324 2.016 . . . . 1.9299999999999999 111.996 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLN . . . . . 0.41 ' HA ' ' HD2' ' C' ' 37' ' ' TYR . 25.6 mm-40 -58.92 -17.2 22.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.63 -0.714 . . . . 4.1200000000000001 112.429 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.465 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -45.1 -33.53 2.21 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.735 0.302 . . . . 2.8900000000000001 111.367 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.74 -49.1 72.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.953 0.406 . . . . 2.46 110.128 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' TYR . . . . . 0.41 ' HD2' ' HA ' ' C' ' 34' ' ' GLN . 58.9 m-85 -70.48 -18.76 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 2.7799999999999998 110.476 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' C' ' 41' ' ' MET . 39.1 tp -60.48 -56.78 17.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.274 -0.421 . . . . 1.6200000000000001 110.496 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.26 -36.46 74.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 1.5900000000000001 110.014 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -74.74 -4.34 36.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.934 -0.576 . . . . 0.65000000000000002 110.747 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.479 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 23.9 ttt -88.52 -37.31 15.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.917 -0.583 . . . . 1.6699999999999999 110.485 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.92 -34.57 69.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 3.4199999999999999 111.252 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.605 HG23 HG23 ' C' ' 79' ' ' THR . 83.0 mt -51.08 -53.58 46.95 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.161 0.43 . . . . 0.89000000000000001 112.161 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.76 -34.4 8.98 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.314 2.01 . . . . 0.40999999999999998 113.231 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -55.19 -62.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 1.76 111.683 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.429 ' HE1' HG13 ' A' ' 110' ' ' ILE . 1.1 t90 -63.38 -53.03 58.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.551 -0.295 . . . . 2.1600000000000001 111.245 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' SER . . . . . 0.467 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 39.9 t -53.7 -31.74 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 1.1699999999999999 111.782 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.61 -49.37 60.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.44 112.652 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.454 HD22 ' SG ' ' A' ' 134' ' ' CYS . 50.1 mt -58.25 -35.67 72.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 1.29 111.441 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.87 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.5 111.602 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 22.5 m-85 -61.34 -38.7 87.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.8300000000000001 111.512 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 45.7 ttp -50.33 -38.23 40.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.26 0.552 . . . . 1.47 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.64 82.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.503 -0.771 . . . . 0.59999999999999998 110.777 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.8 mtt -51.42 -28.87 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.83999999999999997 110.626 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -72.92 -51.56 18.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.65000000000000002 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 127' ' ' VAL . 29.1 pt -76.91 9.37 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 1.55 111.492 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 59.12 51.43 7.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.058 -0.519 . . . . 1.54 111.373 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.472 ' HG3' HD11 ' A' ' 118' ' ' ILE . 6.7 tp-100 -120.73 139.62 52.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 1.79 110.877 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.88 32.52 5.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.93999999999999995 112.205 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -139.4 136.19 34.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 2.3599999999999999 111.03 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.28 136.47 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.428 -0.351 . . . . 1.97 111.15 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.27 91.32 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 2.4399999999999999 110.63 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.85 128.7 55.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 1.54 111.033 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.93 33.66 19.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.076 -0.511 . . . . 1.71 111.093 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 16.05 61.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.769 -0.729 . . . . 1.53 112.499 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.53 125.17 41.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.742 0.306 . . . . 2.23 110.737 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 25.8 pt -75.57 133.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 1.3600000000000001 111.398 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.01 113.01 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.78000000000000003 110.923 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.545 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 91.6 m-70 -75.64 79.07 2.62 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.286 0.565 . . . . 1.0800000000000001 111.211 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -57.73 -34.94 70.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.404 -0.816 . . . . 2.2999999999999998 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.35 -22.68 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.75 111.871 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.8 tpp180 -67.62 -51.47 49.76 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.435 0.532 . . . . 1.51 112.435 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' C' ' 77' ' ' MET . 28.8 p90 -87.1 -30.95 20.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.435 0.532 . . . . 4.6500000000000004 112.435 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.9 tp -56.46 -41.16 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.564 -0.455 . . . . 1.22 110.108 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 19.6 t0 -69.8 -20.61 63.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.994 -0.743 . . . . 1.3100000000000001 108.994 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -89.75 9.9 25.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.249 -0.887 . . . . 1.6799999999999999 110.888 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 92.0 mmm -105.05 -21.86 13.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 1.8 110.152 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.57 -29.1 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 1.1899999999999999 112.163 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.605 HG23 HG23 ' C' ' 43' ' ' ILE . 61.9 m -83.42 -49.49 9.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.212 0.449 . . . . 1.23 112.212 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.2 m -55.05 -50.73 84.79 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 111.898 0.333 . . . . 0.58999999999999997 111.898 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.4 Cg_exo -54.69 -47.92 24.1 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.917 1.745 . . . . 0.67000000000000004 111.665 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.27 -27.71 68.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.921 -0.581 . . . . 0.95999999999999996 110.573 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.501 HD13 ' O ' ' C' ' 83' ' ' LEU . 1.2 tm? -67.55 -38.04 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.257 0.551 . . . . 1.1899999999999999 109.632 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -78.56 -25.63 45.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 1.7 110.871 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.04 -33.0 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 1.6200000000000001 111.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 60.1 m -62.91 -54.06 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.26 110.978 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 pp -61.8 -22.15 65.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.1100000000000001 111.08 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -50.51 52.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 1.51 110.648 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -60.67 -28.23 68.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.406 . . . . 2.0600000000000001 110.68 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -60.88 -52.43 65.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 1.52 110.801 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.25 60.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.191 -0.459 . . . . 1.3 111.056 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 12.9 tpt -86.86 112.89 22.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 1.6200000000000001 110.488 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -86.55 -61.55 1.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 3.2400000000000002 111.442 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -130.97 144.3 51.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 4.6299999999999999 111.301 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 tt -109.32 146.13 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 2.1800000000000002 110.739 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -124.54 -83.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.571 -0.286 . . . . 4.1200000000000001 111.247 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -139.2 3.38 2.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 4.96 111.332 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.41 91.89 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 3.9100000000000001 110.698 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -107.6 -13.59 15.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 5.21 111.29 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 7.3 t -69.35 -27.71 65.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 1.8200000000000001 111.245 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.16 -35.5 75.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 2.0800000000000001 110.957 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.1 -38.9 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.906 -0.588 . . . . 1.8600000000000001 111.294 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -35.5 92.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.58999999999999997 112.571 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -65.17 -35.82 82.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 1.53 110.847 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.25 -45.66 83.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 110.974 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 106' ' ' MET . . . . . 0.421 ' O ' HG13 ' C' ' 110' ' ' ILE . 91.0 mmm -62.44 -43.31 99.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 2.21 110.715 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -53.71 -51.2 64.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 1.28 111.479 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 75.7 p -59.64 -30.34 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 1.22 111.761 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -74.55 -50.45 18.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 2.3300000000000001 111.654 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.619 HG22 ' HE1' ' B' ' 46' ' ' TRP . 58.9 mt -52.34 -34.92 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.399 -0.364 . . . . 1.29 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.22 -48.94 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.0600000000000001 111.494 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.34 -56.55 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.51000000000000001 111.874 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' C' ' 110' ' ' ILE . 25.4 pt -54.51 -32.37 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 1.3700000000000001 111.804 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 20.3 m -60.66 -46.76 89.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.77000000000000002 110.899 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -67.32 -20.58 65.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 1.1899999999999999 110.939 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.72 -40.87 11.61 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.986 -0.626 . . . . 0.5 113.058 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.505 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.8 pp -73.68 -29.65 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.289 . . . . 1.47 111.424 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.505 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.1 tp -81.22 -28.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.806 0.336 . . . . 1.2 110.988 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.46 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.537 . . . . 0.40000000000000002 110.994 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.57 -24.74 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 2.1200000000000001 111.116 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 93.5 mt -88.02 33.83 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.75 110.715 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 83.4 p -77.95 132.73 38.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 1.3799999999999999 111.007 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.99 -25.61 29.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 2.7400000000000002 110.577 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -134.72 152.57 51.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.897 -0.592 . . . . 2.7999999999999998 110.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.91 -11.09 60.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 2.4100000000000001 111.315 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -92.81 -40.64 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.463 -0.335 . . . . 4.2000000000000002 111.071 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.42 -23.9 25.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 1.0800000000000001 110.822 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -66.74 -35.79 80.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.948 -0.569 . . . . 2.5699999999999998 111.0 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -65.0 -32.15 73.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 3.8100000000000001 111.203 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.63 -54.38 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 1.4199999999999999 111.2 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -58.6 -28.68 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.89000000000000001 111.286 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.72 -44.99 80.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 1.26 110.861 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 81.7 mt -56.92 -37.27 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 1.6799999999999999 110.744 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' CYS . . . . . 0.476 ' SG ' HD22 ' B' ' 49' ' ' LEU . 53.8 t -70.36 -27.06 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 1.24 110.766 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.3 -56.7 20.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.54000000000000004 112.385 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.9 -32.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 1.0600000000000001 110.985 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 50.1 t -63.39 -35.71 81.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 110.301 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.75 92.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.775 -0.648 . . . . 0.56999999999999995 110.838 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -69.81 -16.12 63.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.6799999999999999 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.21 -58.59 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 1.7 110.592 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 17.2 pt -71.15 -27.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.78000000000000003 111.596 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.98 -44.31 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.333 -0.394 . . . . 2.2400000000000002 111.221 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.9 tp -55.54 -57.94 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.334 . . . . 1.02 111.078 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -62.77 -24.98 67.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 3.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.23 -16.84 79.61 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 1.27 112.64 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 146' ' ' ILE . . . . . 0.433 ' C ' ' HD2' ' C' ' 149' ' ' PRO . 69.1 mt -105.52 -18.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 1.8899999999999999 111.183 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -62.3 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 1.6000000000000001 111.932 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.672 ' HB2' ' HD3' ' C' ' 149' ' ' PRO . 69.1 m-80 -71.98 -52.7 7.41 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.344 0.498 . . . . 99.989999999999995 112.344 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 23.9 Cg_exo -64.99 -0.43 3.27 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.39 2.06 . . . . 2.73 113.228 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 150' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' C' ' 150' ' ' LEU . 15.1 tp -104.39 59.02 0.71 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 4.2999999999999998 110.918 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? 53.72 64.43 1.84 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.765 -0.652 . . . . 8.9000000000000004 111.238 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' C' ' 148' ' ' ASN . . . -83.22 -39.37 21.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.243 -0.435 . . . . 2.7999999999999998 111.225 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -70.62 -29.15 65.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.183 -0.462 . . . . 5.4400000000000004 110.844 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 12.7 m -66.41 -15.53 63.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 3.3900000000000001 111.158 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -65.32 -25.39 67.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 6.9199999999999999 111.143 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 77.1 p -102.9 5.91 38.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 4.8700000000000001 111.077 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -101.13 -62.05 1.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 4.0499999999999998 110.648 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 39.0 t -115.39 118.53 33.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 3.0299999999999998 110.824 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 63.2 m -75.77 -21.3 57.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 2.96 110.738 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.92 -58.75 3.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 3.7400000000000002 110.777 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.62 -22.06 66.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 2.6499999999999999 111.135 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.78 -46.08 66.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 1.77 111.27 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -62.51 -44.02 97.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 2.96 111.412 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.16 -62.73 1.63 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.124 0.488 . . . . 2.3500000000000001 110.774 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -23.58 46.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.373 -0.83 . . . . 2.6200000000000001 111.192 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.4 -50.48 63.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 2.0899999999999999 110.751 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -61.09 -35.78 77.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 3.2400000000000002 110.821 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.7 -62.81 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 1.6899999999999999 111.227 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.09 -32.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 1.3999999999999999 111.479 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.7 m -57.11 -53.08 62.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.362 . . . . 0.95999999999999996 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -56.16 -39.25 72.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 3.6499999999999999 110.84 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -62.75 -32.13 73.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 1.3700000000000001 111.084 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 34.2 m -73.8 -46.69 43.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.508 . . . . 1.4299999999999999 111.413 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.61 -28.95 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 1.6200000000000001 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.8 tp -80.52 -57.67 3.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.356 -0.384 . . . . 2.0299999999999998 111.678 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.28 -28.14 62.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.748 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.449 ' O ' HG13 ' C' ' 181' ' ' ILE . 34.2 mm -87.83 -23.33 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 1.5800000000000001 110.166 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.51 24.56 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.814 -0.63 . . . . 0.56000000000000005 113.155 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 66.2 m-85 -53.85 -54.97 40.73 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.899 0.349 . . . . 1.3300000000000001 111.069 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 80.4 Cg_exo -45.36 -33.54 9.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.946 1.764 . . . . 0.63 112.664 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.449 HG13 ' O ' ' C' ' 177' ' ' ILE . 87.3 mt -63.9 -61.14 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.568 -0.287 . . . . 0.93000000000000005 111.483 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 p -56.95 -35.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 1.27 111.623 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -57.13 -51.37 69.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.564 -0.289 . . . . 1.77 111.147 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.0 -65.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.371 -0.377 . . . . 2.3900000000000001 111.656 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.427 ' O ' HD12 ' C' ' 185' ' ' ILE . 2.5 pp -52.98 135.92 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.077 0.465 . . . . 1.95 111.248 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 66.02 161.67 0.97 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.944 -0.646 . . . . 1.8799999999999999 112.425 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.51 81.43 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.369 2.046 . . . . 3.1200000000000001 112.166 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 42.5 t 55.15 50.35 15.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.109 -0.496 . . . . 2.6299999999999999 110.755 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -170.34 -96.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.808 -0.711 . . . . 3.04 112.524 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 190' ' ' PHE . . . . . 0.495 ' N ' HD11 ' C' ' 193' ' ' ILE . 87.8 t80 -145.2 -31.93 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 5.6900000000000004 110.856 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 191' ' ' GLY . . . . . 0.567 ' H ' HG12 ' C' ' 193' ' ' ILE . . . 151.24 110.84 0.5 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.72 -0.752 . . . . 3.0800000000000001 112.522 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 57.21 28.89 15.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.72 0.295 . . . . 7.5300000000000002 111.092 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 193' ' ' ILE . . . . . 0.567 HG12 ' H ' ' C' ' 191' ' ' GLY . 20.1 pt -120.38 160.25 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.021 0.438 . . . . 2.8599999999999999 111.213 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -167.28 12.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.954 -0.567 . . . . 3.6899999999999999 110.643 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -92.9 -162.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.069 -0.514 . . . . 5.4800000000000004 110.961 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.8 m -63.0 -19.72 64.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 2.3799999999999999 110.979 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -51.28 -33.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.185 -0.461 . . . . 2.23 111.462 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.52 -56.43 18.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.392 . . . . 2.1600000000000001 111.007 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.6 p -60.99 -31.18 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 1.27 111.478 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.3 -39.0 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 1.7 111.333 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.0 -45.49 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 2.02 111.435 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.21 -3.22 12.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.746 0.308 . . . . 1.8200000000000001 110.984 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 25.6 t -96.19 -40.95 8.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.197 0.522 . . . . 1.3500000000000001 110.072 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 55.5 tp -74.12 -37.55 64.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.512 -0.767 . . . . 0.65000000000000002 111.733 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.666 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 52.1 tp -57.19 -53.84 61.0 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.765 -0.198 . . . . 1.4199999999999999 111.463 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 32.6 Cg_exo -58.59 -42.35 55.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.73 1.62 . . . . 0.63 111.476 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' C' ' 11' ' ' TYR . 51.3 t80 -64.11 -26.43 68.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.106 -0.497 . . . . 1.49 110.393 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.36 -26.01 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 1.7 110.479 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 89.2 p -93.99 -24.88 17.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 1.25 110.811 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.729 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 30.5 m -64.95 -28.57 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 1.6100000000000001 111.279 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.33 -32.46 62.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.78 . . . . 0.81999999999999995 112.619 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.71 -36.76 70.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.671 0.272 . . . . 3.0800000000000001 111.038 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.3 t -61.34 -56.31 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 110.947 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -61.23 -25.54 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 2.5600000000000001 110.853 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.42 -51.08 32.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 1.29 110.827 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.19 -21.47 63.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 2.3900000000000001 111.25 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.56 -35.56 39.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 2.0299999999999998 111.203 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -82.28 -33.4 29.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.972 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -81.14 -18.75 68.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.852 -0.69 . . . . 1.3600000000000001 112.364 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 221' ' ' LEU . . . . . 0.43 HD21 HG12 ' C' ' 32' ' ' VAL . 55.0 tp -58.0 -58.21 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.553 0.216 . . . . 2.8999999999999999 111.211 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 222' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' C' ' 222' ' ' ARG . 7.6 tpm_? 60.29 98.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.256 -0.429 . . . . 4.8899999999999997 110.659 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -56.66 111.7 1.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 4.2300000000000004 111.167 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 96.2 mt -134.8 151.73 51.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.962 -0.563 . . . . 6.1200000000000001 110.84 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -111.62 101.0 9.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 4.5499999999999998 111.013 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -165.31 71.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.139 -0.482 . . . . 6.7800000000000002 110.496 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.8 t -137.26 -64.77 0.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 5.4000000000000004 110.85 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 55.41 82.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 8.3300000000000001 110.997 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 7.9100000000000001 110.845 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.869 0.366 . . . . 5.1100000000000003 110.841 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 56.13 74.26 0.4 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.03 -0.532 . . . . 5.04 110.896 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 34.1 tp -142.91 127.53 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 5.5800000000000001 110.693 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -119.56 132.42 55.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 5.0199999999999996 111.193 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -102.33 137.25 40.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 2.4500000000000002 110.61 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt -104.36 -3.27 24.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.312 -0.404 . . . . 2.4199999999999999 111.261 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.85 -59.67 2.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.332 . . . . 2.0899999999999999 111.171 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 35.5 m80 -59.86 -23.69 63.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 1.1599999999999999 110.586 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.415 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.4 t-105 -66.33 -54.51 23.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.79000000000000004 110.765 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.45 -23.18 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 2.0800000000000001 110.51 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.488 ' OH ' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -60.32 -61.28 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.64 . . . . 1.28 111.108 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 9' ' ' TRP . 8.1 p -57.19 -32.79 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.4 . . . . 1.3200000000000001 111.188 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.85 98.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.63 111.024 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.57 -22.16 78.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.833 -0.699 . . . . 0.55000000000000004 112.365 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.0 mmt -73.29 -42.56 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 1.03 110.825 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.4 p -61.67 -49.85 74.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 1.3 111.11 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.77 -24.27 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 1.3100000000000001 110.982 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.58 -46.6 91.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.766 -0.731 . . . . 0.77000000000000002 112.551 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.1 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.747 0.308 . . . . 0.80000000000000004 111.201 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.92 -28.62 69.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 1.8100000000000001 110.972 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -54.96 -32.79 61.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 1.8799999999999999 110.63 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -75.15 -36.7 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 4.4500000000000002 110.842 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -54.58 -34.72 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.916 0.388 . . . . 3.6899999999999999 110.678 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.8 m -85.31 -29.65 24.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 1.5700000000000001 111.178 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.3 tp -87.27 -5.62 58.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 1.95 111.297 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.1 p -60.2 -19.81 55.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.3799999999999999 111.188 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -50.01 -32.24 14.8 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.187 0.517 . . . . 4.0700000000000003 109.726 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -176.15 132.17 0.4 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.103 -0.953 . . . . 2.7200000000000002 109.912 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -95.52 -176.84 0.39 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.877 2.385 . . . . 1.9099999999999999 112.609 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -86.43 45.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 4.7599999999999998 110.979 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.71 -45.74 3.38 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.881 -0.676 . . . . 1.99 112.613 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.8 118.99 71.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 2.7000000000000002 111.265 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' TYR . 51.2 Cg_exo -55.06 168.61 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.961 2.441 . . . . 1.79 112.351 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -39.63 -18.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.335 -0.848 . . . . 4.1200000000000001 113.17 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 m-30 -41.27 -60.47 1.25 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.887 0.375 . . . . 2.9300000000000002 111.396 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.23 -41.95 97.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.034 -0.53 . . . . 2.8799999999999999 111.597 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -69.27 -19.36 63.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.618 -0.264 . . . . 4.6600000000000001 111.484 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.08 -55.55 10.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.953 0.406 . . . . 1.45 110.268 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.655 HG23 HD12 ' A' ' 82' ' ' LEU . 4.3 p -68.35 -31.32 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.78 111.031 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.6 -13.05 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.524 . . . . 0.63 111.663 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.491 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 17.0 tmm? -89.12 -35.51 16.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 1.48 111.287 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -77.81 -33.81 52.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.279 0.474 . . . . 3.5 112.279 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.592 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 88.6 mt -54.06 -50.54 83.74 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 111.753 0.279 . . . . 1.0800000000000001 111.753 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 12.1 Cg_exo -71.23 -43.22 1.61 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.647 2.232 . . . . 0.53000000000000003 113.059 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 41' ' ' MET . 42.3 mm -56.38 -61.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.778 0.288 . . . . 1.6799999999999999 111.778 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -55.18 -58.36 8.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.652 0.263 . . . . 1.8300000000000001 111.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.6 p -52.01 -42.16 62.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 1.0900000000000001 111.535 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -48.8 -60.35 6.04 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.129 -0.557 . . . . 0.40999999999999998 112.992 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.23 -34.87 58.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.98999999999999999 111.204 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.49 83.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.47999999999999998 111.29 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 57.4 m-85 -63.82 -49.64 72.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.8700000000000001 111.324 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.7 ttp -47.02 -34.4 5.63 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 1.49 110.352 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.96 -44.21 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.762 -0.654 . . . . 0.58999999999999997 110.926 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.404 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 53.5 mtt -52.42 -27.72 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.48999999999999999 110.209 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.87 47.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.718 -0.674 . . . . 0.59999999999999998 110.385 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.4 -2.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 1.3100000000000001 110.847 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.52 43.11 2.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.938 -0.574 . . . . 1.9099999999999999 111.108 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.405 HE21 HG21 ' B' ' 127' ' ' VAL . 6.5 tp-100 -121.56 159.14 27.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.947 -0.569 . . . . 1.6200000000000001 110.509 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.06 13.91 44.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 1.04 112.114 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -132.57 140.2 48.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.787 0.327 . . . . 2.6800000000000002 110.697 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.24 150.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 1.98 111.192 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.64 92.55 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 2.1800000000000002 110.611 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.66 137.48 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.5700000000000001 111.073 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.07 17.18 7.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.511 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.8 -13.07 63.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 1.48 112.699 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -98.45 155.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 2.3199999999999998 111.164 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.6 mt -105.26 106.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.96 -0.564 . . . . 1.4399999999999999 110.861 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.73 138.39 33.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.81999999999999995 111.482 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.8 m-70 -97.73 74.55 2.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.979 -0.555 . . . . 0.90000000000000002 110.615 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -56.41 -45.7 80.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.557 -0.747 . . . . 1.8300000000000001 111.684 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -67.21 -27.16 67.02 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.189 0.44 . . . . 0.62 112.189 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.4 tpp180 -64.16 -51.61 63.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.596 0.591 . . . . 2.3399999999999999 112.596 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.507 ' O ' ' HG3' ' A' ' 77' ' ' MET . 15.9 p90 -87.06 -26.15 23.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.455 -0.498 . . . . 3.4900000000000002 112.297 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 71' ' ' ALA . 9.6 tp -55.87 -42.38 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.6 -0.44 . . . . 1.3700000000000001 110.125 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -70.01 -21.34 63.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.16 -0.682 . . . . 1.3100000000000001 109.16 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -84.77 2.81 40.44 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.364 -0.835 . . . . 1.48 111.243 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 38.9 mtp -103.06 -22.87 13.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 1.46 110.931 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.447 ' O ' HD23 ' A' ' 82' ' ' LEU . 28.9 m -114.52 -36.04 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.453 0.538 . . . . 1.1200000000000001 112.453 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 43' ' ' ILE . 36.0 m -72.58 -52.32 16.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.902 0.334 . . . . 1.1000000000000001 111.902 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.578 HG22 ' NE2' ' A' ' 109' ' ' GLN . 10.5 m -53.82 -51.37 77.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.583 0.586 . . . . 0.59999999999999998 112.583 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 80' ' ' THR . 12.1 Cg_endo -55.72 -44.36 48.6 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.49 1.46 . . . . 0.73999999999999999 111.511 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.655 HD12 HG23 ' A' ' 39' ' ' VAL . 3.9 mm? -64.2 -31.37 72.54 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.601 -0.518 . . . . 1.01 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 83' ' ' LEU . 1.6 tt -68.87 -24.53 64.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.531 0.682 . . . . 1.48 109.206 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.22 -32.11 24.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.129 -0.941 . . . . 1.3799999999999999 110.474 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.67 -36.14 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.751 -0.659 . . . . 1.1899999999999999 111.172 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -58.27 -25.09 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 1.23 110.943 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.57 -40.48 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.88 110.834 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -61.05 -37.26 82.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 1.3899999999999999 111.044 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -73.83 -38.65 64.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.27 -0.423 . . . . 2.3199999999999998 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.21 -29.07 70.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 1.46 111.031 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.29 -40.38 13.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.24 111.239 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.3 mtp -99.99 107.28 19.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 2.0699999999999998 111.076 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -82.17 -27.53 32.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 3.5299999999999998 110.488 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -133.55 138.9 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 4.0800000000000001 110.596 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.04 142.94 23.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 2.1699999999999999 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -124.87 -66.25 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 4.5199999999999996 110.867 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -160.86 80.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 3.75 110.771 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.73 109.55 4.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 3.5299999999999998 110.94 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -129.25 12.04 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 4.9100000000000001 110.741 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.8 t -95.12 -32.22 13.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 1.98 111.395 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 101' ' ' LEU . 1.2 tm? -74.23 -45.13 50.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 1.8300000000000001 110.57 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.37 -33.77 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.391 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.14 -34.77 64.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.62 112.807 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -66.98 -34.99 78.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 1.5800000000000001 111.02 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.2 mt -76.14 -52.1 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.97999999999999998 111.023 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -58.91 -33.25 70.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 1.48 111.451 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.4 p -72.16 -56.62 5.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.43 -0.35 . . . . 1.1299999999999999 111.005 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.0 p -55.75 -25.21 39.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 1.48 110.778 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.578 ' NE2' HG22 ' A' ' 80' ' ' THR . 6.4 tp60 -68.64 -45.98 70.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 2.7000000000000002 110.798 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.436 ' HA ' HD12 ' A' ' 113' ' ' ILE . 60.8 mt -54.37 -36.9 35.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.461 -0.336 . . . . 1.54 110.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.85 -44.66 99.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.28 111.139 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.5 t -66.11 -36.36 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.42999999999999999 111.308 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 110' ' ' ILE . 94.0 mt -60.03 -41.84 87.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.183 -0.462 . . . . 1.74 111.161 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 72.5 m -60.84 -51.7 68.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.63 111.113 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.408 ' HA ' HG22 ' A' ' 118' ' ' ILE . 78.9 p -59.68 -20.16 54.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 1.0900000000000001 110.825 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.79 -36.05 17.13 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.056 -0.592 . . . . 0.41999999999999998 112.898 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -83.09 -28.45 29.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.652 0.263 . . . . 1.3799999999999999 111.625 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.7 tp -83.93 -28.11 7.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.603 -0.271 . . . . 1.6200000000000001 111.574 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.65 74.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.39000000000000001 110.809 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.5 -12.44 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 2.02 110.74 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 118' ' ' ILE . 91.6 mt -90.42 22.04 3.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.76000000000000001 110.788 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.1 m -86.3 120.67 27.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 1.46 110.864 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -90.32 -68.33 0.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 3.3500000000000001 110.849 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.569 ' HB2' HG12 ' A' ' 127' ' ' VAL . 99.6 mtt180 -64.81 139.63 58.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 2.9199999999999999 110.617 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.11 -9.54 58.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 2.77 110.872 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -88.51 -38.5 14.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 3.77 110.927 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.0 p -79.88 -24.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.1599999999999999 111.018 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.42 ' NH1' ' H ' ' A' ' 188' ' ' SER . 29.2 ttm180 -54.41 -43.52 71.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 2.04 111.059 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.99 -33.89 76.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.17 -0.468 . . . . 2.6400000000000001 110.763 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 127' ' ' VAL . 49.8 mt -66.37 -58.48 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 1.8999999999999999 111.135 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.48 ' HE1' ' HB3' ' C' ' 58' ' ' GLN . 4.6 m95 -55.32 -34.31 64.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 1.3999999999999999 111.191 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.41 -48.92 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.28 111.067 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -61.86 -28.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 2.1600000000000001 111.037 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.44 -33.62 74.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.458 . . . . 1.6899999999999999 110.625 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.57 -50.26 26.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.882 -0.675 . . . . 0.52000000000000002 112.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.65 -30.22 48.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.674 0.273 . . . . 1.02 111.262 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.15 -46.5 77.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 1.0800000000000001 110.774 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.51 -29.88 70.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.62 110.969 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.22 -26.85 61.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 1.8400000000000001 110.848 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.85 -53.89 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 1.6899999999999999 111.202 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.7 pt -61.33 -44.95 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 0.81000000000000005 111.443 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.468 ' N ' HG13 ' A' ' 141' ' ' ILE . 89.6 mt -63.88 -36.6 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 2.3700000000000001 111.078 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.69 -28.48 69.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.97999999999999998 110.588 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -72.78 -34.22 66.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 3.27 110.313 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.73 -35.77 34.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.905 -0.664 . . . . 1.25 112.58 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.434 ' O ' ' HD2' ' A' ' 149' ' ' PRO . 97.4 mt -69.9 -26.21 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.947 0.403 . . . . 2.1200000000000001 110.661 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -88.06 3.12 50.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 1.6599999999999999 110.903 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 51.5 t30 -80.81 -47.88 1.16 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 99.989999999999995 112.175 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 95.9 Cg_exo -44.04 -27.54 1.84 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.594 2.196 . . . . 2.6000000000000001 113.16 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.9 tp -53.82 -59.17 4.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.632 -0.258 . . . . 4.6100000000000003 110.735 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 61.61 110.32 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.08 -0.509 . . . . 8.3599999999999994 111.343 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.53 -29.0 66.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 2.75 111.262 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -79.35 -2.67 42.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.175 -0.466 . . . . 5.6799999999999997 111.178 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.2 m -102.53 -20.83 14.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 3.21 111.016 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -65.53 -17.79 64.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 6.8700000000000001 111.144 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.9 t -89.74 -7.42 54.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.277 -0.42 . . . . 4.5599999999999996 111.052 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -94.08 -72.58 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 3.5600000000000001 110.985 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -114.94 113.03 23.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 2.79 110.866 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 m -78.11 -20.37 52.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 2.5899999999999999 110.743 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -74.56 -60.03 2.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 3.4700000000000002 110.952 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.422 HD12 HD23 ' A' ' 164' ' ' LEU . 40.2 tp -61.4 -27.13 68.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 2.5800000000000001 110.903 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.8 -62.59 1.36 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.066 -0.515 . . . . 1.78 111.262 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.98 -28.76 54.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.277 -0.42 . . . . 2.6299999999999999 110.549 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.422 HD23 HD12 ' A' ' 161' ' ' LEU . 25.6 tp -62.83 -44.0 97.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 2.3399999999999999 110.783 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 169' ' ' VAL . 2.4 t80 -81.25 -21.75 39.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 2.77 110.625 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.64 -50.62 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 2.04 111.272 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -74.97 -27.79 60.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.039 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.66 -47.27 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 1.8899999999999999 111.361 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 165' ' ' TYR . 14.3 p -70.93 -30.32 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 1.6399999999999999 111.492 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -56.08 -58.4 8.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 1.24 111.309 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -61.42 -35.21 76.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 2.9700000000000002 110.525 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -65.2 -26.57 68.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 1.48 110.813 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 88.6 m -73.93 -49.54 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 1.55 111.34 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.18 -31.45 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.39 -0.368 . . . . 1.52 111.599 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.413 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.7 mt -77.02 -57.47 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.429 -0.351 . . . . 1.8500000000000001 111.401 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.62 111.545 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.518 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 9.9 tp -87.67 -21.27 7.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.125 0.488 . . . . 1.3500000000000001 110.203 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -64.75 -45.29 93.16 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.711 -0.677 . . . . 0.58999999999999997 112.304 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG22 ' A' ' 182' ' ' VAL . 0.4 OUTLIER -53.32 -55.41 34.68 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.703 0.251 . . . . 1.45 111.053 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.518 ' HD2' ' C ' ' A' ' 177' ' ' ILE . 75.6 Cg_exo -48.96 -38.84 39.73 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.227 1.951 . . . . 0.55000000000000004 112.4 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 184' ' ' ILE . 98.5 mt -54.62 -59.16 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.211 -0.45 . . . . 1.4199999999999999 111.605 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 179' ' ' TYR . 26.5 m -67.69 -24.21 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.308 -0.405 . . . . 0.78000000000000003 111.288 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -59.58 -53.08 62.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.906 0.336 . . . . 0.93999999999999995 111.906 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.0 tt -59.01 -20.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.855 0.317 . . . . 1.4299999999999999 111.855 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 tt -115.76 102.63 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.096 0.474 . . . . 2.02 111.473 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 132.67 -164.83 23.96 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.757 -0.735 . . . . 1.79 112.579 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.5 160.56 49.06 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.614 2.209 . . . . 3.1000000000000001 111.992 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.42 ' H ' ' NH1' ' A' ' 128' ' ' ARG . 47.1 t 59.25 12.01 2.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 2.7400000000000002 110.61 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -131.72 -61.6 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.977 -0.63 . . . . 3.4300000000000002 112.324 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -172.62 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 6.5 110.683 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.58 165.89 7.61 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.994 -0.622 . . . . 3.29 112.649 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -118.27 25.91 9.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 6.1600000000000001 110.712 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 28.5 pt -107.58 162.7 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 2.4199999999999999 111.53 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -167.93 67.63 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 4.29 110.488 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.453 ' HB2' HG22 ' A' ' 197' ' ' ILE . 48.9 mt-30 -112.35 -169.53 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 5.1500000000000004 110.783 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.9 p -69.33 -26.98 64.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 2.4500000000000002 111.174 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 195' ' ' GLN . 7.5 tp -60.25 -38.09 76.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 2.48 111.625 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.98 -57.73 9.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 2.1800000000000002 110.639 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.5 p -60.17 -17.26 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 1.49 111.012 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -81.97 -30.47 31.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 1.77 110.937 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.76 -37.28 22.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 1.4199999999999999 111.195 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -13.79 60.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.478 -0.328 . . . . 1.78 111.309 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 15.7 p -96.15 -37.07 10.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.972 0.415 . . . . 1.3 110.592 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 66.3 tp -72.7 -33.8 66.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.66000000000000003 111.668 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.665 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 47.2 tp -60.72 -53.79 60.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 121.122 -0.231 . . . . 1.6299999999999999 111.348 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.03 -42.34 67.71 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.931 1.754 . . . . 0.64000000000000001 111.44 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.488 ' HB2' ' OH ' ' A' ' 11' ' ' TYR . 90.5 t80 -61.72 -35.63 78.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.111 -0.495 . . . . 1.3600000000000001 110.251 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.418 ' HA ' HG12 ' A' ' 211' ' ' VAL . 72.7 t80 -75.78 -20.94 57.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.834 -0.621 . . . . 1.54 110.846 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.413 ' OG ' HD13 ' A' ' 175' ' ' LEU . 29.8 t -87.46 -12.5 45.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 1.2 111.127 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYR . . . . . 0.739 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 208' ' ' PHE . 9.1 p -72.99 -38.55 56.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.372 . . . . 1.6399999999999999 110.914 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.16 78.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 0.79000000000000004 112.393 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.98 -38.18 90.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 1.6100000000000001 110.674 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.9 m -58.68 -57.38 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 1.1499999999999999 110.794 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -64.03 -22.8 67.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 3.3399999999999999 110.644 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.81 -48.03 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 111.102 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.86 -31.5 72.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.452 -0.34 . . . . 2.23 111.253 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 52.2 mt -70.15 -57.5 4.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 2.4700000000000002 111.115 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.31 -22.82 65.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 111.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.32 -59.44 10.65 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.817 -0.706 . . . . 1.4099999999999999 112.861 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.28 -55.05 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 2.5800000000000001 110.738 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 54.82 82.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 4.9299999999999997 110.841 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -142.87 142.8 31.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.078 -0.51 . . . . 4.6299999999999999 111.009 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.68 104.24 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 6.4699999999999998 111.03 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -100.54 141.27 33.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 5.0700000000000003 110.803 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -130.32 -60.84 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 6.5300000000000002 110.956 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.7 m -142.53 23.74 1.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.368 -0.378 . . . . 5.2199999999999998 110.916 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -74.49 -66.69 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 8.3599999999999994 111.055 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 7.96 110.903 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.771 0.319 . . . . 6.1699999999999999 110.891 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -121.83 91.31 3.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.4 . . . . 4.8200000000000003 110.825 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 19.4 tp -127.23 142.89 51.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 5.5999999999999996 110.7 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -125.59 96.67 4.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.39 -0.368 . . . . 4.7999999999999998 110.964 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 75.3 m -67.76 150.09 49.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.274 -0.421 . . . . 2.3700000000000001 110.876 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt -115.37 -11.53 11.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 2.0699999999999998 110.857 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 39.6 mt -66.34 -48.27 70.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.003 -0.544 . . . . 2.1000000000000001 110.979 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 34.4 m80 -64.76 -24.17 67.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 1.0700000000000001 110.831 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.453 ' O ' HG12 ' B' ' 12' ' ' VAL . 11.2 m95 -70.57 -56.15 7.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 1.48 111.194 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 pt -60.37 -20.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 2.02 110.906 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' B' ' 15' ' ' MET . 6.0 t80 -65.15 -61.3 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.92000000000000004 110.446 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.54 -29.49 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.237 -0.438 . . . . 0.93999999999999995 111.294 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.23 74.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.55000000000000004 110.978 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.58 -26.23 74.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.856 -0.688 . . . . 0.47999999999999998 112.704 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 52.3 mmm -76.81 -37.79 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.35 . . . . 0.84999999999999998 110.908 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 71.2 m -57.58 -55.4 35.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.115 -0.493 . . . . 1.3400000000000001 110.92 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' B' ' 20' ' ' LEU . 1.9 tp -58.45 -36.72 60.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 1.55 110.782 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -45.81 -58.76 5.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.735 -0.745 . . . . 0.69999999999999996 112.293 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.4 74.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.686 0.279 . . . . 0.81000000000000005 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' B' ' 17' ' ' ILE . 97.5 mt -64.58 -28.68 69.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 2.2599999999999998 110.814 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -64.63 -32.83 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 1.78 110.327 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.8 -20.49 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 4.5800000000000001 110.587 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -69.36 -43.52 73.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 3.3500000000000001 110.479 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 65.5 m -79.65 -30.38 41.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 1.5800000000000001 110.7 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.9 tp -86.48 -1.3 57.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 1.8400000000000001 110.58 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -60.86 -11.68 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 1.3700000000000001 110.903 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -47.22 -47.25 24.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.001 -0.74 . . . . 4.9800000000000004 109.001 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.5 p-10 -178.59 129.91 0.28 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.201 -0.909 . . . . 2.1400000000000001 110.337 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' B' ' 31' ' ' GLY . 72.9 Cg_endo -103.32 -82.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.542 2.828 . . . . 1.8200000000000001 112.121 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.538 ' HE ' HD22 ' B' ' 221' ' ' LEU . 49.6 mtp180 -112.63 6.14 18.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.794 0.806 . . . . 5.1900000000000004 109.234 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.523 ' H ' ' HD2' ' B' ' 29' ' ' PRO . . . 123.64 -53.39 0.75 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 114.267 -1.333 . . . . 2.2000000000000002 110.731 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.26 104.98 5.11 Favored Pre-proline 0 C--O 1.232 0.171 0 O-C-N 122.906 -0.173 . . . . 3.6499999999999999 110.692 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.495 ' HG3' ' HG3' ' B' ' 29' ' ' PRO . 69.6 Cg_endo -88.21 107.76 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 119.446 0.838 . . . . 2.6699999999999999 113.117 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -93.47 -58.29 2.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 123.597 1.665 . . . . 4.8799999999999999 108.894 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.556 ' HD2' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -83.4 -61.69 1.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 110.633 -2.985 . . . . 1.8700000000000001 113.823 -177.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.556 ' H ' ' HD2' ' B' ' 35' ' ' TYR . 40.6 tt0 -37.91 -63.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.467 0.914 . . . . 2.6800000000000002 113.467 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -62.34 -40.33 96.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.11 0.411 . . . . 2.9199999999999999 112.11 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -59.23 -65.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.88 0.326 . . . . 1.6399999999999999 111.88 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.58 HG13 HD12 ' B' ' 82' ' ' LEU . 60.5 t -61.93 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.413 0.523 . . . . 1.6000000000000001 112.413 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -14.09 6.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.228 0.455 . . . . 0.68999999999999995 112.228 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.403 ' O ' HG12 ' B' ' 45' ' ' ILE . 27.6 ttt -88.91 -39.65 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 2.5800000000000001 111.546 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -72.01 -42.65 66.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 3.3900000000000001 112.226 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.485 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 93.5 mt -49.62 -52.05 54.02 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.493 0.553 . . . . 0.40999999999999998 112.493 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 50.9 Cg_endo -68.79 -43.44 3.63 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.202 1.935 . . . . 0.48999999999999999 113.302 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.403 HG12 ' O ' ' B' ' 41' ' ' MET . 36.3 mm -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.78 0.324 . . . . 1.29 111.632 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -55.95 -58.3 8.48 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.227 -0.442 . . . . 1.3999999999999999 111.541 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 94.8 p -51.99 -32.9 35.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 1.3799999999999999 111.241 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.67 -57.64 18.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.37 112.48 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.86 -28.12 68.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 1.29 111.067 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.96 -59.11 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.44 111.16 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 35.1 m-85 -63.75 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.5 111.11 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 19.5 ttt -48.85 -42.74 37.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.063 0.458 . . . . 1.4099999999999999 110.456 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.54 -42.05 87.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.55000000000000004 110.616 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -51.55 -29.38 16.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.5 110.212 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.3 -47.34 57.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.54000000000000004 109.901 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -71.92 2.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.499 -0.773 . . . . 1.3 110.804 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 66.78 49.15 1.26 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.751 -0.658 . . . . 2.2400000000000002 111.008 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.01 173.93 7.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 1.77 110.79 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 78.5 21.3 69.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 1.0600000000000001 112.498 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -139.36 144.5 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.722 0.296 . . . . 2.6600000000000001 110.572 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -124.6 146.19 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 1.8899999999999999 111.155 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -101.16 84.04 2.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 2.4100000000000001 110.844 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.87 144.31 42.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 1.5600000000000001 110.925 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 16.29 4.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 111.436 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 -15.44 58.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 1.51 112.885 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -98.19 173.17 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 2.4500000000000002 110.658 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -116.93 118.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.552 . . . . 1.79 111.165 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.89 110.93 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.81999999999999995 111.253 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 57.0 m-70 -70.05 80.31 0.49 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.737 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -65.23 -31.02 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.655 -0.702 . . . . 1.8700000000000001 111.496 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.468 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -79.48 -25.99 41.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.052 0.389 . . . . 0.60999999999999999 112.052 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 22.0 mmt180 -69.6 -51.16 37.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.323 0.49 . . . . 2.3900000000000001 112.323 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 3.5 p90 -76.14 -36.06 58.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.638 -0.425 . . . . 3.6699999999999999 111.964 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 75' ' ' ASP . 16.9 tt -54.21 -43.68 61.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.728 0.299 . . . . 1.6599999999999999 110.933 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.425 ' N ' HG23 ' B' ' 74' ' ' ILE . 11.6 t70 -67.92 -25.59 65.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.235 -0.654 . . . . 1.4099999999999999 109.235 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -85.44 8.56 18.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.677 -0.692 . . . . 1.1599999999999999 110.484 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.527 ' HA ' HD13 ' B' ' 113' ' ' ILE . 45.9 tpp -105.14 -25.64 12.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.684 -0.689 . . . . 1.53 110.713 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.89 -36.75 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.26 -0.427 . . . . 0.89000000000000001 112.129 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -70.54 -57.64 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.919 0.341 . . . . 1.24 111.919 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 31.2 m -48.92 -51.78 52.2 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.535 0.568 . . . . 0.57999999999999996 112.535 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 53.0 Cg_exo -54.16 -45.79 38.34 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.5 1.467 . . . . 0.66000000000000003 111.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.58 HD12 HG13 ' B' ' 39' ' ' VAL . 3.0 mm? -63.03 -32.05 73.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.85 -0.614 . . . . 1.0600000000000001 109.853 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 -23.95 62.34 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.15 -0.685 . . . . 1.22 109.15 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' B' ' 109' ' ' GLN . 16.8 tp -84.41 -29.44 26.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.103 -0.953 . . . . 1.53 110.462 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.69 -38.98 46.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.753 -0.658 . . . . 1.5800000000000001 111.133 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' SER . . . . . 0.417 ' HB2' HG11 ' B' ' 39' ' ' VAL . 39.8 t -56.55 -21.06 23.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 1.3899999999999999 110.921 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.86 -37.61 62.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.517 . . . . 1.1499999999999999 111.115 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.1 t -72.42 -21.69 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 1.5700000000000001 111.176 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.53 -45.49 15.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.133 -0.485 . . . . 2.1699999999999999 111.138 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -66.83 -23.26 66.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 1.4199999999999999 111.248 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.71 -36.85 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 1.1799999999999999 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 79.1 mtp -105.17 101.17 10.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 1.8799999999999999 110.946 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -73.15 -27.79 61.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.4199999999999999 110.863 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -132.14 153.49 50.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 4.0599999999999996 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.44 144.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 2.0899999999999999 111.322 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -165.16 88.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 3.8500000000000001 110.719 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt 58.19 81.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 4.8200000000000003 111.094 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.89 95.8 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 3.7999999999999998 110.859 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -129.07 0.13 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 5.1699999999999999 110.895 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 67.2 p -70.52 -43.3 69.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 2.02 111.095 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 tp -73.37 -36.03 66.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 2.0899999999999999 110.769 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 28.1 mm -60.7 -37.84 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 1.8799999999999999 110.791 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.06 -23.32 63.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.859 -0.686 . . . . 0.56000000000000005 112.357 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.79 -38.77 89.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.332 . . . . 1.78 111.072 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.3 mt -81.06 -44.24 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 1.03 111.001 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 11.0 tpt -56.4 -39.76 73.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.594 -0.73 . . . . 1.6699999999999999 111.476 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -72.03 -51.85 19.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 1.51 111.274 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 27.8 p -53.26 -32.79 50.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.919 0.39 . . . . 1.1799999999999999 111.379 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.466 ' HB2' HD22 ' B' ' 84' ' ' LEU . 26.1 tp60 -65.81 -48.55 71.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.056 -0.52 . . . . 2.1699999999999999 111.024 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.95 -43.71 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.3500000000000001 111.619 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.2 -44.06 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 1.3400000000000001 111.334 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.89 -46.3 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.42999999999999999 111.8 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.61 HD11 ' HG3' ' B' ' 81' ' ' PRO . 44.6 mt -56.92 -37.74 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.586 -0.279 . . . . 1.6000000000000001 111.096 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.5 m -57.84 -49.66 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.95 0.405 . . . . 0.85999999999999999 110.771 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.6 m -62.89 -21.96 66.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.94999999999999996 110.31 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.66 -43.77 17.71 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.02 -0.61 . . . . 0.46000000000000002 112.497 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.473 ' HB3' ' CD2' ' B' ' 73' ' ' TYR . 3.7 pp -77.47 -24.89 50.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.636 0.255 . . . . 1.75 111.163 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.5 mm -82.34 -36.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.408 -0.36 . . . . 1.78 111.09 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.49 -46.81 76.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.38 111.435 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -70.82 -17.41 62.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.395 -0.366 . . . . 1.97 111.234 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.13 20.41 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.454 -0.339 . . . . 0.76000000000000001 111.351 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -78.05 125.04 28.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.47 110.781 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.75 -67.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 2.5 110.976 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.583 ' HB2' HG12 ' B' ' 127' ' ' VAL . 92.0 mtt180 -71.44 152.29 43.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 2.73 110.584 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.53 -16.78 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 2.2000000000000002 110.865 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -81.86 -37.01 27.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 3.3999999999999999 110.747 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.8 p -78.43 -24.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.23 110.939 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -58.05 -34.88 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 3.04 110.827 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -76.24 -21.39 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 4.1399999999999997 111.042 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.99 -60.99 2.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 1.6499999999999999 111.162 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -59.98 -27.48 66.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.398 -0.365 . . . . 0.77000000000000002 110.971 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.68 -45.75 91.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 1.46 110.284 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -65.26 -33.26 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.044 -0.525 . . . . 1.6299999999999999 110.449 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 47.5 t -62.64 -31.12 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 1.4199999999999999 110.723 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.66 -52.98 13.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.838 -0.696 . . . . 0.48999999999999999 112.479 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.38 -31.69 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 1.3 111.335 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 68.5 m -65.08 -46.07 82.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 1.3 110.775 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.93 71.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.62 110.667 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -73.13 -22.77 60.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.74 110.523 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.72 -57.82 4.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 1.76 110.703 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.441 HG13 ' N ' ' B' ' 142' ' ' ILE . 41.2 pt -60.1 -38.43 76.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.68999999999999995 111.517 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.441 ' N ' HG13 ' B' ' 141' ' ' ILE . 94.1 mt -69.81 -34.74 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 1.76 110.956 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.78 -39.59 85.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.291 -0.413 . . . . 1.0600000000000001 110.569 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' TRP . . . . . 0.535 ' O ' ' OD1' ' B' ' 148' ' ' ASN . 89.4 t90 -62.72 -47.08 85.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.532 . . . . 4.1200000000000001 110.799 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' GLY . . . . . 1.157 ' HA2' ' OD1' ' B' ' 148' ' ' ASN . . . -63.53 -34.08 88.98 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.63 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -74.11 -24.16 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.919 0.39 . . . . 1.98 110.603 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -90.6 3.16 54.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 1.4199999999999999 110.897 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 1.157 ' OD1' ' HA2' ' B' ' 145' ' ' GLY . 32.1 m120 -80.89 -47.23 1.18 Allowed Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.913 -0.585 . . . . 99.989999999999995 112.251 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 81.8 Cg_exo -44.49 -24.09 0.97 Allowed 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.6 2.2 . . . . 2.6499999999999999 113.175 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.79 -59.57 5.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.509 -0.314 . . . . 4.3899999999999997 110.866 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 61.1 109.67 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.074 -0.512 . . . . 7.9000000000000004 111.242 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.74 -19.72 62.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.245 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -75.95 -28.71 58.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 6.29 110.814 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 81.4 p -88.58 -6.05 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 3.1000000000000001 110.928 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -62.4 -28.64 69.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 6.4299999999999997 110.881 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 5.1 t -91.43 -23.71 19.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.507 . . . . 4.5700000000000003 111.425 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -65.82 -77.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.441 -0.345 . . . . 3.8300000000000001 110.938 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 66.0 p -111.65 113.42 25.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 3.0699999999999998 110.916 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 45.5 t -77.74 -21.97 51.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 3.4300000000000002 111.049 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.57 -45.1 22.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 3.9199999999999999 111.396 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 47.3 tp -73.16 -28.14 62.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.812 0.339 . . . . 2.7000000000000002 110.966 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.59 -61.65 1.76 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 1.8300000000000001 111.099 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -53.91 -25.71 21.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.071 0.462 . . . . 2.6299999999999999 110.449 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 49.2 tp -65.21 -47.68 76.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 2.4300000000000002 110.759 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.425 ' O ' HG12 ' B' ' 169' ' ' VAL . 1.1 t80 -78.14 -23.68 47.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 2.5800000000000001 111.32 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.74 -59.28 4.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 2.0 110.92 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.31 -26.9 65.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 3.0299999999999998 111.327 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.16 -56.14 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.406 -0.361 . . . . 1.1000000000000001 111.104 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 165' ' ' TYR . 14.4 p -68.97 -22.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 1.75 111.488 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 41.4 m -54.28 -58.91 5.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.48 -0.327 . . . . 0.97999999999999998 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.67 -42.53 95.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 4.2999999999999998 110.501 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.77 -28.2 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.044 -0.526 . . . . 1.3899999999999999 110.789 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.416 ' O ' HG12 ' B' ' 177' ' ' ILE . 90.2 m -73.52 -50.71 20.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 1.1100000000000001 111.119 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.25 -43.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.315 -0.402 . . . . 1.51 111.93 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' B' ' 209' ' ' SER . 3.8 mm? -70.92 -53.24 15.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.955 0.354 . . . . 1.75 111.955 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -24.14 63.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.704 0.288 . . . . 0.59999999999999998 111.194 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.491 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 36.6 mm -87.57 -22.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 1.47 110.26 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -65.44 -41.93 96.13 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.726 -0.67 . . . . 0.55000000000000004 112.696 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.404 ' O ' HG22 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -56.09 -55.41 42.01 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.744 0.272 . . . . 1.6200000000000001 111.124 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.491 ' HD2' ' C ' ' B' ' 177' ' ' ILE . 78.3 Cg_exo -50.57 -38.75 55.43 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.154 1.903 . . . . 0.64000000000000001 112.243 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.497 ' O ' HG22 ' B' ' 184' ' ' ILE . 37.0 mm -54.04 -58.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 1.27 111.512 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 179' ' ' TYR . 20.9 m -69.23 -24.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.68999999999999995 111.262 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -61.75 -52.59 63.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.026 0.38 . . . . 1.1799999999999999 112.026 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 181' ' ' ILE . 21.1 tt -58.23 -17.21 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 111.998 0.37 . . . . 1.77 111.998 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 8.9 tt -121.54 104.02 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 1.6899999999999999 111.532 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 134.56 -157.71 23.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.802 -0.713 . . . . 1.5800000000000001 112.501 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.08 154.8 37.77 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.614 2.21 . . . . 2.5099999999999998 111.894 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 41.7 t 56.87 24.84 9.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 3.5800000000000001 110.661 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . 179.96 65.13 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.699 -0.762 . . . . 4.0300000000000002 112.839 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 64.9 t80 53.68 96.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 6.8899999999999997 111.194 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.99 113.93 0.52 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.83 -0.7 . . . . 3.7000000000000002 112.163 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -88.78 63.18 6.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.342 . . . . 7.5 110.921 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 pt -141.41 140.36 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.238 -0.437 . . . . 2.3500000000000001 111.175 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -150.82 78.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 3.8599999999999999 110.691 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -118.42 -172.95 2.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 5.0499999999999998 110.97 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 46.0 m -67.98 -32.65 73.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 2.6800000000000002 111.05 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 6.4 tp -57.84 -39.24 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.342 -0.39 . . . . 2.4700000000000002 111.389 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.44 -52.95 63.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.5299999999999998 110.914 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 11.4 m -66.64 -19.11 65.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 1.29 110.94 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' PHE . . . . . 0.439 ' HA ' ' SG ' ' B' ' 203' ' ' CYS . 62.2 t80 -83.51 -27.13 29.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 2.6200000000000001 111.125 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.12 -28.78 27.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.736 0.303 . . . . 1.6100000000000001 111.129 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.85 -12.0 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 1.4199999999999999 111.188 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' B' ' 200' ' ' PHE . 17.2 p -96.22 -32.41 12.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 1.4299999999999999 110.477 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.37 -39.33 59.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 1.1200000000000001 111.408 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.656 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.6 tp -57.46 -53.16 68.37 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.622 -0.263 . . . . 1.26 111.523 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 32.0 Cg_exo -58.58 -45.0 32.52 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.918 1.745 . . . . 0.59999999999999998 111.527 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.403 ' O ' HG23 ' B' ' 211' ' ' VAL . 69.8 t80 -61.72 -29.52 70.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.016 -0.538 . . . . 1.3999999999999999 110.234 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -76.83 -26.71 54.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 1.4099999999999999 110.222 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.503 ' HB2' HD12 ' B' ' 175' ' ' LEU . 45.7 t -87.81 -12.72 44.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.817 -0.629 . . . . 1.3200000000000001 110.373 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' LYR . . . . . 0.765 ' H9 ' H183 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.403 HG23 ' O ' ' B' ' 207' ' ' PHE . 57.3 t -80.16 -40.78 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.004 -0.544 . . . . 1.6899999999999999 111.258 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.18 -35.94 86.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.846 -0.693 . . . . 0.79000000000000004 112.785 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.86 -29.17 64.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.301 . . . . 2.96 110.983 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.86 -60.77 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.29 110.918 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 3.1499999999999999 110.98 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -38.45 89.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.51 110.963 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.58 -30.77 69.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 2.1899999999999999 110.831 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.92 -58.69 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 1.98 111.018 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -66.35 -20.49 66.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 2.1699999999999999 111.036 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.15 -57.65 18.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.8 -0.714 . . . . 1.3600000000000001 112.962 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' LEU . . . . . 0.538 HD22 ' HE ' ' B' ' 30' ' ' ARG . 23.3 tp -85.23 -56.11 3.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.581 0.229 . . . . 2.8999999999999999 111.27 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' B' ' 222' ' ' ARG . 4.8 mmp_? 57.38 88.5 0.05 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.352 -0.386 . . . . 5.6100000000000003 110.923 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -140.43 168.43 19.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 4.04 110.767 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 97.5 mt -133.24 98.49 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 6.2999999999999998 111.088 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.53 HD21 ' H ' ' B' ' 228' ' ' ARG . 2.9 t-20 -102.55 122.59 44.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.076 -0.511 . . . . 4.7999999999999998 110.711 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -116.54 -44.59 2.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 6.3899999999999997 111.158 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.4 m -160.49 39.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 5.6100000000000003 111.154 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.53 ' H ' HD21 ' B' ' 225' ' ' ASN . 40.4 ttm180 -92.74 -63.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 8.1999999999999993 110.547 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 8.1699999999999999 110.652 179.736 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.792 0.329 . . . . 5.6200000000000001 110.855 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -127.5 121.1 29.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 5.2800000000000002 110.908 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 27.4 tp -164.69 131.53 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 6.0499999999999998 110.457 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -121.15 122.53 40.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.856 0.36 . . . . 4.79 111.382 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 46.1 t -92.41 120.25 32.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 2.71 110.79 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -84.29 -6.36 59.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 2.52 111.432 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' LEU . . . . . 0.449 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.1 mm? -69.37 -42.1 75.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 1.9299999999999999 110.684 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.608 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 42.4 m80 -72.22 -27.47 62.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 1.26 110.806 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -70.4 -43.87 69.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.521 . . . . 1.6699999999999999 110.928 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.74 -21.47 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 1.8700000000000001 110.661 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -64.41 -53.31 50.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 1.4399999999999999 110.704 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.26 -34.12 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.46999999999999997 111.216 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.66 96.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.58999999999999997 111.224 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.91 76.52 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.5 112.589 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.7 mmt -74.77 -36.86 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.56 0.219 . . . . 0.68000000000000005 111.477 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 71.7 p -64.35 -52.27 59.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 1.3999999999999999 110.828 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.3 -22.55 31.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 1.55 110.873 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.98 -55.64 27.03 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.783 -0.723 . . . . 0.70999999999999996 112.372 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -34.72 72.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.74 0.305 . . . . 0.77000000000000002 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 26.6 tp -62.43 -35.14 78.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.167 -0.47 . . . . 1.9299999999999999 110.771 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -57.16 -28.96 63.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 1.8600000000000001 110.817 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -74.17 -37.5 63.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.01 -0.541 . . . . 4.1399999999999997 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -56.3 -32.64 64.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 3.1499999999999999 110.689 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -81.07 -32.27 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 1.95 111.313 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -86.42 -1.26 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.532 -0.303 . . . . 2.2200000000000002 111.531 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 92.8 p -62.84 -20.12 64.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.487 -0.324 . . . . 1.3700000000000001 111.15 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -48.71 -33.22 9.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.329 0.585 . . . . 5.0300000000000002 109.687 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.502 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.2 p-10 -174.99 131.77 0.45 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.08 -0.964 . . . . 2.3700000000000001 109.884 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 9.6 Cg_endo -90.83 -169.64 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.012 2.475 . . . . 2.0499999999999998 112.373 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -89.88 35.24 0.84 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 4.5199999999999996 110.9 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.8 -46.21 1.43 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.757 -0.735 . . . . 2.1600000000000001 112.758 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' C' ' 33' ' ' PRO . 13.7 m -77.35 134.55 66.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.777 0.322 . . . . 2.5299999999999998 110.836 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' C' ' 35' ' ' TYR . 31.8 Cg_exo -60.5 168.1 7.14 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.712 2.275 . . . . 1.9299999999999999 112.45 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -41.27 -16.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.99 -1.005 . . . . 4.1200000000000001 113.661 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' C' ' 33' ' ' PRO . 3.2 m-30 -39.75 -62.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.924 0.392 . . . . 2.8900000000000001 111.539 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.08 -40.67 77.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 2.46 111.449 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -72.02 -18.57 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 2.7799999999999998 111.715 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.37 -45.69 68.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.915 0.388 . . . . 1.6200000000000001 110.146 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.605 HG13 HD12 ' C' ' 82' ' ' LEU . 58.2 t -75.19 -33.25 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 1.5900000000000001 110.788 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.38 -15.08 61.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.65000000000000002 111.511 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.407 ' O ' HG12 ' C' ' 45' ' ' ILE . 51.9 ttp -89.57 -37.84 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.45 -0.341 . . . . 1.6699999999999999 111.623 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -72.61 -37.99 67.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 3.4199999999999999 112.064 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.505 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -53.71 -52.5 66.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 112.215 0.45 . . . . 0.89000000000000001 112.215 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 40.7 Cg_endo -67.55 -42.19 7.47 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.213 1.942 . . . . 0.40999999999999998 113.1 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.407 HG12 ' O ' ' C' ' 41' ' ' MET . 37.4 mm -55.88 -62.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.6 0.238 . . . . 1.76 111.518 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -57.32 -58.19 9.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.396 -0.365 . . . . 2.1600000000000001 111.29 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 56.7 m -53.26 -26.76 19.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 1.1699999999999999 111.493 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.81 -61.46 6.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.688 -0.768 . . . . 0.44 112.47 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.91 -25.29 63.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.683 0.278 . . . . 1.29 111.298 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -59.26 4.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.944 0.402 . . . . 0.5 111.027 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.503 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 25.7 m-85 -62.52 -41.54 98.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 1.8300000000000001 111.092 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 55.0 ttp -47.93 -39.09 18.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.087 0.47 . . . . 1.47 110.104 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.66 88.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.763 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.1 mtt -52.45 -30.98 32.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 0.83999999999999997 110.138 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.29 -38.43 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.874 -0.603 . . . . 0.65000000000000002 110.238 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mt -77.53 0.34 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.755 -0.657 . . . . 1.55 110.657 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 68.33 42.28 1.69 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.795 -0.638 . . . . 1.54 111.155 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.48 ' HB3' ' HE1' ' A' ' 131' ' ' TRP . 27.6 mm-40 -118.25 173.51 6.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.819 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.46 16.76 67.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 0.93999999999999995 112.371 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' C' ' 69' ' ' HIS . 36.6 mtmm -136.41 150.9 48.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 2.3599999999999999 110.783 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.29 143.44 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.97 111.082 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.26 89.63 6.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 2.4399999999999999 110.989 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.48 139.68 51.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 1.54 111.038 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.75 15.33 4.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.07 -0.514 . . . . 1.71 111.453 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.13 66.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.795 -0.717 . . . . 1.53 112.691 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -105.44 150.69 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 2.23 111.174 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 11.4 pt -97.12 125.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.545 . . . . 1.3600000000000001 111.074 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.69 123.87 48.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.78000000000000003 110.882 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.573 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 31.9 m-70 -81.07 76.44 8.02 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.35 0.595 . . . . 1.0800000000000001 111.052 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' TYR . . . . . 0.433 ' HD2' ' HH ' ' C' ' 73' ' ' TYR . 83.8 t80 -57.41 -36.44 71.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.376 -0.829 . . . . 2.2999999999999998 111.544 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.37 -26.3 55.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.214 0.449 . . . . 0.75 112.214 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.9 tpp180 -64.19 -51.56 63.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.531 0.567 . . . . 1.51 112.531 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.537 ' O ' ' HG3' ' C' ' 77' ' ' MET . 24.2 p90 -86.44 -26.45 24.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.515 0.561 . . . . 4.6500000000000004 112.515 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.0 tp -56.86 -41.58 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.375 -0.53 . . . . 1.22 110.272 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.52 -16.7 62.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.266 -0.642 . . . . 1.3100000000000001 109.266 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' TRP . . . . . 0.437 ' O ' HD12 ' C' ' 113' ' ' ILE . 45.8 m0 -88.54 2.77 52.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.315 -0.857 . . . . 1.6799999999999999 111.439 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 39.3 mtp -105.09 -20.51 13.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.168 -0.469 . . . . 1.8 111.245 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.463 ' O ' HD23 ' C' ' 82' ' ' LEU . 14.5 m -113.77 -39.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.3 0.482 . . . . 1.1899999999999999 112.3 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.505 HG23 HG23 ' C' ' 43' ' ' ILE . 57.0 m -70.34 -49.17 52.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.046 0.387 . . . . 1.23 112.046 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 21.5 m -56.52 -52.08 76.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 0.58999999999999997 112.614 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 80' ' ' THR . 11.7 Cg_endo -55.78 -37.53 95.53 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.53 1.487 . . . . 0.67000000000000004 111.736 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.605 HD12 HG13 ' C' ' 39' ' ' VAL . 3.9 mm? -70.33 -32.21 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.95999999999999996 109.746 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -23.28 63.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.488 0.661 . . . . 1.1899999999999999 109.23 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 tp -84.46 -36.51 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.984 -1.007 . . . . 1.7 110.414 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.83 -34.37 73.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.6200000000000001 110.94 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -62.41 -18.52 61.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 1.26 111.081 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 24.0 mt -78.93 -31.88 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 1.1100000000000001 111.027 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -73.63 -32.23 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 1.51 111.076 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -75.1 -42.04 57.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 2.0600000000000001 111.438 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -69.17 -22.44 63.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 1.52 111.001 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.05 -13.87 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 1.3 111.213 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.3 ttm -128.71 100.94 5.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 1.6200000000000001 110.742 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -68.4 -54.47 16.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 3.2400000000000002 111.053 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -112.52 149.85 32.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 4.6299999999999999 111.179 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.86 145.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.163 -0.471 . . . . 2.1800000000000002 110.723 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.8 -71.46 0.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.303 -0.408 . . . . 4.1200000000000001 111.432 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -140.47 29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.501 -0.318 . . . . 4.96 111.591 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -86.92 138.94 31.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.431 -0.35 . . . . 3.9100000000000001 110.876 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -165.84 -22.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 5.21 110.686 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -70.46 -35.09 73.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 1.8200000000000001 111.591 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.59 -42.46 42.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 2.0800000000000001 110.949 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.91 -31.21 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 1.8600000000000001 110.711 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.62 -29.04 45.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.84 -0.695 . . . . 0.58999999999999997 112.346 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -65.76 -35.36 80.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 1.53 110.83 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 75.1 mt -79.53 -44.98 20.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.994 -0.548 . . . . 1.1100000000000001 111.107 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 10.7 tpt -59.62 -35.91 75.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 2.21 111.328 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.7 m -71.81 -58.3 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 1.28 111.283 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 57.6 p -52.41 -31.02 32.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 1.22 111.163 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.481 ' O ' HG12 ' C' ' 113' ' ' ILE . 22.2 tp60 -62.48 -54.13 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 2.3300000000000001 110.556 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -46.78 -39.94 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 115.93 -0.577 . . . . 1.29 111.316 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.78 -46.92 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.0600000000000001 110.855 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.484 HG11 H193 ' C' ' 210' ' ' LYR . 57.0 t -66.59 -32.33 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.51000000000000001 111.156 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.481 HG12 ' O ' ' C' ' 109' ' ' GLN . 44.8 mm -59.23 -41.3 83.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 1.3700000000000001 110.671 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 93.9 m -62.26 -54.63 38.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.833 -0.621 . . . . 0.77000000000000002 111.296 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -54.82 -24.26 22.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 110.899 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.87 -46.9 12.64 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.811 -0.709 . . . . 0.5 112.673 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' C' ' 114' ' ' THR . 4.3 pp -76.79 -21.24 55.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.716 0.293 . . . . 1.47 111.011 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 38.2 mm -83.37 -36.92 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 1.2 111.205 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.95 -32.55 61.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.40000000000000002 111.327 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.39 -23.66 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 2.1200000000000001 110.977 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.14 34.14 0.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 0.75 111.254 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 71.2 m -91.86 119.05 31.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 1.3799999999999999 110.776 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.22 -58.29 2.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 2.7400000000000002 111.137 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.483 ' HB2' HG12 ' C' ' 127' ' ' VAL . 45.4 mtm180 -89.48 157.61 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 2.7999999999999998 110.965 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -84.54 -15.88 44.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.885 -0.598 . . . . 2.4100000000000001 110.88 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 37.6 t-105 -78.74 -38.75 38.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 4.2000000000000002 110.66 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' C' ' 124' ' ' ARG . 7.4 p -80.83 -28.78 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 1.0800000000000001 111.241 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -56.13 -34.61 66.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 2.5699999999999998 111.281 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -73.68 -25.61 60.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 3.8100000000000001 111.019 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.22 -46.1 24.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 1.4199999999999999 110.968 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -64.65 -37.4 87.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.89000000000000001 111.178 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -55.4 -46.67 76.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 1.26 110.906 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.3 -35.08 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 1.6799999999999999 110.865 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.53 -31.27 72.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.842 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -54.02 13.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.736 -0.745 . . . . 0.54000000000000004 112.635 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.45 -37.96 76.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 1.0600000000000001 111.257 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -52.79 -52.44 56.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 1.0800000000000001 110.626 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.9 -30.81 71.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.56999999999999995 110.891 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.58 -24.53 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 1.6799999999999999 110.932 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.76 -52.91 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 1.7 111.491 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.439 HG13 ' N ' ' C' ' 142' ' ' ILE . 24.6 pt -60.31 -43.99 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.528 -0.305 . . . . 0.78000000000000003 111.763 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.439 ' N ' HG13 ' C' ' 141' ' ' ILE . 43.4 pt -67.4 -29.84 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 2.2400000000000002 110.957 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.12 -38.31 85.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.02 111.018 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 3.0 110.835 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' GLY . . . . . 1.161 ' HA2' ' OD1' ' C' ' 148' ' ' ASN . . . -61.07 -44.52 98.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.899 -0.667 . . . . 1.27 112.532 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 146' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' C' ' 149' ' ' PRO . 69.7 mt -66.22 -24.08 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.8899999999999999 110.758 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -88.8 4.74 46.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.6000000000000001 111.134 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 1.161 ' OD1' ' HA2' ' C' ' 145' ' ' GLY . 32.1 m120 -83.2 -46.78 0.82 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.48 . . . . 99.989999999999995 112.116 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 80.6 Cg_exo -45.46 -23.99 1.56 Allowed 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.591 2.194 . . . . 2.73 112.845 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.02 -58.11 9.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.388 -0.369 . . . . 4.2999999999999998 110.604 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 59.45 104.76 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.064 -0.516 . . . . 8.9000000000000004 111.295 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.36 -21.56 63.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 2.7999999999999998 111.051 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -83.29 -13.75 54.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.073 -0.512 . . . . 5.4400000000000004 110.976 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 34.3 m -95.75 -18.48 20.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.293 -0.412 . . . . 3.3900000000000001 111.368 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -64.75 -21.14 66.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 6.9199999999999999 110.999 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 64.8 p -88.51 7.23 34.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 4.8700000000000001 111.182 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -106.62 -68.63 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 4.0499999999999998 110.672 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 51.4 m -115.46 113.67 24.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.758 -0.655 . . . . 3.0299999999999998 110.555 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.6 p -76.63 -22.77 53.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 2.96 111.179 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -76.79 -54.41 6.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 3.7400000000000002 111.036 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 77.2 mt -63.05 -30.74 71.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 2.6499999999999999 110.951 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.77 -62.46 1.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 1.77 111.432 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.79 -22.82 26.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 2.96 110.616 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.7 tp -67.76 -44.35 77.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 2.3500000000000001 110.704 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -81.38 -25.63 36.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 2.6200000000000001 111.045 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.01 -55.24 31.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 2.0899999999999999 111.162 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -72.07 -32.75 67.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 3.2400000000000002 111.339 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.25 -50.79 72.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 1.6899999999999999 111.276 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.06 -29.93 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 1.3999999999999999 111.264 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -53.29 -58.74 6.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.95999999999999996 111.315 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -63.29 -36.15 82.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 3.6499999999999999 110.701 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.6 -22.59 66.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 1.3700000000000001 110.761 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 25.9 m -73.48 -59.0 2.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 1.4299999999999999 111.358 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.6 p -52.39 -30.82 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.394 -0.366 . . . . 1.6200000000000001 111.642 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.405 HD13 ' OG ' ' C' ' 209' ' ' SER . 94.7 mt -72.38 -57.78 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 2.0299999999999998 111.071 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -19.79 65.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.62 111.04 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.49 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 32.6 mm -87.66 -25.4 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.114 0.483 . . . . 1.5800000000000001 110.36 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 178' ' ' GLY . . . . . 0.48 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -65.76 -40.54 95.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.56000000000000005 112.505 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.465 ' O ' HG22 ' C' ' 182' ' ' VAL . 0.3 OUTLIER -55.7 -55.72 37.63 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.592 0.196 . . . . 1.3300000000000001 111.356 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' C' ' 177' ' ' ILE . 67.2 Cg_exo -50.38 -41.06 52.74 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.074 1.849 . . . . 0.63 112.163 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.48 HD12 ' HA2' ' C' ' 178' ' ' GLY . 82.1 mt -49.69 -61.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.137 -0.483 . . . . 0.93000000000000005 111.493 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.465 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.2 m -63.92 -28.15 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 1.27 111.446 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 183' ' ' TRP . . . . . 0.464 ' HZ3' ' HB2' ' C' ' 188' ' ' SER . 20.5 m95 -65.36 -27.83 68.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 1.77 111.053 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 180' ' ' PRO . 89.2 mt -55.15 -32.93 28.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 2.3900000000000001 111.209 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.62 169.98 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 1.95 111.132 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.16 -161.5 31.63 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 1.8799999999999999 112.457 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.05 158.32 23.74 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.562 2.175 . . . . 3.1200000000000001 112.225 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 188' ' ' SER . . . . . 0.464 ' HB2' ' HZ3' ' C' ' 183' ' ' TRP . 54.8 m 56.95 20.68 5.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.091 -0.504 . . . . 2.6299999999999999 110.825 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -169.3 48.33 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.879 -0.677 . . . . 3.04 112.364 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 60.0 t80 60.66 98.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.876 0.369 . . . . 5.6900000000000004 110.908 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 152.44 117.71 0.73 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 3.0800000000000001 112.393 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -86.26 49.31 1.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.799 0.333 . . . . 7.5300000000000002 110.797 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 43.3 mm -124.97 142.99 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 2.8599999999999999 110.96 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -143.22 -100.47 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.329 -0.396 . . . . 3.6899999999999999 110.878 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 195' ' ' GLN . . . . . 0.462 ' HB2' HG22 ' C' ' 197' ' ' ILE . 96.9 mt-30 57.63 -178.56 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.828 0.347 . . . . 5.4800000000000004 111.609 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 81.8 p -74.25 -25.51 59.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 2.3799999999999999 111.302 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 197' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' C' ' 195' ' ' GLN . 12.4 tt -57.89 -42.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 2.23 111.743 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.4 -53.75 54.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.702 0.287 . . . . 2.1600000000000001 111.401 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 59.4 p -58.81 -21.55 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 1.27 111.613 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -73.35 -39.29 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 1.7 111.489 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.89 -51.56 46.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.695 0.283 . . . . 2.02 111.414 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -67.59 -8.15 32.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.531 -0.304 . . . . 1.8200000000000001 111.313 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 10.9 t -95.86 -41.98 8.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.151 0.5 . . . . 1.3500000000000001 110.666 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.7 tp -74.19 -31.99 62.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.65000000000000002 111.904 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.645 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 54.9 tp -61.0 -54.22 56.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.891 -0.324 . . . . 1.4199999999999999 111.624 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 33.7 Cg_exo -59.45 -39.64 74.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.795 1.663 . . . . 0.63 111.189 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.68 -28.72 70.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 1.49 110.464 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -84.45 -19.49 33.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.949 -0.568 . . . . 1.7 110.82 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 209' ' ' SER . . . . . 0.405 ' OG ' HD13 ' C' ' 175' ' ' LEU . 40.6 t -88.29 -12.37 43.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.995 -0.548 . . . . 1.25 110.898 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 210' ' ' LYR . . . . . 0.745 H192 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.19 -35.4 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.981 0.419 . . . . 1.6100000000000001 110.891 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.12 -29.52 72.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.998 -0.62 . . . . 0.81999999999999995 112.535 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -72.6 -36.87 68.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 3.0800000000000001 110.817 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.0 t -59.16 -54.66 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 1.1499999999999999 110.89 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.14 -20.42 65.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.314 -0.403 . . . . 2.5600000000000001 110.856 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -72.08 -47.1 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 1.29 110.695 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.21 -21.01 64.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 2.3900000000000001 110.573 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 64.2 tp -74.14 -54.31 8.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.887 -0.597 . . . . 2.0299999999999998 111.266 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -79.41 -20.29 47.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 3.21 111.234 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.88 12.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.737 -0.744 . . . . 1.3600000000000001 112.585 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' LEU . . . . . 0.44 HD22 ' N ' ' C' ' 221' ' ' LEU . 3.7 mm? -80.51 -56.67 4.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 2.8999999999999999 110.435 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 54.46 77.97 0.18 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.023 -0.535 . . . . 4.8899999999999997 110.974 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -131.82 168.84 17.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.114 -0.494 . . . . 4.2300000000000004 110.879 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 52.2 tp -130.62 105.31 7.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.029 -0.532 . . . . 6.1200000000000001 110.815 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -111.8 122.54 48.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 4.5499999999999998 111.009 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -111.51 -62.86 1.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 6.7800000000000002 110.727 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 33.1 t -131.51 -0.09 3.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 5.4000000000000004 110.65 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -95.42 87.73 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.552 . . . . 8.3300000000000001 110.842 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 7.9100000000000001 111.013 -179.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.903 0.382 . . . . 2.4199999999999999 111.012 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.3 mm? -76.47 -51.91 10.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 2.0899999999999999 110.602 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -70.95 -24.34 62.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 110.478 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.0 t-105 -64.9 -53.07 52.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.79000000000000004 110.685 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.1 mt -66.33 -22.55 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 2.0800000000000001 110.267 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.404 ' HE2' ' HG ' ' A' ' 203' ' ' CYS . 0.1 OUTLIER -57.22 -55.32 36.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 1.28 110.756 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 52' ' ' MET . 10.0 p -66.87 -30.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 1.3200000000000001 111.274 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.43 80.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.63 111.229 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.4 76.36 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.853 -0.689 . . . . 0.55000000000000004 112.626 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.469 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -74.53 -41.75 60.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 1.03 111.497 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -61.83 -48.19 81.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.3 111.187 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -67.03 -22.59 29.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 1.3100000000000001 110.964 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.49 -58.62 12.36 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.872 -0.68 . . . . 0.77000000000000002 112.492 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.21 73.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.072 0.463 . . . . 0.80000000000000004 110.931 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.4 tp -64.48 -33.93 77.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.956 -0.566 . . . . 1.8100000000000001 110.62 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.61 -28.08 66.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.948 -0.569 . . . . 1.8799999999999999 110.42 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -78.2 -29.31 48.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 4.4500000000000002 110.671 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -63.84 -36.06 82.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.524 . . . . 3.6899999999999999 110.818 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -84.68 -42.31 15.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 1.5700000000000001 110.906 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.8 tp -73.22 -3.4 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.89 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 p -64.38 -24.77 67.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.528 -0.306 . . . . 1.3799999999999999 111.334 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -51.09 -31.95 20.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.128 0.489 . . . . 4.0700000000000003 109.784 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p30 -167.88 132.45 1.5 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.454 -0.793 . . . . 2.7200000000000002 110.147 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 28.3 Cg_endo -94.78 173.71 1.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.05 2.5 . . . . 1.9099999999999999 112.277 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.11 56.4 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 4.7599999999999998 111.082 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.75 -45.87 3.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 1.99 112.747 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.3 127.07 80.09 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 120.539 0.209 . . . . 2.7000000000000002 110.942 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 31.7 Cg_exo -57.74 165.18 6.67 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.412 2.075 . . . . 1.79 112.374 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -61.59 -18.21 58.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.747 -0.66 . . . . 4.1200000000000001 112.579 -178.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.446 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 4.8 p90 -47.97 -42.23 27.15 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.688 0.28 . . . . 2.9300000000000002 111.652 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -68.04 -46.56 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.356 . . . . 2.8799999999999999 110.886 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.12 -23.03 66.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.077 -0.51 . . . . 4.6600000000000001 110.833 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.99 -61.23 2.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.176 -0.465 . . . . 1.45 110.659 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.67 -33.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 1.78 110.224 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.31 -4.78 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 0.63 111.105 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.534 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 28.4 ttt -89.38 -39.94 13.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.055 0.455 . . . . 1.48 111.018 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -73.09 -39.33 65.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 3.5 111.883 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 91.4 mt -50.69 -51.59 64.32 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.241 0.46 . . . . 1.0800000000000001 112.241 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 16.6 Cg_exo -68.65 -41.45 6.04 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.494 2.129 . . . . 0.53000000000000003 113.275 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 41' ' ' MET . 36.3 mm -55.06 -63.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.207 0.447 . . . . 1.6799999999999999 112.207 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.53 -58.39 7.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 1.8300000000000001 111.484 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 90.4 p -52.28 -35.97 51.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 1.0900000000000001 111.244 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.74 16.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.885 -0.674 . . . . 0.40999999999999998 112.661 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.56 -35.48 68.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.98999999999999999 110.893 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.8 79.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.47999999999999998 111.397 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -66.01 -59.68 3.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.447 -0.342 . . . . 1.8700000000000001 111.564 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.619 ' HB3' HG11 ' A' ' 12' ' ' VAL . 24.0 ptm -49.01 -31.08 6.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.01 0.433 . . . . 1.49 110.6 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.84 91.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.58999999999999997 110.831 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.9 mtt -56.36 -31.39 63.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.073 -0.512 . . . . 0.48999999999999999 110.505 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.86 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.59999999999999998 110.526 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.49 HD13 HD23 ' B' ' 130' ' ' LEU . 41.4 pt -78.5 3.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 1.3100000000000001 110.963 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.48 30.14 19.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 1.9099999999999999 111.46 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.622 HE22 ' H ' ' B' ' 123' ' ' GLU . 6.4 tp-100 -92.23 142.27 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 1.6200000000000001 110.767 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.34 17.22 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 1.04 112.346 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -127.23 139.67 52.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 2.6800000000000002 110.819 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.85 141.0 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 1.98 110.727 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.87 95.1 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 2.1800000000000002 111.25 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.1 115.81 27.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 1.5700000000000001 110.79 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 30.52 19.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 1.79 111.121 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.33 -2.01 83.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.742 -0.742 . . . . 1.48 112.847 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -105.82 128.95 54.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 2.3199999999999998 110.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 67' ' ' ILE . 4.8 mp -79.38 127.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 1.4399999999999999 111.007 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 139.89 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.81999999999999995 111.069 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 56.5 m-70 -81.29 64.94 6.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.213 0.53 . . . . 0.90000000000000002 110.758 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.89 -50.84 67.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.753 . . . . 1.8300000000000001 111.443 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -25.31 67.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.263 -0.426 . . . . 0.62 111.844 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 34.8 mmt180 -67.52 -52.48 38.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.713 0.635 . . . . 2.3399999999999999 112.713 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.506 ' O ' ' HG3' ' A' ' 77' ' ' MET . 6.3 p90 -75.93 -36.17 59.48 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.27 0.47 . . . . 3.4900000000000002 112.27 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.0 tt -52.93 -46.54 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.775 -0.37 . . . . 1.3700000000000001 110.902 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.482 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.6 t70 -67.45 -22.03 65.52 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.606 -0.516 . . . . 1.3100000000000001 109.606 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -87.87 5.55 39.84 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.527 -0.76 . . . . 1.48 111.522 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 34.4 mtp -104.55 -19.15 14.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 1.46 110.516 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 1.4 p -114.64 -43.8 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 1.1200000000000001 111.972 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.58 HG23 HG23 ' A' ' 43' ' ' ILE . 66.8 m -66.31 -56.09 12.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.409 . . . . 1.1000000000000001 111.961 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 67.9 m -50.77 -53.93 41.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.569 0.581 . . . . 0.59999999999999998 112.569 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 80' ' ' THR . 13.2 Cg_endo -56.28 -38.84 94.39 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.633 1.555 . . . . 0.73999999999999999 111.195 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -30.48 70.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.942 -0.572 . . . . 1.01 109.761 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.1 tp -71.79 -21.79 61.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.275 -0.639 . . . . 1.48 109.275 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.445 HD22 HE21 ' A' ' 109' ' ' GLN . 20.0 tp -84.58 -31.38 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.034 -0.985 . . . . 1.3799999999999999 110.292 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.52 -32.97 64.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.757 -0.656 . . . . 1.1899999999999999 111.032 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.1 p -58.17 -29.02 65.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.234 -0.439 . . . . 1.23 110.758 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.987 -0.551 . . . . 0.88 110.718 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -60.91 -41.86 96.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.951 -0.568 . . . . 1.3899999999999999 110.955 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.84 -29.75 63.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 2.3199999999999998 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.5 m -59.7 -43.39 94.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.46 111.351 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.92 -36.82 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 1.24 111.435 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 82.0 mtp -88.48 98.87 11.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.396 . . . . 2.0699999999999998 111.124 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -82.62 -5.05 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 3.5299999999999998 110.585 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -163.79 157.29 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.843 -0.617 . . . . 4.0800000000000001 110.705 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tp -128.99 142.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 2.1699999999999999 110.98 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.53 -30.74 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 4.5199999999999996 110.941 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.48 138.33 39.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 3.75 111.151 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.6 115.81 4.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 3.5299999999999998 110.869 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.95 149.45 21.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.475 . . . . 4.9100000000000001 111.1 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.2 p -94.82 -20.94 19.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 1.98 110.985 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.0 tp -54.56 -40.73 69.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 1.8300000000000001 111.155 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.85 -38.19 78.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.463 -0.335 . . . . 1.79 111.052 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.63 -28.05 73.23 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 0.62 112.127 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -72.13 -37.07 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.921 0.391 . . . . 1.5800000000000001 110.951 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.16 -36.63 61.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.97999999999999998 111.496 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 81.0 mtp -68.31 -47.61 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.463 -0.335 . . . . 1.48 111.449 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.8 p -60.89 -53.64 54.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 1.1299999999999999 111.45 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -56.66 -31.88 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 1.48 111.498 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.445 HE21 HD22 ' A' ' 84' ' ' LEU . 6.5 tp-100 -66.64 -40.18 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 2.7000000000000002 110.992 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.16 -35.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 1.54 111.096 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -67.93 -36.96 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 1.28 111.359 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.78 -51.1 48.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.42999999999999999 111.484 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.3 pt -59.96 -24.04 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 1.74 110.822 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 17.6 m -67.44 -43.16 81.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.63 110.465 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -68.15 -21.03 64.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.872 -0.604 . . . . 1.0900000000000001 110.461 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.68 -34.03 26.07 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.043 -0.599 . . . . 0.41999999999999998 113.313 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 118' ' ' ILE . 4.1 pp -79.1 -26.89 42.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 1.3799999999999999 111.288 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 tp -83.93 -29.51 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 1.6200000000000001 111.711 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.08 75.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.39000000000000001 111.423 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.65 -19.3 52.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 2.02 111.066 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -90.5 28.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.42 . . . . 0.76000000000000001 111.25 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -61.66 126.28 26.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 1.46 110.907 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.62 -29.7 23.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.305 -0.407 . . . . 3.3500000000000001 111.075 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.41 ' H ' ' CG2' ' A' ' 127' ' ' VAL . 79.0 mtm180 -137.29 167.1 22.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 2.9199999999999999 110.716 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.94 -13.98 59.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 2.77 110.793 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -90.43 -42.18 11.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 3.77 110.835 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.41 ' CG2' ' H ' ' A' ' 124' ' ' ARG . 18.7 m -65.34 -31.01 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.24 -0.436 . . . . 1.1599999999999999 111.261 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -65.35 -23.68 67.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 2.04 110.97 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -78.59 -25.65 45.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 2.6400000000000001 111.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.46 -52.66 7.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.8999999999999999 111.323 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -60.18 -33.49 72.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.3999999999999999 111.708 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HE2' ' HB3' ' A' ' 183' ' ' TRP . 71.8 t80 -59.13 -48.51 81.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 1.28 110.926 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.1 mt -63.6 -32.46 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 2.1600000000000001 111.199 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.75 -34.64 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.364 . . . . 1.6899999999999999 111.043 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.79 -52.16 44.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.749 . . . . 0.52000000000000002 112.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -64.87 -42.24 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.597 0.237 . . . . 1.02 111.381 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.483 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.9 t -55.41 -40.57 71.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 1.0800000000000001 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.86 98.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.62 110.731 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -63.51 -28.32 69.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 1.8400000000000001 111.134 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 137' ' ' CYS . 93.9 mt -63.21 -60.79 2.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 1.6899999999999999 111.221 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.6 -31.83 44.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.302 -0.408 . . . . 0.81000000000000005 111.34 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.4 mt -75.06 -29.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 2.3700000000000001 111.16 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.9 tp -71.68 -44.08 64.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.97999999999999998 110.811 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.538 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 16.5 t90 -67.38 -27.84 67.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 3.27 110.997 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 1.22 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -83.56 -43.16 7.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.795 -0.717 . . . . 1.25 112.627 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 tt -67.61 -16.54 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.063 0.458 . . . . 2.1200000000000001 110.67 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -91.8 3.62 54.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 110.646 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 1.22 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.84 -0.618 . . . . 99.989999999999995 111.844 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.935 0.398 . . . . 2.3399999999999999 110.95 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.41 -24.86 63.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.872 -0.604 . . . . 2.77 111.397 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.43 -24.64 53.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 2.04 111.215 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -84.37 -39.03 19.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 2.77 111.576 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 169' ' ' VAL . 2.9 pp -77.42 -26.43 51.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.512 -0.313 . . . . 1.8899999999999999 111.841 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.499 ' N ' HD12 ' A' ' 168' ' ' LEU . 13.4 p -74.9 -26.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.936 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.6 m -65.43 -58.61 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 1.24 111.387 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.16 -31.39 72.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 2.9700000000000002 110.725 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -59.71 -48.86 79.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 1.48 111.06 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 177' ' ' ILE . 41.3 p -62.05 -37.87 86.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 1.55 111.588 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.81 -38.4 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.756 0.313 . . . . 1.52 111.503 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.528 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.0 mt -74.57 -55.1 6.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 1.8500000000000001 111.395 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.48 -31.35 55.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.62 111.634 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 173' ' ' THR . 17.6 tt -87.66 -22.41 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 1.3500000000000001 110.69 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.65 -51.29 59.78 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 113.391 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 84.6 m-85 -58.17 -54.86 51.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.802 0.301 . . . . 1.45 111.737 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 76.6 Cg_exo -48.72 -30.33 16.55 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.112 1.875 . . . . 0.55000000000000004 112.934 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 177' ' ' ILE . 94.3 mt -70.04 -57.46 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 1.4199999999999999 111.788 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.5 m -59.14 -25.72 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.187 -0.461 . . . . 0.78000000000000003 111.703 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.504 ' HB3' ' HE2' ' A' ' 132' ' ' TYR . 24.4 m95 -65.09 -25.95 68.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.505 -0.316 . . . . 0.93999999999999995 111.091 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -53.03 -26.13 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 1.4299999999999999 110.946 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.7 pt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 2.02 110.892 179.63 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.74 0.305 . . . . 2.48 110.926 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.4 -56.73 12.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 2.1800000000000002 110.572 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 75.6 p -62.67 -18.83 63.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 1.49 110.891 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -83.48 -30.66 27.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 1.77 110.911 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.9 tp -80.84 -45.55 16.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.314 -0.403 . . . . 1.4199999999999999 111.272 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -74.55 -0.7 18.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 1.78 111.15 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.404 ' HG ' ' HE2' ' A' ' 11' ' ' TYR . 37.8 t -96.35 -47.47 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.433 0.635 . . . . 1.3 110.31 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.16 -28.57 64.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.225 -0.898 . . . . 0.66000000000000003 112.138 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.718 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 37.5 tp -67.2 -55.35 15.92 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.748 -0.381 . . . . 1.6299999999999999 111.408 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.9 Cg_exo -54.86 -37.73 92.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.622 1.548 . . . . 0.64000000000000001 111.207 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 211' ' ' VAL . 74.4 t80 -63.98 -45.76 87.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.076 -0.511 . . . . 1.3600000000000001 110.04 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -63.55 -17.79 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 1.54 110.554 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.528 ' OG ' HD13 ' A' ' 175' ' ' LEU . 16.1 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 1.2 111.045 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 207' ' ' PHE . 18.3 m . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.736 0.303 . . . . 1.6399999999999999 111.494 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.41 80.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.757 -0.735 . . . . 0.79000000000000004 112.685 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -75.58 -33.18 60.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.6100000000000001 111.223 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.3 m -60.99 -60.69 3.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.429 -0.351 . . . . 1.1499999999999999 110.996 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.04 -26.9 67.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 3.3399999999999999 110.951 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.94 -55.45 33.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.374 -0.375 . . . . 1.1899999999999999 111.392 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.19 -34.31 71.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 2.23 111.285 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.32 -52.23 62.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 2.4700000000000002 111.264 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -83.6 -20.72 33.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.336 -0.393 . . . . 1.6200000000000001 111.123 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.17 -59.15 10.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.887 -0.673 . . . . 1.4099999999999999 112.885 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 52.6 tp . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.596 0.236 . . . . 2.5800000000000001 111.049 -179.721 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.712 0.291 . . . . 2.0699999999999998 111.226 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.81 -53.61 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 2.1000000000000001 110.782 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 77.3 m-70 -65.63 -24.26 67.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.152 -0.476 . . . . 1.0700000000000001 110.782 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -67.18 -50.29 61.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.48 110.836 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.7 -20.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 2.02 110.331 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -61.82 -56.01 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.908 -0.587 . . . . 0.92000000000000004 110.594 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -66.26 -28.45 43.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.075 -0.511 . . . . 0.93999999999999995 111.26 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.08 98.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.55000000000000004 111.254 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.06 -29.27 59.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.762 -0.732 . . . . 0.47999999999999998 112.59 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.48 -39.63 62.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 0.84999999999999998 111.229 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 32.0 p -62.1 -51.12 69.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.468 -0.333 . . . . 1.3400000000000001 110.833 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.05 -23.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 1.55 110.943 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.87 -56.16 24.22 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.873 -0.679 . . . . 0.69999999999999996 112.667 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.87 81.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.81000000000000005 110.932 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.04 -32.31 73.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 2.2599999999999998 110.829 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.58 -28.21 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.78 110.46 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -81.57 -30.17 33.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.992 -0.549 . . . . 4.5800000000000001 110.689 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -60.91 -37.23 81.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.839 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.7 p -83.87 -40.54 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 1.5800000000000001 110.892 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.74 -3.87 40.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 1.8400000000000001 110.61 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 58.5 p -61.0 -23.31 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 1.3700000000000001 111.384 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -49.8 -31.42 11.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.255 0.55 . . . . 4.9800000000000004 109.841 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.487 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 8.3 p30 -173.33 132.29 0.6 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.256 -0.884 . . . . 2.1400000000000001 109.992 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 36.0 Cg_endo -94.52 174.23 1.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.691 2.261 . . . . 1.8200000000000001 112.311 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.48 54.58 2.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 5.1900000000000004 111.255 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.62 -35.58 2.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 2.2000000000000002 112.872 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -79.09 130.27 70.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.603 0.239 . . . . 3.6499999999999999 111.199 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.18 166.5 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.896 2.397 . . . . 2.6699999999999999 113.021 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -70.55 -18.32 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.466 -0.788 . . . . 4.8799999999999999 112.96 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -62.24 -24.47 67.27 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.373 -0.531 . . . . 1.8700000000000001 111.367 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.9 -55.95 8.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 2.6800000000000002 110.339 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -67.31 -21.57 65.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 2.9199999999999999 110.739 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 64.0 tp -59.49 -63.52 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 1.6399999999999999 110.717 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.14 -35.57 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.378 . . . . 1.6000000000000001 110.63 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.8 -5.48 41.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.68999999999999995 111.091 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' B' ' 45' ' ' ILE . 53.5 ttp -88.94 -40.92 12.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.422 . . . . 2.5800000000000001 110.711 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -69.95 -32.76 71.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 3.3900000000000001 111.651 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.581 HG23 HG23 ' B' ' 79' ' ' THR . 87.2 mt -55.58 -54.2 53.97 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.234 0.457 . . . . 0.40999999999999998 112.234 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.449 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.8 Cg_endo -70.14 -31.46 18.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.182 1.921 . . . . 0.48999999999999999 113.342 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 41' ' ' MET . 38.0 mm -61.32 -62.37 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.615 0.245 . . . . 1.29 111.599 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.412 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.7 OUTLIER -57.81 -58.28 9.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 1.3999999999999999 111.164 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -54.71 -31.26 57.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.3799999999999999 111.025 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.8 -60.51 8.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 0.37 112.881 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 42.5 mt -60.14 -28.59 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 1.29 111.252 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -49.69 65.7 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.347 -0.388 . . . . 0.44 111.452 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 20.4 m-85 -63.61 -46.29 86.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.5 111.156 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . 0.488 ' HB2' HG11 ' B' ' 12' ' ' VAL . 59.7 ttp -48.04 -38.69 17.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.157 0.503 . . . . 1.4099999999999999 110.374 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.93 96.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.55000000000000004 110.92 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 51.2 mtt -52.89 -30.96 37.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.88 -0.6 . . . . 0.5 110.553 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -70.04 -47.4 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.54000000000000004 110.602 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mt -76.8 -1.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.797 -0.638 . . . . 1.3 111.004 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.97 52.14 2.14 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.919 -0.582 . . . . 2.2400000000000002 111.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -115.69 169.32 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 1.77 110.965 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.64 9.99 79.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.814 -0.708 . . . . 1.0600000000000001 112.493 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -117.77 141.8 48.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 2.6600000000000001 110.93 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.62 138.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 1.8899999999999999 111.044 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.32 94.61 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 2.4100000000000001 111.115 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.54 115.84 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.5600000000000001 111.048 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.59 31.45 20.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 1.8200000000000001 111.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.19 84.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.714 -0.755 . . . . 1.51 112.522 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -115.03 124.48 51.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 2.4500000000000002 110.845 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.74 136.28 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 1.79 110.65 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.47 140.58 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.96 0.41 . . . . 0.81999999999999995 111.109 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 50.9 m-70 -84.16 55.89 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 1.05 110.649 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.442 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.7 t80 -58.52 -58.11 10.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.603 -0.726 . . . . 1.8700000000000001 111.679 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.55 -22.31 66.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.60999999999999999 111.974 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.452 ' HB3' ' HB3' ' B' ' 69' ' ' HIS . 14.0 tpp180 -63.52 -51.48 65.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.023 0.379 . . . . 2.3900000000000001 112.023 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 12.9 p90 -77.4 -29.07 52.94 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.87 -0.332 . . . . 3.6699999999999999 111.279 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.442 HG12 ' O ' ' B' ' 70' ' ' TYR . 21.1 mm -51.36 -53.21 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.806 0.336 . . . . 1.6599999999999999 110.682 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.49 -21.49 66.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.082 -0.508 . . . . 1.4099999999999999 109.982 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . 0.434 ' O ' HD12 ' B' ' 113' ' ' ILE . 44.4 m0 -86.98 -0.14 56.11 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.958 -0.565 . . . . 1.1599999999999999 111.371 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 55.3 ttm -103.63 -18.64 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.512 . . . . 1.53 110.989 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.403 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.2 m -114.09 -31.01 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.085 0.402 . . . . 0.89000000000000001 112.085 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.581 HG23 HG23 ' B' ' 43' ' ' ILE . 48.0 m -80.82 -50.57 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.844 0.313 . . . . 1.24 111.844 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 28.8 m -53.95 -51.53 76.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.257 0.466 . . . . 0.57999999999999996 112.257 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.3 Cg_endo -56.85 -33.18 94.14 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.733 1.622 . . . . 0.66000000000000003 111.333 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.403 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.6 mm? -75.96 -29.96 58.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.963 -0.562 . . . . 1.0600000000000001 110.132 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 15.5 tp -70.23 -21.48 63.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.315 0.579 . . . . 1.22 109.527 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.639 HD22 ' HG3' ' B' ' 109' ' ' GLN . 2.3 tp -84.86 -44.01 13.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.217 -0.901 . . . . 1.53 110.394 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.66 -35.49 72.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.43 -0.805 . . . . 1.5800000000000001 111.074 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 97.9 p -57.49 -32.6 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 1.3899999999999999 110.898 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.459 HD22 HD21 ' B' ' 168' ' ' LEU . 62.3 mt -64.37 -36.79 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 1.1499999999999999 110.925 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -65.11 -34.95 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 1.5700000000000001 110.986 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -73.74 -38.6 64.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 2.1699999999999999 111.126 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 82.2 p -69.26 -23.32 63.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 1.4199999999999999 111.384 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.57 -13.59 21.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 1.1799999999999999 111.147 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 44.7 tpp -127.2 106.36 9.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 1.8799999999999999 110.778 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -67.62 -59.46 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 3.4199999999999999 110.954 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -128.37 137.67 52.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 4.0599999999999996 110.914 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.27 142.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 2.0899999999999999 111.171 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -129.77 -23.31 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.8500000000000001 110.431 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -142.36 141.46 32.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 4.8200000000000003 110.688 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.04 119.1 12.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 3.7999999999999998 111.047 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -84.7 162.72 19.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.48 . . . . 5.1699999999999999 111.002 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 78.9 p -108.61 -22.23 12.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 2.02 111.019 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.76 -29.14 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 2.0899999999999999 110.698 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.7 pt -64.15 -28.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 1.8799999999999999 110.864 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.45 -39.34 22.43 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.813 -0.708 . . . . 0.56000000000000005 112.547 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -67.75 -22.87 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 1.78 110.705 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' B' ' 84' ' ' LEU . 77.2 mt -81.91 -46.22 14.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 1.03 111.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . 0.404 ' O ' HG12 ' B' ' 110' ' ' ILE . 53.5 ttp -67.09 -30.31 70.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.005 -0.543 . . . . 1.6699999999999999 110.91 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 64.0 m -73.63 -52.89 11.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 1.51 111.435 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -56.8 -28.24 61.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 1.1799999999999999 111.443 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.639 ' HG3' HD22 ' B' ' 84' ' ' LEU . 26.3 mm-40 -69.81 -44.11 70.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.753 0.311 . . . . 2.1699999999999999 110.56 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.404 HG12 ' O ' ' B' ' 106' ' ' MET . 46.2 mm -54.64 -32.69 25.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.989 0.423 . . . . 1.3500000000000001 110.459 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.03 -42.38 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.886 -0.597 . . . . 1.3400000000000001 110.835 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.76 -46.66 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.42999999999999999 111.266 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.434 HD12 ' O ' ' B' ' 76' ' ' TRP . 37.4 mm -60.91 -33.24 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 1.6000000000000001 111.088 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.471 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 25.0 m -60.19 -45.43 93.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.85999999999999999 111.044 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 76.5 p -68.63 -20.77 64.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.94999999999999996 110.512 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.07 -35.94 26.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.0 -0.619 . . . . 0.46000000000000002 113.264 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.532 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.6 pp -76.82 -29.37 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.74 0.305 . . . . 1.75 111.409 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.532 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.85 -27.13 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 1.78 111.565 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.88 -39.71 68.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.38 111.27 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -82.41 -25.39 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 1.97 111.148 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -86.26 34.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.76000000000000001 111.157 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 71.4 p -65.99 125.26 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.47 110.863 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.622 ' H ' HE22 ' A' ' 58' ' ' GLN . 23.3 mm-40 -89.02 -22.63 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 2.5 111.036 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' B' ' 127' ' ' VAL . 99.8 mtt180 -137.6 160.21 39.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 2.73 110.772 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.9 -15.65 60.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.121 -0.491 . . . . 2.2000000000000002 110.652 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -92.7 -41.55 10.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 3.3999999999999999 111.024 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' B' ' 124' ' ' ARG . 18.6 m -64.0 -24.63 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 1.23 111.112 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.92 -42.27 85.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 3.04 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.66 -30.85 71.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 4.1399999999999997 110.975 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.49 HD23 HD13 ' A' ' 56' ' ' ILE . 59.7 tp -74.84 -53.63 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 1.6499999999999999 111.285 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -61.15 -24.77 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.305 . . . . 0.77000000000000002 111.362 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -67.52 -58.79 4.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.476 -0.329 . . . . 1.46 111.402 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.3 -22.55 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.472 -0.331 . . . . 1.6299999999999999 111.317 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.36 -36.42 68.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 1.4199999999999999 110.728 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.91 -51.28 47.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.48999999999999999 112.09 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.09 -43.2 98.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 1.3 110.923 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.4 -40.49 74.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.294 -0.412 . . . . 1.3 110.167 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.62 110.395 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -71.54 -24.02 61.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 1.74 110.669 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.84 -57.64 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 1.76 110.953 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 37.2 pt -59.2 -35.29 56.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.335 -0.393 . . . . 0.68999999999999995 111.282 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.96 -26.49 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 1.76 110.688 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.68 -39.58 73.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 1.0600000000000001 110.965 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -73.74 -30.73 62.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 4.1200000000000001 111.084 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.38 -33.96 24.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.776 -0.726 . . . . 1.26 112.635 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 tt -73.91 -21.36 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 1.98 110.471 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -90.78 4.15 52.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 1.4199999999999999 111.006 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 111.945 -179.597 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 C--O 1.233 0.186 0 CA-C-O 121.017 0.437 . . . . 2.4300000000000002 110.813 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.434 ' O ' HG23 ' B' ' 169' ' ' VAL . 2.3 t80 -75.21 -23.04 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.909 -0.587 . . . . 2.5800000000000001 111.314 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.26 -54.64 22.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.92 0.39 . . . . 2.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.99 -30.51 71.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 3.0299999999999998 111.112 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.459 HD21 HD22 ' B' ' 87' ' ' LEU . 54.4 tp -68.76 -54.91 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 1.1000000000000001 111.313 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 165' ' ' TYR . 91.9 t -61.96 -29.86 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.75 111.536 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.8 m -53.48 -58.99 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.97999999999999998 111.538 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.64 -29.02 65.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.347 -0.388 . . . . 4.2999999999999998 110.665 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.44 -34.32 77.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 1.3899999999999999 111.319 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.412 ' O ' HG22 ' B' ' 177' ' ' ILE . 41.3 p -76.23 -38.99 55.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.372 -0.376 . . . . 1.1100000000000001 111.512 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.96 -34.44 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.819 0.342 . . . . 1.51 111.041 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' B' ' 209' ' ' SER . 53.4 tp -77.87 -55.68 5.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 1.75 111.024 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -30.71 43.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.59999999999999998 111.006 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.443 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.3 tp -87.82 -23.38 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.002 0.429 . . . . 1.47 110.417 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.17 -55.29 29.0 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.55000000000000004 113.311 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.636 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 92.6 m-85 -56.19 -55.75 38.62 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.896 0.348 . . . . 1.6200000000000001 111.296 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -46.87 -27.77 6.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.172 1.915 . . . . 0.64000000000000001 112.826 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.443 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -74.24 -58.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 1.27 111.715 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.43 HG22 ' O ' ' B' ' 179' ' ' TYR . 26.0 m -58.67 -24.69 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.68999999999999995 111.67 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -63.91 -26.99 68.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.55 -0.296 . . . . 1.1799999999999999 111.246 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 85.5 mt -52.1 -29.52 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.558 -0.292 . . . . 1.77 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 43.4 pt -126.72 155.61 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 1.6899999999999999 111.191 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 C-N-CA 120.917 -0.659 . . . . 1.5800000000000001 112.667 179.79 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.774 0.321 . . . . 2.4700000000000002 111.019 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.15 -56.85 14.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.165 -0.47 . . . . 2.5299999999999998 110.85 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 44.6 p -68.96 -20.02 64.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 1.29 111.301 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.29 -32.93 55.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 2.6200000000000001 111.333 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.46 -43.53 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 1.6100000000000001 111.355 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.66 -9.33 56.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 1.4199999999999999 111.845 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 19.3 p -96.6 -38.03 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 1.4299999999999999 110.597 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 56.1 tp -72.38 -31.69 65.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.692 -0.685 . . . . 1.1200000000000001 112.073 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.8 tp -65.7 -53.91 33.05 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.951 -0.299 . . . . 1.26 111.266 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.8 Cg_exo -54.91 -42.49 68.47 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.785 1.657 . . . . 0.59999999999999998 111.864 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.83 -38.11 89.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 1.3999999999999999 110.684 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.24 -24.36 65.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 1.4099999999999999 110.682 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.545 ' HB2' HD22 ' B' ' 175' ' ' LEU . 86.1 p . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.3200000000000001 111.252 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.634 0.254 . . . . 1.6899999999999999 111.57 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.7 -29.19 74.57 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.79 -0.719 . . . . 0.79000000000000004 112.885 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -74.01 -39.08 63.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.621 0.248 . . . . 2.96 111.358 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' B' ' 218' ' ' LEU . 49.8 m -58.41 -57.65 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.462 -0.335 . . . . 1.29 111.038 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . 0.44 ' HA ' HD12 ' B' ' 218' ' ' LEU . 85.6 t80 -63.29 -23.43 67.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 3.1499999999999999 111.094 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -64.2 -56.87 11.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 1.51 111.495 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.74 -33.88 70.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 2.1899999999999999 111.637 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' B' ' 215' ' ' PHE . 87.1 mt -55.29 -50.49 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 1.98 111.063 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.66 -20.53 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.1699999999999999 110.908 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.59 -55.03 25.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.853 -0.689 . . . . 1.3600000000000001 113.084 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 C--N 1.326 -0.44 0 CA-C-O 120.704 0.288 . . . . 2.8999999999999999 111.432 -179.382 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.949 0.404 . . . . 2.52 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . 0.441 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.3 mm? -70.34 -45.38 66.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 1.9299999999999999 110.929 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 64.2 m-70 -71.83 -24.35 61.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 1.26 110.7 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.44 ' O ' HG12 ' C' ' 12' ' ' VAL . 61.9 t-105 -66.91 -53.72 29.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 1.6699999999999999 110.564 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -64.9 -21.8 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.99 0.424 . . . . 1.8700000000000001 110.291 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . 0.433 ' HE2' ' HG ' ' C' ' 203' ' ' CYS . 0.1 OUTLIER -57.29 -59.51 5.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.601 -0.727 . . . . 1.4399999999999999 110.5 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' C' ' 52' ' ' MET . 8.4 p -61.59 -30.86 49.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.013 -0.54 . . . . 0.46999999999999997 110.967 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.06 78.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.313 -0.403 . . . . 0.58999999999999997 111.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.62 -23.77 77.61 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.688 -0.767 . . . . 0.5 112.834 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.6 mmt -77.52 -45.2 26.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.68000000000000005 111.33 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.9 p -59.29 -50.03 75.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.354 -0.384 . . . . 1.3999999999999999 110.997 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -30.88 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 1.55 110.666 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.72 -60.22 9.39 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.877 -0.677 . . . . 0.70999999999999996 112.589 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -30.86 63.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.812 0.339 . . . . 0.77000000000000002 111.007 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.67 -33.14 70.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.9299999999999999 110.648 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -60.71 -31.21 70.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 1.8600000000000001 110.52 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -74.45 -29.93 61.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.994 -0.548 . . . . 4.1399999999999997 110.793 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -62.82 -39.02 93.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 3.1499999999999999 110.761 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -84.47 -39.09 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 1.95 110.865 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 tp -74.54 -9.21 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 2.2200000000000002 110.72 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 53.9 p -58.16 -24.92 60.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 1.3700000000000001 111.309 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -48.14 -33.53 8.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.204 0.526 . . . . 5.0300000000000002 109.794 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.7 p-10 -171.08 132.46 0.86 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.276 -0.874 . . . . 2.3700000000000001 109.794 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 19.5 Cg_endo . . . . . 0 N--CA 1.453 -0.876 0 C-N-CA 122.732 2.288 . . . . 2.0499999999999998 112.214 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 19.2 Cg_exo . . . . . 0 N--CA 1.466 -0.121 0 CA-C-O 121.261 0.442 . . . . 1.9299999999999999 112.197 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.7 -18.67 64.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 4.1200000000000001 112.965 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.521 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -55.13 -36.74 66.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.969 0.414 . . . . 2.8900000000000001 110.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.73 -48.93 72.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 2.46 110.734 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.06 -19.05 62.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 2.7799999999999998 110.695 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.88 -63.42 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 1.6200000000000001 110.435 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.33 -32.09 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 1.5900000000000001 110.836 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.67 -6.32 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.65000000000000002 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.442 ' O ' HG12 ' C' ' 45' ' ' ILE . 53.7 ttp -89.83 -43.46 10.62 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.978 -0.556 . . . . 1.6699999999999999 111.392 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -73.07 -39.51 65.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.142 0.423 . . . . 3.4199999999999999 112.142 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.565 HG23 HG23 ' C' ' 79' ' ' THR . 96.6 mt -50.64 -50.6 71.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.255 0.465 . . . . 0.89000000000000001 112.255 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.6 -36.14 6.97 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.113 1.875 . . . . 0.40999999999999998 113.142 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' C' ' 41' ' ' MET . 28.9 mm -57.41 -62.74 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.821 0.343 . . . . 1.76 111.469 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -56.56 -57.12 13.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 2.1600000000000001 111.241 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 47.1 m -51.96 -36.45 49.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 1.1699999999999999 111.134 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.71 -53.02 38.34 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 0.44 112.486 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.402 ' O ' ' HG3' ' C' ' 52' ' ' MET . 4.2 mm? -59.67 -35.92 75.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.414 . . . . 1.29 111.002 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -34.15 75.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.5 111.444 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.3 m-85 -70.6 -57.58 4.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 1.8300000000000001 111.542 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . 0.58 ' HB3' HG11 ' C' ' 12' ' ' VAL . 5.0 ppp? -48.74 -30.72 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.89 0.376 . . . . 1.47 110.707 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.9 80.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.59999999999999998 110.826 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 58.0 mtt -54.54 -30.8 54.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.124 -0.489 . . . . 0.83999999999999997 110.546 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.59 -50.62 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 111.133 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.37 5.94 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 1.55 111.186 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.3 54.94 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 1.54 111.106 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.506 HE21 HD11 ' A' ' 118' ' ' ILE . 57.5 tp60 -123.69 139.64 53.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 1.79 111.028 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.63 -7.66 29.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.804 -0.713 . . . . 0.93999999999999995 112.664 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -103.04 166.14 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.712 0.291 . . . . 2.3599999999999999 110.944 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.73 145.91 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.97 110.998 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -93.51 95.11 9.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.144 -0.48 . . . . 2.4399999999999999 110.953 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.42 107.37 19.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 1.54 111.136 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 33.24 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 1.71 111.389 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.65 2.1 88.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 1.53 112.606 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -102.44 152.23 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 2.23 110.942 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 33.2 mt -105.54 114.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 1.3600000000000001 110.833 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.12 142.42 27.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.78000000000000003 111.547 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.488 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 47.6 m-70 -84.24 58.81 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.884 -0.598 . . . . 1.0800000000000001 110.478 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . 0.495 ' O ' HG12 ' C' ' 74' ' ' ILE . 69.8 t80 -58.69 -58.53 8.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.535 -0.757 . . . . 2.2999999999999998 111.938 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.85 67.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.204 0.446 . . . . 0.75 112.204 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.7 tpp180 -61.64 -51.63 67.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.919 0.34 . . . . 1.51 111.919 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.443 ' O ' ' HG3' ' C' ' 77' ' ' MET . 14.0 p90 -78.13 -28.42 48.45 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.844 -0.342 . . . . 4.6500000000000004 111.039 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.495 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.4 mm -47.31 -56.74 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 120.744 0.307 . . . . 1.22 110.907 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.35 -28.78 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.268 -0.424 . . . . 1.3100000000000001 110.129 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -81.4 8.02 10.31 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.085 -0.507 . . . . 1.6799999999999999 111.172 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.551 ' HA ' HD13 ' C' ' 113' ' ' ILE . 18.9 mtp -104.52 -25.22 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 1.8 110.458 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.44 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 24.7 m -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 1.1899999999999999 111.979 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.565 HG23 HG23 ' C' ' 43' ' ' ILE . 85.1 m -67.12 -58.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.065 0.394 . . . . 1.23 112.065 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 12.6 m -47.94 -52.43 40.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.58999999999999997 112.043 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 63.3 Cg_exo -51.95 -44.4 45.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.822 1.681 . . . . 0.67000000000000004 111.794 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 98.6 mt -66.02 -32.89 74.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 0.95999999999999996 110.555 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -31.69 64.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 1.1899999999999999 109.766 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.471 HD11 ' NE2' ' C' ' 109' ' ' GLN . 19.8 mt -77.83 -44.83 26.15 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.7 110.112 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -50.38 -42.0 52.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.446 -0.797 . . . . 1.6200000000000001 110.384 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.412 ' O ' HG23 ' C' ' 90' ' ' THR . 43.2 t -57.62 -34.23 69.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 1.26 110.945 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 40.7 mt -65.39 -36.74 84.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 1.1100000000000001 111.359 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 69.2 p -69.64 -26.19 64.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 1.51 110.95 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -80.58 -34.83 35.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 2.0600000000000001 111.153 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . 0.412 HG23 ' O ' ' C' ' 86' ' ' SER . 66.6 p -67.87 -26.68 66.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 1.52 111.049 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.65 -44.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 1.3 111.101 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.02 105.62 17.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 1.6200000000000001 111.092 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -80.47 -12.09 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 3.2400000000000002 110.828 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -162.7 137.44 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 4.6299999999999999 110.557 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.8 tt -108.23 144.49 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 2.1800000000000002 111.17 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -131.72 -25.85 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 4.1200000000000001 110.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -146.17 137.58 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 4.96 110.38 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.63 124.45 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 3.9100000000000001 111.326 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -92.84 162.4 14.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 5.21 110.98 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -103.58 -21.42 13.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 1.8200000000000001 110.705 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.413 HD22 ' N ' ' C' ' 101' ' ' LEU . 3.8 mm? -60.3 -31.75 70.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 2.0800000000000001 110.67 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -62.15 -33.15 57.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 1.8600000000000001 110.932 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.08 -27.51 60.02 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.861 -0.685 . . . . 0.58999999999999997 112.098 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -64.84 -39.78 94.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.892 0.377 . . . . 1.53 110.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.88 -50.09 25.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.1100000000000001 111.126 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . 0.412 ' O ' HG13 ' C' ' 110' ' ' ILE . 12.6 tpt -56.88 -41.58 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.785 -0.643 . . . . 2.21 111.514 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t -66.38 -59.38 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 1.28 111.156 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.501 ' HB ' HD12 ' C' ' 142' ' ' ILE . 42.9 p -53.6 -26.4 21.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.22 111.326 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.471 ' NE2' HD11 ' C' ' 84' ' ' LEU . 6.9 tp-100 -68.17 -47.98 66.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 2.3300000000000001 110.923 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.412 HG13 ' O ' ' C' ' 106' ' ' MET . 49.3 mt -55.26 -31.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 1.29 110.635 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.24 -45.74 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.814 -0.63 . . . . 1.0600000000000001 111.118 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.2 -47.77 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.125 -0.489 . . . . 0.51000000000000001 111.079 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.551 HD13 ' HA ' ' C' ' 77' ' ' MET . 60.6 mt -57.53 -35.7 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 1.3700000000000001 110.848 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 18.3 m -57.15 -45.88 83.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.062 0.458 . . . . 0.77000000000000002 110.695 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . 0.447 ' HA ' HG22 ' C' ' 118' ' ' ILE . 62.9 m -69.25 -23.22 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 1.1899999999999999 110.798 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.31 -32.67 42.25 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.983 -0.627 . . . . 0.5 113.048 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.491 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.4 pp -82.54 -28.51 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 1.47 111.396 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.491 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.7 tp -83.92 -26.23 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 1.2 111.483 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.1 70.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.4 . . . . 0.40000000000000002 111.258 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -84.89 -12.96 52.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 2.1200000000000001 110.802 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.43 ' HB2' HD12 ' C' ' 118' ' ' ILE . 96.0 mt -95.88 26.6 3.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.75 111.192 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 67.5 m -65.16 122.24 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.356 . . . . 1.3799999999999999 110.876 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -86.62 -17.04 34.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 2.7400000000000002 110.916 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . 0.434 ' HB2' HG13 ' C' ' 127' ' ' VAL . 98.5 mtt180 -137.01 169.14 18.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 2.7999999999999998 110.946 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.88 -17.13 38.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 2.4100000000000001 110.814 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -90.88 -39.19 12.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 4.2000000000000002 110.549 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' C' ' 124' ' ' ARG . 27.3 m -63.69 -26.91 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 1.0800000000000001 111.117 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -66.53 -34.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.973 -0.558 . . . . 2.5699999999999998 110.994 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -73.87 -27.02 60.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 3.8100000000000001 110.839 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.08 -41.61 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 1.4199999999999999 111.227 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -71.72 -31.04 66.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.89000000000000001 111.052 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -63.69 -58.72 6.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 1.26 110.817 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.08 -29.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.402 . . . . 1.6799999999999999 111.041 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.12 -38.62 88.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 1.24 110.892 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.84 -54.47 21.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.898 -0.668 . . . . 0.54000000000000004 112.604 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.56 -30.67 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.618 0.247 . . . . 1.0600000000000001 111.236 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.38 -47.65 83.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 1.0800000000000001 110.514 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.52 -30.16 71.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.56999999999999995 110.861 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.6 -20.51 61.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 1.6799999999999999 110.586 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.48 -55.67 5.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 1.7 111.028 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 36.2 pt -58.79 -35.92 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.356 -0.384 . . . . 0.78000000000000003 111.891 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.501 HD12 ' HB ' ' C' ' 108' ' ' THR . 17.6 tt -75.94 -23.71 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 2.2400000000000002 111.114 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.13 -48.33 73.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.361 -0.381 . . . . 1.02 110.764 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -68.62 -32.89 73.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 3.0 110.761 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.38 -39.51 61.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 1.27 112.452 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -75.21 -19.93 16.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.161 0.505 . . . . 1.8899999999999999 110.36 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -88.87 3.0 52.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.586 -0.734 . . . . 1.6000000000000001 110.383 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 99.989999999999995 111.96 -179.324 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.948 0.404 . . . . 2.3500000000000001 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.24 -22.95 63.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 2.6200000000000001 111.138 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 -38.9 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.333 -0.394 . . . . 2.0899999999999999 110.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -81.72 -23.47 36.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 3.2400000000000002 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.47 -41.02 41.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 1.6899999999999999 111.254 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.42 -24.49 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 1.3999999999999999 111.377 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . 0.434 ' O ' HG23 ' C' ' 174' ' ' VAL . 38.9 m -59.64 -58.88 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.95999999999999996 111.309 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -67.89 -31.86 71.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 3.6499999999999999 110.766 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.0 -38.51 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 1.3700000000000001 111.639 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.432 ' O ' HG22 ' C' ' 177' ' ' ILE . 38.7 p -73.21 -33.78 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.426 -0.352 . . . . 1.4299999999999999 111.657 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 170' ' ' THR . 62.5 t -60.93 -37.11 76.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.555 -0.293 . . . . 1.6200000000000001 111.773 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.25 -45.5 16.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 2.0299999999999998 111.344 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . 0.404 ' CZ2' HD21 ' C' ' 84' ' ' LEU . 0.9 OUTLIER -57.77 -31.79 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.464 -0.335 . . . . 0.62 110.691 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.434 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.2 tt -87.96 -20.64 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.5800000000000001 110.211 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.49 -56.72 23.58 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.753 -0.658 . . . . 0.56000000000000005 113.407 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.636 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 87.8 m-85 -54.21 -54.42 47.97 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.755 0.278 . . . . 1.3300000000000001 111.437 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.9 Cg_exo -47.09 -30.9 10.88 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.139 1.892 . . . . 0.63 112.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.499 ' O ' HG12 ' C' ' 184' ' ' ILE . 88.2 mt -70.7 -60.49 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.93000000000000005 111.639 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.491 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.6 m -56.18 -24.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.407 0.521 . . . . 1.27 112.407 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -65.69 -17.4 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.429 0.529 . . . . 1.77 112.429 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.586 HG13 HG23 ' C' ' 185' ' ' ILE . 22.5 pt -65.67 -13.19 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.659 0.266 . . . . 2.3900000000000001 111.563 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . 0.586 HG23 HG13 ' C' ' 184' ' ' ILE . 31.0 pt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.424 -0.353 . . . . 1.95 111.28 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.1 m . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.829 0.347 . . . . 2.3799999999999999 110.807 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 46.9 mm -72.49 -48.26 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 2.23 111.279 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.3 -51.96 64.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 2.1600000000000001 111.077 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 87.7 m -64.72 -25.16 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 1.27 111.424 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -82.47 -27.68 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 1.7 111.696 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.87 -48.29 10.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.636 0.255 . . . . 2.02 111.402 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -69.17 1.44 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 1.8200000000000001 111.211 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.433 ' HG ' ' HE2' ' C' ' 11' ' ' TYR . 51.2 t -96.27 -48.8 5.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 1.3500000000000001 110.7 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.8 -30.57 65.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.65000000000000002 111.95 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.659 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 44.6 tp -62.19 -54.62 48.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 120.966 -0.293 . . . . 1.4199999999999999 111.49 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 46.3 Cg_exo -57.3 -41.8 69.21 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.65 1.566 . . . . 0.63 111.516 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.42 -32.01 73.32 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.273 -0.421 . . . . 1.49 110.502 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.75 -25.2 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 1.7 110.839 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 1.25 111.012 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.8 0.333 . . . . 1.6100000000000001 111.479 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.04 -31.65 81.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.74 -0.743 . . . . 0.81999999999999995 112.656 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -75.2 -29.16 60.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.781 0.324 . . . . 3.0800000000000001 111.08 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -63.78 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 1.1499999999999999 111.065 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -62.71 -23.26 67.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 2.5600000000000001 110.977 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.73 -47.37 85.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.971 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -66.78 -35.41 80.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.414 -0.357 . . . . 2.3900000000000001 111.003 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.31 -43.28 88.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 2.0299999999999998 111.01 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -87.44 -19.92 27.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 3.21 110.94 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.69 31.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.993 -0.622 . . . . 1.3600000000000001 113.08 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.555 0.217 . . . . 2.8999999999999999 111.417 -179.354 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.857 0.361 . . . . 2.4199999999999999 110.808 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.36 -42.86 99.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.147 -0.479 . . . . 2.0899999999999999 110.971 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 25.6 m170 -62.94 -35.88 81.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 1.1599999999999999 110.779 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -69.04 -52.47 28.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.79000000000000004 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.0 mt -56.19 -34.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.007 0.432 . . . . 2.0800000000000001 110.407 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.493 ' O ' ' HG2' ' A' ' 15' ' ' MET . 20.1 t80 -57.45 -42.15 81.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 1.28 109.826 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 8' ' ' HIS . 3.1 t -57.25 -48.38 82.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.3200000000000001 111.229 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.06 -44.95 83.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.63 111.681 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.31 94.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.55000000000000004 112.705 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 56.0 mmm -69.16 -32.92 72.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 1.03 110.992 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -60.83 -60.33 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 1.3 111.449 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -57.2 -26.1 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.348 -0.387 . . . . 1.3100000000000001 111.268 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -59.49 -48.55 85.44 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.571 -0.823 . . . . 0.77000000000000002 112.328 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.05 -23.22 63.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 0.80000000000000004 111.01 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.32 -44.13 84.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 1.8100000000000001 110.921 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.94 -20.93 60.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.8799999999999999 110.997 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.83 -48.19 80.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 4.4500000000000002 110.891 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.506 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.1 m-90 -71.55 -35.52 70.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 3.6899999999999999 110.88 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.0 m -70.47 -20.65 62.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 1.5700000000000001 111.333 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 tp -86.18 -10.63 54.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 1.95 111.117 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 52.3 p -65.4 -23.05 66.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.385 -0.37 . . . . 1.3799999999999999 111.152 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -47.07 -32.69 4.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.261 0.553 . . . . 4.0700000000000003 109.699 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -174.18 132.45 0.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.092 -0.958 . . . . 2.7200000000000002 110.216 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -92.47 140.8 2.12 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.777 2.318 . . . . 1.9099999999999999 112.07 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -81.28 72.83 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 4.7599999999999998 111.601 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.76 -46.9 3.19 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.106 -0.568 . . . . 1.99 113.435 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.37 140.52 21.71 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.792 0.296 . . . . 2.7000000000000002 111.222 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.44 165.56 12.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.552 2.168 . . . . 1.79 112.131 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 5.2 pm0 -63.5 -18.6 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 4.1200000000000001 112.233 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -48.09 -36.29 12.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.754 0.311 . . . . 2.9300000000000002 111.317 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.11 -53.33 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.909 0.385 . . . . 2.8799999999999999 110.461 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -68.27 -18.45 64.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 4.6600000000000001 110.669 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.08 -52.87 63.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.189 -0.459 . . . . 1.45 110.406 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 t -65.85 -36.78 78.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.155 0.502 . . . . 1.78 109.795 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.38 -8.37 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.623 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.476 ' O ' HG12 ' A' ' 45' ' ' ILE . 22.4 ttt -88.68 -36.98 15.9 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.2 -0.454 . . . . 1.48 110.746 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -67.99 -32.8 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 3.5 111.222 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 79' ' ' THR . 68.5 mt -56.88 -55.01 48.12 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.307 0.484 . . . . 1.0800000000000001 112.307 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 36.7 Cg_endo -65.38 -33.94 45.8 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.295 1.996 . . . . 0.53000000000000003 113.442 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 41' ' ' MET . 38.8 mm -55.26 -62.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.881 0.326 . . . . 1.6799999999999999 111.881 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.454 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.8 t90 -66.06 -47.89 72.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 1.8300000000000001 110.981 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -61.81 -9.79 7.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 1.0900000000000001 111.238 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.31 -59.53 2.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.40999999999999998 112.134 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.36 -26.95 65.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 0.98999999999999999 110.704 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -51.52 69.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.47999999999999998 110.79 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 27.7 m-85 -69.65 -26.36 64.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 1.8700000000000001 110.938 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -56.42 -36.78 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.514 -0.55 . . . . 1.49 109.514 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -73.16 -44.15 60.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.538 -0.755 . . . . 0.58999999999999997 110.85 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.443 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 51.6 mtt -51.5 -26.48 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.48999999999999999 110.597 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.11 -47.28 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.59999999999999998 111.211 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -84.18 14.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 1.3100000000000001 111.545 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 57.31 55.76 5.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.027 -0.533 . . . . 1.9099999999999999 111.223 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 16.8 mm-40 -125.22 173.01 9.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 1.6200000000000001 110.716 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.45 66.48 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.593 -0.813 . . . . 1.04 112.155 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.75 173.98 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 2.6800000000000002 110.709 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.12 132.49 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 1.98 111.355 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -101.23 88.54 3.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 2.1800000000000002 110.625 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.06 131.72 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.5700000000000001 111.2 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 27.71 17.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.066 -0.515 . . . . 1.79 111.408 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.24 -11.27 37.9 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.713 -0.756 . . . . 1.48 112.643 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -97.87 149.74 22.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.34 . . . . 2.3199999999999998 110.899 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.3 mt -94.15 117.33 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 1.4399999999999999 110.939 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.26 144.83 30.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.81999999999999995 111.233 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.3 m-70 -88.68 68.89 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.90000000000000002 110.958 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.15 -35.71 75.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 1.8300000000000001 111.102 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -73.46 -24.19 60.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.62 111.971 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.7 tpp180 -69.29 -51.71 34.59 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.335 0.494 . . . . 2.3399999999999999 112.335 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -81.23 -31.1 34.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.207 0.447 . . . . 3.4900000000000002 112.207 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 71' ' ' ALA . 10.6 tp -57.53 -43.91 83.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.762 -0.375 . . . . 1.3700000000000001 110.537 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 74' ' ' ILE . 13.3 t70 -68.85 -20.3 64.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.498 -0.556 . . . . 1.3100000000000001 109.498 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -87.7 1.22 54.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.672 -0.694 . . . . 1.48 111.169 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.411 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 56.6 ttm -104.61 -18.71 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 1.46 110.915 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 82' ' ' LEU . 30.0 m -114.11 -32.06 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 1.1200000000000001 111.904 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 43' ' ' ILE . 27.9 m -82.9 -41.38 18.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.898 0.333 . . . . 1.1000000000000001 111.898 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 72.4 m -60.19 -50.27 86.86 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.945 0.35 . . . . 0.59999999999999998 111.945 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 44.9 Cg_exo -56.69 -32.92 92.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.074 1.849 . . . . 0.73999999999999999 112.437 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 78' ' ' VAL . 7.3 mp -82.94 -16.97 45.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.115 -0.493 . . . . 1.01 110.845 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -72.91 -47.03 49.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 1.48 109.948 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 85' ' ' LEU . 3.6 pp -74.92 -29.47 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.555 . . . . 1.3799999999999999 110.988 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 84' ' ' LEU . 9.7 tp -64.03 -36.47 84.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.018 -0.537 . . . . 1.1899999999999999 110.798 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -61.94 -24.41 66.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 1.23 110.554 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.68 -34.01 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.88 110.793 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.5 p -71.28 -28.42 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 1.3899999999999999 110.52 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.86 -26.82 29.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.3199999999999998 110.985 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -81.37 -25.7 36.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.244 -0.435 . . . . 1.46 110.966 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.5 -35.24 12.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.277 -0.419 . . . . 1.24 111.263 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 71.4 mtm -118.18 111.1 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 2.0699999999999998 111.144 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.75 -24.45 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 3.5299999999999998 110.69 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -137.12 141.03 42.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 4.0800000000000001 110.659 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.7 pt -128.39 143.95 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 2.1699999999999999 111.407 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.917 -0.583 . . . . 4.5199999999999996 110.606 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.42 52.45 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.467 . . . . 3.75 110.992 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -135.29 93.69 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 3.5299999999999998 110.858 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -71.65 80.5 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 4.9100000000000001 111.097 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.4 m -120.6 -60.56 1.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.324 -0.398 . . . . 1.98 111.179 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.29 -58.84 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 1.8300000000000001 111.081 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.2 tt -56.55 -36.38 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 1.79 111.24 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.15 -30.63 73.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.62 112.809 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.3 -48.95 75.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.745 0.307 . . . . 1.5800000000000001 110.991 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.97 -43.66 98.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.97999999999999998 111.506 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.412 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 89.4 mtp -56.43 -39.68 73.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 1.48 111.666 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.2 m -71.7 -45.67 61.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.959 0.409 . . . . 1.1299999999999999 111.204 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.419 ' HB ' HD13 ' A' ' 142' ' ' ILE . 68.2 p -64.85 -20.28 66.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 1.48 111.618 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 110' ' ' ILE . 3.0 pt20 -77.76 -41.49 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.586 0.231 . . . . 2.7000000000000002 110.796 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.67 HG22 ' HE1' ' C' ' 46' ' ' TRP . 43.2 mt -61.2 -33.05 54.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.947 0.403 . . . . 1.54 110.807 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.17 -47.88 76.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.916 -0.584 . . . . 1.28 111.219 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.85 -44.07 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.223 -0.444 . . . . 0.42999999999999999 111.457 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 109' ' ' GLN . 74.8 mt -54.77 -40.28 51.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.776 0.322 . . . . 1.74 110.864 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 117' ' ' LEU . 99.0 m -60.15 -39.79 87.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.63 110.913 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -57.72 -57.31 13.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 1.0900000000000001 110.123 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.8 -14.25 65.01 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.985 -0.626 . . . . 0.41999999999999998 112.199 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 114' ' ' THR . 10.0 tt -70.29 -56.41 6.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 1.3799999999999999 110.724 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.432 ' HB ' ' NE1' ' A' ' 131' ' ' TRP . 67.1 mt -83.73 -22.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.004 -0.543 . . . . 1.6200000000000001 111.563 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HA ' ' HD1' ' A' ' 131' ' ' TRP . . . -49.7 -40.13 39.26 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.849 0.357 . . . . 0.39000000000000001 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.73 -21.48 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.02 110.479 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.3 mt -91.87 31.87 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.76000000000000001 110.775 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 t -88.02 128.14 35.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 1.46 110.634 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.59 -69.77 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 3.3500000000000001 111.282 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.683 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.6 ttp180 -74.4 136.94 42.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 2.9199999999999999 111.06 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.67 -9.88 58.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 2.77 111.181 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.683 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 64.1 t-105 -80.2 -46.65 15.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 3.77 110.804 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HB ' HH21 ' A' ' 124' ' ' ARG . 13.3 p -77.19 -23.99 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 1.1599999999999999 111.448 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -56.88 -32.09 65.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 2.04 111.396 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -72.05 -25.24 61.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 2.6400000000000001 111.342 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.551 HD23 HG21 ' C' ' 56' ' ' ILE . 30.8 tp -83.49 -48.18 10.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.538 -0.301 . . . . 1.8999999999999999 111.32 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.432 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 50.4 t-105 -59.88 -28.13 67.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 1.3999999999999999 110.626 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.29 -44.33 79.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 1.28 110.666 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.48 -29.22 44.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 2.1600000000000001 110.815 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 69.2 m -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 1.6899999999999999 110.717 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.8 -56.89 12.43 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.52000000000000002 112.465 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 m -56.25 -33.17 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 1.02 111.092 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.2 t -61.69 -37.08 82.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 1.0800000000000001 110.465 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.18 93.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.802 -0.635 . . . . 0.62 110.625 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.4 -14.88 58.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 1.8400000000000001 110.518 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 140' ' ' LEU . 0.5 OUTLIER -65.85 -56.91 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 1.6899999999999999 110.162 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.9 pt -66.27 -37.47 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.81000000000000005 110.839 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.419 HD13 ' HB ' ' A' ' 108' ' ' THR . 96.6 mt -65.97 -35.96 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 2.3700000000000001 110.801 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.52 -43.49 93.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.97999999999999998 110.339 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.675 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 88.3 t90 -64.49 -28.61 69.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.596 . . . . 3.27 110.434 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 1.372 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -80.25 -33.34 32.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 1.25 112.456 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.54 -24.71 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 2.1200000000000001 110.443 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -88.89 5.05 45.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.863 -0.608 . . . . 1.6599999999999999 111.057 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 1.372 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 99.989999999999995 112.283 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.752 0.31 . . . . 2.3399999999999999 110.998 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.422 ' O ' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -79.45 -31.17 42.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.525 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.54 -44.01 97.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 2.04 111.0 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.4 -19.72 38.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 2.77 111.479 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 42.7 tp -80.65 -39.96 26.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.978 0.362 . . . . 1.8899999999999999 111.978 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 165' ' ' TYR . 14.8 p -75.37 -31.23 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.361 0.504 . . . . 1.6399999999999999 112.361 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 174' ' ' VAL . 6.4 t -57.79 -44.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.712 0.291 . . . . 1.24 111.369 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.4 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 74.5 m-85 -77.09 -28.12 54.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.749 0.309 . . . . 2.9700000000000002 110.612 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -65.56 -46.49 79.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.51 . . . . 1.48 111.216 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -64.11 -40.31 95.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 1.55 111.51 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 170' ' ' THR . 84.4 t -57.52 -35.32 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.804 0.335 . . . . 1.52 111.217 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 73.0 mt -74.26 -57.56 3.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.391 -0.368 . . . . 1.8500000000000001 111.434 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.63 -25.93 54.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.62 111.181 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.469 ' O ' HG12 ' A' ' 181' ' ' ILE . 31.1 mm -87.7 -27.38 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 1.3500000000000001 110.272 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.92 -53.88 34.26 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.58999999999999997 113.172 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.668 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 80.4 m-85 -56.42 -57.24 24.39 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.884 0.342 . . . . 1.45 111.495 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.668 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 86.0 Cg_exo -44.4 -30.36 3.73 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.215 1.943 . . . . 0.55000000000000004 112.96 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -68.19 -58.31 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 1.4199999999999999 111.405 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 179' ' ' TYR . 21.3 m -59.94 -24.96 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.78000000000000003 111.614 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -70.27 -22.69 62.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.531 -0.304 . . . . 0.93999999999999995 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 92.4 mt -56.35 -41.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.4299999999999999 111.424 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 27.9 pt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.42 -0.354 . . . . 2.02 111.392 -179.85 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.665 0.269 . . . . 2.48 111.269 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.77 -60.97 2.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 2.1800000000000002 111.081 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 8.2 t -61.8 -22.29 65.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 1.49 111.461 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.51 -32.32 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 1.77 110.942 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 40.9 tp -83.99 -42.58 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.4199999999999999 111.577 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -70.16 0.35 6.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.751 -0.204 . . . . 1.78 111.458 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.19 -45.65 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.202 0.525 . . . . 1.3 110.466 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.53 -34.04 67.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 0.66000000000000003 111.92 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.691 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 55.1 tp -59.8 -54.6 54.01 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.855 -0.338 . . . . 1.6299999999999999 111.2 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 46.6 Cg_exo -57.63 -35.53 98.8 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.629 1.553 . . . . 0.64000000000000001 111.094 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.416 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 55.4 t80 -60.31 -31.88 70.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.119 -0.491 . . . . 1.3600000000000001 110.018 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -82.22 -19.16 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 1.54 110.591 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 1.2 110.806 -179.928 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.736 0.303 . . . . 1.6399999999999999 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.66 -34.98 71.63 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.897 -0.668 . . . . 0.79000000000000004 112.763 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -71.21 -35.19 71.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.639 0.257 . . . . 1.6100000000000001 111.226 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 40.5 t -55.93 -58.2 8.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 1.1499999999999999 110.873 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -66.97 -20.44 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.3399999999999999 110.821 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -67.2 -58.66 4.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.1899999999999999 110.815 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 -28.3 64.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 2.23 110.969 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.21 -45.53 84.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.192 -0.458 . . . . 2.4700000000000002 110.742 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -77.42 -28.25 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 1.6200000000000001 110.754 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.42 -23.34 68.37 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 1.4099999999999999 112.185 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 2.5800000000000001 110.737 179.86 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.823 0.344 . . . . 2.0699999999999998 110.815 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.452 HD12 HD11 ' B' ' 10' ' ' ILE . 24.4 tp -70.51 -39.44 74.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 2.1000000000000001 111.219 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.6 m80 -71.52 -31.19 66.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0700000000000001 110.86 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -65.33 -57.97 7.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 1.48 111.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.452 HD11 HD12 ' B' ' 7' ' ' LEU . 35.8 pt -55.38 -31.37 27.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.584 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -59.66 -36.36 76.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.621 -0.718 . . . . 0.92000000000000004 109.672 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' B' ' 52' ' ' MET . 3.2 t -66.93 -49.86 70.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.93999999999999995 111.047 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.64 69.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.55000000000000004 111.653 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.28 83.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.639 -0.791 . . . . 0.47999999999999998 112.422 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -76.43 -34.56 58.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.625 0.25 . . . . 0.84999999999999998 111.573 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -62.63 -49.38 75.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.722 0.296 . . . . 1.3400000000000001 111.467 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.439 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -61.55 -36.0 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 1.55 110.683 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -49.75 56.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.728 -0.749 . . . . 0.69999999999999996 112.847 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.74 65.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 0.81000000000000005 111.474 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.93 -36.15 75.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 2.2599999999999998 110.971 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -63.28 -21.55 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 1.78 110.515 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -60.8 -40.83 94.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 4.5800000000000001 110.864 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -73.18 -41.89 63.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 3.3500000000000001 111.004 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 77.7 p -71.12 -19.5 62.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 1.5800000000000001 111.466 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.95 -7.85 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 1.8400000000000001 111.265 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 89.8 p -69.54 -22.48 63.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.482 -0.326 . . . . 1.3700000000000001 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -47.51 -36.41 10.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.292 0.568 . . . . 4.9800000000000004 109.774 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.4 p-10 -171.84 132.35 0.77 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 2.1400000000000001 109.988 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 55.5 Cg_endo -94.86 154.35 1.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.96 2.44 . . . . 1.8200000000000001 112.24 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -85.13 63.5 8.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 5.1900000000000004 110.912 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.78 -39.79 2.22 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.765 -0.731 . . . . 2.2000000000000002 112.508 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.56 129.0 35.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.381 0.134 . . . . 3.6499999999999999 111.142 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 32.2 Cg_exo -57.69 160.88 13.53 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.29 1.993 . . . . 2.6699999999999999 111.854 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.49 -18.06 57.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.788 -0.642 . . . . 4.8799999999999999 112.517 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' B' ' 38' ' ' LEU . 2.9 p90 -46.78 -36.74 7.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.938 0.399 . . . . 1.8700000000000001 111.046 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -66.82 -47.32 72.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 2.6800000000000002 110.231 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -70.58 -18.78 62.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 2.9199999999999999 110.489 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 58.1 tp -60.96 -53.61 55.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 1.6399999999999999 110.006 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.18 -37.13 78.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 110.307 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' B' ' 43' ' ' ILE . . . -72.33 -6.84 46.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.596 -0.729 . . . . 0.68999999999999995 110.94 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.423 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 24.8 ttt -88.79 -39.78 13.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.203 -0.453 . . . . 2.5800000000000001 110.981 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' B' ' 45' ' ' ILE . 25.1 t80 -69.74 -34.13 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 3.3900000000000001 111.516 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.458 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 76.6 mt -52.15 -54.28 43.0 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.988 0.366 . . . . 0.40999999999999998 111.988 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 48.0 Cg_endo -68.62 -32.09 25.04 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.158 1.905 . . . . 0.48999999999999999 112.883 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' B' ' 42' ' ' PHE . 96.1 mt -56.3 -60.12 2.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.657 0.265 . . . . 1.29 111.538 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.648 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -63.71 -55.26 24.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.517 -0.311 . . . . 1.3999999999999999 111.204 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 90.2 p -54.74 -25.97 31.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 1.3799999999999999 111.294 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.93 7.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.711 -0.757 . . . . 0.37 112.429 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -32.09 68.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 1.29 110.837 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.93 -53.53 57.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.57 . . . . 0.44 111.244 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -71.53 -23.26 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.385 . . . . 0.5 111.143 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . 0.48 ' HA ' HG21 ' B' ' 12' ' ' VAL . 15.0 tmm? -57.72 -36.89 72.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.304 0.573 . . . . 1.4099999999999999 109.466 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.33 -39.68 38.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.779 . . . . 0.55000000000000004 110.778 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.9 mtt -53.89 -24.29 15.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.032 -0.531 . . . . 0.5 110.188 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -82.21 -47.95 11.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.853 -0.612 . . . . 0.54000000000000004 110.822 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mt -80.94 10.93 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 1.3 111.166 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.419 ' HA ' ' NZ ' ' B' ' 60' ' ' LYS . 20.0 t70 60.54 65.23 1.08 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.982 -0.554 . . . . 2.2400000000000002 111.172 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -146.66 150.78 36.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 1.77 111.291 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.99 -22.43 29.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.654 . . . . 1.0600000000000001 112.697 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' B' ' 57' ' ' ASP . 22.0 pttm -103.8 143.15 33.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 2.6600000000000001 111.154 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.82 151.63 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.8899999999999999 111.229 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.11 107.39 18.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 2.4100000000000001 110.778 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.33 127.68 53.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.23 -0.441 . . . . 1.5600000000000001 111.256 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.48 37.34 23.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.059 -0.519 . . . . 1.8200000000000001 111.079 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.78 -0.68 42.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.843 -0.694 . . . . 1.51 112.432 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -101.3 139.53 36.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 2.4500000000000002 110.638 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.03 102.47 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 1.79 111.199 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.15 133.9 37.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.81999999999999995 111.073 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 74.6 m-70 -78.66 74.97 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.166 0.508 . . . . 1.05 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.444 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 62.1 t80 -64.47 -30.02 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.611 -0.722 . . . . 1.8700000000000001 111.255 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -79.66 -28.14 40.81 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.181 0.437 . . . . 0.60999999999999999 112.181 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.535 HH21 ' HB ' ' B' ' 199' ' ' THR . 34.2 mmt180 -67.95 -51.64 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.603 0.594 . . . . 2.3900000000000001 112.603 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.459 ' O ' ' HG3' ' B' ' 77' ' ' MET . 5.9 p90 -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.231 0.456 . . . . 3.6699999999999999 112.231 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.433 HG23 ' N ' ' B' ' 75' ' ' ASP . 10.3 tp -54.74 -43.23 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 120.846 -0.341 . . . . 1.6599999999999999 110.802 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.433 ' N ' HG23 ' B' ' 74' ' ' ILE . 26.9 t70 -68.95 -21.64 64.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.474 -0.565 . . . . 1.4099999999999999 109.474 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 19.4 m0 -87.07 6.25 33.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.472 -0.786 . . . . 1.1599999999999999 110.908 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 28.2 mtp -104.91 -23.3 13.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.077 -0.51 . . . . 1.53 110.748 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.18 -33.64 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.56 0.578 . . . . 0.89000000000000001 112.56 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.438 HG23 HG23 ' B' ' 43' ' ' ILE . 34.8 m -76.83 -47.26 21.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.192 0.441 . . . . 1.24 112.192 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 34.6 m -56.5 -51.31 82.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.154 0.427 . . . . 0.57999999999999996 112.154 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 54.3 Cg_exo -52.62 -41.86 65.99 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.921 1.748 . . . . 0.66000000000000003 112.065 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.62 -29.58 62.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 1.0600000000000001 110.638 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.35 -28.75 68.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.117 0.484 . . . . 1.22 110.205 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' B' ' 105' ' ' LEU . 5.9 tt -84.37 -38.75 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 1.53 110.296 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.44 -33.37 73.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.914 -0.585 . . . . 1.5800000000000001 110.625 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 99.5 p -59.39 -24.1 63.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 1.3899999999999999 110.715 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.419 ' HA ' HG22 ' B' ' 90' ' ' THR . 46.6 mt -76.03 -27.43 57.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 1.1499999999999999 110.909 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 52.0 m -75.94 -31.18 58.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 1.5700000000000001 111.163 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.06 -37.27 39.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 2.1699999999999999 111.297 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.419 HG22 ' HA ' ' B' ' 87' ' ' LEU . 8.8 t -73.88 -23.54 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.458 -0.337 . . . . 1.4199999999999999 111.422 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.08 -36.22 12.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 1.1799999999999999 111.252 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -116.52 120.24 38.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.889 0.376 . . . . 1.8799999999999999 111.068 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.98 -27.33 39.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 3.4199999999999999 110.562 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -137.94 148.14 44.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.795 -0.639 . . . . 4.0599999999999996 110.613 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' HD12 ' B' ' 95' ' ' ILE . 4.3 mp -131.95 144.56 36.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.372 -0.376 . . . . 2.0899999999999999 111.064 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -101.18 162.67 12.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 3.8500000000000001 110.863 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.47 91.64 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 4.8200000000000003 110.913 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -147.53 -43.05 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 3.7999999999999998 111.075 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 85.9 m95 54.78 65.25 1.55 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 5.1699999999999999 110.867 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 79.7 p -117.87 -58.23 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 2.02 110.804 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 60.3 tp -71.67 -51.55 22.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 2.0899999999999999 110.712 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.95 -47.37 89.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.977 -0.556 . . . . 1.8799999999999999 111.154 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.4 -33.8 77.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.896 -0.669 . . . . 0.56000000000000005 112.675 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -65.58 -40.28 92.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 1.78 110.866 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.523 ' HB3' HD21 ' B' ' 84' ' ' LEU . 28.8 mt -71.43 -40.72 70.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 1.03 111.201 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 85.9 mtp -58.27 -53.39 58.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 1.6699999999999999 111.221 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 44.0 t -58.35 -39.94 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 1.51 111.128 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.512 HG21 HG21 ' B' ' 142' ' ' ILE . 91.8 m -60.71 -37.93 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 1.1799999999999999 111.286 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.499 ' NE2' HG22 ' B' ' 80' ' ' THR . 16.1 mm100 -64.72 -46.92 80.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 2.1699999999999999 111.31 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.454 HG22 ' HE1' ' A' ' 46' ' ' TRP . 62.3 mt -53.04 -35.03 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.323 -0.399 . . . . 1.3500000000000001 111.262 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.65 -51.35 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.3400000000000001 111.342 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.75 -49.6 82.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.42999999999999999 111.489 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' B' ' 77' ' ' MET . 71.9 mt -52.83 -36.87 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.358 -0.383 . . . . 1.6000000000000001 111.329 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 49.5 m -60.09 -48.3 82.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.85999999999999999 111.237 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 35.9 m -64.94 -21.11 66.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.94999999999999996 111.124 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.27 14.3 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.821 -0.705 . . . . 0.46000000000000002 113.262 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.1 pp -76.24 -27.91 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.87 -0.194 . . . . 1.75 111.507 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.452 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.53 -31.55 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.682 0.277 . . . . 1.78 111.424 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.4 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 0.38 111.013 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.66 -30.24 46.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 1.97 111.007 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.63 14.28 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.76000000000000001 111.267 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 46.6 t -75.36 120.77 21.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 1.47 110.817 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.41 -72.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 2.5 111.025 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.579 ' HB2' HG12 ' B' ' 127' ' ' VAL . 79.3 mtp180 -62.71 140.72 58.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 2.73 110.513 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.92 -19.31 52.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 2.2000000000000002 111.466 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -78.17 -35.03 49.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 3.3999999999999999 111.215 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -81.67 -23.74 9.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.341 -0.391 . . . . 1.23 111.095 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -56.35 -32.92 65.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.13 -0.487 . . . . 3.04 111.037 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -75.27 -19.51 59.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 4.1399999999999997 111.417 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 99.3 mt -78.85 -54.89 5.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 1.6499999999999999 110.97 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -39.98 76.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.77000000000000002 111.334 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -53.01 -45.4 67.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 1.46 111.156 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -71.93 -28.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 1.6299999999999999 111.288 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 76.2 m -68.77 -39.45 80.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 1.4199999999999999 111.176 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.31 -50.8 48.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.8 -0.714 . . . . 0.48999999999999999 112.457 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.97 -29.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 1.3 110.752 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.49 -47.05 87.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.645 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.46 -29.79 71.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.451 . . . . 0.62 110.622 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' B' ' 143' ' ' LEU . 82.2 t80 -75.13 -25.24 58.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 1.74 110.747 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.58 -56.84 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.76 111.476 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.461 HG13 ' N ' ' B' ' 142' ' ' ILE . 23.5 pt -56.17 -44.07 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.68999999999999995 111.128 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.512 HG21 HG21 ' B' ' 108' ' ' THR . 46.5 mm -67.85 -29.31 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.76 110.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' B' ' 139' ' ' PHE . 0.5 OUTLIER -55.37 -50.96 68.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 1.0600000000000001 110.348 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -62.36 -37.55 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 4.1200000000000001 110.666 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.98 -35.58 92.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 1.26 112.514 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 142' ' ' ILE . 98.3 mt -69.17 -27.18 33.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.871 0.367 . . . . 1.98 110.831 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -88.68 4.46 47.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.199 -0.455 . . . . 1.4199999999999999 111.185 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.044 -0.525 . . . . 99.989999999999995 111.841 -179.403 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 121.067 0.461 . . . . 2.4300000000000002 110.761 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.72 -23.48 61.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 2.5800000000000001 111.076 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.21 -55.0 28.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.339 -0.391 . . . . 2.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -78.43 -24.19 46.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 3.0299999999999998 111.383 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.4 tp -68.78 -43.5 75.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 1.1000000000000001 111.311 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.41 -22.31 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 1.75 111.34 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.0 m -62.55 -58.83 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.97999999999999998 111.478 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.84 -34.81 79.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.304 -0.407 . . . . 4.2999999999999998 110.98 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.1 -36.25 74.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 1.3899999999999999 111.048 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.4 ' O ' HG22 ' B' ' 177' ' ' ILE . 66.2 m -69.97 -41.35 74.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 1.1100000000000001 111.095 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.91 -37.07 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.474 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.4 mt -72.5 -56.14 5.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 1.75 111.344 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -31.58 63.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.59999999999999998 111.51 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.437 ' O ' HG13 ' B' ' 181' ' ' ILE . 16.2 tt -87.57 -20.79 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.43 . . . . 1.47 110.566 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.44 -50.57 65.48 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.824 -0.626 . . . . 0.55000000000000004 112.911 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.665 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 67.1 m-85 -58.18 -57.02 29.07 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.773 0.286 . . . . 1.6200000000000001 111.538 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 88.1 Cg_exo -45.95 -31.7 8.62 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.906 1.737 . . . . 0.64000000000000001 112.876 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 177' ' ' ILE . 98.0 mt -66.25 -56.85 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 1.27 111.567 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.0 m -61.63 -25.32 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.68999999999999995 111.546 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -68.92 -18.36 64.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 1.1799999999999999 111.467 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.52 -34.68 66.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.521 -0.309 . . . . 1.77 111.142 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.25 162.36 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.323 . . . . 1.6899999999999999 111.329 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.716 . . . . 1.5800000000000001 112.721 179.792 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.804 0.335 . . . . 2.4700000000000002 111.077 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.96 -56.13 25.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 2.5299999999999998 110.974 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . 0.535 ' HB ' HH21 ' B' ' 72' ' ' ARG . 64.8 p -65.43 -34.52 78.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 1.29 111.157 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.96 -36.0 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 2.6200000000000001 111.144 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.53 -41.78 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.342 -0.39 . . . . 1.6100000000000001 111.495 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -74.63 0.45 15.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.523 -0.308 . . . . 1.4199999999999999 111.345 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.9 t -96.52 -45.03 6.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.206 0.526 . . . . 1.4299999999999999 110.526 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 45.1 tp -72.11 -39.37 68.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.422 -0.808 . . . . 1.1200000000000001 111.918 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.671 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 45.4 tp -55.77 -54.47 51.47 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.953 -0.299 . . . . 1.26 111.33 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.5 Cg_exo -56.11 -41.45 76.64 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.822 1.681 . . . . 0.59999999999999998 111.175 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.457 ' O ' HG12 ' B' ' 211' ' ' VAL . 66.1 t80 -55.2 -37.07 66.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.167 -0.469 . . . . 1.3999999999999999 109.844 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -79.89 -24.27 41.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 1.4099999999999999 110.433 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.84 -0.618 . . . . 1.3200000000000001 111.204 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.457 HG12 ' O ' ' B' ' 207' ' ' PHE . 9.0 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.807 0.336 . . . . 1.6899999999999999 111.135 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 216' ' ' LEU . . . -59.2 -28.07 63.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.79000000000000004 112.24 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -76.77 -30.16 56.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.751 0.31 . . . . 2.96 110.551 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -63.74 -60.58 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.29 110.685 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.02 -26.47 67.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 3.1499999999999999 110.853 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' B' ' 212' ' ' GLY . 6.4 tt -65.33 -50.05 67.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 1.51 110.743 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.406 ' O ' ' HG ' ' B' ' 221' ' ' LEU . 16.5 t70 -63.02 -24.98 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 2.1899999999999999 110.945 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 56.9 tp -71.75 -33.24 68.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 1.98 111.139 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -88.18 -29.19 20.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.43 -0.35 . . . . 2.1699999999999999 111.149 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.52 -20.9 61.92 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.795 -0.717 . . . . 1.3600000000000001 112.433 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 217' ' ' ASP . 77.6 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.654 0.264 . . . . 2.8999999999999999 110.606 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.54 0.21 . . . . 2.52 110.951 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 tp -65.18 -47.67 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 1.9299999999999999 110.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.611 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 25.0 m170 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.26 110.745 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -75.21 -41.16 58.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 1.6699999999999999 110.417 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.09 -20.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.281 0.562 . . . . 1.8700000000000001 110.176 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.29 -50.91 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.461 -0.79 . . . . 1.4399999999999999 110.724 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.46999999999999997 111.257 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.03 85.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.58999999999999997 111.231 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -30.73 73.73 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.856 -0.687 . . . . 0.5 112.747 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.7 mmt -73.04 -28.92 62.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.977 0.418 . . . . 0.68000000000000005 110.839 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.8 m -66.55 -52.91 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 1.3999999999999999 110.917 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . 0.521 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -63.28 -24.18 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.55 110.913 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.72 -47.34 89.88 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.714 -0.755 . . . . 0.70999999999999996 112.259 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.98 65.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.77000000000000002 111.064 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.7 mt -68.09 -30.96 70.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.361 -0.382 . . . . 1.9299999999999999 110.745 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -65.04 -21.25 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 1.8600000000000001 110.812 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.32 -45.13 89.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 4.1399999999999997 110.851 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -71.6 -32.8 68.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 3.1499999999999999 111.228 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 75.2 m -78.09 -23.32 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 1.95 111.291 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 tp -87.3 -2.76 58.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.404 -0.362 . . . . 2.2200000000000002 110.863 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 71.2 p -70.97 -24.13 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 1.3700000000000001 111.109 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -48.85 -32.74 9.31 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.284 0.564 . . . . 5.0300000000000002 109.952 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.2 p-10 -173.79 132.18 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 2.3700000000000001 109.761 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 43.8 Cg_endo . . . . . 0 N--CA 1.453 -0.892 0 C-N-CA 122.772 2.315 . . . . 2.0499999999999998 112.367 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 36.0 Cg_exo . . . . . 0 CA--C 1.527 0.16 0 CA-C-O 120.952 0.313 . . . . 1.9299999999999999 112.132 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -60.04 -18.4 46.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 4.1200000000000001 112.541 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.431 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.7 p90 -50.75 -36.19 35.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.789 0.328 . . . . 2.8900000000000001 111.131 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.7 -53.68 43.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 2.46 110.484 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.5 -20.51 66.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 2.7799999999999998 110.719 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.76 -52.11 66.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 1.6200000000000001 110.198 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.53 -38.95 82.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 1.5900000000000001 110.219 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.68 -7.22 42.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.65000000000000002 111.188 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.408 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 26.1 ttt -88.72 -38.77 14.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 1.6699999999999999 110.925 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.477 ' HA ' HD12 ' C' ' 45' ' ' ILE . 28.8 m-85 -70.77 -30.68 67.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 3.4199999999999999 111.504 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 80.2 mt -55.82 -54.9 46.86 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.595 -0.275 . . . . 0.89000000000000001 111.726 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 49.7 Cg_endo -69.41 -28.11 27.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.165 1.91 . . . . 0.40999999999999998 113.096 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' C' ' 42' ' ' PHE . 91.3 mt -59.66 -62.53 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.166 -0.213 . . . . 1.76 111.332 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.67 ' HE1' HG22 ' A' ' 110' ' ' ILE . 2.8 t90 -64.95 -50.19 67.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.646 0.26 . . . . 2.1600000000000001 110.813 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . 0.435 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 36.8 t -60.98 -15.06 27.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 1.1699999999999999 111.022 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.16 -60.32 3.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 0.44 112.364 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.09 -26.42 64.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.309 . . . . 1.29 110.845 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.58 -54.27 45.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.5 111.272 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.466 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.1 m-85 -67.69 -36.78 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 1.8300000000000001 111.136 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 51.8 ttp -51.53 -33.09 30.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.14 0.495 . . . . 1.47 109.998 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -75.97 -44.92 37.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.59999999999999998 110.638 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . 0.466 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 31.7 mtp -56.49 -19.53 15.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.85 -0.614 . . . . 0.83999999999999997 110.463 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.48 -44.31 17.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.886 -0.597 . . . . 0.65000000000000002 110.34 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.551 HG21 HD23 ' A' ' 130' ' ' LEU . 38.4 pt -84.44 10.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 1.55 111.135 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 63.96 54.04 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.915 -0.584 . . . . 1.54 111.148 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -134.77 151.4 50.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 1.79 110.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.16 14.26 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.788 -0.72 . . . . 0.93999999999999995 112.58 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -124.43 160.31 28.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.801 0.334 . . . . 2.3599999999999999 110.769 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.49 142.06 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.97 111.028 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.55 104.77 17.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 2.4399999999999999 110.656 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.96 124.91 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 1.54 111.226 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.8 27.81 17.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 1.71 111.262 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.29 53.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.874 -0.679 . . . . 1.53 112.733 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -98.15 147.41 24.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 2.23 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.37 116.71 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 1.3600000000000001 111.148 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.85 133.5 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.78000000000000003 110.885 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.429 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 93.8 m-70 -78.59 73.33 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.232 0.539 . . . . 1.0800000000000001 111.054 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.97 -33.01 74.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.582 -0.735 . . . . 2.2999999999999998 110.951 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -75.58 -25.89 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.75 111.784 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.6 tpp180 -67.92 -51.22 50.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.364 0.505 . . . . 1.51 112.364 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -82.08 -30.87 31.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.245 0.461 . . . . 4.6500000000000004 112.245 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.6 tp -56.48 -44.13 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.758 -0.377 . . . . 1.22 110.783 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.452 ' N ' HG23 ' C' ' 74' ' ' ILE . 34.9 t70 -69.54 -20.56 63.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.374 -0.602 . . . . 1.3100000000000001 109.374 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -87.14 3.68 45.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.567 -0.742 . . . . 1.6799999999999999 111.201 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.598 ' HA ' HD13 ' C' ' 113' ' ' ILE . 44.8 ttm -104.61 -21.33 13.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.002 -0.545 . . . . 1.8 110.771 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.422 ' O ' HD23 ' C' ' 82' ' ' LEU . 31.5 m -114.48 -35.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.2 0.444 . . . . 1.1899999999999999 112.2 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.442 HG23 HG23 ' C' ' 43' ' ' ILE . 24.5 m -76.78 -51.7 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.105 0.409 . . . . 1.23 112.105 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 52.3 m -52.72 -50.77 79.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.039 0.385 . . . . 0.58999999999999997 112.039 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 54.4 Cg_exo -52.54 -43.49 54.45 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.943 1.762 . . . . 0.67000000000000004 112.009 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.422 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -71.9 -27.28 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.95999999999999996 110.602 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.75 -29.6 67.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.183 0.516 . . . . 1.1899999999999999 109.743 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -84.04 -39.73 19.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.428 -0.805 . . . . 1.7 110.196 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.94 -32.01 73.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.506 . . . . 1.6200000000000001 110.404 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -61.21 -25.47 67.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 1.26 110.328 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.429 ' HA ' HG22 ' C' ' 90' ' ' THR . 51.2 mt -73.12 -26.32 61.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 1.1100000000000001 110.629 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 1.51 110.795 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.83 -32.46 35.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 2.0600000000000001 111.107 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . 0.429 HG22 ' HA ' ' C' ' 87' ' ' LEU . 10.0 t -81.48 -23.27 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.227 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -36.13 15.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.3 111.274 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -123.24 121.63 36.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 110.948 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -76.35 -35.14 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 3.2400000000000002 110.835 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.99 141.47 46.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.022 -0.536 . . . . 4.6299999999999999 110.796 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.44 142.56 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 2.1800000000000002 110.867 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -91.99 169.42 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 4.1200000000000001 111.095 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.75 81.19 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 4.96 111.114 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.74 -42.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 3.9100000000000001 111.012 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 91.7 m95 51.02 76.98 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 5.21 111.081 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 74.6 p -120.26 -57.79 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.945 -0.57 . . . . 1.8200000000000001 110.985 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.22 -45.07 27.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 2.0800000000000001 110.967 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.94 -33.35 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.341 -0.39 . . . . 1.8600000000000001 110.897 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.07 -42.47 51.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.791 -0.719 . . . . 0.58999999999999997 112.56 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -63.11 -36.61 84.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 1.53 110.869 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' C' ' 84' ' ' LEU . 85.1 mt -67.85 -52.88 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.551 . . . . 1.1100000000000001 110.86 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -53.27 -43.1 67.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.732 . . . . 2.21 110.928 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . 0.422 ' HB3' ' CD1' ' B' ' 42' ' ' PHE . 49.0 m -64.27 -42.38 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.559 . . . . 1.28 110.828 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.567 HG21 HG21 ' C' ' 142' ' ' ILE . 98.3 m -60.93 -27.26 68.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.962 -0.563 . . . . 1.22 111.252 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 6.3 tp-100 -75.14 -33.99 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 2.3300000000000001 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.648 HG22 ' HE1' ' B' ' 46' ' ' TRP . 32.0 mm -62.41 -43.85 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 1.29 111.684 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.461 HG11 HG22 ' B' ' 45' ' ' ILE . 19.9 m -67.07 -41.06 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.881 0.326 . . . . 1.0600000000000001 111.881 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.64 -48.77 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.936 0.347 . . . . 0.51000000000000001 111.936 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' C' ' 77' ' ' MET . 70.2 mt -56.53 -36.74 48.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.718 0.294 . . . . 1.3700000000000001 111.028 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 54.2 m -57.64 -49.64 75.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.77000000000000002 111.223 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -64.29 -20.47 66.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.425 . . . . 1.1899999999999999 110.799 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.34 -32.89 24.28 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.912 -0.661 . . . . 0.5 113.087 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.532 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.7 pp -82.92 -25.39 32.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.707 0.289 . . . . 1.47 111.399 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.532 ' N ' HD12 ' C' ' 117' ' ' LEU . 9.8 tp -83.77 -31.55 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.387 -0.37 . . . . 1.2 111.161 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.9 75.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.40000000000000002 111.027 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.41 -28.62 46.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 2.1200000000000001 110.97 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.1 13.62 2.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.213 -0.449 . . . . 0.75 111.03 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 48.1 t -71.06 127.71 33.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 1.3799999999999999 110.823 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -93.26 -65.08 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 2.7400000000000002 110.707 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . 0.507 ' HB2' HG12 ' C' ' 127' ' ' VAL . 99.1 mtt180 -69.07 141.57 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 2.7999999999999998 110.498 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.3 -11.57 59.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 2.4100000000000001 111.492 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -91.68 -30.24 16.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.67 0.272 . . . . 4.2000000000000002 111.157 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' C' ' 124' ' ' ARG . 8.5 p -80.5 -24.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 1.0800000000000001 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -57.65 -29.41 64.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.5699999999999998 111.029 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.05 -26.57 59.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 3.8100000000000001 111.151 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' C' ' 127' ' ' VAL . 9.4 mp -76.71 -53.57 7.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 1.4199999999999999 111.182 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -32.44 71.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.89000000000000001 111.212 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -57.8 -52.58 64.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.382 . . . . 1.26 110.987 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.85 -32.4 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 1.6799999999999999 111.296 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 81.3 m -63.73 -39.27 93.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 1.24 110.958 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.23 -57.4 15.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.654 -0.784 . . . . 0.54000000000000004 112.411 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -57.85 -32.65 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 1.0600000000000001 111.211 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.9 t -56.49 -43.55 79.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.343 -0.389 . . . . 1.0800000000000001 110.812 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . 0.414 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -65.16 -34.11 77.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 110.644 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -75.46 -22.79 56.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.983 -0.553 . . . . 1.6799999999999999 111.212 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 89.8 mt -68.05 -55.88 10.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.678 0.275 . . . . 1.7 111.275 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.471 HG13 ' N ' ' C' ' 142' ' ' ILE . 37.4 pt -59.46 -42.16 86.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.859 0.361 . . . . 0.78000000000000003 111.171 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.567 HG21 HG21 ' C' ' 108' ' ' THR . 49.5 mm -66.08 -35.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 2.2400000000000002 110.877 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -52.61 -50.27 63.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 1.02 110.751 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -61.48 -32.75 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 3.0 110.504 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.42 -27.69 67.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 1.27 112.479 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . 0.426 HG12 ' O ' ' C' ' 142' ' ' ILE . 43.2 mm -74.5 -27.31 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.057 0.456 . . . . 1.8899999999999999 110.767 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -89.45 4.76 48.05 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.837 -0.62 . . . . 1.6000000000000001 111.233 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 112.402 -179.282 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . 0.493 HD12 ' N ' ' C' ' 165' ' ' TYR . 4.1 pp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.778 0.323 . . . . 2.3500000000000001 111.406 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . 0.493 ' N ' HD12 ' C' ' 164' ' ' LEU . 2.4 t80 -81.39 -25.95 35.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.312 -0.404 . . . . 2.6200000000000001 110.9 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.27 -46.4 64.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 2.0899999999999999 111.11 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . 0.59 ' HB3' ' HZ3' ' C' ' 167' ' ' LYS . 4.9 ttpm? -75.33 -29.48 59.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 3.2400000000000002 110.878 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.402 HD11 HD22 ' C' ' 87' ' ' LEU . 52.4 tp -66.53 -61.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 1.6899999999999999 111.317 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 85.5 t -53.82 -35.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 1.3999999999999999 111.459 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -53.95 -54.15 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.95999999999999996 111.075 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . 0.511 ' O ' HG12 ' C' ' 174' ' ' VAL . 30.0 t80 -70.92 -29.9 66.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.006 -0.543 . . . . 3.6499999999999999 110.806 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -67.48 -31.21 71.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 1.3700000000000001 111.55 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 40.4 p -77.19 -40.61 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.93 0.344 . . . . 1.4299999999999999 111.93 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . 0.511 HG12 ' O ' ' C' ' 171' ' ' TYR . 10.9 p -64.2 -25.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 1.6200000000000001 111.524 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' C' ' 171' ' ' TYR . 87.4 mt -77.66 -57.87 3.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.031 0.443 . . . . 2.0299999999999998 111.257 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 -28.06 62.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.62 111.424 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.423 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.1 tp -87.54 -22.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.993 0.425 . . . . 1.5800000000000001 110.341 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.84 -51.52 57.63 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.56000000000000005 112.844 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.649 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -57.01 -56.42 33.7 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.883 -0.327 . . . . 1.3300000000000001 111.165 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.9 Cg_exo -45.42 -30.47 5.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.177 1.918 . . . . 0.63 112.612 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.419 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.5 mt -65.82 -57.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.93000000000000005 111.314 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.543 HG22 ' O ' ' C' ' 179' ' ' TYR . 17.3 m -62.67 -25.42 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 1.27 111.466 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -69.92 -16.5 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 1.77 111.017 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.21 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.379 -0.373 . . . . 2.3900000000000001 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.0 pt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.392 -0.367 . . . . 1.95 111.157 179.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 79.0 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.887 0.375 . . . . 2.3799999999999999 111.11 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.84 -43.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 2.23 111.068 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.56 -56.9 14.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 2.1600000000000001 111.211 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 77.4 p -64.93 -20.74 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 1.27 111.654 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.99 -37.0 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.331 . . . . 1.7 111.136 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 52.7 tp -78.92 -39.77 33.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 2.02 111.44 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.09 0.62 10.99 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.435 -0.348 . . . . 1.8200000000000001 111.344 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 52.9 t -96.15 -44.85 7.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.049 0.452 . . . . 1.3500000000000001 110.397 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.1 -31.09 62.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.728 -0.669 . . . . 0.65000000000000002 111.799 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.578 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -61.02 -54.8 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.818 -0.353 . . . . 1.4199999999999999 111.053 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 41.9 Cg_exo -58.06 -37.28 96.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.68 1.587 . . . . 0.63 110.687 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.23 -26.88 66.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.975 -0.557 . . . . 1.49 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.38 -28.84 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.651 -0.704 . . . . 1.7 110.511 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 1.25 110.924 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.751 0.31 . . . . 1.6100000000000001 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.16 -33.43 61.14 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.977 -0.63 . . . . 0.81999999999999995 112.785 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -72.71 -32.52 65.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.695 0.283 . . . . 3.0800000000000001 111.01 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . 0.412 ' O ' HD13 ' C' ' 218' ' ' LEU . 48.1 t -58.65 -62.64 1.71 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 1.1499999999999999 110.83 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -60.94 -24.54 66.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 2.5600000000000001 111.242 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.86 -51.52 47.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.29 110.91 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 18.7 t70 -54.59 -40.03 68.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 2.3900000000000001 111.169 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . 0.412 HD13 ' O ' ' C' ' 214' ' ' SER . 11.1 mp -66.13 -37.4 85.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.385 . . . . 2.0299999999999998 111.241 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -75.11 -27.71 59.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 3.21 111.11 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.46 -19.86 79.74 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.687 -0.768 . . . . 1.3600000000000001 112.46 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 79.4 mt . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.68 0.276 . . . . 2.8999999999999999 111.206 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.711 0.291 . . . . 2.4199999999999999 111.002 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.4 mm? -74.69 -27.01 60.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.351 -0.386 . . . . 2.0899999999999999 110.628 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 33.9 m170 -75.37 -34.63 61.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 1.1599999999999999 110.269 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.466 ' O ' HG12 ' A' ' 12' ' ' VAL . 58.9 t-105 -67.37 -48.27 67.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.79000000000000004 110.426 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -66.23 -20.37 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.41 . . . . 2.0800000000000001 110.223 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.475 ' O ' ' HG2' ' A' ' 15' ' ' MET . 7.9 t80 -60.48 -60.54 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.85 -0.614 . . . . 1.28 110.266 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 9' ' ' TRP . 9.7 p -57.92 -30.07 37.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 110.525 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.93 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 0.63 110.943 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.97 -31.53 52.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.55000000000000004 112.365 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 71.4 mmm -69.68 -44.31 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 1.03 110.69 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.4 p -60.22 -58.48 8.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 1.3 111.219 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.8 pp -56.78 -22.42 15.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.301 -0.409 . . . . 1.3100000000000001 111.279 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.27 -62.5 5.57 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.77000000000000002 112.407 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.42 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.289 . . . . 0.80000000000000004 111.262 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 17' ' ' ILE . 86.4 mt -74.89 -35.98 62.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 1.8100000000000001 110.801 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -58.94 -42.52 89.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 1.8799999999999999 110.778 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.45 -20.4 57.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 4.4500000000000002 110.677 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 50.2 t-105 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 3.6899999999999999 110.264 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -79.92 -34.56 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.5700000000000001 110.914 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -81.87 -1.99 49.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 1.95 110.735 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.3 p -56.42 -26.9 55.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 1.3799999999999999 110.714 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -46.98 -36.3 7.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.257 0.551 . . . . 4.0700000000000003 109.825 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.0 p-10 -164.05 131.97 2.63 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.307 -0.861 . . . . 2.7200000000000002 110.132 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 27.7 Cg_endo -94.03 -178.84 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.074 2.516 . . . . 1.9099999999999999 112.502 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -89.35 35.95 0.82 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 4.7599999999999998 111.262 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.78 -40.65 2.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 1.99 112.664 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 HD22 ' A' ' 221' ' ' LEU . 18.0 m -76.46 137.51 67.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 2.7000000000000002 110.889 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 24.0 Cg_exo -65.12 166.08 19.9 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.578 2.185 . . . . 1.79 112.06 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.514 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -60.7 -18.56 54.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 4.1200000000000001 111.66 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.514 ' H ' HE21 ' A' ' 34' ' ' GLN . 2.4 p90 -48.12 -39.29 20.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.737 0.303 . . . . 2.9300000000000002 111.173 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.44 -48.74 63.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.922 0.392 . . . . 2.8799999999999999 110.514 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -59.94 -29.4 68.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 4.6600000000000001 110.632 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.54 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 1.45 110.989 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.02 -27.97 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 1.78 111.081 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.32 -9.95 59.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.63 110.993 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.408 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 49.6 ttp -89.57 -38.89 13.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 1.48 111.222 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.4 -41.42 73.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 3.5 111.861 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 30.7 mm -50.59 -52.25 57.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 112.313 0.486 . . . . 1.0800000000000001 112.313 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.2 Cg_endo -70.15 -32.51 16.82 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.296 1.997 . . . . 0.53000000000000003 113.122 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.69 -62.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.548 0.213 . . . . 1.6799999999999999 111.51 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.582 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.7 OUTLIER -60.66 -58.63 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.735 0.302 . . . . 1.8300000000000001 111.017 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.2 t -55.71 -26.09 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 1.0900000000000001 110.958 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.3 -58.88 11.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.715 -0.755 . . . . 0.40999999999999998 112.249 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.47 -28.44 65.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.835 0.35 . . . . 0.98999999999999999 110.834 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.24 17.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.47999999999999998 111.161 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 30.3 m-85 -62.25 -38.67 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 1.8700000000000001 110.914 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.2 ttp -55.72 -31.07 62.17 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.0 0.429 . . . . 1.49 110.315 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -40.04 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.58999999999999997 110.491 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.9 mtt -55.94 -33.96 65.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.815 -0.63 . . . . 0.48999999999999999 110.322 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -66.15 -49.51 67.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.59999999999999998 110.416 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.546 HG21 HG23 ' B' ' 127' ' ' VAL . 10.5 mt -74.58 -3.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 1.3100000000000001 110.818 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 60.64 51.49 4.97 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.737 -0.665 . . . . 1.9099999999999999 111.269 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -133.67 122.21 23.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 1.6200000000000001 110.933 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.07 -1.05 3.73 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.817 -0.706 . . . . 1.04 112.443 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -111.45 153.71 25.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.32 . . . . 2.6800000000000002 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.84 140.23 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 1.98 111.46 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -87.46 92.64 9.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 2.1800000000000002 110.749 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.15 118.36 35.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.5700000000000001 111.147 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.83 28.32 17.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.79 111.562 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.66 -10.46 64.7 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.705 -0.76 . . . . 1.48 112.949 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -98.07 147.43 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 2.3199999999999998 110.749 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.1 mt -89.72 122.22 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.4399999999999999 111.134 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.92 143.9 28.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.81999999999999995 111.202 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 92.4 m-70 -88.07 64.66 7.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 110.74 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.99 -56.0 18.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 1.8300000000000001 111.39 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.23 -22.54 63.15 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.129 0.418 . . . . 0.62 112.129 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 10.7 mpt_? -68.43 -52.37 33.46 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.921 0.341 . . . . 2.3399999999999999 111.921 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 117' ' ' LEU . 2.4 p90 -69.31 -32.95 72.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 3.4900000000000002 110.819 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.9 mm -51.48 -53.27 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.278 -0.419 . . . . 1.3700000000000001 110.519 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 79' ' ' THR . 22.1 t70 -62.72 -29.32 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 1.3100000000000001 110.002 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -80.94 6.85 12.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.047 -0.524 . . . . 1.48 111.305 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.578 ' HA ' HD13 ' A' ' 113' ' ' ILE . 53.1 tpp -105.11 -20.29 13.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 1.46 110.452 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.4 m -114.26 -36.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.739 0.644 . . . . 1.1200000000000001 112.739 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.1 t -79.9 -35.75 37.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.351 0.5 . . . . 1.1000000000000001 112.351 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 36.7 m -65.97 -50.39 52.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.851 0.315 . . . . 0.59999999999999998 111.851 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 51.8 Cg_exo -56.21 -38.24 95.32 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.787 1.658 . . . . 0.73999999999999999 111.369 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -74.07 -32.08 63.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 1.01 110.823 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.2 tp -67.2 -28.12 67.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.939 0.399 . . . . 1.48 110.381 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 105' ' ' LEU . 5.3 tt -84.08 -36.2 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 1.3799999999999999 110.406 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -61.72 -37.51 84.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.082 -0.508 . . . . 1.1899999999999999 110.479 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.479 ' O ' HG23 ' A' ' 90' ' ' THR . 44.6 t -56.83 -30.51 63.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 1.23 110.701 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.11 -34.51 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.88 111.209 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -71.71 -39.65 70.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 1.3899999999999999 111.393 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -68.73 -26.33 65.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 2.3199999999999998 111.097 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 86' ' ' SER . 71.8 p -82.96 -23.49 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.538 -0.301 . . . . 1.46 111.365 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -33.85 16.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 1.24 111.046 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 86.1 mtp -130.72 99.21 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 2.0699999999999998 110.782 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -62.22 -44.93 95.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 3.5299999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -109.19 147.19 32.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 4.0800000000000001 111.139 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.83 142.05 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 2.1699999999999999 110.599 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -125.06 -67.72 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 4.5199999999999996 110.98 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -146.94 93.07 2.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 3.75 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -166.74 63.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 3.5299999999999998 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -89.68 16.91 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 4.9100000000000001 111.044 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 p -98.22 -25.64 14.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 1.98 111.314 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 101' ' ' LEU . 3.8 mm? -80.96 -53.71 6.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 1.8300000000000001 110.994 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.61 -22.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 1.79 111.306 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.38 -49.34 8.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.62 112.653 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.99 -39.69 86.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 1.5800000000000001 111.056 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.698 ' HB3' HD21 ' A' ' 84' ' ' LEU . 80.4 mt -61.71 -58.62 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.027 -0.533 . . . . 0.97999999999999998 111.051 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.3 ttm -53.67 -32.55 52.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.894 -0.594 . . . . 1.48 111.111 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' C' ' 42' ' ' PHE . 71.5 m -66.13 -55.63 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.1299999999999999 111.167 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -53.88 -29.19 40.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 1.48 111.069 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.459 ' NE2' HG22 ' A' ' 80' ' ' THR . 15.5 mm100 -62.87 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 2.7000000000000002 110.87 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.642 HG22 ' HE1' ' C' ' 46' ' ' TRP . 33.8 mm -53.42 -30.64 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 1.54 110.849 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.44 -49.15 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 1.28 111.233 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.68 -46.17 96.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.42999999999999999 111.319 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 77' ' ' MET . 53.0 mt -58.7 -34.55 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.74 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 41.6 m -56.42 -51.45 68.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.63 110.695 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -65.39 -20.68 66.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.45 -40.71 12.52 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.803 -0.713 . . . . 0.41999999999999998 113.085 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.4 pp -73.85 -29.68 62.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.557 0.217 . . . . 1.3799999999999999 111.422 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.4 tp -83.72 -29.64 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 1.6200000000000001 111.428 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.78 68.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.402 . . . . 0.39000000000000001 111.149 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -80.63 -21.66 41.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 2.02 110.816 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 118' ' ' ILE . 76.9 mt -84.61 10.75 10.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.76000000000000001 111.001 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.5 p -70.08 120.94 16.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 1.46 111.151 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -96.97 -65.17 0.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.129 -0.487 . . . . 3.3500000000000001 110.787 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.6 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.1 mtp180 -69.77 134.12 48.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 2.9199999999999999 110.61 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.68 -11.48 60.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 2.77 110.966 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -81.0 -55.24 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.401 . . . . 3.77 110.635 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.6 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.7 p -65.9 -23.68 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 1.1599999999999999 110.916 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -52.28 -37.24 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 2.04 111.327 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -73.95 -26.46 60.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 2.6400000000000001 111.303 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 130' ' ' LEU . 8.4 mp -79.39 -39.08 33.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 1.8999999999999999 111.567 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -75.75 -26.5 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 1.3999999999999999 111.283 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HE1' ' HB3' ' A' ' 183' ' ' TRP . 53.4 t80 -68.35 -48.25 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 1.28 110.907 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -65.9 -29.81 48.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 2.1600000000000001 110.898 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.4 t -64.43 -38.71 91.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.254 -0.43 . . . . 1.6899999999999999 110.792 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.68 -54.27 23.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.75 -0.738 . . . . 0.52000000000000002 112.636 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.95 -30.77 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.712 0.292 . . . . 1.02 111.545 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.11 -43.65 97.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.866 0.365 . . . . 1.0800000000000001 110.894 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.47 86.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.62 110.709 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -63.03 -28.26 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 1.8400000000000001 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.87 -60.74 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 1.6899999999999999 111.397 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 pt -59.3 -41.13 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.325 -0.398 . . . . 0.81000000000000005 111.867 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -65.51 -33.48 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 2.3700000000000001 111.391 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.3 tp -68.05 -40.14 82.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.445 -0.343 . . . . 0.97999999999999998 111.049 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.702 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 54.3 t-105 -69.28 -25.01 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 3.27 110.881 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.769 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -80.9 -41.66 10.41 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.971 -0.633 . . . . 1.25 112.669 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.86 -18.18 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.374 . . . . 2.1200000000000001 111.14 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -88.0 4.92 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 1.6599999999999999 111.466 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.769 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 112.84 0.682 . . . . 99.989999999999995 112.84 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 CA--C 1.522 -0.13 0 CA-C-O 121.045 0.45 . . . . 2.3399999999999999 110.833 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.7 -22.58 60.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.768 -0.651 . . . . 2.77 111.217 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.07 -50.66 21.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 2.04 111.055 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -75.01 -20.66 59.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 2.77 111.167 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.4 tp -77.07 -50.6 12.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.338 -0.392 . . . . 1.8899999999999999 111.598 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.92 -35.44 49.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.226 -0.443 . . . . 1.6399999999999999 112.08 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -56.95 -35.78 69.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 1.24 110.939 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -77.84 -35.29 51.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 2.9700000000000002 110.487 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -70.01 -22.31 63.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 1.48 110.16 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 57.5 m -79.42 -48.38 14.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.852 -0.613 . . . . 1.55 111.519 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.57 HG13 HD22 ' A' ' 175' ' ' LEU . 7.3 p -62.19 -33.42 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.272 0.471 . . . . 1.52 112.272 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.57 HD22 HG13 ' A' ' 174' ' ' VAL . 4.0 mm? -76.52 -52.77 9.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.8 0.333 . . . . 1.8500000000000001 110.96 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -31.4 64.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.62 110.905 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.469 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 14.4 tt -87.65 -19.51 7.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.053 0.454 . . . . 1.3500000000000001 110.198 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.23 -50.91 60.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.58999999999999997 112.773 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.1 m-85 -58.37 -54.88 51.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.719 0.26 . . . . 1.45 111.308 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.5 Cg_exo -45.7 -30.88 6.86 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.283 1.989 . . . . 0.55000000000000004 112.571 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 177' ' ' ILE . 37.3 mm -68.98 -60.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 1.4199999999999999 111.454 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 179' ' ' TYR . 27.5 m -60.32 -25.53 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.78000000000000003 111.715 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.455 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 38.0 m95 -62.98 -27.23 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.623 -0.262 . . . . 0.93999999999999995 111.016 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.82 -43.69 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 1.4299999999999999 110.779 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 39.5 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.524 . . . . 2.02 111.011 179.876 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.628 0.252 . . . . 2.48 111.588 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.86 -60.86 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 2.1800000000000002 111.271 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.4 t -62.57 -35.25 78.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.367 . . . . 1.49 111.173 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -59.11 -26.87 65.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 1.77 111.062 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 61.5 tp -78.11 -46.8 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.4199999999999999 110.998 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -74.0 -8.19 55.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 1.78 111.377 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.406 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 99.4 m -96.06 -39.2 9.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.086 0.47 . . . . 1.3 110.897 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.0 tp -72.95 -34.34 66.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.66000000000000003 111.734 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.542 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -59.42 -54.54 55.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 121.102 -0.239 . . . . 1.6299999999999999 111.174 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -57.28 -41.89 68.44 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.734 1.623 . . . . 0.64000000000000001 111.456 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.05 -28.05 69.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 1.3600000000000001 110.067 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -83.73 -21.46 32.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.784 -0.644 . . . . 1.54 110.386 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 1.2 110.347 179.603 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.711 0.291 . . . . 1.6399999999999999 111.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.14 -37.13 91.26 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.733 -0.746 . . . . 0.79000000000000004 112.618 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -64.17 -35.69 81.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 1.6100000000000001 110.756 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.2 m -59.83 -60.62 3.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 1.1499999999999999 111.143 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.55 -21.29 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.23 -0.441 . . . . 3.3399999999999999 111.29 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.1 tt -68.88 -44.83 72.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.434 -0.348 . . . . 1.1899999999999999 110.715 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -66.99 -32.51 73.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 2.23 110.993 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.48 -40.68 96.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 2.4700000000000002 110.953 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -86.61 -20.94 27.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 1.6200000000000001 110.888 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.27 99.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 1.4099999999999999 112.457 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.466 HD22 HG12 ' A' ' 32' ' ' VAL . 60.1 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 2.5800000000000001 110.961 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.71 0.29 . . . . 2.0699999999999998 111.273 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.413 ' N ' HD22 ' B' ' 7' ' ' LEU . 3.6 mm? -77.58 -32.0 53.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 2.1000000000000001 110.472 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 26.9 m170 -73.47 -29.12 62.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0700000000000001 110.414 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -70.85 -40.78 72.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.938 -0.574 . . . . 1.48 110.336 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.31 -25.27 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 2.02 110.348 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.67 -53.86 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.653 -0.703 . . . . 0.92000000000000004 110.725 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.91 -29.78 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.93999999999999995 110.778 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.68 87.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.55000000000000004 111.186 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.58 -34.35 54.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.825 -0.702 . . . . 0.47999999999999998 112.481 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.68 76.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.84999999999999998 111.105 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 37.3 m -60.29 -57.34 13.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 1.3400000000000001 111.178 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -60.1 -22.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 1.55 111.187 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.86 -63.7 4.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.69999999999999996 112.573 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -32.0 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.81000000000000005 111.196 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' B' ' 17' ' ' ILE . 95.9 mt -66.63 -39.6 88.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 2.2599999999999998 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.88 -35.16 74.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 1.78 110.726 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -79.23 -20.19 48.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 4.5800000000000001 110.637 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -67.05 -36.67 82.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 3.3500000000000001 110.657 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.6 m -81.44 -35.03 31.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 1.5800000000000001 110.531 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.39 -2.25 44.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.877 -0.602 . . . . 1.8400000000000001 110.34 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 57.7 p -61.98 -23.19 66.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.936 -0.574 . . . . 1.3700000000000001 110.828 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -49.99 -31.98 14.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.159 0.504 . . . . 4.9800000000000004 109.902 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.3 p-10 -170.49 132.13 0.94 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.342 -0.845 . . . . 2.1400000000000001 109.92 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 42.9 Cg_endo -95.26 172.72 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.092 2.528 . . . . 1.8200000000000001 112.55 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.544 ' HD3' HD22 ' B' ' 218' ' ' LEU . 14.9 ptm180 -88.28 45.72 1.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 5.1900000000000004 111.077 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.27 1.77 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.812 -0.709 . . . . 2.2000000000000002 112.824 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.5 123.24 89.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.488 0.185 . . . . 3.6499999999999999 110.986 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.421 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 33.3 Cg_exo -59.23 162.1 14.98 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.376 2.051 . . . . 2.6699999999999999 112.365 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . 0.4 ' HB2' HE21 ' B' ' 34' ' ' GLN . 0.0 OUTLIER -58.86 -18.08 29.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 4.8799999999999999 112.017 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.421 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 2.8 p90 -50.21 -38.09 38.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.682 0.277 . . . . 1.8700000000000001 111.281 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.14 -40.57 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 2.6800000000000002 110.651 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -64.68 -31.57 72.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 2.9199999999999999 110.724 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 104' ' ' PHE . 51.2 tp -62.14 -57.16 12.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 1.6399999999999999 110.706 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 14.4 t -65.07 -36.3 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 1.6000000000000001 110.808 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.12 47.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.68999999999999995 111.205 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 27.6 ttt -89.36 -41.71 11.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 2.5800000000000001 111.082 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -71.87 -34.62 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 3.3900000000000001 111.972 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 99.2 mt -54.57 -53.2 62.73 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.078 0.399 . . . . 0.40999999999999998 112.078 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.1 Cg_endo -70.53 -31.81 16.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.31 2.007 . . . . 0.48999999999999999 113.044 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.38 -62.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.564 0.221 . . . . 1.29 111.543 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.583 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.9 OUTLIER -60.47 -56.55 20.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.73 0.3 . . . . 1.3999999999999999 110.98 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -57.23 -22.31 40.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 1.3799999999999999 110.953 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.29 -61.27 5.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.632 -0.794 . . . . 0.37 112.753 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.512 HD12 ' N ' ' B' ' 50' ' ' ALA . 3.3 pp -58.6 -22.74 57.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.625 0.25 . . . . 1.29 111.339 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.512 ' N ' HD12 ' B' ' 49' ' ' LEU . . . -64.96 -57.47 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.44 110.983 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 30.5 m-85 -63.67 -37.26 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.5 110.653 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -49.63 -38.51 32.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.007 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.66 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.55000000000000004 110.751 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 42.4 mtt -53.25 -24.91 12.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.5 110.527 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -77.13 -48.42 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.54000000000000004 110.78 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.56 11.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 1.3 111.434 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 61.44 67.27 0.79 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.03 -0.532 . . . . 2.2400000000000002 111.355 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -144.9 152.8 40.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.77 110.917 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 92.29 17.27 47.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.81 -0.709 . . . . 1.0600000000000001 112.467 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -128.95 148.81 50.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 2.6600000000000001 110.923 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.77 150.71 29.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 1.8899999999999999 110.859 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.36 94.9 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 2.4100000000000001 110.682 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.71 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 1.5600000000000001 111.152 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.23 30.28 20.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 1.8200000000000001 111.251 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.18 -15.64 48.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.857 -0.687 . . . . 1.51 112.913 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -98.37 146.81 25.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.801 0.334 . . . . 2.4500000000000002 110.781 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 54.6 mt -86.2 131.14 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 1.79 111.263 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.9 143.29 32.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.81999999999999995 111.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 72.3 m-70 -84.48 65.03 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.154 0.502 . . . . 1.05 110.682 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.41 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 76.7 t80 -63.82 -51.91 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.635 -0.712 . . . . 1.8700000000000001 111.581 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.427 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -64.61 -22.46 66.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.60999999999999999 111.933 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' B' ' 69' ' ' HIS . 22.4 tpp180 -68.46 -51.62 41.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.257 0.465 . . . . 2.3900000000000001 112.257 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' B' ' 77' ' ' MET . 6.0 p90 -76.33 -34.4 58.99 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.147 0.425 . . . . 3.6699999999999999 112.147 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.432 HG23 ' N ' ' B' ' 75' ' ' ASP . 18.2 tt -55.39 -43.74 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 120.656 -0.417 . . . . 1.6599999999999999 110.623 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.432 ' N ' HG23 ' B' ' 74' ' ' ILE . 29.6 t70 -68.67 -19.96 64.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.424 -0.584 . . . . 1.4099999999999999 109.424 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -88.43 4.14 47.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 111.306 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.6 ' HA ' HD13 ' B' ' 113' ' ' ILE . 31.8 mtp -101.65 -20.42 15.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.343 -0.39 . . . . 1.53 110.383 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.431 ' O ' HD23 ' B' ' 82' ' ' LEU . 32.7 m -113.92 -29.86 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.89000000000000001 111.87 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.441 HG23 HG23 ' B' ' 43' ' ' ILE . 30.6 m -81.3 -51.38 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.933 0.345 . . . . 1.24 111.933 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 21.8 m -52.27 -50.61 78.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.114 0.413 . . . . 0.57999999999999996 112.114 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.4 Cg_exo -53.75 -49.32 17.62 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.785 1.657 . . . . 0.66000000000000003 111.729 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.431 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -64.27 -31.25 72.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.135 -0.484 . . . . 1.0600000000000001 110.717 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.403 ' O ' HD13 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -63.54 -35.26 79.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.154 0.502 . . . . 1.22 109.956 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -84.27 -35.7 23.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 1.53 111.236 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 88.1 mt -58.61 -41.24 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 1.5800000000000001 111.054 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -59.02 -28.65 66.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 1.3899999999999999 110.827 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 mt -67.47 -32.32 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.1499999999999999 110.905 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -72.93 -39.38 66.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.5700000000000001 111.294 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -70.26 -24.69 63.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 2.1699999999999999 111.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 32.6 m -78.62 -30.95 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 1.4199999999999999 111.178 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.27 -25.41 25.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 1.1799999999999999 111.187 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -132.81 99.36 4.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 1.8799999999999999 110.815 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.28 -50.97 63.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 3.4199999999999999 110.984 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -104.77 143.38 33.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 4.0599999999999996 110.732 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 tt -124.9 142.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 2.0899999999999999 110.887 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.441 ' HG2' ' HG3' ' B' ' 97' ' ' LYS . 38.7 ttpt -128.31 -70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 3.8500000000000001 111.104 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.441 ' HG3' ' HG2' ' B' ' 96' ' ' LYS . 29.9 mtpp -141.81 95.84 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 4.8200000000000003 111.03 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -170.24 83.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 3.7999999999999998 110.907 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -106.49 14.24 27.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 5.1699999999999999 110.721 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 2.8 t -91.15 -42.0 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 2.02 111.424 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.15 -47.07 59.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 2.0899999999999999 111.157 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -63.2 -32.33 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.8799999999999999 111.391 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.35 -31.81 33.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 0.56000000000000005 112.729 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.09 -36.65 72.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 1.78 111.002 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.546 ' HB3' HD21 ' B' ' 84' ' ' LEU . 88.0 mt -74.84 -44.27 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.239 -0.437 . . . . 1.03 111.063 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.7 ttp -65.53 -37.38 86.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 1.6699999999999999 111.351 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -65.7 -50.36 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.343 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 35.9 p -56.79 -34.33 67.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.331 -0.395 . . . . 1.1799999999999999 111.32 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.406 ' CG ' HD13 ' B' ' 84' ' ' LEU . 11.8 mm100 -61.52 -47.32 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 2.1699999999999999 111.139 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.582 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.5 mt -54.85 -35.09 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 1.3500000000000001 110.605 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 t -65.52 -47.32 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 1.3400000000000001 111.094 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.56 -47.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.192 -0.458 . . . . 0.42999999999999999 111.212 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' B' ' 77' ' ' MET . 47.0 mt -58.15 -33.26 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 1.6000000000000001 110.996 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.1 m -58.89 -48.65 80.65 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.178 -0.464 . . . . 0.85999999999999999 110.979 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.5 m -67.3 -23.23 65.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.974 -0.557 . . . . 0.94999999999999996 110.852 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.35 -32.48 34.63 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.92 -0.657 . . . . 0.46000000000000002 113.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.504 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.4 pp -80.85 -28.89 35.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.706 0.289 . . . . 1.75 111.206 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.504 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.55 -31.25 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.385 . . . . 1.78 111.321 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.91 -47.06 74.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.299 -0.41 . . . . 0.38 110.957 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 -21.12 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.97 110.716 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' B' ' 118' ' ' ILE . 98.8 mt -81.64 14.79 2.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.077 -0.51 . . . . 0.76000000000000001 110.831 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 79.0 p -61.24 134.5 57.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 1.47 111.024 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -117.52 -45.21 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 2.5 110.832 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.604 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 59.4 ttp180 -108.23 132.66 53.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 2.73 110.64 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.7 -19.0 63.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 2.2000000000000002 111.252 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.604 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 52.4 t-105 -71.26 -53.65 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.401 -0.363 . . . . 3.3999999999999999 110.868 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.546 HG23 HG21 ' A' ' 56' ' ' ILE . 7.3 p -74.86 -24.09 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.23 111.106 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -52.42 -39.67 61.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 3.04 111.2 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -71.34 -32.59 68.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.391 . . . . 4.1399999999999997 111.384 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.58 -56.84 6.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 1.6499999999999999 111.189 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -58.01 -29.97 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.77000000000000002 111.416 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.26 -53.27 57.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 1.46 110.725 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.85 -31.03 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 1.6299999999999999 110.775 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.48 -34.34 75.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 1.4199999999999999 110.859 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.05 -55.02 8.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.824 -0.703 . . . . 0.48999999999999999 112.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m -59.83 -32.94 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 1.3 110.955 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.3 t -65.61 -36.74 84.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 1.3 110.613 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.21 91.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.62 110.627 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -68.27 -23.23 64.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 1.74 110.787 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -58.82 5.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 1.76 110.802 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.413 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.7 pt -62.6 -40.15 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.68999999999999995 111.503 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.413 ' N ' HG13 ' B' ' 141' ' ' ILE . 87.6 mt -64.61 -33.99 66.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.76 110.909 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.75 -45.0 95.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 1.0600000000000001 110.942 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.81 -25.53 65.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 4.1200000000000001 111.286 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.92 -35.66 21.01 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 1.26 112.746 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.6 -22.47 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 1.98 110.454 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -87.08 4.65 41.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 1.4199999999999999 111.015 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.008 -0.542 . . . . 99.989999999999995 112.147 -179.365 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.018 0.437 . . . . 2.4300000000000002 110.729 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -80.6 -25.16 38.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 2.5800000000000001 111.101 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -75.28 -38.48 60.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 2.0 110.97 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -79.95 -21.6 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 3.0299999999999998 110.791 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 48.7 tp -81.34 -46.12 15.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 1.1000000000000001 111.464 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.35 -33.77 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.75 112.282 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 9.9 t -51.73 -41.48 61.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.617 0.246 . . . . 0.97999999999999998 111.282 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . 0.447 ' O ' HG22 ' B' ' 174' ' ' VAL . 37.3 m-85 -77.02 -40.3 46.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 4.2999999999999998 110.709 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -62.11 -23.24 66.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.162 -0.472 . . . . 1.3899999999999999 110.865 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.408 ' O ' HG22 ' B' ' 177' ' ' ILE . 28.0 m -79.31 -50.8 10.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 1.1100000000000001 111.577 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 171' ' ' TYR . 32.7 m -59.51 -28.94 41.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.986 0.365 . . . . 1.51 111.986 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 77.5 mt -76.27 -57.02 4.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.905 0.383 . . . . 1.75 111.213 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -32.47 56.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.89 -0.596 . . . . 0.59999999999999998 111.224 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.442 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 19.1 tt -87.4 -19.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.451 . . . . 1.47 110.385 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.26 59.45 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.742 -0.663 . . . . 0.55000000000000004 112.953 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 84.5 m-85 -58.22 -54.86 51.42 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.782 0.291 . . . . 1.6200000000000001 111.342 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -45.26 -32.44 7.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.164 1.91 . . . . 0.64000000000000001 112.685 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.428 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.4 mt -65.62 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.27 111.462 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 179' ' ' TYR . 35.2 m -60.23 -27.01 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.68999999999999995 111.404 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -62.93 -25.91 68.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 1.1799999999999999 111.178 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.27 -40.93 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 1.77 110.716 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.59 -179.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.6899999999999999 110.798 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.414 0 C-N-CA 120.748 -0.739 . . . . 1.5800000000000001 112.695 179.86 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.857 0.361 . . . . 2.4700000000000002 110.833 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.23 -60.65 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 2.5299999999999998 110.879 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 8.1 t -62.17 -36.83 83.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 1.29 111.152 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.69 -27.46 64.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.285 -0.416 . . . . 2.6200000000000001 110.758 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -75.89 -50.35 15.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 1.6100000000000001 111.049 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -73.02 -5.85 41.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.565 -0.289 . . . . 1.4199999999999999 110.843 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 60.8 m -96.48 -41.86 8.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.267 0.556 . . . . 1.4299999999999999 110.472 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.51 -38.38 74.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.578 -0.737 . . . . 1.1200000000000001 111.909 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.675 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.3 tp -58.3 -53.94 60.95 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 120.961 -0.296 . . . . 1.26 111.321 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -53.62 -42.08 68.81 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.791 1.661 . . . . 0.59999999999999998 111.399 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.09 -42.99 86.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 1.3999999999999999 110.343 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -69.81 -30.19 67.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.4099999999999999 110.457 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.504 . . . . 1.3200000000000001 110.279 179.609 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.863 0.364 . . . . 1.6899999999999999 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.79 96.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.79000000000000004 112.339 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -69.47 -32.26 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.73 0.3 . . . . 2.96 110.875 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 49.2 m -59.91 -62.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 1.29 110.95 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.13 -20.33 65.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.589 . . . . 3.1499999999999999 110.945 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.11 -54.18 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 1.51 111.279 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.98 -37.48 76.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 2.1899999999999999 111.646 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' B' ' 30' ' ' ARG . 78.8 mt -59.16 -49.1 79.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 1.98 111.144 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -77.08 -20.53 55.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 2.1699999999999999 111.051 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.28 -47.93 86.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.881 -0.676 . . . . 1.3600000000000001 112.88 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.548 0.214 . . . . 2.8999999999999999 111.033 -179.779 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.7 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.834 0.349 . . . . 2.52 110.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.68 -49.06 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 1.9299999999999999 111.312 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 49.1 m-70 -64.72 -24.19 67.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 1.26 110.908 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.446 ' O ' HG12 ' C' ' 12' ' ' VAL . 54.7 t-105 -70.57 -50.03 41.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 1.6699999999999999 110.399 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.48 -21.29 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.204 0.526 . . . . 1.8700000000000001 109.932 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . 0.407 ' HE2' ' HG ' ' C' ' 203' ' ' CYS . 0.3 OUTLIER -61.15 -58.99 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.49 -0.777 . . . . 1.4399999999999999 110.413 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' C' ' 52' ' ' MET . 10.1 p -61.97 -26.84 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.46999999999999997 111.23 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.75 83.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.398 -0.365 . . . . 0.58999999999999997 111.046 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.6 -23.81 77.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.831 -0.699 . . . . 0.5 112.499 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . 0.402 ' HB3' ' HB2' ' C' ' 44' ' ' PRO . 18.9 mmt -77.89 -42.92 31.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.52 0.2 . . . . 0.68000000000000005 111.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 37.6 p -59.1 -50.94 72.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 1.3999999999999999 110.893 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -29.51 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 1.55 110.684 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.17 -61.59 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.861 -0.685 . . . . 0.70999999999999996 112.702 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.41 ' HB1' ' HG3' ' C' ' 41' ' ' MET . . . -56.66 -31.95 64.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.77000000000000002 111.127 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' C' ' 23' ' ' TRP . 93.5 mt -69.13 -29.05 67.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 1.9299999999999999 111.247 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.26 -41.39 84.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.94 0.4 . . . . 1.8600000000000001 110.596 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.94 -24.5 52.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 4.1399999999999997 110.606 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . 0.414 ' HB3' ' O ' ' C' ' 20' ' ' LEU . 73.9 t-105 -55.28 -43.17 74.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.295 -0.411 . . . . 3.1499999999999999 110.631 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 44.2 t -82.73 -37.45 24.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 1.95 110.973 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 38.2 tp -77.42 -3.31 39.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.215 -0.448 . . . . 2.2200000000000002 110.739 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 65.4 p -60.77 -23.62 65.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 1.3700000000000001 110.928 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.6 -26.71 14.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.092 0.473 . . . . 5.0300000000000002 109.771 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 14.6 t-20 -172.95 131.87 0.62 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 2.3700000000000001 110.174 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 35.4 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 C-N-CA 123.147 2.564 . . . . 2.0499999999999998 112.538 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . 0.51 ' HB2' ' CD1' ' C' ' 35' ' ' TYR . 38.8 Cg_exo . . . . . 0 N--CA 1.471 0.174 0 CA-C-O 121.394 0.498 . . . . 1.9299999999999999 112.613 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' C' ' 34' ' ' GLN . 0.0 OUTLIER -62.13 -18.48 60.98 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.806 1.039 . . . . 4.1200000000000001 113.806 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' C' ' 33' ' ' PRO . 6.5 p90 -54.79 -31.88 59.44 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.479 -0.489 . . . . 2.8900000000000001 111.123 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.52 -54.56 11.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 2.46 110.918 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' C' ' 40' ' ' ALA . 85.4 m-85 -65.18 -20.81 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 2.7799999999999998 111.278 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.72 -61.48 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 1.6200000000000001 110.036 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.435 HG13 HD12 ' C' ' 82' ' ' LEU . 42.1 t -66.44 -29.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 1.5900000000000001 110.13 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' C' ' 37' ' ' TYR . . . -74.83 -8.85 57.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.82 -0.627 . . . . 0.65000000000000002 110.807 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.429 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.1 ttt -89.02 -37.14 15.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 1.6699999999999999 110.528 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.439 ' HA ' HG22 ' C' ' 45' ' ' ILE . 46.0 t80 -72.28 -29.81 64.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.7 -0.682 . . . . 3.4199999999999999 111.841 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' C' ' 82' ' ' LEU . 37.8 mm -60.22 -52.04 75.99 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 112.402 0.519 . . . . 0.89000000000000001 112.402 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 64.1 Cg_endo -72.81 -34.55 6.66 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.348 2.032 . . . . 0.40999999999999998 114.25 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.486 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.1 tp -63.17 -50.44 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.338 0.495 . . . . 1.76 112.338 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.642 ' HE1' HG22 ' A' ' 110' ' ' ILE . 1.0 OUTLIER -67.59 -58.77 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 2.1600000000000001 111.345 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.6 p -56.64 -31.35 64.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 1.1699999999999999 110.515 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.82 -57.03 19.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.986 -0.626 . . . . 0.44 112.773 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.28 -29.62 68.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.91 0.386 . . . . 1.29 110.881 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.73 95.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.5 110.974 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -69.51 -47.22 64.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.8300000000000001 110.87 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . 0.455 ' HB2' HG11 ' C' ' 12' ' ' VAL . 50.7 ttp -50.95 -28.23 9.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 1.47 110.457 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -74.24 -43.35 57.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.843 -0.617 . . . . 0.59999999999999998 110.879 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.2 -26.42 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.83999999999999997 110.612 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -77.74 -45.22 25.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.65000000000000002 111.275 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' C' ' 53' ' ' ALA . 31.1 pt -79.45 4.86 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 1.55 111.3 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.2 68.03 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.861 -0.609 . . . . 1.54 111.377 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -149.54 136.59 19.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.79 110.822 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.28 4.84 23.53 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.712 -0.756 . . . . 0.93999999999999995 112.356 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -114.22 152.68 30.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 2.3599999999999999 110.872 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.18 145.47 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 1.97 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.61 91.2 8.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 2.4399999999999999 110.796 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.02 105.94 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 1.54 111.208 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.95 36.33 24.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 1.71 111.367 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.43 -13.49 51.08 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 1.53 112.773 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -99.35 134.53 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 2.23 110.921 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 65.6 mt -76.59 137.25 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 1.3600000000000001 111.006 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.72 143.12 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.78000000000000003 111.073 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.497 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 59.0 m-70 -83.2 61.17 5.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.553 . . . . 1.0800000000000001 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . 0.412 ' O ' HG12 ' C' ' 74' ' ' ILE . 68.6 t80 -60.64 -58.01 10.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 2.2999999999999998 111.671 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.35 -22.44 66.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.324 0.49 . . . . 0.75 112.324 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.6 tpp180 -65.52 -51.6 58.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.101 0.408 . . . . 1.51 112.101 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -74.13 -29.42 61.81 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.875 -0.33 . . . . 4.6500000000000004 111.123 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.412 HG12 ' O ' ' C' ' 70' ' ' TYR . 22.6 mm -52.7 -50.53 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 120.853 0.358 . . . . 1.22 110.496 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.66 -21.98 66.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.112 -0.495 . . . . 1.3100000000000001 109.737 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.56 5.45 39.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.936 -0.574 . . . . 1.6799999999999999 110.709 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.525 ' HA ' HD13 ' C' ' 113' ' ' ILE . 57.0 tpp -102.71 -21.81 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 1.8 110.389 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 2.5 p -113.73 -47.42 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.119 -0.491 . . . . 1.1899999999999999 111.983 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.501 HG23 HG23 ' C' ' 43' ' ' ILE . 96.5 m -61.11 -53.64 54.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.163 0.431 . . . . 1.23 112.163 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 29.9 m -51.66 -54.48 39.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.449 0.537 . . . . 0.58999999999999997 112.449 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 77.1 Cg_exo -49.3 -37.79 40.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.896 1.73 . . . . 0.67000000000000004 112.143 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' C' ' 43' ' ' ILE . 4.1 mm? -74.39 -38.39 63.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.95999999999999996 110.63 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.451 HD13 ' O ' ' C' ' 83' ' ' LEU . 0.3 OUTLIER -57.82 -33.64 68.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.173 0.511 . . . . 1.1899999999999999 109.99 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -80.31 -44.93 18.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.598 -0.728 . . . . 1.7 110.783 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.3 -32.81 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.681 -0.69 . . . . 1.6200000000000001 111.443 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -62.14 -34.53 76.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 1.26 110.691 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.32 -44.46 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 1.1100000000000001 110.9 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 43.4 t -65.83 -23.21 66.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 1.51 111.036 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -83.84 -26.72 29.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 2.0600000000000001 110.666 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -77.1 -39.9 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 1.52 111.254 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.11 -44.29 54.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 1.3 111.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -111.79 101.76 10.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 1.6200000000000001 110.825 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.44 -39.62 70.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 3.2400000000000002 110.938 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -116.44 136.51 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 4.6299999999999999 110.794 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.03 144.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.035 -0.53 . . . . 2.1800000000000002 110.802 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -126.21 -65.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.315 -0.402 . . . . 4.1200000000000001 111.078 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -149.09 110.0 4.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.379 . . . . 4.96 110.846 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -144.26 -84.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 3.9100000000000001 110.902 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 90.9 m95 53.82 24.79 4.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.3 -0.409 . . . . 5.21 111.256 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 38.8 p -120.4 -51.93 2.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.217 -0.447 . . . . 1.8200000000000001 110.907 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 68.1 tp -72.27 -53.1 13.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 2.0800000000000001 110.768 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 13.5 tt -56.55 -32.77 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.033 -0.531 . . . . 1.8600000000000001 111.314 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.8 -35.17 22.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.58999999999999997 112.617 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' B' ' 38' ' ' LEU . 90.1 t80 -70.3 -29.76 66.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 1.53 111.091 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.526 ' HB3' HD21 ' C' ' 84' ' ' LEU . 95.7 mt -79.42 -50.45 10.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 1.1100000000000001 111.134 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -61.53 -30.92 70.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.972 -0.558 . . . . 2.21 111.094 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 95.6 p -68.95 -52.82 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.066 0.46 . . . . 1.28 110.747 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 67.7 p -60.7 -23.96 65.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 1.22 110.677 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.7 -50.37 67.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.033 -0.531 . . . . 2.3300000000000001 110.319 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.583 HG22 ' HE1' ' B' ' 46' ' ' TRP . 43.9 mm -55.85 -33.09 33.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 1.29 110.476 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.408 HG13 HD21 ' B' ' 49' ' ' LEU . 21.8 t -62.89 -45.93 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 1.0600000000000001 110.797 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.64 -47.53 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.945 -0.571 . . . . 0.51000000000000001 111.217 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' C' ' 77' ' ' MET . 29.8 mt -60.15 -31.91 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.3700000000000001 111.057 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 22.7 m -59.49 -48.17 82.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.77000000000000002 111.022 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 44.1 m -70.15 -20.29 63.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.1899999999999999 110.965 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.11 -33.09 30.17 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.837 -0.697 . . . . 0.5 113.26 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.526 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.3 pp -79.89 -29.82 40.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.717 0.258 . . . . 1.47 111.592 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' C' ' 121' ' ' LEU . 8.5 tp -83.81 -26.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 1.2 111.181 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.35 -40.99 68.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.169 -0.468 . . . . 0.40000000000000002 111.049 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 -17.56 48.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 2.1200000000000001 110.903 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' C' ' 118' ' ' ILE . 91.9 mt -90.57 34.77 0.88 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 0.75 111.03 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 94.4 p -91.53 131.29 37.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 1.3799999999999999 110.942 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -101.44 -53.64 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 2.7400000000000002 110.901 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 50.9 ttp180 -89.6 137.0 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.497 . . . . 2.7999999999999998 111.022 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.99 -24.6 65.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 2.4100000000000001 111.188 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . 0.615 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 66.7 t-105 -71.06 -57.24 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 4.2000000000000002 110.75 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' C' ' 124' ' ' ARG . 11.5 p -63.9 -23.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.513 . . . . 1.0800000000000001 110.725 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -57.78 -36.57 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 2.5699999999999998 110.948 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -75.3 -18.16 60.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 3.8100000000000001 110.682 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.03 -42.32 19.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 1.4199999999999999 111.235 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -72.94 -31.09 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 0.89000000000000001 111.371 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . 0.418 ' HE2' ' HB3' ' C' ' 183' ' ' TRP . 66.6 t80 -60.66 -55.38 34.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 1.26 110.937 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.6 tt -60.94 -31.14 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.021 -0.536 . . . . 1.6799999999999999 111.078 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.55 -31.49 72.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 1.24 110.724 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -53.02 15.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.868 -0.682 . . . . 0.54000000000000004 112.775 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 22.2 m -60.54 -38.65 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 1.0600000000000001 111.219 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 67.3 m -56.33 -42.5 77.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.894 0.378 . . . . 1.0800000000000001 110.823 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.14 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.56999999999999995 110.905 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 1.6799999999999999 110.849 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 96.3 mt -66.81 -53.24 34.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 1.7 111.09 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 33.1 pt -66.4 -31.88 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.451 -0.341 . . . . 0.78000000000000003 111.418 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.89 -29.69 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 2.2400000000000002 110.882 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.98 -37.08 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.745 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -76.07 -29.48 58.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 3.0 110.746 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.06 -27.52 49.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 1.27 112.471 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 tt -84.28 -21.51 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.057 0.456 . . . . 1.8899999999999999 110.298 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -87.72 3.21 48.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 1.6000000000000001 110.53 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.908 -0.587 . . . . 99.989999999999995 111.823 -179.326 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 CA--C 1.521 -0.159 0 CA-C-O 120.946 0.403 . . . . 2.3500000000000001 110.784 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -26.16 63.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 2.6200000000000001 110.991 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.05 -59.52 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 2.0899999999999999 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.64 -26.06 63.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 3.2400000000000002 111.14 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.86 -54.67 38.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 1.6899999999999999 110.905 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.48 -28.22 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.3999999999999999 111.287 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 43.5 m -52.66 -58.52 6.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.483 -0.326 . . . . 0.95999999999999996 111.198 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . 0.417 ' O ' HD23 ' C' ' 175' ' ' LEU . 76.1 m-85 -63.56 -38.95 93.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.53 -0.304 . . . . 3.6499999999999999 110.479 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.04 -25.18 65.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 1.3700000000000001 111.004 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.441 ' O ' HG22 ' C' ' 177' ' ' ILE . 46.6 m -79.43 -49.16 12.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 1.4299999999999999 111.722 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.3 -41.28 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 111.736 0.272 . . . . 1.6200000000000001 111.736 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' C' ' 209' ' ' SER . 4.4 mm? -71.09 -55.72 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.855 0.317 . . . . 2.0299999999999998 111.855 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -54.16 -34.63 60.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.456 -0.338 . . . . 0.62 111.528 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.455 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.43 -19.3 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 1.5800000000000001 110.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.77 -44.85 95.59 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.56000000000000005 112.806 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.654 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 82.1 m-85 -62.48 -55.98 34.42 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.704 0.252 . . . . 1.3300000000000001 111.069 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 83.2 Cg_exo -48.32 -27.93 10.61 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.999 1.799 . . . . 0.63 112.453 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.423 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -69.12 -59.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.93000000000000005 111.127 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.581 HG11 HD21 ' C' ' 201' ' ' LEU . 17.2 m -61.59 -24.76 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.006 -0.543 . . . . 1.27 111.203 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . 0.418 ' HB3' ' HE2' ' C' ' 132' ' ' TYR . 31.9 m95 -66.41 -22.75 66.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.27 -0.423 . . . . 1.77 110.727 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.53 -27.48 42.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 2.3900000000000001 111.079 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.262 -0.427 . . . . 1.95 111.115 179.806 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.657 0.265 . . . . 2.3799999999999999 111.243 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 7.3 tp -56.03 -36.1 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 2.23 111.301 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.68 -58.34 7.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 2.1600000000000001 111.03 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 75.0 p -64.07 -20.45 65.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 1.27 111.049 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.26 -31.17 58.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.474 . . . . 1.7 110.9 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . 0.581 HD21 HG11 ' C' ' 182' ' ' VAL . 6.1 tt -68.7 -52.02 35.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 2.02 110.598 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.05 -2.43 18.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 1.8200000000000001 110.935 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.407 ' HG ' ' HE2' ' C' ' 11' ' ' TYR . 11.6 t -96.68 -46.72 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.39 0.614 . . . . 1.3500000000000001 110.862 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.52 -39.52 74.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.158 -0.928 . . . . 0.65000000000000002 112.134 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.674 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 45.2 tp -56.57 -54.31 54.94 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 121.031 -0.268 . . . . 1.4199999999999999 111.504 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.2 Cg_exo -54.76 -41.35 78.89 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.902 1.734 . . . . 0.63 111.408 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.96 -42.43 94.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.188 -0.46 . . . . 1.49 110.378 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -70.78 -22.95 62.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.078 -0.51 . . . . 1.7 110.277 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . 0.47 ' HB2' HD12 ' C' ' 175' ' ' LEU . 47.6 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 1.25 110.364 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.686 0.279 . . . . 1.6100000000000001 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.7 61.18 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.86 -0.686 . . . . 0.81999999999999995 112.634 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -64.9 -22.86 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.615 0.245 . . . . 3.0800000000000001 111.312 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.3 m -63.3 -60.3 3.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 1.1499999999999999 110.621 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.9 -24.78 63.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 2.5600000000000001 110.619 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.69 -55.22 32.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.086 -0.507 . . . . 1.29 110.842 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.35 -32.3 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 2.3900000000000001 111.073 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.27 -52.0 66.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 2.0299999999999998 111.315 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -80.01 -19.47 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.331 -0.395 . . . . 3.21 111.207 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.55 75.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.041 -0.599 . . . . 1.3600000000000001 113.372 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.798 0.299 . . . . 2.8999999999999999 111.216 -179.77 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.726 0.298 . . . . 2.4199999999999999 111.054 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.82 -43.55 83.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 2.0899999999999999 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 22.1 m80 -68.32 -24.14 64.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.372 . . . . 1.1599999999999999 110.675 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.471 ' O ' HG12 ' A' ' 12' ' ' VAL . 63.7 t-105 -72.31 -51.71 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.79000000000000004 110.146 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.52 -21.09 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.277 0.56 . . . . 2.0800000000000001 110.005 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.6 OUTLIER -63.96 -63.18 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.578 -0.737 . . . . 1.28 110.927 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 9' ' ' TRP . 10.5 p -52.7 -33.75 18.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 111.587 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.87 98.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.63 111.107 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.13 -22.55 78.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.817 -0.706 . . . . 0.55000000000000004 112.729 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 86.8 mmm -76.08 -44.36 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.785 0.326 . . . . 1.03 111.041 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.9 p -58.29 -49.87 75.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 1.3 111.061 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -63.5 -29.4 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 1.3100000000000001 110.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.48 -57.87 17.22 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.941 -0.647 . . . . 0.77000000000000002 112.751 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.95 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.80000000000000004 110.956 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -67.19 -36.78 82.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.958 -0.565 . . . . 1.8100000000000001 110.827 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -61.67 -49.3 77.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 1.8799999999999999 110.818 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.405 ' O ' ' OG ' ' A' ' 26' ' ' SER . 96.8 m-85 -68.74 -22.06 64.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 4.4500000000000002 111.026 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.412 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 87.5 t90 -68.21 -32.62 72.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 3.6899999999999999 110.654 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 m -78.74 -35.69 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 1.5700000000000001 110.808 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 tp -83.72 -1.36 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 1.95 110.756 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 23' ' ' TRP . 1.2 m -61.85 -26.21 67.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.453 . . . . 1.3799999999999999 110.871 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -47.76 -35.91 10.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.159 0.504 . . . . 4.0700000000000003 109.876 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.495 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.6 p-10 -164.61 131.72 2.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 2.7200000000000002 110.034 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 39.6 Cg_endo -95.86 -176.35 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.097 2.531 . . . . 1.9099999999999999 112.474 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.21 28.51 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 4.7599999999999998 111.022 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.45 -28.5 6.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.8 -0.714 . . . . 1.99 112.795 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.548 HG22 HD22 ' A' ' 221' ' ' LEU . 71.4 t -83.62 123.21 76.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.511 0.196 . . . . 2.7000000000000002 111.316 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 34.2 Cg_exo -58.92 161.63 15.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.442 2.095 . . . . 1.79 112.003 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.515 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -59.61 -17.94 37.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 4.1200000000000001 112.079 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.515 ' H ' HE21 ' A' ' 34' ' ' GLN . 2.6 p90 -49.71 -36.85 26.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.867 0.365 . . . . 2.9300000000000002 110.997 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.81 -36.36 62.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.322 -0.399 . . . . 2.8799999999999999 110.668 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.25 -37.67 86.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 4.6600000000000001 110.382 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' B' ' 100' ' ' THR . 40.8 tp -60.77 -57.8 11.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.549 . . . . 1.45 111.241 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.06 -44.62 97.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 1.78 111.488 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -10.17 54.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.63 111.823 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.414 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 28.1 ttt -89.44 -33.34 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 1.48 111.067 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -75.38 -29.25 59.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 3.5 112.241 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 67.0 mt -64.08 -49.99 71.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.519 0.563 . . . . 1.0800000000000001 112.519 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 75.1 Cg_endo -74.4 -38.07 2.15 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.646 2.231 . . . . 0.53000000000000003 114.324 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 46' ' ' TRP . 45.1 pt -61.88 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.28 0.474 . . . . 1.6799999999999999 112.28 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.619 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -70.27 -58.76 3.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 1.8300000000000001 110.869 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.4 p -51.29 -44.16 61.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 1.0900000000000001 111.091 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.0 -53.25 27.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.40999999999999998 112.866 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.1 mt -57.44 -34.59 69.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.98999999999999999 110.907 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.69 96.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.47999999999999998 111.342 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 69.2 m-85 -61.75 -49.37 76.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 1.8700000000000001 110.787 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.469 ' HB2' HG11 ' A' ' 12' ' ' VAL . 34.4 ttp -50.48 -34.93 26.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 1.49 110.504 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.88 89.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.58999999999999997 111.301 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -55.59 -33.9 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 0.48999999999999999 110.413 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -72.99 -40.71 65.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.59999999999999998 111.113 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.63 -15.59 19.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 1.3100000000000001 110.968 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t70 63.34 39.43 9.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.724 -0.671 . . . . 1.9099999999999999 110.991 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.45 150.27 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 1.6200000000000001 110.874 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.9 -16.52 46.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.84 -0.695 . . . . 1.04 112.161 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -99.38 144.17 28.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.33 . . . . 2.6800000000000002 110.734 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.54 138.63 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 1.98 111.038 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -92.35 92.81 8.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 2.1800000000000002 110.865 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.5 121.01 33.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 1.5700000000000001 111.069 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.28 28.15 16.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 1.79 111.135 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.57 28.94 45.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 1.48 112.436 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -132.84 119.46 20.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 2.3199999999999998 110.735 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.0 pt -80.08 136.32 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.4399999999999999 110.635 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.88 143.91 37.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.81999999999999995 111.464 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 12.4 m-70 -86.59 53.73 2.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.315 0.579 . . . . 0.90000000000000002 110.695 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 74' ' ' ILE . 58.9 t80 -56.25 -59.18 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 1.8300000000000001 111.893 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.54 66.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.62 111.858 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HG3' ' HZ3' ' A' ' 76' ' ' TRP . 12.4 tpp180 -58.82 -52.8 64.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.585 -0.279 . . . . 2.3399999999999999 111.726 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.518 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 10.1 p90 -77.53 -17.94 57.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.713 -0.395 . . . . 3.4900000000000002 111.088 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.0 mm -55.5 -41.59 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 109.36 -0.608 . . . . 1.3700000000000001 109.36 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.58 -20.62 66.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.365 -0.834 . . . . 1.3100000000000001 110.026 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.518 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -78.88 -21.85 46.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.48 111.13 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 2.3 mtp -90.07 -6.17 55.79 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.12 -0.491 . . . . 1.46 111.468 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.44 HG21 ' CE3' ' A' ' 46' ' ' TRP . 32.8 m -114.81 -31.18 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.507 0.558 . . . . 1.1200000000000001 112.507 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 m -89.95 -58.45 2.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.157 0.429 . . . . 1.1000000000000001 112.157 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -51.92 -51.31 72.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.903 0.705 . . . . 0.59999999999999998 112.903 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 53.7 Cg_exo -53.91 -55.79 3.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.801 1.668 . . . . 0.73999999999999999 112.288 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 HD12 ' A' ' 85' ' ' LEU . 4.2 mm? -61.42 -27.11 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 1.01 110.514 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -36.06 79.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.334 0.588 . . . . 1.48 109.831 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 105' ' ' LEU . 6.9 tt -84.4 -20.32 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.289 -0.869 . . . . 1.3799999999999999 110.86 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 82' ' ' LEU . 79.4 mt -80.15 -39.85 28.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 111.043 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.413 ' HA ' ' HD1' ' A' ' 89' ' ' TRP . 48.1 t -59.33 -20.61 56.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 1.23 110.929 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.12 -32.33 63.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.88 110.968 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -72.42 -38.52 68.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 1.3899999999999999 111.197 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.413 ' HD1' ' HA ' ' A' ' 86' ' ' SER . 96.9 m95 -62.37 -49.84 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.424 . . . . 2.3199999999999998 111.17 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -66.1 -23.5 66.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 1.46 111.213 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 -3.19 59.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 1.24 111.348 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.7 mtt -127.98 110.14 12.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 2.0699999999999998 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -87.67 -26.29 23.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 3.5299999999999998 110.771 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -144.76 139.4 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 4.0800000000000001 110.74 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.53 146.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.305 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -129.69 -70.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 4.5199999999999996 110.749 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -144.83 87.1 1.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 3.75 110.951 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.42 124.15 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.952 0.406 . . . . 3.5299999999999998 111.006 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -131.43 20.02 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 4.9100000000000001 110.996 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.562 HG23 HD23 ' C' ' 38' ' ' LEU . 90.5 m -80.53 -47.85 13.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 1.98 111.357 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.66 -57.96 3.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 1.8300000000000001 111.223 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.2 pt -59.61 -24.06 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 1.79 111.219 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.91 -38.92 10.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.896 -0.668 . . . . 0.62 112.546 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.4 -39.8 85.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 1.5800000000000001 110.855 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 84' ' ' LEU . 71.3 mt -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.97999999999999998 110.915 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 ttt -57.41 -35.45 70.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.869 -0.605 . . . . 1.48 110.895 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.406 ' HG ' ' HD1' ' C' ' 42' ' ' PHE . 11.8 t -63.61 -57.24 10.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.356 -0.384 . . . . 1.1299999999999999 111.152 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 142' ' ' ILE . 73.2 p -57.36 -19.48 23.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 1.48 111.681 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 6.2 tp-100 -77.54 -52.53 8.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.794 0.33 . . . . 2.7000000000000002 111.081 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.653 HG22 ' HE1' ' C' ' 46' ' ' TRP . 63.6 mt -52.19 -36.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 1.54 111.856 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.02 -37.67 53.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 121.054 -0.258 . . . . 1.28 111.222 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 108' ' ' THR . 53.9 t -68.61 -28.47 40.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.906 0.384 . . . . 0.42999999999999999 110.847 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.94 -49.01 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 1.74 110.658 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 54.7 m -52.41 -37.93 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.63 110.445 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 61.5 m -60.3 -56.86 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 1.0900000000000001 110.183 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.84 -11.63 58.21 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.887 -0.673 . . . . 0.41999999999999998 112.18 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 tt -74.65 -54.29 7.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.946 0.403 . . . . 1.3799999999999999 110.523 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.73 -24.01 7.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.033 -0.53 . . . . 1.6200000000000001 111.525 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.73 -40.76 66.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.39000000000000001 110.812 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.5 -19.52 42.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 2.02 110.657 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.73 20.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.76000000000000001 110.752 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.4 p -85.63 119.01 25.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 1.46 110.862 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.534 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 10.2 pt-20 -78.52 -23.29 46.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 3.3500000000000001 110.808 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.7 mtp180 -111.3 149.04 31.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 2.9199999999999999 110.657 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.78 -9.42 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 2.77 110.893 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -90.16 -49.38 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 3.77 111.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -58.39 -28.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.456 . . . . 1.1599999999999999 111.34 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -60.53 -32.45 71.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 2.04 110.986 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.35 -33.04 74.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 2.6400000000000001 111.005 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 127' ' ' VAL . 3.1 mm? -72.95 -50.3 24.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 1.8999999999999999 110.807 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -67.34 -23.77 65.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 1.3999999999999999 110.801 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -70.62 -52.96 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.28 111.069 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 130' ' ' LEU . 47.0 pt -57.41 -29.2 32.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 2.1600000000000001 110.902 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.1 t -67.26 -40.42 86.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 1.6899999999999999 110.805 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -47.49 63.41 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.813 -0.708 . . . . 0.52000000000000002 112.694 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.31 -29.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 1.02 111.173 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 40.7 t -57.86 -51.8 68.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.226 -0.443 . . . . 1.0800000000000001 110.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 142' ' ' ILE . . . -65.49 -28.33 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.62 110.953 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -68.99 -23.83 64.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 1.8400000000000001 111.031 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.53 -53.02 7.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.386 . . . . 1.6899999999999999 111.599 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.7 pt -60.03 -37.93 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.81000000000000005 111.784 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 108' ' ' THR . 10.5 tt -67.84 -44.91 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.643 0.258 . . . . 2.3700000000000001 111.295 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.455 ' N ' HG23 ' A' ' 142' ' ' ILE . 41.6 tp -55.74 -49.12 73.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.97999999999999998 110.904 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.512 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 59.8 t-105 -68.01 -26.32 65.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 3.27 110.759 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.94 -17.13 68.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.877 -0.678 . . . . 1.25 113.013 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.5 pt -104.48 -8.23 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.339 . . . . 2.1200000000000001 111.646 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -86.14 -23.22 26.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.419 -0.355 . . . . 1.6599999999999999 111.734 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.46 -0.337 . . . . 99.989999999999995 111.759 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.917 0.389 . . . . 2.3399999999999999 110.672 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.29 -21.66 60.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 2.77 111.026 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.11 -41.44 97.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 2.04 111.359 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -82.51 -24.14 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 2.77 110.676 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.85 -35.81 57.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 1.8899999999999999 111.387 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 15.0 p -73.34 -21.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 1.6399999999999999 111.178 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.7 m -60.03 -57.93 10.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.24 110.915 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.92 -26.01 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.004 -0.544 . . . . 2.9700000000000002 110.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 63.9 t80 -72.27 -31.36 65.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 1.48 111.116 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 177' ' ' ILE . 97.1 m -74.48 -50.88 16.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 1.55 111.518 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.66 -34.11 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.379 . . . . 1.52 111.705 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.5 tp -75.75 -53.99 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 1.8500000000000001 111.362 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.97 -33.81 62.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.62 111.509 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 173' ' ' THR . 13.3 tt -87.64 -21.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 1.3500000000000001 110.749 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.37 -57.34 20.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.58999999999999997 113.226 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.579 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 74.3 m-85 -53.5 -54.17 48.6 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 111.668 0.247 . . . . 1.45 111.668 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.1 Cg_exo -46.28 -37.05 18.26 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.185 1.923 . . . . 0.55000000000000004 112.276 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 177' ' ' ILE . 91.4 mt -59.25 -61.01 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.235 -0.438 . . . . 1.4199999999999999 111.213 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 179' ' ' TYR . 23.2 m -62.44 -24.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.78000000000000003 111.18 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -66.93 -37.7 84.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.93999999999999995 111.214 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 185' ' ' ILE . 73.1 mt -53.15 -79.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.365 -0.38 . . . . 1.4299999999999999 111.111 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.566 HG23 HG22 ' A' ' 184' ' ' ILE . 2.8 pp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 2.02 110.926 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 77.1 mt . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.818 0.342 . . . . 2.48 111.132 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.71 -60.96 2.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 2.1800000000000002 110.992 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.4 p -75.82 -34.85 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.107 -0.497 . . . . 1.49 111.253 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.22 -26.63 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 1.77 110.975 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 65.9 tp -81.18 -48.58 11.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.194 -0.457 . . . . 1.4199999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -69.69 -11.25 60.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 1.78 111.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 97.5 m -96.74 -45.38 6.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.11 0.481 . . . . 1.3 110.975 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.9 tp -69.94 -34.8 73.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.763 -0.653 . . . . 0.66000000000000003 112.244 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.653 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 53.6 tp -61.32 -53.57 61.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.775 0.287 . . . . 1.6299999999999999 111.775 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.6 Cg_exo -55.17 -47.74 24.7 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.012 1.808 . . . . 0.64000000000000001 111.95 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.89 -31.94 73.29 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.249 -0.432 . . . . 1.3600000000000001 110.843 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -66.67 -31.05 71.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 1.54 110.566 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 1.2 110.349 179.541 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.695 0.283 . . . . 1.6399999999999999 111.364 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.48 98.85 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.567 -0.825 . . . . 0.79000000000000004 112.366 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.59 -28.15 62.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 1.6100000000000001 110.818 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.4 m -58.23 -61.71 2.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 1.1499999999999999 110.999 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -68.25 -20.39 64.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 3.3399999999999999 110.96 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -70.07 -49.7 48.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.984 -0.553 . . . . 1.1899999999999999 111.145 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.15 -40.51 96.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 2.23 111.051 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.462 HD23 HG21 ' A' ' 32' ' ' VAL . 96.9 mt -58.95 -41.75 88.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 2.4700000000000002 111.112 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -79.12 -20.51 48.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 1.6200000000000001 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.01 -19.49 79.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.937 -0.649 . . . . 1.4099999999999999 113.083 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.548 HD22 HG22 ' A' ' 32' ' ' VAL . 41.6 tp . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 2.5800000000000001 111.001 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.691 0.281 . . . . 2.0699999999999998 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.29 -27.99 68.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 2.1000000000000001 110.873 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 90.8 m-70 -76.96 -25.71 53.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.024 -0.535 . . . . 1.0700000000000001 110.493 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -76.22 -45.23 33.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.48 110.405 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 43.6 mm -67.8 -22.54 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.129 0.49 . . . . 2.02 110.296 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . 0.422 ' O ' ' HG2' ' B' ' 15' ' ' MET . 29.4 t80 -66.66 -60.69 2.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.734 -0.667 . . . . 0.92000000000000004 110.969 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.39 -35.98 20.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.156 -0.474 . . . . 0.93999999999999995 111.345 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.77 90.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.406 -0.361 . . . . 0.55000000000000004 111.248 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.91 -23.24 78.25 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.774 -0.727 . . . . 0.47999999999999998 112.571 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 80.4 mmm -73.93 -40.58 63.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.558 0.218 . . . . 0.84999999999999998 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p -62.32 -51.46 67.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 1.3400000000000001 111.087 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.8 pp -62.5 -25.31 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.399 -0.364 . . . . 1.55 111.156 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.25 -59.03 11.08 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.735 -0.745 . . . . 0.69999999999999996 112.474 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.21 68.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.872 0.367 . . . . 0.81000000000000005 111.351 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' B' ' 17' ' ' ILE . 79.0 mt -68.17 -36.68 80.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 2.2599999999999998 111.177 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -61.59 -50.07 74.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 1.78 110.604 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.478 ' O ' ' OG ' ' B' ' 26' ' ' SER . 99.4 m-85 -66.44 -23.18 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 4.5800000000000001 110.637 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -68.48 -30.26 69.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 3.3500000000000001 110.791 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 91.6 p -85.03 -29.79 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 1.5800000000000001 110.64 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.49 -1.34 57.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.55 . . . . 1.8400000000000001 110.489 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 1.8 m -63.86 -26.2 68.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 1.3700000000000001 110.889 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -49.66 -32.6 13.49 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.132 0.491 . . . . 4.9800000000000004 109.924 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 6.2 p30 -164.61 131.62 2.36 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.774 . . . . 2.1400000000000001 110.158 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 51.9 Cg_endo -98.0 175.89 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.275 2.65 . . . . 1.8200000000000001 112.882 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.24 35.19 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 5.1900000000000004 110.866 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.46 -41.94 1.92 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.744 -0.741 . . . . 2.2000000000000002 112.713 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.494 ' HA ' HD22 ' B' ' 221' ' ' LEU . 20.8 m -71.09 136.22 84.78 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.57 0.224 . . . . 3.6499999999999999 111.102 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 32' ' ' VAL . 8.1 Cg_exo -73.37 166.25 30.39 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.877 2.385 . . . . 2.6699999999999999 112.763 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -58.24 -20.09 39.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 4.8799999999999999 113.05 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.451 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 3.2 p90 -60.04 -33.54 72.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.952 0.406 . . . . 1.8700000000000001 110.974 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -69.77 -45.61 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 2.6800000000000002 110.904 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 2.9199999999999999 110.944 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.91 -61.68 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 1.6399999999999999 110.864 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.81 -36.24 77.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 1.6000000000000001 111.066 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.43 -12.69 61.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.68999999999999995 111.457 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.423 ' O ' HG12 ' B' ' 45' ' ' ILE . 60.3 ttp -88.73 -36.19 16.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.485 -0.325 . . . . 2.5800000000000001 111.442 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -71.64 -34.01 69.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.34 0.496 . . . . 3.3900000000000001 112.34 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 88.0 mt -56.46 -52.99 68.94 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.59 0.589 . . . . 0.40999999999999998 112.59 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 61.6 Cg_endo -72.03 -36.6 5.7 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.408 2.072 . . . . 0.48999999999999999 113.704 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.423 HG12 ' O ' ' B' ' 41' ' ' MET . 28.5 mm -56.45 -62.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.81 0.3 . . . . 1.29 111.81 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.633 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.3 OUTLIER -60.54 -57.27 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.418 -0.356 . . . . 1.3999999999999999 111.486 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -51.18 -37.2 45.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 1.3799999999999999 111.518 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.56 73.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.37 112.394 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.19 -32.42 73.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 1.29 110.886 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.02 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.581 . . . . 0.44 111.073 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 19.5 m-85 -61.09 -44.33 97.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.5 110.876 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -50.96 -34.17 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.074 0.464 . . . . 1.4099999999999999 110.167 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.36 81.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.598 -0.728 . . . . 0.55000000000000004 110.792 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 49.1 mtt -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.524 . . . . 0.5 110.24 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -62.94 -49.03 76.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.866 -0.606 . . . . 0.54000000000000004 110.342 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.24 -6.69 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.968 -0.56 . . . . 1.3 110.715 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 61.98 39.63 13.16 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.778 -0.647 . . . . 2.2400000000000002 111.341 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.415 ' HG3' ' HE1' ' C' ' 131' ' ' TRP . 13.9 mm100 -100.14 173.77 6.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 1.77 111.013 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 70.57 27.23 72.85 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.858 -0.687 . . . . 1.0600000000000001 112.428 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.75 174.19 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 2.6600000000000001 110.697 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.69 140.74 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.8899999999999999 111.361 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -101.02 84.52 2.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.286 -0.416 . . . . 2.4100000000000001 110.565 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.17 109.8 22.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 1.5600000000000001 111.353 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.22 24.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 1.8200000000000001 111.534 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 11.72 82.04 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.692 -0.766 . . . . 1.51 112.661 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -115.23 129.15 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 2.4500000000000002 110.778 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.07 115.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 1.79 111.237 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.64 142.27 27.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.81999999999999995 111.349 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 25.3 m-70 -92.43 59.14 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.119 -0.491 . . . . 1.05 111.057 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.41 -49.91 73.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 1.8700000000000001 110.925 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.474 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -57.31 -27.76 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.60999999999999999 111.008 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 4.9 tpp180 -63.05 -49.22 75.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.878 -0.601 . . . . 2.3900000000000001 110.775 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -71.19 -18.06 62.5 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.921 -0.312 . . . . 3.6699999999999999 111.443 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 36.3 mm -65.41 -40.99 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.063 0.458 . . . . 1.6599999999999999 109.842 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.545 ' O ' HG22 ' B' ' 79' ' ' THR . 13.5 t70 -66.37 -14.39 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.657 -0.701 . . . . 1.4099999999999999 110.238 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -85.54 -26.14 26.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.856 -0.611 . . . . 1.1599999999999999 111.173 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.604 ' HG2' ' HB ' ' B' ' 113' ' ' ILE . 19.2 mtp -91.82 4.23 53.32 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 1.53 111.33 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 -29.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.414 0.524 . . . . 0.89000000000000001 112.414 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.545 HG22 ' O ' ' B' ' 75' ' ' ASP . 12.4 t -102.83 -43.71 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.102 0.408 . . . . 1.24 112.102 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 26.0 m -58.9 -50.84 85.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.221 0.452 . . . . 0.57999999999999996 112.221 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.559 ' HA ' ' HG2' ' B' ' 109' ' ' GLN . 20.3 Cg_endo -60.62 -43.78 30.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.86 1.707 . . . . 0.66000000000000003 111.898 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.481 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -73.46 -12.7 60.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 1.0600000000000001 110.692 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' B' ' 79' ' ' THR . 0.2 OUTLIER -75.63 -43.99 44.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 1.22 110.782 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.469 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.3 pp -80.18 -23.51 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 1.53 110.78 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.481 HD12 HD13 ' B' ' 82' ' ' LEU . 50.7 mt -68.18 -39.09 82.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 1.5800000000000001 110.444 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 46.6 t -61.81 -30.08 70.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.3899999999999999 110.713 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 69.5 mt -75.73 -26.13 57.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 1.1499999999999999 110.601 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -70.49 -41.26 72.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 1.5700000000000001 110.823 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -70.12 -35.96 74.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 110.593 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 61.3 m -64.99 -33.28 75.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.4199999999999999 110.945 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.95 -34.01 39.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.1799999999999999 111.15 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.8 mmm -95.07 100.93 12.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 1.8799999999999999 111.168 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -78.0 -33.47 51.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.115 -0.493 . . . . 3.4199999999999999 110.887 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -137.82 135.06 35.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.256 -0.429 . . . . 4.0599999999999996 111.418 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 47.0 pt -138.1 143.23 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 2.0899999999999999 110.855 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -130.15 -56.96 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 3.8500000000000001 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.13 73.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 4.8200000000000003 111.122 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.41 134.66 20.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 3.7999999999999998 110.852 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.84 22.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 5.1699999999999999 110.609 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.475 ' HA ' HD22 ' A' ' 38' ' ' LEU . 90.7 m -80.92 -49.83 10.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 2.02 110.988 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.46 -34.92 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 2.0899999999999999 110.925 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.73 -33.73 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.927 0.394 . . . . 1.8799999999999999 110.798 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.54 -15.19 69.04 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.771 -0.728 . . . . 0.56000000000000005 112.545 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -83.38 -42.79 16.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.785 0.326 . . . . 1.78 110.94 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.01 -45.43 60.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 1.03 110.946 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . 0.433 ' O ' HG13 ' B' ' 110' ' ' ILE . 25.1 ttt -63.08 -39.62 95.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.727 -0.67 . . . . 1.6699999999999999 111.269 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -64.14 -54.18 37.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 1.51 111.541 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.52 ' HB ' HD13 ' B' ' 142' ' ' ILE . 59.1 p -58.68 -21.45 54.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 1.1799999999999999 111.615 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.559 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 48.7 tp60 -79.8 -35.89 37.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.44 -0.345 . . . . 2.1699999999999999 111.384 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.619 HG22 ' HE1' ' A' ' 46' ' ' TRP . 68.5 mt -67.34 -34.87 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.693 0.282 . . . . 1.3500000000000001 111.512 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 m -73.61 -35.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.584 -0.28 . . . . 1.3400000000000001 111.506 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 108' ' ' THR . 70.9 t -70.2 -41.42 78.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.616 -0.265 . . . . 0.42999999999999999 111.68 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 77' ' ' MET . 26.7 pt -70.07 -31.53 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.64 -0.254 . . . . 1.6000000000000001 111.419 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -60.94 -56.95 15.09 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.912 0.387 . . . . 0.85999999999999999 110.526 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.5 p -55.97 -29.03 59.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.95 -0.568 . . . . 0.94999999999999996 110.172 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.02 -47.25 84.48 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.85 -0.691 . . . . 0.46000000000000002 111.951 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.456 HD21 ' SD ' ' B' ' 77' ' ' MET . 56.9 mt -48.89 -58.39 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.155 0.502 . . . . 1.75 110.636 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.494 HD13 HD12 ' B' ' 121' ' ' LEU . 50.3 mm -67.56 -31.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.605 -0.725 . . . . 1.78 111.722 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.53 -40.73 62.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.897 0.379 . . . . 0.38 111.178 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.4 -17.54 30.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 1.97 110.794 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.494 HD12 HD13 ' B' ' 118' ' ' ILE . 83.3 mt -84.84 13.96 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.76000000000000001 111.059 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 56.3 m -76.84 126.47 31.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 1.47 110.781 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 -21.92 27.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 2.5 110.81 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.71 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 38.4 ttm180 -116.66 137.32 52.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 2.73 110.806 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.08 -11.56 60.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 2.2000000000000002 111.433 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.71 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 83.1 t90 -87.66 -51.62 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 3.3999999999999999 110.941 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' B' ' 124' ' ' ARG . 14.9 p -61.03 -26.05 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 1.23 110.945 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -67.54 -24.49 65.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 3.04 110.882 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.66 -35.12 76.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 4.1399999999999997 110.766 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.415 ' N ' HD12 ' B' ' 130' ' ' LEU . 7.1 mp -68.78 -50.47 50.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.333 -0.394 . . . . 1.6499999999999999 110.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.76 -35.63 75.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.77000000000000002 111.419 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.74 -51.65 68.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 1.46 111.179 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.8 mm -53.93 -34.09 25.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.251 -0.431 . . . . 1.6299999999999999 111.101 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.73 -41.15 88.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 1.4199999999999999 111.133 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.98 85.21 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.745 -0.74 . . . . 0.48999999999999999 112.654 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.3 -28.75 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.808 0.337 . . . . 1.3 111.28 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 50.4 t -58.2 -49.65 76.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.017 0.437 . . . . 1.3 110.603 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.07 -47.96 80.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.62 110.785 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.27 -24.19 26.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 1.74 111.056 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -59.2 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.76 110.993 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 pt -65.68 -33.74 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.398 -0.365 . . . . 0.68999999999999995 111.771 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.52 HD13 ' HB ' ' B' ' 108' ' ' THR . 77.4 mt -69.05 -37.12 76.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.47 -0.332 . . . . 1.76 111.313 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.3 -48.59 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.373 . . . . 1.0600000000000001 110.866 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . 0.463 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 77.1 t90 -68.26 -22.74 64.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 4.1200000000000001 110.808 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -18.99 62.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.905 -0.664 . . . . 1.26 112.652 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -106.67 -10.24 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.971 0.415 . . . . 1.98 110.938 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -78.85 -21.45 47.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 1.4199999999999999 111.493 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' B' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 111.896 0.332 . . . . 99.989999999999995 111.896 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 120.987 0.422 . . . . 2.4300000000000002 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.57 -22.78 60.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.79 -0.641 . . . . 2.5800000000000001 111.078 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.8 -25.44 48.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 2.0 111.071 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -84.15 -38.18 20.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.427 . . . . 3.0299999999999998 111.384 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.54 -25.74 38.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.488 -0.323 . . . . 1.1000000000000001 111.856 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.36 -26.54 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 1.75 111.069 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.2 m -54.47 -58.75 6.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.273 -0.422 . . . . 0.97999999999999998 111.132 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.39 -30.4 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 4.2999999999999998 110.459 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.9 -25.82 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.908 -0.587 . . . . 1.3899999999999999 110.889 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.407 ' O ' HG22 ' B' ' 177' ' ' ILE . 29.3 m -79.56 -53.15 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 1.1100000000000001 111.35 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 43.2 t -60.68 -27.03 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 1.51 111.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 50.8 tp -77.61 -55.61 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 1.75 111.233 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -30.27 61.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.59999999999999998 111.267 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.427 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.6 tp -87.92 -24.71 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 1.47 110.878 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.0 -46.38 91.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.915 -0.659 . . . . 0.55000000000000004 113.146 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.492 ' O ' HG22 ' B' ' 182' ' ' VAL . 61.6 m-85 -62.2 -55.4 40.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.26 0.467 . . . . 1.6200000000000001 112.26 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 13.1 Cg_endo -56.69 -28.26 74.63 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.77 1.647 . . . . 0.64000000000000001 112.461 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.478 ' O ' HG22 ' B' ' 184' ' ' ILE . 49.1 mt -60.71 -49.91 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.053 0.454 . . . . 1.27 110.238 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 179' ' ' TYR . 13.0 m -77.55 -23.45 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.709 -0.678 . . . . 0.68999999999999995 110.186 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -68.57 -15.22 63.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.277 -0.874 . . . . 1.1799999999999999 112.605 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.478 HG22 ' O ' ' B' ' 181' ' ' ILE . 17.1 tt -103.14 -25.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.885 0.328 . . . . 1.77 111.885 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 185' ' ' ILE . 20.3 pt -91.06 116.54 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.177 0.436 . . . . 1.6899999999999999 112.177 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.153 0 CA-C-N 115.839 -0.619 . . . . 1.5800000000000001 113.814 178.837 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.732 0.301 . . . . 2.4700000000000002 111.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.37 -57.5 12.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.367 -0.379 . . . . 2.5299999999999998 111.121 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 46.3 p -68.94 -37.98 79.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 1.29 111.112 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.56 -25.1 68.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 2.6200000000000001 111.254 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.9 tp -77.36 -43.62 32.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 1.6100000000000001 110.954 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.51 -9.42 58.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 1.4199999999999999 111.458 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.462 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 98.9 m -96.37 -42.16 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.137 0.494 . . . . 1.4299999999999999 110.719 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.97 -48.8 62.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 1.1200000000000001 112.143 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.651 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 53.6 tp -49.6 -52.86 46.82 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 111.738 0.273 . . . . 1.26 111.738 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -54.56 -50.71 12.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.982 1.788 . . . . 0.59999999999999998 111.904 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.5 -35.79 72.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.284 -0.416 . . . . 1.3999999999999999 110.807 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -69.88 -29.28 66.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 1.4099999999999999 110.684 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 1.3200000000000001 110.822 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.858 0.361 . . . . 1.6899999999999999 110.852 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.88 58.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.79000000000000004 112.487 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -69.65 -23.22 63.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.666 0.269 . . . . 2.96 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.2 t -58.94 -58.28 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.887 0.375 . . . . 1.29 110.584 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -72.64 -20.42 61.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 3.1499999999999999 110.814 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.403 HD23 ' C ' ' B' ' 216' ' ' LEU . 7.3 tt -66.4 -58.37 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 1.51 110.71 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -60.09 -32.05 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.1899999999999999 110.622 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.79 -42.32 98.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.525 . . . . 1.98 111.086 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -87.39 -20.43 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 2.1699999999999999 111.134 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.87 76.86 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.911 -0.661 . . . . 1.3600000000000001 113.053 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' B' ' 32' ' ' VAL . 50.8 tp . . . . . 0 C--N 1.329 -0.304 0 O-C-N 122.739 -0.271 . . . . 2.8999999999999999 110.976 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.496 ' N ' HD12 ' C' ' 6' ' ' LEU . 4.9 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.723 0.297 . . . . 2.52 110.697 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.4 -36.99 81.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 1.9299999999999999 110.903 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 14.6 m170 -72.15 -24.09 61.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 1.26 110.649 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -73.83 -51.41 16.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.6699999999999999 110.48 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -66.77 -19.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 1.8700000000000001 110.388 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -65.53 -58.24 6.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.674 -0.694 . . . . 1.4399999999999999 110.824 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' C' ' 52' ' ' MET . 7.7 p -58.85 -35.98 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.46999999999999997 111.141 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.21 79.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.34 -0.391 . . . . 0.58999999999999997 110.993 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.9 -28.71 60.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.827 -0.702 . . . . 0.5 112.586 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -35.55 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.56 0.219 . . . . 0.68000000000000005 111.21 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 47.5 m -64.67 -50.45 67.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 1.3999999999999999 110.57 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.85 -22.33 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 1.55 110.782 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -59.66 9.47 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.016 -0.611 . . . . 0.70999999999999996 112.535 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -30.87 68.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.919 0.39 . . . . 0.77000000000000002 110.492 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.18 -33.12 74.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 1.9299999999999999 110.49 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.76 -53.29 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 1.8600000000000001 110.582 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . 0.573 ' O ' ' OG ' ' C' ' 26' ' ' SER . 72.9 m-85 -65.19 -24.5 67.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 4.1399999999999997 110.55 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . 0.452 ' HA ' ' OG ' ' C' ' 26' ' ' SER . 55.6 t90 -69.48 -27.21 65.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 3.1499999999999999 110.705 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.4 m -84.69 -34.21 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 1.95 110.657 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.26 -1.51 57.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 2.2200000000000002 110.453 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' C' ' 22' ' ' PHE . 1.4 m -60.72 -23.95 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 1.3700000000000001 110.652 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -48.76 -36.93 17.57 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.231 0.538 . . . . 5.0300000000000002 109.828 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.491 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 8.4 p30 -163.18 131.56 2.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.346 -0.843 . . . . 2.3700000000000001 110.034 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.8 Cg_endo . . . . . 0 N--CA 1.452 -0.958 0 C-N-CA 123.028 2.485 . . . . 2.0499999999999998 112.374 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . 0.4 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 38.9 Cg_exo . . . . . 0 CA--C 1.527 0.171 0 CA-C-O 121.053 0.355 . . . . 1.9299999999999999 112.509 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . 0.415 HE21 HG21 ' A' ' 100' ' ' THR . 19.2 pt20 -62.31 -18.32 61.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.619 -0.719 . . . . 4.1200000000000001 112.417 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.4 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.1 p90 -51.72 -34.73 40.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 2.8900000000000001 111.367 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -76.27 -36.97 58.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 2.46 111.12 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -66.01 -35.14 79.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.368 -0.378 . . . . 2.7799999999999998 111.005 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.562 HD23 HG23 ' A' ' 100' ' ' THR . 1.1 tm? -63.95 -56.71 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 1.6200000000000001 110.651 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.71 -45.47 97.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 1.5900000000000001 111.528 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.89 -12.11 52.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.65000000000000002 111.695 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.406 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 26.9 ttt -89.58 -33.71 16.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.693 0.282 . . . . 1.6699999999999999 111.606 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.406 ' HD1' ' HG ' ' A' ' 107' ' ' SER . 35.2 t80 -75.71 -27.57 58.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 3.4199999999999999 111.914 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.467 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 84.8 mt -64.87 -50.63 62.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.89 0.7 . . . . 0.89000000000000001 112.89 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 72.1 Cg_endo -77.54 -33.01 2.58 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.422 2.081 . . . . 0.40999999999999998 114.059 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.486 HG23 ' N ' ' C' ' 46' ' ' TRP . 19.5 tt -62.2 -48.74 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 1.76 111.904 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.653 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -70.78 -57.97 4.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.728 0.299 . . . . 2.1600000000000001 110.727 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.5 p -51.21 -42.27 60.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 1.1699999999999999 110.908 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.68 -49.29 58.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.914 -0.66 . . . . 0.44 112.572 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' C' ' 45' ' ' ILE . 84.9 mt -55.23 -40.16 70.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 1.29 110.929 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.82 88.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.5 111.17 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 72.4 m-85 -55.55 -50.47 69.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.361 -0.381 . . . . 1.8300000000000001 110.99 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . 0.516 ' HB2' HG11 ' C' ' 12' ' ' VAL . 15.6 tmm? -49.66 -37.87 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 1.47 110.388 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.67 -38.4 83.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.59999999999999998 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 55.4 mtt -54.8 -30.95 58.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.83999999999999997 110.294 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -75.93 -37.81 58.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.842 -0.617 . . . . 0.65000000000000002 110.717 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.455 HG12 ' O ' ' C' ' 52' ' ' MET . 6.6 mm -77.96 -6.4 9.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.957 -0.565 . . . . 1.55 110.99 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.56 46.21 5.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 1.54 111.331 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -111.41 171.35 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 1.79 110.963 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 73.08 24.4 75.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.93999999999999995 112.518 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -137.03 146.47 45.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 2.3599999999999999 110.966 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 141.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 1.97 111.161 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.01 87.96 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 2.4399999999999999 110.851 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.51 122.46 33.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 1.54 111.102 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.08 31.39 16.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 1.71 111.105 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 29.99 53.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.841 -0.695 . . . . 1.53 112.628 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . 0.482 HE21 ' N ' ' C' ' 67' ' ' ILE . 23.3 tp60 -131.34 119.05 21.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 2.23 111.054 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . 0.482 ' N ' HE21 ' C' ' 66' ' ' GLN . 26.5 pt -81.72 128.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 111.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.95 140.62 38.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.78000000000000003 111.267 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -95.61 55.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 1.0800000000000001 110.834 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -63.05 -51.32 67.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 2.2999999999999998 111.053 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' C' ' 74' ' ' ILE . . . -57.28 -25.85 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.958 0.408 . . . . 0.75 110.771 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -64.37 -48.23 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.51 110.801 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.602 ' HB3' HD23 ' C' ' 117' ' ' LEU . 0.2 OUTLIER -72.49 -19.56 61.52 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.858 -0.337 . . . . 4.6500000000000004 111.534 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' C' ' 71' ' ' ALA . 65.0 mt -63.53 -41.94 94.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.172 0.51 . . . . 1.22 109.699 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.496 ' O ' HG22 ' C' ' 79' ' ' THR . 9.0 t70 -66.44 -15.37 63.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.548 -0.751 . . . . 1.3100000000000001 110.071 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.08 -20.45 32.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 1.6799999999999999 111.335 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.505 ' HB3' HD12 ' C' ' 113' ' ' ILE . 8.7 mtm -99.54 4.99 46.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 1.8 111.423 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -114.67 -27.15 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.419 -0.355 . . . . 1.1899999999999999 111.855 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.496 HG22 ' O ' ' C' ' 75' ' ' ASP . 15.1 t -103.8 -34.86 8.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.288 0.477 . . . . 1.23 112.288 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 38.5 m -69.65 -50.76 17.51 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 111.84 0.311 . . . . 0.58999999999999997 111.84 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 32.2 Cg_exo -59.36 -37.51 89.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.928 1.752 . . . . 0.67000000000000004 112.28 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.459 HD13 HD12 ' C' ' 85' ' ' LEU . 4.4 mm? -78.29 -16.92 57.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.95999999999999996 110.619 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -41.75 67.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 1.1899999999999999 110.609 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' C' ' 105' ' ' LEU . 3.9 pp -78.78 -32.33 46.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.7 110.819 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' C' ' 106' ' ' MET . 43.2 mt -61.5 -41.26 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 1.6200000000000001 110.833 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.5 t -60.89 -29.91 69.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.02 -0.537 . . . . 1.26 110.783 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.465 HD22 HD11 ' C' ' 168' ' ' LEU . 59.9 mt -74.71 -27.3 60.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 1.1100000000000001 110.891 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.0 t -69.2 -48.6 61.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 1.51 110.865 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -63.86 -32.74 74.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 2.0600000000000001 111.048 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -66.51 -32.14 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 1.52 111.143 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.53 -4.7 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 1.3 111.379 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.3 mtm -118.09 98.91 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 1.6200000000000001 110.992 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -87.42 -16.2 35.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 3.2400000000000002 110.608 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -146.8 133.86 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.56 . . . . 4.6299999999999999 110.584 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -146.21 142.48 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.94 0.4 . . . . 2.1800000000000002 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -131.46 -68.28 0.66 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.958 -0.565 . . . . 4.1200000000000001 110.539 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -138.93 87.17 2.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 4.96 110.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -163.09 121.53 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 3.9100000000000001 110.971 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -134.93 19.38 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 5.21 110.663 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 64.4 p -76.63 -50.77 12.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 1.8200000000000001 111.174 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.4 mt -70.12 -40.06 75.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 2.0800000000000001 110.976 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.06 -41.93 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 1.8600000000000001 111.063 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.21 -11.15 85.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.58999999999999997 112.575 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . 0.429 ' O ' HG23 ' C' ' 108' ' ' THR . 79.1 t80 -80.52 -41.22 24.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.706 0.289 . . . . 1.53 110.928 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.466 ' HB3' HD13 ' C' ' 84' ' ' LEU . 55.1 mt -74.8 -44.07 51.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 1.1100000000000001 111.182 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . 0.487 ' HG2' HD21 ' C' ' 85' ' ' LEU . 71.5 mtm -58.73 -54.27 48.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.307 -0.406 . . . . 2.21 111.285 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -52.23 -50.73 61.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 1.28 111.821 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.429 HG23 ' O ' ' C' ' 104' ' ' PHE . 61.5 p -63.27 -24.69 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 1.22 111.798 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 8.0 tp-100 -80.82 -35.86 32.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 2.3300000000000001 111.406 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.633 HG22 ' HE1' ' B' ' 46' ' ' TRP . 80.4 mt -65.63 -30.97 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 1.29 111.399 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.31 -37.2 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.606 0.241 . . . . 1.0600000000000001 111.592 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 108' ' ' THR . 73.4 t -67.78 -41.4 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 111.887 0.329 . . . . 0.51000000000000001 111.887 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' C' ' 77' ' ' MET . 38.8 pt -69.4 -34.42 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.748 -0.206 . . . . 1.3700000000000001 111.464 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -60.87 -54.59 43.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.872 0.367 . . . . 0.77000000000000002 110.644 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.5 p -55.88 -29.56 60.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 1.1899999999999999 110.057 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.06 63.72 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.991 -0.623 . . . . 0.5 112.011 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.602 HD23 ' HB3' ' C' ' 73' ' ' TYR . 81.8 mt -48.03 -61.13 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 1.47 110.627 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.16 -32.57 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.569 -0.741 . . . . 1.2 112.002 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.51 61.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.314 . . . . 0.40000000000000002 111.348 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 -19.03 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 2.1200000000000001 110.884 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 117' ' ' LEU . 95.9 mt -83.26 17.68 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.75 110.992 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -89.78 117.76 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.368 . . . . 1.3799999999999999 110.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.94 -31.13 61.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.106 -0.497 . . . . 2.7400000000000002 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' C' ' 127' ' ' VAL . 86.5 mtm180 -93.86 144.23 25.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 2.7999999999999998 110.607 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.37 -13.12 58.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 2.4100000000000001 111.382 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -86.37 -50.73 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 4.2000000000000002 111.141 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.2 p -57.68 -24.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.0800000000000001 111.371 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -62.61 -37.35 85.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.364 . . . . 2.5699999999999998 111.055 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -60.9 -36.1 78.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.39 -0.368 . . . . 3.8100000000000001 111.141 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.7 mm? -66.21 -52.63 46.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.4199999999999999 111.124 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . 0.415 ' HE1' ' HG3' ' B' ' 58' ' ' GLN . 9.3 m95 -64.93 -28.93 69.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.427 . . . . 0.89000000000000001 111.45 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -65.42 -46.67 79.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.539 -0.301 . . . . 1.26 110.782 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.1 mm -58.75 -36.6 61.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 1.6799999999999999 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -63.88 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 1.24 110.671 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -48.83 39.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.842 -0.694 . . . . 0.54000000000000004 112.661 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -68.3 -27.06 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 1.0600000000000001 111.119 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 54.0 t -64.4 -43.47 94.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 1.0800000000000001 110.614 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . 0.434 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -68.94 -29.37 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.783 -0.644 . . . . 0.56999999999999995 111.034 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -71.08 -29.63 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.416 . . . . 1.6799999999999999 110.992 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -70.14 -56.0 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 1.7 111.548 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 28.9 pt -55.71 -37.87 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.78000000000000003 111.751 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.434 HG12 ' O ' ' C' ' 138' ' ' ALA . 44.0 mm -78.33 -33.32 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 2.2400000000000002 111.411 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . 0.405 ' O ' HG22 ' C' ' 146' ' ' ILE . 44.5 tp -61.43 -51.33 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 1.02 110.576 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . 0.493 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 98.7 m95 -70.65 -21.28 62.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 3.0 110.463 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.38 67.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.845 -0.693 . . . . 1.27 112.575 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . 0.405 HG22 ' O ' ' C' ' 143' ' ' LEU . 19.0 tt -102.35 -14.67 8.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 1.8899999999999999 111.201 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -77.3 -33.49 55.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 1.6000000000000001 111.699 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' C' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 112.003 0.371 . . . . 99.989999999999995 112.003 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.925 0.393 . . . . 2.3500000000000001 111.027 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 2.6200000000000001 111.068 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.15 -42.93 93.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 2.0899999999999999 111.162 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.76 -25.04 35.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.138 -0.483 . . . . 3.2400000000000002 111.091 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.465 HD11 HD22 ' C' ' 87' ' ' LEU . 54.5 tp -76.89 -39.03 52.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 1.6899999999999999 111.544 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.4 p -71.64 -16.43 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 1.3999999999999999 111.324 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 41.9 m -57.68 -59.41 5.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.95999999999999996 111.258 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -71.46 -31.75 67.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 3.6499999999999999 110.381 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 91.1 t80 -57.21 -32.97 67.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 1.3700000000000001 110.975 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.465 ' O ' HG22 ' C' ' 177' ' ' ILE . 66.9 m -79.66 -43.3 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 1.4299999999999999 111.494 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -58.3 -36.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 112.18 0.437 . . . . 1.6200000000000001 112.18 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' C' ' 175' ' ' LEU . 4.4 mm? -81.16 -47.39 13.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.729 -0.214 . . . . 2.0299999999999998 111.489 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -30.87 63.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.301 . . . . 0.62 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.465 HG22 ' O ' ' C' ' 173' ' ' THR . 10.9 tp -88.01 -22.9 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 1.5800000000000001 110.472 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.19 -57.8 17.39 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.839 -0.619 . . . . 0.56000000000000005 113.37 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.601 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 88.4 m-85 -53.47 -54.85 40.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.692 0.246 . . . . 1.3300000000000001 111.503 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 97.1 Cg_exo -44.37 -35.82 8.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.316 2.011 . . . . 0.63 112.833 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.401 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.0 mt -64.52 -61.14 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 0.93000000000000005 111.537 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.454 HG22 ' O ' ' C' ' 179' ' ' TYR . 20.2 m -59.76 -24.56 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.27 111.454 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -67.19 -52.45 41.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 1.77 111.41 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.02 -41.74 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.211 0.448 . . . . 2.3900000000000001 112.211 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 10.7 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 1.95 111.739 -179.383 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 74.9 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.919 0.39 . . . . 2.3799999999999999 111.023 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.98 -27.88 36.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 2.23 110.959 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -49.76 -60.97 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 2.1600000000000001 110.821 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 72.4 p -72.27 -18.63 61.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 1.27 111.69 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -74.89 -26.55 59.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 1.7 111.359 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.16 -47.93 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.478 -0.328 . . . . 2.02 111.699 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.51 -14.86 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.473 -0.33 . . . . 1.8200000000000001 111.65 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.426 ' O ' ' HG2' ' C' ' 206' ' ' PRO . 20.7 p -96.66 -39.07 9.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 1.3500000000000001 111.53 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 48.3 tp -71.88 -34.01 68.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.277 -0.419 . . . . 0.65000000000000002 112.046 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' C' ' 206' ' ' PRO . 56.4 tp -62.47 -52.94 61.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 111.971 0.36 . . . . 1.4199999999999999 111.971 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' C' ' 205' ' ' LEU . 17.9 Cg_endo -58.21 -41.9 62.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.899 1.733 . . . . 0.63 111.762 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.35 -34.48 78.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 1.49 110.372 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -70.49 -27.51 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 1.7 110.382 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.002 -0.545 . . . . 1.25 110.61 179.639 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.859 0.361 . . . . 1.6100000000000001 111.034 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.28 -50.43 62.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.932 -0.652 . . . . 0.81999999999999995 112.748 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -66.11 -23.69 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 3.0800000000000001 111.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.1 t -60.93 -62.46 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 1.1499999999999999 110.72 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -69.26 -20.42 63.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 2.5600000000000001 110.973 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.26 -59.14 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 1.29 110.601 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.59 -28.54 67.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.863 0.363 . . . . 2.3900000000000001 110.936 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.42 -52.11 66.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 2.0299999999999998 110.976 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.71 -20.46 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 3.21 110.913 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.54 -29.8 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 1.3600000000000001 112.309 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 2.8999999999999999 110.626 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 6' ' ' LEU . 5.5 mp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.818 0.342 . . . . 2.4199999999999999 110.85 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.24 -50.38 60.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.0899999999999999 111.064 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 68.3 m-70 -63.36 -25.0 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 1.1599999999999999 110.973 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 12' ' ' VAL . 62.7 t-105 -70.04 -59.67 2.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.79000000000000004 111.077 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -60.56 -19.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 2.0800000000000001 110.437 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 207' ' ' PHE . 8.6 t80 -62.16 -58.58 7.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.672 -0.695 . . . . 1.28 110.731 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.4 p -60.47 -29.2 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 1.3200000000000001 110.885 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.32 -46.93 88.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.63 111.166 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.91 -23.58 77.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.799 -0.715 . . . . 0.55000000000000004 112.352 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.69 -38.21 54.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.703 0.287 . . . . 1.03 111.131 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -62.79 -48.6 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.387 -0.37 . . . . 1.3 111.096 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.4 -32.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 1.3100000000000001 110.659 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.04 -54.52 30.94 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.783 -0.722 . . . . 0.77000000000000002 112.698 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -35.31 76.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.749 0.309 . . . . 0.80000000000000004 111.389 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 17' ' ' ILE . 93.5 mt -62.54 -30.66 71.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 1.8100000000000001 111.028 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -59.94 -31.9 70.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 1.8799999999999999 110.692 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 m-85 -75.14 -28.02 59.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.188 -0.46 . . . . 4.4500000000000002 110.685 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -62.25 -39.64 93.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.061 0.458 . . . . 3.6899999999999999 109.829 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.2 m -85.49 -28.25 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.758 -0.656 . . . . 1.5700000000000001 110.7 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 56.8 tp -73.13 -18.23 61.31 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.653 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 p -62.52 -25.03 67.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 1.3799999999999999 111.085 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -51.22 -32.59 24.46 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.093 0.473 . . . . 4.0700000000000003 109.938 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.7 p-10 -165.42 132.01 2.17 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 2.7200000000000002 110.304 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 29.3 Cg_endo -95.99 179.86 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.193 2.595 . . . . 1.9099999999999999 112.139 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -103.48 65.58 0.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.339 -0.391 . . . . 4.7599999999999998 111.276 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.76 -46.61 3.71 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.917 -0.659 . . . . 1.99 112.931 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.23 146.98 32.66 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.625 0.213 . . . . 2.7000000000000002 111.235 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 34.6 Cg_exo -58.89 163.29 11.63 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.382 2.055 . . . . 1.79 112.085 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.21 -17.33 63.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.694 -0.685 . . . . 4.1200000000000001 112.319 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 6.4 p90 -41.27 -40.92 1.76 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.738 0.304 . . . . 2.9300000000000002 111.774 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.05 -45.41 77.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.886 0.374 . . . . 2.8799999999999999 110.587 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.76 -19.37 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.55 . . . . 4.6600000000000001 110.439 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.0 -55.06 28.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.45 110.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.83 -37.31 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.78 110.348 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.75 -10.67 59.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.63 110.618 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.499 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 41.0 ttm -88.14 -28.91 20.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.81 -0.632 . . . . 1.48 110.487 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -72.8 -40.09 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 3.5 111.369 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.666 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 36.8 mm -50.22 -53.04 48.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 111.99 0.367 . . . . 1.0800000000000001 111.99 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.666 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 15.7 Cg_exo -68.68 -33.73 20.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.196 1.931 . . . . 0.53000000000000003 112.595 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.01 -62.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.632 0.253 . . . . 1.6799999999999999 111.367 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.61 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -61.72 -57.97 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 1.8300000000000001 111.017 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB2' HG21 ' A' ' 79' ' ' THR . 35.8 t -54.2 -23.06 13.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 1.0900000000000001 111.356 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.54 -66.12 2.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.40999999999999998 112.524 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.1 mt -56.3 -29.15 60.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.293 . . . . 0.98999999999999999 111.144 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.98 -57.61 12.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.47999999999999998 111.222 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 20.8 m-85 -61.61 -42.48 98.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 1.8700000000000001 111.472 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.22 -36.33 8.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.207 0.527 . . . . 1.49 110.349 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -72.37 -40.21 67.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.58999999999999997 110.9 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 54.2 mtt -53.54 -35.57 60.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.041 0.448 . . . . 0.48999999999999999 110.17 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -67.75 -40.96 84.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.59999999999999998 109.935 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.22 3.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.727 -0.67 . . . . 1.3100000000000001 110.524 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.48 44.64 9.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.667 -0.697 . . . . 1.9099999999999999 111.257 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.4 mm-40 -102.93 170.1 8.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 110.823 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.48 92.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 1.04 112.23 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -123.18 145.86 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 2.6800000000000002 110.783 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.84 141.04 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.98 110.845 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.7 92.24 7.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 2.1800000000000002 110.837 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.76 110.74 22.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 1.5700000000000001 111.246 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.63 34.97 25.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 1.79 111.431 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.06 74.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.847 -0.692 . . . . 1.48 112.754 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -130.28 117.65 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 2.3199999999999998 110.502 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 pt -69.23 127.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 1.4399999999999999 111.154 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.38 144.56 35.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.81999999999999995 111.225 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 93.4 m-70 -89.12 62.84 6.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.29 0.567 . . . . 0.90000000000000002 110.989 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -56.77 -38.15 72.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.295 -0.866 . . . . 1.8300000000000001 111.191 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.33 -22.21 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.053 -0.521 . . . . 0.62 111.82 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 5.3 tpm_? -66.5 -51.72 53.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 2.3399999999999999 112.022 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.9 p90 -72.59 -34.04 67.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.654 -0.418 . . . . 3.4900000000000002 110.712 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -55.47 -46.33 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.324 -0.398 . . . . 1.3700000000000001 110.949 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 47' ' ' SER . 37.8 t70 -65.68 -13.01 58.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 1.3100000000000001 110.425 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -99.75 -0.26 40.33 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.813 -0.63 . . . . 1.48 111.528 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.578 ' HA ' HD13 ' A' ' 113' ' ' ILE . 55.0 ttm -104.59 -6.97 20.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 1.46 110.703 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.527 HG23 HG23 ' A' ' 79' ' ' THR . 27.2 m -114.39 -36.13 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 1.1200000000000001 112.128 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 47' ' ' SER . 62.7 p -88.11 -44.71 10.73 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.339 0.496 . . . . 1.1000000000000001 112.339 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.6 m -56.93 -51.29 82.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.156 0.428 . . . . 0.59999999999999998 112.156 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 80' ' ' THR . 14.6 Cg_endo -56.85 -36.51 98.88 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.679 1.586 . . . . 0.73999999999999999 111.168 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.586 ' HB3' HD11 ' A' ' 43' ' ' ILE . 4.0 mm? -71.1 -34.18 70.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 1.01 109.934 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 83' ' ' LEU . 27.9 mt -68.34 -21.25 64.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.336 -0.616 . . . . 1.48 109.336 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 109' ' ' GLN . 20.8 tp -83.02 -23.88 33.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.142 -0.936 . . . . 1.3799999999999999 109.713 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 82' ' ' LEU . 96.1 mt -84.02 -40.67 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.454 -0.794 . . . . 1.1899999999999999 110.886 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.9 p -63.19 -45.44 91.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 1.23 110.956 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.57 -26.17 68.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.039 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.6 t -68.39 -50.94 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.294 -0.412 . . . . 1.3899999999999999 110.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -65.78 -21.93 66.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 2.3199999999999998 111.024 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.6 m -73.46 -37.51 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.353 -0.385 . . . . 1.46 110.967 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.84 -23.98 26.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 1.24 110.937 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.0 mmm -94.0 84.84 4.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 2.0699999999999998 110.796 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -73.98 -19.34 60.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 3.5299999999999998 111.126 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.78 133.58 43.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.287 -0.415 . . . . 4.0800000000000001 110.996 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.3 pt -140.8 160.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 2.1699999999999999 110.935 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -139.97 -70.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 4.5199999999999996 110.997 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -142.4 14.64 2.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.388 . . . . 3.75 111.04 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.93 129.39 40.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 3.5299999999999998 110.877 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 56.5 t90 -151.63 -13.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 4.9100000000000001 110.926 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -82.94 -34.06 26.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.98 111.283 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.78 -48.47 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 1.8300000000000001 110.897 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 16.0 tt -59.11 -25.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 1.79 111.158 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.44 -46.64 32.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.831 -0.7 . . . . 0.62 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -56.47 -37.93 71.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.63 0.252 . . . . 1.5800000000000001 111.157 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.01 -51.79 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.97999999999999998 110.721 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 84.8 mtp -60.8 -26.08 67.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.48 110.981 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.7 m -68.3 -58.72 3.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 1.1299999999999999 111.139 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.64 HG21 HG21 ' A' ' 142' ' ' ILE . 97.5 m -53.37 -36.18 61.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 1.48 111.142 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.518 ' HB2' HD22 ' A' ' 84' ' ' LEU . 6.2 tp-100 -55.14 -51.69 65.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 2.7000000000000002 110.69 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.8 mm -54.22 -35.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 1.54 111.139 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.77 -44.22 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.045 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.65 -52.26 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.42999999999999999 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 77' ' ' MET . 39.7 mt -53.59 -30.68 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 1.74 111.08 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 54.5 m -64.07 -48.24 76.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.63 110.82 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.8 m -62.98 -21.51 66.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.962 -0.563 . . . . 1.0900000000000001 110.476 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.7 9.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.862 -0.685 . . . . 0.41999999999999998 112.938 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 73' ' ' TYR . 4.0 pp -76.82 -26.75 54.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.682 0.241 . . . . 1.3799999999999999 111.268 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.1 mt -84.08 -38.1 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 CA-C-O 120.709 0.29 . . . . 1.6200000000000001 111.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.18 65.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.39000000000000001 111.281 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.64 -22.07 47.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.172 -0.467 . . . . 2.02 110.887 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.72 5.1 49.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.76000000000000001 111.102 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -64.13 131.03 46.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 1.46 111.028 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.72 -3.06 14.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 3.3500000000000001 111.126 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.503 ' HB2' HG12 ' A' ' 127' ' ' VAL . 72.2 mtm180 -129.83 141.04 50.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.871 0.367 . . . . 2.9199999999999999 110.97 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 2.77 111.133 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -79.3 -41.07 28.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 3.77 110.496 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 124' ' ' ARG . 11.6 p -84.16 -23.66 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.576 . . . . 1.1599999999999999 110.955 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -51.61 -40.28 59.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.197 -0.456 . . . . 2.04 111.09 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -75.1 -30.36 60.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 2.6400000000000001 111.167 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 127' ' ' VAL . 87.9 mt -67.56 -58.49 4.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 1.8999999999999999 111.354 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -63.03 -37.02 85.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.321 -0.4 . . . . 1.3999999999999999 111.928 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -55.03 -54.16 46.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.844 0.354 . . . . 1.28 110.662 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.46 -30.54 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 2.1600000000000001 110.658 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.2 t -62.77 -35.01 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 1.6899999999999999 110.827 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.17 -51.91 15.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.878 -0.677 . . . . 0.52000000000000002 112.646 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.16 -29.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.68 0.276 . . . . 1.02 110.991 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.9 t -69.48 -36.59 76.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0800000000000001 110.684 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.54 68.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.62 110.912 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.13 -22.6 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 1.8400000000000001 110.941 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 140' ' ' LEU . 1.5 tm? -64.62 -62.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.6899999999999999 111.227 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.1 pt -59.05 -46.39 91.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.81000000000000005 112.26 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.64 HG21 HG21 ' A' ' 108' ' ' THR . 33.4 mm -64.34 -31.69 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.726 0.269 . . . . 2.3700000000000001 111.726 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 62.7 tp -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.97999999999999998 110.911 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -65.51 -21.89 66.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.411 . . . . 3.27 110.56 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.33 -17.35 71.68 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.84 -0.695 . . . . 1.25 112.835 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.05 -14.51 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.823 0.344 . . . . 2.1200000000000001 111.109 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -66.65 -55.59 14.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.367 0.506 . . . . 1.6599999999999999 112.367 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.328 -0.333 0 N-CA-C 112.62 0.6 . . . . 99.989999999999995 112.62 -179.09 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.833 0.349 . . . . 2.3399999999999999 111.275 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -22.53 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.262 -0.426 . . . . 2.77 110.839 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.68 -32.48 71.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.006 0.431 . . . . 2.04 110.314 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 170' ' ' THR . 41.3 ttmt -78.33 -22.42 48.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.903 -0.589 . . . . 2.77 110.3 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.49 -56.45 4.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.646 . . . . 1.8899999999999999 111.034 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.0 -34.68 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.677 -0.692 . . . . 1.6399999999999999 112.088 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 167' ' ' LYS . 14.0 t -55.16 -34.09 63.52 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.957 0.408 . . . . 1.24 110.531 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -78.24 -28.52 47.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 2.9700000000000002 110.032 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -73.36 -28.0 61.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.643 -0.708 . . . . 1.48 110.84 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.2 p -76.63 -47.91 20.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.369 -0.378 . . . . 1.55 111.073 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.56 -28.55 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 1.52 111.286 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.4 tp -75.68 -56.73 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 1.8500000000000001 111.053 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.454 ' HZ2' HE22 ' A' ' 109' ' ' GLN . 1.0 OUTLIER -58.48 -29.63 66.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.908 -0.587 . . . . 0.62 111.412 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.508 ' O ' HG12 ' A' ' 181' ' ' ILE . 14.1 tt -87.41 -21.08 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 1.3500000000000001 110.25 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.69 65.06 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.72 -0.673 . . . . 0.58999999999999997 112.87 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.573 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.2 m-85 -55.59 -55.6 38.65 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.797 0.298 . . . . 1.45 110.985 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 85.0 Cg_exo -46.35 -31.63 9.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.062 1.841 . . . . 0.55000000000000004 112.657 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.8 mm -64.8 -58.26 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.816 0.341 . . . . 1.4199999999999999 111.667 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 179' ' ' TYR . 28.2 m -59.6 -27.16 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.78000000000000003 111.58 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -61.65 -23.49 66.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.93999999999999995 110.927 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 89.7 mt -56.68 -39.77 65.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 1.4299999999999999 111.146 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.396 . . . . 2.02 111.004 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.5 mm . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.723 0.297 . . . . 2.48 111.229 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.61 -52.4 63.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 2.1800000000000002 110.682 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -63.93 -25.07 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.519 . . . . 1.49 111.076 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -77.02 -27.59 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 1.77 110.998 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 53.7 tp -84.08 -51.17 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 1.4199999999999999 111.506 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -69.75 1.27 4.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.522 -0.308 . . . . 1.78 111.46 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 35.9 t -96.48 -44.01 7.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 1.3 110.191 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.2 tp -72.38 -33.63 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.427 -0.806 . . . . 0.66000000000000003 111.763 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.1 tt -60.09 -54.57 53.97 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.019 -0.272 . . . . 1.6299999999999999 111.17 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.25 -41.63 74.52 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.654 1.57 . . . . 0.64000000000000001 111.262 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.427 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 81.6 t80 -61.28 -34.01 74.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 1.3600000000000001 110.053 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.0 -21.03 57.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.326 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.3 t . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 115.872 -0.604 . . . . 1.2 110.721 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.833 0.349 . . . . 1.6399999999999999 110.871 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.28 96.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.866 -0.683 . . . . 0.79000000000000004 112.405 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.78 -29.46 69.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.732 0.301 . . . . 1.6100000000000001 110.83 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.6 t -60.49 -58.02 10.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.1499999999999999 110.858 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 218' ' ' LEU . 75.5 t80 -69.1 -23.88 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 3.3399999999999999 110.663 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 216' ' ' LEU . 8.3 tt -67.1 -49.46 64.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 1.1899999999999999 110.766 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.39 -38.23 83.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 2.23 110.856 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 215' ' ' PHE . 95.4 mt -59.3 -50.37 74.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 2.4700000000000002 111.109 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -72.67 -21.41 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 1.6200000000000001 110.871 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.62 -26.54 64.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 1.4099999999999999 112.567 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 2.5800000000000001 111.15 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.676 0.274 . . . . 2.0699999999999998 111.021 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.529 HD12 HD11 ' B' ' 10' ' ' ILE . 54.4 tp -67.61 -42.21 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.434 -0.348 . . . . 2.1000000000000001 111.099 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.625 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 40.4 m-70 -67.71 -25.37 65.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.49 . . . . 1.0700000000000001 110.35 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -72.97 -49.51 28.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 1.48 110.989 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.529 HD11 HD12 ' B' ' 7' ' ' LEU . 45.3 pt -69.0 -19.18 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.957 0.408 . . . . 2.02 110.789 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -66.55 -54.11 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 0.92000000000000004 110.589 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.57 -31.77 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.93999999999999995 111.003 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.39 -47.31 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.55000000000000004 111.236 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.12 74.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.666 -0.778 . . . . 0.47999999999999998 112.485 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.23 -31.51 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.84999999999999998 110.804 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -63.5 -58.11 8.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 1.3400000000000001 110.996 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.6 pp -61.21 -23.61 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 1.55 111.206 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.431 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -60.7 -51.81 56.38 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.632 -0.794 . . . . 0.69999999999999996 112.161 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -68.32 -23.39 64.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.81000000000000005 110.894 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.57 -43.2 90.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 2.2599999999999998 110.622 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.22 -25.43 61.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.78 110.432 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 83.2 t80 -66.1 -37.25 85.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.666 . . . . 4.5800000000000001 110.47 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.4 ' O ' ' OG ' ' B' ' 26' ' ' SER . 86.0 t90 -67.14 -35.41 79.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 3.3500000000000001 110.656 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 40.8 t -80.41 -19.59 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 1.5800000000000001 111.161 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.1 -22.38 39.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 1.8400000000000001 111.267 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 4.8 p -59.5 -24.48 63.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.553 -0.294 . . . . 1.3700000000000001 111.092 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -47.38 -32.43 4.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 4.9800000000000004 110.022 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 6.4 p30 -172.93 132.06 0.63 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 2.1400000000000001 110.278 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 52.2 Cg_endo -95.01 174.52 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.978 2.452 . . . . 1.8200000000000001 112.306 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -102.2 68.06 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 5.1900000000000004 111.366 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 -46.66 3.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.028 -0.606 . . . . 2.2000000000000002 112.84 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.02 144.93 29.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.515 0.198 . . . . 3.6499999999999999 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 165.47 8.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.405 2.07 . . . . 2.6699999999999999 112.218 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -69.2 -17.36 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.658 -0.701 . . . . 4.8799999999999999 112.413 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -41.17 -37.76 0.97 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.765 0.317 . . . . 1.8700000000000001 111.838 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.67 -57.07 12.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 2.6800000000000002 110.476 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.07 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 2.9199999999999999 110.783 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' B' ' 41' ' ' MET . 20.4 tp -60.38 -51.85 67.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.938 0.399 . . . . 1.6399999999999999 110.281 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -63.02 -38.48 82.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.094 0.473 . . . . 1.6000000000000001 109.872 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.82 -9.59 55.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.68999999999999995 110.7 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' B' ' 45' ' ' ILE . 22.0 ttt -87.94 -31.76 19.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 2.5800000000000001 110.426 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -72.65 -34.08 67.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 3.3900000000000001 111.397 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.658 HG23 HG23 ' B' ' 79' ' ' THR . 64.3 mt -52.91 -52.29 66.39 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 111.97 0.359 . . . . 0.40999999999999998 111.97 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.8 Cg_endo -71.18 -35.0 9.29 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.264 1.976 . . . . 0.48999999999999999 113.516 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 41' ' ' MET . 33.1 mm -56.64 -62.69 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.63 -57.38 12.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 1.3999999999999999 111.341 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -55.78 -23.56 30.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 1.3799999999999999 111.505 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.39 -64.42 3.36 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.37 112.552 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 60.0 mt -57.37 -27.52 62.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.325 . . . . 1.29 111.076 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.98 -55.76 26.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.16 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 13.8 m-85 -64.32 -41.09 96.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.5 111.235 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 51.6 ttp -49.41 -34.28 15.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.276 0.56 . . . . 1.4099999999999999 110.139 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.27 -40.09 71.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.449 -0.796 . . . . 0.55000000000000004 110.559 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 58.7 mtt -53.55 -30.6 42.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.5 110.299 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.2 -45.85 58.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.54000000000000004 110.671 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.518 HG21 HG23 ' C' ' 127' ' ' VAL . 13.1 mt -74.34 0.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.508 . . . . 1.3 110.746 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.485 ' HB2' HH12 ' C' ' 124' ' ' ARG . 8.0 m-20 63.76 52.15 2.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.794 -0.639 . . . . 2.2400000000000002 111.131 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -127.98 143.63 51.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.77 110.753 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.3 23.7 7.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.844 -0.693 . . . . 1.0600000000000001 112.394 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -137.43 137.49 38.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 2.6600000000000001 111.046 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.55 147.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.8899999999999999 111.005 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.25 94.01 9.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 2.4100000000000001 110.883 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.42 113.38 24.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 1.5600000000000001 111.182 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.45 30.54 18.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.434 . . . . 1.8200000000000001 111.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.84 -11.1 60.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.733 -0.746 . . . . 1.51 112.58 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.597 HE21 ' HA ' ' B' ' 66' ' ' GLN . 0.1 OUTLIER -100.84 134.63 43.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 2.4500000000000002 110.723 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.26 132.2 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 1.79 110.875 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.03 144.33 32.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.81999999999999995 111.565 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.507 ' HB3' ' HD3' ' B' ' 72' ' ' ARG . 74.4 m-70 -95.5 66.58 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.689 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -68.65 -35.54 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.8700000000000001 111.129 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.88 68.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.60999999999999999 111.61 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.507 ' HD3' ' HB3' ' B' ' 69' ' ' HIS . 10.3 mpt_? -74.21 -51.69 14.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.24 -0.436 . . . . 2.3900000000000001 111.193 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -49.46 77.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 3.6699999999999999 111.353 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.3 -38.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.12 0.415 . . . . 1.6599999999999999 112.12 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.45 -24.75 67.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.349 . . . . 1.4099999999999999 110.406 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -95.87 6.59 48.52 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.08 -0.509 . . . . 1.1599999999999999 110.664 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.62 ' HA ' HD13 ' B' ' 113' ' ' ILE . 53.9 tpp -103.94 -13.82 16.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 1.53 109.455 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.455 ' O ' HD23 ' B' ' 82' ' ' LEU . 26.1 m -114.81 -35.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.437 -0.801 . . . . 0.89000000000000001 111.271 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.658 HG23 HG23 ' B' ' 43' ' ' ILE . 46.2 m -81.48 -60.93 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 1.24 112.179 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.567 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 60.2 m -47.18 -51.27 42.76 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 112.675 0.62 . . . . 0.57999999999999996 112.675 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 80' ' ' THR . 11.0 Cg_endo -54.17 -34.39 78.6 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.048 1.832 . . . . 0.66000000000000003 111.856 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.522 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -79.01 -29.52 43.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 1.0600000000000001 110.769 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.2 tp -68.99 -30.01 68.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.018 0.437 . . . . 1.22 110.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -78.6 -30.36 46.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.749 -0.659 . . . . 1.53 110.072 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.522 HD12 HD13 ' B' ' 82' ' ' LEU . 76.0 mt -68.51 -42.52 78.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 1.5800000000000001 110.706 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -66.18 -41.51 90.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 1.3899999999999999 110.48 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -30.33 68.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.847 -0.615 . . . . 1.1499999999999999 110.53 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -70.72 -48.04 56.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 1.5700000000000001 110.997 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -66.71 -19.19 65.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 2.1699999999999999 111.149 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 34.3 m -79.92 -32.96 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 1.4199999999999999 111.051 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.57 -24.6 23.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.315 -0.402 . . . . 1.1799999999999999 111.431 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.6 mtp -100.01 104.38 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 1.8799999999999999 111.157 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -84.55 -38.15 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 3.4199999999999999 110.935 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.72 133.66 53.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 4.0599999999999996 110.944 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.92 148.53 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 2.0899999999999999 111.034 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -133.67 -67.29 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 3.8500000000000001 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -140.85 26.63 2.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 4.8200000000000003 110.903 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.99 106.49 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 3.7999999999999998 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -135.15 -9.14 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 5.1699999999999999 110.747 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -82.76 -37.0 25.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 2.02 110.959 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.59 -55.23 16.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 2.0899999999999999 110.53 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . 0.495 ' HA ' HD12 ' B' ' 105' ' ' LEU . 16.9 tt -55.4 -28.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 1.8799999999999999 111.14 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 62.97 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.868 -0.682 . . . . 0.56000000000000005 112.537 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.415 ' O ' HG23 ' B' ' 108' ' ' THR . 35.3 t80 -63.47 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 1.78 110.532 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.598 ' HB3' HD21 ' B' ' 84' ' ' LEU . 85.8 mt -59.05 -46.62 87.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 1.03 110.772 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . 0.523 ' O ' HG12 ' B' ' 110' ' ' ILE . 52.3 ttm -68.18 -22.25 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.759 -0.655 . . . . 1.6699999999999999 110.967 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 56.9 m -76.45 -39.93 51.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.93 0.395 . . . . 1.51 110.939 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 104' ' ' PHE . 60.8 p -64.82 -43.34 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 1.1799999999999999 111.533 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.556 HE21 HD13 ' B' ' 84' ' ' LEU . 3.8 pt20 -59.71 -42.87 94.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.539 -0.301 . . . . 2.1699999999999999 111.001 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.61 HG22 ' HE1' ' A' ' 46' ' ' TRP . 43.2 mm -53.55 -41.16 44.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.842 0.353 . . . . 1.3500000000000001 110.52 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 46' ' ' TRP . 26.5 t -62.16 -44.96 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 1.3400000000000001 111.239 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.46 -50.78 78.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.42999999999999999 111.757 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' B' ' 77' ' ' MET . 21.9 mt -58.57 -33.68 49.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.729 0.3 . . . . 1.6000000000000001 110.866 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.8 m -56.22 -40.54 74.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.17 0.509 . . . . 0.85999999999999999 110.172 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 39.2 m -60.51 -56.78 17.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.94999999999999996 110.243 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.87 -16.38 59.3 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.94 -0.648 . . . . 0.46000000000000002 112.278 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.08 -61.56 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.425 . . . . 1.75 110.596 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.77 -21.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.828 -0.624 . . . . 1.78 111.804 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.99 42.09 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.021 0.439 . . . . 0.38 110.949 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.08 -23.75 28.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 1.97 110.712 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.92 19.15 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.76000000000000001 110.853 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -75.68 129.05 36.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 1.47 110.977 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.57 -42.62 5.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 2.5 110.7 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.535 ' HB2' HG12 ' B' ' 127' ' ' VAL . 78.7 mtt180 -79.48 148.22 31.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 2.73 110.269 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.39 -22.33 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 2.2000000000000002 111.942 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 31.5 p90 -83.86 -25.98 29.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.685 0.279 . . . . 3.3999999999999999 111.222 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.535 HG12 ' HB2' ' B' ' 124' ' ' ARG . 8.6 p -83.28 -23.74 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 1.23 110.519 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.67 -37.93 66.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.775 -0.648 . . . . 3.04 110.991 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.68 -19.96 47.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.4 . . . . 4.1399999999999997 110.885 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' B' ' 127' ' ' VAL . 98.7 mt -76.22 -60.37 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 1.6499999999999999 111.139 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -62.74 -28.67 70.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.77000000000000002 111.26 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.4 -59.25 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 1.46 110.838 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.3 pt -61.45 -25.81 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 1.6299999999999999 111.446 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -66.4 -39.39 88.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 1.4199999999999999 111.035 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.71 31.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.816 -0.707 . . . . 0.48999999999999999 112.671 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' B' ' 180' ' ' PRO . 35.5 m -61.75 -32.42 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.65 0.262 . . . . 1.3 111.376 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.65 -30.55 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.3 111.076 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.03 78.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.412 . . . . 0.62 110.825 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.49 -28.41 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 1.74 110.972 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.17 -57.84 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.368 -0.378 . . . . 1.76 111.708 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.462 HG13 ' N ' ' B' ' 142' ' ' ILE . 40.2 pt -55.96 -43.29 74.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.893 0.331 . . . . 0.68999999999999995 111.893 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.462 ' N ' HG13 ' B' ' 141' ' ' ILE . 8.9 tp -72.57 -28.36 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.705 0.288 . . . . 1.76 111.252 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.03 -57.33 13.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 1.0600000000000001 110.797 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -63.82 -27.19 69.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 4.1200000000000001 110.559 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.21 -17.26 78.42 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.775 -0.726 . . . . 1.26 112.491 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.7 tt -109.2 0.31 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 1.98 111.467 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -86.09 -55.01 4.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.846 0.313 . . . . 1.4199999999999999 111.846 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 34.0 m120 . . . . . 0 C--N 1.329 -0.306 0 N-CA-C 112.324 0.49 . . . . 99.989999999999995 112.324 -179.478 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.826 0.346 . . . . 2.4300000000000002 110.968 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -22.3 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 2.5800000000000001 110.885 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.78 -54.08 47.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 2.0 110.837 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -63.26 -30.8 71.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 3.0299999999999998 110.919 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.87 -56.66 9.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 1.1000000000000001 111.147 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.86 -23.01 30.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 1.75 111.443 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 52.2 m -56.41 -58.54 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.95 0.405 . . . . 0.97999999999999998 110.582 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.36 -33.65 71.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 4.2999999999999998 110.515 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -64.78 -35.42 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 1.3899999999999999 111.278 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 53.1 m -72.83 -54.12 9.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.346 -0.388 . . . . 1.1100000000000001 111.639 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.66 -26.49 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.885 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -77.05 -57.78 3.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 1.75 111.279 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.22 -27.54 55.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.59999999999999998 110.862 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.503 ' O ' HG12 ' B' ' 181' ' ' ILE . 85.7 mt -87.65 -23.88 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 1.47 110.214 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.26 -55.44 29.48 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.55000000000000004 113.029 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 60.3 m-85 -54.23 -55.35 37.82 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.854 0.327 . . . . 1.6200000000000001 111.257 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.5 Cg_exo -45.22 -32.22 7.0 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.323 2.016 . . . . 0.64000000000000001 113.016 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.509 ' O ' HG22 ' B' ' 184' ' ' ILE . 47.1 mm -67.26 -61.13 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.392 -0.367 . . . . 1.27 111.739 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.465 HG22 ' O ' ' B' ' 179' ' ' TYR . 21.0 m -57.26 -24.76 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.68999999999999995 112.005 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -62.82 -23.65 67.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.407 -0.361 . . . . 1.1799999999999999 111.906 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.601 HG23 HG23 ' B' ' 185' ' ' ILE . 16.7 tt -57.54 -38.07 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.737 0.273 . . . . 1.77 111.737 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . 0.601 HG23 HG23 ' B' ' 184' ' ' ILE . 26.1 pt -102.34 156.6 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.759 0.314 . . . . 1.6899999999999999 111.137 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 120.725 -0.75 . . . . 1.5800000000000001 112.46 -179.851 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.665 0.269 . . . . 2.4700000000000002 111.081 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -53.83 -51.99 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 2.5299999999999998 110.647 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 61.6 p -63.03 -44.13 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.29 110.967 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.53 -28.83 48.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 2.6200000000000001 110.965 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -84.13 -51.62 6.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 1.6100000000000001 111.779 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -69.34 -2.07 9.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.9 0.333 . . . . 1.4199999999999999 111.9 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -96.83 -42.0 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.044 0.45 . . . . 1.4299999999999999 110.5 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.6 tp -71.82 -33.44 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.629 . . . . 1.1200000000000001 111.844 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.691 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.1 tp -62.8 -54.36 47.96 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.57 -0.252 . . . . 1.26 111.44 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.9 Cg_exo -55.66 -41.22 79.83 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.884 1.723 . . . . 0.59999999999999998 111.415 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -58.71 -36.48 74.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.037 0.446 . . . . 1.3999999999999999 110.173 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.28 -31.9 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 110.507 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.78 179.768 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.047 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.48 -36.64 93.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.79000000000000004 112.653 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.66 -29.2 66.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 2.96 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -62.85 -61.24 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 1.29 110.878 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -64.0 -22.13 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 3.1499999999999999 110.745 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.408 ' C ' HD13 ' B' ' 216' ' ' LEU . 3.2 tm? -71.48 -49.36 42.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 1.51 110.674 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.52 -31.95 72.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 2.1899999999999999 110.852 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.74 -38.27 90.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 1.98 110.724 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -85.28 -20.65 29.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 2.1699999999999999 111.017 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.21 -36.1 73.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.902 -0.666 . . . . 1.3600000000000001 112.762 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.681 0.277 . . . . 2.8999999999999999 111.262 -179.779 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.465 HD23 ' N ' ' C' ' 6' ' ' LEU . 2.5 pt? . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.749 0.309 . . . . 2.52 111.221 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.12 -45.06 82.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.382 -0.372 . . . . 1.9299999999999999 111.084 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 36.3 m-70 -68.26 -25.27 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 1.26 110.782 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -73.07 -48.34 36.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 1.6699999999999999 110.887 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.9 -21.07 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 1.8700000000000001 110.156 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.73 -57.48 9.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 1.4399999999999999 110.711 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.3 -31.75 49.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.199 -0.455 . . . . 0.46999999999999997 111.106 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.4 81.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 0.58999999999999997 111.301 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.07 -24.36 75.89 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.5 112.656 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -77.15 -34.73 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.68000000000000005 111.166 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 46.7 m -65.44 -48.71 71.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 1.3999999999999999 110.997 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . 0.406 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.7 pp -63.82 -29.38 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.379 -0.373 . . . . 1.55 110.952 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.406 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -58.4 -51.74 56.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.70999999999999996 112.389 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 -24.06 66.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.77000000000000002 111.217 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 52.6 tp -67.71 -39.17 84.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 1.9299999999999999 110.731 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.12 -27.62 67.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 1.8600000000000001 110.618 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.63 -39.98 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.94 -0.573 . . . . 4.1399999999999997 110.788 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -62.92 -48.14 80.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 3.1499999999999999 110.763 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 55.1 m -68.54 -19.66 64.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.95 111.359 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.474 ' HG ' HE22 ' C' ' 34' ' ' GLN . 54.1 tp -83.34 -20.68 33.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.439 -0.346 . . . . 2.2200000000000002 111.307 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 75.8 p -60.43 -21.59 62.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.686 -0.234 . . . . 1.3700000000000001 111.096 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -52.03 -31.3 29.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 5.0300000000000002 109.809 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.9 p-10 -171.9 131.91 0.75 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 2.3700000000000001 110.293 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.7 Cg_endo . . . . . 0 N--CA 1.451 -1.009 0 C-N-CA 123.19 2.594 . . . . 2.0499999999999998 112.15 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 CA--C 1.527 0.173 0 CA-C-O 121.212 0.422 . . . . 1.9299999999999999 112.747 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . 0.474 HE22 ' HG ' ' C' ' 25' ' ' LEU . 84.7 mm-40 -66.53 -17.56 64.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.544 -0.753 . . . . 4.1200000000000001 112.658 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -41.36 -38.22 1.17 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.812 0.301 . . . . 2.8900000000000001 111.812 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.33 -53.09 58.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 2.46 110.684 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -66.73 -19.04 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 2.7799999999999998 110.739 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' C' ' 41' ' ' MET . 22.2 tp -61.06 -49.61 76.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.094 0.473 . . . . 1.6200000000000001 110.207 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.42 -42.43 96.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.025 -0.534 . . . . 1.5900000000000001 110.093 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -6.8 35.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.797 -0.638 . . . . 0.65000000000000002 110.872 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 25.8 ttt -87.87 -33.22 18.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 1.6699999999999999 110.402 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' C' ' 45' ' ' ILE . 34.3 t80 -71.37 -36.99 71.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 3.4199999999999999 111.32 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.501 HG23 HG23 ' C' ' 79' ' ' THR . 74.7 mt -49.33 -53.4 40.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.132 0.419 . . . . 0.89000000000000001 112.132 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.27 -33.21 11.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.171 1.914 . . . . 0.40999999999999998 112.912 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 41' ' ' MET . 77.2 mt -53.3 -62.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.631 0.253 . . . . 1.76 111.452 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -62.87 -56.08 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.446 -0.343 . . . . 2.1600000000000001 111.216 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . 0.41 ' HG ' ' HA ' ' C' ' 44' ' ' PRO . 98.6 p -51.73 -23.07 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.045 -0.525 . . . . 1.1699999999999999 111.212 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.34 -64.62 2.69 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.45 -0.881 . . . . 0.44 112.058 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.94 -28.67 62.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 1.29 110.914 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 -58.79 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.5 111.16 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 18.4 m-85 -60.93 -40.62 93.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.387 . . . . 1.8300000000000001 110.972 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.0 ttp -49.48 -38.34 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.439 . . . . 1.47 110.021 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.34 82.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.59999999999999998 110.649 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 56.3 mtt -54.89 -33.08 61.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.83999999999999997 110.174 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.7 -38.48 73.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.821 -0.627 . . . . 0.65000000000000002 110.385 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mt -80.44 -0.42 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 1.55 110.527 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.32 41.84 12.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.794 -0.639 . . . . 1.54 111.177 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -117.05 134.92 54.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 1.79 110.612 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.89 37.66 1.66 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.833 -0.699 . . . . 0.93999999999999995 112.222 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -154.11 132.49 11.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 2.3599999999999999 111.119 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -114.1 142.1 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 1.97 110.836 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.13 96.05 8.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 2.4399999999999999 111.056 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.44 124.71 43.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 1.54 110.962 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.31 27.19 16.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 1.71 111.139 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -13.59 57.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.802 -0.713 . . . . 1.53 112.517 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -100.78 145.15 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.883 0.373 . . . . 2.23 111.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -89.96 135.72 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.769 -0.651 . . . . 1.3600000000000001 110.934 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.92 138.39 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.78000000000000003 111.386 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -88.71 64.55 7.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 1.0800000000000001 110.802 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.57 -35.3 77.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 2.2999999999999998 111.01 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.56 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.75 111.576 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.522 HH22 ' HB2' ' C' ' 203' ' ' CYS . 27.3 mmt180 -70.79 -51.29 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 1.51 111.751 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -47.76 74.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.55 -0.296 . . . . 4.6500000000000004 111.65 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.42 -40.49 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.696 0.628 . . . . 1.22 112.696 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.48 -28.5 69.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.398 -0.521 . . . . 1.3100000000000001 110.37 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -88.54 4.1 47.96 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.181 -0.463 . . . . 1.6799999999999999 111.035 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.651 ' HA ' HD13 ' C' ' 113' ' ' ILE . 50.3 tpp -95.97 -20.09 19.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 1.8 109.994 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.437 ' O ' HD23 ' C' ' 82' ' ' LEU . 12.5 m -114.38 -38.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.582 -0.736 . . . . 1.1899999999999999 111.653 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.501 HG23 HG23 ' C' ' 43' ' ' ILE . 78.4 m -73.65 -55.89 5.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.23 111.998 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 17.9 m -50.1 -51.85 58.55 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.505 0.557 . . . . 0.58999999999999997 112.505 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.2 Cg_exo -53.21 -42.64 63.48 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.781 1.654 . . . . 0.67000000000000004 111.791 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.437 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.1 mm? -67.92 -32.55 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.95999999999999996 110.004 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.497 ' O ' HD23 ' C' ' 87' ' ' LEU . 0.2 OUTLIER -68.87 -25.92 64.87 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.833 -0.802 . . . . 1.1899999999999999 108.833 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' C' ' 109' ' ' GLN . 24.0 tp -80.63 -38.21 29.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.014 -0.994 . . . . 1.7 110.311 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . 0.435 ' HG ' ' HE1' ' C' ' 89' ' ' TRP . 19.7 tp -65.84 -52.78 47.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.208 -0.906 . . . . 1.6200000000000001 111.15 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.3 p -50.93 -44.17 60.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 1.26 111.395 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.497 HD23 ' O ' ' C' ' 83' ' ' LEU . 3.6 mm? -62.37 -33.48 74.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 1.1100000000000001 111.184 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 57.7 m -70.87 -22.67 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 1.51 111.196 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . 0.435 ' HE1' ' HG ' ' C' ' 85' ' ' LEU . 93.4 m95 -80.72 -52.12 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 2.0600000000000001 111.233 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . 0.437 HG23 HD21 ' C' ' 168' ' ' LEU . 9.8 t -62.71 -27.55 69.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 1.52 111.36 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' C' ' 165' ' ' TYR . . . -80.47 -22.97 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.174 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.0 mtp -110.53 102.34 10.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 1.6200000000000001 110.882 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.98 -40.44 39.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 3.2400000000000002 110.897 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -108.14 138.64 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.6299999999999999 111.038 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.1 pt -145.31 146.76 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 2.1800000000000002 110.969 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.63 -74.79 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.948 0.404 . . . . 4.1200000000000001 111.067 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -139.07 25.89 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 4.96 110.771 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.73 129.68 38.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 3.9100000000000001 110.741 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -151.28 -28.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 5.21 110.832 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 1.7 t -63.99 -46.31 85.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.215 -0.448 . . . . 1.8200000000000001 111.475 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.71 -37.19 86.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 2.0800000000000001 110.823 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.87 -29.16 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.8600000000000001 110.64 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.26 -30.26 46.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.956 -0.64 . . . . 0.58999999999999997 112.602 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -71.84 -25.24 61.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 1.53 110.461 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 mt -77.69 -49.38 14.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.1100000000000001 110.81 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.2 ptm -64.95 -24.26 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 2.21 111.045 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 94.5 p -72.33 -50.24 28.33 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.022 0.439 . . . . 1.28 110.504 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -60.03 -24.8 64.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.077 -0.51 . . . . 1.22 110.976 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.507 ' HB2' HD22 ' C' ' 84' ' ' LEU . 24.8 tp60 -66.98 -52.12 46.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 2.3300000000000001 110.613 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.9 -35.41 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.004 -0.544 . . . . 1.29 110.758 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.26 -45.36 98.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 1.0600000000000001 110.929 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.54 -47.86 89.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.51000000000000001 111.394 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' C' ' 77' ' ' MET . 19.7 mt -59.4 -32.55 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 1.3700000000000001 111.009 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -60.5 -43.65 96.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.459 . . . . 0.77000000000000002 110.508 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -59.22 -53.96 52.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 1.1899999999999999 110.428 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.54 -25.56 68.87 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.789 -0.719 . . . . 0.5 111.826 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.402 HD23 ' C ' ' C' ' 117' ' ' LEU . 5.4 tt -60.19 -55.9 28.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.29 0.567 . . . . 1.47 110.329 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' C' ' 121' ' ' LEU . 4.8 tp -81.22 -28.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 1.2 112.188 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.33 46.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.40000000000000002 111.233 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -79.68 -31.15 41.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 2.1200000000000001 110.843 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.547 ' HB2' HD12 ' C' ' 118' ' ' ILE . 73.9 mt -80.79 7.49 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.323 -0.399 . . . . 0.75 110.912 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.0 t -63.42 122.98 17.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 1.3799999999999999 111.223 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.03 -51.55 3.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 2.7400000000000002 110.704 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . 0.661 ' HB2' HG12 ' C' ' 127' ' ' VAL . 90.6 mtt180 -75.65 143.78 42.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 2.7999999999999998 110.662 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.07 -19.09 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 111.667 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -79.46 -54.47 5.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.709 0.29 . . . . 4.2000000000000002 111.108 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' C' ' 124' ' ' ARG . 14.2 p -59.69 -24.04 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 1.0800000000000001 111.367 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -51.52 -47.55 63.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.34 -0.391 . . . . 2.5699999999999998 111.302 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.24 -24.78 62.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.334 -0.393 . . . . 3.8100000000000001 111.339 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.453 HD13 HD13 ' B' ' 56' ' ' ILE . 95.6 mt -72.65 -52.21 16.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.4199999999999999 111.166 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.27 -28.7 66.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.89000000000000001 110.792 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -59.84 -60.41 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.823 -0.626 . . . . 1.26 110.451 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' C' ' 136' ' ' VAL . 16.4 tt -63.95 -26.23 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.917 -0.583 . . . . 1.6799999999999999 111.087 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.54 -35.29 80.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 1.24 110.793 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.61 -53.75 7.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.81 -0.709 . . . . 0.54000000000000004 112.587 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' C' ' 133' ' ' ILE . 34.1 m -59.46 -30.75 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.321 . . . . 1.0600000000000001 111.352 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.8 -35.27 72.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0800000000000001 110.67 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.58 93.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.8 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . 0.401 ' HA ' HG12 ' C' ' 142' ' ' ILE . 79.3 t80 -73.16 -24.04 60.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.903 -0.59 . . . . 1.6799999999999999 111.083 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -60.94 2.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 1.7 111.357 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.416 HG13 ' N ' ' C' ' 142' ' ' ILE . 17.6 pt -58.34 -45.71 89.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.608 0.596 . . . . 0.78000000000000003 112.608 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.416 ' N ' HG13 ' C' ' 141' ' ' ILE . 41.8 pt -66.44 -32.26 57.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.685 0.254 . . . . 2.2400000000000002 111.685 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 56.5 tp -55.76 -56.64 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.603 0.239 . . . . 1.02 110.901 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -64.79 -24.52 67.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 3.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.38 -17.37 76.26 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.343 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . 0.4 HG13 ' O ' ' C' ' 142' ' ' ILE . 68.8 mt -109.24 -12.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.957 0.408 . . . . 1.8899999999999999 111.031 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -72.4 -55.4 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 1.6000000000000001 111.998 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 34.0 m120 . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.406 0.521 . . . . 99.989999999999995 112.406 -179.467 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.243 0.545 . . . . 2.3500000000000001 110.469 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . 0.523 ' CE2' ' HB1' ' C' ' 91' ' ' ALA . 0.4 OUTLIER -61.62 -36.03 79.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 2.6200000000000001 111.108 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.82 -56.22 17.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 2.0899999999999999 111.539 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . 0.418 ' O ' HG22 ' C' ' 170' ' ' THR . 68.5 mttm -59.34 -22.21 60.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 3.2400000000000002 111.461 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.437 HD21 HG23 ' C' ' 90' ' ' THR . 56.3 tp -81.95 -59.05 2.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 1.6899999999999999 111.413 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.67 -29.27 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.3999999999999999 112.192 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . 0.418 HG22 ' O ' ' C' ' 167' ' ' LYS . 15.3 t -57.05 -36.17 70.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.95999999999999996 110.988 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -77.32 -34.71 55.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 3.6499999999999999 109.943 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.24 -22.59 63.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.688 -0.687 . . . . 1.3700000000000001 110.474 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 90.6 m -79.52 -58.56 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 1.4299999999999999 111.264 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.68 -28.52 32.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 1.6200000000000001 111.785 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.424 HD21 ' OG ' ' C' ' 209' ' ' SER . 46.8 tp -73.34 -57.4 4.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 2.0299999999999998 111.163 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.78 -25.55 60.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.62 110.875 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 86.4 mt -87.89 -21.57 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.045 0.45 . . . . 1.5800000000000001 110.414 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . 0.527 ' O ' HG22 ' C' ' 181' ' ' ILE . . . -63.4 -41.6 99.33 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.56000000000000005 112.998 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.525 ' N ' ' HD2' ' C' ' 180' ' ' PRO . 55.5 m-85 -64.47 -52.03 55.82 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 111.988 0.366 . . . . 1.3300000000000001 111.988 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.588 ' HA ' ' NE1' ' C' ' 183' ' ' TRP . 33.1 Cg_endo -63.76 -16.78 56.78 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.01 1.807 . . . . 0.63 113.326 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.527 HG22 ' O ' ' C' ' 178' ' ' GLY . 3.6 tt -88.99 -27.09 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 112.483 0.549 . . . . 0.93000000000000005 112.483 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.429 HG13 ' N ' ' C' ' 183' ' ' TRP . 3.8 p -80.88 -53.78 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.47 0.915 . . . . 1.27 113.47 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . 0.588 ' NE1' ' HA ' ' C' ' 180' ' ' PRO . 0.2 OUTLIER -58.32 -12.11 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.198 0.444 . . . . 1.77 112.198 -178.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.99 -18.84 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.996 0.427 . . . . 2.3900000000000001 110.703 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 2.4 pt . . . . . 0 C--O 1.233 0.206 0 CA-C-N 115.858 -0.61 . . . . 1.95 111.201 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.642 0.258 . . . . 2.3799999999999999 111.408 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 88.3 mt -72.97 -45.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.403 -0.362 . . . . 2.23 111.295 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.25 -46.97 76.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 2.1600000000000001 110.894 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -69.52 -26.92 64.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 1.27 111.08 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -69.71 -33.36 72.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 1.7 110.981 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.22 -45.53 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 2.02 111.396 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -67.5 -7.44 25.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 1.8200000000000001 111.266 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.522 ' HB2' HH22 ' C' ' 72' ' ' ARG . 44.3 t -96.47 -43.52 7.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 1.3500000000000001 110.568 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 39.4 tp -67.82 -37.05 81.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.48 -0.782 . . . . 0.65000000000000002 112.149 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.609 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.4 OUTLIER -60.86 -55.21 46.97 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.942 -0.303 . . . . 1.4199999999999999 111.446 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 66.8 Cg_exo -53.75 -36.78 83.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.691 1.594 . . . . 0.63 111.368 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.86 -46.15 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 1.49 109.985 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -68.29 -16.55 64.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 1.7 110.483 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . 0.424 ' OG ' HD21 ' C' ' 175' ' ' LEU . 30.6 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 1.25 110.914 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.808 0.337 . . . . 1.6100000000000001 111.094 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.89 -40.11 98.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.81999999999999995 112.333 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.93 -27.92 67.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 3.0800000000000001 110.97 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 52.9 m -61.44 -57.15 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 1.1499999999999999 110.967 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.86 -29.41 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 2.5600000000000001 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.451 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.1 tm? -66.04 -40.44 90.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 1.29 110.535 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.01 -22.06 60.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.082 -0.508 . . . . 2.3900000000000001 110.459 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 43.8 tp -74.5 -42.07 59.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 2.0299999999999998 110.552 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -85.13 -20.27 30.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 3.21 111.025 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.57 49.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.991 -0.623 . . . . 1.3600000000000001 112.714 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.733 0.301 . . . . 2.8999999999999999 111.192 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.812 0.339 . . . . 2.4199999999999999 110.775 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.85 -52.33 44.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 2.0899999999999999 110.555 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 40.6 m-70 -68.42 -23.55 64.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.89 -0.596 . . . . 1.1599999999999999 110.101 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -66.57 -52.17 48.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.681 . . . . 0.79000000000000004 111.115 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.0 pt -68.53 -21.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0800000000000001 110.773 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -60.6 -55.06 37.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 1.28 110.56 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.98 -36.24 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.966 -0.561 . . . . 1.3200000000000001 111.127 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.43 -37.63 73.12 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.935 0.398 . . . . 0.63 110.92 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.04 -29.41 58.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.721 -0.752 . . . . 0.55000000000000004 112.178 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -74.81 -31.72 61.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.299 . . . . 1.03 111.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 p -68.11 -50.19 56.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.481 -0.327 . . . . 1.3 111.111 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.47 -26.58 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.287 -0.415 . . . . 1.3100000000000001 110.725 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.49 44.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.61 -0.805 . . . . 0.77000000000000002 111.9 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -64.79 -23.48 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.903 0.382 . . . . 0.80000000000000004 110.716 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -68.78 -41.62 78.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.08 -0.509 . . . . 1.8100000000000001 110.776 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -60.54 -23.53 64.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 1.8799999999999999 110.305 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 84.7 t80 -60.84 -31.9 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.659 -0.7 . . . . 4.4500000000000002 110.566 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.466 ' O ' ' OG ' ' A' ' 26' ' ' SER . 68.4 t-105 -78.51 -45.52 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 3.6899999999999999 110.531 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 p -65.9 -19.72 65.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.978 -0.555 . . . . 1.5700000000000001 110.748 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.96 -12.74 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 1.95 110.743 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 72.7 p -69.64 -18.53 63.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 1.3799999999999999 111.01 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -49.56 -32.98 13.73 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.36 0.6 . . . . 4.0700000000000003 109.575 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -176.86 131.82 0.37 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.959 -1.018 . . . . 2.7200000000000002 110.096 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HB3' ' NE2' ' A' ' 34' ' ' GLN . 72.5 Cg_endo -95.54 177.41 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.007 2.471 . . . . 1.9099999999999999 112.224 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -99.36 63.8 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 4.7599999999999998 111.298 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -46.55 3.5 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.751 -0.737 . . . . 1.99 112.554 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.6 146.43 31.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.526 0.203 . . . . 2.7000000000000002 110.776 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.64 165.49 18.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.367 2.044 . . . . 1.79 112.399 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 29' ' ' PRO . 27.4 mm-40 -72.32 -15.86 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.412 -0.813 . . . . 4.1200000000000001 112.016 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -40.27 -38.98 0.86 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.334 0.494 . . . . 2.9300000000000002 112.334 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 37' ' ' TYR . 11.7 pt-20 -64.84 -46.9 79.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 2.8799999999999999 110.568 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 73.8 m-85 -70.49 -18.6 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 4.6600000000000001 110.488 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 41' ' ' MET . 54.3 tp -63.2 -49.28 74.86 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.219 -0.446 . . . . 1.45 110.321 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -63.5 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.174 0.511 . . . . 1.78 109.663 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 -5.01 40.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.588 -0.733 . . . . 0.63 110.475 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.475 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 22.0 ttt -88.25 -34.07 17.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.094 -0.503 . . . . 1.48 110.473 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.443 ' HA ' HD12 ' A' ' 45' ' ' ILE . 44.3 t80 -75.67 -31.4 59.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 3.5 110.883 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.704 HG23 HG23 ' A' ' 79' ' ' THR . 85.2 mt -52.54 -51.75 70.17 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.336 -0.393 . . . . 1.0800000000000001 111.597 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' C ' ' A' ' 41' ' ' MET . 73.5 Cg_endo -74.3 -32.21 6.76 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.408 2.072 . . . . 0.53000000000000003 112.804 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 42' ' ' PHE . 72.0 mt -53.67 -61.62 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.633 0.254 . . . . 1.6799999999999999 111.539 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.482 ' NE1' HG22 ' B' ' 110' ' ' ILE . 2.1 t90 -64.8 -51.42 62.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.688 0.28 . . . . 1.8300000000000001 111.064 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 44' ' ' PRO . 95.8 p -57.67 -14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.325 -0.398 . . . . 1.0900000000000001 111.196 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.77 -57.95 2.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.40999999999999998 112.491 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.78 -28.41 65.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.98999999999999999 111.032 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.36 -59.36 5.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.541 . . . . 0.47999999999999998 111.267 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 16.0 m-85 -59.47 -43.07 93.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 1.8700000000000001 111.126 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.9 ttp -48.24 -35.4 11.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.187 0.518 . . . . 1.49 110.216 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -67.99 -43.85 77.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.72 -0.673 . . . . 0.58999999999999997 110.648 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 56.1 mtt -52.12 -27.83 15.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.48999999999999999 110.244 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.11 -45.26 58.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.719 -0.673 . . . . 0.59999999999999998 110.622 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 53' ' ' ALA . 20.8 pt -84.18 11.15 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 1.3100000000000001 111.109 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 60.05 50.59 6.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.923 -0.58 . . . . 1.9099999999999999 111.675 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.02 158.25 30.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 1.6200000000000001 110.937 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.23 34.55 32.55 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.733 -0.746 . . . . 1.04 112.307 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -129.9 136.37 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.309 . . . . 2.6800000000000002 110.896 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.3 140.13 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 1.98 111.259 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.82 89.99 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 2.1800000000000002 111.034 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.74 126.11 42.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.332 -0.394 . . . . 1.5700000000000001 111.407 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 34.87 24.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 1.79 111.54 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.17 -0.31 59.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.823 -0.704 . . . . 1.48 112.835 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -98.35 134.27 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.673 0.273 . . . . 2.3199999999999998 110.771 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 mt -89.3 103.79 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 1.4399999999999999 110.942 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.38 135.52 38.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.81999999999999995 110.861 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 53.0 m-70 -82.65 73.71 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.186 0.517 . . . . 0.90000000000000002 110.723 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -58.92 -28.89 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.45 -0.795 . . . . 1.8300000000000001 111.458 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -82.04 -23.96 35.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.62 111.805 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 12.9 tpp180 -67.24 -51.27 55.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 2.3399999999999999 112.386 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 9.1 p90 -82.53 -32.5 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.275 0.472 . . . . 3.4900000000000002 112.275 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 71' ' ' ALA . 17.0 tt -55.23 -42.15 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 C-N-CA 120.713 -0.395 . . . . 1.3700000000000001 110.489 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.33 -22.81 64.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.445 -0.576 . . . . 1.3100000000000001 109.445 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -87.79 5.13 41.56 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.475 -0.784 . . . . 1.48 111.103 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.485 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.3 ttm -104.59 -18.18 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 1.46 110.494 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.415 ' O ' HD23 ' A' ' 82' ' ' LEU . 35.2 m -114.05 -35.29 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 1.1200000000000001 111.517 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.704 HG23 HG23 ' A' ' 43' ' ' ILE . 87.9 m -82.14 -49.0 10.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.246 -0.434 . . . . 1.1000000000000001 111.648 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.582 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.8 m -53.39 -49.92 85.65 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.199 -0.455 . . . . 0.59999999999999998 112.197 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.9 Cg_endo -58.88 -41.51 61.68 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.97 1.78 . . . . 0.73999999999999999 112.17 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -78.8 -7.97 58.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 1.01 110.894 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -81.42 -40.29 23.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.796 0.332 . . . . 1.48 110.283 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 109' ' ' GLN . 3.6 pp -81.62 -31.59 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.3799999999999999 110.223 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.54 -27.94 63.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 1.1899999999999999 110.319 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -63.69 -24.68 67.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 1.23 110.399 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.09 -52.53 18.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.88 110.739 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.2 t -60.21 -21.41 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 1.3899999999999999 110.838 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -76.4 -36.59 57.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 2.3199999999999998 111.052 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 p -80.92 -23.44 38.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 1.46 111.353 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 -37.14 17.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 1.24 111.21 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.9 ttt -97.74 99.42 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 2.0699999999999998 110.435 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -85.91 -48.8 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 3.5299999999999998 111.244 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -104.57 137.32 42.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 4.0800000000000001 111.067 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 pt -123.71 151.43 28.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 2.1699999999999999 110.843 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.12 -54.49 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 4.5199999999999996 110.558 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -150.12 -159.59 1.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 3.75 110.438 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 64.68 105.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.024 0.44 . . . . 3.5299999999999998 111.228 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -119.53 15.86 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.609 . . . . 4.9100000000000001 110.553 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.3 t -87.16 -21.25 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 1.98 110.834 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.47 -51.52 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 1.8300000000000001 110.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -59.19 -30.68 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 1.79 111.081 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.1 -27.19 64.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.62 112.542 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -73.43 -38.41 65.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 1.5800000000000001 110.972 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.3 mt -71.74 -32.54 67.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.97999999999999998 111.119 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.466 ' O ' HG12 ' A' ' 110' ' ' ILE . 61.1 mtt -74.23 -25.3 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 1.48 111.11 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -76.95 -49.44 15.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 1.1299999999999999 111.256 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.5 t -62.41 -35.43 79.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 1.48 111.949 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.591 ' HB3' HD21 ' A' ' 84' ' ' LEU . 13.8 pt20 -67.3 -42.05 84.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.567 0.223 . . . . 2.7000000000000002 111.465 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 106' ' ' MET . 33.1 mm -60.05 -33.45 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.827 0.346 . . . . 1.54 111.067 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.29 -44.6 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.28 111.458 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.64 -50.09 77.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.42999999999999999 111.864 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.412 HD12 ' HG3' ' A' ' 77' ' ' MET . 48.5 pt -57.2 -33.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.626 0.25 . . . . 1.74 111.437 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 85.4 m -63.67 -47.61 80.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.63 111.12 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -63.81 -21.76 66.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.163 -0.471 . . . . 1.0900000000000001 110.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.61 -46.44 7.32 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.937 -0.649 . . . . 0.41999999999999998 112.95 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -66.75 -29.13 69.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.52 0.2 . . . . 1.3799999999999999 111.53 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.1 tp -83.46 -28.4 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.551 -0.295 . . . . 1.6200000000000001 111.161 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.68 71.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.39000000000000001 110.803 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.08 -23.55 41.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 2.02 110.783 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.404 ' HB2' HD12 ' A' ' 118' ' ' ILE . 84.2 mt -83.59 23.72 0.93 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.76000000000000001 110.837 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.1 t -76.31 137.04 39.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 1.46 110.967 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.07 -34.54 8.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 3.3500000000000001 110.922 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.57 ' HB2' HG12 ' A' ' 127' ' ' VAL . 98.5 mtt180 -116.48 143.09 46.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 2.9199999999999999 110.982 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -74.68 -12.11 60.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 2.77 111.137 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -86.58 -39.53 16.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 3.77 111.072 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.591 HG11 ' NE2' ' C' ' 58' ' ' GLN . 14.5 p -77.78 -24.23 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 1.1599999999999999 111.086 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -57.62 -29.28 64.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.005 -0.543 . . . . 2.04 110.754 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.03 -31.42 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 2.6400000000000001 110.964 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 127' ' ' VAL . 3.5 mm? -73.31 -42.28 62.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.067 -0.515 . . . . 1.8999999999999999 111.163 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -74.17 -31.65 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 1.3999999999999999 110.995 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.46 -56.96 15.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.28 110.654 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.8 tt -62.17 -29.4 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.233 -0.439 . . . . 2.1600000000000001 110.933 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.5 t -61.18 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 1.6899999999999999 111.197 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.26 -52.53 10.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.675 -0.774 . . . . 0.52000000000000002 112.535 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.21 -29.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 1.02 111.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 36.4 t -64.44 -42.43 96.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0800000000000001 110.747 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.05 93.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.62 110.925 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -76.73 -15.8 59.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 1.8400000000000001 111.02 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.67 -55.1 6.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.372 . . . . 1.6899999999999999 110.621 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.53 -34.92 63.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.81000000000000005 111.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 146' ' ' ILE . 39.8 mm -71.44 -44.12 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 2.3700000000000001 110.969 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.23 -56.06 24.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.97999999999999998 110.931 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -63.04 -21.89 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 3.27 111.097 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.74 -20.44 61.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 1.25 112.866 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 142' ' ' ILE . 70.3 mt -99.56 -12.68 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.458 . . . . 2.1200000000000001 110.783 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -69.0 -50.64 47.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 1.6599999999999999 111.577 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 99.989999999999995 112.143 -179.091 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 92.5 mt . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.791 0.329 . . . . 2.3399999999999999 110.675 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.64 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 2.77 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -38.85 68.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 2.04 110.921 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.07 -22.79 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.256 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 74.9 mt -73.99 -60.04 2.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.361 -0.381 . . . . 1.8899999999999999 111.135 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.0 t -55.84 -23.84 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.883 -0.598 . . . . 1.6399999999999999 111.45 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.9 m -56.18 -58.94 5.83 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.841 0.353 . . . . 1.24 111.262 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.43 -30.66 69.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 2.9700000000000002 110.805 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.81 -28.65 69.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 1.48 111.05 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.403 HG22 HD12 ' A' ' 177' ' ' ILE . 55.2 m -77.91 -56.64 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 1.55 111.283 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.62 -28.76 28.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.573 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.89 -57.77 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 1.8500000000000001 111.405 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.3 -27.29 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.62 110.885 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.529 ' O ' HG12 ' A' ' 181' ' ' ILE . 90.9 mt -87.73 -25.0 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.235 -0.439 . . . . 1.3500000000000001 110.3 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 181' ' ' ILE . . . -55.81 -55.9 26.61 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.872 -0.603 . . . . 0.58999999999999997 113.311 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.0 m-85 -53.33 -55.8 30.83 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.765 -0.374 . . . . 1.45 110.788 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.2 Cg_exo -45.45 -33.34 9.1 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.084 1.856 . . . . 0.55000000000000004 112.423 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.1 mm -59.39 -53.82 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 121.024 0.44 . . . . 1.4199999999999999 110.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.5 m -58.43 -24.23 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.78000000000000003 111.082 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -83.88 -16.45 44.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.93999999999999995 111.773 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 93.4 mt -50.7 -37.41 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.818 0.342 . . . . 1.4299999999999999 110.95 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 185' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.404 . . . . 2.02 111.333 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 86.1 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.687 0.279 . . . . 2.48 111.275 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.85 -56.12 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 2.1800000000000002 110.888 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.2 p -64.91 -31.67 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 1.49 110.969 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -61.47 -30.89 70.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.03 -0.532 . . . . 1.77 111.084 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.71 -52.45 15.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 1.4199999999999999 111.199 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.94 -6.42 41.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.572 -0.285 . . . . 1.78 111.373 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 29.1 t -96.24 -39.7 9.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 1.3 110.543 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.8 -40.99 65.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.622 -0.717 . . . . 0.66000000000000003 112.094 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -56.39 -54.74 49.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.149 -0.221 . . . . 1.6299999999999999 111.405 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.5 Cg_exo -55.76 -45.18 41.0 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.829 1.686 . . . . 0.64000000000000001 111.538 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.01 -24.62 66.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 1.3600000000000001 110.464 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -81.95 -21.86 36.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 1.54 110.693 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 1.2 111.112 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.803 0.335 . . . . 1.6399999999999999 111.295 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.69 -45.26 90.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.674 -0.774 . . . . 0.79000000000000004 112.916 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -69.72 -28.68 66.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.62 0.248 . . . . 1.6100000000000001 111.196 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -55.19 -62.06 1.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.432 -0.349 . . . . 1.1499999999999999 110.836 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -64.66 -29.34 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 3.3399999999999999 110.46 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.05 -45.98 91.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 1.1899999999999999 110.589 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.21 -35.08 79.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 2.23 110.517 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.065 -0.516 . . . . 2.4700000000000002 110.351 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -83.77 -25.91 30.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 1.6200000000000001 110.847 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -79.47 -24.39 60.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 1.4099999999999999 112.34 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 2.5800000000000001 110.747 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.457 ' N ' HD12 ' B' ' 6' ' ' LEU . 6.7 mp . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.747 0.308 . . . . 2.0699999999999998 110.824 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.413 HD13 ' HD1' ' B' ' 200' ' ' PHE . 57.4 mt -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 2.1000000000000001 111.004 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.642 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.0 m80 -80.01 -24.42 40.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 1.0700000000000001 110.505 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -73.66 -35.34 65.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 1.48 110.812 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 tt -80.73 -26.52 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 2.02 110.693 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' B' ' 15' ' ' MET . 41.8 t80 -62.09 -47.41 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.92000000000000004 110.271 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.43 -36.94 74.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.93999999999999995 111.084 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -36.11 79.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.55000000000000004 110.978 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.74 59.15 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.781 -0.723 . . . . 0.47999999999999998 112.311 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 23.1 mmt -72.73 -27.78 62.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 0.84999999999999998 110.785 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -64.88 -56.41 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 1.3400000000000001 110.88 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.4 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -61.28 -24.94 34.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.044 -0.525 . . . . 1.55 110.984 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.4 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -58.69 -57.72 18.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.636 -0.792 . . . . 0.69999999999999996 112.199 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.661 ' HA ' ' HG3' ' B' ' 41' ' ' MET . . . -62.85 -23.41 67.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.81000000000000005 110.788 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.95 -39.2 83.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 2.2599999999999998 110.571 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -61.41 -22.55 65.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.912 -0.586 . . . . 1.78 110.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' B' ' 34' ' ' GLN . 73.8 t80 -61.04 -40.55 94.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 4.5800000000000001 110.358 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.489 ' O ' ' OG ' ' B' ' 26' ' ' SER . 68.7 m95 -70.8 -41.45 71.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.795 -0.639 . . . . 3.3500000000000001 110.593 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -69.7 -20.81 63.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 1.5800000000000001 110.869 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.88 -15.84 35.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.47 . . . . 1.8400000000000001 110.713 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 67.0 p -67.2 -17.07 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 1.3700000000000001 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.33 -33.67 13.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.409 -0.589 . . . . 4.9800000000000004 109.409 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -177.68 131.63 0.33 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 114.997 -1.002 . . . . 2.1400000000000001 110.216 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -93.8 169.15 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.915 2.41 . . . . 1.8200000000000001 112.251 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -96.41 60.97 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.458 . . . . 5.1900000000000004 110.901 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.9 -46.67 3.66 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.791 -0.718 . . . . 2.2000000000000002 112.416 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . 7.4 p -88.14 131.65 42.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.473 0.177 . . . . 3.6499999999999999 110.631 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 35.4 Cg_exo -59.82 156.66 36.94 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.241 1.961 . . . . 2.6699999999999999 112.054 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . 0.407 ' HB3' ' CZ ' ' B' ' 22' ' ' PHE . 28.0 mm-40 -61.19 -17.72 54.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 4.8799999999999999 112.459 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' B' ' 38' ' ' LEU . 3.6 p90 -43.89 -36.51 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.787 0.327 . . . . 1.8700000000000001 111.567 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.64 -57.12 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 2.6800000000000002 110.664 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -66.77 -18.74 65.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 2.9199999999999999 110.637 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 45.4 tp -57.11 -55.6 32.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 1.6399999999999999 110.152 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.74 -42.9 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 1.6000000000000001 110.524 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.46 -12.44 52.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.68999999999999995 111.138 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.661 ' HG3' ' HA ' ' B' ' 19' ' ' ALA . 0.0 OUTLIER -88.6 -31.03 18.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.358 -0.383 . . . . 2.5800000000000001 111.289 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.49 ' HA ' HD12 ' B' ' 45' ' ' ILE . 36.9 m-85 -72.08 -27.62 62.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 3.3900000000000001 110.386 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.595 HG23 HG23 ' B' ' 79' ' ' THR . 65.3 mt -58.28 -53.94 60.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.085 -0.507 . . . . 0.40999999999999998 112.003 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' C ' ' B' ' 41' ' ' MET . 45.2 Cg_endo -67.75 -35.14 22.56 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.17 1.913 . . . . 0.48999999999999999 112.986 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' B' ' 42' ' ' PHE . 97.0 mt -53.78 -62.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.762 0.282 . . . . 1.29 111.762 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.552 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.7 t90 -61.3 -50.11 74.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.744 0.307 . . . . 1.3999999999999999 111.08 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 59.5 m -60.27 -14.02 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 1.3799999999999999 111.495 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.9 -55.71 3.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.714 -0.755 . . . . 0.37 112.709 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.442 HD22 ' SG ' ' C' ' 134' ' ' CYS . 24.0 mt -58.74 -32.08 68.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.857 0.361 . . . . 1.29 111.084 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.44 111.313 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 9.0 m-85 -60.7 -41.41 95.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.5 110.993 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -50.67 -32.36 18.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.135 0.493 . . . . 1.4099999999999999 110.1 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.7 -39.86 69.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.55000000000000004 110.504 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -54.97 -28.21 49.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.284 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -73.31 -49.51 27.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.737 -0.665 . . . . 0.54000000000000004 110.817 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.43 HG12 ' HA ' ' B' ' 53' ' ' ALA . 36.1 pt -79.52 8.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.471 . . . . 1.3 111.459 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.32 60.73 2.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.055 -0.52 . . . . 2.2400000000000002 111.31 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -143.86 139.99 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.907 0.384 . . . . 1.77 110.876 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.38 5.63 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.882 -0.675 . . . . 1.0600000000000001 112.101 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.62 150.22 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.664 0.268 . . . . 2.6600000000000001 110.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.99 148.0 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 1.8899999999999999 111.077 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.21 93.68 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 2.4100000000000001 110.838 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.32 125.18 50.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 111.279 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.49 30.61 18.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.989 -0.55 . . . . 1.8200000000000001 111.275 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.86 57.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.727 -0.749 . . . . 1.51 112.563 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -107.15 127.61 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.757 0.313 . . . . 2.4500000000000002 110.821 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 45.0 mm -77.37 105.27 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 1.79 111.088 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.8 134.52 37.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.81999999999999995 110.943 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.497 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 81.8 m-70 -79.83 76.18 6.52 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.132 0.492 . . . . 1.05 111.1 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -62.42 -28.0 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.485 -0.78 . . . . 1.8700000000000001 111.082 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -82.27 -28.0 32.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.299 0.481 . . . . 0.60999999999999999 112.299 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 29.2 mmt180 -66.56 -51.51 55.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.629 0.603 . . . . 2.3900000000000001 112.629 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' B' ' 77' ' ' MET . 18.5 p90 -82.89 -30.03 28.84 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.29 -0.564 . . . . 3.6699999999999999 112.497 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' B' ' 71' ' ' ALA . 15.2 tt -56.33 -42.15 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.291 -0.563 . . . . 1.6599999999999999 110.221 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' B' ' 74' ' ' ILE . 26.2 t70 -69.39 -22.25 63.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.996 -0.742 . . . . 1.4099999999999999 108.996 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -86.56 7.65 25.33 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.342 -0.844 . . . . 1.1599999999999999 111.034 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.471 ' HA ' HD13 ' B' ' 113' ' ' ILE . 22.0 mtp -104.73 -21.59 13.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 1.53 110.797 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 m -114.08 -28.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.89000000000000001 111.897 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.595 HG23 HG23 ' B' ' 43' ' ' ILE . 37.8 m -82.21 -52.45 6.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.266 -0.424 . . . . 1.24 112.093 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.578 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 16.9 m -52.4 -49.73 83.8 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.54 0.57 . . . . 0.57999999999999996 112.54 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' B' ' 80' ' ' THR . 12.4 Cg_endo -56.08 -45.52 37.71 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.781 1.654 . . . . 0.66000000000000003 112.262 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.64 -19.47 61.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 1.0600000000000001 110.797 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.32 -30.96 57.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 1.22 110.197 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.534 HD13 ' NE2' ' B' ' 109' ' ' GLN . 4.8 tt -84.69 -27.92 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.642 -0.708 . . . . 1.53 110.128 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.96 -33.84 39.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 1.5800000000000001 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -58.75 -28.08 65.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 1.3899999999999999 111.223 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.499 HD22 HD11 ' B' ' 168' ' ' LEU . 52.9 mt -73.36 -34.23 65.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.4 . . . . 1.1499999999999999 111.12 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.4 m -73.46 -27.04 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.418 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -76.73 -38.62 53.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.349 . . . . 2.1699999999999999 111.12 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -62.41 -41.55 98.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.376 -0.375 . . . . 1.4199999999999999 111.138 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.62 -47.49 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 1.1799999999999999 111.314 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 49.3 tpp -80.4 98.58 7.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 1.8799999999999999 110.784 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -87.8 -37.34 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 3.4199999999999999 110.926 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.31 143.19 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 4.0599999999999996 111.012 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.07 142.24 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 2.0899999999999999 110.579 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -123.96 -74.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 3.8500000000000001 111.159 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -156.03 108.46 2.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 4.8200000000000003 111.034 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.1 -73.62 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 110.66 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 81.8 m95 53.67 36.35 23.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 5.1699999999999999 111.323 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.5 t -120.58 -41.51 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 2.02 111.022 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 96.5 mt -74.31 -38.49 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.16 -0.473 . . . . 2.0899999999999999 110.959 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.5 tt -56.12 -33.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 1.8799999999999999 111.17 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.17 -29.89 36.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.728 -0.748 . . . . 0.56000000000000005 112.287 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.91 -24.51 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 1.78 110.835 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -78.54 -50.08 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 1.03 110.993 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . 0.471 ' O ' HG13 ' B' ' 110' ' ' ILE . 24.6 ptm -60.49 -31.83 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 1.6699999999999999 111.043 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 42' ' ' PHE . 77.6 p -67.29 -51.96 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 1.51 111.6 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.465 ' HB ' HD13 ' B' ' 142' ' ' ILE . 71.3 p -57.92 -25.98 61.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 1.1799999999999999 111.741 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.534 ' NE2' HD13 ' B' ' 84' ' ' LEU . 18.6 mm-40 -78.31 -41.72 32.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 2.1699999999999999 111.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.482 HG22 ' NE1' ' A' ' 46' ' ' TRP . 93.4 mt -56.4 -38.1 54.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 1.3500000000000001 111.8 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.415 HG23 ' N ' ' B' ' 112' ' ' VAL . 29.7 m -72.57 -45.56 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.918 0.34 . . . . 1.3400000000000001 111.918 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.415 ' N ' HG23 ' B' ' 111' ' ' VAL . 84.2 t -60.12 -45.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.631 0.253 . . . . 0.42999999999999999 111.586 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' B' ' 77' ' ' MET . 66.3 mt -64.43 -34.75 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 1.6000000000000001 111.463 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.4 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.4 m -55.2 -61.0 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.85999999999999999 111.234 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.9 p -57.31 -27.44 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.94999999999999996 111.061 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.11 -49.14 59.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.46000000000000002 112.909 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.563 HD12 HG13 ' B' ' 118' ' ' ILE . 3.3 pp -74.21 -21.88 59.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.686 0.254 . . . . 1.75 111.686 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.563 HG13 HD12 ' B' ' 117' ' ' LEU . 82.5 mt -83.4 -33.17 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.687 0.28 . . . . 1.78 111.215 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.15 71.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.38 110.968 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.26 -25.22 46.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 1.97 111.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.78 31.24 0.7 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.405 -0.361 . . . . 0.76000000000000001 110.886 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -82.76 130.96 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.05 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -98.55 -42.98 7.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 2.5 110.673 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.47 ' HB2' HG12 ' B' ' 127' ' ' VAL . 91.4 mtt180 -98.18 146.36 25.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 2.73 110.285 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -80.37 -16.38 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.429 0.529 . . . . 2.2000000000000002 112.429 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.465 ' HE1' ' HD3' ' B' ' 124' ' ' ARG . 67.1 p-90 -93.33 -22.44 18.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.688 0.255 . . . . 3.3999999999999999 111.688 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.529 HG23 HD12 ' B' ' 130' ' ' LEU . 7.3 p -83.66 -23.33 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 1.23 110.945 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -57.76 -35.31 70.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 3.04 110.968 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -68.88 -22.15 64.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 4.1399999999999997 111.283 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.529 HD12 HG23 ' B' ' 127' ' ' VAL . 90.5 mt -76.75 -54.27 6.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 1.6499999999999999 111.141 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.96 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.483 -0.326 . . . . 0.77000000000000002 110.885 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -60.47 -50.06 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 1.46 110.595 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.6 mt -62.74 -30.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 1.6299999999999999 110.822 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 36.1 t -65.65 -41.01 93.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 1.4199999999999999 110.872 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.31 -54.1 39.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.908 -0.663 . . . . 0.48999999999999999 112.365 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 5.8 p -63.46 -39.0 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 1.3 111.067 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.7 t -52.34 -43.56 64.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.286 -0.416 . . . . 1.3 110.7 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.65 84.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.62 110.688 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -71.56 -23.56 61.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 1.74 110.992 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -73.33 -61.08 1.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.379 -0.373 . . . . 1.76 111.266 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.422 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.2 pt -51.88 -37.45 21.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.68999999999999995 111.453 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' B' ' 108' ' ' THR . 85.3 mt -73.45 -41.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 1.76 110.891 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 tp -56.97 -57.92 10.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 1.0600000000000001 110.885 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -62.62 -21.86 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 4.1200000000000001 110.643 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -20.78 59.57 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.85 -0.69 . . . . 1.26 112.989 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.9 pt -100.4 -5.62 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.864 0.332 . . . . 1.98 111.178 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.61 -42.99 17.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 1.4199999999999999 110.98 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 99.989999999999995 111.828 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.862 0.363 . . . . 2.4300000000000002 110.884 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.04 -24.75 60.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 2.5800000000000001 111.12 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.1 -44.66 96.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 2.0 110.719 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -79.72 -21.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 3.0299999999999998 110.77 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.499 HD11 HD22 ' B' ' 87' ' ' LEU . 27.8 tp -68.17 -53.16 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 1.1000000000000001 110.817 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.35 -28.26 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 1.75 111.028 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.7 m -49.09 -57.97 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.97999999999999998 111.29 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.51 -28.83 67.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.279 -0.419 . . . . 4.2999999999999998 110.526 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -63.8 -30.62 71.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 1.3899999999999999 111.481 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 81.6 p -78.82 -59.05 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.595 -0.275 . . . . 1.1100000000000001 111.485 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.6 p -52.89 -29.91 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.526 -0.306 . . . . 1.51 111.645 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.97 -58.19 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 1.75 111.107 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.95 -25.95 61.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.59999999999999998 110.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.467 ' O ' HG13 ' B' ' 181' ' ' ILE . 80.4 mt -87.99 -27.59 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.061 -0.518 . . . . 1.47 110.269 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.95 -52.62 41.87 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.817 -0.629 . . . . 0.55000000000000004 113.124 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.643 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 94.4 m-85 -56.49 -58.05 19.4 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.927 -0.309 . . . . 1.6200000000000001 111.095 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 90.6 Cg_exo -42.68 -38.77 6.69 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.171 1.914 . . . . 0.64000000000000001 112.924 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.467 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.6 mt -58.5 -55.39 22.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.34 -0.391 . . . . 1.27 111.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.628 HG22 ' O ' ' B' ' 179' ' ' TYR . 1.9 m -55.17 -23.88 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.02 -0.536 . . . . 0.68999999999999995 111.497 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -80.88 -33.3 34.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.074 0.398 . . . . 1.1799999999999999 112.074 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 tt -88.29 25.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.443 . . . . 1.77 111.561 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 42.6 pt -134.69 -21.4 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.466 -0.334 . . . . 1.6899999999999999 111.533 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.262 0 C-N-CA 120.438 -0.887 . . . . 1.5800000000000001 112.834 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.871 0.367 . . . . 2.4700000000000002 111.188 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.39 -57.49 12.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 2.5299999999999998 110.864 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . 0.413 ' HB ' HH21 ' B' ' 72' ' ' ARG . 53.3 p -64.77 -31.05 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 1.29 110.932 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . 0.413 ' HD1' HD13 ' B' ' 7' ' ' LEU . 68.1 t80 -60.98 -27.55 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 2.6200000000000001 110.635 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.47 -50.25 14.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 1.6100000000000001 110.886 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -73.14 -7.91 53.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 1.4199999999999999 111.317 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.33 -38.39 10.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 1.4299999999999999 110.862 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.5 tp -73.72 -40.98 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 1.1200000000000001 112.065 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.577 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 2.3 tt -56.27 -54.29 54.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 121.126 -0.23 . . . . 1.26 111.34 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -56.51 -43.9 50.96 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.822 1.682 . . . . 0.59999999999999998 111.373 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.518 ' O ' HG22 ' B' ' 211' ' ' VAL . 89.9 t80 -60.11 -32.74 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 1.3999999999999999 110.29 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -74.3 -19.26 60.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.825 -0.625 . . . . 1.4099999999999999 110.608 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.3200000000000001 111.032 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 207' ' ' PHE . 16.1 m . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.89 0.376 . . . . 1.6899999999999999 111.037 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.11 -46.65 93.83 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.899 -0.667 . . . . 0.79000000000000004 112.453 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -73.24 -22.7 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.618 0.247 . . . . 2.96 110.719 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 60.5 m -60.59 -58.02 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.402 -0.363 . . . . 1.29 110.517 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -67.57 -30.09 69.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 3.1499999999999999 110.26 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.23 -44.21 97.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.6 . . . . 1.51 110.367 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.19 -38.4 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 2.1899999999999999 110.589 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.47 -29.45 69.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.039 -0.528 . . . . 1.98 111.215 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -84.86 -42.18 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 2.1699999999999999 111.218 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.2 -39.4 81.19 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.857 -0.687 . . . . 1.3600000000000001 112.514 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 2.8999999999999999 111.015 -179.829 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.408 HD23 ' N ' ' C' ' 6' ' ' LEU . 2.7 pt? . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.72 0.295 . . . . 2.52 110.971 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 18.1 tp -60.88 -52.68 64.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 1.9299999999999999 110.669 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.654 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 33.1 m170 -61.55 -23.95 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 1.26 110.766 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -75.52 -42.08 53.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 1.6699999999999999 111.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.71 -22.28 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 1.8700000000000001 110.642 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -66.18 -48.32 71.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.533 . . . . 1.4399999999999999 110.31 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.73 -31.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.46999999999999997 110.565 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.81 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.58999999999999997 111.1 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.59 73.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.5 112.486 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -78.37 -33.76 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 0.68000000000000005 110.764 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 89.2 m -61.59 -51.77 67.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 1.3999999999999999 110.815 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . 0.407 ' O ' HD12 ' C' ' 17' ' ' ILE . 1.9 tp -60.19 -39.69 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.135 -0.484 . . . . 1.55 110.965 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.54 -57.6 6.5 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.675 -0.774 . . . . 0.70999999999999996 112.156 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.32 69.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.36 . . . . 0.77000000000000002 111.106 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.77 -27.53 66.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.515 . . . . 1.9299999999999999 111.26 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -60.34 -25.26 65.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 1.8600000000000001 110.72 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' C' ' 37' ' ' TYR . 37.4 m-85 -79.99 -22.97 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 4.1399999999999997 110.75 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . 0.657 ' O ' ' OG ' ' C' ' 26' ' ' SER . 70.9 t-105 -69.81 -35.8 75.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.566 -0.531 . . . . 3.1499999999999999 109.566 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 45.0 t -85.18 -33.21 22.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.544 -0.753 . . . . 1.95 110.468 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 tp -71.91 -20.72 61.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 2.2200000000000002 110.41 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 0.7 OUTLIER -57.2 -25.53 59.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.873 -0.603 . . . . 1.3700000000000001 110.514 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -44.82 -37.61 3.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.143 0.497 . . . . 5.0300000000000002 110.134 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 24.3 p-10 -172.59 132.08 0.67 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.409 -0.814 . . . . 2.3700000000000001 110.287 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 60.0 Cg_endo . . . . . 0 N--CA 1.451 -1.024 0 C-N-CA 123.016 2.478 . . . . 2.0499999999999998 112.05 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 25.4 Cg_exo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 121.06 0.358 . . . . 1.9299999999999999 112.192 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -61.79 -17.34 55.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 4.1200000000000001 112.482 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.431 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -42.16 -40.98 2.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.669 0.271 . . . . 2.8900000000000001 111.602 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -66.44 -43.61 85.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 2.46 110.575 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' C' ' 22' ' ' PHE . 98.6 m-85 -71.81 -19.13 62.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.868 -0.605 . . . . 2.7799999999999998 110.529 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' C' ' 41' ' ' MET . 30.9 tp -64.48 -48.87 73.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 1.6200000000000001 110.394 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.28 -40.38 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 1.5900000000000001 110.05 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.54 -6.81 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.65000000000000002 110.726 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.432 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 36.6 ttm -87.84 -36.01 17.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 1.6699999999999999 110.605 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' C' ' 45' ' ' ILE . 23.2 t80 -70.91 -35.53 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.858 -0.61 . . . . 3.4199999999999999 111.07 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.604 HG23 HG23 ' C' ' 79' ' ' THR . 88.5 mt -49.88 -54.49 31.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.169 0.433 . . . . 0.89000000000000001 112.169 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.4 Cg_endo -71.83 -32.83 10.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.182 1.921 . . . . 0.40999999999999998 113.164 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' C' ' 42' ' ' PHE . 69.1 mt -53.41 -62.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.853 0.316 . . . . 1.76 111.853 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -66.44 -45.91 78.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.76 0.314 . . . . 2.1600000000000001 111.074 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . 0.418 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 45.8 t -61.85 -11.01 10.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 1.1699999999999999 111.266 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.52 -53.6 3.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.44 112.494 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 69.0 mt -59.22 -32.9 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.689 0.28 . . . . 1.29 110.92 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -58.28 9.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.5 111.324 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 13.4 m-85 -59.02 -45.0 91.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 1.8300000000000001 111.085 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 59.8 ttp -48.39 -30.58 5.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 1.47 110.355 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -46.13 59.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.763 -0.653 . . . . 0.59999999999999998 111.077 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 1.2 mpp? -55.52 -20.14 12.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.83999999999999997 110.824 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -78.54 -46.7 18.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.139 -0.482 . . . . 0.65000000000000002 110.293 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.75 11.01 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.844 -0.616 . . . . 1.55 111.014 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 62.6 60.45 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 1.54 111.211 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.591 ' NE2' HG11 ' A' ' 127' ' ' VAL . 87.0 mm-40 -142.58 151.95 42.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.119 -0.492 . . . . 1.79 111.01 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.0 34.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.771 -0.728 . . . . 0.93999999999999995 112.574 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -133.7 135.56 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 2.3599999999999999 110.921 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.93 136.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 1.97 111.161 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.94 94.61 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 2.4399999999999999 110.841 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.12 134.8 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 1.54 110.907 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 30.73 19.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 1.71 111.024 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.93 -1.26 55.52 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 1.53 112.509 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -103.56 122.29 44.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 2.23 111.153 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.45 118.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.3600000000000001 110.947 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.4 133.65 51.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 0.78000000000000003 111.199 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 78.0 m-70 -83.93 75.92 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.075 0.464 . . . . 1.0800000000000001 110.876 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.99 -44.37 97.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.719 -0.673 . . . . 2.2999999999999998 111.323 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -66.45 -23.59 66.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.75 111.878 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 16.7 tpp180 -68.71 -51.61 39.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.302 0.482 . . . . 1.51 112.302 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' C' ' 117' ' ' LEU . 5.7 p90 -83.54 -33.13 25.55 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.068 0.396 . . . . 4.6500000000000004 112.068 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -55.85 -40.53 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 C-N-CA 120.715 -0.394 . . . . 1.22 110.583 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 26.9 t70 -68.38 -25.39 65.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.121 -0.696 . . . . 1.3100000000000001 109.121 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -86.66 9.77 17.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.453 -0.794 . . . . 1.6799999999999999 110.756 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.445 ' HA ' HG21 ' C' ' 113' ' ' ILE . 53.6 tpp -104.49 -23.27 13.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 1.8 110.011 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.4 ' O ' HD23 ' C' ' 82' ' ' LEU . 31.3 m -114.02 -30.05 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 1.1899999999999999 111.576 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.604 HG23 HG23 ' C' ' 43' ' ' ILE . 41.3 m -83.73 -44.78 14.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.448 -0.342 . . . . 1.23 111.62 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 55.8 m -56.21 -49.76 91.42 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.387 -0.37 . . . . 0.58999999999999997 111.875 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -56.47 -47.73 22.56 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.156 1.904 . . . . 0.67000000000000004 112.312 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.4 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.4 mm? -74.74 -11.2 60.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.95999999999999996 111.135 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.427 HD13 ' O ' ' C' ' 83' ' ' LEU . 0.7 OUTLIER -76.76 -47.15 22.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 1.1899999999999999 109.971 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' C' ' 109' ' ' GLN . 2.8 pp -78.99 -32.27 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 1.7 110.67 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.51 -37.33 77.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.676 -0.693 . . . . 1.6200000000000001 111.045 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.2 t -60.63 -19.52 58.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 1.26 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' C' ' 168' ' ' LEU . 71.2 mt -75.99 -34.71 59.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.081 -0.509 . . . . 1.1100000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 89.8 p -74.2 -26.09 60.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 1.51 111.102 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -75.07 -37.26 61.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.37 -0.377 . . . . 2.0600000000000001 110.83 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 72.4 p -67.96 -33.85 75.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.333 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.64 -47.66 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 1.3 111.261 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.8 mtp -86.16 100.33 12.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 1.6200000000000001 111.095 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -83.48 -42.61 16.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 3.2400000000000002 110.764 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -115.31 140.42 49.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.107 -0.497 . . . . 4.6299999999999999 111.119 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 68.1 mt -133.65 142.31 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 2.1800000000000002 110.787 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -120.43 -81.11 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 4.1200000000000001 111.205 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -143.81 97.61 3.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 4.96 111.023 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -172.85 79.66 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 3.9100000000000001 110.771 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.52 42.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 5.21 110.78 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 34.5 m -101.84 -40.54 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 1.8200000000000001 111.54 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.24 -36.72 77.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 2.0800000000000001 111.219 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.2 -41.72 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.8600000000000001 111.27 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.53 -33.52 60.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.838 -0.696 . . . . 0.58999999999999997 112.656 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.51 -52.68 64.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 1.53 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.47 -43.13 99.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 1.1100000000000001 111.357 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . 0.41 ' O ' HG12 ' C' ' 110' ' ' ILE . 42.3 ttm -60.47 -32.81 71.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.526 . . . . 2.21 111.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . 0.474 ' O ' HG23 ' C' ' 111' ' ' VAL . 47.2 t -78.87 -44.74 22.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.778 0.323 . . . . 1.28 111.451 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 77.6 p -64.87 -32.61 74.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 1.22 111.974 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.486 ' HB3' HD21 ' C' ' 84' ' ' LEU . 14.0 pt20 -71.32 -46.09 61.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.637 -0.256 . . . . 2.3300000000000001 111.502 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.552 HG22 ' HE1' ' B' ' 46' ' ' TRP . 35.8 mm -56.02 -34.87 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.679 0.276 . . . . 1.29 111.274 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.474 HG23 ' O ' ' C' ' 107' ' ' SER . 60.1 t -67.85 -47.69 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 1.0600000000000001 111.381 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.21 -48.9 86.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 111.608 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.445 HG21 ' HA ' ' C' ' 77' ' ' MET . 47.7 mt -59.89 -34.66 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.478 -0.328 . . . . 1.3700000000000001 111.207 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 32.0 m -58.63 -48.94 79.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.77000000000000002 111.116 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . 0.4 ' HA ' HG22 ' C' ' 118' ' ' ILE . 77.8 p -67.79 -22.15 65.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.21 -0.45 . . . . 1.1899999999999999 110.92 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.04 -34.57 37.32 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.847 -0.692 . . . . 0.5 113.227 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.519 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.2 pp -81.09 -30.62 34.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.651 0.262 . . . . 1.47 111.549 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.519 ' N ' HD12 ' C' ' 117' ' ' LEU . 8.8 tp -81.03 -28.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.511 -0.313 . . . . 1.2 111.124 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -38.65 78.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.071 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.75 -17.23 48.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 2.1200000000000001 110.823 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.7 mt -91.49 26.99 2.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.15 -0.477 . . . . 0.75 111.063 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . 0.434 ' HB3' ' HE ' ' C' ' 128' ' ' ARG . 44.6 t -83.22 142.76 30.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 1.3799999999999999 110.913 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.17 -41.64 5.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 2.7400000000000002 110.954 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . 0.481 ' HB2' HG12 ' C' ' 127' ' ' VAL . 0.0 OUTLIER -98.94 142.21 30.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 2.7999999999999998 110.625 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.07 -11.33 60.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 2.4100000000000001 111.521 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -91.04 -45.84 8.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 4.2000000000000002 111.023 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -67.2 -24.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 1.0800000000000001 111.272 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' C' ' 122' ' ' SER . 43.1 ttm180 -61.76 -31.52 71.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.337 -0.392 . . . . 2.5699999999999998 111.131 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.76 -20.02 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 3.8100000000000001 110.91 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.424 HD13 HG21 ' B' ' 56' ' ' ILE . 98.8 mt -78.46 -55.75 4.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.257 -0.429 . . . . 1.4199999999999999 111.174 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -60.79 -32.27 71.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.441 -0.345 . . . . 0.89000000000000001 110.989 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -56.55 -47.2 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 1.26 110.594 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.7 mm -67.88 -30.43 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.6799999999999999 110.953 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . 0.442 ' SG ' HD22 ' B' ' 49' ' ' LEU . 38.3 t -64.34 -41.0 96.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 1.24 110.868 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.3 -54.26 27.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.845 -0.693 . . . . 0.54000000000000004 112.757 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . 0.463 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -61.42 -35.58 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.784 0.326 . . . . 1.0600000000000001 111.221 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.26 -40.05 88.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.257 -0.429 . . . . 1.0800000000000001 111.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.11 79.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 111.022 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -76.3 -28.87 57.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 1.6799999999999999 110.883 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 94.4 mt -69.8 -46.71 65.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.41 -0.359 . . . . 1.7 111.478 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.425 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.6 pt -62.02 -41.67 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.78000000000000003 111.481 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.425 ' N ' HG13 ' C' ' 141' ' ' ILE . 49.0 pt -76.34 -27.07 17.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.484 -0.325 . . . . 2.2400000000000002 111.366 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.69 -49.68 65.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.348 -0.387 . . . . 1.02 110.823 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . 0.445 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 85.2 t90 -68.98 -25.69 64.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.246 -0.434 . . . . 3.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.48 -17.24 66.78 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.964 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.67 -13.74 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 1.8899999999999999 111.206 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -76.51 -45.74 29.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 1.6000000000000001 111.22 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' C' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.536 0.411 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 112.113 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.734 0.302 . . . . 2.3500000000000001 110.997 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.74 -27.7 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 2.6200000000000001 111.12 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.72 -39.63 85.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 2.0899999999999999 110.685 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -82.84 -20.86 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 3.2400000000000002 110.816 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' C' ' 87' ' ' LEU . 36.4 tp -70.77 -57.22 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 1.6899999999999999 111.135 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . 0.4 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 33.2 t -62.15 -20.92 25.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 1.3999999999999999 111.295 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 20.9 m -50.43 -58.05 6.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.95999999999999996 111.271 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . 0.509 ' O ' HD23 ' C' ' 175' ' ' LEU . 83.4 m-85 -74.64 -26.13 59.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.121 -0.49 . . . . 3.6499999999999999 110.583 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 90.6 t80 -59.47 -40.8 88.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 1.3700000000000001 111.286 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 4.1 t -77.21 -42.79 36.08 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.747 0.277 . . . . 1.4299999999999999 111.747 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.15 -40.53 77.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 1.6200000000000001 111.526 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.509 HD23 ' O ' ' C' ' 171' ' ' TYR . 4.5 mm? -73.05 -52.09 15.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.321 -0.399 . . . . 2.0299999999999998 111.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -29.59 61.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.84 0.353 . . . . 0.62 110.969 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.48 ' O ' HG13 ' C' ' 181' ' ' ILE . 38.9 mm -87.57 -23.88 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.511 . . . . 1.5800000000000001 110.249 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . 0.512 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.41 -50.59 61.61 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.909 -0.587 . . . . 0.56000000000000005 113.062 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.666 ' O ' HG22 ' C' ' 182' ' ' VAL . 69.4 m-85 -57.67 -55.51 44.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.904 0.352 . . . . 1.3300000000000001 111.205 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.7 Cg_exo -45.84 -29.68 6.02 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.063 1.842 . . . . 0.63 112.416 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.565 ' O ' HG22 ' C' ' 184' ' ' ILE . 83.2 mt -66.05 -57.58 9.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.932 0.396 . . . . 0.93000000000000005 111.484 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.666 HG22 ' O ' ' C' ' 179' ' ' TYR . 11.8 m -55.85 -23.87 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 1.27 111.633 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -73.35 -53.4 10.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.537 0.569 . . . . 1.77 112.537 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.565 HG22 ' O ' ' C' ' 181' ' ' ILE . 10.4 tp -55.21 -27.67 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.058 0.392 . . . . 2.3900000000000001 112.058 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 1.95 111.025 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.835 0.35 . . . . 2.3799999999999999 111.13 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.18 -37.74 74.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.269 -0.423 . . . . 2.23 110.936 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.68 -52.39 60.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 2.1600000000000001 110.3 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 46.1 p -70.47 -22.63 62.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.851 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.24 -27.22 65.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 1.7 110.865 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.99 -50.07 10.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 2.02 111.064 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.1 -10.18 56.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.8200000000000001 111.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 47.5 t -96.56 -40.17 9.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.3500000000000001 110.833 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.9 tp -71.72 -37.24 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 0.65000000000000002 112.164 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 46.4 tp -60.63 -53.84 60.51 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.031 -0.267 . . . . 1.4199999999999999 111.634 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.6 Cg_exo -57.25 -39.23 91.66 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.755 1.637 . . . . 0.63 111.426 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.35 -31.44 70.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 1.49 110.378 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -79.9 -22.78 42.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.7 110.534 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.515 . . . . 1.25 110.902 179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.827 0.346 . . . . 1.6100000000000001 111.058 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.68 57.62 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.81999999999999995 112.689 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -69.58 -22.71 63.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 3.0800000000000001 111.157 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 36.3 t -56.75 -62.31 1.82 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.424 . . . . 1.1499999999999999 110.703 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . 0.492 ' HA ' HD12 ' C' ' 218' ' ' LEU . 97.2 m-85 -67.97 -27.52 66.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 2.5600000000000001 110.793 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.09 -44.16 97.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.067 0.461 . . . . 1.29 110.113 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 11.4 t70 -65.67 -33.45 75.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.845 -0.616 . . . . 2.3900000000000001 110.601 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' C' ' 215' ' ' PHE . 84.4 mt -65.74 -32.97 74.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 2.0299999999999998 111.028 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -87.88 -20.93 25.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.914 0.388 . . . . 3.21 110.964 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.76 -26.53 62.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.841 -0.695 . . . . 1.3600000000000001 112.7 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 97.8 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 2.8999999999999999 111.186 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.781 0.324 . . . . 2.4199999999999999 110.594 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.02 -39.92 65.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 2.0899999999999999 110.524 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.532 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 34.5 m80 -76.7 -26.46 54.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 1.1599999999999999 110.121 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -70.75 -50.0 40.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.79000000000000004 110.658 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 pt -59.9 -31.77 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 121.146 0.498 . . . . 2.0800000000000001 109.971 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -55.87 -43.99 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.467 -0.788 . . . . 1.28 109.393 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 12' ' ' VAL . 2.5 t -57.39 -49.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.79 -1.096 . . . . 1.3200000000000001 111.071 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.45 -37.79 79.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.63 111.0 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.84 -38.45 95.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.55000000000000004 112.673 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.3 mmm -70.31 -40.01 74.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 1.03 110.902 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 m -56.64 -58.56 7.53 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.025 -0.534 . . . . 1.3 111.117 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.36 -23.77 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 1.3100000000000001 110.955 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.2 3.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 0.77000000000000002 112.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.792 0.33 . . . . 0.80000000000000004 111.006 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -57.1 -47.35 81.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 1.8100000000000001 110.932 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -63.21 -35.21 79.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 1.8799999999999999 110.785 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -69.94 -21.87 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.081 -0.508 . . . . 4.4500000000000002 110.831 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.595 ' O ' ' OG ' ' A' ' 26' ' ' SER . 83.6 t90 -75.53 -36.18 60.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 3.6899999999999999 110.892 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -68.34 -42.02 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.266 -0.425 . . . . 1.5700000000000001 110.974 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.04 -1.4 57.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 1.95 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.595 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 94.8 p -63.05 -16.29 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 1.3799999999999999 111.166 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -45.99 -40.2 10.12 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.266 -0.642 . . . . 4.0700000000000003 109.266 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -176.96 131.35 0.36 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.695 -1.138 . . . . 2.7200000000000002 109.381 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG2' ' H ' ' A' ' 32' ' ' VAL . 93.2 Cg_endo -91.98 -151.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.303 2.002 . . . . 1.9099999999999999 111.929 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -57.68 -13.69 4.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.097 0.475 . . . . 4.7599999999999998 110.711 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 33.52 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.985 -0.626 . . . . 1.99 111.996 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.5 ' HB ' ' HE2' ' A' ' 35' ' ' TYR . 12.9 m -128.63 156.36 77.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.578 0.228 . . . . 2.7000000000000002 111.013 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.0 166.35 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.536 2.157 . . . . 1.79 112.854 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -55.8 -17.42 6.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.9 . . . . 4.1200000000000001 112.168 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HE2' ' HB ' ' A' ' 32' ' ' VAL . 2.3 p90 -43.67 -33.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.656 0.265 . . . . 2.9300000000000002 111.314 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.51 -50.14 74.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.99 0.424 . . . . 2.8799999999999999 110.565 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -75.06 -19.55 59.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 4.6600000000000001 111.04 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' B' ' 100' ' ' THR . 38.6 tp -57.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 1.45 110.828 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.3 -37.86 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 1.78 111.045 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.69 -8.43 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.63 111.173 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.418 ' O ' HG12 ' A' ' 45' ' ' ILE . 14.9 tpt -89.41 -45.57 9.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 1.48 111.6 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -71.64 -42.81 67.14 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.552 0.575 . . . . 3.5 112.552 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 89.1 mt -48.37 -53.05 38.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.677 0.621 . . . . 1.0800000000000001 112.677 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.7 Cg_endo -72.62 -37.28 4.15 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.04 1.826 . . . . 0.53000000000000003 113.308 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 41' ' ' MET . 27.2 mm -59.33 -61.25 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.689 0.255 . . . . 1.6799999999999999 111.689 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.472 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.0 OUTLIER -56.99 -58.76 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.879 0.371 . . . . 1.8300000000000001 110.871 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 49.7 m -52.36 -31.59 34.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.831 -0.622 . . . . 1.0900000000000001 111.159 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.66 -59.86 10.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.40999999999999998 112.443 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 mt -61.14 -29.51 69.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.98999999999999999 110.926 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.81 -52.0 66.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.47999999999999998 111.253 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 42.3 m-85 -69.16 -23.21 63.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 1.8700000000000001 111.075 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -62.46 -39.22 92.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.49 109.761 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.55 72.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.452 -0.794 . . . . 0.58999999999999997 110.802 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.0 mtt -57.5 -26.93 62.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.48999999999999999 110.232 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.27 -50.41 22.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.59999999999999998 110.571 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.532 HG21 HG23 ' B' ' 127' ' ' VAL . 17.3 mt -74.41 -5.77 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.491 . . . . 1.3100000000000001 110.634 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.63 65.68 0.72 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.696 -0.684 . . . . 1.9099999999999999 111.106 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -130.56 148.01 52.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 1.6200000000000001 110.909 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 98.21 17.58 29.09 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.872 -0.68 . . . . 1.04 112.352 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -117.44 149.47 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.68 0.276 . . . . 2.6800000000000002 110.78 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.51 142.25 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.334 -0.394 . . . . 1.98 110.976 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -89.05 86.0 6.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 2.1800000000000002 111.086 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.04 116.57 29.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 1.5700000000000001 111.172 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.77 22.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.089 -0.505 . . . . 1.79 111.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.47 -15.01 48.37 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.672 -0.775 . . . . 1.48 112.656 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -98.34 147.56 24.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 2.3199999999999998 110.945 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.3 pt -87.97 139.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.535 . . . . 1.4399999999999999 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.37 138.77 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.81999999999999995 110.708 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 94.5 m-70 -90.8 57.43 3.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.105 0.478 . . . . 0.90000000000000002 111.173 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -64.44 -57.69 8.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 1.8300000000000001 111.176 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -54.74 -32.93 60.5 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.137 0.494 . . . . 0.62 110.644 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.411 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 5.1 tpp180 -57.17 -41.49 79.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.518 -0.764 . . . . 2.3399999999999999 110.593 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.454 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.3 OUTLIER -83.04 -14.0 54.74 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.005 0.372 . . . . 3.4900000000000002 112.005 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 71' ' ' ALA . 48.9 mt -63.4 -45.11 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.009 0.433 . . . . 1.3700000000000001 109.975 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 38.8 t70 -66.49 -11.53 52.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.811 -0.631 . . . . 1.3100000000000001 110.648 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.18 -21.03 26.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 1.48 111.066 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.561 ' HG2' ' HB ' ' A' ' 113' ' ' ILE . 28.6 mtp -90.7 -7.8 51.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.014 -0.539 . . . . 1.46 111.125 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.419 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.9 m -114.85 -32.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 1.1200000000000001 112.151 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.0 m -86.85 -53.09 5.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.936 0.347 . . . . 1.1000000000000001 111.936 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 34.5 m -50.24 -51.63 61.26 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.343 0.497 . . . . 0.59999999999999998 112.343 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 80' ' ' THR . 15.2 Cg_endo -56.74 -33.19 93.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.744 1.629 . . . . 0.73999999999999999 111.851 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.2 mm? -79.61 -26.42 41.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 1.01 110.439 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -69.04 -38.53 79.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 1.48 109.71 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.461 HD21 ' CB ' ' A' ' 105' ' ' LEU . 4.9 tt -77.42 -39.54 46.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.465 -0.789 . . . . 1.3799999999999999 110.439 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.501 HD21 ' SD ' ' A' ' 106' ' ' MET . 29.8 mt -59.45 -38.02 79.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.186 -0.461 . . . . 1.1899999999999999 110.871 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -56.23 -35.61 67.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 1.23 110.525 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.73 -31.42 72.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.557 . . . . 0.88 110.915 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -62.47 -55.4 27.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 1.3899999999999999 111.073 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -65.17 -21.74 66.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 2.3199999999999998 111.236 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -37.18 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 1.46 110.927 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.31 28.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.154 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 81.4 mtp -120.54 112.08 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 2.0699999999999998 110.732 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -68.09 -35.43 78.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 3.5299999999999998 111.299 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.19 143.42 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 4.0800000000000001 111.098 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -105.88 149.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 2.1699999999999999 110.962 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 97' ' ' LYS . 59.1 tttp -133.18 -62.24 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 4.5199999999999996 110.8 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 96' ' ' LYS . 13.2 mmmm -132.03 12.23 4.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 3.75 110.907 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.0 91.53 7.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 3.5299999999999998 111.124 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -128.14 -5.05 5.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 4.9100000000000001 110.781 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.3 p -94.0 -33.31 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 1.98 111.071 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.86 -42.43 97.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.8300000000000001 110.917 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 103' ' ' GLY . 33.5 pt -66.98 -41.15 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 1.79 111.294 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 102' ' ' ILE . . . -65.01 -27.65 72.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.789 -0.72 . . . . 0.62 112.472 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.78 -54.0 32.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 1.5800000000000001 110.97 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.461 ' CB ' HD21 ' A' ' 84' ' ' LEU . 62.6 mt -64.31 -39.46 93.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.97999999999999998 111.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.501 ' SD ' HD21 ' A' ' 85' ' ' LEU . 90.4 mtp -62.59 -46.4 88.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.48 111.238 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.6 m -56.22 -42.89 77.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.93 0.395 . . . . 1.1299999999999999 110.884 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.573 HG21 HG21 ' A' ' 142' ' ' ILE . 79.6 m -59.37 -34.24 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 1.48 111.281 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 12.3 mm100 -72.63 -29.85 63.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.476 -0.329 . . . . 2.7000000000000002 111.49 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.567 HG22 ' HE1' ' C' ' 46' ' ' TRP . 56.9 mt -66.26 -40.06 85.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 1.54 111.753 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 108' ' ' THR . 34.1 m -72.44 -32.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.678 0.275 . . . . 1.28 111.283 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 108' ' ' THR . 93.2 t -72.98 -42.31 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.387 -0.37 . . . . 0.42999999999999999 111.679 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.561 ' HB ' ' HG2' ' A' ' 77' ' ' MET . 48.0 pt -67.24 -35.11 73.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.628 -0.26 . . . . 1.74 111.299 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.404 ' N ' HG13 ' A' ' 113' ' ' ILE . 54.0 m -58.55 -55.35 36.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.856 0.36 . . . . 0.63 110.482 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.6 m -62.13 -21.01 64.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 1.0900000000000001 110.411 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.46 -56.96 7.03 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.009 -0.615 . . . . 0.41999999999999998 112.793 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.557 HD12 HG13 ' A' ' 118' ' ' ILE . 2.5 pp -61.03 -22.22 64.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.61 0.243 . . . . 1.3799999999999999 111.104 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.557 HG13 HD12 ' A' ' 117' ' ' LEU . 67.8 mt -83.15 -31.81 9.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 1.6200000000000001 110.875 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.61 61.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.091 -0.504 . . . . 0.39000000000000001 111.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.37 -22.06 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 2.02 110.934 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.5 15.35 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.76000000000000001 110.951 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.486 ' HB2' ' HE ' ' A' ' 128' ' ' ARG . 50.1 m -82.27 122.97 28.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.46 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.66 -41.21 9.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 3.3500000000000001 110.856 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.544 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.8 mtp180 -92.03 134.25 34.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.505 . . . . 2.9199999999999999 110.706 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.76 -9.11 57.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 2.77 111.018 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -87.85 -42.29 12.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 3.77 110.852 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.3 p -74.79 -26.14 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 1.1599999999999999 111.101 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.486 ' HE ' ' HB2' ' A' ' 122' ' ' SER . 40.5 ttm180 -67.52 -31.15 71.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.24 -0.437 . . . . 2.04 111.007 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -63.68 -34.39 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 2.6400000000000001 111.221 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.568 HD23 HG21 ' C' ' 56' ' ' ILE . 52.6 tp -81.75 -44.25 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 1.8999999999999999 111.242 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.48 ' HE1' ' HG2' ' C' ' 58' ' ' GLN . 4.5 m95 -56.31 -33.73 65.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.327 . . . . 1.3999999999999999 111.2 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.42 -55.84 18.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.48 . . . . 1.28 111.259 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 130' ' ' LEU . 19.4 tt -63.3 -25.27 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.788 0.328 . . . . 2.1600000000000001 111.137 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 88.4 m -63.78 -42.27 97.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 1.6899999999999999 110.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.03 -53.96 27.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.52000000000000002 112.578 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 35.1 m -59.93 -34.14 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 1.02 111.38 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.403 ' HA ' HD12 ' A' ' 140' ' ' LEU . 47.8 t -60.16 -43.78 95.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 1.0800000000000001 111.096 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.62 79.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.62 111.364 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.77 -27.77 61.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 1.8400000000000001 111.05 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.1 mt -66.09 -49.6 67.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.409 -0.36 . . . . 1.6899999999999999 111.636 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 142' ' ' ILE . 23.9 pt -62.34 -43.5 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.81000000000000005 111.815 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.573 HG21 HG21 ' A' ' 108' ' ' THR . 46.5 mm -71.86 -33.69 48.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.625 -0.261 . . . . 2.3700000000000001 111.409 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.4 -42.31 82.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.97999999999999998 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.747 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 84.9 t90 -74.27 -29.76 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 3.27 110.641 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.95 75.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.892 -0.671 . . . . 1.25 112.815 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.24 -19.38 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.847 0.356 . . . . 2.1200000000000001 111.212 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -80.86 1.93 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 1.6599999999999999 111.419 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 120.91 -0.316 . . . . 99.989999999999995 111.519 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.948 0.404 . . . . 2.3399999999999999 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' A' ' 168' ' ' LEU . 0.6 OUTLIER -74.4 -22.63 59.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.941 -0.572 . . . . 2.77 111.333 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.5 -50.86 71.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 2.04 110.823 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.08 -20.67 48.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 2.77 110.744 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 165' ' ' TYR . 0.2 OUTLIER -66.69 -56.27 11.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 1.8899999999999999 110.801 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.14 -24.36 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 1.6399999999999999 111.234 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.0 -58.68 6.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.403 . . . . 1.24 111.127 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.65 -23.99 66.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 2.9700000000000002 110.316 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -69.82 -32.83 71.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 1.48 111.277 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.6 p -76.41 -51.06 12.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.336 -0.393 . . . . 1.55 111.531 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.98 -29.0 40.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.467 -0.333 . . . . 1.52 111.609 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 62.5 tp -80.08 -57.37 3.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.375 -0.375 . . . . 1.8500000000000001 110.914 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -29.17 58.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.62 110.8 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 181' ' ' ILE . 33.0 mm -87.75 -24.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 1.3500000000000001 110.548 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.91 -50.87 58.97 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.844 -0.616 . . . . 0.58999999999999997 113.22 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.613 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 95.6 m-85 -59.76 -55.65 43.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.779 0.289 . . . . 1.45 111.46 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.4 Cg_exo -45.56 -29.84 5.48 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.278 1.985 . . . . 0.55000000000000004 112.92 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 177' ' ' ILE . 90.0 mt -69.11 -59.66 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 1.4199999999999999 111.297 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 179' ' ' TYR . 27.1 m -61.16 -25.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.78000000000000003 111.644 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -62.97 -23.56 67.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.344 . . . . 0.93999999999999995 110.929 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.76 -64.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 1.4299999999999999 110.966 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 50.6 pt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 2.02 111.097 -179.874 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.79 0.328 . . . . 2.48 111.507 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.43 -43.73 93.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 2.1800000000000002 111.032 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 13.7 m -75.02 -23.15 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 1.49 111.007 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -72.51 -31.85 65.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 1.77 111.169 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 67.1 tp -83.38 -32.25 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 1.4199999999999999 111.315 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -75.4 -19.02 59.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 1.78 111.003 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 206' ' ' PRO . 27.4 p -96.34 -31.53 12.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.054 0.454 . . . . 1.3 110.763 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.3 tp -72.64 -32.83 66.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.66000000000000003 111.297 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.527 ' N ' ' HD2' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -63.08 -54.26 47.55 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.536 -0.302 . . . . 1.6299999999999999 111.471 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 205' ' ' LEU . 14.9 Cg_endo -56.5 -44.22 47.83 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.127 1.884 . . . . 0.64000000000000001 111.825 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -66.24 -29.11 69.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 1.3600000000000001 110.252 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 1.54 110.325 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 1.2 110.727 179.665 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.661 0.267 . . . . 1.6399999999999999 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.64 87.63 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.686 -0.769 . . . . 0.79000000000000004 112.386 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.29 -35.2 80.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.731 0.301 . . . . 1.6100000000000001 110.99 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.4 m -60.96 -57.74 11.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 1.1499999999999999 110.748 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -64.75 -20.05 66.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 3.3399999999999999 110.898 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.8 -43.0 38.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 1.1899999999999999 111.32 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.54 -30.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 2.23 111.358 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.22 -58.91 3.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 2.4700000000000002 111.349 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -69.46 -21.72 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 1.6200000000000001 111.091 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.55 -18.89 64.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.864 -0.684 . . . . 1.4099999999999999 112.569 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 56.4 tp . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.279 . . . . 2.5800000000000001 110.985 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.903 0.382 . . . . 2.0699999999999998 110.81 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.12 -57.61 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.871 -0.604 . . . . 2.1000000000000001 111.284 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 35.9 m170 -61.24 -25.23 66.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 1.0700000000000001 110.894 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.404 ' O ' HG12 ' B' ' 12' ' ' VAL . 59.0 t-105 -69.75 -39.92 76.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.48 110.578 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -24.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.127 0.489 . . . . 2.02 110.164 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' B' ' 207' ' ' PHE . 5.5 t80 -61.14 -55.76 28.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.92000000000000004 110.619 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.404 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -58.72 -36.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.245 -0.434 . . . . 0.93999999999999995 110.673 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.41 75.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.55000000000000004 110.813 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.34 -29.3 64.37 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.47999999999999998 111.991 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.35 -32.85 58.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.84999999999999998 110.784 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -63.32 -54.35 38.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 1.3400000000000001 110.454 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.03 -24.1 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 1.55 110.728 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.49 -62.05 6.78 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.764 -0.731 . . . . 0.69999999999999996 112.099 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -34.71 65.39 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.926 0.393 . . . . 0.81000000000000005 110.836 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.39 -44.03 84.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.6 . . . . 2.2599999999999998 110.558 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -65.52 -39.37 91.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 1.78 110.839 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -73.24 -6.32 45.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 4.5800000000000001 110.616 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.445 ' O ' ' OG ' ' B' ' 26' ' ' SER . 65.0 t90 -89.11 -35.78 16.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 3.3500000000000001 110.624 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -70.72 -44.64 66.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 110.865 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.24 -2.81 53.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 1.8400000000000001 110.701 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 92.8 p -58.3 -15.02 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.525 . . . . 1.3700000000000001 111.186 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -48.81 -40.07 27.75 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.692 -0.484 . . . . 4.9800000000000004 109.692 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.6 p-10 179.16 130.8 0.23 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.421 -0.808 . . . . 2.1400000000000001 110.559 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' B' ' 33' ' ' PRO . 71.8 Cg_endo -102.95 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.646 2.897 . . . . 1.8200000000000001 111.967 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' B' ' 30' ' ' ARG . 4.2 mmp_? -106.23 11.22 31.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.453 0.644 . . . . 5.1900000000000004 109.685 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.68 -53.68 0.76 Allowed Glycine 0 CA--C 1.519 0.303 0 CA-C-N 114.857 -1.065 . . . . 2.2000000000000002 112.16 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.65 104.87 5.38 Favored Pre-proline 0 CA--C 1.518 -0.275 0 CA-C-N 117.486 0.643 . . . . 3.6499999999999999 111.69 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.573 ' HB3' ' HG3' ' B' ' 29' ' ' PRO . 83.2 Cg_endo -89.3 107.98 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.773 0.982 . . . . 2.6699999999999999 113.602 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -92.74 -61.13 1.65 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.804 1.764 . . . . 4.8799999999999999 107.735 174.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -39.85 18.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 110.317 -3.129 . . . . 1.8700000000000001 113.148 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -38.3 -64.6 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.638 0.977 . . . . 2.6800000000000002 113.638 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.43 ' CZ ' ' HA ' ' B' ' 26' ' ' SER . 75.0 m-85 -82.69 -18.28 41.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.102 0.408 . . . . 2.9199999999999999 112.102 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 tp -59.3 -65.12 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.867 0.365 . . . . 1.6399999999999999 110.781 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 m -69.25 -37.82 76.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 1.6000000000000001 111.472 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 -12.09 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.52 -0.309 . . . . 0.68999999999999995 111.154 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 45.3 tpp -89.09 -48.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 2.5800000000000001 111.665 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -65.86 -48.95 69.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.849 0.685 . . . . 3.3900000000000001 112.849 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 79.5 mt -45.36 -53.61 17.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.29 0.848 . . . . 0.40999999999999998 113.29 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -71.48 -38.61 4.38 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.228 1.952 . . . . 0.48999999999999999 113.611 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -59.54 -61.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.852 0.315 . . . . 1.29 111.852 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.507 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.1 OUTLIER -58.26 -58.92 6.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 1.3999999999999999 111.314 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.431 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 47.9 t -55.05 -26.24 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 1.3799999999999999 111.025 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.58 -67.57 2.08 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.754 -0.736 . . . . 0.37 112.739 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.09 -24.32 58.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.646 0.26 . . . . 1.29 111.385 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.66 -59.15 5.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.44 111.182 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.8 m-85 -61.76 -35.8 79.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.5 110.95 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 57.6 ttp -51.5 -35.31 39.68 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.072 0.463 . . . . 1.4099999999999999 110.08 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.61 -39.44 70.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.55000000000000004 110.537 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -57.11 -21.12 29.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.5 110.567 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -82.63 -46.18 13.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.046 -0.525 . . . . 0.54000000000000004 111.105 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' B' ' 53' ' ' ALA . 27.0 pt -75.26 -0.05 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 1.3 111.299 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.93 65.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.939 -0.573 . . . . 2.2400000000000002 110.904 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -146.79 114.27 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 1.77 110.846 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' B' ' 70' ' ' TYR . . . 136.23 -1.33 3.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 1.0600000000000001 112.532 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -108.58 151.54 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 2.6600000000000001 111.018 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.26 145.67 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 1.8899999999999999 111.1 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.32 87.95 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 2.4100000000000001 111.143 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.28 118.08 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 1.5600000000000001 110.85 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.86 31.49 20.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 1.8200000000000001 111.13 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.14 0.56 86.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.646 -0.787 . . . . 1.51 112.548 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -101.02 147.19 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 2.4500000000000002 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.3 mt -92.74 121.86 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 1.79 110.81 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.482 ' HB1' HD23 ' B' ' 121' ' ' LEU . . . -99.12 140.07 33.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.81999999999999995 111.276 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.601 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.7 m-70 -82.99 58.29 4.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 1.05 110.879 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.441 ' O ' HG13 ' B' ' 74' ' ' ILE . 65.5 t80 -62.89 -55.75 23.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.506 -0.77 . . . . 1.8700000000000001 111.351 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' B' ' 74' ' ' ILE . . . -63.2 -24.0 67.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.068 0.396 . . . . 0.60999999999999999 112.068 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 58.7 mmt-85 -64.69 -52.46 57.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.231 0.456 . . . . 2.3900000000000001 112.231 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.494 ' CE1' ' HG ' ' B' ' 117' ' ' LEU . 2.1 p90 -64.29 -32.12 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.607 -0.437 . . . . 3.6699999999999999 110.476 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' B' ' 71' ' ' ALA . 57.7 mt -50.44 -53.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 116.125 -0.489 . . . . 1.6599999999999999 110.992 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 24.7 t70 -66.56 -22.76 66.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.196 -0.456 . . . . 1.4099999999999999 110.311 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -89.77 5.1 47.54 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.105 -0.498 . . . . 1.1599999999999999 111.034 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.49 ' HA ' HD13 ' B' ' 113' ' ' ILE . 51.9 ttm -104.89 -18.44 14.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 1.53 110.592 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' B' ' 46' ' ' TRP . 28.1 m -114.46 -33.81 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.087 -0.506 . . . . 0.89000000000000001 112.106 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -79.33 -48.5 13.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.157 0.428 . . . . 1.24 112.157 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 5.6 m -55.6 -50.71 85.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.443 -0.344 . . . . 0.57999999999999996 111.781 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 47.2 Cg_exo -55.54 -33.48 86.68 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.945 1.763 . . . . 0.66000000000000003 111.969 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' B' ' 85' ' ' LEU . 83.8 mt -78.55 -26.47 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 1.0600000000000001 110.868 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.58 -39.17 84.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.847 0.356 . . . . 1.22 110.281 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.8 pp -82.07 -25.96 34.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.976 -0.556 . . . . 1.53 110.323 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.446 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.1 mt -68.62 -34.05 75.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 1.5800000000000001 109.804 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -58.78 -34.84 71.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 1.3899999999999999 110.423 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.05 -29.33 65.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 1.1499999999999999 110.88 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 56.4 m -63.57 -40.05 95.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 1.5700000000000001 110.937 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -82.51 -16.24 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 2.1699999999999999 111.033 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 89.8 m -68.08 -42.92 79.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 1.4199999999999999 111.268 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.77 -33.21 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 1.1799999999999999 111.376 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.5 mtm -118.04 110.23 17.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 1.8799999999999999 110.829 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -76.44 -30.38 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 3.4199999999999999 111.248 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -133.54 140.78 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 4.0599999999999996 110.767 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -107.7 142.03 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 2.0899999999999999 111.14 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -127.0 -50.62 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.152 -0.477 . . . . 3.8500000000000001 110.854 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -137.28 -17.21 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 4.8200000000000003 110.911 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -65.52 113.26 4.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 3.7999999999999998 111.223 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -149.21 -23.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.999 -0.546 . . . . 5.1699999999999999 110.497 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.407 ' HB ' HD22 ' A' ' 38' ' ' LEU . 61.8 p -76.35 -34.92 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 2.02 110.778 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.87 -46.91 82.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.502 . . . . 2.0899999999999999 110.592 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.24 -37.17 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.8799999999999999 110.88 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.29 -18.26 79.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 0.56000000000000005 112.409 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -72.85 -45.02 60.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.78 110.755 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.38 -30.41 63.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 1.03 110.945 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . 0.416 ' O ' HG13 ' B' ' 110' ' ' ILE . 89.5 mtp -69.7 -48.69 58.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 1.6699999999999999 111.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -57.61 -45.32 85.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.364 -0.38 . . . . 1.51 111.077 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.615 ' HB ' HD13 ' B' ' 142' ' ' ILE . 57.8 p -59.14 -33.12 70.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 1.1799999999999999 111.128 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.448 ' O ' HG13 ' B' ' 113' ' ' ILE . 56.8 tp60 -71.17 -36.78 72.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.356 -0.384 . . . . 2.1699999999999999 110.987 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.472 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.6 mt -56.8 -43.32 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 1.3500000000000001 111.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.539 HG22 ' O ' ' B' ' 108' ' ' THR . 18.2 m -70.93 -30.59 42.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 1.3400000000000001 111.347 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 108' ' ' THR . 88.9 t -72.64 -27.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.482 -0.327 . . . . 0.42999999999999999 111.256 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' B' ' 77' ' ' MET . 69.8 mt -80.2 -43.15 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.631 -0.259 . . . . 1.6000000000000001 111.213 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.412 HG22 ' O ' ' B' ' 111' ' ' VAL . 9.7 t -58.92 -29.92 67.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.955 0.407 . . . . 0.85999999999999999 110.176 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -69.15 -50.52 47.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.897 -0.592 . . . . 0.94999999999999996 109.833 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.54 -10.1 66.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.9 -0.667 . . . . 0.46000000000000002 111.51 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.494 ' HG ' ' CE1' ' B' ' 73' ' ' TYR . 4.4 tt -70.43 -56.78 5.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.506 . . . . 1.75 110.346 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.48 -20.62 9.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.647 -0.706 . . . . 1.78 111.546 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.83 -39.41 11.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.38 111.331 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.03 -23.93 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.97 110.842 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.482 HD23 ' HB1' ' B' ' 68' ' ' ALA . 87.8 mt -87.96 29.57 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.76000000000000001 111.15 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -93.91 122.92 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.411 . . . . 1.47 110.735 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.53 -52.52 4.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 2.5 111.263 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.9 ttm180 -77.42 123.71 26.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 2.73 110.809 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.73 -14.24 50.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.144 -0.48 . . . . 2.2000000000000002 111.132 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.584 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 66.1 t-105 -74.53 -56.12 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 3.3999999999999999 110.56 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' B' ' 124' ' ' ARG . 7.7 p -65.15 -27.95 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 1.23 111.059 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -55.07 -26.93 41.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.725 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.54 -34.99 40.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 4.1399999999999997 110.922 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.419 HD22 ' N ' ' B' ' 130' ' ' LEU . 3.8 mm? -72.31 -49.33 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 1.6499999999999999 111.135 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -62.47 -31.9 72.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.77000000000000002 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.464 ' HE1' ' HB3' ' B' ' 183' ' ' TRP . 66.5 t80 -63.34 -55.47 24.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 1.46 110.984 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 tt -68.34 -23.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.027 0.441 . . . . 1.6299999999999999 110.865 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.8 -41.67 91.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 1.4199999999999999 111.276 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.82 -50.49 35.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.48999999999999999 112.799 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 26.9 m -61.31 -38.31 79.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.576 0.227 . . . . 1.3 111.489 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -58.31 -45.29 88.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 1.3 111.331 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.57 77.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.62 111.153 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -69.71 -22.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 1.74 111.361 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 80.5 mt -66.98 -60.61 2.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.703 -0.226 . . . . 1.76 111.278 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 31.0 pt -56.08 -36.33 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.68999999999999995 111.408 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.615 HD13 ' HB ' ' B' ' 108' ' ' THR . 74.5 mt -69.78 -42.63 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 1.76 111.152 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.17 -47.47 81.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0600000000000001 111.069 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . 0.447 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 44.4 t-105 -66.59 -25.91 66.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 4.1200000000000001 110.964 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.65 -21.29 58.28 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.9 -0.667 . . . . 1.26 113.229 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.1 pt -98.94 -6.58 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 1.98 111.717 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -87.59 -2.3 58.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 1.4199999999999999 111.388 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' B' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.297 -0.41 . . . . 99.989999999999995 111.855 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.8 0.333 . . . . 2.4300000000000002 110.962 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.67 -22.38 50.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.534 . . . . 2.5800000000000001 110.885 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.71 -47.35 84.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 2.0 111.164 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.19 -21.0 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 3.0299999999999998 110.633 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.2 -49.57 55.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.141 -0.481 . . . . 1.1000000000000001 110.699 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.33 -23.63 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.75 111.006 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.82 -59.04 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.295 -0.411 . . . . 0.97999999999999998 110.982 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.91 -29.15 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 4.2999999999999998 110.069 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.98 -21.56 64.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.601 -0.727 . . . . 1.3899999999999999 110.843 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 46.6 m -79.14 -58.3 3.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 1.1100000000000001 111.539 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.08 -29.78 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 1.51 111.686 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 44.9 tp -76.39 -58.55 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.474 -0.33 . . . . 1.75 111.562 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -28.89 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.33 -0.395 . . . . 0.59999999999999998 110.854 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.432 ' O ' HG12 ' B' ' 181' ' ' ILE . 42.9 mm -87.93 -24.07 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 1.47 110.482 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.92 48.5 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.55000000000000004 113.228 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.613 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 83.1 m-85 -56.8 -55.78 39.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.912 0.356 . . . . 1.6200000000000001 111.521 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.1 Cg_exo -44.89 -33.32 7.28 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.455 2.103 . . . . 0.64000000000000001 112.84 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.0 mm -66.49 -59.58 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 1.27 111.644 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.09 -28.28 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.68999999999999995 111.831 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . 0.464 ' HB3' ' HE1' ' B' ' 132' ' ' TYR . 38.2 m95 -60.07 -24.22 64.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.59 -0.277 . . . . 1.1799999999999999 111.174 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 89.2 mt -55.63 -61.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.715 0.293 . . . . 1.77 111.179 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 41.2 pt -82.81 165.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 1.6899999999999999 111.267 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.336 0 C-N-CA 120.891 -0.671 . . . . 1.5800000000000001 112.608 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.831 0.348 . . . . 2.4700000000000002 110.763 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 2.5299999999999998 110.451 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -62.91 -28.06 69.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.762 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -66.17 -36.12 82.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 2.6200000000000001 110.977 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.69 -47.81 51.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 1.6100000000000001 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -71.38 -6.21 38.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 1.4199999999999999 111.154 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HD2' ' B' ' 206' ' ' PRO . 47.3 t -96.34 -46.13 6.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.204 0.526 . . . . 1.4299999999999999 110.599 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.1 tp -72.25 -26.01 61.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 1.1200000000000001 111.578 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.671 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 62.2 tp -66.0 -54.48 27.12 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.931 -0.308 . . . . 1.26 111.123 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.5 Cg_exo -55.83 -42.52 66.29 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.697 1.598 . . . . 0.59999999999999998 111.388 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.429 ' HB2' ' CE1' ' B' ' 11' ' ' TYR . 89.4 t80 -63.93 -39.19 93.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 1.3999999999999999 110.456 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.2 -34.31 78.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 1.4099999999999999 111.089 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.317 -0.401 . . . . 1.3200000000000001 110.994 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.209 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.63 63.25 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.823 -0.703 . . . . 0.79000000000000004 112.563 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -66.4 -38.47 87.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 2.96 110.859 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.8 m -60.64 -56.39 21.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 1.29 110.733 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -63.94 -20.12 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 3.1499999999999999 110.683 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.435 ' C ' HD13 ' B' ' 216' ' ' LEU . 3.2 tm? -71.63 -58.18 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 1.51 111.104 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -58.73 -23.89 60.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.375 . . . . 2.1899999999999999 111.209 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.3 tp -68.76 -54.59 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 1.98 111.338 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -77.59 -20.36 54.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.285 -0.416 . . . . 2.1699999999999999 111.311 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.36 67.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.913 -0.66 . . . . 1.3600000000000001 113.102 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 52.7 tp . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.598 0.237 . . . . 2.8999999999999999 111.125 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.789 0.328 . . . . 2.52 110.782 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.31 -41.79 98.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 1.9299999999999999 110.498 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 46.2 m80 -74.1 -23.84 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 1.26 110.389 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.431 ' O ' HG12 ' C' ' 12' ' ' VAL . 64.4 t-105 -72.61 -44.49 61.9 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.914 -0.585 . . . . 1.6699999999999999 110.732 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.45 -23.34 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.183 0.516 . . . . 1.8700000000000001 109.911 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -60.79 -57.35 13.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 1.4399999999999999 110.581 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.431 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.2 p -59.04 -31.42 45.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.31 -0.404 . . . . 0.46999999999999997 110.805 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.16 -33.21 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.58999999999999997 110.449 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.82 -28.67 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.5 112.008 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.4 mmt -75.7 -34.63 60.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.634 0.254 . . . . 0.68000000000000005 111.232 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -63.1 -53.36 54.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 1.3999999999999999 110.867 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -61.91 -26.65 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 1.55 110.809 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.25 -59.94 9.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.70999999999999996 112.278 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.89 65.84 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.796 0.332 . . . . 0.77000000000000002 111.277 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.2 mt -62.79 -42.5 99.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.233 -0.44 . . . . 1.9299999999999999 110.879 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -59.52 -40.76 88.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 1.8600000000000001 110.633 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -70.54 -20.01 62.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 4.1399999999999997 110.831 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . 0.406 ' O ' ' OG ' ' C' ' 26' ' ' SER . 85.7 t90 -71.57 -34.36 69.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 3.1499999999999999 110.655 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 43.9 t -71.39 -47.8 53.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.95 110.879 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 -0.93 30.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 2.2200000000000002 110.778 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 95.1 p -56.09 -17.7 7.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 1.3700000000000001 111.441 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -47.24 -42.83 21.18 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.742 -0.466 . . . . 5.0300000000000002 109.742 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 7.7 p30 -173.67 130.66 0.53 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.468 -0.787 . . . . 2.3700000000000001 110.402 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 73.4 Cg_endo . . . . . 0 N--CA 1.452 -0.936 0 C-N-CA 123.471 2.781 . . . . 2.0499999999999998 112.651 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 121.162 0.401 . . . . 1.9299999999999999 112.969 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -60.03 -17.98 42.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 4.1200000000000001 112.096 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -45.5 -30.84 1.53 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.706 0.289 . . . . 2.8900000000000001 111.641 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.59 -58.75 5.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 2.46 111.142 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -69.76 -19.84 63.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.383 -0.371 . . . . 2.7799999999999998 111.319 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.49 -63.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 1.6200000000000001 110.819 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.53 -30.36 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 1.5900000000000001 111.328 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.17 -13.04 61.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.65000000000000002 111.559 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.429 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 27.2 ttt -89.79 -42.54 11.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.387 -0.37 . . . . 1.6699999999999999 111.906 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.15 -42.0 66.47 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.751 0.648 . . . . 3.4199999999999999 112.751 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.609 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 35.1 mm -51.45 -52.72 57.11 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.78 0.659 . . . . 0.89000000000000001 112.78 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 12.6 Cg_exo -70.33 -39.08 5.78 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.416 2.077 . . . . 0.40999999999999998 113.209 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.19 -61.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.887 0.329 . . . . 1.76 111.887 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.567 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -56.11 -58.94 5.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 2.1600000000000001 111.234 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 30.3 t -53.42 -28.8 31.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.99 -0.55 . . . . 1.1699999999999999 111.213 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.98 -62.54 6.11 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.657 -0.783 . . . . 0.44 112.445 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.447 ' HA ' ' HE2' ' C' ' 52' ' ' MET . 56.1 mt -61.4 -24.12 66.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 1.29 110.838 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . 0.4 ' HB1' ' HB2' ' C' ' 75' ' ' ASP . . . -64.4 -58.04 7.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.5 111.004 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.516 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 36.8 m-85 -63.59 -35.77 81.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 1.8300000000000001 110.982 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' C' ' 49' ' ' LEU . 51.7 ttp -53.48 -35.28 60.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.138 0.494 . . . . 1.47 109.965 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.63 -34.14 64.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.698 -0.683 . . . . 0.59999999999999998 110.69 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . 0.404 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 50.4 mtt -61.82 -20.12 63.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.83999999999999997 110.052 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.24 -48.07 12.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.65000000000000002 110.713 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.568 HG21 HD23 ' A' ' 130' ' ' LEU . 39.6 pt -73.01 -5.44 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.004 -0.544 . . . . 1.55 111.343 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.66 67.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.943 -0.571 . . . . 1.54 111.117 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.48 ' HG2' ' HE1' ' A' ' 131' ' ' TRP . 53.0 tp60 -139.21 139.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.79 110.766 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 110.74 11.14 19.92 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.892 -0.67 . . . . 0.93999999999999995 112.194 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -115.09 148.21 39.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 2.3599999999999999 110.925 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.93 140.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 1.97 111.047 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.43 86.85 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 2.4399999999999999 111.152 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.68 118.9 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 1.54 111.08 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.76 28.75 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 1.71 111.284 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.49 -6.3 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 1.53 112.626 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.94 152.58 19.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 2.23 110.675 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.06 131.68 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 1.3600000000000001 110.894 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.02 144.66 32.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.515 . . . . 0.78000000000000003 111.208 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.438 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 65.2 m-70 -91.56 59.21 3.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 1.0800000000000001 110.779 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.21 -58.18 5.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 2.2999999999999998 111.256 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -55.61 -35.45 65.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.228 0.537 . . . . 0.75 110.429 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 9.1 tpp180 -56.04 -39.29 71.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.338 -0.846 . . . . 1.51 111.008 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.511 ' O ' ' HG3' ' C' ' 77' ' ' MET . 0.2 OUTLIER -82.59 -20.75 35.87 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.04 0.385 . . . . 4.6500000000000004 112.04 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 47.7 mm -58.77 -42.86 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 1.22 110.284 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 25.8 t70 -60.98 -22.73 64.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 1.3100000000000001 110.599 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -81.27 -27.61 35.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 1.6799999999999999 111.267 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.619 ' HG2' HG23 ' C' ' 113' ' ' ILE . 12.8 mtp -75.55 -14.04 60.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.736 -0.665 . . . . 1.8 111.801 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' C' ' 46' ' ' TRP . 16.3 m -114.89 -42.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.451 0.537 . . . . 1.1899999999999999 112.451 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 71.7 m -72.49 -51.82 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.63 0.604 . . . . 1.23 112.63 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.0 m -54.02 -51.02 80.92 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.351 0.5 . . . . 0.58999999999999997 112.351 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.7 Cg_exo -55.28 -35.53 91.57 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.939 1.759 . . . . 0.67000000000000004 112.256 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.441 ' HB3' HD11 ' C' ' 43' ' ' ILE . 4.0 mm? -77.55 -23.8 49.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.95999999999999996 110.663 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -46.36 75.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.1899999999999999 110.492 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.496 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -74.36 -29.26 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.7 110.737 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . 0.496 ' N ' HD12 ' C' ' 84' ' ' LEU . 7.4 tp -64.52 -36.76 85.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 1.6200000000000001 110.501 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 m -61.61 -32.04 72.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.379 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 60.8 mt -66.7 -32.43 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.8 -0.636 . . . . 1.1100000000000001 110.561 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.8 t -62.94 -53.45 53.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.51 110.566 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.97 -26.66 68.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 2.0600000000000001 110.845 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 86.0 m -66.31 -33.15 75.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.257 -0.429 . . . . 1.52 110.891 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.15 -50.73 25.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 1.3 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -124.07 127.58 48.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 1.6200000000000001 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -78.48 -13.12 59.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 3.2400000000000002 110.938 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -133.76 163.26 29.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.194 -0.457 . . . . 4.6299999999999999 111.028 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 36.5 mm -126.44 143.98 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 2.1800000000000002 110.959 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -133.22 -72.73 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 4.1200000000000001 110.863 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.78 1.5 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 4.96 110.88 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.17 96.05 7.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 3.9100000000000001 110.995 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -136.32 -9.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 5.21 110.647 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 82.2 p -88.25 -38.89 14.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 1.8200000000000001 111.017 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.88 -42.12 97.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.534 . . . . 2.0800000000000001 110.704 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.44 -41.14 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.959 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.36 -14.67 77.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.58999999999999997 112.449 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.82 -46.41 24.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.878 0.37 . . . . 1.53 110.568 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.38 -38.72 68.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 1.1100000000000001 110.555 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 22.5 ttt -66.36 -42.04 88.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.574 -0.739 . . . . 2.21 111.61 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 47.7 t -60.29 -50.14 74.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.792 0.33 . . . . 1.28 111.218 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.718 HG21 HG12 ' C' ' 142' ' ' ILE . 39.9 m -55.29 -36.59 66.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 1.22 111.079 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.552 HE21 HD11 ' C' ' 113' ' ' ILE . 56.3 tp60 -63.74 -46.68 84.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 2.3300000000000001 111.257 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.507 HG22 ' HE1' ' B' ' 46' ' ' TRP . 66.5 mt -52.66 -34.5 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.303 -0.408 . . . . 1.29 110.864 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.95 -53.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.564 . . . . 1.0600000000000001 111.357 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 28.6 t -63.49 -27.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 111.37 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.619 HG23 ' HG2' ' C' ' 77' ' ' MET . 22.2 mm -65.43 -50.27 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 1.3700000000000001 111.423 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 92.4 m -54.54 -55.53 28.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.47 -0.332 . . . . 0.77000000000000002 111.044 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 35.4 m -57.38 -21.49 36.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 1.1899999999999999 110.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -61.6 3.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.756 -0.735 . . . . 0.5 112.847 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.41 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -59.85 -22.21 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.702 0.287 . . . . 1.47 110.976 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.41 ' N ' HD12 ' C' ' 117' ' ' LEU . 37.6 mm -81.42 -33.93 12.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 1.2 110.997 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.28 -37.73 48.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.40000000000000002 111.193 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.88 -21.14 28.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 2.1200000000000001 110.946 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.77 28.99 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.431 -0.35 . . . . 0.75 111.025 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -94.71 125.75 39.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 1.3799999999999999 110.783 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.98 -21.2 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 2.7400000000000002 111.245 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . 0.674 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 52.5 ttp180 -114.86 135.83 53.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.382 -0.372 . . . . 2.7999999999999998 110.676 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.01 -11.73 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 2.4100000000000001 111.625 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . 0.674 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 56.6 t90 -81.86 -50.17 9.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 4.2000000000000002 110.845 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' C' ' 124' ' ' ARG . 7.4 p -66.07 -26.61 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 1.0800000000000001 111.015 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -62.37 -21.58 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 2.5699999999999998 111.103 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -77.61 -36.8 51.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 3.8100000000000001 110.816 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.424 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.3 mp -76.76 -30.4 56.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.089 -0.505 . . . . 1.4199999999999999 111.38 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -76.07 -42.53 47.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.715 0.293 . . . . 0.89000000000000001 111.362 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -57.67 -50.96 71.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.247 -0.433 . . . . 1.26 110.944 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.5 -27.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 1.6799999999999999 111.25 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.06 -45.03 90.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 1.24 111.105 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.09 47.62 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.846 -0.692 . . . . 0.54000000000000004 112.878 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.96 -31.73 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.694 0.257 . . . . 1.0600000000000001 111.694 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.19 -48.79 76.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 1.0800000000000001 111.34 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.6 73.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.56999999999999995 111.301 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.08 -22.64 62.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.035 -0.53 . . . . 1.6799999999999999 111.455 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.44 -53.87 9.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.537 -0.301 . . . . 1.7 111.792 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.434 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.7 pt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.833 0.309 . . . . 0.78000000000000003 111.833 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.718 HG12 HG21 ' C' ' 108' ' ' THR . 8.1 tp -72.47 -31.19 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.773 0.32 . . . . 2.2400000000000002 111.44 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.45 -44.96 95.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 1.02 111.004 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . 0.712 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 71.8 t-105 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 3.0 111.259 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.51 -17.57 77.44 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.751 -0.737 . . . . 1.27 113.165 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.64 -26.34 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.872 0.367 . . . . 1.8899999999999999 110.995 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -73.02 -0.28 13.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 1.6000000000000001 111.912 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . 0.712 ' ND2' ' O ' ' C' ' 144' ' ' TRP . 69.1 m-80 . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 99.989999999999995 112.124 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.949 0.404 . . . . 2.3500000000000001 110.77 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.43 -27.28 63.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.867 -0.606 . . . . 2.6200000000000001 110.862 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.87 -42.49 99.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 2.0899999999999999 110.892 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -81.62 -21.15 38.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 3.2400000000000002 110.722 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 55.6 tp -70.61 -54.59 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 1.6899999999999999 111.355 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.46 -24.04 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 1.3999999999999999 111.224 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.9 m -55.05 -59.06 5.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.95999999999999996 111.255 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.12 -26.76 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 3.6499999999999999 110.423 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -70.22 -25.31 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.879 -0.6 . . . . 1.3700000000000001 110.884 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 84.2 m -79.88 -51.69 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.515 . . . . 1.4299999999999999 111.83 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.72 -26.4 34.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 111.925 0.342 . . . . 1.6200000000000001 111.925 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 60.6 tp -83.2 -54.81 4.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.568 -0.287 . . . . 2.0299999999999998 111.299 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -32.41 64.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.4 . . . . 0.62 110.726 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.472 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.3 tt -87.73 -19.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 1.5800000000000001 110.484 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.21 39.76 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.835 -0.62 . . . . 0.56000000000000005 113.034 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.626 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 94.6 m-85 -55.31 -53.8 57.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.807 0.304 . . . . 1.3300000000000001 111.19 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.2 Cg_exo -46.6 -31.6 10.43 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.122 1.881 . . . . 0.63 112.503 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -66.1 -60.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.351 -0.386 . . . . 0.93000000000000005 111.364 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.52 -31.51 49.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.208 -0.451 . . . . 1.27 111.846 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -54.76 -29.03 52.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.568 -0.287 . . . . 1.77 111.469 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 74.5 mt -52.64 -62.44 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 2.3900000000000001 111.237 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 34.6 pt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.95 111.257 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.749 0.309 . . . . 2.3799999999999999 111.223 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt -63.48 -27.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 2.23 110.909 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.02 -48.37 71.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 2.1600000000000001 110.8 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 68.0 p -65.4 -24.99 67.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.27 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -70.56 -36.39 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 1.7 110.883 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.9 tp -76.73 -32.52 57.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 2.02 110.96 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -77.41 -18.93 56.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 1.8200000000000001 110.828 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.5 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.6 m -96.11 -34.27 11.76 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.118 -0.492 . . . . 1.3500000000000001 111.173 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.64 -35.32 72.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.124 -0.489 . . . . 0.65000000000000002 111.586 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.619 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.8 OUTLIER -59.98 -53.78 61.93 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 121.138 -0.225 . . . . 1.4199999999999999 110.813 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 64.7 Cg_exo -52.16 -50.83 12.68 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.197 1.931 . . . . 0.63 112.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -63.13 -32.74 74.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.379 -0.373 . . . . 1.49 110.703 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.63 -30.97 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.12 -0.491 . . . . 1.7 110.555 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 1.25 110.827 179.805 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . 0.436 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.7 p . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.801 0.334 . . . . 1.6100000000000001 110.962 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.436 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -64.3 -28.7 73.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.812 -0.709 . . . . 0.81999999999999995 112.375 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.24 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 3.0800000000000001 110.634 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 45.0 t -60.94 -60.71 3.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 1.1499999999999999 110.85 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -62.8 -20.45 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 2.5600000000000001 111.045 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.93 -56.1 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 1.29 110.757 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.5 -21.13 65.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.329 -0.396 . . . . 2.3900000000000001 111.02 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 68.4 tp -67.27 -51.87 47.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 2.0299999999999998 110.966 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -82.44 -22.49 35.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 3.21 111.01 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.79 -22.55 47.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.899 -0.667 . . . . 1.3600000000000001 112.642 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.323 . . . . 2.8999999999999999 110.574 179.892 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.79 0.329 . . . . 2.4199999999999999 110.76 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.49 -40.81 83.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.0899999999999999 111.094 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.644 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 39.5 m80 -62.12 -35.96 80.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 1.1599999999999999 111.034 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' HG12 ' A' ' 12' ' ' VAL . 50.1 t-105 -69.52 -45.25 69.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.254 -0.43 . . . . 0.79000000000000004 111.186 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mt -68.26 -21.82 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.034 0.445 . . . . 2.0800000000000001 110.457 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -63.95 -54.98 26.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 1.28 110.682 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.3 p -61.64 -31.45 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.314 -0.403 . . . . 1.3200000000000001 111.032 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.31 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.63 111.168 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.33 -33.38 75.55 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.974 -0.631 . . . . 0.55000000000000004 112.951 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -70.47 -31.65 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.805 0.303 . . . . 1.03 111.201 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.8 m -63.02 -62.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.43 -0.35 . . . . 1.3 110.995 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -53.46 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.369 -0.378 . . . . 1.3100000000000001 111.181 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -60.28 -43.24 98.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.808 -0.711 . . . . 0.77000000000000002 112.236 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.86 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.865 0.364 . . . . 0.80000000000000004 111.023 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.61 -31.75 69.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 1.8100000000000001 111.078 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -55.89 -24.51 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.158 -0.474 . . . . 1.8799999999999999 111.267 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -56.45 -56.51 20.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.477 -0.329 . . . . 4.4500000000000002 111.085 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.643 ' O ' ' OG ' ' A' ' 26' ' ' SER . 86.2 t90 -64.24 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 3.6899999999999999 110.978 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -70.13 -23.77 63.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 1.5700000000000001 111.234 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.4 tp -87.76 -4.29 58.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 1.95 110.918 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 29.2 p -69.82 -20.22 63.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 1.3799999999999999 110.96 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.494 ' HG3' HD22 ' A' ' 28' ' ' ASN . 24.9 tpt180 -50.6 -32.14 17.94 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.63 -0.507 . . . . 4.0700000000000003 109.63 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.494 HD22 ' HG3' ' A' ' 27' ' ' ARG . 6.4 p30 -175.55 132.28 0.43 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.371 -0.831 . . . . 2.7200000000000002 110.464 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 57.4 Cg_endo -96.15 158.21 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.226 2.617 . . . . 1.9099999999999999 112.113 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' CZ ' HD22 ' A' ' 218' ' ' LEU . 83.8 mtt180 -84.51 62.12 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.964 0.411 . . . . 4.7599999999999998 110.99 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.69 -46.98 3.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.952 -0.642 . . . . 1.99 112.446 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.0 m -99.75 145.48 30.21 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.468 0.175 . . . . 2.7000000000000002 110.658 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.25 160.83 12.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.317 2.012 . . . . 1.79 112.378 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -62.16 -16.41 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.801 . . . . 4.1200000000000001 112.077 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -41.41 -37.89 1.13 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.022 0.379 . . . . 2.9300000000000002 112.022 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 2.8799999999999999 110.369 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -68.22 -20.19 64.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.021 -0.536 . . . . 4.6600000000000001 110.282 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' MET . 32.8 tp -61.28 -47.75 84.57 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.266 -0.425 . . . . 1.45 110.002 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.67 -41.93 94.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.127 -0.488 . . . . 1.78 109.842 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -70.47 -6.11 33.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.62 -0.718 . . . . 0.63 110.908 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' LEU . 24.1 ttt -87.95 -36.42 17.1 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.17 -0.468 . . . . 1.48 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -71.3 -33.41 69.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.131 -0.486 . . . . 3.5 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 78.3 mt -50.68 -54.83 31.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.025 0.38 . . . . 1.0800000000000001 112.025 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -70.62 -32.21 15.4 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.234 1.956 . . . . 0.53000000000000003 113.082 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 41' ' ' MET . 24.8 mm -55.32 -62.4 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.717 0.294 . . . . 1.6799999999999999 111.726 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -62.66 -53.88 47.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 1.8300000000000001 111.306 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.48 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 91.3 p -58.48 -14.63 8.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 1.0900000000000001 111.545 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.59 -61.21 2.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.40999999999999998 112.589 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 mt -55.96 -27.57 53.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.704 0.287 . . . . 0.98999999999999999 111.358 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.94 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.47999999999999998 111.399 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.2 m-85 -60.86 -38.05 84.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 1.8700000000000001 111.46 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.8 ttp -52.04 -40.41 61.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.11 0.481 . . . . 1.49 110.059 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.45 93.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.58999999999999997 110.738 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.402 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 57.6 mtt -52.48 -35.73 53.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.48999999999999999 110.323 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -65.81 -43.88 87.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.968 -0.56 . . . . 0.59999999999999998 110.093 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.567 HG21 HG23 ' B' ' 127' ' ' VAL . 12.1 mt -70.61 -3.6 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 1.3100000000000001 110.814 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.78 32.57 10.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.794 -0.639 . . . . 1.9099999999999999 111.021 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -114.93 127.63 55.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 1.6200000000000001 110.537 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.65 15.15 2.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.821 -0.704 . . . . 1.04 112.394 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -112.34 141.97 45.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 2.6800000000000002 110.909 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.47 138.16 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 1.98 111.094 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.25 138.9 37.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.11 -0.496 . . . . 2.1800000000000002 110.871 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.33 104.43 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 1.5700000000000001 111.129 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.11 26.11 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 1.79 111.488 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.35 23.1 32.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 1.48 112.602 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -121.77 127.2 50.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 2.3199999999999998 110.678 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -101.84 120.75 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 1.4399999999999999 111.176 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.63 124.58 52.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.062 -0.517 . . . . 0.81999999999999995 110.685 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 74.5 m-70 -70.22 82.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.345 0.593 . . . . 0.90000000000000002 111.161 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.92 -50.96 70.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.314 -0.857 . . . . 1.8300000000000001 111.253 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -22.39 66.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.958 -0.565 . . . . 0.62 112.166 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -68.89 -52.09 33.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.195 0.443 . . . . 2.3399999999999999 112.195 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 4.0 p90 -76.67 -34.34 58.25 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.9 -0.32 . . . . 3.4900000000000002 111.244 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 mm -52.59 -49.85 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.934 0.397 . . . . 1.3700000000000001 110.532 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 26.7 t70 -65.0 -22.25 66.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.927 -0.578 . . . . 1.3100000000000001 109.877 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -87.08 5.29 38.41 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.803 -0.635 . . . . 1.48 111.254 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.479 ' HG3' HD12 ' A' ' 113' ' ' ILE . 43.2 ttm -104.17 -19.75 14.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 1.46 110.61 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.453 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.7 m -113.98 -32.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 1.1200000000000001 111.746 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 43' ' ' ILE . 28.4 m -79.17 -53.57 6.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.369 -0.378 . . . . 1.1000000000000001 111.904 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 32.6 m -50.68 -50.39 73.35 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.078 0.399 . . . . 0.59999999999999998 112.078 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 80' ' ' THR . 11.9 Cg_endo -55.71 -41.6 75.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.713 1.609 . . . . 0.73999999999999999 111.547 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 78' ' ' VAL . 3.6 mm? -65.73 -31.79 72.98 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.715 -0.476 . . . . 1.01 109.715 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -66.82 -26.98 67.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.046 -0.724 . . . . 1.48 109.046 178.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' A' ' 109' ' ' GLN . 11.4 tp -81.74 -39.44 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.917 -1.038 . . . . 1.3799999999999999 110.686 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.75 -38.31 90.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.874 -0.603 . . . . 1.1899999999999999 111.046 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -57.27 -23.66 49.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 1.23 111.117 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -73.93 -29.0 61.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.143 -0.48 . . . . 0.88 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.6 t -80.84 -27.15 36.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 1.3899999999999999 111.166 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -79.03 -31.49 44.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.371 . . . . 2.3199999999999998 111.197 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -82.64 -26.36 32.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 1.46 111.519 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.86 -49.46 9.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.398 -0.364 . . . . 1.24 111.192 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.6 mtt -108.14 110.62 22.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 111.176 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.99 -39.26 89.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 3.5299999999999998 110.399 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -114.39 175.72 5.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.778 -0.646 . . . . 4.0800000000000001 110.471 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -130.26 142.58 43.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.44 -0.346 . . . . 2.1699999999999999 111.022 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.15 174.91 9.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 4.5199999999999996 111.272 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -70.61 -59.29 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 3.75 111.045 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.08 130.0 38.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 3.5299999999999998 111.129 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -106.42 92.15 4.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 4.9100000000000001 110.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.0 t -113.49 -41.07 3.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.413 . . . . 1.98 111.493 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.9 tp -76.92 -41.84 41.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 1.8300000000000001 110.98 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 mm -65.94 -30.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 1.79 111.067 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.19 -40.3 42.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.923 -0.656 . . . . 0.62 112.441 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -63.18 -35.98 82.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 1.5800000000000001 110.88 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 -56.75 13.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.97999999999999998 111.176 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 57.1 ttm -56.95 -40.98 77.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.519 . . . . 1.48 111.234 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -58.31 -51.86 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 1.1299999999999999 111.278 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 112' ' ' VAL . 68.1 p -60.67 -21.14 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.48 111.378 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.538 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 21.7 tp60 -77.25 -30.23 54.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.361 . . . . 2.7000000000000002 110.76 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.31 -39.53 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 1.54 111.199 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 108' ' ' THR . 33.4 m -67.37 -35.73 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.932 -0.307 . . . . 1.28 111.063 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 108' ' ' THR . 81.8 t -66.26 -52.82 43.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.341 -0.39 . . . . 0.42999999999999999 111.433 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.479 HD12 ' HG3' ' A' ' 77' ' ' MET . 45.7 pt -60.03 -27.66 39.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.728 0.299 . . . . 1.74 111.336 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 30.7 m -63.39 -46.71 85.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.63 111.15 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 p -69.65 -24.85 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 1.0900000000000001 110.795 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.98 -32.66 48.49 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.908 -0.663 . . . . 0.41999999999999998 113.217 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -80.53 -28.16 37.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.635 0.255 . . . . 1.3799999999999999 111.513 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.531 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.3 tp -83.49 -27.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 1.6200000000000001 110.87 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.78 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.39000000000000001 111.056 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.61 -21.12 60.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 2.02 111.029 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.7 mt -83.13 16.52 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.76000000000000001 110.902 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -75.24 119.85 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 1.46 110.817 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.66 -53.87 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 3.3500000000000001 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.668 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.7 ttp180 -78.26 132.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 2.9199999999999999 110.606 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.19 -9.38 39.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 2.77 111.485 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.668 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 78.3 t90 -89.51 -52.23 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 3.77 110.915 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.589 HG12 ' HB3' ' A' ' 124' ' ' ARG . 12.4 p -63.02 -23.7 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 1.1599999999999999 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -55.12 -33.59 63.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 2.04 111.077 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.59 -27.52 45.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 2.6400000000000001 111.242 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 127' ' ' VAL . 4.0 mm? -74.78 -54.21 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 1.8999999999999999 111.315 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -61.43 -32.95 72.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 1.3999999999999999 111.769 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -58.69 -45.44 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 1.28 110.645 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.66 -26.73 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 2.1600000000000001 110.6 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 63.4 m -68.65 -34.11 75.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 1.6899999999999999 110.791 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.57 -51.0 33.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.868 -0.682 . . . . 0.52000000000000002 112.622 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.24 -29.76 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.738 0.304 . . . . 1.02 111.019 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.31 -47.12 87.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 1.0800000000000001 110.8 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.38 -33.42 74.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.62 110.903 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' A' ' 142' ' ' ILE . 80.7 t80 -72.03 -27.18 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.8400000000000001 110.948 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.7 mt -65.15 -54.02 36.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 1.6899999999999999 111.576 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 142' ' ' ILE . 37.8 pt -59.18 -42.2 86.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.355 . . . . 0.81000000000000005 111.827 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.45 ' N ' HG13 ' A' ' 141' ' ' ILE . 29.3 pt -73.02 -22.29 19.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.307 . . . . 2.3700000000000001 111.194 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.72 -40.14 91.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.303 -0.408 . . . . 0.97999999999999998 110.853 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -72.66 -36.43 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 3.27 110.421 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.99 -38.35 95.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.891 -0.671 . . . . 1.25 112.642 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.85 -21.32 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 2.1200000000000001 110.965 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -90.39 4.99 49.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 1.6599999999999999 111.174 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.875 -0.602 . . . . 99.989999999999995 111.927 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.87 0.367 . . . . 2.3399999999999999 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 -23.55 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.063 -0.517 . . . . 2.77 110.981 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.1 -42.13 94.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 2.04 110.839 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -83.99 -24.11 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 2.77 110.765 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.83 -51.55 61.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 1.8899999999999999 111.211 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.69 -25.75 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 1.6399999999999999 111.353 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.0 m -53.05 -59.15 4.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.24 111.469 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.451 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 11.2 t80 -68.11 -31.6 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 2.9700000000000002 110.424 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.49 -23.42 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 1.48 111.136 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 -49.81 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 1.55 111.573 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 171' ' ' TYR . 22.5 m -58.75 -29.17 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.561 -0.29 . . . . 1.52 111.738 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 209' ' ' SER . 69.3 mt -77.72 -58.11 3.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.831 0.348 . . . . 1.8500000000000001 111.017 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.63 -23.18 58.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.534 . . . . 0.62 110.777 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 181' ' ' ILE . 10.9 mm -88.07 -29.36 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 1.3500000000000001 110.362 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -52.31 48.18 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.767 -0.651 . . . . 0.58999999999999997 113.766 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.679 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 73.8 m-85 -58.64 -55.38 46.6 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.01 0.405 . . . . 1.45 111.952 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 73.1 Cg_exo -49.06 -28.03 13.17 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.136 1.89 . . . . 0.55000000000000004 112.738 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 184' ' ' ILE . 95.0 mt -71.72 -59.96 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 1.4199999999999999 111.125 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 179' ' ' TYR . 20.4 m -58.17 -24.58 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.379 -0.373 . . . . 0.78000000000000003 111.7 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -64.11 -17.46 63.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.064 0.394 . . . . 0.93999999999999995 112.064 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.702 HG13 HG23 ' A' ' 185' ' ' ILE . 19.3 pt -69.74 -9.79 12.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.988 -0.285 . . . . 1.4299999999999999 111.57 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.702 HG23 HG13 ' A' ' 184' ' ' ILE . 42.4 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 2.02 111.092 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.807 0.337 . . . . 2.48 111.473 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.9 -54.5 44.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 2.1800000000000002 110.904 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.3 p -63.07 -30.27 71.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 1.49 111.021 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -56.75 -38.08 71.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.77 111.163 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 63.0 tp -75.77 -40.51 55.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 1.4199999999999999 111.511 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.99 -6.1 51.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.701 0.26 . . . . 1.78 111.701 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 60.5 m -96.12 -39.96 9.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.915 0.388 . . . . 1.3 110.911 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.75 -35.79 65.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.66000000000000003 111.922 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.673 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.7 tp -58.72 -53.99 60.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.965 -0.294 . . . . 1.6299999999999999 111.252 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 32.1 Cg_exo -58.93 -37.2 94.82 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.683 1.589 . . . . 0.64000000000000001 111.274 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -63.33 -34.16 77.1 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 116.021 -0.536 . . . . 1.3600000000000001 110.13 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -72.25 -24.23 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.625 . . . . 1.54 110.472 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.462 ' HB2' HD22 ' A' ' 175' ' ' LEU . 29.8 t . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 1.2 111.007 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.737 0.303 . . . . 1.6399999999999999 111.342 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.32 71.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.583 -0.818 . . . . 0.79000000000000004 112.408 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -76.34 -34.18 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.62 0.248 . . . . 1.6100000000000001 111.178 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 85.2 p -63.14 -52.22 63.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 1.1499999999999999 110.912 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -62.12 -30.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 3.3399999999999999 110.346 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.5 -47.86 74.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 1.1899999999999999 110.632 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.72 -33.93 68.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.23 111.278 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.411 HD22 ' CZ ' ' A' ' 30' ' ' ARG . 90.3 mt -62.89 -47.27 84.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 2.4700000000000002 111.372 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -74.12 -27.68 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 1.6200000000000001 111.058 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.86 63.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 1.4099999999999999 112.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.588 0.232 . . . . 2.5800000000000001 111.294 -179.755 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.466 ' N ' HD12 ' B' ' 6' ' ' LEU . 5.9 mp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.911 0.386 . . . . 2.0699999999999998 110.746 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 62.5 tp -68.12 -41.15 82.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 2.1000000000000001 110.426 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.7 m80 -61.92 -31.81 72.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 1.0700000000000001 110.474 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -69.79 -44.72 69.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.96 -0.564 . . . . 1.48 110.458 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.89 -20.72 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 2.02 110.119 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.98 -54.64 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.92000000000000004 110.61 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.45 -32.63 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.93999999999999995 111.08 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -53.17 61.23 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.199 -0.455 . . . . 0.55000000000000004 111.037 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.47 -27.34 69.38 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.891 -0.671 . . . . 0.47999999999999998 112.461 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' B' ' 44' ' ' PRO . 22.9 mmt -73.53 -26.9 61.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.696 0.284 . . . . 0.84999999999999998 111.033 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 63.2 m -69.32 -54.32 15.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 1.3400000000000001 110.983 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -60.49 -27.42 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 1.55 111.17 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.73 -51.71 53.87 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.535 -0.841 . . . . 0.69999999999999996 112.245 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.16 68.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.936 0.398 . . . . 0.81000000000000005 111.165 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.37 -31.54 71.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 2.2599999999999998 110.85 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -61.05 -21.94 64.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 1.78 110.978 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.27 -35.67 81.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 4.5800000000000001 110.992 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -80.3 -32.85 37.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 3.3500000000000001 111.082 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 88.8 p -77.3 -19.95 55.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 1.5800000000000001 111.353 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 tp -87.43 -1.76 58.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.342 . . . . 1.8400000000000001 110.958 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 100.0 p -73.39 -19.52 60.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 1.3700000000000001 110.833 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -52.09 -30.72 27.38 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.691 -0.485 . . . . 4.9800000000000004 109.691 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.7 p-10 -174.19 131.83 0.52 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.44 -0.8 . . . . 2.1400000000000001 110.319 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 56.9 Cg_endo -97.29 172.66 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.175 2.583 . . . . 1.8200000000000001 111.892 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -94.5 58.74 2.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.407 . . . . 5.1900000000000004 110.661 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -45.82 3.46 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.007 -0.616 . . . . 2.2000000000000002 112.375 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 34.2 m -101.7 147.03 33.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 O-C-N 122.977 -0.131 . . . . 3.6499999999999999 110.739 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -54.28 163.5 3.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.058 . . . . 2.6699999999999999 112.516 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -64.99 -17.47 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.554 -0.748 . . . . 4.8799999999999999 111.922 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -41.6 -34.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.009 0.374 . . . . 1.8700000000000001 112.009 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.29 -53.43 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 2.6800000000000002 110.334 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -66.48 -19.58 65.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.903 -0.589 . . . . 2.9199999999999999 110.458 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' B' ' 41' ' ' MET . 8.5 tt -59.86 -47.71 84.62 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.659 -0.497 . . . . 1.6399999999999999 109.659 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 52.2 t -62.79 -39.87 86.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.524 -0.547 . . . . 1.6000000000000001 109.524 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.34 -5.89 39.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.663 -0.699 . . . . 0.68999999999999995 110.663 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.535 ' O ' ' HD2' ' B' ' 44' ' ' PRO . 26.6 ttt -88.72 -31.32 18.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.029 -0.532 . . . . 2.5800000000000001 110.455 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -75.47 -34.22 60.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 3.3900000000000001 111.105 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.625 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 67.6 mt -54.21 -51.84 74.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.962 0.356 . . . . 0.40999999999999998 111.962 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 12.2 Cg_exo -70.79 -33.72 12.26 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.637 2.225 . . . . 0.48999999999999999 113.132 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.445 HG12 ' O ' ' B' ' 41' ' ' MET . 24.4 mm -57.28 -62.15 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 111.749 0.278 . . . . 1.29 111.749 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.439 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -59.05 -54.28 48.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.805 0.335 . . . . 1.3999999999999999 111.081 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -55.33 -28.79 56.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 1.3799999999999999 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.99 -58.04 14.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 0.37 112.74 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.22 -29.61 67.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 1.29 111.101 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -52.25 60.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.219 -0.446 . . . . 0.44 111.228 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 22.4 m-85 -64.65 -39.36 93.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.5 111.198 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . 0.436 ' SD ' HD11 ' B' ' 56' ' ' ILE . 12.5 tmm? -49.61 -40.8 40.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.214 0.53 . . . . 1.4099999999999999 110.052 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.58 91.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.679 -0.691 . . . . 0.55000000000000004 110.821 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtt -52.56 -32.27 40.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.5 110.197 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -69.37 -42.64 74.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.957 -0.565 . . . . 0.54000000000000004 110.213 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.436 HD11 ' SD ' ' B' ' 52' ' ' MET . 12.0 mt -75.67 1.89 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 1.3 110.567 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t70 66.16 46.75 2.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.642 -0.708 . . . . 2.2400000000000002 110.714 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.42 ' CD ' HG21 ' C' ' 127' ' ' VAL . 14.6 mm100 -115.72 168.84 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.77 110.954 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 83.65 23.69 52.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 1.0600000000000001 112.466 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.12 142.96 46.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 2.6600000000000001 110.799 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.63 147.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 1.8899999999999999 111.265 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.59 142.51 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 2.4100000000000001 110.762 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.82 98.85 1.37 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 1.5600000000000001 111.299 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.18 29.27 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.04 -0.527 . . . . 1.8200000000000001 111.422 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.94 16.48 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 1.51 112.597 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -116.48 121.29 41.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 2.4500000000000002 110.896 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.69 123.08 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 1.79 111.093 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.97 129.7 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.81999999999999995 111.238 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.505 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 87.9 m-70 -73.03 81.36 1.22 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.05 110.619 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -62.03 -35.4 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 1.8700000000000001 111.586 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -78.85 -22.56 45.92 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.311 0.486 . . . . 0.60999999999999999 112.311 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.505 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 12.8 tpp180 -69.85 -51.32 34.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.132 0.419 . . . . 2.3900000000000001 112.132 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.501 ' O ' ' HG3' ' B' ' 77' ' ' MET . 8.2 p90 -76.3 -38.11 56.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.861 0.319 . . . . 3.6699999999999999 111.861 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.461 HG23 ' N ' ' B' ' 75' ' ' ASP . 11.1 tp -54.04 -44.4 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 1.6599999999999999 110.991 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.461 ' N ' HG23 ' B' ' 74' ' ' ILE . 24.7 t70 -67.22 -21.8 65.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.495 -0.557 . . . . 1.4099999999999999 109.495 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -85.9 4.92 35.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.514 -0.766 . . . . 1.1599999999999999 111.267 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 42.5 mtp -104.83 -18.99 14.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.232 -0.44 . . . . 1.53 110.939 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.516 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.4 m -114.54 -31.65 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.89000000000000001 111.876 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.599 HG23 HG23 ' B' ' 43' ' ' ILE . 60.9 m -79.47 -57.18 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 1.24 112.035 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.549 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 11.0 m -50.42 -50.13 73.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.192 0.442 . . . . 0.57999999999999996 112.192 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.7 Cg_exo -53.91 -42.49 66.18 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.832 1.688 . . . . 0.66000000000000003 111.64 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.516 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -66.97 -29.45 69.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 1.0600000000000001 110.036 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 19.0 tp -70.19 -20.98 63.09 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.176 -0.676 . . . . 1.22 109.176 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' B' ' 109' ' ' GLN . 14.9 tp -83.86 -39.89 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.1 -0.954 . . . . 1.53 109.985 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 22.1 tp -66.94 -35.34 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.343 -0.844 . . . . 1.5800000000000001 111.025 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -60.08 -21.78 61.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 1.3899999999999999 110.804 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.2 -27.21 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 1.1499999999999999 110.7 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -76.74 -33.1 58.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.964 -0.562 . . . . 1.5700000000000001 110.783 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -80.05 -31.77 39.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 2.1699999999999999 110.801 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 88.6 m -72.98 -38.48 66.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 1.4199999999999999 111.067 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.29 -46.43 12.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 1.1799999999999999 111.034 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 80.4 mtp -103.39 120.89 41.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.8799999999999999 111.047 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -75.52 -30.94 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 3.4199999999999999 110.574 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.63 179.44 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.907 -0.588 . . . . 4.0599999999999996 110.664 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tp -132.25 148.31 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 2.0899999999999999 111.25 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.2 161.26 14.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 3.8500000000000001 110.936 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.37 44.51 1.04 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.109 -0.496 . . . . 4.8200000000000003 111.089 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -149.13 113.57 5.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 3.7999999999999998 110.679 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -82.93 78.72 9.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.189 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.8 m -120.93 -59.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.304 -0.407 . . . . 2.02 111.542 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.15 -61.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 2.0899999999999999 111.443 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.8 pt -55.33 -38.09 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.8799999999999999 111.57 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.84 -43.81 98.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.869 -0.681 . . . . 0.56000000000000005 112.798 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -63.21 -36.0 82.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.282 . . . . 1.78 110.985 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.45 -53.47 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 1.03 111.118 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 87.7 mtp -57.95 -36.26 72.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 1.6699999999999999 111.042 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 57.6 m -65.32 -54.43 29.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.12 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.434 ' HB ' HD13 ' B' ' 142' ' ' ILE . 47.4 p -53.98 -26.14 24.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 1.1799999999999999 111.292 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.461 ' HB2' HD22 ' B' ' 84' ' ' LEU . 6.4 tp-100 -71.61 -40.99 69.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 2.1699999999999999 110.709 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.99 -32.07 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 1.3500000000000001 110.973 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.13 -43.01 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 1.3400000000000001 111.264 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.62 -55.4 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.42999999999999999 111.515 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.7 pt -54.32 -33.17 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 1.6000000000000001 111.269 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -60.87 -40.77 94.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.337 -0.392 . . . . 0.85999999999999999 110.607 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -61.54 -59.8 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.94999999999999996 110.365 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.66 -16.33 44.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.781 -0.723 . . . . 0.46000000000000002 112.431 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.96 -61.84 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 1.75 110.702 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 mt -84.04 -20.41 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 1.78 111.759 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.95 57.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.779 0.323 . . . . 0.38 110.956 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.97 -19.65 36.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 1.97 110.822 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.56 22.83 1.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.76000000000000001 111.107 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.4 p -70.97 124.51 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 1.47 110.921 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -99.9 -41.71 7.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 2.5 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.572 ' HB2' HG12 ' B' ' 127' ' ' VAL . 80.3 mtp180 -94.5 140.05 30.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 2.73 111.033 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.13 -19.14 62.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 2.2000000000000002 110.95 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -79.03 -54.02 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 3.3999999999999999 110.894 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' B' ' 124' ' ' ARG . 10.6 p -62.06 -23.66 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.23 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -51.95 -41.38 62.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 3.04 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -77.06 -28.56 54.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.292 -0.413 . . . . 4.1399999999999997 111.16 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' B' ' 127' ' ' VAL . 93.7 mt -70.48 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 1.6499999999999999 111.137 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -56.21 -32.39 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 0.77000000000000002 111.151 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -60.43 -42.6 96.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.911 0.386 . . . . 1.46 110.52 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.76 -28.87 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 110.653 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.7 t -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.895 -0.593 . . . . 1.4199999999999999 110.724 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.28 23.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 0.48999999999999999 112.501 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.42 -30.42 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.789 0.328 . . . . 1.3 111.137 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.55 -40.48 94.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 1.3 110.765 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.19 78.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.62 110.978 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -73.76 -22.72 59.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.74 110.694 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -56.46 10.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.689 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.402 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.7 pt -60.48 -40.86 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.68999999999999995 111.441 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.434 HD13 ' HB ' ' B' ' 108' ' ' THR . 67.3 mt -68.84 -28.86 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.475 -0.329 . . . . 1.76 110.715 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.5 -42.29 99.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0600000000000001 110.979 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . 0.412 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 94.4 m95 -72.31 -27.31 62.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 4.1200000000000001 110.808 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . 1.006 ' HA2' HD21 ' B' ' 148' ' ' ASN . . . -76.16 -27.45 62.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 1.26 112.716 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.44 -13.49 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.771 0.32 . . . . 1.98 111.286 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -99.93 4.67 45.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 1.4199999999999999 111.212 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 1.006 HD21 ' HA2' ' B' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 112.069 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.015 0.436 . . . . 2.4300000000000002 110.824 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.19 -31.64 58.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.749 -0.66 . . . . 2.5800000000000001 111.287 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.44 -42.06 91.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 2.0 110.968 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -83.42 -22.52 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 3.0299999999999998 110.982 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.68 -44.63 77.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 1.1000000000000001 110.926 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.57 -25.68 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 1.75 111.336 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 51.0 m -51.26 -59.13 4.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.97999999999999998 111.367 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -67.2 -34.61 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 4.2999999999999998 110.482 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -63.25 -22.21 66.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 1.3899999999999999 111.003 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.454 ' O ' HG22 ' B' ' 177' ' ' ILE . 48.0 m -79.73 -56.99 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 1.1100000000000001 111.721 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.08 -29.39 15.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.365 0.506 . . . . 1.51 112.365 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 209' ' ' SER . 57.9 tp -79.87 -57.92 3.42 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.891 0.377 . . . . 1.75 111.29 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.3 -29.54 61.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.02 -0.537 . . . . 0.59999999999999998 111.04 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.454 HG22 ' O ' ' B' ' 173' ' ' THR . 9.4 tp -87.91 -21.79 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.064 0.459 . . . . 1.47 110.438 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.98 -54.94 33.49 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.789 -0.642 . . . . 0.55000000000000004 113.129 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 96.3 m-85 -56.41 -54.14 56.4 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.816 0.308 . . . . 1.6200000000000001 111.763 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.7 Cg_exo -46.75 -32.32 11.98 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.223 1.949 . . . . 0.64000000000000001 112.612 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 177' ' ' ILE . 91.0 mt -67.93 -60.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 1.27 111.577 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 179' ' ' TYR . 29.0 m -58.97 -24.71 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.68999999999999995 111.861 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -62.69 -20.05 64.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.52 -0.309 . . . . 1.1799999999999999 111.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 mm -54.44 -49.9 61.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 1.77 110.794 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 15.0 pt -95.5 178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.017 -0.538 . . . . 1.6899999999999999 111.294 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.471 0 C-N-CA 120.887 -0.673 . . . . 1.5800000000000001 112.505 179.881 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 14.1 tt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.703 0.287 . . . . 2.4700000000000002 111.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.07 -49.42 77.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 2.5299999999999998 110.869 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 63.4 p -68.98 -23.27 64.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 1.29 110.896 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.98 -36.8 83.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 2.6200000000000001 111.19 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.26 -45.83 53.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.387 -0.37 . . . . 1.6100000000000001 111.218 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -75.52 -3.43 34.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.745 0.307 . . . . 1.4199999999999999 111.349 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 43.8 t -96.31 -43.47 7.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.279 0.561 . . . . 1.4299999999999999 110.289 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 66.5 tp -71.93 -39.48 69.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.444 -0.798 . . . . 1.1200000000000001 112.055 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.58 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -55.97 -54.77 48.64 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.237 -0.185 . . . . 1.26 111.384 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -56.16 -41.51 75.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.885 1.723 . . . . 0.59999999999999998 111.559 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.61 -31.78 73.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.247 -0.433 . . . . 1.3999999999999999 110.288 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -66.68 -27.49 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 1.4099999999999999 110.572 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.44 ' HB2' HD13 ' B' ' 175' ' ' LEU . 17.3 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 1.3200000000000001 111.053 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.731 0.301 . . . . 1.6899999999999999 110.997 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.27 -30.66 74.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.79000000000000004 112.549 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -74.74 -29.87 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 2.96 110.753 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.1 t -63.0 -59.93 4.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 1.29 110.74 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.79 -28.89 67.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 3.1499999999999999 110.823 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.74 -43.36 89.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 1.51 110.567 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.08 -22.24 65.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 2.1899999999999999 110.873 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.4 tp -69.62 -51.51 34.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 1.98 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -78.09 -30.94 49.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 2.1699999999999999 111.302 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.66 80.43 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.792 -0.718 . . . . 1.3600000000000001 112.933 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 55.1 tp . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 2.8999999999999999 111.012 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.795 0.331 . . . . 2.52 110.927 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 94.3 mt -81.11 -45.16 16.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 1.9299999999999999 111.257 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 60.8 m-70 -64.65 -26.08 68.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.931 0.396 . . . . 1.26 110.475 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.453 ' O ' HG12 ' C' ' 12' ' ' VAL . 62.0 t-105 -72.58 -47.75 45.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 1.6699999999999999 110.059 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.05 -20.8 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.358 0.599 . . . . 1.8700000000000001 109.503 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -59.9 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.224 -0.898 . . . . 1.4399999999999999 110.69 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' C' ' 52' ' ' MET . 14.0 p -58.58 -32.81 46.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.19 -0.459 . . . . 0.46999999999999997 111.035 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.62 41.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.58999999999999997 111.015 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.07 -21.78 68.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.5 112.189 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 8.2 mmt -73.54 -35.85 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.676 0.274 . . . . 0.68000000000000005 110.952 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 59.8 p -66.46 -53.06 39.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 1.3999999999999999 111.185 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . 0.412 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.7 pp -59.98 -26.09 34.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.36 . . . . 1.55 111.016 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.412 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -66.97 -39.51 93.26 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.763 -0.732 . . . . 0.70999999999999996 112.418 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' C' ' 41' ' ' MET . . . -72.67 -28.29 62.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.77000000000000002 110.926 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 28.4 tp -68.49 -29.93 68.65 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 1.9299999999999999 110.516 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -59.19 -22.14 60.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 1.8600000000000001 110.414 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -58.19 -53.73 55.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.018 -0.537 . . . . 4.1399999999999997 110.91 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -60.81 -38.8 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 3.1499999999999999 110.479 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 63.3 m -69.69 -19.56 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 1.95 110.67 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 23.7 mt -80.1 -0.39 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 2.2200000000000002 111.554 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 48.8 p -57.56 -52.04 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.911 -0.316 . . . . 1.3700000000000001 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.74 -27.41 69.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.158 0.98 . . . . 5.0300000000000002 108.508 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.767 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 12.7 m120 -70.32 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 113.473 -1.694 . . . . 2.3700000000000001 108.892 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.767 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 5.8 Cg_exo . . . . . 0 C--N 1.376 2.02 0 C-N-CA 123.763 2.976 . . . . 2.0499999999999998 117.093 -174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo . . . . . 0 N--CA 1.472 0.244 0 N-CA-C 115.543 1.324 . . . . 1.9299999999999999 115.543 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . 0.628 ' HG3' ' HG2' ' C' ' 29' ' ' PRO . 1.4 mp0 -60.93 -14.47 22.7 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 113.435 -1.712 . . . . 4.1200000000000001 112.82 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' C' ' 38' ' ' LEU . 20.8 p90 -39.22 -36.31 0.32 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.708 0.29 . . . . 2.8900000000000001 111.604 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -64.91 -48.35 74.48 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.251 0.548 . . . . 2.46 109.572 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' C' ' 34' ' ' GLN . 33.7 t80 -68.56 -20.48 64.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 2.7799999999999998 110.291 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' C' ' 35' ' ' TYR . 56.1 tp -59.03 -48.29 82.13 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.571 -0.529 . . . . 1.6200000000000001 109.571 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -41.27 91.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.82 -0.627 . . . . 1.5900000000000001 109.581 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -70.87 -6.07 35.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.591 -0.732 . . . . 0.65000000000000002 110.703 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.534 ' HG3' ' HA ' ' C' ' 19' ' ' ALA . 51.0 ttp -88.64 -34.14 17.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.153 -0.476 . . . . 1.6699999999999999 110.519 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' C' ' 45' ' ' ILE . 61.8 t80 -72.43 -30.07 64.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 3.4199999999999999 110.571 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.612 HG23 HG23 ' C' ' 79' ' ' THR . 93.3 mt -54.89 -54.81 45.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.89000000000000001 111.548 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.485 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.6 Cg_endo -71.22 -28.64 18.36 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.224 1.949 . . . . 0.40999999999999998 113.176 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' C' ' 42' ' ' PHE . 80.0 mt -58.1 -62.72 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.623 0.249 . . . . 1.76 111.58 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -55.42 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 2.1600000000000001 111.084 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 85.8 p -52.01 -39.04 58.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 1.1699999999999999 111.303 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.44 -55.14 28.35 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.925 -0.655 . . . . 0.44 112.923 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' C' ' 52' ' ' MET . 69.6 mt -57.04 -29.91 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 1.29 110.829 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -70.42 -35.73 73.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.136 -0.483 . . . . 0.5 111.05 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 49.6 m-85 -71.39 -52.45 18.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 1.8300000000000001 111.466 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . 0.561 ' HB3' HG11 ' C' ' 12' ' ' VAL . 23.8 ptm -49.53 -34.69 17.99 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.882 0.372 . . . . 1.47 110.498 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.07 88.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.59999999999999998 110.727 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 54.2 mtt -52.27 -33.86 43.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.836 -0.62 . . . . 0.83999999999999997 110.553 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.32 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.65000000000000002 110.705 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.465 HG21 HG23 ' A' ' 127' ' ' VAL . 10.2 mm -72.64 -4.75 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 1.55 110.697 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 66.55 35.61 5.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.7 . . . . 1.54 110.815 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -118.35 138.21 52.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 1.79 110.641 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.39 16.83 5.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.847 -0.692 . . . . 0.93999999999999995 112.495 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' C' ' 60' ' ' LYS . 3.3 mptp? -114.67 137.8 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 2.3599999999999999 110.606 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.05 142.56 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.97 111.016 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.27 139.63 42.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.081 -0.509 . . . . 2.4399999999999999 110.915 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.85 102.09 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 1.54 111.072 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.33 30.57 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 1.71 111.24 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.4 40.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 1.53 112.783 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 118.95 31.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.687 0.28 . . . . 2.23 110.609 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -97.18 120.11 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 1.3600000000000001 111.105 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.49 141.92 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.78000000000000003 111.108 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 55.3 m-70 -80.68 82.06 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.08 0.467 . . . . 1.0800000000000001 110.864 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -67.65 -32.72 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.797 -0.638 . . . . 2.2999999999999998 111.392 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.57 -24.99 41.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.288 0.477 . . . . 0.75 112.288 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.559 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.3 mmt180 -71.51 -52.01 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.284 0.476 . . . . 1.51 112.284 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.494 ' O ' ' HG3' ' C' ' 77' ' ' MET . 2.6 p90 -71.43 -40.37 70.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.82 -0.352 . . . . 4.6500000000000004 111.717 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.446 HG23 ' N ' ' C' ' 75' ' ' ASP . 10.4 tp -53.64 -44.01 56.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.581 0.229 . . . . 1.22 111.026 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.446 ' N ' HG23 ' C' ' 74' ' ' ILE . 23.4 t70 -70.08 -21.45 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.447 -0.575 . . . . 1.3100000000000001 109.447 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -87.38 6.93 31.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.436 -0.802 . . . . 1.6799999999999999 111.209 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 30.0 mtp -105.34 -20.68 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 1.8 110.693 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -114.14 -29.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 1.1899999999999999 111.883 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.612 HG23 HG23 ' C' ' 43' ' ' ILE . 88.2 m -81.29 -56.14 4.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.23 111.787 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 25.0 m -50.54 -50.32 72.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.412 0.523 . . . . 0.58999999999999997 112.412 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' C' ' 80' ' ' THR . 12.3 Cg_endo -56.41 -38.49 95.16 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.58 1.52 . . . . 0.67000000000000004 111.446 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.42 -30.94 69.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.95999999999999996 109.577 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.89 -21.23 62.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.445 0.641 . . . . 1.1899999999999999 109.336 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.32 -37.23 21.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.993 -1.003 . . . . 1.7 109.908 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 89.4 mt -67.72 -35.91 79.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.75 -0.659 . . . . 1.6200000000000001 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 88.8 p -56.71 -31.14 64.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.343 -0.389 . . . . 1.26 110.981 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 70.4 mt -66.62 -33.23 75.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.489 . . . . 1.1100000000000001 110.797 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -73.72 -27.47 61.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 1.51 110.961 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.27 -33.6 25.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 2.0600000000000001 110.952 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 82.3 m -76.52 -37.23 57.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 1.52 111.005 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.28 -48.3 12.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 1.3 111.265 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -104.0 115.14 29.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 1.6200000000000001 110.949 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -71.54 -25.07 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 3.2400000000000002 111.016 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -144.77 138.0 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 4.6299999999999999 111.053 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.8 142.08 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.054 -0.521 . . . . 2.1800000000000002 111.022 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -102.89 173.55 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 4.1200000000000001 110.807 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.9 -178.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 4.96 110.758 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 28.6 t70 56.44 84.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 3.9100000000000001 110.868 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -75.16 99.47 3.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 5.21 110.864 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 68.8 m -119.23 -44.86 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 111.261 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.43 HD22 ' N ' ' C' ' 101' ' ' LEU . 3.7 mm? -76.64 -48.41 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 2.0800000000000001 111.095 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 7.6 tp -65.9 -30.09 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 1.8600000000000001 111.329 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.32 -44.84 41.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.769 . . . . 0.58999999999999997 112.776 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.58 -36.54 78.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 1.53 111.352 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.72 -51.25 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 1.1100000000000001 111.3 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.72 -35.87 77.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 2.21 111.029 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 40.9 m -66.87 -55.75 13.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.255 -0.429 . . . . 1.28 111.178 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.444 HG21 HD13 ' C' ' 142' ' ' ILE . 40.1 p -55.78 -25.91 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 1.22 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -68.4 -40.36 81.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 2.3300000000000001 110.376 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.439 HG22 ' HE1' ' B' ' 46' ' ' TRP . 36.4 mm -59.67 -32.17 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.91 -0.586 . . . . 1.29 110.698 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.98 -42.14 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.955 -0.566 . . . . 1.0600000000000001 111.171 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.23 -54.9 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 0.51000000000000001 111.631 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.1 pt -55.02 -27.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.3700000000000001 111.272 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 19.7 m -66.13 -46.57 77.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.436 . . . . 0.77000000000000002 110.883 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -69.03 -23.78 64.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 1.1899999999999999 111.412 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.63 -35.52 32.1 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.712 -0.756 . . . . 0.5 113.266 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.55 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.6 pp -77.06 -29.75 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.568 0.223 . . . . 1.47 111.592 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.55 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.2 tp -83.89 -24.33 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.399 -0.364 . . . . 1.2 111.202 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.24 93.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.40000000000000002 111.105 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -78.36 -14.13 59.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.046 -0.525 . . . . 2.1200000000000001 111.067 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' C' ' 118' ' ' ILE . 96.7 mt -86.29 17.59 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.75 111.125 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 78.5 p -68.38 121.16 15.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 1.3799999999999999 111.11 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -103.23 -37.94 7.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.246 -0.433 . . . . 2.7400000000000002 110.648 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG12 ' C' ' 127' ' ' VAL . 97.7 mtt180 -102.97 137.87 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 2.7999999999999998 110.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.71 -9.43 58.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 2.4100000000000001 111.242 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -88.52 -44.36 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 4.2000000000000002 111.088 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -74.16 -23.94 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 111.187 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -52.53 -47.29 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 2.5699999999999998 111.283 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -67.58 -22.94 65.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 3.8100000000000001 111.391 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 72.4 mt -80.5 -47.22 14.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 1.4199999999999999 111.239 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.68 -34.49 77.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.89000000000000001 111.384 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.85 -33.49 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.097 -0.501 . . . . 1.26 111.135 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.3 mm -73.26 -37.48 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.6799999999999999 111.108 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.59 -30.73 71.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 1.24 110.878 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -54.83 11.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.723 -0.751 . . . . 0.54000000000000004 112.278 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.56 -29.88 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 1.0600000000000001 110.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.37 -49.42 77.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.054 -0.521 . . . . 1.0800000000000001 110.741 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.08 -29.01 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.56999999999999995 110.845 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -74.64 -20.08 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 1.6799999999999999 110.708 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.3 15.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 1.7 111.293 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.456 HG13 ' N ' ' C' ' 142' ' ' ILE . 29.0 pt -59.21 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.78000000000000003 111.241 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.456 ' N ' HG13 ' C' ' 141' ' ' ILE . 7.4 tp -72.48 -27.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.494 -0.321 . . . . 2.2400000000000002 111.003 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.27 -50.84 71.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 1.02 110.67 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -64.42 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.934 -0.575 . . . . 3.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.3 -39.1 97.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.794 -0.717 . . . . 1.27 112.405 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.39 -24.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 1.8899999999999999 110.654 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -89.26 3.93 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 1.6000000000000001 111.043 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.914 -0.585 . . . . 99.989999999999995 111.834 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.086 0.47 . . . . 2.3500000000000001 110.703 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . 0.43 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.5 OUTLIER -77.0 -39.57 49.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.635 . . . . 2.6200000000000001 111.048 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -57.79 -37.12 73.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 2.0899999999999999 111.443 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -81.35 -26.97 35.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 3.2400000000000002 111.137 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.89 -52.17 18.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 111.264 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 165' ' ' TYR . 53.4 t -56.16 -25.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.3999999999999999 111.493 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -54.64 -58.96 5.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.95999999999999996 111.316 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -68.32 -24.58 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.08 -0.509 . . . . 3.6499999999999999 110.499 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -70.62 -35.97 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 1.3700000000000001 111.673 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 41.0 p -70.47 -53.18 17.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.565 -0.288 . . . . 1.4299999999999999 111.655 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 p -53.33 -35.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.958 0.355 . . . . 1.6200000000000001 111.958 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' C' ' 209' ' ' SER . 41.7 tp -75.36 -57.81 3.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.794 0.33 . . . . 2.0299999999999998 111.41 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -28.32 58.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.109 -0.496 . . . . 0.62 110.981 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.426 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 84.9 mt -87.95 -24.29 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.479 . . . . 1.5800000000000001 110.225 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.53 -54.57 31.83 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.728 -0.669 . . . . 0.56000000000000005 113.043 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.627 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 68.1 m-85 -57.47 -55.67 42.1 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.85 0.325 . . . . 1.3300000000000001 111.623 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.0 Cg_exo -45.86 -28.2 4.68 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.254 1.969 . . . . 0.63 112.929 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.502 ' O ' HG22 ' C' ' 184' ' ' ILE . 92.7 mt -70.97 -61.25 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.93000000000000005 111.467 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.446 HG22 ' O ' ' C' ' 179' ' ' TYR . 25.3 m -57.5 -26.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.221 0.452 . . . . 1.27 112.221 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -60.94 -20.02 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.696 -0.229 . . . . 1.77 111.547 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.663 HG23 HG23 ' C' ' 185' ' ' ILE . 14.9 tt -60.64 -29.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 2.3900000000000001 111.011 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . 0.663 HG23 HG23 ' C' ' 184' ' ' ILE . 31.4 pt . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 1.95 111.101 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.739 0.304 . . . . 2.3799999999999999 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' C' ' 200' ' ' PHE . 16.7 tt -57.82 -34.75 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 2.23 111.231 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.58 -56.06 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 2.1600000000000001 110.703 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -69.43 -17.53 63.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.906 -0.588 . . . . 1.27 110.614 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' C' ' 197' ' ' ILE . 91.5 t80 -68.46 -30.81 69.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 1.7 110.947 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.7 -39.36 20.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 2.02 111.271 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -77.12 -8.11 56.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.281 . . . . 1.8200000000000001 111.682 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.461 ' HB3' HH22 ' C' ' 72' ' ' ARG . 17.7 p -96.66 -39.08 9.67 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.148 0.499 . . . . 1.3500000000000001 110.546 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.04 -33.89 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.623 -0.717 . . . . 0.65000000000000002 111.745 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.641 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 42.1 tp -62.53 -53.32 58.36 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.067 -0.253 . . . . 1.4199999999999999 111.577 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.8 Cg_exo -56.23 -39.34 91.91 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.842 1.695 . . . . 0.63 111.48 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -61.12 -34.32 74.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.959 -0.564 . . . . 1.49 110.721 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -66.56 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.009 -0.541 . . . . 1.7 110.951 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . 0.472 ' HB2' HD13 ' C' ' 175' ' ' LEU . 28.0 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 1.25 110.999 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.751 0.31 . . . . 1.6100000000000001 111.0 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.79 69.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.913 -0.661 . . . . 0.81999999999999995 112.704 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -71.28 -34.85 71.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 3.0800000000000001 110.788 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -60.65 -59.3 5.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 1.1499999999999999 110.676 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.56 -23.4 65.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 2.5600000000000001 110.67 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tt -72.28 -40.28 67.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.932 -0.576 . . . . 1.29 110.992 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.53 -30.16 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 2.3900000000000001 111.192 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.11 -48.59 73.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 2.0299999999999998 110.876 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -81.07 -22.53 39.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 3.21 110.853 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.46 61.55 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.772 -0.728 . . . . 1.3600000000000001 112.945 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 30.3 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.704 0.288 . . . . 2.8999999999999999 111.033 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.4 tp . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.577 0.227 . . . . 2.4199999999999999 111.015 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.68 -34.73 77.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.406 -0.361 . . . . 2.0899999999999999 111.13 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 37.4 m80 -72.25 -28.85 63.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.044 0.449 . . . . 1.1599999999999999 110.379 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -72.44 -51.07 21.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.79000000000000004 110.331 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.34 -21.74 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.096 0.474 . . . . 2.0800000000000001 110.249 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -61.48 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 1.28 110.564 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 52' ' ' MET . 8.7 p -58.57 -30.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.01 -0.541 . . . . 1.3200000000000001 111.371 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.0 -55.41 29.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.63 111.429 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.76 -28.45 68.2 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.884 -0.674 . . . . 0.55000000000000004 112.763 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.16 -22.2 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 1.03 111.001 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -72.76 -52.13 16.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 1.3 110.844 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -65.4 -22.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 1.3100000000000001 110.942 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -68.47 -47.84 54.81 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.854 -0.689 . . . . 0.77000000000000002 112.652 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.452 ' HB1' ' HE3' ' A' ' 41' ' ' MET . . . -63.05 -33.88 76.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.80000000000000004 111.042 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -68.43 -36.52 79.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.203 0.525 . . . . 1.8100000000000001 110.532 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.9 t-80 -59.33 -20.99 59.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 110.485 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -62.49 -50.18 72.42 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.062 -0.517 . . . . 4.4500000000000002 110.973 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -58.91 -45.17 90.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 3.6899999999999999 110.495 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.3 m -69.9 -18.66 63.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 1.5700000000000001 110.794 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' HIS . 12.7 tp -76.57 0.26 20.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 1.95 111.933 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 p -66.83 -51.44 55.55 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.277 -0.569 . . . . 1.3799999999999999 111.19 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -54.17 -22.63 11.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.011 0.91 . . . . 4.0700000000000003 108.548 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.812 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.41 -150.98 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 113.757 -1.565 . . . . 2.7200000000000002 108.57 177.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 14.2 Cg_exo 6.91 96.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.713 2.942 . . . . 1.9099999999999999 116.472 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -102.96 96.87 7.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.663 -1.153 . . . . 4.7599999999999998 109.148 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.04 -36.92 2.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.502 -1.039 . . . . 1.99 110.502 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.1 t -111.77 126.2 28.96 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 109.315 -0.624 . . . . 2.7000000000000002 109.315 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 16.9 Cg_exo -65.82 165.83 22.25 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.482 2.121 . . . . 1.79 113.858 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -76.08 -13.3 60.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.507 -1.224 . . . . 4.1200000000000001 111.806 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CD2' ' HB2' ' A' ' 33' ' ' PRO . 1.7 p90 -38.69 -37.92 0.37 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.469 0.544 . . . . 2.9300000000000002 112.469 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.09 -45.19 86.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 2.8799999999999999 110.518 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -74.03 -18.57 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.005 -0.543 . . . . 4.6600000000000001 110.613 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.431 HD11 ' HD1' ' B' ' 104' ' ' PHE . 55.7 tp -60.66 -56.86 16.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.162 -0.472 . . . . 1.45 110.161 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.32 -36.24 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 1.78 109.918 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.21 -6.13 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.724 -0.671 . . . . 0.63 110.89 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.46 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 23.8 ttt -88.74 -35.59 16.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 1.48 110.641 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -72.61 -33.32 66.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 3.5 111.101 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.634 HG23 HG23 ' A' ' 79' ' ' THR . 79.0 mt -53.63 -52.98 62.22 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.271 0.471 . . . . 1.0800000000000001 112.271 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.5 Cg_endo -72.15 -33.3 9.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.28 1.987 . . . . 0.53000000000000003 113.236 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -57.89 -62.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.939 0.348 . . . . 1.6799999999999999 111.939 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.527 ' HE1' HG22 ' B' ' 110' ' ' ILE . 3.0 t90 -61.63 -51.41 68.59 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.626 -0.261 . . . . 1.8300000000000001 111.525 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.448 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 92.5 p -51.52 -54.13 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 1.0900000000000001 111.195 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -44.58 -54.79 6.39 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.208 -0.52 . . . . 0.40999999999999998 113.547 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.3 mt -52.12 -38.94 59.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.748 0.309 . . . . 0.98999999999999999 111.337 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.56 83.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.47999999999999998 111.059 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.507 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 96.8 m-85 -69.48 -44.19 71.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.8700000000000001 110.913 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.428 ' HB2' HG11 ' A' ' 12' ' ' VAL . 16.7 tmm? -49.61 -32.68 13.38 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.285 0.564 . . . . 1.49 110.126 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -72.13 -42.14 66.35 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.58999999999999997 111.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.2 mtt -54.17 -26.45 28.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.48999999999999999 110.363 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.05 -48.54 23.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.576 . . . . 0.59999999999999998 110.673 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 53' ' ' ALA . 44.3 pt -79.94 6.65 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 1.3100000000000001 111.023 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 59.59 55.1 4.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 1.9099999999999999 111.194 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -125.33 124.59 41.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 1.6200000000000001 110.735 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 120.34 29.88 1.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 1.04 112.398 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -150.34 144.74 25.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 2.6800000000000002 111.145 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.48 145.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 1.98 111.165 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -88.74 94.44 9.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 2.1800000000000002 110.893 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.08 133.48 55.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.019 -0.537 . . . . 1.5700000000000001 111.052 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.79 23.72 12.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.245 -0.434 . . . . 1.79 111.14 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.97 -15.1 50.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.83 -0.7 . . . . 1.48 112.534 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -104.73 151.22 24.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.313 . . . . 2.3199999999999998 110.854 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -98.17 138.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 1.4399999999999999 111.118 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.39 118.21 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.495 . . . . 0.81999999999999995 110.848 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 64.5 m-70 -78.96 79.25 5.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.295 0.569 . . . . 0.90000000000000002 111.204 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.88 -41.28 86.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.547 -0.751 . . . . 1.8300000000000001 110.932 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -67.0 -24.05 65.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 0.62 111.595 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.9 tpp180 -67.15 -51.88 48.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.098 -0.501 . . . . 2.3399999999999999 112.322 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.49 ' O ' ' HG3' ' A' ' 77' ' ' MET . 17.7 p90 -88.95 -27.98 20.57 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.511 0.56 . . . . 3.4900000000000002 112.511 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 71' ' ' ALA . 11.0 tp -57.78 -41.26 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.473 -0.491 . . . . 1.3700000000000001 110.069 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.448 ' OD2' ' HA ' ' A' ' 47' ' ' SER . 16.1 t70 -70.93 -17.14 62.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.143 -0.688 . . . . 1.3100000000000001 109.143 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -90.42 6.06 44.9 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.237 -0.892 . . . . 1.48 110.956 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.519 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 32.1 mtp -104.85 -17.68 14.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.488 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.439 ' O ' HD23 ' A' ' 82' ' ' LEU . 27.5 m -114.59 -34.81 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.1200000000000001 111.8 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.634 HG23 HG23 ' A' ' 43' ' ' ILE . 84.8 m -76.0 -59.56 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 1.1000000000000001 112.007 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 83.2 m -49.14 -51.06 59.69 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.503 0.557 . . . . 0.59999999999999998 112.503 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 58.4 Cg_exo -51.67 -52.85 8.1 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.765 1.643 . . . . 0.73999999999999999 111.844 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -63.45 -25.66 68.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 1.01 110.881 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.5 tp -72.91 -28.42 62.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.999 0.428 . . . . 1.48 110.033 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -84.47 -22.22 30.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.3799999999999999 110.103 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' PRO . 95.4 mt -85.07 -31.28 23.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.769 -0.65 . . . . 1.1899999999999999 110.646 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -61.64 -50.34 72.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.23 111.029 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 pp -61.99 -25.74 67.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.88 110.965 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.1 t -67.63 -43.78 79.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 1.3899999999999999 110.842 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -62.16 -40.6 96.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 2.3199999999999998 111.014 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -60.5 -33.9 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 1.46 111.029 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.52 -30.73 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 1.24 111.044 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.8 tpp -75.28 117.3 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 2.0699999999999998 110.817 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.67 -54.69 4.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 3.5299999999999998 111.066 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -137.12 144.82 43.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 4.0800000000000001 111.228 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.9 tt -107.55 148.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 2.1699999999999999 110.817 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -133.43 -75.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 4.5199999999999996 111.2 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -138.35 -13.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 3.75 111.343 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.31 106.82 1.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.457 -0.338 . . . . 3.5299999999999998 110.734 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -128.57 -21.52 3.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.332 -0.394 . . . . 4.9100000000000001 111.036 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.6 p -65.38 -26.01 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 1.98 111.034 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.75 -36.54 79.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 1.8300000000000001 110.951 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.03 -39.0 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 1.79 111.172 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.78 93.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.848 -0.692 . . . . 0.62 112.361 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.93 -41.25 95.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.5800000000000001 111.153 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.05 -48.41 80.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.97999999999999998 111.293 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -61.24 -27.34 68.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 1.48 111.289 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -72.45 -43.25 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.999 0.428 . . . . 1.1299999999999999 111.245 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 112' ' ' VAL . 71.6 p -72.3 -22.8 61.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.163 -0.471 . . . . 1.48 111.548 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 25.0 tp60 -81.79 -45.47 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.322 -0.399 . . . . 2.7000000000000002 111.4 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' HE1' ' C' ' 46' ' ' TRP . 7.9 tp -59.5 -34.97 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.54 111.473 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 142' ' ' ILE . 17.9 m -71.16 -44.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 121.144 -0.223 . . . . 1.28 111.281 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 108' ' ' THR . 78.5 t -59.22 -55.59 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.795 0.331 . . . . 0.42999999999999999 111.537 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.476 HG12 HE21 ' A' ' 109' ' ' GLN . 39.0 mm -56.75 -32.89 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.385 -0.37 . . . . 1.74 111.436 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -55.71 -45.13 77.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.875 0.369 . . . . 0.63 110.554 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -67.34 -27.03 66.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.56 . . . . 1.0900000000000001 111.007 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.56 -41.04 30.73 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.876 -0.678 . . . . 0.41999999999999998 113.502 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -73.96 -28.26 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.806 0.299 . . . . 1.3799999999999999 111.806 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.472 HD11 ' HG3' ' C' ' 58' ' ' GLN . 10.2 tp -82.49 -26.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 1.6200000000000001 111.17 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.56 76.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.39000000000000001 110.894 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.4 -27.41 32.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 2.02 111.041 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.18 34.3 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.76000000000000001 111.257 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.6 m -85.61 131.19 34.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 1.46 110.853 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.472 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 12.1 pt-20 -80.4 -28.7 37.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 3.3500000000000001 111.077 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.524 ' HB2' HG12 ' A' ' 127' ' ' VAL . 78.5 mtm180 -130.17 158.19 40.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 2.9199999999999999 110.971 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.53 -11.9 59.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 2.77 111.048 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -90.06 -45.87 8.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.977 0.418 . . . . 3.77 110.405 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.0 p -65.45 -27.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 1.1599999999999999 110.757 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -65.28 -41.16 94.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 2.04 111.007 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.425 ' O ' HG12 ' A' ' 133' ' ' ILE . 72.2 t80 -56.88 -45.67 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 2.6400000000000001 110.873 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.71 -45.22 92.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 1.8999999999999999 111.376 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.18 70.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 1.3999999999999999 111.049 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -67.55 -43.33 80.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.411 . . . . 1.28 111.146 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 129' ' ' TYR . 38.3 mm -59.05 -39.18 77.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 2.1600000000000001 110.888 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.454 ' SG ' HD22 ' C' ' 49' ' ' LEU . 46.2 t -67.48 -28.45 67.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.222 -0.445 . . . . 1.6899999999999999 110.901 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.65 -55.88 24.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.871 -0.68 . . . . 0.52000000000000002 112.55 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 26.9 m -63.63 -37.25 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.563 0.22 . . . . 1.02 111.298 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.69 -44.2 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.454 -0.339 . . . . 1.0800000000000001 111.023 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.88 -35.67 75.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.62 110.897 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -69.82 -23.13 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 1.8400000000000001 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 86.9 mt -70.26 -59.93 2.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 1.6899999999999999 111.469 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -61.24 -27.02 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.504 -0.317 . . . . 0.81000000000000005 111.69 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 111' ' ' VAL . 72.5 mt -77.99 -50.35 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.483 -0.326 . . . . 2.3700000000000001 111.49 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.1 tp -49.44 -54.21 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.97999999999999998 111.188 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -64.63 -34.34 78.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 3.27 110.984 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.59 68.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.86 -0.686 . . . . 1.25 112.77 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.0 mt -103.73 -19.85 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 2.1200000000000001 111.173 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -59.73 -39.91 86.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.411 . . . . 1.6599999999999999 111.995 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 112.483 0.549 . . . . 99.989999999999995 112.483 -178.726 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 60.8 mt . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.039 0.447 . . . . 2.3399999999999999 110.544 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.46 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.5 OUTLIER -55.41 -39.86 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.662 -0.699 . . . . 2.77 111.08 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -51.69 -56.35 14.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 2.04 111.289 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -58.05 -28.28 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 2.77 111.484 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 165' ' ' TYR . 75.5 mt -72.95 -65.56 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.335 -0.393 . . . . 1.8899999999999999 111.46 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.15 -36.5 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.505 . . . . 1.6399999999999999 111.856 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.2 m -56.74 -52.55 64.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.311 . . . . 1.24 111.521 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.459 ' O ' HD23 ' A' ' 175' ' ' LEU . 75.5 t80 -58.41 -29.54 66.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.364 -0.38 . . . . 2.9700000000000002 110.961 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -71.01 -32.11 68.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 1.48 111.354 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.3 p -79.59 -37.86 35.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 1.55 111.767 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.24 -43.75 94.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.764 0.283 . . . . 1.52 111.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 171' ' ' TYR . 4.3 mm? -75.18 -50.69 15.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.651 -0.249 . . . . 1.8500000000000001 111.634 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.49 -31.65 62.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.62 110.593 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 181' ' ' ILE . 94.8 mt -87.66 -22.09 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.523 . . . . 1.3500000000000001 110.298 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -55.74 27.98 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.58999999999999997 113.097 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.606 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 86.5 m-85 -53.68 -54.98 40.18 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.835 0.317 . . . . 1.45 111.067 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.8 Cg_exo -45.95 -30.18 6.81 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.003 1.802 . . . . 0.55000000000000004 112.671 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -66.36 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 1.4199999999999999 111.164 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 179' ' ' TYR . 28.5 m -58.33 -26.63 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.501 . . . . 0.78000000000000003 111.572 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -66.22 -45.08 81.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.534 -0.303 . . . . 0.93999999999999995 111.227 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.2 mt -62.04 -62.57 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 1.4299999999999999 111.298 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 2.02 111.494 -179.618 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 200' ' ' PHE . 83.3 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.868 0.366 . . . . 2.48 111.382 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.55 -54.45 32.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.374 . . . . 2.1800000000000002 111.24 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -62.55 -32.49 73.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 1.49 111.706 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 197' ' ' ILE . 63.2 t80 -54.77 -38.31 67.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 1.77 111.126 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 49.0 tp -76.67 -46.53 25.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 1.4199999999999999 111.092 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -71.79 1.49 6.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 1.78 111.42 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.9 t -96.5 -46.3 6.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.3 110.507 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.78 -36.94 73.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.66000000000000003 111.998 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -57.21 -54.76 51.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 121.138 -0.225 . . . . 1.6299999999999999 111.293 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -55.48 -44.71 45.82 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.682 1.588 . . . . 0.64000000000000001 111.596 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.29 -25.4 67.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 1.3600000000000001 110.464 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.61 -30.85 59.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 1.54 110.751 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 1.2 110.998 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.785 0.326 . . . . 1.6399999999999999 111.284 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.33 -28.38 72.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.79000000000000004 112.423 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.22 -31.17 58.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.732 0.301 . . . . 1.6100000000000001 110.889 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.6 m -63.55 -62.02 1.94 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 1.1499999999999999 110.889 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.37 -27.86 66.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 3.3399999999999999 110.851 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.39 -48.9 71.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 1.1899999999999999 110.74 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.93 -27.77 69.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 2.23 110.912 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.52 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 2.4700000000000002 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -70.76 -49.09 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 1.6200000000000001 111.054 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.84 55.08 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.849 -0.691 . . . . 1.4099999999999999 112.58 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.0 tp . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 2.5800000000000001 110.89 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.766 0.317 . . . . 2.0699999999999998 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -34.73 71.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 2.1000000000000001 111.148 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.578 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 35.6 m170 -65.32 -33.25 75.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 1.0700000000000001 110.757 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -73.95 -46.87 41.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.16 -0.473 . . . . 1.48 110.617 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.07 -22.29 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.117 0.484 . . . . 2.02 110.262 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.28 -59.13 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.706 -0.679 . . . . 0.92000000000000004 110.538 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.21 -29.46 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.93999999999999995 111.328 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -50.42 67.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.55000000000000004 111.34 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.03 -32.8 85.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.47999999999999998 112.564 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.4 mmt -71.54 -26.02 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.84999999999999998 110.956 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.5 m -69.7 -59.2 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 1.3400000000000001 110.853 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.472 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.6 pp -56.32 -26.13 21.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.096 -0.502 . . . . 1.55 111.307 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.472 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -65.59 -47.94 72.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.608 -0.806 . . . . 0.69999999999999996 112.26 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' B' ' 41' ' ' MET . . . -60.09 -33.84 72.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.81000000000000005 111.047 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.77 -33.5 72.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.335 -0.393 . . . . 2.2599999999999998 110.545 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -61.14 -20.27 62.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 1.78 110.539 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.34 -53.35 58.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 4.5800000000000001 110.968 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.593 ' O ' ' OG ' ' B' ' 26' ' ' SER . 80.8 m95 -62.62 -42.71 99.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.953 -0.567 . . . . 3.3500000000000001 110.955 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 1.5800000000000001 111.253 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -80.73 -5.66 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 1.8400000000000001 110.881 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 15.7 p -72.09 -15.23 62.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 1.3700000000000001 110.775 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -45.95 -40.71 10.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.432 -0.581 . . . . 4.9800000000000004 109.432 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -179.08 130.51 0.27 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.141 -0.936 . . . . 2.1400000000000001 110.219 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -96.28 179.36 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.991 2.461 . . . . 1.8200000000000001 112.182 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -99.85 52.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 5.1900000000000004 111.188 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.1 -46.63 2.02 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.839 -0.696 . . . . 2.2000000000000002 112.552 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 32.7 m -91.87 144.82 29.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.523 0.201 . . . . 3.6499999999999999 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 165.36 17.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.514 2.143 . . . . 2.6699999999999999 112.581 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -62.64 -17.43 60.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 4.8799999999999999 111.837 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -42.3 -35.07 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.726 0.298 . . . . 1.8700000000000001 111.662 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -64.54 -48.31 75.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.932 0.396 . . . . 2.6800000000000002 110.225 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.28 -18.56 61.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 2.9199999999999999 110.703 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' B' ' 41' ' ' MET . 47.7 tp -60.7 -53.44 57.36 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.981 0.42 . . . . 1.6399999999999999 110.325 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.23 -38.74 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 1.6000000000000001 109.893 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.14 -5.62 36.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.629 -0.714 . . . . 0.68999999999999995 110.734 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.466 ' HE3' ' HB1' ' B' ' 19' ' ' ALA . 25.3 ttt -88.65 -36.08 16.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.906 -0.588 . . . . 2.5800000000000001 110.402 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -70.74 -34.2 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.921 -0.582 . . . . 3.3900000000000001 111.078 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.614 HG23 HG23 ' B' ' 79' ' ' THR . 98.7 mt -53.54 -54.76 42.19 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.459 0.54 . . . . 0.40999999999999998 112.459 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 59.9 Cg_endo -70.43 -37.31 7.71 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.405 2.07 . . . . 0.48999999999999999 113.566 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.15 -62.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.748 0.277 . . . . 1.29 111.748 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.619 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -62.08 -52.75 62.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.3999999999999999 111.355 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.442 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 38.4 t -54.04 -31.82 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.3799999999999999 111.566 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.11 -49.75 64.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.37 112.757 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.476 HD22 ' SG ' ' C' ' 134' ' ' CYS . 75.7 mt -54.77 -44.56 73.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 1.29 111.503 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.15 -50.26 67.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.44 111.565 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -63.23 -40.04 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.5 111.303 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.3 ttp -52.39 -34.09 46.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.182 0.515 . . . . 1.4099999999999999 110.196 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -69.78 -40.67 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.598 -0.728 . . . . 0.55000000000000004 110.944 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 56.2 mtt -54.33 -28.64 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.52 . . . . 0.5 110.489 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.83 -52.06 16.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 0.54000000000000004 110.946 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.1 pt -78.65 9.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.913 -0.585 . . . . 1.3 111.539 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 60.03 63.8 1.38 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.063 -0.517 . . . . 2.2400000000000002 111.036 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.468 HE21 ' H ' ' B' ' 59' ' ' GLY . 26.3 tp60 -136.23 128.78 30.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 1.77 110.639 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.468 ' H ' HE21 ' B' ' 58' ' ' GLN . . . 109.87 38.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 1.0600000000000001 112.194 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -150.43 140.81 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 2.6600000000000001 110.81 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.75 141.15 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 1.8899999999999999 111.068 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.43 94.8 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 2.4100000000000001 110.922 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.17 125.04 51.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 1.5600000000000001 111.144 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.05 35.92 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 1.8200000000000001 111.301 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.28 4.7 51.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.74 -0.743 . . . . 1.51 112.547 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -108.46 140.88 41.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.64 0.257 . . . . 2.4500000000000002 110.853 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 55.2 mt -99.27 119.42 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 1.79 110.892 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.48 113.86 27.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.81999999999999995 111.136 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.628 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 93.1 m-70 -73.91 83.34 1.7 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.4 0.619 . . . . 1.05 110.792 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.476 ' HD2' ' HH ' ' B' ' 73' ' ' TYR . 75.6 t80 -52.25 -56.71 12.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 1.8700000000000001 111.567 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -21.93 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.606 0.595 . . . . 0.60999999999999999 112.606 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.628 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 20.3 tpp180 -64.66 -52.54 56.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.275 0.472 . . . . 2.3900000000000001 112.275 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.476 ' HH ' ' HD2' ' B' ' 70' ' ' TYR . 36.7 p90 -87.34 -29.71 21.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.482 -0.487 . . . . 3.6699999999999999 111.418 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.65 -45.96 79.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.692 -0.484 . . . . 1.6599999999999999 109.692 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 16.3 t70 -67.72 -23.47 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 1.4099999999999999 109.139 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 28.9 m0 -86.08 8.18 21.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.457 -0.792 . . . . 1.1599999999999999 111.07 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 -22.51 13.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.758 -0.655 . . . . 1.53 110.571 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.417 ' O ' HD23 ' B' ' 82' ' ' LEU . 35.4 m -113.88 -30.34 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.89000000000000001 111.927 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.614 HG23 HG23 ' B' ' 43' ' ' ILE . 76.1 m -81.29 -52.13 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.008 0.373 . . . . 1.24 112.008 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.584 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 11.9 m -51.8 -49.79 81.48 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.205 0.446 . . . . 0.57999999999999996 112.205 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' B' ' 80' ' ' THR . 10.4 Cg_endo -54.67 -50.94 11.65 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.803 1.669 . . . . 0.66000000000000003 111.782 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.417 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -65.16 -26.13 68.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 1.0600000000000001 110.637 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -36.87 79.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.18 0.514 . . . . 1.22 109.772 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.4 tt -80.36 -25.44 39.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.539 -0.755 . . . . 1.53 110.789 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 98.6 mt -77.78 -36.83 50.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 1.5800000000000001 111.201 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 59.5 m -56.96 -39.68 75.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 1.3899999999999999 110.949 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 98.2 mt -68.58 -35.59 77.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 1.1499999999999999 111.072 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 61.1 m -61.09 -35.31 76.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.326 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -72.24 -36.22 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 2.1699999999999999 110.986 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 29.7 m -66.55 -37.58 85.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 1.4199999999999999 110.81 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -28.59 39.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 1.1799999999999999 110.925 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.1 ttm -77.96 117.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.8799999999999999 110.718 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -86.78 -61.48 1.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 3.4199999999999999 111.223 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.22 160.52 30.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 4.0599999999999996 111.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 70.0 mt -124.9 142.32 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 2.0899999999999999 110.824 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -139.38 -51.08 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 3.8500000000000001 110.83 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -161.93 -161.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 4.8200000000000003 110.511 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 60.76 87.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.448 . . . . 3.7999999999999998 110.795 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -101.13 0.08 37.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 110.852 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.1 p -71.67 -25.91 62.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 2.02 111.293 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.95 -39.71 90.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 2.0899999999999999 110.786 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.61 -38.13 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 1.8799999999999999 111.034 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.4 -29.25 71.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.56000000000000005 112.215 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' B' ' 146' ' ' ILE . 66.2 t80 -65.74 -37.58 86.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.95 0.405 . . . . 1.78 110.588 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.43 ' HB3' HD21 ' B' ' 84' ' ' LEU . 55.4 mt -68.63 -41.37 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.793 -0.64 . . . . 1.03 111.11 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . 0.415 ' O ' HG12 ' B' ' 110' ' ' ILE . 57.9 mtt -64.45 -45.92 85.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 1.6699999999999999 111.135 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 55.6 m -55.58 -42.07 74.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 1.51 111.478 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.479 ' O ' HG23 ' B' ' 112' ' ' VAL . 75.9 p -69.27 -24.94 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 1.1799999999999999 111.416 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -80.49 -44.59 18.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.559 -0.291 . . . . 2.1699999999999999 111.566 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.527 HG22 ' HE1' ' A' ' 46' ' ' TRP . 48.5 mm -57.53 -38.72 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 1.3500000000000001 111.391 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.64 -43.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 1.3400000000000001 111.854 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 108' ' ' THR . 70.2 t -61.03 -55.29 25.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.645 0.26 . . . . 0.42999999999999999 111.62 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.489 HD11 HG21 ' B' ' 80' ' ' THR . 29.7 mm -61.0 -29.26 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 1.6000000000000001 111.23 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.1 m -55.29 -49.34 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.972 0.415 . . . . 0.85999999999999999 110.528 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 75.3 p -70.92 -20.44 62.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.94999999999999996 110.482 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.28 -33.7 43.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.006 -0.616 . . . . 0.46000000000000002 112.975 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.529 HD12 HG13 ' B' ' 118' ' ' ILE . 2.8 pp -82.89 -24.68 33.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 0.235 . . . . 1.75 111.162 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.529 HG13 HD12 ' B' ' 117' ' ' LEU . 85.7 mt -80.21 -36.24 16.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 120.803 0.335 . . . . 1.78 110.838 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.86 -38.24 48.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.539 . . . . 0.38 111.154 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -82.6 -26.74 32.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.006 -0.543 . . . . 1.97 111.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -86.35 22.27 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.341 . . . . 0.76000000000000001 111.185 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -67.27 139.62 57.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.47 110.843 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -94.03 -17.69 22.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 2.5 111.044 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.646 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 48.7 ttp180 -137.88 156.46 47.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.499 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.53 -14.97 60.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 2.2000000000000002 110.935 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.646 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 54.4 t90 -92.96 -37.98 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 3.3999999999999999 111.19 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' B' ' 124' ' ' ARG . 18.4 m -65.34 -24.32 34.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.215 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.8 ttt-85 -63.47 -47.59 81.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 3.04 111.385 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.97 -32.82 68.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 4.1399999999999997 111.557 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.17 -46.56 76.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 1.6499999999999999 110.873 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -74.33 -25.57 59.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.77000000000000002 110.732 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.2 -51.82 61.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.816 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.58 -33.27 60.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.31 -0.405 . . . . 1.6299999999999999 110.804 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.78 -28.22 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.4199999999999999 110.588 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.39 -53.68 16.31 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.925 -0.655 . . . . 0.48999999999999999 112.487 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 28.9 m -61.79 -35.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.593 0.235 . . . . 1.3 111.312 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 90.8 m -61.22 -35.88 78.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.75 0.31 . . . . 1.3 110.725 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.52 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.62 110.637 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.54 -23.5 63.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 1.74 110.892 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 90.5 mt -71.47 -55.62 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.418 . . . . 1.76 111.187 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 43.1 pt -66.59 -28.85 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.68999999999999995 111.534 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.63 -51.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 1.76 111.075 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 54.2 tp -52.75 -49.62 65.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.336 -0.393 . . . . 1.0600000000000001 110.672 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.06 -24.61 65.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.518 . . . . 4.1200000000000001 110.602 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.82 -17.66 74.56 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 1.26 112.776 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.44 HG12 ' HE2' ' B' ' 104' ' ' PHE . 56.7 mt -103.39 -19.52 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.781 0.324 . . . . 1.98 111.127 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -54.86 -50.04 69.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.449 . . . . 1.4199999999999999 111.922 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.91 0.337 . . . . 99.989999999999995 111.91 -178.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.845 0.355 . . . . 2.4300000000000002 110.946 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.33 -29.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 2.5800000000000001 111.013 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.63 -59.04 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 2.0 111.223 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -58.41 -21.57 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 3.0299999999999998 111.767 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.7 -63.58 1.38 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 111.399 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.23 -31.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 1.75 111.634 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -59.88 -52.2 66.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 0.97999999999999998 111.152 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.96 -33.58 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 4.2999999999999998 110.766 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -72.17 -25.91 61.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 1.3899999999999999 110.763 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.438 HG22 HD12 ' B' ' 177' ' ' ILE . 27.2 m -79.35 -40.26 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 1.1100000000000001 111.819 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.6 -35.02 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.492 -0.322 . . . . 1.51 111.484 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.69 -57.05 4.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.316 -0.402 . . . . 1.75 111.624 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -31.06 56.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.59999999999999998 111.028 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.474 ' O ' HG12 ' B' ' 181' ' ' ILE . 92.4 mt -87.67 -21.43 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 1.47 110.521 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -55.9 27.93 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.55000000000000004 113.074 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 90.5 m-85 -54.23 -53.94 53.32 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.73 0.265 . . . . 1.6200000000000001 111.273 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.7 Cg_exo -45.08 -34.57 9.42 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.2 1.934 . . . . 0.64000000000000001 112.966 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.474 HG12 ' O ' ' B' ' 177' ' ' ILE . 48.8 mm -65.79 -60.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.856 0.36 . . . . 1.27 111.503 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.514 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.9 m -56.84 -24.37 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.417 -0.356 . . . . 0.68999999999999995 111.154 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -69.23 -53.66 18.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 1.1799999999999999 111.857 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 185' ' ' ILE . 10.5 tt -62.06 -51.65 69.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 111.852 0.315 . . . . 1.77 111.852 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . 0.425 ' N ' HG23 ' B' ' 184' ' ' ILE . 2.3 pp -60.66 131.02 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 1.6899999999999999 110.647 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 C-N-CA 120.638 -0.791 . . . . 1.5800000000000001 112.365 -179.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.841 0.353 . . . . 2.4700000000000002 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -51.4 -55.68 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 2.5299999999999998 111.04 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -56.87 -38.09 72.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.29 111.658 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -57.0 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 2.6200000000000001 111.342 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 57.1 tp -83.36 -41.75 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.339 . . . . 1.6100000000000001 111.133 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -77.88 -0.97 29.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 1.4199999999999999 111.162 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 37.0 t -96.14 -43.59 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.127 0.489 . . . . 1.4299999999999999 110.263 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 42.9 tp -72.97 -36.82 67.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.665 -0.698 . . . . 1.1200000000000001 111.98 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.688 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 34.2 tp -58.08 -54.51 54.9 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.029 -0.268 . . . . 1.26 111.596 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 34.3 Cg_exo -58.8 -39.44 81.74 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.757 1.638 . . . . 0.59999999999999998 111.471 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.98 -28.23 69.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 1.3999999999999999 110.226 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -75.43 -25.53 57.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.047 -0.524 . . . . 1.4099999999999999 110.546 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 1.3200000000000001 110.55 179.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.805 0.336 . . . . 1.6899999999999999 110.987 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.05 60.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.837 -0.697 . . . . 0.79000000000000004 112.121 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -58.97 -39.06 80.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 2.96 111.211 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 42.2 t -56.49 -61.07 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.29 111.203 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.28 -20.03 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 3.1499999999999999 110.955 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -72.1 -45.23 61.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 1.51 110.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.37 -27.02 67.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 2.1899999999999999 110.82 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.66 -46.19 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 1.98 111.201 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -74.38 -43.41 56.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 2.1699999999999999 111.29 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.64 -18.73 72.33 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.781 -0.723 . . . . 1.3600000000000001 112.86 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.546 0.212 . . . . 2.8999999999999999 111.079 -179.904 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.463 ' N ' HD12 ' C' ' 6' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.46 0.052 0 CA-C-O 120.769 0.319 . . . . 2.52 110.452 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' C' ' 11' ' ' TYR . 3.7 mm? -60.83 -31.58 71.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 1.9299999999999999 110.921 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 32.3 m170 -69.54 -32.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 1.26 110.746 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -75.44 -54.64 6.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.23 -0.441 . . . . 1.6699999999999999 110.954 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 36.6 mm -57.04 -22.21 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.472 . . . . 1.8700000000000001 110.32 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' C' ' 7' ' ' LEU . 4.3 t80 -67.64 -59.34 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.649 -0.705 . . . . 1.4399999999999999 110.773 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.15 -29.22 46.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.46999999999999997 111.351 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.91 -47.81 70.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.58999999999999997 111.369 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.13 79.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.5 112.81 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 24.9 mmt -72.18 -25.04 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.363 . . . . 0.68000000000000005 111.079 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 85.7 m -69.68 -53.33 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.055 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.73 -24.06 34.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 1.55 111.12 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -54.11 30.66 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.87 -0.681 . . . . 0.70999999999999996 112.513 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.9 70.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.77000000000000002 110.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -64.8 -33.68 76.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.128 -0.487 . . . . 1.9299999999999999 110.649 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -63.84 -19.86 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 1.8600000000000001 110.998 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.24 -58.24 9.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 4.1399999999999997 111.127 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.78 -33.78 76.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 3.1499999999999999 111.039 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -71.89 -22.34 61.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 1.95 111.169 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.431 ' HB3' HE22 ' C' ' 34' ' ' GLN . 29.9 tp -84.63 -6.0 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 2.2200000000000002 111.106 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 98.5 p -67.62 -12.89 61.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.3700000000000001 110.82 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -47.94 -42.83 28.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.189 -0.671 . . . . 5.0300000000000002 109.189 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.6 p-10 -177.16 130.66 0.34 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.193 -0.912 . . . . 2.3700000000000001 110.201 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 85.0 Cg_endo . . . . . 0 N--CA 1.451 -1.023 0 C-N-CA 123.242 2.628 . . . . 2.0499999999999998 112.056 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . 0.465 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 35.4 Cg_exo . . . . . 0 C--O 1.23 0.105 0 CA-C-O 121.136 0.39 . . . . 1.9299999999999999 111.996 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . 0.431 HE22 ' HB3' ' C' ' 25' ' ' LEU . 15.1 mm100 -58.92 -17.2 22.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.63 -0.714 . . . . 4.1200000000000001 112.429 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.465 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -45.1 -33.53 2.21 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.735 0.302 . . . . 2.8900000000000001 111.367 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.74 -49.1 72.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.953 0.406 . . . . 2.46 110.128 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . 0.41 ' HD2' ' HA ' ' C' ' 34' ' ' GLN . 58.9 m-85 -70.48 -18.76 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 2.7799999999999998 110.476 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' C' ' 41' ' ' MET . 39.1 tp -60.48 -56.78 17.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.274 -0.421 . . . . 1.6200000000000001 110.496 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.26 -36.46 74.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 1.5900000000000001 110.014 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -74.74 -4.34 36.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.934 -0.576 . . . . 0.65000000000000002 110.747 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.479 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 23.9 ttt -88.52 -37.31 15.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.917 -0.583 . . . . 1.6699999999999999 110.485 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.92 -34.57 69.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 3.4199999999999999 111.252 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.605 HG23 HG23 ' C' ' 79' ' ' THR . 83.0 mt -51.08 -53.58 46.95 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.161 0.43 . . . . 0.89000000000000001 112.161 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.76 -34.4 8.98 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.314 2.01 . . . . 0.40999999999999998 113.231 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -55.19 -62.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 1.76 111.683 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.429 ' HE1' HG13 ' A' ' 110' ' ' ILE . 1.1 t90 -63.38 -53.03 58.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.551 -0.295 . . . . 2.1600000000000001 111.245 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . 0.467 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 39.9 t -53.7 -31.74 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 1.1699999999999999 111.782 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.61 -49.37 60.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.44 112.652 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.454 HD22 ' SG ' ' A' ' 134' ' ' CYS . 50.1 mt -58.25 -35.67 72.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 1.29 111.441 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.87 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.5 111.602 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 22.5 m-85 -61.34 -38.7 87.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.8300000000000001 111.512 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 45.7 ttp -50.33 -38.23 40.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.26 0.552 . . . . 1.47 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.64 82.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.503 -0.771 . . . . 0.59999999999999998 110.777 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.8 mtt -51.42 -28.87 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.83999999999999997 110.626 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -72.92 -51.56 18.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.65000000000000002 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 127' ' ' VAL . 29.1 pt -76.91 9.37 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 1.55 111.492 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 59.12 51.43 7.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.058 -0.519 . . . . 1.54 111.373 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.472 ' HG3' HD11 ' A' ' 118' ' ' ILE . 6.7 tp-100 -120.73 139.62 52.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 1.79 110.877 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.88 32.52 5.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.93999999999999995 112.205 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -139.4 136.19 34.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 2.3599999999999999 111.03 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.28 136.47 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.428 -0.351 . . . . 1.97 111.15 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.27 91.32 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 2.4399999999999999 110.63 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.85 128.7 55.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 1.54 111.033 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.93 33.66 19.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.076 -0.511 . . . . 1.71 111.093 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 16.05 61.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.769 -0.729 . . . . 1.53 112.499 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.53 125.17 41.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.742 0.306 . . . . 2.23 110.737 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 25.8 pt -75.57 133.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 1.3600000000000001 111.398 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.01 113.01 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.78000000000000003 110.923 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.545 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 91.6 m-70 -75.64 79.07 2.62 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.286 0.565 . . . . 1.0800000000000001 111.211 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -57.73 -34.94 70.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.404 -0.816 . . . . 2.2999999999999998 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.35 -22.68 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.75 111.871 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.8 tpp180 -67.62 -51.47 49.76 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.435 0.532 . . . . 1.51 112.435 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' C' ' 77' ' ' MET . 28.8 p90 -87.1 -30.95 20.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.435 0.532 . . . . 4.6500000000000004 112.435 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.9 tp -56.46 -41.16 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.564 -0.455 . . . . 1.22 110.108 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 19.6 t0 -69.8 -20.61 63.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.994 -0.743 . . . . 1.3100000000000001 108.994 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -89.75 9.9 25.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.249 -0.887 . . . . 1.6799999999999999 110.888 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 92.0 mmm -105.05 -21.86 13.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 1.8 110.152 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.57 -29.1 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 1.1899999999999999 112.163 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.605 HG23 HG23 ' C' ' 43' ' ' ILE . 61.9 m -83.42 -49.49 9.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.212 0.449 . . . . 1.23 112.212 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.2 m -55.05 -50.73 84.79 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 111.898 0.333 . . . . 0.58999999999999997 111.898 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.4 Cg_exo -54.69 -47.92 24.1 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.917 1.745 . . . . 0.67000000000000004 111.665 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.27 -27.71 68.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.921 -0.581 . . . . 0.95999999999999996 110.573 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.501 HD13 ' O ' ' C' ' 83' ' ' LEU . 1.2 tm? -67.55 -38.04 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.257 0.551 . . . . 1.1899999999999999 109.632 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -78.56 -25.63 45.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 1.7 110.871 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.04 -33.0 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 1.6200000000000001 111.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 60.1 m -62.91 -54.06 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.26 110.978 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 pp -61.8 -22.15 65.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.1100000000000001 111.08 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -50.51 52.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 1.51 110.648 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -60.67 -28.23 68.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.406 . . . . 2.0600000000000001 110.68 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -60.88 -52.43 65.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 1.52 110.801 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.25 60.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.191 -0.459 . . . . 1.3 111.056 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 12.9 tpt -86.86 112.89 22.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 1.6200000000000001 110.488 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -86.55 -61.55 1.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 3.2400000000000002 111.442 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -130.97 144.3 51.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 4.6299999999999999 111.301 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 tt -109.32 146.13 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 2.1800000000000002 110.739 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -124.54 -83.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.571 -0.286 . . . . 4.1200000000000001 111.247 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -139.2 3.38 2.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 4.96 111.332 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.41 91.89 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 3.9100000000000001 110.698 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -107.6 -13.59 15.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 5.21 111.29 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 7.3 t -69.35 -27.71 65.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 1.8200000000000001 111.245 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.16 -35.5 75.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 2.0800000000000001 110.957 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.1 -38.9 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.906 -0.588 . . . . 1.8600000000000001 111.294 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -35.5 92.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.58999999999999997 112.571 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -65.17 -35.82 82.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 1.53 110.847 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.25 -45.66 83.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 110.974 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . 0.421 ' O ' HG13 ' C' ' 110' ' ' ILE . 91.0 mmm -62.44 -43.31 99.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 2.21 110.715 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -53.71 -51.2 64.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 1.28 111.479 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 75.7 p -59.64 -30.34 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 1.22 111.761 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -74.55 -50.45 18.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 2.3300000000000001 111.654 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.619 HG22 ' HE1' ' B' ' 46' ' ' TRP . 58.9 mt -52.34 -34.92 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.399 -0.364 . . . . 1.29 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.22 -48.94 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.0600000000000001 111.494 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.34 -56.55 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.51000000000000001 111.874 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' C' ' 110' ' ' ILE . 25.4 pt -54.51 -32.37 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 1.3700000000000001 111.804 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 20.3 m -60.66 -46.76 89.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.77000000000000002 110.899 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -67.32 -20.58 65.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 1.1899999999999999 110.939 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.72 -40.87 11.61 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.986 -0.626 . . . . 0.5 113.058 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.505 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.8 pp -73.68 -29.65 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.289 . . . . 1.47 111.424 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.505 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.1 tp -81.22 -28.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.806 0.336 . . . . 1.2 110.988 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.46 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.537 . . . . 0.40000000000000002 110.994 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.57 -24.74 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 2.1200000000000001 111.116 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 93.5 mt -88.02 33.83 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.75 110.715 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 83.4 p -77.95 132.73 38.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 1.3799999999999999 111.007 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.99 -25.61 29.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 2.7400000000000002 110.577 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -134.72 152.57 51.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.897 -0.592 . . . . 2.7999999999999998 110.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.91 -11.09 60.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 2.4100000000000001 111.315 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -92.81 -40.64 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.463 -0.335 . . . . 4.2000000000000002 111.071 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.42 -23.9 25.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 1.0800000000000001 110.822 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -66.74 -35.79 80.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.948 -0.569 . . . . 2.5699999999999998 111.0 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -65.0 -32.15 73.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 3.8100000000000001 111.203 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.63 -54.38 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 1.4199999999999999 111.2 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -58.6 -28.68 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.89000000000000001 111.286 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.72 -44.99 80.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 1.26 110.861 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 81.7 mt -56.92 -37.27 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 1.6799999999999999 110.744 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . 0.476 ' SG ' HD22 ' B' ' 49' ' ' LEU . 53.8 t -70.36 -27.06 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 1.24 110.766 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.3 -56.7 20.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.54000000000000004 112.385 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.9 -32.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 1.0600000000000001 110.985 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 50.1 t -63.39 -35.71 81.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 110.301 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.75 92.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.775 -0.648 . . . . 0.56999999999999995 110.838 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -69.81 -16.12 63.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.6799999999999999 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.21 -58.59 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 1.7 110.592 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 17.2 pt -71.15 -27.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.78000000000000003 111.596 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.98 -44.31 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.333 -0.394 . . . . 2.2400000000000002 111.221 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.9 tp -55.54 -57.94 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.334 . . . . 1.02 111.078 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -62.77 -24.98 67.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 3.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.23 -16.84 79.61 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 1.27 112.64 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 69.1 mt -105.52 -18.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 1.8899999999999999 111.183 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -62.3 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 1.6000000000000001 111.932 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 112.344 0.498 . . . . 99.989999999999995 112.344 -178.796 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 20.0 mt . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.124 0.488 . . . . 2.3500000000000001 110.774 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -23.58 46.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.373 -0.83 . . . . 2.6200000000000001 111.192 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.4 -50.48 63.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 2.0899999999999999 110.751 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -61.09 -35.78 77.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 3.2400000000000002 110.821 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.7 -62.81 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 1.6899999999999999 111.227 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.09 -32.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 1.3999999999999999 111.479 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.7 m -57.11 -53.08 62.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.362 . . . . 0.95999999999999996 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -56.16 -39.25 72.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 3.6499999999999999 110.84 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -62.75 -32.13 73.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 1.3700000000000001 111.084 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 34.2 m -73.8 -46.69 43.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.508 . . . . 1.4299999999999999 111.413 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.61 -28.95 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 1.6200000000000001 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.8 tp -80.52 -57.67 3.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.356 -0.384 . . . . 2.0299999999999998 111.678 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.28 -28.14 62.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.748 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.449 ' O ' HG13 ' C' ' 181' ' ' ILE . 34.2 mm -87.83 -23.33 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 1.5800000000000001 110.166 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.51 24.56 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.814 -0.63 . . . . 0.56000000000000005 113.155 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 66.2 m-85 -53.85 -54.97 40.73 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.899 0.349 . . . . 1.3300000000000001 111.069 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 80.4 Cg_exo -45.36 -33.54 9.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.946 1.764 . . . . 0.63 112.664 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.449 HG13 ' O ' ' C' ' 177' ' ' ILE . 87.3 mt -63.9 -61.14 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.568 -0.287 . . . . 0.93000000000000005 111.483 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 p -56.95 -35.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 1.27 111.623 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -57.13 -51.37 69.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.564 -0.289 . . . . 1.77 111.147 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.0 -65.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.371 -0.377 . . . . 2.3900000000000001 111.656 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . 0.427 ' O ' HD12 ' C' ' 185' ' ' ILE . 2.5 pp . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.077 0.465 . . . . 1.95 111.248 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.861 0.362 . . . . 2.3799999999999999 110.979 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -51.28 -33.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.185 -0.461 . . . . 2.23 111.462 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.52 -56.43 18.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.392 . . . . 2.1600000000000001 111.007 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.6 p -60.99 -31.18 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 1.27 111.478 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.3 -39.0 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 1.7 111.333 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.0 -45.49 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 2.02 111.435 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.21 -3.22 12.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.746 0.308 . . . . 1.8200000000000001 110.984 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 25.6 t -96.19 -40.95 8.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.197 0.522 . . . . 1.3500000000000001 110.072 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 55.5 tp -74.12 -37.55 64.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.512 -0.767 . . . . 0.65000000000000002 111.733 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.666 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 52.1 tp -57.19 -53.84 61.0 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.765 -0.198 . . . . 1.4199999999999999 111.463 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 32.6 Cg_exo -58.59 -42.35 55.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.73 1.62 . . . . 0.63 111.476 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' C' ' 11' ' ' TYR . 51.3 t80 -64.11 -26.43 68.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.106 -0.497 . . . . 1.49 110.393 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.36 -26.01 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 1.7 110.479 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 89.2 p . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 1.25 110.811 179.85 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.779 0.323 . . . . 1.6100000000000001 111.279 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.33 -32.46 62.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.78 . . . . 0.81999999999999995 112.619 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.71 -36.76 70.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.671 0.272 . . . . 3.0800000000000001 111.038 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.3 t -61.34 -56.31 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 110.947 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -61.23 -25.54 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 2.5600000000000001 110.853 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.42 -51.08 32.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 1.29 110.827 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.19 -21.47 63.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 2.3900000000000001 111.25 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.56 -35.56 39.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 2.0299999999999998 111.203 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -82.28 -33.4 29.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.972 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -81.14 -18.75 68.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.852 -0.69 . . . . 1.3600000000000001 112.364 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.553 0.216 . . . . 2.8999999999999999 111.211 -179.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt . . . . . 0 N--CA 1.46 0.062 0 CA-C-O 120.651 0.263 . . . . 2.4199999999999999 111.261 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.85 -59.67 2.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.332 . . . . 2.0899999999999999 111.171 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 35.5 m80 -59.86 -23.69 63.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 1.1599999999999999 110.586 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.415 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.4 t-105 -66.33 -54.51 23.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.79000000000000004 110.765 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.45 -23.18 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 2.0800000000000001 110.51 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.488 ' OH ' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -60.32 -61.28 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.64 . . . . 1.28 111.108 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 9' ' ' TRP . 8.1 p -57.19 -32.79 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.4 . . . . 1.3200000000000001 111.188 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.85 98.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.63 111.024 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.57 -22.16 78.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.833 -0.699 . . . . 0.55000000000000004 112.365 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.0 mmt -73.29 -42.56 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 1.03 110.825 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.4 p -61.67 -49.85 74.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 1.3 111.11 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.77 -24.27 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 1.3100000000000001 110.982 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.58 -46.6 91.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.766 -0.731 . . . . 0.77000000000000002 112.551 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.1 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.747 0.308 . . . . 0.80000000000000004 111.201 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.92 -28.62 69.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 1.8100000000000001 110.972 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -54.96 -32.79 61.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 1.8799999999999999 110.63 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -75.15 -36.7 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 4.4500000000000002 110.842 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -54.58 -34.72 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.916 0.388 . . . . 3.6899999999999999 110.678 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.8 m -85.31 -29.65 24.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 1.5700000000000001 111.178 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.3 tp -87.27 -5.62 58.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 1.95 111.297 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.1 p -60.2 -19.81 55.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.3799999999999999 111.188 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -50.01 -32.24 14.8 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.187 0.517 . . . . 4.0700000000000003 109.726 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -176.15 132.17 0.4 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.103 -0.953 . . . . 2.7200000000000002 109.912 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -95.52 -176.84 0.39 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.877 2.385 . . . . 1.9099999999999999 112.609 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -86.43 45.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 4.7599999999999998 110.979 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.71 -45.74 3.38 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.881 -0.676 . . . . 1.99 112.613 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.8 118.99 71.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 2.7000000000000002 111.265 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' TYR . 51.2 Cg_exo -55.06 168.61 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.961 2.441 . . . . 1.79 112.351 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -39.63 -18.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.335 -0.848 . . . . 4.1200000000000001 113.17 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 m-30 -41.27 -60.47 1.25 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.887 0.375 . . . . 2.9300000000000002 111.396 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.23 -41.95 97.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.034 -0.53 . . . . 2.8799999999999999 111.597 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -69.27 -19.36 63.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.618 -0.264 . . . . 4.6600000000000001 111.484 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.08 -55.55 10.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.953 0.406 . . . . 1.45 110.268 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.655 HG23 HD12 ' A' ' 82' ' ' LEU . 4.3 p -68.35 -31.32 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.78 111.031 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.6 -13.05 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.524 . . . . 0.63 111.663 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.491 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 17.0 tmm? -89.12 -35.51 16.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 1.48 111.287 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -77.81 -33.81 52.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.279 0.474 . . . . 3.5 112.279 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.592 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 88.6 mt -54.06 -50.54 83.74 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 111.753 0.279 . . . . 1.0800000000000001 111.753 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 12.1 Cg_exo -71.23 -43.22 1.61 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.647 2.232 . . . . 0.53000000000000003 113.059 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 41' ' ' MET . 42.3 mm -56.38 -61.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.778 0.288 . . . . 1.6799999999999999 111.778 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -55.18 -58.36 8.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.652 0.263 . . . . 1.8300000000000001 111.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.6 p -52.01 -42.16 62.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 1.0900000000000001 111.535 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -48.8 -60.35 6.04 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.129 -0.557 . . . . 0.40999999999999998 112.992 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.23 -34.87 58.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.98999999999999999 111.204 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.49 83.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.47999999999999998 111.29 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 57.4 m-85 -63.82 -49.64 72.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.8700000000000001 111.324 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.7 ttp -47.02 -34.4 5.63 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 1.49 110.352 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.96 -44.21 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.762 -0.654 . . . . 0.58999999999999997 110.926 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.404 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 53.5 mtt -52.42 -27.72 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.48999999999999999 110.209 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.87 47.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.718 -0.674 . . . . 0.59999999999999998 110.385 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.4 -2.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 1.3100000000000001 110.847 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.52 43.11 2.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.938 -0.574 . . . . 1.9099999999999999 111.108 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.405 HE21 HG21 ' B' ' 127' ' ' VAL . 6.5 tp-100 -121.56 159.14 27.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.947 -0.569 . . . . 1.6200000000000001 110.509 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.06 13.91 44.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 1.04 112.114 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -132.57 140.2 48.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.787 0.327 . . . . 2.6800000000000002 110.697 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.24 150.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 1.98 111.192 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.64 92.55 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 2.1800000000000002 110.611 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.66 137.48 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.5700000000000001 111.073 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.07 17.18 7.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.511 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.8 -13.07 63.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 1.48 112.699 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -98.45 155.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 2.3199999999999998 111.164 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.6 mt -105.26 106.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.96 -0.564 . . . . 1.4399999999999999 110.861 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.73 138.39 33.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.81999999999999995 111.482 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.8 m-70 -97.73 74.55 2.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.979 -0.555 . . . . 0.90000000000000002 110.615 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -56.41 -45.7 80.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.557 -0.747 . . . . 1.8300000000000001 111.684 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -67.21 -27.16 67.02 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.189 0.44 . . . . 0.62 112.189 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.4 tpp180 -64.16 -51.61 63.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.596 0.591 . . . . 2.3399999999999999 112.596 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.507 ' O ' ' HG3' ' A' ' 77' ' ' MET . 15.9 p90 -87.06 -26.15 23.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.455 -0.498 . . . . 3.4900000000000002 112.297 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 71' ' ' ALA . 9.6 tp -55.87 -42.38 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.6 -0.44 . . . . 1.3700000000000001 110.125 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -70.01 -21.34 63.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.16 -0.682 . . . . 1.3100000000000001 109.16 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -84.77 2.81 40.44 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.364 -0.835 . . . . 1.48 111.243 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 38.9 mtp -103.06 -22.87 13.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 1.46 110.931 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.447 ' O ' HD23 ' A' ' 82' ' ' LEU . 28.9 m -114.52 -36.04 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.453 0.538 . . . . 1.1200000000000001 112.453 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 43' ' ' ILE . 36.0 m -72.58 -52.32 16.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.902 0.334 . . . . 1.1000000000000001 111.902 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.578 HG22 ' NE2' ' A' ' 109' ' ' GLN . 10.5 m -53.82 -51.37 77.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.583 0.586 . . . . 0.59999999999999998 112.583 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 80' ' ' THR . 12.1 Cg_endo -55.72 -44.36 48.6 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.49 1.46 . . . . 0.73999999999999999 111.511 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.655 HD12 HG23 ' A' ' 39' ' ' VAL . 3.9 mm? -64.2 -31.37 72.54 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.601 -0.518 . . . . 1.01 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 83' ' ' LEU . 1.6 tt -68.87 -24.53 64.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.531 0.682 . . . . 1.48 109.206 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.22 -32.11 24.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.129 -0.941 . . . . 1.3799999999999999 110.474 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.67 -36.14 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.751 -0.659 . . . . 1.1899999999999999 111.172 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -58.27 -25.09 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 1.23 110.943 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.57 -40.48 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.88 110.834 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -61.05 -37.26 82.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 1.3899999999999999 111.044 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -73.83 -38.65 64.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.27 -0.423 . . . . 2.3199999999999998 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.21 -29.07 70.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 1.46 111.031 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.29 -40.38 13.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.24 111.239 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.3 mtp -99.99 107.28 19.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 2.0699999999999998 111.076 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -82.17 -27.53 32.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 3.5299999999999998 110.488 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -133.55 138.9 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 4.0800000000000001 110.596 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.04 142.94 23.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 2.1699999999999999 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -124.87 -66.25 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 4.5199999999999996 110.867 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -160.86 80.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 3.75 110.771 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.73 109.55 4.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 3.5299999999999998 110.94 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -129.25 12.04 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 4.9100000000000001 110.741 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.8 t -95.12 -32.22 13.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 1.98 111.395 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 101' ' ' LEU . 1.2 tm? -74.23 -45.13 50.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 1.8300000000000001 110.57 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.37 -33.77 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.391 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.14 -34.77 64.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.62 112.807 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -66.98 -34.99 78.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 1.5800000000000001 111.02 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.2 mt -76.14 -52.1 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.97999999999999998 111.023 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -58.91 -33.25 70.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 1.48 111.451 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.4 p -72.16 -56.62 5.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.43 -0.35 . . . . 1.1299999999999999 111.005 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.0 p -55.75 -25.21 39.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 1.48 110.778 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.578 ' NE2' HG22 ' A' ' 80' ' ' THR . 6.4 tp60 -68.64 -45.98 70.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 2.7000000000000002 110.798 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.436 ' HA ' HD12 ' A' ' 113' ' ' ILE . 60.8 mt -54.37 -36.9 35.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.461 -0.336 . . . . 1.54 110.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.85 -44.66 99.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.28 111.139 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.5 t -66.11 -36.36 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.42999999999999999 111.308 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 110' ' ' ILE . 94.0 mt -60.03 -41.84 87.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.183 -0.462 . . . . 1.74 111.161 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 72.5 m -60.84 -51.7 68.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.63 111.113 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.408 ' HA ' HG22 ' A' ' 118' ' ' ILE . 78.9 p -59.68 -20.16 54.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 1.0900000000000001 110.825 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.79 -36.05 17.13 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.056 -0.592 . . . . 0.41999999999999998 112.898 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -83.09 -28.45 29.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.652 0.263 . . . . 1.3799999999999999 111.625 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.7 tp -83.93 -28.11 7.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.603 -0.271 . . . . 1.6200000000000001 111.574 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.65 74.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.39000000000000001 110.809 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.5 -12.44 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 2.02 110.74 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 118' ' ' ILE . 91.6 mt -90.42 22.04 3.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.76000000000000001 110.788 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.1 m -86.3 120.67 27.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 1.46 110.864 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -90.32 -68.33 0.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 3.3500000000000001 110.849 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.569 ' HB2' HG12 ' A' ' 127' ' ' VAL . 99.6 mtt180 -64.81 139.63 58.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 2.9199999999999999 110.617 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.11 -9.54 58.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 2.77 110.872 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -88.51 -38.5 14.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 3.77 110.927 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.0 p -79.88 -24.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.1599999999999999 111.018 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -54.41 -43.52 71.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 2.04 111.059 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.99 -33.89 76.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.17 -0.468 . . . . 2.6400000000000001 110.763 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 127' ' ' VAL . 49.8 mt -66.37 -58.48 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 1.8999999999999999 111.135 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.48 ' HE1' ' HB3' ' C' ' 58' ' ' GLN . 4.6 m95 -55.32 -34.31 64.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 1.3999999999999999 111.191 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.41 -48.92 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.28 111.067 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -61.86 -28.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 2.1600000000000001 111.037 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.44 -33.62 74.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.458 . . . . 1.6899999999999999 110.625 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.57 -50.26 26.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.882 -0.675 . . . . 0.52000000000000002 112.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.65 -30.22 48.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.674 0.273 . . . . 1.02 111.262 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.15 -46.5 77.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 1.0800000000000001 110.774 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.51 -29.88 70.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.62 110.969 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.22 -26.85 61.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 1.8400000000000001 110.848 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.85 -53.89 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 1.6899999999999999 111.202 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.7 pt -61.33 -44.95 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 0.81000000000000005 111.443 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.468 ' N ' HG13 ' A' ' 141' ' ' ILE . 89.6 mt -63.88 -36.6 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 2.3700000000000001 111.078 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.69 -28.48 69.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.97999999999999998 110.588 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -72.78 -34.22 66.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 3.27 110.313 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.73 -35.77 34.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.905 -0.664 . . . . 1.25 112.58 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.9 -26.21 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.947 0.403 . . . . 2.1200000000000001 110.661 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -88.06 3.12 50.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 1.6599999999999999 110.903 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 99.989999999999995 112.175 -179.131 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.6 tp . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.928 0.394 . . . . 2.3399999999999999 110.783 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 169' ' ' VAL . 2.4 t80 -81.25 -21.75 39.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 2.77 110.625 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.64 -50.62 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 2.04 111.272 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -74.97 -27.79 60.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.039 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.66 -47.27 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 1.8899999999999999 111.361 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 165' ' ' TYR . 14.3 p -70.93 -30.32 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 1.6399999999999999 111.492 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -56.08 -58.4 8.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 1.24 111.309 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -61.42 -35.21 76.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 2.9700000000000002 110.525 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -65.2 -26.57 68.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 1.48 110.813 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 88.6 m -73.93 -49.54 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 1.55 111.34 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.18 -31.45 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.39 -0.368 . . . . 1.52 111.599 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.413 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.7 mt -77.02 -57.47 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.429 -0.351 . . . . 1.8500000000000001 111.401 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.62 111.545 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.518 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 9.9 tp -87.67 -21.27 7.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.125 0.488 . . . . 1.3500000000000001 110.203 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -64.75 -45.29 93.16 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.711 -0.677 . . . . 0.58999999999999997 112.304 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG22 ' A' ' 182' ' ' VAL . 0.4 OUTLIER -53.32 -55.41 34.68 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.703 0.251 . . . . 1.45 111.053 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.518 ' HD2' ' C ' ' A' ' 177' ' ' ILE . 75.6 Cg_exo -48.96 -38.84 39.73 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.227 1.951 . . . . 0.55000000000000004 112.4 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 184' ' ' ILE . 98.5 mt -54.62 -59.16 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.211 -0.45 . . . . 1.4199999999999999 111.605 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 179' ' ' TYR . 26.5 m -67.69 -24.21 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.308 -0.405 . . . . 0.78000000000000003 111.288 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -59.58 -53.08 62.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.906 0.336 . . . . 0.93999999999999995 111.906 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.0 tt -59.01 -20.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.855 0.317 . . . . 1.4299999999999999 111.855 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.096 0.474 . . . . 2.02 111.473 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.67 0.271 . . . . 2.48 111.625 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.98 -57.73 9.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 2.1800000000000002 110.639 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.5 p -60.17 -17.26 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 1.49 111.012 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -81.97 -30.47 31.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 1.77 110.937 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.76 -37.28 22.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 1.4199999999999999 111.195 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -13.79 60.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.478 -0.328 . . . . 1.78 111.309 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 15.7 p -96.15 -37.07 10.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.972 0.415 . . . . 1.3 110.592 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 66.3 tp -72.7 -33.8 66.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.66000000000000003 111.668 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.665 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 47.2 tp -60.72 -53.79 60.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 121.122 -0.231 . . . . 1.6299999999999999 111.348 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.03 -42.34 67.71 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.931 1.754 . . . . 0.64000000000000001 111.44 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.488 ' HB2' ' OH ' ' A' ' 11' ' ' TYR . 90.5 t80 -61.72 -35.63 78.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.111 -0.495 . . . . 1.3600000000000001 110.251 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.418 ' HA ' HG12 ' A' ' 211' ' ' VAL . 72.7 t80 -75.78 -20.94 57.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.834 -0.621 . . . . 1.54 110.846 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.413 ' OG ' HD13 ' A' ' 175' ' ' LEU . 29.8 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 1.2 111.127 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 208' ' ' PHE . 9.1 p . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.88 0.372 . . . . 1.6399999999999999 110.914 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.16 78.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 0.79000000000000004 112.393 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.98 -38.18 90.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 1.6100000000000001 110.674 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.9 m -58.68 -57.38 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 1.1499999999999999 110.794 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -64.03 -22.8 67.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 3.3399999999999999 110.644 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.81 -48.03 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 111.102 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.86 -31.5 72.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.452 -0.34 . . . . 2.23 111.253 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 52.2 mt -70.15 -57.5 4.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 2.4700000000000002 111.115 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.31 -22.82 65.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 111.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.32 -59.44 10.65 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.817 -0.706 . . . . 1.4099999999999999 112.861 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 2.5800000000000001 110.738 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.89 0.376 . . . . 2.0699999999999998 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 39.6 mt -66.34 -48.27 70.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.003 -0.544 . . . . 2.1000000000000001 110.979 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 34.4 m80 -64.76 -24.17 67.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 1.0700000000000001 110.831 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.453 ' O ' HG12 ' B' ' 12' ' ' VAL . 11.2 m95 -70.57 -56.15 7.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 1.48 111.194 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 pt -60.37 -20.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 2.02 110.906 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' B' ' 15' ' ' MET . 6.0 t80 -65.15 -61.3 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.92000000000000004 110.446 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.54 -29.49 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.237 -0.438 . . . . 0.93999999999999995 111.294 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.23 74.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.55000000000000004 110.978 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.58 -26.23 74.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.856 -0.688 . . . . 0.47999999999999998 112.704 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 52.3 mmm -76.81 -37.79 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.35 . . . . 0.84999999999999998 110.908 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 71.2 m -57.58 -55.4 35.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.115 -0.493 . . . . 1.3400000000000001 110.92 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' B' ' 20' ' ' LEU . 1.9 tp -58.45 -36.72 60.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 1.55 110.782 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -45.81 -58.76 5.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.735 -0.745 . . . . 0.69999999999999996 112.293 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.4 74.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.686 0.279 . . . . 0.81000000000000005 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' B' ' 17' ' ' ILE . 97.5 mt -64.58 -28.68 69.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 2.2599999999999998 110.814 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -64.63 -32.83 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 1.78 110.327 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.8 -20.49 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 4.5800000000000001 110.587 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -69.36 -43.52 73.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 3.3500000000000001 110.479 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 65.5 m -79.65 -30.38 41.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 1.5800000000000001 110.7 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.9 tp -86.48 -1.3 57.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 1.8400000000000001 110.58 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -60.86 -11.68 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 1.3700000000000001 110.903 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.595 ' HG2' HD22 ' B' ' 28' ' ' ASN . 36.7 ttm180 -47.22 -47.25 24.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.001 -0.74 . . . . 4.9800000000000004 109.001 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . 0.595 HD22 ' HG2' ' B' ' 27' ' ' ARG . 9.0 p30 -178.59 129.91 0.28 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.201 -0.909 . . . . 2.1400000000000001 110.337 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' B' ' 31' ' ' GLY . 72.9 Cg_endo -103.32 -82.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.542 2.828 . . . . 1.8200000000000001 112.121 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.538 ' HE ' HD22 ' B' ' 221' ' ' LEU . 49.6 mtp180 -112.63 6.14 18.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.794 0.806 . . . . 5.1900000000000004 109.234 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.523 ' H ' ' HD2' ' B' ' 29' ' ' PRO . . . 123.64 -53.39 0.75 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 114.267 -1.333 . . . . 2.2000000000000002 110.731 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.26 104.98 5.11 Favored Pre-proline 0 C--O 1.232 0.171 0 O-C-N 122.906 -0.173 . . . . 3.6499999999999999 110.692 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.495 ' HG3' ' HG3' ' B' ' 29' ' ' PRO . 69.6 Cg_endo -88.21 107.76 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 119.446 0.838 . . . . 2.6699999999999999 113.117 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -93.47 -58.29 2.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 123.597 1.665 . . . . 4.8799999999999999 108.894 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.556 ' HD2' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -83.4 -61.69 1.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 110.633 -2.985 . . . . 1.8700000000000001 113.823 -177.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.556 ' H ' ' HD2' ' B' ' 35' ' ' TYR . 40.6 tt0 -37.91 -63.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.467 0.914 . . . . 2.6800000000000002 113.467 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -62.34 -40.33 96.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.11 0.411 . . . . 2.9199999999999999 112.11 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -59.23 -65.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.88 0.326 . . . . 1.6399999999999999 111.88 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.58 HG13 HD12 ' B' ' 82' ' ' LEU . 60.5 t -61.93 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.413 0.523 . . . . 1.6000000000000001 112.413 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -14.09 6.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.228 0.455 . . . . 0.68999999999999995 112.228 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.403 ' O ' HG12 ' B' ' 45' ' ' ILE . 27.6 ttt -88.91 -39.65 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 2.5800000000000001 111.546 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -72.01 -42.65 66.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 3.3900000000000001 112.226 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.485 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 93.5 mt -49.62 -52.05 54.02 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.493 0.553 . . . . 0.40999999999999998 112.493 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 50.9 Cg_endo -68.79 -43.44 3.63 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.202 1.935 . . . . 0.48999999999999999 113.302 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.403 HG12 ' O ' ' B' ' 41' ' ' MET . 36.3 mm -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.78 0.324 . . . . 1.29 111.632 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -55.95 -58.3 8.48 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.227 -0.442 . . . . 1.3999999999999999 111.541 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 94.8 p -51.99 -32.9 35.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 1.3799999999999999 111.241 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.67 -57.64 18.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.37 112.48 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.86 -28.12 68.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 1.29 111.067 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.96 -59.11 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.44 111.16 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 35.1 m-85 -63.75 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.5 111.11 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 19.5 ttt -48.85 -42.74 37.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.063 0.458 . . . . 1.4099999999999999 110.456 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.54 -42.05 87.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.55000000000000004 110.616 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -51.55 -29.38 16.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.5 110.212 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.3 -47.34 57.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.54000000000000004 109.901 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -71.92 2.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.499 -0.773 . . . . 1.3 110.804 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 66.78 49.15 1.26 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.751 -0.658 . . . . 2.2400000000000002 111.008 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.01 173.93 7.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 1.77 110.79 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 78.5 21.3 69.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 1.0600000000000001 112.498 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -139.36 144.5 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.722 0.296 . . . . 2.6600000000000001 110.572 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -124.6 146.19 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 1.8899999999999999 111.155 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -101.16 84.04 2.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 2.4100000000000001 110.844 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.87 144.31 42.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 1.5600000000000001 110.925 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 16.29 4.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 111.436 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 -15.44 58.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 1.51 112.885 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -98.19 173.17 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 2.4500000000000002 110.658 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -116.93 118.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.552 . . . . 1.79 111.165 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.89 110.93 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.81999999999999995 111.253 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 57.0 m-70 -70.05 80.31 0.49 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.737 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -65.23 -31.02 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.655 -0.702 . . . . 1.8700000000000001 111.496 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.468 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -79.48 -25.99 41.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.052 0.389 . . . . 0.60999999999999999 112.052 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 22.0 mmt180 -69.6 -51.16 37.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.323 0.49 . . . . 2.3900000000000001 112.323 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 3.5 p90 -76.14 -36.06 58.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.638 -0.425 . . . . 3.6699999999999999 111.964 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 75' ' ' ASP . 16.9 tt -54.21 -43.68 61.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.728 0.299 . . . . 1.6599999999999999 110.933 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.425 ' N ' HG23 ' B' ' 74' ' ' ILE . 11.6 t70 -67.92 -25.59 65.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.235 -0.654 . . . . 1.4099999999999999 109.235 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -85.44 8.56 18.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.677 -0.692 . . . . 1.1599999999999999 110.484 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.527 ' HA ' HD13 ' B' ' 113' ' ' ILE . 45.9 tpp -105.14 -25.64 12.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.684 -0.689 . . . . 1.53 110.713 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.89 -36.75 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.26 -0.427 . . . . 0.89000000000000001 112.129 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -70.54 -57.64 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.919 0.341 . . . . 1.24 111.919 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 31.2 m -48.92 -51.78 52.2 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.535 0.568 . . . . 0.57999999999999996 112.535 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 53.0 Cg_exo -54.16 -45.79 38.34 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.5 1.467 . . . . 0.66000000000000003 111.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.58 HD12 HG13 ' B' ' 39' ' ' VAL . 3.0 mm? -63.03 -32.05 73.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.85 -0.614 . . . . 1.0600000000000001 109.853 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 -23.95 62.34 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.15 -0.685 . . . . 1.22 109.15 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' B' ' 109' ' ' GLN . 16.8 tp -84.41 -29.44 26.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.103 -0.953 . . . . 1.53 110.462 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.69 -38.98 46.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.753 -0.658 . . . . 1.5800000000000001 111.133 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . 0.417 ' HB2' HG11 ' B' ' 39' ' ' VAL . 39.8 t -56.55 -21.06 23.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 1.3899999999999999 110.921 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.86 -37.61 62.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.517 . . . . 1.1499999999999999 111.115 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.1 t -72.42 -21.69 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 1.5700000000000001 111.176 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.53 -45.49 15.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.133 -0.485 . . . . 2.1699999999999999 111.138 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -66.83 -23.26 66.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 1.4199999999999999 111.248 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.71 -36.85 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 1.1799999999999999 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 79.1 mtp -105.17 101.17 10.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 1.8799999999999999 110.946 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -73.15 -27.79 61.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.4199999999999999 110.863 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -132.14 153.49 50.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 4.0599999999999996 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.44 144.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 2.0899999999999999 111.322 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -165.16 88.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 3.8500000000000001 110.719 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt 58.19 81.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 4.8200000000000003 111.094 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.89 95.8 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 3.7999999999999998 110.859 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -129.07 0.13 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 5.1699999999999999 110.895 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 67.2 p -70.52 -43.3 69.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 2.02 111.095 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 tp -73.37 -36.03 66.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 2.0899999999999999 110.769 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 28.1 mm -60.7 -37.84 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 1.8799999999999999 110.791 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.06 -23.32 63.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.859 -0.686 . . . . 0.56000000000000005 112.357 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.79 -38.77 89.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.332 . . . . 1.78 111.072 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.3 mt -81.06 -44.24 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 1.03 111.001 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 11.0 tpt -56.4 -39.76 73.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.594 -0.73 . . . . 1.6699999999999999 111.476 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -72.03 -51.85 19.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 1.51 111.274 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 27.8 p -53.26 -32.79 50.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.919 0.39 . . . . 1.1799999999999999 111.379 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.466 ' HB2' HD22 ' B' ' 84' ' ' LEU . 6.5 tp-100 -65.81 -48.55 71.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.056 -0.52 . . . . 2.1699999999999999 111.024 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.95 -43.71 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.3500000000000001 111.619 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.2 -44.06 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 1.3400000000000001 111.334 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.89 -46.3 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.42999999999999999 111.8 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.61 HD11 ' HG3' ' B' ' 81' ' ' PRO . 44.6 mt -56.92 -37.74 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.586 -0.279 . . . . 1.6000000000000001 111.096 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.5 m -57.84 -49.66 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.95 0.405 . . . . 0.85999999999999999 110.771 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.6 m -62.89 -21.96 66.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.94999999999999996 110.31 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.66 -43.77 17.71 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.02 -0.61 . . . . 0.46000000000000002 112.497 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.473 ' HB3' ' CD2' ' B' ' 73' ' ' TYR . 3.7 pp -77.47 -24.89 50.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.636 0.255 . . . . 1.75 111.163 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.5 mm -82.34 -36.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.408 -0.36 . . . . 1.78 111.09 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.49 -46.81 76.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.38 111.435 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -70.82 -17.41 62.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.395 -0.366 . . . . 1.97 111.234 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.13 20.41 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.454 -0.339 . . . . 0.76000000000000001 111.351 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -78.05 125.04 28.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.47 110.781 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.75 -67.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 2.5 110.976 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.583 ' HB2' HG12 ' B' ' 127' ' ' VAL . 92.0 mtt180 -71.44 152.29 43.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 2.73 110.584 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.53 -16.78 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 2.2000000000000002 110.865 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -81.86 -37.01 27.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 3.3999999999999999 110.747 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.8 p -78.43 -24.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.23 110.939 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -58.05 -34.88 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 3.04 110.827 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -76.24 -21.39 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 4.1399999999999997 111.042 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.99 -60.99 2.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 1.6499999999999999 111.162 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -59.98 -27.48 66.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.398 -0.365 . . . . 0.77000000000000002 110.971 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.68 -45.75 91.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 1.46 110.284 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -65.26 -33.26 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.044 -0.525 . . . . 1.6299999999999999 110.449 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 47.5 t -62.64 -31.12 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 1.4199999999999999 110.723 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.66 -52.98 13.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.838 -0.696 . . . . 0.48999999999999999 112.479 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.38 -31.69 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 1.3 111.335 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 68.5 m -65.08 -46.07 82.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 1.3 110.775 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.93 71.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.62 110.667 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -73.13 -22.77 60.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.74 110.523 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.72 -57.82 4.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 1.76 110.703 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.441 HG13 ' N ' ' B' ' 142' ' ' ILE . 41.2 pt -60.1 -38.43 76.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.68999999999999995 111.517 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.441 ' N ' HG13 ' B' ' 141' ' ' ILE . 94.1 mt -69.81 -34.74 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 1.76 110.956 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.78 -39.59 85.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.291 -0.413 . . . . 1.0600000000000001 110.569 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . 0.681 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 89.4 t90 -62.72 -47.08 85.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.532 . . . . 4.1200000000000001 110.799 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . 1.307 ' HA2' ' ND2' ' B' ' 148' ' ' ASN . . . -63.53 -34.08 88.98 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.63 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -74.11 -24.16 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.919 0.39 . . . . 1.98 110.603 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -90.6 3.16 54.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 1.4199999999999999 110.897 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 1.307 ' ND2' ' HA2' ' B' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.913 -0.585 . . . . 99.989999999999995 112.251 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.866 0.365 . . . . 2.4300000000000002 110.759 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.425 ' O ' HG12 ' B' ' 169' ' ' VAL . 1.1 t80 -78.14 -23.68 47.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 2.5800000000000001 111.32 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.74 -59.28 4.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 2.0 110.92 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.31 -26.9 65.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 3.0299999999999998 111.327 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.16 -56.14 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.406 -0.361 . . . . 1.1000000000000001 111.104 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 165' ' ' TYR . 14.4 p -68.97 -22.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 1.75 111.488 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 41.4 m -54.28 -58.91 5.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.48 -0.327 . . . . 0.97999999999999998 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.67 -42.53 95.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 4.2999999999999998 110.501 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.77 -28.2 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.044 -0.526 . . . . 1.3899999999999999 110.789 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.416 ' O ' HG12 ' B' ' 177' ' ' ILE . 90.2 m -73.52 -50.71 20.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 1.1100000000000001 111.119 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.25 -43.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.315 -0.402 . . . . 1.51 111.93 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' B' ' 209' ' ' SER . 3.8 mm? -70.92 -53.24 15.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.955 0.354 . . . . 1.75 111.955 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -24.14 63.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.704 0.288 . . . . 0.59999999999999998 111.194 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.491 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 36.6 mm -87.57 -22.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 1.47 110.26 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -65.44 -41.93 96.13 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.726 -0.67 . . . . 0.55000000000000004 112.696 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.404 ' O ' HG22 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -56.09 -55.41 42.01 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.744 0.272 . . . . 1.6200000000000001 111.124 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.491 ' HD2' ' C ' ' B' ' 177' ' ' ILE . 78.3 Cg_exo -50.57 -38.75 55.43 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.154 1.903 . . . . 0.64000000000000001 112.243 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.497 ' O ' HG22 ' B' ' 184' ' ' ILE . 37.0 mm -54.04 -58.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 1.27 111.512 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 179' ' ' TYR . 20.9 m -69.23 -24.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.68999999999999995 111.262 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -61.75 -52.59 63.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.026 0.38 . . . . 1.1799999999999999 112.026 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 181' ' ' ILE . 21.1 tt -58.23 -17.21 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 111.998 0.37 . . . . 1.77 111.998 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 8.9 tt -121.54 104.02 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 1.6899999999999999 111.532 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.802 -0.713 . . . . 1.5800000000000001 112.501 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.769 0.318 . . . . 2.4700000000000002 111.389 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.44 -52.95 63.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.5299999999999998 110.914 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 11.4 m -66.64 -19.11 65.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 1.29 110.94 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . 0.439 ' HA ' ' SG ' ' B' ' 203' ' ' CYS . 62.2 t80 -83.51 -27.13 29.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 2.6200000000000001 111.125 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.12 -28.78 27.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.736 0.303 . . . . 1.6100000000000001 111.129 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.85 -12.0 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 1.4199999999999999 111.188 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' B' ' 200' ' ' PHE . 17.2 p -96.22 -32.41 12.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 1.4299999999999999 110.477 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.37 -39.33 59.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 1.1200000000000001 111.408 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.656 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.6 tp -57.46 -53.16 68.37 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.622 -0.263 . . . . 1.26 111.523 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 32.0 Cg_exo -58.58 -45.0 32.52 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.918 1.745 . . . . 0.59999999999999998 111.527 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.403 ' O ' HG23 ' B' ' 211' ' ' VAL . 69.8 t80 -61.72 -29.52 70.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.016 -0.538 . . . . 1.3999999999999999 110.234 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -76.83 -26.71 54.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 1.4099999999999999 110.222 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.503 ' HB2' HD12 ' B' ' 175' ' ' LEU . 45.7 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.817 -0.629 . . . . 1.3200000000000001 110.373 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.403 HG23 ' O ' ' B' ' 207' ' ' PHE . 57.3 t . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.777 0.322 . . . . 1.6899999999999999 111.258 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.18 -35.94 86.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.846 -0.693 . . . . 0.79000000000000004 112.785 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.86 -29.17 64.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.301 . . . . 2.96 110.983 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.86 -60.77 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.29 110.918 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 3.1499999999999999 110.98 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -38.45 89.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.51 110.963 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.58 -30.77 69.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 2.1899999999999999 110.831 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.92 -58.69 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 1.98 111.018 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -66.35 -20.49 66.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 2.1699999999999999 111.036 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.15 -57.65 18.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.8 -0.714 . . . . 1.3600000000000001 112.962 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . 0.538 HD22 ' HE ' ' B' ' 30' ' ' ARG . 23.3 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.581 0.229 . . . . 2.8999999999999999 111.27 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.602 0.239 . . . . 2.52 111.432 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . 0.449 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.1 mm? -69.37 -42.1 75.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 1.9299999999999999 110.684 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.608 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 42.4 m80 -72.22 -27.47 62.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 1.26 110.806 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -70.4 -43.87 69.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.521 . . . . 1.6699999999999999 110.928 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.74 -21.47 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 1.8700000000000001 110.661 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -64.41 -53.31 50.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 1.4399999999999999 110.704 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.26 -34.12 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.46999999999999997 111.216 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.66 96.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.58999999999999997 111.224 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.91 76.52 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.5 112.589 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.7 mmt -74.77 -36.86 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.56 0.219 . . . . 0.68000000000000005 111.477 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 71.7 p -64.35 -52.27 59.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 1.3999999999999999 110.828 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.3 -22.55 31.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 1.55 110.873 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.98 -55.64 27.03 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.783 -0.723 . . . . 0.70999999999999996 112.372 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -34.72 72.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.74 0.305 . . . . 0.77000000000000002 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 26.6 tp -62.43 -35.14 78.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.167 -0.47 . . . . 1.9299999999999999 110.771 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -57.16 -28.96 63.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 1.8600000000000001 110.817 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -74.17 -37.5 63.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.01 -0.541 . . . . 4.1399999999999997 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -56.3 -32.64 64.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 3.1499999999999999 110.689 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -81.07 -32.27 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 1.95 111.313 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -86.42 -1.26 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.532 -0.303 . . . . 2.2200000000000002 111.531 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 92.8 p -62.84 -20.12 64.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.487 -0.324 . . . . 1.3700000000000001 111.15 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -48.71 -33.22 9.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.329 0.585 . . . . 5.0300000000000002 109.687 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ASN . . . . . 0.502 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.2 p-10 -174.99 131.77 0.45 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.08 -0.964 . . . . 2.3700000000000001 109.884 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 9.6 Cg_endo . . . . . 0 N--CA 1.455 -0.757 0 C-N-CA 123.012 2.475 . . . . 2.0499999999999998 112.373 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' C' ' 35' ' ' TYR . 31.8 Cg_exo . . . . . 0 N--CA 1.464 -0.206 0 CA-C-O 121.164 0.402 . . . . 1.9299999999999999 112.45 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -41.27 -16.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.99 -1.005 . . . . 4.1200000000000001 113.661 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' C' ' 33' ' ' PRO . 3.2 m-30 -39.75 -62.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.924 0.392 . . . . 2.8900000000000001 111.539 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.08 -40.67 77.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 2.46 111.449 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -72.02 -18.57 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 2.7799999999999998 111.715 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.37 -45.69 68.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.915 0.388 . . . . 1.6200000000000001 110.146 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.605 HG13 HD12 ' C' ' 82' ' ' LEU . 58.2 t -75.19 -33.25 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 1.5900000000000001 110.788 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.38 -15.08 61.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.65000000000000002 111.511 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.407 ' O ' HG12 ' C' ' 45' ' ' ILE . 51.9 ttp -89.57 -37.84 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.45 -0.341 . . . . 1.6699999999999999 111.623 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -72.61 -37.99 67.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 3.4199999999999999 112.064 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.505 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -53.71 -52.5 66.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 112.215 0.45 . . . . 0.89000000000000001 112.215 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 40.7 Cg_endo -67.55 -42.19 7.47 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.213 1.942 . . . . 0.40999999999999998 113.1 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.407 HG12 ' O ' ' C' ' 41' ' ' MET . 37.4 mm -55.88 -62.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.6 0.238 . . . . 1.76 111.518 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -57.32 -58.19 9.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.396 -0.365 . . . . 2.1600000000000001 111.29 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 56.7 m -53.26 -26.76 19.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 1.1699999999999999 111.493 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.81 -61.46 6.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.688 -0.768 . . . . 0.44 112.47 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.91 -25.29 63.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.683 0.278 . . . . 1.29 111.298 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -59.26 4.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.944 0.402 . . . . 0.5 111.027 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.503 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 25.7 m-85 -62.52 -41.54 98.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 1.8300000000000001 111.092 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 55.0 ttp -47.93 -39.09 18.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.087 0.47 . . . . 1.47 110.104 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.66 88.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.763 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.1 mtt -52.45 -30.98 32.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 0.83999999999999997 110.138 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.29 -38.43 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.874 -0.603 . . . . 0.65000000000000002 110.238 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mt -77.53 0.34 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.755 -0.657 . . . . 1.55 110.657 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 68.33 42.28 1.69 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.795 -0.638 . . . . 1.54 111.155 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.48 ' HB3' ' HE1' ' A' ' 131' ' ' TRP . 27.6 mm-40 -118.25 173.51 6.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.819 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.46 16.76 67.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 0.93999999999999995 112.371 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' C' ' 69' ' ' HIS . 36.6 mtmm -136.41 150.9 48.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 2.3599999999999999 110.783 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.29 143.44 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.97 111.082 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.26 89.63 6.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 2.4399999999999999 110.989 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.48 139.68 51.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 1.54 111.038 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.75 15.33 4.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.07 -0.514 . . . . 1.71 111.453 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.13 66.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.795 -0.717 . . . . 1.53 112.691 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -105.44 150.69 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 2.23 111.174 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 11.4 pt -97.12 125.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.545 . . . . 1.3600000000000001 111.074 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.69 123.87 48.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.78000000000000003 110.882 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.573 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 31.9 m-70 -81.07 76.44 8.02 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.35 0.595 . . . . 1.0800000000000001 111.052 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . 0.433 ' HD2' ' HH ' ' C' ' 73' ' ' TYR . 83.8 t80 -57.41 -36.44 71.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.376 -0.829 . . . . 2.2999999999999998 111.544 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.37 -26.3 55.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.214 0.449 . . . . 0.75 112.214 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.9 tpp180 -64.19 -51.56 63.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.531 0.567 . . . . 1.51 112.531 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.537 ' O ' ' HG3' ' C' ' 77' ' ' MET . 24.2 p90 -86.44 -26.45 24.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.515 0.561 . . . . 4.6500000000000004 112.515 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.0 tp -56.86 -41.58 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.375 -0.53 . . . . 1.22 110.272 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.52 -16.7 62.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.266 -0.642 . . . . 1.3100000000000001 109.266 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . 0.437 ' O ' HD12 ' C' ' 113' ' ' ILE . 45.8 m0 -88.54 2.77 52.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.315 -0.857 . . . . 1.6799999999999999 111.439 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 39.3 mtp -105.09 -20.51 13.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.168 -0.469 . . . . 1.8 111.245 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.463 ' O ' HD23 ' C' ' 82' ' ' LEU . 14.5 m -113.77 -39.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.3 0.482 . . . . 1.1899999999999999 112.3 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.505 HG23 HG23 ' C' ' 43' ' ' ILE . 57.0 m -70.34 -49.17 52.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.046 0.387 . . . . 1.23 112.046 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 21.5 m -56.52 -52.08 76.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 0.58999999999999997 112.614 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 80' ' ' THR . 11.7 Cg_endo -55.78 -37.53 95.53 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.53 1.487 . . . . 0.67000000000000004 111.736 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.605 HD12 HG13 ' C' ' 39' ' ' VAL . 3.9 mm? -70.33 -32.21 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.95999999999999996 109.746 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -23.28 63.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.488 0.661 . . . . 1.1899999999999999 109.23 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 tp -84.46 -36.51 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.984 -1.007 . . . . 1.7 110.414 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.83 -34.37 73.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.6200000000000001 110.94 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -62.41 -18.52 61.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 1.26 111.081 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 24.0 mt -78.93 -31.88 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 1.1100000000000001 111.027 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -73.63 -32.23 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 1.51 111.076 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -75.1 -42.04 57.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 2.0600000000000001 111.438 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -69.17 -22.44 63.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 1.52 111.001 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.05 -13.87 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 1.3 111.213 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.3 ttm -128.71 100.94 5.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 1.6200000000000001 110.742 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -68.4 -54.47 16.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 3.2400000000000002 111.053 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -112.52 149.85 32.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 4.6299999999999999 111.179 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.86 145.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.163 -0.471 . . . . 2.1800000000000002 110.723 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.8 -71.46 0.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.303 -0.408 . . . . 4.1200000000000001 111.432 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -140.47 29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.501 -0.318 . . . . 4.96 111.591 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -86.92 138.94 31.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.431 -0.35 . . . . 3.9100000000000001 110.876 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -165.84 -22.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 5.21 110.686 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -70.46 -35.09 73.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 1.8200000000000001 111.591 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.59 -42.46 42.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 2.0800000000000001 110.949 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.91 -31.21 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 1.8600000000000001 110.711 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.62 -29.04 45.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.84 -0.695 . . . . 0.58999999999999997 112.346 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -65.76 -35.36 80.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 1.53 110.83 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 75.1 mt -79.53 -44.98 20.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.994 -0.548 . . . . 1.1100000000000001 111.107 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 10.7 tpt -59.62 -35.91 75.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 2.21 111.328 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.7 m -71.81 -58.3 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 1.28 111.283 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 57.6 p -52.41 -31.02 32.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 1.22 111.163 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.481 ' O ' HG12 ' C' ' 113' ' ' ILE . 6.5 tp-100 -62.48 -54.13 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 2.3300000000000001 110.556 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -46.78 -39.94 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 115.93 -0.577 . . . . 1.29 111.316 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.78 -46.92 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.0600000000000001 110.855 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.59 -32.33 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.51000000000000001 111.156 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.481 HG12 ' O ' ' C' ' 109' ' ' GLN . 44.8 mm -59.23 -41.3 83.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 1.3700000000000001 110.671 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 93.9 m -62.26 -54.63 38.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.833 -0.621 . . . . 0.77000000000000002 111.296 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -54.82 -24.26 22.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 110.899 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.87 -46.9 12.64 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.811 -0.709 . . . . 0.5 112.673 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' C' ' 114' ' ' THR . 4.3 pp -76.79 -21.24 55.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.716 0.293 . . . . 1.47 111.011 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 38.2 mm -83.37 -36.92 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 1.2 111.205 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.95 -32.55 61.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.40000000000000002 111.327 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.39 -23.66 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 2.1200000000000001 110.977 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.14 34.14 0.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 0.75 111.254 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 71.2 m -91.86 119.05 31.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 1.3799999999999999 110.776 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.22 -58.29 2.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 2.7400000000000002 111.137 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' ARG . . . . . 0.483 ' HB2' HG12 ' C' ' 127' ' ' VAL . 45.4 mtm180 -89.48 157.61 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 2.7999999999999998 110.965 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -84.54 -15.88 44.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.885 -0.598 . . . . 2.4100000000000001 110.88 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 37.6 t-105 -78.74 -38.75 38.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 4.2000000000000002 110.66 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' C' ' 124' ' ' ARG . 7.4 p -80.83 -28.78 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 1.0800000000000001 111.241 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -56.13 -34.61 66.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 2.5699999999999998 111.281 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -73.68 -25.61 60.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 3.8100000000000001 111.019 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.22 -46.1 24.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 1.4199999999999999 110.968 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -64.65 -37.4 87.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.89000000000000001 111.178 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -55.4 -46.67 76.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 1.26 110.906 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.3 -35.08 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 1.6799999999999999 110.865 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.53 -31.27 72.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.842 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -54.02 13.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.736 -0.745 . . . . 0.54000000000000004 112.635 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.45 -37.96 76.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 1.0600000000000001 111.257 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -52.79 -52.44 56.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 1.0800000000000001 110.626 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.9 -30.81 71.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.56999999999999995 110.891 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.58 -24.53 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 1.6799999999999999 110.932 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.76 -52.91 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 1.7 111.491 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.439 HG13 ' N ' ' C' ' 142' ' ' ILE . 24.6 pt -60.31 -43.99 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.528 -0.305 . . . . 0.78000000000000003 111.763 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.439 ' N ' HG13 ' C' ' 141' ' ' ILE . 43.4 pt -67.4 -29.84 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 2.2400000000000002 110.957 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.12 -38.31 85.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.02 111.018 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . 0.541 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 91.8 m95 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 3.0 110.835 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . 1.311 ' HA2' ' ND2' ' C' ' 148' ' ' ASN . . . -61.07 -44.52 98.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.899 -0.667 . . . . 1.27 112.532 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.22 -24.08 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.8899999999999999 110.758 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -88.8 4.74 46.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.6000000000000001 111.134 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . 1.311 ' ND2' ' HA2' ' C' ' 145' ' ' GLY . 69.1 m-80 . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.48 . . . . 99.989999999999995 112.116 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.7 tp . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.937 0.399 . . . . 2.3500000000000001 110.704 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -81.38 -25.63 36.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 2.6200000000000001 111.045 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.01 -55.24 31.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 2.0899999999999999 111.162 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -72.07 -32.75 67.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 3.2400000000000002 111.339 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.25 -50.79 72.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 1.6899999999999999 111.276 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.06 -29.93 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 1.3999999999999999 111.264 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -53.29 -58.74 6.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.95999999999999996 111.315 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -63.29 -36.15 82.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 3.6499999999999999 110.701 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.6 -22.59 66.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 1.3700000000000001 110.761 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 25.9 m -73.48 -59.0 2.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 1.4299999999999999 111.358 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.6 p -52.39 -30.82 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.394 -0.366 . . . . 1.6200000000000001 111.642 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.405 HD13 ' OG ' ' C' ' 209' ' ' SER . 94.7 mt -72.38 -57.78 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 2.0299999999999998 111.071 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -19.79 65.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.62 111.04 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.49 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 32.6 mm -87.66 -25.4 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.114 0.483 . . . . 1.5800000000000001 110.36 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . 0.48 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -65.76 -40.54 95.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.56000000000000005 112.505 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.465 ' O ' HG22 ' C' ' 182' ' ' VAL . 0.3 OUTLIER -55.7 -55.72 37.63 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.592 0.196 . . . . 1.3300000000000001 111.356 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' C' ' 177' ' ' ILE . 67.2 Cg_exo -50.38 -41.06 52.74 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.074 1.849 . . . . 0.63 112.163 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.48 HD12 ' HA2' ' C' ' 178' ' ' GLY . 82.1 mt -49.69 -61.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.137 -0.483 . . . . 0.93000000000000005 111.493 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.465 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.2 m -63.92 -28.15 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 1.27 111.446 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -65.36 -27.83 68.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 1.77 111.053 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 180' ' ' PRO . 89.2 mt -55.15 -32.93 28.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 2.3900000000000001 111.209 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.3 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 1.95 111.132 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.843 0.354 . . . . 2.3799999999999999 111.302 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 12.4 tt -57.89 -42.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 2.23 111.743 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.4 -53.75 54.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.702 0.287 . . . . 2.1600000000000001 111.401 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 59.4 p -58.81 -21.55 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 1.27 111.613 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -73.35 -39.29 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 1.7 111.489 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.89 -51.56 46.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.695 0.283 . . . . 2.02 111.414 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -67.59 -8.15 32.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.531 -0.304 . . . . 1.8200000000000001 111.313 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 10.9 t -95.86 -41.98 8.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.151 0.5 . . . . 1.3500000000000001 110.666 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.7 tp -74.19 -31.99 62.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.65000000000000002 111.904 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.645 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 54.9 tp -61.0 -54.22 56.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.891 -0.324 . . . . 1.4199999999999999 111.624 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 33.7 Cg_exo -59.45 -39.64 74.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.795 1.663 . . . . 0.63 111.189 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.68 -28.72 70.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 1.49 110.464 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -84.45 -19.49 33.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.949 -0.568 . . . . 1.7 110.82 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . 0.405 ' OG ' HD13 ' C' ' 175' ' ' LEU . 40.6 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.995 -0.548 . . . . 1.25 110.898 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.981 0.419 . . . . 1.6100000000000001 110.891 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.12 -29.52 72.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.998 -0.62 . . . . 0.81999999999999995 112.535 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -72.6 -36.87 68.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 3.0800000000000001 110.817 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.0 t -59.16 -54.66 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 1.1499999999999999 110.89 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.14 -20.42 65.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.314 -0.403 . . . . 2.5600000000000001 110.856 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -72.08 -47.1 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 1.29 110.695 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.21 -21.01 64.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 2.3900000000000001 110.573 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 64.2 tp -74.14 -54.31 8.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.887 -0.597 . . . . 2.0299999999999998 111.266 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -79.41 -20.29 47.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 3.21 111.234 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.88 12.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.737 -0.744 . . . . 1.3600000000000001 112.585 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . 0.44 HD22 ' N ' ' C' ' 221' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 2.8999999999999999 110.435 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.756 0.312 . . . . 5.1100000000000003 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.93 -35.21 22.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 5.04 110.712 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.14 100.51 5.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 5.5800000000000001 110.851 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -123.29 145.94 48.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 5.0199999999999996 110.905 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.0 t -130.8 159.47 37.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 2.4500000000000002 110.914 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.5 pt? -137.62 2.12 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 2.4199999999999999 111.012 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.3 mm? -76.47 -51.91 10.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 2.0899999999999999 110.602 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -70.95 -24.34 62.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 110.478 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.0 t-105 -64.9 -53.07 52.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.79000000000000004 110.685 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.1 mt -66.33 -22.55 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 2.0800000000000001 110.267 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.404 ' HE2' ' HG ' ' A' ' 203' ' ' CYS . 0.1 OUTLIER -57.22 -55.32 36.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 1.28 110.756 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 52' ' ' MET . 10.0 p -66.87 -30.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 1.3200000000000001 111.274 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.43 80.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.63 111.229 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.4 76.36 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.853 -0.689 . . . . 0.55000000000000004 112.626 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.469 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -74.53 -41.75 60.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.734 0.302 . . . . 1.03 111.497 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -61.83 -48.19 81.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.3 111.187 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -67.03 -22.59 29.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 1.3100000000000001 110.964 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.49 -58.62 12.36 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.872 -0.68 . . . . 0.77000000000000002 112.492 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.21 73.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.072 0.463 . . . . 0.80000000000000004 110.931 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.4 tp -64.48 -33.93 77.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.956 -0.566 . . . . 1.8100000000000001 110.62 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.61 -28.08 66.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.948 -0.569 . . . . 1.8799999999999999 110.42 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -78.2 -29.31 48.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 4.4500000000000002 110.671 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -63.84 -36.06 82.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.524 . . . . 3.6899999999999999 110.818 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -84.68 -42.31 15.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 1.5700000000000001 110.906 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.8 tp -73.22 -3.4 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.89 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 p -64.38 -24.77 67.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.528 -0.306 . . . . 1.3799999999999999 111.334 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -51.09 -31.95 20.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.128 0.489 . . . . 4.0700000000000003 109.784 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p30 -167.88 132.45 1.5 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.454 -0.793 . . . . 2.7200000000000002 110.147 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 28.3 Cg_endo -94.78 173.71 1.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.05 2.5 . . . . 1.9099999999999999 112.277 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.11 56.4 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 4.7599999999999998 111.082 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.75 -45.87 3.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 1.99 112.747 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 p -79.3 127.07 80.09 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 120.539 0.209 . . . . 2.7000000000000002 110.942 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 31.7 Cg_exo -57.74 165.18 6.67 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.412 2.075 . . . . 1.79 112.374 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -61.59 -18.21 58.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.747 -0.66 . . . . 4.1200000000000001 112.579 -178.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.446 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 4.8 p90 -47.97 -42.23 27.15 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.688 0.28 . . . . 2.9300000000000002 111.652 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -68.04 -46.56 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.356 . . . . 2.8799999999999999 110.886 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.12 -23.03 66.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.077 -0.51 . . . . 4.6600000000000001 110.833 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.99 -61.23 2.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.176 -0.465 . . . . 1.45 110.659 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.67 -33.1 58.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 1.78 110.224 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.31 -4.78 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 0.63 111.105 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.534 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 28.4 ttt -89.38 -39.94 13.08 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.055 0.455 . . . . 1.48 111.018 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -73.09 -39.33 65.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 3.5 111.883 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 91.4 mt -50.69 -51.59 64.32 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.241 0.46 . . . . 1.0800000000000001 112.241 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 16.6 Cg_exo -68.65 -41.45 6.04 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.494 2.129 . . . . 0.53000000000000003 113.275 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 41' ' ' MET . 36.3 mm -55.06 -63.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.207 0.447 . . . . 1.6799999999999999 112.207 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.53 -58.39 7.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 1.8300000000000001 111.484 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 90.4 p -52.28 -35.97 51.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 1.0900000000000001 111.244 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.65 -56.74 16.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.885 -0.674 . . . . 0.40999999999999998 112.661 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.56 -35.48 68.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.98999999999999999 110.893 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.8 79.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.47999999999999998 111.397 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -66.01 -59.68 3.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.447 -0.342 . . . . 1.8700000000000001 111.564 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.619 ' HB3' HG11 ' A' ' 12' ' ' VAL . 24.0 ptm -49.01 -31.08 6.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.01 0.433 . . . . 1.49 110.6 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.84 91.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.58999999999999997 110.831 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.9 mtt -56.36 -31.39 63.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.073 -0.512 . . . . 0.48999999999999999 110.505 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.86 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.59999999999999998 110.526 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.49 HD13 HD23 ' B' ' 130' ' ' LEU . 41.4 pt -78.5 3.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 1.3100000000000001 110.963 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.48 30.14 19.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 1.9099999999999999 111.46 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.622 HE22 ' H ' ' B' ' 123' ' ' GLU . 6.4 tp-100 -92.23 142.27 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 1.6200000000000001 110.767 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.34 17.22 27.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 1.04 112.346 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -127.23 139.67 52.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 2.6800000000000002 110.819 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.85 141.0 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 1.98 110.727 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.87 95.1 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 2.1800000000000002 111.25 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.1 115.81 27.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 1.5700000000000001 110.79 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 30.52 19.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 1.79 111.121 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.33 -2.01 83.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.742 -0.742 . . . . 1.48 112.847 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -105.82 128.95 54.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 2.3199999999999998 110.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 67' ' ' ILE . 4.8 mp -79.38 127.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 1.4399999999999999 111.007 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 139.89 34.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.81999999999999995 111.069 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 56.5 m-70 -81.29 64.94 6.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.213 0.53 . . . . 0.90000000000000002 110.758 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.89 -50.84 67.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.753 . . . . 1.8300000000000001 111.443 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -25.31 67.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.263 -0.426 . . . . 0.62 111.844 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 34.8 mmt180 -67.52 -52.48 38.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.713 0.635 . . . . 2.3399999999999999 112.713 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.506 ' O ' ' HG3' ' A' ' 77' ' ' MET . 6.3 p90 -75.93 -36.17 59.48 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.27 0.47 . . . . 3.4900000000000002 112.27 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.0 tt -52.93 -46.54 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.775 -0.37 . . . . 1.3700000000000001 110.902 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.6 t70 -67.45 -22.03 65.52 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.606 -0.516 . . . . 1.3100000000000001 109.606 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -87.87 5.55 39.84 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.527 -0.76 . . . . 1.48 111.522 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 34.4 mtp -104.55 -19.15 14.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 1.46 110.516 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 1.4 p -114.64 -43.8 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 1.1200000000000001 111.972 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.58 HG23 HG23 ' A' ' 43' ' ' ILE . 66.8 m -66.31 -56.09 12.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.409 . . . . 1.1000000000000001 111.961 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 67.9 m -50.77 -53.93 41.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.569 0.581 . . . . 0.59999999999999998 112.569 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 80' ' ' THR . 13.2 Cg_endo -56.28 -38.84 94.39 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.633 1.555 . . . . 0.73999999999999999 111.195 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.42 -30.48 70.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.942 -0.572 . . . . 1.01 109.761 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.64 HD22 ' H43' ' A' ' 210' ' ' LYR . 12.1 tp -71.79 -21.79 61.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.275 -0.639 . . . . 1.48 109.275 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.445 HD22 HE21 ' A' ' 109' ' ' GLN . 20.0 tp -84.58 -31.38 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.034 -0.985 . . . . 1.3799999999999999 110.292 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.52 -32.97 64.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.757 -0.656 . . . . 1.1899999999999999 111.032 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.1 p -58.17 -29.02 65.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.234 -0.439 . . . . 1.23 110.758 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.987 -0.551 . . . . 0.88 110.718 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -60.91 -41.86 96.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.951 -0.568 . . . . 1.3899999999999999 110.955 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.84 -29.75 63.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 2.3199999999999998 111.146 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.5 m -59.7 -43.39 94.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.46 111.351 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.92 -36.82 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 1.24 111.435 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 82.0 mtp -88.48 98.87 11.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.396 . . . . 2.0699999999999998 111.124 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -82.62 -5.05 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 3.5299999999999998 110.585 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -163.79 157.29 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.843 -0.617 . . . . 4.0800000000000001 110.705 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.5 tp -128.99 142.15 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 2.1699999999999999 110.98 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.53 -30.74 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 4.5199999999999996 110.941 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.48 138.33 39.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 3.75 111.151 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -61.6 115.81 4.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 3.5299999999999998 110.869 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.95 149.45 21.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.475 . . . . 4.9100000000000001 111.1 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.2 p -94.82 -20.94 19.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 1.98 110.985 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.0 tp -54.56 -40.73 69.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 1.8300000000000001 111.155 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.85 -38.19 78.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.463 -0.335 . . . . 1.79 111.052 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.63 -28.05 73.23 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 0.62 112.127 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -72.13 -37.07 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.921 0.391 . . . . 1.5800000000000001 110.951 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.16 -36.63 61.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.048 -0.524 . . . . 0.97999999999999998 111.496 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 81.0 mtp -68.31 -47.61 67.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.463 -0.335 . . . . 1.48 111.449 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.8 p -60.89 -53.64 54.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 1.1299999999999999 111.45 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -56.66 -31.88 64.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 1.48 111.498 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.445 HE21 HD22 ' A' ' 84' ' ' LEU . 6.5 tp-100 -66.64 -40.18 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 2.7000000000000002 110.992 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.16 -35.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 1.54 111.096 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -67.93 -36.96 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 1.28 111.359 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.78 -51.1 48.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.42999999999999999 111.484 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.3 pt -59.96 -24.04 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 1.74 110.822 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 17.6 m -67.44 -43.16 81.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.63 110.465 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -68.15 -21.03 64.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.872 -0.604 . . . . 1.0900000000000001 110.461 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' H181 ' A' ' 210' ' ' LYR . . . -81.68 -34.03 26.07 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.043 -0.599 . . . . 0.41999999999999998 113.313 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 118' ' ' ILE . 4.1 pp -79.1 -26.89 42.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 1.3799999999999999 111.288 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.5 tp -83.93 -29.51 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 1.6200000000000001 111.711 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.08 75.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.39000000000000001 111.423 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.65 -19.3 52.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 2.02 111.066 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -90.5 28.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.42 . . . . 0.76000000000000001 111.25 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -61.66 126.28 26.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 1.46 110.907 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.62 -29.7 23.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.305 -0.407 . . . . 3.3500000000000001 111.075 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.41 ' H ' ' CG2' ' A' ' 127' ' ' VAL . 79.0 mtm180 -137.29 167.1 22.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 2.9199999999999999 110.716 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.94 -13.98 59.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 2.77 110.793 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -90.43 -42.18 11.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 3.77 110.835 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.41 ' CG2' ' H ' ' A' ' 124' ' ' ARG . 18.7 m -65.34 -31.01 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.24 -0.436 . . . . 1.1599999999999999 111.261 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -65.35 -23.68 67.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 2.04 110.97 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -78.59 -25.65 45.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 2.6400000000000001 111.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.46 -52.66 7.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 1.8999999999999999 111.323 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -60.18 -33.49 72.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.3999999999999999 111.708 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HE2' ' HB3' ' A' ' 183' ' ' TRP . 71.8 t80 -59.13 -48.51 81.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 1.28 110.926 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.1 mt -63.6 -32.46 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 2.1600000000000001 111.199 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 70.9 m -67.75 -34.64 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.364 . . . . 1.6899999999999999 111.043 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.79 -52.16 44.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.749 . . . . 0.52000000000000002 112.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -64.87 -42.24 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.597 0.237 . . . . 1.02 111.381 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.483 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.9 t -55.41 -40.57 71.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 1.0800000000000001 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.86 98.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.62 110.731 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -63.51 -28.32 69.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 1.8400000000000001 111.134 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 137' ' ' CYS . 93.9 mt -63.21 -60.79 2.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 1.6899999999999999 111.221 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.6 -31.83 44.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.302 -0.408 . . . . 0.81000000000000005 111.34 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.4 mt -75.06 -29.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 2.3700000000000001 111.16 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.9 tp -71.68 -44.08 64.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.97999999999999998 110.811 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.538 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 16.5 t90 -67.38 -27.84 67.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 3.27 110.997 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 1.22 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -83.56 -43.16 7.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.795 -0.717 . . . . 1.25 112.627 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 tt -67.61 -16.54 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.063 0.458 . . . . 2.1200000000000001 110.67 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -91.8 3.62 54.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 110.646 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 1.22 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 -82.94 -46.96 0.85 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.84 -0.618 . . . . 99.989999999999995 111.844 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 74.9 Cg_exo -41.51 -30.67 0.96 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.531 2.154 . . . . 2.6000000000000001 112.644 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 150' ' ' LEU . 3.6 mm? -85.91 51.1 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 4.6100000000000003 110.405 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -53.74 142.77 22.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.848 -0.615 . . . . 8.3599999999999994 111.287 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.38 -19.76 57.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 2.75 110.97 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -84.74 -29.35 25.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.16 -0.473 . . . . 5.6799999999999997 110.835 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.0 m -76.63 -7.58 55.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 3.21 111.011 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -61.83 -19.83 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 6.8700000000000001 110.789 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 81.8 p -79.54 -23.85 42.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 4.5599999999999996 111.07 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -64.79 -62.18 1.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 3.5600000000000001 110.867 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.5 t -153.46 113.36 3.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 2.79 110.853 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.7 m -78.01 -23.54 48.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 2.5899999999999999 111.045 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -64.42 -57.91 7.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 3.4700000000000002 110.936 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.74 -25.56 67.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 2.5800000000000001 111.067 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.7 -39.16 70.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 1.78 111.319 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -67.51 -40.93 85.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 2.6299999999999999 110.993 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.6 mt -60.72 -48.62 80.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.153 -0.476 . . . . 2.3399999999999999 110.95 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.41 -24.86 63.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.872 -0.604 . . . . 2.77 111.397 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.43 -24.64 53.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 2.04 111.215 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -84.37 -39.03 19.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 2.77 111.576 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 169' ' ' VAL . 2.9 pp -77.42 -26.43 51.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.512 -0.313 . . . . 1.8899999999999999 111.841 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.499 ' N ' HD12 ' A' ' 168' ' ' LEU . 13.4 p -74.9 -26.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.936 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.6 m -65.43 -58.61 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 1.24 111.387 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.16 -31.39 72.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 2.9700000000000002 110.725 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -59.71 -48.86 79.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 1.48 111.06 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 177' ' ' ILE . 41.3 p -62.05 -37.87 86.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 1.55 111.588 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.81 -38.4 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.756 0.313 . . . . 1.52 111.503 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.528 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.0 mt -74.57 -55.1 6.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 1.8500000000000001 111.395 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.48 -31.35 55.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.62 111.634 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 173' ' ' THR . 17.6 tt -87.66 -22.41 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.985 0.422 . . . . 1.3500000000000001 110.69 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.65 -51.29 59.78 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 113.391 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 84.6 m-85 -58.17 -54.86 51.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 116.802 0.301 . . . . 1.45 111.737 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 76.6 Cg_exo -48.72 -30.33 16.55 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.112 1.875 . . . . 0.55000000000000004 112.934 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 177' ' ' ILE . 94.3 mt -70.04 -57.46 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 1.4199999999999999 111.788 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.5 m -59.14 -25.72 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.187 -0.461 . . . . 0.78000000000000003 111.703 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.504 ' HB3' ' HE2' ' A' ' 132' ' ' TYR . 24.4 m95 -65.09 -25.95 68.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.505 -0.316 . . . . 0.93999999999999995 111.091 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -53.03 -26.13 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 1.4299999999999999 110.946 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.7 pt -128.88 162.71 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 2.02 110.892 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.34 -167.89 29.22 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.717 -0.754 . . . . 1.79 112.426 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.56 156.81 49.39 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.53 2.154 . . . . 3.1000000000000001 112.108 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.7 t 54.89 22.36 4.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 2.7400000000000002 110.786 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -168.49 47.72 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.812 -0.708 . . . . 3.4300000000000002 112.482 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 78.7 t80 58.25 93.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 6.5 111.006 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 155.37 104.56 0.23 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.842 -0.694 . . . . 3.29 112.412 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -94.33 86.24 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 6.1600000000000001 110.93 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 pt -131.87 176.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 2.4199999999999999 111.005 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.421 ' OD1' HG22 ' A' ' 197' ' ' ILE . 14.1 p30 -58.19 148.39 27.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 4.29 110.839 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -86.8 2.11 50.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 5.1500000000000004 110.947 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.9 m -72.96 -52.77 13.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 2.4500000000000002 111.005 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.421 HG22 ' OD1' ' A' ' 194' ' ' ASN . 10.2 tp -69.12 -30.0 44.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.26 -0.427 . . . . 2.48 110.926 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.4 -56.73 12.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 2.1800000000000002 110.572 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 75.6 p -62.67 -18.83 63.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 1.49 110.891 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -83.48 -30.66 27.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 1.77 110.911 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.9 tp -80.84 -45.55 16.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.314 -0.403 . . . . 1.4199999999999999 111.272 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -74.55 -0.7 18.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 1.78 111.15 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.404 ' HG ' ' HE2' ' A' ' 11' ' ' TYR . 37.8 t -96.35 -47.47 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.433 0.635 . . . . 1.3 110.31 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.16 -28.57 64.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.225 -0.898 . . . . 0.66000000000000003 112.138 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.718 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 37.5 tp -67.2 -55.35 15.92 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.748 -0.381 . . . . 1.6299999999999999 111.408 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.9 Cg_exo -54.86 -37.73 92.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.622 1.548 . . . . 0.64000000000000001 111.207 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 211' ' ' VAL . 74.4 t80 -63.98 -45.76 87.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.076 -0.511 . . . . 1.3600000000000001 110.04 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -63.55 -17.79 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 1.54 110.554 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.528 ' OG ' HD13 ' A' ' 175' ' ' LEU . 16.1 t -96.28 -33.27 12.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 1.2 111.045 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.734 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 207' ' ' PHE . 18.3 m -63.69 -33.44 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.463 -0.335 . . . . 1.6399999999999999 111.494 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.41 80.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.757 -0.735 . . . . 0.79000000000000004 112.685 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -75.58 -33.18 60.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.6100000000000001 111.223 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.3 m -60.99 -60.69 3.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.429 -0.351 . . . . 1.1499999999999999 110.996 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.04 -26.9 67.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 3.3399999999999999 110.951 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.94 -55.45 33.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.374 -0.375 . . . . 1.1899999999999999 111.392 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.19 -34.31 71.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 2.23 111.285 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.32 -52.23 62.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 2.4700000000000002 111.264 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -83.6 -20.72 33.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.336 -0.393 . . . . 1.6200000000000001 111.123 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.17 -59.15 10.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.887 -0.673 . . . . 1.4099999999999999 112.885 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 52.6 tp -76.07 -58.44 3.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.596 0.236 . . . . 2.5800000000000001 111.049 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 52.9 75.17 0.25 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.962 0.41 . . . . 4.9299999999999997 110.526 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.596 HD21 ' HB3' ' A' ' 225' ' ' ASN . 53.1 t30 -128.6 149.56 50.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 4.6299999999999999 110.925 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 224' ' ' LEU . 7.0 mp -112.6 -1.08 14.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 6.4699999999999998 110.922 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.596 ' HB3' HD21 ' A' ' 223' ' ' ASN . 29.5 t30 -87.19 115.94 24.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 5.0700000000000003 110.94 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -102.9 154.62 19.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 6.5300000000000002 110.725 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 48.7 m -149.14 107.49 3.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 5.2199999999999998 111.112 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -74.33 170.91 14.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.207 -0.451 . . . . 8.3599999999999994 110.992 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 7.96 110.914 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.675 0.274 . . . . 6.1699999999999999 111.0 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -109.02 6.92 25.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 4.8200000000000003 110.889 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.14 42.07 0.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 5.5999999999999996 111.029 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -79.39 151.81 30.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 4.7999999999999998 111.027 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -139.77 153.8 47.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 2.3700000000000001 110.923 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.91 -1.12 5.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 2.0699999999999998 111.226 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -72.81 -53.61 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 2.1000000000000001 110.782 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 77.3 m-70 -65.63 -24.26 67.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.152 -0.476 . . . . 1.0700000000000001 110.782 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -67.18 -50.29 61.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.48 110.836 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.7 -20.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.028 0.442 . . . . 2.02 110.331 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -61.82 -56.01 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.908 -0.587 . . . . 0.92000000000000004 110.594 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -66.26 -28.45 43.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.075 -0.511 . . . . 0.93999999999999995 111.26 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.08 98.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.55000000000000004 111.254 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.06 -29.27 59.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.762 -0.732 . . . . 0.47999999999999998 112.59 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.48 -39.63 62.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 0.84999999999999998 111.229 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 32.0 p -62.1 -51.12 69.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.468 -0.333 . . . . 1.3400000000000001 110.833 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.05 -23.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 1.55 110.943 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.87 -56.16 24.22 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.873 -0.679 . . . . 0.69999999999999996 112.667 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.87 81.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.81000000000000005 110.932 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.04 -32.31 73.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 2.2599999999999998 110.829 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.58 -28.21 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.78 110.46 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -81.57 -30.17 33.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.992 -0.549 . . . . 4.5800000000000001 110.689 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -60.91 -37.23 81.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 3.3500000000000001 110.839 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.7 p -83.87 -40.54 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 1.5800000000000001 110.892 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.74 -3.87 40.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 1.8400000000000001 110.61 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 58.5 p -61.0 -23.31 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 1.3700000000000001 111.384 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -49.8 -31.42 11.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.255 0.55 . . . . 4.9800000000000004 109.841 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.487 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 8.3 p30 -173.33 132.29 0.6 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.256 -0.884 . . . . 2.1400000000000001 109.992 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 36.0 Cg_endo -94.52 174.23 1.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.691 2.261 . . . . 1.8200000000000001 112.311 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.48 54.58 2.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 5.1900000000000004 111.255 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.62 -35.58 2.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 2.2000000000000002 112.872 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -79.09 130.27 70.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.603 0.239 . . . . 3.6499999999999999 111.199 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.18 166.5 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.896 2.397 . . . . 2.6699999999999999 113.021 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -70.55 -18.32 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.466 -0.788 . . . . 4.8799999999999999 112.96 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -62.24 -24.47 67.27 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.373 -0.531 . . . . 1.8700000000000001 111.367 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.9 -55.95 8.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 2.6800000000000002 110.339 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -67.31 -21.57 65.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 2.9199999999999999 110.739 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 64.0 tp -59.49 -63.52 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 1.6399999999999999 110.717 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.14 -35.57 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.378 . . . . 1.6000000000000001 110.63 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.8 -5.48 41.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.68999999999999995 111.091 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' B' ' 45' ' ' ILE . 53.5 ttp -88.94 -40.92 12.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.422 . . . . 2.5800000000000001 110.711 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -69.95 -32.76 71.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 3.3900000000000001 111.651 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.581 HG23 HG23 ' B' ' 79' ' ' THR . 87.2 mt -55.58 -54.2 53.97 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.234 0.457 . . . . 0.40999999999999998 112.234 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.449 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.8 Cg_endo -70.14 -31.46 18.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.182 1.921 . . . . 0.48999999999999999 113.342 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 41' ' ' MET . 38.0 mm -61.32 -62.37 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.615 0.245 . . . . 1.29 111.599 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.412 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.7 OUTLIER -57.81 -58.28 9.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 1.3999999999999999 111.164 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -54.71 -31.26 57.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.3799999999999999 111.025 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.8 -60.51 8.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 0.37 112.881 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 42.5 mt -60.14 -28.59 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 1.29 111.252 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.51 -49.69 65.7 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.347 -0.388 . . . . 0.44 111.452 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 20.4 m-85 -63.61 -46.29 86.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.5 111.156 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . 0.488 ' HB2' HG11 ' B' ' 12' ' ' VAL . 59.7 ttp -48.04 -38.69 17.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.157 0.503 . . . . 1.4099999999999999 110.374 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.93 96.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 0.55000000000000004 110.92 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 51.2 mtt -52.89 -30.96 37.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.88 -0.6 . . . . 0.5 110.553 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -70.04 -47.4 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.54000000000000004 110.602 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mt -76.8 -1.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.797 -0.638 . . . . 1.3 111.004 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.97 52.14 2.14 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.919 -0.582 . . . . 2.2400000000000002 111.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -115.69 169.32 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 1.77 110.965 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.64 9.99 79.22 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.814 -0.708 . . . . 1.0600000000000001 112.493 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -117.77 141.8 48.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 2.6600000000000001 110.93 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.62 138.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 1.8899999999999999 111.044 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.32 94.61 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 2.4100000000000001 111.115 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.54 115.84 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 1.5600000000000001 111.048 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.59 31.45 20.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 1.8200000000000001 111.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.56 12.19 84.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.714 -0.755 . . . . 1.51 112.522 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -115.03 124.48 51.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 2.4500000000000002 110.845 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.74 136.28 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 1.79 110.65 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.47 140.58 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.96 0.41 . . . . 0.81999999999999995 111.109 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 50.9 m-70 -84.16 55.89 3.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 1.05 110.649 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.442 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.7 t80 -58.52 -58.11 10.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.603 -0.726 . . . . 1.8700000000000001 111.679 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.55 -22.31 66.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.60999999999999999 111.974 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.452 ' HB3' ' HB3' ' B' ' 69' ' ' HIS . 14.0 tpp180 -63.52 -51.48 65.3 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.023 0.379 . . . . 2.3900000000000001 112.023 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 12.9 p90 -77.4 -29.07 52.94 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.87 -0.332 . . . . 3.6699999999999999 111.279 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.442 HG12 ' O ' ' B' ' 70' ' ' TYR . 21.1 mm -51.36 -53.21 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.806 0.336 . . . . 1.6599999999999999 110.682 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.49 -21.49 66.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.082 -0.508 . . . . 1.4099999999999999 109.982 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . 0.434 ' O ' HD12 ' B' ' 113' ' ' ILE . 44.4 m0 -86.98 -0.14 56.11 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.958 -0.565 . . . . 1.1599999999999999 111.371 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 55.3 ttm -103.63 -18.64 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.512 . . . . 1.53 110.989 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.403 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.2 m -114.09 -31.01 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.085 0.402 . . . . 0.89000000000000001 112.085 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.581 HG23 HG23 ' B' ' 43' ' ' ILE . 48.0 m -80.82 -50.57 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.844 0.313 . . . . 1.24 111.844 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 28.8 m -53.95 -51.53 76.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.257 0.466 . . . . 0.57999999999999996 112.257 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.3 Cg_endo -56.85 -33.18 94.14 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.733 1.622 . . . . 0.66000000000000003 111.333 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.403 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.6 mm? -75.96 -29.96 58.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.963 -0.562 . . . . 1.0600000000000001 110.132 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.52 HD22 ' H43' ' B' ' 210' ' ' LYR . 15.5 tp -70.23 -21.48 63.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.315 0.579 . . . . 1.22 109.527 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.639 HD22 ' HG3' ' B' ' 109' ' ' GLN . 2.3 tp -84.86 -44.01 13.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.217 -0.901 . . . . 1.53 110.394 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.66 -35.49 72.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.43 -0.805 . . . . 1.5800000000000001 111.074 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 97.9 p -57.49 -32.6 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 1.3899999999999999 110.898 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.459 HD22 HD21 ' B' ' 168' ' ' LEU . 62.3 mt -64.37 -36.79 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 1.1499999999999999 110.925 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -65.11 -34.95 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 1.5700000000000001 110.986 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -73.74 -38.6 64.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 2.1699999999999999 111.126 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 82.2 p -69.26 -23.32 63.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 1.4199999999999999 111.384 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.57 -13.59 21.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 1.1799999999999999 111.147 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 44.7 tpp -127.2 106.36 9.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 1.8799999999999999 110.778 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -67.62 -59.46 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 3.4199999999999999 110.954 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -128.37 137.67 52.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 4.0599999999999996 110.914 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.27 142.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 2.0899999999999999 111.171 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -129.77 -23.31 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.8500000000000001 110.431 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -142.36 141.46 32.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 4.8200000000000003 110.688 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.04 119.1 12.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 3.7999999999999998 111.047 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -84.7 162.72 19.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.48 . . . . 5.1699999999999999 111.002 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 78.9 p -108.61 -22.23 12.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 2.02 111.019 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.76 -29.14 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.034 -0.53 . . . . 2.0899999999999999 110.698 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.7 pt -64.15 -28.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 1.8799999999999999 110.864 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.45 -39.34 22.43 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.813 -0.708 . . . . 0.56000000000000005 112.547 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -67.75 -22.87 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 1.78 110.705 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' B' ' 84' ' ' LEU . 77.2 mt -81.91 -46.22 14.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 1.03 111.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . 0.404 ' O ' HG12 ' B' ' 110' ' ' ILE . 53.5 ttp -67.09 -30.31 70.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.005 -0.543 . . . . 1.6699999999999999 110.91 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 64.0 m -73.63 -52.89 11.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 1.51 111.435 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -56.8 -28.24 61.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 1.1799999999999999 111.443 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.639 ' HG3' HD22 ' B' ' 84' ' ' LEU . 26.3 mm-40 -69.81 -44.11 70.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.753 0.311 . . . . 2.1699999999999999 110.56 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.404 HG12 ' O ' ' B' ' 106' ' ' MET . 46.2 mm -54.64 -32.69 25.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.989 0.423 . . . . 1.3500000000000001 110.459 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.03 -42.38 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.886 -0.597 . . . . 1.3400000000000001 110.835 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.76 -46.66 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.42999999999999999 111.266 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.434 HD12 ' O ' ' B' ' 76' ' ' TRP . 37.4 mm -60.91 -33.24 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 1.6000000000000001 111.088 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.471 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 25.0 m -60.19 -45.43 93.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.85999999999999999 111.044 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 76.5 p -68.63 -20.77 64.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.94999999999999996 110.512 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.505 ' HA3' H181 ' B' ' 210' ' ' LYR . . . -80.07 -35.94 26.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.0 -0.619 . . . . 0.46000000000000002 113.264 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.532 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.6 pp -76.82 -29.37 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.74 0.305 . . . . 1.75 111.409 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.532 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.85 -27.13 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 1.78 111.565 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.88 -39.71 68.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.38 111.27 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -82.41 -25.39 33.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 1.97 111.148 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -86.26 34.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.76000000000000001 111.157 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 71.4 p -65.99 125.26 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.47 110.863 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.622 ' H ' HE22 ' A' ' 58' ' ' GLN . 23.3 mm-40 -89.02 -22.63 22.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 2.5 111.036 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' B' ' 127' ' ' VAL . 99.8 mtt180 -137.6 160.21 39.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 2.73 110.772 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -75.9 -15.65 60.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.121 -0.491 . . . . 2.2000000000000002 110.652 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -92.7 -41.55 10.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 3.3999999999999999 111.024 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' B' ' 124' ' ' ARG . 18.6 m -64.0 -24.63 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 1.23 111.112 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.92 -42.27 85.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 3.04 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.66 -30.85 71.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 4.1399999999999997 110.975 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.49 HD23 HD13 ' A' ' 56' ' ' ILE . 59.7 tp -74.84 -53.63 8.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 1.6499999999999999 111.285 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -61.15 -24.77 66.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.305 . . . . 0.77000000000000002 111.362 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -67.52 -58.79 4.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.476 -0.329 . . . . 1.46 111.402 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.3 -22.55 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.472 -0.331 . . . . 1.6299999999999999 111.317 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.36 -36.42 68.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 1.4199999999999999 110.728 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.91 -51.28 47.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.48999999999999999 112.09 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.09 -43.2 98.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.303 . . . . 1.3 110.923 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 41.9 t -56.4 -40.49 74.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.294 -0.412 . . . . 1.3 110.167 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.62 110.395 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -71.54 -24.02 61.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 1.74 110.669 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.84 -57.64 8.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 1.76 110.953 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 37.2 pt -59.2 -35.29 56.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.335 -0.393 . . . . 0.68999999999999995 111.282 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 65.4 mt -72.96 -26.49 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 1.76 110.688 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.68 -39.58 73.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 1.0600000000000001 110.965 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -73.74 -30.73 62.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.378 -0.374 . . . . 4.1200000000000001 111.084 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.38 -33.96 24.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.776 -0.726 . . . . 1.26 112.635 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 tt -73.91 -21.36 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 1.98 110.471 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -90.78 4.15 52.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.577 . . . . 1.4199999999999999 111.006 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.513 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 58.5 t-20 -83.22 -46.46 0.83 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 111.945 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 62.0 Cg_exo -36.91 -39.9 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.775 2.316 . . . . 2.6499999999999999 113.112 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 46.1 tp -84.42 65.3 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.133 0.492 . . . . 4.3899999999999997 110.264 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.12 139.2 57.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.938 -0.573 . . . . 7.9000000000000004 110.914 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.16 -18.35 61.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 2.77 111.142 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -86.48 -22.94 26.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 6.29 111.047 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 73.4 p -89.1 3.44 51.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 3.1000000000000001 111.117 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -69.7 -16.37 63.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 6.4299999999999997 110.725 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 80.0 p -76.77 -8.27 56.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 4.5700000000000003 110.94 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -78.74 -70.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 3.8300000000000001 110.849 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p -148.18 117.33 6.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 3.0699999999999998 111.035 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 39.9 t -77.24 -18.68 57.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 3.4300000000000002 110.839 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.01 -49.94 22.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 3.9199999999999999 111.049 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 66.5 tp -67.74 -28.14 67.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.105 -0.498 . . . . 2.7000000000000002 110.838 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.17 -52.51 16.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 1.8300000000000001 111.144 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -58.3 -22.54 53.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 2.6299999999999999 110.588 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 33.6 tp -71.04 -47.12 60.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.76 -0.655 . . . . 2.4300000000000002 110.813 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.434 ' O ' HG23 ' B' ' 169' ' ' VAL . 2.3 t80 -75.21 -23.04 57.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.909 -0.587 . . . . 2.5800000000000001 111.314 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.26 -54.64 22.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.92 0.39 . . . . 2.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.99 -30.51 71.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.945 -0.571 . . . . 3.0299999999999998 111.112 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.459 HD21 HD22 ' B' ' 87' ' ' LEU . 54.4 tp -68.76 -54.91 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 1.1000000000000001 111.313 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 165' ' ' TYR . 91.9 t -61.96 -29.86 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.75 111.536 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.8 m -53.48 -58.99 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.97999999999999998 111.538 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.64 -29.02 65.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.347 -0.388 . . . . 4.2999999999999998 110.665 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.44 -34.32 77.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 1.3899999999999999 111.319 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.412 ' O ' HG22 ' B' ' 177' ' ' ILE . 41.3 p -76.23 -38.99 55.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.372 -0.376 . . . . 1.1100000000000001 111.512 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.96 -34.44 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.819 0.342 . . . . 1.51 111.041 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' B' ' 209' ' ' SER . 53.4 tp -77.87 -55.68 5.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 1.75 111.024 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -30.71 43.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.59999999999999998 111.006 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.443 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.3 tp -87.82 -23.38 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.002 0.429 . . . . 1.47 110.417 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.17 -55.29 29.0 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.55000000000000004 113.311 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.636 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 92.6 m-85 -56.19 -55.75 38.62 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.896 0.348 . . . . 1.6200000000000001 111.296 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -46.87 -27.77 6.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.172 1.915 . . . . 0.64000000000000001 112.826 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.443 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -74.24 -58.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.378 . . . . 1.27 111.715 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.43 HG22 ' O ' ' B' ' 179' ' ' TYR . 26.0 m -58.67 -24.69 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.68999999999999995 111.67 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -63.91 -26.99 68.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.55 -0.296 . . . . 1.1799999999999999 111.246 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 85.5 mt -52.1 -29.52 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.558 -0.292 . . . . 1.77 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 43.4 pt -126.72 155.61 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 1.6899999999999999 111.191 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 95.37 177.48 37.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.917 -0.659 . . . . 1.5800000000000001 112.667 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.08 154.4 33.69 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.746 2.297 . . . . 2.5099999999999998 112.046 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 48.4 t 56.77 15.79 2.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.043 0.449 . . . . 3.5800000000000001 110.461 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -158.7 38.31 0.51 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.731 -0.668 . . . . 4.0300000000000002 112.31 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 50.1 t80 58.25 86.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 6.8899999999999997 110.989 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 167.64 95.72 0.1 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.975 -0.631 . . . . 3.7000000000000002 112.206 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 64.3 t90 -82.56 93.79 7.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.867 0.365 . . . . 7.5 111.002 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 41.3 pt -139.29 177.18 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 2.3500000000000001 111.182 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -57.95 150.15 21.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 3.8599999999999999 110.939 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . 0.48 ' CD ' ' H ' ' B' ' 195' ' ' GLN . 0.0 OUTLIER -87.12 1.03 54.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.003 -0.544 . . . . 5.0499999999999998 110.879 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 52.0 m -73.17 -56.4 5.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.117 -0.492 . . . . 2.6800000000000002 111.051 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.08 -28.61 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 2.4700000000000002 111.019 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.15 -56.85 14.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.165 -0.47 . . . . 2.5299999999999998 110.85 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 44.6 p -68.96 -20.02 64.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 1.29 111.301 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.29 -32.93 55.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 2.6200000000000001 111.333 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.46 -43.53 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 1.6100000000000001 111.355 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.66 -9.33 56.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 1.4199999999999999 111.845 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 19.3 p -96.6 -38.03 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.125 0.488 . . . . 1.4299999999999999 110.597 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 56.1 tp -72.38 -31.69 65.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.692 -0.685 . . . . 1.1200000000000001 112.073 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.8 tp -65.7 -53.91 33.05 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.951 -0.299 . . . . 1.26 111.266 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.8 Cg_exo -54.91 -42.49 68.47 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.785 1.657 . . . . 0.59999999999999998 111.864 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.83 -38.11 89.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 1.3999999999999999 110.684 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.24 -24.36 65.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 1.4099999999999999 110.682 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.545 ' HB2' HD22 ' B' ' 175' ' ' LEU . 86.1 p -96.95 -22.21 16.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.3200000000000001 111.252 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.764 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m -69.96 -33.31 54.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 1.6899999999999999 111.57 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.7 -29.19 74.57 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.79 -0.719 . . . . 0.79000000000000004 112.885 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -74.01 -39.08 63.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.621 0.248 . . . . 2.96 111.358 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' B' ' 218' ' ' LEU . 49.8 m -58.41 -57.65 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.462 -0.335 . . . . 1.29 111.038 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . 0.44 ' HA ' HD12 ' B' ' 218' ' ' LEU . 85.6 t80 -63.29 -23.43 67.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 3.1499999999999999 111.094 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -64.2 -56.87 11.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 1.51 111.495 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.74 -33.88 70.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 2.1899999999999999 111.637 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' B' ' 215' ' ' PHE . 87.1 mt -55.29 -50.49 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 1.98 111.063 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.66 -20.53 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.1699999999999999 110.908 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.59 -55.03 25.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.853 -0.689 . . . . 1.3600000000000001 113.084 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 31.5 tp -79.15 -58.61 3.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.704 0.288 . . . . 2.8999999999999999 111.432 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 52.66 81.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 5.6100000000000003 110.779 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -129.0 145.34 51.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 4.04 110.75 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 62.0 mt -114.88 15.95 17.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.214 -0.448 . . . . 6.2999999999999998 111.066 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -117.5 94.15 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 4.7999999999999998 110.736 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.48 160.33 19.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 6.3899999999999997 110.945 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 43.6 t -142.12 124.51 15.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 5.6100000000000003 110.687 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -84.05 168.61 15.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 8.1999999999999993 111.003 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 8.1699999999999999 111.017 179.889 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.674 0.273 . . . . 5.6200000000000001 111.014 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -107.68 -55.58 2.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 5.2800000000000002 111.103 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 69.5 mt -88.18 91.39 8.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 6.0499999999999998 110.989 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -123.95 147.38 47.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.987 -0.551 . . . . 4.79 110.906 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' C' ' 55' ' ' ALA . 49.0 m -121.85 178.08 5.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 2.71 110.759 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp -155.54 -15.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 2.52 110.872 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . 0.441 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.3 mm? -70.34 -45.38 66.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 1.9299999999999999 110.929 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 64.2 m-70 -71.83 -24.35 61.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 1.26 110.7 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.44 ' O ' HG12 ' C' ' 12' ' ' VAL . 61.9 t-105 -66.91 -53.72 29.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 1.6699999999999999 110.564 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -64.9 -21.8 30.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.99 0.424 . . . . 1.8700000000000001 110.291 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . 0.433 ' HE2' ' HG ' ' C' ' 203' ' ' CYS . 0.1 OUTLIER -57.29 -59.51 5.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.601 -0.727 . . . . 1.4399999999999999 110.5 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' C' ' 52' ' ' MET . 8.4 p -61.59 -30.86 49.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.013 -0.54 . . . . 0.46999999999999997 110.967 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.06 78.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.313 -0.403 . . . . 0.58999999999999997 111.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.62 -23.77 77.61 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.688 -0.767 . . . . 0.5 112.834 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.6 mmt -77.52 -45.2 26.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.68000000000000005 111.33 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.9 p -59.29 -50.03 75.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.354 -0.384 . . . . 1.3999999999999999 110.997 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -30.88 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 1.55 110.666 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.72 -60.22 9.39 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.877 -0.677 . . . . 0.70999999999999996 112.589 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -30.86 63.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.812 0.339 . . . . 0.77000000000000002 111.007 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.67 -33.14 70.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.9299999999999999 110.648 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -60.71 -31.21 70.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 1.8600000000000001 110.52 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -74.45 -29.93 61.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.994 -0.548 . . . . 4.1399999999999997 110.793 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -62.82 -39.02 93.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 3.1499999999999999 110.761 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -84.47 -39.09 19.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 1.95 110.865 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 tp -74.54 -9.21 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 2.2200000000000002 110.72 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 53.9 p -58.16 -24.92 60.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 1.3700000000000001 111.309 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -48.14 -33.53 8.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.204 0.526 . . . . 5.0300000000000002 109.794 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.7 p-10 -171.08 132.46 0.86 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.276 -0.874 . . . . 2.3700000000000001 109.794 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 19.5 Cg_endo -91.75 172.33 2.68 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.732 2.288 . . . . 2.0499999999999998 112.214 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -85.5 47.07 1.37 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.231 -0.44 . . . . 4.5199999999999996 111.29 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 -46.71 1.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.811 -0.709 . . . . 2.1600000000000001 113.055 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' C' ' 33' ' ' PRO . 17.6 m -76.48 140.39 68.42 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.607 0.241 . . . . 2.5299999999999998 111.102 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 19.2 Cg_exo -65.19 166.47 18.88 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.532 2.155 . . . . 1.9299999999999999 112.197 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.7 -18.67 64.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 4.1200000000000001 112.965 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.521 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -55.13 -36.74 66.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.969 0.414 . . . . 2.8900000000000001 110.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.73 -48.93 72.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 2.46 110.734 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.06 -19.05 62.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 2.7799999999999998 110.695 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.88 -63.42 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 1.6200000000000001 110.435 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m -63.33 -32.09 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 1.5900000000000001 110.836 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.67 -6.32 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.65000000000000002 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.442 ' O ' HG12 ' C' ' 45' ' ' ILE . 53.7 ttp -89.83 -43.46 10.62 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.978 -0.556 . . . . 1.6699999999999999 111.392 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -73.07 -39.51 65.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.142 0.423 . . . . 3.4199999999999999 112.142 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.565 HG23 HG23 ' C' ' 79' ' ' THR . 96.6 mt -50.64 -50.6 71.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.255 0.465 . . . . 0.89000000000000001 112.255 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.6 -36.14 6.97 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.113 1.875 . . . . 0.40999999999999998 113.142 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' C' ' 41' ' ' MET . 28.9 mm -57.41 -62.74 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.821 0.343 . . . . 1.76 111.469 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -56.56 -57.12 13.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.319 -0.401 . . . . 2.1600000000000001 111.241 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 47.1 m -51.96 -36.45 49.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 1.1699999999999999 111.134 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.71 -53.02 38.34 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 0.44 112.486 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.402 ' O ' ' HG3' ' C' ' 52' ' ' MET . 4.2 mm? -59.67 -35.92 75.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.414 . . . . 1.29 111.002 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.5 -34.15 75.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.5 111.444 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.3 m-85 -70.6 -57.58 4.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 1.8300000000000001 111.542 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . 0.58 ' HB3' HG11 ' C' ' 12' ' ' VAL . 5.0 ppp? -48.74 -30.72 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.89 0.376 . . . . 1.47 110.707 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.9 80.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.59999999999999998 110.826 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 58.0 mtt -54.54 -30.8 54.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.124 -0.489 . . . . 0.83999999999999997 110.546 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' C' ' 5' ' ' SER . . . -67.59 -50.62 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 111.133 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.37 5.94 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 1.55 111.186 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.3 54.94 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.861 -0.609 . . . . 1.54 111.106 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.506 HE21 HD11 ' A' ' 118' ' ' ILE . 57.5 tp60 -123.69 139.64 53.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 1.79 111.028 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.63 -7.66 29.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.804 -0.713 . . . . 0.93999999999999995 112.664 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -103.04 166.14 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.712 0.291 . . . . 2.3599999999999999 110.944 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.73 145.91 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.97 110.998 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -93.51 95.11 9.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.144 -0.48 . . . . 2.4399999999999999 110.953 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.42 107.37 19.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 1.54 111.136 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 33.24 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 1.71 111.389 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.65 2.1 88.88 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 1.53 112.606 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -102.44 152.23 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 2.23 110.942 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 33.2 mt -105.54 114.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 1.3600000000000001 110.833 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.12 142.42 27.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.78000000000000003 111.547 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.488 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 47.6 m-70 -84.24 58.81 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.884 -0.598 . . . . 1.0800000000000001 110.478 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . 0.495 ' O ' HG12 ' C' ' 74' ' ' ILE . 69.8 t80 -58.69 -58.53 8.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.535 -0.757 . . . . 2.2999999999999998 111.938 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.85 67.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.204 0.446 . . . . 0.75 112.204 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.7 tpp180 -61.64 -51.63 67.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.919 0.34 . . . . 1.51 111.919 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.443 ' O ' ' HG3' ' C' ' 77' ' ' MET . 14.0 p90 -78.13 -28.42 48.45 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.844 -0.342 . . . . 4.6500000000000004 111.039 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.495 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.4 mm -47.31 -56.74 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 120.744 0.307 . . . . 1.22 110.907 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.35 -28.78 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.268 -0.424 . . . . 1.3100000000000001 110.129 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -81.4 8.02 10.31 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.085 -0.507 . . . . 1.6799999999999999 111.172 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.551 ' HA ' HD13 ' C' ' 113' ' ' ILE . 18.9 mtp -104.52 -25.22 12.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 1.8 110.458 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.44 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 24.7 m -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 1.1899999999999999 111.979 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.565 HG23 HG23 ' C' ' 43' ' ' ILE . 85.1 m -67.12 -58.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.065 0.394 . . . . 1.23 112.065 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 12.6 m -47.94 -52.43 40.06 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.58999999999999997 112.043 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 63.3 Cg_exo -51.95 -44.4 45.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.822 1.681 . . . . 0.67000000000000004 111.794 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 98.6 mt -66.02 -32.89 74.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.276 -0.42 . . . . 0.95999999999999996 110.555 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -31.69 64.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 1.1899999999999999 109.766 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.471 HD11 ' NE2' ' C' ' 109' ' ' GLN . 19.8 mt -77.83 -44.83 26.15 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.675 -0.693 . . . . 1.7 110.112 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -50.38 -42.0 52.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.446 -0.797 . . . . 1.6200000000000001 110.384 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.412 ' O ' HG23 ' C' ' 90' ' ' THR . 43.2 t -57.62 -34.23 69.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.415 . . . . 1.26 110.945 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 40.7 mt -65.39 -36.74 84.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 1.1100000000000001 111.359 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 69.2 p -69.64 -26.19 64.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 1.51 110.95 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -80.58 -34.83 35.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 2.0600000000000001 111.153 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . 0.412 HG23 ' O ' ' C' ' 86' ' ' SER . 66.6 p -67.87 -26.68 66.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 1.52 111.049 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.65 -44.54 10.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 1.3 111.101 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.02 105.62 17.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 1.6200000000000001 111.092 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -80.47 -12.09 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 3.2400000000000002 110.828 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -162.7 137.44 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 4.6299999999999999 110.557 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.8 tt -108.23 144.49 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 2.1800000000000002 111.17 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -131.72 -25.85 2.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 4.1200000000000001 110.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -146.17 137.58 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 4.96 110.38 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.63 124.45 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 3.9100000000000001 111.326 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -92.84 162.4 14.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 5.21 110.98 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -103.58 -21.42 13.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 1.8200000000000001 110.705 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.413 HD22 ' N ' ' C' ' 101' ' ' LEU . 3.8 mm? -60.3 -31.75 70.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 2.0800000000000001 110.67 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -62.15 -33.15 57.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 1.8600000000000001 110.932 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.08 -27.51 60.02 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.861 -0.685 . . . . 0.58999999999999997 112.098 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -64.84 -39.78 94.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.892 0.377 . . . . 1.53 110.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.88 -50.09 25.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.1100000000000001 111.126 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . 0.412 ' O ' HG13 ' C' ' 110' ' ' ILE . 12.6 tpt -56.88 -41.58 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.785 -0.643 . . . . 2.21 111.514 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 42.9 t -66.38 -59.38 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.761 0.315 . . . . 1.28 111.156 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.501 ' HB ' HD12 ' C' ' 142' ' ' ILE . 42.9 p -53.6 -26.4 21.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.22 111.326 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.471 ' NE2' HD11 ' C' ' 84' ' ' LEU . 6.9 tp-100 -68.17 -47.98 66.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 2.3300000000000001 110.923 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.412 HG13 ' O ' ' C' ' 106' ' ' MET . 49.3 mt -55.26 -31.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 1.29 110.635 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.24 -45.74 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.814 -0.63 . . . . 1.0600000000000001 111.118 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.2 -47.77 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.125 -0.489 . . . . 0.51000000000000001 111.079 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.551 HD13 ' HA ' ' C' ' 77' ' ' MET . 60.6 mt -57.53 -35.7 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 1.3700000000000001 110.848 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 18.3 m -57.15 -45.88 83.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.062 0.458 . . . . 0.77000000000000002 110.695 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . 0.447 ' HA ' HG22 ' C' ' 118' ' ' ILE . 62.9 m -69.25 -23.22 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 1.1899999999999999 110.798 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.494 ' HA3' H181 ' C' ' 210' ' ' LYR . . . -78.31 -32.67 42.25 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.983 -0.627 . . . . 0.5 113.048 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.491 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.4 pp -82.54 -28.51 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 1.47 111.396 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.491 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.7 tp -83.92 -26.23 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 1.2 111.483 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.1 70.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.4 . . . . 0.40000000000000002 111.258 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -84.89 -12.96 52.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 2.1200000000000001 110.802 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.43 ' HB2' HD12 ' C' ' 118' ' ' ILE . 96.0 mt -95.88 26.6 3.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.75 111.192 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 67.5 m -65.16 122.24 16.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.356 . . . . 1.3799999999999999 110.876 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -86.62 -17.04 34.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 2.7400000000000002 110.916 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.434 ' HB2' HG13 ' C' ' 127' ' ' VAL . 98.5 mtt180 -137.01 169.14 18.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 2.7999999999999998 110.946 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -84.88 -17.13 38.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 2.4100000000000001 110.814 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -90.88 -39.19 12.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 4.2000000000000002 110.549 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' C' ' 124' ' ' ARG . 27.3 m -63.69 -26.91 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 1.0800000000000001 111.117 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -66.53 -34.09 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.973 -0.558 . . . . 2.5699999999999998 110.994 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -73.87 -27.02 60.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 3.8100000000000001 110.839 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.08 -41.61 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 1.4199999999999999 111.227 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -71.72 -31.04 66.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.89000000000000001 111.052 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -63.69 -58.72 6.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 1.26 110.817 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.08 -29.29 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.317 -0.402 . . . . 1.6799999999999999 111.041 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.12 -38.62 88.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 1.24 110.892 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.84 -54.47 21.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.898 -0.668 . . . . 0.54000000000000004 112.604 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.56 -30.67 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.618 0.247 . . . . 1.0600000000000001 111.236 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -62.38 -47.65 83.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 1.0800000000000001 110.514 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.52 -30.16 71.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.56999999999999995 110.861 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.6 -20.51 61.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 1.6799999999999999 110.586 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.48 -55.67 5.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 1.7 111.028 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 36.2 pt -58.79 -35.92 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.356 -0.384 . . . . 0.78000000000000003 111.891 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.501 HD12 ' HB ' ' C' ' 108' ' ' THR . 17.6 tt -75.94 -23.71 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 2.2400000000000002 111.114 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.13 -48.33 73.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.361 -0.381 . . . . 1.02 110.764 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -68.62 -32.89 73.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 3.0 110.761 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.38 -39.51 61.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 1.27 112.452 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -75.21 -19.93 16.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.161 0.505 . . . . 1.8899999999999999 110.36 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -88.87 3.0 52.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.586 -0.734 . . . . 1.6000000000000001 110.383 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.47 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 58.5 t-20 -83.52 -48.41 0.74 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 99.989999999999995 111.96 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 77.0 Cg_exo -40.92 -33.44 1.12 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.489 2.126 . . . . 2.73 112.905 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' C' ' 165' ' ' TYR . 85.7 mt -85.07 49.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 4.2999999999999998 110.504 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -54.72 147.66 14.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.029 -0.532 . . . . 8.9000000000000004 111.174 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.33 -18.15 49.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 2.7999999999999998 110.909 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -82.46 -29.27 30.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.525 . . . . 5.4400000000000004 110.857 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 58.1 p -83.52 4.16 29.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 3.3900000000000001 111.288 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -67.41 -27.34 66.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 6.9199999999999999 110.766 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 72.8 p -76.89 -6.3 51.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.074 -0.512 . . . . 4.8700000000000001 111.224 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -80.14 -56.07 4.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.232 -0.44 . . . . 4.0499999999999998 111.002 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 87.7 p -158.44 113.43 2.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 3.0299999999999998 110.758 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 47.9 t -77.6 -28.38 51.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 2.96 111.021 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.03 -62.66 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 3.7400000000000002 111.172 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 56.2 tp -61.0 -36.95 80.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.2 -0.455 . . . . 2.6499999999999999 111.168 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.81 76.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 1.77 111.476 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -74.95 -30.11 61.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 2.96 111.018 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.05 -51.61 56.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 2.3500000000000001 110.973 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . 0.53 ' HB3' HD21 ' C' ' 150' ' ' LEU . 1.0 OUTLIER -69.24 -22.95 63.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 2.6200000000000001 111.138 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 -38.9 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.333 -0.394 . . . . 2.0899999999999999 110.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -81.72 -23.47 36.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 3.2400000000000002 110.9 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.47 -41.02 41.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 1.6899999999999999 111.254 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.42 -24.49 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.243 -0.435 . . . . 1.3999999999999999 111.377 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . 0.434 ' O ' HG23 ' C' ' 174' ' ' VAL . 38.9 m -59.64 -58.88 6.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.95999999999999996 111.309 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -67.89 -31.86 71.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 3.6499999999999999 110.766 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.0 -38.51 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 1.3700000000000001 111.639 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.432 ' O ' HG22 ' C' ' 177' ' ' ILE . 38.7 p -73.21 -33.78 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.426 -0.352 . . . . 1.4299999999999999 111.657 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 170' ' ' THR . 62.5 t -60.93 -37.11 76.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.555 -0.293 . . . . 1.6200000000000001 111.773 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.25 -45.5 16.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 2.0299999999999998 111.344 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . 0.404 ' CZ2' HD21 ' C' ' 84' ' ' LEU . 0.9 OUTLIER -57.77 -31.79 66.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.464 -0.335 . . . . 0.62 110.691 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.434 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.2 tt -87.96 -20.64 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.5800000000000001 110.211 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.49 -56.72 23.58 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.753 -0.658 . . . . 0.56000000000000005 113.407 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.636 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 87.8 m-85 -54.21 -54.42 47.97 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.755 0.278 . . . . 1.3300000000000001 111.437 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.9 Cg_exo -47.09 -30.9 10.88 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.139 1.892 . . . . 0.63 112.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.499 ' O ' HG12 ' C' ' 184' ' ' ILE . 88.2 mt -70.7 -60.49 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.93000000000000005 111.639 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.491 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.6 m -56.18 -24.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.407 0.521 . . . . 1.27 112.407 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -65.69 -17.4 64.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.429 0.529 . . . . 1.77 112.429 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.586 HG13 HG23 ' C' ' 185' ' ' ILE . 22.5 pt -65.67 -13.19 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.659 0.266 . . . . 2.3900000000000001 111.563 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.586 HG23 HG13 ' C' ' 184' ' ' ILE . 31.0 pt -139.52 151.92 22.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.424 -0.353 . . . . 1.95 111.28 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . 0.507 ' H ' ' HA3' ' C' ' 191' ' ' GLY . . . 96.26 179.83 35.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.842 -0.694 . . . . 1.8799999999999999 112.698 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.96 149.1 63.83 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.739 2.293 . . . . 3.1200000000000001 112.225 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 34.5 m 57.26 19.81 5.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.065 -0.516 . . . . 2.6299999999999999 110.51 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -164.23 42.59 0.31 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.901 -0.666 . . . . 3.04 112.641 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 54.3 t80 57.9 90.68 0.04 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.941 0.4 . . . . 5.6900000000000004 111.159 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . 0.507 ' HA3' ' H ' ' C' ' 186' ' ' GLY . . . 160.13 102.32 0.18 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.815 -0.707 . . . . 3.0800000000000001 112.576 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -90.35 78.84 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.976 0.417 . . . . 7.5300000000000002 110.585 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 23.5 pt -124.31 172.56 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 2.8599999999999999 111.041 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . 0.496 HD21 HG12 ' C' ' 197' ' ' ILE . 29.8 p-10 -57.99 141.28 50.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.425 -0.352 . . . . 3.6899999999999999 111.031 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -74.92 -8.5 56.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.136 -0.483 . . . . 5.4800000000000004 111.218 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.1 m -65.04 -42.26 94.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 2.3799999999999999 110.807 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . 0.496 HG12 HD21 ' C' ' 194' ' ' ASN . 46.9 mm -72.49 -48.26 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 2.23 111.279 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.3 -51.96 64.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 2.1600000000000001 111.077 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 87.7 m -64.72 -25.16 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 1.27 111.424 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -82.47 -27.68 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 1.7 111.696 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.87 -48.29 10.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.636 0.255 . . . . 2.02 111.402 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -69.17 1.44 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 1.8200000000000001 111.211 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.433 ' HG ' ' HE2' ' C' ' 11' ' ' TYR . 51.2 t -96.27 -48.8 5.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 1.3500000000000001 110.7 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.8 -30.57 65.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.65000000000000002 111.95 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.659 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 44.6 tp -62.19 -54.62 48.01 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 120.966 -0.293 . . . . 1.4199999999999999 111.49 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 46.3 Cg_exo -57.3 -41.8 69.21 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.65 1.566 . . . . 0.63 111.516 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.42 -32.01 73.32 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.273 -0.421 . . . . 1.49 110.502 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.75 -25.2 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 1.7 110.839 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t -96.77 -21.96 17.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 1.25 111.012 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.749 H192 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.4 -32.75 51.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.8 0.333 . . . . 1.6100000000000001 111.479 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.04 -31.65 81.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.74 -0.743 . . . . 0.81999999999999995 112.656 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -75.2 -29.16 60.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.781 0.324 . . . . 3.0800000000000001 111.08 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -63.78 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 1.1499999999999999 111.065 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -62.71 -23.26 67.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 2.5600000000000001 110.977 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.73 -47.37 85.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.971 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -66.78 -35.41 80.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.414 -0.357 . . . . 2.3900000000000001 111.003 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.31 -43.28 88.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 2.0299999999999998 111.01 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -87.44 -19.92 27.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 3.21 110.94 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.69 31.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.993 -0.622 . . . . 1.3600000000000001 113.08 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.2 -58.87 2.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.555 0.217 . . . . 2.8999999999999999 111.417 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 51.66 76.37 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.769 0.319 . . . . 4.8899999999999997 110.918 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -127.43 148.42 50.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 4.2300000000000004 111.071 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.31 -8.19 17.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 6.1200000000000001 111.009 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -82.85 115.04 21.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 4.5499999999999998 110.686 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -111.09 146.23 37.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 6.7800000000000002 111.063 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 38.8 t -132.44 133.28 43.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 5.4000000000000004 110.747 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -103.67 167.6 9.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 8.3300000000000001 110.951 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 7.9100000000000001 110.7 179.841 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.825 0.345 . . . . 5.1100000000000003 110.975 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -98.05 -5.65 33.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 5.04 110.886 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 3' ' ' LEU . 6.7 mp -85.19 83.92 7.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 5.5800000000000001 111.205 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -105.53 112.22 25.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 5.0199999999999996 110.74 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.6 p -111.67 138.7 47.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.229 -0.441 . . . . 2.4500000000000002 110.813 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp -114.92 -14.26 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 2.4199999999999999 110.808 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.36 -42.86 99.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.147 -0.479 . . . . 2.0899999999999999 110.971 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 25.6 m170 -62.94 -35.88 81.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 1.1599999999999999 110.779 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -69.04 -52.47 28.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.79000000000000004 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.0 mt -56.19 -34.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.007 0.432 . . . . 2.0800000000000001 110.407 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.493 ' O ' ' HG2' ' A' ' 15' ' ' MET . 20.1 t80 -57.45 -42.15 81.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 1.28 109.826 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 8' ' ' HIS . 3.1 t -57.25 -48.38 82.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 1.3200000000000001 111.229 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.06 -44.95 83.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 0.63 111.681 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.31 94.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.55000000000000004 112.705 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 56.0 mmm -69.16 -32.92 72.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 1.03 110.992 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -60.83 -60.33 3.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 1.3 111.449 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -57.2 -26.1 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.348 -0.387 . . . . 1.3100000000000001 111.268 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -59.49 -48.55 85.44 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.571 -0.823 . . . . 0.77000000000000002 112.328 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.05 -23.22 63.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 0.80000000000000004 111.01 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.1 tp -66.32 -44.13 84.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.271 -0.422 . . . . 1.8100000000000001 110.921 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.94 -20.93 60.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 1.8799999999999999 110.997 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.83 -48.19 80.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 4.4500000000000002 110.891 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.506 ' O ' ' OG ' ' A' ' 26' ' ' SER . 6.1 m-90 -71.55 -35.52 70.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 3.6899999999999999 110.88 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.0 m -70.47 -20.65 62.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 1.5700000000000001 111.333 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.6 tp -86.18 -10.63 54.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 1.95 111.117 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 52.3 p -65.4 -23.05 66.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.385 -0.37 . . . . 1.3799999999999999 111.152 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -47.07 -32.69 4.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.261 0.553 . . . . 4.0700000000000003 109.699 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -174.18 132.45 0.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.092 -0.958 . . . . 2.7200000000000002 110.216 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -92.47 140.8 2.12 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.777 2.318 . . . . 1.9099999999999999 112.07 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -81.28 72.83 8.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 4.7599999999999998 111.601 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.76 -46.9 3.19 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.106 -0.568 . . . . 1.99 113.435 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.37 140.52 21.71 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.792 0.296 . . . . 2.7000000000000002 111.222 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.44 165.56 12.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.552 2.168 . . . . 1.79 112.131 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 5.2 pm0 -63.5 -18.6 63.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 4.1200000000000001 112.233 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -48.09 -36.29 12.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.754 0.311 . . . . 2.9300000000000002 111.317 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.11 -53.33 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.909 0.385 . . . . 2.8799999999999999 110.461 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -68.27 -18.45 64.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 4.6600000000000001 110.669 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.08 -52.87 63.11 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.189 -0.459 . . . . 1.45 110.406 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 t -65.85 -36.78 78.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.155 0.502 . . . . 1.78 109.795 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.38 -8.37 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.663 -0.699 . . . . 0.63 110.623 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.476 ' O ' HG12 ' A' ' 45' ' ' ILE . 22.4 ttt -88.68 -36.98 15.9 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.2 -0.454 . . . . 1.48 110.746 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -67.99 -32.8 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 3.5 111.222 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 79' ' ' THR . 68.5 mt -56.88 -55.01 48.12 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.307 0.484 . . . . 1.0800000000000001 112.307 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 36.7 Cg_endo -65.38 -33.94 45.8 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.295 1.996 . . . . 0.53000000000000003 113.442 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 41' ' ' MET . 38.8 mm -55.26 -62.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.881 0.326 . . . . 1.6799999999999999 111.881 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.454 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.8 t90 -66.06 -47.89 72.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 1.8300000000000001 110.981 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -61.81 -9.79 7.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 1.0900000000000001 111.238 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.31 -59.53 2.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.40999999999999998 112.134 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.36 -26.95 65.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 0.98999999999999999 110.704 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.76 -51.52 69.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.47999999999999998 110.79 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 27.7 m-85 -69.65 -26.36 64.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 1.8700000000000001 110.938 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -56.42 -36.78 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.514 -0.55 . . . . 1.49 109.514 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -73.16 -44.15 60.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.538 -0.755 . . . . 0.58999999999999997 110.85 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.443 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 51.6 mtt -51.5 -26.48 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.48999999999999999 110.597 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.11 -47.28 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.084 -0.507 . . . . 0.59999999999999998 111.211 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -84.18 14.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 1.3100000000000001 111.545 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 57.31 55.76 5.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.027 -0.533 . . . . 1.9099999999999999 111.223 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 16.8 mm-40 -125.22 173.01 9.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.008 -0.542 . . . . 1.6200000000000001 110.716 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.45 66.48 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.593 -0.813 . . . . 1.04 112.155 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.75 173.98 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 2.6800000000000002 110.709 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.12 132.49 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 1.98 111.355 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -101.23 88.54 3.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 2.1800000000000002 110.625 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.06 131.72 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.5700000000000001 111.2 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 27.71 17.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.066 -0.515 . . . . 1.79 111.408 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.24 -11.27 37.9 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.713 -0.756 . . . . 1.48 112.643 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -97.87 149.74 22.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.34 . . . . 2.3199999999999998 110.899 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.3 mt -94.15 117.33 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 1.4399999999999999 110.939 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.26 144.83 30.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.81999999999999995 111.233 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.3 m-70 -88.68 68.89 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.90000000000000002 110.958 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.15 -35.71 75.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.661 -0.7 . . . . 1.8300000000000001 111.102 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -73.46 -24.19 60.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.62 111.971 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.7 tpp180 -69.29 -51.71 34.59 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.335 0.494 . . . . 2.3399999999999999 112.335 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -81.23 -31.1 34.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.207 0.447 . . . . 3.4900000000000002 112.207 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 71' ' ' ALA . 10.6 tp -57.53 -43.91 83.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.762 -0.375 . . . . 1.3700000000000001 110.537 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 74' ' ' ILE . 13.3 t70 -68.85 -20.3 64.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.498 -0.556 . . . . 1.3100000000000001 109.498 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -87.7 1.22 54.35 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.672 -0.694 . . . . 1.48 111.169 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.411 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 56.6 ttm -104.61 -18.71 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 1.46 110.915 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 82' ' ' LEU . 30.0 m -114.11 -32.06 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 1.1200000000000001 111.904 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 43' ' ' ILE . 27.9 m -82.9 -41.38 18.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.898 0.333 . . . . 1.1000000000000001 111.898 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 72.4 m -60.19 -50.27 86.86 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.945 0.35 . . . . 0.59999999999999998 111.945 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 44.9 Cg_exo -56.69 -32.92 92.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.074 1.849 . . . . 0.73999999999999999 112.437 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 78' ' ' VAL . 7.3 mp -82.94 -16.97 45.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.115 -0.493 . . . . 1.01 110.845 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -72.91 -47.03 49.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 1.48 109.948 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 85' ' ' LEU . 3.6 pp -74.92 -29.47 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.98 -0.555 . . . . 1.3799999999999999 110.988 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 84' ' ' LEU . 9.7 tp -64.03 -36.47 84.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.018 -0.537 . . . . 1.1899999999999999 110.798 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -61.94 -24.41 66.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 1.23 110.554 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.68 -34.01 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.88 110.793 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.5 p -71.28 -28.42 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 1.3899999999999999 110.52 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -83.86 -26.82 29.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.3199999999999998 110.985 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -81.37 -25.7 36.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.244 -0.435 . . . . 1.46 110.966 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.5 -35.24 12.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.277 -0.419 . . . . 1.24 111.263 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 71.4 mtm -118.18 111.1 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 2.0699999999999998 111.144 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.75 -24.45 58.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 3.5299999999999998 110.69 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -137.12 141.03 42.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 4.0800000000000001 110.659 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.7 pt -128.39 143.95 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 2.1699999999999999 111.407 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.917 -0.583 . . . . 4.5199999999999996 110.606 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.42 52.45 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.467 . . . . 3.75 110.992 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -135.29 93.69 3.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 3.5299999999999998 110.858 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -71.65 80.5 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 4.9100000000000001 111.097 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.4 m -120.6 -60.56 1.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.324 -0.398 . . . . 1.98 111.179 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.29 -58.84 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 1.8300000000000001 111.081 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.2 tt -56.55 -36.38 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 1.79 111.24 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.15 -30.63 73.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.62 112.809 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -63.3 -48.95 75.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.745 0.307 . . . . 1.5800000000000001 110.991 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.97 -43.66 98.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.97999999999999998 111.506 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.412 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 89.4 mtp -56.43 -39.68 73.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 1.48 111.666 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.2 m -71.7 -45.67 61.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.959 0.409 . . . . 1.1299999999999999 111.204 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.419 ' HB ' HD13 ' A' ' 142' ' ' ILE . 68.2 p -64.85 -20.28 66.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 1.48 111.618 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 110' ' ' ILE . 3.0 pt20 -77.76 -41.49 37.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.586 0.231 . . . . 2.7000000000000002 110.796 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.67 HG22 ' HE1' ' C' ' 46' ' ' TRP . 43.2 mt -61.2 -33.05 54.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.947 0.403 . . . . 1.54 110.807 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.17 -47.88 76.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.916 -0.584 . . . . 1.28 111.219 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.539 HG13 H133 ' A' ' 210' ' ' LYR . 73.8 t -61.85 -44.07 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.223 -0.444 . . . . 0.42999999999999999 111.457 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 109' ' ' GLN . 74.8 mt -54.77 -40.28 51.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.776 0.322 . . . . 1.74 110.864 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 117' ' ' LEU . 99.0 m -60.15 -39.79 87.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.63 110.913 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -57.72 -57.31 13.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.407 -0.36 . . . . 1.0900000000000001 110.123 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.8 -14.25 65.01 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.985 -0.626 . . . . 0.41999999999999998 112.199 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 114' ' ' THR . 10.0 tt -70.29 -56.41 6.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 1.3799999999999999 110.724 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.432 ' HB ' ' NE1' ' A' ' 131' ' ' TRP . 67.1 mt -83.73 -22.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.004 -0.543 . . . . 1.6200000000000001 111.563 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HA ' ' HD1' ' A' ' 131' ' ' TRP . . . -49.7 -40.13 39.26 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.849 0.357 . . . . 0.39000000000000001 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.73 -21.48 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.02 110.479 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.3 mt -91.87 31.87 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.76000000000000001 110.775 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 t -88.02 128.14 35.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 1.46 110.634 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.59 -69.77 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 3.3500000000000001 111.282 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.683 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.6 ttp180 -74.4 136.94 42.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 2.9199999999999999 111.06 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.67 -9.88 58.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 2.77 111.181 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.683 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 64.1 t-105 -80.2 -46.65 15.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 3.77 110.804 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.498 ' HB ' HH21 ' A' ' 124' ' ' ARG . 13.3 p -77.19 -23.99 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 1.1599999999999999 111.448 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -56.88 -32.09 65.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 2.04 111.396 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -72.05 -25.24 61.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 2.6400000000000001 111.342 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.551 HD23 HG21 ' C' ' 56' ' ' ILE . 30.8 tp -83.49 -48.18 10.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.538 -0.301 . . . . 1.8999999999999999 111.32 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.432 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 50.4 t-105 -59.88 -28.13 67.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 1.3999999999999999 110.626 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -67.29 -44.33 79.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 1.28 110.666 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.48 -29.22 44.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 2.1600000000000001 110.815 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 69.2 m -65.74 -38.03 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 1.6899999999999999 110.717 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.8 -56.89 12.43 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.52000000000000002 112.465 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 m -56.25 -33.17 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 1.02 111.092 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.2 t -61.69 -37.08 82.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 1.0800000000000001 110.465 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.18 93.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.802 -0.635 . . . . 0.62 110.625 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.4 -14.88 58.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 1.8400000000000001 110.518 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 140' ' ' LEU . 0.5 OUTLIER -65.85 -56.91 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 1.6899999999999999 110.162 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.9 pt -66.27 -37.47 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.81000000000000005 110.839 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.419 HD13 ' HB ' ' A' ' 108' ' ' THR . 96.6 mt -65.97 -35.96 76.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 2.3700000000000001 110.801 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.52 -43.49 93.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.97999999999999998 110.339 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.675 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 88.3 t90 -64.49 -28.61 69.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.596 . . . . 3.27 110.434 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 1.372 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -80.25 -33.34 32.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 1.25 112.456 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.54 -24.71 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 2.1200000000000001 110.443 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -88.89 5.05 45.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.863 -0.608 . . . . 1.6599999999999999 111.057 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 1.372 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 -83.7 -48.31 0.73 Allowed Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 99.989999999999995 112.283 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 91.0 Cg_exo -41.42 -32.81 1.4 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.685 2.256 . . . . 2.6000000000000001 112.882 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.72 46.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 4.6100000000000003 110.81 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.647 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 43.7 ttp180 -55.98 148.26 17.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.746 -0.661 . . . . 8.3599999999999994 110.593 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.81 -19.73 65.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 2.75 111.363 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.647 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 98.9 mttt -86.67 7.17 27.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.435 -0.348 . . . . 5.6799999999999997 111.595 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 151' ' ' ARG . 72.8 p -79.02 -1.56 36.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.349 . . . . 3.21 111.305 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -66.66 -28.51 68.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 6.8700000000000001 110.68 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 t -94.1 -23.61 17.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 4.5599999999999996 111.202 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.79 -73.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 3.5600000000000001 110.617 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.4 m -157.47 112.86 2.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.488 . . . . 2.79 110.845 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -78.33 -31.25 48.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.041 -0.527 . . . . 2.5899999999999999 110.966 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -63.7 -58.58 6.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.528 . . . . 3.4700000000000002 111.083 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 161' ' ' LEU . 3.5 mm? -60.85 -36.37 78.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 2.5800000000000001 111.083 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.42 -26.93 68.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 1.78 111.061 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.08 -37.7 61.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 2.6299999999999999 110.865 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.54 -32.6 71.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 2.3399999999999999 110.998 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.422 ' O ' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -79.45 -31.17 42.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.525 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.54 -44.01 97.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 2.04 111.0 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.4 -19.72 38.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 2.77 111.479 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 42.7 tp -80.65 -39.96 26.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.978 0.362 . . . . 1.8899999999999999 111.978 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 165' ' ' TYR . 14.8 p -75.37 -31.23 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.361 0.504 . . . . 1.6399999999999999 112.361 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 174' ' ' VAL . 6.4 t -57.79 -44.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.712 0.291 . . . . 1.24 111.369 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.4 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 74.5 m-85 -77.09 -28.12 54.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.749 0.309 . . . . 2.9700000000000002 110.612 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -65.56 -46.49 79.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.51 . . . . 1.48 111.216 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -64.11 -40.31 95.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 1.55 111.51 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 170' ' ' THR . 84.4 t -57.52 -35.32 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.804 0.335 . . . . 1.52 111.217 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 73.0 mt -74.26 -57.56 3.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.391 -0.368 . . . . 1.8500000000000001 111.434 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.63 -25.93 54.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.62 111.181 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.469 ' O ' HG12 ' A' ' 181' ' ' ILE . 31.1 mm -87.7 -27.38 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 1.3500000000000001 110.272 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.92 -53.88 34.26 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.742 -0.663 . . . . 0.58999999999999997 113.172 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.668 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 80.4 m-85 -56.42 -57.24 24.39 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.884 0.342 . . . . 1.45 111.495 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.668 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 86.0 Cg_exo -44.4 -30.36 3.73 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.215 1.943 . . . . 0.55000000000000004 112.96 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -68.19 -58.31 6.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 1.4199999999999999 111.405 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 179' ' ' TYR . 21.3 m -59.94 -24.96 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.78000000000000003 111.614 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -70.27 -22.69 62.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.531 -0.304 . . . . 0.93999999999999995 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 92.4 mt -56.35 -41.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.4299999999999999 111.424 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.92 155.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.42 -0.354 . . . . 2.02 111.392 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.68 176.58 28.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.85 -0.69 . . . . 1.79 112.504 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.18 149.51 35.99 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.683 2.256 . . . . 3.1000000000000001 112.126 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 53.2 m 58.72 15.76 3.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 2.7400000000000002 110.44 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -128.12 -65.18 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.931 -0.652 . . . . 3.4300000000000002 112.554 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -163.07 -26.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.695 0.283 . . . . 6.5 110.986 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.57 170.69 13.84 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.715 -0.755 . . . . 3.29 113.019 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -121.78 72.43 1.02 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.054 0.454 . . . . 6.1600000000000001 110.558 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.546 HG22 ' H ' ' A' ' 194' ' ' ASN . 8.9 mt -100.79 169.52 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 2.4199999999999999 110.242 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.546 ' H ' HG22 ' A' ' 193' ' ' ILE . 3.4 m-20 -47.57 141.31 5.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.93 0.395 . . . . 4.29 111.175 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -78.14 -13.65 59.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 5.1500000000000004 111.173 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.6 p -70.3 -42.17 72.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.39 -0.368 . . . . 2.4500000000000002 110.994 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 95.5 mt -69.96 -40.56 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 2.48 111.269 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.77 -60.97 2.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 2.1800000000000002 111.081 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 8.2 t -61.8 -22.29 65.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 1.49 111.461 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.51 -32.32 64.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 1.77 110.942 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 40.9 tp -83.99 -42.58 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.4199999999999999 111.577 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -70.16 0.35 6.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.751 -0.204 . . . . 1.78 111.458 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.19 -45.65 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.202 0.525 . . . . 1.3 110.466 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.53 -34.04 67.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.566 -0.743 . . . . 0.66000000000000003 111.92 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.691 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 55.1 tp -59.8 -54.6 54.01 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.855 -0.338 . . . . 1.6299999999999999 111.2 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 46.6 Cg_exo -57.63 -35.53 98.8 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.629 1.553 . . . . 0.64000000000000001 111.094 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.416 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 55.4 t80 -60.31 -31.88 70.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.119 -0.491 . . . . 1.3600000000000001 110.018 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -82.22 -19.16 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 1.54 110.591 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t -85.0 -40.99 16.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 1.2 110.806 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.768 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.24 -32.6 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.954 -0.567 . . . . 1.6399999999999999 111.221 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.66 -34.98 71.63 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.897 -0.668 . . . . 0.79000000000000004 112.763 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -71.21 -35.19 71.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.639 0.257 . . . . 1.6100000000000001 111.226 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 40.5 t -55.93 -58.2 8.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 1.1499999999999999 110.873 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -66.97 -20.44 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 3.3399999999999999 110.821 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -67.2 -58.66 4.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.1899999999999999 110.815 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.04 -28.3 64.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 2.23 110.969 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.21 -45.53 84.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.192 -0.458 . . . . 2.4700000000000002 110.742 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -77.42 -28.25 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 1.6200000000000001 110.754 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.42 -23.34 68.37 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 1.4099999999999999 112.185 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.17 -56.61 17.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 2.5800000000000001 110.737 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 61.42 -84.13 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.022 -0.535 . . . . 4.9299999999999997 111.2 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -80.52 131.64 35.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.386 -0.37 . . . . 4.6299999999999999 110.895 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.5 tp -84.43 102.3 12.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 6.4699999999999998 110.976 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -143.41 132.9 23.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 5.0700000000000003 110.872 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -114.41 151.76 32.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 6.5300000000000002 111.008 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.6 m -107.92 122.72 47.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 5.2199999999999998 110.879 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -74.05 -29.32 61.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.482 . . . . 8.3599999999999994 111.129 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.367 -0.379 . . . . 7.96 110.855 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.1 mtm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.845 0.355 . . . . 6.1699999999999999 110.826 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -110.41 16.32 21.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.149 -0.478 . . . . 4.8200000000000003 111.08 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 44.0 tp -108.3 93.91 4.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.429 -0.35 . . . . 5.5999999999999996 111.029 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.1 150.02 27.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.216 -0.447 . . . . 4.7999999999999998 111.074 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -151.03 137.76 18.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 2.3700000000000001 110.71 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt -120.07 -0.01 10.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 2.0699999999999998 110.815 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.452 HD12 HD11 ' B' ' 10' ' ' ILE . 24.4 tp -70.51 -39.44 74.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 2.1000000000000001 111.219 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.6 m80 -71.52 -31.19 66.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0700000000000001 110.86 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -65.33 -57.97 7.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 1.48 111.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.452 HD11 HD12 ' B' ' 7' ' ' LEU . 35.8 pt -55.38 -31.37 27.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.584 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -59.66 -36.36 76.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.621 -0.718 . . . . 0.92000000000000004 109.672 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' B' ' 52' ' ' MET . 3.2 t -66.93 -49.86 70.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.93999999999999995 111.047 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.64 69.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.55000000000000004 111.653 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.28 83.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.639 -0.791 . . . . 0.47999999999999998 112.422 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -76.43 -34.56 58.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.625 0.25 . . . . 0.84999999999999998 111.573 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 65.9 p -62.63 -49.38 75.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.722 0.296 . . . . 1.3400000000000001 111.467 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.439 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -61.55 -36.0 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 1.55 110.683 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -49.75 56.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.728 -0.749 . . . . 0.69999999999999996 112.847 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.63 -24.74 65.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 0.81000000000000005 111.474 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.93 -36.15 75.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.93 0.395 . . . . 2.2599999999999998 110.971 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -63.28 -21.55 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 1.78 110.515 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -60.8 -40.83 94.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.811 -0.631 . . . . 4.5800000000000001 110.864 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -73.18 -41.89 63.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.15 -0.477 . . . . 3.3500000000000001 111.004 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 77.7 p -71.12 -19.5 62.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 1.5800000000000001 111.466 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.95 -7.85 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 1.8400000000000001 111.265 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 89.8 p -69.54 -22.48 63.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.482 -0.326 . . . . 1.3700000000000001 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -47.51 -36.41 10.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.292 0.568 . . . . 4.9800000000000004 109.774 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.4 p-10 -171.84 132.35 0.77 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 2.1400000000000001 109.988 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 55.5 Cg_endo -94.86 154.35 1.81 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.96 2.44 . . . . 1.8200000000000001 112.24 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -85.13 63.5 8.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 5.1900000000000004 110.912 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.78 -39.79 2.22 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.765 -0.731 . . . . 2.2000000000000002 112.508 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.56 129.0 35.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.381 0.134 . . . . 3.6499999999999999 111.142 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 32.2 Cg_exo -57.69 160.88 13.53 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.29 1.993 . . . . 2.6699999999999999 111.854 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.49 -18.06 57.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.788 -0.642 . . . . 4.8799999999999999 112.517 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' B' ' 38' ' ' LEU . 2.9 p90 -46.78 -36.74 7.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.938 0.399 . . . . 1.8700000000000001 111.046 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -66.82 -47.32 72.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 2.6800000000000002 110.231 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -70.58 -18.78 62.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 2.9199999999999999 110.489 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 58.1 tp -60.96 -53.61 55.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.97 -0.559 . . . . 1.6399999999999999 110.006 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.18 -37.13 78.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 110.307 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' B' ' 43' ' ' ILE . . . -72.33 -6.84 46.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.596 -0.729 . . . . 0.68999999999999995 110.94 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.423 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 24.8 ttt -88.79 -39.78 13.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.203 -0.453 . . . . 2.5800000000000001 110.981 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' B' ' 45' ' ' ILE . 25.1 t80 -69.74 -34.13 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 3.3900000000000001 111.516 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.458 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 76.6 mt -52.15 -54.28 43.0 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.988 0.366 . . . . 0.40999999999999998 111.988 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 48.0 Cg_endo -68.62 -32.09 25.04 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.158 1.905 . . . . 0.48999999999999999 112.883 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' B' ' 42' ' ' PHE . 96.1 mt -56.3 -60.12 2.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.657 0.265 . . . . 1.29 111.538 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.648 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -63.71 -55.26 24.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.517 -0.311 . . . . 1.3999999999999999 111.204 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 90.2 p -54.74 -25.97 31.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 1.3799999999999999 111.294 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.93 7.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.711 -0.757 . . . . 0.37 112.429 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -32.09 68.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 1.29 110.837 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.93 -53.53 57.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.57 . . . . 0.44 111.244 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -71.53 -23.26 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.385 . . . . 0.5 111.143 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . 0.48 ' HA ' HG21 ' B' ' 12' ' ' VAL . 15.0 tmm? -57.72 -36.89 72.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.304 0.573 . . . . 1.4099999999999999 109.466 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.33 -39.68 38.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.779 . . . . 0.55000000000000004 110.778 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.9 mtt -53.89 -24.29 15.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.032 -0.531 . . . . 0.5 110.188 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -82.21 -47.95 11.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.853 -0.612 . . . . 0.54000000000000004 110.822 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mt -80.94 10.93 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 1.3 111.166 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.419 ' HA ' ' NZ ' ' B' ' 60' ' ' LYS . 20.0 t70 60.54 65.23 1.08 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.982 -0.554 . . . . 2.2400000000000002 111.172 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -146.66 150.78 36.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 1.77 111.291 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.99 -22.43 29.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.654 . . . . 1.0600000000000001 112.697 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' B' ' 57' ' ' ASP . 22.0 pttm -103.8 143.15 33.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 2.6600000000000001 111.154 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.82 151.63 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.8899999999999999 111.229 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.11 107.39 18.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 2.4100000000000001 110.778 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.33 127.68 53.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.23 -0.441 . . . . 1.5600000000000001 111.256 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.48 37.34 23.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.059 -0.519 . . . . 1.8200000000000001 111.079 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.78 -0.68 42.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.843 -0.694 . . . . 1.51 112.432 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -101.3 139.53 36.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 2.4500000000000002 110.638 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.03 102.47 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 1.79 111.199 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.15 133.9 37.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.81999999999999995 111.073 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 74.6 m-70 -78.66 74.97 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.166 0.508 . . . . 1.05 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.444 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 62.1 t80 -64.47 -30.02 71.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.611 -0.722 . . . . 1.8700000000000001 111.255 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -79.66 -28.14 40.81 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.181 0.437 . . . . 0.60999999999999999 112.181 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.535 HH21 ' HB ' ' B' ' 199' ' ' THR . 34.2 mmt180 -67.95 -51.64 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.603 0.594 . . . . 2.3900000000000001 112.603 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.459 ' O ' ' HG3' ' B' ' 77' ' ' MET . 5.9 p90 -77.76 -34.86 52.23 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.231 0.456 . . . . 3.6699999999999999 112.231 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.433 HG23 ' N ' ' B' ' 75' ' ' ASP . 10.3 tp -54.74 -43.23 65.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 120.846 -0.341 . . . . 1.6599999999999999 110.802 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.433 ' N ' HG23 ' B' ' 74' ' ' ILE . 26.9 t70 -68.95 -21.64 64.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.474 -0.565 . . . . 1.4099999999999999 109.474 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 19.4 m0 -87.07 6.25 33.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.472 -0.786 . . . . 1.1599999999999999 110.908 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 28.2 mtp -104.91 -23.3 13.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.077 -0.51 . . . . 1.53 110.748 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.18 -33.64 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.56 0.578 . . . . 0.89000000000000001 112.56 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.438 HG23 HG23 ' B' ' 43' ' ' ILE . 34.8 m -76.83 -47.26 21.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.192 0.441 . . . . 1.24 112.192 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 34.6 m -56.5 -51.31 82.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.154 0.427 . . . . 0.57999999999999996 112.154 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 54.3 Cg_exo -52.62 -41.86 65.99 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.921 1.748 . . . . 0.66000000000000003 112.065 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.62 -29.58 62.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 1.0600000000000001 110.638 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.35 -28.75 68.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.117 0.484 . . . . 1.22 110.205 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' B' ' 105' ' ' LEU . 5.9 tt -84.37 -38.75 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.788 -0.642 . . . . 1.53 110.296 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 78.9 mt -61.44 -33.37 73.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.914 -0.585 . . . . 1.5800000000000001 110.625 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 99.5 p -59.39 -24.1 63.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.012 -0.54 . . . . 1.3899999999999999 110.715 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.419 ' HA ' HG22 ' B' ' 90' ' ' THR . 46.6 mt -76.03 -27.43 57.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 1.1499999999999999 110.909 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 52.0 m -75.94 -31.18 58.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 1.5700000000000001 111.163 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.06 -37.27 39.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 2.1699999999999999 111.297 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.419 HG22 ' HA ' ' B' ' 87' ' ' LEU . 8.8 t -73.88 -23.54 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.458 -0.337 . . . . 1.4199999999999999 111.422 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.08 -36.22 12.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 1.1799999999999999 111.252 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -116.52 120.24 38.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.889 0.376 . . . . 1.8799999999999999 111.068 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.98 -27.33 39.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 3.4199999999999999 110.562 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -137.94 148.14 44.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.795 -0.639 . . . . 4.0599999999999996 110.613 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' HD12 ' B' ' 95' ' ' ILE . 4.3 mp -131.95 144.56 36.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.372 -0.376 . . . . 2.0899999999999999 111.064 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -101.18 162.67 12.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 3.8500000000000001 110.863 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.47 91.64 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 4.8200000000000003 110.913 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -147.53 -43.05 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 3.7999999999999998 111.075 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 85.9 m95 54.78 65.25 1.55 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 5.1699999999999999 110.867 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 79.7 p -117.87 -58.23 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 2.02 110.804 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 60.3 tp -71.67 -51.55 22.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 2.0899999999999999 110.712 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.95 -47.37 89.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.977 -0.556 . . . . 1.8799999999999999 111.154 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.4 -33.8 77.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.896 -0.669 . . . . 0.56000000000000005 112.675 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -65.58 -40.28 92.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 1.78 110.866 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.523 ' HB3' HD21 ' B' ' 84' ' ' LEU . 28.8 mt -71.43 -40.72 70.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.52 . . . . 1.03 111.201 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 85.9 mtp -58.27 -53.39 58.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 1.6699999999999999 111.221 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 44.0 t -58.35 -39.94 80.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.397 . . . . 1.51 111.128 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.512 HG21 HG21 ' B' ' 142' ' ' ILE . 91.8 m -60.71 -37.93 83.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 1.1799999999999999 111.286 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.499 ' NE2' HG22 ' B' ' 80' ' ' THR . 16.1 mm100 -64.72 -46.92 80.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 2.1699999999999999 111.31 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.454 HG22 ' HE1' ' A' ' 46' ' ' TRP . 62.3 mt -53.04 -35.03 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.323 -0.399 . . . . 1.3500000000000001 111.262 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.65 -51.35 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.3400000000000001 111.342 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.64 HG13 H133 ' B' ' 210' ' ' LYR . 87.2 t -58.75 -49.6 82.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 0.42999999999999999 111.489 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' B' ' 77' ' ' MET . 71.9 mt -52.83 -36.87 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.358 -0.383 . . . . 1.6000000000000001 111.329 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 49.5 m -60.09 -48.3 82.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.85999999999999999 111.237 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 35.9 m -64.94 -21.11 66.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.148 -0.478 . . . . 0.94999999999999996 111.124 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.27 14.3 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.821 -0.705 . . . . 0.46000000000000002 113.262 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.1 pp -76.24 -27.91 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.87 -0.194 . . . . 1.75 111.507 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.452 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.53 -31.55 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.682 0.277 . . . . 1.78 111.424 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.4 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 0.38 111.013 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.66 -30.24 46.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 1.97 111.007 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.63 14.28 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.76000000000000001 111.267 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 46.6 t -75.36 120.77 21.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 1.47 110.817 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.41 -72.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 2.5 111.025 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.579 ' HB2' HG12 ' B' ' 127' ' ' VAL . 79.3 mtp180 -62.71 140.72 58.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 2.73 110.513 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.92 -19.31 52.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.064 -0.516 . . . . 2.2000000000000002 111.466 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -78.17 -35.03 49.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.393 -0.367 . . . . 3.3999999999999999 111.215 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -81.67 -23.74 9.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.341 -0.391 . . . . 1.23 111.095 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -56.35 -32.92 65.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.13 -0.487 . . . . 3.04 111.037 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -75.27 -19.51 59.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 4.1399999999999997 111.417 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 99.3 mt -78.85 -54.89 5.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 1.6499999999999999 110.97 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -39.98 76.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.77000000000000002 111.334 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -53.01 -45.4 67.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 1.46 111.156 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -71.93 -28.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 1.6299999999999999 111.288 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 76.2 m -68.77 -39.45 80.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 1.4199999999999999 111.176 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.31 -50.8 48.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.8 -0.714 . . . . 0.48999999999999999 112.457 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.97 -29.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 1.3 110.752 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.49 -47.05 87.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.645 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.46 -29.79 71.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.451 . . . . 0.62 110.622 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . 0.494 ' HB2' H131 ' B' ' 210' ' ' LYR . 82.2 t80 -75.13 -25.24 58.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 1.74 110.747 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.58 -56.84 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.76 111.476 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.461 HG13 ' N ' ' B' ' 142' ' ' ILE . 23.5 pt -56.17 -44.07 78.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.68999999999999995 111.128 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.512 HG21 HG21 ' B' ' 108' ' ' THR . 46.5 mm -67.85 -29.31 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.76 110.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' B' ' 139' ' ' PHE . 0.5 OUTLIER -55.37 -50.96 68.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 1.0600000000000001 110.348 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -62.36 -37.55 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 4.1200000000000001 110.666 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.98 -35.58 92.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 1.26 112.514 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 142' ' ' ILE . 98.3 mt -69.17 -27.18 33.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.871 0.367 . . . . 1.98 110.831 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -88.68 4.46 47.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.199 -0.455 . . . . 1.4199999999999999 111.185 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 58.5 t-20 -81.7 -48.1 1.0 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.044 -0.525 . . . . 99.989999999999995 111.841 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 71.1 Cg_exo -41.01 -33.69 1.23 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.577 2.184 . . . . 2.6499999999999999 112.578 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 32.2 tp -86.31 54.29 3.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 4.3899999999999997 110.14 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.489 ' HD3' ' HE2' ' B' ' 153' ' ' LYS . 99.5 mtt180 -58.5 168.92 1.0 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.863 -0.608 . . . . 7.9000000000000004 110.907 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.47 -23.01 37.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.305 -0.407 . . . . 2.77 111.18 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . 0.489 ' HE2' ' HD3' ' B' ' 151' ' ' ARG . 63.3 pttt -86.25 5.89 32.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 6.29 111.053 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 15.3 t -65.59 -19.14 65.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 3.1000000000000001 110.92 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -62.73 -19.13 63.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 6.4299999999999997 111.155 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 59.0 p -102.72 -18.84 14.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.105 -0.498 . . . . 4.5700000000000003 111.058 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -83.01 -70.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 3.8300000000000001 110.809 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 33.5 t -162.06 113.24 1.63 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 3.0699999999999998 110.874 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 71.4 p -78.11 -29.85 49.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 3.4300000000000002 111.281 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -67.37 -53.86 25.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.403 . . . . 3.9199999999999999 110.983 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.83 -34.31 75.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 2.7000000000000002 110.838 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.88 64.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.8300000000000001 110.976 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -68.75 -48.85 62.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 2.6299999999999999 110.869 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt -61.17 -42.19 98.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 2.4300000000000002 110.761 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.72 -23.48 61.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 2.5800000000000001 111.076 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.21 -55.0 28.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.339 -0.391 . . . . 2.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -78.43 -24.19 46.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 3.0299999999999998 111.383 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.4 tp -68.78 -43.5 75.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 1.1000000000000001 111.311 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.41 -22.31 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 1.75 111.34 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.0 m -62.55 -58.83 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.97999999999999998 111.478 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.84 -34.81 79.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.304 -0.407 . . . . 4.2999999999999998 110.98 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.1 -36.25 74.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 1.3899999999999999 111.048 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.4 ' O ' HG22 ' B' ' 177' ' ' ILE . 66.2 m -69.97 -41.35 74.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 1.1100000000000001 111.095 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.91 -37.07 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.474 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.4 mt -72.5 -56.14 5.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 1.75 111.344 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -31.58 63.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.59999999999999998 111.51 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.437 ' O ' HG13 ' B' ' 181' ' ' ILE . 16.2 tt -87.57 -20.79 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.43 . . . . 1.47 110.566 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.44 -50.57 65.48 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.824 -0.626 . . . . 0.55000000000000004 112.911 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.665 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 67.1 m-85 -58.18 -57.02 29.07 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.773 0.286 . . . . 1.6200000000000001 111.538 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 88.1 Cg_exo -45.95 -31.7 8.62 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.906 1.737 . . . . 0.64000000000000001 112.876 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 177' ' ' ILE . 98.0 mt -66.25 -56.85 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 1.27 111.567 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.0 m -61.63 -25.32 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.68999999999999995 111.546 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . 0.415 ' CD1' H191 ' B' ' 210' ' ' LYR . 39.9 m95 -68.92 -18.36 64.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 1.1799999999999999 111.467 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.52 -34.68 66.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.521 -0.309 . . . . 1.77 111.142 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.25 162.36 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.323 . . . . 1.6899999999999999 111.329 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.75 -171.88 33.57 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.716 . . . . 1.5800000000000001 112.721 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.02 154.46 72.59 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.809 2.34 . . . . 2.5099999999999998 112.164 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 58.4 m 57.38 18.12 4.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 3.5800000000000001 110.897 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -169.74 63.96 0.18 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.597 -0.811 . . . . 4.0300000000000002 112.609 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 89.4 t80 58.29 95.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.814 0.34 . . . . 6.8899999999999997 111.086 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.19 137.46 3.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.707 -0.758 . . . . 3.7000000000000002 112.477 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -121.92 89.01 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 7.5 110.688 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 46.3 pt -124.76 -179.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 2.3500000000000001 111.161 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -52.9 135.99 35.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 3.8599999999999999 110.849 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -77.21 -11.49 59.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 5.0499999999999998 111.002 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 60.7 p -67.3 -47.66 69.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 2.6800000000000002 111.374 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.1 tp -68.91 -29.36 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.323 -0.399 . . . . 2.4700000000000002 111.077 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.96 -56.13 25.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 2.5299999999999998 110.974 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . 0.535 ' HB ' HH21 ' B' ' 72' ' ' ARG . 64.8 p -65.43 -34.52 78.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 1.29 111.157 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.96 -36.0 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 2.6200000000000001 111.144 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.53 -41.78 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.342 -0.39 . . . . 1.6100000000000001 111.495 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -74.63 0.45 15.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.523 -0.308 . . . . 1.4199999999999999 111.345 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.9 t -96.52 -45.03 6.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.206 0.526 . . . . 1.4299999999999999 110.526 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 45.1 tp -72.11 -39.37 68.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.422 -0.808 . . . . 1.1200000000000001 111.918 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.671 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 45.4 tp -55.77 -54.47 51.47 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 120.953 -0.299 . . . . 1.26 111.33 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.5 Cg_exo -56.11 -41.45 76.64 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.822 1.681 . . . . 0.59999999999999998 111.175 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.457 ' O ' HG12 ' B' ' 211' ' ' VAL . 66.1 t80 -55.2 -37.07 66.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.167 -0.469 . . . . 1.3999999999999999 109.844 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -79.89 -24.27 41.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.674 -0.694 . . . . 1.4099999999999999 110.433 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 56.7 m -85.11 -13.39 50.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.84 -0.618 . . . . 1.3200000000000001 111.204 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.738 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.457 HG12 ' O ' ' B' ' 207' ' ' PHE . 9.0 p -65.43 -29.88 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 1.6899999999999999 111.135 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 216' ' ' LEU . . . -59.2 -28.07 63.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.79000000000000004 112.24 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -76.77 -30.16 56.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.751 0.31 . . . . 2.96 110.551 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -63.74 -60.58 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.29 110.685 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.02 -26.47 67.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 3.1499999999999999 110.853 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' B' ' 212' ' ' GLY . 6.4 tt -65.33 -50.05 67.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 1.51 110.743 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.406 ' O ' ' HG ' ' B' ' 221' ' ' LEU . 16.5 t70 -63.02 -24.98 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 2.1899999999999999 110.945 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 56.9 tp -71.75 -33.24 68.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 1.98 111.139 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -88.18 -29.19 20.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.43 -0.35 . . . . 2.1699999999999999 111.149 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.52 -20.9 61.92 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.795 -0.717 . . . . 1.3600000000000001 112.433 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 217' ' ' ASP . 77.6 mt -69.82 -52.55 24.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.654 0.264 . . . . 2.8999999999999999 110.606 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 61.06 -82.15 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.969 -0.559 . . . . 5.6100000000000003 111.115 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -88.33 146.79 25.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.419 -0.355 . . . . 4.04 110.85 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.34 119.31 29.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 6.2999999999999998 111.011 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -152.14 106.84 3.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.038 -0.528 . . . . 4.7999999999999998 110.724 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -97.28 138.44 34.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 6.3899999999999997 111.134 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 42.4 m -95.1 135.28 36.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 5.6100000000000003 110.729 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -91.99 -10.72 38.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.481 . . . . 8.1999999999999993 110.982 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 8.1699999999999999 110.928 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 73.5 mtm . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.764 0.316 . . . . 5.6200000000000001 110.993 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -93.61 -22.35 18.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.14 -0.482 . . . . 5.2800000000000002 110.777 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . 0.42 ' N ' HD12 ' C' ' 3' ' ' LEU . 7.1 mp -74.13 124.31 26.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 6.0499999999999998 110.626 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -97.61 -66.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 4.79 110.825 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t 60.32 98.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.06 -0.518 . . . . 2.71 111.234 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -113.35 -6.34 13.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 2.52 110.951 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 tp -65.18 -47.67 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 1.9299999999999999 110.706 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.611 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 25.0 m170 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.26 110.745 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -75.21 -41.16 58.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 1.6699999999999999 110.417 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.09 -20.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.281 0.562 . . . . 1.8700000000000001 110.176 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.29 -50.91 58.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.461 -0.79 . . . . 1.4399999999999999 110.724 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.46999999999999997 111.257 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.03 85.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.58999999999999997 111.231 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -30.73 73.73 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.856 -0.687 . . . . 0.5 112.747 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.7 mmt -73.04 -28.92 62.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.977 0.418 . . . . 0.68000000000000005 110.839 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.8 m -66.55 -52.91 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 1.3999999999999999 110.917 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . 0.521 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -63.28 -24.18 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.55 110.913 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.72 -47.34 89.88 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.714 -0.755 . . . . 0.70999999999999996 112.259 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.98 65.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.77000000000000002 111.064 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.7 mt -68.09 -30.96 70.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.361 -0.382 . . . . 1.9299999999999999 110.745 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -65.04 -21.25 66.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 1.8600000000000001 110.812 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.32 -45.13 89.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 4.1399999999999997 110.851 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 42.1 t90 -71.6 -32.8 68.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 3.1499999999999999 111.228 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 75.2 m -78.09 -23.32 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 1.95 111.291 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 tp -87.3 -2.76 58.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.404 -0.362 . . . . 2.2200000000000002 110.863 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 71.2 p -70.97 -24.13 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 1.3700000000000001 111.109 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -48.85 -32.74 9.31 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.284 0.564 . . . . 5.0300000000000002 109.952 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.2 p-10 -173.79 132.18 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 2.3700000000000001 109.761 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 43.8 Cg_endo -95.3 164.79 1.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.772 2.315 . . . . 2.0499999999999998 112.367 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -96.48 66.65 2.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.239 -0.437 . . . . 4.5199999999999996 111.171 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.82 -47.09 3.6 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.724 -0.75 . . . . 2.1600000000000001 112.642 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 71.1 t -91.96 131.27 35.71 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.456 0.17 . . . . 2.5299999999999998 111.014 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 36.0 Cg_exo -57.44 162.16 10.57 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.516 2.144 . . . . 1.9299999999999999 112.132 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -60.04 -18.4 46.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 4.1200000000000001 112.541 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.431 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.7 p90 -50.75 -36.19 35.39 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.789 0.328 . . . . 2.8900000000000001 111.131 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.7 -53.68 43.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 2.46 110.484 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.5 -20.51 66.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 2.7799999999999998 110.719 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.76 -52.11 66.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 1.6200000000000001 110.198 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.53 -38.95 82.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 1.5900000000000001 110.219 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.68 -7.22 42.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.66 . . . . 0.65000000000000002 111.188 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.408 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 26.1 ttt -88.72 -38.77 14.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 1.6699999999999999 110.925 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.477 ' HA ' HD12 ' C' ' 45' ' ' ILE . 28.8 m-85 -70.77 -30.68 67.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 3.4199999999999999 111.504 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 80.2 mt -55.82 -54.9 46.86 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.595 -0.275 . . . . 0.89000000000000001 111.726 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 49.7 Cg_endo -69.41 -28.11 27.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.165 1.91 . . . . 0.40999999999999998 113.096 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' C' ' 42' ' ' PHE . 91.3 mt -59.66 -62.53 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.166 -0.213 . . . . 1.76 111.332 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.67 ' HE1' HG22 ' A' ' 110' ' ' ILE . 2.8 t90 -64.95 -50.19 67.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.646 0.26 . . . . 2.1600000000000001 110.813 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . 0.435 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 36.8 t -60.98 -15.06 27.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 1.1699999999999999 111.022 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.16 -60.32 3.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 0.44 112.364 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.09 -26.42 64.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.309 . . . . 1.29 110.845 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.58 -54.27 45.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.5 111.272 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.466 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.1 m-85 -67.69 -36.78 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 1.8300000000000001 111.136 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 51.8 ttp -51.53 -33.09 30.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.14 0.495 . . . . 1.47 109.998 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -75.97 -44.92 37.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.59999999999999998 110.638 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . 0.466 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 31.7 mtp -56.49 -19.53 15.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.85 -0.614 . . . . 0.83999999999999997 110.463 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.611 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.48 -44.31 17.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.886 -0.597 . . . . 0.65000000000000002 110.34 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.551 HG21 HD23 ' A' ' 130' ' ' LEU . 38.4 pt -84.44 10.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 1.55 111.135 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 63.96 54.04 1.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.915 -0.584 . . . . 1.54 111.148 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -134.77 151.4 50.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 1.79 110.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.16 14.26 39.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.788 -0.72 . . . . 0.93999999999999995 112.58 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -124.43 160.31 28.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.801 0.334 . . . . 2.3599999999999999 110.769 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.49 142.06 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.97 111.028 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.55 104.77 17.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 2.4399999999999999 110.656 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.96 124.91 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 1.54 111.226 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.8 27.81 17.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 1.71 111.262 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.29 53.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.874 -0.679 . . . . 1.53 112.733 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -98.15 147.41 24.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.925 0.393 . . . . 2.23 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.37 116.71 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.023 -0.535 . . . . 1.3600000000000001 111.148 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.85 133.5 47.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.78000000000000003 110.885 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.429 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 93.8 m-70 -78.59 73.33 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.232 0.539 . . . . 1.0800000000000001 111.054 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.97 -33.01 74.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.582 -0.735 . . . . 2.2999999999999998 110.951 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -75.58 -25.89 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.75 111.784 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.6 tpp180 -67.92 -51.22 50.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.364 0.505 . . . . 1.51 112.364 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -82.08 -30.87 31.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.245 0.461 . . . . 4.6500000000000004 112.245 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.6 tp -56.48 -44.13 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.758 -0.377 . . . . 1.22 110.783 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.452 ' N ' HG23 ' C' ' 74' ' ' ILE . 34.9 t70 -69.54 -20.56 63.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.374 -0.602 . . . . 1.3100000000000001 109.374 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -87.14 3.68 45.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.567 -0.742 . . . . 1.6799999999999999 111.201 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.598 ' HA ' HD13 ' C' ' 113' ' ' ILE . 44.8 ttm -104.61 -21.33 13.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.002 -0.545 . . . . 1.8 110.771 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.422 ' O ' HD23 ' C' ' 82' ' ' LEU . 31.5 m -114.48 -35.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.2 0.444 . . . . 1.1899999999999999 112.2 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.442 HG23 HG23 ' C' ' 43' ' ' ILE . 24.5 m -76.78 -51.7 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.105 0.409 . . . . 1.23 112.105 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 52.3 m -52.72 -50.77 79.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 112.039 0.385 . . . . 0.58999999999999997 112.039 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 54.4 Cg_exo -52.54 -43.49 54.45 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.943 1.762 . . . . 0.67000000000000004 112.009 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.422 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -71.9 -27.28 62.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.95999999999999996 110.602 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.75 -29.6 67.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.183 0.516 . . . . 1.1899999999999999 109.743 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -84.04 -39.73 19.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.428 -0.805 . . . . 1.7 110.196 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.94 -32.01 73.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.506 . . . . 1.6200000000000001 110.404 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -61.21 -25.47 67.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 1.26 110.328 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.429 ' HA ' HG22 ' C' ' 90' ' ' THR . 51.2 mt -73.12 -26.32 61.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 1.1100000000000001 110.629 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 1.51 110.795 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.83 -32.46 35.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 2.0600000000000001 111.107 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . 0.429 HG22 ' HA ' ' C' ' 87' ' ' LEU . 10.0 t -81.48 -23.27 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.227 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -36.13 15.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.3 111.274 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -123.24 121.63 36.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 110.948 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -76.35 -35.14 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 3.2400000000000002 110.835 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.99 141.47 46.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.022 -0.536 . . . . 4.6299999999999999 110.796 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -126.44 142.56 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 2.1800000000000002 110.867 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -91.99 169.42 10.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 4.1200000000000001 111.095 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.75 81.19 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 4.96 111.114 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.74 -42.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 3.9100000000000001 111.012 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 91.7 m95 51.02 76.98 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 5.21 111.081 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 74.6 p -120.26 -57.79 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.945 -0.57 . . . . 1.8200000000000001 110.985 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.22 -45.07 27.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 2.0800000000000001 110.967 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.94 -33.35 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.341 -0.39 . . . . 1.8600000000000001 110.897 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.07 -42.47 51.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.791 -0.719 . . . . 0.58999999999999997 112.56 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -63.11 -36.61 84.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 1.53 110.869 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' C' ' 84' ' ' LEU . 85.1 mt -67.85 -52.88 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.551 . . . . 1.1100000000000001 110.86 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -53.27 -43.1 67.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.732 . . . . 2.21 110.928 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . 0.422 ' HB3' ' CD1' ' B' ' 42' ' ' PHE . 49.0 m -64.27 -42.38 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.559 . . . . 1.28 110.828 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.567 HG21 HG21 ' C' ' 142' ' ' ILE . 98.3 m -60.93 -27.26 68.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.962 -0.563 . . . . 1.22 111.252 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 6.3 tp-100 -75.14 -33.99 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 2.3300000000000001 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.648 HG22 ' HE1' ' B' ' 46' ' ' TRP . 32.0 mm -62.41 -43.85 98.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 1.29 111.684 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.461 HG11 HG22 ' B' ' 45' ' ' ILE . 19.9 m -67.07 -41.06 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.881 0.326 . . . . 1.0600000000000001 111.881 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.506 HG13 H133 ' C' ' 210' ' ' LYR . 75.0 t -62.64 -48.77 86.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.936 0.347 . . . . 0.51000000000000001 111.936 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' C' ' 77' ' ' MET . 70.2 mt -56.53 -36.74 48.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.718 0.294 . . . . 1.3700000000000001 111.028 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 54.2 m -57.64 -49.64 75.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.77000000000000002 111.223 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -64.29 -20.47 66.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.425 . . . . 1.1899999999999999 110.799 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.34 -32.89 24.28 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.912 -0.661 . . . . 0.5 113.087 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.532 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.7 pp -82.92 -25.39 32.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.707 0.289 . . . . 1.47 111.399 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.532 ' N ' HD12 ' C' ' 117' ' ' LEU . 9.8 tp -83.77 -31.55 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.387 -0.37 . . . . 1.2 111.161 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.9 75.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.40000000000000002 111.027 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.41 -28.62 46.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 2.1200000000000001 110.97 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.1 13.62 2.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.213 -0.449 . . . . 0.75 111.03 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 48.1 t -71.06 127.71 33.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 1.3799999999999999 110.823 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -93.26 -65.08 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 2.7400000000000002 110.707 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.507 ' HB2' HG12 ' C' ' 127' ' ' VAL . 99.1 mtt180 -69.07 141.57 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 2.7999999999999998 110.498 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.3 -11.57 59.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 2.4100000000000001 111.492 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -91.68 -30.24 16.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.67 0.272 . . . . 4.2000000000000002 111.157 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.507 HG12 ' HB2' ' C' ' 124' ' ' ARG . 8.5 p -80.5 -24.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 1.0800000000000001 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . 0.435 ' CZ ' ' H ' ' C' ' 190' ' ' PHE . 43.0 ttp180 -57.65 -29.41 64.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.5699999999999998 111.029 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.05 -26.57 59.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 3.8100000000000001 111.151 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' C' ' 127' ' ' VAL . 9.4 mp -76.71 -53.57 7.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 1.4199999999999999 111.182 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -32.44 71.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 0.89000000000000001 111.212 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -57.8 -52.58 64.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.382 . . . . 1.26 110.987 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.85 -32.4 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 1.6799999999999999 111.296 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 81.3 m -63.73 -39.27 93.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 1.24 110.958 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.23 -57.4 15.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.654 -0.784 . . . . 0.54000000000000004 112.411 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -57.85 -32.65 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 1.0600000000000001 111.211 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.9 t -56.49 -43.55 79.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.343 -0.389 . . . . 1.0800000000000001 110.812 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . 0.414 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -65.16 -34.11 77.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 110.644 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . 0.451 ' HB2' H131 ' C' ' 210' ' ' LYR . 75.8 t80 -75.46 -22.79 56.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.983 -0.553 . . . . 1.6799999999999999 111.212 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 89.8 mt -68.05 -55.88 10.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.678 0.275 . . . . 1.7 111.275 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.471 HG13 ' N ' ' C' ' 142' ' ' ILE . 37.4 pt -59.46 -42.16 86.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.859 0.361 . . . . 0.78000000000000003 111.171 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.567 HG21 HG21 ' C' ' 108' ' ' THR . 49.5 mm -66.08 -35.43 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 2.2400000000000002 110.877 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -52.61 -50.27 63.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 1.02 110.751 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -61.48 -32.75 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 3.0 110.504 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.42 -27.69 67.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.7 -0.762 . . . . 1.27 112.479 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . 0.426 HG12 ' O ' ' C' ' 142' ' ' ILE . 43.2 mm -74.5 -27.31 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.057 0.456 . . . . 1.8899999999999999 110.767 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -89.45 4.76 48.05 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.837 -0.62 . . . . 1.6000000000000001 111.233 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 58.5 t-20 -82.36 -48.69 0.87 Allowed Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 112.402 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 78.3 Cg_exo -40.33 -30.26 0.45 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.652 2.235 . . . . 2.73 113.009 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 95.6 mt -90.16 51.21 1.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 4.2999999999999998 110.722 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -58.13 163.29 2.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.025 -0.534 . . . . 8.9000000000000004 111.011 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.06 -23.19 52.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 2.7999999999999998 111.045 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -83.1 3.54 30.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 5.4400000000000004 110.649 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 28.9 m -71.91 -16.98 62.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 3.3900000000000001 111.199 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -58.7 -26.63 64.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 6.9199999999999999 111.014 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 68.6 p -93.74 -23.98 18.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 4.8700000000000001 111.245 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.01 -70.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 4.0499999999999998 111.102 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 79.0 p -161.33 115.46 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 3.0299999999999998 111.045 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 48.6 m -77.6 -35.55 52.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 2.96 111.047 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -63.68 -50.77 67.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 3.7400000000000002 111.235 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.06 -34.48 73.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 2.6499999999999999 111.127 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.94 -22.24 59.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 1.77 111.13 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -68.26 -57.52 5.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 2.96 110.98 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . 0.493 HD12 ' N ' ' C' ' 165' ' ' TYR . 4.1 pp -65.74 -24.71 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 2.3500000000000001 111.406 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . 0.493 ' N ' HD12 ' C' ' 164' ' ' LEU . 2.4 t80 -81.39 -25.95 35.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.312 -0.404 . . . . 2.6200000000000001 110.9 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.27 -46.4 64.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 2.0899999999999999 111.11 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . 0.59 ' HB3' ' HZ3' ' C' ' 167' ' ' LYS . 4.9 ttpm? -75.33 -29.48 59.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 3.2400000000000002 110.878 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.402 HD11 HD22 ' C' ' 87' ' ' LEU . 52.4 tp -66.53 -61.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 1.6899999999999999 111.317 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 85.5 t -53.82 -35.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 1.3999999999999999 111.459 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -53.95 -54.15 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 0.95999999999999996 111.075 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . 0.511 ' O ' HG12 ' C' ' 174' ' ' VAL . 30.0 t80 -70.92 -29.9 66.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.006 -0.543 . . . . 3.6499999999999999 110.806 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -67.48 -31.21 71.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 1.3700000000000001 111.55 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 40.4 p -77.19 -40.61 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.93 0.344 . . . . 1.4299999999999999 111.93 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . 0.511 HG12 ' O ' ' C' ' 171' ' ' TYR . 10.9 p -64.2 -25.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 1.6200000000000001 111.524 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' C' ' 171' ' ' TYR . 87.4 mt -77.66 -57.87 3.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.031 0.443 . . . . 2.0299999999999998 111.257 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 -28.06 62.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.62 111.424 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.423 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.1 tp -87.54 -22.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.993 0.425 . . . . 1.5800000000000001 110.341 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.84 -51.52 57.63 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.56000000000000005 112.844 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.649 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -57.01 -56.42 33.7 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.883 -0.327 . . . . 1.3300000000000001 111.165 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.9 Cg_exo -45.42 -30.47 5.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.177 1.918 . . . . 0.63 112.612 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.419 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.5 mt -65.82 -57.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.93000000000000005 111.314 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.543 HG22 ' O ' ' C' ' 179' ' ' TYR . 17.3 m -62.67 -25.42 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 1.27 111.466 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . 0.427 ' CD1' H191 ' C' ' 210' ' ' LYR . 40.7 m95 -69.92 -16.5 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 1.77 111.017 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.21 -38.21 81.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.379 -0.373 . . . . 2.3900000000000001 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.52 170.25 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.392 -0.367 . . . . 1.95 111.157 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 87.15 -170.08 40.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.801 -0.714 . . . . 1.8799999999999999 112.755 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.7 158.28 56.85 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.629 2.22 . . . . 3.1200000000000001 111.703 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 92.4 p 48.99 25.88 1.2 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.336 -0.393 . . . . 2.6299999999999999 110.881 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -173.14 63.86 0.13 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.029 -0.605 . . . . 3.04 112.502 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . 0.435 ' H ' ' CZ ' ' C' ' 128' ' ' ARG . 65.0 t80 56.19 91.44 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.848 0.356 . . . . 5.6900000000000004 111.14 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 137.6 150.99 5.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 3.0800000000000001 112.33 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -133.41 75.83 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 7.5300000000000002 111.016 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 41.5 pt -106.57 -179.39 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 2.8599999999999999 111.012 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -52.65 136.53 32.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.292 -0.413 . . . . 3.6899999999999999 110.952 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -72.5 -22.04 61.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 5.4800000000000004 110.782 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 79.0 p -66.55 -37.26 84.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 2.3799999999999999 111.11 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 44.4 mm -69.84 -43.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 2.23 111.068 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.56 -56.9 14.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 2.1600000000000001 111.211 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 77.4 p -64.93 -20.74 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 1.27 111.654 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.99 -37.0 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.331 . . . . 1.7 111.136 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 52.7 tp -78.92 -39.77 33.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 2.02 111.44 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.09 0.62 10.99 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.435 -0.348 . . . . 1.8200000000000001 111.344 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 52.9 t -96.15 -44.85 7.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.049 0.452 . . . . 1.3500000000000001 110.397 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.1 -31.09 62.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.728 -0.669 . . . . 0.65000000000000002 111.799 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.578 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -61.02 -54.8 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.818 -0.353 . . . . 1.4199999999999999 111.053 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 41.9 Cg_exo -58.06 -37.28 96.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.68 1.587 . . . . 0.63 110.687 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.23 -26.88 66.76 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.975 -0.557 . . . . 1.49 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.38 -28.84 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.651 -0.704 . . . . 1.7 110.511 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 44.5 t -79.33 -40.51 30.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 1.25 110.924 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.774 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.69 -35.27 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 1.6100000000000001 111.1 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.16 -33.43 61.14 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.977 -0.63 . . . . 0.81999999999999995 112.785 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -72.71 -32.52 65.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.695 0.283 . . . . 3.0800000000000001 111.01 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . 0.412 ' O ' HD13 ' C' ' 218' ' ' LEU . 48.1 t -58.65 -62.64 1.71 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.36 -0.382 . . . . 1.1499999999999999 110.83 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -60.94 -24.54 66.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 2.5600000000000001 111.242 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.86 -51.52 47.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.29 110.91 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 18.7 t70 -54.59 -40.03 68.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 2.3900000000000001 111.169 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . 0.412 HD13 ' O ' ' C' ' 214' ' ' SER . 11.1 mp -66.13 -37.4 85.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.385 . . . . 2.0299999999999998 111.241 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -75.11 -27.71 59.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 3.21 111.11 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.46 -19.86 79.74 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.687 -0.768 . . . . 1.3600000000000001 112.46 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 79.4 mt -58.48 -51.78 68.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.68 0.276 . . . . 2.8999999999999999 111.206 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 58.86 -86.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.118 -0.492 . . . . 4.8899999999999997 111.201 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -85.14 142.8 29.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.419 -0.355 . . . . 4.2300000000000004 110.503 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.58 90.2 7.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 6.1200000000000001 111.076 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -122.38 133.79 54.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.051 -0.522 . . . . 4.5499999999999998 110.8 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -119.27 141.91 48.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 6.7800000000000002 111.16 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 49.0 m -99.79 133.76 43.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 5.4000000000000004 110.773 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -100.41 11.44 39.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 8.3300000000000001 111.071 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 7.9100000000000001 110.895 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.831 0.348 . . . . 5.1100000000000003 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -78.09 83.9 4.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 5.04 110.797 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 78.9 mt -76.57 168.17 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 5.5800000000000001 110.872 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.76 32.6 4.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 5.0199999999999996 110.873 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 t -143.66 82.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.565 . . . . 2.4500000000000002 110.649 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.3 mm? -97.37 100.37 11.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 2.4199999999999999 111.002 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.4 mm? -74.69 -27.01 60.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.351 -0.386 . . . . 2.0899999999999999 110.628 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 33.9 m170 -75.37 -34.63 61.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 1.1599999999999999 110.269 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.466 ' O ' HG12 ' A' ' 12' ' ' VAL . 58.9 t-105 -67.37 -48.27 67.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.79000000000000004 110.426 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 pt -66.23 -20.37 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.41 . . . . 2.0800000000000001 110.223 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.475 ' O ' ' HG2' ' A' ' 15' ' ' MET . 7.9 t80 -60.48 -60.54 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.85 -0.614 . . . . 1.28 110.266 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 9' ' ' TRP . 9.7 p -57.92 -30.07 37.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 110.525 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.93 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 0.63 110.943 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.97 -31.53 52.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.55000000000000004 112.365 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 71.4 mmm -69.68 -44.31 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 1.03 110.69 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.4 p -60.22 -58.48 8.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.863 -0.608 . . . . 1.3 111.219 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.8 pp -56.78 -22.42 15.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.301 -0.409 . . . . 1.3100000000000001 111.279 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.27 -62.5 5.57 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.637 -0.792 . . . . 0.77000000000000002 112.407 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.42 59.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.289 . . . . 0.80000000000000004 111.262 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 17' ' ' ILE . 86.4 mt -74.89 -35.98 62.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 1.8100000000000001 110.801 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -58.94 -42.52 89.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 1.8799999999999999 110.778 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.45 -20.4 57.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 4.4500000000000002 110.677 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 50.2 t-105 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 3.6899999999999999 110.264 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -79.92 -34.56 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.5700000000000001 110.914 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -81.87 -1.99 49.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 1.95 110.735 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.3 p -56.42 -26.9 55.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 1.3799999999999999 110.714 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -46.98 -36.3 7.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.257 0.551 . . . . 4.0700000000000003 109.825 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.0 p-10 -164.05 131.97 2.63 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.307 -0.861 . . . . 2.7200000000000002 110.132 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 27.7 Cg_endo -94.03 -178.84 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.074 2.516 . . . . 1.9099999999999999 112.502 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -89.35 35.95 0.82 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 4.7599999999999998 111.262 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.78 -40.65 2.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 1.99 112.664 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 HD22 ' A' ' 221' ' ' LEU . 18.0 m -76.46 137.51 67.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.635 0.255 . . . . 2.7000000000000002 110.889 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 24.0 Cg_exo -65.12 166.08 19.9 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.578 2.185 . . . . 1.79 112.06 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.514 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -60.7 -18.56 54.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 4.1200000000000001 111.66 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.514 ' H ' HE21 ' A' ' 34' ' ' GLN . 2.4 p90 -48.12 -39.29 20.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.737 0.303 . . . . 2.9300000000000002 111.173 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.44 -48.74 63.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.922 0.392 . . . . 2.8799999999999999 110.514 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -59.94 -29.4 68.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 4.6600000000000001 110.632 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.54 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 1.45 110.989 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.02 -27.97 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 1.78 111.081 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.32 -9.95 59.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.63 110.993 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.408 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 49.6 ttp -89.57 -38.89 13.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 1.48 111.222 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.4 -41.42 73.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 3.5 111.861 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 30.7 mm -50.59 -52.25 57.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 112.313 0.486 . . . . 1.0800000000000001 112.313 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.2 Cg_endo -70.15 -32.51 16.82 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.296 1.997 . . . . 0.53000000000000003 113.122 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.69 -62.3 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.548 0.213 . . . . 1.6799999999999999 111.51 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.582 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.7 OUTLIER -60.66 -58.63 7.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.735 0.302 . . . . 1.8300000000000001 111.017 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.2 t -55.71 -26.09 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 1.0900000000000001 110.958 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.3 -58.88 11.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.715 -0.755 . . . . 0.40999999999999998 112.249 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.47 -28.44 65.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.835 0.35 . . . . 0.98999999999999999 110.834 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 -56.24 17.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.47999999999999998 111.161 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 30.3 m-85 -62.25 -38.67 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 1.8700000000000001 110.914 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.2 ttp -55.72 -31.07 62.17 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.0 0.429 . . . . 1.49 110.315 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.14 -40.04 71.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.58999999999999997 110.491 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.9 mtt -55.94 -33.96 65.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.815 -0.63 . . . . 0.48999999999999999 110.322 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -66.15 -49.51 67.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.59999999999999998 110.416 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.546 HG21 HG23 ' B' ' 127' ' ' VAL . 10.5 mt -74.58 -3.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 1.3100000000000001 110.818 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 60.64 51.49 4.97 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.737 -0.665 . . . . 1.9099999999999999 111.269 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -133.67 122.21 23.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 1.6200000000000001 110.933 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.07 -1.05 3.73 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.817 -0.706 . . . . 1.04 112.443 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -111.45 153.71 25.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.771 0.32 . . . . 2.6800000000000002 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.84 140.23 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 1.98 111.46 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -87.46 92.64 9.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 2.1800000000000002 110.749 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.15 118.36 35.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.5700000000000001 111.147 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.83 28.32 17.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 1.79 111.562 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.66 -10.46 64.7 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.705 -0.76 . . . . 1.48 112.949 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -98.07 147.43 24.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 2.3199999999999998 110.749 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.1 mt -89.72 122.22 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.4399999999999999 111.134 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.92 143.9 28.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.81999999999999995 111.202 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 92.4 m-70 -88.07 64.66 7.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 110.74 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.99 -56.0 18.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 1.8300000000000001 111.39 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.23 -22.54 63.15 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.129 0.418 . . . . 0.62 112.129 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 10.7 mpt_? -68.43 -52.37 33.46 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.921 0.341 . . . . 2.3399999999999999 111.921 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 117' ' ' LEU . 2.4 p90 -69.31 -32.95 72.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 3.4900000000000002 110.819 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.9 mm -51.48 -53.27 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.278 -0.419 . . . . 1.3700000000000001 110.519 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 79' ' ' THR . 22.1 t70 -62.72 -29.32 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 1.3100000000000001 110.002 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -80.94 6.85 12.09 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.047 -0.524 . . . . 1.48 111.305 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.578 ' HA ' HD13 ' A' ' 113' ' ' ILE . 53.1 tpp -105.11 -20.29 13.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 1.46 110.452 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.4 m -114.26 -36.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.739 0.644 . . . . 1.1200000000000001 112.739 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.1 t -79.9 -35.75 37.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.351 0.5 . . . . 1.1000000000000001 112.351 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 36.7 m -65.97 -50.39 52.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 111.851 0.315 . . . . 0.59999999999999998 111.851 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 51.8 Cg_exo -56.21 -38.24 95.32 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.787 1.658 . . . . 0.73999999999999999 111.369 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -74.07 -32.08 63.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 1.01 110.823 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.464 ' CD2' ' H43' ' A' ' 210' ' ' LYR . 13.2 tp -67.2 -28.12 67.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.939 0.399 . . . . 1.48 110.381 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 105' ' ' LEU . 5.3 tt -84.08 -36.2 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.918 -0.583 . . . . 1.3799999999999999 110.406 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -61.72 -37.51 84.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.082 -0.508 . . . . 1.1899999999999999 110.479 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.479 ' O ' HG23 ' A' ' 90' ' ' THR . 44.6 t -56.83 -30.51 63.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.972 -0.558 . . . . 1.23 110.701 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.11 -34.51 78.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.88 111.209 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.0 t -71.71 -39.65 70.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 1.3899999999999999 111.393 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -68.73 -26.33 65.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 2.3199999999999998 111.097 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 86' ' ' SER . 71.8 p -82.96 -23.49 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.538 -0.301 . . . . 1.46 111.365 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.25 -33.85 16.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 1.24 111.046 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 86.1 mtp -130.72 99.21 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 2.0699999999999998 110.782 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -62.22 -44.93 95.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 3.5299999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -109.19 147.19 32.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 4.0800000000000001 111.139 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.83 142.05 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 2.1699999999999999 110.599 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -125.06 -67.72 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 4.5199999999999996 110.98 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -146.94 93.07 2.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.182 -0.463 . . . . 3.75 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -166.74 63.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 3.5299999999999998 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -89.68 16.91 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 4.9100000000000001 111.044 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.3 p -98.22 -25.64 14.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 1.98 111.314 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 101' ' ' LEU . 3.8 mm? -80.96 -53.71 6.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 1.8300000000000001 110.994 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.61 -22.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 1.79 111.306 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.38 -49.34 8.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.674 -0.774 . . . . 0.62 112.653 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.99 -39.69 86.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 1.5800000000000001 111.056 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.698 ' HB3' HD21 ' A' ' 84' ' ' LEU . 80.4 mt -61.71 -58.62 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.027 -0.533 . . . . 0.97999999999999998 111.051 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.3 ttm -53.67 -32.55 52.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.894 -0.594 . . . . 1.48 111.111 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' C' ' 42' ' ' PHE . 71.5 m -66.13 -55.63 15.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.1299999999999999 111.167 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -53.88 -29.19 40.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 1.48 111.069 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.459 ' NE2' HG22 ' A' ' 80' ' ' THR . 15.5 mm100 -62.87 -52.91 61.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 2.7000000000000002 110.87 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.642 HG22 ' HE1' ' C' ' 46' ' ' TRP . 33.8 mm -53.42 -30.64 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 1.54 110.849 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.44 -49.15 55.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 1.28 111.233 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.68 -46.17 96.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.42999999999999999 111.319 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 77' ' ' MET . 53.0 mt -58.7 -34.55 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.74 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 41.6 m -56.42 -51.45 68.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.63 110.695 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.4 m -65.39 -20.68 66.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.49 ' HA3' H181 ' A' ' 210' ' ' LYR . . . -80.45 -40.71 12.52 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.803 -0.713 . . . . 0.41999999999999998 113.085 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.4 pp -73.85 -29.68 62.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.557 0.217 . . . . 1.3799999999999999 111.422 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.4 tp -83.72 -29.64 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 1.6200000000000001 111.428 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.78 68.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.402 . . . . 0.39000000000000001 111.149 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -80.63 -21.66 41.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 2.02 110.816 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 118' ' ' ILE . 76.9 mt -84.61 10.75 10.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.76000000000000001 111.001 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.5 p -70.08 120.94 16.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 1.46 111.151 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -96.97 -65.17 0.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.129 -0.487 . . . . 3.3500000000000001 110.787 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.6 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.1 mtp180 -69.77 134.12 48.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 2.9199999999999999 110.61 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.68 -11.48 60.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 2.77 110.966 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -81.0 -55.24 4.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.401 . . . . 3.77 110.635 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.6 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.7 p -65.9 -23.68 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 1.1599999999999999 110.916 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -52.28 -37.24 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 2.04 111.327 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -73.95 -26.46 60.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 2.6400000000000001 111.303 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 130' ' ' LEU . 8.4 mp -79.39 -39.08 33.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 1.8999999999999999 111.567 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -75.75 -26.5 57.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 1.3999999999999999 111.283 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HE1' ' HB3' ' A' ' 183' ' ' TRP . 53.4 t80 -68.35 -48.25 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 1.28 110.907 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -65.9 -29.81 48.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 2.1600000000000001 110.898 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.4 t -64.43 -38.71 91.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.254 -0.43 . . . . 1.6899999999999999 110.792 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.68 -54.27 23.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.75 -0.738 . . . . 0.52000000000000002 112.636 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.95 -30.77 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.712 0.292 . . . . 1.02 111.545 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.11 -43.65 97.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.866 0.365 . . . . 1.0800000000000001 110.894 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.47 86.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.083 -0.508 . . . . 0.62 110.709 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -63.03 -28.26 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 1.8400000000000001 110.853 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.87 -60.74 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 1.6899999999999999 111.397 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 pt -59.3 -41.13 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.325 -0.398 . . . . 0.81000000000000005 111.867 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -65.51 -33.48 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 2.3700000000000001 111.391 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.3 tp -68.05 -40.14 82.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.445 -0.343 . . . . 0.97999999999999998 111.049 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.702 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 54.3 t-105 -69.28 -25.01 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 3.27 110.881 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.769 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -80.9 -41.66 10.41 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.971 -0.633 . . . . 1.25 112.669 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.86 -18.18 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.374 . . . . 2.1200000000000001 111.14 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -88.0 4.92 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 1.6599999999999999 111.466 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.769 ' ND2' ' HA2' ' A' ' 145' ' ' GLY . 69.1 m-80 -91.23 -44.61 0.38 Allowed Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.84 0.682 . . . . 99.989999999999995 112.84 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 26.8 Cg_exo -30.47 -60.68 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.13 2.554 . . . . 2.6000000000000001 113.741 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.469 HD22 ' HB ' ' A' ' 154' ' ' THR . 99.0 mt -147.56 121.23 9.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.551 0.215 . . . . 4.6100000000000003 111.209 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -173.92 -45.74 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.525 -0.307 . . . . 8.3599999999999994 111.82 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.75 -59.18 2.59 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.797 0.665 . . . . 2.75 112.797 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.38 -39.07 54.74 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 112.47 0.544 . . . . 5.6799999999999997 112.47 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.469 ' HB ' HD22 ' A' ' 150' ' ' LEU . 12.5 t -60.98 -14.68 24.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.001 0.371 . . . . 3.21 112.001 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -66.24 -34.74 78.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.619 -0.264 . . . . 6.8700000000000001 111.6 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.2 m -102.71 -28.78 11.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.56 -0.291 . . . . 4.5599999999999996 111.581 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -59.7 -71.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.818 0.342 . . . . 3.5600000000000001 110.96 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.8 t -133.09 119.91 20.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.811 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 55.9 m -76.47 -22.46 54.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 2.5899999999999999 110.873 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.71 -57.12 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 3.4700000000000002 110.986 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.4 tp -65.07 -19.79 66.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 2.5800000000000001 111.018 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.25 -41.4 34.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 1.78 111.184 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.7 -38.83 92.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 2.6299999999999999 111.087 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.57 -46.32 79.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 2.3399999999999999 110.833 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.7 -22.58 60.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.768 -0.651 . . . . 2.77 111.217 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.07 -50.66 21.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 2.04 111.055 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -75.01 -20.66 59.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 2.77 111.167 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.4 tp -77.07 -50.6 12.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.338 -0.392 . . . . 1.8899999999999999 111.598 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.92 -35.44 49.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.226 -0.443 . . . . 1.6399999999999999 112.08 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -56.95 -35.78 69.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.782 0.325 . . . . 1.24 110.939 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -77.84 -35.29 51.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 2.9700000000000002 110.487 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -70.01 -22.31 63.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 1.48 110.16 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 57.5 m -79.42 -48.38 14.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.852 -0.613 . . . . 1.55 111.519 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.57 HG13 HD22 ' A' ' 175' ' ' LEU . 7.3 p -62.19 -33.42 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 112.272 0.471 . . . . 1.52 112.272 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.57 HD22 HG13 ' A' ' 174' ' ' VAL . 4.0 mm? -76.52 -52.77 9.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.8 0.333 . . . . 1.8500000000000001 110.96 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -31.4 64.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.62 110.905 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.469 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 14.4 tt -87.65 -19.51 7.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.053 0.454 . . . . 1.3500000000000001 110.198 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.23 -50.91 60.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.58999999999999997 112.773 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.1 m-85 -58.37 -54.88 51.36 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.719 0.26 . . . . 1.45 111.308 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.5 Cg_exo -45.7 -30.88 6.86 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.283 1.989 . . . . 0.55000000000000004 112.571 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 177' ' ' ILE . 37.3 mm -68.98 -60.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 1.4199999999999999 111.454 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 179' ' ' TYR . 27.5 m -60.32 -25.53 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.78000000000000003 111.715 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.455 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 38.0 m95 -62.98 -27.23 69.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.623 -0.262 . . . . 0.93999999999999995 111.016 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.82 -43.69 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 1.4299999999999999 110.779 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 39.5 pt -97.67 145.68 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.524 . . . . 2.02 111.011 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.86 -163.42 17.31 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.809 -0.71 . . . . 1.79 112.491 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.39 160.98 47.69 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.463 2.109 . . . . 3.1000000000000001 112.1 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 89.4 p 49.86 24.64 1.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 2.7400000000000002 110.766 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -140.12 -68.84 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.02 -0.609 . . . . 3.4300000000000002 112.376 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -167.5 -28.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 6.5 110.535 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.6 -155.95 4.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.96 -0.638 . . . . 3.29 112.626 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -158.65 28.51 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.327 . . . . 6.1600000000000001 110.904 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.5 pt -95.12 153.76 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 2.4199999999999999 111.35 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -156.63 35.35 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.988 -0.551 . . . . 4.29 110.42 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -93.21 -172.52 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.96 -0.564 . . . . 5.1500000000000004 111.065 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 52.3 m -64.31 -34.61 78.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 2.4500000000000002 111.507 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt -58.23 -33.13 46.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.367 -0.378 . . . . 2.48 111.588 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.86 -60.86 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 2.1800000000000002 111.271 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.4 t -62.57 -35.25 78.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.367 . . . . 1.49 111.173 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -59.11 -26.87 65.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 1.77 111.062 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 61.5 tp -78.11 -46.8 19.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.4199999999999999 110.998 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -74.0 -8.19 55.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 1.78 111.377 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.406 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 99.4 m -96.06 -39.2 9.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.086 0.47 . . . . 1.3 110.897 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.0 tp -72.95 -34.34 66.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.928 -0.578 . . . . 0.66000000000000003 111.734 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.542 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -59.42 -54.54 55.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 121.102 -0.239 . . . . 1.6299999999999999 111.174 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -57.28 -41.89 68.44 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.734 1.623 . . . . 0.64000000000000001 111.456 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.05 -28.05 69.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 1.3600000000000001 110.067 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -83.73 -21.46 32.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.784 -0.644 . . . . 1.54 110.386 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.9 p -94.8 -16.11 23.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.961 -0.563 . . . . 1.2 110.347 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.74 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.7 m -80.18 -37.03 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 1.6399999999999999 111.503 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.14 -37.13 91.26 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.733 -0.746 . . . . 0.79000000000000004 112.618 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -64.17 -35.69 81.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 1.6100000000000001 110.756 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.2 m -59.83 -60.62 3.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 1.1499999999999999 111.143 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.55 -21.29 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.23 -0.441 . . . . 3.3399999999999999 111.29 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.1 tt -68.88 -44.83 72.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.434 -0.348 . . . . 1.1899999999999999 110.715 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -66.99 -32.51 73.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 2.23 110.993 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.48 -40.68 96.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 2.4700000000000002 110.953 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -86.61 -20.94 27.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 1.6200000000000001 110.888 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.39 -41.27 99.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 1.4099999999999999 112.457 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.466 HD22 HG12 ' A' ' 32' ' ' VAL . 60.1 tp -65.0 -55.7 17.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 2.5800000000000001 110.961 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 55.4 84.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 4.9299999999999997 110.824 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -66.57 112.07 3.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 4.6299999999999999 111.05 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 52.8 tp -132.76 96.98 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.999 -0.546 . . . . 6.4699999999999998 110.404 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.57 80.04 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 5.0700000000000003 110.748 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.22 65.52 6.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.225 -0.443 . . . . 6.5300000000000002 110.857 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 79.3 p -56.52 107.35 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.565 . . . . 5.2199999999999998 111.035 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -111.41 124.19 51.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 8.3599999999999994 110.843 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 7.96 110.964 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.873 0.368 . . . . 6.1699999999999999 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -76.36 88.56 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 4.8200000000000003 110.678 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.16 150.64 25.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 5.5999999999999996 110.899 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -88.16 23.48 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.516 . . . . 4.7999999999999998 110.966 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.6 m -93.22 -70.87 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 2.3700000000000001 110.803 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 mt 57.21 72.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 2.0699999999999998 111.273 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.413 ' N ' HD22 ' B' ' 7' ' ' LEU . 3.6 mm? -77.58 -32.0 53.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 2.1000000000000001 110.472 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 26.9 m170 -73.47 -29.12 62.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0700000000000001 110.414 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -70.85 -40.78 72.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.938 -0.574 . . . . 1.48 110.336 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.31 -25.27 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 2.02 110.348 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.67 -53.86 52.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.653 -0.703 . . . . 0.92000000000000004 110.725 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -64.91 -29.78 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.93999999999999995 110.778 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.68 87.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.55000000000000004 111.186 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.58 -34.35 54.08 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.825 -0.702 . . . . 0.47999999999999998 112.481 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.68 76.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.84999999999999998 111.105 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 37.3 m -60.29 -57.34 13.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 1.3400000000000001 111.178 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -60.1 -22.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 1.55 111.187 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.86 -63.7 4.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.69999999999999996 112.573 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -32.0 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.81000000000000005 111.196 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' B' ' 17' ' ' ILE . 95.9 mt -66.63 -39.6 88.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 2.2599999999999998 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.88 -35.16 74.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 1.78 110.726 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -79.23 -20.19 48.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 4.5800000000000001 110.637 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -67.05 -36.67 82.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 3.3500000000000001 110.657 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.6 m -81.44 -35.03 31.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 1.5800000000000001 110.531 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.39 -2.25 44.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.877 -0.602 . . . . 1.8400000000000001 110.34 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 57.7 p -61.98 -23.19 66.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.936 -0.574 . . . . 1.3700000000000001 110.828 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -49.99 -31.98 14.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.159 0.504 . . . . 4.9800000000000004 109.902 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.3 p-10 -170.49 132.13 0.94 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.342 -0.845 . . . . 2.1400000000000001 109.92 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 42.9 Cg_endo -95.26 172.72 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.092 2.528 . . . . 1.8200000000000001 112.55 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.544 ' HD3' HD22 ' B' ' 218' ' ' LEU . 14.9 ptm180 -88.28 45.72 1.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 5.1900000000000004 111.077 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.27 1.77 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.812 -0.709 . . . . 2.2000000000000002 112.824 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.5 123.24 89.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.488 0.185 . . . . 3.6499999999999999 110.986 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.421 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 33.3 Cg_exo -59.23 162.1 14.98 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.376 2.051 . . . . 2.6699999999999999 112.365 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . 0.4 ' HB2' HE21 ' B' ' 34' ' ' GLN . 0.0 OUTLIER -58.86 -18.08 29.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 4.8799999999999999 112.017 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.421 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 2.8 p90 -50.21 -38.09 38.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.682 0.277 . . . . 1.8700000000000001 111.281 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -73.14 -40.57 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 2.6800000000000002 110.651 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -64.68 -31.57 72.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 2.9199999999999999 110.724 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 104' ' ' PHE . 51.2 tp -62.14 -57.16 12.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 1.6399999999999999 110.706 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 14.4 t -65.07 -36.3 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 1.6000000000000001 110.808 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.12 47.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.68999999999999995 111.205 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 27.6 ttt -89.36 -41.71 11.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 2.5800000000000001 111.082 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -71.87 -34.62 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 3.3900000000000001 111.972 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 99.2 mt -54.57 -53.2 62.73 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.078 0.399 . . . . 0.40999999999999998 112.078 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.1 Cg_endo -70.53 -31.81 16.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.31 2.007 . . . . 0.48999999999999999 113.044 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 89.6 mt -62.38 -62.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.564 0.221 . . . . 1.29 111.543 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.583 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.9 OUTLIER -60.47 -56.55 20.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.73 0.3 . . . . 1.3999999999999999 110.98 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -57.23 -22.31 40.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 1.3799999999999999 110.953 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.29 -61.27 5.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.632 -0.794 . . . . 0.37 112.753 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.512 HD12 ' N ' ' B' ' 50' ' ' ALA . 3.3 pp -58.6 -22.74 57.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.625 0.25 . . . . 1.29 111.339 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.512 ' N ' HD12 ' B' ' 49' ' ' LEU . . . -64.96 -57.47 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.44 110.983 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 30.5 m-85 -63.67 -37.26 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.5 110.653 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -49.63 -38.51 32.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.007 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.66 77.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.55000000000000004 110.751 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 42.4 mtt -53.25 -24.91 12.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.5 110.527 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -77.13 -48.42 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.979 -0.555 . . . . 0.54000000000000004 110.78 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.56 11.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 1.3 111.434 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 61.44 67.27 0.79 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.03 -0.532 . . . . 2.2400000000000002 111.355 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -144.9 152.8 40.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.77 110.917 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 92.29 17.27 47.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.81 -0.709 . . . . 1.0600000000000001 112.467 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -128.95 148.81 50.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 2.6600000000000001 110.923 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.77 150.71 29.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 1.8899999999999999 110.859 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.36 94.9 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 2.4100000000000001 110.682 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.71 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 1.5600000000000001 111.152 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.23 30.28 20.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 1.8200000000000001 111.251 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.18 -15.64 48.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.857 -0.687 . . . . 1.51 112.913 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -98.37 146.81 25.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.801 0.334 . . . . 2.4500000000000002 110.781 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 54.6 mt -86.2 131.14 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 1.79 111.263 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.9 143.29 32.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.81999999999999995 111.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 72.3 m-70 -84.48 65.03 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.154 0.502 . . . . 1.05 110.682 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.41 ' HA ' ' CE1' ' B' ' 73' ' ' TYR . 76.7 t80 -63.82 -51.91 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.635 -0.712 . . . . 1.8700000000000001 111.581 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.427 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -64.61 -22.46 66.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.60999999999999999 111.933 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' B' ' 69' ' ' HIS . 22.4 tpp180 -68.46 -51.62 41.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.257 0.465 . . . . 2.3900000000000001 112.257 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' B' ' 77' ' ' MET . 6.0 p90 -76.33 -34.4 58.99 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.147 0.425 . . . . 3.6699999999999999 112.147 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.432 HG23 ' N ' ' B' ' 75' ' ' ASP . 18.2 tt -55.39 -43.74 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 120.656 -0.417 . . . . 1.6599999999999999 110.623 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.432 ' N ' HG23 ' B' ' 74' ' ' ILE . 29.6 t70 -68.67 -19.96 64.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.424 -0.584 . . . . 1.4099999999999999 109.424 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -88.43 4.14 47.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 111.306 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.6 ' HA ' HD13 ' B' ' 113' ' ' ILE . 31.8 mtp -101.65 -20.42 15.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.343 -0.39 . . . . 1.53 110.383 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.431 ' O ' HD23 ' B' ' 82' ' ' LEU . 32.7 m -113.92 -29.86 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.89000000000000001 111.87 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.441 HG23 HG23 ' B' ' 43' ' ' ILE . 30.6 m -81.3 -51.38 8.44 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.933 0.345 . . . . 1.24 111.933 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 21.8 m -52.27 -50.61 78.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.114 0.413 . . . . 0.57999999999999996 112.114 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.4 Cg_exo -53.75 -49.32 17.62 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.785 1.657 . . . . 0.66000000000000003 111.729 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.431 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -64.27 -31.25 72.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.135 -0.484 . . . . 1.0600000000000001 110.717 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.403 ' O ' HD13 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -63.54 -35.26 79.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.154 0.502 . . . . 1.22 109.956 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -84.27 -35.7 23.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 1.53 111.236 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 88.1 mt -58.61 -41.24 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 1.5800000000000001 111.054 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -59.02 -28.65 66.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 1.3899999999999999 110.827 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 mt -67.47 -32.32 73.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 1.1499999999999999 110.905 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 48.3 t -72.93 -39.38 66.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.5700000000000001 111.294 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -70.26 -24.69 63.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.36 -0.382 . . . . 2.1699999999999999 111.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 32.6 m -78.62 -30.95 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 1.4199999999999999 111.178 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.27 -25.41 25.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 1.1799999999999999 111.187 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -132.81 99.36 4.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 1.8799999999999999 110.815 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.28 -50.97 63.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 3.4199999999999999 110.984 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -104.77 143.38 33.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 4.0599999999999996 110.732 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 tt -124.9 142.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 2.0899999999999999 110.887 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.441 ' HG2' ' HG3' ' B' ' 97' ' ' LYS . 38.7 ttpt -128.31 -70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 3.8500000000000001 111.104 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.441 ' HG3' ' HG2' ' B' ' 96' ' ' LYS . 29.9 mtpp -141.81 95.84 2.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 4.8200000000000003 111.03 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -170.24 83.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 3.7999999999999998 110.907 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -106.49 14.24 27.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 5.1699999999999999 110.721 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 2.8 t -91.15 -42.0 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.5 . . . . 2.02 111.424 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.15 -47.07 59.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 2.0899999999999999 111.157 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -63.2 -32.33 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.8799999999999999 111.391 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.35 -31.81 33.0 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 0.56000000000000005 112.729 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -71.09 -36.65 72.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 1.78 111.002 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.546 ' HB3' HD21 ' B' ' 84' ' ' LEU . 88.0 mt -74.84 -44.27 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.239 -0.437 . . . . 1.03 111.063 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.7 ttp -65.53 -37.38 86.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.959 -0.564 . . . . 1.6699999999999999 111.351 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -65.7 -50.36 65.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.343 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 35.9 p -56.79 -34.33 67.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.331 -0.395 . . . . 1.1799999999999999 111.32 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.406 ' CG ' HD13 ' B' ' 84' ' ' LEU . 11.8 mm100 -61.52 -47.32 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 2.1699999999999999 111.139 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.582 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.5 mt -54.85 -35.09 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 1.3500000000000001 110.605 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 t -65.52 -47.32 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 1.3400000000000001 111.094 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.56 -47.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.192 -0.458 . . . . 0.42999999999999999 111.212 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' B' ' 77' ' ' MET . 47.0 mt -58.15 -33.26 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 1.6000000000000001 110.996 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.1 m -58.89 -48.65 80.65 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.178 -0.464 . . . . 0.85999999999999999 110.979 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.5 m -67.3 -23.23 65.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.974 -0.557 . . . . 0.94999999999999996 110.852 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.524 ' HA3' H181 ' B' ' 210' ' ' LYR . . . -80.35 -32.48 34.63 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.92 -0.657 . . . . 0.46000000000000002 113.375 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.504 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.4 pp -80.85 -28.89 35.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.706 0.289 . . . . 1.75 111.206 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.504 ' N ' HD12 ' B' ' 117' ' ' LEU . 8.9 tp -83.55 -31.25 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.385 . . . . 1.78 111.321 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.91 -47.06 74.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.299 -0.41 . . . . 0.38 110.957 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 -21.12 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.97 110.716 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' B' ' 118' ' ' ILE . 98.8 mt -81.64 14.79 2.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.077 -0.51 . . . . 0.76000000000000001 110.831 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 79.0 p -61.24 134.5 57.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 1.47 111.024 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -117.52 -45.21 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 2.5 110.832 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.604 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 59.4 ttp180 -108.23 132.66 53.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 2.73 110.64 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.7 -19.0 63.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 2.2000000000000002 111.252 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.604 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 52.4 t-105 -71.26 -53.65 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.401 -0.363 . . . . 3.3999999999999999 110.868 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.546 HG23 HG21 ' A' ' 56' ' ' ILE . 7.3 p -74.86 -24.09 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.23 111.106 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -52.42 -39.67 61.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 3.04 111.2 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -71.34 -32.59 68.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.391 . . . . 4.1399999999999997 111.384 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.58 -56.84 6.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 1.6499999999999999 111.189 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -58.01 -29.97 65.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.77000000000000002 111.416 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -62.26 -53.27 57.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 1.46 110.725 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 54.1 mt -60.85 -31.03 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 1.6299999999999999 110.775 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 18.6 t -61.48 -34.34 75.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 1.4199999999999999 110.859 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.05 -55.02 8.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.824 -0.703 . . . . 0.48999999999999999 112.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m -59.83 -32.94 50.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 1.3 110.955 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.3 t -65.61 -36.74 84.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 1.3 110.613 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.21 91.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.62 110.627 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -68.27 -23.23 64.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 1.74 110.787 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -58.82 5.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 1.76 110.802 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.413 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.7 pt -62.6 -40.15 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.68999999999999995 111.503 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.413 ' N ' HG13 ' B' ' 141' ' ' ILE . 87.6 mt -64.61 -33.99 66.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.76 110.909 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.75 -45.0 95.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 1.0600000000000001 110.942 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.81 -25.53 65.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 4.1200000000000001 111.286 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' B' ' 149' ' ' PRO . . . -81.92 -35.66 21.01 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 1.26 112.746 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 79.5 mt -75.6 -22.47 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.102 0.477 . . . . 1.98 110.454 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -87.08 4.65 41.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 1.4199999999999999 111.015 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.463 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 51.4 t30 -90.3 -47.78 0.38 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.008 -0.542 . . . . 99.989999999999995 112.147 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 79.7 Cg_exo -42.05 -32.95 2.04 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.567 2.178 . . . . 2.6499999999999999 112.869 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 64.6 tp -55.77 -57.7 10.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.416 . . . . 4.3899999999999997 110.387 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 63.44 128.59 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.095 -0.502 . . . . 7.9000000000000004 111.3 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.67 -18.02 57.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.84 -0.618 . . . . 2.77 111.161 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -62.83 -23.95 67.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.49 . . . . 6.29 111.278 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 73.3 p -80.36 -15.37 57.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.485 -0.325 . . . . 3.1000000000000001 111.615 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -70.37 -27.3 64.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.409 -0.36 . . . . 6.4299999999999997 110.891 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 4.6 t -107.5 -16.74 14.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.306 -0.406 . . . . 4.5700000000000003 111.442 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -79.28 -49.36 12.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.425 -0.352 . . . . 3.8300000000000001 110.999 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 66.7 m -151.12 116.2 5.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 3.0699999999999998 110.967 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 44.8 t -77.88 -22.05 50.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 3.4300000000000002 110.918 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.69 -61.86 1.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 3.9199999999999999 110.977 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.91 -25.02 60.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 2.7000000000000002 110.852 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.15 -57.74 3.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 1.8300000000000001 111.036 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -53.52 -23.25 9.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.087 0.47 . . . . 2.6299999999999999 110.427 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.0 tp -73.45 -40.32 64.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.626 -0.715 . . . . 2.4300000000000002 110.729 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -80.6 -25.16 38.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.891 -0.595 . . . . 2.5800000000000001 111.101 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -75.28 -38.48 60.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 2.0 110.97 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -79.95 -21.6 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 3.0299999999999998 110.791 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 48.7 tp -81.34 -46.12 15.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 1.1000000000000001 111.464 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.35 -33.77 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.75 112.282 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 9.9 t -51.73 -41.48 61.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.617 0.246 . . . . 0.97999999999999998 111.282 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . 0.447 ' O ' HG22 ' B' ' 174' ' ' VAL . 37.3 m-85 -77.02 -40.3 46.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 4.2999999999999998 110.709 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -62.11 -23.24 66.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.162 -0.472 . . . . 1.3899999999999999 110.865 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.408 ' O ' HG22 ' B' ' 177' ' ' ILE . 28.0 m -79.31 -50.8 10.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 1.1100000000000001 111.577 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 171' ' ' TYR . 32.7 m -59.51 -28.94 41.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.986 0.365 . . . . 1.51 111.986 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 77.5 mt -76.27 -57.02 4.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.905 0.383 . . . . 1.75 111.213 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -32.47 56.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.89 -0.596 . . . . 0.59999999999999998 111.224 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.442 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 19.1 tt -87.4 -19.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.046 0.451 . . . . 1.47 110.385 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.08 -51.26 59.45 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.742 -0.663 . . . . 0.55000000000000004 112.953 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.623 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 84.5 m-85 -58.22 -54.86 51.42 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.782 0.291 . . . . 1.6200000000000001 111.342 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 82.1 Cg_exo -45.26 -32.44 7.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.164 1.91 . . . . 0.64000000000000001 112.685 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.428 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.4 mt -65.62 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.254 -0.43 . . . . 1.27 111.462 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 179' ' ' TYR . 35.2 m -60.23 -27.01 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.68999999999999995 111.404 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -62.93 -25.91 68.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 1.1799999999999999 111.178 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.27 -40.93 79.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 1.77 110.716 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.59 -179.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.86 -0.609 . . . . 1.6899999999999999 110.798 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 67.86 -159.36 51.01 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.748 -0.739 . . . . 1.5800000000000001 112.695 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.2 160.0 36.52 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.755 2.304 . . . . 2.5099999999999998 112.322 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 59.8 m 56.93 17.75 3.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.094 -0.503 . . . . 3.5800000000000001 110.825 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -133.03 -60.13 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.038 -0.601 . . . . 4.0300000000000002 112.371 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -172.3 -31.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 6.8899999999999997 110.637 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -85.48 -174.78 50.16 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.878 -0.677 . . . . 3.7000000000000002 112.778 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -141.31 74.49 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 7.5 110.326 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 33.7 pt -134.97 146.72 30.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 2.3500000000000001 111.224 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -144.31 39.63 1.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 3.8599999999999999 110.715 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . 0.486 ' HB2' HG22 ' B' ' 197' ' ' ILE . 84.8 mm-40 -85.94 178.39 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 5.0499999999999998 111.098 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 8.6 t -67.69 -28.72 67.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.276 -0.42 . . . . 2.6800000000000002 110.771 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' B' ' 195' ' ' GLN . 7.7 tp -62.2 -29.53 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 2.4700000000000002 110.833 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.23 -60.65 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 2.5299999999999998 110.879 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 8.1 t -62.17 -36.83 83.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 1.29 111.152 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.69 -27.46 64.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.285 -0.416 . . . . 2.6200000000000001 110.758 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -75.89 -50.35 15.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 1.6100000000000001 111.049 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -73.02 -5.85 41.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.565 -0.289 . . . . 1.4199999999999999 110.843 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 60.8 m -96.48 -41.86 8.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.267 0.556 . . . . 1.4299999999999999 110.472 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.51 -38.38 74.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.578 -0.737 . . . . 1.1200000000000001 111.909 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.675 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 41.3 tp -58.3 -53.94 60.95 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 120.961 -0.296 . . . . 1.26 111.321 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -53.62 -42.08 68.81 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.791 1.661 . . . . 0.59999999999999998 111.399 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.09 -42.99 86.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 1.3999999999999999 110.343 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -69.81 -30.19 67.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.4099999999999999 110.457 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -82.31 -17.99 43.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.504 . . . . 1.3200000000000001 110.279 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.754 ' H9 ' H183 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 10.4 p -85.29 -33.19 7.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.273 -0.421 . . . . 1.6899999999999999 110.944 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.79 96.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.79000000000000004 112.339 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -69.47 -32.26 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.73 0.3 . . . . 2.96 110.875 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 49.2 m -59.91 -62.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 1.29 110.95 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.13 -20.33 65.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.589 . . . . 3.1499999999999999 110.945 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.11 -54.18 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 1.51 111.279 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.98 -37.48 76.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 2.1899999999999999 111.646 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' B' ' 30' ' ' ARG . 78.8 mt -59.16 -49.1 79.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 1.98 111.144 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -77.08 -20.53 55.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 2.1699999999999999 111.051 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.28 -47.93 86.19 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.881 -0.676 . . . . 1.3600000000000001 112.88 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 58.7 tp -58.34 -56.1 26.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.548 0.214 . . . . 2.8999999999999999 111.033 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 55.78 84.08 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.315 -0.402 . . . . 5.6100000000000003 110.848 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.53 104.91 6.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 4.04 110.869 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 54.7 tp -88.58 -74.0 0.48 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 6.2999999999999998 110.895 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -141.1 81.23 1.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 4.7999999999999998 110.611 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.12 91.41 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 6.3899999999999997 111.061 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 42.7 t -94.15 83.15 4.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.6100000000000003 110.756 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -87.0 142.61 27.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 8.1999999999999993 110.948 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 8.1699999999999999 110.947 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.792 0.33 . . . . 5.6200000000000001 111.102 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -59.65 152.75 21.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 5.2800000000000002 110.992 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -139.82 -66.42 0.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.04 -0.527 . . . . 6.0499999999999998 110.902 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -138.75 35.18 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 4.79 110.935 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -133.6 76.71 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 2.71 111.021 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.7 mt -100.6 94.27 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 2.52 110.559 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.68 -49.06 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 1.9299999999999999 111.312 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 49.1 m-70 -64.72 -24.19 67.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 1.26 110.908 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.446 ' O ' HG12 ' C' ' 12' ' ' VAL . 54.7 t-105 -70.57 -50.03 41.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 1.6699999999999999 110.399 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.48 -21.29 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.204 0.526 . . . . 1.8700000000000001 109.932 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . 0.407 ' HE2' ' HG ' ' C' ' 203' ' ' CYS . 0.3 OUTLIER -61.15 -58.99 6.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.49 -0.777 . . . . 1.4399999999999999 110.413 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' C' ' 52' ' ' MET . 10.1 p -61.97 -26.84 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.46999999999999997 111.23 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.75 83.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.398 -0.365 . . . . 0.58999999999999997 111.046 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.6 -23.81 77.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.831 -0.699 . . . . 0.5 112.499 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . 0.402 ' HB3' ' HB2' ' C' ' 44' ' ' PRO . 18.9 mmt -77.89 -42.92 31.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.52 0.2 . . . . 0.68000000000000005 111.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 37.6 p -59.1 -50.94 72.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 1.3999999999999999 110.893 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -29.51 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 1.55 110.684 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.17 -61.59 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.861 -0.685 . . . . 0.70999999999999996 112.702 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.41 ' HB1' ' HG3' ' C' ' 41' ' ' MET . . . -56.66 -31.95 64.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.77000000000000002 111.127 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' C' ' 23' ' ' TRP . 93.5 mt -69.13 -29.05 67.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 1.9299999999999999 111.247 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -58.26 -41.39 84.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.94 0.4 . . . . 1.8600000000000001 110.596 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.94 -24.5 52.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 4.1399999999999997 110.606 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . 0.414 ' HB3' ' O ' ' C' ' 20' ' ' LEU . 73.9 t-105 -55.28 -43.17 74.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.295 -0.411 . . . . 3.1499999999999999 110.631 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 44.2 t -82.73 -37.45 24.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 1.95 110.973 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 38.2 tp -77.42 -3.31 39.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.215 -0.448 . . . . 2.2200000000000002 110.739 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 65.4 p -60.77 -23.62 65.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 1.3700000000000001 110.928 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -52.6 -26.71 14.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.092 0.473 . . . . 5.0300000000000002 109.771 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 14.6 t-20 -172.95 131.87 0.62 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 2.3700000000000001 110.174 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 35.4 Cg_endo -95.67 170.54 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.147 2.564 . . . . 2.0499999999999998 112.538 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -86.65 44.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 4.5199999999999996 111.172 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.07 -45.67 1.39 Allowed Glycine 0 CA--C 1.517 0.188 0 C-N-CA 120.827 -0.701 . . . . 2.1600000000000001 112.799 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 4.0 p -74.58 121.45 85.26 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 120.633 0.254 . . . . 2.5299999999999998 111.15 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.51 ' HB2' ' CD1' ' C' ' 35' ' ' TYR . 38.8 Cg_exo -57.68 166.46 5.01 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.642 2.228 . . . . 1.9299999999999999 112.613 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' C' ' 34' ' ' GLN . 0.0 OUTLIER -62.13 -18.48 60.98 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.806 1.039 . . . . 4.1200000000000001 113.806 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' C' ' 33' ' ' PRO . 6.5 p90 -54.79 -31.88 59.44 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.479 -0.489 . . . . 2.8900000000000001 111.123 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -70.52 -54.56 11.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 2.46 110.918 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' C' ' 40' ' ' ALA . 85.4 m-85 -65.18 -20.81 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 2.7799999999999998 111.278 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.72 -61.48 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 1.6200000000000001 110.036 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.435 HG13 HD12 ' C' ' 82' ' ' LEU . 42.1 t -66.44 -29.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 1.5900000000000001 110.13 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' C' ' 37' ' ' TYR . . . -74.83 -8.85 57.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.82 -0.627 . . . . 0.65000000000000002 110.807 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.429 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.1 ttt -89.02 -37.14 15.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 1.6699999999999999 110.528 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.439 ' HA ' HG22 ' C' ' 45' ' ' ILE . 46.0 t80 -72.28 -29.81 64.23 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.7 -0.682 . . . . 3.4199999999999999 111.841 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' C' ' 82' ' ' LEU . 37.8 mm -60.22 -52.04 75.99 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 112.402 0.519 . . . . 0.89000000000000001 112.402 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 64.1 Cg_endo -72.81 -34.55 6.66 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.348 2.032 . . . . 0.40999999999999998 114.25 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.486 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.1 tp -63.17 -50.44 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.338 0.495 . . . . 1.76 112.338 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.642 ' HE1' HG22 ' A' ' 110' ' ' ILE . 1.0 OUTLIER -67.59 -58.77 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 2.1600000000000001 111.345 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.6 p -56.64 -31.35 64.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 1.1699999999999999 110.515 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.82 -57.03 19.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.986 -0.626 . . . . 0.44 112.773 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.28 -29.62 68.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.91 0.386 . . . . 1.29 110.881 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.73 95.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.5 110.974 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -69.51 -47.22 64.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.8300000000000001 110.87 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . 0.455 ' HB2' HG11 ' C' ' 12' ' ' VAL . 50.7 ttp -50.95 -28.23 9.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 1.47 110.457 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -74.24 -43.35 57.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.843 -0.617 . . . . 0.59999999999999998 110.879 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.2 -26.42 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.83999999999999997 110.612 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -77.74 -45.22 25.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.65000000000000002 111.275 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' C' ' 53' ' ' ALA . 31.1 pt -79.45 4.86 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 1.55 111.3 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 60.2 68.03 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.861 -0.609 . . . . 1.54 111.377 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -149.54 136.59 19.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 1.79 110.822 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.28 4.84 23.53 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.712 -0.756 . . . . 0.93999999999999995 112.356 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -114.22 152.68 30.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 2.3599999999999999 110.872 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.18 145.47 28.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 1.97 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.61 91.2 8.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.969 -0.56 . . . . 2.4399999999999999 110.796 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.02 105.94 18.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 1.54 111.208 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.95 36.33 24.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 1.71 111.367 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.43 -13.49 51.08 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 1.53 112.773 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -99.35 134.53 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 2.23 110.921 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 65.6 mt -76.59 137.25 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 1.3600000000000001 111.006 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.72 143.12 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.78000000000000003 111.073 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.497 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 59.0 m-70 -83.2 61.17 5.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.982 -0.553 . . . . 1.0800000000000001 110.937 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . 0.412 ' O ' HG12 ' C' ' 74' ' ' ILE . 68.6 t80 -60.64 -58.01 10.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.76 -0.655 . . . . 2.2999999999999998 111.671 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.35 -22.44 66.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.324 0.49 . . . . 0.75 112.324 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 17.6 tpp180 -65.52 -51.6 58.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.101 0.408 . . . . 1.51 112.101 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -74.13 -29.42 61.81 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.875 -0.33 . . . . 4.6500000000000004 111.123 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.412 HG12 ' O ' ' C' ' 70' ' ' TYR . 22.6 mm -52.7 -50.53 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 120.853 0.358 . . . . 1.22 110.496 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.66 -21.98 66.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.112 -0.495 . . . . 1.3100000000000001 109.737 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.56 5.45 39.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.936 -0.574 . . . . 1.6799999999999999 110.709 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.525 ' HA ' HD13 ' C' ' 113' ' ' ILE . 57.0 tpp -102.71 -21.81 14.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 1.8 110.389 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 2.5 p -113.73 -47.42 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.119 -0.491 . . . . 1.1899999999999999 111.983 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.501 HG23 HG23 ' C' ' 43' ' ' ILE . 96.5 m -61.11 -53.64 54.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.163 0.431 . . . . 1.23 112.163 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 29.9 m -51.66 -54.48 39.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.449 0.537 . . . . 0.58999999999999997 112.449 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 77.1 Cg_exo -49.3 -37.79 40.88 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.896 1.73 . . . . 0.67000000000000004 112.143 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' C' ' 43' ' ' ILE . 4.1 mm? -74.39 -38.39 63.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.95999999999999996 110.63 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.451 HD13 ' O ' ' C' ' 83' ' ' LEU . 0.3 OUTLIER -57.82 -33.64 68.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.173 0.511 . . . . 1.1899999999999999 109.99 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.8 tt -80.31 -44.93 18.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.598 -0.728 . . . . 1.7 110.783 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.3 -32.81 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.681 -0.69 . . . . 1.6200000000000001 111.443 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -62.14 -34.53 76.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 1.26 110.691 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 mt -63.32 -44.46 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 1.1100000000000001 110.9 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 43.4 t -65.83 -23.21 66.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 1.51 111.036 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -83.84 -26.72 29.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 2.0600000000000001 110.666 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -77.1 -39.9 47.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 1.52 111.254 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.11 -44.29 54.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 1.3 111.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -111.79 101.76 10.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.454 . . . . 1.6200000000000001 110.825 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.44 -39.62 70.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 3.2400000000000002 110.938 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -116.44 136.51 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 4.6299999999999999 110.794 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -117.03 144.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.035 -0.53 . . . . 2.1800000000000002 110.802 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -126.21 -65.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.315 -0.402 . . . . 4.1200000000000001 111.078 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -149.09 110.0 4.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.379 . . . . 4.96 110.846 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -144.26 -84.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 3.9100000000000001 110.902 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 90.9 m95 53.82 24.79 4.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.3 -0.409 . . . . 5.21 111.256 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 38.8 p -120.4 -51.93 2.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.217 -0.447 . . . . 1.8200000000000001 110.907 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 68.1 tp -72.27 -53.1 13.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 2.0800000000000001 110.768 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 13.5 tt -56.55 -32.77 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.033 -0.531 . . . . 1.8600000000000001 111.314 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.8 -35.17 22.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.58999999999999997 112.617 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' B' ' 38' ' ' LEU . 90.1 t80 -70.3 -29.76 66.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 1.53 111.091 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.526 ' HB3' HD21 ' C' ' 84' ' ' LEU . 95.7 mt -79.42 -50.45 10.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 1.1100000000000001 111.134 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -61.53 -30.92 70.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.972 -0.558 . . . . 2.21 111.094 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 95.6 p -68.95 -52.82 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.066 0.46 . . . . 1.28 110.747 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 67.7 p -60.7 -23.96 65.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 1.22 110.677 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.7 -50.37 67.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.033 -0.531 . . . . 2.3300000000000001 110.319 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.583 HG22 ' HE1' ' B' ' 46' ' ' TRP . 43.9 mm -55.85 -33.09 33.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 1.29 110.476 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.408 HG13 HD21 ' B' ' 49' ' ' LEU . 21.8 t -62.89 -45.93 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 1.0600000000000001 110.797 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.64 -47.53 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.945 -0.571 . . . . 0.51000000000000001 111.217 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' C' ' 77' ' ' MET . 29.8 mt -60.15 -31.91 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.3700000000000001 111.057 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 22.7 m -59.49 -48.17 82.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.77000000000000002 111.022 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 44.1 m -70.15 -20.29 63.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 1.1899999999999999 110.965 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.501 ' HA3' H181 ' C' ' 210' ' ' LYR . . . -81.11 -33.09 30.17 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.837 -0.697 . . . . 0.5 113.26 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.526 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.3 pp -79.89 -29.82 40.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.717 0.258 . . . . 1.47 111.592 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' C' ' 121' ' ' LEU . 8.5 tp -83.81 -26.65 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 1.2 111.181 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.35 -40.99 68.6 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.169 -0.468 . . . . 0.40000000000000002 111.049 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 -17.56 48.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 2.1200000000000001 110.903 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' C' ' 118' ' ' ILE . 91.9 mt -90.57 34.77 0.88 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 0.75 111.03 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 94.4 p -91.53 131.29 37.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 1.3799999999999999 110.942 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -101.44 -53.64 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 2.7400000000000002 110.901 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 50.9 ttp180 -89.6 137.0 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.497 . . . . 2.7999999999999998 111.022 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.99 -24.6 65.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 2.4100000000000001 111.188 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . 0.615 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 66.7 t-105 -71.06 -57.24 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 4.2000000000000002 110.75 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' C' ' 124' ' ' ARG . 11.5 p -63.9 -23.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.513 . . . . 1.0800000000000001 110.725 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' C' ' 188' ' ' SER . 41.9 ttm180 -57.78 -36.57 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 2.5699999999999998 110.948 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -75.3 -18.16 60.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.375 . . . . 3.8100000000000001 110.682 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.03 -42.32 19.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 1.4199999999999999 111.235 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -72.94 -31.09 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 0.89000000000000001 111.371 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . 0.418 ' HE2' ' HB3' ' C' ' 183' ' ' TRP . 66.6 t80 -60.66 -55.38 34.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 1.26 110.937 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 14.6 tt -60.94 -31.14 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.021 -0.536 . . . . 1.6799999999999999 111.078 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.55 -31.49 72.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 1.24 110.724 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -53.02 15.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.868 -0.682 . . . . 0.54000000000000004 112.775 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 22.2 m -60.54 -38.65 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 1.0600000000000001 111.219 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 67.3 m -56.33 -42.5 77.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.894 0.378 . . . . 1.0800000000000001 110.823 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.14 80.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.56999999999999995 110.905 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -71.98 -24.23 61.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 1.6799999999999999 110.849 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 96.3 mt -66.81 -53.24 34.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 1.7 111.09 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 33.1 pt -66.4 -31.88 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.451 -0.341 . . . . 0.78000000000000003 111.418 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.89 -29.69 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 2.2400000000000002 110.882 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.98 -37.08 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.745 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -76.07 -29.48 58.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 3.0 110.746 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.06 -27.52 49.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 1.27 112.471 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 tt -84.28 -21.51 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.057 0.456 . . . . 1.8899999999999999 110.298 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . 0.414 ' HZ3' HD22 ' C' ' 150' ' ' LEU . 4.7 m95 -87.72 3.21 48.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 1.6000000000000001 110.53 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.502 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 51.5 t30 -87.62 -48.94 0.45 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.908 -0.587 . . . . 99.989999999999995 111.823 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 79.7 Cg_exo -41.69 -32.11 1.46 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.718 2.279 . . . . 2.73 113.117 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . 0.414 HD22 ' HZ3' ' C' ' 147' ' ' TRP . 59.4 tp -55.6 -55.23 34.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.455 -0.339 . . . . 4.2999999999999998 110.281 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 65.21 133.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.775 -0.648 . . . . 8.9000000000000004 111.735 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.56 -18.02 65.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 2.7999999999999998 110.732 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.38 -37.73 81.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.005 -0.543 . . . . 5.4400000000000004 110.815 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.5 HG22 ' HB2' ' C' ' 162' ' ' ALA . 29.2 m -64.06 -28.17 69.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.154 -0.476 . . . . 3.3900000000000001 111.118 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -64.8 -21.72 66.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 6.9199999999999999 110.929 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 61.0 p -116.9 -11.87 10.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 4.8700000000000001 111.251 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -84.41 -60.59 2.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 4.0499999999999998 110.645 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -140.22 115.37 9.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.994 -0.548 . . . . 3.0299999999999998 110.841 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 34.3 t -74.24 -20.0 60.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 2.96 111.127 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.35 -54.81 6.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 3.7400000000000002 110.948 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 30.5 tp -66.77 -19.97 65.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 2.6499999999999999 111.032 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' C' ' 154' ' ' THR . . . -78.58 -40.38 34.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 1.77 111.392 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -65.71 -36.12 82.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 2.96 110.931 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.32 -47.76 69.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.494 . . . . 2.3500000000000001 110.784 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -26.16 63.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 2.6200000000000001 110.991 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.05 -59.52 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 2.0899999999999999 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.64 -26.06 63.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 3.2400000000000002 111.14 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.86 -54.67 38.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 1.6899999999999999 110.905 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.48 -28.22 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.3999999999999999 111.287 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 43.5 m -52.66 -58.52 6.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.483 -0.326 . . . . 0.95999999999999996 111.198 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . 0.417 ' O ' HD23 ' C' ' 175' ' ' LEU . 76.1 m-85 -63.56 -38.95 93.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.53 -0.304 . . . . 3.6499999999999999 110.479 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.04 -25.18 65.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.223 -0.444 . . . . 1.3700000000000001 111.004 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.441 ' O ' HG22 ' C' ' 177' ' ' ILE . 46.6 m -79.43 -49.16 12.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 1.4299999999999999 111.722 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.3 -41.28 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 111.736 0.272 . . . . 1.6200000000000001 111.736 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' C' ' 209' ' ' SER . 4.4 mm? -71.09 -55.72 7.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.855 0.317 . . . . 2.0299999999999998 111.855 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -54.16 -34.63 60.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.456 -0.338 . . . . 0.62 111.528 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.455 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.43 -19.3 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 1.5800000000000001 110.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.77 -44.85 95.59 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.56000000000000005 112.806 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.654 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 82.1 m-85 -62.48 -55.98 34.42 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.704 0.252 . . . . 1.3300000000000001 111.069 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 83.2 Cg_exo -48.32 -27.93 10.61 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.999 1.799 . . . . 0.63 112.453 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.423 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -69.12 -59.93 3.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.93000000000000005 111.127 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.581 HG11 HD21 ' C' ' 201' ' ' LEU . 17.2 m -61.59 -24.76 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.006 -0.543 . . . . 1.27 111.203 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . 0.418 ' HB3' ' HE2' ' C' ' 132' ' ' TYR . 31.9 m95 -66.41 -22.75 66.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.27 -0.423 . . . . 1.77 110.727 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.53 -27.48 42.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.188 -0.46 . . . . 2.3900000000000001 111.079 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt -119.29 162.43 17.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.262 -0.427 . . . . 1.95 111.115 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.71 -157.22 26.25 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.755 -0.736 . . . . 1.8799999999999999 112.498 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 156.17 48.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.542 2.162 . . . . 3.1200000000000001 112.208 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . 0.511 ' HA ' ' HD3' ' C' ' 128' ' ' ARG . 44.7 t 57.6 13.99 2.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.063 -0.517 . . . . 2.6299999999999999 111.17 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -169.52 75.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.749 -0.739 . . . . 3.04 112.5 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 52.34 90.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.759 0.314 . . . . 5.6900000000000004 111.148 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 151.27 168.52 15.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 3.0800000000000001 112.468 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -136.74 31.37 2.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 7.5300000000000002 110.937 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.0 140.63 15.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.319 -0.401 . . . . 2.8599999999999999 110.802 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -155.06 35.45 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.352 -0.385 . . . . 3.6899999999999999 111.274 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.43 -173.09 3.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.34 -0.391 . . . . 5.4800000000000004 111.019 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 77.6 p -63.32 -36.9 85.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 2.3799999999999999 111.243 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 7.3 tp -56.03 -36.1 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 2.23 111.301 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.68 -58.34 7.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 2.1600000000000001 111.03 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 75.0 p -64.07 -20.45 65.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 1.27 111.049 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.26 -31.17 58.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.474 . . . . 1.7 110.9 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . 0.581 HD21 HG11 ' C' ' 182' ' ' VAL . 6.1 tt -68.7 -52.02 35.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 2.02 110.598 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.05 -2.43 18.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 1.8200000000000001 110.935 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.407 ' HG ' ' HE2' ' C' ' 11' ' ' TYR . 11.6 t -96.68 -46.72 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.39 0.614 . . . . 1.3500000000000001 110.862 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.52 -39.52 74.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.158 -0.928 . . . . 0.65000000000000002 112.134 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.674 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 45.2 tp -56.57 -54.31 54.94 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 121.031 -0.268 . . . . 1.4199999999999999 111.504 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.2 Cg_exo -54.76 -41.35 78.89 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.902 1.734 . . . . 0.63 111.408 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.96 -42.43 94.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.188 -0.46 . . . . 1.49 110.378 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -70.78 -22.95 62.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.078 -0.51 . . . . 1.7 110.277 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . 0.47 ' HB2' HD12 ' C' ' 175' ' ' LEU . 47.6 t -87.0 -14.39 41.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.822 -0.626 . . . . 1.25 110.364 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.741 H192 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 29.3 m -79.56 -30.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 1.6100000000000001 111.173 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.7 61.18 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.86 -0.686 . . . . 0.81999999999999995 112.634 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -64.9 -22.86 67.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.615 0.245 . . . . 3.0800000000000001 111.312 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.3 m -63.3 -60.3 3.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 1.1499999999999999 110.621 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.9 -24.78 63.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 2.5600000000000001 110.619 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.69 -55.22 32.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.086 -0.507 . . . . 1.29 110.842 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.35 -32.3 72.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 2.3900000000000001 111.073 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.27 -52.0 66.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 2.0299999999999998 111.315 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . 0.451 ' O ' ' HG3' ' C' ' 222' ' ' ARG . 68.8 m80 -80.01 -19.47 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.331 -0.395 . . . . 3.21 111.207 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.55 75.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.041 -0.599 . . . . 1.3600000000000001 113.372 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 60.9 tp -72.51 -58.68 3.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.798 0.299 . . . . 2.8999999999999999 111.216 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . 0.483 ' HB3' HD23 ' C' ' 224' ' ' LEU . 97.7 mtt180 55.44 89.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.34 -0.391 . . . . 4.8899999999999997 110.967 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -59.65 -73.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.008 -0.542 . . . . 4.2300000000000004 110.882 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' C' ' 222' ' ' ARG . 3.7 mm? 55.59 82.29 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 6.1200000000000001 111.132 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 56.57 89.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 4.5499999999999998 111.029 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.68 -50.41 65.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 6.7800000000000002 111.074 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 43.9 t 54.17 80.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 5.4000000000000004 111.028 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -104.62 136.09 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 8.3300000000000001 110.69 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 7.9100000000000001 110.862 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.775 0.321 . . . . 5.1100000000000003 110.87 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.69 142.2 51.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 5.04 110.71 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.1 pt? -110.13 134.47 52.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 5.5800000000000001 110.804 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -166.53 -19.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 5.0199999999999996 110.683 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.2 p -105.06 125.59 51.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 2.4500000000000002 110.822 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -124.62 12.65 8.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 2.4199999999999999 111.054 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.82 -43.55 83.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 2.0899999999999999 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 22.1 m80 -68.32 -24.14 64.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.372 . . . . 1.1599999999999999 110.675 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.471 ' O ' HG12 ' A' ' 12' ' ' VAL . 63.7 t-105 -72.31 -51.71 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.79000000000000004 110.146 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.52 -21.09 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.277 0.56 . . . . 2.0800000000000001 110.005 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.6 OUTLIER -63.96 -63.18 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.578 -0.737 . . . . 1.28 110.927 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 9' ' ' TRP . 10.5 p -52.7 -33.75 18.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 111.587 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.87 98.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.63 111.107 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.13 -22.55 78.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.817 -0.706 . . . . 0.55000000000000004 112.729 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 86.8 mmm -76.08 -44.36 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.785 0.326 . . . . 1.03 111.041 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.9 p -58.29 -49.87 75.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 1.3 111.061 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -63.5 -29.4 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 1.3100000000000001 110.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.48 -57.87 17.22 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.941 -0.647 . . . . 0.77000000000000002 112.751 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -27.95 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.80000000000000004 110.956 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -67.19 -36.78 82.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.958 -0.565 . . . . 1.8100000000000001 110.827 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -61.67 -49.3 77.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 1.8799999999999999 110.818 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.405 ' O ' ' OG ' ' A' ' 26' ' ' SER . 96.8 m-85 -68.74 -22.06 64.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 4.4500000000000002 111.026 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.412 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 87.5 t90 -68.21 -32.62 72.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 3.6899999999999999 110.654 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 m -78.74 -35.69 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 1.5700000000000001 110.808 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 tp -83.72 -1.36 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 1.95 110.756 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 23' ' ' TRP . 1.2 m -61.85 -26.21 67.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.453 . . . . 1.3799999999999999 110.871 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -47.76 -35.91 10.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.159 0.504 . . . . 4.0700000000000003 109.876 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.495 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.6 p-10 -164.61 131.72 2.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 2.7200000000000002 110.034 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 39.6 Cg_endo -95.86 -176.35 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.097 2.531 . . . . 1.9099999999999999 112.474 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.21 28.51 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 4.7599999999999998 111.022 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.45 -28.5 6.23 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.8 -0.714 . . . . 1.99 112.795 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.548 HG22 HD22 ' A' ' 221' ' ' LEU . 71.4 t -83.62 123.21 76.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.511 0.196 . . . . 2.7000000000000002 111.316 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' HE2' ' A' ' 35' ' ' TYR . 34.2 Cg_exo -58.92 161.63 15.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.442 2.095 . . . . 1.79 112.003 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.515 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -59.61 -17.94 37.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.696 -0.684 . . . . 4.1200000000000001 112.079 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.515 ' H ' HE21 ' A' ' 34' ' ' GLN . 2.6 p90 -49.71 -36.85 26.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.867 0.365 . . . . 2.9300000000000002 110.997 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -74.81 -36.36 62.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.322 -0.399 . . . . 2.8799999999999999 110.668 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.25 -37.67 86.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 4.6600000000000001 110.382 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' B' ' 100' ' ' THR . 40.8 tp -60.77 -57.8 11.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.993 -0.549 . . . . 1.45 111.241 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.06 -44.62 97.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 1.78 111.488 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -10.17 54.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.63 111.823 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.414 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 28.1 ttt -89.44 -33.34 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.805 0.336 . . . . 1.48 111.067 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -75.38 -29.25 59.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 3.5 112.241 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 67.0 mt -64.08 -49.99 71.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.519 0.563 . . . . 1.0800000000000001 112.519 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 75.1 Cg_endo -74.4 -38.07 2.15 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.646 2.231 . . . . 0.53000000000000003 114.324 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 46' ' ' TRP . 45.1 pt -61.88 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 112.28 0.474 . . . . 1.6799999999999999 112.28 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.619 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -70.27 -58.76 3.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 1.8300000000000001 110.869 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.4 p -51.29 -44.16 61.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.534 . . . . 1.0900000000000001 111.091 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.0 -53.25 27.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.924 -0.655 . . . . 0.40999999999999998 112.866 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.1 mt -57.44 -34.59 69.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.98999999999999999 110.907 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.69 96.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.182 -0.463 . . . . 0.47999999999999998 111.342 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 69.2 m-85 -61.75 -49.37 76.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 1.8700000000000001 110.787 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.469 ' HB2' HG11 ' A' ' 12' ' ' VAL . 34.4 ttp -50.48 -34.93 26.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 1.49 110.504 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.88 89.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.58999999999999997 111.301 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -55.59 -33.9 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 0.48999999999999999 110.413 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -72.99 -40.71 65.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.59999999999999998 111.113 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.63 -15.59 19.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 1.3100000000000001 110.968 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 t70 63.34 39.43 9.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.724 -0.671 . . . . 1.9099999999999999 110.991 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.45 150.27 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 1.6200000000000001 110.874 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.9 -16.52 46.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.84 -0.695 . . . . 1.04 112.161 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -99.38 144.17 28.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.33 . . . . 2.6800000000000002 110.734 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.54 138.63 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 1.98 111.038 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -92.35 92.81 8.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 2.1800000000000002 110.865 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.5 121.01 33.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 1.5700000000000001 111.069 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.28 28.15 16.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 1.79 111.135 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.57 28.94 45.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 1.48 112.436 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -132.84 119.46 20.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 2.3199999999999998 110.735 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.0 pt -80.08 136.32 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.4399999999999999 110.635 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.88 143.91 37.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.81999999999999995 111.464 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 12.4 m-70 -86.59 53.73 2.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.315 0.579 . . . . 0.90000000000000002 110.695 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 74' ' ' ILE . 58.9 t80 -56.25 -59.18 5.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.405 -0.816 . . . . 1.8300000000000001 111.893 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.54 66.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.386 . . . . 0.62 111.858 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HG3' ' HZ3' ' A' ' 76' ' ' TRP . 12.4 tpp180 -58.82 -52.8 64.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.585 -0.279 . . . . 2.3399999999999999 111.726 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.518 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 10.1 p90 -77.53 -17.94 57.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.713 -0.395 . . . . 3.4900000000000002 111.088 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.0 mm -55.5 -41.59 64.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 109.36 -0.608 . . . . 1.3700000000000001 109.36 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.58 -20.62 66.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.365 -0.834 . . . . 1.3100000000000001 110.026 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.518 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -78.88 -21.85 46.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.836 -0.62 . . . . 1.48 111.13 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 2.3 mtp -90.07 -6.17 55.79 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.12 -0.491 . . . . 1.46 111.468 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.44 HG21 ' CE3' ' A' ' 46' ' ' TRP . 32.8 m -114.81 -31.18 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.507 0.558 . . . . 1.1200000000000001 112.507 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 m -89.95 -58.45 2.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.157 0.429 . . . . 1.1000000000000001 112.157 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -51.92 -51.31 72.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.903 0.705 . . . . 0.59999999999999998 112.903 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 53.7 Cg_exo -53.91 -55.79 3.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.801 1.668 . . . . 0.73999999999999999 112.288 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 HD12 ' A' ' 85' ' ' LEU . 4.2 mm? -61.42 -27.11 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 1.01 110.514 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.432 ' HG ' ' H11' ' A' ' 210' ' ' LYR . 0.2 OUTLIER -67.73 -36.06 79.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.334 0.588 . . . . 1.48 109.831 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 105' ' ' LEU . 6.9 tt -84.4 -20.32 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.289 -0.869 . . . . 1.3799999999999999 110.86 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 82' ' ' LEU . 79.4 mt -80.15 -39.85 28.56 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 111.043 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.413 ' HA ' ' HD1' ' A' ' 89' ' ' TRP . 48.1 t -59.33 -20.61 56.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 1.23 110.929 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.12 -32.33 63.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.88 110.968 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.7 t -72.42 -38.52 68.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 1.3899999999999999 111.197 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.413 ' HD1' ' HA ' ' A' ' 86' ' ' SER . 96.9 m95 -62.37 -49.84 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.424 . . . . 2.3199999999999998 111.17 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -66.1 -23.5 66.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 1.46 111.213 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 -3.19 59.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 1.24 111.348 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.7 mtt -127.98 110.14 12.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 2.0699999999999998 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -87.67 -26.29 23.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 3.5299999999999998 110.771 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -144.76 139.4 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 4.0800000000000001 110.74 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.53 146.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.305 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -129.69 -70.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.221 -0.445 . . . . 4.5199999999999996 110.749 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -144.83 87.1 1.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 3.75 110.951 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.42 124.15 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.952 0.406 . . . . 3.5299999999999998 111.006 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -131.43 20.02 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 4.9100000000000001 110.996 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.562 HG23 HD23 ' C' ' 38' ' ' LEU . 90.5 m -80.53 -47.85 13.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 1.98 111.357 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.66 -57.96 3.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 1.8300000000000001 111.223 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.2 pt -59.61 -24.06 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 1.79 111.219 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.91 -38.92 10.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.896 -0.668 . . . . 0.62 112.546 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.4 -39.8 85.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 1.5800000000000001 110.855 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 84' ' ' LEU . 71.3 mt -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 0.97999999999999998 110.915 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 ttt -57.41 -35.45 70.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.869 -0.605 . . . . 1.48 110.895 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.406 ' HG ' ' HD1' ' C' ' 42' ' ' PHE . 11.8 t -63.61 -57.24 10.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.356 -0.384 . . . . 1.1299999999999999 111.152 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 142' ' ' ILE . 73.2 p -57.36 -19.48 23.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 1.48 111.681 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 6.2 tp-100 -77.54 -52.53 8.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.794 0.33 . . . . 2.7000000000000002 111.081 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.653 HG22 ' HE1' ' C' ' 46' ' ' TRP . 63.6 mt -52.19 -36.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.527 . . . . 1.54 111.856 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.02 -37.67 53.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 121.054 -0.258 . . . . 1.28 111.222 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 108' ' ' THR . 53.9 t -68.61 -28.47 40.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.906 0.384 . . . . 0.42999999999999999 110.847 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.94 -49.01 47.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 1.74 110.658 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 54.7 m -52.41 -37.93 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.63 110.445 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 61.5 m -60.3 -56.86 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 1.0900000000000001 110.183 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.84 -11.63 58.21 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.887 -0.673 . . . . 0.41999999999999998 112.18 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 tt -74.65 -54.29 7.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.946 0.403 . . . . 1.3799999999999999 110.523 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.73 -24.01 7.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.033 -0.53 . . . . 1.6200000000000001 111.525 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.73 -40.76 66.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 0.39000000000000001 110.812 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.5 -19.52 42.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 2.02 110.657 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.73 20.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.76000000000000001 110.752 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.4 p -85.63 119.01 25.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 1.46 110.862 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.534 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 10.2 pt-20 -78.52 -23.29 46.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 3.3500000000000001 110.808 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.7 mtp180 -111.3 149.04 31.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 2.9199999999999999 110.657 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.78 -9.42 59.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 2.77 110.893 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -90.16 -49.38 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 3.77 111.14 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -58.39 -28.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.456 . . . . 1.1599999999999999 111.34 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -60.53 -32.45 71.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 2.04 110.986 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.35 -33.04 74.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 2.6400000000000001 111.005 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 127' ' ' VAL . 3.1 mm? -72.95 -50.3 24.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 1.8999999999999999 110.807 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -67.34 -23.77 65.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 1.3999999999999999 110.801 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -70.62 -52.96 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.28 111.069 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 130' ' ' LEU . 47.0 pt -57.41 -29.2 32.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 2.1600000000000001 110.902 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.1 t -67.26 -40.42 86.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 1.6899999999999999 110.805 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -47.49 63.41 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.813 -0.708 . . . . 0.52000000000000002 112.694 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.31 -29.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 1.02 111.173 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 40.7 t -57.86 -51.8 68.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.226 -0.443 . . . . 1.0800000000000001 110.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 142' ' ' ILE . . . -65.49 -28.33 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.62 110.953 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -68.99 -23.83 64.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.908 -0.587 . . . . 1.8400000000000001 111.031 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.53 -53.02 7.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.386 . . . . 1.6899999999999999 111.599 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.7 pt -60.03 -37.93 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.81000000000000005 111.784 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 108' ' ' THR . 10.5 tt -67.84 -44.91 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.643 0.258 . . . . 2.3700000000000001 111.295 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.455 ' N ' HG23 ' A' ' 142' ' ' ILE . 41.6 tp -55.74 -49.12 73.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 0.97999999999999998 110.904 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.512 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 59.8 t-105 -68.01 -26.32 65.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 3.27 110.759 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.94 -17.13 68.23 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.877 -0.678 . . . . 1.25 113.013 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.5 pt -104.48 -8.23 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.339 . . . . 2.1200000000000001 111.646 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -86.14 -23.22 26.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.419 -0.355 . . . . 1.6599999999999999 111.734 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.657 ' HB2' ' HD3' ' A' ' 149' ' ' PRO . 69.1 m-80 -81.6 -51.51 0.84 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.46 -0.337 . . . . 99.989999999999995 111.759 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.657 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 25.0 Cg_exo -63.02 -3.6 4.99 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.001 1.8 . . . . 2.6000000000000001 112.201 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.44 HD11 ' HA ' ' A' ' 166' ' ' ASP . 64.3 tp -61.65 -55.71 27.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 4.6100000000000003 111.447 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -141.62 -16.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.511 -0.313 . . . . 8.3599999999999994 111.387 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 148' ' ' ASN . . . -68.88 -46.65 67.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.512 -0.313 . . . . 2.75 111.335 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -83.45 -39.54 20.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 5.6799999999999997 110.977 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 65.4 p -76.57 5.31 7.62 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.347 -0.388 . . . . 3.21 111.27 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -61.31 -37.12 82.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.277 -0.42 . . . . 6.8700000000000001 110.685 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 72.7 p -95.53 -16.68 22.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 4.5599999999999996 111.071 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -83.17 -74.67 0.35 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 3.5600000000000001 110.957 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.9 m -147.36 117.29 7.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.268 -0.424 . . . . 2.79 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.1 m -77.78 -31.16 51.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.029 -0.532 . . . . 2.5899999999999999 111.044 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.67 -55.35 20.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 3.4700000000000002 110.968 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mp -61.61 -20.11 62.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.176 -0.465 . . . . 2.5800000000000001 110.69 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.13 -54.07 16.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.048 -0.524 . . . . 1.78 110.997 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -56.6 -28.3 60.09 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.068 0.461 . . . . 2.6299999999999999 110.389 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.94 -52.74 58.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 2.3399999999999999 110.672 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.29 -21.66 60.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 2.77 111.026 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.44 ' HA ' HD11 ' A' ' 150' ' ' LEU . 24.2 t70 -64.11 -41.44 97.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.448 . . . . 2.04 111.359 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -82.51 -24.14 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 2.77 110.676 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.85 -35.81 57.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 1.8899999999999999 111.387 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 15.0 p -73.34 -21.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 1.6399999999999999 111.178 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.7 m -60.03 -57.93 10.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.24 110.915 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.92 -26.01 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.004 -0.544 . . . . 2.9700000000000002 110.514 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 63.9 t80 -72.27 -31.36 65.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 1.48 111.116 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 177' ' ' ILE . 97.1 m -74.48 -50.88 16.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 1.55 111.518 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.66 -34.11 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.379 . . . . 1.52 111.705 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.587 HD21 ' H42' ' A' ' 210' ' ' LYR . 47.5 tp -75.75 -53.99 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 1.8500000000000001 111.362 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.97 -33.81 62.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.62 111.509 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 173' ' ' THR . 13.3 tt -87.64 -21.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 1.3500000000000001 110.749 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.37 -57.34 20.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.084 -0.579 . . . . 0.58999999999999997 113.226 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.579 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 74.3 m-85 -53.5 -54.17 48.6 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 111.668 0.247 . . . . 1.45 111.668 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.1 Cg_exo -46.28 -37.05 18.26 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.185 1.923 . . . . 0.55000000000000004 112.276 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 177' ' ' ILE . 91.4 mt -59.25 -61.01 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.235 -0.438 . . . . 1.4199999999999999 111.213 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 179' ' ' TYR . 23.2 m -62.44 -24.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.78000000000000003 111.18 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -66.93 -37.7 84.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.93999999999999995 111.214 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 185' ' ' ILE . 73.1 mt -53.15 -79.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.365 -0.38 . . . . 1.4299999999999999 111.111 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.566 HG23 HG22 ' A' ' 184' ' ' ILE . 2.8 pp -111.6 173.99 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 2.02 110.926 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.519 ' HA2' ' HA3' ' A' ' 191' ' ' GLY . . . 88.41 -152.1 23.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.574 -0.822 . . . . 1.79 112.377 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.02 155.88 52.9 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.566 2.177 . . . . 3.1000000000000001 112.138 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m 56.39 17.47 2.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.256 -0.429 . . . . 2.7400000000000002 110.411 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -165.02 29.98 0.22 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.03 -0.605 . . . . 3.4300000000000002 112.598 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 76.9 t80 60.5 96.36 0.03 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.812 0.339 . . . . 6.5 111.161 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.519 ' HA3' ' HA2' ' A' ' 186' ' ' GLY . . . -143.32 170.56 25.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.94 -0.648 . . . . 3.29 112.539 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -58.63 -20.6 49.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.962 0.411 . . . . 6.1600000000000001 110.607 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.1 pt -117.45 140.99 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.876 -0.602 . . . . 2.4199999999999999 111.146 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -154.83 25.31 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.138 -0.483 . . . . 4.29 110.891 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -77.59 -161.99 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 5.1500000000000004 110.861 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.2 p -60.97 -22.0 64.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 2.4500000000000002 111.089 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 77.1 mt -55.94 -26.11 20.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.176 -0.465 . . . . 2.48 111.132 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.71 -60.96 2.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 2.1800000000000002 110.992 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.4 p -75.82 -34.85 60.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.107 -0.497 . . . . 1.49 111.253 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.22 -26.63 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 1.77 110.975 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 65.9 tp -81.18 -48.58 11.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.194 -0.457 . . . . 1.4199999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -69.69 -11.25 60.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 1.78 111.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 97.5 m -96.74 -45.38 6.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.11 0.481 . . . . 1.3 110.975 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.9 tp -69.94 -34.8 73.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.763 -0.653 . . . . 0.66000000000000003 112.244 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.653 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 53.6 tp -61.32 -53.57 61.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.775 0.287 . . . . 1.6299999999999999 111.775 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.6 Cg_exo -55.17 -47.74 24.7 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.012 1.808 . . . . 0.64000000000000001 111.95 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -63.89 -31.94 73.29 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.249 -0.432 . . . . 1.3600000000000001 110.843 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -66.67 -31.05 71.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 1.54 110.566 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 88.7 p -96.84 -16.03 20.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 1.2 110.349 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.728 H183 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.8 m -88.68 -36.82 9.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.281 -0.418 . . . . 1.6399999999999999 111.364 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.76 -40.48 98.85 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.567 -0.825 . . . . 0.79000000000000004 112.366 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.59 -28.15 62.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 1.6100000000000001 110.818 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.4 m -58.23 -61.71 2.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 1.1499999999999999 110.999 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -68.25 -20.39 64.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 3.3399999999999999 110.96 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -70.07 -49.7 48.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.984 -0.553 . . . . 1.1899999999999999 111.145 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.15 -40.51 96.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 2.23 111.051 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.462 HD23 HG21 ' A' ' 32' ' ' VAL . 96.9 mt -58.95 -41.75 88.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 2.4700000000000002 111.112 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -79.12 -20.51 48.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 1.6200000000000001 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.01 -19.49 79.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.937 -0.649 . . . . 1.4099999999999999 113.083 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.548 HD22 HG22 ' A' ' 32' ' ' VAL . 41.6 tp -65.56 -58.74 5.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.681 0.277 . . . . 2.5800000000000001 111.001 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 54.63 79.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 4.9299999999999997 110.934 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -62.92 124.85 22.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.099 -0.501 . . . . 4.6299999999999999 110.929 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 33.4 tp -159.9 -7.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 6.4699999999999998 110.947 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -92.8 -74.54 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 5.0700000000000003 110.873 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -126.74 178.17 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 6.5300000000000002 110.714 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 82.3 p -151.33 120.52 6.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 5.2199999999999998 110.98 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -102.21 144.46 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 8.3599999999999994 110.897 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 7.96 110.977 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.811 0.339 . . . . 6.1699999999999999 111.116 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.56 ' N ' HD22 ' B' ' 2' ' ' ASN . 0.8 OUTLIER 59.22 97.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.042 -0.526 . . . . 4.8200000000000003 111.198 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 55.3 mt -98.59 96.83 8.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.13 -0.486 . . . . 5.5999999999999996 110.974 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -140.99 -42.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 4.7999999999999998 111.077 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 48.3 t -80.23 128.98 34.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.3700000000000001 111.001 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.6 mt -128.71 1.28 5.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.091 -0.504 . . . . 2.0699999999999998 110.916 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.29 -27.99 68.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 2.1000000000000001 110.873 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 90.8 m-70 -76.96 -25.71 53.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.024 -0.535 . . . . 1.0700000000000001 110.493 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -76.22 -45.23 33.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.48 110.405 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 43.6 mm -67.8 -22.54 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.129 0.49 . . . . 2.02 110.296 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . 0.422 ' O ' ' HG2' ' B' ' 15' ' ' MET . 29.4 t80 -66.66 -60.69 2.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.734 -0.667 . . . . 0.92000000000000004 110.969 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.39 -35.98 20.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.156 -0.474 . . . . 0.93999999999999995 111.345 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.77 90.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.406 -0.361 . . . . 0.55000000000000004 111.248 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.91 -23.24 78.25 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.774 -0.727 . . . . 0.47999999999999998 112.571 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 80.4 mmm -73.93 -40.58 63.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.558 0.218 . . . . 0.84999999999999998 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p -62.32 -51.46 67.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 1.3400000000000001 111.087 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.8 pp -62.5 -25.31 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.399 -0.364 . . . . 1.55 111.156 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.25 -59.03 11.08 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.735 -0.745 . . . . 0.69999999999999996 112.474 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.21 68.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.872 0.367 . . . . 0.81000000000000005 111.351 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' B' ' 17' ' ' ILE . 79.0 mt -68.17 -36.68 80.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 2.2599999999999998 111.177 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -61.59 -50.07 74.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 1.78 110.604 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.478 ' O ' ' OG ' ' B' ' 26' ' ' SER . 99.4 m-85 -66.44 -23.18 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 4.5800000000000001 110.637 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -68.48 -30.26 69.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 3.3500000000000001 110.791 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 91.6 p -85.03 -29.79 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 1.5800000000000001 110.64 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 20.4 tp -87.49 -1.34 57.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.989 -0.55 . . . . 1.8400000000000001 110.489 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 1.8 m -63.86 -26.2 68.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 1.3700000000000001 110.889 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -49.66 -32.6 13.49 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.132 0.491 . . . . 4.9800000000000004 109.924 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 6.2 p30 -164.61 131.62 2.36 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.774 . . . . 2.1400000000000001 110.158 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 51.9 Cg_endo -98.0 175.89 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.275 2.65 . . . . 1.8200000000000001 112.882 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -93.24 35.19 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 5.1900000000000004 110.866 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.46 -41.94 1.92 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.744 -0.741 . . . . 2.2000000000000002 112.713 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.494 ' HA ' HD22 ' B' ' 221' ' ' LEU . 20.8 m -71.09 136.22 84.78 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.57 0.224 . . . . 3.6499999999999999 111.102 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 32' ' ' VAL . 8.1 Cg_exo -73.37 166.25 30.39 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.877 2.385 . . . . 2.6699999999999999 112.763 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -58.24 -20.09 39.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.24 -0.891 . . . . 4.8799999999999999 113.05 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.451 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 3.2 p90 -60.04 -33.54 72.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.952 0.406 . . . . 1.8700000000000001 110.974 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -69.77 -45.61 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 2.6800000000000002 110.904 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 2.9199999999999999 110.944 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.91 -61.68 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 1.6399999999999999 110.864 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.81 -36.24 77.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 1.6000000000000001 111.066 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.43 -12.69 61.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.68999999999999995 111.457 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.423 ' O ' HG12 ' B' ' 45' ' ' ILE . 60.3 ttp -88.73 -36.19 16.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.485 -0.325 . . . . 2.5800000000000001 111.442 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -71.64 -34.01 69.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.34 0.496 . . . . 3.3900000000000001 112.34 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 88.0 mt -56.46 -52.99 68.94 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.59 0.589 . . . . 0.40999999999999998 112.59 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 61.6 Cg_endo -72.03 -36.6 5.7 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.408 2.072 . . . . 0.48999999999999999 113.704 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.423 HG12 ' O ' ' B' ' 41' ' ' MET . 28.5 mm -56.45 -62.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.81 0.3 . . . . 1.29 111.81 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.633 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.3 OUTLIER -60.54 -57.27 13.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.418 -0.356 . . . . 1.3999999999999999 111.486 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -51.18 -37.2 45.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 1.3799999999999999 111.518 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.56 73.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.37 112.394 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.19 -32.42 73.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.006 0.431 . . . . 1.29 110.886 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.02 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.581 . . . . 0.44 111.073 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 19.5 m-85 -61.09 -44.33 97.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.5 110.876 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -50.96 -34.17 27.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.074 0.464 . . . . 1.4099999999999999 110.167 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.36 81.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.598 -0.728 . . . . 0.55000000000000004 110.792 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 49.1 mtt -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.524 . . . . 0.5 110.24 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -62.94 -49.03 76.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.866 -0.606 . . . . 0.54000000000000004 110.342 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.24 -6.69 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.968 -0.56 . . . . 1.3 110.715 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 61.98 39.63 13.16 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.778 -0.647 . . . . 2.2400000000000002 111.341 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.415 ' HG3' ' HE1' ' C' ' 131' ' ' TRP . 13.9 mm100 -100.14 173.77 6.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 1.77 111.013 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 70.57 27.23 72.85 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.858 -0.687 . . . . 1.0600000000000001 112.428 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.75 174.19 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 2.6600000000000001 110.697 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.69 140.74 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.8899999999999999 111.361 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -101.02 84.52 2.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.286 -0.416 . . . . 2.4100000000000001 110.565 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.17 109.8 22.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 1.5600000000000001 111.353 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.22 24.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 1.8200000000000001 111.534 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 11.72 82.04 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.692 -0.766 . . . . 1.51 112.661 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -115.23 129.15 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 2.4500000000000002 110.778 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 46.9 mm -96.07 115.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 1.79 111.237 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.64 142.27 27.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.81999999999999995 111.349 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 25.3 m-70 -92.43 59.14 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.119 -0.491 . . . . 1.05 111.057 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.41 -49.91 73.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 1.8700000000000001 110.925 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.474 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -57.31 -27.76 62.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.60999999999999999 111.008 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 4.9 tpp180 -63.05 -49.22 75.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.878 -0.601 . . . . 2.3900000000000001 110.775 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.593 ' HE2' H181 ' B' ' 210' ' ' LYR . 0.3 OUTLIER -71.19 -18.06 62.5 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.921 -0.312 . . . . 3.6699999999999999 111.443 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 36.3 mm -65.41 -40.99 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.063 0.458 . . . . 1.6599999999999999 109.842 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.545 ' O ' HG22 ' B' ' 79' ' ' THR . 13.5 t70 -66.37 -14.39 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.657 -0.701 . . . . 1.4099999999999999 110.238 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -85.54 -26.14 26.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.856 -0.611 . . . . 1.1599999999999999 111.173 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.604 ' HG2' ' HB ' ' B' ' 113' ' ' ILE . 19.2 mtp -91.82 4.23 53.32 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 1.53 111.33 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 -29.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.414 0.524 . . . . 0.89000000000000001 112.414 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.545 HG22 ' O ' ' B' ' 75' ' ' ASP . 12.4 t -102.83 -43.71 5.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.102 0.408 . . . . 1.24 112.102 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 26.0 m -58.9 -50.84 85.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.221 0.452 . . . . 0.57999999999999996 112.221 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.559 ' HA ' ' HG2' ' B' ' 109' ' ' GLN . 20.3 Cg_endo -60.62 -43.78 30.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.86 1.707 . . . . 0.66000000000000003 111.898 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.481 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -73.46 -12.7 60.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 1.0600000000000001 110.692 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' B' ' 79' ' ' THR . 0.2 OUTLIER -75.63 -43.99 44.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 1.22 110.782 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.469 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.3 pp -80.18 -23.51 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 1.53 110.78 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.481 HD12 HD13 ' B' ' 82' ' ' LEU . 50.7 mt -68.18 -39.09 82.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 1.5800000000000001 110.444 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 46.6 t -61.81 -30.08 70.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.3899999999999999 110.713 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 69.5 mt -75.73 -26.13 57.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 1.1499999999999999 110.601 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -70.49 -41.26 72.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 1.5700000000000001 110.823 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -70.12 -35.96 74.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 110.593 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 61.3 m -64.99 -33.28 75.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.4199999999999999 110.945 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.95 -34.01 39.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.1799999999999999 111.15 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.8 mmm -95.07 100.93 12.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 1.8799999999999999 111.168 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -78.0 -33.47 51.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.115 -0.493 . . . . 3.4199999999999999 110.887 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -137.82 135.06 35.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.256 -0.429 . . . . 4.0599999999999996 111.418 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 47.0 pt -138.1 143.23 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 2.0899999999999999 110.855 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -130.15 -56.96 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 3.8500000000000001 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.13 73.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 4.8200000000000003 111.122 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -147.41 134.66 20.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.062 -0.517 . . . . 3.7999999999999998 110.852 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.84 22.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 5.1699999999999999 110.609 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.475 ' HA ' HD22 ' A' ' 38' ' ' LEU . 90.7 m -80.92 -49.83 10.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 2.02 110.988 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.46 -34.92 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 2.0899999999999999 110.925 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.73 -33.73 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.927 0.394 . . . . 1.8799999999999999 110.798 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.54 -15.19 69.04 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.771 -0.728 . . . . 0.56000000000000005 112.545 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -83.38 -42.79 16.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.785 0.326 . . . . 1.78 110.94 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.01 -45.43 60.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 1.03 110.946 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . 0.433 ' O ' HG13 ' B' ' 110' ' ' ILE . 25.1 ttt -63.08 -39.62 95.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.727 -0.67 . . . . 1.6699999999999999 111.269 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -64.14 -54.18 37.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 1.51 111.541 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.52 ' HB ' HD13 ' B' ' 142' ' ' ILE . 59.1 p -58.68 -21.45 54.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 1.1799999999999999 111.615 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.559 ' HG2' ' HA ' ' B' ' 81' ' ' PRO . 48.7 tp60 -79.8 -35.89 37.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.44 -0.345 . . . . 2.1699999999999999 111.384 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.619 HG22 ' HE1' ' A' ' 46' ' ' TRP . 68.5 mt -67.34 -34.87 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.693 0.282 . . . . 1.3500000000000001 111.512 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 m -73.61 -35.61 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.584 -0.28 . . . . 1.3400000000000001 111.506 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 108' ' ' THR . 70.9 t -70.2 -41.42 78.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.616 -0.265 . . . . 0.42999999999999999 111.68 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 77' ' ' MET . 26.7 pt -70.07 -31.53 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.64 -0.254 . . . . 1.6000000000000001 111.419 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 70.6 m -60.94 -56.95 15.09 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.912 0.387 . . . . 0.85999999999999999 110.526 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.5 p -55.97 -29.03 59.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.95 -0.568 . . . . 0.94999999999999996 110.172 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.02 -47.25 84.48 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.85 -0.691 . . . . 0.46000000000000002 111.951 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.456 HD21 ' SD ' ' B' ' 77' ' ' MET . 56.9 mt -48.89 -58.39 4.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.155 0.502 . . . . 1.75 110.636 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.494 HD13 HD12 ' B' ' 121' ' ' LEU . 50.3 mm -67.56 -31.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.605 -0.725 . . . . 1.78 111.722 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.53 -40.73 62.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.897 0.379 . . . . 0.38 111.178 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.4 -17.54 30.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 1.97 110.794 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.494 HD12 HD13 ' B' ' 118' ' ' ILE . 83.3 mt -84.84 13.96 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.76000000000000001 111.059 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 56.3 m -76.84 126.47 31.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 1.47 110.781 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 -21.92 27.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 2.5 110.81 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.71 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 38.4 ttm180 -116.66 137.32 52.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.493 . . . . 2.73 110.806 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.08 -11.56 60.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 2.2000000000000002 111.433 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.71 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 83.1 t90 -87.66 -51.62 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 3.3999999999999999 110.941 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' B' ' 124' ' ' ARG . 14.9 p -61.03 -26.05 37.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 1.23 110.945 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -67.54 -24.49 65.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 3.04 110.882 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.66 -35.12 76.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 4.1399999999999997 110.766 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.415 HD12 ' N ' ' B' ' 130' ' ' LEU . 7.1 mp -68.78 -50.47 50.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.333 -0.394 . . . . 1.6499999999999999 110.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.76 -35.63 75.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.77000000000000002 111.419 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.74 -51.65 68.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 1.46 111.179 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.8 mm -53.93 -34.09 25.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.251 -0.431 . . . . 1.6299999999999999 111.101 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.73 -41.15 88.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 1.4199999999999999 111.133 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.98 85.21 Favored Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.745 -0.74 . . . . 0.48999999999999999 112.654 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.3 -28.75 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.808 0.337 . . . . 1.3 111.28 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 50.4 t -58.2 -49.65 76.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.017 0.437 . . . . 1.3 110.603 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.07 -47.96 80.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.62 110.785 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -55.27 -24.19 26.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 1.74 111.056 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -59.2 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.76 110.993 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 pt -65.68 -33.74 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.398 -0.365 . . . . 0.68999999999999995 111.771 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.52 HD13 ' HB ' ' B' ' 108' ' ' THR . 77.4 mt -69.05 -37.12 76.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.47 -0.332 . . . . 1.76 111.313 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.3 -48.59 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.373 . . . . 1.0600000000000001 110.866 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . 0.463 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 77.1 t90 -68.26 -22.74 64.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 4.1200000000000001 110.808 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -18.99 62.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.905 -0.664 . . . . 1.26 112.652 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -106.67 -10.24 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.971 0.415 . . . . 1.98 110.938 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -78.85 -21.45 47.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 1.4199999999999999 111.493 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.63 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 69.1 m-80 -84.37 -50.72 0.6 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 111.896 0.332 . . . . 99.989999999999995 111.896 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 32.3 Cg_exo -58.78 -6.23 3.23 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.09 1.86 . . . . 2.6499999999999999 112.371 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' B' ' 166' ' ' ASP . 55.1 tp -57.92 -46.29 85.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 4.3899999999999997 111.434 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' B' ' 155' ' ' ARG . 14.3 ptp180 -156.32 -1.21 0.13 Allowed 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.755 0.28 . . . . 7.9000000000000004 111.755 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.04 -41.92 18.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.517 -0.311 . . . . 2.77 111.523 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.19 -41.15 14.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 6.29 111.389 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 8.8 t -78.82 6.52 8.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 3.1000000000000001 111.625 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' B' ' 151' ' ' ARG . 30.3 tpt180 -65.63 -19.34 65.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.848 0.356 . . . . 6.4299999999999997 110.708 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 74.5 p -107.76 -12.39 15.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 4.5700000000000003 111.204 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -95.25 -71.88 0.65 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 3.8300000000000001 110.983 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 25.9 m -141.38 117.53 10.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 3.0699999999999998 111.304 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -77.91 -36.79 49.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.065 -0.516 . . . . 3.4300000000000002 110.926 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.36 -51.33 69.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.119 -0.492 . . . . 3.9199999999999999 111.181 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.81 -32.15 69.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 2.7000000000000002 110.916 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.87 82.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.8300000000000001 111.462 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -68.55 -45.35 72.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.842 0.353 . . . . 2.6299999999999999 110.914 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 41.8 mt -59.41 -43.44 93.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 2.4300000000000002 110.875 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -72.57 -22.78 60.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.79 -0.641 . . . . 2.5800000000000001 111.078 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' B' ' 150' ' ' LEU . 19.6 t70 -77.8 -25.44 48.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 2.0 111.071 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -84.15 -38.18 20.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.427 . . . . 3.0299999999999998 111.384 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.54 -25.74 38.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.488 -0.323 . . . . 1.1000000000000001 111.856 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.36 -26.54 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 1.75 111.069 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.2 m -54.47 -58.75 6.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.273 -0.422 . . . . 0.97999999999999998 111.132 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -67.39 -30.4 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 4.2999999999999998 110.459 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.9 -25.82 67.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.908 -0.587 . . . . 1.3899999999999999 110.889 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.407 ' O ' HG22 ' B' ' 177' ' ' ILE . 29.3 m -79.56 -53.15 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 1.1100000000000001 111.35 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 43.2 t -60.68 -27.03 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 1.51 111.72 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.612 HD21 ' H42' ' B' ' 210' ' ' LYR . 50.8 tp -77.61 -55.61 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 1.75 111.233 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -30.27 61.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.59999999999999998 111.267 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.427 ' O ' HG13 ' B' ' 181' ' ' ILE . 10.6 tp -87.92 -24.71 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 1.47 110.878 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.0 -46.38 91.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.915 -0.659 . . . . 0.55000000000000004 113.146 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.492 ' O ' HG22 ' B' ' 182' ' ' VAL . 61.6 m-85 -62.2 -55.4 40.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.26 0.467 . . . . 1.6200000000000001 112.26 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 13.1 Cg_endo -56.69 -28.26 74.63 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.77 1.647 . . . . 0.64000000000000001 112.461 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.478 ' O ' HG22 ' B' ' 184' ' ' ILE . 49.1 mt -60.71 -49.91 82.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.053 0.454 . . . . 1.27 110.238 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.549 ' HB ' ' HA2' ' B' ' 189' ' ' GLY . 13.0 m -77.55 -23.45 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.709 -0.678 . . . . 0.68999999999999995 110.186 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -68.57 -15.22 63.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.277 -0.874 . . . . 1.1799999999999999 112.605 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.478 HG22 ' O ' ' B' ' 181' ' ' ILE . 17.1 tt -103.14 -25.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 111.885 0.328 . . . . 1.77 111.885 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' B' ' 190' ' ' PHE . 20.3 pt -91.06 116.54 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.177 0.436 . . . . 1.6899999999999999 112.177 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . 0.659 ' HA3' ' HA2' ' B' ' 191' ' ' GLY . . . 56.99 -171.19 2.75 Favored Glycine 0 CA--C 1.516 0.153 0 CA-C-N 115.839 -0.619 . . . . 1.5800000000000001 113.814 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.8 106.35 2.24 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.963 2.442 . . . . 2.5099999999999998 112.651 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 53.8 m 53.8 66.3 1.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 3.5800000000000001 111.709 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . 0.549 ' HA2' ' HB ' ' B' ' 182' ' ' VAL . . . 82.57 123.39 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.628 -0.796 . . . . 4.0300000000000002 113.24 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' B' ' 185' ' ' ILE . 79.3 m-85 62.07 148.16 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.155 0.502 . . . . 6.8899999999999997 111.843 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . 0.659 ' HA2' ' HA3' ' B' ' 186' ' ' GLY . . . -113.63 174.37 15.65 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.821 -0.627 . . . . 3.7000000000000002 112.349 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 54.82 18.78 2.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.984 0.421 . . . . 7.5 110.633 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.416 HD11 ' O ' ' B' ' 189' ' ' GLY . 2.7 pp -137.05 160.09 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 2.3500000000000001 110.864 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -165.58 20.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 3.8599999999999999 110.681 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.04 -170.57 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 5.0499999999999998 111.062 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.9 t -67.58 -15.28 63.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.348 -0.387 . . . . 2.6800000000000002 111.139 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.09 -27.7 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 2.4700000000000002 111.38 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.37 -57.5 12.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.367 -0.379 . . . . 2.5299999999999998 111.121 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 46.3 p -68.94 -37.98 79.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 1.29 111.112 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.56 -25.1 68.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 2.6200000000000001 111.254 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.9 tp -77.36 -43.62 32.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.565 -0.289 . . . . 1.6100000000000001 110.954 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.51 -9.42 58.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 1.4199999999999999 111.458 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.462 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 98.9 m -96.37 -42.16 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.137 0.494 . . . . 1.4299999999999999 110.719 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.97 -48.8 62.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 1.1200000000000001 112.143 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.651 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 53.6 tp -49.6 -52.86 46.82 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 111.738 0.273 . . . . 1.26 111.738 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -54.56 -50.71 12.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.982 1.788 . . . . 0.59999999999999998 111.904 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.5 -35.79 72.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.284 -0.416 . . . . 1.3999999999999999 110.807 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -69.88 -29.28 66.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 1.4099999999999999 110.684 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 88.6 p -94.68 -12.7 26.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 1.3200000000000001 110.822 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.755 H183 ' H9 ' ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.55 -31.7 7.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 1.6899999999999999 110.852 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.88 58.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.79000000000000004 112.487 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -69.65 -23.22 63.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.666 0.269 . . . . 2.96 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.2 t -58.94 -58.28 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.887 0.375 . . . . 1.29 110.584 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -72.64 -20.42 61.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.531 . . . . 3.1499999999999999 110.814 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.403 HD23 ' C ' ' B' ' 216' ' ' LEU . 7.3 tt -66.4 -58.37 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 1.51 110.71 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -60.09 -32.05 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.1899999999999999 110.622 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.79 -42.32 98.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.525 . . . . 1.98 111.086 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -87.39 -20.43 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 2.1699999999999999 111.134 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.12 -18.87 76.86 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.911 -0.661 . . . . 1.3600000000000001 113.053 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' B' ' 32' ' ' VAL . 50.8 tp -63.5 -58.58 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.739 -0.271 . . . . 2.8999999999999999 110.976 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.462 ' HA ' ' HE ' ' B' ' 222' ' ' ARG . 3.6 mmp_? 57.61 82.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 5.6100000000000003 110.711 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -68.69 121.62 16.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.994 0.426 . . . . 4.04 110.927 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 pp -161.29 -5.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.991 -0.549 . . . . 6.2999999999999998 110.997 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.05 -65.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.515 . . . . 4.7999999999999998 110.53 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -145.12 168.45 20.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 6.3899999999999997 110.831 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 38.1 t -134.98 144.23 47.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 5.6100000000000003 110.782 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -132.06 132.33 43.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 8.1999999999999993 111.08 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 8.1699999999999999 110.739 179.781 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.516 ' HG2' HD22 ' C' ' 2' ' ' ASN . 27.2 ttt . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.669 0.271 . . . . 5.6200000000000001 110.861 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . 0.516 HD22 ' HG2' ' C' ' 1' ' ' MET . 37.5 m-80 58.45 92.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.094 -0.503 . . . . 5.2800000000000002 111.192 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . 0.407 HD12 ' N ' ' C' ' 3' ' ' LEU . 8.8 mp -80.71 132.97 35.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 6.0499999999999998 110.832 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -160.98 -21.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 4.79 110.85 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 53.0 m -113.67 111.5 21.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 2.71 111.138 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.496 ' N ' HD12 ' C' ' 6' ' ' LEU . 4.9 mp -104.24 9.82 35.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.198 -0.456 . . . . 2.52 110.697 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.4 -36.99 81.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 1.9299999999999999 110.903 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 14.6 m170 -72.15 -24.09 61.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 1.26 110.649 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -73.83 -51.41 16.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.6699999999999999 110.48 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -66.77 -19.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.092 0.472 . . . . 1.8700000000000001 110.388 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -65.53 -58.24 6.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.674 -0.694 . . . . 1.4399999999999999 110.824 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' C' ' 52' ' ' MET . 7.7 p -58.85 -35.98 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.46999999999999997 111.141 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.21 79.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.34 -0.391 . . . . 0.58999999999999997 110.993 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.9 -28.71 60.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.827 -0.702 . . . . 0.5 112.586 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -35.55 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.56 0.219 . . . . 0.68000000000000005 111.21 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 47.5 m -64.67 -50.45 67.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 1.3999999999999999 110.57 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.85 -22.33 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 1.55 110.782 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -59.66 9.47 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.016 -0.611 . . . . 0.70999999999999996 112.535 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -30.87 68.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.919 0.39 . . . . 0.77000000000000002 110.492 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.18 -33.12 74.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 1.9299999999999999 110.49 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.76 -53.29 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 1.8600000000000001 110.582 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . 0.573 ' O ' ' OG ' ' C' ' 26' ' ' SER . 72.9 m-85 -65.19 -24.5 67.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 4.1399999999999997 110.55 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . 0.452 ' HA ' ' OG ' ' C' ' 26' ' ' SER . 55.6 t90 -69.48 -27.21 65.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 3.1499999999999999 110.705 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.4 m -84.69 -34.21 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 1.95 110.657 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.26 -1.51 57.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 2.2200000000000002 110.453 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' C' ' 22' ' ' PHE . 1.4 m -60.72 -23.95 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 1.3700000000000001 110.652 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -48.76 -36.93 17.57 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.231 0.538 . . . . 5.0300000000000002 109.828 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.491 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 8.4 p30 -163.18 131.56 2.82 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.346 -0.843 . . . . 2.3700000000000001 110.034 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.8 Cg_endo -95.74 -177.4 0.41 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.028 2.485 . . . . 2.0499999999999998 112.374 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -97.8 37.12 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.052 -0.522 . . . . 4.5199999999999996 111.212 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.58 -15.7 31.95 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.749 -0.738 . . . . 2.1600000000000001 112.941 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.4 121.13 64.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.536 0.207 . . . . 2.5299999999999998 111.243 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.4 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 38.9 Cg_exo -56.49 165.58 4.34 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.556 2.17 . . . . 1.9299999999999999 112.509 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . 0.415 HE21 HG21 ' A' ' 100' ' ' THR . 19.2 pt20 -62.31 -18.32 61.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.619 -0.719 . . . . 4.1200000000000001 112.417 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.4 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 2.1 p90 -51.72 -34.73 40.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 2.8900000000000001 111.367 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -76.27 -36.97 58.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 2.46 111.12 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -66.01 -35.14 79.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.368 -0.378 . . . . 2.7799999999999998 111.005 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.562 HD23 HG23 ' A' ' 100' ' ' THR . 1.1 tm? -63.95 -56.71 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 1.6200000000000001 110.651 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.71 -45.47 97.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 1.5900000000000001 111.528 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.89 -12.11 52.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.65000000000000002 111.695 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.406 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 26.9 ttt -89.58 -33.71 16.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.693 0.282 . . . . 1.6699999999999999 111.606 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.406 ' HD1' ' HG ' ' A' ' 107' ' ' SER . 35.2 t80 -75.71 -27.57 58.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 3.4199999999999999 111.914 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.467 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 84.8 mt -64.87 -50.63 62.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.89 0.7 . . . . 0.89000000000000001 112.89 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 72.1 Cg_endo -77.54 -33.01 2.58 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.422 2.081 . . . . 0.40999999999999998 114.059 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.486 HG23 ' N ' ' C' ' 46' ' ' TRP . 19.5 tt -62.2 -48.74 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 1.76 111.904 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.653 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -70.78 -57.97 4.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.728 0.299 . . . . 2.1600000000000001 110.727 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.5 p -51.21 -42.27 60.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 1.1699999999999999 110.908 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.68 -49.29 58.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.914 -0.66 . . . . 0.44 112.572 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' C' ' 45' ' ' ILE . 84.9 mt -55.23 -40.16 70.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 1.29 110.929 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.82 88.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.5 111.17 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 72.4 m-85 -55.55 -50.47 69.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.361 -0.381 . . . . 1.8300000000000001 110.99 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . 0.516 ' HB2' HG11 ' C' ' 12' ' ' VAL . 15.6 tmm? -49.66 -37.87 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 1.47 110.388 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.67 -38.4 83.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.59999999999999998 111.201 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 55.4 mtt -54.8 -30.95 58.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.83999999999999997 110.294 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -75.93 -37.81 58.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.842 -0.617 . . . . 0.65000000000000002 110.717 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.455 HG12 ' O ' ' C' ' 52' ' ' MET . 6.6 mm -77.96 -6.4 9.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.957 -0.565 . . . . 1.55 110.99 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.56 46.21 5.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 1.54 111.331 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -111.41 171.35 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 1.79 110.963 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 73.08 24.4 75.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.93999999999999995 112.518 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -137.03 146.47 45.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 2.3599999999999999 110.966 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 141.11 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 1.97 111.161 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.01 87.96 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 2.4399999999999999 110.851 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.51 122.46 33.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 1.54 111.102 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.08 31.39 16.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 1.71 111.105 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 29.99 53.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.841 -0.695 . . . . 1.53 112.628 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . 0.482 HE21 ' N ' ' C' ' 67' ' ' ILE . 23.3 tp60 -131.34 119.05 21.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 2.23 111.054 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . 0.482 ' N ' HE21 ' C' ' 66' ' ' GLN . 26.5 pt -81.72 128.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 111.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.95 140.62 38.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.78000000000000003 111.267 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -95.61 55.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 1.0800000000000001 110.834 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -63.05 -51.32 67.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 2.2999999999999998 111.053 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' C' ' 74' ' ' ILE . . . -57.28 -25.85 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.958 0.408 . . . . 0.75 110.771 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -64.37 -48.23 76.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 1.51 110.801 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.602 ' HB3' HD23 ' C' ' 117' ' ' LEU . 0.2 OUTLIER -72.49 -19.56 61.52 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.858 -0.337 . . . . 4.6500000000000004 111.534 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' C' ' 71' ' ' ALA . 65.0 mt -63.53 -41.94 94.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.172 0.51 . . . . 1.22 109.699 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.496 ' O ' HG22 ' C' ' 79' ' ' THR . 9.0 t70 -66.44 -15.37 63.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.548 -0.751 . . . . 1.3100000000000001 110.071 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.08 -20.45 32.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 1.6799999999999999 111.335 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.505 ' HB3' HD12 ' C' ' 113' ' ' ILE . 8.7 mtm -99.54 4.99 46.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 1.8 111.423 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -114.67 -27.15 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.419 -0.355 . . . . 1.1899999999999999 111.855 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.496 HG22 ' O ' ' C' ' 75' ' ' ASP . 15.1 t -103.8 -34.86 8.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.288 0.477 . . . . 1.23 112.288 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 38.5 m -69.65 -50.76 17.51 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 111.84 0.311 . . . . 0.58999999999999997 111.84 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 32.2 Cg_exo -59.36 -37.51 89.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.928 1.752 . . . . 0.67000000000000004 112.28 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.459 HD13 HD12 ' C' ' 85' ' ' LEU . 4.4 mm? -78.29 -16.92 57.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.95999999999999996 110.619 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -41.75 67.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 1.1899999999999999 110.609 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' C' ' 105' ' ' LEU . 3.9 pp -78.78 -32.33 46.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.7 110.819 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' C' ' 106' ' ' MET . 43.2 mt -61.5 -41.26 97.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 1.6200000000000001 110.833 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.5 t -60.89 -29.91 69.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.02 -0.537 . . . . 1.26 110.783 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.465 HD22 HD11 ' C' ' 168' ' ' LEU . 59.9 mt -74.71 -27.3 60.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 1.1100000000000001 110.891 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.0 t -69.2 -48.6 61.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 1.51 110.865 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -63.86 -32.74 74.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 2.0600000000000001 111.048 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -66.51 -32.14 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 1.52 111.143 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.53 -4.7 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 1.3 111.379 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.3 mtm -118.09 98.91 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.355 -0.384 . . . . 1.6200000000000001 110.992 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -87.42 -16.2 35.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 3.2400000000000002 110.608 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -146.8 133.86 20.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.56 . . . . 4.6299999999999999 110.584 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -146.21 142.48 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.94 0.4 . . . . 2.1800000000000002 111.498 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -131.46 -68.28 0.66 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.958 -0.565 . . . . 4.1200000000000001 110.539 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -138.93 87.17 2.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 4.96 110.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -163.09 121.53 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 3.9100000000000001 110.971 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -134.93 19.38 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 5.21 110.663 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 64.4 p -76.63 -50.77 12.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 1.8200000000000001 111.174 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.4 mt -70.12 -40.06 75.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 2.0800000000000001 110.976 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.06 -41.93 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 1.8600000000000001 111.063 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.21 -11.15 85.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.58999999999999997 112.575 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . 0.429 ' O ' HG23 ' C' ' 108' ' ' THR . 79.1 t80 -80.52 -41.22 24.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.706 0.289 . . . . 1.53 110.928 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.466 ' HB3' HD13 ' C' ' 84' ' ' LEU . 55.1 mt -74.8 -44.07 51.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 1.1100000000000001 111.182 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . 0.487 ' HG2' HD21 ' C' ' 85' ' ' LEU . 71.5 mtm -58.73 -54.27 48.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.307 -0.406 . . . . 2.21 111.285 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -52.23 -50.73 61.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 1.28 111.821 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.429 HG23 ' O ' ' C' ' 104' ' ' PHE . 61.5 p -63.27 -24.69 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 1.22 111.798 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' C' ' 81' ' ' PRO . 8.0 tp-100 -80.82 -35.86 32.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 2.3300000000000001 111.406 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.633 HG22 ' HE1' ' B' ' 46' ' ' TRP . 80.4 mt -65.63 -30.97 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 1.29 111.399 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.31 -37.2 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.606 0.241 . . . . 1.0600000000000001 111.592 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 108' ' ' THR . 73.4 t -67.78 -41.4 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 111.887 0.329 . . . . 0.51000000000000001 111.887 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' C' ' 77' ' ' MET . 38.8 pt -69.4 -34.42 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.748 -0.206 . . . . 1.3700000000000001 111.464 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 99.8 m -60.87 -54.59 43.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.872 0.367 . . . . 0.77000000000000002 110.644 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.5 p -55.88 -29.56 60.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 1.1899999999999999 110.057 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.06 63.72 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.991 -0.623 . . . . 0.5 112.011 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.602 HD23 ' HB3' ' C' ' 73' ' ' TYR . 81.8 mt -48.03 -61.13 2.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 1.47 110.627 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -63.16 -32.57 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.569 -0.741 . . . . 1.2 112.002 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.51 61.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.314 . . . . 0.40000000000000002 111.348 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 -19.03 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 2.1200000000000001 110.884 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 117' ' ' LEU . 95.9 mt -83.26 17.68 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.75 110.992 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -89.78 117.76 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.368 . . . . 1.3799999999999999 110.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.94 -31.13 61.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.106 -0.497 . . . . 2.7400000000000002 110.686 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' C' ' 127' ' ' VAL . 86.5 mtm180 -93.86 144.23 25.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 2.7999999999999998 110.607 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.37 -13.12 58.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 2.4100000000000001 111.382 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -86.37 -50.73 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 4.2000000000000002 111.141 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.2 p -57.68 -24.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.0800000000000001 111.371 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -62.61 -37.35 85.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.364 . . . . 2.5699999999999998 111.055 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -60.9 -36.1 78.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.39 -0.368 . . . . 3.8100000000000001 111.141 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.7 mm? -66.21 -52.63 46.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.4199999999999999 111.124 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . 0.415 ' HE1' ' HG3' ' B' ' 58' ' ' GLN . 9.3 m95 -64.93 -28.93 69.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.427 . . . . 0.89000000000000001 111.45 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -65.42 -46.67 79.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.539 -0.301 . . . . 1.26 110.782 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.1 mm -58.75 -36.6 61.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 1.6799999999999999 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -63.88 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 1.24 110.671 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -48.83 39.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.842 -0.694 . . . . 0.54000000000000004 112.661 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -68.3 -27.06 35.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 1.0600000000000001 111.119 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 54.0 t -64.4 -43.47 94.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 1.0800000000000001 110.614 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . 0.434 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -68.94 -29.37 67.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.783 -0.644 . . . . 0.56999999999999995 111.034 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -71.08 -29.63 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.416 . . . . 1.6799999999999999 110.992 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -70.14 -56.0 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 1.7 111.548 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 28.9 pt -55.71 -37.87 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.78000000000000003 111.751 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.434 HG12 ' O ' ' C' ' 138' ' ' ALA . 44.0 mm -78.33 -33.32 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 2.2400000000000002 111.411 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . 0.405 ' O ' HG22 ' C' ' 146' ' ' ILE . 44.5 tp -61.43 -51.33 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.798 0.332 . . . . 1.02 110.576 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . 0.493 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 98.7 m95 -70.65 -21.28 62.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 3.0 110.463 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.38 67.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.845 -0.693 . . . . 1.27 112.575 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . 0.405 HG22 ' O ' ' C' ' 143' ' ' LEU . 19.0 tt -102.35 -14.67 8.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.873 0.368 . . . . 1.8899999999999999 111.201 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -77.3 -33.49 55.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 1.6000000000000001 111.699 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.643 ' HB2' ' HD3' ' C' ' 149' ' ' PRO . 69.1 m-80 -70.52 -51.51 12.47 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.003 0.371 . . . . 99.989999999999995 112.003 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 25.2 Cg_exo -62.54 -0.93 2.17 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.114 1.876 . . . . 2.73 112.9 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . 0.508 HD11 ' HA ' ' C' ' 166' ' ' ASP . 68.5 tp -61.11 -64.47 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.463 -0.335 . . . . 4.2999999999999998 111.222 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . 0.456 ' HA ' ' OG1' ' C' ' 154' ' ' THR . 73.4 ttt180 -135.88 -12.7 1.96 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.407 -0.361 . . . . 8.9000000000000004 111.15 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' C' ' 148' ' ' ASN . . . -68.59 -46.38 69.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.478 -0.328 . . . . 2.7999999999999998 111.488 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -86.0 -33.35 21.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.5 -0.318 . . . . 5.4400000000000004 111.249 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.457 ' HA ' ' HB3' ' C' ' 157' ' ' GLN . 60.7 p -78.55 6.35 8.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 3.3900000000000001 111.194 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -60.5 -50.62 72.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.367 -0.378 . . . . 6.9199999999999999 111.038 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 7.5 t -88.14 -10.08 51.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 4.8700000000000001 110.927 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.457 ' HB3' ' HA ' ' C' ' 154' ' ' THR . 53.6 tt0 -86.35 -72.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 4.0499999999999998 110.82 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.4 m -154.51 113.66 3.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 3.0299999999999998 110.758 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 52.2 m -74.61 -33.33 62.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 2.96 110.943 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.44 -49.07 76.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 3.7400000000000002 110.851 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.36 -24.89 67.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 2.6499999999999999 110.901 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.05 -37.86 69.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 1.77 111.217 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -65.13 -37.93 89.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.344 -0.389 . . . . 2.96 110.836 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.89 -54.36 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 2.3500000000000001 111.027 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 2.6200000000000001 111.068 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' C' ' 150' ' ' LEU . 16.8 t70 -65.15 -42.93 93.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 2.0899999999999999 111.162 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.76 -25.04 35.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.138 -0.483 . . . . 3.2400000000000002 111.091 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.465 HD11 HD22 ' C' ' 87' ' ' LEU . 54.5 tp -76.89 -39.03 52.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 1.6899999999999999 111.544 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.4 p -71.64 -16.43 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 1.3999999999999999 111.324 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 41.9 m -57.68 -59.41 5.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.95999999999999996 111.258 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -71.46 -31.75 67.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.43 . . . . 3.6499999999999999 110.381 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 91.1 t80 -57.21 -32.97 67.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 1.3700000000000001 110.975 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.465 ' O ' HG22 ' C' ' 177' ' ' ILE . 66.9 m -79.66 -43.3 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 1.4299999999999999 111.494 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -58.3 -36.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 112.18 0.437 . . . . 1.6200000000000001 112.18 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' C' ' 175' ' ' LEU . 4.4 mm? -81.16 -47.39 13.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.729 -0.214 . . . . 2.0299999999999998 111.489 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -30.87 63.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.537 -0.301 . . . . 0.62 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.465 HG22 ' O ' ' C' ' 173' ' ' THR . 10.9 tp -88.01 -22.9 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 1.5800000000000001 110.472 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.19 -57.8 17.39 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.839 -0.619 . . . . 0.56000000000000005 113.37 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.601 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 88.4 m-85 -53.47 -54.85 40.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.692 0.246 . . . . 1.3300000000000001 111.503 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 97.1 Cg_exo -44.37 -35.82 8.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.316 2.011 . . . . 0.63 112.833 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.401 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.0 mt -64.52 -61.14 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 0.93000000000000005 111.537 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.454 HG22 ' O ' ' C' ' 179' ' ' TYR . 20.2 m -59.76 -24.56 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.27 111.454 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -67.19 -52.45 41.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 1.77 111.41 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.02 -41.74 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.211 0.448 . . . . 2.3900000000000001 112.211 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 10.7 tt -122.0 142.56 37.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 1.95 111.739 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 97.58 -143.01 16.46 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.882 -0.675 . . . . 1.8799999999999999 112.814 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . 0.436 ' HB2' ' OD1' ' C' ' 198' ' ' ASP . 74.2 Cg_endo -73.85 163.52 36.85 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.668 2.246 . . . . 3.1200000000000001 112.075 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 60.2 m 57.22 15.36 2.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 2.6299999999999999 110.132 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.22 26.11 0.27 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.677 -0.692 . . . . 3.04 112.341 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 64.7 t80 59.83 93.84 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.988 0.423 . . . . 5.6900000000000004 111.079 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -143.91 166.71 26.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.9 -0.667 . . . . 3.0800000000000001 112.295 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -59.24 -28.47 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.951 0.405 . . . . 7.5300000000000002 110.777 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 pt -104.6 140.85 21.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 2.8599999999999999 111.22 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -156.91 -103.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 3.6899999999999999 110.85 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 49.77 -161.15 0.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.634 0.254 . . . . 5.4800000000000004 110.997 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 74.9 p -68.84 -15.65 63.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.919 0.39 . . . . 2.3799999999999999 111.023 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.98 -27.88 36.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 2.23 110.959 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' C' ' 187' ' ' PRO . 3.1 t70 -49.76 -60.97 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 2.1600000000000001 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 72.4 p -72.27 -18.63 61.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 1.27 111.69 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -74.89 -26.55 59.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 1.7 111.359 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.16 -47.93 10.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.478 -0.328 . . . . 2.02 111.699 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.51 -14.86 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.473 -0.33 . . . . 1.8200000000000001 111.65 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.426 ' O ' ' HG2' ' C' ' 206' ' ' PRO . 20.7 p -96.66 -39.07 9.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 1.3500000000000001 111.53 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 48.3 tp -71.88 -34.01 68.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.277 -0.419 . . . . 0.65000000000000002 112.046 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' C' ' 206' ' ' PRO . 56.4 tp -62.47 -52.94 61.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 111.971 0.36 . . . . 1.4199999999999999 111.971 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' C' ' 205' ' ' LEU . 17.9 Cg_endo -58.21 -41.9 62.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.899 1.733 . . . . 0.63 111.762 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.35 -34.48 78.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 1.49 110.372 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -70.49 -27.51 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 1.7 110.382 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 48.2 t -93.78 -16.53 24.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.002 -0.545 . . . . 1.25 110.61 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.736 ' H9 ' H192 ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t -86.28 -37.9 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 1.6100000000000001 111.034 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.28 -50.43 62.81 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.932 -0.652 . . . . 0.81999999999999995 112.748 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -66.11 -23.69 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 3.0800000000000001 111.279 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.1 t -60.93 -62.46 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.395 . . . . 1.1499999999999999 110.72 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -69.26 -20.42 63.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 2.5600000000000001 110.973 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.26 -59.14 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 1.29 110.601 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.59 -28.54 67.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.863 0.363 . . . . 2.3900000000000001 110.936 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.42 -52.11 66.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.072 -0.513 . . . . 2.0299999999999998 110.976 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -82.71 -20.46 36.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 3.21 110.913 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.54 -29.8 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 1.3600000000000001 112.309 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 51.8 tp -68.4 -55.25 12.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 2.8999999999999999 110.626 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 32.9 tpt180 52.69 89.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.069 -0.514 . . . . 4.8899999999999997 111.27 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -57.69 138.24 55.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 4.2300000000000004 110.916 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 36.1 tp -162.32 -26.9 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 6.1200000000000001 110.754 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -129.18 124.98 35.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.504 . . . . 4.5499999999999998 110.922 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 15.6 t70 65.15 146.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.963 -0.562 . . . . 6.7800000000000002 111.431 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 36.3 t -157.62 124.7 5.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.915 -0.584 . . . . 5.4000000000000004 110.748 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -100.35 161.82 13.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.426 . . . . 8.3300000000000001 110.896 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 7.9100000000000001 110.95 -179.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.813 0.34 . . . . 5.1100000000000003 110.815 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -130.44 42.48 3.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 5.04 110.656 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.2 mt -99.01 -41.14 7.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.751 -0.658 . . . . 5.5800000000000001 111.131 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -60.17 168.15 2.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.175 -0.466 . . . . 5.0199999999999996 111.073 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.8 t 62.1 102.94 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.087 -0.506 . . . . 2.4500000000000002 111.077 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 6' ' ' LEU . 5.5 mp -117.32 4.68 12.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.076 -0.511 . . . . 2.4199999999999999 110.85 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -67.24 -50.38 60.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.0899999999999999 111.064 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 68.3 m-70 -63.36 -25.0 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 1.1599999999999999 110.973 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 12' ' ' VAL . 62.7 t-105 -70.04 -59.67 2.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.79000000000000004 111.077 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -60.56 -19.38 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 2.0800000000000001 110.437 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 207' ' ' PHE . 8.6 t80 -62.16 -58.58 7.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.672 -0.695 . . . . 1.28 110.731 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.4 p -60.47 -29.2 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 1.3200000000000001 110.885 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.32 -46.93 88.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 0.63 111.166 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.91 -23.58 77.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.799 -0.715 . . . . 0.55000000000000004 112.352 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.69 -38.21 54.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.703 0.287 . . . . 1.03 111.131 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -62.79 -48.6 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.387 -0.37 . . . . 1.3 111.096 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER -62.4 -32.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 1.3100000000000001 110.659 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.04 -54.52 30.94 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.783 -0.722 . . . . 0.77000000000000002 112.698 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -35.31 76.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.749 0.309 . . . . 0.80000000000000004 111.389 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 17' ' ' ILE . 93.5 mt -62.54 -30.66 71.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 1.8100000000000001 111.028 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -59.94 -31.9 70.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 1.8799999999999999 110.692 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 m-85 -75.14 -28.02 59.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.188 -0.46 . . . . 4.4500000000000002 110.685 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -62.25 -39.64 93.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.061 0.458 . . . . 3.6899999999999999 109.829 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.2 m -85.49 -28.25 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.758 -0.656 . . . . 1.5700000000000001 110.7 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 56.8 tp -73.13 -18.23 61.31 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.653 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 p -62.52 -25.03 67.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 1.3799999999999999 111.085 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -51.22 -32.59 24.46 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.093 0.473 . . . . 4.0700000000000003 109.938 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.7 p-10 -165.42 132.01 2.17 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 2.7200000000000002 110.304 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 29.3 Cg_endo -95.99 179.86 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.193 2.595 . . . . 1.9099999999999999 112.139 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -103.48 65.58 0.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.339 -0.391 . . . . 4.7599999999999998 111.276 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' HA3' HD13 ' A' ' 224' ' ' LEU . . . 84.76 -46.61 3.71 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.917 -0.659 . . . . 1.99 112.931 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -99.23 146.98 32.66 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.625 0.213 . . . . 2.7000000000000002 111.235 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . 34.6 Cg_exo -58.89 163.29 11.63 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.382 2.055 . . . . 1.79 112.085 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.21 -17.33 63.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.694 -0.685 . . . . 4.1200000000000001 112.319 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 33' ' ' PRO . 6.4 p90 -41.27 -40.92 1.76 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.738 0.304 . . . . 2.9300000000000002 111.774 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.05 -45.41 77.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.886 0.374 . . . . 2.8799999999999999 110.587 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -69.76 -19.37 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.55 . . . . 4.6600000000000001 110.439 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.0 tp -63.0 -55.06 28.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.45 110.508 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.83 -37.31 77.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.78 110.348 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.75 -10.67 59.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.63 110.618 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.499 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 41.0 ttm -88.14 -28.91 20.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.81 -0.632 . . . . 1.48 110.487 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -72.8 -40.09 66.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 3.5 111.369 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.666 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 36.8 mm -50.22 -53.04 48.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 111.99 0.367 . . . . 1.0800000000000001 111.99 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.666 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 15.7 Cg_exo -68.68 -33.73 20.78 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.196 1.931 . . . . 0.53000000000000003 112.595 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -58.01 -62.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.632 0.253 . . . . 1.6799999999999999 111.367 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.61 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.4 OUTLIER -61.72 -57.97 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 1.8300000000000001 111.017 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB2' HG21 ' A' ' 79' ' ' THR . 35.8 t -54.2 -23.06 13.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 1.0900000000000001 111.356 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.54 -66.12 2.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.40999999999999998 112.524 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.1 mt -56.3 -29.15 60.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.293 . . . . 0.98999999999999999 111.144 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.98 -57.61 12.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.47999999999999998 111.222 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 20.8 m-85 -61.61 -42.48 98.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 1.8700000000000001 111.472 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.22 -36.33 8.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.207 0.527 . . . . 1.49 110.349 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -72.37 -40.21 67.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.58999999999999997 110.9 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 54.2 mtt -53.54 -35.57 60.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.041 0.448 . . . . 0.48999999999999999 110.17 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -67.75 -40.96 84.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.59999999999999998 109.935 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.22 3.46 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.727 -0.67 . . . . 1.3100000000000001 110.524 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 61.48 44.64 9.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.667 -0.697 . . . . 1.9099999999999999 111.257 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.4 mm-40 -102.93 170.1 8.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 110.823 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.15 36.48 92.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 1.04 112.23 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -123.18 145.86 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 2.6800000000000002 110.783 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.84 141.04 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.98 110.845 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.7 92.24 7.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 2.1800000000000002 110.837 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.76 110.74 22.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 1.5700000000000001 111.246 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.63 34.97 25.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 1.79 111.431 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.92 20.06 74.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.847 -0.692 . . . . 1.48 112.754 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -130.28 117.65 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 2.3199999999999998 110.502 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.8 pt -69.23 127.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 1.4399999999999999 111.154 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.38 144.56 35.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.81999999999999995 111.225 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 93.4 m-70 -89.12 62.84 6.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.29 0.567 . . . . 0.90000000000000002 110.989 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -56.77 -38.15 72.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.295 -0.866 . . . . 1.8300000000000001 111.191 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.33 -22.21 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.053 -0.521 . . . . 0.62 111.82 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 5.3 tpm_? -66.5 -51.72 53.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 2.3399999999999999 112.022 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.9 p90 -72.59 -34.04 67.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.654 -0.418 . . . . 3.4900000000000002 110.712 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.2 mm -55.47 -46.33 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.324 -0.398 . . . . 1.3700000000000001 110.949 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 47' ' ' SER . 37.8 t70 -65.68 -13.01 58.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 1.3100000000000001 110.425 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -99.75 -0.26 40.33 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.813 -0.63 . . . . 1.48 111.528 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.578 ' HA ' HD13 ' A' ' 113' ' ' ILE . 55.0 ttm -104.59 -6.97 20.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 1.46 110.703 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.527 HG23 HG23 ' A' ' 79' ' ' THR . 27.2 m -114.39 -36.13 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 1.1200000000000001 112.128 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 47' ' ' SER . 62.7 p -88.11 -44.71 10.73 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.339 0.496 . . . . 1.1000000000000001 112.339 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.6 m -56.93 -51.29 82.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.156 0.428 . . . . 0.59999999999999998 112.156 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 80' ' ' THR . 14.6 Cg_endo -56.85 -36.51 98.88 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.679 1.586 . . . . 0.73999999999999999 111.168 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.586 ' HB3' HD11 ' A' ' 43' ' ' ILE . 4.0 mm? -71.1 -34.18 70.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 1.01 109.934 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.753 HD12 ' H43' ' A' ' 210' ' ' LYR . 27.9 mt -68.34 -21.25 64.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.336 -0.616 . . . . 1.48 109.336 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 109' ' ' GLN . 20.8 tp -83.02 -23.88 33.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.142 -0.936 . . . . 1.3799999999999999 109.713 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 82' ' ' LEU . 96.1 mt -84.02 -40.67 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.454 -0.794 . . . . 1.1899999999999999 110.886 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.9 p -63.19 -45.44 91.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 1.23 110.956 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.57 -26.17 68.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.039 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.6 t -68.39 -50.94 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.294 -0.412 . . . . 1.3899999999999999 110.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -65.78 -21.93 66.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.225 -0.443 . . . . 2.3199999999999998 111.024 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.6 m -73.46 -37.51 65.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.353 -0.385 . . . . 1.46 110.967 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.84 -23.98 26.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 1.24 110.937 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.0 mmm -94.0 84.84 4.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 2.0699999999999998 110.796 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.402 HE22 HH21 ' A' ' 222' ' ' ARG . 92.0 mt-30 -73.98 -19.34 60.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 3.5299999999999998 111.126 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.78 133.58 43.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.287 -0.415 . . . . 4.0800000000000001 110.996 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.3 pt -140.8 160.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 2.1699999999999999 110.935 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -139.97 -70.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 4.5199999999999996 110.997 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -142.4 14.64 2.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.345 -0.388 . . . . 3.75 111.04 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.93 129.39 40.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 3.5299999999999998 110.877 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 56.5 t90 -151.63 -13.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 4.9100000000000001 110.926 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 t -82.94 -34.06 26.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.98 111.283 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.78 -48.47 63.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 1.8300000000000001 110.897 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 16.0 tt -59.11 -25.37 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 1.79 111.158 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.44 -46.64 32.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.831 -0.7 . . . . 0.62 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -56.47 -37.93 71.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.63 0.252 . . . . 1.5800000000000001 111.157 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.01 -51.79 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.97999999999999998 110.721 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 84.8 mtp -60.8 -26.08 67.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.48 110.981 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.7 m -68.3 -58.72 3.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 1.1299999999999999 111.139 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.64 HG21 HG21 ' A' ' 142' ' ' ILE . 97.5 m -53.37 -36.18 61.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 1.48 111.142 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.518 ' HB2' HD22 ' A' ' 84' ' ' LEU . 6.2 tp-100 -55.14 -51.69 65.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 2.7000000000000002 110.69 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.8 mm -54.22 -35.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.937 -0.574 . . . . 1.54 111.139 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.77 -44.22 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.045 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.65 -52.26 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.42999999999999999 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 77' ' ' MET . 39.7 mt -53.59 -30.68 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.367 -0.379 . . . . 1.74 111.08 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 54.5 m -64.07 -48.24 76.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.63 110.82 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.8 m -62.98 -21.51 66.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.962 -0.563 . . . . 1.0900000000000001 110.476 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.16 -37.7 9.73 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.862 -0.685 . . . . 0.41999999999999998 112.938 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 73' ' ' TYR . 4.0 pp -76.82 -26.75 54.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.682 0.241 . . . . 1.3799999999999999 111.268 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 69.1 mt -84.08 -38.1 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 CA-C-O 120.709 0.29 . . . . 1.6200000000000001 111.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.18 65.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.39000000000000001 111.281 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.64 -22.07 47.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.172 -0.467 . . . . 2.02 110.887 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.72 5.1 49.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.76000000000000001 111.102 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.9 m -64.13 131.03 46.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 1.46 111.028 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.72 -3.06 14.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 3.3500000000000001 111.126 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.503 ' HB2' HG12 ' A' ' 127' ' ' VAL . 72.2 mtm180 -129.83 141.04 50.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.871 0.367 . . . . 2.9199999999999999 110.97 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.2 -11.45 59.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 2.77 111.133 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -79.3 -41.07 28.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 3.77 110.496 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 124' ' ' ARG . 11.6 p -84.16 -23.66 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.932 -0.576 . . . . 1.1599999999999999 110.955 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.549 HH11 ' H ' ' A' ' 190' ' ' PHE . 36.0 ttm180 -51.61 -40.28 59.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.197 -0.456 . . . . 2.04 111.09 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -75.1 -30.36 60.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 2.6400000000000001 111.167 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 127' ' ' VAL . 87.9 mt -67.56 -58.49 4.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 1.8999999999999999 111.354 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -63.03 -37.02 85.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.321 -0.4 . . . . 1.3999999999999999 111.928 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -55.03 -54.16 46.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.844 0.354 . . . . 1.28 110.662 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mm -66.46 -30.54 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 2.1600000000000001 110.658 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.2 t -62.77 -35.01 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 1.6899999999999999 110.827 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.17 -51.91 15.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.878 -0.677 . . . . 0.52000000000000002 112.646 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.16 -29.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.68 0.276 . . . . 1.02 110.991 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.9 t -69.48 -36.59 76.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0800000000000001 110.684 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.74 -51.54 68.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.62 110.912 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.13 -22.6 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 1.8400000000000001 110.941 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 140' ' ' LEU . 1.5 tm? -64.62 -62.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.6899999999999999 111.227 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.1 pt -59.05 -46.39 91.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.81000000000000005 112.26 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.64 HG21 HG21 ' A' ' 108' ' ' THR . 33.4 mm -64.34 -31.69 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.726 0.269 . . . . 2.3700000000000001 111.726 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 62.7 tp -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.97999999999999998 110.911 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -65.51 -21.89 66.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.411 . . . . 3.27 110.56 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.33 -17.35 71.68 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.84 -0.695 . . . . 1.25 112.835 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 61.7 mt -109.05 -14.51 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.823 0.344 . . . . 2.1200000000000001 111.109 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -66.65 -55.59 14.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.367 0.506 . . . . 1.6599999999999999 112.367 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.845 ' OD1' ' CB ' ' A' ' 152' ' ' ALA . 51.5 t30 -102.06 -52.98 0.14 Allowed Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.62 0.6 . . . . 99.989999999999995 112.62 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 77.0 Cg_exo -41.96 -31.07 1.37 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.52 2.147 . . . . 2.6000000000000001 113.324 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.475 ' HG ' ' HG3' ' A' ' 151' ' ' ARG . 68.1 tp -62.03 -52.35 64.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 4.6100000000000003 110.451 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.475 ' HG3' ' HG ' ' A' ' 150' ' ' LEU . 99.4 mtt180 -144.42 61.14 1.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.976 -0.556 . . . . 8.3599999999999994 110.676 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.845 ' CB ' ' OD1' ' A' ' 148' ' ' ASN . . . -79.37 -41.39 27.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 2.75 111.059 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.74 -23.15 62.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.128 -0.487 . . . . 5.6799999999999997 111.051 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 31.9 m -65.54 -18.76 65.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 3.21 111.202 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.96 -31.65 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 6.8700000000000001 111.153 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 25.2 m -99.07 -27.55 13.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 4.5599999999999996 111.284 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -66.72 -77.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 3.5600000000000001 111.037 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 80.6 p -127.78 113.46 15.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.251 -0.431 . . . . 2.79 110.857 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 73.4 p -77.94 -20.03 53.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.531 . . . . 2.5899999999999999 111.213 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -68.55 -54.49 16.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 3.4700000000000002 111.152 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.41 -30.6 71.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 2.5800000000000001 110.868 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.29 -30.09 69.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 1.78 110.963 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.47 -30.23 57.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 2.6299999999999999 110.91 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.448 HD22 ' HD3' ' A' ' 222' ' ' ARG . 96.2 mt -67.11 -59.58 3.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 2.3399999999999999 111.275 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -22.53 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.262 -0.426 . . . . 2.77 110.839 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.68 -32.48 71.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.006 0.431 . . . . 2.04 110.314 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 170' ' ' THR . 41.3 ttmt -78.33 -22.42 48.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.903 -0.589 . . . . 2.77 110.3 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.49 -56.45 4.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.646 . . . . 1.8899999999999999 111.034 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.0 -34.68 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.677 -0.692 . . . . 1.6399999999999999 112.088 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 167' ' ' LYS . 14.0 t -55.16 -34.09 63.52 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.957 0.408 . . . . 1.24 110.531 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -78.24 -28.52 47.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 2.9700000000000002 110.032 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -73.36 -28.0 61.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.643 -0.708 . . . . 1.48 110.84 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.2 p -76.63 -47.91 20.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.369 -0.378 . . . . 1.55 111.073 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.56 -28.55 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 1.52 111.286 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.4 tp -75.68 -56.73 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 1.8500000000000001 111.053 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.454 ' HZ2' HE22 ' A' ' 109' ' ' GLN . 1.0 OUTLIER -58.48 -29.63 66.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.908 -0.587 . . . . 0.62 111.412 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.508 ' O ' HG12 ' A' ' 181' ' ' ILE . 14.1 tt -87.41 -21.08 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.421 . . . . 1.3500000000000001 110.25 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.1 -50.69 65.06 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.72 -0.673 . . . . 0.58999999999999997 112.87 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.573 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.2 m-85 -55.59 -55.6 38.65 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.797 0.298 . . . . 1.45 110.985 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 85.0 Cg_exo -46.35 -31.63 9.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.062 1.841 . . . . 0.55000000000000004 112.657 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.8 mm -64.8 -58.26 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.816 0.341 . . . . 1.4199999999999999 111.667 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 179' ' ' TYR . 28.2 m -59.6 -27.16 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.78000000000000003 111.58 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -61.65 -23.49 66.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.93999999999999995 110.927 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 89.7 mt -56.68 -39.77 65.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 1.4299999999999999 111.146 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 32.8 pt -108.33 140.14 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.396 . . . . 2.02 111.004 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 193' ' ' ILE . . . 110.64 -165.97 12.3 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.841 -0.695 . . . . 1.79 112.608 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.13 160.0 50.46 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.428 2.085 . . . . 3.1000000000000001 112.086 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 65.2 m 56.92 17.23 3.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.334 -0.394 . . . . 2.7400000000000002 110.375 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -155.83 25.55 0.57 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.784 -0.644 . . . . 3.4300000000000002 112.324 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.549 ' H ' HH11 ' A' ' 128' ' ' ARG . 65.5 m-85 58.53 72.8 0.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.96 0.41 . . . . 6.5 110.528 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 186' ' ' GLY . . . -124.28 -177.99 15.2 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.708 -0.758 . . . . 3.29 112.797 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -139.25 24.18 2.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 6.1600000000000001 111.034 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.574 HG12 ' HA2' ' A' ' 186' ' ' GLY . 37.3 pt -97.16 175.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 2.4199999999999999 111.234 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -74.63 -172.72 1.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 4.29 110.684 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -93.13 -33.27 14.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.868 0.366 . . . . 5.1500000000000004 110.686 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.2 p -70.65 -31.52 68.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 2.4500000000000002 110.941 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.5 mm -64.48 -47.94 87.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 2.48 111.229 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.61 -52.4 63.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 2.1800000000000002 110.682 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 71.9 p -63.93 -25.07 67.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.519 . . . . 1.49 111.076 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -77.02 -27.59 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 1.77 110.998 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 53.7 tp -84.08 -51.17 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 1.4199999999999999 111.506 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -69.75 1.27 4.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.522 -0.308 . . . . 1.78 111.46 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 35.9 t -96.48 -44.01 7.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 1.3 110.191 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.2 tp -72.38 -33.63 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.427 -0.806 . . . . 0.66000000000000003 111.763 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.1 tt -60.09 -54.57 53.97 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.019 -0.272 . . . . 1.6299999999999999 111.17 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.25 -41.63 74.52 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.654 1.57 . . . . 0.64000000000000001 111.262 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.427 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 81.6 t80 -61.28 -34.01 74.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 1.3600000000000001 110.053 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.0 -21.03 57.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 1.54 110.326 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.3 t -95.41 -20.65 18.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.872 -0.604 . . . . 1.2 110.721 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.753 ' H43' HD12 ' A' ' 83' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.97 -38.17 63.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.215 -0.448 . . . . 1.6399999999999999 110.871 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.28 96.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.866 -0.683 . . . . 0.79000000000000004 112.405 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.78 -29.46 69.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.732 0.301 . . . . 1.6100000000000001 110.83 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.6 t -60.49 -58.02 10.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.1499999999999999 110.858 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 218' ' ' LEU . 75.5 t80 -69.1 -23.88 64.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 3.3399999999999999 110.663 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 216' ' ' LEU . 8.3 tt -67.1 -49.46 64.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 1.1899999999999999 110.766 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.39 -38.23 83.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 2.23 110.856 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 215' ' ' PHE . 95.4 mt -59.3 -50.37 74.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 2.4700000000000002 111.109 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -72.67 -21.41 61.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 1.6200000000000001 110.871 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.62 -26.54 64.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 1.4099999999999999 112.567 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 98.0 mt -68.79 -32.69 72.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 2.5800000000000001 111.15 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.448 ' HD3' HD22 ' A' ' 164' ' ' LEU . 44.4 mtm180 59.77 -87.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.111 -0.495 . . . . 4.9299999999999997 111.173 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -123.78 176.52 6.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 4.6299999999999999 110.815 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.412 HD13 ' HA3' ' A' ' 31' ' ' GLY . 53.2 tp -124.14 115.44 21.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.48 . . . . 6.4699999999999998 110.871 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -148.7 -44.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 5.0700000000000003 110.992 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -95.85 118.71 33.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 6.5300000000000002 110.871 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 49.8 m -141.3 26.88 1.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 5.2199999999999998 110.954 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -158.11 134.3 9.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.483 . . . . 8.3599999999999994 110.978 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.986 -0.552 . . . . 7.96 111.048 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.845 0.355 . . . . 6.1699999999999999 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.424 ' OD1' ' HG ' ' B' ' 3' ' ' LEU . 5.2 p30 -144.0 -23.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 4.8200000000000003 111.032 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.424 ' HG ' ' OD1' ' B' ' 2' ' ' ASN . 94.7 mt -102.09 96.66 7.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 5.5999999999999996 110.609 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.12 -27.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 4.7999999999999998 110.994 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.4 m -131.34 154.5 48.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 2.3700000000000001 110.845 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -134.16 -4.53 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 2.0699999999999998 111.021 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.529 HD12 HD11 ' B' ' 10' ' ' ILE . 54.4 tp -67.61 -42.21 82.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.434 -0.348 . . . . 2.1000000000000001 111.099 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.625 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 40.4 m-70 -67.71 -25.37 65.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.49 . . . . 1.0700000000000001 110.35 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -72.97 -49.51 28.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 1.48 110.989 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.529 HD11 HD12 ' B' ' 7' ' ' LEU . 45.3 pt -69.0 -19.18 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.957 0.408 . . . . 2.02 110.789 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -66.55 -54.11 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 0.92000000000000004 110.589 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.57 -31.77 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.93999999999999995 111.003 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.39 -47.31 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.55000000000000004 111.236 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.12 74.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.666 -0.778 . . . . 0.47999999999999998 112.485 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.8 mmt -73.23 -31.51 64.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.84999999999999998 110.804 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -63.5 -58.11 8.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 1.3400000000000001 110.996 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.6 pp -61.21 -23.61 30.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 1.55 111.206 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.431 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -60.7 -51.81 56.38 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.632 -0.794 . . . . 0.69999999999999996 112.161 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -68.32 -23.39 64.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.81000000000000005 110.894 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.57 -43.2 90.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 2.2599999999999998 110.622 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.22 -25.43 61.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.78 110.432 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 83.2 t80 -66.1 -37.25 85.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.666 . . . . 4.5800000000000001 110.47 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.4 ' O ' ' OG ' ' B' ' 26' ' ' SER . 86.0 t90 -67.14 -35.41 79.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 3.3500000000000001 110.656 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 40.8 t -80.41 -19.59 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 1.5800000000000001 111.161 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.1 -22.38 39.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.366 -0.379 . . . . 1.8400000000000001 111.267 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 4.8 p -59.5 -24.48 63.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.553 -0.294 . . . . 1.3700000000000001 111.092 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -47.38 -32.43 4.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 4.9800000000000004 110.022 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 6.4 p30 -172.93 132.06 0.63 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 2.1400000000000001 110.278 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 52.2 Cg_endo -95.01 174.52 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.978 2.452 . . . . 1.8200000000000001 112.306 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -102.2 68.06 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 5.1900000000000004 111.366 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 -46.66 3.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.028 -0.606 . . . . 2.2000000000000002 112.84 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.02 144.93 29.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.515 0.198 . . . . 3.6499999999999999 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 165.47 8.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.405 2.07 . . . . 2.6699999999999999 112.218 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -69.2 -17.36 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.658 -0.701 . . . . 4.8799999999999999 112.413 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -41.17 -37.76 0.97 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.765 0.317 . . . . 1.8700000000000001 111.838 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.67 -57.07 12.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 2.6800000000000002 110.476 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.07 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.904 -0.589 . . . . 2.9199999999999999 110.783 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' B' ' 41' ' ' MET . 20.4 tp -60.38 -51.85 67.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.938 0.399 . . . . 1.6399999999999999 110.281 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -63.02 -38.48 82.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.094 0.473 . . . . 1.6000000000000001 109.872 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.82 -9.59 55.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.703 -0.68 . . . . 0.68999999999999995 110.7 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' B' ' 45' ' ' ILE . 22.0 ttt -87.94 -31.76 19.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 2.5800000000000001 110.426 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -72.65 -34.08 67.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 3.3900000000000001 111.397 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.658 HG23 HG23 ' B' ' 79' ' ' THR . 64.3 mt -52.91 -52.29 66.39 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 111.97 0.359 . . . . 0.40999999999999998 111.97 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 57.8 Cg_endo -71.18 -35.0 9.29 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.264 1.976 . . . . 0.48999999999999999 113.516 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 41' ' ' MET . 33.1 mm -56.64 -62.69 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.867 0.321 . . . . 1.29 111.867 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.63 -57.38 12.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 1.3999999999999999 111.341 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -55.78 -23.56 30.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.066 -0.516 . . . . 1.3799999999999999 111.505 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.39 -64.42 3.36 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.37 112.552 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 60.0 mt -57.37 -27.52 62.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.325 . . . . 1.29 111.076 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.98 -55.76 26.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.16 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 13.8 m-85 -64.32 -41.09 96.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.5 111.235 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 51.6 ttp -49.41 -34.28 15.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.276 0.56 . . . . 1.4099999999999999 110.139 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.27 -40.09 71.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.449 -0.796 . . . . 0.55000000000000004 110.559 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 58.7 mtt -53.55 -30.6 42.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.897 -0.592 . . . . 0.5 110.299 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.2 -45.85 58.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.54000000000000004 110.671 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.518 HG21 HG23 ' C' ' 127' ' ' VAL . 13.1 mt -74.34 0.04 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.508 . . . . 1.3 110.746 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.485 ' HB2' HH12 ' C' ' 124' ' ' ARG . 8.0 m-20 63.76 52.15 2.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.794 -0.639 . . . . 2.2400000000000002 111.131 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -127.98 143.63 51.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 1.77 110.753 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.3 23.7 7.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.844 -0.693 . . . . 1.0600000000000001 112.394 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -137.43 137.49 38.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 2.6600000000000001 111.046 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.55 147.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.8899999999999999 111.005 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.25 94.01 9.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 2.4100000000000001 110.883 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.42 113.38 24.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 1.5600000000000001 111.182 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.45 30.54 18.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.434 . . . . 1.8200000000000001 111.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.84 -11.1 60.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.733 -0.746 . . . . 1.51 112.58 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.597 HE21 ' HA ' ' B' ' 66' ' ' GLN . 0.1 OUTLIER -100.84 134.63 43.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 2.4500000000000002 110.723 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.26 132.2 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 1.79 110.875 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.03 144.33 32.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.81999999999999995 111.565 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.507 ' HB3' ' HD3' ' B' ' 72' ' ' ARG . 74.4 m-70 -95.5 66.58 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.941 -0.572 . . . . 1.05 110.689 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -68.65 -35.54 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.8700000000000001 111.129 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -26.88 68.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.60999999999999999 111.61 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.507 ' HD3' ' HB3' ' B' ' 69' ' ' HIS . 10.3 mpt_? -74.21 -51.69 14.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.24 -0.436 . . . . 2.3900000000000001 111.193 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -49.46 77.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 3.6699999999999999 111.353 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 tp -55.3 -38.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.12 0.415 . . . . 1.6599999999999999 112.12 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.45 -24.75 67.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.349 . . . . 1.4099999999999999 110.406 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -95.87 6.59 48.52 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.08 -0.509 . . . . 1.1599999999999999 110.664 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.62 ' HA ' HD13 ' B' ' 113' ' ' ILE . 53.9 tpp -103.94 -13.82 16.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.64 -0.709 . . . . 1.53 109.455 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.455 ' O ' HD23 ' B' ' 82' ' ' LEU . 26.1 m -114.81 -35.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.437 -0.801 . . . . 0.89000000000000001 111.271 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.658 HG23 HG23 ' B' ' 43' ' ' ILE . 46.2 m -81.48 -60.93 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 1.24 112.179 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.567 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 60.2 m -47.18 -51.27 42.76 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 112.675 0.62 . . . . 0.57999999999999996 112.675 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 80' ' ' THR . 11.0 Cg_endo -54.17 -34.39 78.6 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.048 1.832 . . . . 0.66000000000000003 111.856 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.522 HD13 HD12 ' B' ' 85' ' ' LEU . 4.2 mm? -79.01 -29.52 43.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 1.0600000000000001 110.769 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.547 HD22 ' H43' ' B' ' 210' ' ' LYR . 13.2 tp -68.99 -30.01 68.33 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.018 0.437 . . . . 1.22 110.048 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.5 tt -78.6 -30.36 46.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.749 -0.659 . . . . 1.53 110.072 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.522 HD12 HD13 ' B' ' 82' ' ' LEU . 76.0 mt -68.51 -42.52 78.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 1.5800000000000001 110.706 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -66.18 -41.51 90.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 1.3899999999999999 110.48 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -30.33 68.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.847 -0.615 . . . . 1.1499999999999999 110.53 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -70.72 -48.04 56.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 1.5700000000000001 110.997 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -66.71 -19.19 65.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 2.1699999999999999 111.149 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 34.3 m -79.92 -32.96 40.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 1.4199999999999999 111.051 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.57 -24.6 23.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.315 -0.402 . . . . 1.1799999999999999 111.431 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 90.6 mtp -100.01 104.38 15.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 1.8799999999999999 111.157 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -84.55 -38.15 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.994 -0.548 . . . . 3.4199999999999999 110.935 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.72 133.66 53.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 4.0599999999999996 110.944 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.92 148.53 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 2.0899999999999999 111.034 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -133.67 -67.29 0.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 3.8500000000000001 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -140.85 26.63 2.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.303 -0.408 . . . . 4.8200000000000003 110.903 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.99 106.49 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 3.7999999999999998 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -135.15 -9.14 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 5.1699999999999999 110.747 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.6 t -82.76 -37.0 25.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 2.02 110.959 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.59 -55.23 16.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 2.0899999999999999 110.53 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . 0.495 ' HA ' HD12 ' B' ' 105' ' ' LEU . 16.9 tt -55.4 -28.47 22.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 1.8799999999999999 111.14 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 62.97 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.868 -0.682 . . . . 0.56000000000000005 112.537 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.415 ' O ' HG23 ' B' ' 108' ' ' THR . 35.3 t80 -63.47 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 1.78 110.532 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.598 ' HB3' HD21 ' B' ' 84' ' ' LEU . 85.8 mt -59.05 -46.62 87.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 1.03 110.772 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . 0.523 ' O ' HG12 ' B' ' 110' ' ' ILE . 52.3 ttm -68.18 -22.25 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.759 -0.655 . . . . 1.6699999999999999 110.967 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 56.9 m -76.45 -39.93 51.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.93 0.395 . . . . 1.51 110.939 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 104' ' ' PHE . 60.8 p -64.82 -43.34 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 1.1799999999999999 111.533 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.556 HE21 HD13 ' B' ' 84' ' ' LEU . 3.8 pt20 -59.71 -42.87 94.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.539 -0.301 . . . . 2.1699999999999999 111.001 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.61 HG22 ' HE1' ' A' ' 46' ' ' TRP . 43.2 mm -53.55 -41.16 44.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.842 0.353 . . . . 1.3500000000000001 110.52 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 46' ' ' TRP . 26.5 t -62.16 -44.96 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 1.3400000000000001 111.239 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.46 -50.78 78.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.42999999999999999 111.757 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' B' ' 77' ' ' MET . 21.9 mt -58.57 -33.68 49.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.729 0.3 . . . . 1.6000000000000001 110.866 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.8 m -56.22 -40.54 74.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.17 0.509 . . . . 0.85999999999999999 110.172 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 39.2 m -60.51 -56.78 17.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.94999999999999996 110.243 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.87 -16.38 59.3 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.94 -0.648 . . . . 0.46000000000000002 112.278 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.08 -61.56 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.991 0.425 . . . . 1.75 110.596 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.77 -21.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.828 -0.624 . . . . 1.78 111.804 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.99 42.09 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.021 0.439 . . . . 0.38 110.949 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.08 -23.75 28.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 1.97 110.712 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.92 19.15 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.76000000000000001 110.853 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -75.68 129.05 36.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 1.47 110.977 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.57 -42.62 5.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 2.5 110.7 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.535 ' HB2' HG12 ' B' ' 127' ' ' VAL . 78.7 mtt180 -79.48 148.22 31.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 2.73 110.269 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.39 -22.33 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 2.2000000000000002 111.942 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 31.5 p90 -83.86 -25.98 29.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.685 0.279 . . . . 3.3999999999999999 111.222 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.535 HG12 ' HB2' ' B' ' 124' ' ' ARG . 8.6 p -83.28 -23.74 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 1.23 110.519 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.67 -37.93 66.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.775 -0.648 . . . . 3.04 110.991 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.68 -19.96 47.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.4 . . . . 4.1399999999999997 110.885 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' B' ' 127' ' ' VAL . 98.7 mt -76.22 -60.37 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 1.6499999999999999 111.139 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -62.74 -28.67 70.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.77000000000000002 111.26 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.4 -59.25 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.342 -0.39 . . . . 1.46 110.838 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 47.3 pt -61.45 -25.81 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 1.6299999999999999 111.446 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.9 t -66.4 -39.39 88.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 1.4199999999999999 111.035 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.93 -52.71 31.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.816 -0.707 . . . . 0.48999999999999999 112.671 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' B' ' 180' ' ' PRO . 35.5 m -61.75 -32.42 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.65 0.262 . . . . 1.3 111.376 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.65 -30.55 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.358 -0.383 . . . . 1.3 111.076 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.03 78.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.412 . . . . 0.62 110.825 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.49 -28.41 62.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 1.74 110.972 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 39.9 mt -65.17 -57.84 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.368 -0.378 . . . . 1.76 111.708 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.462 HG13 ' N ' ' B' ' 142' ' ' ILE . 40.2 pt -55.96 -43.29 74.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.893 0.331 . . . . 0.68999999999999995 111.893 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.462 ' N ' HG13 ' B' ' 141' ' ' ILE . 8.9 tp -72.57 -28.36 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.705 0.288 . . . . 1.76 111.252 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.03 -57.33 13.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 1.0600000000000001 110.797 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -63.82 -27.19 69.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 4.1200000000000001 110.559 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' B' ' 149' ' ' PRO . . . -78.21 -17.26 78.42 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.775 -0.726 . . . . 1.26 112.491 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 16.7 tt -109.2 0.31 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 1.98 111.467 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -86.09 -55.01 4.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.846 0.313 . . . . 1.4199999999999999 111.846 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.604 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 34.0 m120 -101.73 -51.38 0.16 Allowed Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.324 0.49 . . . . 99.989999999999995 112.324 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 85.6 Cg_exo -46.46 -24.18 2.57 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.121 1.881 . . . . 2.6499999999999999 112.709 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.21 -45.72 79.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.419 . . . . 4.3899999999999997 110.169 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.571 ' O ' HG22 ' B' ' 154' ' ' THR . 14.3 ptp180 -163.67 66.68 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 7.9000000000000004 110.515 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' B' ' 148' ' ' ASN . . . -83.28 -18.24 39.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 2.77 111.35 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -86.55 -25.27 25.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 6.29 111.637 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . 0.571 HG22 ' O ' ' B' ' 151' ' ' ARG . 7.7 t -61.99 -19.33 62.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.633 0.254 . . . . 3.1000000000000001 111.301 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -58.16 -35.38 71.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.395 . . . . 6.4299999999999997 110.845 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 69.6 p -89.85 -22.82 21.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 4.5700000000000003 110.874 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -78.33 -75.42 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 3.8300000000000001 111.011 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 65.3 m -127.1 113.15 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 3.0699999999999998 111.122 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 50.7 m -77.79 -20.79 52.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 3.4300000000000002 111.014 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -70.85 -49.83 41.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 3.9199999999999999 111.129 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 41.8 tp -67.4 -28.98 68.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.396 -0.366 . . . . 2.7000000000000002 110.86 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.28 -27.52 60.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 1.8300000000000001 111.197 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -76.17 -31.08 58.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.294 -0.412 . . . . 2.6299999999999999 111.164 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt -67.8 -57.49 6.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.343 -0.39 . . . . 2.4300000000000002 110.968 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -22.3 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 2.5800000000000001 110.885 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.78 -54.08 47.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 2.0 110.837 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -63.26 -30.8 71.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 3.0299999999999998 110.919 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.87 -56.66 9.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 1.1000000000000001 111.147 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.86 -23.01 30.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 1.75 111.443 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 52.2 m -56.41 -58.54 7.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.95 0.405 . . . . 0.97999999999999998 110.582 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.36 -33.65 71.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 4.2999999999999998 110.515 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -64.78 -35.42 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 1.3899999999999999 111.278 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 53.1 m -72.83 -54.12 9.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.346 -0.388 . . . . 1.1100000000000001 111.639 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.66 -26.49 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.885 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -77.05 -57.78 3.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 1.75 111.279 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.22 -27.54 55.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.59999999999999998 110.862 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.503 ' O ' HG12 ' B' ' 181' ' ' ILE . 85.7 mt -87.65 -23.88 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 1.47 110.214 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.26 -55.44 29.48 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.55000000000000004 113.029 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 60.3 m-85 -54.23 -55.35 37.82 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.854 0.327 . . . . 1.6200000000000001 111.257 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.5 Cg_exo -45.22 -32.22 7.0 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.323 2.016 . . . . 0.64000000000000001 113.016 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.509 ' O ' HG22 ' B' ' 184' ' ' ILE . 47.1 mm -67.26 -61.13 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.392 -0.367 . . . . 1.27 111.739 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.465 HG22 ' O ' ' B' ' 179' ' ' TYR . 21.0 m -57.26 -24.76 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.68999999999999995 112.005 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -62.82 -23.65 67.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.407 -0.361 . . . . 1.1799999999999999 111.906 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.601 HG23 HG23 ' B' ' 185' ' ' ILE . 16.7 tt -57.54 -38.07 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.737 0.273 . . . . 1.77 111.737 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.601 HG23 HG23 ' B' ' 184' ' ' ILE . 26.1 pt -102.34 156.6 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.759 0.314 . . . . 1.6899999999999999 111.137 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.39 -165.81 32.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.725 -0.75 . . . . 1.5800000000000001 112.46 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.33 154.5 71.91 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.519 2.146 . . . . 2.5099999999999998 112.161 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 69.9 m 57.72 17.97 4.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 3.5800000000000001 110.667 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -135.1 -63.94 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.91 -0.587 . . . . 4.0300000000000002 112.23 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -155.09 -43.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 6.8899999999999997 110.4 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 99.69 117.39 3.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.861 -0.685 . . . . 3.7000000000000002 113.035 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -167.93 -28.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 7.5 110.71 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 25.8 pt -114.02 174.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 2.3500000000000001 111.17 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -78.56 -166.09 0.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.266 -0.425 . . . . 3.8599999999999999 110.931 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -88.43 -46.37 9.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 5.0499999999999998 111.009 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 24.4 m -58.45 -29.72 66.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.292 -0.413 . . . . 2.6800000000000002 111.219 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 80.9 mt -72.3 -42.83 65.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 2.4700000000000002 111.081 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -53.83 -51.99 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 2.5299999999999998 110.647 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 61.6 p -63.03 -44.13 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.29 110.967 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.53 -28.83 48.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 2.6200000000000001 110.965 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.7 tp -84.13 -51.62 6.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 1.6100000000000001 111.779 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -69.34 -2.07 9.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.9 0.333 . . . . 1.4199999999999999 111.9 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -96.83 -42.0 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.044 0.45 . . . . 1.4299999999999999 110.5 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.6 tp -71.82 -33.44 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.629 . . . . 1.1200000000000001 111.844 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.691 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.1 tp -62.8 -54.36 47.96 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.57 -0.252 . . . . 1.26 111.44 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.9 Cg_exo -55.66 -41.22 79.83 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.884 1.723 . . . . 0.59999999999999998 111.415 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -58.71 -36.48 74.34 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.037 0.446 . . . . 1.3999999999999999 110.173 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -72.28 -31.9 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 110.507 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 31.3 t -79.38 -30.25 42.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.78 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.783 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.87 -38.25 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.499 . . . . 1.6899999999999999 111.047 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.48 -36.64 93.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.74 -0.743 . . . . 0.79000000000000004 112.653 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.66 -29.2 66.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 2.96 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -62.85 -61.24 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 1.29 110.878 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -64.0 -22.13 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 3.1499999999999999 110.745 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.408 ' C ' HD13 ' B' ' 216' ' ' LEU . 3.2 tm? -71.48 -49.36 42.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.481 . . . . 1.51 110.674 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.52 -31.95 72.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 2.1899999999999999 110.852 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.74 -38.27 90.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 1.98 110.724 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -85.28 -20.65 29.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 2.1699999999999999 111.017 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.21 -36.1 73.66 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.902 -0.666 . . . . 1.3600000000000001 112.762 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 94.4 mt -59.42 -37.22 77.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.681 0.277 . . . . 2.8999999999999999 111.262 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 61.24 -84.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.113 -0.494 . . . . 5.6100000000000003 111.242 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -115.78 169.35 9.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.388 -0.369 . . . . 4.04 110.697 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.97 90.51 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 6.2999999999999998 110.973 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -117.57 -62.62 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 4.7999999999999998 110.826 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.68 153.09 44.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 6.3899999999999997 110.963 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.6 t -166.46 4.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.252 -0.431 . . . . 5.6100000000000003 111.028 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -149.68 127.27 11.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.427 . . . . 8.1999999999999993 110.761 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 8.1699999999999999 110.956 -179.759 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.842 0.353 . . . . 5.6200000000000001 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -141.15 -26.7 0.71 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.315 -0.402 . . . . 5.2800000000000002 111.169 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 82.8 mt -116.22 93.21 4.14 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.386 -0.37 . . . . 6.0499999999999998 110.997 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -139.2 -68.63 0.43 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 4.79 110.847 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 89.9 p -80.63 166.74 20.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 2.71 110.924 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.465 HD23 ' N ' ' C' ' 6' ' ' LEU . 2.5 pt? -148.94 -6.03 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 2.52 111.221 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.12 -45.06 82.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.382 -0.372 . . . . 1.9299999999999999 111.084 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 36.3 m-70 -68.26 -25.27 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 1.26 110.782 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -73.07 -48.34 36.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.271 -0.422 . . . . 1.6699999999999999 110.887 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.9 -21.07 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 1.8700000000000001 110.156 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -63.73 -57.48 9.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 1.4399999999999999 110.711 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.3 -31.75 49.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.199 -0.455 . . . . 0.46999999999999997 111.106 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.4 81.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 0.58999999999999997 111.301 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.07 -24.36 75.89 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.5 112.656 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -77.15 -34.73 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.68000000000000005 111.166 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 46.7 m -65.44 -48.71 71.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.4 . . . . 1.3999999999999999 110.997 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . 0.406 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.7 pp -63.82 -29.38 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.379 -0.373 . . . . 1.55 110.952 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.406 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -58.4 -51.74 56.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.761 -0.733 . . . . 0.70999999999999996 112.389 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 -24.06 66.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.827 0.346 . . . . 0.77000000000000002 111.217 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 52.6 tp -67.71 -39.17 84.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 1.9299999999999999 110.731 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -60.12 -27.62 67.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.071 -0.513 . . . . 1.8600000000000001 110.618 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.63 -39.98 95.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.94 -0.573 . . . . 4.1399999999999997 110.788 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -62.92 -48.14 80.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 3.1499999999999999 110.763 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 55.1 m -68.54 -19.66 64.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.95 111.359 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.474 ' HG ' HE22 ' C' ' 34' ' ' GLN . 54.1 tp -83.34 -20.68 33.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.439 -0.346 . . . . 2.2200000000000002 111.307 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 75.8 p -60.43 -21.59 62.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.686 -0.234 . . . . 1.3700000000000001 111.096 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -52.03 -31.3 29.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 5.0300000000000002 109.809 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 23.9 p-10 -171.9 131.91 0.75 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 2.3700000000000001 110.293 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 49.7 Cg_endo -96.54 178.07 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.19 2.594 . . . . 2.0499999999999998 112.15 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -103.43 67.48 0.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 4.5199999999999996 110.908 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.07 -45.16 2.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 2.1600000000000001 112.93 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -100.28 133.87 21.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.496 0.184 . . . . 2.5299999999999998 111.496 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -48.83 161.72 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.722 2.281 . . . . 1.9299999999999999 112.747 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . 0.474 HE22 ' HG ' ' C' ' 25' ' ' LEU . 84.7 mm-40 -66.53 -17.56 64.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.544 -0.753 . . . . 4.1200000000000001 112.658 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -41.36 -38.22 1.17 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.812 0.301 . . . . 2.8900000000000001 111.812 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.33 -53.09 58.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 2.46 110.684 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -66.73 -19.04 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 2.7799999999999998 110.739 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' C' ' 41' ' ' MET . 22.2 tp -61.06 -49.61 76.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.094 0.473 . . . . 1.6200000000000001 110.207 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.42 -42.43 96.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.025 -0.534 . . . . 1.5900000000000001 110.093 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.97 -6.8 35.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.797 -0.638 . . . . 0.65000000000000002 110.872 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 25.8 ttt -87.87 -33.22 18.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 1.6699999999999999 110.402 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' C' ' 45' ' ' ILE . 34.3 t80 -71.37 -36.99 71.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 3.4199999999999999 111.32 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.501 HG23 HG23 ' C' ' 79' ' ' THR . 74.7 mt -49.33 -53.4 40.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.132 0.419 . . . . 0.89000000000000001 112.132 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 57.7 Cg_endo -71.27 -33.21 11.63 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.171 1.914 . . . . 0.40999999999999998 112.912 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 41' ' ' MET . 77.2 mt -53.3 -62.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.631 0.253 . . . . 1.76 111.452 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -62.87 -56.08 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.446 -0.343 . . . . 2.1600000000000001 111.216 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . 0.41 ' HG ' ' HA ' ' C' ' 44' ' ' PRO . 98.6 p -51.73 -23.07 4.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.045 -0.525 . . . . 1.1699999999999999 111.212 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.34 -64.62 2.69 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.45 -0.881 . . . . 0.44 112.058 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.94 -28.67 62.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 1.29 110.914 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 -58.79 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.5 111.16 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 18.4 m-85 -60.93 -40.62 93.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.35 -0.387 . . . . 1.8300000000000001 110.972 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.0 ttp -49.48 -38.34 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.439 . . . . 1.47 110.021 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.34 82.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.59999999999999998 110.649 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 56.3 mtt -54.89 -33.08 61.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.83999999999999997 110.174 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.7 -38.48 73.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.821 -0.627 . . . . 0.65000000000000002 110.385 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mt -80.44 -0.42 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 1.55 110.527 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.32 41.84 12.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.794 -0.639 . . . . 1.54 111.177 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -117.05 134.92 54.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 1.79 110.612 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.89 37.66 1.66 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.833 -0.699 . . . . 0.93999999999999995 112.222 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -154.11 132.49 11.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.785 0.326 . . . . 2.3599999999999999 111.119 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -114.1 142.1 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 1.97 110.836 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -84.13 96.05 8.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 2.4399999999999999 111.056 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.44 124.71 43.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 1.54 110.962 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.31 27.19 16.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.311 -0.404 . . . . 1.71 111.139 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -13.59 57.71 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.802 -0.713 . . . . 1.53 112.517 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -100.78 145.15 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.883 0.373 . . . . 2.23 111.263 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -89.96 135.72 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.769 -0.651 . . . . 1.3600000000000001 110.934 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.92 138.39 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.78000000000000003 111.386 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -88.71 64.55 7.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 1.0800000000000001 110.802 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.57 -35.3 77.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 2.2999999999999998 111.01 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.56 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.75 111.576 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.522 HH22 ' HB2' ' C' ' 203' ' ' CYS . 27.3 mmt180 -70.79 -51.29 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 1.51 111.751 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -47.76 74.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.55 -0.296 . . . . 4.6500000000000004 111.65 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.42 -40.49 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.696 0.628 . . . . 1.22 112.696 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.48 -28.5 69.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.398 -0.521 . . . . 1.3100000000000001 110.37 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -88.54 4.1 47.96 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.181 -0.463 . . . . 1.6799999999999999 111.035 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.651 ' HA ' HD13 ' C' ' 113' ' ' ILE . 50.3 tpp -95.97 -20.09 19.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 1.8 109.994 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.437 ' O ' HD23 ' C' ' 82' ' ' LEU . 12.5 m -114.38 -38.39 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.582 -0.736 . . . . 1.1899999999999999 111.653 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.501 HG23 HG23 ' C' ' 43' ' ' ILE . 78.4 m -73.65 -55.89 5.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 1.23 111.998 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 17.9 m -50.1 -51.85 58.55 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.505 0.557 . . . . 0.58999999999999997 112.505 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.2 Cg_exo -53.21 -42.64 63.48 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.781 1.654 . . . . 0.67000000000000004 111.791 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.437 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.1 mm? -67.92 -32.55 73.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.95999999999999996 110.004 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.497 ' O ' HD23 ' C' ' 87' ' ' LEU . 0.2 OUTLIER -68.87 -25.92 64.87 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.833 -0.802 . . . . 1.1899999999999999 108.833 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' C' ' 109' ' ' GLN . 24.0 tp -80.63 -38.21 29.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.014 -0.994 . . . . 1.7 110.311 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . 0.435 ' HG ' ' HE1' ' C' ' 89' ' ' TRP . 19.7 tp -65.84 -52.78 47.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.208 -0.906 . . . . 1.6200000000000001 111.15 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.3 p -50.93 -44.17 60.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 1.26 111.395 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.497 HD23 ' O ' ' C' ' 83' ' ' LEU . 3.6 mm? -62.37 -33.48 74.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 1.1100000000000001 111.184 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 57.7 m -70.87 -22.67 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 1.51 111.196 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . 0.435 ' HE1' ' HG ' ' C' ' 85' ' ' LEU . 93.4 m95 -80.72 -52.12 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 2.0600000000000001 111.233 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . 0.437 HG23 HD21 ' C' ' 168' ' ' LEU . 9.8 t -62.71 -27.55 69.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 1.52 111.36 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' C' ' 165' ' ' TYR . . . -80.47 -22.97 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.174 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.0 mtp -110.53 102.34 10.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 1.6200000000000001 110.882 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -77.98 -40.44 39.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 3.2400000000000002 110.897 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -108.14 138.64 44.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 4.6299999999999999 111.038 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 15.1 pt -145.31 146.76 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 2.1800000000000002 110.969 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.63 -74.79 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.948 0.404 . . . . 4.1200000000000001 111.067 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -139.07 25.89 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 4.96 110.771 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.73 129.68 38.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 3.9100000000000001 110.741 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -151.28 -28.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 5.21 110.832 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 1.7 t -63.99 -46.31 85.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.215 -0.448 . . . . 1.8200000000000001 111.475 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.71 -37.19 86.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.316 -0.402 . . . . 2.0800000000000001 110.823 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 31.0 mm -65.87 -29.16 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.8600000000000001 110.64 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.26 -30.26 46.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.956 -0.64 . . . . 0.58999999999999997 112.602 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -71.84 -25.24 61.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 1.53 110.461 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.3 mt -77.69 -49.38 14.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.1100000000000001 110.81 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.2 ptm -64.95 -24.26 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 2.21 111.045 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 94.5 p -72.33 -50.24 28.33 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.022 0.439 . . . . 1.28 110.504 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -60.03 -24.8 64.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.077 -0.51 . . . . 1.22 110.976 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.507 ' HB2' HD22 ' C' ' 84' ' ' LEU . 24.8 tp60 -66.98 -52.12 46.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 2.3300000000000001 110.613 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.9 -35.41 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.004 -0.544 . . . . 1.29 110.758 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.26 -45.36 98.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 1.0600000000000001 110.929 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.54 -47.86 89.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.51000000000000001 111.394 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' C' ' 77' ' ' MET . 19.7 mt -59.4 -32.55 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 1.3700000000000001 111.009 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -60.5 -43.65 96.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.459 . . . . 0.77000000000000002 110.508 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -59.22 -53.96 52.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 1.1899999999999999 110.428 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.54 -25.56 68.87 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.789 -0.719 . . . . 0.5 111.826 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.402 HD23 ' C ' ' C' ' 117' ' ' LEU . 5.4 tt -60.19 -55.9 28.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.29 0.567 . . . . 1.47 110.329 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' C' ' 121' ' ' LEU . 4.8 tp -81.22 -28.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.162 -0.926 . . . . 1.2 112.188 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.33 46.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.40000000000000002 111.233 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -79.68 -31.15 41.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 2.1200000000000001 110.843 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.547 ' HB2' HD12 ' C' ' 118' ' ' ILE . 73.9 mt -80.79 7.49 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.323 -0.399 . . . . 0.75 110.912 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.0 t -63.42 122.98 17.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 1.3799999999999999 111.223 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.03 -51.55 3.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 2.7400000000000002 110.704 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.661 ' HB2' HG12 ' C' ' 127' ' ' VAL . 90.6 mtt180 -75.65 143.78 42.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 2.7999999999999998 110.662 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.07 -19.09 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 111.667 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -79.46 -54.47 5.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.709 0.29 . . . . 4.2000000000000002 111.108 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' C' ' 124' ' ' ARG . 14.2 p -59.69 -24.04 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 1.0800000000000001 111.367 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -51.52 -47.55 63.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.34 -0.391 . . . . 2.5699999999999998 111.302 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.24 -24.78 62.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.334 -0.393 . . . . 3.8100000000000001 111.339 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.453 HD13 HD13 ' B' ' 56' ' ' ILE . 95.6 mt -72.65 -52.21 16.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.4199999999999999 111.166 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.27 -28.7 66.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.89000000000000001 110.792 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -59.84 -60.41 3.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.823 -0.626 . . . . 1.26 110.451 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' C' ' 136' ' ' VAL . 16.4 tt -63.95 -26.23 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.917 -0.583 . . . . 1.6799999999999999 111.087 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 51.0 t -63.54 -35.29 80.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 1.24 110.793 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.61 -53.75 7.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.81 -0.709 . . . . 0.54000000000000004 112.587 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' C' ' 133' ' ' ILE . 34.1 m -59.46 -30.75 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.321 . . . . 1.0600000000000001 111.352 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.2 t -70.8 -35.27 72.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.413 . . . . 1.0800000000000001 110.67 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.58 93.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.8 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . 0.401 ' HA ' HG12 ' C' ' 142' ' ' ILE . 79.3 t80 -73.16 -24.04 60.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.903 -0.59 . . . . 1.6799999999999999 111.083 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -60.94 2.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 1.7 111.357 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.416 HG13 ' N ' ' C' ' 142' ' ' ILE . 17.6 pt -58.34 -45.71 89.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.608 0.596 . . . . 0.78000000000000003 112.608 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.416 ' N ' HG13 ' C' ' 141' ' ' ILE . 41.8 pt -66.44 -32.26 57.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.685 0.254 . . . . 2.2400000000000002 111.685 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 56.5 tp -55.76 -56.64 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.603 0.239 . . . . 1.02 110.901 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -64.79 -24.52 67.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 3.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' C' ' 149' ' ' PRO . . . -79.38 -17.37 76.26 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.343 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . 0.4 HG13 ' O ' ' C' ' 142' ' ' ILE . 68.8 mt -109.24 -12.37 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.957 0.408 . . . . 1.8899999999999999 111.031 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -72.4 -55.4 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 1.6000000000000001 111.998 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.616 ' HB2' ' HD3' ' C' ' 149' ' ' PRO . 34.0 m120 -101.92 -53.12 0.15 Allowed Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.406 0.521 . . . . 99.989999999999995 112.406 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.616 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 88.5 Cg_exo -45.04 -25.28 1.63 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.409 2.073 . . . . 2.73 112.853 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.27 -52.96 34.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 4.2999999999999998 110.058 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -149.09 62.89 1.04 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 8.9000000000000004 110.857 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.73 -19.06 38.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.158 -0.473 . . . . 2.7999999999999998 110.925 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -84.03 -24.16 30.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 5.4400000000000004 111.166 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 75.5 p -68.15 -10.39 53.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 3.3900000000000001 110.941 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -65.64 -26.0 67.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.02 -0.536 . . . . 6.9199999999999999 110.761 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 8.0 t -110.96 -2.12 16.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 4.8700000000000001 111.197 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -93.11 -68.95 0.77 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 4.0499999999999998 110.991 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 69.9 m -134.83 115.71 13.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 3.0299999999999998 110.732 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 64.7 m -73.63 -34.54 65.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 2.96 111.374 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -59.34 -54.09 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.823 0.344 . . . . 3.7400000000000002 111.023 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 49.4 tp -58.28 -34.34 70.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.244 -0.434 . . . . 2.6499999999999999 110.842 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.05 -31.6 68.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.016 -0.538 . . . . 1.77 111.2 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -67.26 -36.74 82.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.293 -0.412 . . . . 2.96 110.684 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.31 -46.4 77.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.243 0.545 . . . . 2.3500000000000001 110.469 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . 0.523 ' CE2' ' HB1' ' C' ' 91' ' ' ALA . 0.4 OUTLIER -61.62 -36.03 79.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 2.6200000000000001 111.108 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.82 -56.22 17.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 2.0899999999999999 111.539 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . 0.418 ' O ' HG22 ' C' ' 170' ' ' THR . 68.5 mttm -59.34 -22.21 60.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 3.2400000000000002 111.461 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.437 HD21 HG23 ' C' ' 90' ' ' THR . 56.3 tp -81.95 -59.05 2.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 1.6899999999999999 111.413 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.67 -29.27 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.3999999999999999 112.192 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . 0.418 HG22 ' O ' ' C' ' 167' ' ' LYS . 15.3 t -57.05 -36.17 70.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.95999999999999996 110.988 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -77.32 -34.71 55.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 3.6499999999999999 109.943 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.24 -22.59 63.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.688 -0.687 . . . . 1.3700000000000001 110.474 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 90.6 m -79.52 -58.56 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 1.4299999999999999 111.264 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.68 -28.52 32.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 1.6200000000000001 111.785 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.424 HD21 ' OG ' ' C' ' 209' ' ' SER . 46.8 tp -73.34 -57.4 4.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 2.0299999999999998 111.163 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.78 -25.55 60.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.62 110.875 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 86.4 mt -87.89 -21.57 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.045 0.45 . . . . 1.5800000000000001 110.414 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . 0.527 ' O ' HG22 ' C' ' 181' ' ' ILE . . . -63.4 -41.6 99.33 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.791 -0.64 . . . . 0.56000000000000005 112.998 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.525 ' N ' ' HD2' ' C' ' 180' ' ' PRO . 55.5 m-85 -64.47 -52.03 55.82 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 111.988 0.366 . . . . 1.3300000000000001 111.988 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.588 ' HA ' ' NE1' ' C' ' 183' ' ' TRP . 33.1 Cg_endo -63.76 -16.78 56.78 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.01 1.807 . . . . 0.63 113.326 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.527 HG22 ' O ' ' C' ' 178' ' ' GLY . 3.6 tt -88.99 -27.09 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 112.483 0.549 . . . . 0.93000000000000005 112.483 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.429 HG13 ' N ' ' C' ' 183' ' ' TRP . 3.8 p -80.88 -53.78 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.47 0.915 . . . . 1.27 113.47 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . 0.588 ' NE1' ' HA ' ' C' ' 180' ' ' PRO . 0.2 OUTLIER -58.32 -12.11 3.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.198 0.444 . . . . 1.77 112.198 -178.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.99 -18.84 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.996 0.427 . . . . 2.3900000000000001 110.703 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 2.4 pt -126.67 91.76 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.858 -0.61 . . . . 1.95 111.201 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 151.46 -161.69 29.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.968 -0.635 . . . . 1.8799999999999999 112.157 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.86 149.19 42.85 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.556 2.171 . . . . 3.1200000000000001 111.893 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 94.1 p 51.34 24.61 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.092 -0.504 . . . . 2.6299999999999999 110.947 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -139.02 -91.5 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.872 -0.604 . . . . 3.04 112.238 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -125.0 -32.66 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.357 . . . . 5.6900000000000004 110.66 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 86.52 123.64 1.58 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 3.0800000000000001 112.785 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -174.66 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 7.5300000000000002 110.694 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 22.8 pt -106.98 179.56 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 2.8599999999999999 111.271 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . 0.634 ' H ' HD12 ' C' ' 197' ' ' ILE . 75.8 m-20 -86.57 -167.3 1.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.093 -0.503 . . . . 3.6899999999999999 111.087 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -83.71 -47.66 10.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 5.4800000000000004 110.965 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.7 p -60.93 -27.43 68.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 2.3799999999999999 111.408 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . 0.634 HD12 ' H ' ' C' ' 194' ' ' ASN . 88.3 mt -72.97 -45.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.403 -0.362 . . . . 2.23 111.295 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.25 -46.97 76.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 2.1600000000000001 110.894 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.3 p -69.52 -26.92 64.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 1.27 111.08 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -69.71 -33.36 72.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 1.7 110.981 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.22 -45.53 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 2.02 111.396 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -67.5 -7.44 25.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 1.8200000000000001 111.266 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.522 ' HB2' HH22 ' C' ' 72' ' ' ARG . 44.3 t -96.47 -43.52 7.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 1.3500000000000001 110.568 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 39.4 tp -67.82 -37.05 81.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.48 -0.782 . . . . 0.65000000000000002 112.149 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.609 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.4 OUTLIER -60.86 -55.21 46.97 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.942 -0.303 . . . . 1.4199999999999999 111.446 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 66.8 Cg_exo -53.75 -36.78 83.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.691 1.594 . . . . 0.63 111.368 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.86 -46.15 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 1.49 109.985 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -68.29 -16.55 64.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.787 -0.642 . . . . 1.7 110.483 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . 0.424 ' OG ' HD21 ' C' ' 175' ' ' LEU . 30.6 t -93.83 -27.7 16.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 1.25 110.914 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.761 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.86 -35.01 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.421 . . . . 1.6100000000000001 111.094 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.89 -40.11 98.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.81999999999999995 112.333 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.93 -27.92 67.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.835 0.35 . . . . 3.0800000000000001 110.97 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 52.9 m -61.44 -57.15 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 1.1499999999999999 110.967 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.86 -29.41 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.318 -0.401 . . . . 2.5600000000000001 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.451 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.1 tm? -66.04 -40.44 90.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 1.29 110.535 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.01 -22.06 60.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.082 -0.508 . . . . 2.3900000000000001 110.459 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 43.8 tp -74.5 -42.07 59.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 2.0299999999999998 110.552 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -85.13 -20.27 30.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 3.21 111.025 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.57 49.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.991 -0.623 . . . . 1.3600000000000001 112.714 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.7 -29.61 69.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.733 0.301 . . . . 2.8999999999999999 111.192 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 60.93 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.031 -0.531 . . . . 4.8899999999999997 111.385 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -133.48 148.9 51.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.361 -0.381 . . . . 4.2300000000000004 110.823 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 72.9 mt -92.64 113.98 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 6.1200000000000001 111.026 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -146.2 -45.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 4.5499999999999998 110.853 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.81 132.78 39.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 6.7800000000000002 110.862 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 47.3 t -131.31 -49.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 5.4000000000000004 110.906 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.81 178.83 6.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 8.3300000000000001 110.758 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 7.9100000000000001 110.824 179.911 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.811 0.339 . . . . 5.1100000000000003 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -100.2 -13.71 18.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 5.04 110.958 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -86.04 86.95 7.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.287 -0.415 . . . . 5.5800000000000001 111.05 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -119.49 145.35 46.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.29 -0.414 . . . . 5.0199999999999996 110.733 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -153.69 127.79 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.39 -0.368 . . . . 2.4500000000000002 111.082 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.0 mt -92.19 4.5 53.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 2.4199999999999999 110.775 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.85 -52.33 44.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 2.0899999999999999 110.555 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 40.6 m-70 -68.42 -23.55 64.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.89 -0.596 . . . . 1.1599999999999999 110.101 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -66.57 -52.17 48.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.701 -0.681 . . . . 0.79000000000000004 111.115 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.0 pt -68.53 -21.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0800000000000001 110.773 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -60.6 -55.06 37.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 1.28 110.56 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.98 -36.24 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.966 -0.561 . . . . 1.3200000000000001 111.127 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.43 -37.63 73.12 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.935 0.398 . . . . 0.63 110.92 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.04 -29.41 58.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.721 -0.752 . . . . 0.55000000000000004 112.178 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -74.81 -31.72 61.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.727 0.299 . . . . 1.03 111.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.9 p -68.11 -50.19 56.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.481 -0.327 . . . . 1.3 111.111 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.47 -26.58 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.287 -0.415 . . . . 1.3100000000000001 110.725 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.49 44.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.61 -0.805 . . . . 0.77000000000000002 111.9 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -64.79 -23.48 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.903 0.382 . . . . 0.80000000000000004 110.716 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -68.78 -41.62 78.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.08 -0.509 . . . . 1.8100000000000001 110.776 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -60.54 -23.53 64.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 1.8799999999999999 110.305 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 84.7 t80 -60.84 -31.9 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.659 -0.7 . . . . 4.4500000000000002 110.566 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.466 ' O ' ' OG ' ' A' ' 26' ' ' SER . 68.4 t-105 -78.51 -45.52 21.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 3.6899999999999999 110.531 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 p -65.9 -19.72 65.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.978 -0.555 . . . . 1.5700000000000001 110.748 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.96 -12.74 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 1.95 110.743 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 72.7 p -69.64 -18.53 63.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 1.3799999999999999 111.01 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -49.56 -32.98 13.73 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.36 0.6 . . . . 4.0700000000000003 109.575 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -176.86 131.82 0.37 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.959 -1.018 . . . . 2.7200000000000002 110.096 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HB3' ' NE2' ' A' ' 34' ' ' GLN . 72.5 Cg_endo -95.54 177.41 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.007 2.471 . . . . 1.9099999999999999 112.224 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -99.36 63.8 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 4.7599999999999998 111.298 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.83 -46.55 3.5 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.751 -0.737 . . . . 1.99 112.554 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.6 146.43 31.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.526 0.203 . . . . 2.7000000000000002 110.776 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.64 165.49 18.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.367 2.044 . . . . 1.79 112.399 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 29' ' ' PRO . 27.4 mm-40 -72.32 -15.86 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.412 -0.813 . . . . 4.1200000000000001 112.016 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -40.27 -38.98 0.86 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.334 0.494 . . . . 2.9300000000000002 112.334 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 37' ' ' TYR . 11.7 pt-20 -64.84 -46.9 79.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 2.8799999999999999 110.568 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 73.8 m-85 -70.49 -18.6 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 4.6600000000000001 110.488 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 41' ' ' MET . 54.3 tp -63.2 -49.28 74.86 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.219 -0.446 . . . . 1.45 110.321 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -63.5 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.174 0.511 . . . . 1.78 109.663 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 -5.01 40.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.588 -0.733 . . . . 0.63 110.475 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.475 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 22.0 ttt -88.25 -34.07 17.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.094 -0.503 . . . . 1.48 110.473 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.443 ' HA ' HD12 ' A' ' 45' ' ' ILE . 44.3 t80 -75.67 -31.4 59.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 3.5 110.883 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.704 HG23 HG23 ' A' ' 79' ' ' THR . 85.2 mt -52.54 -51.75 70.17 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.336 -0.393 . . . . 1.0800000000000001 111.597 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' C ' ' A' ' 41' ' ' MET . 73.5 Cg_endo -74.3 -32.21 6.76 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.408 2.072 . . . . 0.53000000000000003 112.804 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 42' ' ' PHE . 72.0 mt -53.67 -61.62 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.633 0.254 . . . . 1.6799999999999999 111.539 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.482 ' NE1' HG22 ' B' ' 110' ' ' ILE . 2.1 t90 -64.8 -51.42 62.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.688 0.28 . . . . 1.8300000000000001 111.064 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 44' ' ' PRO . 95.8 p -57.67 -14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.325 -0.398 . . . . 1.0900000000000001 111.196 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.77 -57.95 2.96 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.40999999999999998 112.491 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.78 -28.41 65.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.98999999999999999 111.032 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.36 -59.36 5.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.541 . . . . 0.47999999999999998 111.267 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 16.0 m-85 -59.47 -43.07 93.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 1.8700000000000001 111.126 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.9 ttp -48.24 -35.4 11.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.187 0.518 . . . . 1.49 110.216 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -67.99 -43.85 77.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.72 -0.673 . . . . 0.58999999999999997 110.648 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 56.1 mtt -52.12 -27.83 15.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.48999999999999999 110.244 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.11 -45.26 58.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.719 -0.673 . . . . 0.59999999999999998 110.622 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 53' ' ' ALA . 20.8 pt -84.18 11.15 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 1.3100000000000001 111.109 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 60.05 50.59 6.46 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.923 -0.58 . . . . 1.9099999999999999 111.675 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.02 158.25 30.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 1.6200000000000001 110.937 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.23 34.55 32.55 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.733 -0.746 . . . . 1.04 112.307 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -129.9 136.37 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.75 0.309 . . . . 2.6800000000000002 110.896 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.3 140.13 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 1.98 111.259 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.82 89.99 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 2.1800000000000002 111.034 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.74 126.11 42.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.332 -0.394 . . . . 1.5700000000000001 111.407 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 34.87 24.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 1.79 111.54 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.17 -0.31 59.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.823 -0.704 . . . . 1.48 112.835 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -98.35 134.27 41.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.673 0.273 . . . . 2.3199999999999998 110.771 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 mt -89.3 103.79 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 1.4399999999999999 110.942 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.38 135.52 38.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.81999999999999995 110.861 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 53.0 m-70 -82.65 73.71 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.186 0.517 . . . . 0.90000000000000002 110.723 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -58.92 -28.89 66.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.45 -0.795 . . . . 1.8300000000000001 111.458 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -82.04 -23.96 35.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.62 111.805 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 12.9 tpp180 -67.24 -51.27 55.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 2.3399999999999999 112.386 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 9.1 p90 -82.53 -32.5 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.275 0.472 . . . . 3.4900000000000002 112.275 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 71' ' ' ALA . 17.0 tt -55.23 -42.15 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 C-N-CA 120.713 -0.395 . . . . 1.3700000000000001 110.489 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.33 -22.81 64.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.445 -0.576 . . . . 1.3100000000000001 109.445 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -87.79 5.13 41.56 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.475 -0.784 . . . . 1.48 111.103 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.485 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 53.3 ttm -104.59 -18.18 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 1.46 110.494 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.415 ' O ' HD23 ' A' ' 82' ' ' LEU . 35.2 m -114.05 -35.29 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 1.1200000000000001 111.517 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.704 HG23 HG23 ' A' ' 43' ' ' ILE . 87.9 m -82.14 -49.0 10.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.246 -0.434 . . . . 1.1000000000000001 111.648 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.582 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 55.8 m -53.39 -49.92 85.65 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.199 -0.455 . . . . 0.59999999999999998 112.197 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.9 Cg_endo -58.88 -41.51 61.68 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.97 1.78 . . . . 0.73999999999999999 112.17 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -78.8 -7.97 58.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 1.01 110.894 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -81.42 -40.29 23.63 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.796 0.332 . . . . 1.48 110.283 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 109' ' ' GLN . 3.6 pp -81.62 -31.59 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.3799999999999999 110.223 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.54 -27.94 63.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 1.1899999999999999 110.319 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -63.69 -24.68 67.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 1.23 110.399 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.09 -52.53 18.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.88 110.739 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.2 t -60.21 -21.41 61.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 1.3899999999999999 110.838 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -76.4 -36.59 57.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 2.3199999999999998 111.052 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 p -80.92 -23.44 38.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 1.46 111.353 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 -37.14 17.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 1.24 111.21 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.9 ttt -97.74 99.42 10.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 2.0699999999999998 110.435 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -85.91 -48.8 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 3.5299999999999998 111.244 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -104.57 137.32 42.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.969 0.414 . . . . 4.0800000000000001 111.067 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 pt -123.71 151.43 28.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 2.1699999999999999 110.843 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.12 -54.49 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 4.5199999999999996 110.558 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -150.12 -159.59 1.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 3.75 110.438 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 64.68 105.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.024 0.44 . . . . 3.5299999999999998 111.228 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -119.53 15.86 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.609 . . . . 4.9100000000000001 110.553 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.3 t -87.16 -21.25 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 1.98 110.834 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.3 tp -69.47 -51.52 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 1.8300000000000001 110.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -59.19 -30.68 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 1.79 111.081 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.1 -27.19 64.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.791 -0.719 . . . . 0.62 112.542 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -73.43 -38.41 65.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 1.5800000000000001 110.972 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.3 mt -71.74 -32.54 67.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.97999999999999998 111.119 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.466 ' O ' HG12 ' A' ' 110' ' ' ILE . 61.1 mtt -74.23 -25.3 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 1.48 111.11 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -76.95 -49.44 15.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 1.1299999999999999 111.256 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.5 t -62.41 -35.43 79.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 1.48 111.949 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.591 ' HB3' HD21 ' A' ' 84' ' ' LEU . 13.8 pt20 -67.3 -42.05 84.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.567 0.223 . . . . 2.7000000000000002 111.465 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 106' ' ' MET . 33.1 mm -60.05 -33.45 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.827 0.346 . . . . 1.54 111.067 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.29 -44.6 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.28 111.458 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.64 -50.09 77.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.146 -0.479 . . . . 0.42999999999999999 111.864 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.412 HD12 ' HG3' ' A' ' 77' ' ' MET . 48.5 pt -57.2 -33.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.626 0.25 . . . . 1.74 111.437 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 85.4 m -63.67 -47.61 80.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.63 111.12 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -63.81 -21.76 66.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.163 -0.471 . . . . 1.0900000000000001 110.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.61 -46.44 7.32 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.937 -0.649 . . . . 0.41999999999999998 112.95 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -66.75 -29.13 69.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.52 0.2 . . . . 1.3799999999999999 111.53 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.1 tp -83.46 -28.4 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.551 -0.295 . . . . 1.6200000000000001 111.161 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.68 71.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.39000000000000001 110.803 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.08 -23.55 41.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 2.02 110.783 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.404 ' HB2' HD12 ' A' ' 118' ' ' ILE . 84.2 mt -83.59 23.72 0.93 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.76000000000000001 110.837 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.1 t -76.31 137.04 39.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 1.46 110.967 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.07 -34.54 8.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 3.3500000000000001 110.922 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.57 ' HB2' HG12 ' A' ' 127' ' ' VAL . 98.5 mtt180 -116.48 143.09 46.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 2.9199999999999999 110.982 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -74.68 -12.11 60.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 2.77 111.137 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -86.58 -39.53 16.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.46 -0.336 . . . . 3.77 111.072 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.591 HG11 ' NE2' ' C' ' 58' ' ' GLN . 14.5 p -77.78 -24.23 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 1.1599999999999999 111.086 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -57.62 -29.28 64.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.005 -0.543 . . . . 2.04 110.754 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.03 -31.42 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 2.6400000000000001 110.964 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 127' ' ' VAL . 3.5 mm? -73.31 -42.28 62.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.067 -0.515 . . . . 1.8999999999999999 111.163 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -74.17 -31.65 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 1.3999999999999999 110.995 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.46 -56.96 15.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.28 110.654 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.8 tt -62.17 -29.4 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.233 -0.439 . . . . 2.1600000000000001 110.933 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.5 t -61.18 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 1.6899999999999999 111.197 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' HA3' H142 ' A' ' 210' ' ' LYR . . . -72.26 -52.53 10.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.675 -0.774 . . . . 0.52000000000000002 112.535 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.21 -29.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 1.02 111.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 36.4 t -64.44 -42.43 96.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0800000000000001 110.747 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.05 93.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.294 -0.412 . . . . 0.62 110.925 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -76.73 -15.8 59.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 1.8400000000000001 111.02 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.67 -55.1 6.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.372 . . . . 1.6899999999999999 110.621 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.53 -34.92 63.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.81000000000000005 111.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 146' ' ' ILE . 39.8 mm -71.44 -44.12 71.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 2.3700000000000001 110.969 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.23 -56.06 24.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.97999999999999998 110.931 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -63.04 -21.89 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 3.27 111.097 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.74 -20.44 61.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 1.25 112.866 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 142' ' ' ILE . 70.3 mt -99.56 -12.68 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.458 . . . . 2.1200000000000001 110.783 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -69.0 -50.64 47.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 1.6599999999999999 111.577 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 69.1 m-80 -53.48 -53.13 60.09 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 99.989999999999995 112.143 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 36.2 Cg_endo -63.9 -10.47 22.87 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.096 1.864 . . . . 2.6000000000000001 112.845 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.28 46.29 2.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.516 -0.311 . . . . 4.6100000000000003 111.237 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -173.04 -65.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 8.3599999999999994 110.963 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.73 -36.45 37.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 2.75 111.25 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -79.96 -22.71 42.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 5.6799999999999997 110.979 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 157' ' ' GLN . 40.1 p -86.76 -4.49 59.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 3.21 111.534 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -63.07 -38.5 91.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.503 -0.317 . . . . 6.8700000000000001 110.889 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 t -100.11 -21.27 15.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 4.5599999999999996 110.842 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 154' ' ' THR . 23.3 tp60 -68.17 -75.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.002 -0.544 . . . . 3.5600000000000001 110.933 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.6 m -156.43 122.62 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 2.79 110.645 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 68.3 p -77.22 -25.79 52.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.073 -0.512 . . . . 2.5899999999999999 111.0 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -69.1 -57.05 5.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 3.4700000000000002 110.941 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 164' ' ' LEU . 6.7 mp -66.95 -23.66 65.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 2.5800000000000001 111.023 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.53 -47.24 82.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 1.78 111.046 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.62 -33.81 76.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 2.6299999999999999 110.698 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 161' ' ' LEU . 92.5 mt -57.76 -60.76 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 2.3399999999999999 110.675 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.64 68.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 2.77 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -38.85 68.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.438 -0.346 . . . . 2.04 110.921 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.07 -22.79 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.256 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 74.9 mt -73.99 -60.04 2.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.361 -0.381 . . . . 1.8899999999999999 111.135 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.0 t -55.84 -23.84 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.883 -0.598 . . . . 1.6399999999999999 111.45 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.9 m -56.18 -58.94 5.83 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.841 0.353 . . . . 1.24 111.262 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.43 -30.66 69.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 2.9700000000000002 110.805 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.81 -28.65 69.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 1.48 111.05 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.403 HG22 HD12 ' A' ' 177' ' ' ILE . 55.2 m -77.91 -56.64 4.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 1.55 111.283 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.9 t -56.62 -28.76 28.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.573 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.89 -57.77 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 1.8500000000000001 111.405 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.3 -27.29 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.62 110.885 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.529 ' O ' HG12 ' A' ' 181' ' ' ILE . 90.9 mt -87.73 -25.0 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.235 -0.439 . . . . 1.3500000000000001 110.3 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 181' ' ' ILE . . . -55.81 -55.9 26.61 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.872 -0.603 . . . . 0.58999999999999997 113.311 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 96.0 m-85 -53.33 -55.8 30.83 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.765 -0.374 . . . . 1.45 110.788 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.2 Cg_exo -45.45 -33.34 9.1 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.084 1.856 . . . . 0.55000000000000004 112.423 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 177' ' ' ILE . 47.1 mm -59.39 -53.82 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-O 121.024 0.44 . . . . 1.4199999999999999 110.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.5 m -58.43 -24.23 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.78000000000000003 111.082 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.558 ' CD1' H191 ' A' ' 210' ' ' LYR . 83.7 m95 -83.88 -16.45 44.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.93999999999999995 111.773 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 93.4 mt -50.7 -37.41 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.818 0.342 . . . . 1.4299999999999999 110.95 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 185' ' ' ILE . 2.2 pp -141.72 157.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.404 . . . . 2.02 111.333 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.427 ' HA3' ' N ' ' A' ' 191' ' ' GLY . . . 87.12 158.01 31.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.927 -0.654 . . . . 1.79 113.285 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.91 90.02 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.755 2.303 . . . . 3.1000000000000001 112.27 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 55.3 m 55.1 50.56 15.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 2.7400000000000002 110.991 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.72 -106.84 0.19 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.695 -0.764 . . . . 3.4300000000000002 112.802 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -150.61 10.94 0.66 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.197 0.523 . . . . 6.5 110.265 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.427 ' N ' ' HA3' ' A' ' 186' ' ' GLY . . . 83.36 145.51 6.24 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.867 -0.683 . . . . 3.29 112.564 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 71.6 m95 59.41 10.73 1.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.537 0.208 . . . . 6.1600000000000001 111.35 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.55 142.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 2.4199999999999999 111.58 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 195' ' ' GLN . 56.3 t30 -157.17 -11.27 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.66 . . . . 4.29 110.126 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.401 ' H ' ' H ' ' A' ' 194' ' ' ASN . 19.9 mt-30 -74.97 -157.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.608 -0.724 . . . . 5.1500000000000004 110.914 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.6 m -57.58 -28.53 63.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 2.4500000000000002 111.332 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 86.1 mt -57.18 -40.51 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.441 -0.345 . . . . 2.48 111.275 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.85 -56.12 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 2.1800000000000002 110.888 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.2 p -64.91 -31.67 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 1.49 110.969 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -61.47 -30.89 70.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.03 -0.532 . . . . 1.77 111.084 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.71 -52.45 15.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 1.4199999999999999 111.199 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.94 -6.42 41.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.572 -0.285 . . . . 1.78 111.373 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 29.1 t -96.24 -39.7 9.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 1.3 110.543 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.1 tp -72.8 -40.99 65.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.622 -0.717 . . . . 0.66000000000000003 112.094 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -56.39 -54.74 49.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.149 -0.221 . . . . 1.6299999999999999 111.405 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 50.5 Cg_exo -55.76 -45.18 41.0 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.829 1.686 . . . . 0.64000000000000001 111.538 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.01 -24.62 66.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 1.3600000000000001 110.464 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -81.95 -21.86 36.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 1.54 110.693 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 92.6 p -95.5 -39.95 9.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 1.2 111.112 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.775 H183 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.42 -31.69 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.446 -0.343 . . . . 1.6399999999999999 111.295 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.69 -45.26 90.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.674 -0.774 . . . . 0.79000000000000004 112.916 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -69.72 -28.68 66.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.62 0.248 . . . . 1.6100000000000001 111.196 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -55.19 -62.06 1.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.432 -0.349 . . . . 1.1499999999999999 110.836 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -64.66 -29.34 70.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 3.3399999999999999 110.46 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.05 -45.98 91.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 1.1899999999999999 110.589 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.21 -35.08 79.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 2.23 110.517 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.065 -0.516 . . . . 2.4700000000000002 110.351 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -83.77 -25.91 30.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 1.6200000000000001 110.847 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -79.47 -24.39 60.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.818 -0.706 . . . . 1.4099999999999999 112.34 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 27.0 tp -77.9 -6.29 53.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 2.5800000000000001 110.747 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -58.37 -75.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.02 -0.536 . . . . 4.9299999999999997 111.23 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -63.85 142.44 58.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 4.6299999999999999 111.034 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.5 mt 61.34 110.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.904 -0.589 . . . . 6.4699999999999998 111.354 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -136.02 85.26 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 5.0700000000000003 110.473 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -131.19 131.06 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 6.5300000000000002 110.982 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.7 t -164.84 103.46 0.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 5.2199999999999998 111.007 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -131.72 82.83 2.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.186 -0.461 . . . . 8.3599999999999994 111.205 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 7.96 110.808 179.803 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mmm . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.856 0.36 . . . . 6.1699999999999999 110.743 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -110.31 9.53 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 4.8200000000000003 110.928 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.56 63.62 0.65 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 5.5999999999999996 110.947 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -96.09 151.82 19.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.043 -0.526 . . . . 4.7999999999999998 110.859 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 92.3 p -159.83 130.9 5.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.447 . . . . 2.3700000000000001 110.965 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.457 ' N ' HD12 ' B' ' 6' ' ' LEU . 6.7 mp -92.7 -3.02 55.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 2.0699999999999998 110.824 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.413 HD13 ' HD1' ' B' ' 200' ' ' PHE . 57.4 mt -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 2.1000000000000001 111.004 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.642 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.0 m80 -80.01 -24.42 40.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 1.0700000000000001 110.505 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -73.66 -35.34 65.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.714 -0.676 . . . . 1.48 110.812 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 tt -80.73 -26.52 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 2.02 110.693 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' B' ' 15' ' ' MET . 41.8 t80 -62.09 -47.41 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.92000000000000004 110.271 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.43 -36.94 74.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.93999999999999995 111.084 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -36.11 79.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.55000000000000004 110.978 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.74 59.15 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.781 -0.723 . . . . 0.47999999999999998 112.311 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 23.1 mmt -72.73 -27.78 62.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 0.84999999999999998 110.785 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -64.88 -56.41 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 1.3400000000000001 110.88 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.4 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -61.28 -24.94 34.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.044 -0.525 . . . . 1.55 110.984 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.4 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -58.69 -57.72 18.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.636 -0.792 . . . . 0.69999999999999996 112.199 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.661 ' HA ' ' HG3' ' B' ' 41' ' ' MET . . . -62.85 -23.41 67.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.81000000000000005 110.788 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.95 -39.2 83.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 2.2599999999999998 110.571 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -61.41 -22.55 65.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.912 -0.586 . . . . 1.78 110.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' B' ' 34' ' ' GLN . 73.8 t80 -61.04 -40.55 94.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.75 -0.659 . . . . 4.5800000000000001 110.358 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.489 ' O ' ' OG ' ' B' ' 26' ' ' SER . 68.7 m95 -70.8 -41.45 71.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.795 -0.639 . . . . 3.3500000000000001 110.593 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -69.7 -20.81 63.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 1.5800000000000001 110.869 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.88 -15.84 35.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.47 . . . . 1.8400000000000001 110.713 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 67.0 p -67.2 -17.07 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 1.3700000000000001 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.33 -33.67 13.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.409 -0.589 . . . . 4.9800000000000004 109.409 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -177.68 131.63 0.33 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 114.997 -1.002 . . . . 2.1400000000000001 110.216 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -93.8 169.15 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.915 2.41 . . . . 1.8200000000000001 112.251 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -96.41 60.97 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.458 . . . . 5.1900000000000004 110.901 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.9 -46.67 3.66 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.791 -0.718 . . . . 2.2000000000000002 112.416 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . 7.4 p -88.14 131.65 42.08 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.473 0.177 . . . . 3.6499999999999999 110.631 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 35.4 Cg_exo -59.82 156.66 36.94 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.241 1.961 . . . . 2.6699999999999999 112.054 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . 0.407 ' HB3' ' CZ ' ' B' ' 22' ' ' PHE . 28.0 mm-40 -61.19 -17.72 54.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 4.8799999999999999 112.459 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' B' ' 38' ' ' LEU . 3.6 p90 -43.89 -36.51 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.787 0.327 . . . . 1.8700000000000001 111.567 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.64 -57.12 12.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 2.6800000000000002 110.664 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -66.77 -18.74 65.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 2.9199999999999999 110.637 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 45.4 tp -57.11 -55.6 32.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.416 . . . . 1.6399999999999999 110.152 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.74 -42.9 97.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 1.6000000000000001 110.524 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.46 -12.44 52.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.68999999999999995 111.138 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.661 ' HG3' ' HA ' ' B' ' 19' ' ' ALA . 0.0 OUTLIER -88.6 -31.03 18.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.358 -0.383 . . . . 2.5800000000000001 111.289 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.49 ' HA ' HD12 ' B' ' 45' ' ' ILE . 36.9 m-85 -72.08 -27.62 62.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 3.3900000000000001 110.386 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.595 HG23 HG23 ' B' ' 79' ' ' THR . 65.3 mt -58.28 -53.94 60.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.085 -0.507 . . . . 0.40999999999999998 112.003 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' C ' ' B' ' 41' ' ' MET . 45.2 Cg_endo -67.75 -35.14 22.56 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.17 1.913 . . . . 0.48999999999999999 112.986 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' B' ' 42' ' ' PHE . 97.0 mt -53.78 -62.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.762 0.282 . . . . 1.29 111.762 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.552 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.7 t90 -61.3 -50.11 74.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.744 0.307 . . . . 1.3999999999999999 111.08 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 59.5 m -60.27 -14.02 15.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 1.3799999999999999 111.495 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.9 -55.71 3.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.714 -0.755 . . . . 0.37 112.709 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.442 HD22 ' SG ' ' C' ' 134' ' ' CYS . 24.0 mt -58.74 -32.08 68.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.857 0.361 . . . . 1.29 111.084 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.44 111.313 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 9.0 m-85 -60.7 -41.41 95.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.5 110.993 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -50.67 -32.36 18.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.135 0.493 . . . . 1.4099999999999999 110.1 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.7 -39.86 69.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.55000000000000004 110.504 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -54.97 -28.21 49.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.284 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -73.31 -49.51 27.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.737 -0.665 . . . . 0.54000000000000004 110.817 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.43 HG12 ' HA ' ' B' ' 53' ' ' ALA . 36.1 pt -79.52 8.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.163 -0.471 . . . . 1.3 111.459 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.32 60.73 2.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.055 -0.52 . . . . 2.2400000000000002 111.31 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -143.86 139.99 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.907 0.384 . . . . 1.77 110.876 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.38 5.63 26.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.882 -0.675 . . . . 1.0600000000000001 112.101 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.62 150.22 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.664 0.268 . . . . 2.6600000000000001 110.834 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.99 148.0 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 1.8899999999999999 111.077 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.21 93.68 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 2.4100000000000001 110.838 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.32 125.18 50.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 111.279 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.49 30.61 18.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.989 -0.55 . . . . 1.8200000000000001 111.275 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.86 57.05 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.727 -0.749 . . . . 1.51 112.563 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -107.15 127.61 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.757 0.313 . . . . 2.4500000000000002 110.821 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 45.0 mm -77.37 105.27 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 1.79 111.088 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.8 134.52 37.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.81999999999999995 110.943 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.497 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 81.8 m-70 -79.83 76.18 6.52 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.132 0.492 . . . . 1.05 111.1 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -62.42 -28.0 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.485 -0.78 . . . . 1.8700000000000001 111.082 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -82.27 -28.0 32.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.299 0.481 . . . . 0.60999999999999999 112.299 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 29.2 mmt180 -66.56 -51.51 55.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.629 0.603 . . . . 2.3900000000000001 112.629 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' B' ' 77' ' ' MET . 18.5 p90 -82.89 -30.03 28.84 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.29 -0.564 . . . . 3.6699999999999999 112.497 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' B' ' 71' ' ' ALA . 15.2 tt -56.33 -42.15 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.291 -0.563 . . . . 1.6599999999999999 110.221 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' B' ' 74' ' ' ILE . 26.2 t70 -69.39 -22.25 63.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.996 -0.742 . . . . 1.4099999999999999 108.996 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 16.7 m0 -86.56 7.65 25.33 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.342 -0.844 . . . . 1.1599999999999999 111.034 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.471 ' HA ' HD13 ' B' ' 113' ' ' ILE . 22.0 mtp -104.73 -21.59 13.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 1.53 110.797 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 m -114.08 -28.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.89000000000000001 111.897 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.595 HG23 HG23 ' B' ' 43' ' ' ILE . 37.8 m -82.21 -52.45 6.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.266 -0.424 . . . . 1.24 112.093 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.578 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 16.9 m -52.4 -49.73 83.8 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.54 0.57 . . . . 0.57999999999999996 112.54 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' B' ' 80' ' ' THR . 12.4 Cg_endo -56.08 -45.52 37.71 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.781 1.654 . . . . 0.66000000000000003 112.262 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.64 -19.47 61.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 1.0600000000000001 110.797 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.32 -30.96 57.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 1.22 110.197 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.534 HD13 ' NE2' ' B' ' 109' ' ' GLN . 4.8 tt -84.69 -27.92 26.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.642 -0.708 . . . . 1.53 110.128 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.96 -33.84 39.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 1.5800000000000001 110.89 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -58.75 -28.08 65.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 1.3899999999999999 111.223 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.499 HD22 HD11 ' B' ' 168' ' ' LEU . 52.9 mt -73.36 -34.23 65.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.4 . . . . 1.1499999999999999 111.12 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.4 m -73.46 -27.04 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.418 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -76.73 -38.62 53.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.433 -0.349 . . . . 2.1699999999999999 111.12 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -62.41 -41.55 98.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.376 -0.375 . . . . 1.4199999999999999 111.138 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.62 -47.49 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 1.1799999999999999 111.314 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 49.3 tpp -80.4 98.58 7.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 1.8799999999999999 110.784 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -87.8 -37.34 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 3.4199999999999999 110.926 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.31 143.19 46.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 4.0599999999999996 111.012 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -133.07 142.24 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 2.0899999999999999 110.579 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -123.96 -74.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 3.8500000000000001 111.159 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -156.03 108.46 2.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 4.8200000000000003 111.034 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.1 -73.62 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 110.66 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 81.8 m95 53.67 36.35 23.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 5.1699999999999999 111.323 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.5 t -120.58 -41.51 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 2.02 111.022 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 96.5 mt -74.31 -38.49 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.16 -0.473 . . . . 2.0899999999999999 110.959 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.5 tt -56.12 -33.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 1.8799999999999999 111.17 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.17 -29.89 36.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.728 -0.748 . . . . 0.56000000000000005 112.287 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.91 -24.51 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 1.78 110.835 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -78.54 -50.08 12.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 1.03 110.993 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . 0.471 ' O ' HG13 ' B' ' 110' ' ' ILE . 24.6 ptm -60.49 -31.83 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 1.6699999999999999 111.043 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.4 ' HB2' ' CD2' ' A' ' 42' ' ' PHE . 77.6 p -67.29 -51.96 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 1.51 111.6 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.465 ' HB ' HD13 ' B' ' 142' ' ' ILE . 71.3 p -57.92 -25.98 61.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 1.1799999999999999 111.741 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.534 ' NE2' HD13 ' B' ' 84' ' ' LEU . 18.6 mm-40 -78.31 -41.72 32.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 2.1699999999999999 111.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.482 HG22 ' NE1' ' A' ' 46' ' ' TRP . 93.4 mt -56.4 -38.1 54.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 1.3500000000000001 111.8 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.415 HG23 ' N ' ' B' ' 112' ' ' VAL . 29.7 m -72.57 -45.56 58.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.918 0.34 . . . . 1.3400000000000001 111.918 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.508 HG13 H133 ' B' ' 210' ' ' LYR . 84.2 t -60.12 -45.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.631 0.253 . . . . 0.42999999999999999 111.586 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' B' ' 77' ' ' MET . 66.3 mt -64.43 -34.75 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.42 -0.355 . . . . 1.6000000000000001 111.463 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.4 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.4 m -55.2 -61.0 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.85999999999999999 111.234 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 80.9 p -57.31 -27.44 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.94999999999999996 111.061 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.11 -49.14 59.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.46000000000000002 112.909 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.563 HD12 HG13 ' B' ' 118' ' ' ILE . 3.3 pp -74.21 -21.88 59.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.686 0.254 . . . . 1.75 111.686 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.563 HG13 HD12 ' B' ' 117' ' ' LEU . 82.5 mt -83.4 -33.17 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.687 0.28 . . . . 1.78 111.215 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.15 71.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.38 110.968 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.26 -25.22 46.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 1.97 111.137 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.78 31.24 0.7 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.405 -0.361 . . . . 0.76000000000000001 110.886 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -82.76 130.96 35.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.05 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -98.55 -42.98 7.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 2.5 110.673 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.47 ' HB2' HG12 ' B' ' 127' ' ' VAL . 91.4 mtt180 -98.18 146.36 25.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 2.73 110.285 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -80.37 -16.38 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.429 0.529 . . . . 2.2000000000000002 112.429 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.465 ' HE1' ' HD3' ' B' ' 124' ' ' ARG . 67.1 p-90 -93.33 -22.44 18.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.688 0.255 . . . . 3.3999999999999999 111.688 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.529 HG23 HD12 ' B' ' 130' ' ' LEU . 7.3 p -83.66 -23.33 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 1.23 110.945 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -57.76 -35.31 70.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 3.04 110.968 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -68.88 -22.15 64.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 4.1399999999999997 111.283 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.529 HD12 HG23 ' B' ' 127' ' ' VAL . 90.5 mt -76.75 -54.27 6.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 1.6499999999999999 111.141 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.96 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.483 -0.326 . . . . 0.77000000000000002 110.885 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -60.47 -50.06 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 1.46 110.595 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.6 mt -62.74 -30.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 1.6299999999999999 110.822 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 36.1 t -65.65 -41.01 93.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 1.4199999999999999 110.872 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.482 ' HA3' H142 ' B' ' 210' ' ' LYR . . . -61.31 -54.1 39.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.908 -0.663 . . . . 0.48999999999999999 112.365 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 5.8 p -63.46 -39.0 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 1.3 111.067 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 43.7 t -52.34 -43.56 64.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.286 -0.416 . . . . 1.3 110.7 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.65 84.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.62 110.688 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -71.56 -23.56 61.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.52 . . . . 1.74 110.992 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -73.33 -61.08 1.95 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.379 -0.373 . . . . 1.76 111.266 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.422 HG13 ' N ' ' B' ' 142' ' ' ILE . 31.2 pt -51.88 -37.45 21.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.226 -0.443 . . . . 0.68999999999999995 111.453 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' B' ' 108' ' ' THR . 85.3 mt -73.45 -41.85 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.361 -0.381 . . . . 1.76 110.891 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 tp -56.97 -57.92 10.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.198 -0.456 . . . . 1.0600000000000001 110.885 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -62.62 -21.86 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 4.1200000000000001 110.643 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.47 -20.78 59.57 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.85 -0.69 . . . . 1.26 112.989 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.9 pt -100.4 -5.62 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.864 0.332 . . . . 1.98 111.178 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.61 -42.99 17.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 1.4199999999999999 110.98 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.577 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 69.1 m-80 -58.23 -50.47 87.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.575 . . . . 99.989999999999995 111.828 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 19.5 Cg_endo -58.92 -14.98 24.96 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.045 1.83 . . . . 2.6499999999999999 112.186 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 71.4 mt -107.11 147.63 29.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.574 . . . . 4.3899999999999997 110.208 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.443 ' HD2' ' HB1' ' B' ' 162' ' ' ALA . 17.6 mmm180 66.8 -76.9 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.351 -0.386 . . . . 7.9000000000000004 111.729 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.29 -46.33 72.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.044 0.387 . . . . 2.77 112.044 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' B' ' 149' ' ' PRO . 10.7 mmmm -81.35 -29.58 34.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.348 -0.387 . . . . 6.29 111.556 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 79.1 p -86.74 5.06 38.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.566 -0.288 . . . . 3.1000000000000001 111.445 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -56.85 -28.37 61.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.942 0.401 . . . . 6.4299999999999997 110.577 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 50.8 m -108.23 -25.57 10.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.61 . . . . 4.5700000000000003 110.574 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.43 -68.12 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 3.8300000000000001 110.861 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 40.4 t -166.11 118.34 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 3.0699999999999998 110.605 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 70.0 m -76.33 -25.92 55.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 3.4300000000000002 110.985 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.7 -57.77 9.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 3.9199999999999999 110.74 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 7.9 mp -65.27 -21.28 66.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.411 . . . . 2.7000000000000002 110.787 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . 0.443 ' HB1' ' HD2' ' B' ' 151' ' ' ARG . . . -68.94 -32.62 72.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.504 . . . . 1.8300000000000001 111.1 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.47 -41.38 55.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.46 . . . . 2.6299999999999999 110.719 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.73 -45.03 91.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.604 . . . . 2.4300000000000002 110.884 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.04 -24.75 60.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 2.5800000000000001 111.12 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.1 -44.66 96.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 2.0 110.719 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -79.72 -21.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 3.0299999999999998 110.77 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.499 HD11 HD22 ' B' ' 87' ' ' LEU . 27.8 tp -68.17 -53.16 27.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 1.1000000000000001 110.817 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.35 -28.26 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 1.75 111.028 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 45.7 m -49.09 -57.97 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.97999999999999998 111.29 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.51 -28.83 67.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.279 -0.419 . . . . 4.2999999999999998 110.526 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -63.8 -30.62 71.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 1.3899999999999999 111.481 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 81.6 p -78.82 -59.05 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.595 -0.275 . . . . 1.1100000000000001 111.485 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 6.6 p -52.89 -29.91 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.526 -0.306 . . . . 1.51 111.645 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.97 -58.19 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 1.75 111.107 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.95 -25.95 61.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.59999999999999998 110.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.467 ' O ' HG13 ' B' ' 181' ' ' ILE . 80.4 mt -87.99 -27.59 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.061 -0.518 . . . . 1.47 110.269 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.95 -52.62 41.87 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.817 -0.629 . . . . 0.55000000000000004 113.124 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.643 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 94.4 m-85 -56.49 -58.05 19.4 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.927 -0.309 . . . . 1.6200000000000001 111.095 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 90.6 Cg_exo -42.68 -38.77 6.69 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.171 1.914 . . . . 0.64000000000000001 112.924 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.467 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.6 mt -58.5 -55.39 22.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.34 -0.391 . . . . 1.27 111.394 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.628 HG22 ' O ' ' B' ' 179' ' ' TYR . 1.9 m -55.17 -23.88 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.02 -0.536 . . . . 0.68999999999999995 111.497 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . 0.583 ' CD1' H191 ' B' ' 210' ' ' LYR . 88.3 m95 -80.88 -33.3 34.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.074 0.398 . . . . 1.1799999999999999 112.074 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 tt -88.29 25.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.443 . . . . 1.77 111.561 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' B' ' 190' ' ' PHE . 42.6 pt -134.69 -21.4 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.466 -0.334 . . . . 1.6899999999999999 111.533 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -162.53 167.28 36.98 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.438 -0.887 . . . . 1.5800000000000001 112.834 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.42 91.96 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.632 2.221 . . . . 2.5099999999999998 112.529 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 34.7 t 54.44 52.81 11.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.007 -0.542 . . . . 3.5800000000000001 111.11 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -177.02 -117.27 0.5 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.204 -0.998 . . . . 4.0300000000000002 113.054 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.552 ' H ' HD11 ' B' ' 193' ' ' ILE . 33.4 t80 -128.77 -19.31 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 6.8899999999999997 110.682 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 121.38 134.34 4.55 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 3.7000000000000002 112.452 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 57.68 17.57 4.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.68 0.276 . . . . 7.5 111.024 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.552 HD11 ' H ' ' B' ' 190' ' ' PHE . 37.5 pt -125.97 142.14 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.002 0.429 . . . . 2.3500000000000001 111.577 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -153.86 2.61 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.75 -0.659 . . . . 3.8599999999999999 110.516 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -85.57 -161.88 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.813 -0.63 . . . . 5.0499999999999998 110.803 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 75.2 p -59.27 -27.56 65.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.465 -0.334 . . . . 2.6800000000000002 111.147 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 7.9 tp -58.34 -31.04 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 2.4700000000000002 111.188 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.39 -57.49 12.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 2.5299999999999998 110.864 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . 0.413 ' HB ' HH21 ' B' ' 72' ' ' ARG . 53.3 p -64.77 -31.05 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 1.29 110.932 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . 0.413 ' HD1' HD13 ' B' ' 7' ' ' LEU . 68.1 t80 -60.98 -27.55 68.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 2.6200000000000001 110.635 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.47 -50.25 14.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 1.6100000000000001 110.886 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -73.14 -7.91 53.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.29 -0.414 . . . . 1.4199999999999999 111.317 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.33 -38.39 10.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.047 0.451 . . . . 1.4299999999999999 110.862 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 67.5 tp -73.72 -40.98 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.753 -0.658 . . . . 1.1200000000000001 112.065 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.577 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 2.3 tt -56.27 -54.29 54.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 121.126 -0.23 . . . . 1.26 111.34 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -56.51 -43.9 50.96 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.822 1.682 . . . . 0.59999999999999998 111.373 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.518 ' O ' HG22 ' B' ' 211' ' ' VAL . 89.9 t80 -60.11 -32.74 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 1.3999999999999999 110.29 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -74.3 -19.26 60.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.825 -0.625 . . . . 1.4099999999999999 110.608 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.6 t -95.79 -48.57 5.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.92 -0.582 . . . . 1.3200000000000001 111.032 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.734 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 207' ' ' PHE . 16.1 m -78.77 -27.42 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 1.6899999999999999 111.037 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.11 -46.65 93.83 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.899 -0.667 . . . . 0.79000000000000004 112.453 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -73.24 -22.7 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.618 0.247 . . . . 2.96 110.719 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 60.5 m -60.59 -58.02 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.402 -0.363 . . . . 1.29 110.517 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -67.57 -30.09 69.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 3.1499999999999999 110.26 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.23 -44.21 97.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.6 . . . . 1.51 110.367 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.19 -38.4 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 2.1899999999999999 110.589 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.47 -29.45 69.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.039 -0.528 . . . . 1.98 111.215 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -84.86 -42.18 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 2.1699999999999999 111.218 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.2 -39.4 81.19 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.857 -0.687 . . . . 1.3600000000000001 112.514 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.69 -32.26 73.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 2.8999999999999999 111.015 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -77.91 82.3 4.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.27 -0.423 . . . . 5.6100000000000003 111.03 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -169.89 -36.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 4.04 110.789 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 65.1 tp -167.58 102.27 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 6.2999999999999998 110.829 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -100.66 128.34 46.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 4.7999999999999998 110.848 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -165.76 105.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 6.3899999999999997 111.019 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 38.6 t -158.86 101.68 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 5.6100000000000003 110.786 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -77.71 -65.44 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.947 -0.57 . . . . 8.1999999999999993 111.063 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 8.1699999999999999 110.874 -179.843 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.853 0.359 . . . . 5.6200000000000001 110.992 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -107.58 -38.23 5.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 5.2800000000000002 110.883 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 63.0 tp -90.58 129.53 36.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 6.0499999999999998 111.017 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -154.15 108.3 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 4.79 110.869 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 51.3 m -119.03 110.84 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 2.71 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.601 HD23 ' H ' ' C' ' 6' ' ' LEU . 2.7 pt? -70.95 -8.54 53.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 2.52 110.971 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 18.1 tp -60.88 -52.68 64.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 1.9299999999999999 110.669 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.654 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 33.1 m170 -61.55 -23.95 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 1.26 110.766 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -75.52 -42.08 53.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 1.6699999999999999 111.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 20.1 tt -77.71 -22.28 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 1.8700000000000001 110.642 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -66.18 -48.32 71.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.533 . . . . 1.4399999999999999 110.31 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.73 -31.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 0.46999999999999997 110.565 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.81 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.084 -0.507 . . . . 0.58999999999999997 111.1 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.59 73.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.5 112.486 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 24.4 mmt -78.37 -33.76 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 0.68000000000000005 110.764 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 89.2 m -61.59 -51.77 67.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 1.3999999999999999 110.815 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . 0.407 ' O ' HD12 ' C' ' 17' ' ' ILE . 1.9 tp -60.19 -39.69 81.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.135 -0.484 . . . . 1.55 110.965 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.54 -57.6 6.5 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.675 -0.774 . . . . 0.70999999999999996 112.156 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.84 -36.32 69.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.36 . . . . 0.77000000000000002 111.106 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.77 -27.53 66.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.515 . . . . 1.9299999999999999 111.26 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -60.34 -25.26 65.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 1.8600000000000001 110.72 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' C' ' 37' ' ' TYR . 37.4 m-85 -79.99 -22.97 41.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 4.1399999999999997 110.75 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . 0.657 ' O ' ' OG ' ' C' ' 26' ' ' SER . 70.9 t-105 -69.81 -35.8 75.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.566 -0.531 . . . . 3.1499999999999999 109.566 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 45.0 t -85.18 -33.21 22.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.544 -0.753 . . . . 1.95 110.468 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 61.4 tp -71.91 -20.72 61.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.142 -0.481 . . . . 2.2200000000000002 110.41 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 0.7 OUTLIER -57.2 -25.53 59.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.873 -0.603 . . . . 1.3700000000000001 110.514 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -44.82 -37.61 3.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.143 0.497 . . . . 5.0300000000000002 110.134 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 24.3 p-10 -172.59 132.08 0.67 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.409 -0.814 . . . . 2.3700000000000001 110.287 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 60.0 Cg_endo -97.01 169.93 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.016 2.478 . . . . 2.0499999999999998 112.05 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -96.17 64.5 2.33 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.833 0.349 . . . . 4.5199999999999996 111.543 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.11 -46.58 3.41 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.834 -0.698 . . . . 2.1600000000000001 112.803 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.455 HG21 HD22 ' C' ' 221' ' ' LEU . 94.4 t -89.19 131.88 39.42 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.453 0.168 . . . . 2.5299999999999998 110.815 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.431 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 25.4 Cg_exo -61.12 157.69 38.32 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.347 2.031 . . . . 1.9299999999999999 112.192 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -61.79 -17.34 55.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 4.1200000000000001 112.482 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.431 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -42.16 -40.98 2.52 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.669 0.271 . . . . 2.8900000000000001 111.602 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -66.44 -43.61 85.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 2.46 110.575 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' C' ' 22' ' ' PHE . 98.6 m-85 -71.81 -19.13 62.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.868 -0.605 . . . . 2.7799999999999998 110.529 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' C' ' 41' ' ' MET . 30.9 tp -64.48 -48.87 73.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 1.6200000000000001 110.394 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.28 -40.38 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 1.5900000000000001 110.05 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.54 -6.81 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.65000000000000002 110.726 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.432 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 36.6 ttm -87.84 -36.01 17.47 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 1.6699999999999999 110.605 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' C' ' 45' ' ' ILE . 23.2 t80 -70.91 -35.53 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.858 -0.61 . . . . 3.4199999999999999 111.07 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.604 HG23 HG23 ' C' ' 79' ' ' THR . 88.5 mt -49.88 -54.49 31.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.169 0.433 . . . . 0.89000000000000001 112.169 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.4 Cg_endo -71.83 -32.83 10.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.182 1.921 . . . . 0.40999999999999998 113.164 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' C' ' 42' ' ' PHE . 69.1 mt -53.41 -62.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.853 0.316 . . . . 1.76 111.853 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -66.44 -45.91 78.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.76 0.314 . . . . 2.1600000000000001 111.074 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . 0.418 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 45.8 t -61.85 -11.01 10.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 1.1699999999999999 111.266 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.52 -53.6 3.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.44 112.494 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 69.0 mt -59.22 -32.9 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.689 0.28 . . . . 1.29 110.92 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -58.28 9.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.5 111.324 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 13.4 m-85 -59.02 -45.0 91.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 1.8300000000000001 111.085 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 59.8 ttp -48.39 -30.58 5.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 1.47 110.355 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -46.13 59.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.763 -0.653 . . . . 0.59999999999999998 111.077 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 1.2 mpp? -55.52 -20.14 12.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.362 -0.381 . . . . 0.83999999999999997 110.824 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -78.54 -46.7 18.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.139 -0.482 . . . . 0.65000000000000002 110.293 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.75 11.01 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.844 -0.616 . . . . 1.55 111.014 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 62.6 60.45 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.722 -0.672 . . . . 1.54 111.211 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.591 ' NE2' HG11 ' A' ' 127' ' ' VAL . 87.0 mm-40 -142.58 151.95 42.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.119 -0.492 . . . . 1.79 111.01 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.0 34.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.771 -0.728 . . . . 0.93999999999999995 112.574 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -133.7 135.56 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 2.3599999999999999 110.921 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.93 136.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 1.97 111.161 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.94 94.61 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 2.4399999999999999 110.841 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.12 134.8 40.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 1.54 110.907 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.62 30.73 19.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 1.71 111.024 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.93 -1.26 55.52 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 1.53 112.509 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -103.56 122.29 44.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 2.23 111.153 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.45 118.72 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.3600000000000001 110.947 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.4 133.65 51.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 0.78000000000000003 111.199 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 78.0 m-70 -83.93 75.92 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.075 0.464 . . . . 1.0800000000000001 110.876 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.99 -44.37 97.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.719 -0.673 . . . . 2.2999999999999998 111.323 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -66.45 -23.59 66.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.75 111.878 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 16.7 tpp180 -68.71 -51.61 39.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.302 0.482 . . . . 1.51 112.302 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' C' ' 117' ' ' LEU . 5.7 p90 -83.54 -33.13 25.55 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.068 0.396 . . . . 4.6500000000000004 112.068 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -55.85 -40.53 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 C-N-CA 120.715 -0.394 . . . . 1.22 110.583 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 26.9 t70 -68.38 -25.39 65.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.121 -0.696 . . . . 1.3100000000000001 109.121 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -86.66 9.77 17.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.453 -0.794 . . . . 1.6799999999999999 110.756 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.445 ' HA ' HG21 ' C' ' 113' ' ' ILE . 53.6 tpp -104.49 -23.27 13.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.701 -0.681 . . . . 1.8 110.011 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.4 ' O ' HD23 ' C' ' 82' ' ' LEU . 31.3 m -114.02 -30.05 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.809 -0.632 . . . . 1.1899999999999999 111.576 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.604 HG23 HG23 ' C' ' 43' ' ' ILE . 41.3 m -83.73 -44.78 14.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.448 -0.342 . . . . 1.23 111.62 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 55.8 m -56.21 -49.76 91.42 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.387 -0.37 . . . . 0.58999999999999997 111.875 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -56.47 -47.73 22.56 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.156 1.904 . . . . 0.67000000000000004 112.312 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.4 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.4 mm? -74.74 -11.2 60.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.95999999999999996 111.135 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.427 HD13 ' O ' ' C' ' 83' ' ' LEU . 0.7 OUTLIER -76.76 -47.15 22.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 1.1899999999999999 109.971 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' C' ' 109' ' ' GLN . 2.8 pp -78.99 -32.27 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 1.7 110.67 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.51 -37.33 77.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.676 -0.693 . . . . 1.6200000000000001 111.045 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.2 t -60.63 -19.52 58.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 1.26 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' C' ' 168' ' ' LEU . 71.2 mt -75.99 -34.71 59.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.081 -0.509 . . . . 1.1100000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 89.8 p -74.2 -26.09 60.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 1.51 111.102 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -75.07 -37.26 61.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.37 -0.377 . . . . 2.0600000000000001 110.83 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 72.4 p -67.96 -33.85 75.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.333 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.64 -47.66 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 1.3 111.261 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 89.8 mtp -86.16 100.33 12.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 1.6200000000000001 111.095 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -83.48 -42.61 16.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 3.2400000000000002 110.764 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -115.31 140.42 49.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.107 -0.497 . . . . 4.6299999999999999 111.119 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 68.1 mt -133.65 142.31 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 2.1800000000000002 110.787 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -120.43 -81.11 0.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 4.1200000000000001 111.205 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -143.81 97.61 3.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.402 -0.363 . . . . 4.96 111.023 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -172.85 79.66 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 3.9100000000000001 110.771 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -94.52 42.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 5.21 110.78 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 34.5 m -101.84 -40.54 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 1.8200000000000001 111.54 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.24 -36.72 77.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 2.0800000000000001 111.219 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.2 -41.72 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.8600000000000001 111.27 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.53 -33.52 60.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.838 -0.696 . . . . 0.58999999999999997 112.656 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -60.51 -52.68 64.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 1.53 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.47 -43.13 99.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 1.1100000000000001 111.357 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . 0.41 ' O ' HG12 ' C' ' 110' ' ' ILE . 42.3 ttm -60.47 -32.81 71.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.526 . . . . 2.21 111.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . 0.474 ' O ' HG23 ' C' ' 111' ' ' VAL . 47.2 t -78.87 -44.74 22.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.778 0.323 . . . . 1.28 111.451 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 77.6 p -64.87 -32.61 74.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 1.22 111.974 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.486 ' HB3' HD21 ' C' ' 84' ' ' LEU . 14.0 pt20 -71.32 -46.09 61.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.637 -0.256 . . . . 2.3300000000000001 111.502 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.552 HG22 ' HE1' ' B' ' 46' ' ' TRP . 35.8 mm -56.02 -34.87 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.679 0.276 . . . . 1.29 111.274 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.474 HG23 ' O ' ' C' ' 107' ' ' SER . 60.1 t -67.85 -47.69 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 1.0600000000000001 111.381 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.461 HG13 H133 ' C' ' 210' ' ' LYR . 62.7 t -61.21 -48.9 86.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 111.608 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.445 HG21 ' HA ' ' C' ' 77' ' ' MET . 47.7 mt -59.89 -34.66 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.478 -0.328 . . . . 1.3700000000000001 111.207 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 32.0 m -58.63 -48.94 79.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.77000000000000002 111.116 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . 0.4 ' HA ' HG22 ' C' ' 118' ' ' ILE . 77.8 p -67.79 -22.15 65.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.21 -0.45 . . . . 1.1899999999999999 110.92 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.469 ' HA2' H182 ' C' ' 210' ' ' LYR . . . -78.04 -34.57 37.32 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.847 -0.692 . . . . 0.5 113.227 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.519 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.2 pp -81.09 -30.62 34.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.651 0.262 . . . . 1.47 111.549 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.519 ' N ' HD12 ' C' ' 117' ' ' LEU . 8.8 tp -81.03 -28.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.511 -0.313 . . . . 1.2 111.124 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -38.65 78.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.071 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.75 -17.23 48.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 2.1200000000000001 110.823 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.7 mt -91.49 26.99 2.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.15 -0.477 . . . . 0.75 111.063 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . 0.434 ' HB3' ' HE ' ' C' ' 128' ' ' ARG . 44.6 t -83.22 142.76 30.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 1.3799999999999999 110.913 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.17 -41.64 5.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 2.7400000000000002 110.954 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.481 ' HB2' HG12 ' C' ' 127' ' ' VAL . 0.0 OUTLIER -98.94 142.21 30.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 2.7999999999999998 110.625 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.07 -11.33 60.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.178 -0.465 . . . . 2.4100000000000001 111.521 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -91.04 -45.84 8.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 4.2000000000000002 111.023 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -67.2 -24.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.322 -0.399 . . . . 1.0800000000000001 111.272 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' C' ' 122' ' ' SER . 43.1 ttm180 -61.76 -31.52 71.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.337 -0.392 . . . . 2.5699999999999998 111.131 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.76 -20.02 61.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 3.8100000000000001 110.91 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.424 HD13 HG21 ' B' ' 56' ' ' ILE . 98.8 mt -78.46 -55.75 4.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.257 -0.429 . . . . 1.4199999999999999 111.174 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -60.79 -32.27 71.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.441 -0.345 . . . . 0.89000000000000001 110.989 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -56.55 -47.2 79.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 1.26 110.594 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.7 mm -67.88 -30.43 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.6799999999999999 110.953 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . 0.442 ' SG ' HD22 ' B' ' 49' ' ' LEU . 38.3 t -64.34 -41.0 96.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 1.24 110.868 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.3 -54.26 27.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.845 -0.693 . . . . 0.54000000000000004 112.757 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . 0.463 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 27.0 m -61.42 -35.58 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.784 0.326 . . . . 1.0600000000000001 111.221 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.26 -40.05 88.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.257 -0.429 . . . . 1.0800000000000001 111.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.11 79.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 111.022 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -76.3 -28.87 57.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 1.6799999999999999 110.883 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 94.4 mt -69.8 -46.71 65.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.41 -0.359 . . . . 1.7 111.478 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.425 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.6 pt -62.02 -41.67 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.78000000000000003 111.481 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.425 ' N ' HG13 ' C' ' 141' ' ' ILE . 49.0 pt -76.34 -27.07 17.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.484 -0.325 . . . . 2.2400000000000002 111.366 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.69 -49.68 65.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.348 -0.387 . . . . 1.02 110.823 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . 0.445 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 85.2 t90 -68.98 -25.69 64.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.246 -0.434 . . . . 3.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.48 -17.24 66.78 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.964 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.67 -13.74 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.84 0.352 . . . . 1.8899999999999999 111.206 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -76.51 -45.74 29.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 1.6000000000000001 111.22 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.514 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 69.1 m-80 -58.08 -50.82 85.99 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 112.113 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 48.7 Cg_endo -67.61 -0.31 5.07 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.183 1.922 . . . . 2.73 112.763 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 89.8 mt -127.07 42.42 3.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.886 0.374 . . . . 4.2999999999999998 111.204 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -169.54 -62.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 8.9000000000000004 110.863 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.65 -43.25 17.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 2.7999999999999998 111.303 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' C' ' 149' ' ' PRO . 75.7 mmtt -74.25 -9.85 59.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 5.4400000000000004 111.186 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 73.0 p -103.21 4.49 36.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.41 -0.359 . . . . 3.3900000000000001 111.589 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -67.35 -36.35 81.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 6.9199999999999999 110.93 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . 0.579 HG23 HE21 ' C' ' 157' ' ' GLN . 4.8 t -93.63 -29.53 15.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 4.8700000000000001 111.107 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.579 HE21 HG23 ' C' ' 156' ' ' THR . 27.4 mm-40 -65.33 -74.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.084 -0.507 . . . . 4.0499999999999998 111.091 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 78.4 p -157.97 122.7 4.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.974 -0.557 . . . . 3.0299999999999998 110.747 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.3 p -77.79 -29.68 50.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 2.96 111.065 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -64.45 -56.61 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 3.7400000000000002 111.055 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.16 -20.04 63.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 2.6499999999999999 110.898 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.14 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.77 111.321 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -72.26 -39.21 68.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 2.96 111.096 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 mt -60.89 -50.57 72.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 2.3500000000000001 110.997 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.74 -27.7 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 2.6200000000000001 111.12 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.72 -39.63 85.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 2.0899999999999999 110.685 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -82.84 -20.86 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 3.2400000000000002 110.816 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' C' ' 87' ' ' LEU . 36.4 tp -70.77 -57.22 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 1.6899999999999999 111.135 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . 0.4 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 33.2 t -62.15 -20.92 25.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 1.3999999999999999 111.295 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 20.9 m -50.43 -58.05 6.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.95999999999999996 111.271 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . 0.509 ' O ' HD23 ' C' ' 175' ' ' LEU . 83.4 m-85 -74.64 -26.13 59.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.121 -0.49 . . . . 3.6499999999999999 110.583 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 90.6 t80 -59.47 -40.8 88.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 1.3700000000000001 111.286 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 4.1 t -77.21 -42.79 36.08 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.747 0.277 . . . . 1.4299999999999999 111.747 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.15 -40.53 77.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 1.6200000000000001 111.526 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.509 HD23 ' O ' ' C' ' 171' ' ' TYR . 4.5 mm? -73.05 -52.09 15.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.321 -0.399 . . . . 2.0299999999999998 111.407 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -29.59 61.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.84 0.353 . . . . 0.62 110.969 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.48 ' O ' HG13 ' C' ' 181' ' ' ILE . 38.9 mm -87.57 -23.88 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.511 . . . . 1.5800000000000001 110.249 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . 0.512 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.41 -50.59 61.61 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.909 -0.587 . . . . 0.56000000000000005 113.062 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.666 ' O ' HG22 ' C' ' 182' ' ' VAL . 69.4 m-85 -57.67 -55.51 44.02 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.904 0.352 . . . . 1.3300000000000001 111.205 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.7 Cg_exo -45.84 -29.68 6.02 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.063 1.842 . . . . 0.63 112.416 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.565 ' O ' HG22 ' C' ' 184' ' ' ILE . 83.2 mt -66.05 -57.58 9.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.932 0.396 . . . . 0.93000000000000005 111.484 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.666 HG22 ' O ' ' C' ' 179' ' ' TYR . 11.8 m -55.85 -23.87 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 1.27 111.633 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . 0.462 ' CD1' H191 ' C' ' 210' ' ' LYR . 36.5 m95 -73.35 -53.4 10.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.537 0.569 . . . . 1.77 112.537 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.565 HG22 ' O ' ' C' ' 181' ' ' ILE . 10.4 tp -55.21 -27.67 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.058 0.392 . . . . 2.3900000000000001 112.058 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 66.3 mt -59.92 -69.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.024 0.44 . . . . 1.95 111.025 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . 0.444 ' H ' ' HD2' ' C' ' 187' ' ' PRO . . . 177.27 -50.72 0.1 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.674 -0.694 . . . . 1.8799999999999999 112.288 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' C' ' 186' ' ' GLY . 70.6 Cg_exo -39.28 150.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.91 2.407 . . . . 3.1200000000000001 112.648 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 68.3 m 59.25 17.43 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.561 . . . . 2.6299999999999999 109.632 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -176.87 41.93 0.1 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.178 -0.919 . . . . 3.04 111.933 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 64.3 t80 67.28 95.23 0.06 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.002 0.43 . . . . 5.6900000000000004 111.21 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' C' ' 186' ' ' GLY . . . -150.61 -167.19 14.27 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 116.03 -0.532 . . . . 3.0800000000000001 112.301 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -63.15 -24.98 68.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 7.5300000000000002 110.827 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . 0.426 ' HB ' ' HG3' ' C' ' 187' ' ' PRO . 37.7 mm -108.68 150.07 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.993 -0.548 . . . . 2.8599999999999999 110.947 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -165.71 -25.97 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.349 -0.387 . . . . 3.6899999999999999 111.016 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -68.47 -164.01 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 5.4800000000000004 111.124 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.3 p -55.29 -23.69 24.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 2.3799999999999999 111.13 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.18 -37.74 74.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.269 -0.423 . . . . 2.23 110.936 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.68 -52.39 60.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 2.1600000000000001 110.3 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 46.1 p -70.47 -22.63 62.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.851 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.24 -27.22 65.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 1.7 110.865 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.99 -50.07 10.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 2.02 111.064 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.1 -10.18 56.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.8200000000000001 111.185 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 47.5 t -96.56 -40.17 9.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.3500000000000001 110.833 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.9 tp -71.72 -37.24 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 0.65000000000000002 112.164 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 46.4 tp -60.63 -53.84 60.51 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.031 -0.267 . . . . 1.4199999999999999 111.634 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.6 Cg_exo -57.25 -39.23 91.66 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.755 1.637 . . . . 0.63 111.426 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -60.35 -31.44 70.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 1.49 110.378 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -79.9 -22.78 42.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.7 110.534 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 45.7 t -87.15 -48.84 7.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.066 -0.515 . . . . 1.25 110.902 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.775 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 89.0 t -79.08 -28.87 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 1.6100000000000001 111.058 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.68 57.62 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.828 -0.701 . . . . 0.81999999999999995 112.689 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -69.58 -22.71 63.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 3.0800000000000001 111.157 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 36.3 t -56.75 -62.31 1.82 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.424 . . . . 1.1499999999999999 110.703 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . 0.492 ' HA ' HD12 ' C' ' 218' ' ' LEU . 97.2 m-85 -67.97 -27.52 66.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 2.5600000000000001 110.793 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.09 -44.16 97.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.067 0.461 . . . . 1.29 110.113 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 11.4 t70 -65.67 -33.45 75.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.845 -0.616 . . . . 2.3900000000000001 110.601 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' C' ' 215' ' ' PHE . 84.4 mt -65.74 -32.97 74.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 2.0299999999999998 111.028 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -87.88 -20.93 25.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.914 0.388 . . . . 3.21 110.964 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.76 -26.53 62.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.841 -0.695 . . . . 1.3600000000000001 112.7 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . 0.455 HD22 HG21 ' C' ' 32' ' ' VAL . 97.8 mt -74.89 -19.46 60.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 2.8999999999999999 111.186 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' C' ' 222' ' ' ARG . 6.2 tpm_? -89.55 81.55 6.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.982 0.42 . . . . 4.8899999999999997 110.972 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -164.29 -33.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.573 . . . . 4.2300000000000004 110.569 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 54.5 tp -173.07 107.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.877 -0.601 . . . . 6.1200000000000001 110.684 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.53 128.78 49.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 4.5499999999999998 110.846 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.39 94.83 1.41 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.192 -0.458 . . . . 6.7800000000000002 110.917 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 79.1 p -135.96 117.41 14.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.478 . . . . 5.4000000000000004 110.778 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . 0.58 ' HG3' ' HG3' ' C' ' 229' ' ' GLN . 24.6 tpp180 -107.72 -52.15 2.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 8.3300000000000001 110.939 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . 0.58 ' HG3' ' HG3' ' C' ' 228' ' ' ARG . 47.2 mt-30 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 7.9100000000000001 110.884 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.804 0.335 . . . . 5.1100000000000003 110.804 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -130.06 9.52 5.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 5.04 111.133 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.9 tp -84.7 138.33 32.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.322 -0.399 . . . . 5.5800000000000001 110.638 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -146.63 129.66 16.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 5.0199999999999996 111.019 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -139.66 130.59 26.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 2.4500000000000002 110.894 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.3 mt -95.1 3.52 54.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 2.4199999999999999 110.594 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.02 -39.92 65.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 2.0899999999999999 110.524 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.532 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 34.5 m80 -76.7 -26.46 54.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 1.1599999999999999 110.121 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -70.75 -50.0 40.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.878 -0.601 . . . . 0.79000000000000004 110.658 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 pt -59.9 -31.77 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 CA-C-O 121.146 0.498 . . . . 2.0800000000000001 109.971 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -55.87 -43.99 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.467 -0.788 . . . . 1.28 109.393 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 12' ' ' VAL . 2.5 t -57.39 -49.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.79 -1.096 . . . . 1.3200000000000001 111.071 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.45 -37.79 79.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.63 111.0 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.84 -38.45 95.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.55000000000000004 112.673 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.3 mmm -70.31 -40.01 74.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 1.03 110.902 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 m -56.64 -58.56 7.53 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.025 -0.534 . . . . 1.3 111.117 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.36 -23.77 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 1.3100000000000001 110.955 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.2 3.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 0.77000000000000002 112.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.792 0.33 . . . . 0.80000000000000004 111.006 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -57.1 -47.35 81.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 1.8100000000000001 110.932 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -63.21 -35.21 79.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 1.8799999999999999 110.785 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -69.94 -21.87 63.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.081 -0.508 . . . . 4.4500000000000002 110.831 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.595 ' O ' ' OG ' ' A' ' 26' ' ' SER . 83.6 t90 -75.53 -36.18 60.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 3.6899999999999999 110.892 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -68.34 -42.02 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.266 -0.425 . . . . 1.5700000000000001 110.974 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.04 -1.4 57.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 1.95 110.426 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.595 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 94.8 p -63.05 -16.29 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 1.3799999999999999 111.166 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -45.99 -40.2 10.12 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.266 -0.642 . . . . 4.0700000000000003 109.266 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -176.96 131.35 0.36 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.695 -1.138 . . . . 2.7200000000000002 109.381 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG2' ' H ' ' A' ' 32' ' ' VAL . 93.2 Cg_endo -91.98 -151.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.303 2.002 . . . . 1.9099999999999999 111.929 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -57.68 -13.69 4.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.097 0.475 . . . . 4.7599999999999998 110.711 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 33.52 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.985 -0.626 . . . . 1.99 111.996 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.5 ' HB ' ' HE2' ' A' ' 35' ' ' TYR . 12.9 m -128.63 156.36 77.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.578 0.228 . . . . 2.7000000000000002 111.013 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -53.0 166.35 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.536 2.157 . . . . 1.79 112.854 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -55.8 -17.42 6.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.9 . . . . 4.1200000000000001 112.168 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HE2' ' HB ' ' A' ' 32' ' ' VAL . 2.3 p90 -43.67 -33.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.656 0.265 . . . . 2.9300000000000002 111.314 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -60.51 -50.14 74.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.99 0.424 . . . . 2.8799999999999999 110.565 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -75.06 -19.55 59.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.836 -0.62 . . . . 4.6600000000000001 111.04 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' B' ' 100' ' ' THR . 38.6 tp -57.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 1.45 110.828 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.3 -37.86 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 1.78 111.045 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.69 -8.43 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.63 111.173 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.418 ' O ' HG12 ' A' ' 45' ' ' ILE . 14.9 tpt -89.41 -45.57 9.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 1.48 111.6 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -71.64 -42.81 67.14 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.552 0.575 . . . . 3.5 112.552 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 89.1 mt -48.37 -53.05 38.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.677 0.621 . . . . 1.0800000000000001 112.677 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.7 Cg_endo -72.62 -37.28 4.15 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.04 1.826 . . . . 0.53000000000000003 113.308 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 41' ' ' MET . 27.2 mm -59.33 -61.25 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.689 0.255 . . . . 1.6799999999999999 111.689 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.472 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.0 OUTLIER -56.99 -58.76 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.879 0.371 . . . . 1.8300000000000001 110.871 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 49.7 m -52.36 -31.59 34.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.831 -0.622 . . . . 1.0900000000000001 111.159 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.66 -59.86 10.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.40999999999999998 112.443 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 mt -61.14 -29.51 69.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.98999999999999999 110.926 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.81 -52.0 66.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.47999999999999998 111.253 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 42.3 m-85 -69.16 -23.21 63.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 1.8700000000000001 111.075 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -62.46 -39.22 92.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.49 109.761 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.93 -37.55 72.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.452 -0.794 . . . . 0.58999999999999997 110.802 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.0 mtt -57.5 -26.93 62.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.48999999999999999 110.232 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -73.27 -50.41 22.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.59999999999999998 110.571 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.532 HG21 HG23 ' B' ' 127' ' ' VAL . 17.3 mt -74.41 -5.77 7.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.491 . . . . 1.3100000000000001 110.634 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.63 65.68 0.72 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.696 -0.684 . . . . 1.9099999999999999 111.106 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -130.56 148.01 52.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 1.6200000000000001 110.909 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 98.21 17.58 29.09 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.872 -0.68 . . . . 1.04 112.352 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -117.44 149.47 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.68 0.276 . . . . 2.6800000000000002 110.78 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.51 142.25 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.334 -0.394 . . . . 1.98 110.976 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -89.05 86.0 6.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 2.1800000000000002 111.086 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.04 116.57 29.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 1.5700000000000001 111.172 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.77 22.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.089 -0.505 . . . . 1.79 111.388 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.47 -15.01 48.37 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.672 -0.775 . . . . 1.48 112.656 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -98.34 147.56 24.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 2.3199999999999998 110.945 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.3 pt -87.97 139.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.535 . . . . 1.4399999999999999 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.37 138.77 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.81999999999999995 110.708 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 94.5 m-70 -90.8 57.43 3.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.105 0.478 . . . . 0.90000000000000002 111.173 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -64.44 -57.69 8.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 1.8300000000000001 111.176 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -54.74 -32.93 60.5 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.137 0.494 . . . . 0.62 110.644 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.411 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 5.1 tpp180 -57.17 -41.49 79.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.518 -0.764 . . . . 2.3399999999999999 110.593 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.486 ' OH ' H181 ' A' ' 210' ' ' LYR . 0.3 OUTLIER -83.04 -14.0 54.74 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.005 0.372 . . . . 3.4900000000000002 112.005 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 71' ' ' ALA . 48.9 mt -63.4 -45.11 98.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.009 0.433 . . . . 1.3700000000000001 109.975 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 38.8 t70 -66.49 -11.53 52.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.811 -0.631 . . . . 1.3100000000000001 110.648 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.592 ' HE1' ' H7 ' ' A' ' 210' ' ' LYR . 1.2 m-90 -87.18 -21.03 26.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 1.48 111.066 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.561 ' HG2' ' HB ' ' A' ' 113' ' ' ILE . 28.6 mtp -90.7 -7.8 51.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.014 -0.539 . . . . 1.46 111.125 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.419 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.9 m -114.85 -32.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 1.1200000000000001 112.151 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.0 m -86.85 -53.09 5.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.936 0.347 . . . . 1.1000000000000001 111.936 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 34.5 m -50.24 -51.63 61.26 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.343 0.497 . . . . 0.59999999999999998 112.343 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 80' ' ' THR . 15.2 Cg_endo -56.74 -33.19 93.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.744 1.629 . . . . 0.73999999999999999 111.851 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.2 mm? -79.61 -26.42 41.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.963 -0.562 . . . . 1.01 110.439 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -69.04 -38.53 79.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 1.48 109.71 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.461 HD21 ' CB ' ' A' ' 105' ' ' LEU . 4.9 tt -77.42 -39.54 46.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.465 -0.789 . . . . 1.3799999999999999 110.439 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.501 HD21 ' SD ' ' A' ' 106' ' ' MET . 29.8 mt -59.45 -38.02 79.66 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.186 -0.461 . . . . 1.1899999999999999 110.871 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -56.23 -35.61 67.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 1.23 110.525 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.73 -31.42 72.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.976 -0.557 . . . . 0.88 110.915 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.8 m -62.47 -55.4 27.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 1.3899999999999999 111.073 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -65.17 -21.74 66.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 2.3199999999999998 111.236 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 83.3 m -67.66 -37.18 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 1.46 110.927 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.31 28.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.154 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 81.4 mtp -120.54 112.08 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 2.0699999999999998 110.732 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -68.09 -35.43 78.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 3.5299999999999998 111.299 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.19 143.42 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 4.0800000000000001 111.098 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -105.88 149.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.04 -0.527 . . . . 2.1699999999999999 110.962 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 97' ' ' LYS . 59.1 tttp -133.18 -62.24 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 4.5199999999999996 110.8 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 96' ' ' LYS . 13.2 mmmm -132.03 12.23 4.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 3.75 110.907 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.0 91.53 7.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 3.5299999999999998 111.124 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -128.14 -5.05 5.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 4.9100000000000001 110.781 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.3 p -94.0 -33.31 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 1.98 111.071 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.86 -42.43 97.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 1.8300000000000001 110.917 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 103' ' ' GLY . 33.5 pt -66.98 -41.15 87.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 1.79 111.294 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 102' ' ' ILE . . . -65.01 -27.65 72.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.789 -0.72 . . . . 0.62 112.472 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.78 -54.0 32.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.87 0.367 . . . . 1.5800000000000001 110.97 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.461 ' CB ' HD21 ' A' ' 84' ' ' LEU . 62.6 mt -64.31 -39.46 93.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.97999999999999998 111.003 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.501 ' SD ' HD21 ' A' ' 85' ' ' LEU . 90.4 mtp -62.59 -46.4 88.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 1.48 111.238 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.6 m -56.22 -42.89 77.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.93 0.395 . . . . 1.1299999999999999 110.884 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.573 HG21 HG21 ' A' ' 142' ' ' ILE . 79.6 m -59.37 -34.24 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 1.48 111.281 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 12.3 mm100 -72.63 -29.85 63.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.476 -0.329 . . . . 2.7000000000000002 111.49 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.567 HG22 ' HE1' ' C' ' 46' ' ' TRP . 56.9 mt -66.26 -40.06 85.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 1.54 111.753 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 108' ' ' THR . 34.1 m -72.44 -32.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.678 0.275 . . . . 1.28 111.283 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 108' ' ' THR . 93.2 t -72.98 -42.31 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.387 -0.37 . . . . 0.42999999999999999 111.679 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.561 ' HB ' ' HG2' ' A' ' 77' ' ' MET . 48.0 pt -67.24 -35.11 73.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.628 -0.26 . . . . 1.74 111.299 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.404 ' N ' HG13 ' A' ' 113' ' ' ILE . 54.0 m -58.55 -55.35 36.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.856 0.36 . . . . 0.63 110.482 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.6 m -62.13 -21.01 64.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 1.0900000000000001 110.411 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.46 -56.96 7.03 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.009 -0.615 . . . . 0.41999999999999998 112.793 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.557 HD12 HG13 ' A' ' 118' ' ' ILE . 2.5 pp -61.03 -22.22 64.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.61 0.243 . . . . 1.3799999999999999 111.104 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.557 HG13 HD12 ' A' ' 117' ' ' LEU . 67.8 mt -83.15 -31.81 9.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.852 0.358 . . . . 1.6200000000000001 110.875 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.61 61.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.091 -0.504 . . . . 0.39000000000000001 111.226 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.37 -22.06 35.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 2.02 110.934 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.5 15.35 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.76000000000000001 110.951 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.486 ' HB2' ' HE ' ' A' ' 128' ' ' ARG . 50.1 m -82.27 122.97 28.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.46 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.66 -41.21 9.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 3.3500000000000001 110.856 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.544 ' HB2' HG12 ' A' ' 127' ' ' VAL . 79.8 mtp180 -92.03 134.25 34.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.505 . . . . 2.9199999999999999 110.706 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.76 -9.11 57.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 2.77 111.018 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -87.85 -42.29 12.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 3.77 110.852 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.3 p -74.79 -26.14 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 1.1599999999999999 111.101 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.486 ' HE ' ' HB2' ' A' ' 122' ' ' SER . 40.5 ttm180 -67.52 -31.15 71.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.24 -0.437 . . . . 2.04 111.007 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -63.68 -34.39 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 2.6400000000000001 111.221 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.568 HD23 HG21 ' C' ' 56' ' ' ILE . 52.6 tp -81.75 -44.25 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 1.8999999999999999 111.242 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.48 ' HE1' ' HG2' ' C' ' 58' ' ' GLN . 4.5 m95 -56.31 -33.73 65.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.327 . . . . 1.3999999999999999 111.2 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.42 -55.84 18.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.48 . . . . 1.28 111.259 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 130' ' ' LEU . 19.4 tt -63.3 -25.27 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.788 0.328 . . . . 2.1600000000000001 111.137 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 88.4 m -63.78 -42.27 97.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 1.6899999999999999 110.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.03 -53.96 27.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.52000000000000002 112.578 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 35.1 m -59.93 -34.14 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 1.02 111.38 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.403 ' HA ' HD12 ' A' ' 140' ' ' LEU . 47.8 t -60.16 -43.78 95.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 1.0800000000000001 111.096 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.62 79.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.62 111.364 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.77 -27.77 61.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 1.8400000000000001 111.05 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.1 mt -66.09 -49.6 67.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.409 -0.36 . . . . 1.6899999999999999 111.636 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 142' ' ' ILE . 23.9 pt -62.34 -43.5 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.81000000000000005 111.815 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.573 HG21 HG21 ' A' ' 108' ' ' THR . 46.5 mm -71.86 -33.69 48.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.625 -0.261 . . . . 2.3700000000000001 111.409 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.4 -42.31 82.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.97999999999999998 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.747 ' O ' ' ND2' ' A' ' 148' ' ' ASN . 84.9 t90 -74.27 -29.76 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 3.27 110.641 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.95 75.97 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.892 -0.671 . . . . 1.25 112.815 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.24 -19.38 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.847 0.356 . . . . 2.1200000000000001 111.212 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -80.86 1.93 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 1.6599999999999999 111.419 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 144' ' ' TRP . 69.1 m-80 -100.4 -51.36 0.19 Allowed Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 120.91 -0.316 . . . . 99.989999999999995 111.519 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.661 ' HD3' ' HB2' ' A' ' 148' ' ' ASN . 17.3 Cg_exo -66.81 -8.35 21.13 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.223 1.948 . . . . 2.6000000000000001 112.445 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.8 mt -96.31 28.1 3.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 4.6100000000000003 111.117 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -167.42 -57.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.397 -0.365 . . . . 8.3599999999999994 111.205 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.17 -45.47 80.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 2.75 111.21 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -75.51 -32.74 60.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 5.6799999999999997 111.002 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.0 p -77.96 -7.68 57.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.794 0.33 . . . . 3.21 111.123 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -71.21 -33.44 69.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.324 -0.398 . . . . 6.8700000000000001 110.934 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.3 t -101.41 -21.56 14.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 4.5599999999999996 111.228 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.26 -71.09 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 3.5600000000000001 110.921 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 161' ' ' LEU . 41.8 t -151.55 122.22 7.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 2.79 111.069 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -74.8 -38.43 62.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 2.5899999999999999 111.085 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.01 -38.54 82.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 3.4700000000000002 110.853 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 158' ' ' SER . 59.1 tp -71.01 -25.91 62.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 2.5800000000000001 110.606 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.91 -34.6 69.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.967 -0.561 . . . . 1.78 111.009 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -67.06 -43.61 82.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 2.6299999999999999 110.749 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 64.1 mt -60.71 -46.33 90.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 2.3399999999999999 111.013 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' A' ' 168' ' ' LEU . 0.6 OUTLIER -74.4 -22.63 59.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.941 -0.572 . . . . 2.77 111.333 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.5 -50.86 71.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 2.04 110.823 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.08 -20.67 48.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 2.77 110.744 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 165' ' ' TYR . 0.2 OUTLIER -66.69 -56.27 11.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 1.8899999999999999 110.801 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.14 -24.36 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 1.6399999999999999 111.234 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.0 -58.68 6.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.403 . . . . 1.24 111.127 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.65 -23.99 66.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 2.9700000000000002 110.316 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -69.82 -32.83 71.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 1.48 111.277 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 70.6 p -76.41 -51.06 12.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.336 -0.393 . . . . 1.55 111.531 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.98 -29.0 40.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.467 -0.333 . . . . 1.52 111.609 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 62.5 tp -80.08 -57.37 3.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.375 -0.375 . . . . 1.8500000000000001 110.914 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -29.17 58.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.62 110.8 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 181' ' ' ILE . 33.0 mm -87.75 -24.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 1.3500000000000001 110.548 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.91 -50.87 58.97 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.844 -0.616 . . . . 0.58999999999999997 113.22 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.613 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 95.6 m-85 -59.76 -55.65 43.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.779 0.289 . . . . 1.45 111.46 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 82.4 Cg_exo -45.56 -29.84 5.48 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.278 1.985 . . . . 0.55000000000000004 112.92 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 177' ' ' ILE . 90.0 mt -69.11 -59.66 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 1.4199999999999999 111.297 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 179' ' ' TYR . 27.1 m -61.16 -25.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.78000000000000003 111.644 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -62.97 -23.56 67.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.344 . . . . 0.93999999999999995 110.929 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.76 -64.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 1.4299999999999999 110.966 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 50.6 pt -80.38 166.37 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 2.02 111.097 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.58 -166.15 37.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.851 -0.69 . . . . 1.79 112.531 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.6 161.5 27.91 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.581 2.188 . . . . 3.1000000000000001 112.082 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.7 t 57.29 17.64 3.79 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.958 0.408 . . . . 2.7400000000000002 110.567 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.97 -76.44 0.11 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.991 -0.623 . . . . 3.4300000000000002 112.398 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -153.87 -26.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.964 0.411 . . . . 6.5 110.714 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -89.22 176.45 43.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.866 -0.683 . . . . 3.29 112.437 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -121.07 38.45 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.347 . . . . 6.1600000000000001 110.858 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 195' ' ' GLN . 75.4 mt -88.94 141.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 2.4199999999999999 110.878 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -139.63 33.09 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.313 -0.403 . . . . 4.29 110.969 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.419 ' H ' HG22 ' A' ' 193' ' ' ILE . 15.2 mm100 -87.02 169.56 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 5.1500000000000004 110.92 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.2 p -74.0 -17.91 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 2.4500000000000002 111.501 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 8.7 tp -65.21 -31.37 53.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 2.48 111.507 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.43 -43.73 93.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 2.1800000000000002 111.032 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 13.7 m -75.02 -23.15 58.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 1.49 111.007 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -72.51 -31.85 65.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 1.77 111.169 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 67.1 tp -83.38 -32.25 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 1.4199999999999999 111.315 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -75.4 -19.02 59.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 1.78 111.003 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 206' ' ' PRO . 27.4 p -96.34 -31.53 12.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.054 0.454 . . . . 1.3 110.763 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.3 tp -72.64 -32.83 66.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.66000000000000003 111.297 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.527 ' N ' ' HD2' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -63.08 -54.26 47.55 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.536 -0.302 . . . . 1.6299999999999999 111.471 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 205' ' ' LEU . 14.9 Cg_endo -56.5 -44.22 47.83 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.127 1.884 . . . . 0.64000000000000001 111.825 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -66.24 -29.11 69.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 1.3600000000000001 110.252 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.75 -27.0 57.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 1.54 110.325 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.4 p -94.17 -24.58 17.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 1.2 110.727 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.73 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.95 -41.85 90.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.228 -0.442 . . . . 1.6399999999999999 111.044 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.64 87.63 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.686 -0.769 . . . . 0.79000000000000004 112.386 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -65.29 -35.2 80.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.731 0.301 . . . . 1.6100000000000001 110.99 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.4 m -60.96 -57.74 11.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 1.1499999999999999 110.748 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -64.75 -20.05 66.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 3.3399999999999999 110.898 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.8 -43.0 38.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 1.1899999999999999 111.32 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.54 -30.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.402 . . . . 2.23 111.358 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.22 -58.91 3.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 2.4700000000000002 111.349 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -69.46 -21.72 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 1.6200000000000001 111.091 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.55 -18.89 64.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.864 -0.684 . . . . 1.4099999999999999 112.569 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 224' ' ' LEU . 56.4 tp -79.64 -29.59 41.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.685 0.279 . . . . 2.5800000000000001 110.985 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 62.07 -82.24 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.023 -0.535 . . . . 4.9299999999999997 111.033 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -152.99 119.13 5.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 4.6299999999999999 110.677 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 221' ' ' LEU . 48.0 tp -162.49 139.69 8.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.009 -0.541 . . . . 6.4699999999999998 110.828 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -167.17 106.14 0.58 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.243 -0.435 . . . . 5.0700000000000003 110.972 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -126.21 127.97 46.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 6.5300000000000002 111.015 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 p -156.58 102.9 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 5.2199999999999998 110.913 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -139.83 14.36 2.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 8.3599999999999994 110.709 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 7.96 110.944 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.806 0.336 . . . . 6.1699999999999999 110.956 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -122.62 -1.36 9.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 4.8200000000000003 110.929 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.74 116.55 19.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 5.5999999999999996 111.091 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.19 125.11 28.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 4.7999999999999998 110.861 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 41.3 t -134.68 130.37 36.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.938 -0.573 . . . . 2.3700000000000001 110.802 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -89.03 -6.99 56.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.114 -0.494 . . . . 2.0699999999999998 110.81 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.12 -57.61 12.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.871 -0.604 . . . . 2.1000000000000001 111.284 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 35.9 m170 -61.24 -25.23 66.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 1.0700000000000001 110.894 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.404 ' O ' HG12 ' B' ' 12' ' ' VAL . 59.0 t-105 -69.75 -39.92 76.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.48 110.578 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -24.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.127 0.489 . . . . 2.02 110.164 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' B' ' 207' ' ' PHE . 5.5 t80 -61.14 -55.76 28.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.639 -0.709 . . . . 0.92000000000000004 110.619 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.404 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -58.72 -36.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.245 -0.434 . . . . 0.93999999999999995 110.673 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.41 75.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.55000000000000004 110.813 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.34 -29.3 64.37 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.47999999999999998 111.991 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.1 mmt -76.35 -32.85 58.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.84999999999999998 110.784 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -63.32 -54.35 38.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 1.3400000000000001 110.454 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.03 -24.1 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 1.55 110.728 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.49 -62.05 6.78 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.764 -0.731 . . . . 0.69999999999999996 112.099 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -34.71 65.39 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.926 0.393 . . . . 0.81000000000000005 110.836 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.39 -44.03 84.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.6 . . . . 2.2599999999999998 110.558 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -65.52 -39.37 91.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 1.78 110.839 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -73.24 -6.32 45.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 4.5800000000000001 110.616 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.445 ' O ' ' OG ' ' B' ' 26' ' ' SER . 65.0 t90 -89.11 -35.78 16.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.425 . . . . 3.3500000000000001 110.624 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 79.2 p -70.72 -44.64 66.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 110.865 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.24 -2.81 53.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.512 . . . . 1.8400000000000001 110.701 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 92.8 p -58.3 -15.02 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.525 . . . . 1.3700000000000001 111.186 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -48.81 -40.07 27.75 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.692 -0.484 . . . . 4.9800000000000004 109.692 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.6 p-10 179.16 130.8 0.23 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.421 -0.808 . . . . 2.1400000000000001 110.559 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' B' ' 33' ' ' PRO . 71.8 Cg_endo -102.95 -80.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.646 2.897 . . . . 1.8200000000000001 111.967 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' B' ' 30' ' ' ARG . 4.2 mmp_? -106.23 11.22 31.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.453 0.644 . . . . 5.1900000000000004 109.685 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.68 -53.68 0.76 Allowed Glycine 0 CA--C 1.519 0.303 0 CA-C-N 114.857 -1.065 . . . . 2.2000000000000002 112.16 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.65 104.87 5.38 Favored Pre-proline 0 CA--C 1.518 -0.275 0 CA-C-N 117.486 0.643 . . . . 3.6499999999999999 111.69 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.573 ' HB3' ' HG3' ' B' ' 29' ' ' PRO . 83.2 Cg_endo -89.3 107.98 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.773 0.982 . . . . 2.6699999999999999 113.602 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -92.74 -61.13 1.65 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.804 1.764 . . . . 4.8799999999999999 107.735 174.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -39.85 18.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 110.317 -3.129 . . . . 1.8700000000000001 113.148 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -38.3 -64.6 0.41 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.638 0.977 . . . . 2.6800000000000002 113.638 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.43 ' CZ ' ' HA ' ' B' ' 26' ' ' SER . 75.0 m-85 -82.69 -18.28 41.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.102 0.408 . . . . 2.9199999999999999 112.102 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 tp -59.3 -65.12 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.867 0.365 . . . . 1.6399999999999999 110.781 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 m -69.25 -37.82 76.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 1.6000000000000001 111.472 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 -12.09 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.52 -0.309 . . . . 0.68999999999999995 111.154 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 45.3 tpp -89.09 -48.74 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 2.5800000000000001 111.665 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -65.86 -48.95 69.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.849 0.685 . . . . 3.3900000000000001 112.849 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 79.5 mt -45.36 -53.61 17.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.29 0.848 . . . . 0.40999999999999998 113.29 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -71.48 -38.61 4.38 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.228 1.952 . . . . 0.48999999999999999 113.611 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -59.54 -61.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.852 0.315 . . . . 1.29 111.852 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.507 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.1 OUTLIER -58.26 -58.92 6.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 1.3999999999999999 111.314 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.431 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 47.9 t -55.05 -26.24 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 1.3799999999999999 111.025 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.58 -67.57 2.08 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.754 -0.736 . . . . 0.37 112.739 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.09 -24.32 58.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.646 0.26 . . . . 1.29 111.385 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.66 -59.15 5.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.44 111.182 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.8 m-85 -61.76 -35.8 79.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.5 110.95 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 57.6 ttp -51.5 -35.31 39.68 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.072 0.463 . . . . 1.4099999999999999 110.08 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -71.61 -39.44 70.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.55000000000000004 110.537 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -57.11 -21.12 29.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.5 110.567 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -82.63 -46.18 13.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.046 -0.525 . . . . 0.54000000000000004 111.105 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' B' ' 53' ' ' ALA . 27.0 pt -75.26 -0.05 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 1.3 111.299 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.93 65.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.939 -0.573 . . . . 2.2400000000000002 110.904 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -146.79 114.27 6.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 1.77 110.846 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' B' ' 70' ' ' TYR . . . 136.23 -1.33 3.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 1.0600000000000001 112.532 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -108.58 151.54 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 2.6600000000000001 111.018 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.26 145.67 18.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 1.8899999999999999 111.1 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.32 87.95 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 2.4100000000000001 111.143 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.28 118.08 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 1.5600000000000001 110.85 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.86 31.49 20.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 1.8200000000000001 111.13 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.14 0.56 86.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.646 -0.787 . . . . 1.51 112.548 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -101.02 147.19 26.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 2.4500000000000002 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.3 mt -92.74 121.86 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 1.79 110.81 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.482 ' HB1' HD23 ' B' ' 121' ' ' LEU . . . -99.12 140.07 33.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.81999999999999995 111.276 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.601 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.7 m-70 -82.99 58.29 4.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.992 -0.549 . . . . 1.05 110.879 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.441 ' O ' HG13 ' B' ' 74' ' ' ILE . 65.5 t80 -62.89 -55.75 23.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.506 -0.77 . . . . 1.8700000000000001 111.351 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.593 ' HA ' HD12 ' B' ' 74' ' ' ILE . . . -63.2 -24.0 67.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.068 0.396 . . . . 0.60999999999999999 112.068 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 58.7 mmt-85 -64.69 -52.46 57.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.231 0.456 . . . . 2.3900000000000001 112.231 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.494 ' CE1' ' HG ' ' B' ' 117' ' ' LEU . 2.1 p90 -64.29 -32.12 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.607 -0.437 . . . . 3.6699999999999999 110.476 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' B' ' 71' ' ' ALA . 57.7 mt -50.44 -53.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 116.125 -0.489 . . . . 1.6599999999999999 110.992 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 24.7 t70 -66.56 -22.76 66.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.196 -0.456 . . . . 1.4099999999999999 110.311 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -89.77 5.1 47.54 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.105 -0.498 . . . . 1.1599999999999999 111.034 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.49 ' HA ' HD13 ' B' ' 113' ' ' ILE . 51.9 ttm -104.89 -18.44 14.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 1.53 110.592 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' B' ' 46' ' ' TRP . 28.1 m -114.46 -33.81 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.087 -0.506 . . . . 0.89000000000000001 112.106 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -79.33 -48.5 13.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.157 0.428 . . . . 1.24 112.157 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 5.6 m -55.6 -50.71 85.4 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.443 -0.344 . . . . 0.57999999999999996 111.781 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 47.2 Cg_exo -55.54 -33.48 86.68 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.945 1.763 . . . . 0.66000000000000003 111.969 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' B' ' 85' ' ' LEU . 83.8 mt -78.55 -26.47 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 1.0600000000000001 110.868 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.567 HD22 ' H43' ' B' ' 210' ' ' LYR . 11.5 tp -67.58 -39.17 84.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.847 0.356 . . . . 1.22 110.281 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.8 pp -82.07 -25.96 34.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.976 -0.556 . . . . 1.53 110.323 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.446 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.1 mt -68.62 -34.05 75.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 1.5800000000000001 109.804 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -58.78 -34.84 71.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.41 -0.814 . . . . 1.3899999999999999 110.423 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.05 -29.33 65.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 1.1499999999999999 110.88 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 56.4 m -63.57 -40.05 95.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 1.5700000000000001 110.937 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -82.51 -16.24 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 2.1699999999999999 111.033 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 89.8 m -68.08 -42.92 79.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 1.4199999999999999 111.268 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.77 -33.21 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 1.1799999999999999 111.376 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.5 mtm -118.04 110.23 17.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 1.8799999999999999 110.829 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -76.44 -30.38 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 3.4199999999999999 111.248 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -133.54 140.78 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 4.0599999999999996 110.767 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -107.7 142.03 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 2.0899999999999999 111.14 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -127.0 -50.62 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.152 -0.477 . . . . 3.8500000000000001 110.854 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -137.28 -17.21 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 4.8200000000000003 110.911 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -65.52 113.26 4.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 3.7999999999999998 111.223 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -149.21 -23.63 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.999 -0.546 . . . . 5.1699999999999999 110.497 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.407 ' HB ' HD22 ' A' ' 38' ' ' LEU . 61.8 p -76.35 -34.92 58.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 2.02 110.778 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.87 -46.91 82.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.502 . . . . 2.0899999999999999 110.592 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.24 -37.17 76.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.8799999999999999 110.88 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.29 -18.26 79.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.786 -0.721 . . . . 0.56000000000000005 112.409 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -72.85 -45.02 60.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.78 110.755 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.38 -30.41 63.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 1.03 110.945 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . 0.416 ' O ' HG13 ' B' ' 110' ' ' ILE . 89.5 mtp -69.7 -48.69 58.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 1.6699999999999999 111.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -57.61 -45.32 85.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.364 -0.38 . . . . 1.51 111.077 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.615 ' HB ' HD13 ' B' ' 142' ' ' ILE . 57.8 p -59.14 -33.12 70.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 1.1799999999999999 111.128 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.448 ' O ' HG13 ' B' ' 113' ' ' ILE . 56.8 tp60 -71.17 -36.78 72.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.356 -0.384 . . . . 2.1699999999999999 110.987 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.472 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.6 mt -56.8 -43.32 79.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 1.3500000000000001 111.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.539 HG22 ' O ' ' B' ' 108' ' ' THR . 18.2 m -70.93 -30.59 42.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 1.3400000000000001 111.347 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 108' ' ' THR . 88.9 t -72.64 -27.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.482 -0.327 . . . . 0.42999999999999999 111.256 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' B' ' 77' ' ' MET . 69.8 mt -80.2 -43.15 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 116.631 -0.259 . . . . 1.6000000000000001 111.213 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.412 HG22 ' O ' ' B' ' 111' ' ' VAL . 9.7 t -58.92 -29.92 67.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.955 0.407 . . . . 0.85999999999999999 110.176 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -69.15 -50.52 47.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.897 -0.592 . . . . 0.94999999999999996 109.833 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.54 -10.1 66.2 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.9 -0.667 . . . . 0.46000000000000002 111.51 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.494 ' HG ' ' CE1' ' B' ' 73' ' ' TYR . 4.4 tt -70.43 -56.78 5.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.506 . . . . 1.75 110.346 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 31.7 mt -83.48 -20.62 9.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.647 -0.706 . . . . 1.78 111.546 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.83 -39.41 11.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.38 111.331 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.03 -23.93 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.97 110.842 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.482 HD23 ' HB1' ' B' ' 68' ' ' ALA . 87.8 mt -87.96 29.57 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.76000000000000001 111.15 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -93.91 122.92 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.411 . . . . 1.47 110.735 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.53 -52.52 4.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 2.5 111.263 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.9 ttm180 -77.42 123.71 26.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 2.73 110.809 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.73 -14.24 50.59 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.144 -0.48 . . . . 2.2000000000000002 111.132 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.584 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 66.1 t-105 -74.53 -56.12 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 3.3999999999999999 110.56 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' B' ' 124' ' ' ARG . 7.7 p -65.15 -27.95 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 1.23 111.059 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -55.07 -26.93 41.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.725 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.54 -34.99 40.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 4.1399999999999997 110.922 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.419 HD22 ' N ' ' B' ' 130' ' ' LEU . 3.8 mm? -72.31 -49.33 35.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 1.6499999999999999 111.135 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -62.47 -31.9 72.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.77000000000000002 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.464 ' HE1' ' HB3' ' B' ' 183' ' ' TRP . 66.5 t80 -63.34 -55.47 24.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 1.46 110.984 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 tt -68.34 -23.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.027 0.441 . . . . 1.6299999999999999 110.865 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.8 -41.67 91.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 1.4199999999999999 111.276 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.82 -50.49 35.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.48999999999999999 112.799 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 26.9 m -61.31 -38.31 79.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.576 0.227 . . . . 1.3 111.489 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -58.31 -45.29 88.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 1.3 111.331 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.22 -40.57 77.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.62 111.153 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -69.71 -22.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.37 . . . . 1.74 111.361 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 80.5 mt -66.98 -60.61 2.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.703 -0.226 . . . . 1.76 111.278 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 31.0 pt -56.08 -36.33 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.68999999999999995 111.408 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.615 HD13 ' HB ' ' B' ' 108' ' ' THR . 74.5 mt -69.78 -42.63 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 1.76 111.152 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.17 -47.47 81.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0600000000000001 111.069 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . 0.447 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 44.4 t-105 -66.59 -25.91 66.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 4.1200000000000001 110.964 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.65 -21.29 58.28 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.9 -0.667 . . . . 1.26 113.229 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.1 pt -98.94 -6.58 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 1.98 111.717 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -87.59 -2.3 58.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 1.4199999999999999 111.388 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.615 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 69.1 m-80 -100.36 -49.92 0.19 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.297 -0.41 . . . . 99.989999999999995 111.855 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 22.9 Cg_exo -64.95 -9.71 22.53 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.525 2.15 . . . . 2.6499999999999999 113.021 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.46 13.23 32.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.695 0.283 . . . . 4.3899999999999997 111.294 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -145.27 -61.0 0.35 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 7.9000000000000004 111.133 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.94 -50.92 70.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.148 -0.478 . . . . 2.77 111.559 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' B' ' 149' ' ' PRO . 67.6 mttm -70.95 -36.77 72.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 6.29 111.115 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 47.3 p -71.14 -17.42 62.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.336 . . . . 3.1000000000000001 110.803 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -65.43 -32.21 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 6.4299999999999997 110.871 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 60.1 m -98.62 -37.51 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 4.5700000000000003 111.09 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -63.52 -74.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 3.8300000000000001 111.142 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 57.0 m -148.54 120.65 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 3.0699999999999998 110.787 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 43.7 t -73.0 -36.83 67.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 3.4300000000000002 111.181 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -62.62 -49.88 73.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 3.9199999999999999 110.885 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.77 -22.12 66.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.034 -0.53 . . . . 2.7000000000000002 111.021 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.92 67.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.363 -0.38 . . . . 1.8300000000000001 111.207 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -62.44 -40.09 95.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 2.6299999999999999 111.035 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.47 -44.66 85.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.127 -0.488 . . . . 2.4300000000000002 110.962 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.67 -22.38 50.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.534 . . . . 2.5800000000000001 110.885 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.71 -47.35 84.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 2.0 111.164 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -82.19 -21.0 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 3.0299999999999998 110.633 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.2 -49.57 55.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.141 -0.481 . . . . 1.1000000000000001 110.699 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.33 -23.63 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.75 111.006 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.3 m -54.82 -59.04 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.295 -0.411 . . . . 0.97999999999999998 110.982 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.91 -29.15 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 4.2999999999999998 110.069 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -68.98 -21.56 64.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.601 -0.727 . . . . 1.3899999999999999 110.843 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 46.6 m -79.14 -58.3 3.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 1.1100000000000001 111.539 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.08 -29.78 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 1.51 111.686 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 44.9 tp -76.39 -58.55 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.474 -0.33 . . . . 1.75 111.562 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -28.89 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.33 -0.395 . . . . 0.59999999999999998 110.854 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.432 ' O ' HG12 ' B' ' 181' ' ' ILE . 42.9 mm -87.93 -24.07 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 1.47 110.482 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.92 48.5 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.937 -0.574 . . . . 0.55000000000000004 113.228 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.613 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 83.1 m-85 -56.8 -55.78 39.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.912 0.356 . . . . 1.6200000000000001 111.521 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.1 Cg_exo -44.89 -33.32 7.28 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.455 2.103 . . . . 0.64000000000000001 112.84 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.0 mm -66.49 -59.58 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 1.27 111.644 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.09 -28.28 44.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.68999999999999995 111.831 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . 0.464 ' HB3' ' HE1' ' B' ' 132' ' ' TYR . 38.2 m95 -60.07 -24.22 64.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.59 -0.277 . . . . 1.1799999999999999 111.174 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 89.2 mt -55.63 -61.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.715 0.293 . . . . 1.77 111.179 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 41.2 pt -82.81 165.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 1.6899999999999999 111.267 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.85 -169.59 40.72 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.891 -0.671 . . . . 1.5800000000000001 112.608 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.15 160.83 44.6 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.542 2.161 . . . . 2.5099999999999998 111.901 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 51.4 m 56.88 17.29 3.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.373 -0.376 . . . . 3.5800000000000001 110.521 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -133.18 -64.38 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.121 -0.561 . . . . 4.0300000000000002 112.415 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -167.57 -32.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.321 . . . . 6.8899999999999997 110.804 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -86.89 166.84 37.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.81 -0.71 . . . . 3.7000000000000002 112.668 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -111.78 51.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.743 0.306 . . . . 7.5 110.867 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.459 HG22 ' H ' ' B' ' 195' ' ' GLN . 24.0 mm -97.61 142.03 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 2.3500000000000001 111.062 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -138.87 28.25 2.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.399 -0.364 . . . . 3.8599999999999999 111.001 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . 0.459 ' H ' HG22 ' B' ' 193' ' ' ILE . 46.8 mt-30 -84.85 155.49 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 5.0499999999999998 110.8 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 65.7 p -64.33 -15.54 60.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 2.6800000000000002 111.657 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . 0.441 HG22 ' HB2' ' B' ' 195' ' ' GLN . 9.9 tp -66.58 -28.71 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 2.4700000000000002 110.763 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 2.5299999999999998 110.451 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -62.91 -28.06 69.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.762 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -66.17 -36.12 82.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 2.6200000000000001 110.977 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.69 -47.81 51.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 1.6100000000000001 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -71.38 -6.21 38.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 1.4199999999999999 111.154 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HD2' ' B' ' 206' ' ' PRO . 47.3 t -96.34 -46.13 6.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.204 0.526 . . . . 1.4299999999999999 110.599 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.1 tp -72.25 -26.01 61.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.7 -0.682 . . . . 1.1200000000000001 111.578 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.671 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 62.2 tp -66.0 -54.48 27.12 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 120.931 -0.308 . . . . 1.26 111.123 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.5 Cg_exo -55.83 -42.52 66.29 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.697 1.598 . . . . 0.59999999999999998 111.388 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.429 ' HB2' ' CE1' ' B' ' 11' ' ' TYR . 89.4 t80 -63.93 -39.19 93.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 1.3999999999999999 110.456 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.2 -34.31 78.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 1.4099999999999999 111.089 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -86.2 -31.57 21.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.317 -0.401 . . . . 1.3200000000000001 110.994 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.759 ' H9 ' H183 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.0 -53.86 41.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 1.6899999999999999 111.209 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.63 63.25 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.823 -0.703 . . . . 0.79000000000000004 112.563 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -66.4 -38.47 87.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 2.96 110.859 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.8 m -60.64 -56.39 21.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 1.29 110.733 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -63.94 -20.12 65.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 3.1499999999999999 110.683 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.435 ' C ' HD13 ' B' ' 216' ' ' LEU . 3.2 tm? -71.63 -58.18 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 1.51 111.104 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -58.73 -23.89 60.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.375 . . . . 2.1899999999999999 111.209 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.3 tp -68.76 -54.59 15.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 1.98 111.338 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -77.59 -20.36 54.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.285 -0.416 . . . . 2.1699999999999999 111.311 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.19 -23.36 67.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.913 -0.66 . . . . 1.3600000000000001 113.102 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 52.7 tp -74.01 -23.08 59.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.598 0.237 . . . . 2.8999999999999999 111.125 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 60.32 -83.46 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.271 -0.422 . . . . 5.6100000000000003 111.183 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -160.35 103.65 1.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.418 -0.356 . . . . 4.04 110.726 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 61.0 tp -150.46 136.55 18.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 6.2999999999999998 111.011 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -116.57 -76.97 0.57 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 4.7999999999999998 111.138 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 15.2 t70 60.8 103.55 0.02 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.16 -0.473 . . . . 6.3899999999999997 111.307 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 75.7 p -158.55 81.65 0.82 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 5.6100000000000003 110.947 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -104.79 -42.23 5.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.296 -0.411 . . . . 8.1999999999999993 111.027 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 8.1699999999999999 110.961 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 45.2 tpp . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.834 0.349 . . . . 5.6200000000000001 110.981 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -120.73 -11.75 8.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 5.2800000000000002 110.965 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.88 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 6.0499999999999998 110.827 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -153.54 120.46 5.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 4.79 110.896 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -130.92 124.99 32.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 2.71 111.107 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.561 HD23 ' H ' ' C' ' 6' ' ' LEU . 2.4 pt? -87.63 -7.21 57.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 2.52 110.782 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.31 -41.79 98.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 1.9299999999999999 110.498 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 46.2 m80 -74.1 -23.84 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.904 -0.589 . . . . 1.26 110.389 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.431 ' O ' HG12 ' C' ' 12' ' ' VAL . 64.4 t-105 -72.61 -44.49 61.9 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.914 -0.585 . . . . 1.6699999999999999 110.732 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.45 -23.34 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.183 0.516 . . . . 1.8700000000000001 109.911 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -60.79 -57.35 13.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 1.4399999999999999 110.581 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.431 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.2 p -59.04 -31.42 45.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.31 -0.404 . . . . 0.46999999999999997 110.805 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.16 -33.21 74.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.58999999999999997 110.449 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.82 -28.67 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.5 112.008 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.4 mmt -75.7 -34.63 60.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.634 0.254 . . . . 0.68000000000000005 111.232 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -63.1 -53.36 54.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 1.3999999999999999 110.867 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' C' ' 20' ' ' LEU . 2.7 pp -61.91 -26.65 40.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 1.55 110.809 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.25 -59.94 9.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.70999999999999996 112.278 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.89 65.84 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.796 0.332 . . . . 0.77000000000000002 111.277 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' C' ' 17' ' ' ILE . 96.2 mt -62.79 -42.5 99.73 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.233 -0.44 . . . . 1.9299999999999999 110.879 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -59.52 -40.76 88.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 1.8600000000000001 110.633 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -70.54 -20.01 62.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 4.1399999999999997 110.831 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . 0.406 ' O ' ' OG ' ' C' ' 26' ' ' SER . 85.7 t90 -71.57 -34.36 69.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 3.1499999999999999 110.655 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 43.9 t -71.39 -47.8 53.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.95 110.879 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 -0.93 30.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 2.2200000000000002 110.778 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 95.1 p -56.09 -17.7 7.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 1.3700000000000001 111.441 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -47.24 -42.83 21.18 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.742 -0.466 . . . . 5.0300000000000002 109.742 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 7.7 p30 -173.67 130.66 0.53 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.468 -0.787 . . . . 2.3700000000000001 110.402 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.473 ' O ' HG22 ' C' ' 32' ' ' VAL . 73.4 Cg_endo -101.89 77.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.471 2.781 . . . . 2.0499999999999998 112.651 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 61.14 6.47 1.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.422 -0.353 . . . . 4.5199999999999996 111.332 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.84 39.26 5.56 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.771 -0.728 . . . . 2.1600000000000001 112.932 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.473 HG22 ' O ' ' C' ' 29' ' ' PRO . 5.4 m -122.71 152.53 62.28 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.755 0.278 . . . . 2.5299999999999998 111.105 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.28 165.69 2.07 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.661 2.241 . . . . 1.9299999999999999 112.969 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -60.03 -17.98 42.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 4.1200000000000001 112.096 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -45.5 -30.84 1.53 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.706 0.289 . . . . 2.8900000000000001 111.641 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.59 -58.75 5.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 2.46 111.142 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -69.76 -19.84 63.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.383 -0.371 . . . . 2.7799999999999998 111.319 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 36.6 tp -58.49 -63.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 1.6200000000000001 110.819 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.53 -30.36 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 1.5900000000000001 111.328 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.17 -13.04 61.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.65000000000000002 111.559 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.429 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 27.2 ttt -89.79 -42.54 11.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.387 -0.37 . . . . 1.6699999999999999 111.906 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -72.15 -42.0 66.47 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.751 0.648 . . . . 3.4199999999999999 112.751 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.609 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 35.1 mm -51.45 -52.72 57.11 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.78 0.659 . . . . 0.89000000000000001 112.78 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 12.6 Cg_exo -70.33 -39.08 5.78 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.416 2.077 . . . . 0.40999999999999998 113.209 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.19 -61.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.887 0.329 . . . . 1.76 111.887 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.567 ' HE1' HG22 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -56.11 -58.94 5.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 2.1600000000000001 111.234 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 30.3 t -53.42 -28.8 31.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.99 -0.55 . . . . 1.1699999999999999 111.213 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.98 -62.54 6.11 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.657 -0.783 . . . . 0.44 112.445 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.447 ' HA ' ' HE2' ' C' ' 52' ' ' MET . 56.1 mt -61.4 -24.12 66.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 1.29 110.838 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . 0.4 ' HB1' ' HB2' ' C' ' 75' ' ' ASP . . . -64.4 -58.04 7.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.5 111.004 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.516 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 36.8 m-85 -63.59 -35.77 81.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 1.8300000000000001 110.982 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' C' ' 49' ' ' LEU . 51.7 ttp -53.48 -35.28 60.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.138 0.494 . . . . 1.47 109.965 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.63 -34.14 64.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.698 -0.683 . . . . 0.59999999999999998 110.69 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . 0.404 ' SD ' ' HA ' ' C' ' 51' ' ' TYR . 50.4 mtt -61.82 -20.12 63.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.83999999999999997 110.052 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -81.24 -48.07 12.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.65000000000000002 110.713 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.568 HG21 HD23 ' A' ' 130' ' ' LEU . 39.6 pt -73.01 -5.44 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.004 -0.544 . . . . 1.55 111.343 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.66 67.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.943 -0.571 . . . . 1.54 111.117 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.48 ' HG2' ' HE1' ' A' ' 131' ' ' TRP . 53.0 tp60 -139.21 139.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.79 110.766 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 110.74 11.14 19.92 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.892 -0.67 . . . . 0.93999999999999995 112.194 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -115.09 148.21 39.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 2.3599999999999999 110.925 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.93 140.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 1.97 111.047 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.43 86.85 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 2.4399999999999999 111.152 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.68 118.9 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 1.54 111.08 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.76 28.75 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 1.71 111.284 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.49 -6.3 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 1.53 112.626 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.94 152.58 19.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 2.23 110.675 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.06 131.68 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 1.3600000000000001 110.894 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.02 144.66 32.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.515 . . . . 0.78000000000000003 111.208 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.438 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 65.2 m-70 -91.56 59.21 3.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 1.0800000000000001 110.779 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.21 -58.18 5.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 2.2999999999999998 111.256 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -55.61 -35.45 65.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.228 0.537 . . . . 0.75 110.429 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 9.1 tpp180 -56.04 -39.29 71.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.338 -0.846 . . . . 1.51 111.008 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.577 ' OH ' H181 ' C' ' 210' ' ' LYR . 0.2 OUTLIER -82.59 -20.75 35.87 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.04 0.385 . . . . 4.6500000000000004 112.04 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 47.7 mm -58.77 -42.86 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 1.22 110.284 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 25.8 t70 -60.98 -22.73 64.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 1.3100000000000001 110.599 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . 0.416 ' HE1' ' H7 ' ' C' ' 210' ' ' LYR . 1.3 m-90 -81.27 -27.61 35.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 1.6799999999999999 111.267 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.619 ' HG2' HG23 ' C' ' 113' ' ' ILE . 12.8 mtp -75.55 -14.04 60.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.736 -0.665 . . . . 1.8 111.801 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' C' ' 46' ' ' TRP . 16.3 m -114.89 -42.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.451 0.537 . . . . 1.1899999999999999 112.451 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 71.7 m -72.49 -51.82 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.63 0.604 . . . . 1.23 112.63 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.0 m -54.02 -51.02 80.92 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.351 0.5 . . . . 0.58999999999999997 112.351 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.7 Cg_exo -55.28 -35.53 91.57 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.939 1.759 . . . . 0.67000000000000004 112.256 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.441 ' HB3' HD11 ' C' ' 43' ' ' ILE . 4.0 mm? -77.55 -23.8 49.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.95999999999999996 110.663 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -46.36 75.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.1899999999999999 110.492 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.496 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -74.36 -29.26 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.7 110.737 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . 0.496 ' N ' HD12 ' C' ' 84' ' ' LEU . 7.4 tp -64.52 -36.76 85.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 1.6200000000000001 110.501 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 21.1 m -61.61 -32.04 72.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.379 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 60.8 mt -66.7 -32.43 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.8 -0.636 . . . . 1.1100000000000001 110.561 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 39.8 t -62.94 -53.45 53.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 1.51 110.566 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -61.97 -26.66 68.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 2.0600000000000001 110.845 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 86.0 m -66.31 -33.15 75.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.257 -0.429 . . . . 1.52 110.891 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.15 -50.73 25.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 1.3 111.031 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -124.07 127.58 48.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 1.6200000000000001 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -78.48 -13.12 59.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 3.2400000000000002 110.938 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -133.76 163.26 29.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.194 -0.457 . . . . 4.6299999999999999 111.028 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 36.5 mm -126.44 143.98 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 2.1800000000000002 110.959 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -133.22 -72.73 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 4.1200000000000001 110.863 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.78 1.5 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 4.96 110.88 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.17 96.05 7.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 3.9100000000000001 110.995 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -136.32 -9.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.501 . . . . 5.21 110.647 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 82.2 p -88.25 -38.89 14.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 1.8200000000000001 111.017 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.88 -42.12 97.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.024 -0.534 . . . . 2.0800000000000001 110.704 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.44 -41.14 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.959 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.36 -14.67 77.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.58999999999999997 112.449 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.82 -46.41 24.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.878 0.37 . . . . 1.53 110.568 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.38 -38.72 68.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 1.1100000000000001 110.555 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 22.5 ttt -66.36 -42.04 88.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.574 -0.739 . . . . 2.21 111.61 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 47.7 t -60.29 -50.14 74.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.792 0.33 . . . . 1.28 111.218 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.718 HG21 HG12 ' C' ' 142' ' ' ILE . 39.9 m -55.29 -36.59 66.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 1.22 111.079 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.552 HE21 HD11 ' C' ' 113' ' ' ILE . 56.3 tp60 -63.74 -46.68 84.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 2.3300000000000001 111.257 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.507 HG22 ' HE1' ' B' ' 46' ' ' TRP . 66.5 mt -52.66 -34.5 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.303 -0.408 . . . . 1.29 110.864 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.95 -53.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.564 . . . . 1.0600000000000001 111.357 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.519 HG12 H182 ' C' ' 210' ' ' LYR . 28.6 t -63.49 -27.73 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 111.37 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.619 HG23 ' HG2' ' C' ' 77' ' ' MET . 22.2 mm -65.43 -50.27 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.206 -0.452 . . . . 1.3700000000000001 111.423 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 92.4 m -54.54 -55.53 28.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.47 -0.332 . . . . 0.77000000000000002 111.044 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 35.4 m -57.38 -21.49 36.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 1.1899999999999999 110.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -61.6 3.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.756 -0.735 . . . . 0.5 112.847 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.41 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -59.85 -22.21 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.702 0.287 . . . . 1.47 110.976 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.41 ' N ' HD12 ' C' ' 117' ' ' LEU . 37.6 mm -81.42 -33.93 12.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.238 -0.437 . . . . 1.2 110.997 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.28 -37.73 48.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.40000000000000002 111.193 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.88 -21.14 28.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.024 -0.535 . . . . 2.1200000000000001 110.946 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.77 28.99 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.431 -0.35 . . . . 0.75 111.025 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 89.4 p -94.71 125.75 39.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 1.3799999999999999 110.783 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.98 -21.2 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 2.7400000000000002 111.245 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.674 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 52.5 ttp180 -114.86 135.83 53.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.382 -0.372 . . . . 2.7999999999999998 110.676 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.01 -11.73 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 2.4100000000000001 111.625 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . 0.674 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 56.6 t90 -81.86 -50.17 9.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 4.2000000000000002 110.845 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' C' ' 124' ' ' ARG . 7.4 p -66.07 -26.61 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 1.0800000000000001 111.015 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -62.37 -21.58 65.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 2.5699999999999998 111.103 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -77.61 -36.8 51.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 3.8100000000000001 110.816 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.424 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.3 mp -76.76 -30.4 56.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.089 -0.505 . . . . 1.4199999999999999 111.38 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -76.07 -42.53 47.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.715 0.293 . . . . 0.89000000000000001 111.362 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -57.67 -50.96 71.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.247 -0.433 . . . . 1.26 110.944 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.5 -27.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 1.6799999999999999 111.25 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.06 -45.03 90.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 1.24 111.105 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.09 47.62 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.846 -0.692 . . . . 0.54000000000000004 112.878 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.96 -31.73 53.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.694 0.257 . . . . 1.0600000000000001 111.694 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.19 -48.79 76.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 1.0800000000000001 111.34 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.6 73.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.56999999999999995 111.301 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.08 -22.64 62.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.035 -0.53 . . . . 1.6799999999999999 111.455 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 70.9 mt -73.44 -53.87 9.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.537 -0.301 . . . . 1.7 111.792 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.434 HG13 ' N ' ' C' ' 142' ' ' ILE . 28.7 pt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.833 0.309 . . . . 0.78000000000000003 111.833 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.718 HG12 HG21 ' C' ' 108' ' ' THR . 8.1 tp -72.47 -31.19 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.773 0.32 . . . . 2.2400000000000002 111.44 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.45 -44.96 95.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 1.02 111.004 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . 0.712 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 71.8 t-105 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 3.0 111.259 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.51 -17.57 77.44 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.751 -0.737 . . . . 1.27 113.165 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.64 -26.34 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.872 0.367 . . . . 1.8899999999999999 110.995 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -73.02 -0.28 13.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 1.6000000000000001 111.912 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.712 ' ND2' ' O ' ' C' ' 144' ' ' TRP . 69.1 m-80 -100.79 -52.05 0.18 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 99.989999999999995 112.124 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' C' ' 148' ' ' ASN . 29.9 Cg_endo -62.8 -20.83 72.24 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.223 1.948 . . . . 2.73 112.732 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.83 45.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 4.2999999999999998 111.231 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -170.68 -46.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 8.9000000000000004 110.895 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.09 -49.62 9.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 2.7999999999999998 111.155 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -71.27 -29.06 64.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 5.4400000000000004 110.923 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' C' ' 162' ' ' ALA . 68.1 p -72.22 -19.14 61.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 3.3900000000000001 111.243 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -66.78 -41.8 87.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 6.9199999999999999 111.048 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 4.9 t -87.93 -27.73 21.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 4.8700000000000001 111.391 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -75.81 -71.33 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.304 -0.407 . . . . 4.0499999999999998 111.16 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.0 m -152.19 121.54 6.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 3.0299999999999998 110.992 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 46.3 t -75.42 -34.82 61.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 2.96 111.096 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.32 -52.0 63.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 3.7400000000000002 110.86 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.79 -24.48 66.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.496 . . . . 2.6499999999999999 111.015 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' C' ' 154' ' ' THR . . . -64.59 -37.69 88.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.093 -0.503 . . . . 1.77 111.047 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -72.46 -42.68 64.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 2.96 110.925 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 87.7 mt -57.54 -47.62 81.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.256 -0.429 . . . . 2.3500000000000001 110.77 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.43 -27.28 63.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.867 -0.606 . . . . 2.6200000000000001 110.862 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.87 -42.49 99.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 2.0899999999999999 110.892 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -81.62 -21.15 38.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 3.2400000000000002 110.722 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 55.6 tp -70.61 -54.59 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 1.6899999999999999 111.355 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.46 -24.04 24.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 1.3999999999999999 111.224 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.9 m -55.05 -59.06 5.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.95999999999999996 111.255 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.12 -26.76 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 3.6499999999999999 110.423 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -70.22 -25.31 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.879 -0.6 . . . . 1.3700000000000001 110.884 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 84.2 m -79.88 -51.69 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.515 . . . . 1.4299999999999999 111.83 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.72 -26.4 34.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 111.925 0.342 . . . . 1.6200000000000001 111.925 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 60.6 tp -83.2 -54.81 4.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.568 -0.287 . . . . 2.0299999999999998 111.299 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -32.41 64.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.4 . . . . 0.62 110.726 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.472 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.3 tt -87.73 -19.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 1.5800000000000001 110.484 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.21 39.76 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.835 -0.62 . . . . 0.56000000000000005 113.034 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.626 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 94.6 m-85 -55.31 -53.8 57.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.807 0.304 . . . . 1.3300000000000001 111.19 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.2 Cg_exo -46.6 -31.6 10.43 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.122 1.881 . . . . 0.63 112.503 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 96.7 mt -66.1 -60.89 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.351 -0.386 . . . . 0.93000000000000005 111.364 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.52 -31.51 49.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.208 -0.451 . . . . 1.27 111.846 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -54.76 -29.03 52.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.568 -0.287 . . . . 1.77 111.469 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 74.5 mt -52.64 -62.44 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 2.3900000000000001 111.237 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 34.6 pt -78.36 172.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.95 111.257 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.04 -165.32 52.08 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.884 -0.674 . . . . 1.8799999999999999 112.625 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.28 163.97 22.02 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.767 2.311 . . . . 3.1200000000000001 112.231 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 47.9 m 59.66 8.91 1.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.186 -0.461 . . . . 2.6299999999999999 110.786 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -123.26 -67.2 0.22 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.084 -0.579 . . . . 3.04 112.237 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -167.06 -28.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.888 0.375 . . . . 5.6900000000000004 110.501 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -83.08 -179.11 52.53 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 3.0800000000000001 112.226 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -126.15 45.29 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.904 0.383 . . . . 7.5300000000000002 110.923 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . 0.487 HG23 ' NE2' ' C' ' 195' ' ' GLN . 28.6 mt -93.66 139.89 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 2.8599999999999999 110.707 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -134.43 13.81 3.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.541 -0.3 . . . . 3.6899999999999999 111.466 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . 0.487 ' NE2' HG23 ' C' ' 193' ' ' ILE . 2.0 mp0 -70.7 154.52 41.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 5.4800000000000004 111.117 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p -67.74 -16.84 64.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 2.3799999999999999 111.223 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt -63.48 -27.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 2.23 110.909 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.02 -48.37 71.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 2.1600000000000001 110.8 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 68.0 p -65.4 -24.99 67.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.27 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -70.56 -36.39 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 1.7 110.883 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.9 tp -76.73 -32.52 57.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 2.02 110.96 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -77.41 -18.93 56.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 1.8200000000000001 110.828 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.5 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.6 m -96.11 -34.27 11.76 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.118 -0.492 . . . . 1.3500000000000001 111.173 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.64 -35.32 72.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.124 -0.489 . . . . 0.65000000000000002 111.586 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.619 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.8 OUTLIER -59.98 -53.78 61.93 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 121.138 -0.225 . . . . 1.4199999999999999 110.813 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 64.7 Cg_exo -52.16 -50.83 12.68 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.197 1.931 . . . . 0.63 112.283 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -63.13 -32.74 74.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.379 -0.373 . . . . 1.49 110.703 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.63 -30.97 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.12 -0.491 . . . . 1.7 110.555 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 88.8 p -93.07 -22.28 19.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 1.25 110.827 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.781 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . 0.436 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.7 p -69.3 -44.76 80.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 1.6100000000000001 110.962 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.436 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -64.3 -28.7 73.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.812 -0.709 . . . . 0.81999999999999995 112.375 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.24 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 3.0800000000000001 110.634 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 45.0 t -60.94 -60.71 3.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 1.1499999999999999 110.85 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -62.8 -20.45 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 2.5600000000000001 111.045 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.93 -56.1 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 1.29 110.757 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.5 -21.13 65.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.329 -0.396 . . . . 2.3900000000000001 111.02 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 68.4 tp -67.27 -51.87 47.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 2.0299999999999998 110.966 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -82.44 -22.49 35.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 3.21 111.01 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.79 -22.55 47.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.899 -0.667 . . . . 1.3600000000000001 112.642 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 33.7 tp -58.86 -56.43 22.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.323 . . . . 2.8999999999999999 110.574 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 56.44 59.19 3.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.522 . . . . 4.8899999999999997 111.561 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 32.5 t30 57.97 108.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.197 -0.456 . . . . 4.2300000000000004 111.614 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 47.2 tp -169.17 93.19 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 6.1200000000000001 110.882 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -127.63 124.95 39.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.047 -0.524 . . . . 4.5499999999999998 110.903 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -134.88 106.92 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 6.7800000000000002 111.055 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.7 t -128.74 98.78 5.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.067 -0.515 . . . . 5.4000000000000004 110.732 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -115.22 -47.56 2.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 8.3300000000000001 110.756 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.453 . . . . 7.9100000000000001 111.007 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.868 0.366 . . . . 5.1100000000000003 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -145.08 34.76 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 5.04 110.711 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.7 mt -80.47 97.32 7.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 5.5800000000000001 110.904 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -143.08 -39.96 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 5.0199999999999996 111.235 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.1 m -63.98 125.72 25.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 2.4500000000000002 111.117 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -114.07 -18.97 11.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.002 -0.545 . . . . 2.4199999999999999 110.76 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.49 -40.81 83.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.0899999999999999 111.094 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.644 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 39.5 m80 -62.12 -35.96 80.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 1.1599999999999999 111.034 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' HG12 ' A' ' 12' ' ' VAL . 50.1 t-105 -69.52 -45.25 69.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.254 -0.43 . . . . 0.79000000000000004 111.186 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mt -68.26 -21.82 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.034 0.445 . . . . 2.0800000000000001 110.457 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -63.95 -54.98 26.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 1.28 110.682 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.3 p -61.64 -31.45 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.314 -0.403 . . . . 1.3200000000000001 111.032 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.23 -54.31 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.63 111.168 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.33 -33.38 75.55 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.974 -0.631 . . . . 0.55000000000000004 112.951 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.8 mmt -70.47 -31.65 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.805 0.303 . . . . 1.03 111.201 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.8 m -63.02 -62.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.43 -0.35 . . . . 1.3 110.995 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -53.46 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.369 -0.378 . . . . 1.3100000000000001 111.181 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -60.28 -43.24 98.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.808 -0.711 . . . . 0.77000000000000002 112.236 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.86 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.865 0.364 . . . . 0.80000000000000004 111.023 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.61 -31.75 69.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 1.8100000000000001 111.078 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -55.89 -24.51 37.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.158 -0.474 . . . . 1.8799999999999999 111.267 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -56.45 -56.51 20.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.477 -0.329 . . . . 4.4500000000000002 111.085 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.643 ' O ' ' OG ' ' A' ' 26' ' ' SER . 86.2 t90 -64.24 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 3.6899999999999999 110.978 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -70.13 -23.77 63.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 1.5700000000000001 111.234 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.4 tp -87.76 -4.29 58.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 1.95 110.918 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 29.2 p -69.82 -20.22 63.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 1.3799999999999999 110.96 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.494 ' HG3' HD22 ' A' ' 28' ' ' ASN . 24.9 tpt180 -50.6 -32.14 17.94 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.63 -0.507 . . . . 4.0700000000000003 109.63 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.494 HD22 ' HG3' ' A' ' 27' ' ' ARG . 6.4 p30 -175.55 132.28 0.43 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.371 -0.831 . . . . 2.7200000000000002 110.464 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 57.4 Cg_endo -96.15 158.21 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.226 2.617 . . . . 1.9099999999999999 112.113 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' CZ ' HD22 ' A' ' 218' ' ' LEU . 83.8 mtt180 -84.51 62.12 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.964 0.411 . . . . 4.7599999999999998 110.99 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.69 -46.98 3.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.952 -0.642 . . . . 1.99 112.446 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.0 m -99.75 145.48 30.21 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.468 0.175 . . . . 2.7000000000000002 110.658 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.25 160.83 12.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.317 2.012 . . . . 1.79 112.378 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -62.16 -16.41 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.801 . . . . 4.1200000000000001 112.077 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -41.41 -37.89 1.13 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.022 0.379 . . . . 2.9300000000000002 112.022 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 2.8799999999999999 110.369 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -68.22 -20.19 64.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.021 -0.536 . . . . 4.6600000000000001 110.282 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' MET . 32.8 tp -61.28 -47.75 84.57 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.266 -0.425 . . . . 1.45 110.002 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.67 -41.93 94.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.127 -0.488 . . . . 1.78 109.842 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -70.47 -6.11 33.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.62 -0.718 . . . . 0.63 110.908 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' LEU . 24.1 ttt -87.95 -36.42 17.1 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.17 -0.468 . . . . 1.48 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -71.3 -33.41 69.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.131 -0.486 . . . . 3.5 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 78.3 mt -50.68 -54.83 31.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.025 0.38 . . . . 1.0800000000000001 112.025 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -70.62 -32.21 15.4 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.234 1.956 . . . . 0.53000000000000003 113.082 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 41' ' ' MET . 24.8 mm -55.32 -62.4 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.717 0.294 . . . . 1.6799999999999999 111.726 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -62.66 -53.88 47.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 1.8300000000000001 111.306 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.48 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 91.3 p -58.48 -14.63 8.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 1.0900000000000001 111.545 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.59 -61.21 2.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.40999999999999998 112.589 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 mt -55.96 -27.57 53.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.704 0.287 . . . . 0.98999999999999999 111.358 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.94 19.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.47999999999999998 111.399 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.2 m-85 -60.86 -38.05 84.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 1.8700000000000001 111.46 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 54.8 ttp -52.04 -40.41 61.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.11 0.481 . . . . 1.49 110.059 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.45 93.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.58999999999999997 110.738 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.402 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 57.6 mtt -52.48 -35.73 53.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.48999999999999999 110.323 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -65.81 -43.88 87.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.968 -0.56 . . . . 0.59999999999999998 110.093 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.567 HG21 HG23 ' B' ' 127' ' ' VAL . 12.1 mt -70.61 -3.6 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.51 -0.768 . . . . 1.3100000000000001 110.814 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.78 32.57 10.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.794 -0.639 . . . . 1.9099999999999999 111.021 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -114.93 127.63 55.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 1.6200000000000001 110.537 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.65 15.15 2.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.821 -0.704 . . . . 1.04 112.394 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -112.34 141.97 45.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 2.6800000000000002 110.909 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -115.47 138.16 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 1.98 111.094 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.25 138.9 37.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.11 -0.496 . . . . 2.1800000000000002 110.871 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.33 104.43 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 1.5700000000000001 111.129 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.11 26.11 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 1.79 111.488 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.35 23.1 32.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 1.48 112.602 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -121.77 127.2 50.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.723 0.297 . . . . 2.3199999999999998 110.678 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -101.84 120.75 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 1.4399999999999999 111.176 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.63 124.58 52.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.062 -0.517 . . . . 0.81999999999999995 110.685 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 74.5 m-70 -70.22 82.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.345 0.593 . . . . 0.90000000000000002 111.161 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -61.92 -50.96 70.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.314 -0.857 . . . . 1.8300000000000001 111.253 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -22.39 66.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.958 -0.565 . . . . 0.62 112.166 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -68.89 -52.09 33.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.195 0.443 . . . . 2.3399999999999999 112.195 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 4.0 p90 -76.67 -34.34 58.25 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.9 -0.32 . . . . 3.4900000000000002 111.244 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.5 mm -52.59 -49.85 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.934 0.397 . . . . 1.3700000000000001 110.532 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 26.7 t70 -65.0 -22.25 66.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.927 -0.578 . . . . 1.3100000000000001 109.877 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -87.08 5.29 38.41 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.803 -0.635 . . . . 1.48 111.254 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.479 ' HG3' HD12 ' A' ' 113' ' ' ILE . 43.2 ttm -104.17 -19.75 14.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 1.46 110.61 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.453 ' O ' HD23 ' A' ' 82' ' ' LEU . 34.7 m -113.98 -32.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 1.1200000000000001 111.746 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 43' ' ' ILE . 28.4 m -79.17 -53.57 6.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.369 -0.378 . . . . 1.1000000000000001 111.904 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.568 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 32.6 m -50.68 -50.39 73.35 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.078 0.399 . . . . 0.59999999999999998 112.078 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 80' ' ' THR . 11.9 Cg_endo -55.71 -41.6 75.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.713 1.609 . . . . 0.73999999999999999 111.547 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 78' ' ' VAL . 3.6 mm? -65.73 -31.79 72.98 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.715 -0.476 . . . . 1.01 109.715 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -66.82 -26.98 67.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.046 -0.724 . . . . 1.48 109.046 178.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' A' ' 109' ' ' GLN . 11.4 tp -81.74 -39.44 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.917 -1.038 . . . . 1.3799999999999999 110.686 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.75 -38.31 90.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.874 -0.603 . . . . 1.1899999999999999 111.046 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -57.27 -23.66 49.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 1.23 111.117 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -73.93 -29.0 61.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.143 -0.48 . . . . 0.88 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.6 t -80.84 -27.15 36.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 1.3899999999999999 111.166 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -79.03 -31.49 44.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.371 . . . . 2.3199999999999998 111.197 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -82.64 -26.36 32.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 1.46 111.519 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.86 -49.46 9.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.398 -0.364 . . . . 1.24 111.192 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.6 mtt -108.14 110.62 22.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 111.176 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.99 -39.26 89.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 3.5299999999999998 110.399 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -114.39 175.72 5.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.778 -0.646 . . . . 4.0800000000000001 110.471 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -130.26 142.58 43.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.44 -0.346 . . . . 2.1699999999999999 111.022 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.15 174.91 9.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 4.5199999999999996 111.272 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -70.61 -59.29 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 3.75 111.045 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.08 130.0 38.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 3.5299999999999998 111.129 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -106.42 92.15 4.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 4.9100000000000001 110.863 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.0 t -113.49 -41.07 3.7 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.413 . . . . 1.98 111.493 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.9 tp -76.92 -41.84 41.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 1.8300000000000001 110.98 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 mm -65.94 -30.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 1.79 111.067 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.19 -40.3 42.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.923 -0.656 . . . . 0.62 112.441 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -63.18 -35.98 82.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 1.5800000000000001 110.88 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.7 -56.75 13.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.97999999999999998 111.176 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 57.1 ttm -56.95 -40.98 77.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.059 -0.519 . . . . 1.48 111.234 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -58.31 -51.86 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 1.1299999999999999 111.278 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 112' ' ' VAL . 68.1 p -60.67 -21.14 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 1.48 111.378 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.538 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 21.7 tp60 -77.25 -30.23 54.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.857 0.361 . . . . 2.7000000000000002 110.76 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.31 -39.53 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 1.54 111.199 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 108' ' ' THR . 33.4 m -67.37 -35.73 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.932 -0.307 . . . . 1.28 111.063 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 108' ' ' THR . 81.8 t -66.26 -52.82 43.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.341 -0.39 . . . . 0.42999999999999999 111.433 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.479 HD12 ' HG3' ' A' ' 77' ' ' MET . 45.7 pt -60.03 -27.66 39.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.728 0.299 . . . . 1.74 111.336 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 30.7 m -63.39 -46.71 85.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.63 111.15 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 p -69.65 -24.85 63.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 1.0900000000000001 110.795 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.566 ' HA3' H181 ' A' ' 210' ' ' LYR . . . -76.98 -32.66 48.49 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.908 -0.663 . . . . 0.41999999999999998 113.217 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.6 pp -80.53 -28.16 37.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.635 0.255 . . . . 1.3799999999999999 111.513 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.531 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.3 tp -83.49 -27.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 1.6200000000000001 110.87 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.78 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.39000000000000001 111.056 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.61 -21.12 60.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 2.02 111.029 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.7 mt -83.13 16.52 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.76000000000000001 110.902 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -75.24 119.85 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 1.46 110.817 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.66 -53.87 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 3.3500000000000001 110.913 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.668 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 53.7 ttp180 -78.26 132.7 37.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 2.9199999999999999 110.606 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.19 -9.38 39.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 2.77 111.485 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.668 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 78.3 t90 -89.51 -52.23 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 3.77 110.915 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.589 HG12 ' HB3' ' A' ' 124' ' ' ARG . 12.4 p -63.02 -23.7 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 1.1599999999999999 111.201 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 189' ' ' GLY . 39.5 ttm180 -55.12 -33.59 63.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 2.04 111.077 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.59 -27.52 45.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 2.6400000000000001 111.242 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 127' ' ' VAL . 4.0 mm? -74.78 -54.21 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 1.8999999999999999 111.315 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -61.43 -32.95 72.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 1.3999999999999999 111.769 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -58.69 -45.44 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 1.28 110.645 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.66 -26.73 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 2.1600000000000001 110.6 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 63.4 m -68.65 -34.11 75.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 1.6899999999999999 110.791 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.57 -51.0 33.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.868 -0.682 . . . . 0.52000000000000002 112.622 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.24 -29.76 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.738 0.304 . . . . 1.02 111.019 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.31 -47.12 87.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 1.0800000000000001 110.8 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.38 -33.42 74.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.62 110.903 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' A' ' 142' ' ' ILE . 80.7 t80 -72.03 -27.18 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.8400000000000001 110.948 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.7 mt -65.15 -54.02 36.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 1.6899999999999999 111.576 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 142' ' ' ILE . 37.8 pt -59.18 -42.2 86.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.355 . . . . 0.81000000000000005 111.827 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.45 ' N ' HG13 ' A' ' 141' ' ' ILE . 29.3 pt -73.02 -22.29 19.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.307 . . . . 2.3700000000000001 111.194 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.72 -40.14 91.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.303 -0.408 . . . . 0.97999999999999998 110.853 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -72.66 -36.43 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 3.27 110.421 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.99 -38.35 95.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.891 -0.671 . . . . 1.25 112.642 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.85 -21.32 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 2.1200000000000001 110.965 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -90.39 4.99 49.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 1.6599999999999999 111.174 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.479 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 51.5 t30 -60.72 -45.5 96.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.875 -0.602 . . . . 99.989999999999995 111.927 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.55 ' HA ' ' HB3' ' A' ' 152' ' ' ALA . 50.7 Cg_exo -55.33 -4.66 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.437 2.091 . . . . 2.6000000000000001 113.32 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.9 tp -50.64 -73.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.894 0.378 . . . . 4.6100000000000003 110.957 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -96.95 -9.73 27.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 8.3599999999999994 110.734 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 149' ' ' PRO . . . -67.11 -17.16 64.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.598 . . . . 2.75 111.127 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -46.7 -27.08 1.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 5.6799999999999997 111.648 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.3 p -78.31 -39.6 39.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 3.21 111.48 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -81.4 -14.45 57.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 6.8700000000000001 111.335 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 49.3 p -84.94 7.08 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.486 -0.325 . . . . 4.5599999999999996 111.255 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 62.69 -80.3 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.183 -0.462 . . . . 3.5600000000000001 111.515 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.4 t -58.73 112.55 1.67 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.841 0.353 . . . . 2.79 111.122 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.8 t -79.03 -37.82 38.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 2.5899999999999999 111.195 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.49 -50.52 73.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.338 -0.392 . . . . 3.4700000000000002 111.207 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -59.51 -39.14 82.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 111.021 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.04 -31.87 73.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.78 111.231 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -70.73 -39.48 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 2.6299999999999999 110.946 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 66.5 mt -61.18 -37.64 83.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.204 -0.453 . . . . 2.3399999999999999 110.839 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -77.88 -23.55 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.063 -0.517 . . . . 2.77 110.981 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.1 -42.13 94.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 2.04 110.839 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -83.99 -24.11 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 2.77 110.765 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.83 -51.55 61.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 1.8899999999999999 111.211 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.69 -25.75 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 1.6399999999999999 111.353 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.0 m -53.05 -59.15 4.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.871 0.367 . . . . 1.24 111.469 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.451 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 11.2 t80 -68.11 -31.6 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 2.9700000000000002 110.424 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.49 -23.42 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 1.48 111.136 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 -49.81 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 1.55 111.573 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 171' ' ' TYR . 22.5 m -58.75 -29.17 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.561 -0.29 . . . . 1.52 111.738 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 209' ' ' SER . 69.3 mt -77.72 -58.11 3.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.831 0.348 . . . . 1.8500000000000001 111.017 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.63 -23.18 58.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.534 . . . . 0.62 110.777 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 181' ' ' ILE . 10.9 mm -88.07 -29.36 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 1.3500000000000001 110.362 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.23 -52.31 48.18 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.767 -0.651 . . . . 0.58999999999999997 113.766 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.679 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 73.8 m-85 -58.64 -55.38 46.6 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.01 0.405 . . . . 1.45 111.952 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 73.1 Cg_exo -49.06 -28.03 13.17 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.136 1.89 . . . . 0.55000000000000004 112.738 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 184' ' ' ILE . 95.0 mt -71.72 -59.96 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 1.4199999999999999 111.125 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 179' ' ' TYR . 20.4 m -58.17 -24.58 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.379 -0.373 . . . . 0.78000000000000003 111.7 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -64.11 -17.46 63.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.064 0.394 . . . . 0.93999999999999995 112.064 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.702 HG13 HG23 ' A' ' 185' ' ' ILE . 19.3 pt -69.74 -9.79 12.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.988 -0.285 . . . . 1.4299999999999999 111.57 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.702 HG23 HG13 ' A' ' 184' ' ' ILE . 42.4 pt -134.09 146.77 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 2.02 111.092 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 98.15 -160.83 20.74 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.919 -0.658 . . . . 1.79 112.47 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.51 150.13 84.2 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.573 2.182 . . . . 3.1000000000000001 111.942 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 71.0 m 56.24 23.57 7.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 2.7400000000000002 110.68 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.412 ' N ' ' HD3' ' A' ' 128' ' ' ARG . . . -169.0 43.81 0.22 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.883 -0.675 . . . . 3.4300000000000002 112.692 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 58.13 89.9 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.756 0.312 . . . . 6.5 111.063 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.28 138.49 5.67 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.791 -0.719 . . . . 3.29 112.371 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -102.75 25.19 9.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.764 0.316 . . . . 6.1600000000000001 111.03 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.9 pt -128.97 149.51 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.284 -0.416 . . . . 2.4199999999999999 111.169 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -156.77 51.64 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 4.29 110.305 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.545 ' HG3' ' H ' ' A' ' 196' ' ' THR . 4.3 tp-100 -113.31 -179.53 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.856 -0.611 . . . . 5.1500000000000004 110.587 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.545 ' H ' ' HG3' ' A' ' 195' ' ' GLN . 65.8 p -55.55 -26.95 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.688 0.255 . . . . 2.4500000000000002 111.688 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 18.3 tt -55.76 -37.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.807 0.337 . . . . 2.48 111.473 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.9 -54.5 44.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 2.1800000000000002 110.904 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.3 p -63.07 -30.27 71.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 1.49 111.021 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -56.75 -38.08 71.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.77 111.163 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 63.0 tp -75.77 -40.51 55.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 1.4199999999999999 111.511 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -76.99 -6.1 51.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.701 0.26 . . . . 1.78 111.701 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 60.5 m -96.12 -39.96 9.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.915 0.388 . . . . 1.3 110.911 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.75 -35.79 65.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.66000000000000003 111.922 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.673 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.7 tp -58.72 -53.99 60.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.965 -0.294 . . . . 1.6299999999999999 111.252 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 32.1 Cg_exo -58.93 -37.2 94.82 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.683 1.589 . . . . 0.64000000000000001 111.274 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -63.33 -34.16 77.1 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 116.021 -0.536 . . . . 1.3600000000000001 110.13 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -72.25 -24.23 61.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.625 . . . . 1.54 110.472 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.462 ' HB2' HD22 ' A' ' 175' ' ' LEU . 29.8 t -95.65 -19.16 19.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.924 -0.58 . . . . 1.2 111.007 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.769 H183 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 24.5 t -67.96 -33.8 63.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.22 -0.446 . . . . 1.6399999999999999 111.342 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.32 71.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.583 -0.818 . . . . 0.79000000000000004 112.408 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -76.34 -34.18 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.62 0.248 . . . . 1.6100000000000001 111.178 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 85.2 p -63.14 -52.22 63.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 1.1499999999999999 110.912 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -62.12 -30.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 3.3399999999999999 110.346 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.5 -47.86 74.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 1.1899999999999999 110.632 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.72 -33.93 68.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.23 111.278 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.411 HD22 ' CZ ' ' A' ' 30' ' ' ARG . 90.3 mt -62.89 -47.27 84.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 2.4700000000000002 111.372 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -74.12 -27.68 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 1.6200000000000001 111.058 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.86 63.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 1.4099999999999999 112.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.77 -37.85 83.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.588 0.232 . . . . 2.5800000000000001 111.294 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.484 ' HA ' ' NE ' ' A' ' 222' ' ' ARG . 5.9 tpm_? 63.73 -80.97 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.008 -0.542 . . . . 4.9299999999999997 111.277 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -147.09 -85.25 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.376 -0.375 . . . . 4.6299999999999999 110.914 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.6 mt 63.82 130.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.185 -0.461 . . . . 6.4699999999999998 111.377 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -124.0 137.71 54.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 5.0700000000000003 110.8 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -139.85 146.41 39.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.411 . . . . 6.5300000000000002 110.962 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.8 m -148.92 111.95 4.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.034 -0.53 . . . . 5.2199999999999998 110.709 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -96.39 -53.38 3.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 8.3599999999999994 110.978 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 7.96 110.876 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.904 0.383 . . . . 6.1699999999999999 110.755 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' B' ' 4' ' ' GLU . 3.1 t-20 -91.59 95.34 9.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 4.8200000000000003 110.662 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.449 ' N ' HD12 ' B' ' 3' ' ' LEU . 6.9 mp -94.52 2.29 55.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 5.5999999999999996 111.324 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.473 ' HB2' HD21 ' B' ' 2' ' ' ASN . 46.1 mt-10 -67.51 -169.98 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.313 -0.403 . . . . 4.7999999999999998 110.751 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.1 t 62.63 92.66 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.181 -0.463 . . . . 2.3700000000000001 111.023 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.466 ' N ' HD12 ' B' ' 6' ' ' LEU . 5.9 mp -105.32 1.31 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 2.0699999999999998 110.746 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 62.5 tp -68.12 -41.15 82.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 2.1000000000000001 110.426 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.7 m80 -61.92 -31.81 72.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.134 -0.485 . . . . 1.0700000000000001 110.474 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -69.79 -44.72 69.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.96 -0.564 . . . . 1.48 110.458 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.89 -20.72 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 2.02 110.119 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.98 -54.64 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.92000000000000004 110.61 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.45 -32.63 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.93999999999999995 111.08 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -53.17 61.23 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.199 -0.455 . . . . 0.55000000000000004 111.037 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.47 -27.34 69.38 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.891 -0.671 . . . . 0.47999999999999998 112.461 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' B' ' 44' ' ' PRO . 22.9 mmt -73.53 -26.9 61.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.696 0.284 . . . . 0.84999999999999998 111.033 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 63.2 m -69.32 -54.32 15.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 1.3400000000000001 110.983 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -60.49 -27.42 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 1.55 111.17 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.73 -51.71 53.87 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.535 -0.841 . . . . 0.69999999999999996 112.245 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.16 68.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.936 0.398 . . . . 0.81000000000000005 111.165 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.37 -31.54 71.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 2.2599999999999998 110.85 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -61.05 -21.94 64.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 1.78 110.978 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.27 -35.67 81.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 4.5800000000000001 110.992 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -80.3 -32.85 37.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 3.3500000000000001 111.082 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 88.8 p -77.3 -19.95 55.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 1.5800000000000001 111.353 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 tp -87.43 -1.76 58.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.819 0.342 . . . . 1.8400000000000001 110.958 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 100.0 p -73.39 -19.52 60.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 1.3700000000000001 110.833 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -52.09 -30.72 27.38 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.691 -0.485 . . . . 4.9800000000000004 109.691 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.7 p-10 -174.19 131.83 0.52 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.44 -0.8 . . . . 2.1400000000000001 110.319 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 56.9 Cg_endo -97.29 172.66 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.175 2.583 . . . . 1.8200000000000001 111.892 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -94.5 58.74 2.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.407 . . . . 5.1900000000000004 110.661 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -45.82 3.46 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.007 -0.616 . . . . 2.2000000000000002 112.375 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.436 HG13 HD21 ' B' ' 224' ' ' LEU . 34.2 m -101.7 147.03 33.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 O-C-N 122.977 -0.131 . . . . 3.6499999999999999 110.739 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -54.28 163.5 3.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.058 . . . . 2.6699999999999999 112.516 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -64.99 -17.47 64.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.554 -0.748 . . . . 4.8799999999999999 111.922 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -41.6 -34.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.009 0.374 . . . . 1.8700000000000001 112.009 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -62.29 -53.43 55.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 2.6800000000000002 110.334 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -66.48 -19.58 65.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.903 -0.589 . . . . 2.9199999999999999 110.458 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' B' ' 41' ' ' MET . 8.5 tt -59.86 -47.71 84.62 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.659 -0.497 . . . . 1.6399999999999999 109.659 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 52.2 t -62.79 -39.87 86.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.524 -0.547 . . . . 1.6000000000000001 109.524 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.34 -5.89 39.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.663 -0.699 . . . . 0.68999999999999995 110.663 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.535 ' O ' ' HD2' ' B' ' 44' ' ' PRO . 26.6 ttt -88.72 -31.32 18.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.029 -0.532 . . . . 2.5800000000000001 110.455 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -75.47 -34.22 60.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 3.3900000000000001 111.105 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.625 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 67.6 mt -54.21 -51.84 74.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.962 0.356 . . . . 0.40999999999999998 111.962 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 12.2 Cg_exo -70.79 -33.72 12.26 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.637 2.225 . . . . 0.48999999999999999 113.132 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.445 HG12 ' O ' ' B' ' 41' ' ' MET . 24.4 mm -57.28 -62.15 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 111.749 0.278 . . . . 1.29 111.749 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.439 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.0 OUTLIER -59.05 -54.28 48.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.805 0.335 . . . . 1.3999999999999999 111.081 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -55.33 -28.79 56.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 1.3799999999999999 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.99 -58.04 14.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 0.37 112.74 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.22 -29.61 67.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 1.29 111.101 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -52.25 60.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.219 -0.446 . . . . 0.44 111.228 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 22.4 m-85 -64.65 -39.36 93.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.5 111.198 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . 0.436 ' SD ' HD11 ' B' ' 56' ' ' ILE . 12.5 tmm? -49.61 -40.8 40.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.214 0.53 . . . . 1.4099999999999999 110.052 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.58 91.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.679 -0.691 . . . . 0.55000000000000004 110.821 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtt -52.56 -32.27 40.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.5 110.197 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -69.37 -42.64 74.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.957 -0.565 . . . . 0.54000000000000004 110.213 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.436 HD11 ' SD ' ' B' ' 52' ' ' MET . 12.0 mt -75.67 1.89 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 1.3 110.567 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t70 66.16 46.75 2.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.642 -0.708 . . . . 2.2400000000000002 110.714 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.42 ' CD ' HG21 ' C' ' 127' ' ' VAL . 14.6 mm100 -115.72 168.84 9.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.77 110.954 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 83.65 23.69 52.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 1.0600000000000001 112.466 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.12 142.96 46.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 2.6600000000000001 110.799 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.63 147.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 1.8899999999999999 111.265 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.59 142.51 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 2.4100000000000001 110.762 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.82 98.85 1.37 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 1.5600000000000001 111.299 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.18 29.27 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.04 -0.527 . . . . 1.8200000000000001 111.422 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.94 16.48 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 1.51 112.597 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -116.48 121.29 41.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 2.4500000000000002 110.896 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.69 123.08 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 1.79 111.093 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.97 129.7 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.81999999999999995 111.238 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.505 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 87.9 m-70 -73.03 81.36 1.22 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.05 110.619 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -62.03 -35.4 78.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 1.8700000000000001 111.586 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -78.85 -22.56 45.92 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.311 0.486 . . . . 0.60999999999999999 112.311 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.505 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 12.8 tpp180 -69.85 -51.32 34.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.132 0.419 . . . . 2.3900000000000001 112.132 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.501 ' O ' ' HG3' ' B' ' 77' ' ' MET . 8.2 p90 -76.3 -38.11 56.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.861 0.319 . . . . 3.6699999999999999 111.861 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.461 HG23 ' N ' ' B' ' 75' ' ' ASP . 11.1 tp -54.04 -44.4 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 1.6599999999999999 110.991 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.461 ' N ' HG23 ' B' ' 74' ' ' ILE . 24.7 t70 -67.22 -21.8 65.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.495 -0.557 . . . . 1.4099999999999999 109.495 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -85.9 4.92 35.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.514 -0.766 . . . . 1.1599999999999999 111.267 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' B' ' 73' ' ' TYR . 42.5 mtp -104.83 -18.99 14.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.232 -0.44 . . . . 1.53 110.939 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.516 ' O ' HD23 ' B' ' 82' ' ' LEU . 33.4 m -114.54 -31.65 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.89000000000000001 111.876 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.599 HG23 HG23 ' B' ' 43' ' ' ILE . 60.9 m -79.47 -57.18 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 1.24 112.035 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.549 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 11.0 m -50.42 -50.13 73.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.192 0.442 . . . . 0.57999999999999996 112.192 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.7 Cg_exo -53.91 -42.49 66.18 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 121.832 1.688 . . . . 0.66000000000000003 111.64 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.516 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -66.97 -29.45 69.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.159 -0.473 . . . . 1.0600000000000001 110.036 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.538 HD22 ' H43' ' B' ' 210' ' ' LYR . 19.0 tp -70.19 -20.98 63.09 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.176 -0.676 . . . . 1.22 109.176 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' B' ' 109' ' ' GLN . 14.9 tp -83.86 -39.89 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.1 -0.954 . . . . 1.53 109.985 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 22.1 tp -66.94 -35.34 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.343 -0.844 . . . . 1.5800000000000001 111.025 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -60.08 -21.78 61.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 1.3899999999999999 110.804 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.2 -27.21 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 1.1499999999999999 110.7 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -76.74 -33.1 58.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.964 -0.562 . . . . 1.5700000000000001 110.783 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -80.05 -31.77 39.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 2.1699999999999999 110.801 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 88.6 m -72.98 -38.48 66.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 1.4199999999999999 111.067 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.29 -46.43 12.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 1.1799999999999999 111.034 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 80.4 mtp -103.39 120.89 41.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.8799999999999999 111.047 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -75.52 -30.94 59.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 3.4199999999999999 110.574 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -124.63 179.44 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.907 -0.588 . . . . 4.0599999999999996 110.664 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 9.8 tp -132.25 148.31 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 2.0899999999999999 111.25 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.2 161.26 14.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.041 -0.527 . . . . 3.8500000000000001 110.936 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -84.37 44.51 1.04 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.109 -0.496 . . . . 4.8200000000000003 111.089 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -149.13 113.57 5.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 3.7999999999999998 110.679 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -82.93 78.72 9.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.189 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.8 m -120.93 -59.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.304 -0.407 . . . . 2.02 111.542 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.15 -61.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 2.0899999999999999 111.443 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.8 pt -55.33 -38.09 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.8799999999999999 111.57 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.84 -43.81 98.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.869 -0.681 . . . . 0.56000000000000005 112.798 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -63.21 -36.0 82.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.282 . . . . 1.78 110.985 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.45 -53.47 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 1.03 111.118 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 87.7 mtp -57.95 -36.26 72.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 1.6699999999999999 111.042 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 57.6 m -65.32 -54.43 29.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 1.51 111.12 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.434 ' HB ' HD13 ' B' ' 142' ' ' ILE . 47.4 p -53.98 -26.14 24.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 1.1799999999999999 111.292 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.461 ' HB2' HD22 ' B' ' 84' ' ' LEU . 6.4 tp-100 -71.61 -40.99 69.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 2.1699999999999999 110.709 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.99 -32.07 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 1.3500000000000001 110.973 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.3 t -71.13 -43.01 75.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 1.3400000000000001 111.264 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.62 -55.4 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.42999999999999999 111.515 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.7 pt -54.32 -33.17 25.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.51 -0.314 . . . . 1.6000000000000001 111.269 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 42.9 m -60.87 -40.77 94.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.337 -0.392 . . . . 0.85999999999999999 110.607 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.1 m -61.54 -59.8 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.94999999999999996 110.365 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.535 ' HA3' H181 ' B' ' 210' ' ' LYR . . . -60.66 -16.33 44.74 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.781 -0.723 . . . . 0.46000000000000002 112.431 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.96 -61.84 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 1.75 110.702 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 mt -84.04 -20.41 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 1.78 111.759 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.95 57.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.779 0.323 . . . . 0.38 110.956 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.424 ' HA ' ' OG ' ' B' ' 188' ' ' SER . 24.8 t70 -82.97 -19.65 36.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 1.97 110.822 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.56 22.83 1.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.76000000000000001 111.107 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.4 p -70.97 124.51 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 1.47 110.921 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -99.9 -41.71 7.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 2.5 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.572 ' HB2' HG12 ' B' ' 127' ' ' VAL . 80.3 mtp180 -94.5 140.05 30.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 2.73 111.033 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.13 -19.14 62.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 2.2000000000000002 110.95 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -79.03 -54.02 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 3.3999999999999999 110.894 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' B' ' 124' ' ' ARG . 10.6 p -62.06 -23.66 32.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.23 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -51.95 -41.38 62.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 3.04 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -77.06 -28.56 54.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.292 -0.413 . . . . 4.1399999999999997 111.16 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' B' ' 127' ' ' VAL . 93.7 mt -70.48 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 1.6499999999999999 111.137 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -56.21 -32.39 64.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 0.77000000000000002 111.151 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -60.43 -42.6 96.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.911 0.386 . . . . 1.46 110.52 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.76 -28.87 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 110.653 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.7 t -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.895 -0.593 . . . . 1.4199999999999999 110.724 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.28 23.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 0.48999999999999999 112.501 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.42 -30.42 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.789 0.328 . . . . 1.3 111.137 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.55 -40.48 94.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 1.3 110.765 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.19 78.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.62 110.978 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -73.76 -22.72 59.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.74 110.694 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -56.46 10.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.689 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.402 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.7 pt -60.48 -40.86 85.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.68999999999999995 111.441 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.434 HD13 ' HB ' ' B' ' 108' ' ' THR . 67.3 mt -68.84 -28.86 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.475 -0.329 . . . . 1.76 110.715 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.5 -42.29 99.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0600000000000001 110.979 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . 0.412 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 94.4 m95 -72.31 -27.31 62.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 4.1200000000000001 110.808 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . 1.006 ' HA2' HD21 ' B' ' 148' ' ' ASN . . . -76.16 -27.45 62.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 1.26 112.716 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.44 -13.49 8.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.771 0.32 . . . . 1.98 111.286 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -99.93 4.67 45.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 1.4199999999999999 111.212 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 1.006 HD21 ' HA2' ' B' ' 145' ' ' GLY . 69.1 m-80 -63.08 -43.44 81.52 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 112.069 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' B' ' 152' ' ' ALA . 82.7 Cg_exo -50.39 -11.03 0.3 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.502 2.134 . . . . 2.6499999999999999 113.494 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 69.8 tp -50.35 -80.5 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.735 0.303 . . . . 4.3899999999999997 111.171 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -89.65 1.54 55.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.937 0.399 . . . . 7.9000000000000004 110.635 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' B' ' 149' ' ' PRO . . . -82.13 -17.08 47.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.566 . . . . 2.77 110.963 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -49.32 -30.23 7.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.972 -0.558 . . . . 6.29 112.003 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 8.8 t -70.95 -35.13 72.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 3.1000000000000001 110.917 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -83.08 -17.63 42.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 6.4299999999999997 110.976 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 76.5 p -84.47 6.9 21.66 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.359 -0.382 . . . . 4.5700000000000003 111.66 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 62.94 -82.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.367 -0.379 . . . . 3.8300000000000001 111.517 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.537 ' HB2' HD23 ' B' ' 161' ' ' LEU . 75.4 p -55.56 113.18 1.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.905 0.383 . . . . 3.0699999999999998 111.182 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 49.0 m -78.14 -46.47 20.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.996 -0.547 . . . . 3.4300000000000002 111.026 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -52.95 -56.47 15.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.187 -0.461 . . . . 3.9199999999999999 111.426 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 158' ' ' SER . 3.8 mm? -55.21 -35.8 65.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.905 0.383 . . . . 2.7000000000000002 110.965 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.09 -31.56 70.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 1.8300000000000001 111.163 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -71.77 -41.27 68.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 2.6299999999999999 110.858 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 56.2 mt -58.43 -37.15 74.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.15 -0.477 . . . . 2.4300000000000002 110.824 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.19 -31.64 58.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.749 -0.66 . . . . 2.5800000000000001 111.287 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.44 -42.06 91.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 2.0 110.968 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -83.42 -22.52 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 3.0299999999999998 110.982 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.68 -44.63 77.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 1.1000000000000001 110.926 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.57 -25.68 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 1.75 111.336 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 51.0 m -51.26 -59.13 4.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.97999999999999998 111.367 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -67.2 -34.61 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 4.2999999999999998 110.482 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -63.25 -22.21 66.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 1.3899999999999999 111.003 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.454 ' O ' HG22 ' B' ' 177' ' ' ILE . 48.0 m -79.73 -56.99 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 1.1100000000000001 111.721 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.08 -29.39 15.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.365 0.506 . . . . 1.51 112.365 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 209' ' ' SER . 57.9 tp -79.87 -57.92 3.42 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.891 0.377 . . . . 1.75 111.29 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -56.3 -29.54 61.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.02 -0.537 . . . . 0.59999999999999998 111.04 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.454 HG22 ' O ' ' B' ' 173' ' ' THR . 9.4 tp -87.91 -21.79 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.064 0.459 . . . . 1.47 110.438 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.98 -54.94 33.49 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.789 -0.642 . . . . 0.55000000000000004 113.129 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 96.3 m-85 -56.41 -54.14 56.4 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.816 0.308 . . . . 1.6200000000000001 111.763 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 84.7 Cg_exo -46.75 -32.32 11.98 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.223 1.949 . . . . 0.64000000000000001 112.612 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 177' ' ' ILE . 91.0 mt -67.93 -60.81 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 1.27 111.577 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 179' ' ' TYR . 29.0 m -58.97 -24.71 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.68999999999999995 111.861 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -62.69 -20.05 64.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.52 -0.309 . . . . 1.1799999999999999 111.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 32.7 mm -54.44 -49.9 61.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 1.77 110.794 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.454 ' HA ' ' HB3' ' B' ' 190' ' ' PHE . 15.0 pt -95.5 178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.017 -0.538 . . . . 1.6899999999999999 111.294 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 73.93 -162.31 54.29 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.887 -0.673 . . . . 1.5800000000000001 112.505 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.67 154.62 64.02 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.634 2.223 . . . . 2.5099999999999998 112.238 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' B' ' 120' ' ' ASP . 46.6 m 58.78 14.95 3.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 3.5800000000000001 110.903 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -135.93 -85.56 0.2 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.994 -0.622 . . . . 4.0300000000000002 112.111 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' B' ' 185' ' ' ILE . 83.6 t80 -113.25 -53.13 2.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.892 0.377 . . . . 6.8899999999999997 110.509 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 100.7 123.7 5.2 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.785 -0.721 . . . . 3.7000000000000002 112.847 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -171.87 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 7.5 110.669 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.624 HD13 ' H ' ' B' ' 193' ' ' ILE . 0.2 OUTLIER -139.81 177.75 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 2.3500000000000001 111.078 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -168.49 16.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 3.8599999999999999 110.771 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -85.43 -164.13 0.96 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 5.0499999999999998 111.076 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 52.9 p -66.78 -20.76 66.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 2.6800000000000002 111.343 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 14.1 tt -59.67 -40.46 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.396 . . . . 2.4700000000000002 111.432 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.07 -49.42 77.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.389 . . . . 2.5299999999999998 110.869 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 63.4 p -68.98 -23.27 64.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 1.29 110.896 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.98 -36.8 83.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.057 -0.52 . . . . 2.6200000000000001 111.19 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.26 -45.83 53.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.387 -0.37 . . . . 1.6100000000000001 111.218 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -75.52 -3.43 34.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.745 0.307 . . . . 1.4199999999999999 111.349 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 43.8 t -96.31 -43.47 7.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.279 0.561 . . . . 1.4299999999999999 110.289 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 66.5 tp -71.93 -39.48 69.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.444 -0.798 . . . . 1.1200000000000001 112.055 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.58 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -55.97 -54.77 48.64 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.237 -0.185 . . . . 1.26 111.384 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -56.16 -41.51 75.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.885 1.723 . . . . 0.59999999999999998 111.559 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.61 -31.78 73.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.247 -0.433 . . . . 1.3999999999999999 110.288 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -66.68 -27.49 67.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 1.4099999999999999 110.572 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.44 ' HB2' HD13 ' B' ' 175' ' ' LEU . 17.3 t -97.04 -27.82 14.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 1.3200000000000001 111.053 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.756 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 46.7 t -73.37 -33.52 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 1.6899999999999999 110.997 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.27 -30.66 74.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.79000000000000004 112.549 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -74.74 -29.87 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 2.96 110.753 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.1 t -63.0 -59.93 4.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 1.29 110.74 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.79 -28.89 67.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 3.1499999999999999 110.823 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.74 -43.36 89.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 1.51 110.567 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.08 -22.24 65.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 2.1899999999999999 110.873 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.4 tp -69.62 -51.51 34.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 1.98 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -78.09 -30.94 49.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 2.1699999999999999 111.302 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.66 80.43 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.792 -0.718 . . . . 1.3600000000000001 112.933 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 55.1 tp -73.28 -35.69 66.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 2.8999999999999999 111.012 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 58.44 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.99 -0.55 . . . . 5.6100000000000003 111.356 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -171.59 151.14 2.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.495 -0.321 . . . . 4.04 110.918 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.468 HD23 ' N ' ' B' ' 224' ' ' LEU . 2.5 pt? -170.14 142.54 2.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.341 -0.391 . . . . 6.2999999999999998 110.77 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -105.42 140.1 39.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.493 . . . . 4.7999999999999998 111.179 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -149.14 117.82 6.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.032 -0.531 . . . . 6.3899999999999997 110.756 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 64.2 m -125.46 113.38 17.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 5.6100000000000003 111.156 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -105.92 -26.31 11.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 8.1999999999999993 110.583 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 8.1699999999999999 110.924 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.888 0.375 . . . . 5.6200000000000001 110.732 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -134.96 69.37 1.45 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 5.2800000000000002 111.09 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.55 94.0 4.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 6.0499999999999998 110.914 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -140.45 -34.41 0.53 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.142 -0.481 . . . . 4.79 110.853 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 48.8 m -66.48 99.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 2.71 110.844 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt -97.12 13.57 28.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.52 110.927 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 94.3 mt -81.11 -45.16 16.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 1.9299999999999999 111.257 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 60.8 m-70 -64.65 -26.08 68.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.931 0.396 . . . . 1.26 110.475 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.453 ' O ' HG12 ' C' ' 12' ' ' VAL . 62.0 t-105 -72.58 -47.75 45.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 1.6699999999999999 110.059 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.05 -20.8 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.358 0.599 . . . . 1.8700000000000001 109.503 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -59.9 4.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.224 -0.898 . . . . 1.4399999999999999 110.69 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' C' ' 52' ' ' MET . 14.0 p -58.58 -32.81 46.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.19 -0.459 . . . . 0.46999999999999997 111.035 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.62 41.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.58999999999999997 111.015 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.07 -21.78 68.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.5 112.189 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 8.2 mmt -73.54 -35.85 65.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.676 0.274 . . . . 0.68000000000000005 110.952 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 59.8 p -66.46 -53.06 39.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 1.3999999999999999 111.185 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . 0.412 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.7 pp -59.98 -26.09 34.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.36 . . . . 1.55 111.016 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.412 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -66.97 -39.51 93.26 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.763 -0.732 . . . . 0.70999999999999996 112.418 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' C' ' 41' ' ' MET . . . -72.67 -28.29 62.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.77000000000000002 110.926 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 28.4 tp -68.49 -29.93 68.65 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 1.9299999999999999 110.516 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -59.19 -22.14 60.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 1.8600000000000001 110.414 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -58.19 -53.73 55.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.018 -0.537 . . . . 4.1399999999999997 110.91 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -60.81 -38.8 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 3.1499999999999999 110.479 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 63.3 m -69.69 -19.56 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 1.95 110.67 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 23.7 mt -80.1 -0.39 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 2.2200000000000002 111.554 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 48.8 p -57.56 -52.04 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.911 -0.316 . . . . 1.3700000000000001 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.74 -27.41 69.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 122.158 0.98 . . . . 5.0300000000000002 108.508 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.767 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 12.7 m120 -70.32 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 113.473 -1.694 . . . . 2.3700000000000001 108.892 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.767 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 5.8 Cg_exo 10.16 96.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.763 2.976 . . . . 2.0499999999999998 117.093 -174.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -109.65 131.61 54.9 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.421 -1.263 . . . . 4.5199999999999996 108.226 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.08 -43.09 3.19 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.005 -1.238 . . . . 2.1600000000000001 110.005 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.536 ' O ' ' HB3' ' C' ' 29' ' ' PRO . 3.3 p -125.66 112.22 25.21 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.331 -0.988 . . . . 2.5299999999999998 108.331 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.82 167.54 21.05 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.038 2.492 . . . . 1.9299999999999999 115.543 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . 0.628 ' HG3' ' HG2' ' C' ' 29' ' ' PRO . 1.4 mp0 -60.93 -14.47 22.7 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 113.435 -1.712 . . . . 4.1200000000000001 112.82 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' C' ' 38' ' ' LEU . 20.8 p90 -39.22 -36.31 0.32 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.708 0.29 . . . . 2.8900000000000001 111.604 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -64.91 -48.35 74.48 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.251 0.548 . . . . 2.46 109.572 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' C' ' 34' ' ' GLN . 33.7 t80 -68.56 -20.48 64.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 2.7799999999999998 110.291 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' C' ' 35' ' ' TYR . 56.1 tp -59.03 -48.29 82.13 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.571 -0.529 . . . . 1.6200000000000001 109.571 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.57 -41.27 91.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.82 -0.627 . . . . 1.5900000000000001 109.581 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -70.87 -6.07 35.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.591 -0.732 . . . . 0.65000000000000002 110.703 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.534 ' HG3' ' HA ' ' C' ' 19' ' ' ALA . 51.0 ttp -88.64 -34.14 17.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.153 -0.476 . . . . 1.6699999999999999 110.519 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' C' ' 45' ' ' ILE . 61.8 t80 -72.43 -30.07 64.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 3.4199999999999999 110.571 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.612 HG23 HG23 ' C' ' 79' ' ' THR . 93.3 mt -54.89 -54.81 45.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.89000000000000001 111.548 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.485 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.6 Cg_endo -71.22 -28.64 18.36 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.224 1.949 . . . . 0.40999999999999998 113.176 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' C' ' 42' ' ' PHE . 80.0 mt -58.1 -62.72 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.623 0.249 . . . . 1.76 111.58 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -55.42 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.418 -0.356 . . . . 2.1600000000000001 111.084 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 85.8 p -52.01 -39.04 58.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 1.1699999999999999 111.303 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.44 -55.14 28.35 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.925 -0.655 . . . . 0.44 112.923 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' C' ' 52' ' ' MET . 69.6 mt -57.04 -29.91 63.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.946 0.403 . . . . 1.29 110.829 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -70.42 -35.73 73.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.136 -0.483 . . . . 0.5 111.05 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 49.6 m-85 -71.39 -52.45 18.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 1.8300000000000001 111.466 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . 0.561 ' HB3' HG11 ' C' ' 12' ' ' VAL . 23.8 ptm -49.53 -34.69 17.99 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.882 0.372 . . . . 1.47 110.498 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.07 88.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.59999999999999998 110.727 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 54.2 mtt -52.27 -33.86 43.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.836 -0.62 . . . . 0.83999999999999997 110.553 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.32 83.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.65000000000000002 110.705 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.465 HG21 HG23 ' A' ' 127' ' ' VAL . 10.2 mm -72.64 -4.75 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.509 . . . . 1.55 110.697 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 66.55 35.61 5.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.7 . . . . 1.54 110.815 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -118.35 138.21 52.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 1.79 110.641 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.39 16.83 5.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.847 -0.692 . . . . 0.93999999999999995 112.495 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' C' ' 60' ' ' LYS . 3.3 mptp? -114.67 137.8 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 2.3599999999999999 110.606 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.05 142.56 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.97 111.016 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.27 139.63 42.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.081 -0.509 . . . . 2.4399999999999999 110.915 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.85 102.09 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 1.54 111.072 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.33 30.57 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 1.71 111.24 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.66 21.4 40.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 1.53 112.783 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 118.95 31.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.687 0.28 . . . . 2.23 110.609 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -97.18 120.11 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 1.3600000000000001 111.105 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.49 141.92 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.78000000000000003 111.108 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 55.3 m-70 -80.68 82.06 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.08 0.467 . . . . 1.0800000000000001 110.864 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -67.65 -32.72 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.797 -0.638 . . . . 2.2999999999999998 111.392 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.57 -24.99 41.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.288 0.477 . . . . 0.75 112.288 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.559 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 22.3 mmt180 -71.51 -52.01 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.284 0.476 . . . . 1.51 112.284 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.494 ' O ' ' HG3' ' C' ' 77' ' ' MET . 2.6 p90 -71.43 -40.37 70.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.82 -0.352 . . . . 4.6500000000000004 111.717 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.446 HG23 ' N ' ' C' ' 75' ' ' ASP . 10.4 tp -53.64 -44.01 56.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.581 0.229 . . . . 1.22 111.026 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.446 ' N ' HG23 ' C' ' 74' ' ' ILE . 23.4 t70 -70.08 -21.45 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.447 -0.575 . . . . 1.3100000000000001 109.447 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -87.38 6.93 31.28 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.436 -0.802 . . . . 1.6799999999999999 111.209 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 30.0 mtp -105.34 -20.68 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 1.8 110.693 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -114.14 -29.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 1.1899999999999999 111.883 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.612 HG23 HG23 ' C' ' 43' ' ' ILE . 88.2 m -81.29 -56.14 4.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.23 111.787 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 25.0 m -50.54 -50.32 72.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.412 0.523 . . . . 0.58999999999999997 112.412 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' C' ' 80' ' ' THR . 12.3 Cg_endo -56.41 -38.49 95.16 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.58 1.52 . . . . 0.67000000000000004 111.446 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.42 -30.94 69.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.95999999999999996 109.577 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.559 HD22 ' H43' ' C' ' 210' ' ' LYR . 25.1 tp -70.89 -21.23 62.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.445 0.641 . . . . 1.1899999999999999 109.336 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 26.5 tp -84.32 -37.23 21.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.993 -1.003 . . . . 1.7 109.908 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 89.4 mt -67.72 -35.91 79.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.75 -0.659 . . . . 1.6200000000000001 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 88.8 p -56.71 -31.14 64.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.343 -0.389 . . . . 1.26 110.981 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 70.4 mt -66.62 -33.23 75.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.489 . . . . 1.1100000000000001 110.797 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -73.72 -27.47 61.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 1.51 110.961 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.27 -33.6 25.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 2.0600000000000001 110.952 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 82.3 m -76.52 -37.23 57.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 1.52 111.005 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.28 -48.3 12.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 1.3 111.265 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -104.0 115.14 29.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 1.6200000000000001 110.949 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -71.54 -25.07 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 3.2400000000000002 111.016 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -144.77 138.0 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 4.6299999999999999 111.053 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.8 142.08 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.054 -0.521 . . . . 2.1800000000000002 111.022 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -102.89 173.55 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 4.1200000000000001 110.807 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.9 -178.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.346 -0.388 . . . . 4.96 110.758 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 28.6 t70 56.44 84.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 3.9100000000000001 110.868 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -75.16 99.47 3.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 5.21 110.864 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 68.8 m -119.23 -44.86 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 111.261 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.43 HD22 ' N ' ' C' ' 101' ' ' LEU . 3.7 mm? -76.64 -48.41 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 2.0800000000000001 111.095 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 7.6 tp -65.9 -30.09 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 1.8600000000000001 111.329 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.32 -44.84 41.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.769 . . . . 0.58999999999999997 112.776 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.58 -36.54 78.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 1.53 111.352 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.72 -51.25 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 1.1100000000000001 111.3 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.72 -35.87 77.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 2.21 111.029 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 40.9 m -66.87 -55.75 13.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.255 -0.429 . . . . 1.28 111.178 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.444 HG21 HD13 ' C' ' 142' ' ' ILE . 40.1 p -55.78 -25.91 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 1.22 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -68.4 -40.36 81.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 2.3300000000000001 110.376 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.439 HG22 ' HE1' ' B' ' 46' ' ' TRP . 36.4 mm -59.67 -32.17 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.91 -0.586 . . . . 1.29 110.698 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.98 -42.14 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.955 -0.566 . . . . 1.0600000000000001 111.171 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.23 -54.9 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 0.51000000000000001 111.631 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.1 pt -55.02 -27.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.3700000000000001 111.272 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 19.7 m -66.13 -46.57 77.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.242 -0.436 . . . . 0.77000000000000002 110.883 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -69.03 -23.78 64.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 1.1899999999999999 111.412 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.526 ' HA3' H181 ' C' ' 210' ' ' LYR . . . -78.63 -35.52 32.1 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.712 -0.756 . . . . 0.5 113.266 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.55 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.6 pp -77.06 -29.75 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.568 0.223 . . . . 1.47 111.592 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.55 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.2 tp -83.89 -24.33 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.399 -0.364 . . . . 1.2 111.202 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.24 93.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.40000000000000002 111.105 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -78.36 -14.13 59.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.046 -0.525 . . . . 2.1200000000000001 111.067 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' C' ' 118' ' ' ILE . 96.7 mt -86.29 17.59 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.75 111.125 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 78.5 p -68.38 121.16 15.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 1.3799999999999999 111.11 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -103.23 -37.94 7.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.246 -0.433 . . . . 2.7400000000000002 110.648 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG12 ' C' ' 127' ' ' VAL . 97.7 mtt180 -102.97 137.87 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 2.7999999999999998 110.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -71.71 -9.43 58.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 2.4100000000000001 111.242 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -88.52 -44.36 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 4.2000000000000002 111.088 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' C' ' 124' ' ' ARG . 12.9 p -74.16 -23.94 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 111.187 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -52.53 -47.29 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 2.5699999999999998 111.283 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -67.58 -22.94 65.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 3.8100000000000001 111.391 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 72.4 mt -80.5 -47.22 14.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 1.4199999999999999 111.239 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.68 -34.49 77.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.89000000000000001 111.384 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.85 -33.49 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.097 -0.501 . . . . 1.26 111.135 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.3 mm -73.26 -37.48 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.6799999999999999 111.108 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.59 -30.73 71.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 1.24 110.878 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -54.83 11.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.723 -0.751 . . . . 0.54000000000000004 112.278 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.56 -29.88 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 1.0600000000000001 110.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.37 -49.42 77.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.054 -0.521 . . . . 1.0800000000000001 110.741 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.08 -29.01 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.56999999999999995 110.845 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -74.64 -20.08 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 1.6799999999999999 110.708 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.3 15.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 1.7 111.293 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.456 HG13 ' N ' ' C' ' 142' ' ' ILE . 29.0 pt -59.21 -41.9 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.78000000000000003 111.241 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.456 ' N ' HG13 ' C' ' 141' ' ' ILE . 7.4 tp -72.48 -27.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.494 -0.321 . . . . 2.2400000000000002 111.003 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.27 -50.84 71.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 1.02 110.67 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -64.42 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.934 -0.575 . . . . 3.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.3 -39.1 97.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.794 -0.717 . . . . 1.27 112.405 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . 0.405 ' O ' ' HD2' ' C' ' 149' ' ' PRO . 82.6 mt -78.39 -24.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 1.8899999999999999 110.654 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -89.26 3.93 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.987 -0.551 . . . . 1.6000000000000001 111.043 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 51.5 t30 -61.61 -46.99 93.83 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.914 -0.585 . . . . 99.989999999999995 111.834 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 57.3 Cg_exo -38.54 -35.04 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.628 2.219 . . . . 2.73 112.761 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' C' ' 151' ' ' ARG . 44.5 tp -60.44 123.11 16.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 4.2999999999999998 109.981 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' C' ' 150' ' ' LEU . 99.3 mtt180 71.64 -13.06 0.59 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.118 -0.492 . . . . 8.9000000000000004 111.186 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' C' ' 150' ' ' LEU . . . -81.68 -17.56 47.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 2.7999999999999998 110.538 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -47.96 -32.35 6.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.858 -0.61 . . . . 5.4400000000000004 111.242 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 70.7 p -54.8 -48.33 72.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.1 -0.5 . . . . 3.3900000000000001 111.04 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -82.07 -16.3 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 6.9199999999999999 110.743 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 8.9 m -76.71 -7.26 55.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.054 -0.521 . . . . 4.8700000000000001 111.022 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 66.31 -77.76 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.004 -0.544 . . . . 4.0499999999999998 111.499 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -59.14 113.31 2.06 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.927 0.394 . . . . 3.0299999999999998 111.104 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 44.7 t -78.41 -38.4 41.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.017 -0.538 . . . . 2.96 111.179 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.78 -57.06 14.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 3.7400000000000002 110.982 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 63.9 tp -55.46 -34.08 64.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 2.6499999999999999 110.959 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.14 93.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.439 . . . . 1.77 110.941 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -63.99 -38.2 90.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 2.96 111.022 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.77 -36.68 72.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.086 0.47 . . . . 2.3500000000000001 110.703 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . 0.43 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.5 OUTLIER -77.0 -39.57 49.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.635 . . . . 2.6200000000000001 111.048 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -57.79 -37.12 73.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 2.0899999999999999 111.443 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -81.35 -26.97 35.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 3.2400000000000002 111.137 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.7 tp -71.89 -52.17 18.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 111.264 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 165' ' ' TYR . 53.4 t -56.16 -25.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 1.3999999999999999 111.493 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -54.64 -58.96 5.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.95999999999999996 111.316 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -68.32 -24.58 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.08 -0.509 . . . . 3.6499999999999999 110.499 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -70.62 -35.97 73.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 1.3700000000000001 111.673 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 41.0 p -70.47 -53.18 17.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.565 -0.288 . . . . 1.4299999999999999 111.655 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 p -53.33 -35.36 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.958 0.355 . . . . 1.6200000000000001 111.958 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' C' ' 209' ' ' SER . 41.7 tp -75.36 -57.81 3.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.794 0.33 . . . . 2.0299999999999998 111.41 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -28.32 58.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.109 -0.496 . . . . 0.62 110.981 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.426 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 84.9 mt -87.95 -24.29 6.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.479 . . . . 1.5800000000000001 110.225 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.53 -54.57 31.83 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.728 -0.669 . . . . 0.56000000000000005 113.043 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.627 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 68.1 m-85 -57.47 -55.67 42.1 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.85 0.325 . . . . 1.3300000000000001 111.623 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.0 Cg_exo -45.86 -28.2 4.68 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.254 1.969 . . . . 0.63 112.929 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.502 ' O ' HG22 ' C' ' 184' ' ' ILE . 92.7 mt -70.97 -61.25 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.93000000000000005 111.467 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.446 HG22 ' O ' ' C' ' 179' ' ' TYR . 25.3 m -57.5 -26.25 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.221 0.452 . . . . 1.27 112.221 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -60.94 -20.02 61.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.696 -0.229 . . . . 1.77 111.547 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.663 HG23 HG23 ' C' ' 185' ' ' ILE . 14.9 tt -60.64 -29.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.79 0.328 . . . . 2.3900000000000001 111.011 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.663 HG23 HG23 ' C' ' 184' ' ' ILE . 31.4 pt -113.38 158.19 13.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 1.95 111.101 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.2 -162.04 30.66 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.858 -0.687 . . . . 1.8799999999999999 112.629 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.32 156.8 58.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.729 2.286 . . . . 3.1200000000000001 112.298 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 38.6 m 59.7 13.76 3.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.981 -0.554 . . . . 2.6299999999999999 110.785 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -140.56 -86.01 0.11 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.884 -0.598 . . . . 3.04 112.089 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -166.04 66.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.01 0.433 . . . . 5.6900000000000004 110.101 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -144.85 146.56 17.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 3.0800000000000001 112.801 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -101.14 2.98 40.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.337 . . . . 7.5300000000000002 110.646 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 41.1 pt -103.52 154.21 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 2.8599999999999999 111.336 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -157.23 46.97 0.4 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.947 -0.569 . . . . 3.6899999999999999 110.411 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -99.07 -168.07 1.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.025 -0.534 . . . . 5.4800000000000004 110.968 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 7.3 t -65.7 -27.13 68.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 2.3799999999999999 111.17 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' C' ' 200' ' ' PHE . 16.7 tt -57.82 -34.75 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 2.23 111.231 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.58 -56.06 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 2.1600000000000001 110.703 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -69.43 -17.53 63.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.906 -0.588 . . . . 1.27 110.614 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' C' ' 197' ' ' ILE . 91.5 t80 -68.46 -30.81 69.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 1.7 110.947 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.7 -39.36 20.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 2.02 111.271 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -77.12 -8.11 56.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.281 . . . . 1.8200000000000001 111.682 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.461 ' HB3' HH22 ' C' ' 72' ' ' ARG . 17.7 p -96.66 -39.08 9.67 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.148 0.499 . . . . 1.3500000000000001 110.546 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.04 -33.89 68.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.623 -0.717 . . . . 0.65000000000000002 111.745 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.641 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 42.1 tp -62.53 -53.32 58.36 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.067 -0.253 . . . . 1.4199999999999999 111.577 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.8 Cg_exo -56.23 -39.34 91.91 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.842 1.695 . . . . 0.63 111.48 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -61.12 -34.32 74.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.959 -0.564 . . . . 1.49 110.721 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -66.56 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.009 -0.541 . . . . 1.7 110.951 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . 0.472 ' HB2' HD13 ' C' ' 175' ' ' LEU . 28.0 t -92.34 -28.55 16.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 1.25 110.999 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.743 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.46 -37.28 56.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 1.6100000000000001 111.0 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.79 69.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.913 -0.661 . . . . 0.81999999999999995 112.704 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -71.28 -34.85 71.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 3.0800000000000001 110.788 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 70.2 m -60.65 -59.3 5.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 1.1499999999999999 110.676 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.56 -23.4 65.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 2.5600000000000001 110.67 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tt -72.28 -40.28 67.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.932 -0.576 . . . . 1.29 110.992 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.53 -30.16 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 2.3900000000000001 111.192 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.11 -48.59 73.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 2.0299999999999998 110.876 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -81.07 -22.53 39.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 3.21 110.853 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.46 61.55 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.772 -0.728 . . . . 1.3600000000000001 112.945 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . 0.472 HD21 HG11 ' C' ' 32' ' ' VAL . 30.3 tp -75.16 -29.46 60.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.704 0.288 . . . . 2.8999999999999999 111.033 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 59.77 -86.05 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.009 -0.541 . . . . 4.8899999999999997 111.2 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -165.34 156.21 13.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 4.2300000000000004 110.663 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.54 ' N ' HD23 ' C' ' 224' ' ' LEU . 1.7 pt? -161.11 -178.02 6.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 6.1200000000000001 110.767 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -158.52 114.75 2.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 4.5499999999999998 110.967 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.69 143.59 51.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 6.7800000000000002 110.84 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 46.6 t -148.55 103.1 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 5.4000000000000004 110.904 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -93.32 -30.07 15.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 8.3300000000000001 110.944 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 7.9100000000000001 110.947 -179.73 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.834 0.35 . . . . 5.1100000000000003 110.902 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.27 162.14 8.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 5.04 110.873 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.9 tp 59.52 91.43 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 5.5800000000000001 110.889 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.43 -46.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 5.0199999999999996 110.757 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.1 t -96.68 165.09 12.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.962 -0.563 . . . . 2.4500000000000002 110.639 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.4 tp -139.97 -20.46 0.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 2.4199999999999999 111.015 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.68 -34.73 77.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.406 -0.361 . . . . 2.0899999999999999 111.13 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 37.4 m80 -72.25 -28.85 63.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.044 0.449 . . . . 1.1599999999999999 110.379 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -72.44 -51.07 21.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.79000000000000004 110.331 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.34 -21.74 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.096 0.474 . . . . 2.0800000000000001 110.249 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -61.48 2.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 1.28 110.564 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 52' ' ' MET . 8.7 p -58.57 -30.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.01 -0.541 . . . . 1.3200000000000001 111.371 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.0 -55.41 29.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.63 111.429 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.76 -28.45 68.2 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.884 -0.674 . . . . 0.55000000000000004 112.763 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.16 -22.2 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.745 0.307 . . . . 1.03 111.001 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -72.76 -52.13 16.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 1.3 110.844 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -65.4 -22.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 1.3100000000000001 110.942 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -68.47 -47.84 54.81 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.854 -0.689 . . . . 0.77000000000000002 112.652 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.452 ' HB1' ' HE3' ' A' ' 41' ' ' MET . . . -63.05 -33.88 76.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.80000000000000004 111.042 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -68.43 -36.52 79.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.203 0.525 . . . . 1.8100000000000001 110.532 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.9 t-80 -59.33 -20.99 59.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.734 -0.666 . . . . 1.8799999999999999 110.485 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -62.49 -50.18 72.42 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.062 -0.517 . . . . 4.4500000000000002 110.973 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -58.91 -45.17 90.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 3.6899999999999999 110.495 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.3 m -69.9 -18.66 63.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 1.5700000000000001 110.794 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' HIS . 12.7 tp -76.57 0.26 20.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 1.95 111.933 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 p -66.83 -51.44 55.55 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.277 -0.569 . . . . 1.3799999999999999 111.19 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -54.17 -22.63 11.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 122.011 0.91 . . . . 4.0700000000000003 108.548 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.812 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.41 -150.98 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 113.757 -1.565 . . . . 2.7200000000000002 108.57 177.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 14.2 Cg_exo 6.91 96.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.713 2.942 . . . . 1.9099999999999999 116.472 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -102.96 96.87 7.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.663 -1.153 . . . . 4.7599999999999998 109.148 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.04 -36.92 2.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.502 -1.039 . . . . 1.99 110.502 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.1 t -111.77 126.2 28.96 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 109.315 -0.624 . . . . 2.7000000000000002 109.315 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 16.9 Cg_exo -65.82 165.83 22.25 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.482 2.121 . . . . 1.79 113.858 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -76.08 -13.3 60.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.507 -1.224 . . . . 4.1200000000000001 111.806 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CD2' ' HB2' ' A' ' 33' ' ' PRO . 1.7 p90 -38.69 -37.92 0.37 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.469 0.544 . . . . 2.9300000000000002 112.469 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.09 -45.19 86.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 2.8799999999999999 110.518 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -74.03 -18.57 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.005 -0.543 . . . . 4.6600000000000001 110.613 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.431 HD11 ' HD1' ' B' ' 104' ' ' PHE . 55.7 tp -60.66 -56.86 16.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.162 -0.472 . . . . 1.45 110.161 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.32 -36.24 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 1.78 109.918 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.21 -6.13 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.724 -0.671 . . . . 0.63 110.89 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.46 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 23.8 ttt -88.74 -35.59 16.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 1.48 110.641 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -72.61 -33.32 66.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.524 . . . . 3.5 111.101 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.634 HG23 HG23 ' A' ' 79' ' ' THR . 79.0 mt -53.63 -52.98 62.22 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.271 0.471 . . . . 1.0800000000000001 112.271 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 60.5 Cg_endo -72.15 -33.3 9.61 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.28 1.987 . . . . 0.53000000000000003 113.236 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -57.89 -62.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 111.939 0.348 . . . . 1.6799999999999999 111.939 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.527 ' HE1' HG22 ' B' ' 110' ' ' ILE . 3.0 t90 -61.63 -51.41 68.59 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.626 -0.261 . . . . 1.8300000000000001 111.525 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.448 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 92.5 p -51.52 -54.13 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 1.0900000000000001 111.195 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -44.58 -54.79 6.39 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.208 -0.52 . . . . 0.40999999999999998 113.547 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 73.3 mt -52.12 -38.94 59.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.748 0.309 . . . . 0.98999999999999999 111.337 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.56 83.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.47999999999999998 111.059 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.507 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 96.8 m-85 -69.48 -44.19 71.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.8700000000000001 110.913 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.428 ' HB2' HG11 ' A' ' 12' ' ' VAL . 16.7 tmm? -49.61 -32.68 13.38 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.285 0.564 . . . . 1.49 110.126 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -72.13 -42.14 66.35 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.58999999999999997 111.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.2 mtt -54.17 -26.45 28.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.48999999999999999 110.363 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.05 -48.54 23.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.576 . . . . 0.59999999999999998 110.673 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 53' ' ' ALA . 44.3 pt -79.94 6.65 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 1.3100000000000001 111.023 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 59.59 55.1 4.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 1.9099999999999999 111.194 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -125.33 124.59 41.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 1.6200000000000001 110.735 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 120.34 29.88 1.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 1.04 112.398 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -150.34 144.74 25.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 2.6800000000000002 111.145 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.48 145.54 35.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 1.98 111.165 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -88.74 94.44 9.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 2.1800000000000002 110.893 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.08 133.48 55.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.019 -0.537 . . . . 1.5700000000000001 111.052 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.79 23.72 12.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.245 -0.434 . . . . 1.79 111.14 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.97 -15.1 50.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.83 -0.7 . . . . 1.48 112.534 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -104.73 151.22 24.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.313 . . . . 2.3199999999999998 110.854 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -98.17 138.24 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 1.4399999999999999 111.118 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.39 118.21 34.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.11 -0.495 . . . . 0.81999999999999995 110.848 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 64.5 m-70 -78.96 79.25 5.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.295 0.569 . . . . 0.90000000000000002 111.204 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.88 -41.28 86.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.547 -0.751 . . . . 1.8300000000000001 110.932 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -67.0 -24.05 65.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 0.62 111.595 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.9 tpp180 -67.15 -51.88 48.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.098 -0.501 . . . . 2.3399999999999999 112.322 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.49 ' O ' ' HG3' ' A' ' 77' ' ' MET . 17.7 p90 -88.95 -27.98 20.57 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.511 0.56 . . . . 3.4900000000000002 112.511 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 71' ' ' ALA . 11.0 tp -57.78 -41.26 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.473 -0.491 . . . . 1.3700000000000001 110.069 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' OD2' ' HA ' ' A' ' 47' ' ' SER . 16.1 t70 -70.93 -17.14 62.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.143 -0.688 . . . . 1.3100000000000001 109.143 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -90.42 6.06 44.9 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.237 -0.892 . . . . 1.48 110.956 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.519 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 32.1 mtp -104.85 -17.68 14.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.488 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.439 ' O ' HD23 ' A' ' 82' ' ' LEU . 27.5 m -114.59 -34.81 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 1.1200000000000001 111.8 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.634 HG23 HG23 ' A' ' 43' ' ' ILE . 84.8 m -76.0 -59.56 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 1.1000000000000001 112.007 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 83.2 m -49.14 -51.06 59.69 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.503 0.557 . . . . 0.59999999999999998 112.503 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 58.4 Cg_exo -51.67 -52.85 8.1 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.765 1.643 . . . . 0.73999999999999999 111.844 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -63.45 -25.66 68.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.94 -0.573 . . . . 1.01 110.881 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.422 HD22 ' H43' ' A' ' 210' ' ' LYR . 23.5 tp -72.91 -28.42 62.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.999 0.428 . . . . 1.48 110.033 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -84.47 -22.22 30.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.3799999999999999 110.103 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 81' ' ' PRO . 95.4 mt -85.07 -31.28 23.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.769 -0.65 . . . . 1.1899999999999999 110.646 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -61.64 -50.34 72.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.23 111.029 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 pp -61.99 -25.74 67.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.88 110.965 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.1 t -67.63 -43.78 79.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 1.3899999999999999 110.842 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -62.16 -40.6 96.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 2.3199999999999998 111.014 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -60.5 -33.9 73.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 1.46 111.029 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.52 -30.73 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 1.24 111.044 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.8 tpp -75.28 117.3 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 2.0699999999999998 110.817 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.67 -54.69 4.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 3.5299999999999998 111.066 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -137.12 144.82 43.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 4.0800000000000001 111.228 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.9 tt -107.55 148.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 2.1699999999999999 110.817 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -133.43 -75.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 4.5199999999999996 111.2 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -138.35 -13.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 3.75 111.343 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.31 106.82 1.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.457 -0.338 . . . . 3.5299999999999998 110.734 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -128.57 -21.52 3.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.332 -0.394 . . . . 4.9100000000000001 111.036 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.6 p -65.38 -26.01 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.383 -0.371 . . . . 1.98 111.034 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.75 -36.54 79.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 1.8300000000000001 110.951 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.03 -39.0 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 1.79 111.172 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.78 93.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.848 -0.692 . . . . 0.62 112.361 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.93 -41.25 95.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 1.5800000000000001 111.153 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.05 -48.41 80.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.97999999999999998 111.293 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -61.24 -27.34 68.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 1.48 111.289 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -72.45 -43.25 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.999 0.428 . . . . 1.1299999999999999 111.245 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 112' ' ' VAL . 71.6 p -72.3 -22.8 61.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.163 -0.471 . . . . 1.48 111.548 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.553 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 25.0 tp60 -81.79 -45.47 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.322 -0.399 . . . . 2.7000000000000002 111.4 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' HE1' ' C' ' 46' ' ' TRP . 7.9 tp -59.5 -34.97 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.54 111.473 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 142' ' ' ILE . 17.9 m -71.16 -44.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 121.144 -0.223 . . . . 1.28 111.281 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 108' ' ' THR . 78.5 t -59.22 -55.59 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 120.795 0.331 . . . . 0.42999999999999999 111.537 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.476 HG12 HE21 ' A' ' 109' ' ' GLN . 39.0 mm -56.75 -32.89 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.385 -0.37 . . . . 1.74 111.436 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -55.71 -45.13 77.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.875 0.369 . . . . 0.63 110.554 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -67.34 -27.03 66.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.56 . . . . 1.0900000000000001 111.007 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.56 -41.04 30.73 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.876 -0.678 . . . . 0.41999999999999998 113.502 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -73.96 -28.26 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.806 0.299 . . . . 1.3799999999999999 111.806 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.472 HD11 ' HG3' ' C' ' 58' ' ' GLN . 10.2 tp -82.49 -26.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 1.6200000000000001 111.17 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.56 76.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.39000000000000001 110.894 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.4 -27.41 32.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 2.02 111.041 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.18 34.3 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.76000000000000001 111.257 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.6 m -85.61 131.19 34.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 1.46 110.853 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.472 ' HG3' ' HG3' ' A' ' 124' ' ' ARG . 12.1 pt-20 -80.4 -28.7 37.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 3.3500000000000001 111.077 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.524 ' HB2' HG12 ' A' ' 127' ' ' VAL . 78.5 mtm180 -130.17 158.19 40.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 2.9199999999999999 110.971 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.53 -11.9 59.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.004 -0.544 . . . . 2.77 111.048 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -90.06 -45.87 8.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.977 0.418 . . . . 3.77 110.405 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.0 p -65.45 -27.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 1.1599999999999999 110.757 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -65.28 -41.16 94.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.031 -0.531 . . . . 2.04 111.007 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.425 ' O ' HG12 ' A' ' 133' ' ' ILE . 72.2 t80 -56.88 -45.67 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 2.6400000000000001 110.873 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.71 -45.22 92.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 1.8999999999999999 111.376 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.18 70.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 1.3999999999999999 111.049 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -67.55 -43.33 80.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.411 . . . . 1.28 111.146 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 129' ' ' TYR . 38.3 mm -59.05 -39.18 77.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 2.1600000000000001 110.888 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.454 ' SG ' HD22 ' C' ' 49' ' ' LEU . 46.2 t -67.48 -28.45 67.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.222 -0.445 . . . . 1.6899999999999999 110.901 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.65 -55.88 24.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.871 -0.68 . . . . 0.52000000000000002 112.55 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 26.9 m -63.63 -37.25 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.563 0.22 . . . . 1.02 111.298 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 85.9 m -59.69 -44.2 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.454 -0.339 . . . . 1.0800000000000001 111.023 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.88 -35.67 75.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.62 110.897 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -69.82 -23.13 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 1.8400000000000001 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 86.9 mt -70.26 -59.93 2.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 1.6899999999999999 111.469 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -61.24 -27.02 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.504 -0.317 . . . . 0.81000000000000005 111.69 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 111' ' ' VAL . 72.5 mt -77.99 -50.35 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.483 -0.326 . . . . 2.3700000000000001 111.49 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.1 tp -49.44 -54.21 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.97999999999999998 111.188 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -64.63 -34.34 78.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 3.27 110.984 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.59 68.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.86 -0.686 . . . . 1.25 112.77 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 65.0 mt -103.73 -19.85 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 2.1200000000000001 111.173 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -59.73 -39.91 86.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.297 -0.411 . . . . 1.6599999999999999 111.995 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.512 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 69.1 m-80 -73.83 -53.81 3.99 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.483 0.549 . . . . 99.989999999999995 112.483 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 18.9 Cg_endo -57.75 -13.57 14.87 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.169 1.913 . . . . 2.6000000000000001 113.055 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.7 mt -84.35 48.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 4.6100000000000003 110.917 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 55.47 70.09 0.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 8.3599999999999994 110.976 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . . . -81.77 -34.42 30.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 2.75 111.022 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.526 ' HG2' HE21 ' A' ' 157' ' ' GLN . 24.2 ttmm -72.86 -16.01 61.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.548 . . . . 5.6799999999999997 110.892 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 m -79.0 -23.64 44.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.272 -0.422 . . . . 3.21 111.138 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -56.04 -32.41 64.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 6.8700000000000001 111.393 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 7.8 t -91.13 -25.06 19.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.35 . . . . 4.5599999999999996 111.199 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.526 HE21 ' HG2' ' A' ' 153' ' ' LYS . 79.7 mt-30 -70.67 -78.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 3.5600000000000001 111.043 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.1 t -100.6 122.99 44.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 2.79 110.864 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 77.9 p -78.03 -35.53 49.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.086 -0.506 . . . . 2.5899999999999999 111.253 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.42 -41.02 89.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 3.4700000000000002 111.11 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.88 -20.35 62.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 2.5800000000000001 110.655 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.75 -34.75 52.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 1.78 110.97 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -67.55 -39.41 84.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 2.6299999999999999 110.41 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 60.8 mt -64.2 -57.61 8.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 2.3399999999999999 110.544 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.46 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.5 OUTLIER -55.41 -39.86 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.662 -0.699 . . . . 2.77 111.08 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -51.69 -56.35 14.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 2.04 111.289 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -58.05 -28.28 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 2.77 111.484 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 165' ' ' TYR . 75.5 mt -72.95 -65.56 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.335 -0.393 . . . . 1.8899999999999999 111.46 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.15 -36.5 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.505 . . . . 1.6399999999999999 111.856 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.2 m -56.74 -52.55 64.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.311 . . . . 1.24 111.521 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.459 ' O ' HD23 ' A' ' 175' ' ' LEU . 75.5 t80 -58.41 -29.54 66.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.364 -0.38 . . . . 2.9700000000000002 110.961 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -71.01 -32.11 68.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 1.48 111.354 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 72.3 p -79.59 -37.86 35.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 1.55 111.767 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.24 -43.75 94.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.764 0.283 . . . . 1.52 111.764 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 171' ' ' TYR . 4.3 mm? -75.18 -50.69 15.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.651 -0.249 . . . . 1.8500000000000001 111.634 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.49 -31.65 62.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.62 110.593 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 181' ' ' ILE . 94.8 mt -87.66 -22.09 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.523 . . . . 1.3500000000000001 110.298 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -55.74 27.98 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.58999999999999997 113.097 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.606 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 86.5 m-85 -53.68 -54.98 40.18 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.835 0.317 . . . . 1.45 111.067 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 80.8 Cg_exo -45.95 -30.18 6.81 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.003 1.802 . . . . 0.55000000000000004 112.671 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 177' ' ' ILE . 46.5 mm -66.36 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 1.4199999999999999 111.164 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 179' ' ' TYR . 28.5 m -58.33 -26.63 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.501 . . . . 0.78000000000000003 111.572 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -66.22 -45.08 81.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.534 -0.303 . . . . 0.93999999999999995 111.227 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.2 mt -62.04 -62.57 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 1.4299999999999999 111.298 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.6 pp -57.46 143.45 11.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 2.02 111.494 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 64.36 171.96 2.63 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.936 -0.65 . . . . 1.79 112.918 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.464 ' HD3' ' H ' ' A' ' 192' ' ' TRP . 85.0 Cg_endo -85.53 82.63 1.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.813 2.342 . . . . 3.1000000000000001 112.231 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.4 m 58.09 37.57 26.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 2.7400000000000002 110.917 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.73 -106.1 0.21 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.896 -0.668 . . . . 3.4300000000000002 112.424 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.507 ' N ' HD11 ' A' ' 193' ' ' ILE . 81.4 t80 -132.92 -30.31 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.863 0.363 . . . . 6.5 110.858 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 193' ' ' ILE . . . 153.15 114.74 0.57 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 3.29 112.627 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.464 ' H ' ' HD3' ' A' ' 187' ' ' PRO . 15.3 m-90 55.95 36.8 27.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.34 . . . . 6.1600000000000001 111.12 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.534 HG12 ' H ' ' A' ' 191' ' ' GLY . 36.1 pt -136.06 149.16 27.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 2.4199999999999999 111.367 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -155.85 8.98 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 4.29 110.702 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -86.66 -157.26 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.13 -0.486 . . . . 5.1500000000000004 110.786 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.6 t -66.11 -16.17 63.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.393 -0.367 . . . . 2.4500000000000002 111.143 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 200' ' ' PHE . 83.3 mt -55.17 -32.94 29.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 2.48 111.382 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.55 -54.45 32.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.374 . . . . 2.1800000000000002 111.24 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 67.8 p -62.55 -32.49 73.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 1.49 111.706 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 197' ' ' ILE . 63.2 t80 -54.77 -38.31 67.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 1.77 111.126 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 49.0 tp -76.67 -46.53 25.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 1.4199999999999999 111.092 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -71.79 1.49 6.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 1.78 111.42 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.9 t -96.5 -46.3 6.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.184 0.516 . . . . 1.3 110.507 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.78 -36.94 73.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.66000000000000003 111.998 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -57.21 -54.76 51.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 121.138 -0.225 . . . . 1.6299999999999999 111.293 -179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -55.48 -44.71 45.82 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.682 1.588 . . . . 0.64000000000000001 111.596 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.29 -25.4 67.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.445 . . . . 1.3600000000000001 110.464 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.61 -30.85 59.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 1.54 110.751 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 87.8 p -94.23 -13.33 26.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 1.2 110.998 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.761 H183 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 28.8 m -67.75 -34.45 67.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 1.6399999999999999 111.284 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.33 -28.38 72.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.79000000000000004 112.423 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.22 -31.17 58.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.732 0.301 . . . . 1.6100000000000001 110.889 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.6 m -63.55 -62.02 1.94 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 1.1499999999999999 110.889 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -59.37 -27.86 66.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 3.3399999999999999 110.851 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.1 tt -65.39 -48.9 71.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 1.1899999999999999 110.74 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.93 -27.77 69.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 2.23 110.912 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.52 -49.86 69.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 2.4700000000000002 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -70.76 -49.09 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 1.6200000000000001 111.054 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.84 55.08 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.849 -0.691 . . . . 1.4099999999999999 112.58 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.04 -56.23 23.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.637 0.256 . . . . 2.5800000000000001 110.89 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 59.57 97.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 4.9299999999999997 110.7 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -56.25 113.11 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 4.6299999999999999 111.101 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 96.8 mt -140.64 150.95 44.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.922 -0.581 . . . . 6.4699999999999998 111.056 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -114.11 104.87 12.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 5.0700000000000003 111.045 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -139.51 -9.74 1.24 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.011 -0.54 . . . . 6.5300000000000002 110.842 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 41.4 t -89.19 132.53 34.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 5.2199999999999998 111.07 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -130.61 38.85 3.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.108 -0.497 . . . . 8.3599999999999994 111.029 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 7.96 110.975 -179.86 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.866 0.365 . . . . 6.1699999999999999 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -95.28 -56.78 2.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 4.8200000000000003 110.912 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 26.9 tp -110.02 127.22 54.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 5.5999999999999996 110.972 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -133.42 -44.8 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 4.7999999999999998 110.955 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 65.4 p -85.96 160.15 19.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.046 -0.525 . . . . 2.3700000000000001 110.917 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp -137.16 -28.57 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 2.0699999999999998 111.148 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -34.73 71.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 2.1000000000000001 111.148 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.578 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 35.6 m170 -65.32 -33.25 75.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 1.0700000000000001 110.757 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -73.95 -46.87 41.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.16 -0.473 . . . . 1.48 110.617 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.07 -22.29 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.117 0.484 . . . . 2.02 110.262 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.28 -59.13 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.706 -0.679 . . . . 0.92000000000000004 110.538 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.21 -29.46 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.93999999999999995 111.328 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -50.42 67.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.55000000000000004 111.34 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.03 -32.8 85.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.758 -0.734 . . . . 0.47999999999999998 112.564 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.4 mmt -71.54 -26.02 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.74 0.305 . . . . 0.84999999999999998 110.956 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 88.5 m -69.7 -59.2 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 1.3400000000000001 110.853 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.472 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.6 pp -56.32 -26.13 21.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.096 -0.502 . . . . 1.55 111.307 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.472 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -65.59 -47.94 72.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.608 -0.806 . . . . 0.69999999999999996 112.26 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' B' ' 41' ' ' MET . . . -60.09 -33.84 72.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.81000000000000005 111.047 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.77 -33.5 72.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.335 -0.393 . . . . 2.2599999999999998 110.545 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -61.14 -20.27 62.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 1.78 110.539 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.34 -53.35 58.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 4.5800000000000001 110.968 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.593 ' O ' ' OG ' ' B' ' 26' ' ' SER . 80.8 m95 -62.62 -42.71 99.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.953 -0.567 . . . . 3.3500000000000001 110.955 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 1.5800000000000001 111.253 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -80.73 -5.66 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 1.8400000000000001 110.881 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 15.7 p -72.09 -15.23 62.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 1.3700000000000001 110.775 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -45.95 -40.71 10.64 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.432 -0.581 . . . . 4.9800000000000004 109.432 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -179.08 130.51 0.27 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.141 -0.936 . . . . 2.1400000000000001 110.219 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -96.28 179.36 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.991 2.461 . . . . 1.8200000000000001 112.182 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -99.85 52.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 5.1900000000000004 111.188 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.1 -46.63 2.02 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.839 -0.696 . . . . 2.2000000000000002 112.552 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 32.7 m -91.87 144.82 29.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.523 0.201 . . . . 3.6499999999999999 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 165.36 17.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.514 2.143 . . . . 2.6699999999999999 112.581 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -62.64 -17.43 60.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 4.8799999999999999 111.837 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -42.3 -35.07 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.726 0.298 . . . . 1.8700000000000001 111.662 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -64.54 -48.31 75.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.932 0.396 . . . . 2.6800000000000002 110.225 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.28 -18.56 61.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 2.9199999999999999 110.703 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' B' ' 41' ' ' MET . 47.7 tp -60.7 -53.44 57.36 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.981 0.42 . . . . 1.6399999999999999 110.325 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.23 -38.74 83.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 1.6000000000000001 109.893 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.14 -5.62 36.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.629 -0.714 . . . . 0.68999999999999995 110.734 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.466 ' HE3' ' HB1' ' B' ' 19' ' ' ALA . 25.3 ttt -88.65 -36.08 16.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.906 -0.588 . . . . 2.5800000000000001 110.402 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -70.74 -34.2 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.921 -0.582 . . . . 3.3900000000000001 111.078 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.614 HG23 HG23 ' B' ' 79' ' ' THR . 98.7 mt -53.54 -54.76 42.19 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.459 0.54 . . . . 0.40999999999999998 112.459 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 59.9 Cg_endo -70.43 -37.31 7.71 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.405 2.07 . . . . 0.48999999999999999 113.566 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.15 -62.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.748 0.277 . . . . 1.29 111.748 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.619 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -62.08 -52.75 62.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.3999999999999999 111.355 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.442 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 38.4 t -54.04 -31.82 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.3799999999999999 111.566 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.11 -49.75 64.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.37 112.757 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.476 HD22 ' SG ' ' C' ' 134' ' ' CYS . 75.7 mt -54.77 -44.56 73.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 1.29 111.503 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.15 -50.26 67.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.44 111.565 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 24.8 m-85 -63.23 -40.04 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.5 111.303 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.3 ttp -52.39 -34.09 46.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.182 0.515 . . . . 1.4099999999999999 110.196 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -69.78 -40.67 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.598 -0.728 . . . . 0.55000000000000004 110.944 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 56.2 mtt -54.33 -28.64 43.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.52 . . . . 0.5 110.489 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.83 -52.06 16.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 0.54000000000000004 110.946 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.1 pt -78.65 9.78 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.913 -0.585 . . . . 1.3 111.539 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 60.03 63.8 1.38 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.063 -0.517 . . . . 2.2400000000000002 111.036 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.468 HE21 ' H ' ' B' ' 59' ' ' GLY . 26.3 tp60 -136.23 128.78 30.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 1.77 110.639 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.468 ' H ' HE21 ' B' ' 58' ' ' GLN . . . 109.87 38.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 1.0600000000000001 112.194 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -150.43 140.81 22.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 2.6600000000000001 110.81 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.75 141.15 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 1.8899999999999999 111.068 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.43 94.8 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 2.4100000000000001 110.922 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.17 125.04 51.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 1.5600000000000001 111.144 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.05 35.92 24.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 1.8200000000000001 111.301 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.28 4.7 51.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.74 -0.743 . . . . 1.51 112.547 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -108.46 140.88 41.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.64 0.257 . . . . 2.4500000000000002 110.853 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 55.2 mt -99.27 119.42 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 1.79 110.892 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.48 113.86 27.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.81999999999999995 111.136 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.628 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 93.1 m-70 -73.91 83.34 1.7 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.4 0.619 . . . . 1.05 110.792 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.476 ' HD2' ' HH ' ' B' ' 73' ' ' TYR . 75.6 t80 -52.25 -56.71 12.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 1.8700000000000001 111.567 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.27 -21.93 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.606 0.595 . . . . 0.60999999999999999 112.606 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.628 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 20.3 tpp180 -64.66 -52.54 56.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.275 0.472 . . . . 2.3900000000000001 112.275 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.476 ' HH ' ' HD2' ' B' ' 70' ' ' TYR . 36.7 p90 -87.34 -29.71 21.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.482 -0.487 . . . . 3.6699999999999999 111.418 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.65 -45.96 79.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.692 -0.484 . . . . 1.6599999999999999 109.692 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 16.3 t70 -67.72 -23.47 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 1.4099999999999999 109.139 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 28.9 m0 -86.08 8.18 21.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.457 -0.792 . . . . 1.1599999999999999 111.07 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.58 -22.51 13.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.758 -0.655 . . . . 1.53 110.571 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.417 ' O ' HD23 ' B' ' 82' ' ' LEU . 35.4 m -113.88 -30.34 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.89000000000000001 111.927 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.614 HG23 HG23 ' B' ' 43' ' ' ILE . 76.1 m -81.29 -52.13 7.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.008 0.373 . . . . 1.24 112.008 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.584 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 11.9 m -51.8 -49.79 81.48 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.205 0.446 . . . . 0.57999999999999996 112.205 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' B' ' 80' ' ' THR . 10.4 Cg_endo -54.67 -50.94 11.65 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.803 1.669 . . . . 0.66000000000000003 111.782 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.417 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -65.16 -26.13 68.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.043 -0.526 . . . . 1.0600000000000001 110.637 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.5 ' HG ' ' H43' ' B' ' 210' ' ' LYR . 0.2 OUTLIER -68.41 -36.87 79.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.18 0.514 . . . . 1.22 109.772 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' B' ' 105' ' ' LEU . 6.4 tt -80.36 -25.44 39.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.539 -0.755 . . . . 1.53 110.789 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 98.6 mt -77.78 -36.83 50.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 1.5800000000000001 111.201 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 59.5 m -56.96 -39.68 75.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 1.3899999999999999 110.949 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 98.2 mt -68.58 -35.59 77.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 1.1499999999999999 111.072 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 61.1 m -61.09 -35.31 76.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.326 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -72.24 -36.22 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 2.1699999999999999 110.986 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 29.7 m -66.55 -37.58 85.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 1.4199999999999999 110.81 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -28.59 39.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 1.1799999999999999 110.925 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.1 ttm -77.96 117.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 1.8799999999999999 110.718 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -86.78 -61.48 1.72 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 3.4199999999999999 111.223 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -126.22 160.52 30.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 4.0599999999999996 111.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 70.0 mt -124.9 142.32 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.991 -0.55 . . . . 2.0899999999999999 110.824 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -139.38 -51.08 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 3.8500000000000001 110.83 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -161.93 -161.14 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 4.8200000000000003 110.511 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 60.76 87.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.448 . . . . 3.7999999999999998 110.795 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -101.13 0.08 37.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 110.852 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 74.1 p -71.67 -25.91 62.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 2.02 111.293 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.95 -39.71 90.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 2.0899999999999999 110.786 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.61 -38.13 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 1.8799999999999999 111.034 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.4 -29.25 71.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.56000000000000005 112.215 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' B' ' 146' ' ' ILE . 66.2 t80 -65.74 -37.58 86.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.95 0.405 . . . . 1.78 110.588 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.43 ' HB3' HD21 ' B' ' 84' ' ' LEU . 55.4 mt -68.63 -41.37 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.793 -0.64 . . . . 1.03 111.11 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . 0.415 ' O ' HG12 ' B' ' 110' ' ' ILE . 57.9 mtt -64.45 -45.92 85.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 1.6699999999999999 111.135 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 55.6 m -55.58 -42.07 74.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 1.51 111.478 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.479 ' O ' HG23 ' B' ' 112' ' ' VAL . 75.9 p -69.27 -24.94 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.761 0.315 . . . . 1.1799999999999999 111.416 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -80.49 -44.59 18.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.559 -0.291 . . . . 2.1699999999999999 111.566 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.527 HG22 ' HE1' ' A' ' 46' ' ' TRP . 48.5 mm -57.53 -38.72 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.391 -0.368 . . . . 1.3500000000000001 111.391 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.64 -43.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 1.3400000000000001 111.854 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 108' ' ' THR . 70.2 t -61.03 -55.29 25.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.645 0.26 . . . . 0.42999999999999999 111.62 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.489 HD11 HG21 ' B' ' 80' ' ' THR . 29.7 mm -61.0 -29.26 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.575 -0.284 . . . . 1.6000000000000001 111.23 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.1 m -55.29 -49.34 72.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.972 0.415 . . . . 0.85999999999999999 110.528 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 75.3 p -70.92 -20.44 62.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.94999999999999996 110.482 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.28 -33.7 43.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.006 -0.616 . . . . 0.46000000000000002 112.975 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.529 HD12 HG13 ' B' ' 118' ' ' ILE . 2.8 pp -82.89 -24.68 33.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 0.235 . . . . 1.75 111.162 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.529 HG13 HD12 ' B' ' 117' ' ' LEU . 85.7 mt -80.21 -36.24 16.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 120.803 0.335 . . . . 1.78 110.838 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.86 -38.24 48.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.539 . . . . 0.38 111.154 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -82.6 -26.74 32.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.006 -0.543 . . . . 1.97 111.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -86.35 22.27 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.341 . . . . 0.76000000000000001 111.185 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -67.27 139.62 57.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.47 110.843 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -94.03 -17.69 22.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 2.5 111.044 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.646 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 48.7 ttp180 -137.88 156.46 47.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.499 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.53 -14.97 60.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 2.2000000000000002 110.935 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.646 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 54.4 t90 -92.96 -37.98 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 3.3999999999999999 111.19 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' B' ' 124' ' ' ARG . 18.4 m -65.34 -24.32 34.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.215 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.8 ttt-85 -63.47 -47.59 81.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 3.04 111.385 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -57.97 -32.82 68.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 4.1399999999999997 111.557 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.17 -46.56 76.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 1.6499999999999999 110.873 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -74.33 -25.57 59.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.77000000000000002 110.732 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.2 -51.82 61.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.816 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.58 -33.27 60.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.31 -0.405 . . . . 1.6299999999999999 110.804 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.78 -28.22 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.4199999999999999 110.588 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.39 -53.68 16.31 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.925 -0.655 . . . . 0.48999999999999999 112.487 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 28.9 m -61.79 -35.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.593 0.235 . . . . 1.3 111.312 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 90.8 m -61.22 -35.88 78.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.75 0.31 . . . . 1.3 110.725 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.52 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.62 110.637 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.54 -23.5 63.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 1.74 110.892 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 90.5 mt -71.47 -55.62 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.418 . . . . 1.76 111.187 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 43.1 pt -66.59 -28.85 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.68999999999999995 111.534 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.63 -51.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 1.76 111.075 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 54.2 tp -52.75 -49.62 65.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.336 -0.393 . . . . 1.0600000000000001 110.672 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -67.06 -24.61 65.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.518 . . . . 4.1200000000000001 110.602 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.82 -17.66 74.56 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 1.26 112.776 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.476 ' C ' ' HD2' ' B' ' 149' ' ' PRO . 56.7 mt -103.39 -19.52 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.781 0.324 . . . . 1.98 111.127 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -54.86 -50.04 69.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.213 -0.449 . . . . 1.4199999999999999 111.922 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.678 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 51.5 t30 -68.93 -53.07 15.32 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 111.91 0.337 . . . . 99.989999999999995 111.91 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 53.0 Cg_exo -52.05 -20.67 10.94 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.158 1.906 . . . . 2.6499999999999999 112.811 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 68.6 mt -81.67 43.38 0.75 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.834 0.349 . . . . 4.3899999999999997 110.957 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 55.04 74.64 0.35 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.036 -0.529 . . . . 7.9000000000000004 110.647 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' B' ' 148' ' ' ASN . . . -82.63 -29.48 30.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 2.77 111.291 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -73.16 -20.0 61.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 6.29 110.886 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 64.1 p -80.48 -5.45 56.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 3.1000000000000001 110.819 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -66.19 -36.33 82.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 6.4299999999999997 110.693 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 68.9 p -98.88 -19.02 17.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 4.5700000000000003 111.379 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -65.89 -68.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 3.8300000000000001 110.937 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 48.0 t -117.93 114.79 23.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 3.0699999999999998 110.944 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 46.6 t -67.75 -29.05 68.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.253 -0.431 . . . . 3.4300000000000002 110.966 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -59.79 -60.53 3.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.11 0.481 . . . . 3.9199999999999999 110.751 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.55 -30.79 70.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.856 -0.611 . . . . 2.7000000000000002 111.073 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.87 97.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.956 0.408 . . . . 1.8300000000000001 111.141 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -65.21 -36.36 83.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.048 -0.523 . . . . 2.6299999999999999 111.039 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.403 HD11 ' NH1' ' B' ' 222' ' ' ARG . 74.0 mt -67.71 -56.9 7.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.419 . . . . 2.4300000000000002 110.946 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.33 -29.9 59.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.922 -0.581 . . . . 2.5800000000000001 111.013 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.63 -59.04 5.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 2.0 111.223 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -58.41 -21.57 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 3.0299999999999998 111.767 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.7 -63.58 1.38 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 111.399 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.23 -31.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 1.75 111.634 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -59.88 -52.2 66.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 0.97999999999999998 111.152 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.96 -33.58 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 4.2999999999999998 110.766 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -72.17 -25.91 61.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 1.3899999999999999 110.763 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.438 HG22 HD12 ' B' ' 177' ' ' ILE . 27.2 m -79.35 -40.26 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 1.1100000000000001 111.819 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.6 -35.02 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.492 -0.322 . . . . 1.51 111.484 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.69 -57.05 4.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.316 -0.402 . . . . 1.75 111.624 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -31.06 56.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.59999999999999998 111.028 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.474 ' O ' HG12 ' B' ' 181' ' ' ILE . 92.4 mt -87.67 -21.43 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 1.47 110.521 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.28 -55.9 27.93 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.55000000000000004 113.074 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 90.5 m-85 -54.23 -53.94 53.32 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.73 0.265 . . . . 1.6200000000000001 111.273 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.7 Cg_exo -45.08 -34.57 9.42 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.2 1.934 . . . . 0.64000000000000001 112.966 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.474 HG12 ' O ' ' B' ' 177' ' ' ILE . 48.8 mm -65.79 -60.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.856 0.36 . . . . 1.27 111.503 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.514 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.9 m -56.84 -24.37 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.417 -0.356 . . . . 0.68999999999999995 111.154 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -69.23 -53.66 18.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 1.1799999999999999 111.857 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 185' ' ' ILE . 10.5 tt -62.06 -51.65 69.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 111.852 0.315 . . . . 1.77 111.852 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.425 ' N ' HG23 ' B' ' 184' ' ' ILE . 2.3 pp -60.66 131.02 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 1.6899999999999999 110.647 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 68.28 165.83 3.57 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.638 -0.791 . . . . 1.5800000000000001 112.365 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.11 85.52 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.446 2.097 . . . . 2.5099999999999998 112.315 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 13.6 m 55.85 42.95 28.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 3.5800000000000001 110.921 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -166.52 -124.7 0.73 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.663 -0.78 . . . . 4.0300000000000002 112.574 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.516 ' H ' HD11 ' B' ' 193' ' ' ILE . 48.6 t80 -113.38 -26.1 8.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 6.8899999999999997 111.011 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . 0.448 ' H ' HG12 ' B' ' 193' ' ' ILE . . . 147.53 116.4 0.92 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.804 -0.712 . . . . 3.7000000000000002 112.532 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 57.47 32.89 22.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.733 0.302 . . . . 7.5 111.159 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.516 HD11 ' H ' ' B' ' 190' ' ' PHE . 47.1 pt -138.44 143.99 31.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.316 -0.402 . . . . 2.3500000000000001 111.454 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -147.85 6.79 0.81 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.05 -0.523 . . . . 3.8599999999999999 110.61 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -82.55 -162.54 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 5.0499999999999998 110.827 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 73.9 p -60.22 -21.3 61.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 2.6800000000000002 111.329 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 48.7 mm -48.15 -35.58 5.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.841 0.353 . . . . 2.4700000000000002 111.111 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -51.4 -55.68 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 2.5299999999999998 111.04 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 72.3 p -56.87 -38.09 72.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.29 111.658 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -57.0 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 2.6200000000000001 111.342 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 57.1 tp -83.36 -41.75 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.455 -0.339 . . . . 1.6100000000000001 111.133 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -77.88 -0.97 29.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 1.4199999999999999 111.162 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 37.0 t -96.14 -43.59 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.127 0.489 . . . . 1.4299999999999999 110.263 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 42.9 tp -72.97 -36.82 67.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.665 -0.698 . . . . 1.1200000000000001 111.98 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.688 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 34.2 tp -58.08 -54.51 54.9 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.029 -0.268 . . . . 1.26 111.596 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 34.3 Cg_exo -58.8 -39.44 81.74 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.757 1.638 . . . . 0.59999999999999998 111.471 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.98 -28.23 69.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 1.3999999999999999 110.226 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -75.43 -25.53 57.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.047 -0.524 . . . . 1.4099999999999999 110.546 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 92.3 p -92.43 -19.25 22.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 1.3200000000000001 110.55 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.762 ' H9 ' H192 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.76 -30.13 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 1.6899999999999999 110.987 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.05 60.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.837 -0.697 . . . . 0.79000000000000004 112.121 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -58.97 -39.06 80.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.744 0.307 . . . . 2.96 111.211 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 42.2 t -56.49 -61.07 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.29 111.203 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.28 -20.03 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 3.1499999999999999 110.955 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tt -72.1 -45.23 61.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 1.51 110.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.37 -27.02 67.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 2.1899999999999999 110.82 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.66 -46.19 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 1.98 111.201 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -74.38 -43.41 56.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 2.1699999999999999 111.29 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.64 -18.73 72.33 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.781 -0.723 . . . . 1.3600000000000001 112.86 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.61 -55.4 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.546 0.212 . . . . 2.8999999999999999 111.079 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' B' ' 164' ' ' LEU . 80.2 mtp180 59.52 96.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.236 -0.438 . . . . 5.6100000000000003 110.743 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.89 124.53 17.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 4.04 111.02 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 93.9 mt -141.68 179.55 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.939 -0.573 . . . . 6.2999999999999998 110.743 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -145.76 94.98 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.504 . . . . 4.7999999999999998 111.066 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.28 18.14 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 6.3899999999999997 110.87 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 49.4 m -119.59 90.6 3.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 5.6100000000000003 110.824 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -97.72 68.67 2.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.301 -0.409 . . . . 8.1999999999999993 110.987 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 8.1699999999999999 111.013 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.715 0.293 . . . . 5.6200000000000001 110.817 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -127.25 -71.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 5.2800000000000002 111.197 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . 0.744 HD23 ' H ' ' C' ' 3' ' ' LEU . 2.5 pt? -107.97 136.64 47.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 6.0499999999999998 111.044 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -135.87 -42.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 4.79 110.949 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 41.0 t -96.46 138.42 34.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 2.71 110.888 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.463 ' N ' HD12 ' C' ' 6' ' ' LEU . 5.4 mp -111.32 -17.3 13.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 2.52 110.452 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' C' ' 11' ' ' TYR . 3.7 mm? -60.83 -31.58 71.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 1.9299999999999999 110.921 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 32.3 m170 -69.54 -32.29 71.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 1.26 110.746 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -75.44 -54.64 6.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.23 -0.441 . . . . 1.6699999999999999 110.954 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 36.6 mm -57.04 -22.21 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.09 0.472 . . . . 1.8700000000000001 110.32 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' C' ' 7' ' ' LEU . 4.3 t80 -67.64 -59.34 3.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.649 -0.705 . . . . 1.4399999999999999 110.773 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.15 -29.22 46.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.46999999999999997 111.351 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.91 -47.81 70.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.58999999999999997 111.369 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.99 -31.13 79.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.5 112.81 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 24.9 mmt -72.18 -25.04 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.363 . . . . 0.68000000000000005 111.079 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 85.7 m -69.68 -53.33 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.055 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.73 -24.06 34.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 1.55 111.12 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -54.11 30.66 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.87 -0.681 . . . . 0.70999999999999996 112.513 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.9 70.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.77000000000000002 110.974 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 41.0 tp -64.8 -33.68 76.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.128 -0.487 . . . . 1.9299999999999999 110.649 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -63.84 -19.86 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 1.8600000000000001 110.998 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.24 -58.24 9.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 4.1399999999999997 111.127 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.78 -33.78 76.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 3.1499999999999999 111.039 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -71.89 -22.34 61.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 1.95 111.169 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.431 ' HB3' HE22 ' C' ' 34' ' ' GLN . 29.9 tp -84.63 -6.0 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 2.2200000000000002 111.106 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 98.5 p -67.62 -12.89 61.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.3700000000000001 110.82 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -47.94 -42.83 28.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.189 -0.671 . . . . 5.0300000000000002 109.189 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.6 p-10 -177.16 130.66 0.34 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.193 -0.912 . . . . 2.3700000000000001 110.201 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 85.0 Cg_endo -99.09 170.26 0.52 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.242 2.628 . . . . 2.0499999999999998 112.056 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -89.22 56.03 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.371 . . . . 4.5199999999999996 110.955 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.28 -44.11 3.31 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.9 -0.667 . . . . 2.1600000000000001 112.648 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.43 HG12 HD21 ' C' ' 221' ' ' LEU . 10.2 p -85.23 132.27 45.77 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.456 0.169 . . . . 2.5299999999999998 111.081 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.465 ' HB2' ' HD2' ' C' ' 35' ' ' TYR . 35.4 Cg_exo -59.17 158.79 24.58 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.324 2.016 . . . . 1.9299999999999999 111.996 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . 0.431 HE22 ' HB3' ' C' ' 25' ' ' LEU . 15.1 mm100 -58.92 -17.2 22.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.63 -0.714 . . . . 4.1200000000000001 112.429 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.465 ' HD2' ' HB2' ' C' ' 33' ' ' PRO . 5.4 p90 -45.1 -33.53 2.21 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.735 0.302 . . . . 2.8900000000000001 111.367 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.74 -49.1 72.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.953 0.406 . . . . 2.46 110.128 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . 0.41 ' HD2' ' HA ' ' C' ' 34' ' ' GLN . 58.9 m-85 -70.48 -18.76 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 2.7799999999999998 110.476 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' C' ' 41' ' ' MET . 39.1 tp -60.48 -56.78 17.29 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.274 -0.421 . . . . 1.6200000000000001 110.496 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.26 -36.46 74.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.229 -0.441 . . . . 1.5900000000000001 110.014 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -74.74 -4.34 36.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.934 -0.576 . . . . 0.65000000000000002 110.747 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.479 ' HB3' ' O ' ' C' ' 38' ' ' LEU . 23.9 ttt -88.52 -37.31 15.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.917 -0.583 . . . . 1.6699999999999999 110.485 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.92 -34.57 69.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 3.4199999999999999 111.252 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.605 HG23 HG23 ' C' ' 79' ' ' THR . 83.0 mt -51.08 -53.58 46.95 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.161 0.43 . . . . 0.89000000000000001 112.161 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.76 -34.4 8.98 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.314 2.01 . . . . 0.40999999999999998 113.231 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 83.7 mt -55.19 -62.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.696 0.284 . . . . 1.76 111.683 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.429 ' HE1' HG13 ' A' ' 110' ' ' ILE . 1.1 t90 -63.38 -53.03 58.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.551 -0.295 . . . . 2.1600000000000001 111.245 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . 0.467 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 39.9 t -53.7 -31.74 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 1.1699999999999999 111.782 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.61 -49.37 60.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.44 112.652 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.454 HD22 ' SG ' ' A' ' 134' ' ' CYS . 50.1 mt -58.25 -35.67 72.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 1.29 111.441 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.87 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.5 111.602 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 22.5 m-85 -61.34 -38.7 87.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 1.8300000000000001 111.512 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 45.7 ttp -50.33 -38.23 40.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.26 0.552 . . . . 1.47 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.64 82.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.503 -0.771 . . . . 0.59999999999999998 110.777 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.8 mtt -51.42 -28.87 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.83999999999999997 110.626 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -72.92 -51.56 18.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.65000000000000002 110.726 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 127' ' ' VAL . 29.1 pt -76.91 9.37 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 1.55 111.492 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 59.12 51.43 7.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.058 -0.519 . . . . 1.54 111.373 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.472 ' HG3' HD11 ' A' ' 118' ' ' ILE . 6.7 tp-100 -120.73 139.62 52.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 1.79 110.877 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.88 32.52 5.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.93999999999999995 112.205 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -139.4 136.19 34.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 2.3599999999999999 111.03 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.28 136.47 59.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.428 -0.351 . . . . 1.97 111.15 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.27 91.32 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 2.4399999999999999 110.63 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.85 128.7 55.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 1.54 111.033 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.93 33.66 19.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.076 -0.511 . . . . 1.71 111.093 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 16.05 61.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.769 -0.729 . . . . 1.53 112.499 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.53 125.17 41.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.742 0.306 . . . . 2.23 110.737 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 25.8 pt -75.57 133.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 1.3600000000000001 111.398 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.01 113.01 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.78000000000000003 110.923 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.545 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 91.6 m-70 -75.64 79.07 2.62 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.286 0.565 . . . . 1.0800000000000001 111.211 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -57.73 -34.94 70.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.404 -0.816 . . . . 2.2999999999999998 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.35 -22.68 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.75 111.871 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.8 tpp180 -67.62 -51.47 49.76 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.435 0.532 . . . . 1.51 112.435 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.519 ' O ' ' HG2' ' C' ' 77' ' ' MET . 28.8 p90 -87.1 -30.95 20.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.435 0.532 . . . . 4.6500000000000004 112.435 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.9 tp -56.46 -41.16 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.564 -0.455 . . . . 1.22 110.108 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 19.6 t0 -69.8 -20.61 63.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.994 -0.743 . . . . 1.3100000000000001 108.994 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -89.75 9.9 25.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.249 -0.887 . . . . 1.6799999999999999 110.888 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 92.0 mmm -105.05 -21.86 13.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 1.8 110.152 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.57 -29.1 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 1.1899999999999999 112.163 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.605 HG23 HG23 ' C' ' 43' ' ' ILE . 61.9 m -83.42 -49.49 9.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.212 0.449 . . . . 1.23 112.212 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 19.2 m -55.05 -50.73 84.79 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 111.898 0.333 . . . . 0.58999999999999997 111.898 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 50.4 Cg_exo -54.69 -47.92 24.1 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.917 1.745 . . . . 0.67000000000000004 111.665 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.27 -27.71 68.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.921 -0.581 . . . . 0.95999999999999996 110.573 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.501 HD13 ' O ' ' C' ' 83' ' ' LEU . 1.2 tm? -67.55 -38.04 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.257 0.551 . . . . 1.1899999999999999 109.632 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tt -78.56 -25.63 45.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 1.7 110.871 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.04 -33.0 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 1.6200000000000001 111.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 60.1 m -62.91 -54.06 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.26 110.978 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 pp -61.8 -22.15 65.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.1100000000000001 111.08 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -50.51 52.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 1.51 110.648 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -60.67 -28.23 68.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.406 . . . . 2.0600000000000001 110.68 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 52.8 m -60.88 -52.43 65.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 1.52 110.801 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.51 -12.25 60.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.191 -0.459 . . . . 1.3 111.056 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 12.9 tpt -86.86 112.89 22.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 1.6200000000000001 110.488 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -86.55 -61.55 1.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.318 -0.401 . . . . 3.2400000000000002 111.442 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -130.97 144.3 51.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 4.6299999999999999 111.301 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 18.7 tt -109.32 146.13 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 2.1800000000000002 110.739 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -124.54 -83.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.571 -0.286 . . . . 4.1200000000000001 111.247 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -139.2 3.38 2.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.72 0.295 . . . . 4.96 111.332 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.41 91.89 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 3.9100000000000001 110.698 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -107.6 -13.59 15.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 5.21 111.29 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 7.3 t -69.35 -27.71 65.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 1.8200000000000001 111.245 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.16 -35.5 75.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 2.0800000000000001 110.957 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.1 -38.9 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.906 -0.588 . . . . 1.8600000000000001 111.294 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -35.5 92.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.58999999999999997 112.571 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -65.17 -35.82 82.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.662 0.268 . . . . 1.53 110.847 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.25 -45.66 83.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 110.974 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . 0.421 ' O ' HG13 ' C' ' 110' ' ' ILE . 91.0 mmm -62.44 -43.31 99.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 2.21 110.715 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -53.71 -51.2 64.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 1.28 111.479 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 75.7 p -59.64 -30.34 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 1.22 111.761 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -74.55 -50.45 18.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 2.3300000000000001 111.654 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.619 HG22 ' HE1' ' B' ' 46' ' ' TRP . 58.9 mt -52.34 -34.92 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.399 -0.364 . . . . 1.29 111.499 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.22 -48.94 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.0600000000000001 111.494 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.34 -56.55 16.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.51000000000000001 111.874 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' C' ' 110' ' ' ILE . 25.4 pt -54.51 -32.37 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 1.3700000000000001 111.804 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 20.3 m -60.66 -46.76 89.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.77000000000000002 110.899 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.1 m -67.32 -20.58 65.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.092 -0.504 . . . . 1.1899999999999999 110.939 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.72 -40.87 11.61 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.986 -0.626 . . . . 0.5 113.058 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.505 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.8 pp -73.68 -29.65 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.289 . . . . 1.47 111.424 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.505 ' N ' HD12 ' C' ' 117' ' ' LEU . 10.1 tp -81.22 -28.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.806 0.336 . . . . 1.2 110.988 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.46 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.02 -0.537 . . . . 0.40000000000000002 110.994 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.57 -24.74 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 2.1200000000000001 111.116 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 93.5 mt -88.02 33.83 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.75 110.715 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 83.4 p -77.95 132.73 38.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 1.3799999999999999 111.007 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.99 -25.61 29.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 2.7400000000000002 110.577 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -134.72 152.57 51.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.897 -0.592 . . . . 2.7999999999999998 110.53 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.91 -11.09 60.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 2.4100000000000001 111.315 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -92.81 -40.64 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.463 -0.335 . . . . 4.2000000000000002 111.071 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.42 -23.9 25.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.242 -0.436 . . . . 1.0800000000000001 110.822 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -66.74 -35.79 80.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.948 -0.569 . . . . 2.5699999999999998 111.0 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -65.0 -32.15 73.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 3.8100000000000001 111.203 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.63 -54.38 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 1.4199999999999999 111.2 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -58.6 -28.68 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.89000000000000001 111.286 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.72 -44.99 80.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 1.26 110.861 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 81.7 mt -56.92 -37.27 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 1.6799999999999999 110.744 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . 0.476 ' SG ' HD22 ' B' ' 49' ' ' LEU . 53.8 t -70.36 -27.06 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 1.24 110.766 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.3 -56.7 20.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.54000000000000004 112.385 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.9 -32.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 1.0600000000000001 110.985 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 50.1 t -63.39 -35.71 81.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 110.301 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.75 92.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.775 -0.648 . . . . 0.56999999999999995 110.838 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -69.81 -16.12 63.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 1.6799999999999999 110.779 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.21 -58.59 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 1.7 110.592 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 17.2 pt -71.15 -27.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.78000000000000003 111.596 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.98 -44.31 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.333 -0.394 . . . . 2.2400000000000002 111.221 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 63.9 tp -55.54 -57.94 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.334 . . . . 1.02 111.078 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -62.77 -24.98 67.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 3.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.23 -16.84 79.61 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 1.27 112.64 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . 0.433 ' C ' ' HD2' ' C' ' 149' ' ' PRO . 69.1 mt -105.52 -18.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 1.8899999999999999 111.183 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -62.3 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 1.6000000000000001 111.932 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.672 ' HB2' ' HD3' ' C' ' 149' ' ' PRO . 69.1 m-80 -71.98 -52.7 7.41 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.344 0.498 . . . . 99.989999999999995 112.344 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 23.9 Cg_exo -64.99 -0.43 3.27 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.39 2.06 . . . . 2.73 113.228 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' C' ' 150' ' ' LEU . 15.1 tp -104.39 59.02 0.71 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 4.2999999999999998 110.918 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? 53.72 64.43 1.84 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.765 -0.652 . . . . 8.9000000000000004 111.238 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' C' ' 148' ' ' ASN . . . -83.22 -39.37 21.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.243 -0.435 . . . . 2.7999999999999998 111.225 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -70.62 -29.15 65.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.183 -0.462 . . . . 5.4400000000000004 110.844 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 12.7 m -66.41 -15.53 63.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 3.3900000000000001 111.158 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -65.32 -25.39 67.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 6.9199999999999999 111.143 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 77.1 p -102.9 5.91 38.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 4.8700000000000001 111.077 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -101.13 -62.05 1.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 4.0499999999999998 110.648 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 39.0 t -115.39 118.53 33.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 3.0299999999999998 110.824 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 63.2 m -75.77 -21.3 57.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 2.96 110.738 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.92 -58.75 3.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 3.7400000000000002 110.777 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.62 -22.06 66.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 2.6499999999999999 111.135 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.78 -46.08 66.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 1.77 111.27 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -62.51 -44.02 97.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 2.96 111.412 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.16 -62.73 1.63 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.124 0.488 . . . . 2.3500000000000001 110.774 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -23.58 46.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.373 -0.83 . . . . 2.6200000000000001 111.192 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.4 -50.48 63.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 2.0899999999999999 110.751 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -61.09 -35.78 77.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 3.2400000000000002 110.821 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.7 -62.81 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 1.6899999999999999 111.227 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.09 -32.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.874 -0.603 . . . . 1.3999999999999999 111.479 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.7 m -57.11 -53.08 62.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.362 . . . . 0.95999999999999996 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -56.16 -39.25 72.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 3.6499999999999999 110.84 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -62.75 -32.13 73.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 1.3700000000000001 111.084 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 34.2 m -73.8 -46.69 43.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.508 . . . . 1.4299999999999999 111.413 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.61 -28.95 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 1.6200000000000001 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.8 tp -80.52 -57.67 3.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.356 -0.384 . . . . 2.0299999999999998 111.678 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.28 -28.14 62.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.748 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.449 ' O ' HG13 ' C' ' 181' ' ' ILE . 34.2 mm -87.83 -23.33 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 1.5800000000000001 110.166 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.51 24.56 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.814 -0.63 . . . . 0.56000000000000005 113.155 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 66.2 m-85 -53.85 -54.97 40.73 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.899 0.349 . . . . 1.3300000000000001 111.069 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 80.4 Cg_exo -45.36 -33.54 9.08 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.946 1.764 . . . . 0.63 112.664 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.449 HG13 ' O ' ' C' ' 177' ' ' ILE . 87.3 mt -63.9 -61.14 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.568 -0.287 . . . . 0.93000000000000005 111.483 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 p -56.95 -35.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 1.27 111.623 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -57.13 -51.37 69.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.564 -0.289 . . . . 1.77 111.147 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 88.9 mt -55.0 -65.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.371 -0.377 . . . . 2.3900000000000001 111.656 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.427 ' O ' HD12 ' C' ' 185' ' ' ILE . 2.5 pp -52.98 135.92 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.077 0.465 . . . . 1.95 111.248 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 66.02 161.67 0.97 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.944 -0.646 . . . . 1.8799999999999999 112.425 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.51 81.43 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.369 2.046 . . . . 3.1200000000000001 112.166 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 42.5 t 55.15 50.35 15.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.109 -0.496 . . . . 2.6299999999999999 110.755 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -170.34 -96.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.808 -0.711 . . . . 3.04 112.524 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . 0.495 ' N ' HD11 ' C' ' 193' ' ' ILE . 87.8 t80 -145.2 -31.93 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 5.6900000000000004 110.856 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . 0.567 ' H ' HG12 ' C' ' 193' ' ' ILE . . . 151.24 110.84 0.5 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.72 -0.752 . . . . 3.0800000000000001 112.522 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 57.21 28.89 15.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.72 0.295 . . . . 7.5300000000000002 111.092 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . 0.567 HG12 ' H ' ' C' ' 191' ' ' GLY . 20.1 pt -120.38 160.25 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.021 0.438 . . . . 2.8599999999999999 111.213 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -167.28 12.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.954 -0.567 . . . . 3.6899999999999999 110.643 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -92.9 -162.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.069 -0.514 . . . . 5.4800000000000004 110.961 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.8 m -63.0 -19.72 64.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 2.3799999999999999 110.979 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 49.1 mm -51.28 -33.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.185 -0.461 . . . . 2.23 111.462 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.52 -56.43 18.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.392 . . . . 2.1600000000000001 111.007 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.6 p -60.99 -31.18 70.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 1.27 111.478 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.3 -39.0 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 1.7 111.333 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.0 -45.49 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 2.02 111.435 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.21 -3.22 12.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.746 0.308 . . . . 1.8200000000000001 110.984 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 25.6 t -96.19 -40.95 8.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.197 0.522 . . . . 1.3500000000000001 110.072 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 55.5 tp -74.12 -37.55 64.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.512 -0.767 . . . . 0.65000000000000002 111.733 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.666 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 52.1 tp -57.19 -53.84 61.0 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.765 -0.198 . . . . 1.4199999999999999 111.463 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 32.6 Cg_exo -58.59 -42.35 55.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.73 1.62 . . . . 0.63 111.476 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' C' ' 11' ' ' TYR . 51.3 t80 -64.11 -26.43 68.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.106 -0.497 . . . . 1.49 110.393 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -75.36 -26.01 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 1.7 110.479 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 89.2 p -93.99 -24.88 17.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 1.25 110.811 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.729 H183 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 30.5 m -64.95 -28.57 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 1.6100000000000001 111.279 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.33 -32.46 62.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.78 . . . . 0.81999999999999995 112.619 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.71 -36.76 70.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.671 0.272 . . . . 3.0800000000000001 111.038 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 47.3 t -61.34 -56.31 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 110.947 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -61.23 -25.54 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 2.5600000000000001 110.853 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.42 -51.08 32.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 1.29 110.827 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.19 -21.47 63.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 2.3900000000000001 111.25 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.56 -35.56 39.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 2.0299999999999998 111.203 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -82.28 -33.4 29.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.972 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -81.14 -18.75 68.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.852 -0.69 . . . . 1.3600000000000001 112.364 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . 0.43 HD21 HG12 ' C' ' 32' ' ' VAL . 55.0 tp -58.0 -58.21 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.553 0.216 . . . . 2.8999999999999999 111.211 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' C' ' 222' ' ' ARG . 7.6 tpm_? 60.29 98.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.256 -0.429 . . . . 4.8899999999999997 110.659 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.66 111.7 1.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 4.2300000000000004 111.167 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 96.2 mt -134.8 151.73 51.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.962 -0.563 . . . . 6.1200000000000001 110.84 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -111.62 101.0 9.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 4.5499999999999998 111.013 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -165.31 71.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.139 -0.482 . . . . 6.7800000000000002 110.496 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.8 t -137.26 -64.77 0.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 5.4000000000000004 110.85 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 55.41 82.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 8.3300000000000001 110.997 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 7.9100000000000001 110.845 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.869 0.366 . . . . 5.1100000000000003 110.841 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 56.13 74.26 0.4 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.03 -0.532 . . . . 5.04 110.896 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 34.1 tp -142.91 127.53 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 5.5800000000000001 110.693 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -119.56 132.42 55.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 5.0199999999999996 111.193 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -102.33 137.25 40.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 2.4500000000000002 110.61 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt -104.36 -3.27 24.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.312 -0.404 . . . . 2.4199999999999999 111.261 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.85 -59.67 2.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.332 . . . . 2.0899999999999999 111.171 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 35.5 m80 -59.86 -23.69 63.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 1.1599999999999999 110.586 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.415 ' O ' HG12 ' A' ' 12' ' ' VAL . 61.4 t-105 -66.33 -54.51 23.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.79000000000000004 110.765 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.45 -23.18 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 2.0800000000000001 110.51 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.488 ' OH ' ' HB2' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -60.32 -61.28 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.64 . . . . 1.28 111.108 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 9' ' ' TRP . 8.1 p -57.19 -32.79 41.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.4 . . . . 1.3200000000000001 111.188 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.85 98.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.63 111.024 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.57 -22.16 78.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.833 -0.699 . . . . 0.55000000000000004 112.365 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.0 mmt -73.29 -42.56 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 1.03 110.825 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.4 p -61.67 -49.85 74.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 1.3 111.11 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.77 -24.27 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.38 -0.373 . . . . 1.3100000000000001 110.982 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.58 -46.6 91.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.766 -0.731 . . . . 0.77000000000000002 112.551 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.1 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.747 0.308 . . . . 0.80000000000000004 111.201 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.92 -28.62 69.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 1.8100000000000001 110.972 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -54.96 -32.79 61.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 1.8799999999999999 110.63 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -75.15 -36.7 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 4.4500000000000002 110.842 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -54.58 -34.72 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.916 0.388 . . . . 3.6899999999999999 110.678 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.8 m -85.31 -29.65 24.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 1.5700000000000001 111.178 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.3 tp -87.27 -5.62 58.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 1.95 111.297 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.1 p -60.2 -19.81 55.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.3799999999999999 111.188 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -50.01 -32.24 14.8 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.187 0.517 . . . . 4.0700000000000003 109.726 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -176.15 132.17 0.4 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.103 -0.953 . . . . 2.7200000000000002 109.912 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -95.52 -176.84 0.39 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.877 2.385 . . . . 1.9099999999999999 112.609 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -86.43 45.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 4.7599999999999998 110.979 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.71 -45.74 3.38 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.881 -0.676 . . . . 1.99 112.613 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.8 118.99 71.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 2.7000000000000002 111.265 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' TYR . 51.2 Cg_exo -55.06 168.61 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.961 2.441 . . . . 1.79 112.351 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -39.63 -18.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.335 -0.848 . . . . 4.1200000000000001 113.17 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 m-30 -41.27 -60.47 1.25 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.887 0.375 . . . . 2.9300000000000002 111.396 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.23 -41.95 97.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.034 -0.53 . . . . 2.8799999999999999 111.597 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -69.27 -19.36 63.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.618 -0.264 . . . . 4.6600000000000001 111.484 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.08 -55.55 10.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.953 0.406 . . . . 1.45 110.268 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.655 HG23 HD12 ' A' ' 82' ' ' LEU . 4.3 p -68.35 -31.32 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.78 111.031 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.6 -13.05 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.524 . . . . 0.63 111.663 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.491 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 17.0 tmm? -89.12 -35.51 16.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 1.48 111.287 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -77.81 -33.81 52.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.279 0.474 . . . . 3.5 112.279 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.592 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 88.6 mt -54.06 -50.54 83.74 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 111.753 0.279 . . . . 1.0800000000000001 111.753 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 12.1 Cg_exo -71.23 -43.22 1.61 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.647 2.232 . . . . 0.53000000000000003 113.059 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 41' ' ' MET . 42.3 mm -56.38 -61.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.778 0.288 . . . . 1.6799999999999999 111.778 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -55.18 -58.36 8.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.652 0.263 . . . . 1.8300000000000001 111.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.6 p -52.01 -42.16 62.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 1.0900000000000001 111.535 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -48.8 -60.35 6.04 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.129 -0.557 . . . . 0.40999999999999998 112.992 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.23 -34.87 58.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.98999999999999999 111.204 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.49 83.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.47999999999999998 111.29 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 57.4 m-85 -63.82 -49.64 72.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.8700000000000001 111.324 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.7 ttp -47.02 -34.4 5.63 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 1.49 110.352 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.96 -44.21 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.762 -0.654 . . . . 0.58999999999999997 110.926 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.404 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 53.5 mtt -52.42 -27.72 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.48999999999999999 110.209 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.87 47.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.718 -0.674 . . . . 0.59999999999999998 110.385 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.4 -2.13 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.002 -0.545 . . . . 1.3100000000000001 110.847 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.52 43.11 2.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.938 -0.574 . . . . 1.9099999999999999 111.108 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.405 HE21 HG21 ' B' ' 127' ' ' VAL . 6.5 tp-100 -121.56 159.14 27.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.947 -0.569 . . . . 1.6200000000000001 110.509 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.06 13.91 44.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.817 -0.706 . . . . 1.04 112.114 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -132.57 140.2 48.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.787 0.327 . . . . 2.6800000000000002 110.697 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.24 150.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 1.98 111.192 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.64 92.55 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 2.1800000000000002 110.611 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.66 137.48 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.5700000000000001 111.073 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.07 17.18 7.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.511 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.8 -13.07 63.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 1.48 112.699 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -98.45 155.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.969 0.414 . . . . 2.3199999999999998 111.164 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.6 mt -105.26 106.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.96 -0.564 . . . . 1.4399999999999999 110.861 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.73 138.39 33.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.81999999999999995 111.482 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.8 m-70 -97.73 74.55 2.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.979 -0.555 . . . . 0.90000000000000002 110.615 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -56.41 -45.7 80.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.557 -0.747 . . . . 1.8300000000000001 111.684 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -67.21 -27.16 67.02 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.189 0.44 . . . . 0.62 112.189 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 20.4 tpp180 -64.16 -51.61 63.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.596 0.591 . . . . 2.3399999999999999 112.596 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.507 ' O ' ' HG3' ' A' ' 77' ' ' MET . 15.9 p90 -87.06 -26.15 23.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.455 -0.498 . . . . 3.4900000000000002 112.297 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 71' ' ' ALA . 9.6 tp -55.87 -42.38 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.6 -0.44 . . . . 1.3700000000000001 110.125 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -70.01 -21.34 63.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.16 -0.682 . . . . 1.3100000000000001 109.16 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -84.77 2.81 40.44 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.364 -0.835 . . . . 1.48 111.243 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 38.9 mtp -103.06 -22.87 13.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 1.46 110.931 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.447 ' O ' HD23 ' A' ' 82' ' ' LEU . 28.9 m -114.52 -36.04 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.453 0.538 . . . . 1.1200000000000001 112.453 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 43' ' ' ILE . 36.0 m -72.58 -52.32 16.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.902 0.334 . . . . 1.1000000000000001 111.902 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.578 HG22 ' NE2' ' A' ' 109' ' ' GLN . 10.5 m -53.82 -51.37 77.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.583 0.586 . . . . 0.59999999999999998 112.583 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 80' ' ' THR . 12.1 Cg_endo -55.72 -44.36 48.6 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.49 1.46 . . . . 0.73999999999999999 111.511 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.655 HD12 HG23 ' A' ' 39' ' ' VAL . 3.9 mm? -64.2 -31.37 72.54 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.601 -0.518 . . . . 1.01 109.601 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 83' ' ' LEU . 1.6 tt -68.87 -24.53 64.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.531 0.682 . . . . 1.48 109.206 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.22 -32.11 24.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.129 -0.941 . . . . 1.3799999999999999 110.474 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.67 -36.14 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.751 -0.659 . . . . 1.1899999999999999 111.172 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.1 t -58.27 -25.09 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 1.23 110.943 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.57 -40.48 63.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.88 110.834 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -61.05 -37.26 82.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 1.3899999999999999 111.044 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -73.83 -38.65 64.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.27 -0.423 . . . . 2.3199999999999998 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.21 -29.07 70.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 1.46 111.031 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.29 -40.38 13.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.24 111.239 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.3 mtp -99.99 107.28 19.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 2.0699999999999998 111.076 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -82.17 -27.53 32.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 3.5299999999999998 110.488 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -133.55 138.9 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 4.0800000000000001 110.596 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.04 142.94 23.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 2.1699999999999999 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -124.87 -66.25 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 4.5199999999999996 110.867 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -160.86 80.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 3.75 110.771 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.73 109.55 4.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 3.5299999999999998 110.94 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -129.25 12.04 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 4.9100000000000001 110.741 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.8 t -95.12 -32.22 13.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 1.98 111.395 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 101' ' ' LEU . 1.2 tm? -74.23 -45.13 50.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 1.8300000000000001 110.57 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.37 -33.77 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.391 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.14 -34.77 64.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.62 112.807 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -66.98 -34.99 78.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 1.5800000000000001 111.02 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.2 mt -76.14 -52.1 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.97999999999999998 111.023 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.5 tpt -58.91 -33.25 70.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 1.48 111.451 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.4 p -72.16 -56.62 5.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.43 -0.35 . . . . 1.1299999999999999 111.005 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.0 p -55.75 -25.21 39.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 1.48 110.778 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.578 ' NE2' HG22 ' A' ' 80' ' ' THR . 6.4 tp60 -68.64 -45.98 70.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 2.7000000000000002 110.798 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.436 ' HA ' HD12 ' A' ' 113' ' ' ILE . 60.8 mt -54.37 -36.9 35.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.461 -0.336 . . . . 1.54 110.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.85 -44.66 99.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.28 111.139 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.5 t -66.11 -36.36 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.42999999999999999 111.308 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 110' ' ' ILE . 94.0 mt -60.03 -41.84 87.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.183 -0.462 . . . . 1.74 111.161 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 72.5 m -60.84 -51.7 68.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.63 111.113 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.408 ' HA ' HG22 ' A' ' 118' ' ' ILE . 78.9 p -59.68 -20.16 54.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 1.0900000000000001 110.825 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.79 -36.05 17.13 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.056 -0.592 . . . . 0.41999999999999998 112.898 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -83.09 -28.45 29.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.652 0.263 . . . . 1.3799999999999999 111.625 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 117' ' ' LEU . 10.7 tp -83.93 -28.11 7.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.603 -0.271 . . . . 1.6200000000000001 111.574 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.65 74.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.39000000000000001 110.809 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.5 -12.44 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 2.02 110.74 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 118' ' ' ILE . 91.6 mt -90.42 22.04 3.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.76000000000000001 110.788 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.1 m -86.3 120.67 27.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 1.46 110.864 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -90.32 -68.33 0.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 3.3500000000000001 110.849 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.569 ' HB2' HG12 ' A' ' 127' ' ' VAL . 99.6 mtt180 -64.81 139.63 58.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 2.9199999999999999 110.617 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.11 -9.54 58.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 2.77 110.872 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -88.51 -38.5 14.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 3.77 110.927 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.0 p -79.88 -24.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.1599999999999999 111.018 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.42 ' NH1' ' H ' ' A' ' 188' ' ' SER . 29.2 ttm180 -54.41 -43.52 71.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 2.04 111.059 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.99 -33.89 76.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.17 -0.468 . . . . 2.6400000000000001 110.763 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 127' ' ' VAL . 49.8 mt -66.37 -58.48 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 1.8999999999999999 111.135 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.48 ' HE1' ' HB3' ' C' ' 58' ' ' GLN . 4.6 m95 -55.32 -34.31 64.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 1.3999999999999999 111.191 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -58.41 -48.92 79.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.28 111.067 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mm -61.86 -28.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 2.1600000000000001 111.037 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.44 -33.62 74.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.458 . . . . 1.6899999999999999 110.625 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.57 -50.26 26.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.882 -0.675 . . . . 0.52000000000000002 112.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.65 -30.22 48.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.674 0.273 . . . . 1.02 111.262 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.15 -46.5 77.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 1.0800000000000001 110.774 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.51 -29.88 70.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.62 110.969 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -73.22 -26.85 61.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 1.8400000000000001 110.848 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.85 -53.89 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 1.6899999999999999 111.202 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 142' ' ' ILE . 24.7 pt -61.33 -44.95 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 0.81000000000000005 111.443 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.468 ' N ' HG13 ' A' ' 141' ' ' ILE . 89.6 mt -63.88 -36.6 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.441 -0.345 . . . . 2.3700000000000001 111.078 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.69 -28.48 69.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.97999999999999998 110.588 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -72.78 -34.22 66.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 3.27 110.313 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.73 -35.77 34.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.905 -0.664 . . . . 1.25 112.58 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.434 ' O ' ' HD2' ' A' ' 149' ' ' PRO . 97.4 mt -69.9 -26.21 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.947 0.403 . . . . 2.1200000000000001 110.661 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -88.06 3.12 50.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.958 -0.565 . . . . 1.6599999999999999 110.903 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 51.5 t30 -80.81 -47.88 1.16 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 99.989999999999995 112.175 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 95.9 Cg_exo -44.04 -27.54 1.84 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.594 2.196 . . . . 2.6000000000000001 113.16 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.9 tp -53.82 -59.17 4.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.632 -0.258 . . . . 4.6100000000000003 110.735 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 61.61 110.32 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.08 -0.509 . . . . 8.3599999999999994 111.343 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.53 -29.0 66.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 2.75 111.262 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -79.35 -2.67 42.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.175 -0.466 . . . . 5.6799999999999997 111.178 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.2 m -102.53 -20.83 14.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 3.21 111.016 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -65.53 -17.79 64.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 6.8700000000000001 111.144 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.9 t -89.74 -7.42 54.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.277 -0.42 . . . . 4.5599999999999996 111.052 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -94.08 -72.58 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 3.5600000000000001 110.985 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -114.94 113.03 23.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 2.79 110.866 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 m -78.11 -20.37 52.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 2.5899999999999999 110.743 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -74.56 -60.03 2.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 3.4700000000000002 110.952 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.422 HD12 HD23 ' A' ' 164' ' ' LEU . 40.2 tp -61.4 -27.13 68.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 2.5800000000000001 110.903 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.8 -62.59 1.36 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.066 -0.515 . . . . 1.78 111.262 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.98 -28.76 54.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.277 -0.42 . . . . 2.6299999999999999 110.549 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.422 HD23 HD12 ' A' ' 161' ' ' LEU . 25.6 tp -62.83 -44.0 97.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 2.3399999999999999 110.783 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 169' ' ' VAL . 2.4 t80 -81.25 -21.75 39.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 2.77 110.625 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.64 -50.62 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 2.04 111.272 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -74.97 -27.79 60.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.039 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.66 -47.27 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 1.8899999999999999 111.361 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 165' ' ' TYR . 14.3 p -70.93 -30.32 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 1.6399999999999999 111.492 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.9 m -56.08 -58.4 8.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 1.24 111.309 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -61.42 -35.21 76.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 2.9700000000000002 110.525 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -65.2 -26.57 68.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.886 -0.597 . . . . 1.48 110.813 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 88.6 m -73.93 -49.54 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 1.55 111.34 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.18 -31.45 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.39 -0.368 . . . . 1.52 111.599 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.413 HD13 ' OG ' ' A' ' 209' ' ' SER . 51.7 mt -77.02 -57.47 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.429 -0.351 . . . . 1.8500000000000001 111.401 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.62 111.545 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.518 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 9.9 tp -87.67 -21.27 7.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.125 0.488 . . . . 1.3500000000000001 110.203 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -64.75 -45.29 93.16 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.711 -0.677 . . . . 0.58999999999999997 112.304 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG22 ' A' ' 182' ' ' VAL . 0.4 OUTLIER -53.32 -55.41 34.68 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.703 0.251 . . . . 1.45 111.053 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.518 ' HD2' ' C ' ' A' ' 177' ' ' ILE . 75.6 Cg_exo -48.96 -38.84 39.73 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.227 1.951 . . . . 0.55000000000000004 112.4 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 184' ' ' ILE . 98.5 mt -54.62 -59.16 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.211 -0.45 . . . . 1.4199999999999999 111.605 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 179' ' ' TYR . 26.5 m -67.69 -24.21 30.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.308 -0.405 . . . . 0.78000000000000003 111.288 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -59.58 -53.08 62.23 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.906 0.336 . . . . 0.93999999999999995 111.906 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.0 tt -59.01 -20.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.855 0.317 . . . . 1.4299999999999999 111.855 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 tt -115.76 102.63 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.096 0.474 . . . . 2.02 111.473 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 132.67 -164.83 23.96 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.757 -0.735 . . . . 1.79 112.579 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.5 160.56 49.06 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.614 2.209 . . . . 3.1000000000000001 111.992 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.42 ' H ' ' NH1' ' A' ' 128' ' ' ARG . 47.1 t 59.25 12.01 2.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 2.7400000000000002 110.61 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -131.72 -61.6 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.977 -0.63 . . . . 3.4300000000000002 112.324 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -172.62 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 6.5 110.683 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.58 165.89 7.61 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.994 -0.622 . . . . 3.29 112.649 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -118.27 25.91 9.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 6.1600000000000001 110.712 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 28.5 pt -107.58 162.7 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 2.4199999999999999 111.53 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -167.93 67.63 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 4.29 110.488 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.453 ' HB2' HG22 ' A' ' 197' ' ' ILE . 48.9 mt-30 -112.35 -169.53 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 5.1500000000000004 110.783 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.9 p -69.33 -26.98 64.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 2.4500000000000002 111.174 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 195' ' ' GLN . 7.5 tp -60.25 -38.09 76.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 2.48 111.625 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.98 -57.73 9.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 2.1800000000000002 110.639 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.5 p -60.17 -17.26 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 1.49 111.012 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -81.97 -30.47 31.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 1.77 110.937 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.76 -37.28 22.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 1.4199999999999999 111.195 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -76.48 -13.79 60.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.478 -0.328 . . . . 1.78 111.309 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 15.7 p -96.15 -37.07 10.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.972 0.415 . . . . 1.3 110.592 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 66.3 tp -72.7 -33.8 66.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.66000000000000003 111.668 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.665 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 47.2 tp -60.72 -53.79 60.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 121.122 -0.231 . . . . 1.6299999999999999 111.348 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.03 -42.34 67.71 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.931 1.754 . . . . 0.64000000000000001 111.44 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.488 ' HB2' ' OH ' ' A' ' 11' ' ' TYR . 90.5 t80 -61.72 -35.63 78.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.111 -0.495 . . . . 1.3600000000000001 110.251 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.418 ' HA ' HG12 ' A' ' 211' ' ' VAL . 72.7 t80 -75.78 -20.94 57.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.834 -0.621 . . . . 1.54 110.846 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.413 ' OG ' HD13 ' A' ' 175' ' ' LEU . 29.8 t -87.46 -12.5 45.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 1.2 111.127 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYR . . . . . 0.739 H192 ' H9 ' ' A' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 208' ' ' PHE . 9.1 p -72.99 -38.55 56.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.372 . . . . 1.6399999999999999 110.914 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.47 -34.16 78.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 0.79000000000000004 112.393 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.98 -38.18 90.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 1.6100000000000001 110.674 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 69.9 m -58.68 -57.38 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 1.1499999999999999 110.794 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -64.03 -22.8 67.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 3.3399999999999999 110.644 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.81 -48.03 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 111.102 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.86 -31.5 72.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.452 -0.34 . . . . 2.23 111.253 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 52.2 mt -70.15 -57.5 4.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 2.4700000000000002 111.115 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.31 -22.82 65.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 1.6200000000000001 111.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.32 -59.44 10.65 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.817 -0.706 . . . . 1.4099999999999999 112.861 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.28 -55.05 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 2.5800000000000001 110.738 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 54.82 82.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 4.9299999999999997 110.841 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.504 HD22 ' ND2' ' A' ' 225' ' ' ASN . 3.0 p-10 -142.87 142.8 31.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.078 -0.51 . . . . 4.6299999999999999 111.009 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.68 104.24 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 6.4699999999999998 111.03 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.504 ' ND2' HD22 ' A' ' 223' ' ' ASN . 0.9 OUTLIER -100.54 141.27 33.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 5.0700000000000003 110.803 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -130.32 -60.84 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 6.5300000000000002 110.956 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.7 m -142.53 23.74 1.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.368 -0.378 . . . . 5.2199999999999998 110.916 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -74.49 -66.69 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 8.3599999999999994 111.055 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 7.96 110.903 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.771 0.319 . . . . 6.1699999999999999 110.891 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -121.83 91.31 3.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.4 . . . . 4.8200000000000003 110.825 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 19.4 tp -127.23 142.89 51.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 5.5999999999999996 110.7 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -125.59 96.67 4.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.39 -0.368 . . . . 4.7999999999999998 110.964 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 75.3 m -67.76 150.09 49.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.274 -0.421 . . . . 2.3700000000000001 110.876 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt -115.37 -11.53 11.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 2.0699999999999998 110.857 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 39.6 mt -66.34 -48.27 70.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.003 -0.544 . . . . 2.1000000000000001 110.979 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 34.4 m80 -64.76 -24.17 67.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 1.0700000000000001 110.831 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.453 ' O ' HG12 ' B' ' 12' ' ' VAL . 11.2 m95 -70.57 -56.15 7.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 1.48 111.194 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 pt -60.37 -20.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 2.02 110.906 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' B' ' 15' ' ' MET . 6.0 t80 -65.15 -61.3 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.92000000000000004 110.446 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.54 -29.49 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.237 -0.438 . . . . 0.93999999999999995 111.294 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.23 74.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.55000000000000004 110.978 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.58 -26.23 74.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.856 -0.688 . . . . 0.47999999999999998 112.704 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 52.3 mmm -76.81 -37.79 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.35 . . . . 0.84999999999999998 110.908 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 71.2 m -57.58 -55.4 35.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.115 -0.493 . . . . 1.3400000000000001 110.92 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' B' ' 20' ' ' LEU . 1.9 tp -58.45 -36.72 60.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 1.55 110.782 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -45.81 -58.76 5.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.735 -0.745 . . . . 0.69999999999999996 112.293 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.76 -36.4 74.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.686 0.279 . . . . 0.81000000000000005 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' B' ' 17' ' ' ILE . 97.5 mt -64.58 -28.68 69.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 2.2599999999999998 110.814 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -64.63 -32.83 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 1.78 110.327 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.8 -20.49 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 4.5800000000000001 110.587 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -69.36 -43.52 73.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 3.3500000000000001 110.479 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 65.5 m -79.65 -30.38 41.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.133 -0.485 . . . . 1.5800000000000001 110.7 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 35.9 tp -86.48 -1.3 57.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 1.8400000000000001 110.58 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 95.0 p -60.86 -11.68 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 1.3700000000000001 110.903 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.595 ' HG2' HD22 ' B' ' 28' ' ' ASN . 36.7 ttm180 -47.22 -47.25 24.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.001 -0.74 . . . . 4.9800000000000004 109.001 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.595 HD22 ' HG2' ' B' ' 27' ' ' ARG . 9.0 p30 -178.59 129.91 0.28 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.201 -0.909 . . . . 2.1400000000000001 110.337 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' B' ' 31' ' ' GLY . 72.9 Cg_endo -103.32 -82.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.542 2.828 . . . . 1.8200000000000001 112.121 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.623 ' HA ' HD21 ' B' ' 223' ' ' ASN . 49.6 mtp180 -112.63 6.14 18.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.794 0.806 . . . . 5.1900000000000004 109.234 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.523 ' H ' ' HD2' ' B' ' 29' ' ' PRO . . . 123.64 -53.39 0.75 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 114.267 -1.333 . . . . 2.2000000000000002 110.731 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.26 104.98 5.11 Favored Pre-proline 0 C--O 1.232 0.171 0 O-C-N 122.906 -0.173 . . . . 3.6499999999999999 110.692 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.495 ' HG3' ' HG3' ' B' ' 29' ' ' PRO . 69.6 Cg_endo -88.21 107.76 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 119.446 0.838 . . . . 2.6699999999999999 113.117 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -93.47 -58.29 2.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 123.597 1.665 . . . . 4.8799999999999999 108.894 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.556 ' HD2' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -83.4 -61.69 1.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 110.633 -2.985 . . . . 1.8700000000000001 113.823 -177.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.556 ' H ' ' HD2' ' B' ' 35' ' ' TYR . 40.6 tt0 -37.91 -63.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.467 0.914 . . . . 2.6800000000000002 113.467 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -62.34 -40.33 96.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.11 0.411 . . . . 2.9199999999999999 112.11 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -59.23 -65.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.88 0.326 . . . . 1.6399999999999999 111.88 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.58 HG13 HD12 ' B' ' 82' ' ' LEU . 60.5 t -61.93 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.413 0.523 . . . . 1.6000000000000001 112.413 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -14.09 6.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.228 0.455 . . . . 0.68999999999999995 112.228 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.403 ' O ' HG12 ' B' ' 45' ' ' ILE . 27.6 ttt -88.91 -39.65 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 2.5800000000000001 111.546 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -72.01 -42.65 66.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 3.3900000000000001 112.226 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.485 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 93.5 mt -49.62 -52.05 54.02 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.493 0.553 . . . . 0.40999999999999998 112.493 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 50.9 Cg_endo -68.79 -43.44 3.63 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.202 1.935 . . . . 0.48999999999999999 113.302 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.403 HG12 ' O ' ' B' ' 41' ' ' MET . 36.3 mm -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.78 0.324 . . . . 1.29 111.632 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -55.95 -58.3 8.48 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.227 -0.442 . . . . 1.3999999999999999 111.541 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 94.8 p -51.99 -32.9 35.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 1.3799999999999999 111.241 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.67 -57.64 18.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.72 -0.752 . . . . 0.37 112.48 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -60.86 -28.12 68.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 1.29 111.067 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.96 -59.11 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.44 111.16 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 35.1 m-85 -63.75 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.5 111.11 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 19.5 ttt -48.85 -42.74 37.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.063 0.458 . . . . 1.4099999999999999 110.456 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.54 -42.05 87.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.55000000000000004 110.616 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.5 mtt -51.55 -29.38 16.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.5 110.212 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.3 -47.34 57.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.54000000000000004 109.901 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mt -71.92 2.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.499 -0.773 . . . . 1.3 110.804 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 66.78 49.15 1.26 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.751 -0.658 . . . . 2.2400000000000002 111.008 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.01 173.93 7.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.116 -0.493 . . . . 1.77 110.79 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' B' ' 71' ' ' ALA . . . 78.5 21.3 69.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 1.0600000000000001 112.498 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -139.36 144.5 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.722 0.296 . . . . 2.6600000000000001 110.572 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -124.6 146.19 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 1.8899999999999999 111.155 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -101.16 84.04 2.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 2.4100000000000001 110.844 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.87 144.31 42.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 1.5600000000000001 110.925 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.43 16.29 4.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 1.8200000000000001 111.436 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 -15.44 58.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 1.51 112.885 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -98.19 173.17 7.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.841 0.353 . . . . 2.4500000000000002 110.658 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -116.93 118.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.552 . . . . 1.79 111.165 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.89 110.93 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.81999999999999995 111.253 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 57.0 m-70 -70.05 80.31 0.49 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.737 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -65.23 -31.02 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.655 -0.702 . . . . 1.8700000000000001 111.496 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.468 ' HB2' ' HA3' ' B' ' 59' ' ' GLY . . . -79.48 -25.99 41.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.052 0.389 . . . . 0.60999999999999999 112.052 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 22.0 mmt180 -69.6 -51.16 37.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.323 0.49 . . . . 2.3900000000000001 112.323 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' B' ' 117' ' ' LEU . 3.5 p90 -76.14 -36.06 58.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.638 -0.425 . . . . 3.6699999999999999 111.964 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 75' ' ' ASP . 16.9 tt -54.21 -43.68 61.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.728 0.299 . . . . 1.6599999999999999 110.933 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.425 ' N ' HG23 ' B' ' 74' ' ' ILE . 11.6 t70 -67.92 -25.59 65.56 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.235 -0.654 . . . . 1.4099999999999999 109.235 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -85.44 8.56 18.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.677 -0.692 . . . . 1.1599999999999999 110.484 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.527 ' HA ' HD13 ' B' ' 113' ' ' ILE . 45.9 tpp -105.14 -25.64 12.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.684 -0.689 . . . . 1.53 110.713 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.89 -36.75 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.26 -0.427 . . . . 0.89000000000000001 112.129 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -70.54 -57.64 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.919 0.341 . . . . 1.24 111.919 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 31.2 m -48.92 -51.78 52.2 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.535 0.568 . . . . 0.57999999999999996 112.535 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 53.0 Cg_exo -54.16 -45.79 38.34 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.5 1.467 . . . . 0.66000000000000003 111.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.58 HD12 HG13 ' B' ' 39' ' ' VAL . 3.0 mm? -63.03 -32.05 73.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.85 -0.614 . . . . 1.0600000000000001 109.853 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 -23.95 62.34 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.15 -0.685 . . . . 1.22 109.15 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' B' ' 109' ' ' GLN . 16.8 tp -84.41 -29.44 26.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.103 -0.953 . . . . 1.53 110.462 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.69 -38.98 46.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.753 -0.658 . . . . 1.5800000000000001 111.133 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . 0.417 ' HB2' HG11 ' B' ' 39' ' ' VAL . 39.8 t -56.55 -21.06 23.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 1.3899999999999999 110.921 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 44.5 mt -74.86 -37.61 62.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.517 . . . . 1.1499999999999999 111.115 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 36.1 t -72.42 -21.69 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 1.5700000000000001 111.176 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.53 -45.49 15.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.133 -0.485 . . . . 2.1699999999999999 111.138 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -66.83 -23.26 66.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 1.4199999999999999 111.248 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.71 -36.85 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 1.1799999999999999 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 79.1 mtp -105.17 101.17 10.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 1.8799999999999999 110.946 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -73.15 -27.79 61.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 3.4199999999999999 110.863 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -132.14 153.49 50.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 4.0599999999999996 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.44 144.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 2.0899999999999999 111.322 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -165.16 88.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 3.8500000000000001 110.719 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt 58.19 81.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 4.8200000000000003 111.094 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.89 95.8 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 3.7999999999999998 110.859 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -129.07 0.13 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 5.1699999999999999 110.895 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 67.2 p -70.52 -43.3 69.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 2.02 111.095 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 tp -73.37 -36.03 66.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 2.0899999999999999 110.769 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 28.1 mm -60.7 -37.84 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 1.8799999999999999 110.791 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.06 -23.32 63.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.859 -0.686 . . . . 0.56000000000000005 112.357 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -65.79 -38.77 89.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.332 . . . . 1.78 111.072 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.3 mt -81.06 -44.24 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 1.03 111.001 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 11.0 tpt -56.4 -39.76 73.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.594 -0.73 . . . . 1.6699999999999999 111.476 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -72.03 -51.85 19.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 1.51 111.274 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 27.8 p -53.26 -32.79 50.22 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.919 0.39 . . . . 1.1799999999999999 111.379 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.466 ' HB2' HD22 ' B' ' 84' ' ' LEU . 6.5 tp-100 -65.81 -48.55 71.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.056 -0.52 . . . . 2.1699999999999999 111.024 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.95 -43.71 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.3500000000000001 111.619 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.2 -44.06 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 1.3400000000000001 111.334 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.89 -46.3 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.42999999999999999 111.8 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.61 HD11 ' HG3' ' B' ' 81' ' ' PRO . 44.6 mt -56.92 -37.74 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.586 -0.279 . . . . 1.6000000000000001 111.096 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 55.5 m -57.84 -49.66 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.95 0.405 . . . . 0.85999999999999999 110.771 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.6 m -62.89 -21.96 66.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.94999999999999996 110.31 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.66 -43.77 17.71 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.02 -0.61 . . . . 0.46000000000000002 112.497 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.473 ' HB3' ' CD2' ' B' ' 73' ' ' TYR . 3.7 pp -77.47 -24.89 50.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.636 0.255 . . . . 1.75 111.163 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 36.5 mm -82.34 -36.76 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.408 -0.36 . . . . 1.78 111.09 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.49 -46.81 76.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.38 111.435 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -70.82 -17.41 62.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.395 -0.366 . . . . 1.97 111.234 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.13 20.41 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.454 -0.339 . . . . 0.76000000000000001 111.351 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -78.05 125.04 28.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.47 110.781 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.75 -67.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 2.5 110.976 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.583 ' HB2' HG12 ' B' ' 127' ' ' VAL . 92.0 mtt180 -71.44 152.29 43.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 2.73 110.584 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.53 -16.78 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 2.2000000000000002 110.865 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -81.86 -37.01 27.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 3.3999999999999999 110.747 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.8 p -78.43 -24.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.23 110.939 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -58.05 -34.88 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 3.04 110.827 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -76.24 -21.39 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 4.1399999999999997 111.042 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.99 -60.99 2.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 1.6499999999999999 111.162 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -59.98 -27.48 66.87 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.398 -0.365 . . . . 0.77000000000000002 110.971 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.68 -45.75 91.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 1.46 110.284 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -65.26 -33.26 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.044 -0.525 . . . . 1.6299999999999999 110.449 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 47.5 t -62.64 -31.12 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 1.4199999999999999 110.723 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.66 -52.98 13.2 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.838 -0.696 . . . . 0.48999999999999999 112.479 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.38 -31.69 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 1.3 111.335 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 68.5 m -65.08 -46.07 82.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.405 -0.361 . . . . 1.3 110.775 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.93 71.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.62 110.667 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -73.13 -22.77 60.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.74 110.523 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.72 -57.82 4.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 1.76 110.703 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.441 HG13 ' N ' ' B' ' 142' ' ' ILE . 41.2 pt -60.1 -38.43 76.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.68999999999999995 111.517 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.441 ' N ' HG13 ' B' ' 141' ' ' ILE . 94.1 mt -69.81 -34.74 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 1.76 110.956 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.78 -39.59 85.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.291 -0.413 . . . . 1.0600000000000001 110.569 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . 0.681 ' O ' ' ND2' ' B' ' 148' ' ' ASN . 89.4 t90 -62.72 -47.08 85.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.031 -0.532 . . . . 4.1200000000000001 110.799 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . 1.307 ' HA2' ' ND2' ' B' ' 148' ' ' ASN . . . -63.53 -34.08 88.98 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.63 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -74.11 -24.16 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.919 0.39 . . . . 1.98 110.603 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -90.6 3.16 54.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 1.4199999999999999 110.897 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 1.307 ' ND2' ' HA2' ' B' ' 145' ' ' GLY . 69.1 m-80 -80.89 -47.23 1.18 Allowed Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.913 -0.585 . . . . 99.989999999999995 112.251 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 81.8 Cg_exo -44.49 -24.09 0.97 Allowed 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.6 2.2 . . . . 2.6499999999999999 113.175 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.79 -59.57 5.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.509 -0.314 . . . . 4.3899999999999997 110.866 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 61.1 109.67 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.074 -0.512 . . . . 7.9000000000000004 111.242 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.74 -19.72 62.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.245 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -75.95 -28.71 58.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 6.29 110.814 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 81.4 p -88.58 -6.05 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 3.1000000000000001 110.928 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -62.4 -28.64 69.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 6.4299999999999997 110.881 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 5.1 t -91.43 -23.71 19.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.507 . . . . 4.5700000000000003 111.425 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -65.82 -77.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.441 -0.345 . . . . 3.8300000000000001 110.938 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 66.0 p -111.65 113.42 25.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 3.0699999999999998 110.916 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 45.5 t -77.74 -21.97 51.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 3.4300000000000002 111.049 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.57 -45.1 22.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 3.9199999999999999 111.396 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 47.3 tp -73.16 -28.14 62.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.812 0.339 . . . . 2.7000000000000002 110.966 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.59 -61.65 1.76 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 1.8300000000000001 111.099 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -53.91 -25.71 21.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.071 0.462 . . . . 2.6299999999999999 110.449 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 49.2 tp -65.21 -47.68 76.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.74 -0.664 . . . . 2.4300000000000002 110.759 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.425 ' O ' HG12 ' B' ' 169' ' ' VAL . 1.1 t80 -78.14 -23.68 47.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 2.5800000000000001 111.32 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.74 -59.28 4.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 2.0 110.92 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.31 -26.9 65.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 3.0299999999999998 111.327 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.16 -56.14 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.406 -0.361 . . . . 1.1000000000000001 111.104 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 165' ' ' TYR . 14.4 p -68.97 -22.66 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 1.75 111.488 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 41.4 m -54.28 -58.91 5.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.48 -0.327 . . . . 0.97999999999999998 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.67 -42.53 95.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 4.2999999999999998 110.501 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.77 -28.2 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.044 -0.526 . . . . 1.3899999999999999 110.789 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.416 ' O ' HG12 ' B' ' 177' ' ' ILE . 90.2 m -73.52 -50.71 20.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 1.1100000000000001 111.119 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.25 -43.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.315 -0.402 . . . . 1.51 111.93 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' B' ' 209' ' ' SER . 3.8 mm? -70.92 -53.24 15.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.955 0.354 . . . . 1.75 111.955 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -24.14 63.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.704 0.288 . . . . 0.59999999999999998 111.194 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.491 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 36.6 mm -87.57 -22.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 1.47 110.26 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -65.44 -41.93 96.13 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.726 -0.67 . . . . 0.55000000000000004 112.696 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.404 ' O ' HG22 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -56.09 -55.41 42.01 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.744 0.272 . . . . 1.6200000000000001 111.124 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.491 ' HD2' ' C ' ' B' ' 177' ' ' ILE . 78.3 Cg_exo -50.57 -38.75 55.43 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.154 1.903 . . . . 0.64000000000000001 112.243 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.497 ' O ' HG22 ' B' ' 184' ' ' ILE . 37.0 mm -54.04 -58.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 1.27 111.512 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 179' ' ' TYR . 20.9 m -69.23 -24.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.68999999999999995 111.262 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -61.75 -52.59 63.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.026 0.38 . . . . 1.1799999999999999 112.026 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 181' ' ' ILE . 21.1 tt -58.23 -17.21 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 111.998 0.37 . . . . 1.77 111.998 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 8.9 tt -121.54 104.02 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.037 0.446 . . . . 1.6899999999999999 111.532 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 134.56 -157.71 23.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.802 -0.713 . . . . 1.5800000000000001 112.501 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.08 154.8 37.77 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.614 2.21 . . . . 2.5099999999999998 111.894 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 41.7 t 56.87 24.84 9.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 3.5800000000000001 110.661 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . 179.96 65.13 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.699 -0.762 . . . . 4.0300000000000002 112.839 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 64.9 t80 53.68 96.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 6.8899999999999997 111.194 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.99 113.93 0.52 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.83 -0.7 . . . . 3.7000000000000002 112.163 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -88.78 63.18 6.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.342 . . . . 7.5 110.921 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 pt -141.41 140.36 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.238 -0.437 . . . . 2.3500000000000001 111.175 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -150.82 78.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 3.8599999999999999 110.691 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -118.42 -172.95 2.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 5.0499999999999998 110.97 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 46.0 m -67.98 -32.65 73.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 2.6800000000000002 111.05 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 6.4 tp -57.84 -39.24 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.342 -0.39 . . . . 2.4700000000000002 111.389 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.44 -52.95 63.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.5299999999999998 110.914 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 11.4 m -66.64 -19.11 65.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 1.29 110.94 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . 0.439 ' HA ' ' SG ' ' B' ' 203' ' ' CYS . 62.2 t80 -83.51 -27.13 29.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 2.6200000000000001 111.125 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.12 -28.78 27.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.736 0.303 . . . . 1.6100000000000001 111.129 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.85 -12.0 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 1.4199999999999999 111.188 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' B' ' 200' ' ' PHE . 17.2 p -96.22 -32.41 12.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 1.4299999999999999 110.477 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.37 -39.33 59.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 1.1200000000000001 111.408 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.656 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 37.6 tp -57.46 -53.16 68.37 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.622 -0.263 . . . . 1.26 111.523 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 32.0 Cg_exo -58.58 -45.0 32.52 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.918 1.745 . . . . 0.59999999999999998 111.527 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.403 ' O ' HG23 ' B' ' 211' ' ' VAL . 69.8 t80 -61.72 -29.52 70.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.016 -0.538 . . . . 1.3999999999999999 110.234 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -76.83 -26.71 54.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 1.4099999999999999 110.222 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.503 ' HB2' HD12 ' B' ' 175' ' ' LEU . 45.7 t -87.81 -12.72 44.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.817 -0.629 . . . . 1.3200000000000001 110.373 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' LYR . . . . . 0.765 ' H9 ' H183 ' B' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.403 HG23 ' O ' ' B' ' 207' ' ' PHE . 57.3 t -80.16 -40.78 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.004 -0.544 . . . . 1.6899999999999999 111.258 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.18 -35.94 86.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.846 -0.693 . . . . 0.79000000000000004 112.785 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -71.86 -29.17 64.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.301 . . . . 2.96 110.983 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.86 -60.77 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.29 110.918 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -61.87 -30.3 70.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 3.1499999999999999 110.98 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -38.45 89.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.51 110.963 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.58 -30.77 69.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 2.1899999999999999 110.831 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.92 -58.69 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 1.98 111.018 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -66.35 -20.49 66.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 2.1699999999999999 111.036 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.15 -57.65 18.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.8 -0.714 . . . . 1.3600000000000001 112.962 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . 0.538 HD22 ' HE ' ' B' ' 30' ' ' ARG . 23.3 tp -85.23 -56.11 3.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.581 0.229 . . . . 2.8999999999999999 111.27 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' B' ' 222' ' ' ARG . 4.8 mmp_? 57.38 88.5 0.05 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.352 -0.386 . . . . 5.6100000000000003 110.923 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . 0.623 HD21 ' HA ' ' B' ' 30' ' ' ARG . 7.4 p30 -140.43 168.43 19.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 4.04 110.767 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 97.5 mt -133.24 98.49 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 6.2999999999999998 111.088 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.53 HD21 ' H ' ' B' ' 228' ' ' ARG . 2.9 t-20 -102.55 122.59 44.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.076 -0.511 . . . . 4.7999999999999998 110.711 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -116.54 -44.59 2.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 6.3899999999999997 111.158 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.4 m -160.49 39.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 5.6100000000000003 111.154 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.53 ' H ' HD21 ' B' ' 225' ' ' ASN . 40.4 ttm180 -92.74 -63.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 8.1999999999999993 110.547 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . 0.505 HE21 ' HG2' ' B' ' 228' ' ' ARG . 28.6 mm-40 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 8.1699999999999999 110.652 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.792 0.329 . . . . 5.6200000000000001 110.855 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -127.5 121.1 29.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 5.2800000000000002 110.908 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 27.4 tp -164.69 131.53 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 6.0499999999999998 110.457 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -121.15 122.53 40.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.856 0.36 . . . . 4.79 111.382 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 46.1 t -92.41 120.25 32.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 2.71 110.79 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -84.29 -6.36 59.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 2.52 111.432 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . 0.449 HD22 ' N ' ' C' ' 7' ' ' LEU . 3.1 mm? -69.37 -42.1 75.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 1.9299999999999999 110.684 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.608 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 42.4 m80 -72.22 -27.47 62.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 1.26 110.806 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -70.4 -43.87 69.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.521 . . . . 1.6699999999999999 110.928 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.74 -21.47 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 1.8700000000000001 110.661 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -64.41 -53.31 50.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 1.4399999999999999 110.704 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.26 -34.12 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.46999999999999997 111.216 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.66 96.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.58999999999999997 111.224 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.91 76.52 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.5 112.589 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 20.7 mmt -74.77 -36.86 62.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.56 0.219 . . . . 0.68000000000000005 111.477 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 71.7 p -64.35 -52.27 59.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 1.3999999999999999 110.828 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.3 -22.55 31.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 1.55 110.873 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.98 -55.64 27.03 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.783 -0.723 . . . . 0.70999999999999996 112.372 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -34.72 72.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.74 0.305 . . . . 0.77000000000000002 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 26.6 tp -62.43 -35.14 78.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.167 -0.47 . . . . 1.9299999999999999 110.771 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -57.16 -28.96 63.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 1.8600000000000001 110.817 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -74.17 -37.5 63.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.01 -0.541 . . . . 4.1399999999999997 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -56.3 -32.64 64.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 3.1499999999999999 110.689 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -81.07 -32.27 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 1.95 111.313 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.2 mt -86.42 -1.26 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.532 -0.303 . . . . 2.2200000000000002 111.531 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 92.8 p -62.84 -20.12 64.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.487 -0.324 . . . . 1.3700000000000001 111.15 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -48.71 -33.22 9.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.329 0.585 . . . . 5.0300000000000002 109.687 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.502 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.2 p-10 -174.99 131.77 0.45 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.08 -0.964 . . . . 2.3700000000000001 109.884 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 9.6 Cg_endo -90.83 -169.64 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.012 2.475 . . . . 2.0499999999999998 112.373 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -89.88 35.24 0.84 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 4.5199999999999996 110.9 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.8 -46.21 1.43 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.757 -0.735 . . . . 2.1600000000000001 112.758 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' C' ' 33' ' ' PRO . 13.7 m -77.35 134.55 66.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.777 0.322 . . . . 2.5299999999999998 110.836 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' C' ' 35' ' ' TYR . 31.8 Cg_exo -60.5 168.1 7.14 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.712 2.275 . . . . 1.9299999999999999 112.45 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -41.27 -16.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.99 -1.005 . . . . 4.1200000000000001 113.661 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' C' ' 33' ' ' PRO . 3.2 m-30 -39.75 -62.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.924 0.392 . . . . 2.8900000000000001 111.539 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.08 -40.67 77.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 2.46 111.449 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -72.02 -18.57 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 2.7799999999999998 111.715 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.37 -45.69 68.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.915 0.388 . . . . 1.6200000000000001 110.146 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.605 HG13 HD12 ' C' ' 82' ' ' LEU . 58.2 t -75.19 -33.25 28.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 1.5900000000000001 110.788 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.38 -15.08 61.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.65000000000000002 111.511 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.407 ' O ' HG12 ' C' ' 45' ' ' ILE . 51.9 ttp -89.57 -37.84 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.45 -0.341 . . . . 1.6699999999999999 111.623 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -72.61 -37.99 67.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 3.4199999999999999 112.064 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.505 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -53.71 -52.5 66.78 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 112.215 0.45 . . . . 0.89000000000000001 112.215 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 40.7 Cg_endo -67.55 -42.19 7.47 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.213 1.942 . . . . 0.40999999999999998 113.1 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.407 HG12 ' O ' ' C' ' 41' ' ' MET . 37.4 mm -55.88 -62.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.6 0.238 . . . . 1.76 111.518 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -57.32 -58.19 9.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.396 -0.365 . . . . 2.1600000000000001 111.29 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 56.7 m -53.26 -26.76 19.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 1.1699999999999999 111.493 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.81 -61.46 6.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.688 -0.768 . . . . 0.44 112.47 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.91 -25.29 63.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.683 0.278 . . . . 1.29 111.298 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -59.26 4.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.944 0.402 . . . . 0.5 111.027 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.503 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 25.7 m-85 -62.52 -41.54 98.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 1.8300000000000001 111.092 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 55.0 ttp -47.93 -39.09 18.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.087 0.47 . . . . 1.47 110.104 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.66 88.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.763 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.1 mtt -52.45 -30.98 32.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.851 -0.613 . . . . 0.83999999999999997 110.138 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.29 -38.43 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.874 -0.603 . . . . 0.65000000000000002 110.238 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mt -77.53 0.34 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.755 -0.657 . . . . 1.55 110.657 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 68.33 42.28 1.69 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.795 -0.638 . . . . 1.54 111.155 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.48 ' HB3' ' HE1' ' A' ' 131' ' ' TRP . 27.6 mm-40 -118.25 173.51 6.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.819 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.46 16.76 67.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 0.93999999999999995 112.371 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' C' ' 69' ' ' HIS . 36.6 mtmm -136.41 150.9 48.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 2.3599999999999999 110.783 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.29 143.44 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.97 111.082 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.26 89.63 6.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 2.4399999999999999 110.989 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.48 139.68 51.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 1.54 111.038 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.75 15.33 4.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.07 -0.514 . . . . 1.71 111.453 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.13 66.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.795 -0.717 . . . . 1.53 112.691 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -105.44 150.69 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 2.23 111.174 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 11.4 pt -97.12 125.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.545 . . . . 1.3600000000000001 111.074 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.69 123.87 48.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.78000000000000003 110.882 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.573 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 31.9 m-70 -81.07 76.44 8.02 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.35 0.595 . . . . 1.0800000000000001 111.052 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . 0.433 ' HD2' ' HH ' ' C' ' 73' ' ' TYR . 83.8 t80 -57.41 -36.44 71.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.376 -0.829 . . . . 2.2999999999999998 111.544 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -76.37 -26.3 55.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.214 0.449 . . . . 0.75 112.214 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 23.9 tpp180 -64.19 -51.56 63.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.531 0.567 . . . . 1.51 112.531 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.537 ' O ' ' HG3' ' C' ' 77' ' ' MET . 24.2 p90 -86.44 -26.45 24.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.515 0.561 . . . . 4.6500000000000004 112.515 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.0 tp -56.86 -41.58 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.375 -0.53 . . . . 1.22 110.272 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.52 -16.7 62.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.266 -0.642 . . . . 1.3100000000000001 109.266 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . 0.437 ' O ' HD12 ' C' ' 113' ' ' ILE . 45.8 m0 -88.54 2.77 52.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.315 -0.857 . . . . 1.6799999999999999 111.439 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 39.3 mtp -105.09 -20.51 13.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.168 -0.469 . . . . 1.8 111.245 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.463 ' O ' HD23 ' C' ' 82' ' ' LEU . 14.5 m -113.77 -39.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.3 0.482 . . . . 1.1899999999999999 112.3 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.505 HG23 HG23 ' C' ' 43' ' ' ILE . 57.0 m -70.34 -49.17 52.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.046 0.387 . . . . 1.23 112.046 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 21.5 m -56.52 -52.08 76.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 0.58999999999999997 112.614 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 80' ' ' THR . 11.7 Cg_endo -55.78 -37.53 95.53 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.53 1.487 . . . . 0.67000000000000004 111.736 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.605 HD12 HG13 ' C' ' 39' ' ' VAL . 3.9 mm? -70.33 -32.21 69.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.95999999999999996 109.746 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.21 -23.28 63.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.488 0.661 . . . . 1.1899999999999999 109.23 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 tp -84.46 -36.51 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.984 -1.007 . . . . 1.7 110.414 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.83 -34.37 73.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 1.6200000000000001 110.94 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -62.41 -18.52 61.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 1.26 111.081 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 24.0 mt -78.93 -31.88 45.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 1.1100000000000001 111.027 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -73.63 -32.23 63.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 1.51 111.076 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -75.1 -42.04 57.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 2.0600000000000001 111.438 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -69.17 -22.44 63.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 1.52 111.001 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.05 -13.87 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 1.3 111.213 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.3 ttm -128.71 100.94 5.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 1.6200000000000001 110.742 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -68.4 -54.47 16.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 3.2400000000000002 111.053 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -112.52 149.85 32.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 4.6299999999999999 111.179 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.86 145.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.163 -0.471 . . . . 2.1800000000000002 110.723 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -124.8 -71.46 0.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.303 -0.408 . . . . 4.1200000000000001 111.432 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -140.47 29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.501 -0.318 . . . . 4.96 111.591 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -86.92 138.94 31.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.431 -0.35 . . . . 3.9100000000000001 110.876 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -165.84 -22.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 5.21 110.686 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -70.46 -35.09 73.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.979 -0.555 . . . . 1.8200000000000001 111.591 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.59 -42.46 42.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.533 -0.303 . . . . 2.0800000000000001 110.949 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 70.0 mt -60.91 -31.21 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 1.8600000000000001 110.711 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.62 -29.04 45.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.84 -0.695 . . . . 0.58999999999999997 112.346 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -65.76 -35.36 80.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 1.53 110.83 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 75.1 mt -79.53 -44.98 20.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.994 -0.548 . . . . 1.1100000000000001 111.107 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 10.7 tpt -59.62 -35.91 75.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 2.21 111.328 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.7 m -71.81 -58.3 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 1.28 111.283 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 57.6 p -52.41 -31.02 32.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 1.22 111.163 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.481 ' O ' HG12 ' C' ' 113' ' ' ILE . 6.5 tp-100 -62.48 -54.13 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 2.3300000000000001 110.556 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -46.78 -39.94 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 115.93 -0.577 . . . . 1.29 111.316 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.78 -46.92 90.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.0600000000000001 110.855 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.484 HG11 H193 ' C' ' 210' ' ' LYR . 57.0 t -66.59 -32.33 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.51000000000000001 111.156 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.481 HG12 ' O ' ' C' ' 109' ' ' GLN . 44.8 mm -59.23 -41.3 83.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 1.3700000000000001 110.671 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 93.9 m -62.26 -54.63 38.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.833 -0.621 . . . . 0.77000000000000002 111.296 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 78.7 p -54.82 -24.26 22.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 110.899 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.87 -46.9 12.64 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.811 -0.709 . . . . 0.5 112.673 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' C' ' 114' ' ' THR . 4.3 pp -76.79 -21.24 55.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.716 0.293 . . . . 1.47 111.011 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 38.2 mm -83.37 -36.92 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 1.2 111.205 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.95 -32.55 61.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.40000000000000002 111.327 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.39 -23.66 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 2.1200000000000001 110.977 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.14 34.14 0.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.377 -0.374 . . . . 0.75 111.254 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 71.2 m -91.86 119.05 31.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 1.3799999999999999 110.776 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.22 -58.29 2.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 2.7400000000000002 111.137 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.483 ' HB2' HG12 ' C' ' 127' ' ' VAL . 45.4 mtm180 -89.48 157.61 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 2.7999999999999998 110.965 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -84.54 -15.88 44.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.885 -0.598 . . . . 2.4100000000000001 110.88 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 37.6 t-105 -78.74 -38.75 38.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 4.2000000000000002 110.66 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' C' ' 124' ' ' ARG . 7.4 p -80.83 -28.78 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 1.0800000000000001 111.241 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -56.13 -34.61 66.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 2.5699999999999998 111.281 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -73.68 -25.61 60.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 3.8100000000000001 111.019 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.22 -46.1 24.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 1.4199999999999999 110.968 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -64.65 -37.4 87.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.89000000000000001 111.178 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -55.4 -46.67 76.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 1.26 110.906 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.3 -35.08 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 1.6799999999999999 110.865 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 52.7 t -64.53 -31.27 72.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.842 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.83 -54.02 13.55 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.736 -0.745 . . . . 0.54000000000000004 112.635 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.45 -37.96 76.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 1.0600000000000001 111.257 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 53.8 t -52.79 -52.44 56.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 1.0800000000000001 110.626 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.9 -30.81 71.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.56999999999999995 110.891 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -69.58 -24.53 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 1.6799999999999999 110.932 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.76 -52.91 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 1.7 111.491 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.439 HG13 ' N ' ' C' ' 142' ' ' ILE . 24.6 pt -60.31 -43.99 94.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.528 -0.305 . . . . 0.78000000000000003 111.763 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.439 ' N ' HG13 ' C' ' 141' ' ' ILE . 43.4 pt -67.4 -29.84 47.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 2.2400000000000002 110.957 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.12 -38.31 85.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.02 111.018 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . 0.541 ' O ' ' ND2' ' C' ' 148' ' ' ASN . 91.8 m95 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 3.0 110.835 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . 1.311 ' HA2' ' ND2' ' C' ' 148' ' ' ASN . . . -61.07 -44.52 98.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.899 -0.667 . . . . 1.27 112.532 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' C' ' 149' ' ' PRO . 69.7 mt -66.22 -24.08 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.8899999999999999 110.758 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -88.8 4.74 46.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.867 -0.606 . . . . 1.6000000000000001 111.134 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 1.311 ' ND2' ' HA2' ' C' ' 145' ' ' GLY . 69.1 m-80 -83.2 -46.78 0.82 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.143 -0.48 . . . . 99.989999999999995 112.116 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' C' ' 148' ' ' ASN . 80.6 Cg_exo -45.46 -23.99 1.56 Allowed 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.591 2.194 . . . . 2.73 112.845 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.02 -58.11 9.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.388 -0.369 . . . . 4.2999999999999998 110.604 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 59.45 104.76 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.064 -0.516 . . . . 8.9000000000000004 111.295 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.36 -21.56 63.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 2.7999999999999998 111.051 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -83.29 -13.75 54.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.073 -0.512 . . . . 5.4400000000000004 110.976 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 34.3 m -95.75 -18.48 20.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.293 -0.412 . . . . 3.3900000000000001 111.368 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -64.75 -21.14 66.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 6.9199999999999999 110.999 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 64.8 p -88.51 7.23 34.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 4.8700000000000001 111.182 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -106.62 -68.63 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 4.0499999999999998 110.672 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 51.4 m -115.46 113.67 24.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.758 -0.655 . . . . 3.0299999999999998 110.555 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.6 p -76.63 -22.77 53.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 2.96 111.179 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -76.79 -54.41 6.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 3.7400000000000002 111.036 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 77.2 mt -63.05 -30.74 71.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 2.6499999999999999 110.951 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.77 -62.46 1.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 1.77 111.432 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.79 -22.82 26.42 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 2.96 110.616 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.7 tp -67.76 -44.35 77.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 2.3500000000000001 110.704 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -81.38 -25.63 36.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 2.6200000000000001 111.045 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.01 -55.24 31.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 2.0899999999999999 111.162 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -72.07 -32.75 67.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 3.2400000000000002 111.339 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.25 -50.79 72.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 1.6899999999999999 111.276 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.06 -29.93 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 1.3999999999999999 111.264 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -53.29 -58.74 6.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.95999999999999996 111.315 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -63.29 -36.15 82.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 3.6499999999999999 110.701 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -65.6 -22.59 66.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 1.3700000000000001 110.761 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 25.9 m -73.48 -59.0 2.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 1.4299999999999999 111.358 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.6 p -52.39 -30.82 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.394 -0.366 . . . . 1.6200000000000001 111.642 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.405 HD13 ' OG ' ' C' ' 209' ' ' SER . 94.7 mt -72.38 -57.78 3.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 2.0299999999999998 111.071 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -19.79 65.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.62 111.04 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.49 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 32.6 mm -87.66 -25.4 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.114 0.483 . . . . 1.5800000000000001 110.36 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . 0.48 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -65.76 -40.54 95.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.56000000000000005 112.505 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.465 ' O ' HG22 ' C' ' 182' ' ' VAL . 0.3 OUTLIER -55.7 -55.72 37.63 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.592 0.196 . . . . 1.3300000000000001 111.356 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' C' ' 177' ' ' ILE . 67.2 Cg_exo -50.38 -41.06 52.74 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.074 1.849 . . . . 0.63 112.163 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.48 HD12 ' HA2' ' C' ' 178' ' ' GLY . 82.1 mt -49.69 -61.16 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.137 -0.483 . . . . 0.93000000000000005 111.493 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.465 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.2 m -63.92 -28.15 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 1.27 111.446 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . 0.464 ' HZ3' ' HB2' ' C' ' 188' ' ' SER . 20.5 m95 -65.36 -27.83 68.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 1.77 111.053 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.424 HG13 ' O ' ' C' ' 180' ' ' PRO . 89.2 mt -55.15 -32.93 28.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 2.3900000000000001 111.209 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.62 169.98 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 1.95 111.132 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.16 -161.5 31.63 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 1.8799999999999999 112.457 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.05 158.32 23.74 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.562 2.175 . . . . 3.1200000000000001 112.225 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . 0.464 ' HB2' ' HZ3' ' C' ' 183' ' ' TRP . 54.8 m 56.95 20.68 5.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.091 -0.504 . . . . 2.6299999999999999 110.825 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -169.3 48.33 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.879 -0.677 . . . . 3.04 112.364 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 60.0 t80 60.66 98.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.876 0.369 . . . . 5.6900000000000004 110.908 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 152.44 117.71 0.73 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 3.0800000000000001 112.393 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -86.26 49.31 1.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.799 0.333 . . . . 7.5300000000000002 110.797 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 43.3 mm -124.97 142.99 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 2.8599999999999999 110.96 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . 0.467 HD22 ' N ' ' C' ' 195' ' ' GLN . 0.2 OUTLIER -143.22 -100.47 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.329 -0.396 . . . . 3.6899999999999999 110.878 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . 0.467 ' N ' HD22 ' C' ' 194' ' ' ASN . 96.9 mt-30 57.63 -178.56 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.828 0.347 . . . . 5.4800000000000004 111.609 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 81.8 p -74.25 -25.51 59.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 2.3799999999999999 111.302 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' C' ' 195' ' ' GLN . 12.4 tt -57.89 -42.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 2.23 111.743 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.4 -53.75 54.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.702 0.287 . . . . 2.1600000000000001 111.401 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 59.4 p -58.81 -21.55 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 1.27 111.613 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -73.35 -39.29 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 1.7 111.489 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.89 -51.56 46.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.695 0.283 . . . . 2.02 111.414 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -67.59 -8.15 32.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.531 -0.304 . . . . 1.8200000000000001 111.313 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 10.9 t -95.86 -41.98 8.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.151 0.5 . . . . 1.3500000000000001 110.666 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.7 tp -74.19 -31.99 62.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.65000000000000002 111.904 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.645 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 54.9 tp -61.0 -54.22 56.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.891 -0.324 . . . . 1.4199999999999999 111.624 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 33.7 Cg_exo -59.45 -39.64 74.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.795 1.663 . . . . 0.63 111.189 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.68 -28.72 70.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 1.49 110.464 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -84.45 -19.49 33.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.949 -0.568 . . . . 1.7 110.82 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . 0.405 ' OG ' HD13 ' C' ' 175' ' ' LEU . 40.6 t -88.29 -12.37 43.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.995 -0.548 . . . . 1.25 110.898 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' LYR . . . . . 0.745 H192 ' H9 ' ' C' ' 210' ' ' LYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.19 -35.4 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.981 0.419 . . . . 1.6100000000000001 110.891 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.12 -29.52 72.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.998 -0.62 . . . . 0.81999999999999995 112.535 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -72.6 -36.87 68.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 3.0800000000000001 110.817 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.0 t -59.16 -54.66 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 1.1499999999999999 110.89 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.14 -20.42 65.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.314 -0.403 . . . . 2.5600000000000001 110.856 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.3 tt -72.08 -47.1 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 1.29 110.695 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.21 -21.01 64.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 2.3900000000000001 110.573 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 64.2 tp -74.14 -54.31 8.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.887 -0.597 . . . . 2.0299999999999998 111.266 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -79.41 -20.29 47.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 3.21 111.234 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.88 12.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.737 -0.744 . . . . 1.3600000000000001 112.585 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . 0.44 HD22 ' N ' ' C' ' 221' ' ' LEU . 3.7 mm? -80.51 -56.67 4.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 2.8999999999999999 110.435 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 54.46 77.97 0.18 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.023 -0.535 . . . . 4.8899999999999997 110.974 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -131.82 168.84 17.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.114 -0.494 . . . . 4.2300000000000004 110.879 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 52.2 tp -130.62 105.31 7.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.029 -0.532 . . . . 6.1200000000000001 110.815 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -111.8 122.54 48.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 4.5499999999999998 111.009 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -111.51 -62.86 1.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 6.7800000000000002 110.727 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 33.1 t -131.51 -0.09 3.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 5.4000000000000004 110.65 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -95.42 87.73 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.552 . . . . 8.3300000000000001 110.842 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 7.9100000000000001 111.013 -179.987 . . . . . . . . 0 0 . 1 stop_ save_